Citrus Sinensis ID: 039957

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-
Protein Sequence
MTGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPDFKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE
Secondary Structure (PSIPRED)
cEEccccccccccccccEEcccccccEEccHHHHccccccEEEcccccccccccHHHHHccccccEEEccccEEEEcccHHHHcccccccEEcccccccccccccccccccccEEEcccccccccccccccccccHHHHcccccccEEcccccccccccHHHHHHHHcccEEEcccccccccccHHHHcccccccEEcccccccccccHHHHccccccccccccccccccccccccccccccHHHccccccEEEccccccccccccEEEcccccEEEEcccHHHHHHHHHHHHHcccccccccccccccccEEEEEEcccccccccHHHHHccccccccEEEEccccEEEEEEcccccEEEEEEEccccccccccHHHHHHHHcccccccccccHHcccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHcccccccccEEEccccccccccccccEEEEccccccccccc
Secondary Structure Prediction (SSPRO)
ccccccHHHccccccEEEEcccccccccccHHHcccccccEEEcccccccccccHHHHHHHccccEEEEccccccccccHHHccccccEEEEEccccccccccHHHccccccEEEEEccccccccccccccccccHHHccccccEEEEEccccccccccHHHHcccHHccEEEcccccccccccHHHcccccccEEEcEEccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHcccccEEEEEccccccccccHHHccccccEEEEEccccccccccHHHcccccHHEEEccccccccccccccccccEEEEEEEcccccccccccHHHHHHHHHHHHHHHHHHHccccccHcccccccHHHHHccccccccHHHHHHHHHHHHHHHHHHHcccccccEEcccccHHHEEEcccccEEEccccccHHccc
Coil and Loop (DISEMBL)
mtgqipteignlqnlkslflgannlsglippmifnISTIrnlnlggnrlsghlpsmighslpnikylelgdnnligtipnsiTNATKLIILDLgfntfsghipntfgnLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILsgnplggilppsignfstsLQRFSasecklkgtipkeiGHLRGLIYLSlgfndlngtiptsIGTLKQLqgfflpetnlqgyvphnlchLEMLNLLhlggnklsghippclasltslreldlgsnkltssipsslwsLGYILEINlssnllndslpsnvqkLKVLRVLDLSrnqlsgdipstiGALVDLETISLAgsfgsvykgtisdgTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILsscstpdfkfmpngslekrlyshNYFLDILERLNIMIDVGStleylhhghssapiihcdlkptsilldenmvahvsdfgiskllge
Flexible Loop (DISEMBL)
MTGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKIlsscstpdfKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE
Low Complexity Region (SEG)
MTGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPhnlchlemlnllhlggnKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEInlssnllndslpsnVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPDFKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE
Disordered region (IsUnstruct)
********IGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPDFKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGIS*****
Disordered Region (DISOPRED)
MTGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLN**********KVLRVLDLSRNQLSGDIPSTIGALVDLETISLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPDFKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE
Disordered Region (DISEMBL)
MTGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPDFKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE
Disordered Region (DISPRO)
*TGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPDFKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MTGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPDFKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	481	2.2.26 [Sep-21-2011]
C0LGP4	1010	Probable LRR receptor-lik	yes	no	0.910	0.433	0.332	2e-57
C0LGT6	1031	LRR receptor-like serine/	no	no	0.954	0.445	0.319	1e-54
Q9SD62	1025	Putative receptor-like pr	no	no	0.945	0.443	0.330	3e-49
Q9ZUI0	980	Putative leucine-rich rep	no	no	0.948	0.465	0.334	1e-48
C0LGS2	1136	Probable LRR receptor-lik	no	no	0.735	0.311	0.361	6e-47
Q9FIZ3	1252	LRR receptor-like serine/	no	no	0.690	0.265	0.367	1e-45
Q9SGP2	996	Receptor-like protein kin	no	no	0.964	0.465	0.291	4e-45
Q9FL28	1173	LRR receptor-like serine/	no	no	0.968	0.397	0.296	1e-44
Q9LHP4	1141	Receptor-like protein kin	no	no	0.692	0.291	0.349	3e-44
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.690	0.265	0.361	5e-44

>sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1

 Score =  223 bits (569), Expect = 2e-57,   Method: Compositional matrix adjust.
 Identities = 169/509 (33%), Positives = 265/509 (52%), Gaps = 71/509 (13%)

Query: 1   MTGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHS 60
           ++G +PT +G L NL+ L L +N LSG IP  I N++ +  L+L  N   G +P+ +G+ 
Sbjct: 397 LSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETLDLSNNGFEGIVPTSLGNC 456

Query: 61  LPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMN 120
             ++  L +GDN L GTIP  I    +L+ LD+  N+  G +P   G L++L  LSL  N
Sbjct: 457 -SHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLIGSLPQDIGALQNLGTLSLGDN 515

Query: 121 NLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLK 180
            L+ +           +L NC  +  L L GN   G +P   G     ++    S   L 
Sbjct: 516 KLSGK--------LPQTLGNCLTMESLFLEGNLFYGDIPDLKG--LVGVKEVDLSNNDLS 565

Query: 181 GTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEM 240
           G+IP+       L YL+L FN+L G +P        ++G F   T +     ++LC    
Sbjct: 566 GSIPEYFASFSKLEYLNLSFNNLEGKVP--------VKGIFENATTVSIVGNNDLC---- 613

Query: 241 LNLLHLGGNKLSGHIPPCLASLTSLREL---DLGSNKLTSSIPSSLWSLGYILEINL--- 294
                  G  +   + PCL+   S+ +     L    +  S+  +L  L ++  + L   
Sbjct: 614 -------GGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWL 666

Query: 295 ----SSNLLNDSLPSNVQKL-KVLRVLDLSRNQLSGDIPSTIGALVDLETISLAGSFGSV 349
                +   N+  PS ++ L + +   DL RN  +G   S +           +GSFG+V
Sbjct: 667 RKRKKNKETNNPTPSTLEVLHEKISYGDL-RNATNGFSSSNMVG---------SGSFGTV 716

Query: 350 YKGTI-SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPDFK---- 404
           YK  + ++   VA+K+ N+QR  A +SF +ECE L+++RH+NL+K+L++CS+ DF+    
Sbjct: 717 YKALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEF 776

Query: 405 ------FMPNGSLE--------KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPI 450
                 FMPNGSL+        + ++  +  L +LERLNI IDV S L+YLH  H   PI
Sbjct: 777 RALIYEFMPNGSLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHV-HCHEPI 835

Query: 451 IHCDLKPTSILLDENMVAHVSDFGISKLL 479
            HCDLKP+++LLD+++ AHVSDFG+++LL
Sbjct: 836 AHCDLKPSNVLLDDDLTAHVSDFGLARLL 864

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1

 Score =  214 bits (544), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 171/535 (31%), Positives = 256/535 (47%), Gaps = 76/535 (14%)

Query: 3   GQIPTEIGNLQN-LKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSL 61
           G++P  I NL   L SLFLG N +SG IP  I N+ +++ L+L  N LSG LP   G  L
Sbjct: 358 GELPASIANLSTTLTSLFLGQNLISGTIPHDIGNLVSLQELSLETNMLSGELPVSFGK-L 416

Query: 62  PNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNN 121
            N++ ++L  N + G IP+   N T+L  L L  N+F G IP + G  R+L  L +  N 
Sbjct: 417 LNLQVVDLYSNAISGEIPSYFGNMTRLQKLHLNSNSFHGRIPQSLGRCRYLLDLWMDTNR 476

Query: 122 LTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKG 181
           L          +    +     L Y+ LS N L G  P  +G     L    AS  KL G
Sbjct: 477 LNG--------TIPQEILQIPSLAYIDLSNNFLTGHFPEEVGKLEL-LVGLGASYNKLSG 527

Query: 182 TIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEML 241
            +P+ IG    + +L +  N  +G IP  I  L  L+       NL G +P  L  L  L
Sbjct: 528 KMPQAIGGCLSMEFLFMQGNSFDGAIP-DISRLVSLKNVDFSNNNLSGRIPRYLASLPSL 586

Query: 242 NLLHLGGNKLSGHIP-----------------------------PCLASLTSLRELDLG- 271
             L+L  NK  G +P                             PC+   +  +   L  
Sbjct: 587 RNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGVREMQLKPCIVQASPRKRKPLSV 646

Query: 272 SNKLTSSIPSSLWSLGYILEI--------NLSSNLLNDSLPSNVQKLKVLRVLDLSRNQL 323
             K+ S I   + SL  I+ +            N  +D  PS+   L +         ++
Sbjct: 647 RKKVVSGICIGIASLLLIIIVASLCWFMKRKKKNNASDGNPSDSTTLGMFH------EKV 700

Query: 324 SGDIPSTIGALVDLETISLAGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECEV 382
           S +   +  +      +  +G+FG+V+KG +  +   VA+K+ NL +  A +SF +ECE 
Sbjct: 701 SYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECET 760

Query: 383 LRNVRHQNLIKILSSCSTPD----------FKFMPNGSLE--------KRLYSHNYFLDI 424
            + +RH+NL+K+++ CS+ D          ++FMP GSL+        +R+  H+  L  
Sbjct: 761 FKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSLTP 820

Query: 425 LERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
            E+LNI IDV S LEYLH  H   P+ HCD+KP++ILLD+++ AHVSDFG+++LL
Sbjct: 821 AEKLNIAIDVASALEYLHV-HCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLL 874

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1

 Score =  196 bits (498), Expect = 3e-49,   Method: Compositional matrix adjust.
 Identities = 171/517 (33%), Positives = 263/517 (50%), Gaps = 62/517 (11%)

Query: 1   MTGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHS 60
           ++G IP  IGNL +L++L LG N L+G +PP +  +S +R + L  N LSG +PS +G+ 
Sbjct: 389 ISGSIPHGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGN- 447

Query: 61  LPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMN 120
           +  + YL L +N+  G+IP+S+ + + L+ L+LG N  +G IP+    L  L VL++  N
Sbjct: 448 ISGLTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSFN 507

Query: 121 NLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLK 180
            L               +   ++L+ L +S N L G +P ++ N   SL+          
Sbjct: 508 LLVGP--------LRQDIGKLKFLLALDVSYNKLSGQIPQTLAN-CLSLEFLLLQGNSFV 558

Query: 181 GTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVP-----HNL 235
           G IP +I  L GL +L L  N+L+GTIP  +    +LQ   L   N  G VP      N 
Sbjct: 559 GPIP-DIRGLTGLRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNT 617

Query: 236 CHLEMLNLLHLGGNKLSGHIPPCLASL----TSLREL--------DLGSNKLTSSIPSSL 283
             + +   ++L G   S  + PC   L    +S+R++              L   +    
Sbjct: 618 SAMSVFGNINLCGGIPSLQLQPCSVELPRRHSSVRKIITICVSAVMAALLLLCLCVVYLC 677

Query: 284 WSLGYILEIN--LSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETIS 341
           W   Y L +    ++N  ND   S V+        D        ++  T G       I 
Sbjct: 678 W---YKLRVKSVRANNNENDRSFSPVKSFYEKISYD--------ELYKTTGGFSSSNLIG 726

Query: 342 LAGSFGSVYKGTI-SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCST 400
            +G+FG+V+KG + S    VAIK+ NL +  A +SF +ECE L  +RH+NL+K+++ CS+
Sbjct: 727 -SGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSS 785

Query: 401 PDFK----------FMPNGSLEKRLYSH--------NYFLDILERLNIMIDVGSTLEYLH 442
            DF+          FMPNG+L+  L+          +  L +  RLNI IDV S L YLH
Sbjct: 786 SDFEGNDFRALVYEFMPNGNLDMWLHPDEIEETGNPSRTLGLFARLNIAIDVASALVYLH 845

Query: 443 HGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
             +   PI HCD+KP++ILLD+++ AHVSDFG+++LL
Sbjct: 846 T-YCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLL 881

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1

 Score =  194 bits (494), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 167/500 (33%), Positives = 243/500 (48%), Gaps = 44/500 (8%)

Query: 3   GQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLP 62
           G IP E+  L  L+ ++L  N+L+G IP  + +I  +  L++  N LSG +P   G+ L 
Sbjct: 335 GPIPRELCKLSKLERVYLSNNHLTGEIPMELGDIPRLGLLDVSRNNLSGSIPDSFGN-LS 393

Query: 63  NIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIP-NTFGNLRHLSV-LSLLMN 120
            ++ L L  N+L GT+P S+     L ILDL  N  +G IP     NLR+L + L+L  N
Sbjct: 394 QLRRLLLYGNHLSGTVPQSLGKCINLEILDLSHNNLTGTIPVEVVSNLRNLKLYLNLSSN 453

Query: 121 NLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLK 180
           +L+              L+    ++ + LS N L G +PP +G+   +L+  + S     
Sbjct: 454 HLSG--------PIPLELSKMDMVLSVDLSSNELSGKIPPQLGS-CIALEHLNLSRNGFS 504

Query: 181 GTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEM 240
            T+P  +G L  L  L + FN L G IP S      L+        L G V       ++
Sbjct: 505 STLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHLNFSFNLLSGNVSDKGSFSKL 564

Query: 241 LNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSS-LWSLGY--ILEINLSSN 297
                LG + L G I    A     +   +    L S I +  L   GY  +       N
Sbjct: 565 TIESFLGDSLLCGSIKGMQACKKKHKYPSVLLPVLLSLIATPVLCVFGYPLVQRSRFGKN 624

Query: 298 L-------LNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAGS--FGS 348
           L       + D    N    K  R+   S  QL       I A       SL GS  FG 
Sbjct: 625 LTVYAKEEVEDEEKQNQNDPKYPRI---SYQQL-------IAATGGFNASSLIGSGRFGH 674

Query: 349 VYKGTISDGTDVAIKIFNLQRERAFR-SFNSECEVLRNVRHQNLIKILSSCSTPDFK--- 404
           VYKG + + T VA+K+ + +    F  SF  EC++L+  RH+NLI+I+++CS P F    
Sbjct: 675 VYKGVLRNNTKVAVKVLDPKTALEFSGSFKRECQILKRTRHRNLIRIITTCSKPGFNALV 734

Query: 405 --FMPNGSLEKRLYSHNYF---LDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTS 459
              MPNGSLE+ LY   Y    LD+++ +NI  DV   + YLHH +S   ++HCDLKP++
Sbjct: 735 LPLMPNGSLERHLYPGEYSSKNLDLIQLVNICSDVAEGIAYLHH-YSPVKVVHCDLKPSN 793

Query: 460 ILLDENMVAHVSDFGISKLL 479
           ILLD+ M A V+DFGIS+L+
Sbjct: 794 ILLDDEMTALVTDFGISRLV 813

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGS2|Y4361_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g36180 OS=Arabidopsis thaliana GN=At4g36180 PE=1 SV=1

 Score =  188 bits (478), Expect = 6e-47,   Method: Compositional matrix adjust.
 Identities = 134/371 (36%), Positives = 201/371 (54%), Gaps = 17/371 (4%)

Query: 1   MTGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHS 60
           +TG+IP  +GNLQ+L+ L+L  N L G +P  I N S++ +L+   N + G +P+  G +
Sbjct: 198 LTGEIPASLGNLQSLQYLWLDFNLLQGTLPSAISNCSSLVHLSASENEIGGVIPAAYG-A 256

Query: 61  LPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHI-PNTFGNLRH-LSVLSLL 118
           LP ++ L L +NN  GT+P S+   T L I+ LGFN FS  + P T  N R  L VL L 
Sbjct: 257 LPKLEVLSLSNNNFSGTVPFSLFCNTSLTIVQLGFNAFSDIVRPETTANCRTGLQVLDLQ 316

Query: 119 MNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECK 178
            N ++          F   LTN   L  L +SGN   G +PP IGN    L+    +   
Sbjct: 317 ENRISGR--------FPLWLTNILSLKNLDVSGNLFSGEIPPDIGNLK-RLEELKLANNS 367

Query: 179 LKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHL 238
           L G IP EI     L  L    N L G IP  +G +K L+   L   +  GYVP ++ +L
Sbjct: 368 LTGEIPVEIKQCGSLDVLDFEGNSLKGQIPEFLGYMKALKVLSLGRNSFSGYVPSSMVNL 427

Query: 239 EMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNL 298
           + L  L+LG N L+G  P  L +LTSL ELDL  N+ + ++P S+ +L  +  +NLS N 
Sbjct: 428 QQLERLNLGENNLNGSFPVELMALTSLSELDLSGNRFSGAVPVSISNLSNLSFLNLSGNG 487

Query: 299 LNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAGSFGSVYKGTISDGT 358
            +  +P++V  L  L  LDLS+  +SG++P  +  L +++ I+L    G+ + G + +G 
Sbjct: 488 FSGEIPASVGNLFKLTALDLSKQNMSGEVPVELSGLPNVQVIALQ---GNNFSGVVPEGF 544

Query: 359 D--VAIKIFNL 367
              V+++  NL
Sbjct: 545 SSLVSLRYVNL 555

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2

 Score =  184 bits (468), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 126/343 (36%), Positives = 181/343 (52%), Gaps = 11/343 (3%)

Query: 1   MTGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHS 60
           + G++P EIG L  L+ ++L  N  SG +P  I N + ++ ++  GNRLSG +PS IG  
Sbjct: 421 LEGKVPKEIGFLGKLEIMYLYENRFSGEMPVEIGNCTRLQEIDWYGNRLSGEIPSSIGR- 479

Query: 61  LPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMN 120
           L ++  L L +N L+G IP S+ N  ++ ++DL  N  SG IP++FG L  L +  +  N
Sbjct: 480 LKDLTRLHLRENELVGNIPASLGNCHQMTVIDLADNQLSGSIPSSFGFLTALELFMIYNN 539

Query: 121 NLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLK 180
           +L        Q +   SL N + L  +  S N   G + P  G  S+S   F  +E   +
Sbjct: 540 SL--------QGNLPDSLINLKNLTRINFSSNKFNGSISPLCG--SSSYLSFDVTENGFE 589

Query: 181 GTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEM 240
           G IP E+G    L  L LG N   G IP + G + +L    +   +L G +P  L   + 
Sbjct: 590 GDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIPVELGLCKK 649

Query: 241 LNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLN 300
           L  + L  N LSG IP  L  L  L EL L SNK   S+P+ ++SL  IL + L  N LN
Sbjct: 650 LTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLN 709

Query: 301 DSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLA 343
            S+P  +  L+ L  L+L  NQLSG +PSTIG L  L  + L+
Sbjct: 710 GSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRLS 752

Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SGP2|HSL1_ARATH Receptor-like protein kinase HSL1 OS=Arabidopsis thaliana GN=HSL1 PE=2 SV=1

 Score =  182 bits (463), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 164/563 (29%), Positives = 255/563 (45%), Gaps = 99/563 (17%)

Query: 1   MTGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHS 60
           +TG+IP E+  +  L+SL L  NNL G +P  I     +  + + GNRL+G LP  +G +
Sbjct: 289 LTGKIPDELCRVP-LESLNLYENNLEGELPASIALSPNLYEIRIFGNRLTGGLPKDLGLN 347

Query: 61  LPNIKYLEL------GD------------------NNLIGTIPNSITNATKLIILDLGFN 96
            P +++L++      GD                  N+  G IP S+ +   L  + L +N
Sbjct: 348 SP-LRWLDVSENEFSGDLPADLCAKGELEELLIIHNSFSGVIPESLADCRSLTRIRLAYN 406

Query: 97  TFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGG 156
            FSG +P  F  L H+++L L+ N+ + E S         S+     L  LILS N   G
Sbjct: 407 RFSGSVPTGFWGLPHVNLLELVNNSFSGEISK--------SIGGASNLSLLILSNNEFTG 458

Query: 157 ILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQ 216
            LP  IG+   +L + SAS  K  G++P  +  L  L  L L  N  +G + + I + K+
Sbjct: 459 SLPEEIGSLD-NLNQLSASGNKFSGSLPDSLMSLGELGTLDLHGNQFSGELTSGIKSWKK 517

Query: 217 LQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLT 276
           L    L +    G +P  +  L +LN L L GN  SG IP  L SL  L +L+L  N+L+
Sbjct: 518 LNELNLADNEFTGKIPDEIGSLSVLNYLDLSGNMFSGKIPVSLQSL-KLNQLNLSYNRLS 576

Query: 277 S----SIPSSLWSLGYILEINLSSNLLNDSLPSNVQK----------------------- 309
                S+   ++   +I    L  ++       N  K                       
Sbjct: 577 GDLPPSLAKDMYKNSFIGNPGLCGDIKGLCGSENEAKKRGYVWLLRSIFVLAAMVLLAGV 636

Query: 310 ---------LKVLRVLDLSRNQLS-----GDIPSTIGALVDLETISLAGSFGSVYKGTIS 355
                     K  R ++ S+  L      G     I   +D + +  AG+ G VYK  ++
Sbjct: 637 AWFYFKYRTFKKARAMERSKWTLMSFHKLGFSEHEILESLDEDNVIGAGASGKVYKVVLT 696

Query: 356 DGTDVAIKIF---------NLQRERAFR------SFNSECEVLRNVRHQNLIKILSSCST 400
           +G  VA+K           +   E+ ++      +F +E E L  +RH+N++K+   CST
Sbjct: 697 NGETVAVKRLWTGSVKETGDCDPEKGYKPGVQDEAFEAEVETLGKIRHKNIVKLWCCCST 756

Query: 401 PD-----FKFMPNGSLEKRLYS-HNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
            D     +++MPNGSL   L+S     L    R  I++D    L YLHH  S  PI+H D
Sbjct: 757 RDCKLLVYEYMPNGSLGDLLHSSKGGMLGWQTRFKIILDAAEGLSYLHH-DSVPPIVHRD 815

Query: 455 LKPTSILLDENMVAHVSDFGISK 477
           +K  +IL+D +  A V+DFG++K
Sbjct: 816 IKSNNILIDGDYGARVADFGVAK 838

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1

 Score =  181 bits (460), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 155/523 (29%), Positives = 252/523 (48%), Gaps = 57/523 (10%)

Query: 1    MTGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHS 60
             TG+IP E+ NL  L+ L + +N+L G IP  +F++  +  L+L  N+ SG +P++    
Sbjct: 515  FTGRIPREMSNLTLLQGLRMYSNDLEGPIPEEMFDMKLLSVLDLSNNKFSGQIPALFSK- 573

Query: 61   LPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTF-GNLRHLSVLSLLM 119
            L ++ YL L  N   G+IP S+ + + L   D+  N  +G IP     +L+++ +     
Sbjct: 574  LESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDNLLTGTIPGELLASLKNMQLYLNFS 633

Query: 120  NNLTTE-----------------SSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSI 162
            NNL T                  S++ +  S   SL  C+ +  L  S N L G +P  +
Sbjct: 634  NNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQACKNVFTLDFSQNNLSGHIPDEV 693

Query: 163  GNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFL 222
                  +   + S     G IP+  G++  L+ L L  N+L G IP S+  L  L+   L
Sbjct: 694  FQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKL 753

Query: 223  PETNLQGYVPH-----NLCHLEMLNLLHLGGNKLSGHIPPC--------LASLTSLRELD 269
               NL+G+VP      N+   +++    L G+K    + PC         +  T +  + 
Sbjct: 754  ASNNLKGHVPESGVFKNINASDLMGNTDLCGSK--KPLKPCTIKQKSSHFSKRTRVILII 811

Query: 270  LGSNKLTSSIPSSLWSLGYILEINLS-SNLLNDSLP--SNVQKLKVLRVLDLSRNQLSGD 326
            LGS      +   +  L    +      N    SLP   +  KLK     +L +   S +
Sbjct: 812  LGSAAALLLVLLLVLILTCCKKKEKKIENSSESSLPDLDSALKLKRFEPKELEQATDSFN 871

Query: 327  IPSTIGALVDLETISLAGSFGSVYKGTISDGTDVAIKIFNLQR--ERAFRSFNSECEVLR 384
              + IG          + S  +VYKG + DGT +A+K+ NL+     + + F +E + L 
Sbjct: 872  SANIIG----------SSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDKWFYTEAKTLS 921

Query: 385  NVRHQNLIKIL----SSCSTPD--FKFMPNGSLEKRLY-SHNYFLDILERLNIMIDVGST 437
             ++H+NL+KIL     S  T      FM NG+LE  ++ S      +LE++++ + + S 
Sbjct: 922  QLKHRNLVKILGFAWESGKTKALVLPFMENGNLEDTIHGSAAPIGSLLEKIDLCVHIASG 981

Query: 438  LEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG 480
            ++YLH G+   PI+HCDLKP +ILLD + VAHVSDFG +++LG
Sbjct: 982  IDYLHSGY-GFPIVHCDLKPANILLDSDRVAHVSDFGTARILG 1023

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1

 Score =  179 bits (455), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 120/343 (34%), Positives = 185/343 (53%), Gaps = 10/343 (2%)

Query: 1   MTGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHS 60
           ++G +P+ +G L+ L++L +    +SG IP  + N S + +L L  N LSG +P  IG  
Sbjct: 238 VSGNLPSSLGKLKKLETLSIYTTMISGEIPSDLGNCSELVDLFLYENSLSGSIPREIGQ- 296

Query: 61  LPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMN 120
           L  ++ L L  N+L+G IP  I N + L ++DL  N  SG IP++ G L  L    +   
Sbjct: 297 LTKLEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLNLLSGSIPSSIGRLSFLEEFMI--- 353

Query: 121 NLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLK 180
                S + +  S  ++++NC  LV L L  N + G++P  +G   T L  F A   +L+
Sbjct: 354 -----SDNKFSGSIPTTISNCSSLVQLQLDKNQISGLIPSELGTL-TKLTLFFAWSNQLE 407

Query: 181 GTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEM 240
           G+IP  +     L  L L  N L GTIP+ +  L+ L    L   +L G++P  + +   
Sbjct: 408 GSIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLRNLTKLLLISNSLSGFIPQEIGNCSS 467

Query: 241 LNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLN 300
           L  L LG N+++G IP  + SL  +  LD  SN+L   +P  + S   +  I+LS+N L 
Sbjct: 468 LVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGSCSELQMIDLSNNSLE 527

Query: 301 DSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLA 343
            SLP+ V  L  L+VLD+S NQ SG IP+++G LV L  + L+
Sbjct: 528 GSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVSLNKLILS 570

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  179 bits (453), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 124/343 (36%), Positives = 182/343 (53%), Gaps = 11/343 (3%)

Query: 1   MTGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHS 60
           + G++P EI  L+ L+ LFL  N  SG IP  I N ++++ +++ GN   G +P  IG  
Sbjct: 420 LEGKLPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGR- 478

Query: 61  LPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMN 120
           L  +  L L  N L+G +P S+ N  +L ILDL  N  SG IP++FG L+ L  L L  N
Sbjct: 479 LKELNLLHLRQNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNN 538

Query: 121 NLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLK 180
           +L        Q +   SL + R L  + LS N L G + P  G  S+S   F  +    +
Sbjct: 539 SL--------QGNLPDSLISLRNLTRINLSHNRLNGTIHPLCG--SSSYLSFDVTNNGFE 588

Query: 181 GTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEM 240
             IP E+G+ + L  L LG N L G IP ++G +++L    +    L G +P  L   + 
Sbjct: 589 DEIPLELGNSQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKK 648

Query: 241 LNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLN 300
           L  + L  N LSG IPP L  L+ L EL L SN+   S+P+ L++   +L ++L  N LN
Sbjct: 649 LTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLN 708

Query: 301 DSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLA 343
            S+P  +  L  L VL+L +NQ SG +P  +G L  L  + L+
Sbjct: 709 GSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLS 751

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	481
298204751	1979	unnamed protein product [Vitis vinifera]	0.993	0.241	0.440	1e-109
297743586	737	unnamed protein product [Vitis vinifera]	0.975	0.636	0.440	2e-94
297740829	1892	unnamed protein product [Vitis vinifera]	0.972	0.247	0.431	1e-93
302143445	2843	unnamed protein product [Vitis vinifera]	0.887	0.150	0.435	5e-93
224075305	1009	predicted protein [Populus trichocarpa]	0.987	0.470	0.416	3e-91
147866276	1326	hypothetical protein VITISV_033547 [Viti	0.904	0.328	0.400	1e-90
147864989	797	hypothetical protein VITISV_033877 [Viti	0.975	0.588	0.409	3e-89
297740832	1686	unnamed protein product [Vitis vinifera]	0.875	0.249	0.412	5e-88
296085726	932	unnamed protein product [Vitis vinifera]	0.970	0.501	0.382	7e-85
125581304	1077	hypothetical protein OsJ_05889 [Oryza sa	0.989	0.441	0.364	8e-85

>gi|298204751|emb|CBI25249.3| unnamed protein product [Vitis vinifera]

 Score =  401 bits (1030), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 267/606 (44%), Positives = 341/606 (56%), Gaps = 128/606 (21%)

Query: 2    TGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSL 61
             G++P EIG+L  L  L +  N+L+G IP  IFNIS++ + +L  N LSG+LP   G  L
Sbjct: 757  AGEVPCEIGSLCTLNVLNIEDNSLTGHIPFQIFNISSMVSGSLTRNNLSGNLPPNFGSYL 816

Query: 62   PNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNN 121
            PN++ L L  N L G IP+SI NA+KL  LD G+N  +G IP+  G+LR L  L+L +NN
Sbjct: 817  PNLENLILEINWLSGIIPSSIGNASKLRSLDFGYNMLTGSIPHALGSLRFLERLNLGVNN 876

Query: 122  LTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKG 181
            L  ES    + SFL+SLTNC+ L  L LS NPL GILP SIGN STSLQRF A+ CKLKG
Sbjct: 877  LKGESY-IQELSFLTSLTNCKRLRILYLSFNPLIGILPISIGNLSTSLQRFEANTCKLKG 935

Query: 182  TIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEML 241
             IP EIG+L  L  LSL  NDL GTIP SIG L++LQG +LP   LQG +P+++C L  L
Sbjct: 936  NIPTEIGNLSNLYLLSLNNNDLTGTIPPSIGQLQKLQGLYLPSNKLQGSIPNDICQLRNL 995

Query: 242  NLLHLGGNKLSGHIPPCLASLTSLREL--------------------------------- 268
              L L  N+LSG IP CL  LT LR L                                 
Sbjct: 996  GELFLTNNQLSGSIPACLGELTFLRHLYLGSNKLNSTIPSTLWSLIHILSLDMSSNFLVG 1055

Query: 269  ---------------DLGSNKLTSSIPSSLWSL--------------GYILE-------- 291
                           DL  N+L+  IPS++  L              G IL         
Sbjct: 1056 YLPSDMGNLKVLVKIDLSRNQLSGEIPSNIGGLQDLTSLSLAHNRFEGPILHSFSNLKSL 1115

Query: 292  --INLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIP--------------------S 329
              ++LS N L   +P +++ L  L+ LD+S N L G+IP                     
Sbjct: 1116 EFMDLSDNALFGEIPKSLEGLVYLKYLDVSFNGLYGEIPPEGPFANFSAESFMMNKALCR 1175

Query: 330  TIGALVDLETISL---------------------------AGSFGSVYKGTISDGTDVAI 362
               A++  ++ SL                            GS GSVY+GT+SDG + AI
Sbjct: 1176 KRNAVLPTQSESLLTATWRRISYQEIFQATNGFSAGNLLGRGSLGSVYRGTLSDGKNAAI 1235

Query: 363  KIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTP--DFK-----FMPNGSLEKRL 415
            K+FNLQ E AF+SF++ECEV+ ++RH+NLIKI+SSCS    DFK     ++PNGSLE+ L
Sbjct: 1236 KVFNLQEEAAFKSFDAECEVMHHIRHRNLIKIVSSCSNSYIDFKALVLEYVPNGSLERWL 1295

Query: 416  YSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGI 475
            YSHNY LDIL+RLNIMIDV   +EYLHHG  S P++HCDLKP++ILLDE+   HV DFGI
Sbjct: 1296 YSHNYCLDILQRLNIMIDVALAMEYLHHG-CSTPVVHCDLKPSNILLDEDFGGHVGDFGI 1354

Query: 476  SKLLGE 481
            +KLL E
Sbjct: 1355 AKLLRE 1360

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297743586|emb|CBI36453.3| unnamed protein product [Vitis vinifera]

 Score =  353 bits (905), Expect = 2e-94,   Method: Compositional matrix adjust.
 Identities = 229/520 (44%), Positives = 310/520 (59%), Gaps = 51/520 (9%)

Query: 3   GQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNL---NLGGNRLSGHLPSMIGH 59
           G +  E+G L  L SL LG NNL G IP  + NIST+  L   +L  NR  G +P  IG 
Sbjct: 120 GHLYQELGILPKLDSLLLGGNNLRGTIPSSLGNISTLEELLFASLSYNRFDGQIPEEIG- 178

Query: 60  SLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLM 119
           SL N++ L LG N+L G IP+SI N + L IL L  N   G IP+T GNL +LS L L +
Sbjct: 179 SLRNLEELYLGGNHLTGPIPSSIGNISSLQILFLEDNKIQGSIPSTLGNLLNLSYLVLEL 238

Query: 120 NNLTTESSSAYQWSF-LSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECK 178
           N LT    +  Q  F +SSL     ++ + +  N   G +PPS+GN    LQ  S  E +
Sbjct: 239 NELT---GAIPQEIFNISSLQ----ILSIDIGNNLFTGPIPPSLGNLKF-LQTLSLGENQ 290

Query: 179 LKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHL 238
           LKG IP  IG L+ L  L LG N+LNG IP++IG L+ LQ   +    L+G +P  LC L
Sbjct: 291 LKGHIPSGIGSLKNLGTLELGDNNLNGNIPSTIGRLENLQRMNIFNNELEGPIPEELCGL 350

Query: 239 EMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNL 298
             L  L L  NKLSG IP C+ +L+ L++L L SN LTSSIP+ LWSLG +L +NLS N 
Sbjct: 351 RDLGELSLYNNKLSGSIPHCIGNLSRLQKLFLSSNSLTSSIPTGLWSLGNLLFLNLSFNS 410

Query: 299 LNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLA-GSFGSVYKGTISDG 357
           L  SLPS++  L V+  +DLS N+L G+IP  +G    L +++L+  SF      T+   
Sbjct: 411 LGGSLPSDMGTLTVIEDIDLSWNKLIGNIPGILGTFESLYSLNLSRNSFQEAIPETLGKT 470

Query: 358 TDV-------------------------------AIKIFNLQRERAFRSFNSECEVLRNV 386
            +                                 +K+ NL+ E AF+SF++EC+VL  +
Sbjct: 471 QESKTKQVLLKYVLPGIAAVVVFGALYYMLKNYRKVKVLNLRLEGAFKSFDAECKVLARI 530

Query: 387 RHQNLIKILSSCSTPDFK-----FMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYL 441
           RH+NLIK++SSCS  D +     +M NGSLEK LYSHNY L++ +R++IM+DV   LEYL
Sbjct: 531 RHRNLIKVISSCSNLDVRALVLQYMSNGSLEKWLYSHNYCLNLFQRVSIMLDVALALEYL 590

Query: 442 HHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
           HH  S  P++HCDLKP+++LLD++MVAHV DFG++K+L E
Sbjct: 591 HHSQSE-PVVHCDLKPSNVLLDDDMVAHVGDFGLAKILVE 629

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297740829|emb|CBI31011.3| unnamed protein product [Vitis vinifera]

 Score =  350 bits (897), Expect = 1e-93,   Method: Compositional matrix adjust.
 Identities = 219/507 (43%), Positives = 305/507 (60%), Gaps = 39/507 (7%)

Query: 1    MTGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMI--- 57
             TG IP  IG+L NL+ L+L  N L+G IP  I N+S +  L LG N +SG +P+ I   
Sbjct: 1269 FTGGIPQAIGSLSNLEELYLNYNKLTGGIPREIGNLSNLNILQLGSNGISGPIPAEIFTN 1328

Query: 58   --GHSLP-------NIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGN 108
                 LP        +  L L  N   G+IP  I N +KL  +DL  N+  G IP +FGN
Sbjct: 1329 HLSGQLPTTLSLCRELLSLALPMNKFTGSIPREIGNLSKLEEIDLSENSLIGSIPTSFGN 1388

Query: 109  LRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTS 168
            L  L  L L +        + +  +   S++N   L  L LS N   G LP S+GN   +
Sbjct: 1389 LMTLKFLRLYI------GINEFSGTIPMSISNMSKLTVLSLSDNSFTGTLPNSLGNLPIA 1442

Query: 169  LQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQ 228
            L+ F AS C+ +GTIP  IG+L  LI+L LG NDL G+IPT++G L++LQ   +    ++
Sbjct: 1443 LEIFIASACQFRGTIPTGIGNLTNLIWLDLGANDLTGSIPTTLGQLQKLQALSIVGNRIR 1502

Query: 229  GYVPHNLCHLEMLNLLHLG--GNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSL 286
            G +P++LCHL+ L  L L    N L+ +IP    SL  L  L+L SN LT         L
Sbjct: 1503 GSIPNDLCHLKNLGYLQLSLDSNVLAFNIPMSFWSLRDLLVLNLSSNFLT-----EFGDL 1557

Query: 287  GYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPS-------TIGALVDLET 339
              +  ++LS N L+ ++P  ++ L  L+ L++S N+L G+IP+       T  + +  E 
Sbjct: 1558 VSLESLDLSQNNLSGTIPKTLEALIYLKYLNVSFNKLQGEIPNGGPFVKFTAESFMFNEA 1617

Query: 340  ISLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCS 399
            +  A  F  V    +S+G  VAIK+FNL+ + A RSFNSECEV++ +RH+NL++I++ CS
Sbjct: 1618 LCGAPHF-QVMAWVLSNGLTVAIKVFNLEFQGALRSFNSECEVMQGIRHRNLVRIITCCS 1676

Query: 400  TPDF-----KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
              DF     K+MPNGSLEK LYSH YFLD+++RLNIMIDV S LEYLHH  SS  ++HCD
Sbjct: 1677 NLDFKALVLKYMPNGSLEKLLYSHYYFLDLIQRLNIMIDVASALEYLHHDCSSL-VVHCD 1735

Query: 455  LKPTSILLDENMVAHVSDFGISKLLGE 481
            LKP+++LLD++MVAHV+DFGI+KLL E
Sbjct: 1736 LKPSNVLLDDDMVAHVADFGIAKLLTE 1762

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|302143445|emb|CBI22006.3| unnamed protein product [Vitis vinifera]

 Score =  348 bits (892), Expect = 5e-93,   Method: Compositional matrix adjust.
 Identities = 213/489 (43%), Positives = 295/489 (60%), Gaps = 62/489 (12%)

Query: 3    GQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLP 62
            G IP E+G L NL+ L LG NNL+G++P  I NIS ++ L+L  N LSG LPS IG  LP
Sbjct: 1417 GNIPKELGKLINLQILHLGQNNLTGIVPEAIINISKLQVLSLSLNHLSGSLPSSIGTWLP 1476

Query: 63   NIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNL 122
            N++ L +G N   G IP SI+N +KL+ +D+  N F G++P    +              
Sbjct: 1477 NLEGLYIGANEFSGKIPMSISNMSKLLFMDISNNYFIGNLPKDLDS-------------- 1522

Query: 123  TTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGT 182
                    + +F +SLTNC  L  L + GNPL GI+P S+GN S S++R  A  C+L+GT
Sbjct: 1523 --------ELAFFTSLTNCISLRKLRIGGNPLKGIIPNSLGNLSISIERIGARSCQLRGT 1574

Query: 183  IPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLN 242
            IP   G L+    ++L  N L   IP+S+  L+ L    L    L G +P  + +++ L 
Sbjct: 1575 IPT--GKLQA---INLHSNGLASEIPSSLWILRYLLFLNLSSNFLNGELPLEVGNMKSLE 1629

Query: 243  LLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDS 302
             L L  N+ SG+IP  ++ L +L +L L  NKL   IP +   L                
Sbjct: 1630 ELDLSKNQFSGNIPSTISLLQNLLQLYLSHNKLQGHIPPNFDDLA--------------- 1674

Query: 303  LPSNVQKLKVLRVLDLSRNQLSGDIP-----STIGALVDLETISLAGS--FGSVYKGTIS 355
                   LK L+ L++S N+L G+IP     +   A   +  ++L G+   G+VYKG +S
Sbjct: 1675 -------LKYLKYLNVSFNKLQGEIPNGGPFANFTAESFISNLALCGAPRLGTVYKGVLS 1727

Query: 356  DGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPDFK-----FMPNGS 410
            DG  VA+K+FNL+ + AF+SF  ECEV++N+RH+NL KI+SSCS  DFK     +MPNGS
Sbjct: 1728 DGLIVAVKVFNLELQGAFKSFEVECEVMQNIRHRNLAKIISSCSNLDFKALVLEYMPNGS 1787

Query: 411  LEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHV 470
            LEK LYSHNY+LD ++RL IMIDV S LEYLHH +SS P++HCDLKP ++LLD++MVAH+
Sbjct: 1788 LEKWLYSHNYYLDFVQRLKIMIDVASGLEYLHHDYSS-PVVHCDLKPNNVLLDDDMVAHI 1846

Query: 471  SDFGISKLL 479
            SDFGI+KLL
Sbjct: 1847 SDFGIAKLL 1855

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224075305|ref|XP_002304590.1| predicted protein [Populus trichocarpa] gi|222842022|gb|EEE79569.1| predicted protein [Populus trichocarpa]

 Score =  342 bits (876), Expect = 3e-91,   Method: Compositional matrix adjust.
 Identities = 231/554 (41%), Positives = 311/554 (56%), Gaps = 79/554 (14%)

Query: 1   MTGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHS 60
           +TG +P E+G L NLK+L +  N L G +P  +FNIS I  + +  N LSG LP  +G  
Sbjct: 272 LTGVLPPELGGLSNLKTLRMDDNALIGNVPSALFNISAIEVIGMYTNLLSGSLPPTMGLF 331

Query: 61  LPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMN 120
           +PN++ L LG N L GTIP+SI+NA+ L ++DL  N+F+G IP T GNLR L VL+L  N
Sbjct: 332 MPNLRELRLGGNELEGTIPSSISNASTLAVVDLSNNSFTGLIPGTIGNLRQLQVLNLANN 391

Query: 121 NLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLK 180
           +LT+ESS+  Q S LS+L NC+ L  +  S NPL   LP S GN S+SL++F A +C LK
Sbjct: 392 HLTSESSTP-QLSILSALGNCKNLRRIYFSVNPLNTTLPISFGNLSSSLEQFWADDCNLK 450

Query: 181 GTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEM 240
           G IP  IG+L  LI LSL  N+L   +PT+   L  LQ   L    L+G +  NLCH + 
Sbjct: 451 GNIPNTIGNLSSLIALSLANNELASVVPTTTERLTNLQLLDLQGNQLEGNITDNLCHSDS 510

Query: 241 LNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLN 300
           L  L LGGNKLSG IP CL +LT+LR L+L SN  TS+IP SL +L  IL +NLSSN L+
Sbjct: 511 LFDLSLGGNKLSGSIPECLGNLTTLRHLNLSSNNFTSTIPLSLGNLAGILVLNLSSNFLS 570

Query: 301 DSLPSNVQKLKVLRVLDLSRNQLSGD------------------------IPSTIGALVD 336
            SLP   ++L V   +DLSRNQLSG                         IP ++   V 
Sbjct: 571 GSLPLVFRQLMVAEEIDLSRNQLSGQIPNSTWFHKNLAYLSLATNRLQGPIPGSLSFAVS 630

Query: 337 LETISLA-GSFGSVYKGTISDGTDVAIKIFNLQ---------RERAFRSFNSECEVLRN- 385
           LE + L+  S   +   ++   T + +K FN+           E  FR+F+++  ++ N 
Sbjct: 631 LEFLDLSHNSLSGLIPKSLE--TLLHLKYFNVSFNVLQGEIPSEGPFRNFSAQSYMMNNE 688

Query: 386 -----------------------------------VRHQNLIKILSSCSTPDFK-----F 405
                                                    + I    +  +FK     +
Sbjct: 689 LCGAPRLKVPPCKTYALRGSTVTLVFLLELILPLIAATMAALFIFICSNAVNFKALVIEY 748

Query: 406 MPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDEN 465
           M NGSL+K LY+HNY LDIL+RL+IMI+  S LEYLH G S   IIH DLKP++ILLDE+
Sbjct: 749 MVNGSLDKWLYTHNYSLDILQRLDIMINTASALEYLHSGCSRI-IIHGDLKPSNILLDED 807

Query: 466 MVAHVSDFGISKLL 479
           M++ +SDF IS+ L
Sbjct: 808 MISRLSDFSISQFL 821

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147866276|emb|CAN79935.1| hypothetical protein VITISV_033547 [Vitis vinifera]

 Score =  340 bits (872), Expect = 1e-90,   Method: Compositional matrix adjust.
 Identities = 231/577 (40%), Positives = 299/577 (51%), Gaps = 142/577 (24%)

Query: 3    GQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLP 62
            G IPT  GNL+ LK L LG+NNL+G+IP  IFNIS ++ L L  N LSG  PS IG  L 
Sbjct: 664  GSIPTSFGNLKALKFLQLGSNNLTGMIPEGIFNISKLQTLALAQNHLSGGFPSSIGTWLL 723

Query: 63   NIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNL 122
            +++ L +G N   GTIP  I+N +KLI L +  N F+G++P    NLR L VL+L  N L
Sbjct: 724  DLEGLFIGGNEFNGTIPVYISNMSKLIRLHISDNYFTGNVPKDLNNLRKLEVLNLAGNQL 783

Query: 123  TTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGT 182
            T+E                     +IL    L G LP S+GN S +L+ F+AS C   GT
Sbjct: 784  TSE--------------------IIIL----LKGTLPNSLGNLSVALESFTASACHFXGT 819

Query: 183  IPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLN 242
            IP  IG+L  LI+L LG NDL G+IP ++ T  +      P  NL GY            
Sbjct: 820  IPTGIGNLTNLIWLDLGANDLTGSIPATLWTATEA-----PAINL-GY------------ 861

Query: 243  LLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDS 302
             LHL  NKLSG IP C   L  LR+L L SN L  +IP+S WSL  +L ++LSSN L  +
Sbjct: 862  -LHLSSNKLSGSIPSCFGDLPMLRQLSLDSNVLAFNIPTSFWSLRDLLVLSLSSNFLTGN 920

Query: 303  LPSNVQKLKV------------------------------------------------LR 314
            LP  V  +K                                                 L 
Sbjct: 921  LPLEVGNMKSITTLDLSKNLISGYIPRRIGELQNLVNLSLSQNKLQGSIPVEFGDLLSLE 980

Query: 315  VLDLSRNQLSGDIPSTIGALVDL-----------ETISLAGSF---------------GS 348
             +DLSRN LSG IP ++ A + L           E IS  G F               G+
Sbjct: 981  SMDLSRNNLSGTIPKSLEAFIYLKYLNVSFNKLQEEISNGGPFXNFIAELFIFNKALCGA 1040

Query: 349  VYKGTISDGTD-------------------VAIKIFNLQRERAFRSFNSECEVLRNVRHQ 389
             +   I+   +                   V   +FNL+ + A RSF+SECEV++ + H+
Sbjct: 1041 RHFQVIACDKNNCTQSWKTKSFILKYILLPVGSTVFNLEFQGALRSFDSECEVMQGICHR 1100

Query: 390  NLIKILSSCSTPDFK-----FMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHG 444
            NLI+I++ CS  DFK     +MP GSL+K LYSHNYFLD+ +RL IMIDV S LEYLHH 
Sbjct: 1101 NLIRIITCCSNLDFKALVLEYMPKGSLDKWLYSHNYFLDLFQRLTIMIDVASALEYLHHD 1160

Query: 445  HSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
              S  ++HCDLKP+++LLD NMVAHV+DFGI++LL E
Sbjct: 1161 CLSL-VVHCDLKPSNVLLDNNMVAHVADFGIARLLTE 1196

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147864989|emb|CAN79365.1| hypothetical protein VITISV_033877 [Vitis vinifera]

 Score =  335 bits (859), Expect = 3e-89,   Method: Compositional matrix adjust.
 Identities = 226/552 (40%), Positives = 307/552 (55%), Gaps = 83/552 (15%)

Query: 3   GQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLP 62
           G IP EIGNLQNL  +    NN +GLIP  IFNIST+  ++L  N LSG LP+ +G  LP
Sbjct: 125 GTIPNEIGNLQNLMGIGFAENNFTGLIPLTIFNISTLEQISLEDNSLSGTLPATLGLLLP 184

Query: 63  NIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNL 122
           N++ + L  N L G IP  ++N ++L+ L LG N F+G +P   G+L  L +L L  N L
Sbjct: 185 NLEKVGLVLNKLSGVIPLYLSNCSQLVRLGLGENRFTGEVPGNIGHLEQLQILVLDGNQL 244

Query: 123 TTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGT 182
           T           + SLTN   L  L LS N L G +P +I     SLQR      +L+ +
Sbjct: 245 TGSIPRG-----IGSLTN---LTMLALSNNNLSGAIPSTIKGMK-SLQRLYLDGNQLEDS 295

Query: 183 IPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQG----------------------F 220
           IP EI  LR L  + L  N L+G+IP+ I  L QLQ                       +
Sbjct: 296 IPNEICLLRNLGEMVLRNNKLSGSIPSCIENLSQLQIMLLDSNSLSSSIPSNLWSLENLW 355

Query: 221 FLPET--NLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSS 278
           FL  +  +L G +  N+  ++ML  + L  N++SG IP  L +  SL  LDL  N    S
Sbjct: 356 FLDLSFNSLGGSLHANMRSIKMLQTMDLSWNRISGDIPTILGAFESLSSLDLSGNLFWGS 415

Query: 279 IPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPS----TIGAL 334
           IP SL  L  +  ++LS N L+ S+P ++  L  LR L+LS N+LSG+IP      + AL
Sbjct: 416 IPESLGELITLDYMDLSHNNLSGSIPKSLVALSHLRHLNLSFNKLSGEIPRDGLPILVAL 475

Query: 335 V------------DLETISLA----------------------------GSFGSVYKGTI 354
           V             L T+ +A                            GSFGSV+KG +
Sbjct: 476 VLLMIKXRQSKVETLXTVDVAPAVEHRMISYQELRHATXDFSEANILGVGSFGSVFKGLL 535

Query: 355 SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPDFK-----FMPNG 409
           S+GT VA+K+ NLQ E AF+SF++EC+VL  VRH+NL+K ++SCS P+ +     +M NG
Sbjct: 536 SEGTLVAVKVLNLQLEGAFKSFDAECKVLARVRHRNLVKXITSCSNPELRALVLQYMXNG 595

Query: 410 SLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAH 469
           SLEK LYS NY L + +R++I  DV   LEYLHHG S  P++HCDLKP+++LLD+ MVAH
Sbjct: 596 SLEKWLYSFNYXLSLFQRVSIXXDVALALEYLHHGQSE-PVVHCDLKPSNVLLDDEMVAH 654

Query: 470 VSDFGISKLLGE 481
           V DFGI+K+L E
Sbjct: 655 VGDFGIAKILAE 666

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297740832|emb|CBI31014.3| unnamed protein product [Vitis vinifera]

 Score =  331 bits (849), Expect = 5e-88,   Method: Compositional matrix adjust.
 Identities = 205/497 (41%), Positives = 280/497 (56%), Gaps = 76/497 (15%)

Query: 1    MTGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHS 60
            + G IPT  GN + LK L LG NNL+G++P   FNIS ++ L L  N LSG LPS IG  
Sbjct: 1134 LIGSIPTSFGNFKALKFLNLGINNLTGMVPEASFNISKLQALALVQNHLSGSLPSSIGTW 1193

Query: 61   LPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMN 120
            LP++++L +G N   G IP SI+N +KLI L +  N+FSG++P                 
Sbjct: 1194 LPDLEWLSIGANEFSGIIPFSISNMSKLIQLHVACNSFSGNVPKDL-------------- 1239

Query: 121  NLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLK 180
                                               G LP S+GNFS +L+ F AS C+L+
Sbjct: 1240 -----------------------------------GTLPNSLGNFSIALEIFVASACQLR 1264

Query: 181  GTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEM 240
            G+IP  IG+L  LI L LG NDL G IPT++G L++LQ   +    ++G +P++L HL+ 
Sbjct: 1265 GSIPTGIGNLTNLIELDLGANDLIGLIPTTLGRLQKLQLLHIARNRIRGSIPNDLFHLKN 1324

Query: 241  LNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLN 300
            L  LHL  NKL G IP C   L +L+ L   SN L  +IPSSLWSL  +L +NLSSN L 
Sbjct: 1325 LGYLHLSSNKLFGSIPSCFGDLPTLQALSFDSNALAFNIPSSLWSLKDLLFLNLSSNFLT 1384

Query: 301  DSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAGSFGSVYKGTISDGTDV 360
             +LP  V  +K +  L LS+N +S +IP   G  V+    S    F     G        
Sbjct: 1385 GNLPPKVGNMKSITALALSKNLVS-EIPDG-GPFVNFTAKSFI--FNEALCGA------P 1434

Query: 361  AIKIFNLQRERAFRSFNSECEVLRN-----------VRHQNLIKILSSCSTPDFK----- 404
              ++    +    +S+ ++  +L+            V   NL++I++ CS  +FK     
Sbjct: 1435 HFQVIACDKNTPSQSWKTKSFILKYILLPVASTVTLVAFINLVRIITCCSNLNFKALVLE 1494

Query: 405  FMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDE 464
            +MPNGSL+K LYSHNYFLD+++RLNIMIDV S LEYLHH  SS  ++HCDLKP ++LLD+
Sbjct: 1495 YMPNGSLDKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCSSL-VVHCDLKPNNVLLDD 1553

Query: 465  NMVAHVSDFGISKLLGE 481
            NMVAHV+DFGI++LL E
Sbjct: 1554 NMVAHVADFGIARLLTE 1570

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|296085726|emb|CBI29526.3| unnamed protein product [Vitis vinifera]

 Score =  320 bits (821), Expect = 7e-85,   Method: Compositional matrix adjust.
 Identities = 211/552 (38%), Positives = 303/552 (54%), Gaps = 85/552 (15%)

Query: 1   MTGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHS 60
           + G IPT  GNL+ LK L LG NNL+G +P  IFNIS +++L +  N LSG LPS IG  
Sbjct: 220 LIGSIPTSFGNLKALKFLNLGINNLTGTVPEAIFNISKLQSLAMVKNHLSGSLPSSIGTW 279

Query: 61  LPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHI------------------ 102
           LP+++ L +  N   G IP SI+N +KL +L L  N+F+G++                  
Sbjct: 280 LPDLEGLFIAGNEFSGIIPMSISNMSKLTVLGLSANSFTGNVGFLTSLTNCKFLKNLWIG 339

Query: 103 --------PNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPL 154
                   PN+ GNL  +++ S +       S+  ++ +  + + N   L+ L L  N L
Sbjct: 340 NIPFKGTLPNSLGNLP-IALESFI------ASACQFRGTIPTGIGNLTNLIRLDLGANDL 392

Query: 155 GGILPPSIGNFSTSLQRFSASECKLKGTIPKEI-----------------------GHLR 191
            G +P ++G     LQ    +  +++G+IP ++                         LR
Sbjct: 393 TGSIPTTLGQLQ-KLQWLYIAGNRIRGSIPNDLYLLALQELFLDSNVLAFNIPTSLWSLR 451

Query: 192 GLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKL 251
            L+ L+L  N L G +P  +G +K +    L +  + GY+P  +  L+ L  L L  N+L
Sbjct: 452 DLLALNLSSNFLTGNLPPEVGNMKSITTLDLSKNLVSGYIPSKMGKLQSLITLSLSQNRL 511

Query: 252 SGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLK 311
            G IP     L SL  LDL  N L+ +IP SL +L Y+  +N+S N L   +P N     
Sbjct: 512 QGPIPIEFGDLVSLESLDLSQNNLSGTIPKSLEALIYLKYLNVSLNKLQGEIP-NGGPFI 570

Query: 312 VLRVLDLSRNQLSGDIPSTIGALV--DLETISL-----------------AGSFGSVYKG 352
                   R+ +  +IP+ I + +    E IS                   GS G VYKG
Sbjct: 571 NFTAESFIRDNM--EIPTPIDSWLPGTHEKISHQQLLYATNDFGEDNLIGKGSQGMVYKG 628

Query: 353 TISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPDFK-----FMP 407
            +S+G  VAIK+FNL+ + A RSF+SECEV++ +RH+NL++I++ CS  DFK     +MP
Sbjct: 629 VLSNGLTVAIKVFNLEFQGALRSFDSECEVMQGIRHRNLVRIITCCSNLDFKALVLEYMP 688

Query: 408 NGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMV 467
           NGSLEK LYSHNYFLD+++RLNIMIDV S LEYLHH  SS  ++HCDLKP ++LLD++MV
Sbjct: 689 NGSLEKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCSSL-VVHCDLKPNNVLLDDDMV 747

Query: 468 AHVSDFGISKLL 479
           AHV+DFGI+KLL
Sbjct: 748 AHVADFGITKLL 759

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|125581304|gb|EAZ22235.1| hypothetical protein OsJ_05889 [Oryza sativa Japonica Group]

 Score =  320 bits (821), Expect = 8e-85,   Method: Compositional matrix adjust.
 Identities = 210/576 (36%), Positives = 306/576 (53%), Gaps = 100/576 (17%)

Query: 1   MTGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHS 60
           +TG IP  +GNL +L  L+L  N L+G IP  I N+S++R  N+  N+L+G LP+    +
Sbjct: 353 LTGSIPPSLGNLHSLTDLYLDRNQLTGYIPSSISNLSSLRIFNVRDNQLTGSLPTGNRVN 412

Query: 61  LPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMN 120
            P ++    G N   G IP  + N++ L    +  N  SG +P     L  LSVL++  N
Sbjct: 413 FPLLQIFNAGYNQFEGAIPTWMCNSSMLSSFSIEMNMISGVVPPCVDGLNSLSVLTIQNN 472

Query: 121 NLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLK 180
            L  +++ +Y W FLSSLTN   L +L  S N   G LP ++ N ST+L+ F+ SE  + 
Sbjct: 473 QL--QANDSYGWGFLSSLTNSSQLEFLDFSSNKFRGTLPNAVANLSTNLKAFALSENMIS 530

Query: 181 GTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEM 240
           G IP+ IG+L  L+YL +  N   G IP+S+GTL +L    L   NL G +P  L +L  
Sbjct: 531 GKIPEGIGNLVNLLYLFMSNNSFEGNIPSSLGTLWKLSHLDLGFNNLLGQIPPALGNLTS 590

Query: 241 LNLLHLGGNKLSGHIPPCL----------------------------------------- 259
           LN L+LG N LSG +P  L                                         
Sbjct: 591 LNKLYLGQNSLSGPLPSDLKNCTLEKIDIQHNMLSGPIPREVFLISTLSDFMYFQSNMFS 650

Query: 260 -------ASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKV 312
                  ++L ++ ++D  +N+++  IP S+     +    +  N L   +P++V +LK 
Sbjct: 651 GSLPLEISNLKNIADIDFSNNQISGEIPPSIGDCQSLQYFKIQGNFLQGPIPASVSRLKG 710

Query: 313 LRVLDLSRNQLSGDIPSTIGALVDLETISLA----------------------------- 343
           L+VLDLS N  SGDIP  + ++  L +++L+                             
Sbjct: 711 LQVLDLSHNNFSGDIPQFLASMNGLASLNLSFNHFEGPVPNDGIFLNINETAIEGNEGLC 770

Query: 344 -GSFGSVYKG--TISDG-TDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCS 399
            GSFGSVYKG  TI D    VA+K+ NLQ+  A +SF +ECE LR VRH+NL+KIL+ CS
Sbjct: 771 GGSFGSVYKGRMTIQDQEVTVAVKVLNLQQRGASQSFIAECEALRCVRHRNLVKILTVCS 830

Query: 400 TPD----------FKFMPNGSLEKRLYSH------NYFLDILERLNIMIDVGSTLEYLHH 443
           + D          ++FMPNG+L++ L+ H      +  L+I++RL+I IDV S L+YLH 
Sbjct: 831 SIDIQGHDFKALVYEFMPNGNLDQWLHQHLEENGEDKVLNIIKRLDIAIDVVSALDYLHQ 890

Query: 444 GHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
            H   PIIHCDLKP++ILLD  MVAHV DFG++++L
Sbjct: 891 -HRPLPIIHCDLKPSNILLDSEMVAHVGDFGLARVL 925

Source: Oryza sativa Japonica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	481
UNIPROTKB|Q40640	1025	Xa21 "Receptor kinase-like pro	0.681	0.32	0.382	1.9e-82
TAIR|locus:2075661	1025	AT3G47110 [Arabidopsis thalian	0.708	0.332	0.364	1.7e-80
TAIR|locus:2047525	980	AT2G24130 [Arabidopsis thalian	0.754	0.370	0.313	5.7e-70
TAIR|locus:2075631	1009	AT3G47090 [Arabidopsis thalian	0.802	0.382	0.329	1.4e-66
TAIR|locus:2079142	1010	AT3G47570 [Arabidopsis thalian	0.802	0.382	0.330	4.7e-66
TAIR|locus:2149922	1031	EFR "EF-TU receptor" [Arabidop	0.729	0.340	0.337	9.4e-64
TAIR|locus:2079157	1011	AT3G47580 [Arabidopsis thalian	0.717	0.341	0.323	4.2e-61
TAIR|locus:2156349	1252	GSO2 "GASSHO 2" [Arabidopsis t	0.690	0.265	0.338	1.4e-59
TAIR|locus:2120362	1249	GSO1 "GASSHO1" [Arabidopsis th	0.690	0.265	0.332	4.9e-59
TAIR|locus:2007918	1088	PEPR2 "PEP1 receptor 2" [Arabi	0.783	0.346	0.311	1.6e-58

UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 525 (189.9 bits), Expect = 1.9e-82, Sum P(2) = 1.9e-82
 Identities = 128/335 (38%), Positives = 186/335 (55%)

Query:     1 MTGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHS 60
             ++G IP+ +G L +L ++ LG NNLSG+IP  I+N+S++R  ++  N+L G +P+    +
Sbjct:   212 LSGAIPSSLGQLSSLLTMNLGQNNLSGMIPNSIWNLSSLRAFSVRENKLGGMIPTNAFKT 271

Query:    61 LPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMN 120
             L  ++ +++G N   G IP S+ NA+ L ++ +  N FSG I + FG LR+L+ L L  N
Sbjct:   272 LHLLEVIDMGTNRFHGKIPASVANASHLTVIQIYGNLFSGIITSGFGRLRNLTELYLWRN 331

Query:   121 NLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASEC-KL 179
                T       W F+S LTNC  L  L L  N LGG+LP S  N STSL  F A E  K+
Sbjct:   332 LFQTREQD--DWGFISDLTNCSKLQTLNLGENNLGGVLPNSFSNLSTSLS-FLALELNKI 388

Query:   180 KGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLP-ETNLQGYVPXXXXXX 238
              G+IPK+IG+L GL +L L  N+  G++P+S+G LK L G  L  E NL G +P      
Sbjct:   389 TGSIPKDIGNLIGLQHLYLCNNNFRGSLPSSLGRLKNL-GILLAYENNLSGSIPLAIGNL 447

Query:   239 XXXXXXXXXXXKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYI-LEIXXXXX 297
                        K SG IP  L++LT+L  L L +N L+  IPS L+++  + + I     
Sbjct:   448 TELNILLLGTNKFSGWIPYTLSNLTNLLSLGLSTNNLSGPIPSELFNIQTLSIMINVSKN 507

Query:   298 XXXXXXXXXVQKLKVLRVLDLSRNQLSGDIPSTIG 332
                      +  LK L       N+LSG IP+T+G
Sbjct:   508 NLEGSIPQEIGHLKNLVEFHAESNRLSGKIPNTLG 542

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)]

 Score = 516 (186.7 bits), Expect = 1.7e-80, Sum P(3) = 1.7e-80
 Identities = 125/343 (36%), Positives = 177/343 (51%)

Query:     3 GQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLP 62
             G+IP +I  L+ +    +  N  +G+ PP I+N+S++  L++ GN  SG L    G  LP
Sbjct:   215 GEIPGDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFGSLLP 274

Query:    63 NIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNL 122
             N++ L +G N+  GTIP +++N + L  LD+  N  +G IP +FG L++L +L L  N+L
Sbjct:   275 NLQILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNSL 334

Query:   123 TTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGT 182
                SS      FL +LTNC  L YL +  N LGG LP  I N ST L   S     + G+
Sbjct:   335 GNYSSG--DLDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGNLISGS 392

Query:   183 IPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPXXXXXXXXXX 242
             IP  IG+L  L  L LG N L G +P S+G L +L+   L    L G +P          
Sbjct:   393 IPHGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLT 452

Query:   243 XXXXXXXKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEIXXXXXXXXXX 302
                       G IP  L S + L +L+LG+NKL  SIP  L  L  ++ +          
Sbjct:   453 YLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSFNLLVGP 512

Query:   303 XXXXVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAGS 345
                 + KLK L  LD+S N+LSG IP T+   + LE + L G+
Sbjct:   513 LRQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGN 555

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)]

 Score = 411 (149.7 bits), Expect = 5.7e-70, Sum P(2) = 5.7e-70
 Identities = 118/376 (31%), Positives = 187/376 (49%)

Query:     3 GQIPTEIGNLQNLKSLFLGANNLSGLIPPMIF---NISTIRNLNLGGNRLSGHLPSMIGH 59
             G IP E+G L  L  L LG+N L+G IP  +F   + S+++ ++L  N L+G +P     
Sbjct:   129 GNIPQELGLLNRLVYLDLGSNRLNGSIPVQLFCNGSSSSLQYIDLSNNSLTGEIPLNYHC 188

Query:    60 SLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPN-TFGNLRHLSVLSLL 118
              L  +++L L  N L GT+P+S++N+T L  +DL  N  SG +P+     +  L  L L 
Sbjct:   189 HLKELRFLLLWSNKLTGTVPSSLSNSTNLKWMDLESNMLSGELPSQVISKMPQLQFLYLS 248

Query:   119 MNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECK 178
              N+  + +++     F +SL N   L  L L+GN LGG +  S+ + S +L +    + +
Sbjct:   249 YNHFVSHNNNTNLEPFFASLANSSDLQELELAGNSLGGEITSSVRHLSVNLVQIHLDQNR 308

Query:   179 LKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPXXXXXX 238
             + G+IP EI +L  L  L+L  N L+G IP  +  L +L+  +L   +L G +P      
Sbjct:   309 IHGSIPPEISNLLNLTLLNLSSNLLSGPIPRELCKLSKLERVYLSNNHLTGEIPMELGDI 368

Query:   239 XXXXXXXXXXXKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEIXXXXXX 298
                         LSG IP    +L+ LR L L  N L+ ++P SL      LEI      
Sbjct:   369 PRLGLLDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQSLGKC-INLEILDLSHN 427

Query:   299 XXXXXX--XXVQKLKVLRV-LDLSRNQLSGDIPSTIGALVDLETISLAGSFGSVYKGTIS 355
                       V  L+ L++ L+LS N LSG IP  +  +  + ++ L+ +  S   G I 
Sbjct:   428 NLTGTIPVEVVSNLRNLKLYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELS---GKIP 484

Query:   356 D--GTDVAIKIFNLQR 369
                G+ +A++  NL R
Sbjct:   485 PQLGSCIALEHLNLSR 500

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)]

 Score = 495 (179.3 bits), Expect = 1.4e-66, Sum P(2) = 1.4e-66
 Identities = 129/392 (32%), Positives = 187/392 (47%)

Query:     1 MTGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHS 60
             + G+IP +I  L  + SL L  NN SG+ PP  +N+S++ NL L GN  SG+L    G+ 
Sbjct:   198 LEGEIPDDIAMLSQMVSLTLTMNNFSGVFPPAFYNLSSLENLYLLGNGFSGNLKPDFGNL 257

Query:    61 LPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMN 120
             LPNI  L L  N L G IP ++ N + L +  +G N  +G I   FG L +L  L L  N
Sbjct:   258 LPNIHELSLHGNFLTGAIPTTLANISTLEMFGIGKNRMTGSISPNFGKLENLHYLELANN 317

Query:   121 NLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLK 180
             +L + S      +FL +LTNC +L  L +S N LGG LP SI N ST L   +     + 
Sbjct:   318 SLGSYSFG--DLAFLDALTNCSHLHGLSVSYNRLGGALPTSIVNMSTELTVLNLKGNLIY 375

Query:   181 GTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPXXXXXXXX 240
             G+IP +IG+L GL  L L  N L G +PTS+G L  L    L      G +P        
Sbjct:   376 GSIPHDIGNLIGLQSLLLADNLLTGPLPTSLGNLVGLGELILFSNRFSGEIPSFIGNLTQ 435

Query:   241 XXXXXXXXXKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEIXXXXXXXX 300
                         G +PP L   + + +L +G NKL  +IP  +  +  ++ +        
Sbjct:   436 LVKLYLSNNSFEGIVPPSLGDCSHMLDLQIGYNKLNGTIPKEIMQIPTLVHLNMESNSLS 495

Query:   301 XXXXXXVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAGSFGSVYKGTISDGTDV 360
                   + +L+ L  L L  N LSG +P T+G  + +E I L  +    + GTI D   +
Sbjct:   496 GSLPNDIGRLQNLVELLLGNNNLSGHLPQTLGKCLSMEVIYLQENH---FDGTIPDIKGL 552

Query:   361 -AIKIFNLQRERAFRSFNSECEVLRNVRHQNL 391
               +K  +L       S +   E    + + NL
Sbjct:   553 MGVKNVDLSNNNLSGSISEYFENFSKLEYLNL 584

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009507 "chloroplast" evidence=IDA

TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)]

 Score = 497 (180.0 bits), Expect = 4.7e-66, Sum P(2) = 4.7e-66
 Identities = 131/396 (33%), Positives = 200/396 (50%)

Query:     1 MTGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHS 60
             + G+IP+++  L  + SL L ANN SG+ PP ++N+S+++ L +G N  SG L   +G  
Sbjct:   198 LEGEIPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGIL 257

Query:    61 LPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMN 120
             LPN+    +G N   G+IP +++N + L  L +  N  +G IP TFGN+ +L +L L  N
Sbjct:   258 LPNLLSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIP-TFGNVPNLKLLFLHTN 316

Query:   121 NLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLK 180
             +L ++SS   +  FL+SLTNC  L  L +  N LGG LP SI N S  L         + 
Sbjct:   317 SLGSDSSRDLE--FLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTLIS 374

Query:   181 GTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPXXXXXXXX 240
             G+IP +IG+L  L  L L  N L+G +PTS+G L  L+   L    L G +P        
Sbjct:   375 GSIPYDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTM 434

Query:   241 XXXXXXXXXKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEIXXXXXXXX 300
                         G +P  L + + L EL +G NKL  +IP  +  +  +L +        
Sbjct:   435 LETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLI 494

Query:   301 XXXXXXVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAGS--FGSV--YKGTIS- 355
                   +  L+ L  L L  N+LSG +P T+G  + +E++ L G+  +G +   KG +  
Sbjct:   495 GSLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPDLKGLVGV 554

Query:   356 DGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNL 391
                D++    +      F SF S+ E L N+   NL
Sbjct:   555 KEVDLSNNDLSGSIPEYFASF-SKLEYL-NLSFNNL 588

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)]

 Score = 484 (175.4 bits), Expect = 9.4e-64, Sum P(2) = 9.4e-64
 Identities = 120/356 (33%), Positives = 176/356 (49%)

Query:     1 MTGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHS 60
             M G+IP E+  L  +    +  N+ SG  PP ++NIS++ +L+L  N  SG+L +  G+ 
Sbjct:   205 MRGEIPDEVARLTQMVFFQIALNSFSGGFPPALYNISSLESLSLADNSFSGNLRADFGYL 264

Query:    61 LPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMN 120
             LPN++ L LG N   G IP ++ N + L   D+  N  SG IP +FG LR+L  L +  N
Sbjct:   265 LPNLRRLLLGTNQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNN 324

Query:   121 NLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLK 180
             +L   SSS  +  F+ ++ NC  L YL +  N LGG LP SI N ST+L      +  + 
Sbjct:   325 SLGNNSSSGLE--FIGAVANCTQLEYLDVGYNRLGGELPASIANLSTTLTSLFLGQNLIS 382

Query:   181 GTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPXXXXXXXX 240
             GTIP +IG+L  L  LSL  N L+G +P S G L  LQ   L    + G +P        
Sbjct:   383 GTIPHDIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTR 442

Query:   241 XXXXXXXXXKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEIXXXXXXXX 300
                         G IP  L     L +L + +N+L  +IP  +  +  +  I        
Sbjct:   443 LQKLHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAYIDLSNNFLT 502

Query:   301 XXXXXXVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAGSFGSVYKGTISD 356
                   V KL++L  L  S N+LSG +P  IG  + +E + + G+    + G I D
Sbjct:   503 GHFPEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNS---FDGAIPD 555

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010204 "defense response signaling pathway, resistance gene-independent" evidence=IMP

GO:0016045 "detection of bacterium" evidence=RCA;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0002764 "immune response-regulating signaling pathway" evidence=IMP

GO:0009626 "plant-type hypersensitive response" evidence=IMP

GO:0019199 "transmembrane receptor protein kinase activity" evidence=TAS

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050776 "regulation of immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)]

 Score = 463 (168.0 bits), Expect = 4.2e-61, Sum P(2) = 4.2e-61
 Identities = 113/349 (32%), Positives = 172/349 (49%)

Query:     3 GQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLP 62
             G++P E+  L  +  L L  N   G+ PP I+N+S + +L L G+  SG L    G+ LP
Sbjct:   200 GEVPDELARLSQMVGLGLSMNKFFGVFPPAIYNLSALEDLFLFGSGFSGSLKPDFGNLLP 259

Query:    63 NIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNL 122
             NI+ L LG+N+L+G IP +++N + L    +  N  +G I   FG +  L  L L  N L
Sbjct:   260 NIRELNLGENDLVGAIPTTLSNISTLQKFGINKNMMTGGIYPNFGKVPSLQYLDLSENPL 319

Query:   123 TTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGT 182
              + +    +  F+ SLTNC +L  L +    LGG LP SI N ST L   +       G+
Sbjct:   320 GSYTFGDLE--FIDSLTNCTHLQLLSVGYTRLGGALPTSIANMSTELISLNLIGNHFFGS 377

Query:   183 IPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPXXXXXXXXXX 242
             IP++IG+L GL  L LG N L G +PTS+G L +L    L    + G +P          
Sbjct:   378 IPQDIGNLIGLQRLQLGKNMLTGPLPTSLGKLLRLGLLSLYSNRMSGEIPSFIGNLTQLE 437

Query:   243 XXXXXXXKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEIXXXXXXXXXX 302
                       G +PP L   + + +L +G NKL  +IP  +  +  ++ +          
Sbjct:   438 ILYLSNNSFEGIVPPSLGKCSHMLDLRIGYNKLNGTIPKEIMQIPTLVNLSMEGNSLSGS 497

Query:   303 XXXXVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAG-SF-GSV 349
                 +  L+ L  L L  N+ SG +P T+G  + +E + L G SF G++
Sbjct:   498 LPNDIGSLQNLVKLSLENNKFSGHLPQTLGNCLAMEQLFLQGNSFDGAI 546

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 445 (161.7 bits), Expect = 1.4e-59, Sum P(2) = 1.4e-59
 Identities = 116/343 (33%), Positives = 168/343 (48%)

Query:     1 MTGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHS 60
             + G++P EIG L  L+ ++L  N  SG +P  I N + ++ ++  GNRLSG +PS IG  
Sbjct:   421 LEGKVPKEIGFLGKLEIMYLYENRFSGEMPVEIGNCTRLQEIDWYGNRLSGEIPSSIGR- 479

Query:    61 LPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMN 120
             L ++  L L +N L+G IP S+ N  ++ ++DL  N  SG IP++FG L  L +  +  N
Sbjct:   480 LKDLTRLHLRENELVGNIPASLGNCHQMTVIDLADNQLSGSIPSSFGFLTALELFMIYNN 539

Query:   121 NLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLK 180
             +L        Q +   SL N + L  +  S N   G + P  G  S+S   F  +E   +
Sbjct:   540 SL--------QGNLPDSLINLKNLTRINFSSNKFNGSISPLCG--SSSYLSFDVTENGFE 589

Query:   181 GTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPXXXXXXXX 240
             G IP E+G    L  L LG N   G IP + G + +L    +   +L G +P        
Sbjct:   590 GDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIPVELGLCKK 649

Query:   241 XXXXXXXXXKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEIXXXXXXXX 300
                       LSG IP  L  L  L EL L SNK   S+P+ ++SL  IL +        
Sbjct:   650 LTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLN 709

Query:   301 XXXXXXVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLA 343
                   +  L+ L  L+L  NQLSG +PSTIG L  L  + L+
Sbjct:   710 GSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRLS 752

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009553 "embryo sac development" evidence=IMP

GO:0008544 "epidermis development" evidence=IGI

GO:0009790 "embryo development" evidence=IGI

TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)]

 Score = 428 (155.7 bits), Expect = 4.9e-59, Sum P(2) = 4.9e-59
 Identities = 114/343 (33%), Positives = 168/343 (48%)

Query:     1 MTGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHS 60
             + G++P EI  L+ L+ LFL  N  SG IP  I N ++++ +++ GN   G +P  IG  
Sbjct:   420 LEGKLPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGR- 478

Query:    61 LPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMN 120
             L  +  L L  N L+G +P S+ N  +L ILDL  N  SG IP++FG L+ L  L L  N
Sbjct:   479 LKELNLLHLRQNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNN 538

Query:   121 NLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLK 180
             +L        Q +   SL + R L  + LS N L G + P  G  S+S   F  +    +
Sbjct:   539 SL--------QGNLPDSLISLRNLTRINLSHNRLNGTIHPLCG--SSSYLSFDVTNNGFE 588

Query:   181 GTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPXXXXXXXX 240
               IP E+G+ + L  L LG N L G IP ++G +++L    +    L G +P        
Sbjct:   589 DEIPLELGNSQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKK 648

Query:   241 XXXXXXXXXKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEIXXXXXXXX 300
                       LSG IPP L  L+ L EL L SN+   S+P+ L++   +L +        
Sbjct:   649 LTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLN 708

Query:   301 XXXXXXVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLA 343
                   +  L  L VL+L +NQ SG +P  +G L  L  + L+
Sbjct:   709 GSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLS 751

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0008544 "epidermis development" evidence=IGI

GO:0009790 "embryo development" evidence=IGI

TAIR|locus:2007918 PEPR2 "PEP1 receptor 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 421 (153.3 bits), Expect = 1.6e-58, Sum P(2) = 1.6e-58
 Identities = 121/389 (31%), Positives = 181/389 (46%)

Query:     1 MTGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHS 60
             ++GQ+ +EIG L++L +L L  N+ SGL+P  + N +++  L+L  N  SG +P + G S
Sbjct:    88 LSGQLGSEIGELKSLVTLDLSLNSFSGLLPSTLGNCTSLEYLDLSNNDFSGEVPDIFG-S 146

Query:    61 LPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMN 120
             L N+ +L L  NNL G IP S+    +L+ L + +N  SG IP   GN   L  L+L  N
Sbjct:   147 LQNLTFLYLDRNNLSGLIPASVGGLIELVDLRMSYNNLSGTIPELLGNCSKLEYLALNNN 206

Query:   121 NLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLK 180
              L          S  +SL     L  L +S N LGG L     N    L     S    +
Sbjct:   207 KLNG--------SLPASLYLLENLGELFVSNNSLGGRLHFGSSNCK-KLVSLDLSFNDFQ 257

Query:   181 GTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPXXXXXXXX 240
             G +P EIG+   L  L +   +L GTIP+S+G L+++    L +  L G +P        
Sbjct:   258 GGVPPEIGNCSSLHSLVMVKCNLTGTIPSSMGMLRKVSVIDLSDNRLSGNIPQELGNCSS 317

Query:   241 XXXXXXXXXKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEIXXXXXXXX 300
                      +L G IPP L+ L  L+ L+L  NKL+  IP  +W +  + ++        
Sbjct:   318 LETLKLNDNQLQGEIPPALSKLKKLQSLELFFNKLSGEIPIGIWKIQSLTQMLVYNNTLT 377

Query:   301 XXXXXXVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAGS-FGSVYKGTISDGTD 359
                   V +LK L+ L L  N   GDIP ++G    LE + L G+ F       +  G  
Sbjct:   378 GELPVEVTQLKHLKKLTLFNNGFYGDIPMSLGLNRSLEEVDLLGNRFTGEIPPHLCHGQK 437

Query:   360 VAIKIFNL-QRERAFRSFNSECEVLRNVR 387
             + + I    Q      +   +C+ L  VR
Sbjct:   438 LRLFILGSNQLHGKIPASIRQCKTLERVR 466

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009611 "response to wounding" evidence=IEP

GO:0009753 "response to jasmonic acid stimulus" evidence=IEP

GO:0042277 "peptide binding" evidence=IDA

GO:0042742 "defense response to bacterium" evidence=IMP

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009873 "ethylene mediated signaling pathway" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

No EC number assignment, probably not an enzyme!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00014285001 SubName- Full=Chromosome chr18 scaffold_1, whole genome shotgun sequence; (1016 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	481
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	8e-51
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-47
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-47
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-45
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-43
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-42
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	7e-37
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-31
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-31
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	7e-29
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-27
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	3e-27
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	4e-24
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	6e-24
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-23
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-23
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-20
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	8e-20
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-16
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-15
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-14
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-14
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	7e-14
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-13
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-13
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-13
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	5e-13
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	6e-13
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-12
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-12
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-12
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-12
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	4e-12
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	5e-12
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	5e-12
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	6e-12
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	9e-12
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	9e-12
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	9e-12
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-11
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-11
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-11
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-11
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	4e-11
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	7e-11
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	7e-11
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	8e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-10
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-10
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-10
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-10
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-10
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-10
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-10
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	5e-10
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	7e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-09
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-09
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-09
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-09
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-09
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-09
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-09
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	5e-09
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	5e-09
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	6e-09
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	7e-09
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	8e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-08
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-08
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-08
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-08
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-08
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-08
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-08
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-08
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-08
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-08
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-08
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	5e-08
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	6e-08
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	6e-08
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	7e-08
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	8e-08
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	9e-08
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	9e-08
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-07
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-07
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-07
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-07
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-07
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-07
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-07
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-07
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-07
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-07
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-07
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-07
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-07
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-07
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-07
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-07
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-07
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	4e-07
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	7e-07
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	7e-07
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	8e-07
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	8e-07
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	9e-07
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-06
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-06
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-06
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-06
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-06
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-06
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-06
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-06
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-06
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-06
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-06
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	4e-06
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	5e-06
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	5e-06
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	5e-06
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	6e-06
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	8e-06
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-05
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-05
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-05
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-05
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-05
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-05
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-05
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-05
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-05
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-05
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-05
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-05
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	3e-05
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-05
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-05
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	4e-05
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	4e-05
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	4e-05
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	4e-05
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	4e-05
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	5e-05
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	6e-05
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	6e-05
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	7e-05
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	8e-05
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	9e-05
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	9e-05
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-04
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-04
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-04
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-04
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-04
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-04
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-04
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-04
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-04
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-04
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-04
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-04
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	2e-04
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	3e-04
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-04
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-04
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	4e-04
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	4e-04
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	5e-04
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	5e-04
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	5e-04
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	5e-04
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	5e-04
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	6e-04
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	6e-04
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	6e-04
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	7e-04
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	7e-04
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	7e-04
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	8e-04
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	9e-04
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	0.001
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	0.001
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	0.001
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	0.001
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	0.001
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	0.001
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	0.001
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	0.002
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	0.002
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	0.002
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	0.002
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.002
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	0.002
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	0.002
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	0.002
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	0.003
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	0.003
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	0.003
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.004
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	0.004
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	0.004
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	0.004
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	0.004

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  185 bits (471), Expect = 8e-51
 Identities = 125/343 (36%), Positives = 185/343 (53%), Gaps = 11/343 (3%)

Query: 1   MTGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHS 60
           +TG IP+ +GNL+NL+ LFL  N LSG IPP IF++  + +L+L  N LSG +P ++   
Sbjct: 248 LTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQ- 306

Query: 61  LPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMN 120
           L N++ L L  NN  G IP ++T+  +L +L L  N FSG IP   G   +L+VL L  N
Sbjct: 307 LQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTN 366

Query: 121 NLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLK 180
           NLT E            L +   L  LIL  N L G +P S+G    SL+R    +    
Sbjct: 367 NLTGE--------IPEGLCSSGNLFKLILFSNSLEGEIPKSLGACR-SLRRVRLQDNSFS 417

Query: 181 GTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEM 240
           G +P E   L  + +L +  N+L G I +    +  LQ   L      G +P +    + 
Sbjct: 418 GELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLP-DSFGSKR 476

Query: 241 LNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLN 300
           L  L L  N+ SG +P  L SL+ L +L L  NKL+  IP  L S   ++ ++LS N L+
Sbjct: 477 LENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLS 536

Query: 301 DSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLA 343
             +P++  ++ VL  LDLS+NQLSG+IP  +G +  L  ++++
Sbjct: 537 GQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNIS 579

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  176 bits (448), Expect = 1e-47
 Identities = 126/322 (39%), Positives = 169/322 (52%), Gaps = 13/322 (4%)

Query: 11  NLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELG 70
           N   + S+ L   N+SG I   IF +  I+ +NL  N+LSG +P  I  +  +++YL L 
Sbjct: 67  NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLS 126

Query: 71  DNNLIGTIPN-SITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSA 129
           +NN  G+IP  SI N   L  LDL  N  SG IPN  G+   L VL L  N L  +  + 
Sbjct: 127 NNNFTGSIPRGSIPN---LETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPN- 182

Query: 130 YQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGH 189
                  SLTN   L +L L+ N L G +P  +G    SL+        L G IP EIG 
Sbjct: 183 -------SLTNLTSLEFLTLASNQLVGQIPRELGQMK-SLKWIYLGYNNLSGEIPYEIGG 234

Query: 190 LRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGN 249
           L  L +L L +N+L G IP+S+G LK LQ  FL +  L G +P ++  L+ L  L L  N
Sbjct: 235 LTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDN 294

Query: 250 KLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQK 309
            LSG IP  +  L +L  L L SN  T  IP +L SL  +  + L SN  +  +P N+ K
Sbjct: 295 SLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGK 354

Query: 310 LKVLRVLDLSRNQLSGDIPSTI 331
              L VLDLS N L+G+IP  +
Sbjct: 355 HNNLTVLDLSTNNLTGEIPEGL 376

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  175 bits (445), Expect = 2e-47
 Identities = 127/330 (38%), Positives = 172/330 (52%), Gaps = 13/330 (3%)

Query: 1   MTGQIPTEIGNL-QNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGH 59
           ++G IP +I     +L+ L L  NN +G IP    +I  +  L+L  N LSG +P+ IG 
Sbjct: 105 LSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRG--SIPNLETLDLSNNMLSGEIPNDIG- 161

Query: 60  SLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLM 119
           S  ++K L+LG N L+G IPNS+TN T L  L L  N   G IP   G ++ L  + L  
Sbjct: 162 SFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGY 221

Query: 120 NNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKL 179
           NNL+ E    Y+   L+SL N   LVY     N L G +P S+GN   +LQ     + KL
Sbjct: 222 NNLSGEIP--YEIGGLTSL-NHLDLVY-----NNLTGPIPSSLGNL-KNLQYLFLYQNKL 272

Query: 180 KGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLE 239
            G IP  I  L+ LI L L  N L+G IP  +  L+ L+   L   N  G +P  L  L 
Sbjct: 273 SGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLP 332

Query: 240 MLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLL 299
            L +L L  NK SG IP  L    +L  LDL +N LT  IP  L S G + ++ L SN L
Sbjct: 333 RLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSL 392

Query: 300 NDSLPSNVQKLKVLRVLDLSRNQLSGDIPS 329
              +P ++   + LR + L  N  SG++PS
Sbjct: 393 EGEIPKSLGACRSLRRVRLQDNSFSGELPS 422

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  169 bits (430), Expect = 2e-45
 Identities = 123/343 (35%), Positives = 177/343 (51%), Gaps = 13/343 (3%)

Query: 1   MTGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNIS-TIRNLNLGGNRLSGHLPSMIGH 59
           ++G+I + I  L  ++++ L  N LSG IP  IF  S ++R LNL  N  +G +P     
Sbjct: 81  ISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIP---RG 137

Query: 60  SLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLM 119
           S+PN++ L+L +N L G IPN I + + L +LDLG N   G IPN+  NL  L  L+L  
Sbjct: 138 SIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLAS 197

Query: 120 NNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKL 179
           N L  +            L   + L ++ L  N L G +P  IG   TSL         L
Sbjct: 198 NQLVGQIPR--------ELGQMKSLKWIYLGYNNLSGEIPYEIGGL-TSLNHLDLVYNNL 248

Query: 180 KGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLE 239
            G IP  +G+L+ L YL L  N L+G IP SI +L++L    L + +L G +P  +  L+
Sbjct: 249 TGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQ 308

Query: 240 MLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLL 299
            L +LHL  N  +G IP  L SL  L+ L L SNK +  IP +L     +  ++LS+N L
Sbjct: 309 NLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNL 368

Query: 300 NDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISL 342
              +P  +     L  L L  N L G+IP ++GA   L  + L
Sbjct: 369 TGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRL 411

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  163 bits (414), Expect = 2e-43
 Identities = 111/335 (33%), Positives = 166/335 (49%), Gaps = 14/335 (4%)

Query: 1   MTGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHS 60
           ++G+IP +IG+  +LK L LG N L G IP  + N++++  L L  N+L G +P  +G  
Sbjct: 152 LSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQ- 210

Query: 61  LPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMN 120
           + ++K++ LG NNL G IP  I   T L  LDL +N  +G IP++ GNL++L  L L  N
Sbjct: 211 MKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQN 270

Query: 121 NLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFST--SLQRFSASECK 178
            L+             S+ + + L+ L LS N L G +P  +        L  FS     
Sbjct: 271 KLSG--------PIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSN---N 319

Query: 179 LKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHL 238
             G IP  +  L  L  L L  N  +G IP ++G    L    L   NL G +P  LC  
Sbjct: 320 FTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSS 379

Query: 239 EMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNL 298
             L  L L  N L G IP  L +  SLR + L  N  +  +PS    L  +  +++S+N 
Sbjct: 380 GNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNN 439

Query: 299 LNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGA 333
           L   + S    +  L++L L+RN+  G +P + G+
Sbjct: 440 LQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS 474

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  160 bits (406), Expect = 3e-42
 Identities = 120/348 (34%), Positives = 172/348 (49%), Gaps = 41/348 (11%)

Query: 1   MTGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHS 60
           + GQIP E+G +++LK ++LG NNLSG IP  I  ++++ +L+L  N L+G +PS +G +
Sbjct: 200 LVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLG-N 258

Query: 61  LPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMN 120
           L N++YL L  N L G IP SI +  KLI LDL  N+ SG IP     L++L +L L  N
Sbjct: 259 LKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSN 318

Query: 121 NLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLK 180
           N T +   A     L+SL     L  L L  N   G +P ++G    +L     S   L 
Sbjct: 319 NFTGKIPVA-----LTSLPR---LQVLQLWSNKFSGEIPKNLGK-HNNLTVLDLSTNNLT 369

Query: 181 GTIPKEI---GHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCH 237
           G IP+ +   G+L  LI  S   N L G IP S+G  + L+   L + +  G +P     
Sbjct: 370 GEIPEGLCSSGNLFKLILFS---NSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTK 426

Query: 238 LEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSN 297
           L ++  L +  N L G I      + SL+ L L  NK    +P S  S            
Sbjct: 427 LPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS------------ 474

Query: 298 LLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAGS 345
                        K L  LDLSRNQ SG +P  +G+L +L  + L+ +
Sbjct: 475 -------------KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSEN 509

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  144 bits (365), Expect = 7e-37
 Identities = 106/328 (32%), Positives = 153/328 (46%), Gaps = 33/328 (10%)

Query: 1   MTGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHS 60
           ++G IP  I +LQ L SL L  N+LSG IP ++  +  +  L+L  N  +G +P  +  S
Sbjct: 272 LSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALT-S 330

Query: 61  LPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMN 120
           LP ++ L+L  N   G IP ++     L +LDL  N  +G IP    +  +L  L L  N
Sbjct: 331 LPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSN 390

Query: 121 NLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPP-------------SIGNFS- 166
           +L  E           SL  CR L  + L  N   G LP              S  N   
Sbjct: 391 SLEGEIPK--------SLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQG 442

Query: 167 ---------TSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQL 217
                     SLQ  S +  K  G +P   G  R L  L L  N  +G +P  +G+L +L
Sbjct: 443 RINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKR-LENLDLSRNQFSGAVPRKLGSLSEL 501

Query: 218 QGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTS 277
               L E  L G +P  L   + L  L L  N+LSG IP   + +  L +LDL  N+L+ 
Sbjct: 502 MQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSG 561

Query: 278 SIPSSLWSLGYILEINLSSNLLNDSLPS 305
            IP +L ++  ++++N+S N L+ SLPS
Sbjct: 562 EIPKNLGNVESLVQVNISHNHLHGSLPS 589

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  128 bits (324), Expect = 1e-31
 Identities = 92/275 (33%), Positives = 130/275 (47%), Gaps = 13/275 (4%)

Query: 83  TNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCR 142
            N+++++ +DL     SG I +    L ++  ++L  N L+               T   
Sbjct: 66  NNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDI-------FTTSS 118

Query: 143 YLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFND 202
            L YL LS N   G +P        +L+    S   L G IP +IG    L  L LG N 
Sbjct: 119 SLRYLNLSNNNFTGSIP---RGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNV 175

Query: 203 LNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASL 262
           L G IP S+  L  L+   L    L G +P  L  ++ L  ++LG N LSG IP  +  L
Sbjct: 176 LVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGL 235

Query: 263 TSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQ 322
           TSL  LDL  N LT  IPSSL +L  +  + L  N L+  +P ++  L+ L  LDLS N 
Sbjct: 236 TSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNS 295

Query: 323 LSGDIPSTIGALVDLETISLAGSFGSVYKGTISDG 357
           LSG+IP  +  L +LE + L   F + + G I   
Sbjct: 296 LSGEIPELVIQLQNLEILHL---FSNNFTGKIPVA 327

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  127 bits (321), Expect = 3e-31
 Identities = 98/319 (30%), Positives = 156/319 (48%), Gaps = 23/319 (7%)

Query: 1   MTGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHS 60
           ++G+IP  +  LQNL+ L L +NN +G IP  + ++  ++ L L  N+ SG +P  +G  
Sbjct: 296 LSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKH 355

Query: 61  LPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMN 120
             N+  L+L  NNL G IP  + ++  L  L L  N+  G IP + G  R L  + L  N
Sbjct: 356 -NNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDN 414

Query: 121 NLTTESSSAYQW------------SFLSSLTNCRY----LVYLILSGNPLGGILPPSIGN 164
           + + E  S +              +    + + ++    L  L L+ N   G LP S G 
Sbjct: 415 SFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFG- 473

Query: 165 FSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPE 224
            S  L+    S  +  G +P+++G L  L+ L L  N L+G IP  + + K+L    L  
Sbjct: 474 -SKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSH 532

Query: 225 TNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLW 284
             L G +P +   + +L+ L L  N+LSG IP  L ++ SL ++++  N L  S+PS+  
Sbjct: 533 NQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPST-- 590

Query: 285 SLGYILEINLSSNLLNDSL 303
             G  L IN S+   N  L
Sbjct: 591 --GAFLAINASAVAGNIDL 607

Length = 968

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  113 bits (284), Expect = 7e-29
 Identities = 50/146 (34%), Positives = 69/146 (47%), Gaps = 12/146 (8%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQ-RERAFRSFNSECEVLRNVRHQNLIKILSSCSTP 401
           G FG+VY       G  VAIKI   +           E E+L+ + H N++K+       
Sbjct: 4   GGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDE 63

Query: 402 DFK-----FMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLK 456
           +       +   GSL+  L  +   L   E L I++ +   LEYLH    S  IIH DLK
Sbjct: 64  NHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH----SNGIIHRDLK 119

Query: 457 PTSILLDE-NMVAHVSDFGISKLLGE 481
           P +ILLD  N    ++DFG+SKLL  
Sbjct: 120 PENILLDSDNGKVKLADFGLSKLLTS 145

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  110 bits (277), Expect = 1e-27
 Identities = 49/147 (33%), Positives = 74/147 (50%), Gaps = 13/147 (8%)

Query: 343 AGSFGSVYKGT-ISDGTDVAIKIFNLQRER--AFRSFNSECEVLRNVRHQNLIKILSSCS 399
           +GSFG+VYK      G  VA+KI   + E+    ++   E  +LR + H N+++++ +  
Sbjct: 9   SGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFE 68

Query: 400 TPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
             D      ++   G L   L          E   I + +   LEYLH    S  IIH D
Sbjct: 69  DKDHLYLVMEYCEGGDLFDYLSRGGPL-SEDEAKKIALQILRGLEYLH----SNGIIHRD 123

Query: 455 LKPTSILLDENMVAHVSDFGISKLLGE 481
           LKP +ILLDEN V  ++DFG++K L +
Sbjct: 124 LKPENILLDENGVVKIADFGLAKKLLK 150

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  109 bits (275), Expect = 3e-27
 Identities = 43/145 (29%), Positives = 68/145 (46%), Gaps = 12/145 (8%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRERAFR-SFNSECEVLRNVRHQNLIKILSSCSTP 401
           GSFG VY       G  VAIK+   ++ +  R     E ++L+ ++H N++++       
Sbjct: 10  GSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDE 69

Query: 402 D-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLK 456
           D      ++   G L   L          E    +  + S LEYLH    S  I+H DLK
Sbjct: 70  DKLYLVMEYCEGGDLFDLLKKRGRL-SEDEARFYLRQILSALEYLH----SKGIVHRDLK 124

Query: 457 PTSILLDENMVAHVSDFGISKLLGE 481
           P +ILLDE+    ++DFG+++ L  
Sbjct: 125 PENILLDEDGHVKLADFGLARQLDP 149

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  101 bits (253), Expect = 4e-24
 Identities = 43/148 (29%), Positives = 72/148 (48%), Gaps = 15/148 (10%)

Query: 343 AGSFGSVYKGTI-----SDGTDVAIKIFNLQ-RERAFRSFNSECEVLRNVRHQNLIKILS 396
            G+FG VYKGT+        T VA+K       E     F  E  +++ + H N++++L 
Sbjct: 9   EGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLLG 68

Query: 397 SCSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPII 451
            C+  +      ++MP G L   L  H   L + + L + + +   +EYL     S   +
Sbjct: 69  VCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE----SKNFV 124

Query: 452 HCDLKPTSILLDENMVAHVSDFGISKLL 479
           H DL   + L+ EN+V  +SDFG+S+ +
Sbjct: 125 HRDLAARNCLVTENLVVKISDFGLSRDI 152

Length = 258

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  105 bits (263), Expect = 6e-24
 Identities = 130/491 (26%), Positives = 209/491 (42%), Gaps = 69/491 (14%)

Query: 1   MTGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHS 60
           +TG+IP  + +  NL  L L +N+L G IP  +    ++R + L  N  SG LPS     
Sbjct: 368 LTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEF-TK 426

Query: 61  LPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMN 120
           LP + +L++ +NNL G I +   +   L +L L  N F G +P++FG+ R          
Sbjct: 427 LPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKR---------- 476

Query: 121 NLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLK 180
                                  L  L LS N   G +P  +G+ S  +Q    SE KL 
Sbjct: 477 -----------------------LENLDLSRNQFSGAVPRKLGSLSELMQ-LKLSENKLS 512

Query: 181 GTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEM 240
           G IP E+   + L+ L L  N L+G IP S   +  L    L +  L G +P NL ++E 
Sbjct: 513 GEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVES 572

Query: 241 LNLLHLGGNKLSGHIPPCLASL----TSLR-ELDLGSNKLTSSIP-------SSLW---- 284
           L  +++  N L G +P   A L    +++   +DL     TS +P       +  W    
Sbjct: 573 LVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYI 632

Query: 285 --SLGYILEINLSSNLLNDSLPSNVQKLKVLRVLD--------LSRNQLSGDIPSTIGAL 334
             +LG  L + L +         N  +LK +   D         S+   S  I   + +L
Sbjct: 633 TCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSL 692

Query: 335 VDLETISLAGSFGSVYKG-TISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIK 393
            +   IS  G  G+ YKG +I +G    +K  N        S  ++   +  ++H N++K
Sbjct: 693 KEENVIS-RGKKGASYKGKSIKNGMQFVVKEIN-DVNSIPSSEIAD---MGKLQHPNIVK 747

Query: 394 ILSSCSTPDFKFMPNGSLE-KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
           ++  C +    ++ +  +E K L      L    R  I I +   L +L H   S  ++ 
Sbjct: 748 LIGLCRSEKGAYLIHEYIEGKNLSEVLRNLSWERRRKIAIGIAKALRFL-HCRCSPAVVV 806

Query: 453 CDLKPTSILLD 463
            +L P  I++D
Sbjct: 807 GNLSPEKIIID 817

Length = 968

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 99.5 bits (249), Expect = 1e-23
 Identities = 43/149 (28%), Positives = 72/149 (48%), Gaps = 15/149 (10%)

Query: 344 GSFGSVYKGTISD-----GTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSS 397
           G+FG VYKG +         +VA+K       E+    F  E  ++R + H N++K+L  
Sbjct: 10  GAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLLGV 69

Query: 398 CSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
           C+  +      ++M  G L   L  +   L + + L+  + +   +EYL     S   IH
Sbjct: 70  CTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE----SKNFIH 125

Query: 453 CDLKPTSILLDENMVAHVSDFGISKLLGE 481
            DL   + L+ EN+V  +SDFG+S+ L +
Sbjct: 126 RDLAARNCLVGENLVVKISDFGLSRDLYD 154

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 98.8 bits (247), Expect = 2e-23
 Identities = 45/150 (30%), Positives = 74/150 (49%), Gaps = 16/150 (10%)

Query: 344 GSFGSVYKGTISDG-----TDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSS 397
           G+FG VYKGT+         +VA+K       E+    F  E  ++R + H N++K+L  
Sbjct: 10  GAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLLGV 69

Query: 398 CSTPD-----FKFMPNGSLEKRL-YSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPII 451
           C+  +      ++MP G L   L  +    L + + L+  + +   +EYL     S   I
Sbjct: 70  CTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE----SKNFI 125

Query: 452 HCDLKPTSILLDENMVAHVSDFGISKLLGE 481
           H DL   + L+ EN+V  +SDFG+S+ L +
Sbjct: 126 HRDLAARNCLVGENLVVKISDFGLSRDLYD 155

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 89.9 bits (224), Expect = 2e-20
 Identities = 41/154 (26%), Positives = 70/154 (45%), Gaps = 22/154 (14%)

Query: 344 GSFGSVYKGTISDG----TDVAIKIFNLQRERAFRS-FNSECEVLRNVRHQNLIKILSSC 398
           G+FG VYKG +       T+VA+K          R  F  E  V++ + H N++++L  C
Sbjct: 6   GAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVC 65

Query: 399 STPD-----FKFMPNGSLEKRLYSH--------NYFLDILERLNIMIDVGSTLEYLHHGH 445
           +  +      ++M  G L   L              L + + L+  I +   +EYL    
Sbjct: 66  TEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA--- 122

Query: 446 SSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
            S   +H DL   + L+ E++V  +SDFG+S+ +
Sbjct: 123 -SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDV 155

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 88.4 bits (220), Expect = 8e-20
 Identities = 46/157 (29%), Positives = 68/157 (43%), Gaps = 33/157 (21%)

Query: 344 GSFGSVYKGTISD-GTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCST 400
           GSFGSVY     D G  +A+K   L    E    +   E  +L +++H N+++   S   
Sbjct: 11  GSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERD 70

Query: 401 PDFK-------FMPNGSLEKRLYS---------HNYFLDILERLNIMIDVGSTLEYLHHG 444
            +         ++  GSL   L             Y   ILE        G  L YLH  
Sbjct: 71  EEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILE--------G--LAYLH-- 118

Query: 445 HSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
             S  I+H D+K  +IL+D + V  ++DFG +K LG+
Sbjct: 119 --SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 79.2 bits (196), Expect = 1e-16
 Identities = 48/148 (32%), Positives = 70/148 (47%), Gaps = 11/148 (7%)

Query: 336 DLETISLAGSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKI 394
            LE I   G FG VYK      G +VAIK+  L+ +       +E ++L+  +H N++K 
Sbjct: 4   ILEKIG-KGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKY 62

Query: 395 LSSCSTPDF-----KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAP 449
             S    D      +F   GSL+  L S N  L   +   +  ++   LEYLH    S  
Sbjct: 63  YGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH----SNG 118

Query: 450 IIHCDLKPTSILLDENMVAHVSDFGISK 477
           IIH D+K  +ILL  +    + DFG+S 
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLSA 146

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 74.8 bits (185), Expect = 3e-15
 Identities = 44/151 (29%), Positives = 68/151 (45%), Gaps = 23/151 (15%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNL------QRERAFRSFNSECEVLRNVRHQNLIKILS 396
           GSFG VY     SDG    +K  +L      +RE A      E ++L+ + H N+IK   
Sbjct: 11  GSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALN----EVKILKKLNHPNIIKYYE 66

Query: 397 SCSTPDF-----KFMPNGSLEKRLYSHNYFLDIL---ERLNIMIDVGSTLEYLHHGHSSA 448
           S           ++   G L +++             + L+  + +   L+YLH    S 
Sbjct: 67  SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH----SR 122

Query: 449 PIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
            I+H D+KP +I L  N +  + DFGISK+L
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISKVL 153

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 72.9 bits (179), Expect = 2e-14
 Identities = 43/144 (29%), Positives = 71/144 (49%), Gaps = 10/144 (6%)

Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD- 402
           G FG V++G   +   VAIKI         + F  E + L+ +RH++LI + + CS  + 
Sbjct: 17  GYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEP 76

Query: 403 ----FKFMPNGSLEKRLYS-HNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKP 457
                + M  GSL   L S     L +   +++   V   + YL   +     IH DL  
Sbjct: 77  VYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN----SIHRDLAA 132

Query: 458 TSILLDENMVAHVSDFGISKLLGE 481
            +IL+ E++V  V+DFG+++L+ E
Sbjct: 133 RNILVGEDLVCKVADFGLARLIKE 156

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 72.0 bits (177), Expect = 3e-14
 Identities = 47/151 (31%), Positives = 75/151 (49%), Gaps = 15/151 (9%)

Query: 334 LVDLETISLAGSFGSVYKGTISDGTDVAIKIFNLQRE-RAFRSFNSECEVLRNVRHQNLI 392
           L    TI   G FG V  G    G  VA+K   L+ +  A ++F +E  V+  +RH NL+
Sbjct: 8   LKLGATIG-KGEFGDVMLGDYR-GQKVAVK--CLKDDSTAAQAFLAEASVMTTLRHPNLV 63

Query: 393 KILSSCSTPD-----FKFMPNGSLEKRLYSH-NYFLDILERLNIMIDVGSTLEYLHHGHS 446
           ++L      +      ++M  GSL   L S     + + ++L   +DV   +EYL     
Sbjct: 64  QLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---- 119

Query: 447 SAPIIHCDLKPTSILLDENMVAHVSDFGISK 477
               +H DL   ++L+ E++VA VSDFG++K
Sbjct: 120 EKNFVHRDLAARNVLVSEDLVAKVSDFGLAK 150

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 71.4 bits (175), Expect = 7e-14
 Identities = 47/156 (30%), Positives = 69/156 (44%), Gaps = 26/156 (16%)

Query: 344 GSFGSVYKGTIS--DGT--DVAIKIFNLQ--RERAFRSFNSECEVLRNVRHQNLIKILSS 397
           G FGSV +G +S  DG+   VA+K   L          F SE   +++  H N++K++  
Sbjct: 10  GEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGV 69

Query: 398 CSTPDFK-----------FMPNGSLEK-----RLYSHNYFLDILERLNIMIDVGSTLEYL 441
           C                 FM +G L       RL      L +   L  M+D+   +EYL
Sbjct: 70  CFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYL 129

Query: 442 HHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK 477
               S+   IH DL   + +L E+M   V+DFG+SK
Sbjct: 130 ----SNRNFIHRDLAARNCMLREDMTVCVADFGLSK 161

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 70.8 bits (174), Expect = 1e-13
 Identities = 45/156 (28%), Positives = 66/156 (42%), Gaps = 33/156 (21%)

Query: 344 GSFGSVYKG-TISDGTDVAIKIFNLQRER--AFRSFNSECEVLRNVRHQNLIK------- 393
           G+FG VY    +  G  +A+K   +Q       +    E +VL  ++H NL+K       
Sbjct: 11  GTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH 70

Query: 394 ------ILSSCSTPDFKFMPNGSLEKRLYSHNYFLD--ILERLNIMIDVGSTLEYLHHGH 445
                  +  CS         G+LE  L  H   LD  ++    + +  G  L YLH   
Sbjct: 71  REKVYIFMEYCS--------GGTLE-ELLEHGRILDEHVIRVYTLQLLEG--LAYLH--- 116

Query: 446 SSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
            S  I+H D+KP +I LD N V  + DFG +  L  
Sbjct: 117 -SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKN 151

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 69.2 bits (170), Expect = 3e-13
 Identities = 47/143 (32%), Positives = 75/143 (52%), Gaps = 17/143 (11%)

Query: 344 GSFGSVYKG-TISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCST 400
           G+FG VYKG  +  G  VAIK  +L++  E A +S   E ++L+N++H N++K + S  T
Sbjct: 11  GAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET 70

Query: 401 PDF-----KFMPNGSLEKRLYSHNYFLDILERLNI--MIDVGSTLEYLHHGHSSAPIIHC 453
            D      ++  NGSL + +     F    E L    +  V   L YLH       +IH 
Sbjct: 71  SDSLYIILEYAENGSLRQIIKKFGPFP---ESLVAVYVYQVLQGLAYLH----EQGVIHR 123

Query: 454 DLKPTSILLDENMVAHVSDFGIS 476
           D+K  +IL  ++ V  ++DFG++
Sbjct: 124 DIKAANILTTKDGVVKLADFGVA 146

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 69.2 bits (170), Expect = 4e-13
 Identities = 46/158 (29%), Positives = 71/158 (44%), Gaps = 23/158 (14%)

Query: 336 DLETISL--AGSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRS-FNSECEVLRNVRHQNL 391
           DLE + +   GS G VYK      G   A+K  ++  +  FR     E + LR+     +
Sbjct: 2   DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYV 61

Query: 392 IKILSSCSTPDFK---------FMPNGSLEKRLYSHNYFLD-ILERLNIMIDVGSTLEYL 441
           +K    C    +K         +M  GSL   L       + +L  +   I  G  L+YL
Sbjct: 62  VK----CYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKG--LDYL 115

Query: 442 HHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
           H       IIH D+KP+++L++      ++DFGISK+L
Sbjct: 116 HTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVL 150

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 69.0 bits (169), Expect = 5e-13
 Identities = 48/173 (27%), Positives = 75/173 (43%), Gaps = 34/173 (19%)

Query: 335 VDLETISL-----AGSFGSVYKGTIS------DGTDVAIKIF-NLQRERAFRSFNSECEV 382
           V  +TI L      G+FG V+ G         D   VA+K         A + F  E E+
Sbjct: 2   VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAEL 61

Query: 383 LRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRLYSHNYFLDIL------------ 425
           L N +H+N++K    C+  D     F++M +G L K L SH      L            
Sbjct: 62  LTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTL 121

Query: 426 -ERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK 477
            + L I + + S + YL    +S   +H DL   + L+  ++V  + DFG+S+
Sbjct: 122 SQLLQIAVQIASGMVYL----ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR 170

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 68.8 bits (169), Expect = 6e-13
 Identities = 47/148 (31%), Positives = 70/148 (47%), Gaps = 15/148 (10%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFN---LQRERAFRSFNSECEVL-RNVRHQNLIKILSSC 398
           GSF +V          + AIKI +   L +E+  +    E EVL R   H  +IK+  + 
Sbjct: 12  GSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF 71

Query: 399 STPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHC 453
              +      ++ PNG L + +      LD         ++   LEYLH    S  IIH 
Sbjct: 72  QDEENLYFVLEYAPNGELLQYI-RKYGSLDEKCTRFYAAEILLALEYLH----SKGIIHR 126

Query: 454 DLKPTSILLDENMVAHVSDFGISKLLGE 481
           DLKP +ILLD++M   ++DFG +K+L  
Sbjct: 127 DLKPENILLDKDMHIKITDFGTAKVLDP 154

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 67.8 bits (166), Expect = 1e-12
 Identities = 47/149 (31%), Positives = 76/149 (51%), Gaps = 22/149 (14%)

Query: 343 AGSFGSVYKG-TISDGTDVAIKIFNL-----QRERAFRSFNSECEVLRNVRHQNLIKILS 396
           +GSFGSVY+G  + DG   A+K  +L       + A +    E  +L  ++H N+++ L 
Sbjct: 10  SGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLG 69

Query: 397 SCSTPD-----FKFMPNGSLEKRLYSHNYFLDILERL---NIMIDVGSTLEYLHHGHSSA 448
           +    D      + +P GSL K L  +  F + + RL    I+      LEYLH  +   
Sbjct: 70  TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQIL----LGLEYLHDRN--- 122

Query: 449 PIIHCDLKPTSILLDENMVAHVSDFGISK 477
             +H D+K  +IL+D N V  ++DFG++K
Sbjct: 123 -TVHRDIKGANILVDTNGVVKLADFGMAK 150

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 67.5 bits (165), Expect = 1e-12
 Identities = 45/144 (31%), Positives = 72/144 (50%), Gaps = 18/144 (12%)

Query: 344 GSFGSVYKGTISDGTDVAIK-----IFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSC 398
           G+FG VYKG +   T+VA+K     +    + +    F  E E+L+   H N++K++  C
Sbjct: 6   GNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRK----FLQEAEILKQYDHPNIVKLIGVC 61

Query: 399 --STPDF---KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHC 453
               P +   + +P GSL   L      L + + L + +D  + +EYL     S   IH 
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE----SKNCIHR 117

Query: 454 DLKPTSILLDENMVAHVSDFGISK 477
           DL   + L+ EN V  +SDFG+S+
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 44/144 (30%), Positives = 68/144 (47%), Gaps = 14/144 (9%)

Query: 343 AGSFGSVYKGTISDGTDVAIKIFNLQRERAF--RSFNSECEVLRNVRHQNLIKILSSC-- 398
           +G FG V+ G   +   VAIK     RE A     F  E +V+  + H  L+++   C  
Sbjct: 14  SGQFGLVWLGYWLEKRKVAIKTI---REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70

Query: 399 STPD---FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDL 455
            +P    F+FM +G L   L +          L + +DV   + YL     S+ +IH DL
Sbjct: 71  RSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE----SSNVIHRDL 126

Query: 456 KPTSILLDENMVAHVSDFGISKLL 479
              + L+ EN V  VSDFG+++ +
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRFV 150

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 67.0 bits (164), Expect = 2e-12
 Identities = 46/163 (28%), Positives = 79/163 (48%), Gaps = 36/163 (22%)

Query: 338 ETISL-----AGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLI 392
           E++ L     AG FG V+ GT +  T VA+K        +  +F  E ++++ +RH  L+
Sbjct: 6   ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLK-PGTMSPEAFLQEAQIMKKLRHDKLV 64

Query: 393 KILSSCSTPD-----FKFMPNGSLEKRLYSHNYFLDILE-------RLNIMID----VGS 436
           ++ + CS  +      ++M  GSL          LD L+       RL  ++D    +  
Sbjct: 65  QLYAVCSEEEPIYIVTEYMSKGSL----------LDFLKSGEGKKLRLPQLVDMAAQIAE 114

Query: 437 TLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
            + YL     S   IH DL   +IL+ EN+V  ++DFG+++L+
Sbjct: 115 GMAYLE----SRNYIHRDLAARNILVGENLVCKIADFGLARLI 153

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 65.8 bits (160), Expect = 4e-12
 Identities = 45/141 (31%), Positives = 70/141 (49%), Gaps = 12/141 (8%)

Query: 344 GSFGSVYKGTISDGTDVAIKIF--NLQRERAFRSFNSECEVLRNVRHQNLIKILSSCS-- 399
           G+FG V+KGT+ D T VA+K    +L +E   + F SE  +L+   H N++K++  C+  
Sbjct: 6   GNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIK-FLSEARILKQYDHPNIVKLIGVCTQR 64

Query: 400 TPDFKFM---PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLK 456
            P +  M   P G     L      L   + +   +D  + + YL     S   IH DL 
Sbjct: 65  QPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE----SKNCIHRDLA 120

Query: 457 PTSILLDENMVAHVSDFGISK 477
             + L+ EN V  +SDFG+S+
Sbjct: 121 ARNCLVGENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 65.7 bits (160), Expect = 5e-12
 Identities = 46/154 (29%), Positives = 82/154 (53%), Gaps = 17/154 (11%)

Query: 334 LVDLETISLA-----GSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRH 388
           L++L+ ++L      G FG+V +G  + G  VA+K  N++ +   ++F  E  V+  + H
Sbjct: 2   LLNLQKLTLGEIIGEGEFGAVLQGEYT-GQKVAVK--NIKCDVTAQAFLEETAVMTKLHH 58

Query: 389 QNLIK----ILSSCSTPDFKFMPNGSLEKRLYSHNYFL-DILERLNIMIDVGSTLEYLHH 443
           +NL++    IL +      + M  G+L   L +    L  +++ L   +DV   +EYL  
Sbjct: 59  KNLVRLLGVILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE- 117

Query: 444 GHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK 477
              S  ++H DL   +IL+ E+ VA VSDFG+++
Sbjct: 118 ---SKKLVHRDLAARNILVSEDGVAKVSDFGLAR 148

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 65.7 bits (160), Expect = 5e-12
 Identities = 46/157 (29%), Positives = 70/157 (44%), Gaps = 18/157 (11%)

Query: 328 PSTIGALVDLETISLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRS--FNSECEVLRN 385
           P  +  L +L T    G FG V  G      DVAIK+    +E +     F  E +V+  
Sbjct: 3   PKDLTFLKELGT----GQFGVVKYGKWRGQYDVAIKMI---KEGSMSEDEFIEEAKVMMK 55

Query: 386 VRHQNLIKILSSCST--PDF---KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEY 440
           + H+ L+++   C+   P +   ++M NG L   L  H       + L +  DV   + Y
Sbjct: 56  LSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAY 115

Query: 441 LHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK 477
           L     S   IH DL   + L+D+     VSDFG+S+
Sbjct: 116 LE----SKQFIHRDLAARNCLVDDQGCVKVSDFGLSR 148

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 65.9 bits (161), Expect = 6e-12
 Identities = 45/151 (29%), Positives = 70/151 (46%), Gaps = 17/151 (11%)

Query: 344 GSFGSVYKGT---ISDGT--DVAIKIFNLQRERAFRS-FNSECEVLRNVRHQNLIKILSS 397
           G FG V       + D T   VA+K  N   E   RS F  E E+LR + H+N++K    
Sbjct: 15  GHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGV 74

Query: 398 CSTPDFK-------FMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPI 450
           C  P  +       ++P+GSL   L  H   +++   L     +   ++YL         
Sbjct: 75  CEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR----Y 130

Query: 451 IHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
           IH DL   +IL++   +  +SDFG++K+L E
Sbjct: 131 IHRDLAARNILVESEDLVKISDFGLAKVLPE 161

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 65.2 bits (159), Expect = 9e-12
 Identities = 45/162 (27%), Positives = 75/162 (46%), Gaps = 31/162 (19%)

Query: 344 GSFGSVYKGTI------SDGTDVAIKIFNLQRERAFRS-FNSECEVLRNVRHQNLIKILS 396
           G+FG VYKG +         T VAIK      E   +  F  E E++ +++H N++ +L 
Sbjct: 16  GAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLG 75

Query: 397 SC--STPD---FKFMPNGSLEKRLYSHN---------------YFLDILERLNIMIDVGS 436
            C    P    F+++ +G L + L  ++                 LD  + L+I I + +
Sbjct: 76  VCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAA 135

Query: 437 TLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL 478
            +EYL    SS   +H DL   + L+ E +   +SDFG+S+ 
Sbjct: 136 GMEYL----SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRD 173

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 64.9 bits (158), Expect = 9e-12
 Identities = 45/157 (28%), Positives = 79/157 (50%), Gaps = 14/157 (8%)

Query: 335 VDLETISLAGSFGSVYKGTIS----DGTDVAIKIFNL-QRERAFRSFNSECEVLRNVRHQ 389
           V +E +  AG FG V +G +         VAIK       E+  R F SE  ++    H 
Sbjct: 6   VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHP 65

Query: 390 NLIKI--LSSCSTPDF---KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHG 444
           N+I +  + + S P     +FM NG+L+  L  ++    +++ + ++  + + ++YL   
Sbjct: 66  NIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL--- 122

Query: 445 HSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
            S    +H DL   +IL++ N+V  VSDFG+S+ L +
Sbjct: 123 -SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 65.0 bits (158), Expect = 9e-12
 Identities = 42/149 (28%), Positives = 76/149 (51%), Gaps = 18/149 (12%)

Query: 343 AGSFGSVYKGTI--SDGTDVAIKIFNLQ---RERAFRSFNSECEVLRNVRHQNLIKILSS 397
           AG FG V++G +      +VA+ I  L+    E+  + F SE  ++    H N+I++   
Sbjct: 15  AGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGV 74

Query: 398 CSTPDFK-------FMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPI 450
            +   FK       +M NG+L+K L  H+      + + ++  + + ++YL    S    
Sbjct: 75  VTK--FKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL----SDMNY 128

Query: 451 IHCDLKPTSILLDENMVAHVSDFGISKLL 479
           +H DL   +IL++ N+   VSDFG+S++L
Sbjct: 129 VHRDLAARNILVNSNLECKVSDFGLSRVL 157

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 65.1 bits (159), Expect = 1e-11
 Identities = 44/159 (27%), Positives = 79/159 (49%), Gaps = 14/159 (8%)

Query: 333 ALVDLETISLAGSFGSVYKGTIS----DGTDVAIKIFNLQ-RERAFRSFNSECEVLRNVR 387
           + V +E +   G FG V +G +        DVAIK       ++    F +E  ++    
Sbjct: 4   SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFD 63

Query: 388 HQNLIKILS--SCSTPDF---KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLH 442
           H N+I++    + S P     ++M NGSL+K L  ++    + + + ++  + S ++YL 
Sbjct: 64  HPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYL- 122

Query: 443 HGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
              S    +H DL   +IL++ N+V  VSDFG+S+ L +
Sbjct: 123 ---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 64.6 bits (158), Expect = 1e-11
 Identities = 42/166 (25%), Positives = 72/166 (43%), Gaps = 29/166 (17%)

Query: 337 LETISLAGSFGSVYKGT-ISDGTDVAIKIFNL----QRERAFRSFNSECEVLRNVRHQNL 391
           LETI   GSFG+V K    SDG  +  K  +     ++E+  +   SE  +LR ++H N+
Sbjct: 5   LETIG-KGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEK--QQLVSEVNILRELKHPNI 61

Query: 392 IK---------------ILSSCSTPDFKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGS 436
           ++               ++  C   D        L ++      +++      I+  +  
Sbjct: 62  VRYYDRIIDRSNQTLYIVMEYCEGGDL-----AQLIQKCKKERKYIEEEFIWRILTQLLL 116

Query: 437 TLEYLHHG-HSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
            L   H+       ++H DLKP +I LD N    + DFG++K+LG 
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH 162

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 64.5 bits (157), Expect = 1e-11
 Identities = 44/155 (28%), Positives = 80/155 (51%), Gaps = 14/155 (9%)

Query: 335 VDLETISLAGSFGSVYKGTIS--DGTDVAIKIFNLQ---RERAFRSFNSECEVLRNVRHQ 389
           + +E +  AG FG V  G +      ++ + I  L+    E+  R F SE  ++    H 
Sbjct: 6   IKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHP 65

Query: 390 NLIKI--LSSCSTPDF---KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHG 444
           N+I +  + + S P     ++M NGSL+  L  H+    +++ + ++  + S ++YL   
Sbjct: 66  NIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYL--- 122

Query: 445 HSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
            S    +H DL   +IL++ N+V  VSDFG+S++L
Sbjct: 123 -SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 64.1 bits (156), Expect = 2e-11
 Identities = 43/147 (29%), Positives = 71/147 (48%), Gaps = 16/147 (10%)

Query: 344 GSFGSVYKGTISD-GTDVAIKIFNLQRERAFR--SFNSECEVLRNVRHQNLIKILSSCS- 399
           G +G VY+G        VA+K     +E       F  E  V++ ++H NL+++L  C+ 
Sbjct: 17  GQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 73

Query: 400 TPDF----KFMPNGSLEKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
            P F    +FM  G+L   L   N   ++ +  L +   + S +EYL   +     IH D
Sbjct: 74  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----FIHRD 129

Query: 455 LKPTSILLDENMVAHVSDFGISKLLGE 481
           L   + L+ EN +  V+DFG+S+L+  
Sbjct: 130 LAARNCLVGENHLVKVADFGLSRLMTG 156

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 63.3 bits (155), Expect = 4e-11
 Identities = 39/145 (26%), Positives = 69/145 (47%), Gaps = 23/145 (15%)

Query: 344 GSFGSVYKG-TISDGTDVAIKIFNLQRER------AFRSFNSECEVLRNVRHQNLIK--- 393
           G++G VYK      G  VA+K   ++ E+      A R    E ++L+ +RH N+++   
Sbjct: 10  GTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR----EIKLLQKLRHPNIVRLKE 65

Query: 394 ILSSCSTPD----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAP 449
           I++S         F++M +  L   L S        +    M  +   L+YLH       
Sbjct: 66  IVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG---- 120

Query: 450 IIHCDLKPTSILLDENMVAHVSDFG 474
           I+H D+K ++IL++ + V  ++DFG
Sbjct: 121 ILHRDIKGSNILINNDGVLKLADFG 145

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 62.4 bits (151), Expect = 7e-11
 Identities = 40/141 (28%), Positives = 76/141 (53%), Gaps = 10/141 (7%)

Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCST-PD 402
           G FG V+ GT +  T VAIK        +  +F  E +V++ +RH+ L+++ +  S  P 
Sbjct: 17  GCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI 75

Query: 403 F---KFMPNGSLEKRLY-SHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPT 458
           +   ++M  GSL   L      +L + + +++   + S + Y+   +     +H DL+  
Sbjct: 76  YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN----YVHRDLRAA 131

Query: 459 SILLDENMVAHVSDFGISKLL 479
           +IL+ EN+V  V+DFG+++L+
Sbjct: 132 NILVGENLVCKVADFGLARLI 152

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 62.3 bits (152), Expect = 7e-11
 Identities = 42/149 (28%), Positives = 68/149 (45%), Gaps = 21/149 (14%)

Query: 344 GSFGSVYKG-TISDGTDVAIKIFNLQRE------RAFRSFNSECEVLRNVRHQNLIKILS 396
           G++G VYK      G  VAIK   L+ E       A R    E ++L+ + H N+IK+L 
Sbjct: 10  GTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR----EIKLLKELNHPNIIKLLD 65

Query: 397 SCSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPII 451
                      F+FM +  L K +      L      + +  +   L + H    S  I+
Sbjct: 66  VFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH----SHGIL 120

Query: 452 HCDLKPTSILLDENMVAHVSDFGISKLLG 480
           H DLKP ++L++   V  ++DFG+++  G
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSFG 149

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 63.2 bits (152), Expect = 8e-11
 Identities = 48/150 (32%), Positives = 71/150 (47%), Gaps = 18/150 (12%)

Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRER---AFRSFNSECEVLRNVRHQ-NLIKILSSCS 399
           GSFG VY     D   VA+K+   + E        F  E ++L ++ H  N++K+     
Sbjct: 11  GSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQ 68

Query: 400 TPD-----FKFMPNGSLEKRLYSHNYFLDILERLN--IMIDVGSTLEYLHHGHSSAPIIH 452
                    +++  GSLE  L        + E     I+  + S LEYLH    S  IIH
Sbjct: 69  DEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH----SKGIIH 124

Query: 453 CDLKPTSILLDEN-MVAHVSDFGISKLLGE 481
            D+KP +ILLD +  V  + DFG++KLL +
Sbjct: 125 RDIKPENILLDRDGRVVKLIDFGLAKLLPD 154

Length = 384

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 63.7 bits (155), Expect = 1e-10
 Identities = 39/116 (33%), Positives = 57/116 (49%), Gaps = 24/116 (20%)

Query: 219 GFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSS 278
           G  L    L+G++P+++  L  L  ++L GN + G+IPP L S+TSL  LDL  N    S
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481

Query: 279 IPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGAL 334
           IP SL                         +L  LR+L+L+ N LSG +P+ +G  
Sbjct: 482 IPESL------------------------GQLTSLRILNLNGNSLSGRVPAALGGR 513

Length = 623

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 61.4 bits (150), Expect = 1e-10
 Identities = 39/144 (27%), Positives = 64/144 (44%), Gaps = 16/144 (11%)

Query: 344 GSFGSVYKGTI-SDGTDVAIKIFN---LQRERAFRSFNSECEVLRNVRHQNLIKILSSCS 399
           GSFG V        G   A+K+     + + +      +E  +L  + H  ++K+  +  
Sbjct: 4   GSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQ 63

Query: 400 TPDF-----KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLH-HGHSSAPIIHC 453
           T +      ++ P G L   L     F +   R     ++   LEYLH  G     II+ 
Sbjct: 64  TEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF-YAAEIVLALEYLHSLG-----IIYR 117

Query: 454 DLKPTSILLDENMVAHVSDFGISK 477
           DLKP +ILLD +    ++DFG++K
Sbjct: 118 DLKPENILLDADGHIKLTDFGLAK 141

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 61.3 bits (149), Expect = 2e-10
 Identities = 42/155 (27%), Positives = 75/155 (48%), Gaps = 31/155 (20%)

Query: 343 AGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           AG FG V++G  ++ T VA+K          + F +E ++++ +RH  LI++ + C+  +
Sbjct: 16  AGQFGEVWEGLWNNTTPVAVKTLKPGTMDP-KDFLAEAQIMKKLRHPKLIQLYAVCTLEE 74

Query: 403 -----FKFMPNGSLEKRLYSHNYFLDILER-------LNIMID----VGSTLEYLHHGHS 446
                 + M  GSL          L+ L+        L  +ID    V S + YL   + 
Sbjct: 75  PIYIVTELMKYGSL----------LEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN- 123

Query: 447 SAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
               IH DL   ++L+ EN +  V+DFG+++++ E
Sbjct: 124 ---YIHRDLAARNVLVGENNICKVADFGLARVIKE 155

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 61.1 bits (149), Expect = 2e-10
 Identities = 42/148 (28%), Positives = 70/148 (47%), Gaps = 17/148 (11%)

Query: 340 ISLAGSFGSVYKG-TISDGTDVAIKIFN---LQRERAFRSFNSECEVLRNVRHQNLIKIL 395
           IS  G++G V+     S G   AIK+     + R+       +E ++L   +   ++K+ 
Sbjct: 1   IS-KGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY 59

Query: 396 SSCSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLH-HGHSSAP 449
            S           +++P G L   L +     + + R   + ++   LEYLH +G     
Sbjct: 60  YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVAR-IYIAEIVLALEYLHSNG----- 113

Query: 450 IIHCDLKPTSILLDENMVAHVSDFGISK 477
           IIH DLKP +IL+D N    ++DFG+SK
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSK 141

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 61.1 bits (149), Expect = 2e-10
 Identities = 40/144 (27%), Positives = 71/144 (49%), Gaps = 11/144 (7%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           G+ G VYK T  + G +VAIK   L+++      N E  ++++ +H N++    S    D
Sbjct: 30  GASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN-EILIMKDCKHPNIVDYYDSYLVGD 88

Query: 403 -----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKP 457
                 ++M  GSL   +  +   ++  +   +  +V   LEYLH    S  +IH D+K 
Sbjct: 89  ELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH----SQNVIHRDIKS 144

Query: 458 TSILLDENMVAHVSDFGISKLLGE 481
            +ILL ++    ++DFG +  L +
Sbjct: 145 DNILLSKDGSVKLADFGFAAQLTK 168

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 61.0 bits (148), Expect = 2e-10
 Identities = 49/152 (32%), Positives = 78/152 (51%), Gaps = 20/152 (13%)

Query: 343 AGSFGSVYKG-TISDGTDVAIK--------IFNLQRERA-FRSFNSECEVLRNVRHQNLI 392
           +GSFGSVY G   S G  +A+K          +  R+R+   +   E  +L+ ++H+N++
Sbjct: 10  SGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIV 69

Query: 393 KILSSCSTPDF-----KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSS 447
           + L S    D      +++P GS+   L ++  F + L R N +  +   L YLH    +
Sbjct: 70  QYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-NFVRQILKGLNYLH----N 124

Query: 448 APIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
             IIH D+K  +IL+D      +SDFGISK L
Sbjct: 125 RGIIHRDIKGANILVDNKGGIKISDFGISKKL 156

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 60.2 bits (146), Expect = 3e-10
 Identities = 47/141 (33%), Positives = 67/141 (47%), Gaps = 14/141 (9%)

Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRERAFRS--FNSECEVLRNVRHQNLIKILSSCST- 400
           G FG V+ G      DVAIK+    RE A     F  E +V+  + H NL+++   C+  
Sbjct: 15  GQFGVVHLGKWRGKIDVAIKMI---REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ 71

Query: 401 -PDF---KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLK 456
            P F   ++M NG L   L      L     L++  DV   +EYL     S   IH DL 
Sbjct: 72  RPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE----SNGFIHRDLA 127

Query: 457 PTSILLDENMVAHVSDFGISK 477
             + L+ E+ V  VSDFG+++
Sbjct: 128 ARNCLVGEDNVVKVSDFGLAR 148

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 60.2 bits (147), Expect = 5e-10
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 27/156 (17%)

Query: 343 AGSFGSVYKGT-ISDGTDVAIK-IFNLQRE-----RAFRSFNSECEVLRNVRHQNLIKIL 395
           +G++G V        G  VAIK I N+  +     R  R    E ++LR++RH+N+I +L
Sbjct: 10  SGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR----EIKLLRHLRHENIIGLL 65

Query: 396 S---SCSTPDFK-------FMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGH 445
                 S  DF         M    L K + S     D   +   +  +   L+YLH   
Sbjct: 66  DILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQY-FLYQILRGLKYLH--- 120

Query: 446 SSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
            SA +IH DLKP++IL++ N    + DFG+++ +  
Sbjct: 121 -SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 59.6 bits (144), Expect = 7e-10
 Identities = 41/159 (25%), Positives = 67/159 (42%), Gaps = 29/159 (18%)

Query: 344 GSFGSVYKGTIS------DGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSS 397
           G+FG V+           D   VA+K      E A + F  E E+L  ++HQ++++    
Sbjct: 16  GAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGV 75

Query: 398 CSTPD-----FKFMPNGSLEKRLYSHNYFLDILER--------------LNIMIDVGSTL 438
           C+        F++M +G L + L SH     IL                L I   + S +
Sbjct: 76  CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGM 135

Query: 439 EYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK 477
            YL   H     +H DL   + L+ + +V  + DFG+S+
Sbjct: 136 VYLASLH----FVHRDLATRNCLVGQGLVVKIGDFGMSR 170

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 60.6 bits (147), Expect = 1e-09
 Identities = 33/88 (37%), Positives = 47/88 (53%)

Query: 196 LSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHI 255
           L L    L G IP  I  L+ LQ   L   +++G +P +L  +  L +L L  N  +G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 256 PPCLASLTSLRELDLGSNKLTSSIPSSL 283
           P  L  LTSLR L+L  N L+  +P++L
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 59.8 bits (145), Expect = 1e-09
 Identities = 51/174 (29%), Positives = 84/174 (48%), Gaps = 32/174 (18%)

Query: 324 SGDIPSTIGALVDLETISL--AGSFGSVYKGT-ISDGTDVAIK-IFNLQRERAFRSFNSE 379
           SG  PS   +L +LE ++   +G+ G+VYK      G   A+K I+    +   R    E
Sbjct: 63  SGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICRE 122

Query: 380 CEVLRNVRHQNLIK------------ILSSCSTPDFKFMPNGSLEKRLYSHNYFLDILER 427
            E+LR+V H N++K            +L        +FM  GSLE    +   FL  + R
Sbjct: 123 IEILRDVNHPNVVKCHDMFDHNGEIQVL-------LEFMDGGSLEGTHIADEQFLADVAR 175

Query: 428 LNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
                 + S + YLH  H    I+H D+KP+++L++      ++DFG+S++L +
Sbjct: 176 -----QILSGIAYLHRRH----IVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220

Length = 353

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 43/141 (30%), Positives = 67/141 (47%), Gaps = 14/141 (9%)

Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD- 402
           G FG V  G    G  VA+K   ++ +   ++F +E  V+  +RH NL+++L        
Sbjct: 17  GEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 73

Query: 403 -----FKFMPNGSLEKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLK 456
                 ++M  GSL   L S     L     L   +DV   +EYL     +   +H DL 
Sbjct: 74  GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE----ANNFVHRDLA 129

Query: 457 PTSILLDENMVAHVSDFGISK 477
             ++L+ E+ VA VSDFG++K
Sbjct: 130 ARNVLVSEDNVAKVSDFGLTK 150

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 59.8 bits (145), Expect = 2e-09
 Identities = 27/80 (33%), Positives = 50/80 (62%), Gaps = 1/80 (1%)

Query: 3   GQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLP 62
           G IP +I  L++L+S+ L  N++ G IPP + +I+++  L+L  N  +G +P  +G  L 
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQ-LT 490

Query: 63  NIKYLELGDNNLIGTIPNSI 82
           +++ L L  N+L G +P ++
Sbjct: 491 SLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 59.4 bits (144), Expect = 2e-09
 Identities = 31/84 (36%), Positives = 46/84 (54%)

Query: 179 LKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHL 238
           L+G IP +I  LR L  ++L  N + G IP S+G++  L+   L   +  G +P +L  L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489

Query: 239 EMLNLLHLGGNKLSGHIPPCLASL 262
             L +L+L GN LSG +P  L   
Sbjct: 490 TSLRILNLNGNSLSGRVPAALGGR 513

Length = 623

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 59.1 bits (143), Expect = 2e-09
 Identities = 32/91 (35%), Positives = 52/91 (57%), Gaps = 1/91 (1%)

Query: 39  IRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTF 98
           I  L L    L G +P+ I   L +++ + L  N++ G IP S+ + T L +LDL +N+F
Sbjct: 420 IDGLGLDNQGLRGFIPNDIS-KLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478

Query: 99  SGHIPNTFGNLRHLSVLSLLMNNLTTESSSA 129
           +G IP + G L  L +L+L  N+L+    +A
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAA 509

Length = 623

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 39/147 (26%), Positives = 69/147 (46%), Gaps = 14/147 (9%)

Query: 344 GSFGSVYKGT-ISDG----TDVAIKIFNLQRER-AFRSFNSECEVLRNVRHQNLIKILSS 397
           G+FG+VYKG  I +G      VAIK+   +    A +    E  V+ +V H +++++L  
Sbjct: 18  GAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGI 77

Query: 398 CSTPDF----KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHC 453
           C +       + MP G L   + +H   +     LN  + +   + YL        ++H 
Sbjct: 78  CLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR----LVHR 133

Query: 454 DLKPTSILLDENMVAHVSDFGISKLLG 480
           DL   ++L+       ++DFG++KLL 
Sbjct: 134 DLAARNVLVKTPQHVKITDFGLAKLLD 160

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 57.5 bits (139), Expect = 3e-09
 Identities = 45/150 (30%), Positives = 74/150 (49%), Gaps = 21/150 (14%)

Query: 344 GSFGSVYKG-TISDGTDVAIKIFNLQRERAFR----------SFNSECEVLRNVRHQNLI 392
           G++G VY    ++ G  +A+K   L    A R          +  SE E L+++ H N++
Sbjct: 12  GTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIV 71

Query: 393 KILSSCSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSS 447
           + L   +T +      +++P GS+   L ++  F + L R      V   L YLH    S
Sbjct: 72  QYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVR-FFTEQVLEGLAYLH----S 126

Query: 448 APIIHCDLKPTSILLDENMVAHVSDFGISK 477
             I+H DLK  ++L+D + +  +SDFGISK
Sbjct: 127 KGILHRDLKADNLLVDADGICKISDFGISK 156

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 58.0 bits (141), Expect = 3e-09
 Identities = 45/148 (30%), Positives = 72/148 (48%), Gaps = 16/148 (10%)

Query: 344 GSFGSVYKGT-ISDGTDVAIK-IFNLQRERAFRSFN----SECEVLRNVRHQNLIKILSS 397
           G++  VYK      G  VAIK I   +R+ A    N     E ++L+ ++H N+I +L  
Sbjct: 11  GTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDV 70

Query: 398 CSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
                     F+FM    LEK +   +  L   +  + M+     LEYLH    S  I+H
Sbjct: 71  FGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH----SNWILH 125

Query: 453 CDLKPTSILLDENMVAHVSDFGISKLLG 480
            DLKP ++L+  + V  ++DFG+++  G
Sbjct: 126 RDLKPNNLLIASDGVLKLADFGLARSFG 153

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 57.2 bits (138), Expect = 3e-09
 Identities = 45/148 (30%), Positives = 76/148 (51%), Gaps = 16/148 (10%)

Query: 344 GSFGSVY--KGTISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCS 399
           G+FG V+  +   +D   V IK   +++  +    +  +EC+VL+ + H N+I+   +  
Sbjct: 11  GAFGIVHLCRRK-ADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFL 69

Query: 400 TPD-----FKFMPNGSLEKRLYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHC 453
                    ++ P G+L + +    N  LD    L+  + +   L  LHH H+   I+H 
Sbjct: 70  EDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQI---LLALHHVHTKL-ILHR 125

Query: 454 DLKPTSILLDEN-MVAHVSDFGISKLLG 480
           DLK  +ILLD++ MV  + DFGISK+L 
Sbjct: 126 DLKTQNILLDKHKMVVKIGDFGISKILS 153

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 58.7 bits (142), Expect = 5e-09
 Identities = 39/135 (28%), Positives = 61/135 (45%), Gaps = 17/135 (12%)

Query: 357 GTDVAIKIF---NLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD------FKFMP 407
           G +VAIK+      + E     F  E  +   + H N++ +L S   P       F+++P
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62

Query: 408 NGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILL---DE 464
             +L + L +    L   E   +M+ V   L+ L   H+   I+H DLKP +I++     
Sbjct: 63  GRTLREVLAADGA-LPAGETGRLMLQV---LDALACAHNQG-IVHRDLKPQNIMVSQTGV 117

Query: 465 NMVAHVSDFGISKLL 479
              A V DFGI  LL
Sbjct: 118 RPHAKVLDFGIGTLL 132

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 57.4 bits (138), Expect = 5e-09
 Identities = 40/147 (27%), Positives = 73/147 (49%), Gaps = 14/147 (9%)

Query: 343 AGSFGSVYKGT-ISDGTDV----AIKIFN-LQRERAFRSFNSECEVLRNVRHQNLIKILS 396
           +G+FG+VYKG  + +G  V    AIKI N     +A   F  E  ++ ++ H +L+++L 
Sbjct: 17  SGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLG 76

Query: 397 SCSTPDFKF----MPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
            C +P  +     MP+G L   ++ H   +     LN  + +   + YL        ++H
Sbjct: 77  VCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR----LVH 132

Query: 453 CDLKPTSILLDENMVAHVSDFGISKLL 479
            DL   ++L+       ++DFG+++LL
Sbjct: 133 RDLAARNVLVKSPNHVKITDFGLARLL 159

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 56.6 bits (136), Expect = 6e-09
 Identities = 41/157 (26%), Positives = 71/157 (45%), Gaps = 27/157 (17%)

Query: 344 GSFGSVYKGTI------SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSS 397
           G+FG V+           D   VA+K      + A + F+ E E+L N++H++++K    
Sbjct: 16  GAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGV 75

Query: 398 CSTPD-----FKFMPNGSLEKRLYSHN------------YFLDILERLNIMIDVGSTLEY 440
           C   D     F++M +G L K L +H               L   + L+I   + + + Y
Sbjct: 76  CVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVY 135

Query: 441 LHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK 477
           L   H     +H DL   + L+ EN++  + DFG+S+
Sbjct: 136 LASQH----FVHRDLATRNCLVGENLLVKIGDFGMSR 168

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 56.1 bits (136), Expect = 7e-09
 Identities = 44/149 (29%), Positives = 62/149 (41%), Gaps = 32/149 (21%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           GS+GSVYK      G  VAIK+  +  E   +    E  +L+      ++K   S     
Sbjct: 14  GSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVKYYGS----- 66

Query: 403 FKFMPNGSL----EKRLY-SHNYFLDILERLN----------IMIDVGSTLEYLHHGHSS 447
             +  N  L    E   Y       DI++  N          I+      LEYLH    S
Sbjct: 67  --YFKNTDLWIVME---YCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH----S 117

Query: 448 APIIHCDLKPTSILLDENMVAHVSDFGIS 476
              IH D+K  +ILL+E   A ++DFG+S
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGVS 146

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 56.2 bits (135), Expect = 8e-09
 Identities = 38/141 (26%), Positives = 73/141 (51%), Gaps = 10/141 (7%)

Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCST-PD 402
           G FG V+ GT +  T VAIK           +F  E ++++ +RH  L+ + +  S  P 
Sbjct: 17  GCFGEVWMGTWNGTTKVAIKTLK-PGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPI 75

Query: 403 F---KFMPNGSLEKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPT 458
           +   +FM  GSL   L   +  +L + + +++   +   + Y+   +     IH DL+  
Sbjct: 76  YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN----YIHRDLRAA 131

Query: 459 SILLDENMVAHVSDFGISKLL 479
           +IL+ +N+V  ++DFG+++L+
Sbjct: 132 NILVGDNLVCKIADFGLARLI 152

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 57.5 bits (139), Expect = 1e-08
 Identities = 33/90 (36%), Positives = 54/90 (60%), Gaps = 3/90 (3%)

Query: 20  LGANN--LSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGT 77
           LG +N  L G IP  I  +  ++++NL GN + G++P  +G S+ +++ L+L  N+  G+
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG-SITSLEVLDLSYNSFNGS 481

Query: 78  IPNSITNATKLIILDLGFNTFSGHIPNTFG 107
           IP S+   T L IL+L  N+ SG +P   G
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 55.6 bits (134), Expect = 1e-08
 Identities = 41/158 (25%), Positives = 69/158 (43%), Gaps = 36/158 (22%)

Query: 343 AGSFGSVYKGTISD-GTDVAIKIFNLQRE-----RAFRSFNSECEVLRNVRHQNLIKILS 396
            G+FG VY     D G ++A+K      +     +   +   E ++L+N++H+ +++   
Sbjct: 12  QGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYG 71

Query: 397 SCSTPD------FKFMPNGSLEKRLYSH---------NYFLDILERLNIMIDVGSTLEYL 441
            C   D       ++MP GS++ +L ++          Y   ILE           +EYL
Sbjct: 72  -CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILE----------GVEYL 120

Query: 442 HHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
           H       I+H D+K  +IL D      + DFG SK L
Sbjct: 121 HSNM----IVHRDIKGANILRDSAGNVKLGDFGASKRL 154

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 55.2 bits (134), Expect = 2e-08
 Identities = 43/147 (29%), Positives = 68/147 (46%), Gaps = 17/147 (11%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRSFNSEC--EV--LRNVRHQNLIKILSSC 398
           G++G VYK      G  VA+K   L  E       S    E+  L+ ++H N++K+L   
Sbjct: 10  GTYGVVYKARDKKTGEIVALKKIRLDNEE--EGIPSTALREISLLKELKHPNIVKLLDVI 67

Query: 399 STPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHC 453
            T       F++     L+K L      L      +IM  +   L Y H    S  I+H 
Sbjct: 68  HTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH----SHRILHR 122

Query: 454 DLKPTSILLDENMVAHVSDFGISKLLG 480
           DLKP +IL++ + V  ++DFG+++  G
Sbjct: 123 DLKPQNILINRDGVLKLADFGLARAFG 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 45/158 (28%), Positives = 74/158 (46%), Gaps = 22/158 (13%)

Query: 336 DLETISL--AGSFGSVY--KGTISDGTDVAIKIFNLQ---RERAFRSFNSECEVLRNVRH 388
           DLE I     G+FG V+  +  IS     A+K+  +    R +  +  ++E  VL+ V H
Sbjct: 2   DLERIKTVGTGTFGRVHLVRDRIS-EHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 389 QNLIKILSSCSTPD-------FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYL 441
             +I++    +  D        +++P G L   L +   F +         ++   LEYL
Sbjct: 61  PFIIRLF--WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLF-YASEIVCALEYL 117

Query: 442 HHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
           H    S  I++ DLKP +ILLD+     ++DFG +K L
Sbjct: 118 H----SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL 151

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 45/155 (29%), Positives = 67/155 (43%), Gaps = 25/155 (16%)

Query: 344 GSFGSVYKGTISDGT---DVAIKIFNLQ--RERAFRSFNSECEVLRNVRHQNLIKILSSC 398
           G FGSV +G ++       VA+K   +          F SE   ++   H N+++++  C
Sbjct: 10  GEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVC 69

Query: 399 -------STPD----FKFMPNGSLEK-----RLYSHNYFLDILERLNIMIDVGSTLEYLH 442
                    P       FM +G L       RL     +L     +  M D+ S +EYL 
Sbjct: 70  LQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYL- 128

Query: 443 HGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK 477
              SS   IH DL   + +L+ENM   V+DFG+SK
Sbjct: 129 ---SSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 55.3 bits (133), Expect = 2e-08
 Identities = 45/152 (29%), Positives = 68/152 (44%), Gaps = 21/152 (13%)

Query: 344 GSFGSV----YKGTISDGTDVAIKIFNLQRERAFR---SFNSECEVLRNVRHQNLIKILS 396
           G FG V    Y    +DGT   + +  L+RE   +    +  E  +L+ + H+N++K   
Sbjct: 15  GHFGKVSLYCYDPA-NDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKG 73

Query: 397 SCSTPDFK-------FMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAP 449
            CS    K       ++P GSL   L  H   L  L      I  G  + YLH  H    
Sbjct: 74  CCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEG--MAYLHSQH---- 127

Query: 450 IIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
            IH DL   ++LLD + +  + DFG++K + E
Sbjct: 128 YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 38/146 (26%), Positives = 66/146 (45%), Gaps = 12/146 (8%)

Query: 343 AGSFGSVYKGTI---SDGTDVAIKIFNLQRERAFR-SFNSECEVLRNVRHQNLIKILSSC 398
           +G+FG V KG         DVAIK+   + E++ R     E E++  + +  +++++  C
Sbjct: 5   SGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVC 64

Query: 399 STPDF----KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
                    +    G L K L      + +   + +M  V   ++YL   +     +H D
Sbjct: 65  EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN----FVHRD 120

Query: 455 LKPTSILLDENMVAHVSDFGISKLLG 480
           L   ++LL     A +SDFG+SK LG
Sbjct: 121 LAARNVLLVNQHYAKISDFGLSKALG 146

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 54.6 bits (132), Expect = 2e-08
 Identities = 41/153 (26%), Positives = 62/153 (40%), Gaps = 32/153 (20%)

Query: 344 GSFGSVYKG-TISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSS----- 397
           G++G VYK   I+ G  VAIK+  L+    F     E  +L+  RH N++    S     
Sbjct: 14  GTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRD 73

Query: 398 --------C---STPDFKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHS 446
                   C   S  D   +  G L +   ++           +  +    L YLH    
Sbjct: 74  KLWIVMEYCGGGSLQDIYQVTRGPLSELQIAY-----------VCRETLKGLAYLHETG- 121

Query: 447 SAPIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
               IH D+K  +ILL E+    ++DFG+S  L
Sbjct: 122 ---KIHRDIKGANILLTEDGDVKLADFGVSAQL 151

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 55.0 bits (132), Expect = 3e-08
 Identities = 41/160 (25%), Positives = 69/160 (43%), Gaps = 30/160 (18%)

Query: 344 GSFGSVYKGT------ISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSS 397
           G+FG V+           D   VA+K        A + F  E E+L N++H++++K    
Sbjct: 16  GAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGV 75

Query: 398 CSTPD-----FKFMPNGSLEKRLYSH---------------NYFLDILERLNIMIDVGST 437
           C   D     F++M +G L K L +H                  L + + L+I   + S 
Sbjct: 76  CGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASG 135

Query: 438 LEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK 477
           + YL   H     +H DL   + L+  N++  + DFG+S+
Sbjct: 136 MVYLASQH----FVHRDLATRNCLVGANLLVKIGDFGMSR 171

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 54.5 bits (132), Expect = 3e-08
 Identities = 43/150 (28%), Positives = 70/150 (46%), Gaps = 28/150 (18%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVR-------HQNLIKIL 395
           G+FGSVY       G  VAIK       + F S+  EC  LR V+       H N++K+ 
Sbjct: 10  GTFGSVYLARNKETGELVAIKKMK----KKFYSW-EECMNLREVKSLRKLNEHPNIVKLK 64

Query: 396 SSCSTPD-----FKFMPNGSLEK--RLYSHNYFLDILERLNIMIDVGSTLEYLH-HGHSS 447
                 D     F++M  G+L +  +      F + + R +I+  +   L ++H HG   
Sbjct: 65  EVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIR-SIIYQILQGLAHIHKHGF-- 120

Query: 448 APIIHCDLKPTSILLDENMVAHVSDFGISK 477
               H DLKP ++L+    V  ++DFG+++
Sbjct: 121 ---FHRDLKPENLLVSGPEVVKIADFGLAR 147

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 53.9 bits (130), Expect = 4e-08
 Identities = 42/155 (27%), Positives = 65/155 (41%), Gaps = 16/155 (10%)

Query: 336 DLETISL--AGSFGSVYKGT-ISDGTDVAIKIFNL-QRERAFRSFNSECEVLRNVRHQNL 391
           DLE +    AG+ G V K      G  +A+K   L   E   +    E ++L       +
Sbjct: 2   DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYI 61

Query: 392 IKILSSCSTPD-----FKFMPNGSLEK--RLYSHNYFLDILERLNIMIDVGSTLEYLHHG 444
           +    +           ++M  GSL+K  +         IL +  I + V   L YLH  
Sbjct: 62  VGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK--IAVAVLKGLTYLHEK 119

Query: 445 HSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
           H    IIH D+KP++IL++      + DFG+S  L
Sbjct: 120 HK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQL 151

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 53.6 bits (129), Expect = 5e-08
 Identities = 42/148 (28%), Positives = 67/148 (45%), Gaps = 16/148 (10%)

Query: 344 GSFGSVYK---GTISDGTD--VAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSC 398
           G+FGSV       + D T   VA+K          R F  E E+L++++H N++K    C
Sbjct: 15  GNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVC 74

Query: 399 STPD-------FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPII 451
            +          +++P GSL   L  H   LD  + L     +   +EYL     S   +
Sbjct: 75  YSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYL----GSKRYV 130

Query: 452 HCDLKPTSILLDENMVAHVSDFGISKLL 479
           H DL   +IL++      + DFG++K+L
Sbjct: 131 HRDLATRNILVESENRVKIGDFGLTKVL 158

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 53.5 bits (128), Expect = 6e-08
 Identities = 37/141 (26%), Positives = 72/141 (51%), Gaps = 10/141 (7%)

Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCST-PD 402
           G FG V+ GT +  T VA+K        +  SF  E ++++ +RH  L+++ +  S  P 
Sbjct: 17  GQFGEVWMGTWNGNTKVAVKTLK-PGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSEEPI 75

Query: 403 F---KFMPNGSLEKRLYS-HNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPT 458
           +   ++M  GSL   L       L +   +++   V + + Y+   +     IH DL+  
Sbjct: 76  YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN----YIHRDLRSA 131

Query: 459 SILLDENMVAHVSDFGISKLL 479
           +IL+ + +V  ++DFG+++L+
Sbjct: 132 NILVGDGLVCKIADFGLARLI 152

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 53.8 bits (129), Expect = 6e-08
 Identities = 48/159 (30%), Positives = 72/159 (45%), Gaps = 29/159 (18%)

Query: 344 GSFGSVYKGTI-SDG--TDVAIK-IFNLQRERAFRSFNSECEVL-RNVRHQNLIKILSSC 398
           G+FG V K  I  DG   D AIK +     +   R F  E EVL +   H N+I +L +C
Sbjct: 18  GNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC 77

Query: 399 STPDF-----KFMPNGSL-----EKRLYSHNYFLDILER----------LNIMIDVGSTL 438
               +     ++ P+G+L     + R+   +    I             L+   DV   +
Sbjct: 78  EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGM 137

Query: 439 EYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK 477
           +YL    S    IH DL   +IL+ EN VA ++DFG+S+
Sbjct: 138 DYL----SQKQFIHRDLAARNILVGENYVAKIADFGLSR 172

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 54.8 bits (132), Expect = 7e-08
 Identities = 28/81 (34%), Positives = 45/81 (55%)

Query: 268 LDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDI 327
           L L +  L   IP+ +  L ++  INLS N +  ++P ++  +  L VLDLS N  +G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 328 PSTIGALVDLETISLAGSFGS 348
           P ++G L  L  ++L G+  S
Sbjct: 483 PESLGQLTSLRILNLNGNSLS 503

Length = 623

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 53.0 bits (127), Expect = 8e-08
 Identities = 35/148 (23%), Positives = 71/148 (47%), Gaps = 18/148 (12%)

Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQ------RERAFRSFNSECEVLRNVRHQNLIKILSS 397
           G++G+VY G  + G  +A+K   L        E+ +     E ++L++++H N+++ L +
Sbjct: 11  GAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGT 70

Query: 398 CSTPD-----FKFMPNGSLEKRLYSHNYFLDI-LERLNIMIDVGSTLEYLHHGHSSAPII 451
           C   +      +F+P GS+   L       +    +    I  G  + YLH+      ++
Sbjct: 71  CLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDG--VAYLHNNC----VV 124

Query: 452 HCDLKPTSILLDENMVAHVSDFGISKLL 479
           H D+K  +++L  N +  + DFG ++ L
Sbjct: 125 HRDIKGNNVMLMPNGIIKLIDFGCARRL 152

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 53.0 bits (128), Expect = 9e-08
 Identities = 46/159 (28%), Positives = 64/159 (40%), Gaps = 51/159 (32%)

Query: 344 GSFGSVYKGTI-SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTP- 401
           GSFG VYK         VAIK+ +L+          E E +     Q  I+ LS C +P 
Sbjct: 12  GSFGEVYKAIDKRTNQVVAIKVIDLE------EAEDEIEDI-----QQEIQFLSQCRSPY 60

Query: 402 ----------DFK------FMPNGSLEKRLYSHNYFLDILE--RLN------IMIDVGST 437
                       K      +   GS           LD+L+  +L+      I+ +V   
Sbjct: 61  ITKYYGSFLKGSKLWIIMEYCGGGSC----------LDLLKPGKLDETYIAFILREVLLG 110

Query: 438 LEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGIS 476
           LEYLH        IH D+K  +ILL E     ++DFG+S
Sbjct: 111 LEYLH----EEGKIHRDIKAANILLSEEGDVKLADFGVS 145

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 52.7 bits (126), Expect = 9e-08
 Identities = 38/141 (26%), Positives = 67/141 (47%), Gaps = 11/141 (7%)

Query: 344 GSFGSVYKGTI-SDGTDVAIKIFNLQRERAFRS-FNSECEVLRNVRHQNLIKILSSCST- 400
           G+FG V+ G + +D T VA+K          ++ F  E  +L+   H N+++++  C+  
Sbjct: 6   GNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK 65

Query: 401 -PDFKFMP---NGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLK 456
            P +  M     G     L +    L + E + ++ +  + +EYL   H     IH DL 
Sbjct: 66  QPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHC----IHRDLA 121

Query: 457 PTSILLDENMVAHVSDFGISK 477
             + L+ E  V  +SDFG+S+
Sbjct: 122 ARNCLVTEKNVLKISDFGMSR 142

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 53.7 bits (129), Expect = 1e-07
 Identities = 22/56 (39%), Positives = 37/56 (66%)

Query: 3   GQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIG 58
           G IP  +G++ +L+ L L  N+ +G IP  +  ++++R LNL GN LSG +P+ +G
Sbjct: 456 GNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 52.7 bits (127), Expect = 1e-07
 Identities = 39/153 (25%), Positives = 69/153 (45%), Gaps = 27/153 (17%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQR------ERAFRSFNSECEVLRNVRHQNLIKIL- 395
           G+ G V+K      G  VA+K   L+R       +A R    E + L+  +H  ++K+L 
Sbjct: 11  GAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALR----EIKALQACQHPYVVKLLD 66

Query: 396 -----SSCSTPDFKFMPNGSLEKRL--YSHNYFLDILERLNIMIDVGSTLEYLHHGHSSA 448
                S       ++MP   L + L           ++    M+  G  + Y+H    + 
Sbjct: 67  VFPHGSGFVLV-MEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKG--VAYMH----AN 118

Query: 449 PIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
            I+H DLKP ++L+  + V  ++DFG+++L  E
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSE 151

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 52.7 bits (127), Expect = 1e-07
 Identities = 42/156 (26%), Positives = 70/156 (44%), Gaps = 23/156 (14%)

Query: 338 ETISLAG--SFGSVYKGTISD-GTDVAIKIF------NLQRERAFRSFNSECEVLRNVRH 388
           E + + G  ++G V K      G  VAIK F         ++ A R    E +VLR +RH
Sbjct: 4   EVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALR----EVKVLRQLRH 59

Query: 389 QNLIKILSSCSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHH 443
           +N++ +  +          F+++    LE  L +    L      + +  +   + Y H 
Sbjct: 60  ENIVNLKEAFRRKGRLYLVFEYVERTLLEL-LEASPGGLPPDAVRSYIWQLLQAIAYCH- 117

Query: 444 GHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
              S  IIH D+KP +IL+ E+ V  + DFG ++ L
Sbjct: 118 ---SHNIIHRDIKPENILVSESGVLKLCDFGFARAL 150

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 39/147 (26%), Positives = 64/147 (43%), Gaps = 17/147 (11%)

Query: 344 GSFGSVYKG-TISDGTDVAIKIFNLQRERA-FRSFNSECEVLRNVRHQNLIKILSSCSTP 401
           G+   VY    + +   VAIK  +L++ +        E + +    H N++K  +S    
Sbjct: 12  GATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVG 71

Query: 402 D-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTL---EYLH-HGHSSAPIIH 452
           D       ++  GSL   +   +Y    L+   I   +   L   EYLH +G      IH
Sbjct: 72  DELWLVMPYLSGGSLLD-IMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ-----IH 125

Query: 453 CDLKPTSILLDENMVAHVSDFGISKLL 479
            D+K  +ILL E+    ++DFG+S  L
Sbjct: 126 RDIKAGNILLGEDGSVKIADFGVSASL 152

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 46/168 (27%), Positives = 75/168 (44%), Gaps = 29/168 (17%)

Query: 335 VDLETISLAGSFGSVYKGTIS-DGT--DVAIKIFN-LQRERAFRSFNSECEVLRNV-RHQ 389
           +  E +   G+FG V +  I  DG   + AIK+      E   R F  E EVL  +  H 
Sbjct: 4   IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHP 63

Query: 390 NLIKILSSCSTPDF-----KFMPNGSL------EKRLYSHNYF---------LDILERLN 429
           N+I +L +C    +     ++ P G+L       + L +   F         L   + L 
Sbjct: 64  NIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQ 123

Query: 430 IMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK 477
              DV + ++YL    S    IH DL   ++L+ EN+ + ++DFG+S+
Sbjct: 124 FASDVATGMQYL----SEKQFIHRDLAARNVLVGENLASKIADFGLSR 167

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 52.8 bits (127), Expect = 1e-07
 Identities = 43/150 (28%), Positives = 70/150 (46%), Gaps = 25/150 (16%)

Query: 344 GSFGSVYKGTISD-GTDVAIKIFNLQRER-------AFRSFNSECEVLRNVRHQNLIKIL 395
           GS+G V K    + G  VAIK F L+ E        A R    E  +L+ +RH+NL+ ++
Sbjct: 12  GSYGMVMKCKHKETGQIVAIKKF-LESEDDKMVKKIAMR----EIRMLKQLRHENLVNLI 66

Query: 396 SSCSTPD-----FKFMPNGSL-EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAP 449
                       F+F+ +  L +   Y +   LD       +  +   +E+ H    S  
Sbjct: 67  EVFRRKKRLYLVFEFVDHTVLDDLEKYPNG--LDESRVRKYLFQILRGIEFCH----SHN 120

Query: 450 IIHCDLKPTSILLDENMVAHVSDFGISKLL 479
           IIH D+KP +IL+ ++ V  + DFG ++ L
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTL 150

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 53.7 bits (129), Expect = 2e-07
 Identities = 29/82 (35%), Positives = 40/82 (48%), Gaps = 1/82 (1%)

Query: 154 LGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGT 213
           L G +P  I      LQ  + S   ++G IP  +G +  L  L L +N  NG+IP S+G 
Sbjct: 430 LRGFIPNDISKLR-HLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQ 488

Query: 214 LKQLQGFFLPETNLQGYVPHNL 235
           L  L+   L   +L G VP  L
Sbjct: 489 LTSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)

Query: 343 AGSFGSVYKGT-ISDGTDVAIKI-FNLQRE----RAFRSFNSECEVLRNVRHQNLIKILS 396
           +G+FG+VYKG  I +G  V I +     RE    +A +    E  V+ +V + ++ ++L 
Sbjct: 17  SGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLG 76

Query: 397 SCSTPDFKF----MPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
            C T   +     MP G L   +  H   +     LN  + +   + YL        ++H
Sbjct: 77  ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR----LVH 132

Query: 453 CDLKPTSILLDENMVAHVSDFGISKLLG 480
            DL   ++L+       ++DFG++KLLG
Sbjct: 133 RDLAARNVLVKTPQHVKITDFGLAKLLG 160

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 52.2 bits (125), Expect = 2e-07
 Identities = 47/156 (30%), Positives = 71/156 (45%), Gaps = 26/156 (16%)

Query: 344 GSFGSVYKGTI--SDGT--DVAIKIF--NLQRERAFRSFNSECEVLRNVRHQNLIKIL-- 395
           G FGSV +  +   DG+   VA+K+   ++        F  E   ++   H N+IK++  
Sbjct: 10  GEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGV 69

Query: 396 SSCSTPD---------FKFMPNGSLE-----KRLYSHNYFLDILERLNIMIDVGSTLEYL 441
           S  S              FM +G L       R+    + L +   +  MID+ S +EYL
Sbjct: 70  SLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYL 129

Query: 442 HHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK 477
               SS   IH DL   + +L+ENM   V+DFG+SK
Sbjct: 130 ----SSKNFIHRDLAARNCMLNENMTVCVADFGLSK 161

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 52.1 bits (125), Expect = 2e-07
 Identities = 43/152 (28%), Positives = 62/152 (40%), Gaps = 25/152 (16%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQ------RERAFRSFNSECEVLRNVRHQNLIKILS 396
           GSFG V+K    +D    A+K  +L       RE A      E  VL  +    +I+   
Sbjct: 11  GSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAID----EARVLAKLDSSYIIRYYE 66

Query: 397 SCSTPD-----FKFMPNGSLEKRLYSHN---YFLDILERLNIMIDVGSTLEYLHHGHSSA 448
           S           ++  NG L K L          D + R  I I +G  L +LH    S 
Sbjct: 67  SFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG--LAHLH----SK 120

Query: 449 PIIHCDLKPTSILLDENMVAHVSDFGISKLLG 480
            I+H D+K  ++ LD      + D G++KLL 
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS 152

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 46/149 (30%), Positives = 69/149 (46%), Gaps = 19/149 (12%)

Query: 344 GSFGSVYK-GTISDGTDVAIKIFNL----QRERAFRSFNSECEVLRNVRHQNLIK----- 393
           GS+GSVYK   +SD    A+K  +L    Q+ER   + N E  +L +V H N+I      
Sbjct: 11  GSYGSVYKVKRLSDNQFYALKEVDLGSMSQKERE-DAVN-EIRILASVNHPNIISYKEAF 68

Query: 394 ILSSCSTPDFKFMPNGSLEKRLYSHNYFLDILER---LNIMIDVGSTLEYLHHGHSSAPI 450
           +  +      ++ P G L K +        ++       I I +   L+ LH       I
Sbjct: 69  LDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH----EQKI 124

Query: 451 IHCDLKPTSILLDENMVAHVSDFGISKLL 479
           +H DLK  +ILL  N +  + D GISK+L
Sbjct: 125 LHRDLKSANILLVANDLVKIGDLGISKVL 153

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 51.6 bits (124), Expect = 2e-07
 Identities = 40/152 (26%), Positives = 64/152 (42%), Gaps = 22/152 (14%)

Query: 344 GSFGSVYKGTISDGT----DVAIKIFNLQRER---AFRSFNSECEVLRNVRHQNLIK--- 393
           GSFG V +G  S        VA+K   L+ ++       F  E  ++ ++ H+NLI+   
Sbjct: 6   GSFGVVRRGEWSTSGGKVIPVAVKC--LKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYG 63

Query: 394 -ILSSCSTPDFKFMPNGSLEKRLYSHN---YFLDILERLNIMIDVGSTLEYLHHGHSSAP 449
            +L+       +  P GSL  RL       + +  L    + I  G  + YL        
Sbjct: 64  VVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANG--MRYLESKR---- 117

Query: 450 IIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
            IH DL   +ILL  +    + DFG+ + L +
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQ 149

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 51.9 bits (125), Expect = 2e-07
 Identities = 40/145 (27%), Positives = 66/145 (45%), Gaps = 14/145 (9%)

Query: 344 GSFGSVYKGTISDGTDV-AIKIFNLQ---RERAFRSFNSECEVLRNVRHQNLIKILSSCS 399
           G+FG V      D   + A+K  N Q    + + R+  +E  +L+ + H  L+ +  S  
Sbjct: 11  GAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQ 70

Query: 400 TPDFKF-----MPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
             +  +     +  G L   L     F +   +   + ++   LEYLH    S  IIH D
Sbjct: 71  DEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKF-WICEIVLALEYLH----SKGIIHRD 125

Query: 455 LKPTSILLDENMVAHVSDFGISKLL 479
           +KP +ILLDE    H++DF I+  +
Sbjct: 126 IKPDNILLDEQGHVHITDFNIATKV 150

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 51.9 bits (125), Expect = 3e-07
 Identities = 47/174 (27%), Positives = 73/174 (41%), Gaps = 57/174 (32%)

Query: 337 LETISLAGSFGSVYKGT-ISDGTDVAIKIFNLQRERAF-------RSFNSECEVLRNVRH 388
           +E I  +G++G V        G  VAIK    +   AF       R+   E ++LR+ +H
Sbjct: 10  IENIG-SGAYGVVCSAIDTRSGKKVAIK----KIPHAFDVPTLAKRTLR-ELKILRHFKH 63

Query: 389 QNLIKILSSCSTPDFKFMPNGSLEKRLY----------------------SH-NYFLDIL 425
            N+I I            P G+  K +Y                       H  YFL  L
Sbjct: 64  DNIIAIRDI-------LRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQL 116

Query: 426 ERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
            R          L+Y+H    SA +IH DLKP+++L++E+    + DFG+++ L
Sbjct: 117 LR---------GLKYIH----SANVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 52.0 bits (124), Expect = 3e-07
 Identities = 45/166 (27%), Positives = 72/166 (43%), Gaps = 19/166 (11%)

Query: 318 LSRNQLSGDIPSTIGALVDLETISLAGSFGSVYKGTISD-GTDVAIKIFNLQRERAFRSF 376
           + R+    ++   IG L D       G+FG VYK    + G   A K+   + E     +
Sbjct: 4   VRRDLDPNEVWEIIGELGD-------GAFGKVYKAKNKETGALAAAKVIETKSEEELEDY 56

Query: 377 NSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRLYSHNYFLDI-LERLNI 430
             E E+L    H  ++K+L +           +F P G+++  +      LD  L    I
Sbjct: 57  MVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLE----LDRGLTEPQI 112

Query: 431 MIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGIS 476
            +     LE L + HS   IIH DLK  ++LL  +    ++DFG+S
Sbjct: 113 QVICRQMLEALQYLHSMK-IIHRDLKAGNVLLTLDGDIKLADFGVS 157

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 51.5 bits (123), Expect = 3e-07
 Identities = 42/157 (26%), Positives = 72/157 (45%), Gaps = 18/157 (11%)

Query: 336 DLETISLAGS--FGSVYKGT-ISDGTD----VAIK-IFNLQRERAFRSFNSECEVLRNVR 387
           +L  + L GS  FG+V+KG  I +G      VAIK I +    + F+        + ++ 
Sbjct: 8   ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLD 67

Query: 388 HQNLIKILSSCSTPDFK----FMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLH- 442
           H  ++++L  C     +      P GSL   +  H   LD    LN  + +   + YL  
Sbjct: 68  HAYIVRLLGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEE 127

Query: 443 HGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
           H      ++H +L   +ILL  + +  ++DFG++ LL
Sbjct: 128 HR-----MVHRNLAARNILLKSDSIVQIADFGVADLL 159

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 51.6 bits (123), Expect = 3e-07
 Identities = 43/149 (28%), Positives = 69/149 (46%), Gaps = 13/149 (8%)

Query: 336 DLETISLAGS--FGSVYKG-TISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLI 392
           D E I   GS  +G VYK   ++ G   AIK+  L+    F     E  ++++ +H N++
Sbjct: 10  DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69

Query: 393 KILSSCSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSS 447
               S    D      +F   GSL+  +Y   +    L    I      TL+ L++ HS 
Sbjct: 70  AYFGSYLRRDKLWICMEFCGGGSLQD-IY---HVTGPLSESQIAYVSRETLQGLYYLHSK 125

Query: 448 APIIHCDLKPTSILLDENMVAHVSDFGIS 476
             + H D+K  +ILL +N    ++DFG+S
Sbjct: 126 GKM-HRDIKGANILLTDNGHVKLADFGVS 153

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 51.3 bits (123), Expect = 4e-07
 Identities = 37/157 (23%), Positives = 66/157 (42%), Gaps = 13/157 (8%)

Query: 334 LVDLETISLAGSFGSVYKGT----ISDGTDVAIKIFNLQRERAFRS-FNSECEVLRNVRH 388
            + L      G FG VY+G      ++   VA+K        + R  F  E  ++R   H
Sbjct: 7   DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDH 66

Query: 389 QNLIKILSSCS-TPDFKFM---PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHG 444
            +++K++   +  P +  M   P G L   L  + Y LD+   +     + + L YL   
Sbjct: 67  PHIVKLIGVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE-- 124

Query: 445 HSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
             S   +H D+   ++L+       + DFG+S+ L +
Sbjct: 125 --SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 50.0 bits (120), Expect = 7e-07
 Identities = 39/147 (26%), Positives = 62/147 (42%), Gaps = 14/147 (9%)

Query: 343 AGSFGSVYKGT--ISDGT--DVAIKIFNLQRERAFRS-FNSECEVLRNVRHQNLIKILSS 397
            G+FGSV KG   +  G   +VA+K    +   A +  F  E  V+  + H  +++++  
Sbjct: 5   HGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGV 64

Query: 398 CSTPDF----KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHC 453
           C         +  P G L K L          +   +   V   + YL   H     +H 
Sbjct: 65  CKGEPLMLVMELAPLGPLLKYLKKRREIPVS-DLKELAHQVAMGMAYLESKH----FVHR 119

Query: 454 DLKPTSILLDENMVAHVSDFGISKLLG 480
           DL   ++LL     A +SDFG+S+ LG
Sbjct: 120 DLAARNVLLVNRHQAKISDFGMSRALG 146

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 50.6 bits (121), Expect = 7e-07
 Identities = 43/144 (29%), Positives = 64/144 (44%), Gaps = 15/144 (10%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFN----LQRERAFRSFNSECEVLRNVRHQNLIKILSSC 398
           GSFG V      +DG   A+K+      L+++           +L+NV+H  L+ +  S 
Sbjct: 6   GSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSF 65

Query: 399 STPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHC 453
            T D       ++  G L   L     F +   R     ++ S L YLH    S  II+ 
Sbjct: 66  QTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLH----SLNIIYR 120

Query: 454 DLKPTSILLDENMVAHVSDFGISK 477
           DLKP +ILLD      ++DFG+ K
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK 144

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 50.1 bits (120), Expect = 8e-07
 Identities = 42/160 (26%), Positives = 69/160 (43%), Gaps = 41/160 (25%)

Query: 344 GSFGS--VYKGTISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCS 399
           G+FG   +Y+ T  D + V  K  NL R  E+  R   +E  +L  ++H N+I   +   
Sbjct: 11  GAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH-- 67

Query: 400 TPDFKFMPNGSL-------------------EKRLYSHNYFLDILERLNIMIDVGSTLEY 440
                FM + +L                   + +L+     L  L +      + S + Y
Sbjct: 68  -----FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQ------IVSAVSY 116

Query: 441 LHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG 480
           +H     A I+H D+K  +I L +  +  + DFGISK+LG
Sbjct: 117 IH----KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILG 152

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 50.0 bits (119), Expect = 8e-07
 Identities = 44/148 (29%), Positives = 73/148 (49%), Gaps = 20/148 (13%)

Query: 344 GSFGSVYKGTISD-GTDVAIK--IFNLQRERAFRSFNS-ECEV--LRNVRHQNLIKILSS 397
           G+FG VY    +D G ++A+K   F+   +   +  N+ ECE+  L+N+RH  +++    
Sbjct: 13  GAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGC 72

Query: 398 CSTPDFK-------FMPNGSLEKRLYSHNYFLD-ILERLNIMIDVGSTLEYLHHGHSSAP 449
              P+ K       +MP GS++ +L ++    + +  R    I  G  + YLH    S  
Sbjct: 73  LRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQG--VSYLH----SNM 126

Query: 450 IIHCDLKPTSILLDENMVAHVSDFGISK 477
           I+H D+K  +IL D      + DFG SK
Sbjct: 127 IVHRDIKGANILRDSAGNVKLGDFGASK 154

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 50.0 bits (120), Expect = 9e-07
 Identities = 41/161 (25%), Positives = 68/161 (42%), Gaps = 29/161 (18%)

Query: 344 GSFGSVYKG---TISDG---TDVAIKIFNLQ---RERAFRSFNSECEVLRNVRHQNLIKI 394
           GSFG VY+G    +  G   T VAIK  N     RER    F +E  V++     +++++
Sbjct: 17  GSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRER--IEFLNEASVMKEFNCHHVVRL 74

Query: 395 LSSCST--PDF---KFMPNGSLEKRLYSH------NYFLDILERLNIM---IDVGSTLEY 440
           L   ST  P     + M  G L+  L S       N  L        +    ++   + Y
Sbjct: 75  LGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAY 134

Query: 441 LHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
           L         +H DL   + ++ E++   + DFG+++ + E
Sbjct: 135 LAAKK----FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYE 171

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 51.0 bits (122), Expect = 1e-06
 Identities = 28/71 (39%), Positives = 43/71 (60%), Gaps = 1/71 (1%)

Query: 142 RYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFN 201
           R+L  + LSGN + G +PPS+G+  TSL+    S     G+IP+ +G L  L  L+L  N
Sbjct: 442 RHLQSINLSGNSIRGNIPPSLGSI-TSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGN 500

Query: 202 DLNGTIPTSIG 212
            L+G +P ++G
Sbjct: 501 SLSGRVPAALG 511

Length = 623

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 32/143 (22%), Positives = 73/143 (51%), Gaps = 11/143 (7%)

Query: 343 AGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           AG FG V+ G  ++ T VA+K        + ++F  E  +++ ++H  L+++ +  +  +
Sbjct: 16  AGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEE 74

Query: 403 -----FKFMPNGSLEKRLYSHNYFLDILERL-NIMIDVGSTLEYLHHGHSSAPIIHCDLK 456
                 ++M  GSL   L S      +L +L +    +   + Y+   +     IH DL+
Sbjct: 75  PIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN----YIHRDLR 130

Query: 457 PTSILLDENMVAHVSDFGISKLL 479
             ++L+ E+++  ++DFG+++++
Sbjct: 131 AANVLVSESLMCKIADFGLARVI 153

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 41/152 (26%), Positives = 67/152 (44%), Gaps = 26/152 (17%)

Query: 344 GSFGSV----YKGTISDGTDVAIKIFNLQ----RERAFRSFNSECEVLRNVRHQNLIKIL 395
           GS+G V    ++   +DG    IK  NL+    RER  ++   E ++L  ++H N++   
Sbjct: 11  GSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRER--KAAEQEAQLLSQLKHPNIVAYR 65

Query: 396 SSCSTPD------FKFMPNGSLEKRLYSHNYFLDILER--LNIMIDVGSTLEYLHHGHSS 447
            S    D        F   G L  +L      L + E   +   + +   L+YLH  H  
Sbjct: 66  ESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKL-LPENQVVEWFVQIAMALQYLHEKH-- 122

Query: 448 APIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
             I+H DLK  ++ L    +  V D GI+++L
Sbjct: 123 --ILHRDLKTQNVFLTRTNIIKVGDLGIARVL 152

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 49.5 bits (118), Expect = 1e-06
 Identities = 36/142 (25%), Positives = 73/142 (51%), Gaps = 10/142 (7%)

Query: 343 AGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCST-P 401
           AG FG V+ G  +  T VAIK    Q   +  +F +E  +++ ++H  L+++ +  +  P
Sbjct: 16  AGQFGEVWMGYYNGHTKVAIKSLK-QGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQEP 74

Query: 402 DF---KFMPNGSLEKRL-YSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKP 457
            +   ++M NGSL   L       L I + +++   +   + ++   +     IH DL+ 
Sbjct: 75  IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY----IHRDLRA 130

Query: 458 TSILLDENMVAHVSDFGISKLL 479
            +IL+ E +   ++DFG+++L+
Sbjct: 131 ANILVSETLCCKIADFGLARLI 152

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 49.5 bits (119), Expect = 1e-06
 Identities = 45/166 (27%), Positives = 71/166 (42%), Gaps = 34/166 (20%)

Query: 336 DLETISL--AGSFGSV----YKGTISDGTDVAIKIFNLQ---RERAFRSFNSECEVLRNV 386
           D E I     GSFG V    +KG+   G   A+KI +     + +      +E  +L+++
Sbjct: 2   DFEFIKTLGTGSFGRVMLVRHKGS---GKYYALKILSKAKIVKLKQVEHVLNEKRILQSI 58

Query: 387 RHQNLIKILSSCSTPDFKFM-----PNGSLEKRLYSHNYFLDILERLNIMI------DVG 435
           RH  L+ +  S       ++     P G L    +SH   L    R    +       V 
Sbjct: 59  RHPFLVNLYGSFQDDSNLYLVMEYVPGGEL----FSH---LRKSGRFPEPVARFYAAQVV 111

Query: 436 STLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
             LEYLH       I++ DLKP ++LLD +    ++DFG +K +  
Sbjct: 112 LALEYLHSLD----IVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 49.4 bits (118), Expect = 2e-06
 Identities = 39/162 (24%), Positives = 71/162 (43%), Gaps = 28/162 (17%)

Query: 343 AGSFGSVYK--GTISDGTDVAIKIFNL----------QRERAFRSFNSECEVLR-NVRHQ 389
           +G+FG VYK     +    +A+K  N+          +R+++     SE  +++  +RH 
Sbjct: 10  SGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHP 69

Query: 390 NLIKILSSCSTPD-----FKFMPNGSLEKRLYS----HNYFLDILERL-NIMIDVGSTLE 439
           N+++   +    D        +    L +   S       F +  ER+ NI + +   L 
Sbjct: 70  NIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTE--ERIWNIFVQMVLALR 127

Query: 440 YLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
           YLH       I+H DL P +I+L E+    ++DFG++K    
Sbjct: 128 YLH---KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQP 166

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 49.1 bits (117), Expect = 2e-06
 Identities = 48/165 (29%), Positives = 82/165 (49%), Gaps = 41/165 (24%)

Query: 335 VDLETISLAGSFGSVYKGT-ISDGTDVAIK-IFN-----LQRERAFRSFNSECEVLRNVR 387
           VDL+ + + G+FG V        G +VAIK I       +  +R +R    E ++L+++R
Sbjct: 13  VDLQPVGM-GAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR----ELKLLKHLR 67

Query: 388 HQNLIKILSSCSTP--DFKF------------MPNGSLEKRLYSHNYFLDILERLNIMID 433
           H+N+I +     +P  D  F            + +  LEK+     YFL  + R      
Sbjct: 68  HENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFI--QYFLYQILR------ 119

Query: 434 VGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL 478
               L+Y+H    SA ++H DLKP++IL++EN    + DFG++++
Sbjct: 120 ---GLKYVH----SAGVVHRDLKPSNILINENCDLKICDFGLARI 157

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 49.2 bits (118), Expect = 2e-06
 Identities = 42/159 (26%), Positives = 76/159 (47%), Gaps = 37/159 (23%)

Query: 343 AGSFGSVYKGTISD-GTDVAIKIFN--LQRE----RAFRSFNSECEVLRNVRHQNLIKIL 395
           +G++G V     +  G  VAIK  +   Q      R +R    E  +L+++ H+N+I +L
Sbjct: 25  SGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR----ELRLLKHMDHENVIGLL 80

Query: 396 SSCSTPDFKFMPNGSLEK--RLYSHNYFLD-----IL--ERLN------IMIDVGSTLEY 440
                    F P  SLE    +Y   + +      I+  ++L+      ++  +   L+Y
Sbjct: 81  DV-------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKY 133

Query: 441 LHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
           +H    SA IIH DLKP++I ++E+    + DFG+++  
Sbjct: 134 IH----SAGIIHRDLKPSNIAVNEDCELKILDFGLARHT 168

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 48.6 bits (116), Expect = 3e-06
 Identities = 44/146 (30%), Positives = 70/146 (47%), Gaps = 30/146 (20%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRE-RAFRSFNSECEVLRNVRHQNLIKILSSCSTP 401
           GS G V   T  S G  VA+K  +L+++ R    FN E  ++R+ +H N++++ SS    
Sbjct: 30  GSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFN-EVVIMRDYQHPNIVEMYSSYLVG 88

Query: 402 D-----FKFMPNGSLEKRLYSHNYFLDILE--RLN------IMIDVGSTLEYLHHGHSSA 448
           D      +F+  G+L           DI+   R+N      + + V   L +LH    + 
Sbjct: 89  DELWVVMEFLEGGALT----------DIVTHTRMNEEQIATVCLAVLKALSFLH----AQ 134

Query: 449 PIIHCDLKPTSILLDENMVAHVSDFG 474
            +IH D+K  SILL  +    +SDFG
Sbjct: 135 GVIHRDIKSDSILLTSDGRVKLSDFG 160

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 48.6 bits (116), Expect = 3e-06
 Identities = 39/151 (25%), Positives = 64/151 (42%), Gaps = 26/151 (17%)

Query: 343 AGSFGSVYKGTISDGTDV--AIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCST 400
            G+FG VYK      T +  A KI  ++ E     F  E ++L   +H N++ +  +   
Sbjct: 15  DGAFGKVYK-AQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFY 73

Query: 401 PD-----FKFMPNGSLEKRLYSHNYFLDILER-LN------IMIDVGSTLEYLHHGHSSA 448
            +      +F   G+L+         +  LER L       +   +   L +LH    S 
Sbjct: 74  ENKLWILIEFCDGGALDS-------IMLELERGLTEPQIRYVCRQMLEALNFLH----SH 122

Query: 449 PIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
            +IH DLK  +ILL  +    ++DFG+S   
Sbjct: 123 KVIHRDLKAGNILLTLDGDVKLADFGVSAKN 153

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 48.4 bits (115), Expect = 3e-06
 Identities = 31/129 (24%), Positives = 62/129 (48%), Gaps = 12/129 (9%)

Query: 357 GTDVAIKIFNLQ-RERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-------FKFMPN 408
           G  VA+K    +           E E+LRN+ H+N++K    C+           +F+P+
Sbjct: 33  GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 92

Query: 409 GSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVA 468
           GSL++ L  +   +++ ++L   + +   ++YL     S   +H DL   ++L++     
Sbjct: 93  GSLKEYLPRNKNKINLKQQLKYAVQICKGMDYL----GSRQYVHRDLAARNVLVESEHQV 148

Query: 469 HVSDFGISK 477
            + DFG++K
Sbjct: 149 KIGDFGLTK 157

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 48.3 bits (115), Expect = 4e-06
 Identities = 42/171 (24%), Positives = 66/171 (38%), Gaps = 43/171 (25%)

Query: 343 AGSFGSVYKGTI------SDGTDVAIKIFNLQRERAF----RSFNSECEVLRNVRHQNLI 392
            G+FG V++            T VA+K+    +E A       F  E  ++    H N++
Sbjct: 15  QGAFGRVFQARAPGLLPYEPFTMVAVKML---KEEASADMQADFQREAALMAEFDHPNIV 71

Query: 393 KILSSCSTPD-----FKFMPNGSL--------------------EKRLYSHNYF-LDILE 426
           K+L  C+        F++M  G L                      R    N   L   E
Sbjct: 72  KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131

Query: 427 RLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK 477
           +L I   V + + YL         +H DL   + L+ ENMV  ++DFG+S+
Sbjct: 132 QLCIAKQVAAGMAYLSERK----FVHRDLATRNCLVGENMVVKIADFGLSR 178

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 48.0 bits (114), Expect = 5e-06
 Identities = 38/137 (27%), Positives = 65/137 (47%), Gaps = 12/137 (8%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           G+ G+VY    ++ G +VAIK  NLQ++       +E  V+R  +H N++  L S    D
Sbjct: 30  GASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGD 89

Query: 403 -----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKP 457
                 +++  GSL   +      +D  +   +  +    LE+LH       +IH D+K 
Sbjct: 90  ELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHSNQ----VIHRDIKS 143

Query: 458 TSILLDENMVAHVSDFG 474
            +ILL  +    ++DFG
Sbjct: 144 DNILLGMDGSVKLTDFG 160

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 47.6 bits (114), Expect = 5e-06
 Identities = 40/153 (26%), Positives = 57/153 (37%), Gaps = 28/153 (18%)

Query: 344 GSFGSVYK-GTISDGTDVAIKIFN---LQRERAFRSFNSECEVLRNVRHQNLIKILSSCS 399
           G FG V      S     A+K      +          SE E+L    H  ++K+  +  
Sbjct: 4   GGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRT-- 61

Query: 400 TPDFK----------FMPNGSLEKRLYSHNYFLDILERLNI--MIDVGSTLEYLHHGHSS 447
              FK          +   G L   L     F +   R  I  ++      EYLH+    
Sbjct: 62  ---FKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVV---LAFEYLHNRG-- 113

Query: 448 APIIHCDLKPTSILLDENMVAHVSDFGISKLLG 480
             II+ DLKP ++LLD N    + DFG +K L 
Sbjct: 114 --IIYRDLKPENLLLDSNGYVKLVDFGFAKKLK 144

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 47.5 bits (113), Expect = 5e-06
 Identities = 45/155 (29%), Positives = 68/155 (43%), Gaps = 33/155 (21%)

Query: 344 GSFGSVYKG-TISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           G++G VY    +S    +AIK    +  R  +  + E  +   ++H+N+++ L S S   
Sbjct: 19  GTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENG 78

Query: 403 F--KFM---PNGSLEKRLYSH------------NYFLDILERLNIMIDVGSTLEYLHHGH 445
           F   FM   P GSL   L S              Y   ILE           L+YLH   
Sbjct: 79  FFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILE----------GLKYLHDNQ 128

Query: 446 SSAPIIHCDLKPTSILLDE-NMVAHVSDFGISKLL 479
               I+H D+K  ++L++  + V  +SDFG SK L
Sbjct: 129 ----IVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 47.4 bits (112), Expect = 6e-06
 Identities = 49/159 (30%), Positives = 72/159 (45%), Gaps = 29/159 (18%)

Query: 344 GSFGSVYKGTIS-DG--TDVAIKIFN-LQRERAFRSFNSECEVLRNV-RHQNLIKILSSC 398
           G+FG V K  I  DG   D AIK       +   R F  E EVL  +  H N+I +L +C
Sbjct: 6   GNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC 65

Query: 399 STPDF-----KFMPNGSL------EKRLYSHNYF---------LDILERLNIMIDVGSTL 438
               +     ++ P+G+L       + L +   F         L   + L+   DV   +
Sbjct: 66  EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGM 125

Query: 439 EYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK 477
           +YL    S    IH DL   +IL+ EN VA ++DFG+S+
Sbjct: 126 DYL----SQKQFIHRDLAARNILVGENYVAKIADFGLSR 160

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 47.0 bits (111), Expect = 8e-06
 Identities = 42/149 (28%), Positives = 72/149 (48%), Gaps = 18/149 (12%)

Query: 344 GSFGSVYKGTISD-GTDVAIKI--FNLQRERAFRSFNS-ECEV--LRNVRHQNLIKILSS 397
           G+FG VY    +D G ++A+K   F+ +     +  N+ ECE+  L+N+ H+ +++    
Sbjct: 13  GAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGC 72

Query: 398 CSTPD-------FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPI 450
              P         + MP GS++ +L S+    + + R          LE + + HS+  I
Sbjct: 73  LRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTR----QILEGVSYLHSNM-I 127

Query: 451 IHCDLKPTSILLDENMVAHVSDFGISKLL 479
           +H D+K  +IL D      + DFG SK L
Sbjct: 128 VHRDIKGANILRDSVGNVKLGDFGASKRL 156

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 46.7 bits (111), Expect = 1e-05
 Identities = 44/168 (26%), Positives = 68/168 (40%), Gaps = 47/168 (27%)

Query: 337 LETISLAGSFGSVYKGT-ISDGTDVAIKIFNL----------QRERAFRSFNSECEVLRN 385
           LE I   G++G+VY+G  +  G  VA+KI NL          QRE A  S       LR 
Sbjct: 6   LELIG-RGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLS------QLRQ 58

Query: 386 VRHQNLIKILSS-------CSTPDF-------KFMPNGSLEKRLYSHNYFLDILERLNIM 431
            +  N+ K   S           ++         M  G + ++  S            I+
Sbjct: 59  SQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV-----------II 107

Query: 432 IDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
            +V   L+Y+H       +IH D+K  +IL+       + DFG++ LL
Sbjct: 108 REVLVALKYIHK----VGVIHRDIKAANILVTNTGNVKLCDFGVAALL 151

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 43/144 (29%), Positives = 66/144 (45%), Gaps = 15/144 (10%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFN----LQRERAFRSFNSECEVLRNVRHQNLIKILSSC 398
           GSFG V      SDG+  A+K+      L+++           +L+N++H  L+ +  S 
Sbjct: 6   GSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF 65

Query: 399 STPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHC 453
            T +       ++  G L   L     FL+   R     +V S + YLH    S  II+ 
Sbjct: 66  QTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYLH----SLNIIYR 120

Query: 454 DLKPTSILLDENMVAHVSDFGISK 477
           DLKP +ILLD      ++DFG+ K
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK 144

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 38/147 (25%), Positives = 68/147 (46%), Gaps = 14/147 (9%)

Query: 343 AGSFGSVYKGT-ISDGTDVAIKI-FNLQRE----RAFRSFNSECEVLRNVRHQNLIKILS 396
           +G+FG+VYKG  I DG +V I +   + RE    +A +    E  V+  V    + ++L 
Sbjct: 17  SGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLG 76

Query: 397 SCSTPDFKF----MPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
            C T   +     MP G L   +  +   +   + LN  + +   + YL        ++H
Sbjct: 77  ICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE----EVRLVH 132

Query: 453 CDLKPTSILLDENMVAHVSDFGISKLL 479
            DL   ++L+       ++DFG+++LL
Sbjct: 133 RDLAARNVLVKSPNHVKITDFGLARLL 159

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 42/153 (27%), Positives = 77/153 (50%), Gaps = 29/153 (18%)

Query: 343 AGSFGSV-YKGTISDGTDVAIKIF------NLQRERAFRSFNSECEVLRNVRHQNLIKIL 395
           +G++G+V        G  VAIK         L  +RA+R    E  +L++++H+N+I +L
Sbjct: 25  SGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLKHMKHENVIGLL 80

Query: 396 SSCSTPD---------FKFMP-NGSLEKRLYSHNYFLDILERLNIMI-DVGSTLEYLHHG 444
               TPD         +  MP  G+   +L  H    +  +R+  ++  +   L+Y+H  
Sbjct: 81  D-VFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSE--DRIQFLVYQMLKGLKYIH-- 135

Query: 445 HSSAPIIHCDLKPTSILLDENMVAHVSDFGISK 477
             +A IIH DLKP ++ ++E+    + DFG+++
Sbjct: 136 --AAGIIHRDLKPGNLAVNEDCELKILDFGLAR 166

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 36/142 (25%), Positives = 71/142 (50%), Gaps = 10/142 (7%)

Query: 343 AGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCS-TP 401
           AG FG V+  T +  T VA+K        +  +F +E  V++ ++H  L+K+ +  +  P
Sbjct: 16  AGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEP 74

Query: 402 DF---KFMPNGSLEKRLYSHNYFLDILERL-NIMIDVGSTLEYLHHGHSSAPIIHCDLKP 457
            +   +FM  GSL   L S       L +L +    +   + ++   +     IH DL+ 
Sbjct: 75  IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN----YIHRDLRA 130

Query: 458 TSILLDENMVAHVSDFGISKLL 479
            +IL+  ++V  ++DFG+++++
Sbjct: 131 ANILVSASLVCKIADFGLARVI 152

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 46.5 bits (111), Expect = 2e-05
 Identities = 43/145 (29%), Positives = 66/145 (45%), Gaps = 42/145 (28%)

Query: 357 GTDVAIKI---FNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPDFK------- 404
           G  VAIK    F  Q   +R  R    E ++LR  +H+N+I IL     P F+       
Sbjct: 30  GVKVAIKKISPFEHQTFCQRTLR----EIKILRRFKHENIIGILDIIRPPSFESFNDVYI 85

Query: 405 ---FMPNGSLEKRLYSHN-------YFL-DILERLNIMIDVGSTLEYLHHGHSSAPIIHC 453
               M    L K + + +       YFL  IL            L+Y+H    SA ++H 
Sbjct: 86  VQELMET-DLYKLIKTQHLSNDHIQYFLYQILR----------GLKYIH----SANVLHR 130

Query: 454 DLKPTSILLDENMVAHVSDFGISKL 478
           DLKP+++LL+ N    + DFG++++
Sbjct: 131 DLKPSNLLLNTNCDLKICDFGLARI 155

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 46.2 bits (110), Expect = 2e-05
 Identities = 43/146 (29%), Positives = 68/146 (46%), Gaps = 37/146 (25%)

Query: 357 GTDVAIKIFNLQR--------ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPDFKFMPN 408
           G +VAIK   L R        +RA+R       +++ V H+N+I +L+        F P 
Sbjct: 41  GQNVAIK--KLSRPFQNVTHAKRAYREL----VLMKLVNHKNIIGLLNV-------FTPQ 87

Query: 409 GSLEKRLYSHNYFLDILERLN----IMIDVG-STLEYL--------HHGHSSAPIIHCDL 455
            SLE+  +   Y +  L   N    I +D+    + YL         H HS A IIH DL
Sbjct: 88  KSLEE--FQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHS-AGIIHRDL 144

Query: 456 KPTSILLDENMVAHVSDFGISKLLGE 481
           KP++I++  +    + DFG+++  G 
Sbjct: 145 KPSNIVVKSDCTLKILDFGLARTAGT 170

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 46.2 bits (110), Expect = 2e-05
 Identities = 34/140 (24%), Positives = 55/140 (39%), Gaps = 17/140 (12%)

Query: 344 GSFGSVYKGTISDGTDVAIKIFNL--QRERAFRSFNSECEVLRNVRHQNLIKILSSCSTP 401
                + K   +  T VA+K  NL    +   +    E    R ++H N++  ++S    
Sbjct: 13  LMIVHLAKHKPT-NTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD 71

Query: 402 D-----FKFMPNGSLEKRLYSHNYFLDILERL---NIMIDVGSTLEYLHHGHSSAPIIHC 453
                    M  GS E  L +H  F + L  L    I+ DV + L+Y+H        IH 
Sbjct: 72  SELYVVSPLMAYGSCEDLLKTH--FPEGLPELAIAFILKDVLNALDYIHSKG----FIHR 125

Query: 454 DLKPTSILLDENMVAHVSDF 473
            +K + ILL  +    +S  
Sbjct: 126 SVKASHILLSGDGKVVLSGL 145

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 58/187 (31%), Positives = 89/187 (47%), Gaps = 15/187 (8%)

Query: 4   QIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPN 63
            +P+ + NL NLK+L L  N+LS  +P ++ N+S + NL+L GN++S  LP  I   L  
Sbjct: 154 SLPSPLRNLPNLKNLDLSFNDLSD-LPKLLSNLSNLNNLDLSGNKIS-DLPPEIEL-LSA 210

Query: 64  IKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLT 123
           ++ L+L +N++I  + +S++N   L  L+L  N     +P + GNL +L  L L  N ++
Sbjct: 211 LEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED-LPESIGNLSNLETLDLSNNQIS 268

Query: 124 TESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTI 183
                    S L SLTN R    L LSGN L   LP             +         +
Sbjct: 269 -------SISSLGSLTNLR---ELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKALEL 318

Query: 184 PKEIGHL 190
                 L
Sbjct: 319 KLNSILL 325

Length = 394

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 35/155 (22%), Positives = 69/155 (44%), Gaps = 31/155 (20%)

Query: 344 GSFGSVYKG-TISDGTDVAIKIFNLQRER------AFRSFNSECEVLRNVRHQNLIKILS 396
           G+FG V+K         VA+K   ++ E+      A R    E ++L+ ++H+N++ ++ 
Sbjct: 23  GTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR----EIKILQLLKHENVVNLIE 78

Query: 397 SCSTPDFKFMPNGS--------------LEKRLYSHNYFLDILERLNIMIDVGSTLEYLH 442
            C T       N                L   L + N    + E   +M  + + L Y+H
Sbjct: 79  ICRTK--ATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH 136

Query: 443 HGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK 477
                  I+H D+K  +IL+ ++ +  ++DFG+++
Sbjct: 137 ----RNKILHRDMKAANILITKDGILKLADFGLAR 167

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 39/143 (27%), Positives = 67/143 (46%), Gaps = 18/143 (12%)

Query: 344 GSFGSVYKGTISD-GTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           G+FG VYK    + G   A K+ + + E     +  E ++L +  H N++K+L +    +
Sbjct: 16  GAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN 75

Query: 403 -----FKFMPNGSLEKRLYSHNYFLDILERL----NIMIDVGSTLEYLHHGHSSAPIIHC 453
                 +F   G+++  +         LER      I +    TLE L++ H +  IIH 
Sbjct: 76  NLWILIEFCAGGAVDAVMLE-------LERPLTEPQIRVVCKQTLEALNYLHENK-IIHR 127

Query: 454 DLKPTSILLDENMVAHVSDFGIS 476
           DLK  +IL   +    ++DFG+S
Sbjct: 128 DLKAGNILFTLDGDIKLADFGVS 150

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 45.6 bits (108), Expect = 2e-05
 Identities = 43/142 (30%), Positives = 65/142 (45%), Gaps = 14/142 (9%)

Query: 343 AGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCST-- 400
           +G FG V+ G       VAIK  N +   +   F  E +V+  + H  L+++   C+   
Sbjct: 14  SGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQK 72

Query: 401 PDF---KFMPNGSLEKRLYSHNYFL--DILERLNIMIDVGSTLEYLHHGHSSAPIIHCDL 455
           P +   +FM NG L   L      L  D+L  L++  DV   +EYL         IH DL
Sbjct: 73  PLYIVTEFMENGCLLNYLRQRQGKLSKDML--LSMCQDVCEGMEYLERNS----FIHRDL 126

Query: 456 KPTSILLDENMVAHVSDFGISK 477
              + L+    V  VSDFG+++
Sbjct: 127 AARNCLVSSTGVVKVSDFGMTR 148

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 46.1 bits (109), Expect = 3e-05
 Identities = 61/208 (29%), Positives = 95/208 (45%), Gaps = 17/208 (8%)

Query: 6   PTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIK 65
            +E+  L NL SL L  NN++ + P +    S ++ L+L  N++   LPS + + LPN+K
Sbjct: 109 ISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRN-LPNLK 166

Query: 66  YLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTE 125
            L+L  N+L   +P  ++N + L  LDL  N  S  +P     L  L  L L  N++   
Sbjct: 167 NLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-- 222

Query: 126 SSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPK 185
                    LSSL+N + L  L LS N L     P      ++L+    S  ++  +   
Sbjct: 223 -------ELLSSLSNLKNLSGLELSNNKL--EDLPESIGNLSNLETLDLSNNQI--SSIS 271

Query: 186 EIGHLRGLIYLSLGFNDLNGTIPTSIGT 213
            +G L  L  L L  N L+  +P     
Sbjct: 272 SLGSLTNLRELDLSGNSLSNALPLIALL 299

Length = 394

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 45.1 bits (107), Expect = 3e-05
 Identities = 40/151 (26%), Positives = 67/151 (44%), Gaps = 18/151 (11%)

Query: 344 GSFGSVYKGT-ISDGTDVA---IKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCS 399
           G F  VYK   + DG  VA   ++IF +   +A +    E ++L+ + H N+IK L+S  
Sbjct: 13  GQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI 72

Query: 400 TPD-----FKFMPNGSLEKRLYSHNYFLD--ILERL--NIMIDVGSTLEYLHHGHSSAPI 450
             +      +    G L  R+  H       I ER      + + S LE++H    S  I
Sbjct: 73  ENNELNIVLELADAGDL-SRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH----SKRI 127

Query: 451 IHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
           +H D+KP ++ +    V  + D G+ +    
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGLGRFFSS 158

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 45.0 bits (106), Expect = 3e-05
 Identities = 41/149 (27%), Positives = 68/149 (45%), Gaps = 13/149 (8%)

Query: 336 DLETISLAGS--FGSVYKG-TISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLI 392
           D E I   GS  +G VYK   +  G   A+KI  L+    F     E  +++  +H N++
Sbjct: 10  DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIV 69

Query: 393 KILSSCSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSS 447
               S  + +      ++   GSL+  +Y   +    L  L I      TL+ L + HS 
Sbjct: 70  AYFGSYLSREKLWICMEYCGGGSLQD-IY---HVTGPLSELQIAYVCRETLQGLAYLHSK 125

Query: 448 APIIHCDLKPTSILLDENMVAHVSDFGIS 476
             + H D+K  +ILL +N    ++DFG++
Sbjct: 126 GKM-HRDIKGANILLTDNGDVKLADFGVA 153

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 45.7 bits (108), Expect = 4e-05
 Identities = 60/163 (36%), Positives = 90/163 (55%), Gaps = 8/163 (4%)

Query: 183 IPKEIGHL-RGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEML 241
           IP  IG L   L  L L  N +  ++P+ +  L  L+   L   +L   +P  L +L  L
Sbjct: 131 IPPLIGLLKSNLKELDLSDNKI-ESLPSPLRNLPNLKNLDLSFNDLSD-LPKLLSNLSNL 188

Query: 242 NLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLND 301
           N L L GNK+S  +PP +  L++L ELDL +N +   + SSL +L  +  + LS+N L D
Sbjct: 189 NNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIE-LLSSLSNLKNLSGLELSNNKLED 246

Query: 302 SLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAG 344
            LP ++  L  L  LDLS NQ+S    S++G+L +L  + L+G
Sbjct: 247 -LPESIGNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSG 286

Length = 394

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 44.8 bits (106), Expect = 4e-05
 Identities = 43/161 (26%), Positives = 72/161 (44%), Gaps = 32/161 (19%)

Query: 343 AGSFGSVYKGTISD----GTD---VAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLI 392
           +G+FG VY+GT +D    G+    VA+K   L++   ++  + F  E  ++ N  H N++
Sbjct: 5   SGAFGEVYEGTATDILGPGSGPIRVAVK--TLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 393 KILSSCSTPD-----FKFMPNGSL------EKRLYSHNYFLDILERLNIMIDVGSTLEYL 441
           K+L  C   +      + M  G L       +        L + E L+I +DV     YL
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122

Query: 442 HHGHSSAPIIHCDLKPTSILLDE-----NMVAHVSDFGISK 477
              H     IH DL   + L+ E     + V  + DFG+++
Sbjct: 123 EQMH----FIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 45.4 bits (107), Expect = 4e-05
 Identities = 43/144 (29%), Positives = 62/144 (43%), Gaps = 15/144 (10%)

Query: 344 GSFGSVYKGTIS-DGTDVAIKIFN----LQRERAFRSFNSECEVLRNVRHQNLIKILSSC 398
           GSFG V       DG   A+K+      L R+           +L+NV+H  L+ +  S 
Sbjct: 6   GSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSF 65

Query: 399 STPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHC 453
            T +       F+  G L   L     F +   R     ++ S L YLH    S  I++ 
Sbjct: 66  QTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLH----SINIVYR 120

Query: 454 DLKPTSILLDENMVAHVSDFGISK 477
           DLKP +ILLD      ++DFG+ K
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK 144

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 45.1 bits (107), Expect = 4e-05
 Identities = 39/155 (25%), Positives = 71/155 (45%), Gaps = 35/155 (22%)

Query: 344 GSFGSVYKGTISD-GTDVAIKIF------NLQRERAFRSFNSECEVLRNVRHQNLIKILS 396
           GS+G V+K    + G  VAIK F       + ++ A R    E  +L+ ++H NL+ ++ 
Sbjct: 12  GSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALR----EIRMLKQLKHPNLVNLIE 67

Query: 397 SCSTPDFKFMPNGSLEKRL-----YSHNYFLDILER-------LNIMIDVGSTLEYLHHG 444
                 F+       +++L     Y  +  L+ LE+         I   +  TL+ ++  
Sbjct: 68  V-----FR------RKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFC 116

Query: 445 HSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
           H     IH D+KP +IL+ +     + DFG +++L
Sbjct: 117 HKHN-CIHRDVKPENILITKQGQIKLCDFGFARIL 150

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 45.0 bits (107), Expect = 4e-05
 Identities = 61/232 (26%), Positives = 87/232 (37%), Gaps = 56/232 (24%)

Query: 135 LSSLTNCRYLVYLILSGNPLGGILPPSIGNF--STSLQRFSASECKLKGTIPKEIG---- 188
           L  LT    L  L LS N LG      + +   S+SLQ    +   L     + +     
Sbjct: 74  LQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLK 133

Query: 189 ----HLRGLIYLSLGFNDLNGTIPT-------SIGTLKQLQGFFLPETNLQGY------- 230
                L  L+   LG N L G           +   LK+L    L    +          
Sbjct: 134 DLPPALEKLV---LGRNRLEGASCEALAKALRANRDLKELN---LANNGIGDAGIRALAE 187

Query: 231 -VPHNLCHLEMLNL-----LHLGGNKLSGHIPPCLASLTSLRELDLGSNKLT-------- 276
            +  N C+LE+L+L        G + L+      LASL SL  L+LG N LT        
Sbjct: 188 GLKAN-CNLEVLDLNNNGLTDEGASALAE----TLASLKSLEVLNLGDNNLTDAGAAALA 242

Query: 277 SSIPSSLWSLGYILEINLSSNLLND----SLPSNVQKLKVLRVLDLSRNQLS 324
           S++ S   SL   L ++LS N + D     L   + + + L  LDL  N+  
Sbjct: 243 SALLSPNISL---LTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFG 291

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 44.6 bits (105), Expect = 5e-05
 Identities = 40/160 (25%), Positives = 71/160 (44%), Gaps = 31/160 (19%)

Query: 345 SFGSVYKGTIS-DGTD----VAIKIF-NLQRERAFRSFNSECEVLRNVRHQNLIKILSSC 398
           +FG +YKG +   G D    VAIK   ++   + +  F  E  ++  + H N++ +L   
Sbjct: 17  AFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVV 76

Query: 399 STPD-----FKFMPNGSLEKRLYSHN----------------YFLDILERLNIMIDVGST 437
           +        F+++  G L + L   +                  LD  + L+I I + + 
Sbjct: 77  TQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAG 136

Query: 438 LEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK 477
           +EYL    SS   +H DL   +IL+ E +   +SD G+S+
Sbjct: 137 MEYL----SSHFFVHKDLAARNILIGEQLHVKISDLGLSR 172

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 44.6 bits (106), Expect = 6e-05
 Identities = 41/159 (25%), Positives = 69/159 (43%), Gaps = 40/159 (25%)

Query: 344 GSFGSVYKG-TISDGTDVAIKIFNLQRER------AFRSFNSECEVLRNVRHQNLIKILS 396
           G++G VYK      G  VA+K   L+ E       A R    E  +L+ + H N++++L 
Sbjct: 10  GTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR----EISLLKELNHPNIVRLLD 65

Query: 397 SCSTPDFKFMPNGSLEKRLYSHNYFLDI-LERL-----NIMIDVGSTLEYLH-------- 442
              +           E +LY    FLD+ L++         +D      YL+        
Sbjct: 66  VVHS-----------ENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAY 114

Query: 443 -HGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG 480
            H H    ++H DLKP ++L+D      ++DFG+++  G
Sbjct: 115 CHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFG 150

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 44.4 bits (105), Expect = 6e-05
 Identities = 42/153 (27%), Positives = 71/153 (46%), Gaps = 28/153 (18%)

Query: 344 GSFGSVYKG-TISDGTDVAIKIFNLQRER------AFRSFNSECEVLRNVRHQNLIKILS 396
           G++G VYK      G  VA+K   L  E       A R    E  +L+ + H N++K+L 
Sbjct: 11  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR----EISLLKELNHPNIVKLLD 66

Query: 397 SCSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMID-VGSTLEYLHHGHS---S 447
              T +     F+F+ +  L+K       F+D      I +  + S L  L  G +   S
Sbjct: 67  VIHTENKLYLVFEFL-HQDLKK-------FMDASPLSGIPLPLIKSYLFQLLQGLAFCHS 118

Query: 448 APIIHCDLKPTSILLDENMVAHVSDFGISKLLG 480
             ++H DLKP ++L++      ++DFG+++  G
Sbjct: 119 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFG 151

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 44.0 bits (104), Expect = 7e-05
 Identities = 40/147 (27%), Positives = 68/147 (46%), Gaps = 19/147 (12%)

Query: 344 GSFGSVYKGTI--SDGTDVAIKIFNLQRERAFRS---FNSECEVLRNVRHQNLIKILSSC 398
           G FG VY GT+  SDG  +   + +L R         F  E  ++++  H N++ +L  C
Sbjct: 6   GHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGIC 65

Query: 399 STPD------FKFMPNGSLEK--RLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPI 450
              +        +M +G L    R  +HN  +  L  +   + V   +EYL    +S   
Sbjct: 66  LPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDL--IGFGLQVAKGMEYL----ASKKF 119

Query: 451 IHCDLKPTSILLDENMVAHVSDFGISK 477
           +H DL   + +LDE+    V+DFG+++
Sbjct: 120 VHRDLAARNCMLDESFTVKVADFGLAR 146

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 44.0 bits (104), Expect = 8e-05
 Identities = 24/66 (36%), Positives = 38/66 (57%), Gaps = 7/66 (10%)

Query: 413 KRLYSHNYFL--DILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHV 470
           K++Y     +  DIL +  I + +   LEYLH   S   +IH D+KP+++L++ N    +
Sbjct: 91  KKVYDKGLTIPEDILGK--IAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKL 145

Query: 471 SDFGIS 476
            DFGIS
Sbjct: 146 CDFGIS 151

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 43.9 bits (103), Expect = 9e-05
 Identities = 38/149 (25%), Positives = 68/149 (45%), Gaps = 18/149 (12%)

Query: 344 GSFGSVYKGT-ISDGTDVAIK---IFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCS 399
           G F  VY+ T + DG  VA+K   IF+L   +A      E ++L+ + H N+IK  +S  
Sbjct: 13  GQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI 72

Query: 400 TPD-----FKFMPNGSLEK--RLYSHNYFLDILERL--NIMIDVGSTLEYLHHGHSSAPI 450
             +      +    G L +  + +     L I E+      + + S LE++H    S  +
Sbjct: 73  EDNELNIVLELADAGDLSRMIKHFKKQKRL-IPEKTVWKYFVQLCSALEHMH----SRRV 127

Query: 451 IHCDLKPTSILLDENMVAHVSDFGISKLL 479
           +H D+KP ++ +    V  + D G+ +  
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGLGRFF 156

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 44.1 bits (104), Expect = 9e-05
 Identities = 33/136 (24%), Positives = 63/136 (46%), Gaps = 20/136 (14%)

Query: 360 VAIKIFNLQRERAFRS-FNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEK 413
           VA+K+      +  R+ F  E +++  ++  N+I++L+ C T D      ++M NG L +
Sbjct: 49  VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108

Query: 414 RLYSHNY----------FLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLD 463
            L  H             +     + +   + S ++YL    SS   +H DL   + L+ 
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL----SSLNFVHRDLATRNCLVG 164

Query: 464 ENMVAHVSDFGISKLL 479
           +N    ++DFG+S+ L
Sbjct: 165 KNYTIKIADFGMSRNL 180

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 43.9 bits (103), Expect = 1e-04
 Identities = 39/143 (27%), Positives = 70/143 (48%), Gaps = 24/143 (16%)

Query: 344 GSFGSVYKGTI-SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           GS G V   T+ S G  VA+K  +L++++      +E  ++R+ +H+N++++ +S    D
Sbjct: 31  GSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD 90

Query: 403 -----FKFMPNGSLEKRLYSHNYFLDILERLN------IMIDVGSTLEYLHHGHSSAPII 451
                 +F+  G+L   + +H        R+N      + + V   L  LH    +  +I
Sbjct: 91  ELWVVMEFLEGGALTD-IVTHT-------RMNEEQIAAVCLAVLKALSVLH----AQGVI 138

Query: 452 HCDLKPTSILLDENMVAHVSDFG 474
           H D+K  SILL  +    +SDFG
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFG 161

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 43.6 bits (103), Expect = 1e-04
 Identities = 37/163 (22%), Positives = 71/163 (43%), Gaps = 34/163 (20%)

Query: 344 GSFGSVYKGTISDGTD-------VAIKIFNLQR-ERAFRSFNSECEVLRNV-RHQNLIKI 394
           G+FG V K   + G D       VA+K+      E+      SE E+++ + +H+N+I +
Sbjct: 23  GAFGQVVKAE-AVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINL 81

Query: 395 LSSCST--PDF---KFMPNGSLEKRLYSH-------NYFLDILERLNIMI--------DV 434
           L  C+   P +   ++  +G+L   L +        +          +           V
Sbjct: 82  LGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQV 141

Query: 435 GSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK 477
              +E+L    +S   IH DL   ++L+ E+ V  ++DFG+++
Sbjct: 142 ARGMEFL----ASKKCIHRDLAARNVLVTEDHVMKIADFGLAR 180

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 43.4 bits (102), Expect = 1e-04
 Identities = 38/148 (25%), Positives = 61/148 (41%), Gaps = 17/148 (11%)

Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRERAF----RSFNSECEVLRNVRHQNLIKILSSCS 399
           G FG V  G ++ G   A  +    R  A       F  E +  R+++H NL++ L  C+
Sbjct: 6   GWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCT 65

Query: 400 --TPDF---KFMPNGSLEKRLYS----HNYFLDILERLNIMIDVGSTLEYLHHGHSSAPI 450
             TP     +F P G L+  L S         D      +  ++   L +LH  +     
Sbjct: 66  EVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN----F 121

Query: 451 IHCDLKPTSILLDENMVAHVSDFGISKL 478
           IH DL   + LL  ++   + D+G+S  
Sbjct: 122 IHSDLALRNCLLTADLTVKIGDYGLSHN 149

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 43.7 bits (103), Expect = 1e-04
 Identities = 45/151 (29%), Positives = 79/151 (52%), Gaps = 26/151 (17%)

Query: 343 AGSFGSVYKGT-ISDGTDVAIKIFN--LQRE----RAFRSFNSECEVLRNVRHQNLIKIL 395
           +G++GSV        G  VAIK  +   Q E    RA+R    E  +L++++H+N+I +L
Sbjct: 25  SGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR----ELTLLKHMQHENVIGLL 80

Query: 396 ----SSCSTPDFK----FMPNGSLE-KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHS 446
               S+ S  +F+     MP    + +++  H    D ++ L   +  G  L+Y+H    
Sbjct: 81  DVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCG--LKYIH---- 134

Query: 447 SAPIIHCDLKPTSILLDENMVAHVSDFGISK 477
           SA IIH DLKP ++ ++E+    + DFG+++
Sbjct: 135 SAGIIHRDLKPGNLAVNEDCELKILDFGLAR 165

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 40/135 (29%), Positives = 67/135 (49%), Gaps = 25/135 (18%)

Query: 357 GTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL 411
           G  VA+K+ +L++++      +E  ++R+ +HQN++++  S    +      +F+  G+L
Sbjct: 46  GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105

Query: 412 EKRLYSHNYFLDILE--RLN---IMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENM 466
                      DI+   RLN   I     S L+ L + HS   +IH D+K  SILL  + 
Sbjct: 106 T----------DIVSQTRLNEEQIATVCESVLQALCYLHSQG-VIHRDIKSDSILLTLDG 154

Query: 467 VAHVSDFG----ISK 477
              +SDFG    ISK
Sbjct: 155 RVKLSDFGFCAQISK 169

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 43.5 bits (103), Expect = 1e-04
 Identities = 45/164 (27%), Positives = 72/164 (43%), Gaps = 49/164 (29%)

Query: 344 GSFGSVYKG-TISDGTDVAIKIFNLQRER------AFRSFNSECEVLRNVRHQNLIKIL- 395
           G+FG VYK   I  G  VA+K   +  E+      A R    E ++L+ ++H N++ ++ 
Sbjct: 19  GTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR----EIKILKKLKHPNVVPLID 74

Query: 396 --------SSCSTPDFKFM--P------NGSLE----KRLYSH--NYFLDILERLNIMID 433
                   S        +M  P      +G LE    K   S    Y L +LE +N    
Sbjct: 75  MAVERPDKSKRKRGSV-YMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGIN---- 129

Query: 434 VGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK 477
                 YLH  H    I+H D+K  +IL+D   +  ++DFG+++
Sbjct: 130 ------YLHENH----ILHRDIKAANILIDNQGILKIADFGLAR 163

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 32/123 (26%), Positives = 62/123 (50%), Gaps = 11/123 (8%)

Query: 357 GTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL 411
           G  VA+K  +L++++      +E  ++R+  H+N++ + +S    D      +F+  G+L
Sbjct: 47  GKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106

Query: 412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVS 471
              + +H   ++  +   + + V   L YLH    +  +IH D+K  SILL  +    +S
Sbjct: 107 TD-IVTHTR-MNEEQIATVCLSVLRALSYLH----NQGVIHRDIKSDSILLTSDGRIKLS 160

Query: 472 DFG 474
           DFG
Sbjct: 161 DFG 163

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 43.4 bits (102), Expect = 2e-04
 Identities = 42/154 (27%), Positives = 72/154 (46%), Gaps = 38/154 (24%)

Query: 344 GSFGSVYKGTIS--DGTDVAIKIFNLQRERAFRSFNS--ECEVLRNVRHQNLI---KILS 396
           GS+ +VYKG IS  +G  VA+K+ +++ E     F +  E  +L+ ++H N++    I+ 
Sbjct: 16  GSYATVYKG-ISRINGQLVALKVISMKTEEGV-PFTAIREASLLKGLKHANIVLLHDIIH 73

Query: 397 SCSTPDFKF-------------MPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHH 443
           +  T  F F              P G     L+ +N  L        M  +   L Y+H 
Sbjct: 74  TKETLTFVFEYMHTDLAQYMIQHPGG-----LHPYNVRL-------FMFQLLRGLAYIHG 121

Query: 444 GHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK 477
            H    I+H DLKP ++L+       ++DFG+++
Sbjct: 122 QH----ILHRDLKPQNLLISYLGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 43.1 bits (102), Expect = 2e-04
 Identities = 18/41 (43%), Positives = 24/41 (58%), Gaps = 3/41 (7%)

Query: 436 STLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGIS 476
             L YL   H    +IH D+KP++ILLD +    + DFGIS
Sbjct: 125 KALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGIS 162

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 37/149 (24%), Positives = 67/149 (44%), Gaps = 18/149 (12%)

Query: 344 GSFGSVYKG-TISDGTDVAIKIFNLQRE-----RAFRSFNSECEVLRNVRHQNLIKILSS 397
           G+FG VY    +  G ++A K      E     +   +   E ++L+N++H+ +++    
Sbjct: 13  GAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGC 72

Query: 398 CS-------TPDFKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPI 450
                    T   ++MP GS++ +L ++    + + R      +   + YLH    S  I
Sbjct: 73  LRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTR-KYTRQILEGMSYLH----SNMI 127

Query: 451 IHCDLKPTSILLDENMVAHVSDFGISKLL 479
           +H D+K  +IL D      + DFG SK L
Sbjct: 128 VHRDIKGANILRDSAGNVKLGDFGASKRL 156

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 43.2 bits (102), Expect = 2e-04
 Identities = 35/154 (22%), Positives = 76/154 (49%), Gaps = 22/154 (14%)

Query: 344 GSFGSVYKGTISD-GTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKI---LSSCS 399
           GS G V+    SD    VA+K   L   ++ +    E +++R + H N++K+   L    
Sbjct: 16  GSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSG 75

Query: 400 TPDFKFMPNGSLEKRLYSHNYFLD-----ILERLNI--------MIDVGSTLEYLHHGHS 446
           +   + + + +    +Y    +++     +LE+  +        M  +   L+Y+H    
Sbjct: 76  SDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIH---- 131

Query: 447 SAPIIHCDLKPTSILLD-ENMVAHVSDFGISKLL 479
           SA ++H DLKP ++ ++ E++V  + DFG+++++
Sbjct: 132 SANVLHRDLKPANVFINTEDLVLKIGDFGLARIV 165

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 39/148 (26%), Positives = 61/148 (41%), Gaps = 21/148 (14%)

Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRERAF----RSFNSECEVLRNVRHQNLIKILSSC- 398
           G FG V  G    G   A  +    R  A       F  E +  R + H N+++ L  C 
Sbjct: 6   GWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCI 65

Query: 399 -STP---DFKFMPNGSLEKRLYSHNYFL------DILERLNIMIDVGSTLEYLHHGHSSA 448
            S P     +F P G L+  L S+   +      D+L+R+    +V S L +LH      
Sbjct: 66  ESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM--ACEVASGLLWLHQAD--- 120

Query: 449 PIIHCDLKPTSILLDENMVAHVSDFGIS 476
             IH DL   +  L  ++   + D+G++
Sbjct: 121 -FIHSDLALRNCQLTADLSVKIGDYGLA 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 43/144 (29%), Positives = 67/144 (46%), Gaps = 15/144 (10%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFN---LQRERAFRSFNSECEVL-RNVRHQNLIKILSSC 398
           GSFG V      ++    A+K+     + +++  +   SE  VL +NV+H  L+ +  S 
Sbjct: 6   GSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF 65

Query: 399 STPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHC 453
            T D       ++  G L   L     FL+   R     ++ S L YLH    S  I++ 
Sbjct: 66  QTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH----SLNIVYR 120

Query: 454 DLKPTSILLDENMVAHVSDFGISK 477
           DLKP +ILLD      ++DFG+ K
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLCK 144

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 22/48 (45%), Positives = 32/48 (66%), Gaps = 6/48 (12%)

Query: 429 NIMIDVGSTLEYLH-HGHSSAPIIHCDLKPTSILLDENMVAHVSDFGI 475
           NIM D+ +TLEY+H HG     I H D+KP +I++D N   ++ D+GI
Sbjct: 130 NIMKDMLTTLEYIHEHG-----ISHGDIKPENIMVDGNNRGYIIDYGI 172

Length = 294

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 42.4 bits (100), Expect = 3e-04
 Identities = 41/149 (27%), Positives = 70/149 (46%), Gaps = 19/149 (12%)

Query: 344 GSFGSVYKGTISD-GTDVAIKIFNLQRERAFRSFNS--ECEVLRNVRHQNLIKILSSC-- 398
           G++G VY+   +  G  VA+K   +  ER     +S  E  +L N+RH N++++      
Sbjct: 18  GTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVG 77

Query: 399 STPDFKFMPNGSLEKRLYSHNYFLD-------ILERLNIMIDVGSTLEYLHHGHSSAPII 451
              D  F+     E+ L S    LD         +   +M+ +   L+YLH       II
Sbjct: 78  KHLDSIFLVMEYCEQDLAS---LLDNMPTPFSESQVKCLMLQLLRGLQYLHENF----II 130

Query: 452 HCDLKPTSILLDENMVAHVSDFGISKLLG 480
           H DLK +++LL +     ++DFG+++  G
Sbjct: 131 HRDLKVSNLLLTDKGCLKIADFGLARTYG 159

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 42.5 bits (100), Expect = 3e-04
 Identities = 42/144 (29%), Positives = 60/144 (41%), Gaps = 14/144 (9%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRSFN---SECEVLRNVRHQNLIKILSSCS 399
           GSFG+VY    +     VAIK  +   +++   +     E   L+ +RH N I+    C 
Sbjct: 26  GSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIE-YKGCY 84

Query: 400 TPD---FKFMPN--GSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
             +   +  M    GS    L  H   L  +E   I       L YLH    S   IH D
Sbjct: 85  LREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLH----SHERIHRD 140

Query: 455 LKPTSILLDENMVAHVSDFGISKL 478
           +K  +ILL E     ++DFG + L
Sbjct: 141 IKAGNILLTEPGTVKLADFGSASL 164

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 42.4 bits (100), Expect = 3e-04
 Identities = 29/110 (26%), Positives = 47/110 (42%), Gaps = 18/110 (16%)

Query: 379 ECEVLRNVRHQNLIKILSSCSTPD-------FKFMPNGSLE---KRLYSHNYFLDILER- 427
           E E+ ++ +   ++K   +             ++   GSL+   K++        I E+ 
Sbjct: 49  ELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRG--GRIGEKV 106

Query: 428 -LNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGIS 476
              I   V   L YLH    S  IIH D+KP++ILL       + DFG+S
Sbjct: 107 LGKIAESVLKGLSYLH----SRKIIHRDIKPSNILLTRKGQVKLCDFGVS 152

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 42.0 bits (98), Expect = 4e-04
 Identities = 37/137 (27%), Positives = 66/137 (48%), Gaps = 12/137 (8%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           G+ G+VY    ++ G +VAI+  NLQ++       +E  V+R  ++ N++  L S    D
Sbjct: 31  GASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD 90

Query: 403 -----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKP 457
                 +++  GSL   +      +D  +   +  +    LE+LH    S  +IH D+K 
Sbjct: 91  ELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLH----SNQVIHRDIKS 144

Query: 458 TSILLDENMVAHVSDFG 474
            +ILL  +    ++DFG
Sbjct: 145 DNILLGMDGSVKLTDFG 161

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 42.0 bits (98), Expect = 4e-04
 Identities = 34/137 (24%), Positives = 66/137 (48%), Gaps = 12/137 (8%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           G+ G+V+    ++ G +VAIK  NLQ++       +E  V++ +++ N++  L S    D
Sbjct: 30  GASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGD 89

Query: 403 -----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKP 457
                 +++  GSL   +      +D  +   +  +    LE+LH       +IH D+K 
Sbjct: 90  ELFVVMEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQ----VIHRDIKS 143

Query: 458 TSILLDENMVAHVSDFG 474
            ++LL  +    ++DFG
Sbjct: 144 DNVLLGMDGSVKLTDFG 160

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 42.0 bits (98), Expect = 5e-04
 Identities = 38/137 (27%), Positives = 66/137 (48%), Gaps = 12/137 (8%)

Query: 344 GSFGSVYKG-TISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           G+ G+VY    I+ G +VAIK  NLQ++       +E  V+R  ++ N++  L S    D
Sbjct: 30  GASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD 89

Query: 403 -----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKP 457
                 +++  GSL   +      +D  +   +  +    L++LH    S  +IH D+K 
Sbjct: 90  ELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLH----SNQVIHRDIKS 143

Query: 458 TSILLDENMVAHVSDFG 474
            +ILL  +    ++DFG
Sbjct: 144 DNILLGMDGSVKLTDFG 160

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 41.9 bits (98), Expect = 5e-04
 Identities = 41/157 (26%), Positives = 77/157 (49%), Gaps = 37/157 (23%)

Query: 343 AGSFGSVYKG-TISDGTDVAIKIFN------LQRERAFRSFNSECEVLRNVRHQNLIKIL 395
           +G++GSV        G  VA+K  +      +  +R +R    E  +L++++H+N+I +L
Sbjct: 27  SGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIGLL 82

Query: 396 SSCSTPDFKFMPNGSLEK----RLYSHNYFLDI-----LERLN------IMIDVGSTLEY 440
                    F P  SLE+     L +H    D+      ++L       ++  +   L+Y
Sbjct: 83  DV-------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 135

Query: 441 LHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK 477
           +H    SA IIH DLKP+++ ++E+    + DFG+++
Sbjct: 136 IH----SADIIHRDLKPSNLAVNEDCELKILDFGLAR 168

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 41.7 bits (98), Expect = 5e-04
 Identities = 46/147 (31%), Positives = 70/147 (47%), Gaps = 20/147 (13%)

Query: 344 GSFGSVY---KGTISD-GTDVAIKIF---NLQRERAFRSFNSECEVLRNVRHQNLIKILS 396
           GSFG V+   K T  D G   A+K+     L+     R+   E ++L  V H  ++K+  
Sbjct: 7   GSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKM-ERDILAEVNHPFIVKLHY 65

Query: 397 SCSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNI-MIDVGSTLEYLHHGHSSAPI 450
           +  T         F+  G L  RL     F +  E +   + ++   L++LH    S  I
Sbjct: 66  AFQTEGKLYLILDFLRGGDLFTRLSKEVMFTE--EDVKFYLAELALALDHLH----SLGI 119

Query: 451 IHCDLKPTSILLDENMVAHVSDFGISK 477
           I+ DLKP +ILLDE     ++DFG+SK
Sbjct: 120 IYRDLKPENILLDEEGHIKLTDFGLSK 146

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 41.8 bits (98), Expect = 5e-04
 Identities = 38/145 (26%), Positives = 67/145 (46%), Gaps = 30/145 (20%)

Query: 360 VAIKIFNLQRERAFRS-FNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEK 413
           VA+KI      +  R+ F  E ++L  ++  N+I++L  C   D      ++M NG L +
Sbjct: 49  VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108

Query: 414 RLYSHNYFLDILER-------------------LNIMIDVGSTLEYLHHGHSSAPIIHCD 454
            L S ++  D  E                    L++ + + S ++YL    SS   +H D
Sbjct: 109 FL-SSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL----SSLNFVHRD 163

Query: 455 LKPTSILLDENMVAHVSDFGISKLL 479
           L   + L+ EN+   ++DFG+S+ L
Sbjct: 164 LATRNCLVGENLTIKIADFGMSRNL 188

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 41.6 bits (97), Expect = 5e-04
 Identities = 49/160 (30%), Positives = 74/160 (46%), Gaps = 34/160 (21%)

Query: 337 LETISLAGSFGSVYKGTISDGTD--VAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKI 394
           LE I   GSFG V+KG I + T   VAIKI +L+          E E +     Q  I +
Sbjct: 9   LEKIG-KGSFGEVFKG-IDNRTQKVVAIKIIDLEEAE------DEIEDI-----QQEITV 55

Query: 395 LSSCSTPDF-KFMPNGSLEKRLY------SHNYFLDILER--------LNIMIDVGSTLE 439
           LS C +P   K+  +   + +L+           LD+LE           I+ ++   L+
Sbjct: 56  LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLD 115

Query: 440 YLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
           YLH    S   IH D+K  ++LL E+    ++DFG++  L
Sbjct: 116 YLH----SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL 151

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 41.5 bits (97), Expect = 6e-04
 Identities = 38/169 (22%), Positives = 63/169 (37%), Gaps = 39/169 (23%)

Query: 344 GSFGSVYKGT------ISDGTDVAIKIFNLQRERA-FRSFNSECEVLRNVRHQNLIKILS 396
           G FG V K T       +  T VA+K+       +  R   SE  +L+ V H ++IK+  
Sbjct: 11  GEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYG 70

Query: 397 SCSTPD-----FKFMPNGSLEKRL-----------------YSHNYFLDILERLNIMI-- 432
           +CS         ++   GSL   L                  S          L +    
Sbjct: 71  ACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLI 130

Query: 433 ----DVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK 477
                +   ++YL    +   ++H DL   ++L+ E     +SDFG+S+
Sbjct: 131 SFAWQISRGMQYL----AEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 41.5 bits (97), Expect = 6e-04
 Identities = 31/137 (22%), Positives = 67/137 (48%), Gaps = 21/137 (15%)

Query: 360 VAIKIFNLQRERAFRS-FNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEK 413
           VA+K+      +  R+ F  E +++  +++ N+I++L  C + D      ++M NG L +
Sbjct: 47  VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106

Query: 414 RL--------YSHNYFLDILERLNIM---IDVGSTLEYLHHGHSSAPIIHCDLKPTSILL 462
            L        ++H   +  +   N++   + + S ++YL    +S   +H DL   + L+
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL----ASLNFVHRDLATRNCLV 162

Query: 463 DENMVAHVSDFGISKLL 479
             +    ++DFG+S+ L
Sbjct: 163 GNHYTIKIADFGMSRNL 179

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 41.3 bits (97), Expect = 6e-04
 Identities = 46/161 (28%), Positives = 70/161 (43%), Gaps = 28/161 (17%)

Query: 334 LVDLE---TISLAGSFGSV----YKGTISDGTDVAIKIFNLQ---RERAFRSFNSECEVL 383
           L D E   T+   GSFG V    +KGT   G   AIK    +   + +  +    E  +L
Sbjct: 17  LSDFEMGETLG-TGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSIL 72

Query: 384 RNVRHQNLIKILSSCSTPD-------FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGS 436
             + H  ++ ++  CS  D        +F+  G L   L     F + + +     ++  
Sbjct: 73  MELSHPFIVNMM--CSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKF-YHAELVL 129

Query: 437 TLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK 477
             EYLH    S  II+ DLKP ++LLD      V+DFG +K
Sbjct: 130 AFEYLH----SKDIIYRDLKPENLLLDNKGHVKVTDFGFAK 166

Length = 329

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 41.2 bits (96), Expect = 7e-04
 Identities = 31/105 (29%), Positives = 51/105 (48%), Gaps = 10/105 (9%)

Query: 378 SECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMI 432
           +E  VL+N RH  L  +  S  T D      +++  G L   L     F +   R     
Sbjct: 44  TESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRF-YGA 102

Query: 433 DVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK 477
           ++ S L+YLH G     I++ DLK  +++LD++    ++DFG+ K
Sbjct: 103 EIVSALDYLHSGK----IVYRDLKLENLMLDKDGHIKITDFGLCK 143

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 41.2 bits (96), Expect = 7e-04
 Identities = 35/142 (24%), Positives = 68/142 (47%), Gaps = 26/142 (18%)

Query: 358 TDVAIKIFNLQ-RERAFRSFNSECEVLRNV-RHQNLIKILSSCST--PDF---KFMPNGS 410
           T VA+K+      E+      SE E+++ + +H+N+I +L +C+   P +   ++   G+
Sbjct: 51  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 110

Query: 411 LEKRL---------YSHN------YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDL 455
           L + L         Y +N        L   + ++    V   +EYL    +S   IH DL
Sbjct: 111 LREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL----ASKKCIHRDL 166

Query: 456 KPTSILLDENMVAHVSDFGISK 477
              ++L+ E+ V  ++DFG+++
Sbjct: 167 AARNVLVTEDNVMKIADFGLAR 188

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 40.9 bits (96), Expect = 7e-04
 Identities = 37/155 (23%), Positives = 63/155 (40%), Gaps = 25/155 (16%)

Query: 344 GSFGSVYKGTIS----DGTDVAIKIFNLQ---RERAFRSFNSECEVLRNVRHQNLIKILS 396
           G+FG VY+G       D  ++ + +  L     E+    F  E  ++    HQN+++++ 
Sbjct: 17  GAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIG 76

Query: 397 SC--STPDF---KFMPNGSLEKRLY------SHNYFLDILERLNIMIDVGSTLEYLHHGH 445
                 P F   + M  G L+  L            L + + L    DV    +YL   H
Sbjct: 77  VSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH 136

Query: 446 SSAPIIHCDLKPTSILLD---ENMVAHVSDFGISK 477
                IH D+   + LL       VA ++DFG+++
Sbjct: 137 ----FIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 40.9 bits (96), Expect = 8e-04
 Identities = 41/160 (25%), Positives = 69/160 (43%), Gaps = 41/160 (25%)

Query: 344 GSFGSVYKG-TISDGTDVAIKIFNLQRER------AFRSFNSECEVLRNVRHQNLIKILS 396
           G++G VYKG     G  VA+K   L+ E       A R    E  +L+ ++H N++ +  
Sbjct: 11  GTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR----EISLLKELQHPNIVCLQD 66

Query: 397 SCSTPDFKFMPNGSLEKRLYSHNYFLDI-LERLNIMIDVGSTLE------YLH------- 442
                          E RLY    FL + L++    +  G  ++      YL+       
Sbjct: 67  VLMQ-----------ESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGIL 115

Query: 443 --HGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG 480
             H      ++H DLKP ++L+D   V  ++DFG+++  G
Sbjct: 116 FCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFG 152

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 40.9 bits (96), Expect = 9e-04
 Identities = 38/151 (25%), Positives = 64/151 (42%), Gaps = 21/151 (13%)

Query: 344 GSFGSVY----KGTISDGTDVAIKIFN----LQRERAFRSFNSECEVLRNVRHQNLIKIL 395
           G++G V+     G    G   A+K+      +Q+ +      +E +VL  VR    +  L
Sbjct: 11  GAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTL 70

Query: 396 SSCSTPDFK------FMPNGSLEKRLYSHNYFLDILERLNIMI-DVGSTLEYLHHGHSSA 448
                 D K      ++  G L   LY   +F      + + I ++   L++LH      
Sbjct: 71  HYAFQTDTKLHLILDYVNGGELFTHLYQREHF--TESEVRVYIAEIVLALDHLHQ----L 124

Query: 449 PIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
            II+ D+K  +ILLD      ++DFG+SK  
Sbjct: 125 GIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 40.7 bits (96), Expect = 0.001
 Identities = 38/164 (23%), Positives = 72/164 (43%), Gaps = 42/164 (25%)

Query: 344 GSFGSVYKGT-ISDGTDVAIK--IFNLQRERAFRSFNSECEVLRNVR---HQNLIKILSS 397
           G++G+VYK   ++ G  VA+K     L  E    S   E  +L+ +    H N++++L  
Sbjct: 10  GAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDV 69

Query: 398 CSTPD----------FKFMPNGSLEKRLYSHNYFLDILERL-----------NIMIDVGS 436
           C  P           F+ +     ++ L    Y    L +            ++M  +  
Sbjct: 70  CHGPRTDRELKLTLVFEHV-----DQDL--ATY----LSKCPKPGLPPETIKDLMRQLLR 118

Query: 437 TLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG 480
            +++LH    S  I+H DLKP +IL+  +    ++DFG++++  
Sbjct: 119 GVDFLH----SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 40.8 bits (96), Expect = 0.001
 Identities = 18/41 (43%), Positives = 27/41 (65%)

Query: 436 STLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGIS 476
           +T++ L++      IIH D+KP++ILLD N    + DFGIS
Sbjct: 115 ATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGIS 155

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 40.6 bits (96), Expect = 0.001
 Identities = 47/156 (30%), Positives = 80/156 (51%), Gaps = 32/156 (20%)

Query: 344 GSFGSVYKGT-ISDGTDVAIK-IFNLQR-----ERAFRSFNSECEVLRNVR-HQNLIKIL 395
           G++G V+K         VA+K IF+  R     +R FR    E   L+ +  H N++K+L
Sbjct: 18  GAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR----EIMFLQELGDHPNIVKLL 73

Query: 396 S---SCSTPD----FKFMPNGSLEKRLYS---HNYFLDILERLNIMIDVGSTLEYLHHGH 445
           +   + +  D    F++M     E  L++    N   D+ +R  IM  +   L+Y+H   
Sbjct: 74  NVIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRY-IMYQLLKALKYIH--- 124

Query: 446 SSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
            S  +IH DLKP++ILL+ +    ++DFG+++ L E
Sbjct: 125 -SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 40.6 bits (95), Expect = 0.001
 Identities = 40/145 (27%), Positives = 69/145 (47%), Gaps = 18/145 (12%)

Query: 344 GSFGSVYKGTIS-DGTDVAIKIFNLQRERA-FRSFNSECEVLRNVRHQNLIKI-----LS 396
           G++GSVYK      G  +A+K   L+ + + F     E ++L       ++       + 
Sbjct: 12  GNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIE 71

Query: 397 SCSTPDFKFMPNGSLEKRLYSHNYFL-----DILERLNIMIDVGSTLEYLHHGHSSAPII 451
                  ++M  GSL+K LY+          D+L R+   +  G  L++L   H+   II
Sbjct: 72  GAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKG--LKFLKEEHN---II 125

Query: 452 HCDLKPTSILLDENMVAHVSDFGIS 476
           H D+KPT++L++ N    + DFG+S
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVS 150

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 40.3 bits (94), Expect = 0.001
 Identities = 40/149 (26%), Positives = 67/149 (44%), Gaps = 16/149 (10%)

Query: 344 GSFGSVY--KGTISDGTDVAIKIFNLQRERAFRSFNSECEV--LRNVRHQNLIKILSSCS 399
           GSFG +Y  K   SD     IK  +L +        S+ EV  L  ++H N++   +S  
Sbjct: 11  GSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQ 69

Query: 400 TPD-----FKFMPNGSLEKRL-YSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHC 453
                    ++   G L KR+           + L+  + +   L+++H       I+H 
Sbjct: 70  ENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH----DRKILHR 125

Query: 454 DLKPTSILLDEN-MVAHVSDFGISKLLGE 481
           D+K  +I L +N MVA + DFGI++ L +
Sbjct: 126 DIKSQNIFLSKNGMVAKLGDFGIARQLND 154

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 45/152 (29%), Positives = 66/152 (43%), Gaps = 31/152 (20%)

Query: 344 GSFGSVYKGTISDGTD-VAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           GSFG VYKG  +   + VAIKI +L+          E E +     Q  I +LS C +P 
Sbjct: 15  GSFGEVYKGIDNRTKEVVAIKIIDLEEAE------DEIEDI-----QQEITVLSQCDSPY 63

Query: 403 FKFMPNGSLE--KRLYSHNYF-----LDILER--------LNIMIDVGSTLEYLHHGHSS 447
                   L+  K      Y      LD+L+           I+ ++   L+YLH    S
Sbjct: 64  ITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLH----S 119

Query: 448 APIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
              IH D+K  ++LL E     ++DFG++  L
Sbjct: 120 ERKIHRDIKAANVLLSEQGDVKLADFGVAGQL 151

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 38/151 (25%), Positives = 67/151 (44%), Gaps = 22/151 (14%)

Query: 344 GSFGSVYKGT-ISDGTDVAIK---IFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCS 399
           G F  VY+ T + D   VA+K   IF +   +A +    E ++L+ + H N+IK L S  
Sbjct: 13  GQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI 72

Query: 400 TPD-----FKFMPNGSLEKRLYSHNYFLD----ILERL--NIMIDVGSTLEYLHHGHSSA 448
             +      +    G L + +    YF      I ER      + + S +E++H    S 
Sbjct: 73  EDNELNIVLELADAGDLSQMI---KYFKKQKRLIPERTVWKYFVQLCSAVEHMH----SR 125

Query: 449 PIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
            ++H D+KP ++ +    V  + D G+ +  
Sbjct: 126 RVMHRDIKPANVFITATGVVKLGDLGLGRFF 156

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 39.8 bits (93), Expect = 0.002
 Identities = 36/145 (24%), Positives = 65/145 (44%), Gaps = 20/145 (13%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQR------ERAFRSFNSECEVLRNVRHQNLIKIL- 395
           G+F S Y+   +  GT +A+K     R      E    +   E  ++  + H ++I++L 
Sbjct: 11  GAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLG 70

Query: 396 SSCSTPDF----KFMPNGSLEKRLYSHNYFLD-ILERLNIMIDVGSTLEYLHHGHSSAPI 450
           ++C    F    ++M  GS+   L  +  F + ++      +  G  L YLH       I
Sbjct: 71  ATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRG--LSYLHENQ----I 124

Query: 451 IHCDLKPTSILLDEN-MVAHVSDFG 474
           IH D+K  ++L+D       ++DFG
Sbjct: 125 IHRDVKGANLLIDSTGQRLRIADFG 149

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 39/164 (23%), Positives = 72/164 (43%), Gaps = 34/164 (20%)

Query: 344 GSFGSVY--------KGTISDGTDVAIKIF-NLQRERAFRSFNSECEVLRNV-RHQNLIK 393
           G FG V         K    +   VA+K+  +   E+      SE E+++ + +H+N+I 
Sbjct: 26  GCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIN 85

Query: 394 ILSSCSTPD-----FKFMPNGSLEKRLYSH-----NYFLDIL----------ERLNIMID 433
           +L +C+         ++   G+L + L +       Y  DI           + ++    
Sbjct: 86  LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQ 145

Query: 434 VGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK 477
           V   +EYL    +S   IH DL   ++L+ EN V  ++DFG+++
Sbjct: 146 VARGMEYL----ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 185

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 34/122 (27%), Positives = 62/122 (50%), Gaps = 29/122 (23%)

Query: 370 ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPDFKFMPNGSLE--KRLYSHNYFLDI--- 424
           +RA+R    E  +L+ V H+N+I +L+        F P  SLE  + +Y     +D    
Sbjct: 65  KRAYR----ELVLLKCVNHKNIISLLNV-------FTPQKSLEEFQDVYLVMELMDANLC 113

Query: 425 --------LERLNIMI-DVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGI 475
                    ER++ ++  +   +++LH    SA IIH DLKP++I++  +    + DFG+
Sbjct: 114 QVIHMELDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGL 169

Query: 476 SK 477
           ++
Sbjct: 170 AR 171

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 39.7 bits (92), Expect = 0.002
 Identities = 36/142 (25%), Positives = 71/142 (50%), Gaps = 14/142 (9%)

Query: 344 GSFGSVYKG-TISDGTDVAIKIFNLQRERA--FRSFNSECEVLRNVRHQNLIKILSSCST 400
           GS+ +VYKG +  +G  VA+K+  LQ E    F +   E  +L+ ++H N++ +     T
Sbjct: 16  GSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIVLLHDIIHT 74

Query: 401 PD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDL 455
            +     F+++ +  L + +  H   L        +  +   L Y+H  +    I+H DL
Sbjct: 75  KETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY----ILHRDL 129

Query: 456 KPTSILLDENMVAHVSDFGISK 477
           KP ++L+ +     ++DFG+++
Sbjct: 130 KPQNLLISDTGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 36.0 bits (84), Expect = 0.002
 Identities = 22/60 (36%), Positives = 30/60 (50%)

Query: 264 SLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQL 323
           +L+ LDL +N+LT     +   L  +  ++LS N L    P     L  LR LDLS N L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 39.7 bits (92), Expect = 0.002
 Identities = 43/155 (27%), Positives = 68/155 (43%), Gaps = 37/155 (23%)

Query: 344 GSFGSVYKGTISDGTD--VAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTP 401
           GSFG V+KG I + T   VAIKI +L+          E E +     Q  I +LS C +P
Sbjct: 15  GSFGEVFKG-IDNRTQQVVAIKIIDLEEAE------DEIEDI-----QQEITVLSQCDSP 62

Query: 402 D-----------------FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHG 444
                              +++  GS    L +  +  D  +   ++ ++   L+YLH  
Sbjct: 63  YVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPF--DEFQIATMLKEILKGLDYLH-- 118

Query: 445 HSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
             S   IH D+K  ++LL E     ++DFG++  L
Sbjct: 119 --SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQL 151

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 39.7 bits (93), Expect = 0.002
 Identities = 17/41 (41%), Positives = 29/41 (70%), Gaps = 4/41 (9%)

Query: 438 LEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL 478
           L+YLH    SA I+H D+KP ++L++ N V  + DFG++++
Sbjct: 116 LKYLH----SAGILHRDIKPGNLLVNSNCVLKICDFGLARV 152

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 40/159 (25%), Positives = 73/159 (45%), Gaps = 41/159 (25%)

Query: 343 AGSFGSVYKG-TISDGTDVAIKIFNLQRERAFRSF------NSECEVLRNVRHQNLIKIL 395
           +G++GSV           VA+K    +  R F+S         E  +L++++H+N+I +L
Sbjct: 25  SGAYGSVCSAYDTRLRQKVAVK----KLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80

Query: 396 SSCSTPDFKFMPNGSLEKRLYSHNYFLDIL----------------ERLNIMI-DVGSTL 438
                    F P  S+E   ++  Y +  L                E +  +I  +   L
Sbjct: 81  DV-------FTPATSIEN--FNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGL 131

Query: 439 EYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK 477
           +Y+H    SA IIH DLKP+++ ++E+    + DFG+++
Sbjct: 132 KYIH----SAGIIHRDLKPSNVAVNEDCELRILDFGLAR 166

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 39.6 bits (92), Expect = 0.003
 Identities = 35/123 (28%), Positives = 62/123 (50%), Gaps = 25/123 (20%)

Query: 370 ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPDFKFMPNGSLE--KRLYSHNYFLD--IL 425
           +RA+R    E  +++ V H+N+I +L+        F P  SLE  + +Y     +D  + 
Sbjct: 68  KRAYR----ELVLMKCVNHKNIIGLLNV-------FTPQKSLEEFQDVYIVMELMDANLC 116

Query: 426 ERLNIMIDVGSTLEYL--------HHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK 477
           + + + +D    + YL         H HS A IIH DLKP++I++  +    + DFG+++
Sbjct: 117 QVIQMELD-HERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174

Query: 478 LLG 480
             G
Sbjct: 175 TAG 177

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 39.4 bits (92), Expect = 0.003
 Identities = 44/162 (27%), Positives = 76/162 (46%), Gaps = 41/162 (25%)

Query: 344 GSFGSVYKGTISD-GTDVAIKIFNLQRER------AFRSFNSECEVLRNVRHQNLIK--- 393
           G++G VYK    D G  VA+K   L  E+      A R    E ++LR + H+N++    
Sbjct: 18  GTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR----EIKILRQLNHRNIVNLKE 73

Query: 394 ILSSCSTP-DFK-----------FMPN---GSLEKRL--YSHNYFLDILERLNIMIDVGS 436
           I++      DFK           +M +   G LE  L  +S ++    +++L        
Sbjct: 74  IVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQL-------- 125

Query: 437 TLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL 478
            LE L++ H     +H D+K ++ILL+      ++DFG+++L
Sbjct: 126 -LEGLNYCHKKN-FLHRDIKCSNILLNNKGQIKLADFGLARL 165

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 39.3 bits (91), Expect = 0.003
 Identities = 34/124 (27%), Positives = 60/124 (48%), Gaps = 27/124 (21%)

Query: 370 ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPDFKFMPNGSLEKRLYSHNYFLDILERLN 429
           +RA+R    E  +++ V H+N+I +L+        F P  SLE+  +   Y +  L   N
Sbjct: 61  KRAYR----ELVLMKCVNHKNIISLLNV-------FTPQKSLEE--FQDVYLVMELMDAN 107

Query: 430 IMIDVGSTLEY-------------LHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGIS 476
           +   +   L++             + H HS A IIH DLKP++I++  +    + DFG++
Sbjct: 108 LCQVIQMELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLA 166

Query: 477 KLLG 480
           +  G
Sbjct: 167 RTAG 170

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 35.6 bits (83), Expect = 0.004
 Identities = 20/59 (33%), Positives = 28/59 (47%)

Query: 241 LNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLL 299
           L  L L  N+L+         L +L+ LDL  N LTS  P +   L  +  ++LS N L
Sbjct: 2   LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 38.9 bits (91), Expect = 0.004
 Identities = 36/146 (24%), Positives = 68/146 (46%), Gaps = 22/146 (15%)

Query: 344 GSFGSVYKGTISDGTD--VAIKIFNLQRER-----AFRSFNSECEVLRNVRHQNLIKILS 396
           GS+ +VYKG  S  T   VA+K   L+ E      A R    E  +L++++H N++ +  
Sbjct: 16  GSYATVYKG-RSKLTGQLVALKEIRLEHEEGAPFTAIR----EASLLKDLKHANIVTLHD 70

Query: 397 SCSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPII 451
              T       F+++ +  L++ +      L +      +  +   L Y H       ++
Sbjct: 71  IIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR----VL 125

Query: 452 HCDLKPTSILLDENMVAHVSDFGISK 477
           H DLKP ++L+ E     ++DFG+++
Sbjct: 126 HRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 38.7 bits (91), Expect = 0.004
 Identities = 40/159 (25%), Positives = 73/159 (45%), Gaps = 24/159 (15%)

Query: 337 LETISLAGSFGSVYKGT-ISDGTDVAIKIFNLQRER------AFRSFNSECEVLRNVRHQ 389
           L  I   G++G VY+      G  VA+K   +++E+      + R  N    +L  ++H 
Sbjct: 10  LNRIE-EGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREIN----ILLKLQHP 64

Query: 390 NLIKI--LSSCSTPDFKFMPNGSLEKRLYS-----HNYFLDILERLNIMIDVGSTLEYLH 442
           N++ +  +   S  D  +M    +E  L S        FL   E   +M+ + S + +LH
Sbjct: 65  NIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFL-QSEVKCLMLQLLSGVAHLH 123

Query: 443 HGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
                  I+H DLK +++LL+   +  + DFG+++  G 
Sbjct: 124 DNW----ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 38.8 bits (90), Expect = 0.004
 Identities = 36/145 (24%), Positives = 69/145 (47%), Gaps = 20/145 (13%)

Query: 344 GSFGSVYKGTIS-DGTDVAIKIFNLQRER-----AFRSFNSECEVLRNVRHQNLIKI--- 394
           G++ +V+KG        VA+K   L+ E      A R    E  +L+N++H N++ +   
Sbjct: 16  GTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR----EVSLLKNLKHANIVTLHDI 71

Query: 395 --LSSCSTPDFKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
                C T  F+++ +  L++ L +    + +      M  +   L Y H       I+H
Sbjct: 72  IHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK----RKILH 126

Query: 453 CDLKPTSILLDENMVAHVSDFGISK 477
            DLKP ++L++E     ++DFG+++
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 39.1 bits (91), Expect = 0.004
 Identities = 28/116 (24%), Positives = 49/116 (42%), Gaps = 17/116 (14%)

Query: 374 RSFNSECEVLRNVRHQNLIKILSSCSTPDFKFMPNGSLEKRLYSHNYF--LDILERLN-- 429
           ++   E ++L+ + H+ +I ++ +     +++     +    Y  + F  +D    L   
Sbjct: 131 KTPGREIDILKTISHRAIINLIHA-----YRWKSTVCMVMPKYKCDLFTYVDRSGPLPLE 185

Query: 430 --IMIDVG--STLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
             I I       L YLH       IIH D+K  +I LDE   A + DFG +  L  
Sbjct: 186 QAITIQRRLLEALAYLH----GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237

Length = 392

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	481
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.98
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.97
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.97
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.96
KOG0192	362	consensus Tyrosine kinase specific for activated (	99.93
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.93
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.92
KOG0595	429	consensus Serine/threonine-protein kinase involved	99.92
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.92
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.92
KOG0581	364	consensus Mitogen-activated protein kinase kinase	99.91
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	99.91
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.91
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.91
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.9
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.9
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	99.89
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	99.89
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.89
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	99.88
KOG0575	592	consensus Polo-like serine/threonine protein kinas	99.88
KOG0598	357	consensus Ribosomal protein S6 kinase and related	99.88
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	99.87
KOG0198	313	consensus MEKK and related serine/threonine protei	99.87
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	99.87
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.87
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.87
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	99.86
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.86
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	99.86
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.86
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	99.86
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.85
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	99.85
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.84
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	99.84
KOG0583	370	consensus Serine/threonine protein kinase [Signal	99.84
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.84
KOG0661	538	consensus MAPK related serine/threonine protein ki	99.84
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.83
KOG3653	534	consensus Transforming growth factor beta/activin	99.83
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.83
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	99.83
KOG0605	550	consensus NDR and related serine/threonine kinases	99.83
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.83
KOG0611	668	consensus Predicted serine/threonine protein kinas	99.82
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.82
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.82
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.82
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.82
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.82
PHA02988	283	hypothetical protein; Provisional	99.81
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.81
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.81
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.81
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.81
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.81
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.81
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.81
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.81
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.81
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.81
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.81
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.81
KOG0582	516	consensus Ste20-like serine/threonine protein kina	99.81
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.81
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.81
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.8
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.8
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.8
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.8
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.8
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.8
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.8
KOG0578	550	consensus p21-activated serine/threonine protein k	99.8
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.8
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.8
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.8
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.8
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.8
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.8
PTZ00267	478	NIMA-related protein kinase; Provisional	99.8
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.8
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.8
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.79
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.79
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.79
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.79
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.79
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.79
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.79
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.79
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.79
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.79
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.79
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.79
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.79
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.79
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.79
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.79
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.79
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.79
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.79
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.79
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.79
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.79
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.78
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.78
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.78
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.78
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.78
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.78
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.78
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.78
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.78
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.78
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.78
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.78
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.78
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.78
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.78
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.78
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.78
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.78
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.78
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.78
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.78
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.78
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.78
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.77
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.77
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.77
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.77
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.77
PHA03211	461	serine/threonine kinase US3; Provisional	99.77
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.77
KOG0586	596	consensus Serine/threonine protein kinase [General	99.77
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.77
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.77
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.77
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.77
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.77
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.77
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.77
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.77
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.77
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.77
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.77
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.77
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.77
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.77
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.77
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.77
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.77
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.77
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.77
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.77
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.77
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.77
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.77
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.77
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.77
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.76
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.76
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.76
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.76
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.76
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.76
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.76
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.76
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.76
PHA03212	391	serine/threonine kinase US3; Provisional	99.76
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.76
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.76
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.76
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.76
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.76
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.76
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.76
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.76
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.76
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.76
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.76
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.76
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.76
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.76
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.76
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.76
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.76
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.76
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.76
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.76
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.75
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.75
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.75
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.75
KOG0610	459	consensus Putative serine/threonine protein kinase	99.75
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.75
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.75
KOG0694	694	consensus Serine/threonine protein kinase [Signal	99.75
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.75
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.75
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.75
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.75
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.75
PHA03209	357	serine/threonine kinase US3; Provisional	99.75
PTZ00283	496	serine/threonine protein kinase; Provisional	99.75
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.75
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.75
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.75
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.75
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.75
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.75
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.75
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.75
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.75
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.75
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	99.75
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.75
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.74
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.74
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.74
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.74
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.74
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.74
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.74
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.74
PTZ00036	440	glycogen synthase kinase; Provisional	99.74
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.74
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.74
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.74
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.74
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.74
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.74
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.74
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.74
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.74
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.74
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.74
PRK09188	365	serine/threonine protein kinase; Provisional	99.74
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.74
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.74
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.74
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.74
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.74
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.74
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.74
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.73
KOG0589	426	consensus Serine/threonine protein kinase [General	99.73
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.73
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.73
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.73
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.73
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.73
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.73
KOG0584	632	consensus Serine/threonine protein kinase [General	99.73
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.73
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.73
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.73
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.73
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.73
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.73
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.73
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.73
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.73
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.73
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.73
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.73
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.73
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.73
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.73
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.72
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.72
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.72
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.72
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.72
PHA03207	392	serine/threonine kinase US3; Provisional	99.72
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.72
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.72
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.72
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.72
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.72
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.72
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.71
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.71
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.71
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.71
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.71
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.71
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.71
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.71
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.71
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.71
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.71
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.71
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.71
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.71
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.71
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.71
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.71
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.71
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.71
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.71
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.7
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.7
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.7
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.7
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.7
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.7
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.7
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.7
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.7
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.7
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.7
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.7
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.7
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.7
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.7
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.7
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.7
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.7
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.7
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.7
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.69
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.69
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.69
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.69
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.69
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.69
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.69
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.69
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.69
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.69
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.69
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.69
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.69
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.69
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.69
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.69
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.68
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.68
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.68
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.68
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.68
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.68
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.68
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.67
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.67
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.67
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.67
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.67
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.67
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.67
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.67
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.67
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.67
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.67
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.67
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.67
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.67
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.66
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.66
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.66
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.66
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.66
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.66
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.66
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.66
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.66
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.66
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.66
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.66
PHA03210	501	serine/threonine kinase US3; Provisional	99.65
PLN00009	294	cyclin-dependent kinase A; Provisional	99.65
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.65
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.65
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.65
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.65
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.65
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.65
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.65
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.65
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.65
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.65
PTZ00284	467	protein kinase; Provisional	99.64
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.64
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.63
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.63
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.63
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.63
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.63
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.63
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.62
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.62
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.62
PHA02882	294	putative serine/threonine kinase; Provisional	99.61
PRK10345	210	hypothetical protein; Provisional	99.61
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.61
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.61
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.6
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.6
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.59
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.59
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.59
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.59
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.58
KOG1152	772	consensus Signal transduction serine/threonine kin	99.58
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.56
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.55
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.55
PRK14879	211	serine/threonine protein kinase; Provisional	99.54
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.54
PRK12274	218	serine/threonine protein kinase; Provisional	99.53
smart00090	237	RIO RIO-like kinase.	99.53
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.53
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.52
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.51
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.51
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.49
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.49
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.47
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.44
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.41
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.4
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.39
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.39
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.38
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.37
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.37
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.37
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.35
PLN03150	623	hypothetical protein; Provisional	99.33
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.31
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.3
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.28
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.27
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.27
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.25
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.23
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.23
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.22
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.22
PLN03150	623	hypothetical protein; Provisional	99.2
PLN00181	793	protein SPA1-RELATED; Provisional	99.19
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.16
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.14
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.14
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.14
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.13
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	99.13
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.09
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	99.05
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.04
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.02
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.02
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	99.0
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	98.99
KOG1290	590	consensus Serine/threonine protein kinase [Signal	98.98
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	98.95
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	98.93
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	98.91
KOG0590	601	consensus Checkpoint kinase and related serine/thr	98.87
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.81
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	98.73
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	98.71
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	98.68
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.6
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.59
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	98.57
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	98.56
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	98.55
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.54
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.5
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.5
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	98.45
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.41
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.4
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.36
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	98.35
KOG3087	229	consensus Serine/threonine protein kinase [General	98.28
PRK15386	426	type III secretion protein GogB; Provisional	98.26
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.2
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.19
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	98.13
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	98.12
KOG1243	690	consensus Protein kinase [General function predict	98.11
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.0
PRK15386	426	type III secretion protein GogB; Provisional	97.94
KOG0590	601	consensus Checkpoint kinase and related serine/thr	97.93
COG5238	388	RNA1 Ran GTPase-activating protein (RanGAP) involv	97.91
PRK09902	216	hypothetical protein; Provisional	97.89
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	97.89
KOG1644	233	consensus U2-associated snRNP A' protein [RNA proc	97.89
KOG0606	1205	consensus Microtubule-associated serine/threonine	97.85
KOG1644	233	consensus U2-associated snRNP A' protein [RNA proc	97.83

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=8.4e-61  Score=527.67  Aligned_cols=463  Identities=32%  Similarity=0.476  Sum_probs=333.1

Q ss_pred             eeccCcchhCCCCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchh
Q 039957            2 TGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNS   81 (481)
Q Consensus         2 ~g~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~   81 (481)
                      +|.+|.+|+++++|++|+|++|++++.+|..|.++++|++|++++|++++.+|..+. .+++|++|++++|.+.+.+|..
T Consensus       225 ~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~Ls~n~l~~~~p~~  303 (968)
T PLN00113        225 SGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIF-SLQKLISLDLSDNSLSGEIPEL  303 (968)
T ss_pred             CCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHh-hccCcCEEECcCCeeccCCChh
Confidence            456677777777777777777777777777777777777777777777666666665 5666666777666666666666


Q ss_pred             ccccccCceeecccCcceecCcccccCCCCCCEEEcccccCccccCCCcc------------------------------
Q 039957           82 ITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQ------------------------------  131 (481)
Q Consensus        82 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~------------------------------  131 (481)
                      +..+++|+.|++++|.+++..|..+..+++|+.|++++|.+++..+..+.                              
T Consensus       304 ~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~  383 (968)
T PLN00113        304 VIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLF  383 (968)
T ss_pred             HcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCC
Confidence            66666666666666666666666666666666666666665543211100                              


Q ss_pred             ----------ccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEccCCceeecCCcccccCCCCCeEecccc
Q 039957          132 ----------WSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFN  201 (481)
Q Consensus       132 ----------~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N  201 (481)
                                ...+..+..+++|+.|++++|++++.+|..+..+ +.|+.|++++|.+++.+|..+..+++|++|++++|
T Consensus       384 ~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n  462 (968)
T PLN00113        384 KLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKL-PLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARN  462 (968)
T ss_pred             EEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcC-CCCCEEECcCCcccCccChhhccCCCCcEEECcCc
Confidence                      0011122333444444444444444444444443 34444455555444444444444555555555555


Q ss_pred             cceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCcCcccCCc
Q 039957          202 DLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPS  281 (481)
Q Consensus       202 ~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~  281 (481)
                      ++.+.+|..+ ..++|+.|++++|++++..|..+..+++|+.|++++|++.+.+|..+..+++|++|++++|.+++.+|.
T Consensus       463 ~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  541 (968)
T PLN00113        463 KFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPA  541 (968)
T ss_pred             eeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCCh
Confidence            5555555443 345677778888888888888888899999999999999999999999999999999999999999999


Q ss_pred             chhccccCcEEEccCcccCCCCCCccccCCcCcEEEccCCeeeeecccc--cc-----------------------ccCC
Q 039957          282 SLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPST--IG-----------------------ALVD  336 (481)
Q Consensus       282 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~-----------------------~l~~  336 (481)
                      .+..++.|+.|++++|++.+.+|..+..++.|+.+++++|++.+.+|..  +.                       .+..
T Consensus       542 ~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~  621 (968)
T PLN00113        542 SFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKR  621 (968)
T ss_pred             hHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCcc
Confidence            9999999999999999999999999999999999999999999877632  00                       0000


Q ss_pred             --------------------------------------hh----------------------------------hhhccc
Q 039957          337 --------------------------------------LE----------------------------------TISLAG  344 (481)
Q Consensus       337 --------------------------------------L~----------------------------------~l~~~g  344 (481)
                                                            .+                                  ...++|
T Consensus       622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G  701 (968)
T PLN00113        622 VRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRG  701 (968)
T ss_pred             ccccceeeeehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhHHHHHhhCCcccEEccC
Confidence                                                  00                                  001468


Q ss_pred             cccceeeeec-cCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHHhhcC
Q 039957          345 SFGSVYKGTI-SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRLYSH  418 (481)
Q Consensus       345 ~~g~vy~~~l-~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~l~~~  418 (481)
                      +||.||+|.. .+|..||||.+.....    ....|++.+++++|||||+++|+|...+     +||+++|+|.++++. 
T Consensus       702 ~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-  776 (968)
T PLN00113        702 KKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-  776 (968)
T ss_pred             CCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc-
Confidence            9999999986 5789999998754322    2234688999999999999999997765     689999999999863 


Q ss_pred             CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcc
Q 039957          419 NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK  477 (481)
Q Consensus       419 ~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~  477 (481)
                         ++|.++.+||.+||+|++|+|+.+ +++|+|||+||+||++|+++.++++ ||.++
T Consensus       777 ---l~~~~~~~i~~~ia~~L~yLH~~~-~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~  830 (968)
T PLN00113        777 ---LSWERRRKIAIGIAKALRFLHCRC-SPAVVVGNLSPEKIIIDGKDEPHLR-LSLPG  830 (968)
T ss_pred             ---CCHHHHHHHHHHHHHHHHHhccCC-CCCeecCCCCHHhEEECCCCceEEE-ecccc
Confidence               789999999999999999999876 6899999999999999999998886 66543

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3.5e-42  Score=379.86  Aligned_cols=343  Identities=36%  Similarity=0.543  Sum_probs=253.6

Q ss_pred             CeeccCcchhCCCCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecch
Q 039957            1 MTGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPN   80 (481)
Q Consensus         1 ~~g~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~   80 (481)
                      ++|.+|..++.+++|++|+|++|++++.+|..+.++++|++|++++|++++.+|..+. .+++|++|++++|++++.+|.
T Consensus       200 l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~L~~n~l~~~~p~  278 (968)
T PLN00113        200 LVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLG-NLKNLQYLFLYQNKLSGPIPP  278 (968)
T ss_pred             CcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHh-CCCCCCEEECcCCeeeccCch
Confidence            3578999999999999999999999999999999999999999999999999999887 799999999999999999999


Q ss_pred             hccccccCceeecccCcceecCcccccCCCCCCEEEcccccCccccCCCcc----------------ccccccCCCCCCC
Q 039957           81 SITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQ----------------WSFLSSLTNCRYL  144 (481)
Q Consensus        81 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~----------------~~~~~~l~~l~~L  144 (481)
                      ++.++++|++|++++|.+++.+|..|.++++|++|++++|.+++..+..+.                ...+..+..+++|
T Consensus       279 ~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L  358 (968)
T PLN00113        279 SIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNL  358 (968)
T ss_pred             hHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCC
Confidence            999999999999999999999999999999999999999999875332210                0122334455666


Q ss_pred             cEEEccCCccceeCChhhhhcccCccEEEccCCceeecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecCC
Q 039957          145 VYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPE  224 (481)
Q Consensus       145 ~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~  224 (481)
                      +.|++++|++++.+|..+... .+++.|++++|.+.+.+|..+..+++|+.|++++|++++.+|..+..++.|+.+++++
T Consensus       359 ~~L~Ls~n~l~~~~p~~~~~~-~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~  437 (968)
T PLN00113        359 TVLDLSTNNLTGEIPEGLCSS-GNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISN  437 (968)
T ss_pred             cEEECCCCeeEeeCChhHhCc-CCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcC
Confidence            666666666666666555443 3455555555555555555555555666666666666655555555555555555555


Q ss_pred             CcCCCCCCccccCcc-----------------------CCCeeecCCCeeeecCCcccccCCCCCcEEcCCCcCcccCCc
Q 039957          225 TNLQGYVPHNLCHLE-----------------------MLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPS  281 (481)
Q Consensus       225 n~l~~~~p~~~~~l~-----------------------~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~  281 (481)
                      |.+++.+|..+..++                       +|+.|++++|++++.+|..|..+++|+.|++++|++.+.+|.
T Consensus       438 N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~  517 (968)
T PLN00113        438 NNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPD  517 (968)
T ss_pred             CcccCccChhhccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCCh
Confidence            555555544444443                       445555555555555666666667777777777777777777


Q ss_pred             chhccccCcEEEccCcccCCCCCCccccCCcCcEEEccCCeeeeeccccccccCChhhhhcccc
Q 039957          282 SLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAGS  345 (481)
Q Consensus       282 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~~~g~  345 (481)
                      .+..++.|++|++++|.+++.+|..+..+++|+.||+++|++++.+|..+..+.+|+.++++++
T Consensus       518 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N  581 (968)
T PLN00113        518 ELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHN  581 (968)
T ss_pred             HHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCC
Confidence            7777777777777777777777777777777777777777777777777777777777776543

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=1e-39  Score=311.30  Aligned_cols=327  Identities=21%  Similarity=0.246  Sum_probs=272.8

Q ss_pred             ccCcchhCCCCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhcc
Q 039957            4 QIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSIT   83 (481)
Q Consensus         4 ~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~   83 (481)
                      .||.-.+...+|+.|+|.+|.|+.+..+++..++.|+.||||.|.|+ ++|...+..-.++++|+|+.|+|+..-.+.|.
T Consensus       116 ~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is-~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~  194 (873)
T KOG4194|consen  116 RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLIS-EIPKPSFPAKVNIKKLNLASNRITTLETGHFD  194 (873)
T ss_pred             hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhh-cccCCCCCCCCCceEEeecccccccccccccc
Confidence            35554444455777777777777777777777777777777777777 66655443446778888888887777677777


Q ss_pred             ccccCceeecccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhh
Q 039957           84 NATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIG  163 (481)
Q Consensus        84 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~  163 (481)
                      .+.+|.+|.|+.|+++...+..|.+|++|+.|+|..|+|..+...+        +.++++|+.|.|..|.++..-...|+
T Consensus       195 ~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~lt--------FqgL~Sl~nlklqrN~I~kL~DG~Fy  266 (873)
T KOG4194|consen  195 SLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLT--------FQGLPSLQNLKLQRNDISKLDDGAFY  266 (873)
T ss_pred             ccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhh--------hcCchhhhhhhhhhcCcccccCccee
Confidence            7778888888888888777777777888888888888777653333        45777888888888888876666777


Q ss_pred             hcccCccEEEccCCceeecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCe
Q 039957          164 NFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNL  243 (481)
Q Consensus       164 ~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~  243 (481)
                      .+ ..+++|+|+.|++...-..++.+++.|+.|+||+|.|..+.++++.-+++|+.|+|+.|+++...+..|..|.+|+.
T Consensus       267 ~l-~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~  345 (873)
T KOG4194|consen  267 GL-EKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEE  345 (873)
T ss_pred             ee-cccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhh
Confidence            76 58999999999999877888999999999999999999999999999999999999999999999999999999999


Q ss_pred             eecCCCeeeecCCcccccCCCCCcEEcCCCcCcccCCc---chhccccCcEEEccCcccCCCCCCccccCCcCcEEEccC
Q 039957          244 LHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPS---SLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSR  320 (481)
Q Consensus       244 L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~---~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~  320 (481)
                      |+|++|+++..-..+|..+++|++|||++|.+++.+.+   .|.+++.|+.|++.+|+++.+.-.+|.++..|+.|||.+
T Consensus       346 LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~  425 (873)
T KOG4194|consen  346 LNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGD  425 (873)
T ss_pred             hcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCC
Confidence            99999999988888999999999999999999987754   467899999999999999988888999999999999999


Q ss_pred             CeeeeeccccccccCChhhhh
Q 039957          321 NQLSGDIPSTIGALVDLETIS  341 (481)
Q Consensus       321 N~l~~~~p~~~~~l~~L~~l~  341 (481)
                      |.|...-|.+|..+ .|+.|.
T Consensus       426 NaiaSIq~nAFe~m-~Lk~Lv  445 (873)
T KOG4194|consen  426 NAIASIQPNAFEPM-ELKELV  445 (873)
T ss_pred             Ccceeecccccccc-hhhhhh
Confidence            99999999999988 777774

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-38  Score=303.57  Aligned_cols=320  Identities=24%  Similarity=0.264  Sum_probs=263.2

Q ss_pred             CCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeecc
Q 039957           15 LKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLG   94 (481)
Q Consensus        15 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls   94 (481)
                      -++||+++|.++.+.+..|.++++|++++|..|.++ .+|.... ...+|+.|+|.+|.|+.+-.+++..++.|+.||||
T Consensus        80 t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~-~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLS  157 (873)
T KOG4194|consen   80 TQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGH-ESGHLEKLDLRHNLISSVTSEELSALPALRSLDLS  157 (873)
T ss_pred             eeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccc-cccceeEEeeeccccccccHHHHHhHhhhhhhhhh
Confidence            467999999999999999999999999999999998 8998664 67889999999999998888889999999999999


Q ss_pred             cCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEc
Q 039957           95 FNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSA  174 (481)
Q Consensus        95 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l  174 (481)
                      .|.|+.+.-.+|..=.++++|+|++|.|+.+....        +.++.+|.+|.|+.|+++...+..|.++ +.|+.|+|
T Consensus       158 rN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~--------F~~lnsL~tlkLsrNrittLp~r~Fk~L-~~L~~LdL  228 (873)
T KOG4194|consen  158 RNLISEIPKPSFPAKVNIKKLNLASNRITTLETGH--------FDSLNSLLTLKLSRNRITTLPQRSFKRL-PKLESLDL  228 (873)
T ss_pred             hchhhcccCCCCCCCCCceEEeecccccccccccc--------ccccchheeeecccCcccccCHHHhhhc-chhhhhhc
Confidence            99999877778888899999999999999986655        4566789999999999996555556556 68999999


Q ss_pred             cCCceeecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeeeec
Q 039957          175 SECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGH  254 (481)
Q Consensus       175 ~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  254 (481)
                      ..|+|.-.---.|.++++|+.|.|..|.+...-...|-.+.++++|+|+.|+++..-..++.+|++|+.|+||+|.|..+
T Consensus       229 nrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~ri  308 (873)
T KOG4194|consen  229 NRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRI  308 (873)
T ss_pred             cccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhhee
Confidence            99998744345678888888888888888877777888888888888888888887788888888888888888888888


Q ss_pred             CCcccccCCCCCcEEcCCCcCcccCCcchhccccCcEEEccCcccCCCCCCccccCCcCcEEEccCCeeeeeccc---cc
Q 039957          255 IPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPS---TI  331 (481)
Q Consensus       255 ~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~---~~  331 (481)
                      .++.+..+++|++|+|++|+++...+.+|..+..|++|+|+.|++.......|..+++|++|||++|.++..+.+   .|
T Consensus       309 h~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f  388 (873)
T KOG4194|consen  309 HIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAF  388 (873)
T ss_pred             ecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhh
Confidence            888888888888888888888888888888888888888888887766666677777777777777777665543   34


Q ss_pred             cccCChhhhhcccc
Q 039957          332 GALVDLETISLAGS  345 (481)
Q Consensus       332 ~~l~~L~~l~~~g~  345 (481)
                      ..+++|+.|.+.|+
T Consensus       389 ~gl~~LrkL~l~gN  402 (873)
T KOG4194|consen  389 NGLPSLRKLRLTGN  402 (873)
T ss_pred             ccchhhhheeecCc
Confidence            45555555555544

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-33  Score=267.44  Aligned_cols=141  Identities=44%  Similarity=0.711  Sum_probs=126.3

Q ss_pred             hhhccccccceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC------cccccCCChh
Q 039957          339 TISLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD------FKFMPNGSLE  412 (481)
Q Consensus       339 ~l~~~g~~g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~~~~g~l~  412 (481)
                      .+.+.|+||.||+|.+.+|..||||++........++|..|+.++++++|||+|+++|||.+.+      ||||++|+|.
T Consensus        81 ~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~  160 (361)
T KOG1187|consen   81 NLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLE  160 (361)
T ss_pred             cceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHH
Confidence            3557899999999999999999999876644321456999999999999999999999998654      7899999999


Q ss_pred             HHhhcCCC-ccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          413 KRLYSHNY-FLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       413 ~~l~~~~~-~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      ++++.... .++|..|++||.++|+||+|||+.+ .++||||||||+|||||++++|||+|||+|+...
T Consensus       161 d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~-~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~  228 (361)
T KOG1187|consen  161 DHLHGKKGEPLDWETRLKIALGAARGLAYLHEGC-PPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGP  228 (361)
T ss_pred             HHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCC-CCCEecCCCCHHHeeECCCCCEEccCccCcccCC
Confidence            99998665 8899999999999999999999988 7899999999999999999999999999998754

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.98  E-value=1.8e-35  Score=284.26  Aligned_cols=303  Identities=28%  Similarity=0.419  Sum_probs=209.8

Q ss_pred             ccCcchhCCCCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCcc-ccChhhhcCCCCccEEEccCccceeecchhc
Q 039957            4 QIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSG-HLPSMIGHSLPNIKYLELGDNNLIGTIPNSI   82 (481)
Q Consensus         4 ~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~   82 (481)
                      ++|++++.+.+|+.|.+++|++..+ -..+..++.|+.+++..|++.. -+|..+| .+..|++||||+|+++ ..|..+
T Consensus        46 ~vPeEL~~lqkLEHLs~~HN~L~~v-hGELs~Lp~LRsv~~R~N~LKnsGiP~diF-~l~dLt~lDLShNqL~-EvP~~L  122 (1255)
T KOG0444|consen   46 QVPEELSRLQKLEHLSMAHNQLISV-HGELSDLPRLRSVIVRDNNLKNSGIPTDIF-RLKDLTILDLSHNQLR-EVPTNL  122 (1255)
T ss_pred             hChHHHHHHhhhhhhhhhhhhhHhh-hhhhccchhhHHHhhhccccccCCCCchhc-ccccceeeecchhhhh-hcchhh
Confidence            5788888899999999999988754 4567888888888888888853 3788887 6888999999999987 778888


Q ss_pred             cccccCceeecccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccc-------
Q 039957           83 TNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLG-------  155 (481)
Q Consensus        83 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~-------  155 (481)
                      ...+++-+|+||+|+|..+....|-+|+.|-.||||+|.+..+|+..         ..+..|++|+|++|.+.       
T Consensus       123 E~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe~LPPQ~---------RRL~~LqtL~Ls~NPL~hfQLrQL  193 (1255)
T KOG0444|consen  123 EYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLEMLPPQI---------RRLSMLQTLKLSNNPLNHFQLRQL  193 (1255)
T ss_pred             hhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhhhcCHHH---------HHHhhhhhhhcCCChhhHHHHhcC
Confidence            88888899999999988766666888888889999999888776542         34455556666666542       


Q ss_pred             ------------------eeCChhhhhcccCccEEEccCCceeecCCcccccCCCCCeEecccccceecCCcCCcCCCCC
Q 039957          156 ------------------GILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQL  217 (481)
Q Consensus       156 ------------------~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L  217 (481)
                                        .-+|.++..+ .+|..+|+|.|.+. .+|..+.++.+|+.|+||+|+|+ .+....+.+.+|
T Consensus       194 PsmtsL~vLhms~TqRTl~N~Ptsld~l-~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~l  270 (1255)
T KOG0444|consen  194 PSMTSLSVLHMSNTQRTLDNIPTSLDDL-HNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENL  270 (1255)
T ss_pred             ccchhhhhhhcccccchhhcCCCchhhh-hhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhh
Confidence                              1234444444 35666666666666 56666666666666666666665 334444555666


Q ss_pred             CeeecCCCcCCCCCCccccCccCCCeeecCCCeee-ecCCcccccCCCCCcEEcCCCcCcccCCcchhccccCcEEEccC
Q 039957          218 QGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLS-GHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSS  296 (481)
Q Consensus       218 ~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~  296 (481)
                      ++|++|.|+++. .|.++|.++.|+.|.+.+|+++ .-+|..++.+..|+.+..++|++. .+|..++.+..|+.|.|+.
T Consensus       271 EtLNlSrNQLt~-LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~  348 (1255)
T KOG0444|consen  271 ETLNLSRNQLTV-LPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDH  348 (1255)
T ss_pred             hhhccccchhcc-chHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhcccc
Confidence            666666666663 5666666666666666666654 125666666666666666666665 6666666666666666666


Q ss_pred             cccCCCCCCccccCCcCcEEEccCCeee
Q 039957          297 NLLNDSLPSNVQKLKVLRVLDLSRNQLS  324 (481)
Q Consensus       297 N~l~~~~p~~~~~l~~L~~L~l~~N~l~  324 (481)
                      |++- .+|+.+.-++.|.+||+..|.=-
T Consensus       349 NrLi-TLPeaIHlL~~l~vLDlreNpnL  375 (1255)
T KOG0444|consen  349 NRLI-TLPEAIHLLPDLKVLDLRENPNL  375 (1255)
T ss_pred             ccee-echhhhhhcCCcceeeccCCcCc
Confidence            6664 35666666666666666666544

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.97  E-value=5.8e-35  Score=267.52  Aligned_cols=326  Identities=29%  Similarity=0.459  Sum_probs=171.6

Q ss_pred             cCcchhCCCCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccc
Q 039957            5 IPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITN   84 (481)
Q Consensus         5 lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~   84 (481)
                      +|++++.+.+|+.|+.++|++.. .|+.++.+..++.|+..+|+++ .+|+.++ .+.+|..|++.+|+++...|+.+. 
T Consensus       106 lp~~i~s~~~l~~l~~s~n~~~e-l~~~i~~~~~l~dl~~~~N~i~-slp~~~~-~~~~l~~l~~~~n~l~~l~~~~i~-  181 (565)
T KOG0472|consen  106 LPEQIGSLISLVKLDCSSNELKE-LPDSIGRLLDLEDLDATNNQIS-SLPEDMV-NLSKLSKLDLEGNKLKALPENHIA-  181 (565)
T ss_pred             ccHHHhhhhhhhhhhccccceee-cCchHHHHhhhhhhhccccccc-cCchHHH-HHHHHHHhhccccchhhCCHHHHH-
Confidence            44444444444444444444432 3334444444445555555554 4444444 344555555555555433333332 


Q ss_pred             cccCceeecccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhh
Q 039957           85 ATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGN  164 (481)
Q Consensus        85 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~  164 (481)
                      ++.|++||...|.+. .+|..++.|.+|+-|+|..|+|..+|.          +.+|+.|++|+++.|+|. .+|.+.+.
T Consensus       182 m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~~lPe----------f~gcs~L~Elh~g~N~i~-~lpae~~~  249 (565)
T KOG0472|consen  182 MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIRFLPE----------FPGCSLLKELHVGENQIE-MLPAEHLK  249 (565)
T ss_pred             HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccccCCC----------CCccHHHHHHHhcccHHH-hhHHHHhc
Confidence            555666666666555 566667777777777777777766542          334444444444444443 34444442


Q ss_pred             cccCccEEEccCCceeecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcCC----------------
Q 039957          165 FSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQ----------------  228 (481)
Q Consensus       165 ~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~----------------  228 (481)
                      -..++..||+.+|+++ ..|+.+..+++|.+||+|+|.++ ..|.+++++ .|+.|-+.+|.+.                
T Consensus       250 ~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLK  326 (565)
T KOG0472|consen  250 HLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLK  326 (565)
T ss_pred             ccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHH
Confidence            2234555555555554 34555555555555555555554 233444444 3433333333321                


Q ss_pred             --------------------------------------------------------------------------------
Q 039957          229 --------------------------------------------------------------------------------  228 (481)
Q Consensus       229 --------------------------------------------------------------------------------  228 (481)
                                                                                                      
T Consensus       327 yLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~elPk~  406 (565)
T KOG0472|consen  327 YLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLCELPKR  406 (565)
T ss_pred             HHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHhhhhhh
Confidence                                                                                            


Q ss_pred             ------------------CCCCccccCccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCcCcccCCcchhccccCc
Q 039957          229 ------------------GYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYIL  290 (481)
Q Consensus       229 ------------------~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~  290 (481)
                                        +++|..++.++.|..|+|++|-+. .+|..++.+..|+.||++.|++. .+|..+..+..++
T Consensus       407 L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lE  484 (565)
T KOG0472|consen  407 LVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLE  484 (565)
T ss_pred             hHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHH
Confidence                              122333333444444444444443 23444444444444444444443 3444444444444


Q ss_pred             EEEccCcccCCCCCCccccCCcCcEEEccCCeeeeeccccccccCChhhhhccccccceeee
Q 039957          291 EINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAGSFGSVYKG  352 (481)
Q Consensus       291 ~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~~~g~~g~vy~~  352 (481)
                      .+-.++|++....|..+.+|.+|.+|||.+|.+. .+|..++++++|++|.+.|+--.+.++
T Consensus       485 tllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr~Pr~  545 (565)
T KOG0472|consen  485 TLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFRQPRH  545 (565)
T ss_pred             HHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccCCCHH
Confidence            4444444454444555788899999999999998 788889999999999998876555443

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.97  E-value=1.9e-33  Score=270.43  Aligned_cols=325  Identities=28%  Similarity=0.424  Sum_probs=260.1

Q ss_pred             eccCcchhCCCCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCcccee-ecchh
Q 039957            3 GQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIG-TIPNS   81 (481)
Q Consensus         3 g~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~-~~p~~   81 (481)
                      |..|..+..|+.++.|-|...++. .+|+.++.+.+|++|.+++|++. .+-..+. .+|.|+.+++.+|++.. -+|..
T Consensus        22 ~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs-~Lp~LRsv~~R~N~LKnsGiP~d   98 (1255)
T KOG0444|consen   22 DRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELS-DLPRLRSVIVRDNNLKNSGIPTD   98 (1255)
T ss_pred             CcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhc-cchhhHHHhhhccccccCCCCch
Confidence            567888889999999999888886 57889999999999999999987 5555564 78999999999998753 35667


Q ss_pred             ccccccCceeecccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChh
Q 039957           82 ITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPS  161 (481)
Q Consensus        82 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~  161 (481)
                      +..+..|.+||||+|++. ..|..+..-+++-+|+||+|+|..+|...        +.+++-|-+||||+|++. .+|+.
T Consensus        99 iF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~l--------finLtDLLfLDLS~NrLe-~LPPQ  168 (1255)
T KOG0444|consen   99 IFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSL--------FINLTDLLFLDLSNNRLE-MLPPQ  168 (1255)
T ss_pred             hcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchH--------HHhhHhHhhhccccchhh-hcCHH
Confidence            788999999999999998 67888999999999999999999887644        457888999999999997 67888


Q ss_pred             hhhcccCccEEEccCCceee-------------------------cCCcccccCCCCCeEecccccceecCCcCCcCCCC
Q 039957          162 IGNFSTSLQRFSASECKLKG-------------------------TIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQ  216 (481)
Q Consensus       162 ~~~~~~~L~~L~l~~n~l~~-------------------------~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~  216 (481)
                      +..+ ..|++|+|++|.+..                         .+|.++..+.+|..+|+|.|.+. ..|+.+-++.+
T Consensus       169 ~RRL-~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~  246 (1255)
T KOG0444|consen  169 IRRL-SMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRN  246 (1255)
T ss_pred             HHHH-hhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhh
Confidence            8777 468888888887631                         25666667777777778877776 67777777778


Q ss_pred             CCeeecCCCcCCCCCCccccCccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCcCc-ccCCcchhccccCcEEEcc
Q 039957          217 LQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLT-SSIPSSLWSLGYILEINLS  295 (481)
Q Consensus       217 L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~-~~~p~~~~~l~~L~~L~l~  295 (481)
                      |+.|+||+|+++. .........+|++|+||+|+++ .+|.++..++.|+.|++.+|+++ .-+|+.++.+..|+++..+
T Consensus       247 LrrLNLS~N~ite-L~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aa  324 (1255)
T KOG0444|consen  247 LRRLNLSGNKITE-LNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAA  324 (1255)
T ss_pred             hheeccCcCceee-eeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhh
Confidence            8888888887774 3334455667778888888887 57888888888888888888875 3477888888888888888


Q ss_pred             CcccCCCCCCccccCCcCcEEEccCCeeeeeccccccccCChhhhhccccc
Q 039957          296 SNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAGSF  346 (481)
Q Consensus       296 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~~~g~~  346 (481)
                      +|.+. ..|+.++.+..|+.|.|++|++. .+|..+.-++.|+.|++..+-
T Consensus       325 nN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNp  373 (1255)
T KOG0444|consen  325 NNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENP  373 (1255)
T ss_pred             ccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCc
Confidence            88885 67888888888888899999887 678888888888888876543

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.96  E-value=3.3e-32  Score=249.51  Aligned_cols=310  Identities=27%  Similarity=0.401  Sum_probs=264.4

Q ss_pred             eeccCcchhCCCCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchh
Q 039957            2 TGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNS   81 (481)
Q Consensus         2 ~g~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~   81 (481)
                      -|++|++++.|.+|..|||.+|.|.. .| .|.+++.|++|+++.|+|+ .+|+.....+++|.+|||.+|+++ ..|+.
T Consensus       195 L~tlP~~lg~l~~L~~LyL~~Nki~~-lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde  270 (565)
T KOG0472|consen  195 LETLPPELGGLESLELLYLRRNKIRF-LP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDE  270 (565)
T ss_pred             hhcCChhhcchhhhHHHHhhhccccc-CC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchH
Confidence            37899999999999999999999985 45 8999999999999999998 999999889999999999999997 88999


Q ss_pred             ccccccCceeecccCcceecCcccccCCCCCCEEEcccccCccccCCCc-------------------------------
Q 039957           82 ITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAY-------------------------------  130 (481)
Q Consensus        82 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~-------------------------------  130 (481)
                      ++-+++|++||+|+|.|++ +|.++++| .|+.|.+.+|-+.++...-.                               
T Consensus       271 ~clLrsL~rLDlSNN~is~-Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~  348 (565)
T KOG0472|consen  271 ICLLRSLERLDLSNNDISS-LPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAM  348 (565)
T ss_pred             HHHhhhhhhhcccCCcccc-CCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccC
Confidence            9999999999999999994 78899999 99999999997754421100                               


Q ss_pred             ---cccccccCCCCCCCcEEEccCCccceeCChhhhhccc--CccEEEccCCceeecCCcccccCCCCCe-Eecccccce
Q 039957          131 ---QWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFST--SLQRFSASECKLKGTIPKEIGHLRGLIY-LSLGFNDLN  204 (481)
Q Consensus       131 ---~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~--~L~~L~l~~n~l~~~~p~~~~~l~~L~~-L~l~~N~l~  204 (481)
                         .|. .+........+.|++++-+++ .+|+.++....  -....+++.|++. ++|..+..++.+.+ +++++|.+ 
T Consensus       349 t~~~~~-~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~i-  424 (565)
T KOG0472|consen  349 TLPSES-FPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKI-  424 (565)
T ss_pred             CCCCCc-ccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCcc-
Confidence               011 122334567889999999998 57777765432  2678999999999 78988887776655 45555555 


Q ss_pred             ecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCcCcccCCcchh
Q 039957          205 GTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLW  284 (481)
Q Consensus       205 ~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~  284 (481)
                      +.+|..++.+++|..|++++|-+. .+|..++.+..|+.+|+++|++. .+|.+...+..++.+-.++|++....|+.+.
T Consensus       425 sfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~  502 (565)
T KOG0472|consen  425 SFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLK  502 (565)
T ss_pred             ccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhh
Confidence            588888999999999999888776 47889999999999999999998 6899998888999999999999877777799


Q ss_pred             ccccCcEEEccCcccCCCCCCccccCCcCcEEEccCCeee
Q 039957          285 SLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLS  324 (481)
Q Consensus       285 ~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  324 (481)
                      +|.+|..||+.+|.+. .+|..++++.+|++|++.+|+|.
T Consensus       503 nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  503 NMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             hhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence            9999999999999996 67888999999999999999998

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=99.93  E-value=4.1e-26  Score=218.95  Aligned_cols=135  Identities=36%  Similarity=0.589  Sum_probs=118.1

Q ss_pred             hccccccceeeeeccCCcceEEEEEeccchh--hhhhhhHHHHHhhhhccCccceeecccCCCC------cccccCCChh
Q 039957          341 SLAGSFGSVYKGTISDGTDVAIKIFNLQRER--AFRSFNSECEVLRNVRHQNLIKILSSCSTPD------FKFMPNGSLE  412 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~g~~vavK~l~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~~~~g~l~  412 (481)
                      .+.|+||.||+|.+.....||||++......  ..+.|.+|+.++.+++|||||+++|+|..+.      +|||++|+|.
T Consensus        49 iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~  128 (362)
T KOG0192|consen   49 LGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLS  128 (362)
T ss_pred             cccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHH
Confidence            4789999999998754344999998764422  2558999999999999999999999998874      5899999999


Q ss_pred             HHhhc-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCC-eeeCCCCCCCeeeCCCC-cEEEccccCcccC
Q 039957          413 KRLYS-HNYFLDILERLNIMIDVGSTLEYLHHGHSSAP-IIHCDLKPTSILLDENM-VAHVSDFGISKLL  479 (481)
Q Consensus       413 ~~l~~-~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~-i~H~dlk~~nill~~~~-~~kl~Dfgl~~~~  479 (481)
                      ++++. ....++|..++++|.+||+||.|||.    .. ||||||||+|||++.++ ++||||||+++..
T Consensus       129 ~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~----~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~  194 (362)
T KOG0192|consen  129 VLLHKKRKRKLPLKVRLRIALDIARGMEYLHS----EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREK  194 (362)
T ss_pred             HHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc----CCCeeecccChhhEEEcCCCCEEEECCCccceee
Confidence            99987 46789999999999999999999994    45 99999999999999997 9999999999764

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.93  E-value=1.7e-27  Score=239.36  Aligned_cols=198  Identities=33%  Similarity=0.463  Sum_probs=138.9

Q ss_pred             CCCcEEEccCCccceeCChhhhhcccCccEEEccCCceee----------------------cCCcccccCCCCCeEecc
Q 039957          142 RYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKG----------------------TIPKEIGHLRGLIYLSLG  199 (481)
Q Consensus       142 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~----------------------~~p~~~~~l~~L~~L~l~  199 (481)
                      .+|+++++++|++++ +|++++.+ .+|+.+++.+|+++.                      -+|....+++.|++|||.
T Consensus       241 ~nl~~~dis~n~l~~-lp~wi~~~-~nle~l~~n~N~l~~lp~ri~~~~~L~~l~~~~nel~yip~~le~~~sL~tLdL~  318 (1081)
T KOG0618|consen  241 LNLQYLDISHNNLSN-LPEWIGAC-ANLEALNANHNRLVALPLRISRITSLVSLSAAYNELEYIPPFLEGLKSLRTLDLQ  318 (1081)
T ss_pred             ccceeeecchhhhhc-chHHHHhc-ccceEecccchhHHhhHHHHhhhhhHHHHHhhhhhhhhCCCcccccceeeeeeeh
Confidence            467788888888874 55777666 467777777777642                      134444456666666666


Q ss_pred             cccceecCCcCCc--------------------------CCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeeee
Q 039957          200 FNDLNGTIPTSIG--------------------------TLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSG  253 (481)
Q Consensus       200 ~N~l~~~~p~~~~--------------------------~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~  253 (481)
                      .|++.. .|+.+.                          ..+.|+.|++.+|.++...-+.+.+...|++|+|++|++..
T Consensus       319 ~N~L~~-lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~  397 (1081)
T KOG0618|consen  319 SNNLPS-LPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNS  397 (1081)
T ss_pred             hccccc-cchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeeccccccc
Confidence            666642 222110                          12235556666666665555566677778888888888876


Q ss_pred             cCCcccccCCCCCcEEcCCCcCcccCCcchhccccCcEEEccCcccCCCCCCccccCCcCcEEEccCCeeeeec-ccccc
Q 039957          254 HIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDI-PSTIG  332 (481)
Q Consensus       254 ~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-p~~~~  332 (481)
                      .+..++.++..|++|+||+|+++ .+|..+..++.|++|...+|++. ..| ++..++.|+++|++.|+++... |... 
T Consensus       398 fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~-  473 (1081)
T KOG0618|consen  398 FPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEAL-  473 (1081)
T ss_pred             CCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhC-
Confidence            66677888888888888888887 67788888888888888888886 466 7889999999999999997543 3322 


Q ss_pred             ccCChhhhhccccc
Q 039957          333 ALVDLETISLAGSF  346 (481)
Q Consensus       333 ~l~~L~~l~~~g~~  346 (481)
                      ..++|++|+++|+-
T Consensus       474 p~p~LkyLdlSGN~  487 (1081)
T KOG0618|consen  474 PSPNLKYLDLSGNT  487 (1081)
T ss_pred             CCcccceeeccCCc
Confidence            23789999988875

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.92  E-value=4.7e-25  Score=228.14  Aligned_cols=267  Identities=27%  Similarity=0.361  Sum_probs=212.1

Q ss_pred             CCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceee
Q 039957           13 QNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILD   92 (481)
Q Consensus        13 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~   92 (481)
                      .+-..|+|+.|.++. +|+.+.  ++|+.|++++|+++ .+|.    ..++|++|++++|+|+ .+|..   .++|+.|+
T Consensus       201 ~~~~~LdLs~~~Lts-LP~~l~--~~L~~L~L~~N~Lt-~LP~----lp~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~  268 (788)
T PRK15387        201 NGNAVLNVGESGLTT-LPDCLP--AHITTLVIPDNNLT-SLPA----LPPELRTLEVSGNQLT-SLPVL---PPGLLELS  268 (788)
T ss_pred             CCCcEEEcCCCCCCc-CCcchh--cCCCEEEccCCcCC-CCCC----CCCCCcEEEecCCccC-cccCc---ccccceee
Confidence            446789999999985 676664  47999999999998 6885    3588999999999998 45543   46899999


Q ss_pred             cccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEE
Q 039957           93 LGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRF  172 (481)
Q Consensus        93 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L  172 (481)
                      +++|.++. +|..+   .+|+.|++++|+++.++..            .++|+.|+|++|++++ +|.    ...+|+.|
T Consensus       269 Ls~N~L~~-Lp~lp---~~L~~L~Ls~N~Lt~LP~~------------p~~L~~LdLS~N~L~~-Lp~----lp~~L~~L  327 (788)
T PRK15387        269 IFSNPLTH-LPALP---SGLCKLWIFGNQLTSLPVL------------PPGLQELSVSDNQLAS-LPA----LPSELCKL  327 (788)
T ss_pred             ccCCchhh-hhhch---hhcCEEECcCCcccccccc------------ccccceeECCCCcccc-CCC----Cccccccc
Confidence            99999984 55433   6788999999999977431            3579999999999986 443    23468899


Q ss_pred             EccCCceeecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeee
Q 039957          173 SASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLS  252 (481)
Q Consensus       173 ~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~  252 (481)
                      ++++|++++ +|..   ..+|++|++++|+|++ +|..   ..+|+.|++++|+++. +|...   ..|+.|++++|+++
T Consensus       328 ~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~-LP~l~---~~L~~LdLs~N~Lt  395 (788)
T PRK15387        328 WAYNNQLTS-LPTL---PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPALP---SGLKELIVSGNRLT  395 (788)
T ss_pred             ccccCcccc-cccc---ccccceEecCCCccCC-CCCC---Ccccceehhhcccccc-Ccccc---cccceEEecCCccc
Confidence            999999984 6642   2479999999999984 5543   3567888999999986 55433   57899999999998


Q ss_pred             ecCCcccccCCCCCcEEcCCCcCcccCCcchhccccCcEEEccCcccCCCCCCccccCCcCcEEEccCCeeeeecccccc
Q 039957          253 GHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIG  332 (481)
Q Consensus       253 ~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~  332 (481)
                      + +|..   .++|+.|++++|++++ +|...   ..|+.|++++|+++ .+|..+..++.|+.+++++|+|++..+..+.
T Consensus       396 ~-LP~l---~s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~  466 (788)
T PRK15387        396 S-LPVL---PSELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALR  466 (788)
T ss_pred             C-CCCc---ccCCCEEEccCCcCCC-CCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHH
Confidence            5 4543   3689999999999985 66543   46788999999997 5788899999999999999999988777663


Q ss_pred             c
Q 039957          333 A  333 (481)
Q Consensus       333 ~  333 (481)
                      .
T Consensus       467 ~  467 (788)
T PRK15387        467 E  467 (788)
T ss_pred             H
Confidence            3

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.92  E-value=2.8e-25  Score=205.29  Aligned_cols=135  Identities=32%  Similarity=0.558  Sum_probs=117.1

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      .+.|.|++||+|... ++..||||.+....  ....+....|+.+|+.++|+|||++++++..++     +|||.+|+|.
T Consensus        18 iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs   97 (429)
T KOG0595|consen   18 IGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLS   97 (429)
T ss_pred             ccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHH
Confidence            578999999999975 57899999997763  445566788999999999999999999998886     6899999999


Q ss_pred             HHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCC------CcEEEccccCcccCC
Q 039957          413 KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDEN------MVAHVSDFGISKLLG  480 (481)
Q Consensus       413 ~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~------~~~kl~Dfgl~~~~~  480 (481)
                      .+++..+ .+........+.|+|.|+++||    +.+||||||||.|||++..      -.+||+|||+||.+.
T Consensus        98 ~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~----~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~  166 (429)
T KOG0595|consen   98 DYIRRRG-RLPEATARHFMQQLASALQFLH----ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ  166 (429)
T ss_pred             HHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence            9998754 4566677789999999999999    6789999999999999764      468999999999875

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.92  E-value=1.3e-27  Score=219.04  Aligned_cols=253  Identities=22%  Similarity=0.209  Sum_probs=182.5

Q ss_pred             CCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccC-ccceeecchhccccccCceee
Q 039957           14 NLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGD-NNLIGTIPNSITNATKLIILD   92 (481)
Q Consensus        14 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~   92 (481)
                      .-+.++|..|+|+.+.|.+|..+.+|+.||||+|.|+ .|.+..|..+++|..|-+-+ |+|+....+.|.++..|+.|.
T Consensus        68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is-~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLl  146 (498)
T KOG4237|consen   68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNIS-FIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLL  146 (498)
T ss_pred             cceEEEeccCCcccCChhhccchhhhceecccccchh-hcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHh
Confidence            3567788888888888888888888888888888887 44444445777777665555 788766666788888888888


Q ss_pred             cccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCcc------------------
Q 039957           93 LGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPL------------------  154 (481)
Q Consensus        93 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l------------------  154 (481)
                      +.-|++.-+..++|..|++|..|.+..|.+..+....|        ..+..++.+.+..|.+                  
T Consensus       147 lNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf--------~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~i  218 (498)
T KOG4237|consen  147 LNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTF--------QGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPI  218 (498)
T ss_pred             cChhhhcchhHHHHHHhhhcchhcccchhhhhhccccc--------cchhccchHhhhcCccccccccchhhhHHhhchh
Confidence            88888887788888888888888888888877765443        3455566666666652                  


Q ss_pred             ------------------ceeCChhhhhcccCccEEEccCCceeecCC-cccccCCCCCeEecccccceecCCcCCcCCC
Q 039957          155 ------------------GGILPPSIGNFSTSLQRFSASECKLKGTIP-KEIGHLRGLIYLSLGFNDLNGTIPTSIGTLK  215 (481)
Q Consensus       155 ------------------~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~  215 (481)
                                        ...-+..|.....++..--.+.+...++-| ..|..+++|+.|+|++|+++++-+.+|.++.
T Consensus       219 etsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a  298 (498)
T KOG4237|consen  219 ETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAA  298 (498)
T ss_pred             hcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchh
Confidence                              111111111111111111122222222333 3578888999999999999988888999999


Q ss_pred             CCCeeecCCCcCCCCCCccccCccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCcC
Q 039957          216 QLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKL  275 (481)
Q Consensus       216 ~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l  275 (481)
                      .++.|+|..|++..+....|.++..|+.|+|.+|+|+..-|.+|..+.+|.+|.+-.|.+
T Consensus       299 ~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~  358 (498)
T KOG4237|consen  299 ELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPF  358 (498)
T ss_pred             hhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcc
Confidence            999999999998887788888899999999999999988888888888888888888765

>PLN03210 Resistant to P

Probab=99.92  E-value=4.6e-24  Score=236.66  Aligned_cols=313  Identities=23%  Similarity=0.298  Sum_probs=183.8

Q ss_pred             cCcchhCCC-CCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhcc
Q 039957            5 IPTEIGNLQ-NLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSIT   83 (481)
Q Consensus         5 lp~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~   83 (481)
                      +|..|..++ +|+.|++.+|.+. .+|..| ...+|++|+|++|++. .+|..+. .+++|++|+|++|...+.+|. +.
T Consensus       580 lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~-~l~~Lk~L~Ls~~~~l~~ip~-ls  654 (1153)
T PLN03210        580 LPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVH-SLTGLRNIDLRGSKNLKEIPD-LS  654 (1153)
T ss_pred             cCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccc-cCCCCCEEECCCCCCcCcCCc-cc
Confidence            444444443 3555555555553 234444 3456666666666665 4555543 566666666666544345553 55


Q ss_pred             ccccCceeecccCcceecCcccccCCCCCCEEEcccc-cCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhh
Q 039957           84 NATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMN-NLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSI  162 (481)
Q Consensus        84 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~  162 (481)
                      .+++|+.|+|++|.....+|..++.+++|+.|++++| .++.++.         .+ ++++|++|++++|...+.+|.. 
T Consensus       655 ~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~---------~i-~l~sL~~L~Lsgc~~L~~~p~~-  723 (1153)
T PLN03210        655 MATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPT---------GI-NLKSLYRLNLSGCSRLKSFPDI-  723 (1153)
T ss_pred             cCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCC---------cC-CCCCCCEEeCCCCCCccccccc-
Confidence            6666666666666555556666666666666666654 2333211         11 4556666666666554444432 


Q ss_pred             hhcccCccEEEccCCceeecCCcccccCCCCCeEecccccc-------eecCCcCCcCCCCCCeeecCCCcCCCCCCccc
Q 039957          163 GNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDL-------NGTIPTSIGTLKQLQGFFLPETNLQGYVPHNL  235 (481)
Q Consensus       163 ~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l-------~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~  235 (481)
                         ..+|+.|++++|.+. .+|..+ .+++|++|++.++..       ....|..+...++|+.|++++|...+.+|..+
T Consensus       724 ---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si  798 (1153)
T PLN03210        724 ---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSI  798 (1153)
T ss_pred             ---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhh
Confidence               245666666666665 345433 345555555544221       11111122234567777887777777777778


Q ss_pred             cCccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCcCcccCCcchhccccCcEEEccCcccCCCCCCccccCCcCcE
Q 039957          236 CHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRV  315 (481)
Q Consensus       236 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~  315 (481)
                      +++++|+.|++++|...+.+|..+ .+++|+.|++++|.....+|..   ..+++.|++++|.++ .+|.++..+++|+.
T Consensus       799 ~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~  873 (1153)
T PLN03210        799 QNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSF  873 (1153)
T ss_pred             hCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCE
Confidence            888888888887765444556554 6777888888877654455543   256777888888876 46777788888888


Q ss_pred             EEccCC-eeeeeccccccccCChhhhhccc
Q 039957          316 LDLSRN-QLSGDIPSTIGALVDLETISLAG  344 (481)
Q Consensus       316 L~l~~N-~l~~~~p~~~~~l~~L~~l~~~g  344 (481)
                      |++++| ++. .+|..+..+.+|+.+++.+
T Consensus       874 L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~  902 (1153)
T PLN03210        874 LDMNGCNNLQ-RVSLNISKLKHLETVDFSD  902 (1153)
T ss_pred             EECCCCCCcC-ccCcccccccCCCeeecCC
Confidence            888874 444 4565666666666665443

syringae 6; Provisional

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=99.91  E-value=9.8e-25  Score=199.91  Aligned_cols=141  Identities=28%  Similarity=0.385  Sum_probs=119.2

Q ss_pred             CChhhhh--ccccccceeeeecc-CCcceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC------cc
Q 039957          335 VDLETIS--LAGSFGSVYKGTIS-DGTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD------FK  404 (481)
Q Consensus       335 ~~L~~l~--~~g~~g~vy~~~l~-~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~  404 (481)
                      ..|+.+.  |+|+.|+||++... ++..+|+|.+.... ....+++.+|++++.+++||+||+.+|.|....      +|
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE  158 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME  158 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence            3555554  78999999999864 68899999985543 445668899999999999999999999887654      68


Q ss_pred             cccCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          405 FMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       405 ~~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ||.+|+|.+.+... ...+...--+||.+|.+||.|||+   .+.||||||||+|||+...|++||||||+++.+
T Consensus       159 YMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~---~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~l  229 (364)
T KOG0581|consen  159 YMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHE---ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGIL  229 (364)
T ss_pred             hcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhh---ccCeeeccCCHHHeeeccCCCEEeccccccHHh
Confidence            99999999987653 345556667899999999999995   478999999999999999999999999999875

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=99.91  E-value=1.1e-24  Score=208.86  Aligned_cols=134  Identities=31%  Similarity=0.616  Sum_probs=120.1

Q ss_pred             ccccccceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHHhh
Q 039957          342 LAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRLY  416 (481)
Q Consensus       342 ~~g~~g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~l~  416 (481)
                      |+|.||.|+.|.+.....||+|.+... ....+.|.+|++++.+++|++||+++|.|..++     +|||+.|+|.+++.
T Consensus       215 G~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr  293 (468)
T KOG0197|consen  215 GSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLR  293 (468)
T ss_pred             cCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhh
Confidence            789999999999876678999988764 333467889999999999999999999998865     78999999999998


Q ss_pred             c-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          417 S-HNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       417 ~-~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      . .+..+...+-+.+|.|||+||+||+    ++++|||||.++||||+++..|||||||+||.+.
T Consensus       294 ~~~~~~l~~~~Ll~~a~qIaeGM~YLe----s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~  354 (468)
T KOG0197|consen  294 TREGGLLNLPQLLDFAAQIAEGMAYLE----SKNYIHRDLAARNILVDEDLVVKISDFGLARLIG  354 (468)
T ss_pred             hcCCCccchHHHHHHHHHHHHHHHHHH----hCCccchhhhhhheeeccCceEEEcccccccccC
Confidence            6 5567888899999999999999999    7889999999999999999999999999999654

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.91  E-value=5e-24  Score=220.56  Aligned_cols=253  Identities=26%  Similarity=0.351  Sum_probs=202.8

Q ss_pred             ccCcchhCCCCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhcc
Q 039957            4 QIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSIT   83 (481)
Q Consensus         4 ~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~   83 (481)
                      +||..+.  ++|+.|++++|+++.+ |.   ..++|++|+|++|+|+ .+|..    .++|+.|++++|.++ .+|..+ 
T Consensus       215 sLP~~l~--~~L~~L~L~~N~Lt~L-P~---lp~~Lk~LdLs~N~Lt-sLP~l----p~sL~~L~Ls~N~L~-~Lp~lp-  281 (788)
T PRK15387        215 TLPDCLP--AHITTLVIPDNNLTSL-PA---LPPELRTLEVSGNQLT-SLPVL----PPGLLELSIFSNPLT-HLPALP-  281 (788)
T ss_pred             cCCcchh--cCCCEEEccCCcCCCC-CC---CCCCCcEEEecCCccC-cccCc----ccccceeeccCCchh-hhhhch-
Confidence            5788775  4899999999999864 54   3689999999999998 67752    468999999999987 455533 


Q ss_pred             ccccCceeecccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhh
Q 039957           84 NATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIG  163 (481)
Q Consensus        84 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~  163 (481)
                        ++|+.|++++|+++. +|.   .+++|+.|++++|++++++..+            ..|+.|++++|.+++ +|.   
T Consensus       282 --~~L~~L~Ls~N~Lt~-LP~---~p~~L~~LdLS~N~L~~Lp~lp------------~~L~~L~Ls~N~L~~-LP~---  339 (788)
T PRK15387        282 --SGLCKLWIFGNQLTS-LPV---LPPGLQELSVSDNQLASLPALP------------SELCKLWAYNNQLTS-LPT---  339 (788)
T ss_pred             --hhcCEEECcCCcccc-ccc---cccccceeECCCCccccCCCCc------------ccccccccccCcccc-ccc---
Confidence              568899999999995 554   3578999999999999875422            347889999999985 553   


Q ss_pred             hcccCccEEEccCCceeecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCe
Q 039957          164 NFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNL  243 (481)
Q Consensus       164 ~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~  243 (481)
                       +..+|+.|++++|+|++ +|..   ..+|+.|++++|++++ +|..   ..+|+.|++++|++++ +|..   .+.|+.
T Consensus       340 -lp~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~-LP~l---~s~L~~  406 (788)
T PRK15387        340 -LPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LPVL---PSELKE  406 (788)
T ss_pred             -cccccceEecCCCccCC-CCCC---Ccccceehhhcccccc-Cccc---ccccceEEecCCcccC-CCCc---ccCCCE
Confidence             23579999999999994 6653   3578889999999984 6654   3578999999999986 4443   357899


Q ss_pred             eecCCCeeeecCCcccccCCCCCcEEcCCCcCcccCCcchhccccCcEEEccCcccCCCCCCcccc
Q 039957          244 LHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQK  309 (481)
Q Consensus       244 L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~  309 (481)
                      |++++|++++ +|..+   .+|+.|++++|+++ .+|..+..++.|..|++++|++++..+..+..
T Consensus       407 LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~  467 (788)
T PRK15387        407 LMVSGNRLTS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALRE  467 (788)
T ss_pred             EEccCCcCCC-CCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHHH
Confidence            9999999986 56533   47889999999998 78999999999999999999999877765533

>PLN03210 Resistant to P

Probab=99.91  E-value=2.7e-23  Score=230.62  Aligned_cols=313  Identities=21%  Similarity=0.262  Sum_probs=249.7

Q ss_pred             cchhCCCCCCeeeCcCCc------ccccCChhccCCc-CCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecc
Q 039957            7 TEIGNLQNLKSLFLGANN------LSGLIPPMIFNIS-TIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIP   79 (481)
Q Consensus         7 ~~~~~l~~L~~L~L~~N~------l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p   79 (481)
                      ..|.+|++|+.|.+..+.      +...+|+.|..++ +|+.|++.+|.+. .+|..+  ...+|++|+|++|++. .+|
T Consensus       552 ~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f--~~~~L~~L~L~~s~l~-~L~  627 (1153)
T PLN03210        552 NAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF--RPENLVKLQMQGSKLE-KLW  627 (1153)
T ss_pred             HHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC--CccCCcEEECcCcccc-ccc
Confidence            468999999999997654      3445777787775 5999999999997 889876  4789999999999987 677


Q ss_pred             hhccccccCceeecccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCC
Q 039957           80 NSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILP  159 (481)
Q Consensus        80 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p  159 (481)
                      ..+..+++|+.|+|++|...+.+|. ++.+++|+.|+|++|.....        .+.++.++++|+.|++++|...+.+|
T Consensus       628 ~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~--------lp~si~~L~~L~~L~L~~c~~L~~Lp  698 (1153)
T PLN03210        628 DGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVE--------LPSSIQYLNKLEDLDMSRCENLEILP  698 (1153)
T ss_pred             cccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccc--------cchhhhccCCCCEEeCCCCCCcCccC
Confidence            8889999999999998875556774 88999999999998754322        23557789999999999987666777


Q ss_pred             hhhhhcccCccEEEccCCceeecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcC-------CCCCC
Q 039957          160 PSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNL-------QGYVP  232 (481)
Q Consensus       160 ~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l-------~~~~p  232 (481)
                      ..+ ++ ++|+.|++++|...+.+|..   ..+|++|++++|.+. .+|..+ .+++|+.|.+.++..       ....+
T Consensus       699 ~~i-~l-~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~  771 (1153)
T PLN03210        699 TGI-NL-KSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTP  771 (1153)
T ss_pred             CcC-CC-CCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccch
Confidence            765 33 68999999999776666653   467899999999986 567655 578888888876332       22222


Q ss_pred             ccccCccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCcCcccCCcchhccccCcEEEccCcccCCCCCCccccCCc
Q 039957          233 HNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKV  312 (481)
Q Consensus       233 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~  312 (481)
                      ..+...++|+.|++++|...+.+|..+.++++|+.|++++|...+.+|..+ .+++|+.|++++|.....+|..   ..+
T Consensus       772 ~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~n  847 (1153)
T PLN03210        772 LMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STN  847 (1153)
T ss_pred             hhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccc
Confidence            233345789999999998887899999999999999999986556778766 7899999999998765566653   367


Q ss_pred             CcEEEccCCeeeeeccccccccCChhhhhccc
Q 039957          313 LRVLDLSRNQLSGDIPSTIGALVDLETISLAG  344 (481)
Q Consensus       313 L~~L~l~~N~l~~~~p~~~~~l~~L~~l~~~g  344 (481)
                      |+.|++++|.++ .+|.++..+++|++|++.+
T Consensus       848 L~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~  878 (1153)
T PLN03210        848 ISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNG  878 (1153)
T ss_pred             cCEeECCCCCCc-cChHHHhcCCCCCEEECCC
Confidence            999999999998 6788999999999998776

syringae 6; Provisional

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.90  E-value=9.3e-26  Score=226.94  Aligned_cols=315  Identities=28%  Similarity=0.312  Sum_probs=231.6

Q ss_pred             eeccCcchhCCCCCCeeeCcCCcccccCChhccCCcCCCEEE--------------------eeCCcCccccChhhhcCC
Q 039957            2 TGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLN--------------------LGGNRLSGHLPSMIGHSL   61 (481)
Q Consensus         2 ~g~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~--------------------L~~N~l~~~~p~~~~~~l   61 (481)
                      .|.++.++..++.  .|||.+|++...   .+.++.+|+.|.                    .++|.+....+..   .-
T Consensus       169 ~~~~~~~i~~l~~--~ldLr~N~~~~~---dls~~~~l~~l~c~rn~ls~l~~~g~~l~~L~a~~n~l~~~~~~p---~p  240 (1081)
T KOG0618|consen  169 GGSFLIDIYNLTH--QLDLRYNEMEVL---DLSNLANLEVLHCERNQLSELEISGPSLTALYADHNPLTTLDVHP---VP  240 (1081)
T ss_pred             ccchhcchhhhhe--eeecccchhhhh---hhhhccchhhhhhhhcccceEEecCcchheeeeccCcceeecccc---cc
Confidence            3566666776666  688888877621   233444444444                    4444444211111   12


Q ss_pred             CCccEEEccCccceeecchhccccccCceeecccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCC
Q 039957           62 PNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNC  141 (481)
Q Consensus        62 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l  141 (481)
                      .+|+++++++|+++ .+|++++.+.+|+.++..+|+++ .+|..+..+++|+.|.+.+|.++.+++         .+..+
T Consensus       241 ~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~yip~---------~le~~  309 (1081)
T KOG0618|consen  241 LNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELEYIPP---------FLEGL  309 (1081)
T ss_pred             ccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhhhCCC---------ccccc
Confidence            46788888888877 45588888888888888888885 677777788888888888888877643         34567


Q ss_pred             CCCcEEEccCCccceeCChhhhhcc-cCccEEEccCCceeecCCc-ccccCCCCCeEecccccceecCCcCCcCCCCCCe
Q 039957          142 RYLVYLILSGNPLGGILPPSIGNFS-TSLQRFSASECKLKGTIPK-EIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQG  219 (481)
Q Consensus       142 ~~L~~L~Ls~N~l~~~~p~~~~~~~-~~L~~L~l~~n~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~  219 (481)
                      +.|++|+|..|.+. .+|+.+.... .+++.|..+.|++. ..|. .=..++.|+.|.+.+|.++...-+.+.+.+.|+.
T Consensus       310 ~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~-~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKV  387 (1081)
T KOG0618|consen  310 KSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLS-TLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKV  387 (1081)
T ss_pred             ceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhcccc-ccccccchhhHHHHHHHHhcCcccccchhhhccccceee
Confidence            88999999999997 5566554433 34778888888887 3442 1223667999999999999877778899999999


Q ss_pred             eecCCCcCCCCCCccccCccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCcCcccCCcchhccccCcEEEccCccc
Q 039957          220 FFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLL  299 (481)
Q Consensus       220 l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l  299 (481)
                      |+|++|++.......+.++..|+.|+||+|+++ .+|.++..+..|++|...+|++. ..| .+..++.|+.+|++.|.+
T Consensus       388 LhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L  464 (1081)
T KOG0618|consen  388 LHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNL  464 (1081)
T ss_pred             eeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchh
Confidence            999999999877778899999999999999998 57899999999999999999997 677 889999999999999999


Q ss_pred             CCCCCCccccCCcCcEEEccCCeeeeeccccccccCChhhh
Q 039957          300 NDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETI  340 (481)
Q Consensus       300 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l  340 (481)
                      +...-..-...++|++||+++|.-....-..+..+..+...
T Consensus       465 ~~~~l~~~~p~p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~  505 (1081)
T KOG0618|consen  465 SEVTLPEALPSPNLKYLDLSGNTRLVFDHKTLKVLKSLSQM  505 (1081)
T ss_pred             hhhhhhhhCCCcccceeeccCCcccccchhhhHHhhhhhhe
Confidence            75432222233899999999998533333444444444443

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.90  E-value=7.2e-24  Score=204.65  Aligned_cols=136  Identities=31%  Similarity=0.623  Sum_probs=121.2

Q ss_pred             hhhhhccccccceeeeeccCCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCCc----ccccCCC
Q 039957          337 LETISLAGSFGSVYKGTISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPDF----KFMPNGS  410 (481)
Q Consensus       337 L~~l~~~g~~g~vy~~~l~~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----~~~~~g~  410 (481)
                      +..-.|+|.||+||+|.+..  .||||.++...  ....+.|+.||+++++-||.||+-+.|||..+.+    .++++.+
T Consensus       396 l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~AIiTqwCeGsS  473 (678)
T KOG0193|consen  396 LGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPLAIITQWCEGSS  473 (678)
T ss_pred             ccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCceeeeehhccCch
Confidence            33345899999999998753  69999998764  3356789999999999999999999999998874    4789999


Q ss_pred             hhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          411 LEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       411 l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      |+.++|.....++..+.+.||.|||+||.|||    ..+|||||+|..||+++++++|||+|||+|..
T Consensus       474 LY~hlHv~etkfdm~~~idIAqQiaqGM~YLH----AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatv  537 (678)
T KOG0193|consen  474 LYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH----AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATV  537 (678)
T ss_pred             hhhhccchhhhhhHHHHHHHHHHHHHhhhhhh----hhhhhhhhccccceEEccCCcEEEecccceee
Confidence            99999988888899999999999999999999    68899999999999999999999999999854

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=99.89  E-value=1.7e-23  Score=193.36  Aligned_cols=134  Identities=31%  Similarity=0.553  Sum_probs=110.8

Q ss_pred             ccccccceeeee-ccCCcceEEEEEeccchh-------hhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccC
Q 039957          342 LAGSFGSVYKGT-ISDGTDVAIKIFNLQRER-------AFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPN  408 (481)
Q Consensus       342 ~~g~~g~vy~~~-l~~g~~vavK~l~~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~  408 (481)
                      |+|+||.|-.|. -.+|+.||||+++.....       ......+|+++|.+++|||||++.+++..++     +|||.+
T Consensus       181 GsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~G  260 (475)
T KOG0615|consen  181 GSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEG  260 (475)
T ss_pred             cCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEecC
Confidence            789999999887 457999999999765421       1223468999999999999999999998876     478999


Q ss_pred             CChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCC---CcEEEccccCcccCC
Q 039957          409 GSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDEN---MVAHVSDFGISKLLG  480 (481)
Q Consensus       409 g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~---~~~kl~Dfgl~~~~~  480 (481)
                      |+|.+.+-+... +....--.++.|+..|+.|||    ++||+||||||+|||+..+   ..+||+|||+||...
T Consensus       261 GeLfd~vv~nk~-l~ed~~K~~f~Qll~avkYLH----~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g  330 (475)
T KOG0615|consen  261 GELFDKVVANKY-LREDLGKLLFKQLLTAVKYLH----SQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSG  330 (475)
T ss_pred             ccHHHHHHhccc-cccchhHHHHHHHHHHHHHHH----HcCcccccCCcceEEeccCCcceEEEecccchhhccc
Confidence            999998876432 233334558999999999999    7899999999999999654   899999999999874

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.89  E-value=2.5e-23  Score=196.93  Aligned_cols=134  Identities=29%  Similarity=0.428  Sum_probs=115.7

Q ss_pred             ccccccceeeee-ccCCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC-------cccccCCCh
Q 039957          342 LAGSFGSVYKGT-ISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-------FKFMPNGSL  411 (481)
Q Consensus       342 ~~g~~g~vy~~~-l~~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-------~~~~~~g~l  411 (481)
                      +.|.||.||++. ..+|..||+|++....  ........+||.+|+++.||||+++.+...+..       ||||+ -+|
T Consensus       126 GeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMd-hDL  204 (560)
T KOG0600|consen  126 GEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMD-HDL  204 (560)
T ss_pred             cCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEeccc-chh
Confidence            789999999997 5679999999987665  334445678999999999999999998876652       78886 467


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      ...+...+..++-.+.-.++.|+..||+|+|    +.+|+|||||++|||+|.+|.+||+|||+|+++.
T Consensus       205 ~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH----~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~  269 (560)
T KOG0600|consen  205 SGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH----SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYT  269 (560)
T ss_pred             hhhhcCCCcccChHHHHHHHHHHHHHHHHHh----hcCeeeccccccceEEcCCCCEEeccccceeecc
Confidence            7777766777788888899999999999999    6889999999999999999999999999999764

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.89  E-value=1.8e-25  Score=205.11  Aligned_cols=279  Identities=21%  Similarity=0.237  Sum_probs=216.5

Q ss_pred             CCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeeccc-CcceecCcccccCCCCCCEEE
Q 039957           38 TIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGF-NTFSGHIPNTFGNLRHLSVLS  116 (481)
Q Consensus        38 ~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~  116 (481)
                      .-..++|..|+|+ .||+..|+.+++|+.||||+|+|+.+-|++|.++.+|..|-+.+ |+|+.+..+.|++|.+|+.|.
T Consensus        68 ~tveirLdqN~I~-~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLl  146 (498)
T KOG4237|consen   68 ETVEIRLDQNQIS-SIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLL  146 (498)
T ss_pred             cceEEEeccCCcc-cCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHh
Confidence            4678999999998 89998888999999999999999999999999999988876665 999988888999999999999


Q ss_pred             cccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEccCCcee------------ecCC
Q 039957          117 LLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLK------------GTIP  184 (481)
Q Consensus       117 L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~------------~~~p  184 (481)
                      +.-|++..+...+        +..+++|..|.+-+|.+..+--.+|..+ .+++.+.+..|.+.            ...|
T Consensus       147 lNan~i~Cir~~a--------l~dL~~l~lLslyDn~~q~i~~~tf~~l-~~i~tlhlA~np~icdCnL~wla~~~a~~~  217 (498)
T KOG4237|consen  147 LNANHINCIRQDA--------LRDLPSLSLLSLYDNKIQSICKGTFQGL-AAIKTLHLAQNPFICDCNLPWLADDLAMNP  217 (498)
T ss_pred             cChhhhcchhHHH--------HHHhhhcchhcccchhhhhhccccccch-hccchHhhhcCccccccccchhhhHHhhch
Confidence            9999999886554        4567889999999999985544466655 57888888887732            2234


Q ss_pred             cccccCCCCCeEecccccceecCCcCCcCC-CCCCeeecCCCcCCCCCC-ccccCccCCCeeecCCCeeeecCCcccccC
Q 039957          185 KEIGHLRGLIYLSLGFNDLNGTIPTSIGTL-KQLQGFFLPETNLQGYVP-HNLCHLEMLNLLHLGGNKLSGHIPPCLASL  262 (481)
Q Consensus       185 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l-~~L~~l~l~~n~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  262 (481)
                      ..++...-..-..+.++++....+..|... ..+..-..+.....+.-| ..|..+++|+.++|++|+++++.+.+|.++
T Consensus       218 ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~  297 (498)
T KOG4237|consen  218 IETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGA  297 (498)
T ss_pred             hhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcch
Confidence            445555555555556666654444444322 122111222333333334 368888999999999999998888899999


Q ss_pred             CCCCcEEcCCCcCcccCCcchhccccCcEEEccCcccCCCCCCccccCCcCcEEEccCCeeeee
Q 039957          263 TSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGD  326 (481)
Q Consensus       263 ~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~  326 (481)
                      .++++|.|..|++.......|.++..|++|+|.+|+|+...|..|..+.+|.+|+|-.|++.+.
T Consensus       298 a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~Cn  361 (498)
T KOG4237|consen  298 AELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCN  361 (498)
T ss_pred             hhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCc
Confidence            9999999999998877777888888899999999999888888898888999999888888753

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=99.88  E-value=1.2e-22  Score=177.62  Aligned_cols=135  Identities=30%  Similarity=0.507  Sum_probs=118.4

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccch--hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQRE--RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      -|+|.||.||+|.. ..|+.||+|++.....  +......+|+..|+.++|+||+++++.+...+     +|||+ -+|+
T Consensus        10 lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~-tdLe   88 (318)
T KOG0659|consen   10 LGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMP-TDLE   88 (318)
T ss_pred             hcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEecc-ccHH
Confidence            37899999999984 5789999999987643  23446788999999999999999999987664     78987 6888


Q ss_pred             HHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          413 KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       413 ~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      ..+.+....++-...-.++..+.+|++|+|    ...|+|||+||.|+|++++|.+||+|||+|+.+.
T Consensus        89 ~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H----~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~  152 (318)
T KOG0659|consen   89 VVIKDKNIILSPADIKSYMLMTLKGLAYCH----SKWILHRDLKPNNLLISSDGQLKIADFGLARFFG  152 (318)
T ss_pred             HHhcccccccCHHHHHHHHHHHHHHHHHHH----hhhhhcccCCccceEEcCCCcEEeecccchhccC
Confidence            889888888888888899999999999999    6779999999999999999999999999999874

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.88  E-value=1.2e-22  Score=196.95  Aligned_cols=136  Identities=27%  Similarity=0.413  Sum_probs=120.5

Q ss_pred             hhccccccceeeeec-cCCcceEEEEEecc---chhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCC
Q 039957          340 ISLAGSFGSVYKGTI-SDGTDVAIKIFNLQ---RERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGS  410 (481)
Q Consensus       340 l~~~g~~g~vy~~~l-~~g~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~  410 (481)
                      +-|+|+|+.+|+++. ..|..+|+|.+...   .....+...+|+++.+.++|||||+++++|.+.+     .|+|++|+
T Consensus        25 ~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~s  104 (592)
T KOG0575|consen   25 FLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGS  104 (592)
T ss_pred             eeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCcc
Confidence            458999999999986 78999999998664   2344566888999999999999999999999886     45789999


Q ss_pred             hhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          411 LEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       411 l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      |..++. .+..++..++..+..||+.|+.|||    +.+|+|||||-.|+++++++++||+|||+|..+.
T Consensus       105 L~el~K-rrk~ltEpEary~l~QIv~GlkYLH----~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le  169 (592)
T KOG0575|consen  105 LMELLK-RRKPLTEPEARYFLRQIVEGLKYLH----SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLE  169 (592)
T ss_pred             HHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHH----hcCceecccchhheeecCcCcEEecccceeeeec
Confidence            999877 5667888899999999999999999    6889999999999999999999999999998764

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=99.88  E-value=8.7e-23  Score=187.10  Aligned_cols=134  Identities=30%  Similarity=0.487  Sum_probs=113.6

Q ss_pred             hhccccccceeeeecc-CCcceEEEEEeccch---hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCC
Q 039957          340 ISLAGSFGSVYKGTIS-DGTDVAIKIFNLQRE---RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGS  410 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~  410 (481)
                      +.+.|+||.||.+.-. +++.+|+|.++++..   ...+....|..++.+++||.||++...|++.+     .+|+.||+
T Consensus        32 viGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGe  111 (357)
T KOG0598|consen   32 VIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGE  111 (357)
T ss_pred             eeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCcc
Confidence            4589999999998754 588999999876542   33566788999999999999999998888775     56999999


Q ss_pred             hhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          411 LEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       411 l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      |..++...+.+.+-..|. +++.|+.||+|||    +.+|||||+||+|||+|++|+++++|||+||.
T Consensus       112 Lf~hL~~eg~F~E~~arf-YlaEi~lAL~~LH----~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~  174 (357)
T KOG0598|consen  112 LFYHLQREGRFSEDRARF-YLAEIVLALGYLH----SKGIIYRDLKPENILLDEQGHIKLTDFGLCKE  174 (357)
T ss_pred             HHHHHHhcCCcchhHHHH-HHHHHHHHHHHHH----hCCeeeccCCHHHeeecCCCcEEEeccccchh
Confidence            999998766554444444 6779999999999    78899999999999999999999999999985

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=99.87  E-value=9.6e-23  Score=181.21  Aligned_cols=134  Identities=24%  Similarity=0.350  Sum_probs=110.3

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccch-hh-hhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhH
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQRE-RA-FRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEK  413 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~~-~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~  413 (481)
                      |+|+||+|||++.. +|+.||||++..+.. .. .+-..+|+.+|.+++|+|+|.++..|....     |||+..--|.+
T Consensus        11 GEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTvL~e   90 (396)
T KOG0593|consen   11 GEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTVLHE   90 (396)
T ss_pred             ccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchHHHHH
Confidence            78999999999876 489999999865432 22 334578999999999999999999987653     78887655544


Q ss_pred             HhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          414 RLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       414 ~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      . .......+.....++..|+++|+.|.|    ..+|+||||||+|||++.++.+|+||||+||.+.
T Consensus        91 L-e~~p~G~~~~~vk~~l~Q~l~ai~~cH----k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~  152 (396)
T KOG0593|consen   91 L-ERYPNGVPSELVKKYLYQLLKAIHFCH----KNNCIHRDIKPENILITQNGVVKLCDFGFARTLS  152 (396)
T ss_pred             H-HhccCCCCHHHHHHHHHHHHHHhhhhh----hcCeecccCChhheEEecCCcEEeccchhhHhhc
Confidence            3 222334566677789999999999999    6789999999999999999999999999999875

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.87  E-value=3.1e-22  Score=186.46  Aligned_cols=137  Identities=33%  Similarity=0.473  Sum_probs=116.5

Q ss_pred             hhccccccceeeeeccC-CcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCC-------CcccccCCCh
Q 039957          340 ISLAGSFGSVYKGTISD-GTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTP-------DFKFMPNGSL  411 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~~-g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------~~~~~~~g~l  411 (481)
                      +-+.|.||.||.+...+ |...|||..........+...+|+.+|.+++|||||+.+|.....       -+||+++|+|
T Consensus        24 ~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL  103 (313)
T KOG0198|consen   24 LLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSL  103 (313)
T ss_pred             cccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcH
Confidence            34789999999998764 899999988776433355678899999999999999999963221       2689999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCC-CCcEEEccccCcccCC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDE-NMVAHVSDFGISKLLG  480 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~-~~~~kl~Dfgl~~~~~  480 (481)
                      .+.+...+..++.....+.+.+|.+||+|||    +++||||||||+|||++. ++.+||+|||+|+...
T Consensus       104 ~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH----s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~  169 (313)
T KOG0198|consen  104 SDLIKRYGGKLPEPLVRRYTRQILEGLAYLH----SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLE  169 (313)
T ss_pred             HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH----hCCEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence            9998875546778888899999999999999    789999999999999999 7999999999998654

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=99.87  E-value=1.7e-22  Score=192.87  Aligned_cols=137  Identities=30%  Similarity=0.465  Sum_probs=115.0

Q ss_pred             hhccccccceeeeec-cCCcceEEEEEeccc---hhhhhhhhHHHHHhhhh-ccCccceeecccCCCC-----cccccCC
Q 039957          340 ISLAGSFGSVYKGTI-SDGTDVAIKIFNLQR---ERAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD-----FKFMPNG  409 (481)
Q Consensus       340 l~~~g~~g~vy~~~l-~~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----~~~~~~g  409 (481)
                      ..|.|+|..|++|+- ..++.+|+|.+++..   +...+-...|-.+|.++ .||.|++++..|.+..     ++|+++|
T Consensus        80 ~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nG  159 (604)
T KOG0592|consen   80 ILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNG  159 (604)
T ss_pred             eeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCC
Confidence            347899999999984 468999999987653   33344456788888888 7999999998888764     5799999


Q ss_pred             ChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCCC
Q 039957          410 SLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE  481 (481)
Q Consensus       410 ~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~~  481 (481)
                      +|.+++..-+ .++......+|.+|..|++|||    +.|||||||||+|||+|++|++||+|||-||.+.+
T Consensus       160 dll~~i~K~G-sfde~caR~YAAeIldAleylH----~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~  226 (604)
T KOG0592|consen  160 DLLDLIKKYG-SFDETCARFYAAEILDALEYLH----SNGIIHRDLKPENILLDKDGHIKITDFGSAKILSP  226 (604)
T ss_pred             cHHHHHHHhC-cchHHHHHHHHHHHHHHHHHHH----hcCceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence            9999998643 3455556679999999999999    78999999999999999999999999999999863

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.87  E-value=3.4e-22  Score=208.31  Aligned_cols=247  Identities=26%  Similarity=0.384  Sum_probs=168.3

Q ss_pred             CCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceee
Q 039957           13 QNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILD   92 (481)
Q Consensus        13 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~   92 (481)
                      .+.+.|+++++.++. +|..+  .+.|+.|+|++|+|+ .+|..++   ++|++|++++|+++ .+|..+.  .+|+.|+
T Consensus       178 ~~~~~L~L~~~~Lts-LP~~I--p~~L~~L~Ls~N~Lt-sLP~~l~---~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~  247 (754)
T PRK15370        178 NNKTELRLKILGLTT-IPACI--PEQITTLILDNNELK-SLPENLQ---GNIKTLYANSNQLT-SIPATLP--DTIQEME  247 (754)
T ss_pred             cCceEEEeCCCCcCc-CCccc--ccCCcEEEecCCCCC-cCChhhc---cCCCEEECCCCccc-cCChhhh--ccccEEE
Confidence            356788888888875 45444  257888899989888 6787654   57888889888887 5565543  4688888


Q ss_pred             cccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEE
Q 039957           93 LGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRF  172 (481)
Q Consensus        93 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L  172 (481)
                      |++|.+. .+|..+.  .+|+.|++++|+++.++..         +  .++|++|++++|++++ +|..+.   .+|+.|
T Consensus       248 Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~~LP~~---------l--~~sL~~L~Ls~N~Lt~-LP~~lp---~sL~~L  309 (754)
T PRK15370        248 LSINRIT-ELPERLP--SALQSLDLFHNKISCLPEN---------L--PEELRYLSVYDNSIRT-LPAHLP---SGITHL  309 (754)
T ss_pred             CcCCccC-cCChhHh--CCCCEEECcCCccCccccc---------c--CCCCcEEECCCCcccc-Ccccch---hhHHHH
Confidence            8888888 5566554  4788888888888866431         1  1368888888888874 454332   367788


Q ss_pred             EccCCceeecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeee
Q 039957          173 SASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLS  252 (481)
Q Consensus       173 ~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~  252 (481)
                      ++++|+++. +|..+.  ++|+.|++++|.+++ +|..+.  ++|+.|++++|+++. +|..+.  +.|+.|++++|+++
T Consensus       310 ~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~~-LP~~lp--~~L~~LdLs~N~Lt  380 (754)
T PRK15370        310 NVQSNSLTA-LPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQITV-LPETLP--PTITTLDVSRNALT  380 (754)
T ss_pred             HhcCCcccc-CCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCCc-CChhhc--CCcCEEECCCCcCC
Confidence            888888874 554432  577888888888774 555543  577777787777764 454442  46777777777777


Q ss_pred             ecCCcccccCCCCCcEEcCCCcCcccCCcchh----ccccCcEEEccCcccC
Q 039957          253 GHIPPCLASLTSLRELDLGSNKLTSSIPSSLW----SLGYILEINLSSNLLN  300 (481)
Q Consensus       253 ~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~----~l~~L~~L~l~~N~l~  300 (481)
                      . +|..+.  .+|+.|++++|+++ .+|..+.    .++.+..+++.+|.++
T Consensus       381 ~-LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls  428 (754)
T PRK15370        381 N-LPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS  428 (754)
T ss_pred             C-CCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence            4 444443  35777777777776 4454433    2355667777777765

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.87  E-value=4.2e-22  Score=194.02  Aligned_cols=136  Identities=29%  Similarity=0.463  Sum_probs=118.3

Q ss_pred             hhccccccceeeeeccCC----cc-eEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccc
Q 039957          340 ISLAGSFGSVYKGTISDG----TD-VAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFM  406 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~~g----~~-vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~  406 (481)
                      .-|+|+||.||+|++..+    .. ||||....+.   .....++..|.+++++++|+|||+++|++....     +|+|
T Consensus       164 kLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~  243 (474)
T KOG0194|consen  164 KLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELC  243 (474)
T ss_pred             eeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEec
Confidence            347899999999997542    23 8999887522   344568999999999999999999999987654     7899


Q ss_pred             cCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          407 PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       407 ~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +||+|.+++......++..++++.+.++|+||+|||    ..+++||||-++|+|++.++.+||||||+++.-
T Consensus       244 ~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh----~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~  312 (474)
T KOG0194|consen  244 NGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH----SKNCIHRDIAARNCLYSKKGVVKISDFGLSRAG  312 (474)
T ss_pred             CCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH----HCCCcchhHhHHHheecCCCeEEeCccccccCC
Confidence            999999999876667899999999999999999999    688999999999999999999999999998763

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=2.9e-22  Score=176.39  Aligned_cols=140  Identities=24%  Similarity=0.409  Sum_probs=113.7

Q ss_pred             hccccccceeeee-ccCCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecc-cCCCC------cccccCCC
Q 039957          341 SLAGSFGSVYKGT-ISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSS-CSTPD------FKFMPNGS  410 (481)
Q Consensus       341 ~~~g~~g~vy~~~-l~~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~-~~~~~------~~~~~~g~  410 (481)
                      .|.|.||.|||+. +++|..+|.|.+.-..  .+..+....||.+|++++|||||+.++. +.+..      +||+..|+
T Consensus        27 IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GD  106 (375)
T KOG0591|consen   27 IGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGD  106 (375)
T ss_pred             HcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccC
Confidence            4889999999997 6789999999876332  2334567889999999999999998873 32222      67999999


Q ss_pred             hhHHhhc---CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          411 LEKRLYS---HNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       411 l~~~l~~---~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      |...+..   .....+....+++..|+++||..+|......-|+||||||.||++|.+|.||++|||++|++.
T Consensus       107 LsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~  179 (375)
T KOG0591|consen  107 LSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS  179 (375)
T ss_pred             HHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence            9987753   344566788899999999999999953312239999999999999999999999999999874

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.86  E-value=8.2e-22  Score=205.44  Aligned_cols=247  Identities=23%  Similarity=0.342  Sum_probs=197.0

Q ss_pred             cCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeecccCcceecCcccccCCCCCCEEE
Q 039957           37 STIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLS  116 (481)
Q Consensus        37 ~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  116 (481)
                      .+...|+++++.++ .+|..+.   ++|+.|+|++|+++ .+|..+.  ++|+.|++++|+++. +|..+.  .+|+.|+
T Consensus       178 ~~~~~L~L~~~~Lt-sLP~~Ip---~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lts-LP~~l~--~~L~~L~  247 (754)
T PRK15370        178 NNKTELRLKILGLT-TIPACIP---EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLTS-IPATLP--DTIQEME  247 (754)
T ss_pred             cCceEEEeCCCCcC-cCCcccc---cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCcccc-CChhhh--ccccEEE
Confidence            35789999999998 7887664   57999999999998 5666554  589999999999994 566553  4799999


Q ss_pred             cccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEccCCceeecCCcccccCCCCCeE
Q 039957          117 LLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYL  196 (481)
Q Consensus       117 L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L  196 (481)
                      |++|+++.++..         +  .++|++|++++|+++ .+|+.+.   .+|+.|++++|++++ +|..+.  .+|+.|
T Consensus       248 Ls~N~L~~LP~~---------l--~s~L~~L~Ls~N~L~-~LP~~l~---~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L  309 (754)
T PRK15370        248 LSINRITELPER---------L--PSALQSLDLFHNKIS-CLPENLP---EELRYLSVYDNSIRT-LPAHLP--SGITHL  309 (754)
T ss_pred             CcCCccCcCChh---------H--hCCCCEEECcCCccC-ccccccC---CCCcEEECCCCcccc-Ccccch--hhHHHH
Confidence            999999876432         1  247999999999998 4676553   479999999999994 665543  478999


Q ss_pred             ecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCcCc
Q 039957          197 SLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLT  276 (481)
Q Consensus       197 ~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~  276 (481)
                      ++++|.++. +|..+.  ++|+.|++++|.+++ +|..+.  ++|+.|++++|+++. +|..+.  ++|+.|++++|+++
T Consensus       310 ~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~~-LP~~lp--~~L~~LdLs~N~Lt  380 (754)
T PRK15370        310 NVQSNSLTA-LPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQITV-LPETLP--PTITTLDVSRNALT  380 (754)
T ss_pred             HhcCCcccc-CCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCCc-CChhhc--CCcCEEECCCCcCC
Confidence            999999984 555443  689999999999987 566554  689999999999984 666553  68999999999998


Q ss_pred             ccCCcchhccccCcEEEccCcccCCCCCCcc----ccCCcCcEEEccCCeee
Q 039957          277 SSIPSSLWSLGYILEINLSSNLLNDSLPSNV----QKLKVLRVLDLSRNQLS  324 (481)
Q Consensus       277 ~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~----~~l~~L~~L~l~~N~l~  324 (481)
                       .+|..+.  ..|+.|++++|++.. +|..+    ..++.+..+++.+|+++
T Consensus       381 -~LP~~l~--~sL~~LdLs~N~L~~-LP~sl~~~~~~~~~l~~L~L~~Npls  428 (754)
T PRK15370        381 -NLPENLP--AALQIMQASRNNLVR-LPESLPHFRGEGPQPTRIIVEYNPFS  428 (754)
T ss_pred             -CCCHhHH--HHHHHHhhccCCccc-CchhHHHHhhcCCCccEEEeeCCCcc
Confidence             5666554  368899999999974 56544    34578899999999997

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.86  E-value=1.1e-21  Score=184.35  Aligned_cols=134  Identities=28%  Similarity=0.425  Sum_probs=110.1

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccch--------------hhhhhhhHHHHHhhhhccCccceeecccCCCC---
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQRE--------------RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD---  402 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~--------------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---  402 (481)
                      .|+|.||.|-.|.- .+++.+|+|++.....              ...+...+|++++.+++|+|||+++....++.   
T Consensus       105 iG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~s~~  184 (576)
T KOG0585|consen  105 IGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPESDK  184 (576)
T ss_pred             hcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcccCc
Confidence            47899999998874 4789999999865321              01235778999999999999999999887664   


Q ss_pred             ----cccccCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          403 ----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       403 ----~~~~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                          +|||..|.+...-.+ ...++..++.++..++..||+|||    .++||||||||+|+|++++|+|||+|||.+-.
T Consensus       185 ~YlVley~s~G~v~w~p~d-~~els~~~Ar~ylrDvv~GLEYLH----~QgiiHRDIKPsNLLl~~~g~VKIsDFGVs~~  259 (576)
T KOG0585|consen  185 LYLVLEYCSKGEVKWCPPD-KPELSEQQARKYLRDVVLGLEYLH----YQGIIHRDIKPSNLLLSSDGTVKISDFGVSNE  259 (576)
T ss_pred             eEEEEEeccCCccccCCCC-cccccHHHHHHHHHHHHHHHHHHH----hcCeeccccchhheEEcCCCcEEeeccceeee
Confidence                578888888654222 122778899999999999999999    68899999999999999999999999999875


Q ss_pred             C
Q 039957          479 L  479 (481)
Q Consensus       479 ~  479 (481)
                      .
T Consensus       260 ~  260 (576)
T KOG0585|consen  260 F  260 (576)
T ss_pred             c
Confidence            4

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.86  E-value=6.4e-22  Score=181.10  Aligned_cols=132  Identities=31%  Similarity=0.494  Sum_probs=102.8

Q ss_pred             hhccccccceeeeecc-CCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC----------cccccC
Q 039957          340 ISLAGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----------FKFMPN  408 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----------~~~~~~  408 (481)
                      +.+.|.||.||+|.+. .+..+|||+.-....    --.+|.++++++.|||||++.-++....          +|||| 
T Consensus        31 liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP-  105 (364)
T KOG0658|consen   31 LIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMP-  105 (364)
T ss_pred             EEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhch-
Confidence            4578999999999965 478999997643321    2246899999999999999987775431          56887 


Q ss_pred             CChhHHhhc---CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCC-CcEEEccccCcccCC
Q 039957          409 GSLEKRLYS---HNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDEN-MVAHVSDFGISKLLG  480 (481)
Q Consensus       409 g~l~~~l~~---~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~-~~~kl~Dfgl~~~~~  480 (481)
                      .+|+..++.   .....+....--++.|+.+|++|||    +.+||||||||.|||+|.+ |.+||||||=||.+.
T Consensus       106 ~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh----~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~  177 (364)
T KOG0658|consen  106 ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH----SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV  177 (364)
T ss_pred             HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH----hcCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence            577776653   1222333344458899999999999    6889999999999999986 999999999999864

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=99.86  E-value=1.1e-21  Score=174.02  Aligned_cols=134  Identities=31%  Similarity=0.448  Sum_probs=114.8

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      +.|+||.|..+... .|..+|+|.++...   .+..++..+|..+|..+.||.++++.+.|.+..     ++|+++|.+.
T Consensus        53 GtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElF  132 (355)
T KOG0616|consen   53 GTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELF  132 (355)
T ss_pred             ccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCccHH
Confidence            78999999988754 58899999997764   344567788999999999999999999988775     6789999999


Q ss_pred             HHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          413 KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       413 ~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      ++++..+..-+ ..+.-+|.+|+.|++|||    +..|++||+||+|||+|++|++||.|||+||...
T Consensus       133 S~Lrk~~rF~e-~~arFYAAeivlAleylH----~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~  195 (355)
T KOG0616|consen  133 SYLRKSGRFSE-PHARFYAAEIVLALEYLH----SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS  195 (355)
T ss_pred             HHHHhcCCCCc-hhHHHHHHHHHHHHHHHH----hcCeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence            99987554433 445569999999999999    6789999999999999999999999999999754

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.85  E-value=6e-22  Score=199.42  Aligned_cols=134  Identities=31%  Similarity=0.542  Sum_probs=117.0

Q ss_pred             ccccccceeeeeccC------CcceEEEEEeccchh-hhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCC
Q 039957          342 LAGSFGSVYKGTISD------GTDVAIKIFNLQRER-AFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNG  409 (481)
Q Consensus       342 ~~g~~g~vy~~~l~~------g~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g  409 (481)
                      +.|.||.||+|....      ...||||.++..... ...+|.+|++.++.++|+|||+++|.|..++     ||||..|
T Consensus       495 GegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~G  574 (774)
T KOG1026|consen  495 GEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHG  574 (774)
T ss_pred             cCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecccc
Confidence            789999999998542      367999999765544 6789999999999999999999999999886     8999999


Q ss_pred             ChhHHhhcC---------C----CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCc
Q 039957          410 SLEKRLYSH---------N----YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGIS  476 (481)
Q Consensus       410 ~l~~~l~~~---------~----~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~  476 (481)
                      +|.++|...         +    ..++-.+.+.||.|||.||+||-    ++..|||||-++|+||.+++.|||+|||++
T Consensus       575 DL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs----~~~FVHRDLATRNCLVge~l~VKIsDfGLs  650 (774)
T KOG1026|consen  575 DLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS----SHHFVHRDLATRNCLVGENLVVKISDFGLS  650 (774)
T ss_pred             cHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH----hCcccccchhhhhceeccceEEEecccccc
Confidence            999998641         1    12677899999999999999998    567999999999999999999999999999


Q ss_pred             ccC
Q 039957          477 KLL  479 (481)
Q Consensus       477 ~~~  479 (481)
                      |.+
T Consensus       651 Rdi  653 (774)
T KOG1026|consen  651 RDI  653 (774)
T ss_pred             hhh
Confidence            853

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=99.85  E-value=3.7e-21  Score=173.43  Aligned_cols=145  Identities=22%  Similarity=0.381  Sum_probs=112.6

Q ss_pred             ccccCChhhhh-----ccccccceeeeecc-CCcceEEEEEeccchhh--hhhhhHHHHHhhhhccCccceeecccCCCC
Q 039957          331 IGALVDLETIS-----LAGSFGSVYKGTIS-DGTDVAIKIFNLQRERA--FRSFNSECEVLRNVRHQNLIKILSSCSTPD  402 (481)
Q Consensus       331 ~~~l~~L~~l~-----~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  402 (481)
                      ++.|.+.+...     .+|.||.||+|+.. ++..||+|+++...+..  .-...+|+.+|.+++|||||.+-......+
T Consensus        69 l~gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~  148 (419)
T KOG0663|consen   69 LGGCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN  148 (419)
T ss_pred             ccCcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc
Confidence            45555554432     57999999999865 57889999998766443  234578999999999999998766554332


Q ss_pred             -------cccccCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccC
Q 039957          403 -------FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGI  475 (481)
Q Consensus       403 -------~~~~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl  475 (481)
                             ++||+ -+|.+.+..-.....-.+.-.++.|+.+|++|||    ..-|+|||+|++|+|+...|..||||||+
T Consensus       149 ~d~iy~VMe~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH----~~wilHRDLK~SNLLm~~~G~lKiaDFGL  223 (419)
T KOG0663|consen  149 MDKIYIVMEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLH----DNWILHRDLKTSNLLLSHKGILKIADFGL  223 (419)
T ss_pred             cceeeeeHHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHh----hceeEecccchhheeeccCCcEEecccch
Confidence                   45654 4566666553344556677789999999999999    56799999999999999999999999999


Q ss_pred             cccCC
Q 039957          476 SKLLG  480 (481)
Q Consensus       476 ~~~~~  480 (481)
                      ||.++
T Consensus       224 AR~yg  228 (419)
T KOG0663|consen  224 AREYG  228 (419)
T ss_pred             hhhhc
Confidence            99875

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.84  E-value=3.2e-21  Score=185.24  Aligned_cols=134  Identities=28%  Similarity=0.495  Sum_probs=117.6

Q ss_pred             ccccccceeeeeccCCcceEEEEEeccchhh-hhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHHh
Q 039957          342 LAGSFGSVYKGTISDGTDVAIKIFNLQRERA-FRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRL  415 (481)
Q Consensus       342 ~~g~~g~vy~~~l~~g~~vavK~l~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~l  415 (481)
                      ++|.||.|.......+..||||.++...... ..+|.+|+++|.+++|||||+++|.|...+     .|||++|+|..++
T Consensus       547 GeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl  626 (807)
T KOG1094|consen  547 GEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFL  626 (807)
T ss_pred             cCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHH
Confidence            7899999999988777999999998766544 478999999999999999999999998765     6899999999998


Q ss_pred             hcCCCcc-CHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          416 YSHNYFL-DILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       416 ~~~~~~~-~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .++.... +-..-.+|+.|||.||+||.    +.++||||+.++|+|+|+++++||||||++|-+
T Consensus       627 ~aheapt~~t~~~vsi~tqiasgmaYLe----s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~l  687 (807)
T KOG1094|consen  627 SAHELPTAETAPGVSICTQIASGMAYLE----SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNL  687 (807)
T ss_pred             HhccCcccccchhHHHHHHHHHHHHHHH----hhchhhccccccceeecCcccEEecCccccccc
Confidence            8764332 44566789999999999998    678999999999999999999999999999843

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=99.84  E-value=7.4e-21  Score=174.31  Aligned_cols=134  Identities=28%  Similarity=0.426  Sum_probs=110.3

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccch--hhhhhhhHHHHHhhhhccCc-cceeecccCCCC-----------ccc
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQRE--RAFRSFNSECEVLRNVRHQN-LIKILSSCSTPD-----------FKF  405 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~-----------~~~  405 (481)
                      .++|.||.||+|.. .+|..||+|++.....  +......+|+.++.+++|+| ||.+.+.+....           |||
T Consensus        19 lGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~   98 (323)
T KOG0594|consen   19 LGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEF   98 (323)
T ss_pred             hCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEe
Confidence            48899999999984 5789999999887644  34456688999999999999 999999887644           334


Q ss_pred             ccCCChhHHhhcCC---CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          406 MPNGSLEKRLYSHN---YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       406 ~~~g~l~~~l~~~~---~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      + .-+|.+++....   ...+-....+++.|+.+|++|+|    +++|+||||||.|||+++.|.+||+|||+|+..
T Consensus        99 ~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H----~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~  170 (323)
T KOG0594|consen   99 L-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH----SHGILHRDLKPQNLLISSSGVLKLADFGLARAF  170 (323)
T ss_pred             e-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH----hCCeecccCCcceEEECCCCcEeeeccchHHHh
Confidence            4 356777766533   23555667789999999999999    688999999999999999999999999999865

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.84  E-value=7.3e-21  Score=184.48  Aligned_cols=134  Identities=34%  Similarity=0.476  Sum_probs=115.2

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccc----h-hhhhhhhHHHHHhhhhc-cCccceeecccCCCC-----cccccC
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQR----E-RAFRSFNSECEVLRNVR-HQNLIKILSSCSTPD-----FKFMPN  408 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~----~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-----~~~~~~  408 (481)
                      -++|+||.|+.|.. .+|..||+|.++.+.    . ...+...+|+.++++++ ||||+++..++....     +||+.+
T Consensus        25 lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~g  104 (370)
T KOG0583|consen   25 LGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSG  104 (370)
T ss_pred             ecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCC
Confidence            47899999999974 468999999776542    2 23445668999999999 999999999988765     789999


Q ss_pred             CChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCC-CcEEEccccCcccC
Q 039957          409 GSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDEN-MVAHVSDFGISKLL  479 (481)
Q Consensus       409 g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~-~~~kl~Dfgl~~~~  479 (481)
                      |+|.+++.. ...+...+..++..|++.|++|+|    +++|+||||||+|||+|.+ +.+||+|||++...
T Consensus       105 GdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H----~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~  171 (370)
T KOG0583|consen  105 GDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCH----SRGIVHRDLKPENILLDGNEGNLKLSDFGLSAIS  171 (370)
T ss_pred             ccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHH----hCCEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence            999999987 445555788899999999999999    7899999999999999999 99999999999876

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.84  E-value=1.3e-21  Score=193.71  Aligned_cols=144  Identities=30%  Similarity=0.522  Sum_probs=126.6

Q ss_pred             cCChhhhhccccccceeeeeccC----CcceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----c
Q 039957          334 LVDLETISLAGSFGSVYKGTISD----GTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----F  403 (481)
Q Consensus       334 l~~L~~l~~~g~~g~vy~~~l~~----g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~  403 (481)
                      +...+.+.++|.||.||+|.+.-    ...||+|.++... ++...+|..|..++.+..||||+++-|......     .
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT  709 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT  709 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence            44556667899999999998752    3679999998765 455678999999999999999999999887653     5


Q ss_pred             ccccCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCCC
Q 039957          404 KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE  481 (481)
Q Consensus       404 ~~~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~~  481 (481)
                      |||+||+|..+++.....++|.+-..+..|||.||.||-    +.++|||||-++|||++.+..+||+|||++|.+.|
T Consensus       710 EyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLs----dm~YVHRDLAARNILVNsnLvCKVsDFGLSRvled  783 (996)
T KOG0196|consen  710 EYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLS----DMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  783 (996)
T ss_pred             hhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHh----hcCchhhhhhhhheeeccceEEEeccccceeeccc
Confidence            899999999999987777889999999999999999998    78999999999999999999999999999998753

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.84  E-value=2e-21  Score=182.80  Aligned_cols=133  Identities=31%  Similarity=0.446  Sum_probs=114.3

Q ss_pred             ccccccceeeee-ccCCcceEEEEEeccchhhhhh--hhHHHHHhhhhc-cCccceeecccCCCC------cccccCCCh
Q 039957          342 LAGSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRS--FNSECEVLRNVR-HQNLIKILSSCSTPD------FKFMPNGSL  411 (481)
Q Consensus       342 ~~g~~g~vy~~~-l~~g~~vavK~l~~~~~~~~~~--~~~e~~~l~~l~-h~niv~l~~~~~~~~------~~~~~~g~l  411 (481)
                      |.|.||.||+|+ ..+|..||||+++..... +++  -.+|+..|+++. |||||++...+.+.+      ||||. ..|
T Consensus        19 GDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md-~NL   96 (538)
T KOG0661|consen   19 GDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMD-CNL   96 (538)
T ss_pred             cCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhh-hhH
Confidence            789999999998 556888999987654222 232  357999999999 999999999888776      67885 688


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      +..+.+++..++......|+.||.+||+|+|    .+|+.|||+||+|||+.....+||+|||+||-+.
T Consensus        97 YqLmK~R~r~fse~~irnim~QilqGL~hiH----k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~  161 (538)
T KOG0661|consen   97 YQLMKDRNRLFSESDIRNIMYQILQGLAHIH----KHGFFHRDLKPENILISGNDVIKIADFGLAREVR  161 (538)
T ss_pred             HHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH----hcCcccccCChhheEecccceeEecccccccccc
Confidence            8888888788888999999999999999999    6889999999999999999999999999999764

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.83  E-value=2e-20  Score=180.61  Aligned_cols=136  Identities=28%  Similarity=0.475  Sum_probs=115.8

Q ss_pred             hhccccccceeeeecc-CCc----ceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC----cccccCC
Q 039957          340 ISLAGSFGSVYKGTIS-DGT----DVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----FKFMPNG  409 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~-~g~----~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~~~~g  409 (481)
                      .-++|+||.||+|... +|.    .||+|.+.... ....+.+..|+.+++.++|+||++++|+|....    ++|+++|
T Consensus        14 ~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~~~~v~e~~~~g   93 (316)
T cd05108          14 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFG   93 (316)
T ss_pred             eeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCCceeeeecCCCC
Confidence            3478999999999853 343    38899886443 234457888999999999999999999987654    5689999


Q ss_pred             ChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          410 SLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       410 ~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ++.+++......+++...++++.+|++||+|||    +.+|+||||||+||++++++.+||+|||+++.+
T Consensus        94 ~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH----~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~  159 (316)
T cd05108          94 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE----ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (316)
T ss_pred             CHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH----hcCeeccccchhheEecCCCcEEEccccccccc
Confidence            999998876666888899999999999999999    678999999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.83  E-value=6.9e-21  Score=179.06  Aligned_cols=137  Identities=28%  Similarity=0.472  Sum_probs=112.7

Q ss_pred             hhhhccccccceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHh--hhhccCccceeecccCCCC---------cccc
Q 039957          338 ETISLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVL--RNVRHQNLIKILSSCSTPD---------FKFM  406 (481)
Q Consensus       338 ~~l~~~g~~g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l--~~l~h~niv~l~~~~~~~~---------~~~~  406 (481)
                      -.+.++|.||.||||.+. ++.||||++.....   +.|..|-++.  -.++|+||++++++-...+         .+|-
T Consensus       215 ~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~k---qs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh  290 (534)
T KOG3653|consen  215 LELIGRGRFGCVWKAQLD-NRLVAVKIFPEQEK---QSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFH  290 (534)
T ss_pred             HHHhhcCccceeehhhcc-CceeEEEecCHHHH---HHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeec
Confidence            345588999999999985 58999999865443   3455565544  4578999999998765543         3477


Q ss_pred             cCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcC-----CCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          407 PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHG-----HSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       407 ~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~-----~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      ++|+|.+++...  ..+|.+..+||..+|+||+|||++     +..++|+|||||++||||..|+++.|+|||+|..+.
T Consensus       291 ~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~  367 (534)
T KOG3653|consen  291 PKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLE  367 (534)
T ss_pred             cCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEec
Confidence            999999999864  589999999999999999999974     225689999999999999999999999999998764

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.83  E-value=1.2e-20  Score=183.87  Aligned_cols=135  Identities=28%  Similarity=0.488  Sum_probs=111.7

Q ss_pred             hccccccceeeeec------cCCcceEEEEEeccc-hhhhhhhhHHHHHhhhh-ccCccceeecccCCCC------cccc
Q 039957          341 SLAGSFGSVYKGTI------SDGTDVAIKIFNLQR-ERAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD------FKFM  406 (481)
Q Consensus       341 ~~~g~~g~vy~~~l------~~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~------~~~~  406 (481)
                      .+.|+||.||+|..      .++..||+|.+.... ......+..|+.++.++ +|+||++++++|...+      +||+
T Consensus        15 lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~   94 (338)
T cd05102          15 LGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFC   94 (338)
T ss_pred             eccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecC
Confidence            47899999999963      235689999886432 23345688899999999 8999999999887543      6799


Q ss_pred             cCCChhHHhhcCC-------------------------------------------------------------CccCHH
Q 039957          407 PNGSLEKRLYSHN-------------------------------------------------------------YFLDIL  425 (481)
Q Consensus       407 ~~g~l~~~l~~~~-------------------------------------------------------------~~~~~~  425 (481)
                      ++|+|.+++....                                                             ..+++.
T Consensus        95 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  174 (338)
T cd05102          95 KYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTME  174 (338)
T ss_pred             CCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCCCHH
Confidence            9999998876421                                                             236677


Q ss_pred             HHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          426 ERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       426 ~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +..+++.+|++||+|||    +.+|+||||||+|||+++++.+||+|||+|+.+
T Consensus       175 ~~~~~~~qi~~aL~~LH----~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~  224 (338)
T cd05102         175 DLICYSFQVARGMEFLA----SRKCIHRDLAARNILLSENNVVKICDFGLARDI  224 (338)
T ss_pred             HHHHHHHHHHHHHHHHH----HCCEECCCCccceEEEcCCCcEEEeeccccccc
Confidence            88899999999999999    678999999999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=99.83  E-value=1.2e-20  Score=180.68  Aligned_cols=137  Identities=31%  Similarity=0.472  Sum_probs=116.6

Q ss_pred             hhhhccccccceeeeecc-CCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCC
Q 039957          338 ETISLAGSFGSVYKGTIS-DGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNG  409 (481)
Q Consensus       338 ~~l~~~g~~g~vy~~~l~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g  409 (481)
                      -+..|.|.||.||||+-. +.+.||+|.+++..  .+..+...+||+++++++|||||..+++|....     .||+.+ 
T Consensus         7 ~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-   85 (808)
T KOG0597|consen    7 YEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-   85 (808)
T ss_pred             HHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-
Confidence            345689999999999865 47889999987643  334567889999999999999999999987764     467765 


Q ss_pred             ChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          410 SLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       410 ~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      +|..++.+. ..+.......||.+++.||.|||    +.+|.|||+||.|||++..|++|+||||+||.+.
T Consensus        86 ~L~~il~~d-~~lpEe~v~~~a~~LVsaL~yLh----s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~  151 (808)
T KOG0597|consen   86 DLFTILEQD-GKLPEEQVRAIAYDLVSALYYLH----SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMS  151 (808)
T ss_pred             hHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH----hcCcccccCCcceeeecCCCceeechhhhhhhcc
Confidence            999998754 45666788899999999999999    6889999999999999999999999999999764

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=99.83  E-value=1.9e-20  Score=179.00  Aligned_cols=134  Identities=24%  Similarity=0.349  Sum_probs=112.4

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccch---hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQRE---RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      .+.|+||.||.+.- .+|..+|+|++..+..   ........|-++|....+++||+++..|.+.+     +||+|||++
T Consensus       149 IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~  228 (550)
T KOG0605|consen  149 IGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDM  228 (550)
T ss_pred             eccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccH
Confidence            47899999999975 4689999999987642   34567888999999999999999999998886     689999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ...+...+. ++......++.+.+-|++.+|    ..|+|||||||+|+|+|..|++|++|||||+-+
T Consensus       229 mTLL~~~~~-L~e~~arfYiaE~vlAI~~iH----~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl  291 (550)
T KOG0605|consen  229 MTLLMRKDT-LTEDWARFYIAETVLAIESIH----QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL  291 (550)
T ss_pred             HHHHHhcCc-CchHHHHHHHHHHHHHHHHHH----HcCcccccCChhheeecCCCCEeeccccccchh
Confidence            999876443 333334446667788999999    688999999999999999999999999999654

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.83  E-value=4.5e-20  Score=175.29  Aligned_cols=135  Identities=30%  Similarity=0.499  Sum_probs=116.6

Q ss_pred             hccccccceeeeec-----cCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-------cccccC
Q 039957          341 SLAGSFGSVYKGTI-----SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-------FKFMPN  408 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-----~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-------~~~~~~  408 (481)
                      .++|+||.||++..     .++..+++|.+........+.+..|++++++++|+|++++.+++...+       ++|+++
T Consensus        12 lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~   91 (284)
T cd05081          12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPY   91 (284)
T ss_pred             ccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCC
Confidence            47899999999874     247789999987655555667889999999999999999999775432       578999


Q ss_pred             CChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          409 GSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       409 g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      |+|.+++......++|..+..++.++++||+|||    ..+|+||||||+||++++++.+||+|||+++.+
T Consensus        92 ~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH----~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          92 GSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG----SKRYVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             CCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH----HCCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            9999998765556889999999999999999999    678999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=99.82  E-value=1.1e-20  Score=174.26  Aligned_cols=134  Identities=27%  Similarity=0.450  Sum_probs=117.0

Q ss_pred             ccccccceeeeec-cCCcceEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          342 LAGSFGSVYKGTI-SDGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       342 ~~g~~g~vy~~~l-~~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      ++|.||.|-++.- ..|+.||||.+....   .+..-.+.+|+++++.++||||+.++..|...+     +||..+|.|+
T Consensus        62 GkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLY  141 (668)
T KOG0611|consen   62 GKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELY  141 (668)
T ss_pred             cCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCccHH
Confidence            7899999999874 679999999886543   344556889999999999999999999998775     8999999999


Q ss_pred             HHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          413 KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       413 ~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      +++...+ .++..+...+..||..|+.|.|    ..++||||+|-+|||+|+++.+||+|||++-++.
T Consensus       142 DYiSer~-~LsErEaRhfFRQIvSAVhYCH----knrVvHRDLKLENILLD~N~NiKIADFGLSNly~  204 (668)
T KOG0611|consen  142 DYISERG-SLSEREARHFFRQIVSAVHYCH----KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA  204 (668)
T ss_pred             HHHHHhc-cccHHHHHHHHHHHHHHHHHHh----hccceecccchhheeecCCCCeeeeccchhhhhc
Confidence            9997543 5666778889999999999999    5789999999999999999999999999987654

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.82  E-value=1.7e-20  Score=195.66  Aligned_cols=134  Identities=31%  Similarity=0.541  Sum_probs=117.7

Q ss_pred             hccccccceeeeeccC--Cc----ceEEEEEecc-chhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccC
Q 039957          341 SLAGSFGSVYKGTISD--GT----DVAIKIFNLQ-RERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPN  408 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~--g~----~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~  408 (481)
                      .+.|.||.||+|+..+  |.    .||+|.+... +.+...+|..|..++++++|||||+++|.|.+..     .|||.+
T Consensus       700 lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~g  779 (1025)
T KOG1095|consen  700 LGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEG  779 (1025)
T ss_pred             eccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhccc
Confidence            3789999999999754  43    3788877543 3556678999999999999999999999998764     689999


Q ss_pred             CChhHHhhcC------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          409 GSLEKRLYSH------NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       409 g~l~~~l~~~------~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      |+|.+++++.      ...+...+-+.+|.+||+|+.||+    +...|||||.++|+||++...|||+|||+||.
T Consensus       780 GDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe----~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArD  851 (1025)
T KOG1095|consen  780 GDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE----SKHFVHRDLAARNCLLDERRVVKIADFGLARD  851 (1025)
T ss_pred             CcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH----hCCCcCcchhhhheeecccCcEEEcccchhHh
Confidence            9999999986      566888899999999999999999    67799999999999999999999999999994

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.82  E-value=4.6e-20  Score=177.07  Aligned_cols=135  Identities=30%  Similarity=0.500  Sum_probs=111.9

Q ss_pred             hccccccceeeeeccC-----------------CcceEEEEEeccch-hhhhhhhHHHHHhhhhccCccceeecccCCCC
Q 039957          341 SLAGSFGSVYKGTISD-----------------GTDVAIKIFNLQRE-RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD  402 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~-----------------g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  402 (481)
                      .++|+||.||++...+                 +..||+|.+..... .....+.+|++++.+++|+||++++++|...+
T Consensus        13 lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   92 (304)
T cd05096          13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDED   92 (304)
T ss_pred             ecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEecCC
Confidence            4789999999986432                 34689998865432 23456889999999999999999999987654


Q ss_pred             -----cccccCCChhHHhhcCC------------------CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCC
Q 039957          403 -----FKFMPNGSLEKRLYSHN------------------YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTS  459 (481)
Q Consensus       403 -----~~~~~~g~l~~~l~~~~------------------~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~n  459 (481)
                           +||+++|+|.+++....                  ..++|....+++.+|++|++|||    +.+|+||||||+|
T Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH----~~~ivH~dlkp~N  168 (304)
T cd05096          93 PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS----SLNFVHRDLATRN  168 (304)
T ss_pred             ceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH----HCCccccCcchhh
Confidence                 67999999998875421                  24678889999999999999999    6789999999999


Q ss_pred             eeeCCCCcEEEccccCcccC
Q 039957          460 ILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       460 ill~~~~~~kl~Dfgl~~~~  479 (481)
                      ||+++++.+||+|||+++.+
T Consensus       169 ill~~~~~~kl~DfG~~~~~  188 (304)
T cd05096         169 CLVGENLTIKIADFGMSRNL  188 (304)
T ss_pred             eEEcCCccEEECCCccceec
Confidence            99999999999999998754

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.82  E-value=9.6e-20  Score=179.78  Aligned_cols=136  Identities=26%  Similarity=0.416  Sum_probs=112.7

Q ss_pred             hhccccccceeeeec------cCCcceEEEEEeccc-hhhhhhhhHHHHHhhhh-ccCccceeecccCCCC-----cccc
Q 039957          340 ISLAGSFGSVYKGTI------SDGTDVAIKIFNLQR-ERAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD-----FKFM  406 (481)
Q Consensus       340 l~~~g~~g~vy~~~l------~~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----~~~~  406 (481)
                      ..++|+||.||+++.      ..+..||||.+.... ....+.+.+|++++..+ +||||++++++|...+     +||+
T Consensus        42 ~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~  121 (375)
T cd05104          42 TLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYC  121 (375)
T ss_pred             eecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhc
Confidence            347899999999863      235679999886433 23345678899999999 8999999999998765     6799


Q ss_pred             cCCChhHHhhcCC-------------------------------------------------------------------
Q 039957          407 PNGSLEKRLYSHN-------------------------------------------------------------------  419 (481)
Q Consensus       407 ~~g~l~~~l~~~~-------------------------------------------------------------------  419 (481)
                      ++|+|.+++....                                                                   
T Consensus       122 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  201 (375)
T cd05104         122 CYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTS  201 (375)
T ss_pred             cCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccccHH
Confidence            9999998875321                                                                   


Q ss_pred             -------CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          420 -------YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       420 -------~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                             ..++|....+++.+|++|++|||    +.+|+||||||+||++++++.+||+|||+++.+
T Consensus       202 ~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~  264 (375)
T cd05104         202 EILEEDELALDTEDLLSFSYQVAKGMSFLA----SKNCIHRDLAARNILLTHGRITKICDFGLARDI  264 (375)
T ss_pred             HHHhccCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCchhhEEEECCCcEEEecCccceec
Confidence                   24678889999999999999999    678999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.82  E-value=8.9e-21  Score=163.52  Aligned_cols=132  Identities=25%  Similarity=0.395  Sum_probs=112.7

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      +.|.||.||.|... .+..||+|.+..++   .+....+.+||++-+.++||||+++++++.+..     .||.++|+++
T Consensus        31 gkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~gel~  110 (281)
T KOG0580|consen   31 GKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELY  110 (281)
T ss_pred             cCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCCchHH
Confidence            57999999999864 56889999987654   233457889999999999999999999998875     6899999999


Q ss_pred             HHhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcc
Q 039957          413 KRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK  477 (481)
Q Consensus       413 ~~l~~~~-~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~  477 (481)
                      ..+.+.. ...+-.....++.++|.|+.|.|    .+.|+||||||+|+|++.++..|++|||.+-
T Consensus       111 k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h----~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV  172 (281)
T KOG0580|consen  111 KDLQEGRMKRFDEQRAATYIKQLANALLYCH----LKRVIHRDIKPENLLLGSAGELKIADFGWSV  172 (281)
T ss_pred             HHHHhcccccccccchhHHHHHHHHHHHHhc----cCCcccCCCCHHHhccCCCCCeeccCCCcee
Confidence            9988533 33555667788999999999999    6889999999999999999999999999864

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.82  E-value=5.8e-20  Score=177.82  Aligned_cols=132  Identities=27%  Similarity=0.338  Sum_probs=112.8

Q ss_pred             ccccccceeeeec-cCCcceEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          342 LAGSFGSVYKGTI-SDGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       342 ~~g~~g~vy~~~l-~~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      +.|+||.||++.. .+|..+|+|.+....   ......+..|+.++++++|+||+++.+++...+     +||+++|+|.
T Consensus         4 G~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~   83 (323)
T cd05571           4 GKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELF   83 (323)
T ss_pred             eeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHH
Confidence            6799999999975 468899999987542   223345678999999999999999998887665     6799999999


Q ss_pred             HHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          413 KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       413 ~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      +++... ..+++.+...++.+|++||+|||    +.+|+||||||+||+++.++.+||+|||+|+.
T Consensus        84 ~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH----~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~  144 (323)
T cd05571          84 FHLSRE-RVFSEDRARFYGAEIVSALGYLH----SCDVVYRDLKLENLMLDKDGHIKITDFGLCKE  144 (323)
T ss_pred             HHHHHc-CCCCHHHHHHHHHHHHHHHHHHH----hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcc
Confidence            888653 35678888899999999999999    67899999999999999999999999999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PHA02988 hypothetical protein; Provisional

Probab=99.81  E-value=6.1e-20  Score=174.15  Aligned_cols=133  Identities=23%  Similarity=0.291  Sum_probs=113.4

Q ss_pred             ccccccceeeeeccCCcceEEEEEeccchh---hhhhhhHHHHHhhhhccCccceeecccCC--C-------CcccccCC
Q 039957          342 LAGSFGSVYKGTISDGTDVAIKIFNLQRER---AFRSFNSECEVLRNVRHQNLIKILSSCST--P-------DFKFMPNG  409 (481)
Q Consensus       342 ~~g~~g~vy~~~l~~g~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~-------~~~~~~~g  409 (481)
                      ..|+++.||+|.. +|..||+|.+......   ..+.+.+|+.++.+++|+||++++|++.+  .       .+||+++|
T Consensus        29 ~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g  107 (283)
T PHA02988         29 KENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRG  107 (283)
T ss_pred             eeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCC
Confidence            5789999999987 6889999998654322   24667899999999999999999998865  2       16799999


Q ss_pred             ChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          410 SLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       410 ~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +|.+++... ..++|..+.+++.+++.|++|+|.   ..+++||||||+||++++++.+||+|||+++.+
T Consensus       108 ~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~  173 (283)
T PHA02988        108 YLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYK---YTNKPYKNLTSVSFLVTENYKLKIICHGLEKIL  173 (283)
T ss_pred             cHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHh---cCCCCCCcCChhhEEECCCCcEEEcccchHhhh
Confidence            999998754 357889999999999999999994   246889999999999999999999999998753

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.81  E-value=7.6e-20  Score=176.15  Aligned_cols=132  Identities=27%  Similarity=0.322  Sum_probs=112.8

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      +.|+||.||++... ++..+|+|.+....   ......+..|+.++.+++|+||+++.+++...+     ++|+++|+|.
T Consensus         2 g~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~   81 (312)
T cd05585           2 GKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELF   81 (312)
T ss_pred             CcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHH
Confidence            57999999999865 57889999886532   223445778999999999999999998887665     6789999999


Q ss_pred             HHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          413 KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       413 ~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      +++... ..+++..+..++.++++||+|||    +.+|+||||||+||+++.++.+||+|||+++.
T Consensus        82 ~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH----~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~  142 (312)
T cd05585          82 HHLQRE-GRFDLSRARFYTAELLCALENLH----KFNVIYRDLKPENILLDYQGHIALCDFGLCKL  142 (312)
T ss_pred             HHHHhc-CCCCHHHHHHHHHHHHHHHHHHH----hCCeEeCCCCHHHeEECCCCcEEEEECccccc
Confidence            988653 35778888999999999999999    67899999999999999999999999999875

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.81  E-value=6e-20  Score=185.84  Aligned_cols=134  Identities=26%  Similarity=0.407  Sum_probs=115.3

Q ss_pred             ccccccceeeeeccCC-cceEEEEEeccchhhhhhhhHHHHHhhhhc-cCccceeeccc-CCC---C--------ccccc
Q 039957          342 LAGSFGSVYKGTISDG-TDVAIKIFNLQRERAFRSFNSECEVLRNVR-HQNLIKILSSC-STP---D--------FKFMP  407 (481)
Q Consensus       342 ~~g~~g~vy~~~l~~g-~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~-~~~---~--------~~~~~  407 (481)
                      -+|+|+.||.+....+ ..+|+|++-..++...+...+|++++++++ |+|||.+++.. ...   .        +|||+
T Consensus        46 AEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~  125 (738)
T KOG1989|consen   46 AEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCK  125 (738)
T ss_pred             ccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhcc
Confidence            4799999999987655 999999987777778888999999999998 99999999832 111   1        57999


Q ss_pred             CCChhHHhhc-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcc
Q 039957          408 NGSLEKRLYS-HNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK  477 (481)
Q Consensus       408 ~g~l~~~l~~-~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~  477 (481)
                      +|.|-+++.. ....++..+.++|++++++|+++||..  .++|+|||||.+|||++.++.-||||||=|.
T Consensus       126 gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~--~pPiIHRDLKiENvLls~~g~~KLCDFGSat  194 (738)
T KOG1989|consen  126 GGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL--KPPIIHRDLKIENVLLSADGNYKLCDFGSAT  194 (738)
T ss_pred             CCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC--CCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence            9999998874 223488899999999999999999963  6899999999999999999999999999764

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.81  E-value=4.6e-20  Score=172.74  Aligned_cols=136  Identities=38%  Similarity=0.622  Sum_probs=114.6

Q ss_pred             hhccccccceeeeecc-----CCcceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccC
Q 039957          340 ISLAGSFGSVYKGTIS-----DGTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPN  408 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~-----~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~  408 (481)
                      ..+.|.||.||+|.+.     .+..|+||.+.... ......+.+|++.+++++|+||++++|+|...+     +||+++
T Consensus         6 ~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~   85 (259)
T PF07714_consen    6 QIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPG   85 (259)
T ss_dssp             EEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TT
T ss_pred             EEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccccc
Confidence            3478999999999876     24678999986533 334678899999999999999999999998543     689999


Q ss_pred             CChhHHhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          409 GSLEKRLYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       409 g~l~~~l~~~-~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      |+|.+++... ...+++..+.+|+.+||+||+|||    +.+|+|+||+++||++++++.+||+|||+++..
T Consensus        86 g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh----~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~  153 (259)
T PF07714_consen   86 GSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH----SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPI  153 (259)
T ss_dssp             EBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH----HTTEEEST-SGGGEEEETTTEEEEESTTTGEET
T ss_pred             ccccccccccccccccccccccccccccccccccc----ccccccccccccccccccccccccccccccccc
Confidence            9999999876 567899999999999999999999    567999999999999999999999999998765

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.81  E-value=1e-19  Score=172.92  Aligned_cols=135  Identities=25%  Similarity=0.336  Sum_probs=114.0

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccch---hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQRE---RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      .++|+||.||++.. .+|..+|+|.+.....   .....+.+|+.++++++|++++++.+++...+     ++|+++|+|
T Consensus         8 lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L   87 (285)
T cd05631           8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDL   87 (285)
T ss_pred             EecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcH
Confidence            37899999999985 4689999998865432   22335678999999999999999998887665     578999999


Q ss_pred             hHHhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          412 EKRLYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~-~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ..++... ...+++..+..++.+++.|++|||    +.+|+||||||+|||+++++.+||+|||+++.+
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~  152 (285)
T cd05631          88 KFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ----RERIVYRDLKPENILLDDRGHIRISDLGLAVQI  152 (285)
T ss_pred             HHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH----hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEc
Confidence            8877542 335788899999999999999999    688999999999999999999999999998764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.81  E-value=7.2e-20  Score=177.12  Aligned_cols=132  Identities=27%  Similarity=0.343  Sum_probs=112.6

Q ss_pred             ccccccceeeeec-cCCcceEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          342 LAGSFGSVYKGTI-SDGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       342 ~~g~~g~vy~~~l-~~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      +.|+||.||++.. .+|..+|+|.+....   ......+..|+.++.+++||||+++.+++...+     +||+++|+|.
T Consensus         4 G~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~   83 (323)
T cd05595           4 GKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELF   83 (323)
T ss_pred             eeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHH
Confidence            6799999999985 468899999987542   223345677999999999999999998887665     6799999998


Q ss_pred             HHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          413 KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       413 ~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      .++... ..+++.....++.+++.||+|||    +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        84 ~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~  144 (323)
T cd05595          84 FHLSRE-RVFTEERARFYGAEIVSALEYLH----SRDVVYRDIKLENLMLDKDGHIKITDFGLCKE  144 (323)
T ss_pred             HHHHHc-CCCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHEEEcCCCCEEecccHHhcc
Confidence            887643 35778889999999999999999    67899999999999999999999999999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.81  E-value=1.3e-21  Score=189.26  Aligned_cols=281  Identities=23%  Similarity=0.255  Sum_probs=155.8

Q ss_pred             eeeCcCCccc-ccCChhccCCcCCCEEEeeCCcCcc----ccChhhhcCCCCccEEEccCcccee------ecchhcccc
Q 039957           17 SLFLGANNLS-GLIPPMIFNISTIRNLNLGGNRLSG----HLPSMIGHSLPNIKYLELGDNNLIG------TIPNSITNA   85 (481)
Q Consensus        17 ~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~~l~~L~~L~L~~N~l~~------~~p~~~~~l   85 (481)
                      .|+|..++++ ...+..|..+.+|++|++++|.++.    .++..+. ..++|++|+++++.+.+      .++..+..+
T Consensus         2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~-~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~   80 (319)
T cd00116           2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALR-PQPSLKELCLSLNETGRIPRGLQSLLQGLTKG   80 (319)
T ss_pred             ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHh-hCCCceEEeccccccCCcchHHHHHHHHHHhc
Confidence            5778888886 4445566777788888888888853    2444443 56778888888887752      234556677


Q ss_pred             ccCceeecccCcceecCcccccCCCC---CCEEEcccccCccccCCCccccccccCCCC-CCCcEEEccCCccceeCCh-
Q 039957           86 TKLIILDLGFNTFSGHIPNTFGNLRH---LSVLSLLMNNLTTESSSAYQWSFLSSLTNC-RYLVYLILSGNPLGGILPP-  160 (481)
Q Consensus        86 ~~L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l-~~L~~L~Ls~N~l~~~~p~-  160 (481)
                      ++|+.|++++|.+.+..+..|..+.+   |++|++++|.++.....    .....+..+ ++|+.|++++|.+++.... 
T Consensus        81 ~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~----~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~  156 (319)
T cd00116          81 CGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLR----LLAKGLKDLPPALEKLVLGRNRLEGASCEA  156 (319)
T ss_pred             CceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHH----HHHHHHHhCCCCceEEEcCCCcCCchHHHH
Confidence            78888888888887666666665555   88888887776632110    011223344 6677777777777642221 


Q ss_pred             ---hhhhcccCccEEEccCCceeec----CCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCc
Q 039957          161 ---SIGNFSTSLQRFSASECKLKGT----IPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPH  233 (481)
Q Consensus       161 ---~~~~~~~~L~~L~l~~n~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~  233 (481)
                         .+... ..|++|++++|.+++.    ++..+..+++|++|++++|.+++....                    .++.
T Consensus       157 ~~~~~~~~-~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~--------------------~l~~  215 (319)
T cd00116         157 LAKALRAN-RDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGAS--------------------ALAE  215 (319)
T ss_pred             HHHHHHhC-CCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHH--------------------HHHH
Confidence               12221 3466666666665521    222233344566666666555421110                    1112


Q ss_pred             cccCccCCCeeecCCCeeeecCCcccc-----cCCCCCcEEcCCCcCcc----cCCcchhccccCcEEEccCcccCCC--
Q 039957          234 NLCHLEMLNLLHLGGNKLSGHIPPCLA-----SLTSLRELDLGSNKLTS----SIPSSLWSLGYILEINLSSNLLNDS--  302 (481)
Q Consensus       234 ~~~~l~~L~~L~L~~N~l~~~~p~~~~-----~l~~L~~L~ls~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~--  302 (481)
                      .+..+++|+.|++++|.+++.....+.     ..+.|+.|++++|.++.    .+...+..++.|+++++++|.+...  
T Consensus       216 ~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~  295 (319)
T cd00116         216 TLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGA  295 (319)
T ss_pred             HhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHH
Confidence            233344555555555555432111111     12566666666666641    1223334445666666666666543  


Q ss_pred             --CCCccccC-CcCcEEEccCCee
Q 039957          303 --LPSNVQKL-KVLRVLDLSRNQL  323 (481)
Q Consensus       303 --~p~~~~~l-~~L~~L~l~~N~l  323 (481)
                        ....+... +.++++|+.+|++
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~  319 (319)
T cd00116         296 QLLAESLLEPGNELESLWVKDDSF  319 (319)
T ss_pred             HHHHHHHhhcCCchhhcccCCCCC
Confidence              22222223 5677777777653

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.81  E-value=9.4e-20  Score=176.67  Aligned_cols=132  Identities=28%  Similarity=0.363  Sum_probs=112.9

Q ss_pred             ccccccceeeeec-cCCcceEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          342 LAGSFGSVYKGTI-SDGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       342 ~~g~~g~vy~~~l-~~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      +.|+||.||++.. .+|..+|+|.+....   ......+..|++++++++|+||+++.+++...+     +||+++|+|.
T Consensus         4 G~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~   83 (328)
T cd05593           4 GKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELF   83 (328)
T ss_pred             eeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHH
Confidence            6799999999975 468899999986542   223456778999999999999999998887665     6799999999


Q ss_pred             HHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          413 KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       413 ~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      .++... ..+++.+...++.+|+.||+|||    +.+|+||||||+|||+++++.+||+|||+++.
T Consensus        84 ~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH----~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~  144 (328)
T cd05593          84 FHLSRE-RVFSEDRTRFYGAEIVSALDYLH----SGKIVYRDLKLENLMLDKDGHIKITDFGLCKE  144 (328)
T ss_pred             HHHHhc-CCCCHHHHHHHHHHHHHHHHHHH----hCCeEecccCHHHeEECCCCcEEEecCcCCcc
Confidence            887643 35788889999999999999999    67899999999999999999999999999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.81  E-value=1.7e-19  Score=168.64  Aligned_cols=134  Identities=27%  Similarity=0.490  Sum_probs=114.0

Q ss_pred             ccccccceeeeecc---CCcceEEEEEeccchh-hhhhhhHHHHHhhhhccCccceeecccCCCC----cccccCCChhH
Q 039957          342 LAGSFGSVYKGTIS---DGTDVAIKIFNLQRER-AFRSFNSECEVLRNVRHQNLIKILSSCSTPD----FKFMPNGSLEK  413 (481)
Q Consensus       342 ~~g~~g~vy~~~l~---~g~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~~~~g~l~~  413 (481)
                      +.|+||.||+|...   .+..+|+|.+...... ..+.+.+|+.++++++|+|++++++.|....    +||+++|+|.+
T Consensus         4 g~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~~~~L~~   83 (257)
T cd05115           4 GSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPLNK   83 (257)
T ss_pred             CCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCCCCCHHH
Confidence            57999999998753   3456899988654332 3456889999999999999999999886543    57899999999


Q ss_pred             HhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          414 RLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       414 ~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ++......+++..+.+++.++++|++|+|    +.+|+||||||+||+++.++.+|++|||+++.+
T Consensus        84 ~l~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~  145 (257)
T cd05115          84 FLSGKKDEITVSNVVELMHQVSMGMKYLE----GKNFVHRDLAARNVLLVNQHYAKISDFGLSKAL  145 (257)
T ss_pred             HHHhCCCCCCHHHHHHHHHHHHHHHHHHH----hcCeeecccchheEEEcCCCcEEeccCCccccc
Confidence            98765567889999999999999999999    578999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.81  E-value=1.1e-19  Score=172.94  Aligned_cols=133  Identities=26%  Similarity=0.443  Sum_probs=112.0

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccch-hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHH
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQRE-RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKR  414 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~  414 (481)
                      +.|+||.||+|... ++..||+|.+..... .....+.+|++++++++|+||+++++++....     +||++ |++.++
T Consensus        14 g~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~   92 (288)
T cd07871          14 GEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD-SDLKQY   92 (288)
T ss_pred             ecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC-cCHHHH
Confidence            68999999999854 678999998865432 22345678999999999999999999887664     56776 589888


Q ss_pred             hhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          415 LYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       415 l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +.......++.....++.+|++||+|||    +.+|+||||||+||++++++.+||+|||+++..
T Consensus        93 l~~~~~~~~~~~~~~~~~qi~~aL~~LH----~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~  153 (288)
T cd07871          93 LDNCGNLMSMHNVKIFMFQLLRGLSYCH----KRKILHRDLKPQNLLINEKGELKLADFGLARAK  153 (288)
T ss_pred             HHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEECCCCCEEECcCcceeec
Confidence            8765556778888999999999999999    678999999999999999999999999998753

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.81  E-value=1.1e-19  Score=178.89  Aligned_cols=134  Identities=24%  Similarity=0.335  Sum_probs=114.2

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      .+.|+||.||++... +|..+|+|.+....   ......+..|+.++.+++|++|+++++.+....     +||+++|+|
T Consensus         9 LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L   88 (363)
T cd05628           9 IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDM   88 (363)
T ss_pred             EEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcH
Confidence            378999999999754 58899999986542   223346778999999999999999999887764     679999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+++... ..+++.....++.+++.||+|||    +.+|+||||||+|||+++++++||+|||+|+.+
T Consensus        89 ~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH----~~givHrDlKp~NILi~~~~~vkL~DFGla~~~  151 (363)
T cd05628          89 MTLLMKK-DTLTEEETQFYIAETVLAIDSIH----QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGL  151 (363)
T ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH----hCCeEecCCCHHHeEECCCCCEEEeeccCcccc
Confidence            9998753 35778888999999999999999    678999999999999999999999999999754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.81  E-value=8.7e-20  Score=173.94  Aligned_cols=134  Identities=28%  Similarity=0.385  Sum_probs=114.3

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccch---hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRE---RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      .+.|+||.||++... +|..+|+|.+.....   ...+.+.+|+.++++++||||+++++++.+.+     ++|+++|+|
T Consensus         9 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L   88 (291)
T cd05612           9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGEL   88 (291)
T ss_pred             eecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCH
Confidence            368999999999865 588999999865432   23456788999999999999999998887664     678999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+++... ..+++.....++.++++|++|||    +.+|+||||||+||++++++.+||+|||+++.+
T Consensus        89 ~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~  151 (291)
T cd05612          89 FSYLRNS-GRFSNSTGLFYASEIVCALEYLH----SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL  151 (291)
T ss_pred             HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCHHHeEECCCCCEEEEecCcchhc
Confidence            9988754 35677888899999999999999    678999999999999999999999999998764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.81  E-value=1e-19  Score=177.08  Aligned_cols=133  Identities=26%  Similarity=0.355  Sum_probs=113.1

Q ss_pred             ccccccceeeeeccC--CcceEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          342 LAGSFGSVYKGTISD--GTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       342 ~~g~~g~vy~~~l~~--g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      +.|+||.||+|....  +..+|+|.+....   ......+..|+.+++.++||||+++++++...+     +||+++|+|
T Consensus        39 g~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L  118 (340)
T PTZ00426         39 GTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEF  118 (340)
T ss_pred             eecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcH
Confidence            789999999997543  3679999886532   223456778999999999999999999987765     678999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+++... ..+++..+..++.+++.||+|||    +.+|+||||||+|||++.++++||+|||+|+.+
T Consensus       119 ~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~  181 (340)
T PTZ00426        119 FTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQ----SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV  181 (340)
T ss_pred             HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH----HCCeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence            9988753 35678888899999999999999    678999999999999999999999999999764

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.81  E-value=1e-19  Score=170.12  Aligned_cols=140  Identities=29%  Similarity=0.417  Sum_probs=116.4

Q ss_pred             Chhhhhccccccceeeee-ccCCcceEEEEEeccchhh-hhhhhHHHHHhhhhccCccceeecccCCCC-----cccccC
Q 039957          336 DLETISLAGSFGSVYKGT-ISDGTDVAIKIFNLQRERA-FRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPN  408 (481)
Q Consensus       336 ~L~~l~~~g~~g~vy~~~-l~~g~~vavK~l~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~  408 (481)
                      .|....+.|.-++||+|. .+.+..||||+++.+++.. .....+|+..++.++||||+++...|....     +.||.+
T Consensus        29 eL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~  108 (516)
T KOG0582|consen   29 ELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAG  108 (516)
T ss_pred             eEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcC
Confidence            344455778889999997 5778999999999887654 477889999999999999999988876654     569999


Q ss_pred             CChhHHhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          409 GSLEKRLYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       409 g~l~~~l~~~-~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      |++.+.+... ...++......|..++.+||.|||    .+|.|||||||.|||+|++|.+||+|||..-.+
T Consensus       109 GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH----~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l  176 (516)
T KOG0582|consen  109 GSLLDIIKTYYPDGLEEASIATILREVLKALDYLH----QNGHIHRDVKAGNILIDSDGTVKLADFGVSASL  176 (516)
T ss_pred             CcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH----hcCceecccccccEEEcCCCcEEEcCceeeeee
Confidence            9999988652 122555666778899999999999    578999999999999999999999999986544

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.81  E-value=1.2e-19  Score=179.65  Aligned_cols=134  Identities=20%  Similarity=0.334  Sum_probs=113.5

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      .++|+||.||+|.. .++..+|+|.+....   ......+..|++++.+++|+||+++++++...+     +||+++|+|
T Consensus         9 LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L   88 (381)
T cd05626           9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDM   88 (381)
T ss_pred             EeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcH
Confidence            37899999999975 467899999986543   223456788999999999999999999988765     679999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+++.... .+++.....++.+++.||+|||    ..+|+||||||+|||++.++++||+|||+++.+
T Consensus        89 ~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH----~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~  151 (381)
T cd05626          89 MSLLIRME-VFPEVLARFYIAELTLAIESVH----KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGF  151 (381)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence            99887543 4566777788999999999999    678999999999999999999999999998643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.81  E-value=1.2e-19  Score=176.06  Aligned_cols=134  Identities=27%  Similarity=0.354  Sum_probs=113.9

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      .+.|+||.||++... +|..+|+|.+....   ....+.+.+|+.++.+++|+||+++++++...+     +||+++|+|
T Consensus        26 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L  105 (329)
T PTZ00263         26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGEL  105 (329)
T ss_pred             EEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChH
Confidence            378999999999865 57889999986542   223456788999999999999999999887765     578999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+++... ..++......++.++++||+|||    +.+|+||||||+|||+++++.+||+|||+++..
T Consensus       106 ~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH----~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  168 (329)
T PTZ00263        106 FTHLRKA-GRFPNDVAKFYHAELVLAFEYLH----SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV  168 (329)
T ss_pred             HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCHHHEEECCCCCEEEeeccCceEc
Confidence            9988754 34567777889999999999999    678999999999999999999999999998764

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.80  E-value=2.4e-19  Score=167.56  Aligned_cols=133  Identities=30%  Similarity=0.430  Sum_probs=115.2

Q ss_pred             ccccccceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHHhh
Q 039957          342 LAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRLY  416 (481)
Q Consensus       342 ~~g~~g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~l~  416 (481)
                      +.|+||.||++...++..+++|.+.... .....+..|++++++++|+|+++++++|...+     ++|+++|+|.+++.
T Consensus        13 g~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~   91 (256)
T cd05114          13 GSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLR   91 (256)
T ss_pred             cCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHH
Confidence            6899999999988777789999875432 22356788999999999999999999987664     67899999999987


Q ss_pred             cCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          417 SHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       417 ~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .....++|..+.+++.+++.|++|||    +.+|+|||+||+||++++++.+|++|||.++..
T Consensus        92 ~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~  150 (256)
T cd05114          92 QRQGKLSKDMLLSMCQDVCEGMEYLE----RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYV  150 (256)
T ss_pred             hCccCCCHHHHHHHHHHHHHHHHHHH----HCCccccccCcceEEEcCCCeEEECCCCCcccc
Confidence            65456789999999999999999999    578999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.80  E-value=3e-19  Score=166.96  Aligned_cols=134  Identities=30%  Similarity=0.461  Sum_probs=115.3

Q ss_pred             hccccccceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHHh
Q 039957          341 SLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRL  415 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~l  415 (481)
                      .+.|++|.||.+...++..+|+|.+.... .....+.+|++.+.+++||||++++++|...+     +||+++|++.+++
T Consensus        12 lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i   90 (256)
T cd05113          12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYL   90 (256)
T ss_pred             ecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHH
Confidence            36799999999987666679999876432 22356888999999999999999999987654     5788999999998


Q ss_pred             hcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          416 YSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       416 ~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ......+++.++++++.+|+.|++|||    +.+|+||||||+||++++++.+||+|||.++..
T Consensus        91 ~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~  150 (256)
T cd05113          91 REHGKRFQPSQLLEMCKDVCEGMAYLE----SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYV  150 (256)
T ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccccCcceEEEcCCCCEEECCCccceec
Confidence            765456789999999999999999999    678999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.80  E-value=2.2e-19  Score=168.86  Aligned_cols=135  Identities=22%  Similarity=0.371  Sum_probs=114.9

Q ss_pred             hhccccccceeeeecc----CCcceEEEEEeccch-hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCC
Q 039957          340 ISLAGSFGSVYKGTIS----DGTDVAIKIFNLQRE-RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNG  409 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~----~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g  409 (481)
                      ..++|+||.||+|...    .+..+|+|.+..... .....+.+|+..+.+++|+|++++.+++...+     +||+++|
T Consensus        12 ~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   91 (266)
T cd05064          12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNG   91 (266)
T ss_pred             eecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCC
Confidence            3478999999999753    356789998865432 23356888999999999999999999987764     6799999


Q ss_pred             ChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          410 SLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       410 ~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      +|.+++......+++.++++++.+++.|++|||    +.+++||||||+||+++.++.+|++|||.+..
T Consensus        92 ~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH----~~~iiH~dikp~nili~~~~~~~l~dfg~~~~  156 (266)
T cd05064          92 ALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS----EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQE  156 (266)
T ss_pred             cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----HCCEeeccccHhhEEEcCCCcEEECCCccccc
Confidence            999998765556889999999999999999999    67899999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.80  E-value=9.6e-20  Score=159.89  Aligned_cols=135  Identities=33%  Similarity=0.455  Sum_probs=108.7

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccch--------hhhhhhhHHHHHhhhh-ccCccceeecccCCCC-----ccc
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQRE--------RAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD-----FKF  405 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~--------~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----~~~  405 (481)
                      -+.|...+|.+... +.|...|+|++.....        ...+.-.+|+.+|+++ .||+|+++.+.+.+..     |+.
T Consensus        25 lgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl  104 (411)
T KOG0599|consen   25 LGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDL  104 (411)
T ss_pred             hcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhh
Confidence            35566666666654 4578889998865321        1223456789999997 5999999999998875     457


Q ss_pred             ccCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          406 MPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       406 ~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      |+.|.|.+++.+. ..++..+..+|+.++-+|++|||    ...|||||+||+|||+|+++.+||+|||+|+.+.
T Consensus       105 ~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylH----a~~IVHRDLKpENILlddn~~i~isDFGFa~~l~  174 (411)
T KOG0599|consen  105 MPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLH----ARNIVHRDLKPENILLDDNMNIKISDFGFACQLE  174 (411)
T ss_pred             cccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHH----HhhhhhcccChhheeeccccceEEeccceeeccC
Confidence            8999999999754 34666777899999999999999    6789999999999999999999999999998775

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.80  E-value=1.5e-19  Score=170.68  Aligned_cols=134  Identities=19%  Similarity=0.305  Sum_probs=110.2

Q ss_pred             hccccccceeeeeccC-------------------------CcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceee
Q 039957          341 SLAGSFGSVYKGTISD-------------------------GTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKIL  395 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~-------------------------g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~  395 (481)
                      .+.|+||.||+|.+..                         ...|++|.+..........+..|+.++++++|+||++++
T Consensus         3 lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~~   82 (274)
T cd05076           3 LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVH   82 (274)
T ss_pred             cCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeEE
Confidence            4689999999997521                         134778877655444455678888999999999999999


Q ss_pred             cccCCCC-----cccccCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCC----
Q 039957          396 SSCSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENM----  466 (481)
Q Consensus       396 ~~~~~~~-----~~~~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~----  466 (481)
                      ++|....     +||+++|+|..++......+++..+++++.+|++||+|||    +.+|+||||||+||++++.+    
T Consensus        83 ~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          83 GVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE----DKNLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             EEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----cCCccCCCCCcccEEEeccCcccC
Confidence            9997764     6799999999988765556788999999999999999999    67899999999999997643    


Q ss_pred             ---cEEEccccCccc
Q 039957          467 ---VAHVSDFGISKL  478 (481)
Q Consensus       467 ---~~kl~Dfgl~~~  478 (481)
                         .+|++|||+++.
T Consensus       159 ~~~~~kl~d~g~~~~  173 (274)
T cd05076         159 TSPFIKLSDPGVSFT  173 (274)
T ss_pred             ccceeeecCCccccc
Confidence               489999998753

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.80  E-value=1.3e-19  Score=178.60  Aligned_cols=134  Identities=22%  Similarity=0.332  Sum_probs=114.6

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      .+.|+||.||++... +|..||+|.+....   ......+.+|++++..++|+||+++++++...+     +||+++|+|
T Consensus         9 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L   88 (364)
T cd05599           9 IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDM   88 (364)
T ss_pred             EEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHH
Confidence            478999999999864 58899999987542   223345778999999999999999999887765     678999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+++.... .++......++.+++.||+|||    +.+|+||||||+|||++.++.+||+|||+++.+
T Consensus        89 ~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH----~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  151 (364)
T cd05599          89 MTLLMKKD-TFTEEETRFYIAETILAIDSIH----KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGL  151 (364)
T ss_pred             HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEeccCCHHHeEECCCCCEEEeecccceec
Confidence            99887543 4677888899999999999999    678999999999999999999999999998754

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.80  E-value=2.5e-19  Score=173.54  Aligned_cols=133  Identities=26%  Similarity=0.329  Sum_probs=111.9

Q ss_pred             ccccccceeeeec-cCCcceEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          342 LAGSFGSVYKGTI-SDGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       342 ~~g~~g~vy~~~l-~~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      ++|+||.||++.. .+|..+|+|.+....   ......+..|++++..++|+||+++.+++...+     +||+++|+|.
T Consensus         4 G~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~   83 (325)
T cd05594           4 GKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELF   83 (325)
T ss_pred             eeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHH
Confidence            6799999999874 468899999987542   222345677889999999999999998877655     6799999999


Q ss_pred             HHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          413 KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       413 ~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      +++... ..+++.....++.+|+.||+|||.   ..+|+||||||+|||+++++.+||+|||+|+.
T Consensus        84 ~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~---~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~  145 (325)
T cd05594          84 FHLSRE-RVFSEDRARFYGAEIVSALDYLHS---EKNVVYRDLKLENLMLDKDGHIKITDFGLCKE  145 (325)
T ss_pred             HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---cCCEEecCCCCCeEEECCCCCEEEecCCCCee
Confidence            887643 357888899999999999999993   26899999999999999999999999999874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.80  E-value=1e-19  Score=175.27  Aligned_cols=133  Identities=29%  Similarity=0.430  Sum_probs=117.1

Q ss_pred             ccccccceeeee-ccCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHHh
Q 039957          342 LAGSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRL  415 (481)
Q Consensus       342 ~~g~~g~vy~~~-l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~l  415 (481)
                      +.|.-|.||.+. ..++..||+|++++......+-...|+.+++..+|+|||.++..+...+     +|||.+|+|-+.+
T Consensus       282 gqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvV  361 (550)
T KOG0578|consen  282 GQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVV  361 (550)
T ss_pred             ccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhh
Confidence            678999999997 5678999999999877666677889999999999999999998776654     8999999998887


Q ss_pred             hcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          416 YSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       416 ~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      ..  ..++..+...|..++.+||+|||    ..+|+|||||..|||++.+|.+||+|||+|..+.
T Consensus       362 t~--~~~~E~qIA~Icre~l~aL~fLH----~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~  420 (550)
T KOG0578|consen  362 TK--TRMTEGQIAAICREILQGLKFLH----ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQIS  420 (550)
T ss_pred             hc--ccccHHHHHHHHHHHHHHHHHHH----hcceeeeccccceeEeccCCcEEEeeeeeeeccc
Confidence            54  34667788889999999999999    7889999999999999999999999999998764

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.80  E-value=1.6e-19  Score=177.65  Aligned_cols=132  Identities=20%  Similarity=0.277  Sum_probs=112.1

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      +.|+||.||++... ++..+|+|.+....   ......+..|+.+++.++||||+++++++...+     +||+++|+|.
T Consensus        52 G~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~  131 (370)
T cd05621          52 GRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLV  131 (370)
T ss_pred             EecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHH
Confidence            78999999999865 57889999886432   223345778999999999999999999887765     6789999999


Q ss_pred             HHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          413 KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       413 ~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +++...  .++......++.+|+.||+|||    +.+|+||||||+|||+++++.+||+|||+|+.+
T Consensus       132 ~~l~~~--~~~~~~~~~~~~qil~aL~~LH----~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~  192 (370)
T cd05621         132 NLMSNY--DVPEKWAKFYTAEVVLALDAIH----SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM  192 (370)
T ss_pred             HHHHhc--CCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHEEECCCCCEEEEecccceec
Confidence            988654  3567778889999999999999    678999999999999999999999999999764

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.80  E-value=1.8e-19  Score=178.22  Aligned_cols=133  Identities=24%  Similarity=0.301  Sum_probs=112.5

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      .+.|+||.||++.. .+|..+|+|.+....   ......+..|++++.+++|+||+++++++...+     +||+++|+|
T Consensus         9 lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L   88 (377)
T cd05629           9 IGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDL   88 (377)
T ss_pred             EeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcH
Confidence            36899999999875 468899999886432   223456778999999999999999999988765     678999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      .+++... ..++......++.+++.||+|||    +.+|+||||||+|||++.++.+|++|||+|+.
T Consensus        89 ~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH----~~givHrDlkp~NIll~~~~~~kl~DfGla~~  150 (377)
T cd05629          89 MTMLIKY-DTFSEDVTRFYMAECVLAIEAVH----KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTG  150 (377)
T ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHEEECCCCCEEEeecccccc
Confidence            9988653 34566777789999999999999    67899999999999999999999999999964

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.80  E-value=3.1e-19  Score=169.05  Aligned_cols=135  Identities=27%  Similarity=0.490  Sum_probs=111.8

Q ss_pred             hccccccceeeeec-cCCc----ceEEEEEeccch-hhhhhhhHHHHHhhhhccCccceeecccCCCC----cccccCCC
Q 039957          341 SLAGSFGSVYKGTI-SDGT----DVAIKIFNLQRE-RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----FKFMPNGS  410 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~----~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~~~~g~  410 (481)
                      .+.|+||.||+|.. .+|.    .+++|....... ....++..|+..+++++|+||+++++++....    ++|+++|+
T Consensus        15 lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~~~~~i~e~~~~gs   94 (279)
T cd05111          15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQLVTQLSPLGS   94 (279)
T ss_pred             cCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCCccEEEEEeCCCCc
Confidence            36899999999985 3454    366777643322 23356777888889999999999999886543    56899999


Q ss_pred             hhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          411 LEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       411 l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      |.+++......++|.....++.+|++|++|+|    +.+++||||||+||++++++.+||+|||+++.+
T Consensus        95 L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~  159 (279)
T cd05111          95 LLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE----EHRMVHRNLAARNILLKSDSIVQIADFGVADLL  159 (279)
T ss_pred             HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----HCCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence            99999876667889999999999999999999    578999999999999999999999999999754

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.80  E-value=3.3e-19  Score=166.16  Aligned_cols=134  Identities=27%  Similarity=0.467  Sum_probs=115.2

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHH
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKR  414 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~  414 (481)
                      +.|+||.||++... +|..+++|...... ......+.+|++++++++|+||++++++|....     +||+++++|.++
T Consensus         4 g~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   83 (252)
T cd05084           4 GRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTF   83 (252)
T ss_pred             CcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHH
Confidence            57899999999864 68889999875432 233456888999999999999999999987665     578899999999


Q ss_pred             hhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          415 LYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       415 l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +......+++..+..++.++++|++|||    +.+|+||||||+||+++.++.+|++|||+++..
T Consensus        84 ~~~~~~~~~~~~~~~~~~qi~~~L~~lH----~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  144 (252)
T cd05084          84 LRTEGPRLKVKELIQMVENAAAGMEYLE----SKHCIHRDLAARNCLVTEKNVLKISDFGMSREE  144 (252)
T ss_pred             HHhCCCCCCHHHHHHHHHHHHHHHHHHH----hCCccccccchheEEEcCCCcEEECccccCccc
Confidence            8765556789999999999999999999    678999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.80  E-value=3.9e-19  Score=168.41  Aligned_cols=135  Identities=27%  Similarity=0.489  Sum_probs=113.9

Q ss_pred             hccccccceeeeec-cCCc----ceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC----cccccCCC
Q 039957          341 SLAGSFGSVYKGTI-SDGT----DVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----FKFMPNGS  410 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~----~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~~~~g~  410 (481)
                      .+.|+||.||+|.. ++|.    .||+|.+.... ......+..|+..+..++|+|+++++++|....    ++|+++|+
T Consensus        15 lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~l~~~~~~~g~   94 (279)
T cd05109          15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQLVTQLMPYGC   94 (279)
T ss_pred             cCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCCcEEEEEcCCCCC
Confidence            36899999999974 4554    37889876433 233456788999999999999999999987654    56899999


Q ss_pred             hhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          411 LEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       411 l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +.+++......+++..++.++.++++|++|||    +.+|+||||||+||++++++.+||+|||+++.+
T Consensus        95 l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH----~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          95 LLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE----EVRLVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (279)
T ss_pred             HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH----HCCeeccccccceEEEcCCCcEEECCCCceeec
Confidence            99998765556788999999999999999999    678999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.80  E-value=2.8e-21  Score=186.83  Aligned_cols=277  Identities=25%  Similarity=0.286  Sum_probs=160.8

Q ss_pred             EEEeeCCcCccccChhhhcCCCCccEEEccCccceee----cchhccccccCceeecccCccee------cCcccccCCC
Q 039957           41 NLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGT----IPNSITNATKLIILDLGFNTFSG------HIPNTFGNLR  110 (481)
Q Consensus        41 ~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~------~~p~~~~~l~  110 (481)
                      .|+|..+.+++.--..++..+.+|++|+++++.++..    ++..+...+.|+.|+++++.+.+      .++..|..++
T Consensus         2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~   81 (319)
T cd00116           2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC   81 (319)
T ss_pred             ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence            4677777777432223333677788888888877432    44455566667777777776652      2334455566


Q ss_pred             CCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEccCCceeecCCcccccC
Q 039957          111 HLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHL  190 (481)
Q Consensus       111 ~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l  190 (481)
                      +|+.|++++|.+.......+.    ..... ++|++|++++|++++....                     .+...+..+
T Consensus        82 ~L~~L~l~~~~~~~~~~~~~~----~l~~~-~~L~~L~ls~~~~~~~~~~---------------------~l~~~l~~~  135 (319)
T cd00116          82 GLQELDLSDNALGPDGCGVLE----SLLRS-SSLQELKLNNNGLGDRGLR---------------------LLAKGLKDL  135 (319)
T ss_pred             ceeEEEccCCCCChhHHHHHH----HHhcc-CcccEEEeeCCccchHHHH---------------------HHHHHHHhC
Confidence            666666666655432111100    00011 3355555555555421111                     111223333


Q ss_pred             -CCCCeEecccccceec----CCcCCcCCCCCCeeecCCCcCCCC----CCccccCccCCCeeecCCCeeeec----CCc
Q 039957          191 -RGLIYLSLGFNDLNGT----IPTSIGTLKQLQGFFLPETNLQGY----VPHNLCHLEMLNLLHLGGNKLSGH----IPP  257 (481)
Q Consensus       191 -~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~l~l~~n~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~  257 (481)
                       ++|+.|++++|.+++.    ++..+..+++|+.|++++|.+++.    ++..+...+.|+.|++++|.+++.    ++.
T Consensus       136 ~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~  215 (319)
T cd00116         136 PPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAE  215 (319)
T ss_pred             CCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHH
Confidence             4555555555555421    223344455666666666666531    223344556888888888887643    234


Q ss_pred             ccccCCCCCcEEcCCCcCcccCCcchhc-----cccCcEEEccCcccCC----CCCCccccCCcCcEEEccCCeeeee--
Q 039957          258 CLASLTSLRELDLGSNKLTSSIPSSLWS-----LGYILEINLSSNLLND----SLPSNVQKLKVLRVLDLSRNQLSGD--  326 (481)
Q Consensus       258 ~~~~l~~L~~L~ls~N~l~~~~p~~~~~-----l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~--  326 (481)
                      .+..+++|++|++++|.+++.....+..     ...|+.|++++|.++.    .+...+..++.|+.+++++|.++..  
T Consensus       216 ~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~  295 (319)
T cd00116         216 TLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGA  295 (319)
T ss_pred             HhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHH
Confidence            5667889999999999998643333322     3789999999999873    2233455668999999999999854  


Q ss_pred             --cccccccc-CChhhhhcc
Q 039957          327 --IPSTIGAL-VDLETISLA  343 (481)
Q Consensus       327 --~p~~~~~l-~~L~~l~~~  343 (481)
                        ....+... ..++.++..
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~  315 (319)
T cd00116         296 QLLAESLLEPGNELESLWVK  315 (319)
T ss_pred             HHHHHHHhhcCCchhhcccC
Confidence              22333333 455655543

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.80  E-value=2.3e-19  Score=182.51  Aligned_cols=137  Identities=23%  Similarity=0.313  Sum_probs=115.0

Q ss_pred             hhhccccccceeeeecc-C-CcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          339 TISLAGSFGSVYKGTIS-D-GTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       339 ~l~~~g~~g~vy~~~l~-~-g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      .+.+.|++|.||++... + +..|++|............+..|+.++++++|||||+++++|...+     +||+++|+|
T Consensus        73 ~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L  152 (478)
T PTZ00267         73 TLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDL  152 (478)
T ss_pred             EEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCH
Confidence            34478999999999743 3 5678888766555454556788999999999999999999987765     679999999


Q ss_pred             hHHhhc---CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          412 EKRLYS---HNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~---~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+++.+   ....+++.+...++.+|+.||+|+|    +.+|+||||||+|||++.++.+||+|||+|+.+
T Consensus       153 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH----~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~  219 (478)
T PTZ00267        153 NKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH----SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY  219 (478)
T ss_pred             HHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----hCCEEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence            988754   2345778888899999999999999    678999999999999999999999999999864

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.80  E-value=2.8e-19  Score=173.66  Aligned_cols=135  Identities=20%  Similarity=0.265  Sum_probs=115.4

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccch---hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRE---RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      .+.|+||.||++... +|..+|+|.+.....   .....+..|+.++..++|++++++.+++...+     ++|+++|+|
T Consensus         9 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   88 (330)
T cd05601           9 VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDL   88 (330)
T ss_pred             EEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCH
Confidence            478999999999854 688999999875432   23345778899999999999999998887654     678999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+++......+++.....++.++++||+|||    +.+|+||||||+||++++++.+||+|||+|+.+
T Consensus        89 ~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH----~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~  152 (330)
T cd05601          89 LSLLNRYEDQFDEDMAQFYLAELVLAIHSVH----QMGYVHRDIKPENVLIDRTGHIKLADFGSAARL  152 (330)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----HCCeEcccCchHheEECCCCCEEeccCCCCeEC
Confidence            9998765456788888899999999999999    678999999999999999999999999999764

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.80  E-value=2.7e-19  Score=176.39  Aligned_cols=135  Identities=26%  Similarity=0.456  Sum_probs=111.2

Q ss_pred             hccccccceeeeec------cCCcceEEEEEeccc-hhhhhhhhHHHHHhhhh-ccCccceeecccCCCC-----ccccc
Q 039957          341 SLAGSFGSVYKGTI------SDGTDVAIKIFNLQR-ERAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD-----FKFMP  407 (481)
Q Consensus       341 ~~~g~~g~vy~~~l------~~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----~~~~~  407 (481)
                      -+.|+||.||++..      .++..||+|.+.... ......+.+|+++++++ +|+|||+++++|...+     ++|++
T Consensus        46 LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~  125 (374)
T cd05106          46 LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCC  125 (374)
T ss_pred             ecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhcc
Confidence            37899999998863      123579999986543 22345678899999999 8999999999987764     57999


Q ss_pred             CCChhHHhhcCC--------------------------------------------------------------------
Q 039957          408 NGSLEKRLYSHN--------------------------------------------------------------------  419 (481)
Q Consensus       408 ~g~l~~~l~~~~--------------------------------------------------------------------  419 (481)
                      +|+|.+++....                                                                    
T Consensus       126 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  205 (374)
T cd05106         126 YGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTED  205 (374)
T ss_pred             CCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccchhccCC
Confidence            999998875311                                                                    


Q ss_pred             -CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          420 -YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       420 -~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                       ..+++.+..+|+.+|++||+|||    +.+|+||||||+||++++++++||+|||+++.+
T Consensus       206 ~~~l~~~~~~~i~~qi~~aL~yLH----~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~  262 (374)
T cd05106         206 SWPLDLDDLLRFSSQVAQGMDFLA----SKNCIHRDVAARNVLLTDGRVAKICDFGLARDI  262 (374)
T ss_pred             CCCcCHHHHHHHHHHHHHHHHHHH----HCCEEeccCchheEEEeCCCeEEEeeceeeeec
Confidence             23677888999999999999999    678999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.79  E-value=2.6e-19  Score=177.47  Aligned_cols=133  Identities=20%  Similarity=0.330  Sum_probs=112.2

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      .+.|+||.||++.. .++..+|+|.+....   ......+..|+.++++++|+||+++++.+...+     +||+++|+|
T Consensus         9 LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L   88 (382)
T cd05625           9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDM   88 (382)
T ss_pred             EEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcH
Confidence            37899999999985 457889999986543   223456788999999999999999999987765     679999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      .+++.... .++......++.+|+.||+|+|    +.+||||||||+|||++.++++||+|||+|+.
T Consensus        89 ~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH----~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~  150 (382)
T cd05625          89 MSLLIRMG-IFPEDLARFYIAELTCAVESVH----KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG  150 (382)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEECCCCCEEEeECCCCcc
Confidence            99886543 4566667778999999999999    67899999999999999999999999999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.79  E-value=5e-19  Score=166.92  Aligned_cols=137  Identities=31%  Similarity=0.528  Sum_probs=111.6

Q ss_pred             hhhccccccceeeeeccCC-c--ceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCC-----------C
Q 039957          339 TISLAGSFGSVYKGTISDG-T--DVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTP-----------D  402 (481)
Q Consensus       339 ~l~~~g~~g~vy~~~l~~g-~--~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----------~  402 (481)
                      ...+.|+||.||+|...+. .  .+|+|.+....  ....+.+..|++++++++|+||++++++|...           -
T Consensus         5 ~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v   84 (272)
T cd05075           5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVI   84 (272)
T ss_pred             cccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEE
Confidence            3457899999999986543 2  58888876542  33345788899999999999999999877432           1


Q ss_pred             cccccCCChhHHhhc-----CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcc
Q 039957          403 FKFMPNGSLEKRLYS-----HNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK  477 (481)
Q Consensus       403 ~~~~~~g~l~~~l~~-----~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~  477 (481)
                      ++|+++|++.+++..     ....+++.....++.+++.|++|||    +.+|+||||||+||++++++.+||+|||+++
T Consensus        85 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  160 (272)
T cd05075          85 LPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS----SKSFIHRDLAARNCMLNENMNVCVADFGLSK  160 (272)
T ss_pred             EEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH----HCCeeccccchhheEEcCCCCEEECCCCccc
Confidence            568999999887642     2245788899999999999999999    5789999999999999999999999999988


Q ss_pred             cC
Q 039957          478 LL  479 (481)
Q Consensus       478 ~~  479 (481)
                      .+
T Consensus       161 ~~  162 (272)
T cd05075         161 KI  162 (272)
T ss_pred             cc
Confidence            64

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.79  E-value=5.3e-19  Score=165.84  Aligned_cols=134  Identities=19%  Similarity=0.343  Sum_probs=111.1

Q ss_pred             ccccccceeeeeccCC-------------cceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----c
Q 039957          342 LAGSFGSVYKGTISDG-------------TDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----F  403 (481)
Q Consensus       342 ~~g~~g~vy~~~l~~g-------------~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~  403 (481)
                      +.|+||.||+|+..+.             ..+++|.+..........+..|+..+++++||||++++++|....     +
T Consensus         4 g~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   83 (262)
T cd05077           4 GRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVE   83 (262)
T ss_pred             ccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEE
Confidence            6899999999985321             247788776554444556788899999999999999999987654     5


Q ss_pred             ccccCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCc-------EEEccccCc
Q 039957          404 KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMV-------AHVSDFGIS  476 (481)
Q Consensus       404 ~~~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~-------~kl~Dfgl~  476 (481)
                      +|+++|++..++......+++..+.+++.+|++|++|||    +.+|+||||||+|||++.++.       +|++|||++
T Consensus        84 e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~  159 (262)
T cd05077          84 EFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE----DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP  159 (262)
T ss_pred             ecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh----hCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCC
Confidence            789999998888765566889999999999999999999    688999999999999987654       899999998


Q ss_pred             ccC
Q 039957          477 KLL  479 (481)
Q Consensus       477 ~~~  479 (481)
                      ...
T Consensus       160 ~~~  162 (262)
T cd05077         160 ITV  162 (262)
T ss_pred             ccc
Confidence            653

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.79  E-value=5.3e-19  Score=165.24  Aligned_cols=135  Identities=31%  Similarity=0.447  Sum_probs=115.2

Q ss_pred             hhccccccceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHH
Q 039957          340 ISLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKR  414 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~  414 (481)
                      .-+.|++|.||++...++..+++|.+.... .....+..|++++++++|+|++++++++...+     +||+++++|.++
T Consensus        11 ~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   89 (256)
T cd05059          11 ELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNY   89 (256)
T ss_pred             hhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHH
Confidence            347899999999987777789999875432 22345778999999999999999999887665     568899999999


Q ss_pred             hhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          415 LYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       415 l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +.......++....+++.+++.|++|||    +.+|+|||+||+||++++++.+|++|||+++..
T Consensus        90 l~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~  150 (256)
T cd05059          90 LRERKGKLGTEWLLDMCSDVCEAMEYLE----SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYV  150 (256)
T ss_pred             HHhcccCCCHHHHHHHHHHHHHHHHHHH----HCCcccccccHhhEEECCCCcEEECCcccceec
Confidence            8765556889999999999999999999    678999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.79  E-value=3.8e-19  Score=168.56  Aligned_cols=134  Identities=27%  Similarity=0.346  Sum_probs=112.2

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccch---hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQRE---RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      +.|+||.||++... +|..+|+|.+.....   ...+.+..|++++++++|++++++.+++....     ++|+++|+|.
T Consensus         2 g~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~   81 (280)
T cd05608           2 GKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLR   81 (280)
T ss_pred             CCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHH
Confidence            57999999999754 688999998865432   22345678999999999999999988776654     6799999998


Q ss_pred             HHhhc---CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          413 KRLYS---HNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       413 ~~l~~---~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .++..   ....+++..+..++.+|++|++|||    +.+|+||||||+||++++++.+||+|||+++.+
T Consensus        82 ~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  147 (280)
T cd05608          82 YHIYNVDEENPGFPEPRACFYTAQIISGLEHLH----QRRIIYRDLKPENVLLDNDGNVRISDLGLAVEL  147 (280)
T ss_pred             HHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEEeeCccceec
Confidence            87643   2345788999999999999999999    678999999999999999999999999998754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.79  E-value=4e-19  Score=166.29  Aligned_cols=133  Identities=20%  Similarity=0.388  Sum_probs=111.4

Q ss_pred             ccccccceeeeeccCCc-----------ceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC----cccc
Q 039957          342 LAGSFGSVYKGTISDGT-----------DVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----FKFM  406 (481)
Q Consensus       342 ~~g~~g~vy~~~l~~g~-----------~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~~  406 (481)
                      +.|+||.||+|...+..           .+++|.+...... ...+.+|+.++++++|+|+++++++|....    ++|+
T Consensus         4 g~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~   82 (259)
T cd05037           4 GQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVRDENIMVEEYV   82 (259)
T ss_pred             cccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEecCCcEEEEEcC
Confidence            67999999999876432           3666766544332 567888999999999999999999886532    6789


Q ss_pred             cCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCC-------cEEEccccCcccC
Q 039957          407 PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENM-------VAHVSDFGISKLL  479 (481)
Q Consensus       407 ~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~-------~~kl~Dfgl~~~~  479 (481)
                      ++|+|.+++......+++..+++++.+|+.||+|||    +.+|+||||||+||+++.++       .+|++|||+++..
T Consensus        83 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH----~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~  158 (259)
T cd05037          83 KFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE----DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITV  158 (259)
T ss_pred             CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh----hCCeecccCccceEEEecCccccCCceeEEeCCCCccccc
Confidence            999999998765546788999999999999999999    67899999999999999887       8999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.79  E-value=3.5e-19  Score=171.99  Aligned_cols=133  Identities=30%  Similarity=0.392  Sum_probs=112.4

Q ss_pred             ccccccceeeeec----cCCcceEEEEEeccch--hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCC
Q 039957          342 LAGSFGSVYKGTI----SDGTDVAIKIFNLQRE--RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGS  410 (481)
Q Consensus       342 ~~g~~g~vy~~~l----~~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~  410 (481)
                      +.|+||.||++..    .+|..+|+|.+.....  .....+..|++++++++|+||+++.+++...+     +||+++|+
T Consensus         5 g~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~   84 (318)
T cd05582           5 GQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGD   84 (318)
T ss_pred             eeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCc
Confidence            6799999998864    3578899999875432  22345677999999999999999999887665     67899999


Q ss_pred             hhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          411 LEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       411 l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      |.+++... ..+++.....++.+|++||+|||    +.+|+||||||+||++++++.+||+|||+++..
T Consensus        85 L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  148 (318)
T cd05582          85 LFTRLSKE-VMFTEEDVKFYLAELALALDHLH----SLGIIYRDLKPENILLDEEGHIKLTDFGLSKES  148 (318)
T ss_pred             HHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH----HCCEecCCCCHHHeEECCCCcEEEeeccCCccc
Confidence            99988643 35788899999999999999999    678999999999999999999999999998754

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.79  E-value=5.4e-19  Score=165.64  Aligned_cols=135  Identities=31%  Similarity=0.537  Sum_probs=119.0

Q ss_pred             hccccccceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHHh
Q 039957          341 SLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRL  415 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~l  415 (481)
                      .+.|++|.||+|...++..+++|.+..........+..|++++++++|+|++++++++...+     ++|+++|+|.+++
T Consensus        14 ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~   93 (261)
T cd05148          14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFL   93 (261)
T ss_pred             hccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHH
Confidence            47899999999998888999999987665545567888999999999999999999887665     6789999999998


Q ss_pred             hcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          416 YSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       416 ~~~-~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ... ...+++.++.+++.+++.|++|||    +.+|+||||||+||++++++.+||+|||+++.+
T Consensus        94 ~~~~~~~~~~~~~~~~~~~i~~al~~lH----~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~  154 (261)
T cd05148          94 RSPEGQVLPVASLIDMACQVAEGMAYLE----EQNSIHRDLAARNILVGEDLVCKVADFGLARLI  154 (261)
T ss_pred             hcCCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeccccCcceEEEcCCceEEEccccchhhc
Confidence            763 345789999999999999999999    678999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.79  E-value=3.7e-19  Score=172.76  Aligned_cols=135  Identities=23%  Similarity=0.282  Sum_probs=114.3

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      .++|+||.||++... ++..+|+|.+....   ....+.+..|..++..++|++|+++.+++...+     +||+++|+|
T Consensus         9 lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L   88 (331)
T cd05597           9 IGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDL   88 (331)
T ss_pred             EEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcH
Confidence            368999999999864 58899999986432   222345778899999999999999999887665     678999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+++......++......++.+|+.||+|||    +.+|+||||||+|||++.++.+||+|||+|+.+
T Consensus        89 ~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  152 (331)
T cd05597          89 LTLLSKFEDRLPEDMARFYLAEMVLAIDSVH----QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRL  152 (331)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----hCCeEECCCCHHHEEECCCCCEEEEECCceeec
Confidence            9998764556777888889999999999999    678999999999999999999999999998654

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.79  E-value=7e-19  Score=163.77  Aligned_cols=134  Identities=31%  Similarity=0.502  Sum_probs=116.1

Q ss_pred             hccccccceeeeeccCCcceEEEEEeccch-hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHH
Q 039957          341 SLAGSFGSVYKGTISDGTDVAIKIFNLQRE-RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKR  414 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~  414 (481)
                      .+.|+||.||+|...++..+++|.+..... .....+.+|++.+++++|+|+++++++|...+     +||+++|++.++
T Consensus         3 ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   82 (250)
T cd05085           3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSF   82 (250)
T ss_pred             cCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHH
Confidence            367999999999988888999998765432 23346788999999999999999999987664     578999999998


Q ss_pred             hhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          415 LYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       415 l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      +......+++..+.+++.+++.|+.|+|    ..+++|||+||+||++++++.+|++|||+++.
T Consensus        83 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~  142 (250)
T cd05085          83 LRKKKDELKTKQLVKFALDAAAGMAYLE----SKNCIHRDLAARNCLVGENNVLKISDFGMSRQ  142 (250)
T ss_pred             HHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeecccChheEEEcCCCeEEECCCcccee
Confidence            8765556789999999999999999999    67899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.79  E-value=1.8e-19  Score=177.65  Aligned_cols=138  Identities=34%  Similarity=0.519  Sum_probs=114.4

Q ss_pred             hhccccccceeeee-ccCCcceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----------cccc
Q 039957          340 ISLAGSFGSVYKGT-ISDGTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----------FKFM  406 (481)
Q Consensus       340 l~~~g~~g~vy~~~-l~~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----------~~~~  406 (481)
                      .-|.|+||.||+|. -..|..||||.++... .+..+....|++++++++|+|||++++.-....           +||+
T Consensus        20 ~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC   99 (732)
T KOG4250|consen   20 RLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYC   99 (732)
T ss_pred             hhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeec
Confidence            34789999999998 4579999999887643 344566788999999999999999987654332           6799


Q ss_pred             cCCChhHHhhcCC--CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeC--CCC--cEEEccccCcccCC
Q 039957          407 PNGSLEKRLYSHN--YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLD--ENM--VAHVSDFGISKLLG  480 (481)
Q Consensus       407 ~~g~l~~~l~~~~--~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~--~~~--~~kl~Dfgl~~~~~  480 (481)
                      .+|+|++.+.++.  ..+...+.+.+..+++.||.|||    ..+||||||||.||++-  ++|  -=||+|||.||-++
T Consensus       100 ~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr----En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~  175 (732)
T KOG4250|consen  100 SGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR----ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELD  175 (732)
T ss_pred             CCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH----HcCceeccCCCCcEEEeecCCCceEEeeecccccccCC
Confidence            9999999998743  45777889999999999999999    57899999999999983  334  35999999999876


Q ss_pred             C
Q 039957          481 E  481 (481)
Q Consensus       481 ~  481 (481)
                      +
T Consensus       176 d  176 (732)
T KOG4250|consen  176 D  176 (732)
T ss_pred             C
Confidence            4

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.79  E-value=3.2e-19  Score=173.51  Aligned_cols=134  Identities=25%  Similarity=0.374  Sum_probs=114.3

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      .+.|+||.||+|... +|..||+|.+....   ......+..|++++.+++|+||+++++++...+     +||+++|+|
T Consensus         9 ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L   88 (333)
T cd05600           9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDF   88 (333)
T ss_pred             EeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCH
Confidence            367999999999865 57899999987543   223456778999999999999999999887765     579999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+++... ..+++.....++.+++.||+|||    +.+|+||||||+||++++++.+||+|||+|+..
T Consensus        89 ~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~  151 (333)
T cd05600          89 RTLLNNL-GVLSEDHARFYMAEMFEAVDALH----ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGI  151 (333)
T ss_pred             HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEECCCCCEEEEeCcCCccc
Confidence            9998653 34677888889999999999999    678999999999999999999999999999754

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.79  E-value=6.6e-19  Score=165.09  Aligned_cols=134  Identities=28%  Similarity=0.525  Sum_probs=115.4

Q ss_pred             hccccccceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHHh
Q 039957          341 SLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRL  415 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~l  415 (481)
                      .+.|++|.||+|...++..+++|.+..... ..+.+..|+.++++++|+|++++.+++...+     ++|+++++|.+++
T Consensus        14 lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~   92 (261)
T cd05068          14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYL   92 (261)
T ss_pred             ecccCCccEEEEEecCCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHH
Confidence            367999999999877778899998865432 2456788999999999999999999887654     5788999999998


Q ss_pred             hcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          416 YSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       416 ~~~-~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ... ...++|....+++.+++.|++|+|    +.+|+||||||+||++++++.+||+|||+++.+
T Consensus        93 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~  153 (261)
T cd05068          93 QGGAGRALKLPQLIDMAAQVASGMAYLE----AQNYIHRDLAARNVLVGENNICKVADFGLARVI  153 (261)
T ss_pred             hccCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeeccCCcceEEEcCCCCEEECCcceEEEc
Confidence            653 346789999999999999999999    578999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.79  E-value=3.4e-19  Score=172.47  Aligned_cols=133  Identities=24%  Similarity=0.374  Sum_probs=110.4

Q ss_pred             hccccccceeeeecc----CCcceEEEEEeccc----hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----ccccc
Q 039957          341 SLAGSFGSVYKGTIS----DGTDVAIKIFNLQR----ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMP  407 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~----~g~~vavK~l~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~  407 (481)
                      .+.|+||.||++...    .+..+|+|.+....    ......+..|+.++++++|+||+++++++...+     ++|++
T Consensus         4 lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~   83 (323)
T cd05584           4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLS   83 (323)
T ss_pred             eeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCC
Confidence            367999999998753    46889999986532    122345678999999999999999998887664     57899


Q ss_pred             CCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          408 NGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       408 ~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      +|+|.+++.... .+.......++.++++||+|||    +.+|+||||||+||++++++.+||+|||+++.
T Consensus        84 ~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  149 (323)
T cd05584          84 GGELFMHLEREG-IFMEDTACFYLSEISLALEHLH----QQGIIYRDLKPENILLDAQGHVKLTDFGLCKE  149 (323)
T ss_pred             CchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEECCCCCEEEeeCcCCee
Confidence            999999886543 4566677789999999999999    67899999999999999999999999999874

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.79  E-value=4.2e-19  Score=174.85  Aligned_cols=132  Identities=20%  Similarity=0.294  Sum_probs=110.8

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      +.|+||.||++... +|..+|+|.+....   ......+..|+.+++.++|+||+++.+++...+     +||+++|+|.
T Consensus        52 g~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~  131 (370)
T cd05596          52 GRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLV  131 (370)
T ss_pred             eeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHH
Confidence            68999999999864 57889999986432   122345678999999999999999998887765     5799999999


Q ss_pred             HHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          413 KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       413 ~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +++....  ++......++.++++||+|||    +.+|+||||||+|||+++++.+||+|||+++.+
T Consensus       132 ~~l~~~~--l~~~~~~~~~~qi~~aL~~LH----~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~  192 (370)
T cd05596         132 NLMSNYD--IPEKWARFYTAEVVLALDAIH----SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM  192 (370)
T ss_pred             HHHHhcC--CCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence            9886543  455667778999999999999    678999999999999999999999999998754

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.79  E-value=5.2e-19  Score=169.65  Aligned_cols=132  Identities=27%  Similarity=0.436  Sum_probs=110.9

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccch-hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHH
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQRE-RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKR  414 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~  414 (481)
                      +.|+||.||+|... +|..+|+|.+..... .....+.+|+.++++++|+|++++.+++...+     ++|++ +++.++
T Consensus        14 g~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~   92 (303)
T cd07869          14 GEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQY   92 (303)
T ss_pred             EecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCHHHH
Confidence            68999999999865 688999999865432 22335678999999999999999999887665     56775 788887


Q ss_pred             hhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          415 LYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       415 l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      +......++......++.++++||+|||    +.+|+||||||+||++++++.+||+|||+|+.
T Consensus        93 ~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  152 (303)
T cd07869          93 MDKHPGGLHPENVKLFLFQLLRGLSYIH----QRYILHRDLKPQNLLISDTGELKLADFGLARA  152 (303)
T ss_pred             HHhCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEECCCCCEEECCCCccee
Confidence            7665555777888899999999999999    67899999999999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.79  E-value=5.2e-19  Score=166.58  Aligned_cols=133  Identities=26%  Similarity=0.387  Sum_probs=108.7

Q ss_pred             ccccccceeeeeccCC---cceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          342 LAGSFGSVYKGTISDG---TDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       342 ~~g~~g~vy~~~l~~g---~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      +.|+||.||+|...++   ..+++|.+.... ......+.+|+..++.++|+||++++++|...+     +||+++|+|.
T Consensus         4 g~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~   83 (269)
T cd05042           4 GNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLK   83 (269)
T ss_pred             CccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHH
Confidence            5799999999975543   457777665432 223346778999999999999999999887664     6789999999


Q ss_pred             HHhhcCC----CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          413 KRLYSHN----YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       413 ~~l~~~~----~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      +++....    ...++....+++.+++.|++|||    +.+|+||||||+||++++++.+||+|||+++.
T Consensus        84 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~  149 (269)
T cd05042          84 NYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH----QADFIHSDLALRNCQLTADLSVKIGDYGLALE  149 (269)
T ss_pred             HHHHhccccccccccHHHHHHHHHHHHHHHHHHH----hcCEecccccHhheEecCCCcEEEeccccccc
Confidence            9987532    22456777899999999999999    67899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.79  E-value=7e-19  Score=165.42  Aligned_cols=136  Identities=29%  Similarity=0.498  Sum_probs=115.8

Q ss_pred             hhccccccceeeeeccC----CcceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCC
Q 039957          340 ISLAGSFGSVYKGTISD----GTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNG  409 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~~----g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g  409 (481)
                      ..+.|+||.||+|....    ...+++|.+.... ......+..|+.++++++|+|++++.+++...+     ++|+++|
T Consensus        11 ~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~   90 (266)
T cd05033          11 VIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENG   90 (266)
T ss_pred             EecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCC
Confidence            34789999999998642    3568999876543 233456888999999999999999999886654     6789999


Q ss_pred             ChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          410 SLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       410 ~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +|.+++......+++....+++.+++.|++|||    +.+|+||||||+||++++++.+|++|||+++.+
T Consensus        91 ~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh----~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~  156 (266)
T cd05033          91 SLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS----EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRL  156 (266)
T ss_pred             CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence            999998765557889999999999999999999    678999999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.79  E-value=4.6e-19  Score=172.07  Aligned_cols=135  Identities=22%  Similarity=0.240  Sum_probs=114.0

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      .+.|+||.||++... ++..+|+|.+....   ......+..|..++..++|++|+++.+++...+     +||+++|+|
T Consensus         9 lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L   88 (331)
T cd05624           9 IGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDL   88 (331)
T ss_pred             EeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcH
Confidence            378999999999865 57889999886532   222344677888999999999999999887665     678999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+++......+++..+..++.+++.||+|+|    +.+|+||||||+||+++.++.+||+|||+|+.+
T Consensus        89 ~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH----~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~  152 (331)
T cd05624          89 LTLLSKFEDRLPEDMARFYIAEMVLAIHSIH----QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKM  152 (331)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----HCCeeeccCchHHEEEcCCCCEEEEeccceeec
Confidence            9998764456778888889999999999999    688999999999999999999999999998754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.79  E-value=8.5e-19  Score=164.33  Aligned_cols=133  Identities=23%  Similarity=0.495  Sum_probs=115.0

Q ss_pred             ccccccceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHHhh
Q 039957          342 LAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRLY  416 (481)
Q Consensus       342 ~~g~~g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~l~  416 (481)
                      +.|++|.||+|...++..+++|.+..... ..+.+..|+.++++++|+|++++++.+...+     ++|+++|+|.+++.
T Consensus        15 g~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   93 (261)
T cd05072          15 GAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLK   93 (261)
T ss_pred             CCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHH
Confidence            67999999999988888899998764332 2456788999999999999999998887664     57899999999886


Q ss_pred             cC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          417 SH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       417 ~~-~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .. ....++.++..++.++++|++|||    +.+++||||||+||++++++.+|++|||+++..
T Consensus        94 ~~~~~~~~~~~~~~~~~~l~~~l~~LH----~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~  153 (261)
T cd05072          94 SDEGGKVLLPKLIDFSAQIAEGMAYIE----RKNYIHRDLRAANVLVSESLMCKIADFGLARVI  153 (261)
T ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeccccchhhEEecCCCcEEECCCccceec
Confidence            53 456788899999999999999999    578999999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.79  E-value=5e-19  Score=175.11  Aligned_cols=132  Identities=20%  Similarity=0.328  Sum_probs=111.3

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      +.|+||.||++... +|..+|+|.+....   ......+.+|++++++++|+||+++++.+...+     +||+++|+|.
T Consensus        10 G~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~   89 (376)
T cd05598          10 GIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMM   89 (376)
T ss_pred             EeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHH
Confidence            68999999999854 58899999886432   123355778999999999999999999887765     6799999999


Q ss_pred             HHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          413 KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       413 ~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      +++.... .++......++.+|+.||+|||    +.+|+||||||+|||++.++.+||+|||+|+.
T Consensus        90 ~~i~~~~-~~~~~~~~~~~~qi~~al~~lH----~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~  150 (376)
T cd05598          90 SLLIRLG-IFEEDLARFYIAELTCAIESVH----KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG  150 (376)
T ss_pred             HHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEeCCCCHHHEEECCCCCEEEEeCCCCcc
Confidence            9987543 4566667778999999999999    67899999999999999999999999999853

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.79  E-value=4.4e-19  Score=173.83  Aligned_cols=134  Identities=22%  Similarity=0.365  Sum_probs=115.2

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccch---hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRE---RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      .+.|+||.||++... +|..+|+|.+.....   .....+..|+.++..++|+|++++++++...+     ++|+++|+|
T Consensus         9 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   88 (350)
T cd05573           9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDL   88 (350)
T ss_pred             EEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCCH
Confidence            368999999999865 688999999875431   23456788999999999999999998887665     578999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+++... ..++......++.+|++||+|||    +.+|+||||||+||+++.++.+||+|||+++.+
T Consensus        89 ~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH----~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~  151 (350)
T cd05573          89 MNLLIRK-DVFPEETARFYIAELVLALDSVH----KLGFIHRDIKPDNILIDADGHIKLADFGLCKKM  151 (350)
T ss_pred             HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHeEECCCCCEEeecCCCCccC
Confidence            9998754 45778888899999999999999    688999999999999999999999999999865

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.78  E-value=5e-19  Score=173.48  Aligned_cols=129  Identities=31%  Similarity=0.478  Sum_probs=108.4

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccch-hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHH
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQRE-RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKR  414 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~  414 (481)
                      +.|+||.||++... +|..||+|.+..... .....+.+|++++++++|+||+++++++...+     +||+++|+|.+.
T Consensus        83 g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~  162 (353)
T PLN00034         83 GSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT  162 (353)
T ss_pred             cCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCccccc
Confidence            78999999999854 689999999865432 23456888999999999999999999887654     678999998653


Q ss_pred             hhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          415 LYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       415 l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .     ..+......++.+|++||+|||    +.+|+||||||+|||+++++.+||+|||+++.+
T Consensus       163 ~-----~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~  218 (353)
T PLN00034        163 H-----IADEQFLADVARQILSGIAYLH----RRHIVHRDIKPSNLLINSAKNVKIADFGVSRIL  218 (353)
T ss_pred             c-----cCCHHHHHHHHHHHHHHHHHHH----HCCEeecCCCHHHEEEcCCCCEEEcccccceec
Confidence            2     2345667789999999999999    678999999999999999999999999998764

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.78  E-value=9.3e-19  Score=166.26  Aligned_cols=135  Identities=26%  Similarity=0.509  Sum_probs=114.7

Q ss_pred             hccccccceeeeec-----cCCcceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC-------ccccc
Q 039957          341 SLAGSFGSVYKGTI-----SDGTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-------FKFMP  407 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-----~~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-------~~~~~  407 (481)
                      .++|+||.||.+..     .++..+++|.+.... ......+.+|++++++++|+|++++.++|...+       ++|++
T Consensus        12 lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~   91 (284)
T cd05079          12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLP   91 (284)
T ss_pred             cCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccC
Confidence            36899999998863     346789999886543 333456889999999999999999999886541       57899


Q ss_pred             CCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          408 NGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       408 ~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +++|.+++.......+|.++..++.+++.|++|+|    +.+|+||||||+||+++.++.+||+|||+++.+
T Consensus        92 g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH----~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05079          92 SGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG----SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI  159 (284)
T ss_pred             CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----HCCeeecccchheEEEcCCCCEEECCCcccccc
Confidence            99999998765456789999999999999999999    678999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.78  E-value=8.7e-19  Score=164.34  Aligned_cols=134  Identities=27%  Similarity=0.499  Sum_probs=111.3

Q ss_pred             ccccccceeeeeccC----CcceEEEEEecc-chhhhhhhhHHHHHhhhhccCccceeecccCCCC------cccccCCC
Q 039957          342 LAGSFGSVYKGTISD----GTDVAIKIFNLQ-RERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD------FKFMPNGS  410 (481)
Q Consensus       342 ~~g~~g~vy~~~l~~----g~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~~~~g~  410 (481)
                      +.|+||.||+|...+    +..+|+|.+... .......+..|+.++++++|+|+++++++|...+      ++|+++|+
T Consensus         4 g~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~   83 (262)
T cd05058           4 GKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGD   83 (262)
T ss_pred             cccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCC
Confidence            679999999998532    356889987532 2334456788999999999999999999775432      56889999


Q ss_pred             hhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          411 LEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       411 l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      |.+++.......++.....++.++++|++|||    +.+|+||||||+||++++++.+||+|||+++.+
T Consensus        84 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~  148 (262)
T cd05058          84 LRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA----SKKFVHRDLAARNCMLDESFTVKVADFGLARDI  148 (262)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCccccccCcceEEEcCCCcEEECCccccccc
Confidence            99998765555678888999999999999999    578999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.78  E-value=7e-19  Score=170.67  Aligned_cols=132  Identities=22%  Similarity=0.289  Sum_probs=111.7

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccc---hhhhhhhhHHHHHhhhh-ccCccceeecccCCCC-----cccccCCCh
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      +.|+||.||++... ++..+|+|.+....   ......+..|..++.++ +|+||+++.+++....     +||+++|+|
T Consensus         4 G~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L   83 (329)
T cd05588           4 GRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDL   83 (329)
T ss_pred             eeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCH
Confidence            67999999999864 57889999987542   22234567788888887 6999999999887664     679999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      .+++... ..+++..+..++.+++.||+|||    +.+|+||||||+||++++++.+||+|||+++.
T Consensus        84 ~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~  145 (329)
T cd05588          84 MFHMQRQ-RKLPEEHARFYSAEISLALNFLH----ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE  145 (329)
T ss_pred             HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHeEECCCCCEEECcCccccc
Confidence            9887643 45788899999999999999999    67899999999999999999999999999874

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.78  E-value=3e-21  Score=158.07  Aligned_cols=159  Identities=34%  Similarity=0.580  Sum_probs=108.3

Q ss_pred             ccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeecccCcceecCcccccCCCCC
Q 039957           33 IFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHL  112 (481)
Q Consensus        33 ~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  112 (481)
                      +.+++.++.|.||+|+++ .+|+.+. .+.+|+.|++.+|++. .+|.+++.+++|+.|+++-|++. +.|..|+.++.|
T Consensus        29 Lf~~s~ITrLtLSHNKl~-~vppnia-~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~l  104 (264)
T KOG0617|consen   29 LFNMSNITRLTLSHNKLT-VVPPNIA-ELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPAL  104 (264)
T ss_pred             ccchhhhhhhhcccCcee-ecCCcHH-Hhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchh
Confidence            556777888888888888 7777776 7888888899888886 77888888888999988888887 788889888888


Q ss_pred             CEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEccCCceeecCCcccccCCC
Q 039957          113 SVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRG  192 (481)
Q Consensus       113 ~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~  192 (481)
                      ++|||.+|++..-                               .+|..|+-+ +.|+.|.+++|.+. .+|..++++++
T Consensus       105 evldltynnl~e~-------------------------------~lpgnff~m-~tlralyl~dndfe-~lp~dvg~lt~  151 (264)
T KOG0617|consen  105 EVLDLTYNNLNEN-------------------------------SLPGNFFYM-TTLRALYLGDNDFE-ILPPDVGKLTN  151 (264)
T ss_pred             hhhhccccccccc-------------------------------cCCcchhHH-HHHHHHHhcCCCcc-cCChhhhhhcc
Confidence            8888888887653                               122233322 23444445555544 44555555555


Q ss_pred             CCeEecccccceecCCcCCcCCCCCCeeecCCCcCCC
Q 039957          193 LIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQG  229 (481)
Q Consensus       193 L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~  229 (481)
                      |+.|.+..|.+. .+|..++.+++|+.|.+.+|+++.
T Consensus       152 lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~v  187 (264)
T KOG0617|consen  152 LQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLTV  187 (264)
T ss_pred             eeEEeeccCchh-hCcHHHHHHHHHHHHhcccceeee
Confidence            555555555554 455555555555555555555553

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.78  E-value=7.4e-19  Score=170.92  Aligned_cols=137  Identities=26%  Similarity=0.472  Sum_probs=112.2

Q ss_pred             hhhccccccceeeeecc------CCcceEEEEEeccch-hhhhhhhHHHHHhhhh-ccCccceeecccCCCC------cc
Q 039957          339 TISLAGSFGSVYKGTIS------DGTDVAIKIFNLQRE-RAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD------FK  404 (481)
Q Consensus       339 ~l~~~g~~g~vy~~~l~------~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~------~~  404 (481)
                      ...+.|+||.||+|...      .+..||+|.+..... ...+.+..|+.++.++ +|+||++++++|...+      ++
T Consensus        13 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~e   92 (337)
T cd05054          13 KPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVE   92 (337)
T ss_pred             cccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEe
Confidence            34578999999998632      346899998864332 2334577899999999 7999999999886543      67


Q ss_pred             cccCCChhHHhhcCC------------------------------------------------------------CccCH
Q 039957          405 FMPNGSLEKRLYSHN------------------------------------------------------------YFLDI  424 (481)
Q Consensus       405 ~~~~g~l~~~l~~~~------------------------------------------------------------~~~~~  424 (481)
                      |+++|+|.+++....                                                            ..++|
T Consensus        93 y~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  172 (337)
T cd05054          93 YCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTL  172 (337)
T ss_pred             cCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCCH
Confidence            999999998875311                                                            25688


Q ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          425 LERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       425 ~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ..+.+++.+|++|++|+|    +.+|+||||||+||++++++.+||+|||+|+.+
T Consensus       173 ~~~~~~~~qi~~aL~~lH----~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~  223 (337)
T cd05054         173 EDLISYSFQVARGMEFLA----SRKCIHRDLAARNILLSENNVVKICDFGLARDI  223 (337)
T ss_pred             HHHHHHHHHHHHHHHHHH----hCCeecCCCCcceEEEeCCCcEEEeccccchhc
Confidence            999999999999999999    678999999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.78  E-value=6.3e-19  Score=170.94  Aligned_cols=133  Identities=22%  Similarity=0.280  Sum_probs=110.8

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc---hhhhhhhhHHHHHhhhh-ccCccceeecccCCCC-----cccccCCC
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD-----FKFMPNGS  410 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----~~~~~~g~  410 (481)
                      -++|+||.||++... ++..+|+|.+....   ......+..|+.++.++ +|+||+++++++...+     +||+++|+
T Consensus         3 lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~   82 (329)
T cd05618           3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGD   82 (329)
T ss_pred             eeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCC
Confidence            368999999999864 57889999987542   22334566788887766 7999999999887664     67999999


Q ss_pred             hhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          411 LEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       411 l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      |..++... ..+++.....++.+++.|++|||    +.+|+||||||+||+++.++.+||+|||+++.
T Consensus        83 L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH----~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~  145 (329)
T cd05618          83 LMFHMQRQ-RKLPEEHARFYSAEISLALNYLH----ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE  145 (329)
T ss_pred             HHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCCHHHEEECCCCCEEEeeCCcccc
Confidence            98887643 35778888999999999999999    67899999999999999999999999999875

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.78  E-value=1.2e-18  Score=163.92  Aligned_cols=135  Identities=31%  Similarity=0.532  Sum_probs=114.2

Q ss_pred             hccccccceeeeecc-C---CcceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCC
Q 039957          341 SLAGSFGSVYKGTIS-D---GTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGS  410 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~---g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~  410 (481)
                      -+.|+||.||+|... +   +..+++|.+.... ....+.+..|+.++.+++|||++++.+++...+     +||+++|+
T Consensus        12 lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   91 (267)
T cd05066          12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGS   91 (267)
T ss_pred             ecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCC
Confidence            378999999999753 2   3368888876432 233457888999999999999999999887665     56889999


Q ss_pred             hhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          411 LEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       411 l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      |.+++.......++.+..+|+.+++.|++|+|    +.+|+||||||+||++++++.+|++|||+++.+
T Consensus        92 L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH----~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd05066          92 LDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS----DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL  156 (267)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence            99998765556789999999999999999999    678999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.78  E-value=1.1e-18  Score=165.11  Aligned_cols=134  Identities=23%  Similarity=0.339  Sum_probs=111.9

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccch---hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQRE---RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      +.|+||.||++... +|..+|+|.+.....   ........|++++.+++|+||+++.+.+....     +||+++|+|.
T Consensus         2 g~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~   81 (277)
T cd05607           2 GKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLK   81 (277)
T ss_pred             CCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHH
Confidence            57999999999864 589999998864322   12234556899999999999999998887654     6789999998


Q ss_pred             HHhhc-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          413 KRLYS-HNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       413 ~~l~~-~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +++.. ....+++..+..++.+++.|++|+|    +.+|+||||||+||++++++.+||+|||++..+
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~  145 (277)
T cd05607          82 YHIYNVGERGLEMERVIHYSAQITCGILHLH----SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVEL  145 (277)
T ss_pred             HHHHhccccCCCHHHHHHHHHHHHHHHHHHH----HCCEEEccCChHhEEEcCCCCEEEeeceeeeec
Confidence            88764 3345788899999999999999999    678999999999999999999999999998754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.78  E-value=1.5e-18  Score=163.43  Aligned_cols=133  Identities=26%  Similarity=0.408  Sum_probs=110.1

Q ss_pred             ccccccceeeeeccC---CcceEEEEEeccch-hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          342 LAGSFGSVYKGTISD---GTDVAIKIFNLQRE-RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       342 ~~g~~g~vy~~~l~~---g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      ++|+||.||+|...+   +..+++|.+..... .....+.+|+.++++++|+|+++++++|.+..     +||+++|+|.
T Consensus         4 g~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~   83 (269)
T cd05087           4 GNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLK   83 (269)
T ss_pred             cccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHH
Confidence            679999999997643   35688888765432 23346788999999999999999999887654     6799999999


Q ss_pred             HHhhcC----CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          413 KRLYSH----NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       413 ~~l~~~----~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      +++...    ....++....+++.++++|++|+|    +.+++||||||+||++++++++|++|||+++.
T Consensus        84 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~  149 (269)
T cd05087          84 GYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH----KNNFIHSDLALRNCLLTADLTVKIGDYGLSHN  149 (269)
T ss_pred             HHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH----HCCEeccccCcceEEEcCCCcEEECCcccccc
Confidence            998652    224567777889999999999999    67899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.78  E-value=7.8e-19  Score=172.61  Aligned_cols=134  Identities=23%  Similarity=0.335  Sum_probs=113.7

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      .+.|+||.||++... +|..+|+|.+....   ......+..|+.++.+++|++++++++.+...+     +||+++|+|
T Consensus         9 lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L   88 (360)
T cd05627           9 IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDM   88 (360)
T ss_pred             EeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccH
Confidence            378999999999864 58899999986532   223446778999999999999999998887665     679999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+++... ..++......++.+++.||+|||    +.+|+||||||+|||++.++++||+|||+|+.+
T Consensus        89 ~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH----~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~  151 (360)
T cd05627          89 MTLLMKK-DTLSEEATQFYIAETVLAIDAIH----QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGL  151 (360)
T ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH----HCCeEccCCCHHHEEECCCCCEEEeeccCCccc
Confidence            9988753 34677888889999999999999    688999999999999999999999999998754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.78  E-value=1.3e-18  Score=168.94  Aligned_cols=134  Identities=25%  Similarity=0.297  Sum_probs=113.6

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHH
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKR  414 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~  414 (481)
                      +.|+||.||++... +|..+|+|.+.... ......+.+|++++.+++|+||+++++++...+     ++|+++|+|.++
T Consensus        14 g~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~   93 (331)
T cd06649          14 GAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQV   93 (331)
T ss_pred             cCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHH
Confidence            68999999999865 57889999887643 233456889999999999999999999887654     679999999998


Q ss_pred             hhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          415 LYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       415 l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +... ..+++....+++.+++.|++|||+   ..+|+||||||+||++++++.+||+|||+++.+
T Consensus        94 l~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  154 (331)
T cd06649          94 LKEA-KRIPEEILGKVSIAVLRGLAYLRE---KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  154 (331)
T ss_pred             HHHc-CCCCHHHHHHHHHHHHHHHHHHhh---cCCEEcCCCChhhEEEcCCCcEEEccCcccccc
Confidence            8653 346778888999999999999994   246999999999999999999999999998754

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.78  E-value=9e-19  Score=173.53  Aligned_cols=137  Identities=25%  Similarity=0.440  Sum_probs=112.3

Q ss_pred             hhhccccccceeeeecc------CCcceEEEEEeccc-hhhhhhhhHHHHHhhhhc-cCccceeecccCCCC-----ccc
Q 039957          339 TISLAGSFGSVYKGTIS------DGTDVAIKIFNLQR-ERAFRSFNSECEVLRNVR-HQNLIKILSSCSTPD-----FKF  405 (481)
Q Consensus       339 ~l~~~g~~g~vy~~~l~------~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-----~~~  405 (481)
                      .+.++|+||.||+|+..      .+..||+|.+.... ....+.+.+|+++++++. ||||++++++|...+     +||
T Consensus        43 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey  122 (400)
T cd05105          43 RILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEY  122 (400)
T ss_pred             heecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEe
Confidence            34578999999998742      12469999886533 233456888999999996 999999999997764     689


Q ss_pred             ccCCChhHHhhcC-------------------------------------------------------------------
Q 039957          406 MPNGSLEKRLYSH-------------------------------------------------------------------  418 (481)
Q Consensus       406 ~~~g~l~~~l~~~-------------------------------------------------------------------  418 (481)
                      +++|+|.++++..                                                                   
T Consensus       123 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  202 (400)
T cd05105         123 CFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSD  202 (400)
T ss_pred             cCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhhh
Confidence            9999998877531                                                                   


Q ss_pred             ----------------------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 039957          419 ----------------------------NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHV  470 (481)
Q Consensus       419 ----------------------------~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl  470 (481)
                                                  ...+++..+.+++.++++|++|||    +.+|+||||||+||++++++.+||
T Consensus       203 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH----~~~ivH~dikp~Nill~~~~~~kL  278 (400)
T cd05105         203 IQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA----SKNCVHRDLAARNVLLAQGKIVKI  278 (400)
T ss_pred             cccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCChHhEEEeCCCEEEE
Confidence                                        123677788999999999999999    678999999999999999999999


Q ss_pred             ccccCcccC
Q 039957          471 SDFGISKLL  479 (481)
Q Consensus       471 ~Dfgl~~~~  479 (481)
                      +|||+++.+
T Consensus       279 ~DfGla~~~  287 (400)
T cd05105         279 CDFGLARDI  287 (400)
T ss_pred             EeCCcceec
Confidence            999998754

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.78  E-value=3.9e-19  Score=162.62  Aligned_cols=135  Identities=29%  Similarity=0.460  Sum_probs=109.0

Q ss_pred             hhccccccceeeeecc-CCcceEEEEEe--ccchhhhhhhhHHHHHhhhhccCccceeecccCCCC----------cccc
Q 039957          340 ISLAGSFGSVYKGTIS-DGTDVAIKIFN--LQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----------FKFM  406 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~-~g~~vavK~l~--~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----------~~~~  406 (481)
                      ..|.|.||.|.++... +|..||+|++.  ....-..++..+|+..++.++|+||+.+...+..+.          +++|
T Consensus        29 ~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elM  108 (359)
T KOG0660|consen   29 PIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELM  108 (359)
T ss_pred             cccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHH
Confidence            3488999999999854 68999999876  233334556778999999999999999998876632          2345


Q ss_pred             cCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          407 PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       407 ~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                       .-+|...++.. ..++-........|+.+|+.|+|    +.+|+|||+||+|++++.++..||||||+||.+.
T Consensus       109 -etDL~~iik~~-~~L~d~H~q~f~YQiLrgLKyiH----SAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~  176 (359)
T KOG0660|consen  109 -ETDLHQIIKSQ-QDLTDDHAQYFLYQILRGLKYIH----SANVIHRDLKPSNLLLNADCDLKICDFGLARYLD  176 (359)
T ss_pred             -hhHHHHHHHcC-ccccHHHHHHHHHHHHHhcchhh----cccccccccchhheeeccCCCEEeccccceeecc
Confidence             45666666543 33666777788999999999999    6789999999999999999999999999999874

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.78  E-value=9.7e-19  Score=170.71  Aligned_cols=136  Identities=29%  Similarity=0.485  Sum_probs=111.8

Q ss_pred             hhccccccceeeeec------cCCcceEEEEEeccc-hhhhhhhhHHHHHhhhh-ccCccceeecccCCCC------ccc
Q 039957          340 ISLAGSFGSVYKGTI------SDGTDVAIKIFNLQR-ERAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD------FKF  405 (481)
Q Consensus       340 l~~~g~~g~vy~~~l------~~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~------~~~  405 (481)
                      ..+.|+||.||+|..      .++..||||.+.... ......+.+|+.++.++ +|+|+++++++|...+      ++|
T Consensus        14 ~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey   93 (343)
T cd05103          14 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEF   93 (343)
T ss_pred             cccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEec
Confidence            447899999999862      356889999986543 22345678899999999 6899999999886543      579


Q ss_pred             ccCCChhHHhhcCC------------------------------------------------------------------
Q 039957          406 MPNGSLEKRLYSHN------------------------------------------------------------------  419 (481)
Q Consensus       406 ~~~g~l~~~l~~~~------------------------------------------------------------------  419 (481)
                      +++|+|.+++....                                                                  
T Consensus        94 ~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (343)
T cd05103          94 CKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYK  173 (343)
T ss_pred             cCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhhhhh
Confidence            99999998875421                                                                  


Q ss_pred             CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          420 YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       420 ~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ..++|..+.+++.++++|++|+|    +.+|+||||||+||++++++++|++|||+++.+
T Consensus       174 ~~~~~~~~~~~~~qi~~al~~lH----~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~  229 (343)
T cd05103         174 KVLTLEDLICYSFQVAKGMEFLA----SRKCIHRDLAARNILLSENNVVKICDFGLARDI  229 (343)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCccCeEEEcCCCcEEEEeccccccc
Confidence            13577888999999999999999    678999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.78  E-value=1.2e-18  Score=165.45  Aligned_cols=135  Identities=27%  Similarity=0.490  Sum_probs=112.1

Q ss_pred             hccccccceeeeec-----cCCcceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCC
Q 039957          341 SLAGSFGSVYKGTI-----SDGTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNG  409 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-----~~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g  409 (481)
                      .+.|+||.||+|..     ..+..+++|.+.... ......+.+|++++++++|+|++++++++...+     +||+++|
T Consensus        13 lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~   92 (283)
T cd05090          13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQG   92 (283)
T ss_pred             ccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCC
Confidence            36899999999974     245789999886433 233456888999999999999999999887654     6789999


Q ss_pred             ChhHHhhcC----------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 039957          410 SLEKRLYSH----------------NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDF  473 (481)
Q Consensus       410 ~l~~~l~~~----------------~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Df  473 (481)
                      +|.+++...                ...+++.+.+.++.+++.|++|||    +.+|+||||||+||++++++.+|++||
T Consensus        93 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH----~~~i~H~dlkp~nili~~~~~~kl~df  168 (283)
T cd05090          93 DLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS----SHFFVHKDLAARNILIGEQLHVKISDL  168 (283)
T ss_pred             cHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH----hcCeehhccccceEEEcCCCcEEeccc
Confidence            999987531                124678888999999999999999    578999999999999999999999999


Q ss_pred             cCcccC
Q 039957          474 GISKLL  479 (481)
Q Consensus       474 gl~~~~  479 (481)
                      |+++..
T Consensus       169 g~~~~~  174 (283)
T cd05090         169 GLSREI  174 (283)
T ss_pred             cccccc
Confidence            999753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.78  E-value=1.2e-18  Score=164.06  Aligned_cols=135  Identities=28%  Similarity=0.382  Sum_probs=115.3

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHH
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKR  414 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~  414 (481)
                      .+.|+||.||+|... ++..+++|.+........+.+.+|+.++++++|+||+++++++...+     ++|+++++|.++
T Consensus        16 lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~   95 (268)
T cd06624          16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSAL   95 (268)
T ss_pred             EecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHH
Confidence            468999999999854 57789999887665555667889999999999999999999988765     568899999999


Q ss_pred             hhcCCCcc--CHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCC-CCcEEEccccCcccC
Q 039957          415 LYSHNYFL--DILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDE-NMVAHVSDFGISKLL  479 (481)
Q Consensus       415 l~~~~~~~--~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~-~~~~kl~Dfgl~~~~  479 (481)
                      +.......  ++.....++.+|++|++|||    +.+|+|||+||+||+++. ++.+||+|||++..+
T Consensus        96 l~~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~  159 (268)
T cd06624          96 LRSKWGPLKDNEQTIIFYTKQILEGLKYLH----DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL  159 (268)
T ss_pred             HHHhcccCCCcHHHHHHHHHHHHHHHHHHH----HCCEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence            87643334  77888889999999999999    678999999999999987 689999999998654

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.78  E-value=7.7e-19  Score=169.85  Aligned_cols=132  Identities=25%  Similarity=0.316  Sum_probs=110.2

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccc---hhhhhhhhHHHHHhhhh-ccCccceeecccCCCC-----cccccCCCh
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      +.|+||.||+|... +|..+|+|.+....   ......+..|.+++..+ +|++|+++++++...+     +||+++|+|
T Consensus         4 G~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L   83 (321)
T cd05591           4 GKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDL   83 (321)
T ss_pred             ccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcH
Confidence            67999999999864 57889999986542   22234466788888765 7999999999887664     679999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      ..++... ..+++..+..++.++++||+|||    +.+|+||||||+||++++++.+||+|||+|+.
T Consensus        84 ~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~  145 (321)
T cd05591          84 MFQIQRS-RKFDEPRSRFYAAEVTLALMFLH----RHGVIYRDLKLDNILLDAEGHCKLADFGMCKE  145 (321)
T ss_pred             HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHeEECCCCCEEEeeccccee
Confidence            9887653 35678888899999999999999    67899999999999999999999999999874

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.78  E-value=8.7e-19  Score=169.79  Aligned_cols=132  Identities=30%  Similarity=0.404  Sum_probs=108.3

Q ss_pred             ccccccceeeeec-cCCcceEEEEEeccch---hhhhhhhHHHH-HhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          342 LAGSFGSVYKGTI-SDGTDVAIKIFNLQRE---RAFRSFNSECE-VLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       342 ~~g~~g~vy~~~l-~~g~~vavK~l~~~~~---~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      +.|+||.||++.. .+|..+|+|.+.....   .....+..|.. +++.++|+||+++++++...+     ++|+++|++
T Consensus         4 G~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L   83 (325)
T cd05604           4 GKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGEL   83 (325)
T ss_pred             eeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCH
Confidence            6799999999975 4688999999865421   22234445554 467799999999998887654     679999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      ..++... ..+++.+...++.+|++||+|||    +.+|+||||||+|||+++++.+||+|||+++.
T Consensus        84 ~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH----~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~  145 (325)
T cd05604          84 FFHLQRE-RSFPEPRARFYAAEIASALGYLH----SINIVYRDLKPENILLDSQGHVVLTDFGLCKE  145 (325)
T ss_pred             HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCHHHeEECCCCCEEEeecCCccc
Confidence            9887643 35678888899999999999999    67899999999999999999999999999874

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.78  E-value=1.8e-18  Score=162.96  Aligned_cols=138  Identities=30%  Similarity=0.530  Sum_probs=116.5

Q ss_pred             hhhhccccccceeeeeccC-C---cceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----ccccc
Q 039957          338 ETISLAGSFGSVYKGTISD-G---TDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMP  407 (481)
Q Consensus       338 ~~l~~~g~~g~vy~~~l~~-g---~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~  407 (481)
                      ....+.|+||.||+|.... |   ..+++|.+.... ......|..|++++++++|+|++++.+++....     +||++
T Consensus         9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~   88 (269)
T cd05065           9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFME   88 (269)
T ss_pred             EeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCC
Confidence            3345789999999998653 3   359999886542 334467889999999999999999999887654     57899


Q ss_pred             CCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          408 NGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       408 ~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +|+|.+++......+++.++..++.+++.|++|||    +.+++||||||+||++++++.+|++|||+++.+
T Consensus        89 ~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH----~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~  156 (269)
T cd05065          89 NGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS----EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL  156 (269)
T ss_pred             CCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH----HCCEeecccChheEEEcCCCcEEECCCcccccc
Confidence            99999998765556789999999999999999999    678999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.78  E-value=8.5e-19  Score=170.36  Aligned_cols=135  Identities=23%  Similarity=0.265  Sum_probs=113.7

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      .+.|+||.||++... .+..+|+|.+....   ......+..|+.++..++|++++++.+++...+     +||+++|+|
T Consensus         9 lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L   88 (332)
T cd05623           9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDL   88 (332)
T ss_pred             EEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcH
Confidence            378999999999865 46789999886432   122334778889999999999999998887665     679999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+++......+++.....++.+++.|++|||    +.+|+||||||+||+++.++.+||+|||+|+.+
T Consensus        89 ~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH----~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~  152 (332)
T cd05623          89 LTLLSKFEDRLPEDMARFYLAEMVIAIDSVH----QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL  152 (332)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHEEECCCCCEEEeecchheec
Confidence            9999765556788888889999999999999    678999999999999999999999999998653

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.78  E-value=1.8e-18  Score=161.79  Aligned_cols=133  Identities=25%  Similarity=0.425  Sum_probs=112.7

Q ss_pred             ccccccceeeeec---cCCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC----cccccCCChh
Q 039957          342 LAGSFGSVYKGTI---SDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----FKFMPNGSLE  412 (481)
Q Consensus       342 ~~g~~g~vy~~~l---~~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~~~~g~l~  412 (481)
                      ++|+||.||+|..   .++..+|+|.+....  ....+.+..|+.++++++|+|++++++++....    ++|+++|+|.
T Consensus         4 g~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~   83 (257)
T cd05116           4 GSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAELGPLN   83 (257)
T ss_pred             CCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCCCCcHH
Confidence            6799999999864   356889999886443  233457888999999999999999999886543    5788999999


Q ss_pred             HHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          413 KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       413 ~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +++... ..+++..+.+++.+++.|++|+|    +.+|+||||||+||++++++.+||+|||+++.+
T Consensus        84 ~~l~~~-~~~~~~~~~~i~~qi~~al~~lH----~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~  145 (257)
T cd05116          84 KFLQKN-KHVTEKNITELVHQVSMGMKYLE----ETNFVHRDLAARNVLLVTQHYAKISDFGLSKAL  145 (257)
T ss_pred             HHHHhc-CCCCHHHHHHHHHHHHHHHHHHH----HCCEeecccchhhEEEcCCCeEEECCCcccccc
Confidence            988643 35788899999999999999999    678999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.78  E-value=1.5e-18  Score=166.43  Aligned_cols=135  Identities=30%  Similarity=0.543  Sum_probs=112.8

Q ss_pred             hccccccceeeeecc-CCc----ceEEEEEeccch-hhhhhhhHHHHHhhhhccCccceeecccCCCC----cccccCCC
Q 039957          341 SLAGSFGSVYKGTIS-DGT----DVAIKIFNLQRE-RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----FKFMPNGS  410 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~----~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~~~~g~  410 (481)
                      .+.|+||.||+|... +|.    .+++|.+..... .....+.+|+.++++++|+|+++++++|....    ++|+++|+
T Consensus        15 lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~v~e~~~~g~   94 (303)
T cd05110          15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGC   94 (303)
T ss_pred             cccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCCceeeehhcCCCC
Confidence            478999999999753 444    467887754332 22346788999999999999999999987653    56899999


Q ss_pred             hhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          411 LEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       411 l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +.+++......+++..+..++.++++|++|||    +.+|+||||||+||++++++.+||+|||+++.+
T Consensus        95 l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH----~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~  159 (303)
T cd05110          95 LLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE----ERRLVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (303)
T ss_pred             HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHh----hcCeeccccccceeeecCCCceEEccccccccc
Confidence            99998766556788899999999999999999    678999999999999999999999999999754

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.77  E-value=9.3e-19  Score=169.14  Aligned_cols=132  Identities=27%  Similarity=0.374  Sum_probs=110.3

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccc---hhhhhhhhHHHHHhhhh-ccCccceeecccCCCC-----cccccCCCh
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      ++|+||.||++... ++..+|+|.+....   ......+..|..++... +|+||+++++++...+     +||+++|+|
T Consensus         4 g~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L   83 (320)
T cd05590           4 GKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDL   83 (320)
T ss_pred             eeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchH
Confidence            67999999999864 57889999986532   22334566778888765 6999999999887665     679999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      .+++... ..++...+..++.+++.||+|||    +.+|+||||||+||++++++.+||+|||+++.
T Consensus        84 ~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH----~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~  145 (320)
T cd05590          84 MFHIQKS-RRFDEARARFYAAEITSALMFLH----DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKE  145 (320)
T ss_pred             HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH----HCCeEeCCCCHHHeEECCCCcEEEeeCCCCee
Confidence            9887653 35778888999999999999999    67899999999999999999999999999874

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.77  E-value=1.1e-18  Score=171.78  Aligned_cols=132  Identities=20%  Similarity=0.264  Sum_probs=110.9

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      +.|+||.||++... ++..+|+|.+....   ......+..|+.+++.++||||+++++.+....     +||+++|+|.
T Consensus        52 G~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~  131 (371)
T cd05622          52 GRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV  131 (371)
T ss_pred             eecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHH
Confidence            68999999999865 57889999886432   222345678899999999999999999887665     5789999999


Q ss_pred             HHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          413 KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       413 ~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +++...  .++...+..++.+|+.||+|||    +.+|+||||||+|||++.++.+||+|||+|+.+
T Consensus       132 ~~~~~~--~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~  192 (371)
T cd05622         132 NLMSNY--DVPEKWARFYTAEVVLALDAIH----SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM  192 (371)
T ss_pred             HHHHhc--CCCHHHHHHHHHHHHHHHHHHH----HCCEEeCCCCHHHEEECCCCCEEEEeCCceeEc
Confidence            988653  3566677789999999999999    678999999999999999999999999998754

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.77  E-value=1.4e-18  Score=168.88  Aligned_cols=135  Identities=25%  Similarity=0.308  Sum_probs=113.8

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhH
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEK  413 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~  413 (481)
                      .+.|+||.||++... +|..+++|.+.... ......+.+|++++.+++|+||++++++|...+     ++|+++|+|.+
T Consensus        13 lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~   92 (333)
T cd06650          13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ   92 (333)
T ss_pred             ccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHH
Confidence            368999999999865 57888999876543 233456889999999999999999999987765     67899999999


Q ss_pred             HhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          414 RLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       414 ~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ++... ..+++.....++.++++|++|||+   ..+|+||||||+||++++++.+||+|||+++.+
T Consensus        93 ~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~  154 (333)
T cd06650          93 VLKKA-GRIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  154 (333)
T ss_pred             HHHHc-CCCCHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChhhEEEcCCCCEEEeeCCcchhh
Confidence            88653 346778888999999999999994   346999999999999999999999999998754

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.77  E-value=1.1e-18  Score=168.81  Aligned_cols=132  Identities=30%  Similarity=0.395  Sum_probs=107.2

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccch---hhhhhhhHHHH-HhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQRE---RAFRSFNSECE-VLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~~---~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      +.|+||.||++... +|..+|+|.+.....   .....+..|.. +++.++|+||+++.+++...+     +||+++|+|
T Consensus         4 g~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L   83 (321)
T cd05603           4 GKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGEL   83 (321)
T ss_pred             eeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCH
Confidence            67999999999864 578899999865422   22233445554 577899999999998887664     679999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      ..++... ..+...+...++.+|++||+|||    +.+|+||||||+||+++.++.+||+|||+++.
T Consensus        84 ~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH----~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~  145 (321)
T cd05603          84 FFHLQRE-RCFLEPRARFYAAEVASAIGYLH----SLNIIYRDLKPENILLDSQGHVVLTDFGLCKE  145 (321)
T ss_pred             HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH----HCCeEeccCCHHHeEECCCCCEEEccCCCCcc
Confidence            8887643 34566677789999999999999    67899999999999999999999999999875

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.77  E-value=2.2e-18  Score=163.51  Aligned_cols=135  Identities=26%  Similarity=0.401  Sum_probs=116.5

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHH
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKR  414 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~  414 (481)
                      -+.|+||.||++... ++..+++|.+..........+..|++++++++|+|+++++++|....     ++|+++|++...
T Consensus        13 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~   92 (282)
T cd06643          13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAV   92 (282)
T ss_pred             cccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHH
Confidence            367999999999865 47788899887655555567888999999999999999999887665     578999999888


Q ss_pred             hhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          415 LYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       415 l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +......+++..+..++.++++||+|||    +.+|+||||||+||+++.++.+|++|||+++..
T Consensus        93 ~~~~~~~l~~~~~~~~~~qi~~~L~~LH----~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  153 (282)
T cd06643          93 MLELERPLTEPQIRVVCKQTLEALNYLH----ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKN  153 (282)
T ss_pred             HHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCcccEEEccCCCEEEccccccccc
Confidence            7665556889999999999999999999    678999999999999999999999999998653

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.77  E-value=9.6e-19  Score=175.51  Aligned_cols=128  Identities=21%  Similarity=0.277  Sum_probs=108.0

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHH
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKR  414 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~  414 (481)
                      .+.|+||.||++... .+..|++|...      ...+.+|++++++++|+|||++++++....     ++|+ .|++.++
T Consensus       177 Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~~~L~~~  249 (461)
T PHA03211        177 LTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-RSDLYTY  249 (461)
T ss_pred             EccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-CCCHHHH
Confidence            367999999999865 46789999532      224567999999999999999999887655     3444 4788888


Q ss_pred             hhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          415 LYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       415 l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +......++|.++.+|+.++++||+|||    +.+||||||||+|||++.++.+||+|||+|+.+
T Consensus       250 l~~~~~~l~~~~~~~i~~qi~~aL~yLH----~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~  310 (461)
T PHA03211        250 LGARLRPLGLAQVTAVARQLLSAIDYIH----GEGIIHRDIKTENVLVNGPEDICLGDFGAACFA  310 (461)
T ss_pred             HHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCEEECcCCHHHEEECCCCCEEEcccCCceec
Confidence            7665556899999999999999999999    678999999999999999999999999998764

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.77  E-value=2e-18  Score=162.00  Aligned_cols=133  Identities=29%  Similarity=0.541  Sum_probs=113.2

Q ss_pred             ccccccceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC----cccccCCChhHHhhc
Q 039957          342 LAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----FKFMPNGSLEKRLYS  417 (481)
Q Consensus       342 ~~g~~g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~~~~g~l~~~l~~  417 (481)
                      +.|++|.||+|...++..+++|.+..... ....+.+|++++++++|+|++++++.+....    ++|+++|++.+++..
T Consensus        15 g~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~   93 (262)
T cd05071          15 GQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKG   93 (262)
T ss_pred             CCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECCCCcEEEEEcCCCCcHHHHHhh
Confidence            67999999999877667799998865332 2346788999999999999999998775443    678999999999875


Q ss_pred             C-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          418 H-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       418 ~-~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      . ....++..+.+++.++++||+|+|    +.+|+||||||+||++++++.+||+|||.++.+
T Consensus        94 ~~~~~~~~~~~~~~~~~l~~aL~~lH----~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~  152 (262)
T cd05071          94 EMGKYLRLPQLVDMAAQIASGMAYVE----RMNYVHRDLRAANILVGENLVCKVADFGLARLI  152 (262)
T ss_pred             ccccCCCHHHHHHHHHHHHHHHHHHH----HCCccccccCcccEEEcCCCcEEeccCCceeec
Confidence            3 345788999999999999999999    678999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.77  E-value=6.6e-19  Score=171.30  Aligned_cols=135  Identities=31%  Similarity=0.487  Sum_probs=115.8

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccch--hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRE--RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      .++|+|+.|..+... .|..||+|.++....  .....+.+|++++..++|||||+++.+.....     +||..+|.++
T Consensus        64 ig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~  143 (596)
T KOG0586|consen   64 IGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELF  143 (596)
T ss_pred             eccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchhH
Confidence            478999999999854 589999999987653  23345788999999999999999999887654     6799999999


Q ss_pred             HHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          413 KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       413 ~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      +++..++...+ .....+..++.+|++|+|    +..|||||||++|||||+++.+||+|||++..+.
T Consensus       144 ~yl~~~gr~~e-~~ar~~F~q~vsaveYcH----~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~  206 (596)
T KOG0586|consen  144 DYLVKHGRMKE-KEARAKFRQIVSAVEYCH----SKNIVHRDLKAENILLDENMNIKIADFGFSTFFD  206 (596)
T ss_pred             HHHHhcccchh-hhhhhhhHHHHHHHHHHh----hcceeccccchhhcccccccceeeeccccceeec
Confidence            99988766666 566678899999999999    6779999999999999999999999999987764

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.77  E-value=1.2e-18  Score=168.62  Aligned_cols=132  Identities=31%  Similarity=0.411  Sum_probs=108.0

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccch---hhhhhhhHHHH-HhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQRE---RAFRSFNSECE-VLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~~---~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      +.|+||.||++... +|..+|+|.+.....   .....+..|.. +++.++|+||+++.+.+...+     ++|+++|+|
T Consensus         4 g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L   83 (323)
T cd05575           4 GKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGEL   83 (323)
T ss_pred             eeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCH
Confidence            67999999999864 689999999865422   12233444444 567799999999998887654     679999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      .+++... ..+++.....++.+|++||+|||    +.+|+||||||+|||+++++.+||+|||+++.
T Consensus        84 ~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH----~~givH~dikp~NIll~~~~~~kl~Dfg~~~~  145 (323)
T cd05575          84 FFHLQRE-RSFPEPRARFYAAEIASALGYLH----SLNIIYRDLKPENILLDSQGHVVLTDFGLCKE  145 (323)
T ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH----HCCeEeCCCCHHHeEECCCCcEEEeccCCCcc
Confidence            9888653 35677888889999999999999    67899999999999999999999999999875

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.77  E-value=2.2e-18  Score=161.73  Aligned_cols=134  Identities=29%  Similarity=0.517  Sum_probs=114.4

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHH
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKR  414 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~  414 (481)
                      .+.|++|.||++... .+..+++|.+.... .....+.+|++++++++|+|+++++++|...+     ++|+++|+|.++
T Consensus        14 ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   92 (263)
T cd05052          14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY   92 (263)
T ss_pred             cCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHH
Confidence            367999999999865 47889999876432 23456788999999999999999999887664     578999999998


Q ss_pred             hhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          415 LYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       415 l~~~-~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +... ...+++..+..++.++++|++|||    +.+|+||||||+||++++++.+||+|||+++..
T Consensus        93 ~~~~~~~~l~~~~~~~~~~ql~~~l~~lH----~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~  154 (263)
T cd05052          93 LRECNRQEVNAVVLLYMATQISSAMEYLE----KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM  154 (263)
T ss_pred             HHhCCCCCCCHHHHHHHHHHHHHHHHHHH----hCCEeecccCcceEEEcCCCcEEeCCCcccccc
Confidence            8653 345789999999999999999999    678999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.77  E-value=2e-18  Score=164.41  Aligned_cols=136  Identities=30%  Similarity=0.515  Sum_probs=114.5

Q ss_pred             hhccccccceeeeecc------CCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccC
Q 039957          340 ISLAGSFGSVYKGTIS------DGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPN  408 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~------~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~  408 (481)
                      ..+.|+||.||++...      ++..+++|.+..........+..|++++.+++|++++++.++|...+     ++|+++
T Consensus        12 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   91 (288)
T cd05093          12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKH   91 (288)
T ss_pred             ccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCC
Confidence            3478999999998742      24568888886655555567889999999999999999999987664     678999


Q ss_pred             CChhHHhhcCC------------CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCc
Q 039957          409 GSLEKRLYSHN------------YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGIS  476 (481)
Q Consensus       409 g~l~~~l~~~~------------~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~  476 (481)
                      |+|.+++....            ..+++..+.+++.+++.|++|||    +.+|+||||||+||++++++.+||+|||++
T Consensus        92 ~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH----~~~i~H~dlkp~Nili~~~~~~kl~dfg~~  167 (288)
T cd05093          92 GDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA----SQHFVHRDLATRNCLVGENLLVKIGDFGMS  167 (288)
T ss_pred             CCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeecccCcceEEEccCCcEEeccCCcc
Confidence            99999886422            24788999999999999999999    678999999999999999999999999998


Q ss_pred             ccC
Q 039957          477 KLL  479 (481)
Q Consensus       477 ~~~  479 (481)
                      +.+
T Consensus       168 ~~~  170 (288)
T cd05093         168 RDV  170 (288)
T ss_pred             ccc
Confidence            754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.77  E-value=1.3e-18  Score=167.91  Aligned_cols=132  Identities=25%  Similarity=0.315  Sum_probs=107.4

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccc---hhhhhhhhHHHHHhhh-hccCccceeecccCCCC-----cccccCCCh
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQR---ERAFRSFNSECEVLRN-VRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      +.|+||.||++... ++..||+|.+....   ....+.+..|..++.. .+|+||+++++++...+     +||+++|+|
T Consensus         4 G~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L   83 (316)
T cd05592           4 GKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDL   83 (316)
T ss_pred             eeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcH
Confidence            67999999999864 57889999987542   1223334456666654 48999999998887654     678999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      ..++... ..++......++.+++.||+|||    +.+|+||||||+||+++.++.+||+|||+|+.
T Consensus        84 ~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH----~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~  145 (316)
T cd05592          84 MFHIQSS-GRFDEARARFYAAEIICGLQFLH----KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKE  145 (316)
T ss_pred             HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH----HCCEEeCCCCHHHeEECCCCCEEEccCcCCeE
Confidence            9888653 34677788889999999999999    67899999999999999999999999999875

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.77  E-value=1.2e-18  Score=168.02  Aligned_cols=132  Identities=26%  Similarity=0.340  Sum_probs=109.7

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccc---hhhhhhhhHHHHHhhh-hccCccceeecccCCCC-----cccccCCCh
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQR---ERAFRSFNSECEVLRN-VRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      +.|+||.||+|... ++..+|+|.+....   ......+..|..++.. .+||||+++++++...+     ++|+++|+|
T Consensus         4 G~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L   83 (316)
T cd05619           4 GKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDL   83 (316)
T ss_pred             eeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcH
Confidence            67999999999865 47889999987542   1223345567777765 58999999999887664     679999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      .+++... ..+++.+...++.++++|++|||    +.+|+||||||+||++++++.+||+|||+++.
T Consensus        84 ~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH----~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~  145 (316)
T cd05619          84 MFHIQSC-HKFDLPRATFYAAEIICGLQFLH----SKGIVYRDLKLDNILLDTDGHIKIADFGMCKE  145 (316)
T ss_pred             HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH----hCCeEeCCCCHHHEEECCCCCEEEccCCcceE
Confidence            9988643 35678888999999999999999    67899999999999999999999999999874

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.77  E-value=2.3e-18  Score=164.18  Aligned_cols=136  Identities=30%  Similarity=0.503  Sum_probs=114.3

Q ss_pred             hhccccccceeeeecc------CCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccC
Q 039957          340 ISLAGSFGSVYKGTIS------DGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPN  408 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~------~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~  408 (481)
                      ..+.|+||.||++...      ++..+++|.+........+.+.+|++.+++++|+|++++.+++...+     ++|+++
T Consensus        12 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   91 (291)
T cd05094          12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKH   91 (291)
T ss_pred             eecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCC
Confidence            3467999999998742      34568888876555555567889999999999999999999987765     578999


Q ss_pred             CChhHHhhcCC---------------CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 039957          409 GSLEKRLYSHN---------------YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDF  473 (481)
Q Consensus       409 g~l~~~l~~~~---------------~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Df  473 (481)
                      |+|.+++....               ..++|..+.+++.+++.|++|||    +.+|+||||||+||+++.++.+||+||
T Consensus        92 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH----~~~i~H~dlkp~Nil~~~~~~~~l~df  167 (291)
T cd05094          92 GDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA----SQHFVHRDLATRNCLVGANLLVKIGDF  167 (291)
T ss_pred             CcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH----hCCeeecccCcceEEEccCCcEEECCC
Confidence            99999986422               23788999999999999999999    678999999999999999999999999


Q ss_pred             cCcccC
Q 039957          474 GISKLL  479 (481)
Q Consensus       474 gl~~~~  479 (481)
                      |+++..
T Consensus       168 g~a~~~  173 (291)
T cd05094         168 GMSRDV  173 (291)
T ss_pred             Cccccc
Confidence            998753

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.77  E-value=2.7e-18  Score=162.67  Aligned_cols=136  Identities=28%  Similarity=0.521  Sum_probs=114.9

Q ss_pred             hhccccccceeeeecc-CCc----ceEEEEEeccch-hhhhhhhHHHHHhhhhccCccceeecccCCCC----cccccCC
Q 039957          340 ISLAGSFGSVYKGTIS-DGT----DVAIKIFNLQRE-RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----FKFMPNG  409 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~-~g~----~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~~~~g  409 (481)
                      ..+.|+||.||+|... +|.    .+++|....... .....+.+|+..+++++|+|+++++++|....    ++|+++|
T Consensus        14 ~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~g   93 (279)
T cd05057          14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQLITQLMPLG   93 (279)
T ss_pred             eecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCceEEEEecCCCC
Confidence            3478999999999854 332    578887765433 33456888999999999999999999987643    5789999


Q ss_pred             ChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          410 SLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       410 ~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +|.+++......+++....+++.++++|++|||    +.+|+||||||+||++++++.+||+|||+++.+
T Consensus        94 ~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH----~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~  159 (279)
T cd05057          94 CLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE----EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (279)
T ss_pred             cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----hCCEEecccCcceEEEcCCCeEEECCCcccccc
Confidence            999998876556889999999999999999999    678999999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.77  E-value=1.6e-18  Score=162.04  Aligned_cols=134  Identities=29%  Similarity=0.455  Sum_probs=114.6

Q ss_pred             ccccccceeeeeccC--C--cceEEEEEeccch-hhhhhhhHHHHHhhhhccCccceeecccCCCC----cccccCCChh
Q 039957          342 LAGSFGSVYKGTISD--G--TDVAIKIFNLQRE-RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----FKFMPNGSLE  412 (481)
Q Consensus       342 ~~g~~g~vy~~~l~~--g--~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~~~~g~l~  412 (481)
                      ++|++|.||+|....  +  ..+|+|.+..... ...+.+..|++.+++++|+|++++++.+....    +||+++|+|.
T Consensus         4 g~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~~L~   83 (257)
T cd05040           4 GDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPLGSLL   83 (257)
T ss_pred             CccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcCCeEEEEEEecCCCcHH
Confidence            679999999998643  3  3589998876554 45567889999999999999999999887622    5688999999


Q ss_pred             HHhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          413 KRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       413 ~~l~~~~-~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +++.... ..++|.....++.++++|++|||    +.+++||||||+||+++.++.+||+|||+++.+
T Consensus        84 ~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH----~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~  147 (257)
T cd05040          84 DRLRKDALGHFLISTLCDYAVQIANGMRYLE----SKRFIHRDLAARNILLASDDKVKIGDFGLMRAL  147 (257)
T ss_pred             HHHHhcccccCcHHHHHHHHHHHHHHHHHHH----hCCccccccCcccEEEecCCEEEeccccccccc
Confidence            9987644 46789999999999999999999    678999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.77  E-value=1.4e-18  Score=169.40  Aligned_cols=133  Identities=26%  Similarity=0.400  Sum_probs=109.4

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC----------ccccc
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----------FKFMP  407 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----------~~~~~  407 (481)
                      -+.|+||.||+|... +|..||+|.+....  ......+.+|+.++++++|+||+++.+++....          +||++
T Consensus         8 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~   87 (338)
T cd07859           8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME   87 (338)
T ss_pred             EeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecCC
Confidence            367999999999854 68999999886432  223345778999999999999999998774321          45774


Q ss_pred             CCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          408 NGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       408 ~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                       +++.+++... ..+++..+..++.+|++||+|||    +.+|+||||||+|||+++++.+||+|||+|+..
T Consensus        88 -~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          88 -SDLHQVIKAN-DDLTPEHHQFFLYQLLRALKYIH----TANVFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             -CCHHHHHHhc-ccCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence             6888877643 35788899999999999999999    678999999999999999999999999998753

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.77  E-value=2e-18  Score=162.68  Aligned_cols=136  Identities=24%  Similarity=0.434  Sum_probs=115.2

Q ss_pred             hhccccccceeeeeccCC----cceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC----cccccCCC
Q 039957          340 ISLAGSFGSVYKGTISDG----TDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----FKFMPNGS  410 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~~g----~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~~~~g~  410 (481)
                      .-+.|+||.||+|...+.    ..+++|...... ....+.+.+|+.++++++|+|+++++++|....    ++|+++|+
T Consensus        13 ~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~lv~e~~~~~~   92 (270)
T cd05056          13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENPVWIVMELAPLGE   92 (270)
T ss_pred             eeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCCCcEEEEEcCCCCc
Confidence            346899999999986432    468888876544 334457888999999999999999999887654    57899999


Q ss_pred             hhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          411 LEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       411 l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      |.+++......+++..+..++.+++.|++|+|    +.+++||||||+||+++.++.+|++|||+++..
T Consensus        93 L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~  157 (270)
T cd05056          93 LRSYLQVNKYSLDLASLILYSYQLSTALAYLE----SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL  157 (270)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccccChheEEEecCCCeEEccCceeeec
Confidence            99998765556889999999999999999999    678999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.77  E-value=2.7e-19  Score=171.53  Aligned_cols=134  Identities=28%  Similarity=0.459  Sum_probs=109.4

Q ss_pred             ccCChhhhhccccccceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----ccccc
Q 039957          333 ALVDLETISLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMP  407 (481)
Q Consensus       333 ~l~~L~~l~~~g~~g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~  407 (481)
                      ....|++| ++|+.|.||.|.+. +..||||+.+...       ..++.-|++++|+||+.+.|.|....     +||++
T Consensus       125 ~IsELeWl-GSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa  195 (904)
T KOG4721|consen  125 EISELEWL-GSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCA  195 (904)
T ss_pred             Hhhhhhhh-ccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccc
Confidence            33344444 68999999999985 6789998754322       23688899999999999999998764     78999


Q ss_pred             CCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          408 NGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       408 ~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      .|.|+..+...+.. .-........+||.||.|||    .+.|||||+|.-|||+..+..+||+|||.++-+.
T Consensus       196 ~GqL~~VLka~~~i-tp~llv~Wsk~IA~GM~YLH----~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~  263 (904)
T KOG4721|consen  196 QGQLYEVLKAGRPI-TPSLLVDWSKGIAGGMNYLH----LHKIIHRDLKSPNILISYDDVVKISDFGTSKELS  263 (904)
T ss_pred             cccHHHHHhccCcc-CHHHHHHHHHHhhhhhHHHH----HhhHhhhccCCCceEeeccceEEeccccchHhhh
Confidence            99999999875533 33445667889999999999    5779999999999999999999999999988653

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.77  E-value=2.2e-18  Score=163.65  Aligned_cols=133  Identities=29%  Similarity=0.485  Sum_probs=111.4

Q ss_pred             hccccccceeeee-----ccCCcceEEEEEeccch-hhhhhhhHHHHHhhhhccCccceeecccCCCC-------ccccc
Q 039957          341 SLAGSFGSVYKGT-----ISDGTDVAIKIFNLQRE-RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-------FKFMP  407 (481)
Q Consensus       341 ~~~g~~g~vy~~~-----l~~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-------~~~~~  407 (481)
                      -+.|+||.||.+.     ..++..+|+|.+..... .....+.+|++++++++|+|++++.++|...+       ++|++
T Consensus        12 lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~   91 (283)
T cd05080          12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVP   91 (283)
T ss_pred             cccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCC
Confidence            3679999997653     23578899998865432 23456788999999999999999999875432       56889


Q ss_pred             CCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          408 NGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       408 ~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +|+|.+++...  .+++.++.+++.++++|++|||    +.+|+||||||+||++++++.+||+|||+++.+
T Consensus        92 ~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH----~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  157 (283)
T cd05080          92 LGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLH----SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  157 (283)
T ss_pred             CCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHH----HCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence            99999988653  4789999999999999999999    678999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.77  E-value=1.6e-18  Score=168.53  Aligned_cols=134  Identities=25%  Similarity=0.318  Sum_probs=111.0

Q ss_pred             hccccccceeeeec----cCCcceEEEEEeccc----hhhhhhhhHHHHHhhhhc-cCccceeecccCCCC-----cccc
Q 039957          341 SLAGSFGSVYKGTI----SDGTDVAIKIFNLQR----ERAFRSFNSECEVLRNVR-HQNLIKILSSCSTPD-----FKFM  406 (481)
Q Consensus       341 ~~~g~~g~vy~~~l----~~g~~vavK~l~~~~----~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-----~~~~  406 (481)
                      .+.|+||.||++..    .+|..+|+|.+....    ....+.+..|+.++.+++ |++|+++.+++...+     ++|+
T Consensus         8 lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   87 (332)
T cd05614           8 LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYV   87 (332)
T ss_pred             EeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCC
Confidence            37899999998864    357889999886432    223345778999999985 899999988876654     6799


Q ss_pred             cCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          407 PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       407 ~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ++|+|.+++... ..+++.+...++.+|++||+|||    +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        88 ~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH----~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~  155 (332)
T cd05614          88 SGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLH----KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (332)
T ss_pred             CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH----HCCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence            999999988653 34677888899999999999999    678999999999999999999999999998753

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.77  E-value=1.7e-18  Score=164.50  Aligned_cols=135  Identities=26%  Similarity=0.347  Sum_probs=113.7

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccch---hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQRE---RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      .+.|+||.||++.. .++..||+|.+.....   .....+.+|+.++++++|+|++++.+.+...+     ++|+++|+|
T Consensus         8 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L   87 (285)
T cd05605           8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDL   87 (285)
T ss_pred             EecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcH
Confidence            36899999999985 4688999998865332   22234677999999999999999999887665     678999999


Q ss_pred             hHHhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          412 EKRLYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~-~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+++... ...+++.....++.+++.|++|||    +.+|+||||||+||++++++.+||+|||+++.+
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~  152 (285)
T cd05605          88 KFHIYNMGNPGFDEERAVFYAAEITCGLEDLH----RERIVYRDLKPENILLDDYGHIRISDLGLAVEI  152 (285)
T ss_pred             HHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH----HCCcEecCCCHHHEEECCCCCEEEeeCCCceec
Confidence            9887643 345788899999999999999999    678999999999999999999999999998764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.77  E-value=1.3e-18  Score=182.81  Aligned_cols=135  Identities=25%  Similarity=0.332  Sum_probs=113.5

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      .+.|+||.||+|... +|..||+|.+....   ....+++.+|++++++++|||+++++++|...+     ++|+++|+|
T Consensus        10 LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL   89 (932)
T PRK13184         10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTL   89 (932)
T ss_pred             EecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCH
Confidence            378999999999854 58899999986432   223456888999999999999999999887664     678999999


Q ss_pred             hHHhhcC----------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          412 EKRLYSH----------NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~----------~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+++...          ....++...++++.+|++||+|||    +.+|+||||||+||+++.++.+||+|||+|+..
T Consensus        90 ~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH----s~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i  163 (932)
T PRK13184         90 KSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH----SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFK  163 (932)
T ss_pred             HHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH----HCCccccCCchheEEEcCCCCEEEEecCcceec
Confidence            9887531          123466778899999999999999    678999999999999999999999999999865

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.77  E-value=1.8e-18  Score=166.41  Aligned_cols=133  Identities=23%  Similarity=0.423  Sum_probs=111.5

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccch-hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHH
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQRE-RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKR  414 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~  414 (481)
                      +.|+||.||+|... ++..+|+|.+..... .....+.+|++++++++|+|++++++++...+     ++|++ +++.++
T Consensus        15 g~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~   93 (309)
T cd07872          15 GEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLD-KDLKQY   93 (309)
T ss_pred             cccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCC-CCHHHH
Confidence            67999999999864 578899998875432 22345678999999999999999999987654     56776 588887


Q ss_pred             hhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          415 LYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       415 l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +......+++.....++.++++||+|||    +.+|+||||||+||++++++.+||+|||+++..
T Consensus        94 ~~~~~~~~~~~~~~~~~~qi~~aL~~lH----~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  154 (309)
T cd07872          94 MDDCGNIMSMHNVKIFLYQILRGLAYCH----RRKVLHRDLKPQNLLINERGELKLADFGLARAK  154 (309)
T ss_pred             HHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEECCCCCEEECccccceec
Confidence            7665556788888899999999999999    678999999999999999999999999998753

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.77  E-value=3.4e-18  Score=160.17  Aligned_cols=134  Identities=28%  Similarity=0.516  Sum_probs=113.1

Q ss_pred             hccccccceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC----cccccCCChhHHhh
Q 039957          341 SLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----FKFMPNGSLEKRLY  416 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~~~~g~l~~~l~  416 (481)
                      .+.|++|.||++....+..+++|.+.... ...+.+..|++++++++|++++++.+++....    ++|+++|+|.+++.
T Consensus        14 ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~~~   92 (260)
T cd05069          14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMGKGSLLDFLK   92 (260)
T ss_pred             ecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcEEEEEcCCCCCHHHHHh
Confidence            46799999999987777779999875432 22346788999999999999999998875433    57889999999987


Q ss_pred             cC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          417 SH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       417 ~~-~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .. ....+|..+..++.+++.|++|||    +.+|+||||||+||++++++.+||+|||+++..
T Consensus        93 ~~~~~~~~~~~~~~~~~~l~~al~~lH----~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~  152 (260)
T cd05069          93 EGDGKYLKLPQLVDMAAQIADGMAYIE----RMNYIHRDLRAANILVGDNLVCKIADFGLARLI  152 (260)
T ss_pred             hCCCCCCCHHHHHHHHHHHHHHHHHHH----hCCEeecccCcceEEEcCCCeEEECCCccceEc
Confidence            53 345789999999999999999999    578999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.77  E-value=2.6e-18  Score=160.96  Aligned_cols=134  Identities=27%  Similarity=0.505  Sum_probs=115.0

Q ss_pred             hccccccceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC----cccccCCChhHHhh
Q 039957          341 SLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----FKFMPNGSLEKRLY  416 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~~~~g~l~~~l~  416 (481)
                      .+.|++|.||++...++..+++|.+..... ..+.+.+|+.++++++|++++++++++....    ++|+++|+|.+++.
T Consensus        14 ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~   92 (260)
T cd05070          14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLK   92 (260)
T ss_pred             eccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECCCCcEEEEEecCCCcHHHHHH
Confidence            467999999999888888899998865432 2356888999999999999999998876543    67899999999987


Q ss_pred             cC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          417 SH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       417 ~~-~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +. ...+++.++.+++.+++.|++|||    +.+|+||||||+||++++++.+|++|||+++.+
T Consensus        93 ~~~~~~~~~~~~~~~~~~l~~al~~lH----~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~  152 (260)
T cd05070          93 DGEGRALKLPNLVDMAAQVAAGMAYIE----RMNYIHRDLRSANILVGDGLVCKIADFGLARLI  152 (260)
T ss_pred             hcCCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCccceEEEeCCceEEeCCceeeeec
Confidence            53 345789999999999999999999    578999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.77  E-value=2.9e-18  Score=159.75  Aligned_cols=134  Identities=34%  Similarity=0.547  Sum_probs=116.2

Q ss_pred             ccccccceeeeeccCCcceEEEEEeccchh-hhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHHh
Q 039957          342 LAGSFGSVYKGTISDGTDVAIKIFNLQRER-AFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRL  415 (481)
Q Consensus       342 ~~g~~g~vy~~~l~~g~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~l  415 (481)
                      +.|++|.||++...++..+++|........ ....+..|++++++++|++++++++++....     ++|++++++.+++
T Consensus         4 g~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l   83 (251)
T cd05041           4 GKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFL   83 (251)
T ss_pred             ccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHH
Confidence            578999999999877899999987654433 4457888999999999999999999887664     5688999999998


Q ss_pred             hcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          416 YSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       416 ~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ......+++.....++.+++.|++|||    +.+++||||||+||+++.++.+||+|||+++..
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~l~~lH----~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~  143 (251)
T cd05041          84 RKKKNRLTVKKLLQMSLDAAAGMEYLE----SKNCIHRDLAARNCLVGENNVLKISDFGMSREE  143 (251)
T ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCEehhhcCcceEEEcCCCcEEEeeccccccc
Confidence            765556788889999999999999999    578999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.77  E-value=2.5e-18  Score=161.81  Aligned_cols=133  Identities=21%  Similarity=0.365  Sum_probs=107.4

Q ss_pred             ccccccceeeeeccCCc---ceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          342 LAGSFGSVYKGTISDGT---DVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       342 ~~g~~g~vy~~~l~~g~---~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      +.|+||.||++...++.   .+++|.+.... ....+.+.+|+..+++++|||++++++.|....     +||+++|+|.
T Consensus         4 g~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~   83 (268)
T cd05086           4 GNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLK   83 (268)
T ss_pred             CCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHH
Confidence            57999999999765443   34566554432 234457888999999999999999999987664     6799999999


Q ss_pred             HHhhcCC---CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          413 KRLYSHN---YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       413 ~~l~~~~---~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      +++....   ...++.....++.+|++|++|||    +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        84 ~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH----~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~  148 (268)
T cd05086          84 SYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH----KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPS  148 (268)
T ss_pred             HHHHhhhcccccccHHHHHHHHHHHHHHHHHHH----HCCeeccCCccceEEEcCCccEEecccccccc
Confidence            9987532   23455667789999999999999    57899999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.77  E-value=3.3e-18  Score=161.37  Aligned_cols=137  Identities=32%  Similarity=0.532  Sum_probs=112.8

Q ss_pred             hhhccccccceeeeeccC----CcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC----------
Q 039957          339 TISLAGSFGSVYKGTISD----GTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----------  402 (481)
Q Consensus       339 ~l~~~g~~g~vy~~~l~~----g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----------  402 (481)
                      ...+.|+||.||+|....    +..+|+|.+....  ......+..|++.+++++|+|++++++++....          
T Consensus         5 ~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~   84 (273)
T cd05035           5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMV   84 (273)
T ss_pred             cccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEE
Confidence            344789999999998642    3679999886543  233456888999999999999999999875533          


Q ss_pred             -cccccCCChhHHhhcC-----CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCc
Q 039957          403 -FKFMPNGSLEKRLYSH-----NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGIS  476 (481)
Q Consensus       403 -~~~~~~g~l~~~l~~~-----~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~  476 (481)
                       ++|+++|++.+++...     ...+++.....++.+++.|++|+|    +.+|+||||||+||++++++.+||+|||+|
T Consensus        85 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  160 (273)
T cd05035          85 ILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS----NRNFIHRDLAARNCMLREDMTVCVADFGLS  160 (273)
T ss_pred             EEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH----hCCeeccccchheEEECCCCeEEECCccce
Confidence             3689999999887542     235788889999999999999999    578999999999999999999999999998


Q ss_pred             ccC
Q 039957          477 KLL  479 (481)
Q Consensus       477 ~~~  479 (481)
                      +..
T Consensus       161 ~~~  163 (273)
T cd05035         161 KKI  163 (273)
T ss_pred             eec
Confidence            754

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.77  E-value=2.9e-18  Score=160.26  Aligned_cols=134  Identities=32%  Similarity=0.535  Sum_probs=115.5

Q ss_pred             hhccccccceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHH
Q 039957          340 ISLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKR  414 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~  414 (481)
                      ..+.|++|.||++... |..+++|.+..... ..+++.+|+.++++++|+|++++++++...+     ++|+++|+|.++
T Consensus        13 ~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~   90 (256)
T cd05039          13 TIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDY   90 (256)
T ss_pred             eeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHH
Confidence            3478999999999864 78899999876543 4567888999999999999999999887654     578999999998


Q ss_pred             hhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          415 LYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       415 l~~~~-~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +.... ..+++.....++.+++.|++|||    +.+|+||||||+||++++++.+||+|||.++..
T Consensus        91 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lh----~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~  152 (256)
T cd05039          91 LRSRGRAVITLAQQLGFALDVCEGMEYLE----EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEA  152 (256)
T ss_pred             HHhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCccchhcccceEEEeCCCCEEEccccccccc
Confidence            87543 35789999999999999999999    678999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.77  E-value=3.2e-18  Score=161.11  Aligned_cols=137  Identities=29%  Similarity=0.530  Sum_probs=115.9

Q ss_pred             hhhccccccceeeeeccC-C---cceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccC
Q 039957          339 TISLAGSFGSVYKGTISD-G---TDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPN  408 (481)
Q Consensus       339 ~l~~~g~~g~vy~~~l~~-g---~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~  408 (481)
                      ...+.|++|.||+|.... +   ..+++|...... ....+.+..|+.++++++|+|++++.+++...+     +||+++
T Consensus        11 ~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   90 (268)
T cd05063          11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMEN   90 (268)
T ss_pred             eEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCC
Confidence            345789999999998752 3   368888876542 333456888999999999999999999987665     678999


Q ss_pred             CChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          409 GSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       409 g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      |+|.+++......+++.++..++.+++.|++|+|    +.+|+|||+||+||++++++.+|++|||+++..
T Consensus        91 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH----~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  157 (268)
T cd05063          91 GALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS----DMNYVHRDLAARNILVNSNLECKVSDFGLSRVL  157 (268)
T ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeccccchhhEEEcCCCcEEECCCccceec
Confidence            9999998766566889999999999999999999    678999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.77  E-value=1.7e-18  Score=167.66  Aligned_cols=132  Identities=25%  Similarity=0.341  Sum_probs=108.8

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc---hhhhhhhhHHHHH---hhhhccCccceeecccCCCC-----cccccC
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR---ERAFRSFNSECEV---LRNVRHQNLIKILSSCSTPD-----FKFMPN  408 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~---~~~~~~~~~e~~~---l~~l~h~niv~l~~~~~~~~-----~~~~~~  408 (481)
                      .+.|+||.||++... +|..||+|.+....   ....+.+..|+.+   +++++|+||+++++++...+     +||+++
T Consensus         7 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~   86 (324)
T cd05589           7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAG   86 (324)
T ss_pred             EeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCCC
Confidence            368999999999754 68899999987542   1223345556554   45678999999999887665     679999


Q ss_pred             CChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          409 GSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       409 g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      |+|..++..  ..+++.+...++.+++.|++|||    +.+|+||||||+||++++++.+||+|||+++.
T Consensus        87 ~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH----~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~  150 (324)
T cd05589          87 GDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLH----ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKE  150 (324)
T ss_pred             CcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH----hCCeEecCCCHHHeEECCCCcEEeCcccCCcc
Confidence            999888754  35788999999999999999999    67899999999999999999999999999874

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.77  E-value=1.7e-18  Score=166.93  Aligned_cols=132  Identities=24%  Similarity=0.329  Sum_probs=109.1

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccch---hhhhhhhHHHHHhhh-hccCccceeecccCCCC-----cccccCCCh
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQRE---RAFRSFNSECEVLRN-VRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      +.|+||.||++... +|..+|+|.+.....   ........|..++.. .+|++++++++++...+     +||+++|+|
T Consensus         4 g~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L   83 (316)
T cd05620           4 GKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDL   83 (316)
T ss_pred             eeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcH
Confidence            67999999999865 578899999875421   223345567777765 48999999999887665     678999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      .+++... ..+++.+...++.++++||+|||    +.+|+||||||+||++++++.+||+|||+++.
T Consensus        84 ~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH----~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~  145 (316)
T cd05620          84 MFHIQDK-GRFDLYRATFYAAEIVCGLQFLH----SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKE  145 (316)
T ss_pred             HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHeEECCCCCEEeCccCCCee
Confidence            9887653 35678888899999999999999    67899999999999999999999999999864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.76  E-value=2.4e-18  Score=170.46  Aligned_cols=137  Identities=22%  Similarity=0.417  Sum_probs=112.8

Q ss_pred             hhhccccccceeeeecc------CCcceEEEEEeccch-hhhhhhhHHHHHhhhhc-cCccceeecccCCCC-----ccc
Q 039957          339 TISLAGSFGSVYKGTIS------DGTDVAIKIFNLQRE-RAFRSFNSECEVLRNVR-HQNLIKILSSCSTPD-----FKF  405 (481)
Q Consensus       339 ~l~~~g~~g~vy~~~l~------~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-----~~~  405 (481)
                      ..-+.|+||.||++...      .+..||+|.+..... .....+..|++++.++. |+|||+++++|....     +||
T Consensus        43 ~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~  122 (401)
T cd05107          43 RTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEY  122 (401)
T ss_pred             hhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEec
Confidence            34578999999999753      235799999875432 22346788999999997 999999999997764     679


Q ss_pred             ccCCChhHHhhcCC------------------------------------------------------------------
Q 039957          406 MPNGSLEKRLYSHN------------------------------------------------------------------  419 (481)
Q Consensus       406 ~~~g~l~~~l~~~~------------------------------------------------------------------  419 (481)
                      +++|+|.++++...                                                                  
T Consensus       123 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  202 (401)
T cd05107         123 CRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYA  202 (401)
T ss_pred             cCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhhhh
Confidence            99999999885321                                                                  


Q ss_pred             -------------------------------CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcE
Q 039957          420 -------------------------------YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVA  468 (481)
Q Consensus       420 -------------------------------~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~  468 (481)
                                                     ..++|....+++.++++|++|||    +.+|+||||||+|||+++++.+
T Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH----~~~ivHrdlkp~NiLl~~~~~~  278 (401)
T cd05107         203 DIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA----SKNCVHRDLAARNVLICEGKLV  278 (401)
T ss_pred             hhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh----cCCcCcccCCcceEEEeCCCEE
Confidence                                           13567778899999999999999    6789999999999999999999


Q ss_pred             EEccccCcccC
Q 039957          469 HVSDFGISKLL  479 (481)
Q Consensus       469 kl~Dfgl~~~~  479 (481)
                      |++|||+++.+
T Consensus       279 kL~DfGla~~~  289 (401)
T cd05107         279 KICDFGLARDI  289 (401)
T ss_pred             EEEecCcceec
Confidence            99999999754

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.76  E-value=3e-18  Score=162.66  Aligned_cols=135  Identities=31%  Similarity=0.535  Sum_probs=116.1

Q ss_pred             ccccccceeeeecc-----CCcceEEEEEeccchh-hhhhhhHHHHHhhhhccCccceeecccCCCC-------cccccC
Q 039957          342 LAGSFGSVYKGTIS-----DGTDVAIKIFNLQRER-AFRSFNSECEVLRNVRHQNLIKILSSCSTPD-------FKFMPN  408 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-----~g~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-------~~~~~~  408 (481)
                      +.|+||.||++...     ++..+|+|.+...... ....+..|++.+++++|+|++++.+++....       ++|+++
T Consensus        13 g~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~   92 (284)
T cd05038          13 GEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPS   92 (284)
T ss_pred             ccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCC
Confidence            67999999999853     3678999988755443 4567889999999999999999999886622       578899


Q ss_pred             CChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          409 GSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       409 g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      |++.+++......++|..+..++.+++.|++|||    +.+|+||||||+||+++.++.+|++|||+++...
T Consensus        93 ~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH----~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038          93 GSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG----SQRYIHRDLAARNILVESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             CCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence            9999998776556899999999999999999999    5789999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.76  E-value=2.6e-18  Score=163.10  Aligned_cols=134  Identities=23%  Similarity=0.415  Sum_probs=111.4

Q ss_pred             ccccccceeeeeccC------CcceEEEEEeccch-hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCC
Q 039957          342 LAGSFGSVYKGTISD------GTDVAIKIFNLQRE-RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNG  409 (481)
Q Consensus       342 ~~g~~g~vy~~~l~~------g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g  409 (481)
                      +.|+||.||+|...+      +..+|+|.+..... ...+.+..|+.++.+++|+||+++++++....     ++|++++
T Consensus        14 g~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~   93 (283)
T cd05091          14 GEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHS   93 (283)
T ss_pred             CCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCC
Confidence            789999999997532      46799999875432 23356788999999999999999999987664     5688999


Q ss_pred             ChhHHhhcC---------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEcccc
Q 039957          410 SLEKRLYSH---------------NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFG  474 (481)
Q Consensus       410 ~l~~~l~~~---------------~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfg  474 (481)
                      ++.+++...               ...+++..+.+++.++++|++|+|    +.+|+||||||+||++++++.+||+|||
T Consensus        94 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH----~~gi~H~dlkp~Nil~~~~~~~kl~Dfg  169 (283)
T cd05091          94 DLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS----SHHVVHKDLATRNVLVFDKLNVKISDLG  169 (283)
T ss_pred             cHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH----HcCccccccchhheEecCCCceEecccc
Confidence            999887521               124678888999999999999999    6789999999999999999999999999


Q ss_pred             CcccC
Q 039957          475 ISKLL  479 (481)
Q Consensus       475 l~~~~  479 (481)
                      +++.+
T Consensus       170 ~~~~~  174 (283)
T cd05091         170 LFREV  174 (283)
T ss_pred             ccccc
Confidence            98754

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.76  E-value=9.3e-19  Score=174.45  Aligned_cols=135  Identities=29%  Similarity=0.502  Sum_probs=119.7

Q ss_pred             ccccccceeeee-ccCC----cceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC----cccccCCCh
Q 039957          342 LAGSFGSVYKGT-ISDG----TDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----FKFMPNGSL  411 (481)
Q Consensus       342 ~~g~~g~vy~~~-l~~g----~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~~~~g~l  411 (481)
                      ++|.||.||||. .|.|    .+||+|.+.... .+...++.+|+-++++++|+|+++++|.|....    .+|||.|.|
T Consensus       705 GsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~~qlvtq~mP~G~L  784 (1177)
T KOG1025|consen  705 GSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLSTLQLVTQLMPLGCL  784 (1177)
T ss_pred             ccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccchHHHHHHhcccchH
Confidence            789999999997 5665    568888875443 345678899999999999999999999998876    469999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      .++++.++..+....-+.+..|||+||.|||    .+.+|||||-++||||.+=.++||.|||+|+++.
T Consensus       785 lDyvr~hr~~igsq~lLnw~~QIAkgM~YLe----~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~  849 (1177)
T KOG1025|consen  785 LDYVREHRDNIGSQDLLNWCYQIAKGMKYLE----EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLA  849 (1177)
T ss_pred             HHHHHHhhccccHHHHHHHHHHHHHHHHHHH----hcchhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence            9999988888888889999999999999999    6789999999999999999999999999999875

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.76  E-value=2e-18  Score=167.39  Aligned_cols=133  Identities=20%  Similarity=0.257  Sum_probs=111.4

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccch---hhhhhhhHHHHHhhhh-ccCccceeecccCCCC-----cccccCCC
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRE---RAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD-----FKFMPNGS  410 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----~~~~~~g~  410 (481)
                      -+.|+||.||++... ++..+|+|.+.....   .....+..|+.++.++ +|++|+++.+++...+     +||+++|+
T Consensus         3 lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   82 (327)
T cd05617           3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGD   82 (327)
T ss_pred             eeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCc
Confidence            367999999999865 578899999875432   2334567788888887 6999999999886654     67999999


Q ss_pred             hhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          411 LEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       411 l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      |..++... ..+++..+..++.++++|++|||    +.+|+||||||+||++++++.+||+|||+++.
T Consensus        83 L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH----~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~  145 (327)
T cd05617          83 LMFHMQRQ-RKLPEEHARFYAAEICIALNFLH----ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKE  145 (327)
T ss_pred             HHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHEEEeCCCCEEEecccccee
Confidence            98887643 35788899999999999999999    67899999999999999999999999999874

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.76  E-value=3.3e-18  Score=163.41  Aligned_cols=136  Identities=26%  Similarity=0.461  Sum_probs=111.3

Q ss_pred             hhccccccceeeeeccC-------------C--cceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC-
Q 039957          340 ISLAGSFGSVYKGTISD-------------G--TDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-  402 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~~-------------g--~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-  402 (481)
                      .-+.|+||.||++....             +  ..+|+|...... ......+.+|++++.+++|+|++++++++...+ 
T Consensus        12 ~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~   91 (295)
T cd05097          12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDP   91 (295)
T ss_pred             ccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCc
Confidence            34789999999876532             2  247888876542 223346888999999999999999999987664 


Q ss_pred             ----cccccCCChhHHhhcCC-----------CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCc
Q 039957          403 ----FKFMPNGSLEKRLYSHN-----------YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMV  467 (481)
Q Consensus       403 ----~~~~~~g~l~~~l~~~~-----------~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~  467 (481)
                          +||+++++|.+++....           ...+|.++++++.++++|++|||    +.+++||||||+||++++++.
T Consensus        92 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH----~~~i~H~dlkp~Nill~~~~~  167 (295)
T cd05097          92 LCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA----SLNFVHRDLATRNCLVGNHYT  167 (295)
T ss_pred             cEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH----hcCeeccccChhhEEEcCCCc
Confidence                67999999999885421           13678899999999999999999    678999999999999999999


Q ss_pred             EEEccccCcccC
Q 039957          468 AHVSDFGISKLL  479 (481)
Q Consensus       468 ~kl~Dfgl~~~~  479 (481)
                      +||+|||+++.+
T Consensus       168 ~kl~dfg~~~~~  179 (295)
T cd05097         168 IKIADFGMSRNL  179 (295)
T ss_pred             EEeccccccccc
Confidence            999999998753

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.76  E-value=4.4e-18  Score=159.24  Aligned_cols=135  Identities=30%  Similarity=0.569  Sum_probs=117.0

Q ss_pred             ccccccceeeeeccC----CcceEEEEEeccchh-hhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          342 LAGSFGSVYKGTISD----GTDVAIKIFNLQRER-AFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       342 ~~g~~g~vy~~~l~~----g~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      +.|+||.||++....    +..+++|.+...... ..+.+..|++.+..++|++++++++++....     ++|+++|+|
T Consensus         4 g~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   83 (262)
T cd00192           4 GEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDL   83 (262)
T ss_pred             ccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcH
Confidence            579999999998653    788999988765433 2567888999999999999999999887754     578899999


Q ss_pred             hHHhhcC--------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          412 EKRLYSH--------NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       412 ~~~l~~~--------~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      .+++...        ...+++.++.+++.++++|++|||    +.+|+||||||+||++++++.+|++|||.++...
T Consensus        84 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH----~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~  156 (262)
T cd00192          84 LDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA----SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY  156 (262)
T ss_pred             HHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH----cCCcccCccCcceEEECCCCcEEEcccccccccc
Confidence            9998765        466889999999999999999999    6789999999999999999999999999998653

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.76  E-value=3.2e-18  Score=162.65  Aligned_cols=135  Identities=26%  Similarity=0.329  Sum_probs=113.5

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccch---hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRE---RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      .+.|+||.||++... +|..+|+|.+.....   .....+..|++++++++|++++.+.+++...+     ++|+++|++
T Consensus         8 lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   87 (285)
T cd05632           8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDL   87 (285)
T ss_pred             EecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccH
Confidence            368999999999854 688999998865432   22345677999999999999999988877664     578999999


Q ss_pred             hHHhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          412 EKRLYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~-~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+++... ...+++.....++.++++|++|||    +.+|+||||||+||++++++.+||+|||+++..
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH----~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~  152 (285)
T cd05632          88 KFHIYNMGNPGFEEERALFYAAEILCGLEDLH----RENTVYRDLKPENILLDDYGHIRISDLGLAVKI  152 (285)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeecCCCHHHEEECCCCCEEEecCCcceec
Confidence            9887653 345889999999999999999999    678999999999999999999999999998653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.76  E-value=3e-18  Score=161.17  Aligned_cols=133  Identities=26%  Similarity=0.411  Sum_probs=114.3

Q ss_pred             ccccccceeeeec-cCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHHh
Q 039957          342 LAGSFGSVYKGTI-SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRL  415 (481)
Q Consensus       342 ~~g~~g~vy~~~l-~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~l  415 (481)
                      +.|+||.||+|.. .+|..+++|.+..........+.+|+.++.+++|+|++++.+++...+     +||+++|+|.+++
T Consensus        18 g~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~   97 (267)
T cd06646          18 GSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIY   97 (267)
T ss_pred             ecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHH
Confidence            6799999999985 568889999987654444456778999999999999999999887654     5789999999988


Q ss_pred             hcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          416 YSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       416 ~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ... ..+++..+..++.++++|++|||    +.+|+|||+||+||+++.++.+||+|||+++.+
T Consensus        98 ~~~-~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~  156 (267)
T cd06646          98 HVT-GPLSELQIAYVCRETLQGLAYLH----SKGKMHRDIKGANILLTDNGDVKLADFGVAAKI  156 (267)
T ss_pred             Hhc-CCCCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEECCCCCEEECcCccceee
Confidence            643 35678889999999999999999    678999999999999999999999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.76  E-value=2.1e-18  Score=170.81  Aligned_cols=126  Identities=22%  Similarity=0.285  Sum_probs=105.4

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHH
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKR  414 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~  414 (481)
                      .+.|+||.||++... ++..||+|...      ...+.+|++++++++||||+++.+++....     ++|+ .+++.++
T Consensus       100 lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~-~~~L~~~  172 (391)
T PHA03212        100 FTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY-KTDLYCY  172 (391)
T ss_pred             EcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC-CCCHHHH
Confidence            368999999999854 57889999643      234578999999999999999999887655     2344 4788887


Q ss_pred             hhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          415 LYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       415 l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      +... ..+++.+...++.+|++||+|+|    +.+||||||||+||+++.++.+||+|||+|+.
T Consensus       173 l~~~-~~l~~~~~~~i~~qi~~aL~ylH----~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~  231 (391)
T PHA03212        173 LAAK-RNIAICDILAIERSVLRAIQYLH----ENRIIHRDIKAENIFINHPGDVCLGDFGAACF  231 (391)
T ss_pred             HHhc-CCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCChHhEEEcCCCCEEEEeCCcccc
Confidence            7543 35788899999999999999999    67899999999999999999999999999975

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.76  E-value=4.8e-18  Score=160.14  Aligned_cols=133  Identities=35%  Similarity=0.564  Sum_probs=109.9

Q ss_pred             hccccccceeeeeccC-Cc--ceEEEEEeccc-hhhhhhhhHHHHHhhhh-ccCccceeecccCCCC-----cccccCCC
Q 039957          341 SLAGSFGSVYKGTISD-GT--DVAIKIFNLQR-ERAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD-----FKFMPNGS  410 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~-g~--~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----~~~~~~g~  410 (481)
                      .+.|+||.||+|...+ |.  .+++|.+.... ....+.+..|++++.++ +|+|+++++++|....     ++|+++|+
T Consensus         3 lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   82 (270)
T cd05047           3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGN   82 (270)
T ss_pred             CCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCc
Confidence            3679999999998754 43  46777765322 33345788899999999 7999999999887664     57899999


Q ss_pred             hhHHhhcCC---------------CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccC
Q 039957          411 LEKRLYSHN---------------YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGI  475 (481)
Q Consensus       411 l~~~l~~~~---------------~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl  475 (481)
                      |.+++....               ..+++.+..+++.+++.|++|||    +.+|+||||||+||++++++.+|++|||+
T Consensus        83 L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH----~~~i~H~dikp~nili~~~~~~kl~dfgl  158 (270)
T cd05047          83 LLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS----QKQFIHRDLAARNILVGENYVAKIADFGL  158 (270)
T ss_pred             HHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH----HCCEeecccccceEEEcCCCeEEECCCCC
Confidence            999886421               23678899999999999999999    67899999999999999999999999999


Q ss_pred             cc
Q 039957          476 SK  477 (481)
Q Consensus       476 ~~  477 (481)
                      ++
T Consensus       159 ~~  160 (270)
T cd05047         159 SR  160 (270)
T ss_pred             cc
Confidence            85

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.76  E-value=3.9e-19  Score=172.00  Aligned_cols=134  Identities=30%  Similarity=0.516  Sum_probs=114.8

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHHh
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRL  415 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~l  415 (481)
                      +.|.||.||.|.+. ....||||.++.. ....++|..|.+++..++|||+|+++|.|....     .|||.+|.|.+++
T Consensus       276 GGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYL  354 (1157)
T KOG4278|consen  276 GGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYL  354 (1157)
T ss_pred             CCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHH
Confidence            56889999999876 3688999988654 445678999999999999999999999998653     4799999999999


Q ss_pred             hcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          416 YSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       416 ~~~~-~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      .... ..+.-.--+.+|.||+.||+||.    ....||||+-++|+|+.++.-+||+|||+++++.
T Consensus       355 Recnr~ev~avvLlyMAtQIsSaMeYLE----kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMt  416 (1157)
T KOG4278|consen  355 RECNRSEVPAVVLLYMATQISSAMEYLE----KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMT  416 (1157)
T ss_pred             HHhchhhcchhHHHHHHHHHHHHHHHHH----HhhhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence            8732 23344456789999999999998    5679999999999999999999999999999874

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.76  E-value=4.1e-18  Score=161.22  Aligned_cols=134  Identities=25%  Similarity=0.434  Sum_probs=110.2

Q ss_pred             ccccccceeeeecc------CCcceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCC
Q 039957          342 LAGSFGSVYKGTIS------DGTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNG  409 (481)
Q Consensus       342 ~~g~~g~vy~~~l~------~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g  409 (481)
                      +.|++|.||+|...      .+..+|+|.+.... .....++.+|+.++++++|+|++++++++....     ++|+++|
T Consensus        15 g~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~   94 (277)
T cd05062          15 GQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRG   94 (277)
T ss_pred             ccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCC
Confidence            67999999988642      24679999875432 223446788999999999999999999987654     5789999


Q ss_pred             ChhHHhhcCC---------CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          410 SLEKRLYSHN---------YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       410 ~l~~~l~~~~---------~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +|.+++....         ...+|.....++.++++|++|||    +.+++||||||+||++++++++|++|||+++.+
T Consensus        95 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~  169 (277)
T cd05062          95 DLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN----ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI  169 (277)
T ss_pred             CHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCcchheEEEcCCCCEEECCCCCcccc
Confidence            9999886421         23578888999999999999999    678999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.76  E-value=1.6e-18  Score=143.02  Aligned_cols=134  Identities=28%  Similarity=0.422  Sum_probs=111.0

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhH
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEK  413 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~  413 (481)
                      ++|.||+|+++.-. .+..||+|+.....  ++...+..+|+-+++.++|+|||++++...+..     |||+. .+|.+
T Consensus        11 gegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cd-qdlkk   89 (292)
T KOG0662|consen   11 GEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKK   89 (292)
T ss_pred             cCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhh-HHHHH
Confidence            78999999999854 47889999887654  334456788999999999999999998776653     66764 56777


Q ss_pred             HhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          414 RLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       414 ~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      +...-...++.......+.|+.+|+.|-|    ++.+.|||+||.|.|+..+|+.|++|||+|+.++
T Consensus        90 yfdslng~~d~~~~rsfmlqllrgl~fch----shnvlhrdlkpqnllin~ngelkladfglarafg  152 (292)
T KOG0662|consen   90 YFDSLNGDLDPEIVRSFMLQLLRGLGFCH----SHNVLHRDLKPQNLLINRNGELKLADFGLARAFG  152 (292)
T ss_pred             HHHhcCCcCCHHHHHHHHHHHHhhhhhhh----hhhhhhccCCcceEEeccCCcEEecccchhhhcC
Confidence            76655556777777788999999999999    6779999999999999999999999999998753

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.76  E-value=4e-18  Score=161.54  Aligned_cols=135  Identities=27%  Similarity=0.405  Sum_probs=118.1

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHH
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKR  414 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~  414 (481)
                      .+.|++|.||++... ++..+++|..........+.+..|+.++++++|+|++++++.+....     +||+++|+|.++
T Consensus        13 l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   92 (280)
T cd06611          13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSI   92 (280)
T ss_pred             hcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHH
Confidence            367999999999864 57889999987665555667889999999999999999999887665     578999999998


Q ss_pred             hhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          415 LYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       415 l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +......+++....+++.+++.|++|||    +.+|+|||+||+||+++.++.+||+|||++...
T Consensus        93 ~~~~~~~l~~~~~~~~~~ql~~~l~~lh----~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~  153 (280)
T cd06611          93 MLELERGLTEPQIRYVCRQMLEALNFLH----SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKN  153 (280)
T ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCChhhEEECCCCCEEEccCccchhh
Confidence            8765566888999999999999999999    678999999999999999999999999987643

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.76  E-value=2.7e-18  Score=166.32  Aligned_cols=133  Identities=25%  Similarity=0.259  Sum_probs=108.9

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc---hhhhhhhhHHHHHhhhhccC-ccceeecccCCCC-----cccccCCC
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQ-NLIKILSSCSTPD-----FKFMPNGS  410 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~-----~~~~~~g~  410 (481)
                      .+.|+||.||+|... ++..+|+|.+....   ....+.+..|..++..++|+ +++++.+++...+     +||+++|+
T Consensus         8 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~   87 (324)
T cd05587           8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGD   87 (324)
T ss_pred             EeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCc
Confidence            368999999999865 46789999987542   22344567788888888765 5777877776554     67899999


Q ss_pred             hhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          411 LEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       411 l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      |.+++... ..+++..+..++.++++||+|||    ..+|+||||||+|||+++++.+||+|||+++.
T Consensus        88 L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH----~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~  150 (324)
T cd05587          88 LMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLH----SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKE  150 (324)
T ss_pred             HHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHeEEcCCCCEEEeecCccee
Confidence            99888653 34678889999999999999999    67899999999999999999999999999864

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.76  E-value=4.5e-18  Score=159.08  Aligned_cols=133  Identities=27%  Similarity=0.459  Sum_probs=112.4

Q ss_pred             ccccccceeeeecc--C--CcceEEEEEeccch-hhhhhhhHHHHHhhhhccCccceeecccCCCC----cccccCCChh
Q 039957          342 LAGSFGSVYKGTIS--D--GTDVAIKIFNLQRE-RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----FKFMPNGSLE  412 (481)
Q Consensus       342 ~~g~~g~vy~~~l~--~--g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~~~~g~l~  412 (481)
                      +.|+||.||+|...  +  +..+++|.+..... ...+.+..|+++++++.|+|++++++++....    ++|+++|+|.
T Consensus         4 g~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~~L~   83 (257)
T cd05060           4 GHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAPLGPLL   83 (257)
T ss_pred             CccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEeCCCCcHH
Confidence            57999999999743  2  26789998865543 23456888999999999999999999886543    5688999999


Q ss_pred             HHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          413 KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       413 ~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +++.... .+++..+.+++.+++.|++|||    ..+|+||||||+||+++.++.+||+|||+++.+
T Consensus        84 ~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh----~~~i~H~di~p~nili~~~~~~kl~df~~~~~~  145 (257)
T cd05060          84 KYLKKRR-EIPVSDLKELAHQVAMGMAYLE----SKHFVHRDLAARNVLLVNRHQAKISDFGMSRAL  145 (257)
T ss_pred             HHHHhCC-CCCHHHHHHHHHHHHHHHHHHh----hcCeeccCcccceEEEcCCCcEEecccccccee
Confidence            9987543 6788999999999999999999    578999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.76  E-value=2.9e-18  Score=165.59  Aligned_cols=132  Identities=25%  Similarity=0.317  Sum_probs=110.6

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccc---hhhhhhhhHHHHHhhhh-ccCccceeecccCCCC-----cccccCCCh
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      +.|+||.||++... ++..+|+|.+....   ......+..|..++..+ +|+||+++++++...+     +||+++|+|
T Consensus         4 G~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   83 (318)
T cd05570           4 GKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDL   83 (318)
T ss_pred             eeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCH
Confidence            67999999999865 47889999987542   22234456777888776 6999999999887665     578999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      ..++... ..+++.....++.++++||+|||    +.+|+||||||+||++++++.+||+|||+++.
T Consensus        84 ~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH----~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  145 (318)
T cd05570          84 MFHIQRS-GRFDEPRARFYAAEIVLGLQFLH----ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKE  145 (318)
T ss_pred             HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH----hCCeEccCCCHHHeEECCCCcEEecccCCCee
Confidence            9887643 35788999999999999999999    67899999999999999999999999999864

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.76  E-value=5.2e-18  Score=158.53  Aligned_cols=132  Identities=33%  Similarity=0.492  Sum_probs=111.1

Q ss_pred             hccccccceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC------cccccCCChhHH
Q 039957          341 SLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD------FKFMPNGSLEKR  414 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~~~~g~l~~~  414 (481)
                      .+.|++|.||++... |..+++|......  ..+.+..|+.++++++|++++++++++...+      ++|+++|+|.++
T Consensus        14 lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~   90 (256)
T cd05082          14 IGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDY   90 (256)
T ss_pred             ecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHH
Confidence            367999999999754 7789999875432  2346788999999999999999998764332      578999999999


Q ss_pred             hhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          415 LYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       415 l~~~~-~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +.... ...++....+++.+++.|++|||    +.+|+||||||+||++++++.+|++|||+++..
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~  152 (256)
T cd05082          91 LRSRGRSVLGGDCLLKFSLDVCEAMEYLE----ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA  152 (256)
T ss_pred             HHhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCEeccccchheEEEcCCCcEEecCCccceec
Confidence            87643 34788999999999999999999    678999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.76  E-value=3.9e-18  Score=161.60  Aligned_cols=137  Identities=24%  Similarity=0.432  Sum_probs=114.0

Q ss_pred             hhhccccccceeeeeccC-----CcceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC------cccc
Q 039957          339 TISLAGSFGSVYKGTISD-----GTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD------FKFM  406 (481)
Q Consensus       339 ~l~~~g~~g~vy~~~l~~-----g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~~  406 (481)
                      .+.+.|+||.||+|...+     +..|++|.+.... ......+..|+.++++++|+|++++++++...+      ++|+
T Consensus        12 ~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~   91 (280)
T cd05043          12 DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYM   91 (280)
T ss_pred             eeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcC
Confidence            345789999999998755     6778888875432 233456788999999999999999999886642      4578


Q ss_pred             cCCChhHHhhcCC-------CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          407 PNGSLEKRLYSHN-------YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       407 ~~g~l~~~l~~~~-------~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ++|++.+++....       ..+++..+..++.+++.|++|||    +.+|+||||||+||++++++.+||+|||+++.+
T Consensus        92 ~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH----~~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~  167 (280)
T cd05043          92 NWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH----KRGVIHKDIAARNCVIDEELQVKITDNALSRDL  167 (280)
T ss_pred             CCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH----HCCEeecccCHhhEEEcCCCcEEECCCCCcccc
Confidence            8999999886532       35788999999999999999999    678999999999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.76  E-value=3.9e-18  Score=162.48  Aligned_cols=137  Identities=27%  Similarity=0.445  Sum_probs=111.6

Q ss_pred             hhhccccccceeeeecc------CCcceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccc
Q 039957          339 TISLAGSFGSVYKGTIS------DGTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFM  406 (481)
Q Consensus       339 ~l~~~g~~g~vy~~~l~------~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~  406 (481)
                      ...+.|+||.||+|...      ....+++|.+.... ......+.+|+..+++++|+||+++++.|...+     ++|+
T Consensus         6 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   85 (290)
T cd05045           6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYA   85 (290)
T ss_pred             ccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEec
Confidence            34478999999999742      22467888775433 223456888999999999999999999887664     5789


Q ss_pred             cCCChhHHhhcC-----------------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeC
Q 039957          407 PNGSLEKRLYSH-----------------------NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLD  463 (481)
Q Consensus       407 ~~g~l~~~l~~~-----------------------~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~  463 (481)
                      ++|+|.+++...                       ...+++...+.++.+++.|++|||    +.+|+||||||+||+++
T Consensus        86 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH----~~~ivH~dikp~nill~  161 (290)
T cd05045          86 KYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA----EMKLVHRDLAARNVLVA  161 (290)
T ss_pred             CCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH----HCCeehhhhhhheEEEc
Confidence            999999887531                       124678889999999999999999    67899999999999999


Q ss_pred             CCCcEEEccccCcccC
Q 039957          464 ENMVAHVSDFGISKLL  479 (481)
Q Consensus       464 ~~~~~kl~Dfgl~~~~  479 (481)
                      +++.+||+|||+++..
T Consensus       162 ~~~~~kl~dfg~~~~~  177 (290)
T cd05045         162 EGRKMKISDFGLSRDV  177 (290)
T ss_pred             CCCcEEeccccccccc
Confidence            9999999999998753

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.76  E-value=4.5e-18  Score=162.30  Aligned_cols=135  Identities=26%  Similarity=0.484  Sum_probs=112.3

Q ss_pred             hccccccceeeeeccC------CcceEEEEEeccc-hhhhhhhhHHHHHhhhh-ccCccceeecccCCCC-----ccccc
Q 039957          341 SLAGSFGSVYKGTISD------GTDVAIKIFNLQR-ERAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD-----FKFMP  407 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~------g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----~~~~~  407 (481)
                      .+.|+||.||++....      ...+++|.+.... .+....+.+|++++.++ +|+|+++++++|....     ++|++
T Consensus        20 ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~   99 (293)
T cd05053          20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAA   99 (293)
T ss_pred             ecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCC
Confidence            3689999999997532      3568899876532 23345678899999999 7999999999987664     57889


Q ss_pred             CCChhHHhhc---------------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 039957          408 NGSLEKRLYS---------------HNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSD  472 (481)
Q Consensus       408 ~g~l~~~l~~---------------~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~D  472 (481)
                      +|+|.+++..               ....+++...++++.+++.|++|||    +.+|+||||||+||++++++.+|++|
T Consensus       100 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH----~~~ivH~dlkp~Nil~~~~~~~kL~D  175 (293)
T cd05053         100 HGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA----SKKCIHRDLAARNVLVTEDHVMKIAD  175 (293)
T ss_pred             CCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH----HCCccccccceeeEEEcCCCeEEeCc
Confidence            9999998853               2245788999999999999999999    67899999999999999999999999


Q ss_pred             ccCcccC
Q 039957          473 FGISKLL  479 (481)
Q Consensus       473 fgl~~~~  479 (481)
                      ||+++.+
T Consensus       176 fg~~~~~  182 (293)
T cd05053         176 FGLARDI  182 (293)
T ss_pred             ccccccc
Confidence            9999764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.76  E-value=5.4e-18  Score=158.83  Aligned_cols=134  Identities=25%  Similarity=0.487  Sum_probs=115.1

Q ss_pred             hccccccceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC----cccccCCChhHHhh
Q 039957          341 SLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----FKFMPNGSLEKRLY  416 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~~~~g~l~~~l~  416 (481)
                      .+.|+||.||++...++..+|+|.+..... ....+..|+.++++++|+|++++.+++....    ++|+++|+|.+++.
T Consensus        14 ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~~~   92 (260)
T cd05067          14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITEYMENGSLVDFLK   92 (260)
T ss_pred             eccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEccCCcEEEEEcCCCCCHHHHHH
Confidence            478999999999988889999998865432 2356788999999999999999998875433    57889999999876


Q ss_pred             c-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          417 S-HNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       417 ~-~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      . .+...++.++..++.+++.|++|||    +.+++||||||+||++++++.++++|||+++..
T Consensus        93 ~~~~~~~~~~~~~~i~~~i~~al~~LH----~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  152 (260)
T cd05067          93 TPEGIKLTINKLIDMAAQIAEGMAFIE----RKNYIHRDLRAANILVSETLCCKIADFGLARLI  152 (260)
T ss_pred             hcCCCCCCHHHHHHHHHHHHHHHHHHh----cCCeecccccHHhEEEcCCCCEEEccCcceeec
Confidence            5 3346788999999999999999999    678999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.76  E-value=3.5e-18  Score=165.59  Aligned_cols=132  Identities=30%  Similarity=0.387  Sum_probs=106.0

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccch---hhhhhhhHHHH-HhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQRE---RAFRSFNSECE-VLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~~---~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      +.|+||.||++... ++..+|+|.+.....   .....+..|.. +++.++|+||+++.+++...+     +||+++|++
T Consensus         4 g~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L   83 (325)
T cd05602           4 GKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL   83 (325)
T ss_pred             eeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcH
Confidence            67999999999864 567899999865321   12223344443 567789999999998887665     679999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      .+++.... .........++.+|++||+|||    +.+|+||||||+||+++.++.+||+|||+|+.
T Consensus        84 ~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH----~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~  145 (325)
T cd05602          84 FYHLQRER-CFLEPRARFYAAEIASALGYLH----SLNIVYRDLKPENILLDSQGHIVLTDFGLCKE  145 (325)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHeEECCCCCEEEccCCCCcc
Confidence            99887543 3455666779999999999999    67899999999999999999999999999875

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.76  E-value=4e-18  Score=163.62  Aligned_cols=135  Identities=26%  Similarity=0.501  Sum_probs=111.6

Q ss_pred             hccccccceeeeec--------cCCcceEEEEEeccc-hhhhhhhhHHHHHhhhh-ccCccceeecccCCCC-----ccc
Q 039957          341 SLAGSFGSVYKGTI--------SDGTDVAIKIFNLQR-ERAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD-----FKF  405 (481)
Q Consensus       341 ~~~g~~g~vy~~~l--------~~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----~~~  405 (481)
                      .+.|+||.||++..        .++..+++|...... ....+.+.+|+.++..+ +|+||+++++++....     ++|
T Consensus        23 lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~  102 (304)
T cd05101          23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEY  102 (304)
T ss_pred             eeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEEEEec
Confidence            36899999998863        134568899876432 23346788899999999 8999999999887664     678


Q ss_pred             ccCCChhHHhhcC---------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 039957          406 MPNGSLEKRLYSH---------------NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHV  470 (481)
Q Consensus       406 ~~~g~l~~~l~~~---------------~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl  470 (481)
                      +++|+|.+++...               ...++|..+.+++.+|++|++|||    +.+|+||||||+||++++++.+||
T Consensus       103 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH----~~givH~dlkp~Nili~~~~~~kl  178 (304)
T cd05101         103 ASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA----SQKCIHRDLAARNVLVTENNVMKI  178 (304)
T ss_pred             CCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH----HCCeeecccccceEEEcCCCcEEE
Confidence            9999999988652               124678889999999999999999    678999999999999999999999


Q ss_pred             ccccCcccC
Q 039957          471 SDFGISKLL  479 (481)
Q Consensus       471 ~Dfgl~~~~  479 (481)
                      +|||+|+.+
T Consensus       179 ~D~g~~~~~  187 (304)
T cd05101         179 ADFGLARDV  187 (304)
T ss_pred             CCCccceec
Confidence            999998754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.76  E-value=4.2e-18  Score=161.40  Aligned_cols=134  Identities=30%  Similarity=0.502  Sum_probs=113.8

Q ss_pred             hccccccceeeeecc------CCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCC
Q 039957          341 SLAGSFGSVYKGTIS------DGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNG  409 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~------~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g  409 (481)
                      .+.|+||.||++...      ++..+++|.+..........+.+|++.+++++|+||+++++++...+     ++|+++|
T Consensus        13 lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   92 (280)
T cd05092          13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHG   92 (280)
T ss_pred             cCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCC
Confidence            467999999998632      35678888877655555667889999999999999999999887665     5789999


Q ss_pred             ChhHHhhcCC--------------CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccC
Q 039957          410 SLEKRLYSHN--------------YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGI  475 (481)
Q Consensus       410 ~l~~~l~~~~--------------~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl  475 (481)
                      +|.+++....              ..+++..+..++.+++.|++|||    +.+|+||||||+||++++++.+||+|||+
T Consensus        93 ~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH----~~~i~H~dlkp~nil~~~~~~~kL~dfg~  168 (280)
T cd05092          93 DLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA----SLHFVHRDLATRNCLVGQGLVVKIGDFGM  168 (280)
T ss_pred             CHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH----HCCeecccccHhhEEEcCCCCEEECCCCc
Confidence            9999886532              24788999999999999999999    67899999999999999999999999999


Q ss_pred             ccc
Q 039957          476 SKL  478 (481)
Q Consensus       476 ~~~  478 (481)
                      ++.
T Consensus       169 ~~~  171 (280)
T cd05092         169 SRD  171 (280)
T ss_pred             eeE
Confidence            864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.76  E-value=1.4e-18  Score=168.41  Aligned_cols=144  Identities=27%  Similarity=0.492  Sum_probs=124.2

Q ss_pred             cCChhhhhccccccceeeeecc---CC--cceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC----c
Q 039957          334 LVDLETISLAGSFGSVYKGTIS---DG--TDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----F  403 (481)
Q Consensus       334 l~~L~~l~~~g~~g~vy~~~l~---~g--~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~  403 (481)
                      +..|..+.|.|.||.||+|...   .|  ..||||..+... ....+.|.+|.-++++++|||||+++|.|.+..    +
T Consensus       390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P~Wivm  469 (974)
T KOG4257|consen  390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQPMWIVM  469 (974)
T ss_pred             hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccceeEEE
Confidence            3455666789999999999853   23  458889887643 344678999999999999999999999998875    7


Q ss_pred             ccccCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCCC
Q 039957          404 KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE  481 (481)
Q Consensus       404 ~~~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~~  481 (481)
                      |..+-|.|..++.....+++...-..++.||+.||+|||    +...|||||-++|||+.....+|++|||++|-+.+
T Consensus       470 EL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe----SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed  543 (974)
T KOG4257|consen  470 ELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE----SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLED  543 (974)
T ss_pred             ecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH----hhchhhhhhhhhheeecCcceeeecccchhhhccc
Confidence            889999999999887778888888899999999999999    67799999999999999999999999999997753

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.76  E-value=5.5e-18  Score=158.26  Aligned_cols=135  Identities=28%  Similarity=0.364  Sum_probs=115.9

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      .+.|++|.+|++... +|..+++|.+....  ......+..|+.++++++|+|++++++++...+     +||+++++|.
T Consensus         8 l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   87 (256)
T cd08529           8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLH   87 (256)
T ss_pred             ecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHH
Confidence            357999999999864 58889999886532  334456788999999999999999999887765     6789999999


Q ss_pred             HHhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          413 KRLYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       413 ~~l~~~-~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +++... ...+++....+++.++++|++|||    +.+|+|||+||+||++++++.+|++|||+++.+
T Consensus        88 ~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH----~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~  151 (256)
T cd08529          88 KLLKMQRGRPLPEDQVWRFFIQILLGLAHLH----SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL  151 (256)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCcceEEEeCCCCEEEcccccceec
Confidence            998764 456788899999999999999999    678999999999999999999999999998764

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.76  E-value=3.7e-18  Score=165.77  Aligned_cols=132  Identities=25%  Similarity=0.280  Sum_probs=106.9

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccch---hhhhhhhHHHHHhhhh---ccCccceeecccCCCC-----cccccCC
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQRE---RAFRSFNSECEVLRNV---RHQNLIKILSSCSTPD-----FKFMPNG  409 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~-----~~~~~~g  409 (481)
                      +.|+||.||++... +|..+|+|.+.....   ........|..++.+.   +|++|+++.+.+...+     ++|+++|
T Consensus         2 G~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g   81 (330)
T cd05586           2 GKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGG   81 (330)
T ss_pred             CCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCC
Confidence            57999999999854 588999999865321   1222344456666554   6999999998877664     5789999


Q ss_pred             ChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          410 SLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       410 ~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      +|.+++... ..++......++.+|++|++|||    +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        82 ~L~~~l~~~-~~~~~~~~~~~~~qil~al~~LH----~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~  145 (330)
T cd05586          82 ELFWHLQKE-GRFSEDRAKFYIAELVLALEHLH----KYDIVYRDLKPENILLDATGHIALCDFGLSKA  145 (330)
T ss_pred             hHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH----HCCeEeccCCHHHeEECCCCCEEEecCCcCcC
Confidence            999887643 35678888899999999999999    67899999999999999999999999999875

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.76  E-value=5.2e-18  Score=160.69  Aligned_cols=136  Identities=32%  Similarity=0.532  Sum_probs=114.7

Q ss_pred             hhccccccceeeeeccC------CcceEEEEEeccchh-hhhhhhHHHHHhhhhccCccceeecccCCCC-----ccccc
Q 039957          340 ISLAGSFGSVYKGTISD------GTDVAIKIFNLQRER-AFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMP  407 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~~------g~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~  407 (481)
                      ..+.|+||.||+|...+      +..+|+|.+...... ..+.+.+|++++++++|+|++++++++....     ++|++
T Consensus        12 ~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   91 (280)
T cd05049          12 ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYME   91 (280)
T ss_pred             hccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCC
Confidence            44789999999997643      467999988654433 4467889999999999999999999987764     67899


Q ss_pred             CCChhHHhhcCC-------------CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEcccc
Q 039957          408 NGSLEKRLYSHN-------------YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFG  474 (481)
Q Consensus       408 ~g~l~~~l~~~~-------------~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfg  474 (481)
                      +|+|.+++...+             ..+.+.....++.+++.|++|+|    +.+|+||||||+||+++.++.+|++|||
T Consensus        92 ~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH----~~~i~h~dlkp~nili~~~~~~kl~d~g  167 (280)
T cd05049          92 HGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA----SQHFVHRDLATRNCLVGYDLVVKIGDFG  167 (280)
T ss_pred             CCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh----hCCeeccccccceEEEcCCCeEEECCcc
Confidence            999999886431             34678888999999999999999    6789999999999999999999999999


Q ss_pred             CcccC
Q 039957          475 ISKLL  479 (481)
Q Consensus       475 l~~~~  479 (481)
                      +++.+
T Consensus       168 ~~~~~  172 (280)
T cd05049         168 MSRDV  172 (280)
T ss_pred             cceec
Confidence            98753

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.75  E-value=5.2e-18  Score=162.22  Aligned_cols=135  Identities=31%  Similarity=0.548  Sum_probs=110.4

Q ss_pred             hhccccccceeeeeccC-Cc--ceEEEEEecc-chhhhhhhhHHHHHhhhh-ccCccceeecccCCCC-----cccccCC
Q 039957          340 ISLAGSFGSVYKGTISD-GT--DVAIKIFNLQ-RERAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD-----FKFMPNG  409 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~~-g~--~vavK~l~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----~~~~~~g  409 (481)
                      ..+.|+||.||+|...+ |.  .+++|.+... .....+.+..|++++.++ +|+|++++.+++...+     ++|+++|
T Consensus         9 ~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~   88 (297)
T cd05089           9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYG   88 (297)
T ss_pred             eecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCC
Confidence            44789999999998754 33  4677776532 223345688899999998 7999999999887654     5688999


Q ss_pred             ChhHHhhcCC---------------CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEcccc
Q 039957          410 SLEKRLYSHN---------------YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFG  474 (481)
Q Consensus       410 ~l~~~l~~~~---------------~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfg  474 (481)
                      +|.+++....               ..+++....+++.+++.|++|||    +.+|+||||||+||++++++.+||+|||
T Consensus        89 ~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH----~~~ivH~dlkp~Nill~~~~~~kl~dfg  164 (297)
T cd05089          89 NLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS----EKQFIHRDLAARNVLVGENLASKIADFG  164 (297)
T ss_pred             cHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCcCCcceEEECCCCeEEECCcC
Confidence            9999886421               24678889999999999999999    6789999999999999999999999999


Q ss_pred             Cccc
Q 039957          475 ISKL  478 (481)
Q Consensus       475 l~~~  478 (481)
                      +++.
T Consensus       165 ~~~~  168 (297)
T cd05089         165 LSRG  168 (297)
T ss_pred             CCcc
Confidence            9864

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.75  E-value=3.8e-18  Score=163.07  Aligned_cols=132  Identities=28%  Similarity=0.438  Sum_probs=114.6

Q ss_pred             ccccccceeeeec-cCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHHh
Q 039957          342 LAGSFGSVYKGTI-SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRL  415 (481)
Q Consensus       342 ~~g~~g~vy~~~l-~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~l  415 (481)
                      +.|++|.||+|.. .++..+++|.+..........+.+|+.+++.++|+|++++.+.+....     ++|+++|+|.+++
T Consensus        29 g~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~  108 (296)
T cd06654          29 GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV  108 (296)
T ss_pred             cCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHH
Confidence            6799999999974 468899999887665555567888999999999999999999887654     6789999999988


Q ss_pred             hcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          416 YSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       416 ~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ...  .+++.+...++.+++.|++|||    +.+|+||||||+||+++.++.+||+|||+++..
T Consensus       109 ~~~--~~~~~~~~~i~~ql~~aL~~LH----~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~  166 (296)
T cd06654         109 TET--CMDEGQIAAVCRECLQALEFLH----SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI  166 (296)
T ss_pred             Hhc--CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEEcCCCCEEECccccchhc
Confidence            643  4688899999999999999999    678999999999999999999999999998653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.75  E-value=6.4e-18  Score=161.21  Aligned_cols=134  Identities=28%  Similarity=0.422  Sum_probs=116.7

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHH
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKR  414 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~  414 (481)
                      -+.|+||.||+|... ++..+++|.+........+.+..|++++++++|+|++++.+.+....     ++|++++++..+
T Consensus        20 lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~   99 (292)
T cd06644          20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAI   99 (292)
T ss_pred             ecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHH
Confidence            367999999999865 47889999987665555667888999999999999999999876654     678999999888


Q ss_pred             hhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          415 LYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       415 l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      +.+....+++..+..++.+++.|++|||    +.+|+|||+||+||+++.++.+||+|||+++.
T Consensus       100 ~~~~~~~l~~~~~~~~~~ql~~~l~~lH----~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~  159 (292)
T cd06644         100 MLELDRGLTEPQIQVICRQMLEALQYLH----SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAK  159 (292)
T ss_pred             HHhhcCCCCHHHHHHHHHHHHHHHHHHh----cCCeeecCCCcceEEEcCCCCEEEccCcccee
Confidence            7665556889999999999999999999    67899999999999999999999999999764

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.75  E-value=3.8e-18  Score=165.16  Aligned_cols=133  Identities=25%  Similarity=0.257  Sum_probs=108.5

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccch---hhhhhhhHHHHHhhhh-ccCccceeecccCCCC-----cccccCCC
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRE---RAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD-----FKFMPNGS  410 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----~~~~~~g~  410 (481)
                      .++|+||.||++... ++..+|+|.+.....   .....+..|..++... +|++++++.+++...+     +||+++|+
T Consensus         8 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~   87 (323)
T cd05616           8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGD   87 (323)
T ss_pred             EeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCC
Confidence            368999999999865 578899999875422   2223455677777666 5888998888877654     67999999


Q ss_pred             hhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          411 LEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       411 l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      |.+++... ..+++.++..++.+++.||+|||    +.+|+||||||+|||+++++.+||+|||+++.
T Consensus        88 L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~  150 (323)
T cd05616          88 LMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLH----SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  150 (323)
T ss_pred             HHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH----HCCEEecCCCHHHeEECCCCcEEEccCCCcee
Confidence            99887643 34678889999999999999999    67899999999999999999999999999874

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.75  E-value=3.9e-18  Score=158.35  Aligned_cols=134  Identities=25%  Similarity=0.322  Sum_probs=113.1

Q ss_pred             ccccccceeeeeccC-CcceEEEEEeccch---hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          342 LAGSFGSVYKGTISD-GTDVAIKIFNLQRE---RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       342 ~~g~~g~vy~~~l~~-g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      |.|.-|+||.+.+.+ +...|+|.++....   ....+...|-++|+.+.||.++.+++.+.+..     +|||+||+|.
T Consensus        86 G~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~  165 (459)
T KOG0610|consen   86 GCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLH  165 (459)
T ss_pred             CCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHH
Confidence            789999999999765 58899999976542   22345667889999999999999999998876     6799999999


Q ss_pred             HHhhc-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          413 KRLYS-HNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       413 ~~l~~-~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ...+. ....++.....-+|..|.-||+|||    -.|||.||+||+||||.++|++.++||.++...
T Consensus       166 ~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH----mlGivYRDLKPENILvredGHIMLsDFDLS~~~  229 (459)
T KOG0610|consen  166 SLRQKQPGKRFSESAARFYAAEVLLALEYLH----MLGIVYRDLKPENILVREDGHIMLSDFDLSLRC  229 (459)
T ss_pred             HHHhhCCCCccchhhHHHHHHHHHHHHHHHH----hhceeeccCCcceeEEecCCcEEeeeccccccC
Confidence            98765 3455666666668889999999999    789999999999999999999999999997643

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.75  E-value=5.4e-18  Score=161.37  Aligned_cols=135  Identities=24%  Similarity=0.431  Sum_probs=109.9

Q ss_pred             hccccccceeeeecc------CCcceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccC
Q 039957          341 SLAGSFGSVYKGTIS------DGTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPN  408 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~------~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~  408 (481)
                      -+.|+||.||+|...      .+..+|+|.+.... ......+..|+..+++++|+|++++++++...+     +||+++
T Consensus        14 lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   93 (288)
T cd05061          14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAH   93 (288)
T ss_pred             ecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCC
Confidence            468999999998643      24578999875433 223345778999999999999999999887664     678999


Q ss_pred             CChhHHhhcC---------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          409 GSLEKRLYSH---------NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       409 g~l~~~l~~~---------~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      |+|.+++...         ....++....+++.+++.|++|||    +++|+||||||+||++++++.+|++|||+++.+
T Consensus        94 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~  169 (288)
T cd05061          94 GDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN----AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI  169 (288)
T ss_pred             CCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH----hCCCcCCCCChheEEEcCCCcEEECcCCccccc
Confidence            9999998642         123456778899999999999999    678999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.75  E-value=1.9e-18  Score=169.22  Aligned_cols=135  Identities=29%  Similarity=0.407  Sum_probs=110.7

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHHh
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRL  415 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~l  415 (481)
                      ++|.||+||.|..- ....+|||.+.....+..+....|++..+.++|+|||+++|.|....     +|-+|||+|.+.+
T Consensus       584 GKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLL  663 (1226)
T KOG4279|consen  584 GKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLL  663 (1226)
T ss_pred             ecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHH
Confidence            77999999999854 45678999887776676777888999999999999999999998776     4567999999988


Q ss_pred             hcCCCcc--CHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCC-CCcEEEccccCcccCC
Q 039957          416 YSHNYFL--DILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDE-NMVAHVSDFGISKLLG  480 (481)
Q Consensus       416 ~~~~~~~--~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~-~~~~kl~Dfgl~~~~~  480 (481)
                      ...=.++  ....---+..||.+||.|||    +..|||||||..|||+.. .|.+||+|||.+|.++
T Consensus       664 rskWGPlKDNEstm~fYtkQILeGLkYLH----en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA  727 (1226)
T KOG4279|consen  664 RSKWGPLKDNESTMNFYTKQILEGLKYLH----ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA  727 (1226)
T ss_pred             HhccCCCccchhHHHHHHHHHHHHhhhhh----hcceeeccccCCcEEEeeccceEEecccccchhhc
Confidence            7532222  12233456789999999999    577999999999999976 6999999999998763

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.75  E-value=2.4e-18  Score=169.36  Aligned_cols=131  Identities=25%  Similarity=0.363  Sum_probs=107.7

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccc---hhhhhhhhHHHHHhhhh-ccCccceeecccCCCC-----cccccCCCh
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      +.|+||.|+.+... ++..+|||.+++..   ....+....|..++... +||.++.+++++...+     +||+.||++
T Consensus       377 GkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm  456 (694)
T KOG0694|consen  377 GRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGDL  456 (694)
T ss_pred             ccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCCcE
Confidence            78999999999865 57889999998754   23345556666666554 6999999999998876     789999995


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      .-+.+  ...++..+..-+|+.|+.||+|||    ..+||+||+|-+|||||.+|++||+|||+||-
T Consensus       457 ~~~~~--~~~F~e~rarfyaAev~l~L~fLH----~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe  517 (694)
T KOG0694|consen  457 MHHIH--TDVFSEPRARFYAAEVVLGLQFLH----ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKE  517 (694)
T ss_pred             EEEEe--cccccHHHHHHHHHHHHHHHHHHH----hcCceeeecchhheEEcccCcEEecccccccc
Confidence            54443  234666777779999999999999    68899999999999999999999999999985

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.75  E-value=4.9e-18  Score=162.38  Aligned_cols=132  Identities=28%  Similarity=0.437  Sum_probs=114.7

Q ss_pred             ccccccceeeeec-cCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHHh
Q 039957          342 LAGSFGSVYKGTI-SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRL  415 (481)
Q Consensus       342 ~~g~~g~vy~~~l-~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~l  415 (481)
                      +.|++|.||++.. .+|..+++|.+........+.+..|+.++++++|+|+++++++|...+     ++|++++++.+++
T Consensus        28 g~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~  107 (297)
T cd06656          28 GQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV  107 (297)
T ss_pred             ccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHH
Confidence            6799999999985 468999999987655555566788999999999999999999887664     5789999999988


Q ss_pred             hcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          416 YSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       416 ~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ...  ..++.++.+++.+++.|++|||    +.+|+||||||+||+++.++.+||+|||+++..
T Consensus       108 ~~~--~~~~~~~~~~~~~l~~~L~~LH----~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~  165 (297)
T cd06656         108 TET--CMDEGQIAAVCRECLQALDFLH----SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI  165 (297)
T ss_pred             HhC--CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEECcCccceEc
Confidence            643  4678889999999999999999    678999999999999999999999999998754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.75  E-value=1.9e-18  Score=161.65  Aligned_cols=134  Identities=22%  Similarity=0.374  Sum_probs=111.1

Q ss_pred             ccccccceeeeeccC--------CcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccC
Q 039957          342 LAGSFGSVYKGTISD--------GTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPN  408 (481)
Q Consensus       342 ~~g~~g~vy~~~l~~--------g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~  408 (481)
                      +.|+||.||+|....        ...+++|..........+.+..|+.++++++|+|++++++++...+     +||+++
T Consensus         4 g~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   83 (258)
T cd05078           4 GQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKF   83 (258)
T ss_pred             CcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCC
Confidence            679999999997532        2347777776544444567788999999999999999999987654     679999


Q ss_pred             CChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCc--------EEEccccCcccC
Q 039957          409 GSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMV--------AHVSDFGISKLL  479 (481)
Q Consensus       409 g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~--------~kl~Dfgl~~~~  479 (481)
                      |+|.+++......+++..+.+++.+|+.|++|||    +.+|+||||||+||+++.++.        +|++|||++...
T Consensus        84 g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~  158 (258)
T cd05078          84 GSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE----DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV  158 (258)
T ss_pred             CcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence            9999998876556889999999999999999999    678999999999999988765        699999988643

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.75  E-value=5.5e-18  Score=162.43  Aligned_cols=136  Identities=24%  Similarity=0.432  Sum_probs=113.3

Q ss_pred             hhccccccceeeeecc------CCcceEEEEEeccc-hhhhhhhhHHHHHhhhh-ccCccceeecccCCCC-----cccc
Q 039957          340 ISLAGSFGSVYKGTIS------DGTDVAIKIFNLQR-ERAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD-----FKFM  406 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~------~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----~~~~  406 (481)
                      ..+.|+||.||++...      ++..+|+|.+.... ....+.+..|+++++++ +|+||++++++|...+     +||+
T Consensus        42 ~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~  121 (302)
T cd05055          42 TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYC  121 (302)
T ss_pred             eeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcC
Confidence            3478999999998641      24578899876543 23345688899999999 7999999999887664     6789


Q ss_pred             cCCChhHHhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          407 PNGSLEKRLYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       407 ~~g~l~~~l~~~-~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ++|+|.+++... ...+++.+..+++.+++.|++|||    +.+|+|+||||+||++++++.+|++|||+++.+
T Consensus       122 ~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~  191 (302)
T cd05055         122 CYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA----SKNCIHRDLAARNVLLTHGKIVKICDFGLARDI  191 (302)
T ss_pred             CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeehhhhccceEEEcCCCeEEECCCcccccc
Confidence            999999998753 234789999999999999999999    678999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.75  E-value=7e-18  Score=160.10  Aligned_cols=135  Identities=32%  Similarity=0.609  Sum_probs=111.7

Q ss_pred             hccccccceeeeeccC------CcceEEEEEeccch-hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccC
Q 039957          341 SLAGSFGSVYKGTISD------GTDVAIKIFNLQRE-RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPN  408 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~------g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~  408 (481)
                      .+.|+||.||+|....      +..+++|.+..... .....+.+|++.+++++|+|++++++++....     ++|+++
T Consensus        13 lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~   92 (283)
T cd05048          13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAH   92 (283)
T ss_pred             ccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCCC
Confidence            3679999999997543      25688898764432 23456888999999999999999999887654     678999


Q ss_pred             CChhHHhhcCC---------------CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 039957          409 GSLEKRLYSHN---------------YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDF  473 (481)
Q Consensus       409 g~l~~~l~~~~---------------~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Df  473 (481)
                      |+|.+++....               ..+++.+...++.+++.|++|||    +.+|+||||||+||++++++.+||+||
T Consensus        93 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH----~~~i~H~dlkp~Nil~~~~~~~~L~df  168 (283)
T cd05048          93 GDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS----SHHFVHRDLAARNCLVGEGLTVKISDF  168 (283)
T ss_pred             CcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccccccceEEEcCCCcEEECCC
Confidence            99999886421               34678888999999999999999    678999999999999999999999999


Q ss_pred             cCcccC
Q 039957          474 GISKLL  479 (481)
Q Consensus       474 gl~~~~  479 (481)
                      |+++..
T Consensus       169 g~~~~~  174 (283)
T cd05048         169 GLSRDI  174 (283)
T ss_pred             cceeec
Confidence            998753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.75  E-value=4.2e-18  Score=162.02  Aligned_cols=133  Identities=23%  Similarity=0.345  Sum_probs=110.6

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhH
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEK  413 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~  413 (481)
                      +.|+||.||++... ++..+|+|++....  ....+.+.+|++++++++|+||+++.+++...+     +||++++.+..
T Consensus        10 g~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~   89 (287)
T cd07848          10 GEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLEL   89 (287)
T ss_pred             cccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHH
Confidence            67999999999865 57889999886542  223456778999999999999999999887654     67888877665


Q ss_pred             HhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          414 RLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       414 ~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +. .....+++..+..++.+++.|++|||    +.+|+||||||+||+++.++.+||+|||+|+.+
T Consensus        90 ~~-~~~~~~~~~~~~~~~~qi~~~L~~lH----~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  150 (287)
T cd07848          90 LE-EMPNGVPPEKVRSYIYQLIKAIHWCH----KNDIVHRDIKPENLLISHNDVLKLCDFGFARNL  150 (287)
T ss_pred             HH-hcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEEcCCCcEEEeeccCcccc
Confidence            43 33345778888999999999999999    678999999999999999999999999998764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.75  E-value=3.4e-18  Score=167.74  Aligned_cols=126  Identities=25%  Similarity=0.332  Sum_probs=106.6

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHHh
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRL  415 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~l  415 (481)
                      +.|+||.||+|... .+..||+|....      .....|+.++++++|+||+++++++....     ++|+ .|++.+++
T Consensus        75 g~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~~~l~~~l  147 (357)
T PHA03209         75 TPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYL  147 (357)
T ss_pred             cCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc-CCcHHHHH
Confidence            68999999999865 467788886322      22346899999999999999999987765     3344 47888888


Q ss_pred             hcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          416 YSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       416 ~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      ......+++..+.+|+.+|++||+|||    +.+||||||||+|||+++++.+||+|||+++.
T Consensus       148 ~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  206 (357)
T PHA03209        148 TKRSRPLPIDQALIIEKQILEGLRYLH----AQRIIHRDVKTENIFINDVDQVCIGDLGAAQF  206 (357)
T ss_pred             HhccCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEECCCCCEEEecCccccc
Confidence            766667899999999999999999999    67899999999999999999999999999875

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.75  E-value=4.4e-18  Score=173.27  Aligned_cols=136  Identities=26%  Similarity=0.350  Sum_probs=112.1

Q ss_pred             hhccccccceeeeec-cCCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCC-------------Cc
Q 039957          340 ISLAGSFGSVYKGTI-SDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTP-------------DF  403 (481)
Q Consensus       340 l~~~g~~g~vy~~~l-~~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------------~~  403 (481)
                      ..+.|+||.||++.. .+|..+|+|.+....  ......+..|+..+..++|+++++....+...             .+
T Consensus        39 ~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~  118 (496)
T PTZ00283         39 VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVL  118 (496)
T ss_pred             EEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEE
Confidence            347899999999974 468999999986543  23344577899999999999999987655321             25


Q ss_pred             ccccCCChhHHhhcC---CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          404 KFMPNGSLEKRLYSH---NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       404 ~~~~~g~l~~~l~~~---~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +|+++|+|.+++...   ...++......++.++++||+|+|    +.+|+||||||+|||+++++.+||+|||+++.+
T Consensus       119 Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH----~~~IiHrDLKP~NILl~~~~~vkL~DFGls~~~  193 (496)
T PTZ00283        119 DYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH----SKHMIHRDIKSANILLCSNGLVKLGDFGFSKMY  193 (496)
T ss_pred             eCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEEeCCCCEEEEecccCeec
Confidence            789999999988642   245677888999999999999999    688999999999999999999999999998764

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.75  E-value=4e-18  Score=164.93  Aligned_cols=133  Identities=24%  Similarity=0.258  Sum_probs=109.1

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc---hhhhhhhhHHHHHhhhhc-cCccceeecccCCCC-----cccccCCC
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVR-HQNLIKILSSCSTPD-----FKFMPNGS  410 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-----~~~~~~g~  410 (481)
                      -+.|+||.||++... +|..||+|.+....   ....+.+..|..++..+. |++++++.+++...+     +||+++|+
T Consensus         8 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~   87 (323)
T cd05615           8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGD   87 (323)
T ss_pred             EEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCc
Confidence            478999999999854 68899999987542   222345667888887775 567778887776654     67999999


Q ss_pred             hhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          411 LEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       411 l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      |.+++... ..+++.++..++.+++.|++|||    +.+|+||||||+|||+++++.+||+|||+++.
T Consensus        88 L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH----~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~  150 (323)
T cd05615          88 LMYHIQQV-GKFKEPQAVFYAAEISVGLFFLH----RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  150 (323)
T ss_pred             HHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHeEECCCCCEEEeccccccc
Confidence            99887643 35788899999999999999999    67899999999999999999999999999875

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.75  E-value=6.9e-18  Score=162.21  Aligned_cols=134  Identities=26%  Similarity=0.288  Sum_probs=112.8

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHH
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKR  414 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~  414 (481)
                      +.|+||.||++... +|..+++|.+.... ......+.+|++++.+++|+||++++++|...+     +||+++|+|.++
T Consensus        10 g~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~   89 (308)
T cd06615          10 GAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQV   89 (308)
T ss_pred             cCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHH
Confidence            68999999999854 57888888876542 223345778999999999999999999987765     678999999999


Q ss_pred             hhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          415 LYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       415 l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +... ..+++.....++.++++|++|||+   ..+|+||||||+||++++++.+||+|||+++.+
T Consensus        90 l~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  150 (308)
T cd06615          90 LKKA-GRIPENILGKISIAVLRGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  150 (308)
T ss_pred             HHhc-CCCCHHHHHHHHHHHHHHHHHHHh---hCCEEECCCChHHEEEecCCcEEEccCCCcccc
Confidence            8754 346778888999999999999994   257999999999999999999999999998754

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.75  E-value=6.5e-18  Score=161.63  Aligned_cols=134  Identities=31%  Similarity=0.462  Sum_probs=114.3

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccchh-----hhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCC
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRER-----AFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNG  409 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g  409 (481)
                      .+.|++|.||+|... +|..+++|.+......     ....+..|++++++++|+|++++++++...+     ++|+ +|
T Consensus         8 lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~   86 (298)
T cd07841           8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-ET   86 (298)
T ss_pred             eeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-CC
Confidence            367999999999864 6889999998654322     2344667899999999999999999988754     5788 89


Q ss_pred             ChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          410 SLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       410 ~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +|.+++......+++.++.+++.+|++||+|||    +.+|+||||||+||+++.++.+||+|||+++..
T Consensus        87 ~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~  152 (298)
T cd07841          87 DLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH----SNWILHRDLKPNNLLIASDGVLKLADFGLARSF  152 (298)
T ss_pred             CHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeecCCChhhEEEcCCCCEEEccceeeeec
Confidence            999998765446889999999999999999999    678999999999999999999999999998764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.75  E-value=8.1e-18  Score=157.66  Aligned_cols=134  Identities=31%  Similarity=0.551  Sum_probs=115.2

Q ss_pred             hccccccceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHHh
Q 039957          341 SLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRL  415 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~l  415 (481)
                      .+.|++|.||++...++..+++|.+..... ....+..|+.++++++|+|++++++++....     ++|+++++|.+++
T Consensus        14 ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i   92 (261)
T cd05034          14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFL   92 (261)
T ss_pred             eccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHH
Confidence            367999999999877778899998865432 2356788999999999999999999887643     5688999999998


Q ss_pred             hcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          416 YSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       416 ~~~~-~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .... ..+++.++..++.+++.|++|||    +.+|+|+||||+||++++++.+|++|||.++.+
T Consensus        93 ~~~~~~~~~~~~~~~~~~~i~~al~~lh----~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~  153 (261)
T cd05034          93 KSGEGKKLRLPQLVDMAAQIAEGMAYLE----SRNYIHRDLAARNILVGENLVCKIADFGLARLI  153 (261)
T ss_pred             hccccCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCcchheEEEcCCCCEEECccccceec
Confidence            7633 46789999999999999999999    578999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.75  E-value=6.8e-18  Score=161.87  Aligned_cols=134  Identities=35%  Similarity=0.560  Sum_probs=109.7

Q ss_pred             hccccccceeeeecc-CCc--ceEEEEEeccc-hhhhhhhhHHHHHhhhh-ccCccceeecccCCCC-----cccccCCC
Q 039957          341 SLAGSFGSVYKGTIS-DGT--DVAIKIFNLQR-ERAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD-----FKFMPNGS  410 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~--~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----~~~~~~g~  410 (481)
                      .+.|+||.||+|... +|.  .+++|.+.... ....+.+.+|+.++.++ +|+|++++.+++...+     +||+++|+
T Consensus        15 lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   94 (303)
T cd05088          15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGN   94 (303)
T ss_pred             ecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCc
Confidence            468999999999864 454  35666654322 23345678899999999 8999999999987765     57899999


Q ss_pred             hhHHhhcCC---------------CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccC
Q 039957          411 LEKRLYSHN---------------YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGI  475 (481)
Q Consensus       411 l~~~l~~~~---------------~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl  475 (481)
                      |.+++....               ..+++.++..++.++++|++|||    +.+|+||||||+|||+++++.+||+|||+
T Consensus        95 L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH----~~gi~H~dlkp~Nili~~~~~~kl~dfg~  170 (303)
T cd05088          95 LLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS----QKQFIHRDLAARNILVGENYVAKIADFGL  170 (303)
T ss_pred             HHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH----hCCccccccchheEEecCCCcEEeCcccc
Confidence            999886421               24678899999999999999999    67899999999999999999999999999


Q ss_pred             ccc
Q 039957          476 SKL  478 (481)
Q Consensus       476 ~~~  478 (481)
                      ++.
T Consensus       171 ~~~  173 (303)
T cd05088         171 SRG  173 (303)
T ss_pred             Ccc
Confidence            863

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.75  E-value=5.7e-18  Score=161.34  Aligned_cols=134  Identities=26%  Similarity=0.429  Sum_probs=105.1

Q ss_pred             hccccccceeeeec-c-CCcceEEEEEeccch--hhhhhhhHHHHHhhhh---ccCccceeecccCCC-----C-----c
Q 039957          341 SLAGSFGSVYKGTI-S-DGTDVAIKIFNLQRE--RAFRSFNSECEVLRNV---RHQNLIKILSSCSTP-----D-----F  403 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~-~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~-----~-----~  403 (481)
                      .+.|+||.||++.. . .|..+|+|.+.....  .....+.+|+.++.++   +||||++++++|...     .     +
T Consensus         9 lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~   88 (290)
T cd07862           9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVF   88 (290)
T ss_pred             eccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEE
Confidence            36899999999975 3 467899998865432  2223455677766655   699999999987421     1     4


Q ss_pred             ccccCCChhHHhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          404 KFMPNGSLEKRLYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       404 ~~~~~g~l~~~l~~~-~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +|++ |++.+++... ...+++..+..++.++++||+|||    +.+|+||||||+|||+++++.+||+|||+|+..
T Consensus        89 e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH----~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T cd07862          89 EHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH----SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY  160 (290)
T ss_pred             ccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence            5665 6888887653 344788899999999999999999    678999999999999999999999999998754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.75  E-value=4.2e-18  Score=162.09  Aligned_cols=136  Identities=29%  Similarity=0.526  Sum_probs=107.8

Q ss_pred             ccccccceeeeec-cCCcceEEEEEeccch--hhhhhhhHHHHHhhhhccCccceeecccCCCCcc--ccc--CCChhHH
Q 039957          342 LAGSFGSVYKGTI-SDGTDVAIKIFNLQRE--RAFRSFNSECEVLRNVRHQNLIKILSSCSTPDFK--FMP--NGSLEKR  414 (481)
Q Consensus       342 ~~g~~g~vy~~~l-~~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~--~~~--~g~l~~~  414 (481)
                      ++|.||+||-|+. ..|+.||||.+++.+.  +.....+.|+++|.+++||.||.+-..|..++--  .|+  +|+..+.
T Consensus       573 GSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDMLEM  652 (888)
T KOG4236|consen  573 GSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDMLEM  652 (888)
T ss_pred             cCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchHHHH
Confidence            7899999999985 4699999999977553  2335678899999999999999998888877633  333  5777776


Q ss_pred             hhc-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCC---CcEEEccccCcccCCC
Q 039957          415 LYS-HNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDEN---MVAHVSDFGISKLLGE  481 (481)
Q Consensus       415 l~~-~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~---~~~kl~Dfgl~~~~~~  481 (481)
                      +.. ...++.....--++.||..||.|||    ..+|||+|+||+|||+...   -.+|+||||+||+++|
T Consensus       653 ILSsEkgRL~er~TkFlvtQIL~ALr~LH----~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE  719 (888)
T KOG4236|consen  653 ILSSEKGRLPERITKFLVTQILVALRYLH----FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE  719 (888)
T ss_pred             HHHhhcccchHHHHHHHHHHHHHHHHHhh----hcceeeccCCchheeeccCCCCCceeeccccceeecch
Confidence            654 2334444444457789999999999    5789999999999999653   4799999999999865

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.75  E-value=9.2e-18  Score=156.66  Aligned_cols=131  Identities=31%  Similarity=0.552  Sum_probs=112.1

Q ss_pred             hccccccceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC----cccccCCChhHHhh
Q 039957          341 SLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----FKFMPNGSLEKRLY  416 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~~~~g~l~~~l~  416 (481)
                      .+.|+||.||++.. .+..+++|......  ....+..|+.++++++|+|++++.+++....    ++|+++|+|.+++.
T Consensus        14 lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~l~   90 (254)
T cd05083          14 IGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMELMSKGNLVNFLR   90 (254)
T ss_pred             eccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCcEEEEECCCCCCHHHHHH
Confidence            46899999999874 67889999875432  2346788999999999999999999886654    57899999999987


Q ss_pred             cCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          417 SHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       417 ~~~-~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      ... ...++..+.+++.+++.|++|+|    +.+++|||+||+||+++.++.+||+|||+++.
T Consensus        91 ~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~  149 (254)
T cd05083          91 TRGRALVSVIQLLQFSLDVAEGMEYLE----SKKLVHRDLAARNILVSEDGVAKVSDFGLARV  149 (254)
T ss_pred             hcCcCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccccCcceEEEcCCCcEEECCCcccee
Confidence            543 35788899999999999999999    57899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.75  E-value=6.2e-18  Score=162.49  Aligned_cols=134  Identities=27%  Similarity=0.496  Sum_probs=111.3

Q ss_pred             ccccccceeeeecc--------CCcceEEEEEeccc-hhhhhhhhHHHHHhhhh-ccCccceeecccCCCC-----cccc
Q 039957          342 LAGSFGSVYKGTIS--------DGTDVAIKIFNLQR-ERAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD-----FKFM  406 (481)
Q Consensus       342 ~~g~~g~vy~~~l~--------~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----~~~~  406 (481)
                      ++|+||.||++...        ++..+|+|.+.... ......+..|+.++.++ +|+|+++++++|...+     ++|+
T Consensus        27 g~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~  106 (307)
T cd05098          27 GEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA  106 (307)
T ss_pred             ccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecC
Confidence            68999999988642        23468999886532 23345677899999998 7999999999987665     5789


Q ss_pred             cCCChhHHhhcCC---------------CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 039957          407 PNGSLEKRLYSHN---------------YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVS  471 (481)
Q Consensus       407 ~~g~l~~~l~~~~---------------~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~  471 (481)
                      ++|+|.+++....               ..++|.++.+++.+++.|++|+|    +.+++||||||+||++++++++||+
T Consensus       107 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH----~~gi~H~dlkp~Nill~~~~~~kL~  182 (307)
T cd05098         107 SKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA----SKKCIHRDLAARNVLVTEDNVMKIA  182 (307)
T ss_pred             CCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH----HCCcccccccHHheEEcCCCcEEEC
Confidence            9999999986521               24788999999999999999999    6789999999999999999999999


Q ss_pred             cccCcccC
Q 039957          472 DFGISKLL  479 (481)
Q Consensus       472 Dfgl~~~~  479 (481)
                      |||.++.+
T Consensus       183 dfg~a~~~  190 (307)
T cd05098         183 DFGLARDI  190 (307)
T ss_pred             CCcccccc
Confidence            99998754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.75  E-value=4.5e-18  Score=162.16  Aligned_cols=132  Identities=27%  Similarity=0.433  Sum_probs=114.1

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHHh
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRL  415 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~l  415 (481)
                      +.|+||.||++... ++..+++|.+........+.+.+|+..+++++|+|++++++.+...+     +||++++++.+++
T Consensus        31 g~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~  110 (292)
T cd06658          31 GEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIV  110 (292)
T ss_pred             cCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHH
Confidence            68999999999854 58899999887655555566888999999999999999999887665     5789999999987


Q ss_pred             hcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          416 YSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       416 ~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ...  .+++.+...++.+|+.|++|||    +.+|+||||||+||++++++.+||+|||+++..
T Consensus       111 ~~~--~l~~~~~~~~~~qi~~~l~~LH----~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~  168 (292)
T cd06658         111 THT--RMNEEQIATVCLSVLRALSYLH----NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQV  168 (292)
T ss_pred             hcC--CCCHHHHHHHHHHHHHHHHHHH----HCCEeecCCCHHHEEEcCCCCEEEccCcchhhc
Confidence            543  4678899999999999999999    678999999999999999999999999998653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.75  E-value=2.7e-18  Score=167.90  Aligned_cols=132  Identities=26%  Similarity=0.395  Sum_probs=111.8

Q ss_pred             ccccccceeeeec-cCCcceEEEEEeccch---hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          342 LAGSFGSVYKGTI-SDGTDVAIKIFNLQRE---RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       342 ~~g~~g~vy~~~l-~~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      |.|+-|.|..|+. .+|+.+|||++..+..   .....+.+|+.+++-+.|||++++++.+....     .||+++|.|.
T Consensus        21 G~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELF  100 (786)
T KOG0588|consen   21 GKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELF  100 (786)
T ss_pred             cCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhH
Confidence            6788888988874 5799999999876632   12345678999999999999999999887764     5799999999


Q ss_pred             HHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          413 KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       413 ~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      +++..++. +...++.+...||..|++|.|    ..+|+|||+||+|+|+|..+.+||+|||+|.+
T Consensus       101 dylv~kG~-l~e~eaa~ff~QIi~gv~yCH----~~~icHRDLKpENlLLd~~~nIKIADFGMAsL  161 (786)
T KOG0588|consen  101 DYLVRKGP-LPEREAAHFFRQILDGVSYCH----AFNICHRDLKPENLLLDVKNNIKIADFGMASL  161 (786)
T ss_pred             HHHHhhCC-CCCHHHHHHHHHHHHHHHHHh----hhcceeccCCchhhhhhcccCEeeeccceeec
Confidence            99886654 445677889999999999999    46699999999999999999999999999976

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.75  E-value=9.7e-18  Score=156.66  Aligned_cols=135  Identities=32%  Similarity=0.599  Sum_probs=115.3

Q ss_pred             hccccccceeeeeccC-----CcceEEEEEeccchh-hhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCC
Q 039957          341 SLAGSFGSVYKGTISD-----GTDVAIKIFNLQRER-AFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNG  409 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~-----g~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g  409 (481)
                      .+.|+||.||++...+     +..+++|.+...... ....+..|++.+..++|+|++++++++...+     ++|++++
T Consensus         7 lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~   86 (258)
T smart00219        7 LGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGG   86 (258)
T ss_pred             eccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCC
Confidence            3679999999998654     377999998655433 4567888999999999999999999887754     5688999


Q ss_pred             ChhHHhhcCCCc-cCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          410 SLEKRLYSHNYF-LDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       410 ~l~~~l~~~~~~-~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ++.+++...... +++.....++.+++.|++|||    +.+++||||||+||++++++.+|++|||+++..
T Consensus        87 ~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh----~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~  153 (258)
T smart00219       87 DLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE----SKNFIHRDLAARNCLVGENLVVKISDFGLSRDL  153 (258)
T ss_pred             CHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh----cCCeeecccccceEEEccCCeEEEcccCCceec
Confidence            999998764433 789999999999999999999    678999999999999999999999999998754

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.74  E-value=1e-17  Score=161.46  Aligned_cols=136  Identities=25%  Similarity=0.470  Sum_probs=111.8

Q ss_pred             hhccccccceeeeecc--------CCcceEEEEEeccc-hhhhhhhhHHHHHhhhh-ccCccceeecccCCCC-----cc
Q 039957          340 ISLAGSFGSVYKGTIS--------DGTDVAIKIFNLQR-ERAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD-----FK  404 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~--------~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----~~  404 (481)
                      ..+.|+||.||++...        .+..+|+|.+.... ......+..|+.++.++ +|+||++++++|....     ++
T Consensus        19 ~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e   98 (314)
T cd05099          19 PLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVE   98 (314)
T ss_pred             eecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEe
Confidence            3478999999998631        23568888876432 23345678899999998 6999999999887654     57


Q ss_pred             cccCCChhHHhhcC---------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEE
Q 039957          405 FMPNGSLEKRLYSH---------------NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAH  469 (481)
Q Consensus       405 ~~~~g~l~~~l~~~---------------~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~k  469 (481)
                      |+++|+|.+++...               ...++|.+..+++.+++.|++|+|    +.+|+||||||+||++++++.+|
T Consensus        99 ~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH----~~gi~H~dlkp~Nill~~~~~~k  174 (314)
T cd05099          99 YAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE----SRRCIHRDLAARNVLVTEDNVMK  174 (314)
T ss_pred             cCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH----HCCeeeccccceeEEEcCCCcEE
Confidence            89999999988642               134788899999999999999999    67899999999999999999999


Q ss_pred             EccccCcccC
Q 039957          470 VSDFGISKLL  479 (481)
Q Consensus       470 l~Dfgl~~~~  479 (481)
                      ++|||+++..
T Consensus       175 L~Dfg~~~~~  184 (314)
T cd05099         175 IADFGLARGV  184 (314)
T ss_pred             Eccccccccc
Confidence            9999999754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.74  E-value=8.5e-18  Score=161.07  Aligned_cols=133  Identities=24%  Similarity=0.431  Sum_probs=112.1

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccch-hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHH
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQRE-RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKR  414 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~  414 (481)
                      +.|+||.||++... ++..||+|.+..... .....+..|+..+++++|+||+++.+++...+     ++|++ +++.++
T Consensus        15 g~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~   93 (301)
T cd07873          15 GEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQY   93 (301)
T ss_pred             ccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHHHH
Confidence            67999999999864 578899998865432 22345678999999999999999999987665     56776 688888


Q ss_pred             hhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          415 LYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       415 l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +......+++.....++.++++||+|||    +.+|+||||||+||++++++.+||+|||+++..
T Consensus        94 l~~~~~~~~~~~~~~~~~qi~~aL~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  154 (301)
T cd07873          94 LDDCGNSINMHNVKLFLFQLLRGLNYCH----RRKVLHRDLKPQNLLINERGELKLADFGLARAK  154 (301)
T ss_pred             HHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCCHHHEEECCCCcEEECcCcchhcc
Confidence            7765556788889999999999999999    678999999999999999999999999998753

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.74  E-value=6.1e-18  Score=164.06  Aligned_cols=139  Identities=26%  Similarity=0.462  Sum_probs=117.9

Q ss_pred             Chhhhhccccccceeeeecc-CCcceEEEEEeccchh---hhhhhhHHHHHhhhhc-cCccceeecccCCCC-----ccc
Q 039957          336 DLETISLAGSFGSVYKGTIS-DGTDVAIKIFNLQRER---AFRSFNSECEVLRNVR-HQNLIKILSSCSTPD-----FKF  405 (481)
Q Consensus       336 ~L~~l~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-----~~~  405 (481)
                      .+....+.|.||.||++... +|..+|+|.+......   ......+|+++++++. |||+|.+.+.+.+.+     +|+
T Consensus        38 ~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL  117 (382)
T KOG0032|consen   38 ELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMEL  117 (382)
T ss_pred             EehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEe
Confidence            34456689999999999865 4999999998765443   2357889999999998 999999999998775     678


Q ss_pred             ccCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCC----CCcEEEccccCcccCC
Q 039957          406 MPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDE----NMVAHVSDFGISKLLG  480 (481)
Q Consensus       406 ~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~----~~~~kl~Dfgl~~~~~  480 (481)
                      +.+|+|.+.+...  .++-.....++.+|+.|++|+|    +.+|||||+||+|+|+..    ++.+|++|||+|+...
T Consensus       118 ~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH----~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~  190 (382)
T KOG0032|consen  118 CEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLH----SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK  190 (382)
T ss_pred             cCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHH----hCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence            9999999998765  2677788899999999999999    689999999999999964    2589999999998764

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.74  E-value=5.5e-18  Score=162.01  Aligned_cols=132  Identities=28%  Similarity=0.418  Sum_probs=113.6

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHHh
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRL  415 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~l  415 (481)
                      +.|+||.||++... ++..+++|.+........+.+.+|+..++.++|+|++++++++...+     ++|++++++.+++
T Consensus        30 g~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~  109 (297)
T cd06659          30 GEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIV  109 (297)
T ss_pred             CCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHH
Confidence            68999999999854 68899999987654444556788999999999999999999887664     5789999999876


Q ss_pred             hcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          416 YSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       416 ~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ..  ..+++.....++.+++.|++|+|    +.+|+||||||+||+++.++.+||+|||+++.+
T Consensus       110 ~~--~~~~~~~~~~~~~qi~~~L~~LH----~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~  167 (297)
T cd06659         110 SQ--TRLNEEQIATVCESVLQALCYLH----SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI  167 (297)
T ss_pred             hh--cCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHeEEccCCcEEEeechhHhhc
Confidence            54  34688899999999999999999    678999999999999999999999999998643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.74  E-value=9e-18  Score=158.65  Aligned_cols=133  Identities=21%  Similarity=0.379  Sum_probs=112.7

Q ss_pred             ccccccceeeeecc------CCcceEEEEEeccchh-hhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCC
Q 039957          342 LAGSFGSVYKGTIS------DGTDVAIKIFNLQRER-AFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNG  409 (481)
Q Consensus       342 ~~g~~g~vy~~~l~------~g~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g  409 (481)
                      +.|+||.||++...      +...+++|.+...... ....+..|++++++++|+|+++++++|...+     ++|+++|
T Consensus        14 g~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   93 (275)
T cd05046          14 GRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLG   93 (275)
T ss_pred             cccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCC
Confidence            67999999999853      2356888887654433 3457888999999999999999999987654     5788999


Q ss_pred             ChhHHhhcCC--------CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          410 SLEKRLYSHN--------YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       410 ~l~~~l~~~~--------~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      +|.+++....        ..+++..+..++.++++|++|||    +.+|+||||||+||++++++.+|++|||+++.
T Consensus        94 ~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH----~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~  166 (275)
T cd05046          94 DLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS----NARFVHRDLAARNCLVSSQREVKVSLLSLSKD  166 (275)
T ss_pred             cHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh----hcCcccCcCccceEEEeCCCcEEEcccccccc
Confidence            9999986532        15789999999999999999999    57899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.74  E-value=4.2e-20  Score=151.37  Aligned_cols=165  Identities=30%  Similarity=0.489  Sum_probs=131.1

Q ss_pred             hhCCCCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccC
Q 039957            9 IGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKL   88 (481)
Q Consensus         9 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L   88 (481)
                      +-.+++++.|.||+|.++. .|+.++.+.+|+.|++++|+|. .+|..+. +++.|+.|+++-|++. +.|..|+.++.|
T Consensus        29 Lf~~s~ITrLtLSHNKl~~-vppnia~l~nlevln~~nnqie-~lp~~is-sl~klr~lnvgmnrl~-~lprgfgs~p~l  104 (264)
T KOG0617|consen   29 LFNMSNITRLTLSHNKLTV-VPPNIAELKNLEVLNLSNNQIE-ELPTSIS-SLPKLRILNVGMNRLN-ILPRGFGSFPAL  104 (264)
T ss_pred             ccchhhhhhhhcccCceee-cCCcHHHhhhhhhhhcccchhh-hcChhhh-hchhhhheecchhhhh-cCccccCCCchh
Confidence            3457888999999999985 5667999999999999999998 8999986 8999999999999987 899999999999


Q ss_pred             ceeecccCccee-cCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhccc
Q 039957           89 IILDLGFNTFSG-HIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFST  167 (481)
Q Consensus        89 ~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~  167 (481)
                      ++|||.+|++.. .+|..|..|+.|+-|+|+.|.+..++         ..++++++|+.|.+.+|.+- .+|.+++.+ +
T Consensus       105 evldltynnl~e~~lpgnff~m~tlralyl~dndfe~lp---------~dvg~lt~lqil~lrdndll-~lpkeig~l-t  173 (264)
T KOG0617|consen  105 EVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILP---------PDVGKLTNLQILSLRDNDLL-SLPKEIGDL-T  173 (264)
T ss_pred             hhhhccccccccccCCcchhHHHHHHHHHhcCCCcccCC---------hhhhhhcceeEEeeccCchh-hCcHHHHHH-H
Confidence            999999999874 57888888888888888888777653         33466777777777777665 456666665 3


Q ss_pred             CccEEEccCCceeecCCccccc
Q 039957          168 SLQRFSASECKLKGTIPKEIGH  189 (481)
Q Consensus       168 ~L~~L~l~~n~l~~~~p~~~~~  189 (481)
                      .|++|.+.+|+++ .+|.++++
T Consensus       174 ~lrelhiqgnrl~-vlppel~~  194 (264)
T KOG0617|consen  174 RLRELHIQGNRLT-VLPPELAN  194 (264)
T ss_pred             HHHHHhcccceee-ecChhhhh
Confidence            5666666666666 44554443

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.74  E-value=1.2e-17  Score=156.06  Aligned_cols=135  Identities=27%  Similarity=0.395  Sum_probs=114.8

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      .+.|.||.+|.+.. .++..+++|.+....  ......+.+|++++++++|+|++++++++.+.+     ++|+++|+|.
T Consensus         8 ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~   87 (256)
T cd08221           8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLY   87 (256)
T ss_pred             ecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHH
Confidence            36789998888774 457889999886543  334456788999999999999999999987765     5789999999


Q ss_pred             HHhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          413 KRLYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       413 ~~l~~~-~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +++... ...+++.+...++.++++|++|||    +.+++|||+||+||++++++.+||+|||+++..
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh----~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~  151 (256)
T cd08221          88 DKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH----KAGILHRDIKTLNIFLTKAGLIKLGDFGISKIL  151 (256)
T ss_pred             HHHHhccccCCCHHHHHHHHHHHHHHHHHHH----hCCccccCCChHhEEEeCCCCEEECcCcceEEc
Confidence            988754 445788899999999999999999    578999999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.74  E-value=8.8e-18  Score=160.50  Aligned_cols=132  Identities=26%  Similarity=0.445  Sum_probs=114.8

Q ss_pred             ccccccceeeeec-cCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHHh
Q 039957          342 LAGSFGSVYKGTI-SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRL  415 (481)
Q Consensus       342 ~~g~~g~vy~~~l-~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~l  415 (481)
                      +.|.+|.||++.. .+|..+++|.+........+.+..|+..+++++|+|++++++++...+     ++|+++|+|.+++
T Consensus        28 g~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~  107 (296)
T cd06655          28 GQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV  107 (296)
T ss_pred             ecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHH
Confidence            6799999999974 568899999887655445567788999999999999999999887664     5789999999987


Q ss_pred             hcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          416 YSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       416 ~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ...  .+++.++..++.++++|++|||    +.+|+||||||+||+++.++.+||+|||+++.+
T Consensus       108 ~~~--~l~~~~~~~i~~~l~~al~~LH----~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~  165 (296)
T cd06655         108 TET--CMDEAQIAAVCRECLQALEFLH----ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQI  165 (296)
T ss_pred             Hhc--CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEEccCccchhc
Confidence            643  4789999999999999999999    678999999999999999999999999998754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.74  E-value=6.7e-18  Score=169.86  Aligned_cols=130  Identities=31%  Similarity=0.409  Sum_probs=103.1

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCC-------------Ccccc
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTP-------------DFKFM  406 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------------~~~~~  406 (481)
                      .+.|+||.||+|... .+..||+|.+....    ....+|+.++++++|+||+++.+++...             .++|+
T Consensus        74 LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~  149 (440)
T PTZ00036         74 IGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFI  149 (440)
T ss_pred             EEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecC
Confidence            478999999999864 57899999875432    2235699999999999999988765321             14577


Q ss_pred             cCCChhHHhhc---CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCC-CcEEEccccCcccC
Q 039957          407 PNGSLEKRLYS---HNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDEN-MVAHVSDFGISKLL  479 (481)
Q Consensus       407 ~~g~l~~~l~~---~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~-~~~kl~Dfgl~~~~  479 (481)
                      + |++.+++..   ....+++.....++.+|++||+|||    +.+|+||||||+|||++.+ +.+||+|||+|+.+
T Consensus       150 ~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH----~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~  221 (440)
T PTZ00036        150 P-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH----SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL  221 (440)
T ss_pred             C-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCEecCCcCHHHEEEcCCCCceeeeccccchhc
Confidence            6 466665542   3456778888899999999999999    6789999999999999976 57999999999854

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.74  E-value=9e-18  Score=159.64  Aligned_cols=135  Identities=27%  Similarity=0.379  Sum_probs=114.4

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHH
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKR  414 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~  414 (481)
                      +.|+||.||++... +|..+|+|.+.... ......+.+|+.++.+++|+|++++++++...+     +||++++++.++
T Consensus        10 g~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~   89 (286)
T cd06622          10 GKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKL   89 (286)
T ss_pred             cccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHH
Confidence            68999999999865 68899999886542 233456788999999999999999999887665     679999999888


Q ss_pred             hhcC--CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          415 LYSH--NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       415 l~~~--~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +...  ...+++....+++.+++.|++|||+   ..+|+||||||+||+++.++.+||+|||+++.+
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  153 (286)
T cd06622          90 YAGGVATEGIPEDVLRRITYAVVKGLKFLKE---EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNL  153 (286)
T ss_pred             HHhccccCCCCHHHHHHHHHHHHHHHHHHHh---cCCEeeCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            7653  2357889999999999999999995   357999999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.74  E-value=1.3e-17  Score=155.66  Aligned_cols=133  Identities=32%  Similarity=0.443  Sum_probs=116.6

Q ss_pred             hccccccceeeeeccC-CcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHH
Q 039957          341 SLAGSFGSVYKGTISD-GTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKR  414 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~-g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~  414 (481)
                      .+.|++|.+|++...+ +..+++|.+.....  .+.+.+|++.+++++|+|++++.+++....     ++|+++++|.++
T Consensus        11 i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~   88 (256)
T cd06612          11 LGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDI   88 (256)
T ss_pred             hcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHH
Confidence            4678999999998764 78899998865433  567889999999999999999999887764     578999999999


Q ss_pred             hhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          415 LYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       415 l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +......+++.....++.++++|++|||    +.+|+|||++|+||++++++.+||+|||++..+
T Consensus        89 l~~~~~~l~~~~~~~~~~~l~~~l~~lh----~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~  149 (256)
T cd06612          89 MKITNKTLTEEEIAAILYQTLKGLEYLH----SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQL  149 (256)
T ss_pred             HHhCccCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCcceEEECCCCcEEEcccccchhc
Confidence            8766667899999999999999999999    578999999999999999999999999998764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.74  E-value=7.5e-18  Score=177.51  Aligned_cols=134  Identities=24%  Similarity=0.421  Sum_probs=113.3

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      .+.|+||.||+|... ++..||+|.+....   ......+..|+.++..++|+||+++++.+...+     ++|+++|+|
T Consensus        12 LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L   91 (669)
T cd05610          12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDV   91 (669)
T ss_pred             EecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCH
Confidence            368999999999865 68899999986543   222356778999999999999999998776554     678999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+++... ..+++....+|+.+|+.||+|||    ..+||||||||+|||++.++++||+|||+++..
T Consensus        92 ~~li~~~-~~l~~~~~~~i~~qil~aL~yLH----~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~  154 (669)
T cd05610          92 KSLLHIY-GYFDEEMAVKYISEVALALDYLH----RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVT  154 (669)
T ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH----hCCEEeCCccHHHEEEcCCCCEEEEeCCCCccc
Confidence            9988653 34677888999999999999999    578999999999999999999999999999864

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.74  E-value=1.3e-17  Score=162.29  Aligned_cols=135  Identities=25%  Similarity=0.479  Sum_probs=111.4

Q ss_pred             hccccccceeeeecc--------CCcceEEEEEeccc-hhhhhhhhHHHHHhhhh-ccCccceeecccCCCC-----ccc
Q 039957          341 SLAGSFGSVYKGTIS--------DGTDVAIKIFNLQR-ERAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD-----FKF  405 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~--------~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----~~~  405 (481)
                      .+.|+||.||++...        .+..+|+|.+.... ....+.+..|++++.++ +|+||++++++|...+     ++|
T Consensus        20 ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~   99 (334)
T cd05100          20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEY   99 (334)
T ss_pred             eccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEec
Confidence            478999999998632        12358889776432 23346788899999999 7999999999987765     578


Q ss_pred             ccCCChhHHhhcC---------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 039957          406 MPNGSLEKRLYSH---------------NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHV  470 (481)
Q Consensus       406 ~~~g~l~~~l~~~---------------~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl  470 (481)
                      +++|+|.+++...               ...++|.++++++.++++|++|||    +.+|+||||||+||++++++.+||
T Consensus       100 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH----~~givH~dlkp~Nill~~~~~~kL  175 (334)
T cd05100         100 ASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA----SQKCIHRDLAARNVLVTEDNVMKI  175 (334)
T ss_pred             CCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH----HCCeeccccccceEEEcCCCcEEE
Confidence            9999999988642               124788899999999999999999    678999999999999999999999


Q ss_pred             ccccCcccC
Q 039957          471 SDFGISKLL  479 (481)
Q Consensus       471 ~Dfgl~~~~  479 (481)
                      +|||+++.+
T Consensus       176 ~Dfg~~~~~  184 (334)
T cd05100         176 ADFGLARDV  184 (334)
T ss_pred             CCcccceec
Confidence            999998754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.74  E-value=9.5e-18  Score=157.76  Aligned_cols=137  Identities=23%  Similarity=0.427  Sum_probs=115.0

Q ss_pred             hhhccccccceeeeec-cCCcceEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCC
Q 039957          339 TISLAGSFGSVYKGTI-SDGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNG  409 (481)
Q Consensus       339 ~l~~~g~~g~vy~~~l-~~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g  409 (481)
                      ...+.|++|.||++.. .+|..+++|.+....   .....++..|+.+++.++|+|++++++++...+     ++|++++
T Consensus         8 ~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~   87 (267)
T cd08229           8 KKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAG   87 (267)
T ss_pred             hhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCC
Confidence            3457899999999985 578999999876432   223456788999999999999999999887654     5688999


Q ss_pred             ChhHHhhc---CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          410 SLEKRLYS---HNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       410 ~l~~~l~~---~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +|.+++..   ....+++....+++.++++|++|||    +.+|+|+||||+||+++.++.+|++|||+++.+
T Consensus        88 ~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH----~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd08229          88 DLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH----SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF  156 (267)
T ss_pred             CHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence            99988763   2345788899999999999999999    678999999999999999999999999998754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.74  E-value=1.4e-17  Score=155.97  Aligned_cols=136  Identities=24%  Similarity=0.454  Sum_probs=114.7

Q ss_pred             hhhccccccceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC----cccccCCChhHH
Q 039957          339 TISLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----FKFMPNGSLEKR  414 (481)
Q Consensus       339 ~l~~~g~~g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~~~~g~l~~~  414 (481)
                      ..-+.|+||.||++...++..+++|.+.... .....+.+|++++++++|+|++++.+.+....    ++|+++|++.++
T Consensus        12 ~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~   90 (260)
T cd05073          12 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDF   90 (260)
T ss_pred             eEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcCCCeEEEEEeCCCCcHHHH
Confidence            3446899999999987777789999876432 23456788999999999999999998876643    568899999999


Q ss_pred             hhc-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          415 LYS-HNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       415 l~~-~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +.. .....++.++..++.+++.|++|||    +.+++||||||+||+++.++.+|++|||.++.+
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~l~~aL~~lH----~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~  152 (260)
T cd05073          91 LKSDEGSKQPLPKLIDFSAQIAEGMAFIE----QRNYIHRDLRAANILVSASLVCKIADFGLARVI  152 (260)
T ss_pred             HHhCCccccCHHHHHHHHHHHHHHHHHHH----hCCccccccCcceEEEcCCCcEEECCCcceeec
Confidence            875 3455788899999999999999999    578999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.74  E-value=9.5e-19  Score=155.59  Aligned_cols=133  Identities=26%  Similarity=0.405  Sum_probs=116.0

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCC-CC----cccccCCChhHHh
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCST-PD----FKFMPNGSLEKRL  415 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~----~~~~~~g~l~~~l  415 (481)
                      +.|+||.||++... .|..+|+|..-.  ....+++..|+.++.+++.+.+|+++|.+.. .+    +|||..|++.+.+
T Consensus        42 GEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~  119 (502)
T KOG0574|consen   42 GEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIM  119 (502)
T ss_pred             cCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHH
Confidence            68999999999864 589999997654  3445678889999999999999999986643 33    7899999999999


Q ss_pred             hcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          416 YSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       416 ~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      +.....+...+...|..+..+||+|||    ...-+|||||+-|||+..+|.+|++|||+|..+.
T Consensus       120 R~R~K~L~E~EIs~iL~~TLKGL~YLH----~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLT  180 (502)
T KOG0574|consen  120 RARRKPLSEQEISAVLRDTLKGLQYLH----DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLT  180 (502)
T ss_pred             HHhcCCccHHHHHHHHHHHHhHHHHHH----HHHHHHhhcccccEEEcccchhhhhhccccchhh
Confidence            988888888888889999999999999    4567899999999999999999999999998764

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.74  E-value=1.2e-17  Score=157.00  Aligned_cols=135  Identities=23%  Similarity=0.423  Sum_probs=112.4

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      -+.|+||.||+|... ++..+++|.+....   ......+..|++++++++|+|++++++++...+     ++|+++|++
T Consensus        10 l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   89 (267)
T cd08228          10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDL   89 (267)
T ss_pred             eccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcH
Confidence            367999999999854 68899999875422   233456788999999999999999999887654     568899999


Q ss_pred             hHHhhc---CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          412 EKRLYS---HNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~---~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+++..   ....++.....+++.++++|++|||    +.+|+||||||+||+++.++.++++|||+++.+
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH----~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~  156 (267)
T cd08228          90 SQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH----SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF  156 (267)
T ss_pred             HHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh----hCCeeCCCCCHHHEEEcCCCCEEECccccceec
Confidence            987753   2334677888999999999999999    678999999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.74  E-value=1.3e-17  Score=159.30  Aligned_cols=136  Identities=26%  Similarity=0.427  Sum_probs=112.7

Q ss_pred             hhccccccceeeeeccC-----------------CcceEEEEEeccch-hhhhhhhHHHHHhhhhccCccceeecccCCC
Q 039957          340 ISLAGSFGSVYKGTISD-----------------GTDVAIKIFNLQRE-RAFRSFNSECEVLRNVRHQNLIKILSSCSTP  401 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~~-----------------g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  401 (481)
                      ..+.|+||.||++...+                 +..+++|.+..... .....+.+|++++++++|+|+++++++|...
T Consensus        12 ~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   91 (296)
T cd05051          12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVD   91 (296)
T ss_pred             cccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEEecC
Confidence            34789999999887542                 24578888765432 3345788899999999999999999988765


Q ss_pred             C-----cccccCCChhHHhhcCC----------CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCC
Q 039957          402 D-----FKFMPNGSLEKRLYSHN----------YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENM  466 (481)
Q Consensus       402 ~-----~~~~~~g~l~~~l~~~~----------~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~  466 (481)
                      +     ++|+++++|.+++....          ..+++.....++.++++|++|||    +.+|+||||||+||+++.++
T Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH----~~~i~H~dlkp~Nili~~~~  167 (296)
T cd05051          92 PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE----SLNFVHRDLATRNCLVGKNY  167 (296)
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH----HcCccccccchhceeecCCC
Confidence            4     56889999999886532          25788899999999999999999    57899999999999999999


Q ss_pred             cEEEccccCcccC
Q 039957          467 VAHVSDFGISKLL  479 (481)
Q Consensus       467 ~~kl~Dfgl~~~~  479 (481)
                      .+|++|||+++.+
T Consensus       168 ~~~l~dfg~~~~~  180 (296)
T cd05051         168 TIKIADFGMSRNL  180 (296)
T ss_pred             ceEEccccceeec
Confidence            9999999998753

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.74  E-value=1.1e-17  Score=157.34  Aligned_cols=134  Identities=28%  Similarity=0.412  Sum_probs=114.4

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHH
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKR  414 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~  414 (481)
                      .+.|+||.+|++.. .++..+++|.+..........+.+|+.+++.++|+|++++++.+...+     ++|+++|+|.++
T Consensus        17 lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~   96 (267)
T cd06645          17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDI   96 (267)
T ss_pred             hCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHH
Confidence            37899999999985 458889999887655444556778999999999999999999887654     578899999998


Q ss_pred             hhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          415 LYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       415 l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +... ..++..+...++.+++.|++|||    +.+|+||||||+||+++.++.+||+|||+++.+
T Consensus        97 ~~~~-~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd06645          97 YHVT-GPLSESQIAYVSRETLQGLYYLH----SKGKMHRDIKGANILLTDNGHVKLADFGVSAQI  156 (267)
T ss_pred             HHhc-CCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEECCCCCEEECcceeeeEc
Confidence            7643 35778889999999999999999    578999999999999999999999999998643

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.74  E-value=9.5e-18  Score=165.65  Aligned_cols=133  Identities=29%  Similarity=0.392  Sum_probs=109.2

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC----------ccccc
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----------FKFMP  407 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----------~~~~~  407 (481)
                      .+.|+||.||++... +|..||+|.+....  ....+.+.+|+.+++.++|+||+++++++...+          ++|+.
T Consensus         8 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~   87 (372)
T cd07853           8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ   87 (372)
T ss_pred             eeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccc
Confidence            478999999999854 68999999875432  223456788999999999999999999886654          23554


Q ss_pred             CCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          408 NGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       408 ~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                       +++.+.+.. ...+++.....++.+|++||+|||    +.+|+||||||+|||+++++.+||+|||+|+..
T Consensus        88 -~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH----~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          88 -SDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLH----SAGILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             -cCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCChHHEEECCCCCEEeccccceeec
Confidence             677776653 345788889999999999999999    678999999999999999999999999998753

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.74  E-value=8.2e-18  Score=161.74  Aligned_cols=132  Identities=22%  Similarity=0.244  Sum_probs=100.0

Q ss_pred             Chhhhhccccccceeeeecc--CCcceEEEEEecc-----chhhhhhhhHHHHHhhhhccCccce-eecccCCC--Cccc
Q 039957          336 DLETISLAGSFGSVYKGTIS--DGTDVAIKIFNLQ-----RERAFRSFNSECEVLRNVRHQNLIK-ILSSCSTP--DFKF  405 (481)
Q Consensus       336 ~L~~l~~~g~~g~vy~~~l~--~g~~vavK~l~~~-----~~~~~~~~~~e~~~l~~l~h~niv~-l~~~~~~~--~~~~  405 (481)
                      .+....++|+||.||+|...  ++..+|||+....     .......+.+|++++.+++|++++. +..+ ...  .+||
T Consensus        21 ~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-~~~~LVmE~   99 (365)
T PRK09188         21 VETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-GKDGLVRGW   99 (365)
T ss_pred             eEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-CCcEEEEEc
Confidence            34445589999999999754  4677899986532     1122446889999999999999985 4432 211  2689


Q ss_pred             ccCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCC-CCCCeeeCCCCcEEEccccCcccCC
Q 039957          406 MPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDL-KPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       406 ~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dl-k~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      +++++|... ...       ...+++.++++||+|+|    +.+|+|||| ||+|||++.++.+||+|||+|+.+.
T Consensus       100 ~~G~~L~~~-~~~-------~~~~~~~~i~~aL~~lH----~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~  163 (365)
T PRK09188        100 TEGVPLHLA-RPH-------GDPAWFRSAHRALRDLH----RAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR  163 (365)
T ss_pred             cCCCCHHHh-Ccc-------chHHHHHHHHHHHHHHH----HCCCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence            999999632 111       11457789999999999    688999999 9999999999999999999998653

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.74  E-value=4.9e-18  Score=158.89  Aligned_cols=143  Identities=30%  Similarity=0.483  Sum_probs=113.8

Q ss_pred             cccccCChhhhhccccccceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhh--hhccCccceeecccCCCC-----
Q 039957          330 TIGALVDLETISLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLR--NVRHQNLIKILSSCSTPD-----  402 (481)
Q Consensus       330 ~~~~l~~L~~l~~~g~~g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~--~l~h~niv~l~~~~~~~~-----  402 (481)
                      +++.-..|....|+|.||.||+|.+ .|..||||++....++   ++.+|.++-+  .+||+||+++++.=....     
T Consensus       208 TiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE~---SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ  283 (513)
T KOG2052|consen  208 TIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDER---SWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ  283 (513)
T ss_pred             hhhheeEEEEEecCccccceeeccc-cCCceEEEEecccchh---hhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence            3444445566678999999999986 5889999999766554   3455666554  479999999887533221     


Q ss_pred             ----cccccCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcC----CCCCCeeeCCCCCCCeeeCCCCcEEEcccc
Q 039957          403 ----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHG----HSSAPIIHCDLKPTSILLDENMVAHVSDFG  474 (481)
Q Consensus       403 ----~~~~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~----~~~~~i~H~dlk~~nill~~~~~~kl~Dfg  474 (481)
                          .+|-+.|||++++..  ..++...-+++|..+|.||++||.+    ...|.|.|||||+.|||+..++.+-|+|+|
T Consensus       284 LwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG  361 (513)
T KOG2052|consen  284 LWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  361 (513)
T ss_pred             EEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence                348899999999975  4577888999999999999999962    125789999999999999999999999999


Q ss_pred             Cccc
Q 039957          475 ISKL  478 (481)
Q Consensus       475 l~~~  478 (481)
                      +|-.
T Consensus       362 LAv~  365 (513)
T KOG2052|consen  362 LAVR  365 (513)
T ss_pred             eeEE
Confidence            9853

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.74  E-value=1.6e-17  Score=157.12  Aligned_cols=135  Identities=25%  Similarity=0.433  Sum_probs=112.0

Q ss_pred             hccccccceeeeeccC------CcceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccC
Q 039957          341 SLAGSFGSVYKGTISD------GTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPN  408 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~------g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~  408 (481)
                      .+.|+||.||+|...+      +..+++|.+.... ......+..|++++..++|+|++++++++....     +||+++
T Consensus        14 lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~   93 (277)
T cd05032          14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAK   93 (277)
T ss_pred             ecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCC
Confidence            3679999999987542      3679999876443 233456788999999999999999999987765     578899


Q ss_pred             CChhHHhhcC---------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          409 GSLEKRLYSH---------NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       409 g~l~~~l~~~---------~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      |+|.+++...         ...++|..+++++.+++.|++|||    +.+|+||||||+||++++++.+||+|||+++.+
T Consensus        94 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~di~p~nill~~~~~~kl~dfg~~~~~  169 (277)
T cd05032          94 GDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA----AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDI  169 (277)
T ss_pred             CCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH----hCCccccccChheEEEcCCCCEEECCcccchhh
Confidence            9999988642         123678899999999999999999    678999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.74  E-value=1.4e-17  Score=159.09  Aligned_cols=135  Identities=27%  Similarity=0.453  Sum_probs=110.8

Q ss_pred             hccccccceeeeecc-----------------CCcceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC
Q 039957          341 SLAGSFGSVYKGTIS-----------------DGTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD  402 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-----------------~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  402 (481)
                      .+.|+||.||++...                 ++..+|+|.+.... ......+..|++++++++|+|++++++++...+
T Consensus        13 lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~   92 (296)
T cd05095          13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSD   92 (296)
T ss_pred             ccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            468999999987422                 23468888876543 233457889999999999999999999887654


Q ss_pred             -----cccccCCChhHHhhcCC----------CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCc
Q 039957          403 -----FKFMPNGSLEKRLYSHN----------YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMV  467 (481)
Q Consensus       403 -----~~~~~~g~l~~~l~~~~----------~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~  467 (481)
                           ++|+++|+|.+++....          ..+++....+++.+++.|++|||    +.+|+||||||+||++++++.
T Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH----~~~i~H~dlkp~Nili~~~~~  168 (296)
T cd05095          93 PLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS----SLNFVHRDLATRNCLVGKNYT  168 (296)
T ss_pred             ccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH----HCCeecccCChheEEEcCCCC
Confidence                 57889999999886522          23667889999999999999999    678999999999999999999


Q ss_pred             EEEccccCcccC
Q 039957          468 AHVSDFGISKLL  479 (481)
Q Consensus       468 ~kl~Dfgl~~~~  479 (481)
                      +|++|||+++.+
T Consensus       169 ~~l~dfg~~~~~  180 (296)
T cd05095         169 IKIADFGMSRNL  180 (296)
T ss_pred             EEeccCcccccc
Confidence            999999998754

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.74  E-value=1.5e-17  Score=157.31  Aligned_cols=135  Identities=26%  Similarity=0.393  Sum_probs=111.0

Q ss_pred             hccccccceeeeeccC------CcceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccC
Q 039957          341 SLAGSFGSVYKGTISD------GTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPN  408 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~------g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~  408 (481)
                      .+.|++|.||+|...+      +..+++|...... ......+..|+.++++++|+||+++++++...+     ++|+++
T Consensus        14 lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g   93 (277)
T cd05036          14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAG   93 (277)
T ss_pred             CCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCC
Confidence            4789999999998653      4668888775433 233456888999999999999999999877654     568899


Q ss_pred             CChhHHhhcCC------CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCC---cEEEccccCcccC
Q 039957          409 GSLEKRLYSHN------YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENM---VAHVSDFGISKLL  479 (481)
Q Consensus       409 g~l~~~l~~~~------~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~---~~kl~Dfgl~~~~  479 (481)
                      |+|.+++....      ..++|.++.+++.+|++|++|||    +.+++||||||+||+++.++   .+|++|||+++.+
T Consensus        94 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH----~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~  169 (277)
T cd05036          94 GDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE----ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDI  169 (277)
T ss_pred             CCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH----HCCEeecccchheEEEeccCCCcceEeccCcccccc
Confidence            99999886532      25789999999999999999999    57899999999999998754   6999999999754

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.74  E-value=1.1e-17  Score=157.08  Aligned_cols=134  Identities=25%  Similarity=0.498  Sum_probs=114.0

Q ss_pred             hccccccceeeeeccCCcceEEEEEeccc------hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCC
Q 039957          341 SLAGSFGSVYKGTISDGTDVAIKIFNLQR------ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNG  409 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~g~~vavK~l~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g  409 (481)
                      .+.|.||.||+|...+|..+|+|.+....      ......+.+|++.+++++|+|++++.++|...+     +||+++|
T Consensus         8 ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   87 (265)
T cd06631           8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGG   87 (265)
T ss_pred             EeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCC
Confidence            36799999999988788999999876432      122345788999999999999999999987765     5789999


Q ss_pred             ChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          410 SLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       410 ~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +|.+++.... .+++.....++.+++.|++|+|    +.+|+|+||||+||++++++.+|++|||+++..
T Consensus        88 ~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  152 (265)
T cd06631          88 SISSILNRFG-PLPEPVFCKYTKQILDGVAYLH----NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRL  152 (265)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCcccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence            9999986533 4678888899999999999999    577999999999999999999999999998653

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.74  E-value=1.2e-17  Score=158.63  Aligned_cols=135  Identities=24%  Similarity=0.333  Sum_probs=112.7

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccch---hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRE---RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      .+.|+||.||++... ++..+|+|.+.....   .....+..|+.++++++|++++.+.+.+...+     ++|+++|+|
T Consensus         8 ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L   87 (285)
T cd05630           8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDL   87 (285)
T ss_pred             eecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcH
Confidence            368999999998754 688999998865322   22234677999999999999999998887654     578999999


Q ss_pred             hHHhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          412 EKRLYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~-~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+++... ...+++.++..++.+++.|++|+|    +.+|+||||||+||++++++.++|+|||++...
T Consensus        88 ~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH----~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~  152 (285)
T cd05630          88 KFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH----QERIVYRDLKPENILLDDHGHIRISDLGLAVHV  152 (285)
T ss_pred             HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----hCCEEeCCCCHHHEEECCCCCEEEeeccceeec
Confidence            9887542 335788889999999999999999    688999999999999999999999999998653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.74  E-value=1.5e-17  Score=156.26  Aligned_cols=135  Identities=27%  Similarity=0.416  Sum_probs=111.5

Q ss_pred             hhccccccceeeeecc-CCcceEEEEEeccc-----hhhhhhhhHHHHHhhhhccCccceeecccCCCC-------cccc
Q 039957          340 ISLAGSFGSVYKGTIS-DGTDVAIKIFNLQR-----ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-------FKFM  406 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~-~g~~vavK~l~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-------~~~~  406 (481)
                      ..+.|+||.||++... +|..+++|.+....     ....+.+.+|++++.+++|+|++++.+++.+..       ++|+
T Consensus         9 ~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~   88 (265)
T cd06652           9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHM   88 (265)
T ss_pred             EEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEec
Confidence            3467999999999864 58899999875432     122346788999999999999999999876532       4688


Q ss_pred             cCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          407 PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       407 ~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ++|+|.+++... ..+++....+++.+++.||+|||    +.+|+|+||||+||+++.++.+||+|||+++.+
T Consensus        89 ~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH----~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~  156 (265)
T cd06652          89 PGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLH----SNMIVHRDIKGANILRDSVGNVKLGDFGASKRL  156 (265)
T ss_pred             CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence            999999988654 23677788899999999999999    578999999999999999999999999998743

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.73  E-value=1.4e-17  Score=158.54  Aligned_cols=133  Identities=29%  Similarity=0.509  Sum_probs=111.5

Q ss_pred             ccccccceeeeecc------CCcceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCC
Q 039957          342 LAGSFGSVYKGTIS------DGTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNG  409 (481)
Q Consensus       342 ~~g~~g~vy~~~l~------~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g  409 (481)
                      +.|+||.||++...      ++..+++|.+.... ......+..|++++++++|+|+++++++|...+     ++|+++|
T Consensus        14 g~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   93 (288)
T cd05050          14 GQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYG   93 (288)
T ss_pred             cccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCC
Confidence            67999999998753      35788999886543 233456888999999999999999999887764     5789999


Q ss_pred             ChhHHhhcC---------------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcE
Q 039957          410 SLEKRLYSH---------------------NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVA  468 (481)
Q Consensus       410 ~l~~~l~~~---------------------~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~  468 (481)
                      +|.+++...                     ...+++..+++++.+++.|++|+|    +.+++||||||+||++++++.+
T Consensus        94 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH----~~~i~H~dl~p~nil~~~~~~~  169 (288)
T cd05050          94 DLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS----ERKFVHRDLATRNCLVGENMVV  169 (288)
T ss_pred             CHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH----hCCeecccccHhheEecCCCce
Confidence            999988631                     123677888999999999999999    6789999999999999999999


Q ss_pred             EEccccCccc
Q 039957          469 HVSDFGISKL  478 (481)
Q Consensus       469 kl~Dfgl~~~  478 (481)
                      ||+|||+++.
T Consensus       170 ~l~dfg~~~~  179 (288)
T cd05050         170 KIADFGLSRN  179 (288)
T ss_pred             EECcccccee
Confidence            9999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.73  E-value=4.6e-18  Score=162.80  Aligned_cols=137  Identities=24%  Similarity=0.389  Sum_probs=114.4

Q ss_pred             hhccccccceeeeecc-CCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC------cccccCCC
Q 039957          340 ISLAGSFGSVYKGTIS-DGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD------FKFMPNGS  410 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~~~~g~  410 (481)
                      ..+.|+||.++..... ++..+++|.+....  .+..+...+|+.++++++|||||.+.+.+...+      ++|++||+
T Consensus        11 ~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~   90 (426)
T KOG0589|consen   11 QVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGD   90 (426)
T ss_pred             hcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCC
Confidence            3478999998876643 56789999887654  233346678999999999999999998887654      57999999


Q ss_pred             hhHHhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          411 LEKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       411 l~~~l~~~~-~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      +++.+.... ...+-....+...|+..|+.|||    +..|+|||+|+.||+++.+..+|++|||+||.+.
T Consensus        91 l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH----~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~  157 (426)
T KOG0589|consen   91 LAQLIKEQKGVLFPEERILKWFVQILLAVNYLH----ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILN  157 (426)
T ss_pred             HHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH----hhhhhcccchhhhhhccccCceeecchhhhhhcC
Confidence            999887643 45666777889999999999999    5679999999999999999999999999999875

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.73  E-value=1.5e-17  Score=158.10  Aligned_cols=133  Identities=23%  Similarity=0.342  Sum_probs=112.3

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccch--hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhH
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQRE--RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEK  413 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~  413 (481)
                      ++|++|.||++... +|..+++|.+.....  ...+.+..|+.++++++|+|++++++++....     +||++++.+..
T Consensus        10 ~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~   89 (286)
T cd07847          10 GEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNE   89 (286)
T ss_pred             cccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHH
Confidence            67999999999865 588999998864322  22345778999999999999999999887664     67899888877


Q ss_pred             HhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          414 RLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       414 ~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +... ...+++..+.+++.++++|++|||    +.+|+||||||+||++++++++||+|||+++.+
T Consensus        90 ~~~~-~~~~~~~~~~~~~~ql~~~l~~LH----~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  150 (286)
T cd07847          90 LEKN-PRGVPEHLIKKIIWQTLQAVNFCH----KHNCIHRDVKPENILITKQGQIKLCDFGFARIL  150 (286)
T ss_pred             HHhC-CCCCCHHHHHHHHHHHHHHHHHHH----HCCceecCCChhhEEEcCCCcEEECccccceec
Confidence            6543 335789999999999999999999    678999999999999999999999999998764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.73  E-value=8.1e-18  Score=157.79  Aligned_cols=132  Identities=30%  Similarity=0.451  Sum_probs=113.3

Q ss_pred             ccccccceeeeeccC-CcceEEEEEeccch---hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          342 LAGSFGSVYKGTISD-GTDVAIKIFNLQRE---RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       342 ~~g~~g~vy~~~l~~-g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      +.|++|.+|++.... |..+++|.+.....   .....+..|++.+.+++|+|++++.+.+....     ++|+++++|.
T Consensus         2 g~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   81 (265)
T cd05579           2 SKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLA   81 (265)
T ss_pred             CCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHH
Confidence            468999999998764 88999998865433   34456788999999999999999998876654     5688999999


Q ss_pred             HHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          413 KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       413 ~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      +++.... .+++..+.+++.++++||+|||    +.+|+||||+|+||++++++.+|++|||++..
T Consensus        82 ~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH----~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~  142 (265)
T cd05579          82 SLLENVG-SLDEDVARIYIAEIVLALEYLH----SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKV  142 (265)
T ss_pred             HHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HcCeecCCCCHHHeEEcCCCCEEEEecccchh
Confidence            9887543 5788899999999999999999    57899999999999999999999999999765

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.73  E-value=1.7e-17  Score=155.03  Aligned_cols=134  Identities=30%  Similarity=0.493  Sum_probs=114.0

Q ss_pred             hccccccceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHHh
Q 039957          341 SLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRL  415 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~l  415 (481)
                      .+.|+||.||++....+..+++|.+..... ....+..|++++++++|++++++++++....     ++|+++|+|.+++
T Consensus        12 ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~   90 (256)
T cd05112          12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYL   90 (256)
T ss_pred             ecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHH
Confidence            367999999999876678899998754322 2346788999999999999999999886654     5688999999998


Q ss_pred             hcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          416 YSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       416 ~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ......+++.....++.+++.|++|||    +.+++|||+||+||+++.++.+||+|||+++..
T Consensus        91 ~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~  150 (256)
T cd05112          91 RAQRGKFSQETLLGMCLDVCEGMAYLE----SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFV  150 (256)
T ss_pred             HhCccCCCHHHHHHHHHHHHHHHHHHH----HCCccccccccceEEEcCCCeEEECCCcceeec
Confidence            765556788889999999999999999    577999999999999999999999999998743

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.73  E-value=1.2e-17  Score=163.02  Aligned_cols=132  Identities=24%  Similarity=0.343  Sum_probs=106.8

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccch--hhhhhhhHHHHHhhhhccCccceeecccCCCC-----------cccc
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQRE--RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----------FKFM  406 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----------~~~~  406 (481)
                      .+.|+||.||++.. .++..||+|.+.....  ...+.+.+|+.++.+++|+||+++++++....           +++ 
T Consensus        23 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~-  101 (343)
T cd07878          23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNL-  101 (343)
T ss_pred             cccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeec-
Confidence            37899999999975 4678899998864322  23345678999999999999999998775331           112 


Q ss_pred             cCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          407 PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       407 ~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .++++.+++..  ..+++.....++.++++||+|||    +.+|+||||||+||++++++.+||+|||+++..
T Consensus       102 ~~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH----~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~  168 (343)
T cd07878         102 MGADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIH----SAGIIHRDLKPSNVAVNEDCELRILDFGLARQA  168 (343)
T ss_pred             CCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH----HCCeecccCChhhEEECCCCCEEEcCCccceec
Confidence            36788777653  34778889999999999999999    678999999999999999999999999998764

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.73  E-value=1.3e-17  Score=161.09  Aligned_cols=132  Identities=26%  Similarity=0.375  Sum_probs=103.5

Q ss_pred             hccccccceeeeecc---CCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-------cccccCCC
Q 039957          341 SLAGSFGSVYKGTIS---DGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-------FKFMPNGS  410 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~---~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-------~~~~~~g~  410 (481)
                      -+.|+||.||+|...   ++..+|+|.+....  ......+|++++++++|+||+++.+.+....       ++|+. ++
T Consensus         9 lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~   85 (317)
T cd07868           9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HD   85 (317)
T ss_pred             cccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-CC
Confidence            378999999999854   45789999875432  2234678999999999999999998775432       35654 57


Q ss_pred             hhHHhhcC--------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeee----CCCCcEEEccccCccc
Q 039957          411 LEKRLYSH--------NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILL----DENMVAHVSDFGISKL  478 (481)
Q Consensus       411 l~~~l~~~--------~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill----~~~~~~kl~Dfgl~~~  478 (481)
                      +.+++...        ...+++.....++.||+.||+|||    +.+|+||||||+|||+    ++.+.+||+|||+|+.
T Consensus        86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH----~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07868          86 LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH----ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             HHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH----hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence            77665421        124677788899999999999999    6789999999999999    4568999999999976


Q ss_pred             C
Q 039957          479 L  479 (481)
Q Consensus       479 ~  479 (481)
                      +
T Consensus       162 ~  162 (317)
T cd07868         162 F  162 (317)
T ss_pred             c
Confidence            4

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.73  E-value=1.4e-17  Score=157.11  Aligned_cols=134  Identities=26%  Similarity=0.373  Sum_probs=112.2

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccchhhhhhhhHHHHHhhhh-ccCccceeecccCCC-----------Cccccc
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECEVLRNV-RHQNLIKILSSCSTP-----------DFKFMP  407 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-----------~~~~~~  407 (481)
                      -+.|+||.||+|... ++..+|+|.+.... .....+..|+.++.++ +|+|++++.++|...           .+||++
T Consensus        14 lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~   92 (272)
T cd06637          14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCG   92 (272)
T ss_pred             eeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCC
Confidence            477999999999865 57889999886543 2334677899999988 699999999987542           156899


Q ss_pred             CCChhHHhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          408 NGSLEKRLYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       408 ~g~l~~~l~~~-~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +|++.+++... ...+++.....++.+++.|++|||    +.+|+|||+||+||++++++.+||+|||+++.+
T Consensus        93 ~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH----~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~  161 (272)
T cd06637          93 AGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH----QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  161 (272)
T ss_pred             CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----HCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence            99999988763 345788889999999999999999    578999999999999999999999999998754

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.73  E-value=2.2e-18  Score=167.95  Aligned_cols=143  Identities=26%  Similarity=0.443  Sum_probs=116.2

Q ss_pred             CChhhhhccccccceeeeecc-CCcceEEEEEecc----chhhhhhhhHHHHHhhhhccCccceeecccCCCC-------
Q 039957          335 VDLETISLAGSFGSVYKGTIS-DGTDVAIKIFNLQ----RERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-------  402 (481)
Q Consensus       335 ~~L~~l~~~g~~g~vy~~~l~-~g~~vavK~l~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-------  402 (481)
                      ....+..++|.|-+||||... +|..||...+...    ..+..++|..|+.+|..++|+||++++.++.+..       
T Consensus        42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i  121 (632)
T KOG0584|consen   42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI  121 (632)
T ss_pred             eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence            345556689999999999864 4777875433221    2344578899999999999999999999887764       


Q ss_pred             cccccCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCC-CcEEEccccCcccCC
Q 039957          403 FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDEN-MVAHVSDFGISKLLG  480 (481)
Q Consensus       403 ~~~~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~-~~~kl~Dfgl~~~~~  480 (481)
                      .|.|..|+|..|....+ ........+.+.||.+||.|||..  +|||+|||||-.||++.++ |.|||+|.|+|.++.
T Consensus       122 TEL~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs~--~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r  197 (632)
T KOG0584|consen  122 TELFTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHSQ--DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR  197 (632)
T ss_pred             eecccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhcC--CCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence            46889999999987653 355667778899999999999974  6999999999999999885 999999999998753

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.73  E-value=1.8e-17  Score=155.84  Aligned_cols=135  Identities=26%  Similarity=0.425  Sum_probs=112.0

Q ss_pred             hhccccccceeeeecc-CCcceEEEEEeccc-----hhhhhhhhHHHHHhhhhccCccceeecccCCC--C-----cccc
Q 039957          340 ISLAGSFGSVYKGTIS-DGTDVAIKIFNLQR-----ERAFRSFNSECEVLRNVRHQNLIKILSSCSTP--D-----FKFM  406 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~-~g~~vavK~l~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~-----~~~~  406 (481)
                      ..+.|+||.||++... +|..+++|.+....     .+....+.+|++++++++|+|++++.+++...  .     ++|+
T Consensus         9 ~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~   88 (266)
T cd06651           9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYM   88 (266)
T ss_pred             eecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCC
Confidence            3478999999999864 58899999875432     12334678899999999999999999887543  2     4688


Q ss_pred             cCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          407 PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       407 ~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ++++|.+++.... .+++.....++.++++|++|||    +.+|+|||+||+||+++.++.+||+|||+++.+
T Consensus        89 ~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH----~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~  156 (266)
T cd06651          89 PGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLH----SNMIVHRDIKGANILRDSAGNVKLGDFGASKRL  156 (266)
T ss_pred             CCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence            9999999887533 4678888899999999999999    678999999999999999999999999998754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.73  E-value=1.7e-17  Score=155.06  Aligned_cols=134  Identities=32%  Similarity=0.463  Sum_probs=114.6

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccch-----hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCC
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRE-----RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNG  409 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g  409 (481)
                      .+.|++|.||+|... ++..+++|.+.....     ...+.+..|++++++++|+|++++.+++....     +||++++
T Consensus         8 ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~   87 (258)
T cd06632           8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGG   87 (258)
T ss_pred             eeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCC
Confidence            468999999999876 788999998865431     23456888999999999999999999887654     5789999


Q ss_pred             ChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          410 SLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       410 ~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +|.+++... ..+++.....++.++++|++|||    +.+|+|+||||+||++++++.+||+|||+++..
T Consensus        88 ~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~  152 (258)
T cd06632          88 SLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLH----DRNTVHRDIKGANILVDTNGVVKLADFGMAKQV  152 (258)
T ss_pred             cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEEccCccceec
Confidence            999988654 34678888999999999999999    678999999999999999999999999998754

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.73  E-value=1.9e-17  Score=155.15  Aligned_cols=134  Identities=31%  Similarity=0.447  Sum_probs=116.0

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHHh
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRL  415 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~l  415 (481)
                      +.|++|.+|++... ++..+++|.+........+.+..|++++++++|+|++++++++....     ++|++++++.+++
T Consensus        12 ~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~   91 (262)
T cd06613          12 GSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIY   91 (262)
T ss_pred             cCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHH
Confidence            67999999999864 56789999987665555667889999999999999999999876654     5788999999988


Q ss_pred             hcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          416 YSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       416 ~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ......++..+...++.+++.|++|||    +.+|+|||+||+||++++++.+||+|||++..+
T Consensus        92 ~~~~~~l~~~~~~~~~~ql~~~l~~lh----~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~  151 (262)
T cd06613          92 QVTRGPLSELQIAYVCRETLKGLAYLH----ETGKIHRDIKGANILLTEDGDVKLADFGVSAQL  151 (262)
T ss_pred             HhhccCCCHHHHHHHHHHHHHHHHHHH----hCCceecCCChhhEEECCCCCEEECccccchhh
Confidence            765456788899999999999999999    578999999999999999999999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.73  E-value=2e-17  Score=156.53  Aligned_cols=133  Identities=30%  Similarity=0.411  Sum_probs=113.8

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhH
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEK  413 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~  413 (481)
                      -+.|+||.||+|... ++..+++|.+.... ......+..|++.+++++|+|++++++++...+     +||++++++.+
T Consensus        12 l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   91 (277)
T cd06642          12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALD   91 (277)
T ss_pred             hcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHH
Confidence            367999999999754 57889999886443 333456888999999999999999999887664     67999999999


Q ss_pred             HhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          414 RLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       414 ~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ++..  ..+++.....++.++++|++|+|    +.+|+|+||+|+||++++++.+|++|||+++.+
T Consensus        92 ~~~~--~~~~~~~~~~~~~~i~~~l~~lH----~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~  151 (277)
T cd06642          92 LLKP--GPLEETYIATILREILKGLDYLH----SERKIHRDIKAANVLLSEQGDVKLADFGVAGQL  151 (277)
T ss_pred             Hhhc--CCCCHHHHHHHHHHHHHHHHHHh----cCCeeccCCChheEEEeCCCCEEEccccccccc
Confidence            8764  34678889999999999999999    578999999999999999999999999998764

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.73  E-value=2.6e-17  Score=155.33  Aligned_cols=136  Identities=31%  Similarity=0.512  Sum_probs=110.7

Q ss_pred             hhccccccceeeeecc----CCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----------
Q 039957          340 ISLAGSFGSVYKGTIS----DGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----------  402 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~----~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----------  402 (481)
                      ..+.|+||.||+|...    .+..+|+|.+....  ....+.+.+|++++++++|+|++++++++....           
T Consensus         6 ~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~   85 (273)
T cd05074           6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVI   85 (273)
T ss_pred             cccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEE
Confidence            3478999999999753    35789999886532  233456788999999999999999999775431           


Q ss_pred             cccccCCChhHHhhc-----CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcc
Q 039957          403 FKFMPNGSLEKRLYS-----HNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK  477 (481)
Q Consensus       403 ~~~~~~g~l~~~l~~-----~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~  477 (481)
                      ++|+++|++.+++..     ....+++....+++.+++.|++|||    +.+|+||||||+||++++++.+|++|||+++
T Consensus        86 ~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH----~~~i~H~dikp~nili~~~~~~kl~dfg~~~  161 (273)
T cd05074          86 LPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS----SKNFIHRDLAARNCMLNENMTVCVADFGLSK  161 (273)
T ss_pred             EecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH----hCCEeecccchhhEEEcCCCCEEECcccccc
Confidence            357889999887643     1234678889999999999999999    5789999999999999999999999999987


Q ss_pred             cC
Q 039957          478 LL  479 (481)
Q Consensus       478 ~~  479 (481)
                      .+
T Consensus       162 ~~  163 (273)
T cd05074         162 KI  163 (273)
T ss_pred             cc
Confidence            64

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.73  E-value=1.5e-17  Score=156.45  Aligned_cols=135  Identities=33%  Similarity=0.498  Sum_probs=112.7

Q ss_pred             hhccccccceeeeecc-CCcceEEEEEeccch---------hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cc
Q 039957          340 ISLAGSFGSVYKGTIS-DGTDVAIKIFNLQRE---------RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FK  404 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~---------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~  404 (481)
                      ..+.|++|.||+|... ++..+++|.+.....         ...+.+..|++++.+++|+|++++++++...+     ++
T Consensus         7 ~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (267)
T cd06628           7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLE   86 (267)
T ss_pred             eeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEE
Confidence            3467999999999754 578899998764322         12245778999999999999999999887654     56


Q ss_pred             cccCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          405 FMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       405 ~~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      |+++++|.+++... ..+++.....++.+++.|++|||    +.+++||||||+||++++++.+||+|||.++.+
T Consensus        87 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH----~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~  156 (267)
T cd06628          87 YVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLH----NRGIIHRDIKGANILVDNKGGIKISDFGISKKL  156 (267)
T ss_pred             ecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHH----hcCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence            88999999988653 34677888899999999999999    578999999999999999999999999998765

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.73  E-value=2.2e-17  Score=155.18  Aligned_cols=136  Identities=25%  Similarity=0.430  Sum_probs=114.9

Q ss_pred             hhccccccceeeeecc-CCcceEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCC
Q 039957          340 ISLAGSFGSVYKGTIS-DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGS  410 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~  410 (481)
                      ..+.|++|.||+|... +|..+++|.+....   ......+.+|++++++++|++++++++++...+     ++|+++|+
T Consensus         9 ~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   88 (267)
T cd08224           9 KIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGD   88 (267)
T ss_pred             eeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCC
Confidence            3468999999999876 78999999876432   223456888999999999999999999887664     67899999


Q ss_pred             hhHHhhc---CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          411 LEKRLYS---HNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       411 l~~~l~~---~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      |.+++..   ....+++.++.+++.++++|++|||    +.+|+||||||+||++++++.+|++|||+++.+
T Consensus        89 L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh----~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~  156 (267)
T cd08224          89 LSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH----SKRIMHRDIKPANVFITATGVVKLGDLGLGRFF  156 (267)
T ss_pred             HHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH----hCCEecCCcChhhEEECCCCcEEEeccceeeec
Confidence            9988753   2345788899999999999999999    678999999999999999999999999998754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.73  E-value=1.1e-17  Score=147.98  Aligned_cols=134  Identities=16%  Similarity=0.157  Sum_probs=98.7

Q ss_pred             hccccccceeeeeccCCcceEEEEEeccchh--h-------hhhh-----------------hHHHHHhhhhccCcccee
Q 039957          341 SLAGSFGSVYKGTISDGTDVAIKIFNLQRER--A-------FRSF-----------------NSECEVLRNVRHQNLIKI  394 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~g~~vavK~l~~~~~~--~-------~~~~-----------------~~e~~~l~~l~h~niv~l  394 (481)
                      .++|++|.||+|..++|..||+|.+......  .       ...|                 ..|++.+.++.++++...
T Consensus         5 ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~~p   84 (190)
T cd05147           5 ISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIPCP   84 (190)
T ss_pred             cccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCCCC
Confidence            4689999999999888999999998654211  0       1112                 348889999987765332


Q ss_pred             ecccCC---CCcccccCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 039957          395 LSSCST---PDFKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVS  471 (481)
Q Consensus       395 ~~~~~~---~~~~~~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~  471 (481)
                      ..+...   ..+||++++++...... ...++..+..+++.+++.+++|+||   +.+|+|||+||+||+++ ++.+++.
T Consensus        85 ~~~~~~~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-~~~v~Li  159 (190)
T cd05147          85 EPILLKSHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-DGKLYII  159 (190)
T ss_pred             cEEEecCCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-CCcEEEE
Confidence            221111   13789988776544222 2356778889999999999999954   56899999999999998 4789999


Q ss_pred             cccCcccC
Q 039957          472 DFGISKLL  479 (481)
Q Consensus       472 Dfgl~~~~  479 (481)
                      |||+|...
T Consensus       160 DFG~a~~~  167 (190)
T cd05147         160 DVSQSVEH  167 (190)
T ss_pred             EccccccC
Confidence            99999753

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.73  E-value=2.2e-17  Score=155.77  Aligned_cols=135  Identities=30%  Similarity=0.448  Sum_probs=113.2

Q ss_pred             hhccccccceeeeec-cCCcceEEEEEeccch----------hhhhhhhHHHHHhhhhccCccceeecccCCCC-----c
Q 039957          340 ISLAGSFGSVYKGTI-SDGTDVAIKIFNLQRE----------RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----F  403 (481)
Q Consensus       340 l~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~----------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~  403 (481)
                      .-+.|++|.||+|.. .+|..+|+|.+.....          ...+.+..|+.++++++|+|++++++++...+     +
T Consensus         8 ~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   87 (272)
T cd06629           8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFL   87 (272)
T ss_pred             eecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEEEE
Confidence            347899999999975 4688999998754211          11235778999999999999999999987765     5


Q ss_pred             ccccCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          404 KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       404 ~~~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ||+++|+|.+++... ..+++..+..++.+|+.|++|||    +.+++||||||+||++++++.+|++|||+++..
T Consensus        88 e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~  158 (272)
T cd06629          88 EYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLH----SKGILHRDLKADNLLVDADGICKISDFGISKKS  158 (272)
T ss_pred             ecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHh----hCCeeecCCChhhEEEcCCCeEEEeeccccccc
Confidence            789999999988754 35778888899999999999999    678999999999999999999999999998753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.73  E-value=1.5e-17  Score=158.47  Aligned_cols=132  Identities=26%  Similarity=0.431  Sum_probs=111.5

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccch-hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHH
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQRE-RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKR  414 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~  414 (481)
                      +.|++|.||++... ++..+++|.+..... .....+..|++++++++|+||+++.+++...+     +||++ ++|.++
T Consensus        14 g~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~L~~~   92 (291)
T cd07844          14 GEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD-TDLKQY   92 (291)
T ss_pred             eecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC-CCHHHH
Confidence            67999999999865 678899998865432 22334667999999999999999999987665     56777 589888


Q ss_pred             hhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          415 LYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       415 l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      +......+++.....++.++++||+|||    +.+|+||||||+||++++++.+||+|||+++.
T Consensus        93 ~~~~~~~~~~~~~~~~~~ql~~al~~lH----~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  152 (291)
T cd07844          93 MDDCGGGLSMHNVRLFLFQLLRGLAYCH----QRRVLHRDLKPQNLLISERGELKLADFGLARA  152 (291)
T ss_pred             HHhCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeecccCCHHHEEEcCCCCEEECccccccc
Confidence            8765556788888999999999999999    67899999999999999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.73  E-value=2e-17  Score=155.18  Aligned_cols=136  Identities=26%  Similarity=0.438  Sum_probs=113.4

Q ss_pred             hhhccccccceeeeecc-CCcceEEEEEeccch-----hhhhhhhHHHHHhhhhccCccceeecccCCCC-----ccccc
Q 039957          339 TISLAGSFGSVYKGTIS-DGTDVAIKIFNLQRE-----RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMP  407 (481)
Q Consensus       339 ~l~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~  407 (481)
                      ...+.|++|.||++... ++..+++|.+.....     .....+.+|++++++++|+||+++++++...+     ++|++
T Consensus         8 ~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   87 (263)
T cd06625           8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMP   87 (263)
T ss_pred             ceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECC
Confidence            34578999999999854 588999998764321     12346788999999999999999999987765     56889


Q ss_pred             CCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          408 NGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       408 ~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ++++.+++... ..+++....+++.+++.|++|||    +.+|+||||||+||++++++.+||+|||+++.+
T Consensus        88 ~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH----~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~  154 (263)
T cd06625          88 GGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLH----SNMIVHRDIKGANILRDSAGNVKLGDFGASKRL  154 (263)
T ss_pred             CCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence            99999988653 34677888899999999999999    678999999999999999999999999998754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.73  E-value=1.8e-17  Score=156.97  Aligned_cols=130  Identities=27%  Similarity=0.331  Sum_probs=109.4

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhH
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEK  413 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~  413 (481)
                      .+.|++|.||++.. .++..+|+|.+.... ....+.+..|+.++.+++|+|+++++++|...+     +||+++|++..
T Consensus         9 lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~   88 (279)
T cd06619           9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDV   88 (279)
T ss_pred             eccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHH
Confidence            46899999999975 468889999886542 233456888999999999999999999887664     57899999865


Q ss_pred             HhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          414 RLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       414 ~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +.     ..++.....++.+++.|++|+|    +.+|+|+||||+||+++.++.+||+|||+++.+
T Consensus        89 ~~-----~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~  145 (279)
T cd06619          89 YR-----KIPEHVLGRIAVAVVKGLTYLW----SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL  145 (279)
T ss_pred             hh-----cCCHHHHHHHHHHHHHHHHHHH----HCCEeeCCCCHHHEEECCCCCEEEeeCCcceec
Confidence            42     2466778889999999999999    678999999999999999999999999998753

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.73  E-value=1.9e-17  Score=160.53  Aligned_cols=134  Identities=19%  Similarity=0.257  Sum_probs=111.3

Q ss_pred             hhccc--cccceeeeec-cCCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCC
Q 039957          340 ISLAG--SFGSVYKGTI-SDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNG  409 (481)
Q Consensus       340 l~~~g--~~g~vy~~~l-~~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g  409 (481)
                      +.+.|  +++.||++.. .+|..||+|.+....  ....+.+..|+++++.++||||++++++|...+     ++|+++|
T Consensus         5 ~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~   84 (327)
T cd08227           5 VIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYG   84 (327)
T ss_pred             hccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCC
Confidence            44566  6788999875 468999999987643  233445677999999999999999999987765     5789999


Q ss_pred             ChhHHhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcc
Q 039957          410 SLEKRLYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK  477 (481)
Q Consensus       410 ~l~~~l~~~-~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~  477 (481)
                      ++.+++... ...+++....+++.++++||+|||    +.+|+||||||+||+++.++.++++|||.+.
T Consensus        85 ~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH----~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~  149 (327)
T cd08227          85 SAKDLICTHFMDGMSELAIAYILQGVLKALDYIH----HMGYVHRSVKASHILISVDGKVYLSGLRSNL  149 (327)
T ss_pred             cHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH----HCCEecCCCChhhEEEecCCcEEEcccchhh
Confidence            999988643 234788899999999999999999    6789999999999999999999999998643

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.73  E-value=1.2e-17  Score=157.30  Aligned_cols=134  Identities=31%  Similarity=0.529  Sum_probs=110.4

Q ss_pred             ccccccceeeeeccC-------CcceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccC
Q 039957          342 LAGSFGSVYKGTISD-------GTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPN  408 (481)
Q Consensus       342 ~~g~~g~vy~~~l~~-------g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~  408 (481)
                      +.|+||.||+|...+       +..+++|.+.... ......+.+|++++++++|+||++++++|...+     ++|+++
T Consensus         4 g~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~   83 (269)
T cd05044           4 GSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEG   83 (269)
T ss_pred             ccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCC
Confidence            679999999998642       2468888765432 233456788999999999999999999987664     578999


Q ss_pred             CChhHHhhcC------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCC-----cEEEccccCcc
Q 039957          409 GSLEKRLYSH------NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENM-----VAHVSDFGISK  477 (481)
Q Consensus       409 g~l~~~l~~~------~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~-----~~kl~Dfgl~~  477 (481)
                      |+|.+++...      ...++|.+++.++.+++.|++|+|    +.+++|+|+||+||+++.++     .+|++|||+++
T Consensus        84 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~  159 (269)
T cd05044          84 GDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE----QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR  159 (269)
T ss_pred             CcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH----hCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence            9999998642      234688999999999999999999    57799999999999999877     99999999986


Q ss_pred             cC
Q 039957          478 LL  479 (481)
Q Consensus       478 ~~  479 (481)
                      .+
T Consensus       160 ~~  161 (269)
T cd05044         160 DI  161 (269)
T ss_pred             cc
Confidence            43

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.73  E-value=2e-17  Score=157.10  Aligned_cols=133  Identities=26%  Similarity=0.404  Sum_probs=115.3

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhH
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEK  413 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~  413 (481)
                      +.|++|.+|+|... +|..+++|.+....  ......+..|+.++++++|+|++++++++....     ++|+ +++|.+
T Consensus         9 ~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~   87 (286)
T cd07832           9 GEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSE   87 (286)
T ss_pred             ccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHH
Confidence            67999999999864 68899999987644  233456888999999999999999999887664     5688 999999


Q ss_pred             HhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          414 RLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       414 ~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ++......+++.++.+++.+|++|++|||    +.+|+|+||||+||++++++.+|++|||+++..
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~  149 (286)
T cd07832          88 VLRDEERPLPEAQVKSYMRMLLKGVAYMH----ANGIMHRDLKPANLLISADGVLKIADFGLARLF  149 (286)
T ss_pred             HHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCcCHHHEEEcCCCcEEEeeeeecccc
Confidence            88765566889999999999999999999    678999999999999999999999999998764

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.72  E-value=1.8e-17  Score=157.33  Aligned_cols=133  Identities=25%  Similarity=0.406  Sum_probs=111.8

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccch--hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhH
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQRE--RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEK  413 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~  413 (481)
                      +.|++|.||++... +|..+++|.+.....  .....+.+|++++++++|+|++++++++....     ++|++ +++.+
T Consensus         9 ~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~   87 (284)
T cd07839           9 GEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD-QDLKK   87 (284)
T ss_pred             cccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-CCHHH
Confidence            57899999999864 688999998865422  22345678999999999999999999887665     45776 67888


Q ss_pred             HhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          414 RLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       414 ~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ++......+++.....++.+|++|++|||    +.+|+||||||+||+++.++.+||+|||+++.+
T Consensus        88 ~~~~~~~~~~~~~~~~~~~qi~~al~~LH----~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~  149 (284)
T cd07839          88 YFDSCNGDIDPEIVKSFMFQLLKGLAFCH----SHNVLHRDLKPQNLLINKNGELKLADFGLARAF  149 (284)
T ss_pred             HHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCEecCCCCHHHEEEcCCCcEEECccchhhcc
Confidence            77655556889999999999999999999    678999999999999999999999999998754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.72  E-value=8.3e-18  Score=165.05  Aligned_cols=141  Identities=27%  Similarity=0.465  Sum_probs=119.4

Q ss_pred             Chhhhhccccccceeeeecc--CC--cceEEEEEeccchh-hhhhhhHHHHHhhhhccCccceeecccCCCC----cccc
Q 039957          336 DLETISLAGSFGSVYKGTIS--DG--TDVAIKIFNLQRER-AFRSFNSECEVLRNVRHQNLIKILSSCSTPD----FKFM  406 (481)
Q Consensus       336 ~L~~l~~~g~~g~vy~~~l~--~g--~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~~  406 (481)
                      .|-++-++|.||+|++|.+.  .|  ..||||++...... ...+|.+|+.++.+++|+++++++|...+..    +|.+
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp~mMV~ELa  192 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQPAMMVFELA  192 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccchhhHHhhhc
Confidence            45566789999999999864  45  45889998765433 5678999999999999999999999988654    6789


Q ss_pred             cCCChhHHhhc-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          407 PNGSLEKRLYS-HNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       407 ~~g~l~~~l~~-~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      +.|+|.+.+++ ....+-...-..+|.|||.||+||-    +.+.||||+-++|+|+-..-.+||||||+.|.+.
T Consensus       193 plGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe----skrlvHRDLAARNlllasprtVKI~DFGLmRaLg  263 (1039)
T KOG0199|consen  193 PLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE----SKRLVHRDLAARNLLLASPRTVKICDFGLMRALG  263 (1039)
T ss_pred             ccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh----hhhhhhhhhhhhhheecccceeeeecccceeccC
Confidence            99999999987 3334445566789999999999998    6789999999999999999999999999998875

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.72  E-value=2.5e-17  Score=156.49  Aligned_cols=133  Identities=27%  Similarity=0.458  Sum_probs=111.0

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccch--hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhH
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQRE--RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEK  413 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~  413 (481)
                      +.|++|.||+|... +|..+++|.+.....  .....+..|+.++.+++|+|++++.+++...+     ++|++ |++.+
T Consensus         9 ~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~   87 (285)
T cd07861           9 GEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKK   87 (285)
T ss_pred             cccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHH
Confidence            57999999999864 688999998865432  23356778999999999999999999987765     46776 68888


Q ss_pred             HhhcC--CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          414 RLYSH--NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       414 ~l~~~--~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ++...  ...+++.....++.++++||+|||    +.+|+||||||+||++++++.+||+|||+++..
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH----~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  151 (285)
T cd07861          88 YLDSLPKGQYMDAELVKSYLYQILQGILFCH----SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF  151 (285)
T ss_pred             HHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH----hCCeeecCCCHHHEEEcCCCcEEECcccceeec
Confidence            77542  245788899999999999999999    678999999999999999999999999998643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.72  E-value=2.8e-17  Score=154.22  Aligned_cols=134  Identities=31%  Similarity=0.455  Sum_probs=115.8

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccchh--hhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRER--AFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      .+.|++|.+|++... ++..+++|.+......  ..+.+..|+.++++++|+||+++++.+...+     +||+++++|.
T Consensus         8 lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   87 (264)
T cd06626           8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLE   87 (264)
T ss_pred             eecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHH
Confidence            368999999999854 6889999998765443  5567889999999999999999999876654     6789999999


Q ss_pred             HHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          413 KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       413 ~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +++... ...++..+..++.++++|++|||    +.+|+|+||||+||++++++.+||+|||++...
T Consensus        88 ~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh----~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~  149 (264)
T cd06626          88 ELLEHG-RILDEHVIRVYTLQLLEGLAYLH----SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKL  149 (264)
T ss_pred             HHHhhc-CCCChHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEEccccccccc
Confidence            998754 34678889999999999999999    678999999999999999999999999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.72  E-value=2.8e-17  Score=156.58  Aligned_cols=134  Identities=28%  Similarity=0.394  Sum_probs=114.2

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      .+.|++|.||++... ++..+++|.+....   ......+.+|++++++++|+|++++++++...+     ++|+++|+|
T Consensus         9 ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   88 (290)
T cd05580           9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGEL   88 (290)
T ss_pred             eecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCH
Confidence            367999999999864 57899999886432   223456788999999999999999999887765     678999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+++... ..++...+..++.++++|++|||    +.+|+||||+|+||++++++.+||+|||+++..
T Consensus        89 ~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH----~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~  151 (290)
T cd05580          89 FSHLRKS-GRFPEPVARFYAAQVVLALEYLH----SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRV  151 (290)
T ss_pred             HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH----HCCEecCCCCHHHEEECCCCCEEEeeCCCcccc
Confidence            9988654 45678888999999999999999    678999999999999999999999999998865

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.72  E-value=1.7e-17  Score=164.88  Aligned_cols=127  Identities=25%  Similarity=0.331  Sum_probs=104.3

Q ss_pred             ccccccceeeeecc---CCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhH
Q 039957          342 LAGSFGSVYKGTIS---DGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEK  413 (481)
Q Consensus       342 ~~g~~g~vy~~~l~---~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~  413 (481)
                      +.|+||.||++...   .+..|++|.....     ....+|++++++++|+||+++++++....     ++|+ .+++.+
T Consensus       101 g~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~~~l~~  174 (392)
T PHA03207        101 TPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKY-KCDLFT  174 (392)
T ss_pred             cCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhc-CCCHHH
Confidence            67999999998643   3567888876532     23457999999999999999998876554     3344 478888


Q ss_pred             HhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          414 RLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       414 ~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ++. ....+++.++..++.++++||+|||    +.+||||||||+|||++.++.+||+|||+|+.+
T Consensus       175 ~l~-~~~~l~~~~~~~i~~ql~~aL~~LH----~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~  235 (392)
T PHA03207        175 YVD-RSGPLPLEQAITIQRRLLEALAYLH----GRGIIHRDVKTENIFLDEPENAVLGDFGAACKL  235 (392)
T ss_pred             HHH-hcCCCCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence            774 3356789999999999999999999    678999999999999999999999999998754

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.72  E-value=2.7e-17  Score=158.78  Aligned_cols=132  Identities=24%  Similarity=0.364  Sum_probs=103.7

Q ss_pred             hccccccceeeeecc---CCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-------cccccCCC
Q 039957          341 SLAGSFGSVYKGTIS---DGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-------FKFMPNGS  410 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~---~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-------~~~~~~g~  410 (481)
                      .+.|+||.||+|...   ++..+|+|.+....  ....+.+|++++++++|+|++++.+++....       ++|++ ++
T Consensus         9 lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~   85 (317)
T cd07867           9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-HD   85 (317)
T ss_pred             eccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-Cc
Confidence            367999999999864   34679999875432  2235678999999999999999999875432       45665 46


Q ss_pred             hhHHhhc--------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeee----CCCCcEEEccccCccc
Q 039957          411 LEKRLYS--------HNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILL----DENMVAHVSDFGISKL  478 (481)
Q Consensus       411 l~~~l~~--------~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill----~~~~~~kl~Dfgl~~~  478 (481)
                      +.+++..        ....+++....+++.++++||+|||    +.+|+||||||+||++    ++++.+||+|||+|+.
T Consensus        86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH----~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07867          86 LWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH----ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             HHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH----hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence            6665532        1224677888899999999999999    6789999999999999    5568999999999986


Q ss_pred             C
Q 039957          479 L  479 (481)
Q Consensus       479 ~  479 (481)
                      +
T Consensus       162 ~  162 (317)
T cd07867         162 F  162 (317)
T ss_pred             c
Confidence            4

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.72  E-value=3.3e-17  Score=156.17  Aligned_cols=132  Identities=27%  Similarity=0.443  Sum_probs=108.8

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccchh-hhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHH
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQRER-AFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKR  414 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~  414 (481)
                      +.|+||.||+|... +|..+++|.+...... ....+.+|+.++++++|+|++++.+++...+     ++|++ +++.++
T Consensus        14 g~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~   92 (291)
T cd07870          14 GEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQY   92 (291)
T ss_pred             EecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHH
Confidence            68999999999754 6889999988654322 2235678999999999999999999887764     46775 777776


Q ss_pred             hhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          415 LYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       415 l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      +......+.+.+...++.++++||+|||    +.+|+||||||+||+++.++.+||+|||+++.
T Consensus        93 ~~~~~~~~~~~~~~~~~~qi~~~L~~lH----~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~  152 (291)
T cd07870          93 MIQHPGGLHPYNVRLFMFQLLRGLAYIH----GQHILHRDLKPQNLLISYLGELKLADFGLARA  152 (291)
T ss_pred             HHhCCCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCChHHEEEcCCCcEEEeccccccc
Confidence            6554445677788889999999999999    57899999999999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.72  E-value=1.5e-17  Score=155.71  Aligned_cols=133  Identities=37%  Similarity=0.536  Sum_probs=112.2

Q ss_pred             hccccccceeeeeccC-CcceEEEEEeccchhhh--hhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          341 SLAGSFGSVYKGTISD-GTDVAIKIFNLQRERAF--RSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~-g~~vavK~l~~~~~~~~--~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      -++|+||.||++.... +..+|+|.+........  .....|+..+.+++|+||+++.+++....     ++|+++++|.
T Consensus         7 lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~   86 (260)
T PF00069_consen    7 LGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQ   86 (260)
T ss_dssp             EEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHH
T ss_pred             EEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccccccccc
Confidence            3689999999998664 66899999987653322  23355899999999999999999887654     5788999999


Q ss_pred             HHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          413 KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       413 ~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      +++. ....+++..+..++.++++||+|||    +.+|+||||||+||++++++.++|+|||.+..
T Consensus        87 ~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh----~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~  147 (260)
T PF00069_consen   87 DYLQ-KNKPLSEEEILKIAYQILEALAYLH----SKGIVHRDIKPENILLDENGEVKLIDFGSSVK  147 (260)
T ss_dssp             HHHH-HHSSBBHHHHHHHHHHHHHHHHHHH----HTTEEESSBSGGGEEESTTSEEEESSGTTTEE
T ss_pred             cccc-ccccccccccccccccccccccccc----cccccccccccccccccccccccccccccccc
Confidence            9887 2345688999999999999999999    57899999999999999999999999999864

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.72  E-value=2.5e-17  Score=161.64  Aligned_cols=131  Identities=24%  Similarity=0.332  Sum_probs=105.5

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----------cccc
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----------FKFM  406 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----------~~~~  406 (481)
                      .+.|+||.||++... .+..+|+|.+....  ......+.+|+.+++.++|+||+++++++....           ++|+
T Consensus        25 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~  104 (355)
T cd07874          25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM  104 (355)
T ss_pred             eeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhh
Confidence            378999999999753 57889999886432  233456678999999999999999998775331           4566


Q ss_pred             cCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          407 PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       407 ~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      + +++...+..   .+++.....++.++++||+|||    +.+|+||||||+||+++.++.+||+|||+|+..
T Consensus       105 ~-~~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH----~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~  169 (355)
T cd07874         105 D-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_pred             c-ccHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence            5 456555532   3677888899999999999999    678999999999999999999999999999764

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.72  E-value=4.4e-17  Score=156.57  Aligned_cols=134  Identities=30%  Similarity=0.370  Sum_probs=111.9

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      .+.|.+|.||+|... +|..+++|.+....   ....+.+.+|+.++++++|+|++++.++|...+     ++|++ |++
T Consensus        23 lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g~l  101 (307)
T cd06607          23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSA  101 (307)
T ss_pred             ecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-CCH
Confidence            468999999999865 58899999876432   223356788999999999999999999987765     46776 677


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+.+......+++..+..++.+++.|+.|||    +.+|+||||+|+||++++++.+||+|||+++..
T Consensus       102 ~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH----~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~  165 (307)
T cd06607         102 SDILEVHKKPLQEVEIAAICHGALQGLAYLH----SHERIHRDIKAGNILLTEPGTVKLADFGSASLV  165 (307)
T ss_pred             HHHHHHcccCCCHHHHHHHHHHHHHHHHHHH----HCCceecCCCcccEEECCCCCEEEeecCcceec
Confidence            7766554556889999999999999999999    678999999999999999999999999998754

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.72  E-value=4.6e-17  Score=154.70  Aligned_cols=132  Identities=28%  Similarity=0.421  Sum_probs=113.6

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHH
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKR  414 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~  414 (481)
                      .+.|++|.+|++.. .++..+++|.+........+.+.+|+.++++++|+|++++++++...+     ++|+++++|.++
T Consensus        27 lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~  106 (285)
T cd06648          27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDI  106 (285)
T ss_pred             eccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHH
Confidence            36789999999985 467889999887654444556788999999999999999999877655     578999999998


Q ss_pred             hhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          415 LYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       415 l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      +..  ..+++.+...++.+++.|++|+|    +.+|+||||||+||++++++.+|++|||+++.
T Consensus       107 ~~~--~~~~~~~~~~~~~ql~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~  164 (285)
T cd06648         107 VTH--TRMNEEQIATVCLAVLKALSFLH----AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQ  164 (285)
T ss_pred             HHh--CCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCChhhEEEcCCCcEEEcccccchh
Confidence            876  35788899999999999999999    67899999999999999999999999998764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.71  E-value=5.3e-17  Score=151.60  Aligned_cols=135  Identities=21%  Similarity=0.346  Sum_probs=113.4

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhH
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEK  413 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~  413 (481)
                      .+.|+||.||++... ++..+++|.+.... ....+.+..|+.++++++|+|++++.+.+...+     ++|+++|++.+
T Consensus         8 lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~   87 (255)
T cd08219           8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQ   87 (255)
T ss_pred             eeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHH
Confidence            467999999999754 57889999886533 334456778999999999999999999887665     57899999998


Q ss_pred             Hhhc-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          414 RLYS-HNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       414 ~l~~-~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ++.. ....++.....+++.++++|++|||    +.+|+|+||||+||++++++.++++|||.++..
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~i~~al~~lH----~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~  150 (255)
T cd08219          88 KIKLQRGKLFPEDTILQWFVQMCLGVQHIH----EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLL  150 (255)
T ss_pred             HHHhccCCCCCHHHHHHHHHHHHHHHHHHh----hCCcccCCCCcceEEECCCCcEEEcccCcceee
Confidence            8764 3344677888899999999999999    678999999999999999999999999998754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.71  E-value=9.7e-18  Score=150.50  Aligned_cols=134  Identities=25%  Similarity=0.406  Sum_probs=113.3

Q ss_pred             hhccccccceeeee-ccCCcceEEEEEeccchhhhhhhhHHHHHhhhhc-cCccceeecccCCCC-----cccccCCChh
Q 039957          340 ISLAGSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVR-HQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       340 l~~~g~~g~vy~~~-l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      +-++|.|+.|--+. +..|..+|||++++.......+..+|++++..++ |+||++++.+|.+.+     ||-|.+|+|.
T Consensus        85 ~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplL  164 (463)
T KOG0607|consen   85 LLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLL  164 (463)
T ss_pred             HhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHH
Confidence            34789999987665 6789999999998876666677889999999986 999999999998875     5668999999


Q ss_pred             HHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCC---CCcEEEccccCccc
Q 039957          413 KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDE---NMVAHVSDFGISKL  478 (481)
Q Consensus       413 ~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~---~~~~kl~Dfgl~~~  478 (481)
                      .+++++.. ....++.+++.+||.||.|||    ..+|.|||+||+|||...   -..+|||||.++.-
T Consensus       165 shI~~~~~-F~E~EAs~vvkdia~aLdFlH----~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg  228 (463)
T KOG0607|consen  165 SHIQKRKH-FNEREASRVVKDIASALDFLH----TKGIAHRDLKPENILCESPNKVSPVKICDFDLGSG  228 (463)
T ss_pred             HHHHHhhh-ccHHHHHHHHHHHHHHHHHHh----hcCcccccCCccceeecCCCCcCceeeeccccccc
Confidence            99986544 445677889999999999999    688999999999999854   35789999998754

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.71  E-value=1.7e-18  Score=149.77  Aligned_cols=141  Identities=25%  Similarity=0.462  Sum_probs=112.8

Q ss_pred             CChhhhhccccccceeeee-ccCCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccc
Q 039957          335 VDLETISLAGSFGSVYKGT-ISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFM  406 (481)
Q Consensus       335 ~~L~~l~~~g~~g~vy~~~-l~~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~  406 (481)
                      -++....+.|.|..||+.. .+.|+..|+|+++...  .+.++...+|+.+.+.++|||||++...+.+..     |++|
T Consensus        13 y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m   92 (355)
T KOG0033|consen   13 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV   92 (355)
T ss_pred             hhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecc
Confidence            3456667899999999986 5678888888876543  345678889999999999999999998877765     5678


Q ss_pred             cCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCC---CCcEEEccccCcccCC
Q 039957          407 PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDE---NMVAHVSDFGISKLLG  480 (481)
Q Consensus       407 ~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~---~~~~kl~Dfgl~~~~~  480 (481)
                      .+|+|..-+-+. ...+....-..+.||.+|+.|-|    ..+|||||+||+|+++-.   .-.+|++|||+|..+.
T Consensus        93 ~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH----~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~  164 (355)
T KOG0033|consen   93 TGGELFEDIVAR-EFYSEADASHCIQQILEALAYCH----SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN  164 (355)
T ss_pred             cchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHH----hcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence            999997655432 33444556678899999999999    688999999999999954   3578999999998654

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.71  E-value=3.5e-17  Score=156.18  Aligned_cols=133  Identities=23%  Similarity=0.376  Sum_probs=111.2

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccchh--hhhhhhHHHHHhhhhccCccceeecccCCC--C-----cccccCCCh
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQRER--AFRSFNSECEVLRNVRHQNLIKILSSCSTP--D-----FKFMPNGSL  411 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~-----~~~~~~g~l  411 (481)
                      +.|.+|.||+|... ++..+++|.+......  ....+.+|+.++++++|+|++++.+++...  .     ++|++ ++|
T Consensus        14 g~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L   92 (293)
T cd07843          14 EEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE-HDL   92 (293)
T ss_pred             cCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC-cCH
Confidence            67999999999875 5788999988654322  223456799999999999999999987655  3     45776 588


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+.+......+++.+..+++.+|+.||+|||    +.+|+||||||+||++++++.+||+|||+++.+
T Consensus        93 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~  156 (293)
T cd07843          93 KSLMETMKQPFLQSEVKCLMLQLLSGVAHLH----DNWILHRDLKTSNLLLNNRGILKICDFGLAREY  156 (293)
T ss_pred             HHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----HCCeeeccCCHHHEEECCCCcEEEeecCceeec
Confidence            8887765556889999999999999999999    578999999999999999999999999998754

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.71  E-value=4.6e-18  Score=152.05  Aligned_cols=134  Identities=26%  Similarity=0.408  Sum_probs=103.5

Q ss_pred             ccccccceeeeeccCC-----cceEEEEEeccch--hhhhhhhHHHHHhhhhccCccceeecccCCCC------cccccC
Q 039957          342 LAGSFGSVYKGTISDG-----TDVAIKIFNLQRE--RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD------FKFMPN  408 (481)
Q Consensus       342 ~~g~~g~vy~~~l~~g-----~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~~~~  408 (481)
                      ++|.||.||++.-.++     ..+|+|.++.+..  +...+..+|++.++.++|+|++++...+.+-+      |+|.+ 
T Consensus        33 g~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAE-  111 (438)
T KOG0666|consen   33 GRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYAE-  111 (438)
T ss_pred             cccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhhh-
Confidence            6799999999965432     3688888876532  33456788999999999999999988776533      45654 


Q ss_pred             CChhHHhhcC----CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCC----CcEEEccccCcccCC
Q 039957          409 GSLEKRLYSH----NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDEN----MVAHVSDFGISKLLG  480 (481)
Q Consensus       409 g~l~~~l~~~----~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~----~~~kl~Dfgl~~~~~  480 (481)
                      -+|...++-+    ...+.-...-.|..||..|+.|||+    .=|+|||+||+|||+..+    |.+||+|||+||++.
T Consensus       112 hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~----NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~  187 (438)
T KOG0666|consen  112 HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS----NWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFN  187 (438)
T ss_pred             hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh----hheeeccCCcceEEEeccCCccCeeEeecccHHHHhh
Confidence            4565555432    2344555667899999999999994    559999999999999877    999999999999864

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.71  E-value=3.5e-17  Score=160.87  Aligned_cols=131  Identities=25%  Similarity=0.347  Sum_probs=105.2

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----------cccc
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----------FKFM  406 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----------~~~~  406 (481)
                      .+.|+||.||++... +|..+|+|.+....  ......+.+|+.++..++|+||+++++++....           ++|+
T Consensus        29 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~  108 (359)
T cd07876          29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM  108 (359)
T ss_pred             eecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCC
Confidence            378999999999754 58899999886432  233456778999999999999999998875332           3566


Q ss_pred             cCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          407 PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       407 ~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      + +++.+.+..   .+++.....++.++++||+|||    +.+|+||||||+||+++.++.+||+|||+|+..
T Consensus       109 ~-~~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH----~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~  173 (359)
T cd07876         109 D-ANLCQVIHM---ELDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  173 (359)
T ss_pred             C-cCHHHHHhc---cCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence            5 456555432   3567788889999999999999    678999999999999999999999999998753

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.71  E-value=5.1e-17  Score=154.59  Aligned_cols=133  Identities=27%  Similarity=0.436  Sum_probs=105.1

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccch--hhhhhhhHHHHHhhhh---ccCccceeecccCCCC----------ccc
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQRE--RAFRSFNSECEVLRNV---RHQNLIKILSSCSTPD----------FKF  405 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~----------~~~  405 (481)
                      +.|+||.||++... +|..+|+|.+.....  .....+..|++++.++   +|+||+++++++....          ++|
T Consensus         9 g~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~   88 (288)
T cd07863           9 GVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEH   88 (288)
T ss_pred             eecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEcc
Confidence            67999999999865 588899998865432  1223455677766655   6999999998875421          456


Q ss_pred             ccCCChhHHhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          406 MPNGSLEKRLYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       406 ~~~g~l~~~l~~~-~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ++ +++.+++... ...+++.+...++.+++.|++|+|    +.+|+||||||+||++++++.+||+|||+++.+
T Consensus        89 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~  158 (288)
T cd07863          89 VD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH----ANCIVHRDLKPENILVTSGGQVKLADFGLARIY  158 (288)
T ss_pred             cc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence            66 5788777642 234788899999999999999999    678999999999999999999999999998764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.71  E-value=4.7e-17  Score=152.80  Aligned_cols=135  Identities=27%  Similarity=0.459  Sum_probs=112.0

Q ss_pred             hhccccccceeeeecc-CCcceEEEEEeccc-----hhhhhhhhHHHHHhhhhccCccceeecccCCCC-------cccc
Q 039957          340 ISLAGSFGSVYKGTIS-DGTDVAIKIFNLQR-----ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-------FKFM  406 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~-~g~~vavK~l~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-------~~~~  406 (481)
                      +-+.|++|.+|++... +|..+++|......     ......+.+|++++++++|+|++++.+++....       ++|+
T Consensus         9 ~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~   88 (264)
T cd06653           9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYM   88 (264)
T ss_pred             eEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeC
Confidence            4467999999999854 58899999875321     223456788999999999999999999876532       4688


Q ss_pred             cCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          407 PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       407 ~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ++++|.+++.... .+++....+++.+++.|++|||    +.+|+|||+||+||+++.++.+||+|||+++..
T Consensus        89 ~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH----~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  156 (264)
T cd06653          89 PGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLH----SNMIVHRDIKGANILRDSAGNVKLGDFGASKRI  156 (264)
T ss_pred             CCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence            9999999886432 4677888899999999999999    678999999999999999999999999998753

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.71  E-value=3.4e-17  Score=153.21  Aligned_cols=134  Identities=28%  Similarity=0.397  Sum_probs=115.0

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      .+.|+||.||++... ++..+++|.+....   .+..+.+.+|++++++++|+|++++++.+....     ++|+++++|
T Consensus         8 i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   87 (258)
T cd05578           8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDL   87 (258)
T ss_pred             eccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCH
Confidence            367999999999865 58889999887543   234567888999999999999999998887665     578999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+++... ..++..+...++.++++|++|||    +.+|+|+||||+||++++++.+|++|||.+...
T Consensus        88 ~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh----~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~  150 (258)
T cd05578          88 RYHLSQK-VKFSEEQVKFWICEIVLALEYLH----SKGIIHRDIKPDNILLDEQGHVHITDFNIATKV  150 (258)
T ss_pred             HHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHeEEcCCCCEEEeeccccccc
Confidence            9988654 46778889999999999999999    678999999999999999999999999998754

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.71  E-value=1.4e-17  Score=173.01  Aligned_cols=50  Identities=34%  Similarity=0.580  Sum_probs=46.7

Q ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          425 LERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       425 ~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      ...+++..+|++||+|+|    +.+||||||||.||++|++..+||+|||+|+.
T Consensus       697 d~~wrLFreIlEGLaYIH----~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~  746 (1351)
T KOG1035|consen  697 DEAWRLFREILEGLAYIH----DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATD  746 (1351)
T ss_pred             HHHHHHHHHHHHHHHHHH----hCceeeccCCcceeEEcCCCCeeecccccchh
Confidence            456788999999999999    78899999999999999999999999999986

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.71  E-value=4e-17  Score=154.45  Aligned_cols=134  Identities=25%  Similarity=0.344  Sum_probs=112.0

Q ss_pred             ccccccceeeeec-cCCcceEEEEEeccch---hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          342 LAGSFGSVYKGTI-SDGTDVAIKIFNLQRE---RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       342 ~~g~~g~vy~~~l-~~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      +.|+||.||++.. .+|..+++|.+.....   .....+..|++++++++|++++++.+.+...+     ++|+++++|.
T Consensus         2 g~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   81 (277)
T cd05577           2 GKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLK   81 (277)
T ss_pred             CCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHH
Confidence            4689999999874 4688999998865321   22335567999999999999999998876654     5789999999


Q ss_pred             HHhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          413 KRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       413 ~~l~~~~-~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +++.... ..+++..+..++.+++.|++|||    ..+|+||||||+||++++++.+|++|||+++.+
T Consensus        82 ~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH----~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~  145 (277)
T cd05577          82 YHIYNVGEPGFPEARAIFYAAQIICGLEHLH----QRRIVYRDLKPENVLLDDHGNVRISDLGLAVEL  145 (277)
T ss_pred             HHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEECCCCCEEEccCcchhhh
Confidence            9887533 35788899999999999999999    678999999999999999999999999998754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.71  E-value=4.1e-17  Score=155.68  Aligned_cols=132  Identities=30%  Similarity=0.451  Sum_probs=113.5

Q ss_pred             ccccccceeeeec-cCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHHh
Q 039957          342 LAGSFGSVYKGTI-SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRL  415 (481)
Q Consensus       342 ~~g~~g~vy~~~l-~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~l  415 (481)
                      +.|+||.||++.. .++..+++|.+........+.+..|+.++++++|+|++++.++|...+     ++|+++|++.+++
T Consensus        28 g~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~  107 (293)
T cd06647          28 GQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV  107 (293)
T ss_pred             cCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHH
Confidence            6799999999974 467889999887655455567888999999999999999999887654     5789999999988


Q ss_pred             hcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          416 YSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       416 ~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ...  .+++.++..++.++++|++|||    +.+++|||+||+||+++.++.+||+|||++...
T Consensus       108 ~~~--~l~~~~~~~i~~~l~~al~~LH----~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~  165 (293)
T cd06647         108 TET--CMDEGQIAAVCRECLQALEFLH----SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI  165 (293)
T ss_pred             hhc--CCCHHHHHHHHHHHHHHHHHHH----hCCEeeccCCHHHEEEcCCCCEEEccCcceecc
Confidence            653  4678899999999999999999    678999999999999999999999999987643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.71  E-value=4.2e-17  Score=154.03  Aligned_cols=133  Identities=32%  Similarity=0.397  Sum_probs=114.7

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHH
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKR  414 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~  414 (481)
                      +.|++|.||+|... ++..+++|.+.... ......+.+|++++++++|+|++++.+++....     +||+++++|.++
T Consensus        10 g~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~   89 (274)
T cd06609          10 GKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDL   89 (274)
T ss_pred             cCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHH
Confidence            57999999999865 57889999886543 333456788999999999999999999887654     578899999999


Q ss_pred             hhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          415 LYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       415 l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      +...  .+++.....++.+++.|++|||    +.+|+|||++|+||++++++.++++|||+++.+.
T Consensus        90 ~~~~--~~~~~~~~~~~~ql~~~l~~lh----~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~  149 (274)
T cd06609          90 LKPG--KLDETYIAFILREVLLGLEYLH----EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLT  149 (274)
T ss_pred             Hhhc--CCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEECCCCCEEEcccccceeec
Confidence            8754  6788999999999999999999    6789999999999999999999999999987653

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.71  E-value=6.9e-17  Score=150.92  Aligned_cols=134  Identities=28%  Similarity=0.476  Sum_probs=112.2

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC------cccccCCChh
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD------FKFMPNGSLE  412 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~~~~g~l~  412 (481)
                      +.|++|.||++... ++..+++|.+....  ....+.+..|++++++++|+|++++.+.+...+      ++|++++++.
T Consensus         9 g~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~   88 (257)
T cd08223           9 GKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLY   88 (257)
T ss_pred             cCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHH
Confidence            57899999999854 57889999886543  233456788999999999999999988765332      5688999999


Q ss_pred             HHhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          413 KRLYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       413 ~~l~~~-~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +++... ...+++.++.+++.+++.|++|+|    +.+|+||||||+||++++++.+||+|||+++.+
T Consensus        89 ~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH----~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~  152 (257)
T cd08223          89 HKLKEQKGKLLPENQVVEWFVQIAMALQYLH----EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVL  152 (257)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCchhEEEecCCcEEEecccceEEe
Confidence            988753 345788999999999999999999    678999999999999999999999999998754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.71  E-value=4.7e-18  Score=164.91  Aligned_cols=132  Identities=28%  Similarity=0.412  Sum_probs=114.8

Q ss_pred             ccccccceeeeeccC-CcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHHh
Q 039957          342 LAGSFGSVYKGTISD-GTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRL  415 (481)
Q Consensus       342 ~~g~~g~vy~~~l~~-g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~l  415 (481)
                      |.|.||.||++.-.+ +...|.|.+........++|.-|+++|+.+.||+||++++.|+..+     .+||+||-....+
T Consensus        41 GDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaim  120 (1187)
T KOG0579|consen   41 GDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIM  120 (1187)
T ss_pred             cCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHH
Confidence            679999999998654 5566778888777777888999999999999999999998666544     5799999998887


Q ss_pred             hcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcc
Q 039957          416 YSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK  477 (481)
Q Consensus       416 ~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~  477 (481)
                      ..-+..+.-.+..-|..++..||.|||    +..|+|||+|+-|||++-+|.+|++|||++-
T Consensus       121 lEL~r~LtE~QIqvvc~q~ldALn~LH----s~~iIHRDLKAGNiL~TldGdirLADFGVSA  178 (1187)
T KOG0579|consen  121 LELGRVLTEDQIQVVCYQVLDALNWLH----SQNIIHRDLKAGNILLTLDGDIRLADFGVSA  178 (1187)
T ss_pred             HHhccccchHHHHHHHHHHHHHHHHHh----hcchhhhhccccceEEEecCcEeeecccccc
Confidence            776667777787788999999999999    6889999999999999999999999999964

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.71  E-value=5.3e-17  Score=155.90  Aligned_cols=132  Identities=24%  Similarity=0.345  Sum_probs=111.8

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccch---hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQRE---RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      +.|+||.||++... ++..|++|.+.....   .....+..|+.+++.++|+||+++++.+...+     +||+++|+|.
T Consensus        10 ~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~   89 (305)
T cd05609          10 SNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCA   89 (305)
T ss_pred             ecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHH
Confidence            57999999999854 578899998865432   22346778999999999999999999887665     5789999999


Q ss_pred             HHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          413 KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       413 ~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      +++... ..+.+.....++.++++|++|+|    +.+|+|||+||+||+++.++.+|++|||+++.
T Consensus        90 ~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~  150 (305)
T cd05609          90 TLLKNI-GALPVDMARMYFAETVLALEYLH----NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKI  150 (305)
T ss_pred             HHHHHc-CCCCHHHHHHHHHHHHHHHHHHH----HCCccccCCchHHEEECCCCCEEEeeCCCccc
Confidence            998654 35678888889999999999999    57899999999999999999999999999874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.71  E-value=5.6e-17  Score=156.54  Aligned_cols=134  Identities=28%  Similarity=0.347  Sum_probs=114.3

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccchh---hhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQRER---AFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      +.|++|.||++... ++..+++|.+......   ..+.+..|++++.+++|++|+++++.+....     ++|+.+++|.
T Consensus        10 g~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   89 (316)
T cd05574          10 GKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELF   89 (316)
T ss_pred             cCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHH
Confidence            67999999999865 4889999988754322   3456788999999999999999999887665     5688999999


Q ss_pred             HHhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          413 KRLYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       413 ~~l~~~-~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +++... ...+++.....++.++++|++|||    +.+|+||||||+||+++.++.++|+|||+++..
T Consensus        90 ~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  153 (316)
T cd05574          90 RLLQRQPGKCLSEEVARFYAAEVLLALEYLH----LLGIVYRDLKPENILLHESGHIMLSDFDLSKQS  153 (316)
T ss_pred             HHHHhCCCCccCHHHHHHHHHHHHHHHHHHH----HCCeeccCCChHHeEEcCCCCEEEeecchhhcc
Confidence            988653 356788889999999999999999    678999999999999999999999999998754

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.71  E-value=2.7e-17  Score=156.29  Aligned_cols=134  Identities=28%  Similarity=0.408  Sum_probs=112.5

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccch--hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRE--RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      .+.|++|.||++... .+..+++|.+.....  ...+.+.+|++++++++|+|++++++++....     ++|++++++.
T Consensus         9 lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~   88 (286)
T cd07846           9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLD   88 (286)
T ss_pred             eccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHH
Confidence            367999999999875 478899998754322  22346778999999999999999999997765     5788988888


Q ss_pred             HHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          413 KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       413 ~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ++.... ..++|.+...++.+|++|++|||    +.+|+|||++|+||++++++.+||+|||+++.+
T Consensus        89 ~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH----~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~  150 (286)
T cd07846          89 DLEKYP-NGLDESRVRKYLFQILRGIEFCH----SHNIIHRDIKPENILVSQSGVVKLCDFGFARTL  150 (286)
T ss_pred             HHHhcc-CCCCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEECCCCcEEEEeeeeeeec
Confidence            776533 34789999999999999999999    578999999999999999999999999998754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.71  E-value=5.8e-17  Score=153.48  Aligned_cols=133  Identities=26%  Similarity=0.315  Sum_probs=105.2

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccchh---hhhhhhHHHHHh---hhhccCccceeecccCCCC-----cccccCC
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQRER---AFRSFNSECEVL---RNVRHQNLIKILSSCSTPD-----FKFMPNG  409 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~---~~~~~~~e~~~l---~~l~h~niv~l~~~~~~~~-----~~~~~~g  409 (481)
                      ++|+||.||++... +|..+|+|.+......   ....+..|..++   ...+|++++++.+++...+     +||+++|
T Consensus         3 g~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   82 (279)
T cd05633           3 GRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGG   82 (279)
T ss_pred             ccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCCC
Confidence            57999999999864 5789999988653221   112233343333   3347999999988876654     6799999


Q ss_pred             ChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          410 SLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       410 ~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +|.+++... ..+++.....++.+++.|++|||    +.+|+||||||+||++++++.+|++|||+++..
T Consensus        83 ~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH----~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~  147 (279)
T cd05633          83 DLHYHLSQH-GVFSEKEMRFYATEIILGLEHMH----NRFVVYRDLKPANILLDEHGHVRISDLGLACDF  147 (279)
T ss_pred             CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH----HCCcCCCCCCHHHEEECCCCCEEEccCCcceec
Confidence            999887653 35788999999999999999999    678999999999999999999999999998643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.71  E-value=5.8e-17  Score=151.95  Aligned_cols=133  Identities=27%  Similarity=0.349  Sum_probs=113.3

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccch---hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQRE---RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      +.|++|.||++... ++..+++|.+.....   ...+.+..|++++++++|+|++++++.+....     ++|+++|+|.
T Consensus         2 g~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   81 (262)
T cd05572           2 GVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELW   81 (262)
T ss_pred             CCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHH
Confidence            56899999999865 478899998865432   23456888999999999999999999887664     5688999999


Q ss_pred             HHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          413 KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       413 ~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +++... ..+++..+..++.+++.|++|+|    +.+++|+||||+||++++++.+|++|||+++..
T Consensus        82 ~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH----~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~  143 (262)
T cd05572          82 TILRDR-GLFDEYTARFYIACVVLAFEYLH----NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL  143 (262)
T ss_pred             HHHhhc-CCCCHHHHHHHHHHHHHHHHHHh----hCCcccCCCCHHHEEEcCCCCEEEeeCCccccc
Confidence            998754 34678888999999999999999    678999999999999999999999999998865

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.70  E-value=8.4e-17  Score=150.31  Aligned_cols=135  Identities=24%  Similarity=0.426  Sum_probs=114.4

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      .+.|+||.+|++... +|..+++|.+....  ....+++.+|+.++++++|+|++++.+++...+     ++|++++++.
T Consensus         8 lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~   87 (256)
T cd08218           8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLY   87 (256)
T ss_pred             eccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHH
Confidence            367999999998754 57889999886532  233457888999999999999999999887665     5789999999


Q ss_pred             HHhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          413 KRLYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       413 ~~l~~~-~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +++... ...+++.+..+++.+++.|++|||    +.+++|+|++|+||+++.++.+|++|||+++.+
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh----~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~  151 (256)
T cd08218          88 KKINAQRGVLFPEDQILDWFVQICLALKHVH----DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL  151 (256)
T ss_pred             HHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEEcCCCCEEEeeccceeec
Confidence            988653 335688889999999999999999    578999999999999999999999999998754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.70  E-value=2e-17  Score=159.55  Aligned_cols=134  Identities=30%  Similarity=0.394  Sum_probs=110.3

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      |.|+||.||-+... +...||+|....+-   ...+.++..|+..|++++|||.+.+-|+|....     +|||- |+-.
T Consensus        35 GHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl-GSAs  113 (948)
T KOG0577|consen   35 GHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSAS  113 (948)
T ss_pred             cCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh-ccHH
Confidence            78999999998754 56789999876432   345677889999999999999999999886553     67875 5666


Q ss_pred             HHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          413 KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       413 ~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      +.+.-+...+.-.+...|.-|+..||+|||    +.+-||||||+-|||+++.|.||++|||-|.+..
T Consensus       114 DlleVhkKplqEvEIAAi~~gaL~gLaYLH----S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~  177 (948)
T KOG0577|consen  114 DLLEVHKKPLQEVEIAAITHGALQGLAYLH----SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA  177 (948)
T ss_pred             HHHHHHhccchHHHHHHHHHHHHHHHHHHH----HhhHHhhhccccceEecCCCeeeeccccchhhcC
Confidence            665544556666777788899999999999    6789999999999999999999999999987654

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.70  E-value=7.3e-17  Score=152.66  Aligned_cols=133  Identities=31%  Similarity=0.428  Sum_probs=113.7

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhH
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEK  413 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~  413 (481)
                      .+.|+||.||+|.. .++..+|+|...... ......+.+|+..+++++|+|++++++++...+     +||+++|++.+
T Consensus        12 ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~   91 (277)
T cd06641          12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD   91 (277)
T ss_pred             EeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHH
Confidence            47899999999975 467889999876543 233456788999999999999999999887665     67899999999


Q ss_pred             HhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          414 RLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       414 ~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ++...  .+++.....++.+++.|++|||    +.+++|+|+||+||+++.++.++++|||+++.+
T Consensus        92 ~i~~~--~~~~~~~~~~~~~l~~~l~~lh----~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~  151 (277)
T cd06641          92 LLEPG--PLDETQIATILREILKGLDYLH----SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL  151 (277)
T ss_pred             HHhcC--CCCHHHHHHHHHHHHHHHHHHc----cCCeecCCCCHHhEEECCCCCEEEeecccceec
Confidence            88643  4788999999999999999999    578999999999999999999999999998654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.70  E-value=6.1e-17  Score=154.26  Aligned_cols=134  Identities=25%  Similarity=0.307  Sum_probs=110.7

Q ss_pred             hccccccceeeeec----cCCcceEEEEEeccc----hhhhhhhhHHHHHhhhh-ccCccceeecccCCCC-----cccc
Q 039957          341 SLAGSFGSVYKGTI----SDGTDVAIKIFNLQR----ERAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD-----FKFM  406 (481)
Q Consensus       341 ~~~g~~g~vy~~~l----~~g~~vavK~l~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----~~~~  406 (481)
                      .+.|+||.||.+..    .+|..+|+|.+....    ....+.+..|++++.++ +|++|+++.+.+....     ++|+
T Consensus         8 lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   87 (290)
T cd05613           8 LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYI   87 (290)
T ss_pred             eccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecC
Confidence            36899999999875    368899999886432    12335677899999999 5899999988776554     5789


Q ss_pred             cCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          407 PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       407 ~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ++|+|.+++... ..+++.....++.++++|++|||    +.+++||||||+||++++++.+||+|||+++.+
T Consensus        88 ~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH----~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  155 (290)
T cd05613          88 NGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLH----KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  155 (290)
T ss_pred             CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence            999999988653 34667788888889999999999    678999999999999999999999999998764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.70  E-value=5.4e-17  Score=159.85  Aligned_cols=131  Identities=24%  Similarity=0.326  Sum_probs=105.9

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----------cccc
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----------FKFM  406 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----------~~~~  406 (481)
                      .++|+||.||++... .+..+|+|.+....  ......+.+|+.+++.++|+|++++++.+...+           ++|+
T Consensus        32 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~  111 (364)
T cd07875          32 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM  111 (364)
T ss_pred             eecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCC
Confidence            378999999999754 57889999886432  223456778999999999999999998765432           4566


Q ss_pred             cCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          407 PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       407 ~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      + +++.+.+..   .+++.....++.++++||+|||    +.+|+||||||+||+++.++.+||+|||+|+..
T Consensus       112 ~-~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~  176 (364)
T cd07875         112 D-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  176 (364)
T ss_pred             C-CCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHh----hCCeecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence            5 466666542   3677888899999999999999    678999999999999999999999999999764

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.70  E-value=7.6e-17  Score=153.28  Aligned_cols=134  Identities=28%  Similarity=0.429  Sum_probs=116.2

Q ss_pred             hhccccccceeeeecc-CCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhH
Q 039957          340 ISLAGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEK  413 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~  413 (481)
                      ..+.|++|.+|++... ++..+++|.+..... ..+.+..|++.+++++|+|++++++++...+     ++|+++++|.+
T Consensus        26 ~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~  104 (286)
T cd06614          26 KIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTD  104 (286)
T ss_pred             hccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHH
Confidence            3467999999999876 578899999876543 4456788999999999999999999887654     56889999999


Q ss_pred             HhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          414 RLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       414 ~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      ++......+++.++..++.+++.|++|||    ..+|+|+|+||+||+++.++.+||+|||++..
T Consensus       105 ~l~~~~~~l~~~~~~~i~~~i~~~L~~lH----~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~  165 (286)
T cd06614         105 IITQNFVRMNEPQIAYVCREVLQGLEYLH----SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQ  165 (286)
T ss_pred             HHHHhccCCCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCChhhEEEcCCCCEEECccchhhh
Confidence            98875446899999999999999999999    68899999999999999999999999998754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.70  E-value=9.6e-17  Score=154.94  Aligned_cols=134  Identities=28%  Similarity=0.366  Sum_probs=112.3

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      .+.|+||.+|++... +|..+++|.+....   ......+..|++++++++|+|++++.++|...+     ++|++ |++
T Consensus        33 lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-g~l  111 (317)
T cd06635          33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSA  111 (317)
T ss_pred             eccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCC-CCH
Confidence            378999999999854 57889999886432   233456788999999999999999999987664     56776 577


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+.+......++|.++..++.+++.|+.|||    +.+|+||||+|+||+++.++.+||+|||+++..
T Consensus       112 ~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH----~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~  175 (317)
T cd06635         112 SDLLEVHKKPLQEVEIAAITHGALQGLAYLH----SHNMIHRDIKAGNILLTEPGQVKLADFGSASIA  175 (317)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCcccEEECCCCCEEEecCCCcccc
Confidence            7777655566889999999999999999999    678999999999999999999999999998754

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.70  E-value=7.1e-17  Score=153.32  Aligned_cols=134  Identities=25%  Similarity=0.320  Sum_probs=113.7

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhH
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEK  413 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~  413 (481)
                      .+.|++|.||++... +|..+++|.+.... ......+.+|+++++.++|+|++++.+++...+     +||+++|+|.+
T Consensus        13 ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   92 (284)
T cd06620          13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDR   92 (284)
T ss_pred             cCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHH
Confidence            378999999999854 58889999876543 233456888999999999999999999988765     67999999998


Q ss_pred             HhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          414 RLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       414 ~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      ++... ..+++.....++.+++.|++|||+   ..+|+|||+||+||++++++.++|+|||+++.
T Consensus        93 ~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~---~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~  153 (284)
T cd06620          93 IYKKG-GPIPVEILGKIAVAVVEGLTYLYN---VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGE  153 (284)
T ss_pred             HHHhc-cCCCHHHHHHHHHHHHHHHHHHHH---hcCeeccCCCHHHEEECCCCcEEEccCCcccc
Confidence            87653 357888899999999999999995   35799999999999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.70  E-value=7.9e-17  Score=152.43  Aligned_cols=133  Identities=29%  Similarity=0.429  Sum_probs=114.0

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhH
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEK  413 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~  413 (481)
                      .+.|+||.+|+|... ++..+++|.+.... ......+..|++++++++|++++++++++....     +||+++|+|.+
T Consensus        12 lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   91 (277)
T cd06640          12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALD   91 (277)
T ss_pred             cccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHH
Confidence            468999999999864 57889999887543 334567888999999999999999999887765     67899999999


Q ss_pred             HhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          414 RLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       414 ~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ++...  .+++.+...++.++++|++|+|    +.+++|+||+|+||+++.++.++++|||+++.+
T Consensus        92 ~i~~~--~l~~~~~~~~~~~l~~~l~~lh----~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~  151 (277)
T cd06640          92 LLRAG--PFDEFQIATMLKEILKGLDYLH----SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQL  151 (277)
T ss_pred             HHhcC--CCCHHHHHHHHHHHHHHHHHHH----hCCccCcCCChhhEEEcCCCCEEEcccccceec
Confidence            88643  4677888899999999999999    578999999999999999999999999998654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.70  E-value=7.8e-17  Score=153.16  Aligned_cols=134  Identities=24%  Similarity=0.339  Sum_probs=109.4

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccchhhhhhhhHHHHHhhhh-ccCccceeecccCC-----CC-----cccccC
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECEVLRNV-RHQNLIKILSSCST-----PD-----FKFMPN  408 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~-----~~-----~~~~~~  408 (481)
                      .+.|+||.||++... ++..+++|.+.... .....+..|+.++.++ +|+|+++++++|..     .+     +||+++
T Consensus        26 lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~  104 (286)
T cd06638          26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNG  104 (286)
T ss_pred             eccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCC
Confidence            368999999999754 57889999875432 2234577899999998 69999999998742     11     578999


Q ss_pred             CChhHHhhc---CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          409 GSLEKRLYS---HNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       409 g~l~~~l~~---~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      |+|.+++..   .....++.....++.++++|++|||    +.+|+|||+||+||++++++.+|++|||+++.+
T Consensus       105 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  174 (286)
T cd06638         105 GSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH----VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQL  174 (286)
T ss_pred             CCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH----hCCccccCCCHHhEEECCCCCEEEccCCceeec
Confidence            999987653   2345677888899999999999999    678999999999999999999999999998754

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.70  E-value=6.6e-17  Score=152.07  Aligned_cols=134  Identities=25%  Similarity=0.389  Sum_probs=112.6

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccch------hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccC
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQRE------RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPN  408 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~  408 (481)
                      .+.|++|.+|++.. .++..+++|.+.....      ...+.+..|++.+++++|+|++++++++...+     ++|+++
T Consensus         8 lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~   87 (268)
T cd06630           8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAG   87 (268)
T ss_pred             ecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccCC
Confidence            46799999999974 5688999998864331      23456788999999999999999999987765     578999


Q ss_pred             CChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCC-cEEEccccCcccC
Q 039957          409 GSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENM-VAHVSDFGISKLL  479 (481)
Q Consensus       409 g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~-~~kl~Dfgl~~~~  479 (481)
                      ++|.+++... ..+++....+++.+++.|++|||    +.+++||||||+||+++.++ .+||+|||.++.+
T Consensus        88 ~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH----~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          88 GSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLH----ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             CcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            9999988653 35678888999999999999999    67899999999999998875 6999999998654

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.70  E-value=5.9e-17  Score=154.45  Aligned_cols=133  Identities=27%  Similarity=0.415  Sum_probs=113.8

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHH
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKR  414 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~  414 (481)
                      .+.|++|.||++.. .+|..+++|.+..........+.+|+.++++++|+|++++++++...+     +||++++++.++
T Consensus        28 lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~  107 (292)
T cd06657          28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDI  107 (292)
T ss_pred             cCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHH
Confidence            37899999999986 468899999886544444556888999999999999999999887665     578999999988


Q ss_pred             hhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          415 LYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       415 l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +...  ..++.....++.+++.|++|+|    +.+++|||+||+||+++++++++|+|||++..+
T Consensus       108 ~~~~--~~~~~~~~~~~~ql~~~l~~lH----~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~  166 (292)
T cd06657         108 VTHT--RMNEEQIAAVCLAVLKALSVLH----AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV  166 (292)
T ss_pred             HhcC--CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEECCCCCEEEcccccceec
Confidence            7543  4688889999999999999999    578999999999999999999999999987643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.70  E-value=8.5e-17  Score=152.15  Aligned_cols=133  Identities=27%  Similarity=0.440  Sum_probs=113.3

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccc-hhhhhhhhHHHHHhhhhc---cCccceeecccCCCC-----cccccCCC
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQR-ERAFRSFNSECEVLRNVR---HQNLIKILSSCSTPD-----FKFMPNGS  410 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~-----~~~~~~g~  410 (481)
                      -+.|+||.+|+|.. .+|..+++|.+.... ......+..|++++++++   |+|++++.++|....     ++|+++++
T Consensus         9 l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~   88 (277)
T cd06917           9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGS   88 (277)
T ss_pred             eeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCc
Confidence            46899999999985 568899999886542 233456778999999887   999999999887654     67899999


Q ss_pred             hhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          411 LEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       411 l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      |.+++...  .+++.....++.++++|++|||    +.+|+||||+|+||++++++.++++|||+++.+
T Consensus        89 L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh----~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  151 (277)
T cd06917          89 VRTLMKAG--PIAEKYISVIIREVLVALKYIH----KVGVIHRDIKAANILVTNTGNVKLCDFGVAALL  151 (277)
T ss_pred             HHHHHHcc--CCCHHHHHHHHHHHHHHHHHHH----hCCcccCCcCHHHEEEcCCCCEEEccCCceeec
Confidence            99987653  5788999999999999999999    678999999999999999999999999998764

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.70  E-value=6.4e-17  Score=153.61  Aligned_cols=133  Identities=26%  Similarity=0.436  Sum_probs=111.3

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccch--hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhH
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQRE--RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEK  413 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~  413 (481)
                      +.|++|.||++... +|..+++|.+.....  .....+..|++++++++|+|++++++++...+     ++|++ +++.+
T Consensus         9 ~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~   87 (284)
T cd07860           9 GEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKK   87 (284)
T ss_pred             cCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHH
Confidence            57899999999864 688999998865432  22346788999999999999999999987765     56775 68888


Q ss_pred             HhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          414 RLYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       414 ~l~~~-~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ++... ...+++.....++.++++|++|||    +.+++||||+|+||++++++.+|++|||+++.+
T Consensus        88 ~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh----~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~  150 (284)
T cd07860          88 FMDASPLSGIPLPLIKSYLFQLLQGLAFCH----SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF  150 (284)
T ss_pred             HHHhCCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEECCCCCEEEeeccchhhc
Confidence            77643 345788899999999999999999    678999999999999999999999999998754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.70  E-value=8.4e-17  Score=142.80  Aligned_cols=134  Identities=19%  Similarity=0.192  Sum_probs=99.5

Q ss_pred             hccccccceeeeeccCCcceEEEEEeccchhh--------------------------hhhhhHHHHHhhhhccCcccee
Q 039957          341 SLAGSFGSVYKGTISDGTDVAIKIFNLQRERA--------------------------FRSFNSECEVLRNVRHQNLIKI  394 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~g~~vavK~l~~~~~~~--------------------------~~~~~~e~~~l~~l~h~niv~l  394 (481)
                      .++|++|.||+|...+|..||||.+.......                          ......|.+.+.+++|+++...
T Consensus         5 ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p   84 (190)
T cd05145           5 ISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVPVP   84 (190)
T ss_pred             eecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCCCc
Confidence            36799999999997789999999987542100                          1112467888889988887433


Q ss_pred             ecccCCC---CcccccCCChhHH-hhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 039957          395 LSSCSTP---DFKFMPNGSLEKR-LYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHV  470 (481)
Q Consensus       395 ~~~~~~~---~~~~~~~g~l~~~-l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl  470 (481)
                      ..+....   .+||++++++... +..  ...+..+..+++.++++++.|+|+   ..+|+|||+||+||+++ ++.++|
T Consensus        85 ~~~~~~~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~---~~givHrDlkP~NIll~-~~~~~l  158 (190)
T cd05145          85 EPILLKKNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQ---EAGLVHGDLSEYNILYH-DGKPYI  158 (190)
T ss_pred             eEEEecCCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCChhhEEEE-CCCEEE
Confidence            2222122   3678888755432 322  345667788999999999999994   27899999999999999 899999


Q ss_pred             ccccCcccCC
Q 039957          471 SDFGISKLLG  480 (481)
Q Consensus       471 ~Dfgl~~~~~  480 (481)
                      +|||+|+.+.
T Consensus       159 iDFG~a~~~~  168 (190)
T cd05145         159 IDVSQAVELD  168 (190)
T ss_pred             EEcccceecC
Confidence            9999998764

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.70  E-value=7.8e-17  Score=156.98  Aligned_cols=133  Identities=27%  Similarity=0.445  Sum_probs=109.8

Q ss_pred             hhccccccceeeeecc-CCcceEEEEEecc--chhhhhhhhHHHHHhhhh-ccCccceeecccCCCC-------cccccC
Q 039957          340 ISLAGSFGSVYKGTIS-DGTDVAIKIFNLQ--RERAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD-------FKFMPN  408 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~-~g~~vavK~l~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-------~~~~~~  408 (481)
                      ..+.|+||.+|+|... +|..+++|.+...  .......+..|+.+++++ +|+||++++++|...+       ++|++ 
T Consensus        14 ~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-   92 (337)
T cd07852          14 KLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-   92 (337)
T ss_pred             hhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccc-
Confidence            3468999999999865 5788999987542  222334567799999999 9999999999876542       45776 


Q ss_pred             CChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          409 GSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       409 g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ++|..++...  .++|..+..++.+++.|++|||    +.+|+||||||+||++++++.+||+|||+++.+
T Consensus        93 ~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH----~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~  157 (337)
T cd07852          93 TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIH----SGNVIHRDLKPSNILLNSDCRVKLADFGLARSL  157 (337)
T ss_pred             cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence            6888887654  6788899999999999999999    678999999999999999999999999998754

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.70  E-value=9.3e-17  Score=153.08  Aligned_cols=133  Identities=29%  Similarity=0.384  Sum_probs=110.3

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccchhhhhhhhHHHHHhhhh-ccCccceeecccCCCC----------cccccCC
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD----------FKFMPNG  409 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~----------~~~~~~g  409 (481)
                      ++|+||.||++... +|..+++|.+.... .....+..|+.++.++ +|+|+++++++|...+          ++|+++|
T Consensus        31 ~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~  109 (291)
T cd06639          31 GKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGG  109 (291)
T ss_pred             ecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCC
Confidence            67999999999864 57889999876432 2234567788888888 7999999999875432          5689999


Q ss_pred             ChhHHhhc---CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          410 SLEKRLYS---HNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       410 ~l~~~l~~---~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +|.+++..   ....+++.....++.+++.|++|||    +.+|+||||||+||++++++.+||+|||+++.+
T Consensus       110 sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~  178 (291)
T cd06639         110 SVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH----NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQL  178 (291)
T ss_pred             cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHEEEcCCCCEEEeecccchhc
Confidence            99988753   3345788899999999999999999    678999999999999999999999999998754

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.70  E-value=4.1e-17  Score=141.70  Aligned_cols=139  Identities=22%  Similarity=0.310  Sum_probs=117.8

Q ss_pred             hhhccccccceeeee-ccCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC----------ccccc
Q 039957          339 TISLAGSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----------FKFMP  407 (481)
Q Consensus       339 ~l~~~g~~g~vy~~~-l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----------~~~~~  407 (481)
                      .+-+.|+|.-||.++ +.++..+|+|++.....+..+...+|++.-++++|||++++++++....          +.|-.
T Consensus        27 ~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~  106 (302)
T KOG2345|consen   27 RLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYK  106 (302)
T ss_pred             eeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhc
Confidence            344789999999887 6788999999988776666777889999999999999999998875432          34667


Q ss_pred             CCChhHHhhc---CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          408 NGSLEKRLYS---HNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       408 ~g~l~~~l~~---~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .|++.+.+..   .+...+..+.++|..||++||++||..  .++++||||||.|||+.+.+.+++.|||-+...
T Consensus       107 ~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~--~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a  179 (302)
T KOG2345|consen  107 RGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK--EPPYAHRDIKPANILLSDSGLPVLMDLGSATQA  179 (302)
T ss_pred             cccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc--CCcccccCCCcceeEecCCCceEEEeccCcccc
Confidence            8999988764   455678889999999999999999964  367999999999999999999999999987653

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.70  E-value=7.2e-17  Score=153.35  Aligned_cols=133  Identities=27%  Similarity=0.422  Sum_probs=113.0

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCC--C-----cccccCCCh
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTP--D-----FKFMPNGSL  411 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~-----~~~~~~g~l  411 (481)
                      +.|++|.||+|... +|..+++|.+....  ......+..|++++++++|+|++++.+++...  .     ++|++ +++
T Consensus         8 ~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l   86 (287)
T cd07840           8 GEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD-HDL   86 (287)
T ss_pred             ccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecccc-ccH
Confidence            67899999999865 47899999987653  33345677899999999999999999988766  3     46776 588


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+++.......++.++..++.++++|++|||    +.+++|+||||+||++++++.+|++|||+++..
T Consensus        87 ~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH----~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~  150 (287)
T cd07840          87 TGLLDSPEVKFTESQIKCYMKQLLEGLQYLH----SNGILHRDIKGSNILINNDGVLKLADFGLARPY  150 (287)
T ss_pred             HHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----HCCceeccCcHHHeEEcCCCCEEEccccceeec
Confidence            8887665456789999999999999999999    578999999999999999999999999998754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.70  E-value=9.6e-17  Score=150.48  Aligned_cols=138  Identities=26%  Similarity=0.422  Sum_probs=112.9

Q ss_pred             ccccccceeeeec-cCCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC-------cccccCCCh
Q 039957          342 LAGSFGSVYKGTI-SDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-------FKFMPNGSL  411 (481)
Q Consensus       342 ~~g~~g~vy~~~l-~~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-------~~~~~~g~l  411 (481)
                      +.|++|.||++.. .+|..+++|.+....  ....+.+..|++++++++|+|++++++++....       +||+++++|
T Consensus         9 g~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L   88 (265)
T cd08217           9 GKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDL   88 (265)
T ss_pred             ccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCH
Confidence            5799999999975 467889999886432  233456778999999999999999998775432       568899999


Q ss_pred             hHHhhcC---CCccCHHHHHHHHHHHHHHHHHHhcCC-CCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          412 EKRLYSH---NYFLDILERLNIMIDVGSTLEYLHHGH-SSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~---~~~~~~~~~~~i~~~ia~~l~~lH~~~-~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+++...   ...+++.+...++.++++|++|+|..+ .+.+|+||||||+||++++++.+|++|||+++.+
T Consensus        89 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          89 AQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             HHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            9988642   456788999999999999999999431 0367999999999999999999999999998865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.69  E-value=1.1e-16  Score=150.08  Aligned_cols=134  Identities=28%  Similarity=0.376  Sum_probs=116.1

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccch-hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhH
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRE-RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEK  413 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~  413 (481)
                      .+.|++|.+|++... +|..+++|.+..... .....+..|+..+.+++|+|++++.+++....     ++|+++++|.+
T Consensus         9 i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   88 (264)
T cd06623           9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLAD   88 (264)
T ss_pred             eeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHH
Confidence            457899999999876 488999998876543 34567888999999999999999999887764     57899999999


Q ss_pred             HhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCC-CCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          414 RLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSS-APIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       414 ~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~-~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ++... ..++...+.+++.++++|++|+|    + .+++|||++|+||+++.++.+||+|||.++.+
T Consensus        89 ~l~~~-~~l~~~~~~~~~~~l~~~l~~lh----~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~  150 (264)
T cd06623          89 LLKKV-GKIPEPVLAYIARQILKGLDYLH----TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVL  150 (264)
T ss_pred             HHHHc-CCCCHHHHHHHHHHHHHHHHHHh----ccCCCccCCCCHHHEEECCCCCEEEccCccceec
Confidence            98754 45788899999999999999999    6 88999999999999999999999999998764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.69  E-value=1e-16  Score=152.09  Aligned_cols=134  Identities=25%  Similarity=0.346  Sum_probs=105.9

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccch-hhhhhhhHHHHH-hhhhccCccceeecccCCCC-----cccccCCChhH
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQRE-RAFRSFNSECEV-LRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEK  413 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~~-~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~  413 (481)
                      +.|+||.||++... +|..||+|.+..... .....+..|+.. ++..+|+|++++++++...+     ++|++ |++.+
T Consensus        10 g~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~   88 (283)
T cd06617          10 GRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDK   88 (283)
T ss_pred             cccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHH
Confidence            68999999999864 689999998865432 222344455554 56678999999999887654     56775 77776


Q ss_pred             Hhhc---CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          414 RLYS---HNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       414 ~l~~---~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+..   ....+++....+++.+|+.|++|||+   ..+++||||||+||++++++.+||+|||+++.+
T Consensus        89 ~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~  154 (283)
T cd06617          89 FYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL  154 (283)
T ss_pred             HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence            6543   33457888999999999999999994   237999999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.69  E-value=1.3e-16  Score=148.23  Aligned_cols=134  Identities=34%  Similarity=0.509  Sum_probs=117.0

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHHh
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRL  415 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~l  415 (481)
                      +.|++|.+|++... ++..+++|.+..........+.+|++.+++++|++++++.+.+....     ++|+++++|.+++
T Consensus         9 ~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~   88 (253)
T cd05122           9 GKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLL   88 (253)
T ss_pred             ccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHH
Confidence            57899999999875 68889999987665545567889999999999999999999886654     5789999999988


Q ss_pred             hcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          416 YSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       416 ~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ......+++.....++.++++|++|+|    ..+++|||++|+||++++++.+||+|||.+...
T Consensus        89 ~~~~~~~~~~~~~~i~~~i~~~l~~lh----~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~  148 (253)
T cd05122          89 KSTNQTLTESQIAYVCKELLKGLEYLH----SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQL  148 (253)
T ss_pred             hhcCCCCCHHHHHHHHHHHHHHHHHhh----cCCEecCCCCHHHEEEccCCeEEEeeccccccc
Confidence            765456789999999999999999999    578999999999999999999999999998765

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.69  E-value=8.9e-17  Score=152.59  Aligned_cols=133  Identities=24%  Similarity=0.452  Sum_probs=111.6

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccch-hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHH
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQRE-RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKR  414 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~  414 (481)
                      +.|++|.+|+|... +|..+++|.+..... .....+..|++++++++|+|++++.+++...+     ++|++ |++.++
T Consensus         9 ~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~   87 (284)
T cd07836           9 GEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD-KDLKKY   87 (284)
T ss_pred             ccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC-ccHHHH
Confidence            57899999999865 588899998875432 23345678999999999999999999987765     56777 588887


Q ss_pred             hhcCC--CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          415 LYSHN--YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       415 l~~~~--~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +....  ..+++.++.+++.++++|++|||    +.+|+|||+||+||++++++.+|++|||+++..
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~  150 (284)
T cd07836          88 MDTHGVRGALDPNTVKSFTYQLLKGIAFCH----ENRVLHRDLKPQNLLINKRGELKLADFGLARAF  150 (284)
T ss_pred             HHhcCCCCCcCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCCHHHEEECCCCcEEEeecchhhhh
Confidence            76533  45789999999999999999999    578999999999999999999999999998753

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.69  E-value=1.7e-17  Score=155.17  Aligned_cols=136  Identities=33%  Similarity=0.446  Sum_probs=113.6

Q ss_pred             hhhccccccceeeeec-cCCcceEEEEEeccchh-hhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          339 TISLAGSFGSVYKGTI-SDGTDVAIKIFNLQRER-AFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       339 ~l~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      .+.+.|.||.||+|.. ..++.||+|.+++.... ..++..+|+.+++.++++||.+++|.+..+.     +|||.+|+.
T Consensus        19 ~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv   98 (467)
T KOG0201|consen   19 ELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSV   98 (467)
T ss_pred             hhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcch
Confidence            5668999999999985 45788999999886543 3567888999999999999999999887664     789999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+.+..... ++..+..-|...+..|+.|+|    ..+.+|||||+.|||+..+|.+|++|||++-.+
T Consensus        99 ~~lL~~~~~-~~E~~i~~ilre~l~~l~ylH----~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql  161 (467)
T KOG0201|consen   99 LDLLKSGNI-LDEFEIAVILREVLKGLDYLH----SEKKIHRDIKAANILLSESGDVKLADFGVAGQL  161 (467)
T ss_pred             hhhhccCCC-CccceeeeehHHHHHHhhhhh----hcceecccccccceeEeccCcEEEEecceeeee
Confidence            998875432 233344457788999999999    577999999999999999999999999998665

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.69  E-value=1.1e-16  Score=151.88  Aligned_cols=133  Identities=27%  Similarity=0.445  Sum_probs=112.3

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccch--hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhH
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQRE--RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEK  413 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~  413 (481)
                      +.|.+|.||+|... +|..+++|++.....  ...+.+..|++.+++++|++++++.+++...+     ++|++ +++.+
T Consensus         8 ~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~   86 (283)
T cd07835           8 GEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKK   86 (283)
T ss_pred             cCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-cCHHH
Confidence            67899999999854 689999998875432  22346778999999999999999999988765     46774 78888


Q ss_pred             HhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          414 RLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       414 ~l~~~~-~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ++.... ..+++..+.+++.++++|++|||    +.+++|||++|+||+++.++.+||+|||+++.+
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH----~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~  149 (283)
T cd07835          87 YMDSSPLTGLDPPLIKSYLYQLLQGIAYCH----SHRVLHRDLKPQNLLIDREGALKLADFGLARAF  149 (283)
T ss_pred             HHhhCCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeCCCCCHHHEEEcCCCcEEEeeccccccc
Confidence            876533 35789999999999999999999    578999999999999999999999999998754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.69  E-value=1.4e-16  Score=148.38  Aligned_cols=134  Identities=33%  Similarity=0.486  Sum_probs=114.8

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccch--hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRE--RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      .+.|++|.+|++... ++..+++|.+.....  .....+..|++++++++|++++++.+++....     ++|+++++|.
T Consensus         8 l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~   87 (254)
T cd06627           8 IGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLR   87 (254)
T ss_pred             EcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHH
Confidence            367999999999754 578899998866543  34567889999999999999999998887654     5688999999


Q ss_pred             HHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          413 KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       413 ~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +++... ..+++..+..++.+++.|++|||    +.+|+||||||+||+++.++.+||+|||+++..
T Consensus        88 ~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~  149 (254)
T cd06627          88 QIIKKF-GPFPESLVAVYVYQVLQGLAYLH----EQGVIHRDIKAANILTTKDGVVKLADFGVATKL  149 (254)
T ss_pred             HHHHhc-cCCCHHHHHHHHHHHHHHHHHHh----hCCcccCCCCHHHEEECCCCCEEEeccccceec
Confidence            987654 46789999999999999999999    678999999999999999999999999998764

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.69  E-value=1.2e-16  Score=152.02  Aligned_cols=134  Identities=26%  Similarity=0.322  Sum_probs=112.0

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccch-hhhhhhhHHHHHhhhhccCccceeecccCCCC-------cccccCCChh
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQRE-RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-------FKFMPNGSLE  412 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-------~~~~~~g~l~  412 (481)
                      +.|.+|.||++... ++..+++|.+..... .....+.+|++++++++|+||++++++|....       ++|+++|+|.
T Consensus        10 g~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~   89 (287)
T cd06621          10 GEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLD   89 (287)
T ss_pred             ccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHH
Confidence            57999999999875 578899998875433 33456888999999999999999999875432       5789999998


Q ss_pred             HHhhc---CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          413 KRLYS---HNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       413 ~~l~~---~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +++..   ....++......++.++++|++|+|    +.+++|+|++|+||++++++.+||+|||++...
T Consensus        90 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH----~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~  155 (287)
T cd06621          90 SIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH----SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL  155 (287)
T ss_pred             HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEEecCCeEEEeeccccccc
Confidence            87643   3345677888999999999999999    678999999999999999999999999998753

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.69  E-value=1.7e-16  Score=149.44  Aligned_cols=137  Identities=26%  Similarity=0.457  Sum_probs=110.8

Q ss_pred             hhccccccceeeeeccC--CcceEEEEEeccc----------hhhhhhhhHHHHHhhh-hccCccceeecccCCCC----
Q 039957          340 ISLAGSFGSVYKGTISD--GTDVAIKIFNLQR----------ERAFRSFNSECEVLRN-VRHQNLIKILSSCSTPD----  402 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~~--g~~vavK~l~~~~----------~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~----  402 (481)
                      ..+.|+||.||++....  +..+++|.+....          ......+..|+.++.+ ++|+|+++++++|...+    
T Consensus         7 ~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~l   86 (269)
T cd08528           7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYI   86 (269)
T ss_pred             hhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEE
Confidence            34789999999998765  5779999875422          1223446678887765 79999999999887765    


Q ss_pred             -cccccCCChhHHhhc---CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          403 -FKFMPNGSLEKRLYS---HNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       403 -~~~~~~g~l~~~l~~---~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                       +||++++++.+++..   ....+++..+.+++.+++.|++|||+   ..+|+||||||+||++++++.+||+|||+++.
T Consensus        87 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~  163 (269)
T cd08528          87 VMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK---EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQ  163 (269)
T ss_pred             EEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc---CCceeecCCCHHHEEECCCCcEEEecccceee
Confidence             678999999987643   34457888899999999999999994   35799999999999999999999999999875


Q ss_pred             C
Q 039957          479 L  479 (481)
Q Consensus       479 ~  479 (481)
                      .
T Consensus       164 ~  164 (269)
T cd08528         164 K  164 (269)
T ss_pred             c
Confidence            4

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.69  E-value=2.6e-17  Score=171.82  Aligned_cols=134  Identities=28%  Similarity=0.444  Sum_probs=110.1

Q ss_pred             ccccccceeeee-ccCCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhH
Q 039957          342 LAGSFGSVYKGT-ISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEK  413 (481)
Q Consensus       342 ~~g~~g~vy~~~-l~~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~  413 (481)
                      +.|.||.||-+. +..|...|+|.+....  .+..+...+|+.++..++|||+|+.+|.-.+.+     +|||.+|+|.+
T Consensus      1244 g~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ 1323 (1509)
T KOG4645|consen 1244 GGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLAS 1323 (1509)
T ss_pred             CCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcHHH
Confidence            568899999887 5568889999876543  345567888999999999999999998866554     78999999999


Q ss_pred             HhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          414 RLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       414 ~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      .+... ...+..-...+..+++.|++|||    ..+||||||||+||++|.+|-+|.+|||.|..+.
T Consensus      1324 ll~~g-ri~dE~vt~vyt~qll~gla~LH----~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1324 LLEHG-RIEDEMVTRVYTKQLLEGLAYLH----EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred             HHHhc-chhhhhHHHHHHHHHHHHHHHHH----hcCceecCCCccceeeecCCcEEeecccceeEec
Confidence            87643 33343333447789999999999    6789999999999999999999999999998653

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.69  E-value=1.6e-16  Score=150.44  Aligned_cols=133  Identities=26%  Similarity=0.310  Sum_probs=105.6

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccchh---hhhhhhHHHH---HhhhhccCccceeecccCCCC-----cccccCC
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQRER---AFRSFNSECE---VLRNVRHQNLIKILSSCSTPD-----FKFMPNG  409 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~---~~~~~~~e~~---~l~~l~h~niv~l~~~~~~~~-----~~~~~~g  409 (481)
                      +.|+||.||++... +|..+|+|.+......   ....+..|..   .+....|++++++.+++...+     +||+++|
T Consensus         3 g~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~   82 (278)
T cd05606           3 GRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGG   82 (278)
T ss_pred             ccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCCC
Confidence            57999999999764 5789999988654211   1112333333   344457999999988877654     5789999


Q ss_pred             ChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          410 SLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       410 ~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +|..++... ..+++.++..++.++++|++|||    +.+|+||||||+||++++++.+|++|||+++.+
T Consensus        83 ~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH----~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~  147 (278)
T cd05606          83 DLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMH----NRFVVYRDLKPANILLDEHGHVRISDLGLACDF  147 (278)
T ss_pred             cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH----HCCEEcCCCCHHHEEECCCCCEEEccCcCcccc
Confidence            999887643 45789999999999999999999    678999999999999999999999999998754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.69  E-value=1.1e-16  Score=150.26  Aligned_cols=136  Identities=27%  Similarity=0.341  Sum_probs=114.7

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhH
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEK  413 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~  413 (481)
                      .+.|++|.||++... ++..+++|.+.... ......+.+|++.+++++|+|++++.+.+....     ++|+++++|.+
T Consensus         9 ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   88 (265)
T cd06605           9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDK   88 (265)
T ss_pred             hcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHH
Confidence            467999999999865 58889999886653 233456788999999999999999998887664     56889999999


Q ss_pred             HhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          414 RLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       414 ~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ++......++.....+++.++++|++|+|.   ..+++||||||+||++++++.+||+|||.+..+
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~  151 (265)
T cd06605          89 ILKEVQGRIPERILGKIAVAVLKGLTYLHE---KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQL  151 (265)
T ss_pred             HHHHccCCCCHHHHHHHHHHHHHHHHHHcC---CCCeecCCCCHHHEEECCCCCEEEeecccchhh
Confidence            887654567778888999999999999993   278999999999999999999999999998653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.69  E-value=1.5e-16  Score=152.42  Aligned_cols=133  Identities=26%  Similarity=0.393  Sum_probs=109.6

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccch--hhhhhhhHHHHHhhhhccCccceeecccCCCC---------------c
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQRE--RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD---------------F  403 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---------------~  403 (481)
                      +.|.+|.||+|... +|..+++|.+.....  .....+.+|++++++++|+|++++.+++.+..               +
T Consensus        16 g~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~   95 (302)
T cd07864          16 GEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVF   95 (302)
T ss_pred             cccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEE
Confidence            67999999999975 578899998865432  22345677999999999999999998876532               3


Q ss_pred             ccccCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          404 KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       404 ~~~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +|+++ ++.+.+......+++.....++.+|+.|++|||    +.+|+|||+||+||++++++.+||+|||+++.+
T Consensus        96 e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~  166 (302)
T cd07864          96 EYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH----KKNFLHRDIKCSNILLNNKGQIKLADFGLARLY  166 (302)
T ss_pred             cccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEECCCCcEEeCcccccccc
Confidence            56664 676666654456789999999999999999999    678999999999999999999999999998764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.69  E-value=1.2e-16  Score=168.86  Aligned_cols=139  Identities=23%  Similarity=0.379  Sum_probs=110.7

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC-------cccccCCC
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-------FKFMPNGS  410 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-------~~~~~~g~  410 (481)
                      .+.|+||.||++... .+..+++|.+....  ......+..|+.++.+++|||||++++++....       ++|+++|+
T Consensus        21 LG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGS  100 (1021)
T PTZ00266         21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGD  100 (1021)
T ss_pred             EecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCc
Confidence            368999999999864 46788999876532  233456888999999999999999999774431       67999999


Q ss_pred             hhHHhhcC---CCccCHHHHHHHHHHHHHHHHHHhcCCC---CCCeeeCCCCCCCeeeCC-----------------CCc
Q 039957          411 LEKRLYSH---NYFLDILERLNIMIDVGSTLEYLHHGHS---SAPIIHCDLKPTSILLDE-----------------NMV  467 (481)
Q Consensus       411 l~~~l~~~---~~~~~~~~~~~i~~~ia~~l~~lH~~~~---~~~i~H~dlk~~nill~~-----------------~~~  467 (481)
                      |.+++...   ...+++...+.|+.+|+.||+|||....   ..+||||||||+|||++.                 ...
T Consensus       101 L~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~i  180 (1021)
T PTZ00266        101 LSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI  180 (1021)
T ss_pred             HHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCc
Confidence            99988642   2457888999999999999999995320   146999999999999964                 345


Q ss_pred             EEEccccCcccC
Q 039957          468 AHVSDFGISKLL  479 (481)
Q Consensus       468 ~kl~Dfgl~~~~  479 (481)
                      +||+|||+++.+
T Consensus       181 VKLsDFGlAr~l  192 (1021)
T PTZ00266        181 AKIGDFGLSKNI  192 (1021)
T ss_pred             eEEccCCccccc
Confidence            999999998764

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.69  E-value=2.8e-17  Score=159.71  Aligned_cols=133  Identities=23%  Similarity=0.406  Sum_probs=109.1

Q ss_pred             ccccccceeeee-ccCCcceEEEEEeccch---hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          342 LAGSFGSVYKGT-ISDGTDVAIKIFNLQRE---RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       342 ~~g~~g~vy~~~-l~~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      +-|.||.|..+. ..+...+|.|.+.+.+.   ........|-++|+....+.||+++-.|.+.+     ++|+|+|++.
T Consensus       638 GvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmM  717 (1034)
T KOG0608|consen  638 GVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMM  717 (1034)
T ss_pred             cccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHH
Confidence            558999998775 33356688888866542   23446778999999999999999998888776     6799999999


Q ss_pred             HHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          413 KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       413 ~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +.+-.-+.+-+-..|..|| .++.|+++.|    ..|.|||||||.|||+|.+|++|+.|||+|.-+
T Consensus       718 SLLIrmgIFeE~LARFYIA-EltcAiesVH----kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGf  779 (1034)
T KOG0608|consen  718 SLLIRMGIFEEDLARFYIA-ELTCAIESVH----KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF  779 (1034)
T ss_pred             HHHHHhccCHHHHHHHHHH-HHHHHHHHHH----hccceecccCccceEEccCCceeeeeccccccc
Confidence            9988766665666777555 7888999999    789999999999999999999999999998644

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.69  E-value=1.4e-16  Score=153.62  Aligned_cols=131  Identities=27%  Similarity=0.281  Sum_probs=106.8

Q ss_pred             ccccceeeeeccCCcceEEEEEecc--chhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHHhh
Q 039957          344 GSFGSVYKGTISDGTDVAIKIFNLQ--RERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRLY  416 (481)
Q Consensus       344 g~~g~vy~~~l~~g~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~l~  416 (481)
                      |+++.+|++.. +|..+|+|.+...  .......+..|++.+++++|+||+++++++...+     ++|+++|++.+++.
T Consensus        13 ~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~   91 (314)
T cd08216          13 LMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK   91 (314)
T ss_pred             CceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence            34444455444 6899999998654  2334567889999999999999999999887654     57899999999887


Q ss_pred             cC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          417 SH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       417 ~~-~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .. ...++......++.++++|++|||    +.+|+||||||+||+++.++.+|++|||.+..+
T Consensus        92 ~~~~~~~~~~~~~~~~~~l~~~L~~LH----~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~  151 (314)
T cd08216          92 THFPEGLPELAIAFILKDVLNALDYIH----SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSM  151 (314)
T ss_pred             HhcccCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCcceEEEecCCceEEecCccceee
Confidence            53 334677888899999999999999    678999999999999999999999999987643

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.68  E-value=1.2e-16  Score=160.32  Aligned_cols=136  Identities=22%  Similarity=0.291  Sum_probs=102.8

Q ss_pred             hhccccccceeeeec-----------------cCCcceEEEEEeccchhhh--------------hhhhHHHHHhhhhcc
Q 039957          340 ISLAGSFGSVYKGTI-----------------SDGTDVAIKIFNLQRERAF--------------RSFNSECEVLRNVRH  388 (481)
Q Consensus       340 l~~~g~~g~vy~~~l-----------------~~g~~vavK~l~~~~~~~~--------------~~~~~e~~~l~~l~h  388 (481)
                      ..++|+||.||+|..                 .++..||||++........              +.+..|+..+.+++|
T Consensus       152 ~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l~~  231 (507)
T PLN03224        152 KLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKIKR  231 (507)
T ss_pred             EeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHhhc
Confidence            347899999999863                 2346799999865432211              223446677777877


Q ss_pred             Ccc-----ceeecccCCC-------------CcccccCCChhHHhhcCC-----------------------CccCHHHH
Q 039957          389 QNL-----IKILSSCSTP-------------DFKFMPNGSLEKRLYSHN-----------------------YFLDILER  427 (481)
Q Consensus       389 ~ni-----v~l~~~~~~~-------------~~~~~~~g~l~~~l~~~~-----------------------~~~~~~~~  427 (481)
                      .++     ++++++|...             .++|+++|+|.++++...                       ...+|..+
T Consensus       232 ~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~  311 (507)
T PLN03224        232 NPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVI  311 (507)
T ss_pred             ccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHH
Confidence            655     5677777532             167999999999886421                       12457778


Q ss_pred             HHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          428 LNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       428 ~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ..++.++++|++|+|    ..+|+||||||+||+++.++.+||+|||+++.+
T Consensus       312 ~~i~~ql~~aL~~lH----~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~  359 (507)
T PLN03224        312 KGVMRQVLTGLRKLH----RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDM  359 (507)
T ss_pred             HHHHHHHHHHHHHHH----HCCeecCCCchHhEEECCCCcEEEEeCcCcccc
Confidence            889999999999999    578999999999999999999999999998653

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.68  E-value=7.9e-18  Score=147.46  Aligned_cols=141  Identities=27%  Similarity=0.385  Sum_probs=101.7

Q ss_pred             Chhhhh--ccccccceeeeec-cCCcceEEEEEeccc-hhhhhhhhHHHHHhhh-hccCccceeecccCCCC-----ccc
Q 039957          336 DLETIS--LAGSFGSVYKGTI-SDGTDVAIKIFNLQR-ERAFRSFNSECEVLRN-VRHQNLIKILSSCSTPD-----FKF  405 (481)
Q Consensus       336 ~L~~l~--~~g~~g~vy~~~l-~~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~-----~~~  405 (481)
                      +|+.|.  +.|+||+|+|-.. +.|+..|||++.... +...+++..|.+...+ -.-||||+++|.+....     +|.
T Consensus        65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL  144 (361)
T KOG1006|consen   65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL  144 (361)
T ss_pred             hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence            455554  7899999999875 468999999987654 3556677788875544 56899999999887654     454


Q ss_pred             ccC--CChhHHhhc-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          406 MPN--GSLEKRLYS-HNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       406 ~~~--g~l~~~l~~-~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      |.-  --++++.+. ....+...-.-+|+...++||.||..   ...|+|||+||+|||+|..|.+|+||||++..+
T Consensus       145 Md~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~---~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqL  218 (361)
T KOG1006|consen  145 MDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE---ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQL  218 (361)
T ss_pred             HhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH---HhhhhhccCChhheEEecCCCEeeecccchHhH
Confidence            421  112333332 11122223334577778899999996   567999999999999999999999999998765

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.68  E-value=1.7e-16  Score=153.13  Aligned_cols=134  Identities=26%  Similarity=0.428  Sum_probs=108.5

Q ss_pred             hccccccceeeeecc---CCcceEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCC--C-----ccccc
Q 039957          341 SLAGSFGSVYKGTIS---DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTP--D-----FKFMP  407 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~---~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~-----~~~~~  407 (481)
                      .+.|++|.||+|...   ++..+|+|.+....   ....+.+.+|++++.+++|+|++++.+++...  .     +||++
T Consensus         8 ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~   87 (316)
T cd07842           8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAE   87 (316)
T ss_pred             eccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCC
Confidence            357899999999864   47889999987633   33345677899999999999999999998876  3     45665


Q ss_pred             CCChhHHhhcC----CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCC----CCcEEEccccCcccC
Q 039957          408 NGSLEKRLYSH----NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDE----NMVAHVSDFGISKLL  479 (481)
Q Consensus       408 ~g~l~~~l~~~----~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~----~~~~kl~Dfgl~~~~  479 (481)
                       +++.+.+...    ...++......++.+++.|++|||    +.+|+||||||+||++++    ++.+||+|||+++.+
T Consensus        88 -~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~  162 (316)
T cd07842          88 -HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH----SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF  162 (316)
T ss_pred             -cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH----hCCEeeCCCCHHHEEEcCCCCccceEEECCCcccccc
Confidence             4666655431    124677788899999999999999    678999999999999999    999999999998864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.68  E-value=2e-16  Score=152.23  Aligned_cols=133  Identities=26%  Similarity=0.390  Sum_probs=109.8

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccchh--hhhhhhHHHHHhhhhccCccceeecccCCCC-------cccccCCCh
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQRER--AFRSFNSECEVLRNVRHQNLIKILSSCSTPD-------FKFMPNGSL  411 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-------~~~~~~g~l  411 (481)
                      +.|+||.||++... +|..||+|.+......  ....+.+|++++.+++|+|++++.+++....       ++|+. +++
T Consensus        16 g~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l   94 (309)
T cd07845          16 GEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE-QDL   94 (309)
T ss_pred             eecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCC-CCH
Confidence            67999999999864 5889999988654322  1234567999999999999999998875442       45665 578


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+++......+++.+...++.++++|++|||    +.+|+||||||+||++++++.+||+|||+++.+
T Consensus        95 ~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~  158 (309)
T cd07845          95 ASLLDNMPTPFSESQVKCLMLQLLRGLQYLH----ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTY  158 (309)
T ss_pred             HHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEECCCCCEEECccceeeec
Confidence            8777654456889999999999999999999    678999999999999999999999999998764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.68  E-value=1.7e-16  Score=148.22  Aligned_cols=135  Identities=26%  Similarity=0.465  Sum_probs=112.8

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccch--hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRE--RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      .+.|++|.||++... +|..+++|.+.....  ...+.+.+|++++++++|+|++++++.+....     +||+++++|.
T Consensus         8 l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   87 (257)
T cd08225           8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLM   87 (257)
T ss_pred             ecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHH
Confidence            357899999999865 578899998865421  23346778999999999999999999887764     6789999999


Q ss_pred             HHhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCC-cEEEccccCcccC
Q 039957          413 KRLYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENM-VAHVSDFGISKLL  479 (481)
Q Consensus       413 ~~l~~~-~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~-~~kl~Dfgl~~~~  479 (481)
                      +++... ...+++..+.+++.++++|++|||    +.+|+|+|+||+||++++++ .+|++|||.+..+
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh----~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (257)
T cd08225          88 KRINRQRGVLFSEDQILSWFVQISLGLKHIH----DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL  152 (257)
T ss_pred             HHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccccCCHHHEEEcCCCCeEEecccccchhc
Confidence            988653 335789999999999999999999    57899999999999999875 5799999998754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.68  E-value=1.5e-16  Score=151.24  Aligned_cols=147  Identities=22%  Similarity=0.340  Sum_probs=120.7

Q ss_pred             cccccCChhhhhccccccceeeee-ccCCcceEEEEEeccch--hhhhhhhHHHHHhhhhccCccceeecccCCCC----
Q 039957          330 TIGALVDLETISLAGSFGSVYKGT-ISDGTDVAIKIFNLQRE--RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----  402 (481)
Q Consensus       330 ~~~~l~~L~~l~~~g~~g~vy~~~-l~~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----  402 (481)
                      -+..+-.|+.--+.|.|.+|-.+. ...|..||||.++....  -...+..+|+..+.-++|||||+++.....+.    
T Consensus        15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyL   94 (864)
T KOG4717|consen   15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYL   94 (864)
T ss_pred             ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEE
Confidence            345677888888999999998876 46899999999987653  23456788999999999999999998876554    


Q ss_pred             -cccccCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCC-CCcEEEccccCcccCC
Q 039957          403 -FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDE-NMVAHVSDFGISKLLG  480 (481)
Q Consensus       403 -~~~~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~-~~~~kl~Dfgl~~~~~  480 (481)
                       .|.-.+|+|++++..+...+......++.+||..|+.|.|..    -+||||+||+||.+-+ -|-+|+.|||++-.+.
T Consensus        95 iLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqL----HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~  170 (864)
T KOG4717|consen   95 ILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQL----HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ  170 (864)
T ss_pred             EEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhh----hhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence             234478999999988776677677788999999999999954    4999999999998866 6999999999986553

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.68  E-value=1.3e-16  Score=155.26  Aligned_cols=133  Identities=28%  Similarity=0.421  Sum_probs=109.0

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccch--hhhhhhhHHHHHhhhhccCccceeecccCCCC---------cccccC
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRE--RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD---------FKFMPN  408 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---------~~~~~~  408 (481)
                      .+.|++|.||++... +|..+++|.+.....  .....+..|+.++.+++|+||+++.+++....         ++|+. 
T Consensus        13 lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-   91 (334)
T cd07855          13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-   91 (334)
T ss_pred             eecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhh-
Confidence            367999999999854 588999998865422  23445677999999999999999988775321         45774 


Q ss_pred             CChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          409 GSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       409 g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      |++.+++... ..+++.....++.+|++||+|||    +.+|+||||||+||++++++.+||+|||+++..
T Consensus        92 ~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~  157 (334)
T cd07855          92 SDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIH----SANVIHRDLKPSNLLVNEDCELRIGDFGMARGL  157 (334)
T ss_pred             hhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence            6888887643 34788999999999999999999    578999999999999999999999999998653

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.67  E-value=2.4e-16  Score=151.63  Aligned_cols=133  Identities=26%  Similarity=0.442  Sum_probs=108.6

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccchh--hhhhhhHHHHHhhhhccCccceeecccCCCC-------------ccc
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQRER--AFRSFNSECEVLRNVRHQNLIKILSSCSTPD-------------FKF  405 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-------------~~~  405 (481)
                      +.|++|.||++... +|..+|+|.+......  ....+.+|++++++++|+|+++++++|....             ++|
T Consensus        21 g~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~  100 (310)
T cd07865          21 GQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEF  100 (310)
T ss_pred             ecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcC
Confidence            67999999999854 6889999988654322  2234567999999999999999998875432             346


Q ss_pred             ccCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          406 MPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       406 ~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +. +++.+.+......+++.+..+++.+|+.|++|||    +.+|+||||||+||++++++.+||+|||+++.+
T Consensus       101 ~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH----~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  169 (310)
T cd07865         101 CE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH----RNKILHRDMKAANILITKDGILKLADFGLARAF  169 (310)
T ss_pred             CC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence            54 5777777655556789999999999999999999    578999999999999999999999999998754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.67  E-value=2.3e-16  Score=149.52  Aligned_cols=133  Identities=31%  Similarity=0.445  Sum_probs=113.4

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhH
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEK  413 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~  413 (481)
                      +.|.+|.+|+|... ++..+++|.+....  ....+.+..|++++++++|+|++++.+++...+     ++|++ +++.+
T Consensus         8 g~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~   86 (282)
T cd07829           8 GEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKK   86 (282)
T ss_pred             cccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHH
Confidence            67899999999865 48899999887653  333456778999999999999999999887764     45776 68999


Q ss_pred             HhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          414 RLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       414 ~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ++......+++..+.+++.++++|++|||    +.+|+||||+|+||++++++.+||+|||.++..
T Consensus        87 ~i~~~~~~~~~~~~~~~~~~i~~~l~~LH----~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~  148 (282)
T cd07829          87 YLDKRPGPLSPNLIKSIMYQLLRGLAYCH----SHRILHRDLKPQNILINRDGVLKLADFGLARAF  148 (282)
T ss_pred             HHHhhccCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCChheEEEcCCCCEEEecCCccccc
Confidence            88765456889999999999999999999    578999999999999999999999999998754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.67  E-value=8.9e-18  Score=146.01  Aligned_cols=136  Identities=23%  Similarity=0.425  Sum_probs=107.4

Q ss_pred             hhccccccceeeeecc-CCcceEEEEEec--cchhhhhhhhHHHHHhhhhccCccceeecccCCCCcc--------cc--
Q 039957          340 ISLAGSFGSVYKGTIS-DGTDVAIKIFNL--QRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPDFK--------FM--  406 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~-~g~~vavK~l~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~--------~~--  406 (481)
                      ..++|.||.|+++... .|+.||+|+.-.  +.++......+|+.++..++|+|++.++..|......        |+  
T Consensus        24 kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf  103 (376)
T KOG0669|consen   24 KIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVF  103 (376)
T ss_pred             hcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeH
Confidence            3578999999999865 477888876433  3344445667899999999999999999988654211        22  


Q ss_pred             --cCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          407 --PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       407 --~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                        -.-+|+..+......++..+.-+++.++..||.|+|    ...|+|||+||+|+|++.++..||+|||+|+.+
T Consensus       104 ~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH----r~kilHRDmKaaNvLIt~dgilklADFGlar~f  174 (376)
T KOG0669|consen  104 DFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH----RNKILHRDMKAANVLITKDGILKLADFGLARAF  174 (376)
T ss_pred             HHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHH----HhhHHhhcccHhhEEEcCCceEEeeccccccce
Confidence              123555555555566778888899999999999999    577999999999999999999999999999865

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.67  E-value=3e-16  Score=146.48  Aligned_cols=135  Identities=31%  Similarity=0.484  Sum_probs=112.3

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      .+.|++|.+|++... ++..+++|.+....  ......+..|+.++++++|+|++++++.+...+     ++|+++++|.
T Consensus         8 lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   87 (256)
T cd08220           8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLA   87 (256)
T ss_pred             ecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHH
Confidence            367999999998754 57889999886542  223456788999999999999999998776554     6789999999


Q ss_pred             HHhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCC-CcEEEccccCcccC
Q 039957          413 KRLYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDEN-MVAHVSDFGISKLL  479 (481)
Q Consensus       413 ~~l~~~-~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~-~~~kl~Dfgl~~~~  479 (481)
                      +++... ...+++..+.+++.++++|++|+|    +.+|+||||||+||+++++ +.+|++|||+++.+
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh----~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (256)
T cd08220          88 EYIQKRCNSLLDEDTILHFFVQILLALHHVH----TKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL  152 (256)
T ss_pred             HHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEEccCCCceec
Confidence            998763 344788899999999999999999    6789999999999999864 57899999998754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.67  E-value=4.4e-16  Score=150.04  Aligned_cols=132  Identities=30%  Similarity=0.383  Sum_probs=110.7

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccch---hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQRE---RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      +.|++|.||+|... +|..+++|.+.....   .....+..|++++++++|+|++++.+++...+     ++|++ |++.
T Consensus        30 g~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~  108 (313)
T cd06633          30 GHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSAS  108 (313)
T ss_pred             ccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-CCHH
Confidence            67999999999864 578899998864322   23356778999999999999999999987765     46775 6777


Q ss_pred             HHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          413 KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       413 ~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      +.+......+++.++..++.+++.|++|||    +.+|+|||+||+||++++++.+||+|||++..
T Consensus       109 ~~l~~~~~~l~~~~~~~~~~qi~~al~~LH----~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~  170 (313)
T cd06633         109 DLLEVHKKPLQEVEIAAITHGALQGLAYLH----SHNMIHRDIKAGNILLTEPGQVKLADFGSASK  170 (313)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCChhhEEECCCCCEEEeecCCCcc
Confidence            777655556889999999999999999999    57899999999999999999999999999764

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.67  E-value=3.3e-16  Score=152.87  Aligned_cols=131  Identities=27%  Similarity=0.379  Sum_probs=107.6

Q ss_pred             ccccccceeeeec-cCCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----------ccccc
Q 039957          342 LAGSFGSVYKGTI-SDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----------FKFMP  407 (481)
Q Consensus       342 ~~g~~g~vy~~~l-~~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----------~~~~~  407 (481)
                      +.|++|.||++.. .+|..||+|.+....  ......+..|++++++++|+||+++.+++....           ++|+ 
T Consensus        24 g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-  102 (343)
T cd07880          24 GSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-  102 (343)
T ss_pred             eecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecC-
Confidence            6899999999974 468999999885432  223345778999999999999999998875432           2355 


Q ss_pred             CCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          408 NGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       408 ~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ++++.+++..  ..+++.....++.++++|++|||    +.+|+||||||+||++++++.+|++|||+++..
T Consensus       103 ~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH----~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~  168 (343)
T cd07880         103 GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIH----AAGIIHRDLKPGNLAVNEDCELKILDFGLARQT  168 (343)
T ss_pred             CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence            6788877654  35788889999999999999999    678999999999999999999999999998754

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.67  E-value=4e-16  Score=145.62  Aligned_cols=135  Identities=30%  Similarity=0.477  Sum_probs=115.2

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccch--hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRE--RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      .+.|++|.+|++... ++..+++|.+.....  .....+..|++++++++|+|++++.+.+....     ++|+++++|.
T Consensus         8 l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~   87 (258)
T cd08215           8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLS   87 (258)
T ss_pred             eccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHH
Confidence            357999999999865 578899998876432  34556788999999999999999998876654     5688999999


Q ss_pred             HHhhcC---CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          413 KRLYSH---NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       413 ~~l~~~---~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +++...   ...+++.+...++.++++|++|||    ..+++|+|++|+||++++++.+||+|||++...
T Consensus        88 ~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh----~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~  153 (258)
T cd08215          88 QKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH----SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVL  153 (258)
T ss_pred             HHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH----hCCEecccCChHHeEEcCCCcEEECCccceeec
Confidence            988764   366889999999999999999999    578999999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.67  E-value=3.8e-16  Score=150.13  Aligned_cols=133  Identities=29%  Similarity=0.397  Sum_probs=110.6

Q ss_pred             ccccccceeeeecc-CCcceEEEEEecc---chhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQ---RERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      +.|++|.||+|... ++..+++|.+...   ......++..|++++++++|+|++++.+++....     ++|+. |++.
T Consensus        24 g~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~  102 (308)
T cd06634          24 GHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSAS  102 (308)
T ss_pred             eeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHH
Confidence            67999999999864 5788999987642   2233456778999999999999999999887664     45775 6887


Q ss_pred             HHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          413 KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       413 ~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +.+......+++.++..++.+++.|++|||    +.+++||||||+||+++.++.+|++|||+++.+
T Consensus       103 ~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH----~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  165 (308)
T cd06634         103 DLLEVHKKPLQEVEIAAVTHGALQGLAYLH----SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM  165 (308)
T ss_pred             HHHHHcCCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHhEEECCCCcEEECCcccceee
Confidence            776555556788899999999999999999    578999999999999999999999999998754

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.67  E-value=2.9e-16  Score=152.35  Aligned_cols=130  Identities=24%  Similarity=0.299  Sum_probs=108.9

Q ss_pred             cccccceeeeec-cCCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHH
Q 039957          343 AGSFGSVYKGTI-SDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKR  414 (481)
Q Consensus       343 ~g~~g~vy~~~l-~~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~  414 (481)
                      .|+|+.||.+.. .+|..||+|......  ....+.+.+|+.+++.++|+||++++++|...+     ++|+++|++.++
T Consensus        10 ~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~   89 (328)
T cd08226          10 FCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSL   89 (328)
T ss_pred             ccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHH
Confidence            458889999985 478999999986543  223456788899999999999999999987765     568899999998


Q ss_pred             hhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCc
Q 039957          415 LYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGIS  476 (481)
Q Consensus       415 l~~~-~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~  476 (481)
                      +... ....++.....++.+++.||+|||    +.+|+||||||+||+++.++.+|++|||.+
T Consensus        90 l~~~~~~~~~~~~~~~~~~qi~~aL~~lH----~~~ivHrDlkp~Nill~~~~~~~~~~~~~~  148 (328)
T cd08226          90 LKTYFPEGMSEALIGNILFGALRGLNYLH----QNGYIHRNIKASHILISGDGLVSLSGLSHL  148 (328)
T ss_pred             HHhhcccCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEeCCCcEEEechHHH
Confidence            7653 234677888899999999999999    678999999999999999999999999753

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.67  E-value=3.6e-16  Score=146.87  Aligned_cols=134  Identities=30%  Similarity=0.425  Sum_probs=113.6

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHH
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKR  414 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~  414 (481)
                      +.|++|.+|+|... ++..+++|.+.... ......+..|++.++.++|+|++++.+.+...+     ++|++++++.++
T Consensus        10 g~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~   89 (267)
T cd06610          10 GVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDI   89 (267)
T ss_pred             cCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHH
Confidence            57999999999854 57889999886543 224567888999999999999999998877654     568899999999


Q ss_pred             hhcC--CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          415 LYSH--NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       415 l~~~--~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +...  ...+++.....++.+++.|++|||    +.+|+|||+||+||++++++.+|++|||+++.+
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~ql~~al~~lh----~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~  152 (267)
T cd06610          90 MKSSYPRGGLDEAIIATVLKEVLKGLEYLH----SNGQIHRDIKAGNILLGEDGSVKIADFGVSASL  152 (267)
T ss_pred             HHHhcccCCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHhEEEcCCCCEEEcccchHHHh
Confidence            8653  235788888999999999999999    678999999999999999999999999998654

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.67  E-value=3.2e-16  Score=146.30  Aligned_cols=134  Identities=29%  Similarity=0.436  Sum_probs=115.9

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccch--hhhhhhhHHHHHhhhhccCccceeecccCCC--C-----cccccCCC
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRE--RAFRSFNSECEVLRNVRHQNLIKILSSCSTP--D-----FKFMPNGS  410 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~-----~~~~~~g~  410 (481)
                      .+.|++|.+|+|... ++..+++|.+.....  ...+.+..|++.+++++|+|++++++.+...  .     ++|+++++
T Consensus         8 i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~   87 (260)
T cd06606           8 LGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGS   87 (260)
T ss_pred             eeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCc
Confidence            357899999999876 688999998876542  3456788899999999999999999988766  3     56888999


Q ss_pred             hhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          411 LEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       411 l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      |.+++.... .+++..+..++.++++|++|||    +.+++|+|++|+||+++.++.+||+|||.+...
T Consensus        88 L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh----~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~  151 (260)
T cd06606          88 LSSLLKKFG-KLPEPVIRKYTRQILEGLAYLH----SNGIVHRDIKGANILVDSDGVVKLADFGCAKRL  151 (260)
T ss_pred             HHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEEcCCCCEEEcccccEEec
Confidence            999887644 7789999999999999999999    578999999999999999999999999998764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.67  E-value=4.8e-17  Score=152.49  Aligned_cols=136  Identities=26%  Similarity=0.340  Sum_probs=112.4

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccchh---hhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRER---AFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      .+.|+||.||..... +|+.+|.|.++...-+   .......|-.++.+++.+.||.+-..+.+.+     +..|.+|+|
T Consensus       193 lGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDL  272 (591)
T KOG0986|consen  193 LGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDL  272 (591)
T ss_pred             EecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCce
Confidence            478999999988754 5899999988655422   2234567889999999999999877776665     447999999


Q ss_pred             hHHhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          412 EKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       412 ~~~l~~~~-~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      .=+++..+ ...+..+..-+|.+|+.||++||    ...||.||+||+|||+|+.|+++|||.|+|.-+.
T Consensus       273 kfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH----~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~  338 (591)
T KOG0986|consen  273 KFHIYNHGNPGFDEQRARFYAAEIICGLEHLH----RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP  338 (591)
T ss_pred             eEEeeccCCCCCchHHHHHHHHHHHhhHHHHH----hcceeeccCChhheeeccCCCeEeeccceEEecC
Confidence            98887744 34677788889999999999999    6789999999999999999999999999997654

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.67  E-value=3e-16  Score=148.78  Aligned_cols=132  Identities=23%  Similarity=0.324  Sum_probs=107.8

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccch-hhhhhhhHHHHHhhhhc-cCccceeecccCCC--C-----cccccCCCh
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQRE-RAFRSFNSECEVLRNVR-HQNLIKILSSCSTP--D-----FKFMPNGSL  411 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~-----~~~~~~g~l  411 (481)
                      +.|++|.||++... ++..+|+|.+..... ........|+..+.++. |+|++++++++...  +     ++|++ |++
T Consensus         8 g~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l   86 (282)
T cd07831           8 GEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD-MNL   86 (282)
T ss_pred             cccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC-ccH
Confidence            67999999999854 688899998765321 12223346888888885 99999999988766  3     45775 688


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+.+......++|.++..++.+++.||+|||    +.+|+||||||+||+++. +.+||+|||+++.+
T Consensus        87 ~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH----~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~  149 (282)
T cd07831          87 YELIKGRKRPLPEKRVKSYMYQLLKSLDHMH----RNGIFHRDIKPENILIKD-DILKLADFGSCRGI  149 (282)
T ss_pred             HHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----HCCceecccCHHHEEEcC-CCeEEEeccccccc
Confidence            8877665556889999999999999999999    578999999999999999 99999999998764

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.67  E-value=1.9e-16  Score=150.57  Aligned_cols=134  Identities=29%  Similarity=0.388  Sum_probs=111.2

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      .+.|++|.+|++... ++..+++|.+....  ......+.+|++++++++|+|++++++++...+     ++|++++.+.
T Consensus         9 i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~   88 (288)
T cd07833           9 VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLE   88 (288)
T ss_pred             ecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHH
Confidence            367999999999865 57889999876532  223456788999999999999999999987665     5688877666


Q ss_pred             HHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          413 KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       413 ~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .... ....+++.+...++.+|++|++|||    ..+|+|||++|+||++++++.+||+|||+++.+
T Consensus        89 ~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH----~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~  150 (288)
T cd07833          89 LLEA-SPGGLPPDAVRSYIWQLLQAIAYCH----SHNIIHRDIKPENILVSESGVLKLCDFGFARAL  150 (288)
T ss_pred             HHHh-cCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEECCCCCEEEEeeeccccc
Confidence            5543 3345788899999999999999999    578999999999999999999999999998764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.66  E-value=3.5e-16  Score=153.39  Aligned_cols=130  Identities=25%  Similarity=0.365  Sum_probs=106.3

Q ss_pred             ccccccceeeeec-cCCcceEEEEEecc--chhhhhhhhHHHHHhhhhccCccceeecccCCCC-----------ccccc
Q 039957          342 LAGSFGSVYKGTI-SDGTDVAIKIFNLQ--RERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----------FKFMP  407 (481)
Q Consensus       342 ~~g~~g~vy~~~l-~~g~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----------~~~~~  407 (481)
                      +.|+||.||++.. .+|..+|+|.+...  .......+.+|+.++.+++|+|++++++++....           ++|+.
T Consensus        25 g~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~  104 (353)
T cd07850          25 GSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD  104 (353)
T ss_pred             ccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccC
Confidence            6899999999985 46889999987543  2233345677999999999999999998775331           45664


Q ss_pred             CCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          408 NGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       408 ~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                       +++.+.+...   ++..+...++.++++||+|||    +.+|+||||||+||++++++.+||+|||+++..
T Consensus       105 -~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH----~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  168 (353)
T cd07850         105 -ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  168 (353)
T ss_pred             -CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence             5777776532   677888899999999999999    578999999999999999999999999999764

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.66  E-value=3.4e-16  Score=152.34  Aligned_cols=137  Identities=21%  Similarity=0.339  Sum_probs=111.5

Q ss_pred             hhhhhccccccceeeeecc-CCcceEEEEEeccchhh--------------hhhhhHHHHHhhhhccCccceeecccCCC
Q 039957          337 LETISLAGSFGSVYKGTIS-DGTDVAIKIFNLQRERA--------------FRSFNSECEVLRNVRHQNLIKILSSCSTP  401 (481)
Q Consensus       337 L~~l~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~~--------------~~~~~~e~~~l~~l~h~niv~l~~~~~~~  401 (481)
                      +....+.|+||.||++... +|..+|+|.+.......              ...+.+|++++++++|+|++++++++...
T Consensus        13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   92 (335)
T PTZ00024         13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG   92 (335)
T ss_pred             hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence            3444578999999999854 68899999875432211              12466899999999999999999988766


Q ss_pred             C-----cccccCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCc
Q 039957          402 D-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGIS  476 (481)
Q Consensus       402 ~-----~~~~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~  476 (481)
                      +     +||++ |++.+++.. ...+++.....++.++++|++|||    +.+|+||||||+||+++.++.+|++|||++
T Consensus        93 ~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH----~~~i~H~dl~~~nill~~~~~~kl~dfg~~  166 (335)
T PTZ00024         93 DFINLVMDIMA-SDLKKVVDR-KIRLTESQVKCILLQILNGLNVLH----KWYFMHRDLSPANIFINSKGICKIADFGLA  166 (335)
T ss_pred             CcEEEEEeccc-cCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH----hCCeecccccHHHeEECCCCCEEECCccce
Confidence            5     45775 788888754 335778888999999999999999    678999999999999999999999999998


Q ss_pred             ccC
Q 039957          477 KLL  479 (481)
Q Consensus       477 ~~~  479 (481)
                      +..
T Consensus       167 ~~~  169 (335)
T PTZ00024        167 RRY  169 (335)
T ss_pred             eec
Confidence            754

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.66  E-value=4e-16  Score=147.99  Aligned_cols=135  Identities=27%  Similarity=0.401  Sum_probs=110.3

Q ss_pred             hhccccccceeeeec-cCCcceEEEEEeccchhhhhhhhHHHHHhhhh-ccCccceeecccCCC------C-----cccc
Q 039957          340 ISLAGSFGSVYKGTI-SDGTDVAIKIFNLQRERAFRSFNSECEVLRNV-RHQNLIKILSSCSTP------D-----FKFM  406 (481)
Q Consensus       340 l~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~------~-----~~~~  406 (481)
                      .-+.|+||.||+|.. .++..+++|....... ....+..|+.++.++ +|+|++++.+++...      +     +||+
T Consensus        23 ~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~  101 (282)
T cd06636          23 VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFC  101 (282)
T ss_pred             eeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeC
Confidence            347899999999986 4578899998765432 234577788888888 699999999987531      1     5789


Q ss_pred             cCCChhHHhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          407 PNGSLEKRLYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       407 ~~g~l~~~l~~~-~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ++|++.+++... ...+++.....++.++++|++|||    +.+|+|||+||+||++++++.+||+|||+++..
T Consensus       102 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH----~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~  171 (282)
T cd06636         102 GAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH----AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  171 (282)
T ss_pred             CCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEEeeCcchhhh
Confidence            999999987652 334677778889999999999999    678999999999999999999999999998643

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.66  E-value=4.1e-16  Score=152.36  Aligned_cols=132  Identities=24%  Similarity=0.364  Sum_probs=106.9

Q ss_pred             ccccccceeeeec-cCCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC----------cccccC
Q 039957          342 LAGSFGSVYKGTI-SDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----------FKFMPN  408 (481)
Q Consensus       342 ~~g~~g~vy~~~l-~~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----------~~~~~~  408 (481)
                      ++|+||.||++.. .+|..||+|.+....  ....+.+.+|+.++.+++|+||+++.+++....          .++..+
T Consensus        26 g~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~~  105 (345)
T cd07877          26 GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG  105 (345)
T ss_pred             eecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhcc
Confidence            6899999999974 468899999886532  222345778999999999999999998775321          112347


Q ss_pred             CChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          409 GSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       409 g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +++.+++...  .+++..+..++.++++|++|||    +.+|+||||||+||++++++.+||+|||+++..
T Consensus       106 ~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~  170 (345)
T cd07877         106 ADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHT  170 (345)
T ss_pred             cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCChHHEEEcCCCCEEEecccccccc
Confidence            8888776543  4788899999999999999999    678999999999999999999999999998754

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.66  E-value=3.5e-16  Score=148.03  Aligned_cols=134  Identities=34%  Similarity=0.485  Sum_probs=114.2

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc---hhhhhhhhHHHHHhhhhc-cCccceeecccCCCC-----cccccCCC
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVR-HQNLIKILSSCSTPD-----FKFMPNGS  410 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-----~~~~~~g~  410 (481)
                      .+.|++|.||++... +|..+++|.+....   ....+.+..|.+++.+++ |+|++++++.+...+     ++|+++++
T Consensus         9 lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   88 (280)
T cd05581           9 IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGE   88 (280)
T ss_pred             ecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCc
Confidence            368999999999865 68899999886532   223356778899999998 999999999887664     56889999


Q ss_pred             hhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          411 LEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       411 l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      |.+++... ..+++.....++.+++.|++|||    +.+++|+|+||+||++++++.++++|||++...
T Consensus        89 L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh----~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~  152 (280)
T cd05581          89 LLQYIRKY-GSLDEKCTRFYAAEILLALEYLH----SKGIIHRDLKPENILLDKDMHIKITDFGTAKVL  152 (280)
T ss_pred             HHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCHHHeEECCCCCEEecCCcccccc
Confidence            99988754 36889999999999999999999    578999999999999999999999999998764

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.66  E-value=3.5e-16  Score=152.31  Aligned_cols=132  Identities=29%  Similarity=0.442  Sum_probs=106.8

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC----------cccccC
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----------FKFMPN  408 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----------~~~~~~  408 (481)
                      -+.|++|.||+|.. .+|..||+|.+.... ......+..|++++.+++|+|++++.+++....          ++|++ 
T Consensus        13 lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-   91 (336)
T cd07849          13 IGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELME-   91 (336)
T ss_pred             EEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhcc-
Confidence            36799999999974 468899999886422 223345678999999999999999998765432          34554 


Q ss_pred             CChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          409 GSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       409 g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +++.+.+..  ..+++.....++.++++|++|||    +.+|+||||||+||+++.++.+||+|||+++..
T Consensus        92 ~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH----~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~  156 (336)
T cd07849          92 TDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIH----SANVLHRDLKPSNLLLNTNCDLKICDFGLARIA  156 (336)
T ss_pred             cCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHEEECCCCCEEECcccceeec
Confidence            577776643  34778888999999999999999    678999999999999999999999999998754

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.66  E-value=3.9e-16  Score=149.07  Aligned_cols=134  Identities=22%  Similarity=0.345  Sum_probs=108.1

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccch--hhhhhhhHHHHHhhhhc-cCccceeecccCCCC----------cccc
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRE--RAFRSFNSECEVLRNVR-HQNLIKILSSCSTPD----------FKFM  406 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~----------~~~~  406 (481)
                      .+.|+||.||++... +|..|++|.......  .....+.+|++++++++ |+|++++++++...+          ++|+
T Consensus         9 lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~   88 (295)
T cd07837           9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYL   88 (295)
T ss_pred             ecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeecc
Confidence            367999999999864 688999998765432  22346778999999995 699999998775432          4577


Q ss_pred             cCCChhHHhhcC----CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCC-CCcEEEccccCcccC
Q 039957          407 PNGSLEKRLYSH----NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDE-NMVAHVSDFGISKLL  479 (481)
Q Consensus       407 ~~g~l~~~l~~~----~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~-~~~~kl~Dfgl~~~~  479 (481)
                      + +++.+++...    ...+++.....++.+|++||+|||    +.+|+||||||+||+++. ++.+||+|||+++.+
T Consensus        89 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH----~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~  161 (295)
T cd07837          89 D-SDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH----KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF  161 (295)
T ss_pred             C-cCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCChHHEEEecCCCeEEEeecccceec
Confidence            7 4788877542    235788999999999999999999    678999999999999999 899999999998753

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.66  E-value=4.6e-16  Score=145.69  Aligned_cols=133  Identities=24%  Similarity=0.325  Sum_probs=106.1

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccch---hhhhhhhHHHHH-hhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQRE---RAFRSFNSECEV-LRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~~---~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      +.|++|.||+|... +|..+|+|.+.....   .....+..|... ....+|+|++++++++...+     +||+++|+|
T Consensus         5 ~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   84 (260)
T cd05611           5 SKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDC   84 (260)
T ss_pred             CcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCH
Confidence            56899999999864 578999998864321   112233444443 34568999999999987654     578999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+++... ..++.....+++.+++.||+|+|    +.+|+||||+|+||++++++.+||+|||+++..
T Consensus        85 ~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH----~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  147 (260)
T cd05611          85 ASLIKTL-GGLPEDWAKQYIAEVVLGVEDLH----QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG  147 (260)
T ss_pred             HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEECCCCcEEEeecccceec
Confidence            9988643 34677888899999999999999    678999999999999999999999999998753

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.66  E-value=3.3e-16  Score=152.13  Aligned_cols=133  Identities=30%  Similarity=0.418  Sum_probs=111.3

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC----------ccccc
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----------FKFMP  407 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----------~~~~~  407 (481)
                      .+.|++|.||++... .|..+++|.+....  ....+.+..|+..++.++|+|++++.+++...+          ++|++
T Consensus         8 ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~   87 (330)
T cd07834           8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME   87 (330)
T ss_pred             ecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchh
Confidence            467999999999865 48899999886543  334457888999999999999999999887653          34565


Q ss_pred             CCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          408 NGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       408 ~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                       +++.+++.... .+++..+..++.++++|++|||    +.+|+||||||+||++++++.+||+|||+++..
T Consensus        88 -~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH----~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          88 -TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLH----SANVIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             -hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence             57888776543 6788999999999999999999    678999999999999999999999999998764

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.66  E-value=3.9e-16  Score=148.00  Aligned_cols=133  Identities=29%  Similarity=0.427  Sum_probs=112.0

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccch--hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhH
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQRE--RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEK  413 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~  413 (481)
                      +.|++|.+|++... +|..+++|.+.....  .....+..|++++++++|++++++.+++...+     ++|++ +++.+
T Consensus         8 ~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~   86 (283)
T cd05118           8 GEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD-TDLYK   86 (283)
T ss_pred             ecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC-CCHHH
Confidence            56899999999865 578899998865432  23456778999999999999999999887765     56776 58888


Q ss_pred             HhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          414 RLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       414 ~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+......+++..+..++.++++|++|||    +.+|+|+||||+||++++++.+||+|||.+..+
T Consensus        87 ~l~~~~~~~~~~~~~~~~~~i~~~l~~LH----~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~  148 (283)
T cd05118          87 LIKDRQRGLPESLIKSYLYQLLQGLAFCH----SHGILHRDLKPENLLINTEGVLKLADFGLARSF  148 (283)
T ss_pred             HHHhhcccCCHHHHHHHHHHHHHHHHHHH----HCCeeecCcCHHHEEECCCCcEEEeeeeeeEec
Confidence            77665557889999999999999999999    678999999999999999999999999998654

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.66  E-value=4.5e-16  Score=148.74  Aligned_cols=134  Identities=25%  Similarity=0.318  Sum_probs=106.3

Q ss_pred             ccccccceeeeeccC-CcceEEEEEeccch-hhhhhhhHHHHHhhhhc-cCccceeecccCCCC-----cccccCCChhH
Q 039957          342 LAGSFGSVYKGTISD-GTDVAIKIFNLQRE-RAFRSFNSECEVLRNVR-HQNLIKILSSCSTPD-----FKFMPNGSLEK  413 (481)
Q Consensus       342 ~~g~~g~vy~~~l~~-g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-----~~~~~~g~l~~  413 (481)
                      +.|++|.||++...+ |..+|+|.+..... .....+..|+..+.+.. |+|+++++++|....     ++|++ +.+.+
T Consensus        24 g~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~  102 (296)
T cd06618          24 GSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS-TCLDK  102 (296)
T ss_pred             eccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC-cCHHH
Confidence            679999999999764 88999999865432 22344556777666665 999999999987765     45654 46666


Q ss_pred             HhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          414 RLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       414 ~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ........+++..+.+|+.++++|++|||.   ..+|+||||+|+||++++++.+||+|||+++.+
T Consensus       103 l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~  165 (296)
T cd06618         103 LLKRIQGPIPEDILGKMTVAIVKALHYLKE---KHGVIHRDVKPSNILLDASGNVKLCDFGISGRL  165 (296)
T ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---hCCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence            554434568889999999999999999994   358999999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.66  E-value=2.6e-16  Score=147.06  Aligned_cols=138  Identities=28%  Similarity=0.482  Sum_probs=111.7

Q ss_pred             hccccccceeeee-ccCCcceEEEEEeccc-------hhhhhhhhHHHHHhhhhccCccceeecccCCCC------cccc
Q 039957          341 SLAGSFGSVYKGT-ISDGTDVAIKIFNLQR-------ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD------FKFM  406 (481)
Q Consensus       341 ~~~g~~g~vy~~~-l~~g~~vavK~l~~~~-------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~~  406 (481)
                      -+.|+|..||++. +...+-||||+-....       ....+...+|-++...+.|+.||++++|+.-..      .||+
T Consensus       471 LGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYc  550 (775)
T KOG1151|consen  471 LGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYC  550 (775)
T ss_pred             hccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeec
Confidence            4789999999997 4456778999764422       112345677888999999999999999986542      6899


Q ss_pred             cCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeC---CCCcEEEccccCcccCCC
Q 039957          407 PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLD---ENMVAHVSDFGISKLLGE  481 (481)
Q Consensus       407 ~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~---~~~~~kl~Dfgl~~~~~~  481 (481)
                      ++.+|.-++..+.. .+..++..|+.+|+.||.||...  .+||+|=|+||.|||+-   ..|++||.|||++|++++
T Consensus       551 eGNDLDFYLKQhkl-mSEKEARSIiMQiVnAL~YLNEi--kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdd  625 (775)
T KOG1151|consen  551 EGNDLDFYLKQHKL-MSEKEARSIIMQIVNALKYLNEI--KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDD  625 (775)
T ss_pred             CCCchhHHHHhhhh-hhHHHHHHHHHHHHHHHHHHhcc--CCCeeeeccCCccEEEecCcccceeEeeecchhhhccC
Confidence            99999988876543 34567788999999999999964  58999999999999983   369999999999999863

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.65  E-value=1.3e-16  Score=162.95  Aligned_cols=135  Identities=23%  Similarity=0.297  Sum_probs=96.9

Q ss_pred             hccccccceeeeeccC--CcceEEEEEe--------------c---cchhhhhhhhHHHHHhhhhccCccceeecccCCC
Q 039957          341 SLAGSFGSVYKGTISD--GTDVAIKIFN--------------L---QRERAFRSFNSECEVLRNVRHQNLIKILSSCSTP  401 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~--g~~vavK~l~--------------~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  401 (481)
                      .+.|+||.||++....  +...+.|...              .   ........+.+|+.++++++|+|||++++++...
T Consensus       156 LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  235 (501)
T PHA03210        156 LPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSE  235 (501)
T ss_pred             ecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcEeEEEEEC
Confidence            3789999999876432  2212211100              0   0112234577899999999999999999998777


Q ss_pred             Ccccc----cCCChhHHhhcCC----CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 039957          402 DFKFM----PNGSLEKRLYSHN----YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDF  473 (481)
Q Consensus       402 ~~~~~----~~g~l~~~l~~~~----~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Df  473 (481)
                      +..|+    ..+++.+++....    ......+..+|+.+++.||+|||    +.+||||||||+|||++.++.+||+||
T Consensus       236 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH----~~gIiHrDLKP~NILl~~~~~vkL~DF  311 (501)
T PHA03210        236 ANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH----DKKLIHRDIKLENIFLNCDGKIVLGDF  311 (501)
T ss_pred             CeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEECCCCCEEEEeC
Confidence            64443    2456666654321    11223456689999999999999    678999999999999999999999999


Q ss_pred             cCcccC
Q 039957          474 GISKLL  479 (481)
Q Consensus       474 gl~~~~  479 (481)
                      |+|+.+
T Consensus       312 Gla~~~  317 (501)
T PHA03210        312 GTAMPF  317 (501)
T ss_pred             CCceec
Confidence            999764

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.65  E-value=6.4e-16  Score=147.51  Aligned_cols=133  Identities=23%  Similarity=0.440  Sum_probs=107.2

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccch--hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhH
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQRE--RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEK  413 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~  413 (481)
                      +.|.+|.||+|... +|..+++|.+.....  ...+.+..|++++++++|+|++++++++...+     ++|++ +++.+
T Consensus        11 ~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~   89 (294)
T PLN00009         11 GEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKK   89 (294)
T ss_pred             cCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-ccHHH
Confidence            56899999999865 688899998765432  22346778999999999999999999987765     56775 57877


Q ss_pred             HhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCC-CCcEEEccccCcccC
Q 039957          414 RLYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDE-NMVAHVSDFGISKLL  479 (481)
Q Consensus       414 ~l~~~-~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~-~~~~kl~Dfgl~~~~  479 (481)
                      ++... ....++.....++.+|+.|++|||    +.+|+||||||+||++++ ++.+||+|||+++..
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH----~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~  153 (294)
T PLN00009         90 HMDSSPDFAKNPRLIKTYLYQILRGIAYCH----SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF  153 (294)
T ss_pred             HHHhCCCCCcCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCCcceEEEECCCCEEEEccccccccc
Confidence            76542 233566777789999999999999    578999999999999985 568999999998753

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.65  E-value=4.7e-16  Score=147.53  Aligned_cols=134  Identities=26%  Similarity=0.378  Sum_probs=111.1

Q ss_pred             hccccccceeeeeccC-CcceEEEEEeccchh-hhhhhhHHHHHhhhhc-cCccceeecccCCCC-----cccccCCChh
Q 039957          341 SLAGSFGSVYKGTISD-GTDVAIKIFNLQRER-AFRSFNSECEVLRNVR-HQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~-g~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      .+.|++|.||+|...+ +..+++|.+...... ......+|+..+++++ |+|++++++++...+     ++|+ +|++.
T Consensus         7 ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~   85 (283)
T cd07830           7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLY   85 (283)
T ss_pred             eccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHH
Confidence            3679999999999764 778999987654321 1223456888999999 999999999987765     5677 88999


Q ss_pred             HHhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          413 KRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       413 ~~l~~~~-~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +.+.... ..+++.++..++.++++|++|||    +.+|+|+||||+||++++++.+||+|||+++..
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh----~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~  149 (283)
T cd07830          86 QLMKDRKGKPFSESVIRSIIYQILQGLAHIH----KHGFFHRDLKPENLLVSGPEVVKIADFGLAREI  149 (283)
T ss_pred             HHHHhcccccCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCChhhEEEcCCCCEEEeecccceec
Confidence            8877543 46789999999999999999999    578999999999999999999999999998754

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.65  E-value=4.4e-16  Score=148.17  Aligned_cols=134  Identities=25%  Similarity=0.344  Sum_probs=110.3

Q ss_pred             hccccccceeeeec----cCCcceEEEEEeccc----hhhhhhhhHHHHHhhhh-ccCccceeecccCCCC-----cccc
Q 039957          341 SLAGSFGSVYKGTI----SDGTDVAIKIFNLQR----ERAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD-----FKFM  406 (481)
Q Consensus       341 ~~~g~~g~vy~~~l----~~g~~vavK~l~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----~~~~  406 (481)
                      .+.|++|.||++..    .++..+|+|.+....    ....+.+..|++++.++ +|++++++.+.+....     ++|+
T Consensus         8 ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   87 (288)
T cd05583           8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYV   87 (288)
T ss_pred             eccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecC
Confidence            46899999999874    256789999886432    22335677899999999 5999999988776554     6789


Q ss_pred             cCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          407 PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       407 ~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ++|+|.+++... ..+++.....++.++++|++|||    +.+++|||+||+||++++++.+|++|||+++.+
T Consensus        88 ~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH----~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~  155 (288)
T cd05583          88 NGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLH----QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (288)
T ss_pred             CCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence            999999987643 34677888889999999999999    678999999999999999999999999998764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.65  E-value=6.4e-16  Score=145.79  Aligned_cols=134  Identities=28%  Similarity=0.401  Sum_probs=111.8

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccchhhhhhhhHHHHHhhhh-ccCccceeecccCCCC-----------ccccc
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD-----------FKFMP  407 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----------~~~~~  407 (481)
                      -+.|++|.+|+|... ++..+++|.+..... ..+.+..|+.+++++ .|+|++++++++....           ++|++
T Consensus        14 l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~   92 (275)
T cd06608          14 IGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCG   92 (275)
T ss_pred             ecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCC
Confidence            357899999999865 577899998865433 335688899999998 6999999999885422           57899


Q ss_pred             CCChhHHhhcC---CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          408 NGSLEKRLYSH---NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       408 ~g~l~~~l~~~---~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +++|.+++...   ...+++..+..++.++++|++|||    +.+|+|+||+|+||++++++.+|++|||++...
T Consensus        93 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH----~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~  163 (275)
T cd06608          93 GGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH----ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL  163 (275)
T ss_pred             CCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh----cCCcccCCCCHHHEEEccCCeEEECCCccceec
Confidence            99999887542   346788899999999999999999    678999999999999999999999999998653

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.65  E-value=4.7e-16  Score=143.53  Aligned_cols=126  Identities=16%  Similarity=0.146  Sum_probs=103.4

Q ss_pred             ccccceeeeecc-CCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHHhhc
Q 039957          344 GSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRLYS  417 (481)
Q Consensus       344 g~~g~vy~~~l~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~l~~  417 (481)
                      |.++.||++... +|..+++|.+....     .+..|...+....|+|++++.+++...+     +||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            788999998754 67889999886542     2233444455567999999999887664     678999999998865


Q ss_pred             CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          418 HNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       418 ~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      . ..+++.....++.++++|++|+|    ..+|+||||||+||++++++.+|++|||.++..
T Consensus        79 ~-~~l~~~~~~~~~~ql~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~  135 (237)
T cd05576          79 F-LNIPEECVKRWAAEMVVALDALH----REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEV  135 (237)
T ss_pred             h-cCCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHEEEcCCCCEEEecccchhcc
Confidence            3 34788899999999999999999    678999999999999999999999999987543

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.65  E-value=6.6e-16  Score=143.61  Aligned_cols=133  Identities=29%  Similarity=0.407  Sum_probs=112.9

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccch---hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQRE---RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      +.|++|.+|++... ++..+++|.+.....   .....+..|++++++++|+|++++++.+....     ++|+++++|.
T Consensus         2 g~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~   81 (250)
T cd05123           2 GKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELF   81 (250)
T ss_pred             CCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHH
Confidence            56899999999865 488899998865432   23446788999999999999999998887665     5688899999


Q ss_pred             HHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          413 KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       413 ~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +++.... .+++.....++.++++|+.|+|    ..+++|+||||+||+++.+++++++|||++...
T Consensus        82 ~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh----~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~  143 (250)
T cd05123          82 SHLSKEG-RFSEERARFYAAEIVLALEYLH----SLGIIYRDLKPENILLDADGHIKLTDFGLAKEL  143 (250)
T ss_pred             HHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCceecCCCcceEEEcCCCcEEEeecCcceec
Confidence            9886543 4788899999999999999999    578999999999999999999999999998754

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.65  E-value=6.5e-16  Score=150.48  Aligned_cols=132  Identities=27%  Similarity=0.393  Sum_probs=108.0

Q ss_pred             ccccccceeeeec-cCCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC----------cccccC
Q 039957          342 LAGSFGSVYKGTI-SDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----------FKFMPN  408 (481)
Q Consensus       342 ~~g~~g~vy~~~l-~~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----------~~~~~~  408 (481)
                      +.|+||.||++.. .+|..|++|.+....  ......+..|+.++++++|+|++++.+++....          ++|+. 
T Consensus        14 g~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-   92 (337)
T cd07858          14 GRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-   92 (337)
T ss_pred             ccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCCC-
Confidence            6799999999985 468899999876432  223345677999999999999999998775432          34664 


Q ss_pred             CChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          409 GSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       409 g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +++.+++... ..++......++.+++.|++|||    +.+++||||||+||+++.++.+||+|||+++..
T Consensus        93 ~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH----~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  158 (337)
T cd07858          93 TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIH----SANVLHRDLKPSNLLLNANCDLKICDFGLARTT  158 (337)
T ss_pred             CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence            6888877643 35788889999999999999999    678999999999999999999999999998754

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.65  E-value=8e-16  Score=144.71  Aligned_cols=128  Identities=26%  Similarity=0.324  Sum_probs=103.3

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccchhhhhhhhHHHHHhhh-hccCccceeecccCCCC-----cccccCCChhHH
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECEVLRN-VRHQNLIKILSSCSTPD-----FKFMPNGSLEKR  414 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~  414 (481)
                      +.|.||.||++... ++..+++|.........   .  |+..... .+|+|++++++++...+     +||+++|+|.++
T Consensus        25 g~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~--e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~   99 (267)
T PHA03390         25 IDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---I--EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDL   99 (267)
T ss_pred             cCCCceEEEEEEEcCCCcEEEEEEEehhhcch---h--hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHH
Confidence            78999999999854 57888999876432211   1  2222221 26999999999887665     678999999999


Q ss_pred             hhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCC-cEEEccccCcccC
Q 039957          415 LYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENM-VAHVSDFGISKLL  479 (481)
Q Consensus       415 l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~-~~kl~Dfgl~~~~  479 (481)
                      +.... .+++.+...++.++++|++|+|    +.+|+||||||+||+++.++ .++|+|||+++..
T Consensus       100 l~~~~-~l~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~  160 (267)
T PHA03390        100 LKKEG-KLSEAEVKKIIRQLVEALNDLH----KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKII  160 (267)
T ss_pred             HHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence            87543 6789999999999999999999    67899999999999999988 9999999998754

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.65  E-value=7.9e-16  Score=143.57  Aligned_cols=134  Identities=32%  Similarity=0.446  Sum_probs=112.2

Q ss_pred             ccccccceeeeec-cCCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhH
Q 039957          342 LAGSFGSVYKGTI-SDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEK  413 (481)
Q Consensus       342 ~~g~~g~vy~~~l-~~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~  413 (481)
                      +.|++|.+|++.. .++..+++|.+....  ......+..|++.+++++|+|++++.+++....     ++|+++++|.+
T Consensus         9 ~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~   88 (256)
T cd08530           9 GKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSK   88 (256)
T ss_pred             cCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHH
Confidence            5689999999874 467889999886543  223446678999999999999999998877654     56889999999


Q ss_pred             Hhhc---CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          414 RLYS---HNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       414 ~l~~---~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ++..   ....+++.....++.++++|++|||    +.+++||||+|+||++++++.+|++|||+++..
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh----~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~  153 (256)
T cd08530          89 AISKRKKKRKLIPEQEIWRIFIQLLRGLQALH----EQKILHRDLKSANILLVANDLVKIGDLGISKVL  153 (256)
T ss_pred             HHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh----hCCcccCCCCcceEEEecCCcEEEeeccchhhh
Confidence            8765   2245788899999999999999999    678999999999999999999999999998764

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.65  E-value=4.7e-16  Score=147.95  Aligned_cols=135  Identities=27%  Similarity=0.350  Sum_probs=105.8

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccch-hhhhhhhHHHHHhhhhc-cCccceeecccCCCC-----cccccCCChh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRE-RAFRSFNSECEVLRNVR-HQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      .+.|+||.||++... +|..+|+|.+..... .....+..|+..+.++. |+|++++++++....     ++|++ +++.
T Consensus        12 lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~-~~l~   90 (288)
T cd06616          12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD-ISLD   90 (288)
T ss_pred             hCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc-CCHH
Confidence            378999999998854 578999998865432 33456788999999986 999999999886654     34544 3443


Q ss_pred             H---Hhhc-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          413 K---RLYS-HNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       413 ~---~l~~-~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +   .+.. ....+++....+++.+++.|++|||+   ..+|+||||||+||++++++.+||+|||+++.+
T Consensus        91 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  158 (288)
T cd06616          91 KFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE---ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL  158 (288)
T ss_pred             HHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---cCCeeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence            3   3222 23457888899999999999999995   357999999999999999999999999998643

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.65  E-value=1.1e-16  Score=142.68  Aligned_cols=130  Identities=26%  Similarity=0.344  Sum_probs=100.6

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccchhhhhhhhHHHHHhhhh-ccCccceeecccCCC---------CcccccCCC
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECEVLRNV-RHQNLIKILSSCSTP---------DFKFMPNGS  410 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~---------~~~~~~~g~  410 (481)
                      +.|--|.|...... .|...|+|.+.-     .+..++|++..++. .|+|||++++.+...         .+|+|+||.
T Consensus        71 G~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGe  145 (400)
T KOG0604|consen   71 GAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGE  145 (400)
T ss_pred             ccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchH
Confidence            45555666555432 455666665432     23456789988776 499999999987654         268999999


Q ss_pred             hhHHhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCC---CCcEEEccccCcccCC
Q 039957          411 LEKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDE---NMVAHVSDFGISKLLG  480 (481)
Q Consensus       411 l~~~l~~~~-~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~---~~~~kl~Dfgl~~~~~  480 (481)
                      |...+.+++ ...+..++-.|+.+|+.|++|||    +..|.|||+||+|+|...   +-..|++|||+||...
T Consensus       146 Lfsriq~~g~~afTErea~eI~~qI~~Av~~lH----~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~  215 (400)
T KOG0604|consen  146 LFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH----SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQ  215 (400)
T ss_pred             HHHHHHHcccccchHHHHHHHHHHHHHHHHHHH----hcchhhccCChhheeeecCCCCcceEecccccccccC
Confidence            999988744 45677888999999999999999    688999999999999964   5689999999999753

>PTZ00284 protein kinase; Provisional

Probab=99.64  E-value=8.8e-16  Score=156.15  Aligned_cols=132  Identities=23%  Similarity=0.286  Sum_probs=100.3

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccchhhhhhhhHHHHHhhhhccC------ccceeecccCCCC------ccccc
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQ------NLIKILSSCSTPD------FKFMP  407 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~------niv~l~~~~~~~~------~~~~~  407 (481)
                      .+.|+||.||++... .+..||||++.... ...+....|++++.+++|.      +++++.+++....      +++ .
T Consensus       137 lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~-~  214 (467)
T PTZ00284        137 LGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPK-Y  214 (467)
T ss_pred             EEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEec-c
Confidence            478999999999854 57889999986432 2233455677777777654      4778888776543      122 3


Q ss_pred             CCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCC----------------cEEEc
Q 039957          408 NGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENM----------------VAHVS  471 (481)
Q Consensus       408 ~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~----------------~~kl~  471 (481)
                      ++++.+++... ..+.+.....|+.+|+.||+|||+   ..+||||||||+|||++.++                .+||+
T Consensus       215 g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~---~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~  290 (467)
T PTZ00284        215 GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHT---ELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRIC  290 (467)
T ss_pred             CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEEC
Confidence            67888887654 357888899999999999999994   25899999999999998765                49999


Q ss_pred             cccCccc
Q 039957          472 DFGISKL  478 (481)
Q Consensus       472 Dfgl~~~  478 (481)
                      |||.+..
T Consensus       291 DfG~~~~  297 (467)
T PTZ00284        291 DLGGCCD  297 (467)
T ss_pred             CCCcccc
Confidence            9998754

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.64  E-value=4.6e-16  Score=131.60  Aligned_cols=135  Identities=24%  Similarity=0.308  Sum_probs=97.0

Q ss_pred             ccccccceeeeec-cCCcceEEEEEeccch-hhhhhhhHHHHHhhh-hccCccceeecccCCCC-----cccccCCChhH
Q 039957          342 LAGSFGSVYKGTI-SDGTDVAIKIFNLQRE-RAFRSFNSECEVLRN-VRHQNLIKILSSCSTPD-----FKFMPNGSLEK  413 (481)
Q Consensus       342 ~~g~~g~vy~~~l-~~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~-----~~~~~~g~l~~  413 (481)
                      +.|+||.|-+-.+ +.|...|+|++...-+ +...+...|+++..+ ...|.+|.++|......     +|.|. -|+.+
T Consensus        55 GrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~-tSldk  133 (282)
T KOG0984|consen   55 GRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD-TSLDK  133 (282)
T ss_pred             cCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh-hhHHH
Confidence            6788999877664 5789999999876543 333455667765544 56899999998665442     33332 23332


Q ss_pred             Hh---hcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          414 RL---YSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       414 ~l---~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      +-   ...+......-.=+||..|.+||.|||+   ...|+|||+||+|||++.+|.+|+||||++..+.
T Consensus       134 fy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~---kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~  200 (282)
T KOG0984|consen  134 FYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS---KLSVIHRDVKPSNILINYDGQVKICDFGISGYLV  200 (282)
T ss_pred             HHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH---HhhhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence            21   1233333334445799999999999996   5689999999999999999999999999987653

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.63  E-value=6.9e-16  Score=160.33  Aligned_cols=135  Identities=26%  Similarity=0.476  Sum_probs=114.5

Q ss_pred             hhccccccceeeeecc----C----CcceEEEEEeccc-hhhhhhhhHHHHHhhhh-ccCccceeecccCCCC-----cc
Q 039957          340 ISLAGSFGSVYKGTIS----D----GTDVAIKIFNLQR-ERAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD-----FK  404 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~----~----g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----~~  404 (481)
                      ..++|.||.|++|.+.    .    ...||||.+.... ....+.+..|++++..+ +|+|++.++|+|....     .|
T Consensus       303 ~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~E  382 (609)
T KOG0200|consen  303 YLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVE  382 (609)
T ss_pred             eeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEE
Confidence            5588999999999753    1    3568999886543 34456788999999886 5999999999998843     57


Q ss_pred             cccCCChhHHhhcCC---------------CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEE
Q 039957          405 FMPNGSLEKRLYSHN---------------YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAH  469 (481)
Q Consensus       405 ~~~~g~l~~~l~~~~---------------~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~k  469 (481)
                      |+..|+|.+++...+               ..+.....+.+|.|||.|++||+    +.++||||+-++|||+.++..+|
T Consensus       383 y~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~----~~~~vHRDLAaRNVLi~~~~~~k  458 (609)
T KOG0200|consen  383 YAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA----SVPCVHRDLAARNVLITKNKVIK  458 (609)
T ss_pred             eccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh----hCCccchhhhhhhEEecCCCEEE
Confidence            999999999998655               34777889999999999999999    67899999999999999999999


Q ss_pred             EccccCccc
Q 039957          470 VSDFGISKL  478 (481)
Q Consensus       470 l~Dfgl~~~  478 (481)
                      |||||+||.
T Consensus       459 IaDFGlar~  467 (609)
T KOG0200|consen  459 IADFGLARD  467 (609)
T ss_pred             Eccccceec
Confidence            999999985

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.63  E-value=1.6e-15  Score=144.13  Aligned_cols=133  Identities=26%  Similarity=0.415  Sum_probs=106.6

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccch--hhhhhhhHHHHHhhhh---ccCccceeecccCCCCc----------cc
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQRE--RAFRSFNSECEVLRNV---RHQNLIKILSSCSTPDF----------KF  405 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~----------~~  405 (481)
                      +.|++|.||++... ++..+++|.+.....  .....+..|++++.++   +|+|++++.+++...+.          +|
T Consensus         8 ~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~   87 (287)
T cd07838           8 GEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEH   87 (287)
T ss_pred             cccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehh
Confidence            67899999999976 488999999865322  2233455677766655   59999999999876542          45


Q ss_pred             ccCCChhHHhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          406 MPNGSLEKRLYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       406 ~~~g~l~~~l~~~-~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ++ +++.+++... ...+++..+..++.++++|++|||    +.+++|+|+||+||++++++.+||+|||+++.+
T Consensus        88 ~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH----~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~  157 (287)
T cd07838          88 VD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH----SHRIVHRDLKPQNILVTSDGQVKIADFGLARIY  157 (287)
T ss_pred             cc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeeccCChhhEEEccCCCEEEeccCcceec
Confidence            55 5788877653 235789999999999999999999    578999999999999999999999999998764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.63  E-value=1.3e-15  Score=146.60  Aligned_cols=134  Identities=25%  Similarity=0.388  Sum_probs=108.3

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccch--hhhhhhhHHHHHhhhhccCccceeecccCCCC-------------cc
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRE--RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-------------FK  404 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-------------~~  404 (481)
                      .+.|++|.||++... ++..+++|.+.....  .....+.+|++++++++|+||+++++++....             ++
T Consensus        16 lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~   95 (311)
T cd07866          16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTP   95 (311)
T ss_pred             eccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEe
Confidence            367999999999854 578899998865432  22335678999999999999999988764332             24


Q ss_pred             cccCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          405 FMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       405 ~~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      |+. +++...+.......++.+...++.++++||+|||    +.+|+|||+||+||++++++.+|++|||+++..
T Consensus        96 ~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH----~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  165 (311)
T cd07866          96 YMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLH----ENHILHRDIKAANILIDNQGILKIADFGLARPY  165 (311)
T ss_pred             cCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence            554 4676666655557889999999999999999999    678999999999999999999999999998754

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.63  E-value=1.4e-15  Score=147.73  Aligned_cols=133  Identities=23%  Similarity=0.320  Sum_probs=105.4

Q ss_pred             hccccccceeeeecc-C--CcceEEEEEeccch--hhhhhhhHHHHHhhhhc-cCccceeecccCCC--C-------ccc
Q 039957          341 SLAGSFGSVYKGTIS-D--GTDVAIKIFNLQRE--RAFRSFNSECEVLRNVR-HQNLIKILSSCSTP--D-------FKF  405 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~--g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~-------~~~  405 (481)
                      .+.|+||.||++... +  +..+|+|.+.....  ...+.+.+|++++.+++ |+||+++++.+...  .       ++|
T Consensus         8 lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~   87 (332)
T cd07857           8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEEL   87 (332)
T ss_pred             ccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEec
Confidence            367999999999854 3  67899998764321  22345778999999984 99999999865322  1       223


Q ss_pred             ccCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          406 MPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       406 ~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      + +++|.+++.. ...+++.....++.+|++||+|||    +.+|+||||||+||++++++.+||+|||+|+.+
T Consensus        88 ~-~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH----~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~  155 (332)
T cd07857          88 M-EADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIH----SANVLHRDLKPGNLLVNADCELKICDFGLARGF  155 (332)
T ss_pred             c-cCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence            4 4788888754 345788899999999999999999    678999999999999999999999999998754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.63  E-value=2.3e-16  Score=162.88  Aligned_cols=135  Identities=22%  Similarity=0.293  Sum_probs=110.6

Q ss_pred             hhccccccceeeeecc-CCcceEEEEEeccch---hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCC
Q 039957          340 ISLAGSFGSVYKGTIS-DGTDVAIKIFNLQRE---RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGS  410 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~  410 (481)
                      +.|.|+||.|..+... .+..+|+|+++.+..   ....-|+.|-+++.....+.||.+.-.|.+..     ++|||||+
T Consensus        82 vIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGD  161 (1317)
T KOG0612|consen   82 VIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGD  161 (1317)
T ss_pred             HhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCch
Confidence            4589999999998864 578899999877532   22345788899999999999999998888775     67999999


Q ss_pred             hhHHhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          411 LEKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       411 l~~~l~~~~-~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      |...+.... .+-+|  +.-++..|+-|++-+|    +.|+|||||||.|||+|..|++|++|||-|-.+.
T Consensus       162 lltLlSk~~~~pE~~--ArFY~aEiVlAldslH----~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~  226 (1317)
T KOG0612|consen  162 LLTLLSKFDRLPEDW--ARFYTAEIVLALDSLH----SMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMD  226 (1317)
T ss_pred             HHHHHhhcCCChHHH--HHHHHHHHHHHHHHHH----hccceeccCCcceeEecccCcEeeccchhHHhcC
Confidence            999988765 33344  3346678888999999    7899999999999999999999999999875543

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.63  E-value=1.8e-16  Score=139.49  Aligned_cols=133  Identities=26%  Similarity=0.390  Sum_probs=101.3

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCCcc-----ccc----CC
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPDFK-----FMP----NG  409 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-----~~~----~g  409 (481)
                      +.|.||.||.++.+ +|+.|+.|++-.-.  -...+.+.+|.+++.-.+|.|++..++....+...     |+.    ..
T Consensus        62 GYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQS  141 (449)
T KOG0664|consen   62 GYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQS  141 (449)
T ss_pred             cccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHHh
Confidence            67999999999876 68999988764321  22345677899999999999999988877655422     321    24


Q ss_pred             ChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          410 SLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       410 ~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +|.+.+-.. ..++-...--...+|.+|+.|||    +.+|.||||||-|.|+..+...||||||+||.-
T Consensus       142 DLHKIIVSP-Q~Ls~DHvKVFlYQILRGLKYLH----sA~ILHRDIKPGNLLVNSNCvLKICDFGLARve  206 (449)
T KOG0664|consen  142 DLHKIIVSP-QALTPDHVKVFVYQILRGLKYLH----TANILHRDIKPGNLLVNSNCILKICDFGLARTW  206 (449)
T ss_pred             hhhheeccC-CCCCcchhhhhHHHHHhhhHHHh----hcchhhccCCCccEEeccCceEEeccccccccc
Confidence            455544433 33444444456789999999999    678999999999999999999999999999863

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.62  E-value=1.2e-16  Score=151.81  Aligned_cols=134  Identities=27%  Similarity=0.403  Sum_probs=109.8

Q ss_pred             ccccccceeeeeccCC-cceEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCCCcccc-----cCCChh
Q 039957          342 LAGSFGSVYKGTISDG-TDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPDFKFM-----PNGSLE  412 (481)
Q Consensus       342 ~~g~~g~vy~~~l~~g-~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~-----~~g~l~  412 (481)
                      +-|+||.|-.+..... ...|+|+++...   .+..++..+|-.++..++.+.||+++..|.+..|.||     -+|.+.
T Consensus       429 GvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElW  508 (732)
T KOG0614|consen  429 GVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELW  508 (732)
T ss_pred             ccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhh
Confidence            6799999977765432 347777775542   3445677889999999999999999999998887764     689999


Q ss_pred             HHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          413 KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       413 ~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      ..+.+.+.+-+...| -++..+.+|++|||    +.+||.||+||+|.++|.+|.+|+.|||+||.+.
T Consensus       509 TiLrdRg~Fdd~tar-F~~acv~EAfeYLH----~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~  571 (732)
T KOG0614|consen  509 TILRDRGSFDDYTAR-FYVACVLEAFEYLH----RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG  571 (732)
T ss_pred             hhhhhcCCcccchhh-hhHHHHHHHHHHHH----hcCceeccCChhheeeccCCceEEeehhhHHHhc
Confidence            999887665555555 47778999999999    6889999999999999999999999999999864

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.62  E-value=2.6e-15  Score=145.61  Aligned_cols=131  Identities=28%  Similarity=0.415  Sum_probs=106.7

Q ss_pred             ccccccceeeeec-cCCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC------cccccCCChh
Q 039957          342 LAGSFGSVYKGTI-SDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD------FKFMPNGSLE  412 (481)
Q Consensus       342 ~~g~~g~vy~~~l-~~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~~~~g~l~  412 (481)
                      +.|+||.||++.. .+|..+++|++....  ....+.+..|++++.+++|||++++.++|....      ++|+ ++++.
T Consensus        19 g~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~   97 (328)
T cd07856          19 GMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLH   97 (328)
T ss_pred             cccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHH
Confidence            5799999999974 478899999875432  223456778999999999999999999875432      4566 56888


Q ss_pred             HHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          413 KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       413 ~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +++...  .+++.....++.++++|++|||    +.+|+|||+||+||++++++.+|++|||.++..
T Consensus        98 ~~~~~~--~~~~~~~~~~~~ql~~aL~~LH----~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~  158 (328)
T cd07856          98 RLLTSR--PLEKQFIQYFLYQILRGLKYVH----SAGVVHRDLKPSNILINENCDLKICDFGLARIQ  158 (328)
T ss_pred             HHHhcC--CCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEeECCCCCEEeCcccccccc
Confidence            777543  3567777889999999999999    678999999999999999999999999998754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.62  E-value=1.9e-15  Score=147.54  Aligned_cols=130  Identities=28%  Similarity=0.398  Sum_probs=103.6

Q ss_pred             ccccccceeeeec-cCCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----------ccccc
Q 039957          342 LAGSFGSVYKGTI-SDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----------FKFMP  407 (481)
Q Consensus       342 ~~g~~g~vy~~~l-~~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----------~~~~~  407 (481)
                      +.|++|.||+|.. .+|..+|+|.+....  ......+.+|++++++++|+||+++.+++....           ++|+.
T Consensus        24 g~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~  103 (342)
T cd07879          24 GSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ  103 (342)
T ss_pred             eecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEecccc
Confidence            6799999999985 468899999876432  222345778999999999999999999876432           23443


Q ss_pred             CCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          408 NGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       408 ~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                       +++.++..   ..+++.....++.++++|++|||    +.+|+||||||+||+++.++.+|++|||+++..
T Consensus       104 -~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH----~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~  167 (342)
T cd07879         104 -TDLQKIMG---HPLSEDKVQYLVYQMLCGLKYIH----SAGIIHRDLKPGNLAVNEDCELKILDFGLARHA  167 (342)
T ss_pred             -cCHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence             35554432   24678888999999999999999    678999999999999999999999999998754

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.61  E-value=1.2e-15  Score=145.54  Aligned_cols=136  Identities=26%  Similarity=0.345  Sum_probs=92.0

Q ss_pred             hhhccccccceeeeeccC----CcceEEEEEeccchhhh-----------hhhhHHHHHhhhhccCccceeecccCCCC-
Q 039957          339 TISLAGSFGSVYKGTISD----GTDVAIKIFNLQRERAF-----------RSFNSECEVLRNVRHQNLIKILSSCSTPD-  402 (481)
Q Consensus       339 ~l~~~g~~g~vy~~~l~~----g~~vavK~l~~~~~~~~-----------~~~~~e~~~l~~l~h~niv~l~~~~~~~~-  402 (481)
                      .+-++|+||.||+|...+    +..+++|..........           .....+...+..+.|++++++++++.... 
T Consensus        18 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~   97 (294)
T PHA02882         18 KLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFKRC   97 (294)
T ss_pred             eEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeEecC
Confidence            345899999999998654    34455664332221100           01112233455678999999998654432 


Q ss_pred             ---cccccC----CChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccC
Q 039957          403 ---FKFMPN----GSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGI  475 (481)
Q Consensus       403 ---~~~~~~----g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl  475 (481)
                         +.|+..    .++.+.+.. ....++.....|+.++++|++|+|    +.+|+||||||+|||+++++.+||+|||+
T Consensus        98 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH----~~~iiHrDiKp~Nill~~~~~~~l~DFGl  172 (294)
T PHA02882         98 RMYYRFILLEKLVENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIH----EHGISHGDIKPENIMVDGNNRGYIIDYGI  172 (294)
T ss_pred             CceEEEEEEehhccCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCcEEEEEcCC
Confidence               233321    233333322 122456777899999999999999    67899999999999999999999999999


Q ss_pred             cccC
Q 039957          476 SKLL  479 (481)
Q Consensus       476 ~~~~  479 (481)
                      |+.+
T Consensus       173 a~~~  176 (294)
T PHA02882        173 ASHF  176 (294)
T ss_pred             ceee
Confidence            8754

>PRK10345 hypothetical protein; Provisional

Probab=99.61  E-value=2.2e-15  Score=134.40  Aligned_cols=129  Identities=18%  Similarity=0.236  Sum_probs=95.2

Q ss_pred             hhccccccceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhhhh-----ccCccceeecccCCCC---------ccc
Q 039957          340 ISLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNV-----RHQNLIKILSSCSTPD---------FKF  405 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~~~~~~~~---------~~~  405 (481)
                      +.++|+++.||.  .++....+||..........+.+.+|+..++.+     .|+||++++|++.+..         ++|
T Consensus         9 ~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~   86 (210)
T PRK10345          9 PLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADF   86 (210)
T ss_pred             eecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecC
Confidence            347899999996  443333468887665444456789999999999     5799999999887652         346


Q ss_pred             --ccCCChhHHhhcCCCccCHHHHHHHHHHHHHHH-HHHhcCCCCCCeeeCCCCCCCeeeCC----CCcEEEcc-ccCcc
Q 039957          406 --MPNGSLEKRLYSHNYFLDILERLNIMIDVGSTL-EYLHHGHSSAPIIHCDLKPTSILLDE----NMVAHVSD-FGISK  477 (481)
Q Consensus       406 --~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l-~~lH~~~~~~~i~H~dlk~~nill~~----~~~~kl~D-fgl~~  477 (481)
                        +++|+|.+++.+..  ++..  ..++.++..++ +|+|    +.+||||||||+|||++.    +..++|+| ||.+.
T Consensus        87 ~G~~~~tL~~~l~~~~--~~e~--~~~~~~~L~~l~~yLh----~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~~  158 (210)
T PRK10345         87 DGKPSITLTEFAEQCR--YEED--VAQLRQLLKKLKRYLL----DNRIVTMELKPQNILCQRISESEVIPVVCDNIGEST  158 (210)
T ss_pred             CCCcchhHHHHHHccc--ccHh--HHHHHHHHHHHHHHHH----HCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCcc
Confidence              45789999986532  3333  34567777777 9999    678999999999999974    34899999 55544


Q ss_pred             c
Q 039957          478 L  478 (481)
Q Consensus       478 ~  478 (481)
                      .
T Consensus       159 ~  159 (210)
T PRK10345        159 F  159 (210)
T ss_pred             e
Confidence            3

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.61  E-value=1.7e-15  Score=133.53  Aligned_cols=141  Identities=26%  Similarity=0.324  Sum_probs=98.1

Q ss_pred             Chhhhh--ccccccceeeeec-cCCcceEEEEEeccch-hhhhhhhHHHHHhhhhc-cCccceeecccCCCC-----ccc
Q 039957          336 DLETIS--LAGSFGSVYKGTI-SDGTDVAIKIFNLQRE-RAFRSFNSECEVLRNVR-HQNLIKILSSCSTPD-----FKF  405 (481)
Q Consensus       336 ~L~~l~--~~g~~g~vy~~~l-~~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-----~~~  405 (481)
                      .|+.+.  ++|.-|.|++.+. ..|...|||......+ ...+++...++++.+.+ .|.||+-+|||....     +|.
T Consensus        93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel  172 (391)
T KOG0983|consen   93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL  172 (391)
T ss_pred             HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence            344443  7899999999985 4688999998765433 23445666677776655 799999999986542     333


Q ss_pred             ccCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          406 MPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       406 ~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      |.. -..+.+..-.......-.=++...+..||.||.+   .++|+|||+||+|||+|+.|.+|+||||++..+.
T Consensus       173 Ms~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe---KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlv  243 (391)
T KOG0983|consen  173 MST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV  243 (391)
T ss_pred             HHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH---hcceeecccCccceEEccCCCEEeecccccceee
Confidence            310 1111221111112222233677889999999996   5689999999999999999999999999987653

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.61  E-value=1.9e-15  Score=147.49  Aligned_cols=131  Identities=25%  Similarity=0.421  Sum_probs=107.1

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCC-------------------
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTP-------------------  401 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------------------  401 (481)
                      +.|+||.||+|... +|..|++|.+........+.+.+|++++++++|+|++++++++...                   
T Consensus        14 g~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l   93 (342)
T cd07854          14 GCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYI   93 (342)
T ss_pred             cCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEE
Confidence            67999999999854 5889999998766555556788899999999999999998765432                   


Q ss_pred             CcccccCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCC-CCcEEEccccCcccC
Q 039957          402 DFKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDE-NMVAHVSDFGISKLL  479 (481)
Q Consensus       402 ~~~~~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~-~~~~kl~Dfgl~~~~  479 (481)
                      .++|++ +++.+.+...  .+++.....++.+|++|++|||    +.+|+||||||+||+++. ++.+|++|||.++.+
T Consensus        94 v~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH----~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~  165 (342)
T cd07854          94 VQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYIH----SANVLHRDLKPANVFINTEDLVLKIGDFGLARIV  165 (342)
T ss_pred             Eeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEEcCCCceEEECCcccceec
Confidence            145665 5887776532  4678888899999999999999    578999999999999985 568999999998754

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.60  E-value=2.8e-15  Score=138.30  Aligned_cols=130  Identities=33%  Similarity=0.498  Sum_probs=111.8

Q ss_pred             cccceeeeecc-CCcceEEEEEeccchhh-hhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHHhhc
Q 039957          345 SFGSVYKGTIS-DGTDVAIKIFNLQRERA-FRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRLYS  417 (481)
Q Consensus       345 ~~g~vy~~~l~-~g~~vavK~l~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~l~~  417 (481)
                      +||.+|++... +|..+++|.+....... .+.+.+|++.+++++|++++++.+++....     ++|+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            47899999876 48899999987655433 567889999999999999999999987653     678899999998865


Q ss_pred             CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          418 HNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       418 ~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ... .++....+++.+++++++|||    ..+|+|+|++|+||++++++.++++|||.+...
T Consensus        81 ~~~-~~~~~~~~~~~~l~~~l~~lh----~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~  137 (244)
T smart00220       81 RGR-LSEDEARFYARQILSALEYLH----SNGIIHRDLKPENILLDEDGHVKLADFGLARQL  137 (244)
T ss_pred             ccC-CCHHHHHHHHHHHHHHHHHHH----HcCeecCCcCHHHeEECCCCcEEEccccceeee
Confidence            332 788899999999999999999    568999999999999999999999999998764

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.60  E-value=9.3e-16  Score=153.97  Aligned_cols=131  Identities=31%  Similarity=0.492  Sum_probs=98.6

Q ss_pred             ccccccc-eeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhhhh-ccCccceeecccCCCCcccc----cCCChhHHh
Q 039957          342 LAGSFGS-VYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNV-RHQNLIKILSSCSTPDFKFM----PNGSLEKRL  415 (481)
Q Consensus       342 ~~g~~g~-vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~----~~g~l~~~l  415 (481)
                      +.|.-|. ||+|.. +|+.||||++-...   ..-..+|++.++.- .|+|||++++.-.+..|.|+    -.-+|.+++
T Consensus       518 G~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~sL~dli  593 (903)
T KOG1027|consen  518 GYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCACSLQDLI  593 (903)
T ss_pred             ccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhhhHHHHH
Confidence            4566554 799986 57899999874432   23356799999876 59999999877777777775    246777777


Q ss_pred             hcCCC---ccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCC-----CCcEEEccccCcccCC
Q 039957          416 YSHNY---FLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDE-----NMVAHVSDFGISKLLG  480 (481)
Q Consensus       416 ~~~~~---~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~-----~~~~kl~Dfgl~~~~~  480 (481)
                      ..+..   ...-.....+..++++||++||    +.+|||||+||.|||++.     ..+|+|+|||++|.++
T Consensus       594 e~~~~d~~~~~~i~~~~~l~q~~~GlaHLH----sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  594 ESSGLDVEMQSDIDPISVLSQIASGLAHLH----SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             hccccchhhcccccHHHHHHHHHHHHHHHH----hcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            65311   1111344678899999999999    678999999999999965     3689999999999874

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.59  E-value=4.8e-15  Score=138.79  Aligned_cols=135  Identities=24%  Similarity=0.354  Sum_probs=105.8

Q ss_pred             hhccccccceeeeeccC-CcceEEEEEeccc-----hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccC
Q 039957          340 ISLAGSFGSVYKGTISD-GTDVAIKIFNLQR-----ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPN  408 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~~-g~~vavK~l~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~  408 (481)
                      ..+.|+||.||++.... +..+++|......     ......+..|+.++++++|||++++++++....     ++|+++
T Consensus         7 ~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   86 (260)
T cd08222           7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEG   86 (260)
T ss_pred             eecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCC
Confidence            34689999999987543 3445555543211     112234567888999999999999999887654     678999


Q ss_pred             CChhHHhhc---CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          409 GSLEKRLYS---HNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       409 g~l~~~l~~---~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +++.+++..   ....+++.++..++.++++|++|||    +.+++|+|+||+||++++ +.+|++|||+++.+
T Consensus        87 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~  155 (260)
T cd08222          87 RDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH----QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLL  155 (260)
T ss_pred             CCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH----HcCccccCCChhheEeec-CCEeecccCceeec
Confidence            999988763   3346789999999999999999999    678999999999999975 56999999998754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.59  E-value=9.2e-16  Score=138.19  Aligned_cols=132  Identities=30%  Similarity=0.356  Sum_probs=104.5

Q ss_pred             ccccccceeeeec-cCCcceEEEEEeccch---hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          342 LAGSFGSVYKGTI-SDGTDVAIKIFNLQRE---RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       342 ~~g~~g~vy~~~l-~~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      +.|.||.|..+.- ..|+.+|+|+++...-   ....+-..|-.+|...+||.+..+-..+...+     ++|..+|.|.
T Consensus       177 GkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf  256 (516)
T KOG0690|consen  177 GKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELF  256 (516)
T ss_pred             cCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEe
Confidence            7899999987764 4688999999876532   12233455778999999999998766666654     7899999999


Q ss_pred             HHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          413 KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       413 ~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      -++...+...+ ....-+...|+.||.|||    +.+||.||+|-+|.|+|.+|++||+|||+||-
T Consensus       257 ~HLsrer~FsE-~RtRFYGaEIvsAL~YLH----s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE  317 (516)
T KOG0690|consen  257 FHLSRERVFSE-DRTRFYGAEIVSALGYLH----SRNIVYRDLKLENLLLDKDGHIKITDFGLCKE  317 (516)
T ss_pred             eehhhhhcccc-hhhhhhhHHHHHHhhhhh----hCCeeeeechhhhheeccCCceEeeecccchh
Confidence            88765443333 333447778999999999    67899999999999999999999999999984

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.59  E-value=4.1e-15  Score=145.16  Aligned_cols=131  Identities=26%  Similarity=0.377  Sum_probs=107.2

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----------ccccc
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----------FKFMP  407 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----------~~~~~  407 (481)
                      +.|++|.+|+|... ++..+++|.+....  ......+..|+.++++++|+|++++.+++...+           ++|+ 
T Consensus        24 g~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-  102 (343)
T cd07851          24 GSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-  102 (343)
T ss_pred             ccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC-
Confidence            67999999999865 57889999876432  223345677999999999999999988765432           2344 


Q ss_pred             CCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          408 NGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       408 ~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +++|.+++..  ..+++....+++.++++|++|||    +.+|+||||||+||++++++.+||+|||++...
T Consensus       103 ~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH----~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~  168 (343)
T cd07851         103 GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIH----SAGIIHRDLKPSNIAVNEDCELKILDFGLARHT  168 (343)
T ss_pred             CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEECCCCCEEEccccccccc
Confidence            6788888764  34788899999999999999999    678999999999999999999999999998764

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.59  E-value=7.5e-15  Score=133.93  Aligned_cols=135  Identities=29%  Similarity=0.492  Sum_probs=115.4

Q ss_pred             hccccccceeeeeccC-CcceEEEEEeccchh-hhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhH
Q 039957          341 SLAGSFGSVYKGTISD-GTDVAIKIFNLQRER-AFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEK  413 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~-g~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~  413 (481)
                      .+.|+++.+|++...+ +..+++|.+...... ..+.+..|++.+.+++|++++++++++...+     ++|+++++|.+
T Consensus         7 i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~   86 (225)
T smart00221        7 LGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFD   86 (225)
T ss_pred             eecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHH
Confidence            3578999999999775 788999998765544 5567888999999999999999999877654     56888899999


Q ss_pred             HhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          414 RLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       414 ~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ++.......++.....++.+++++++|+|    ..+++|+|++|+||+++.++.++++|||.+...
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh----~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~  148 (225)
T smart00221       87 YLRKKGGKLSEEEARFYLRQILEALEYLH----SLGIVHRDLKPENILLGMDGLVKLADFGLARFI  148 (225)
T ss_pred             HHHhcccCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEe
Confidence            88754332788899999999999999999    568999999999999999999999999998764

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.58  E-value=1.3e-14  Score=130.48  Aligned_cols=134  Identities=37%  Similarity=0.571  Sum_probs=114.3

Q ss_pred             ccccccceeeeeccC-CcceEEEEEeccchh-hhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHH
Q 039957          342 LAGSFGSVYKGTISD-GTDVAIKIFNLQRER-AFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKR  414 (481)
Q Consensus       342 ~~g~~g~vy~~~l~~-g~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~  414 (481)
                      ++|.+|.+|++.... |..+++|.+...... ....+.+|++.+++++|++++++.+++....     ++|++++++.++
T Consensus         2 ~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~   81 (215)
T cd00180           2 GEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDL   81 (215)
T ss_pred             CcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHH
Confidence            468899999998764 888999998765432 3456888999999999999999999887754     568888999998


Q ss_pred             hhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCC-CCcEEEccccCcccC
Q 039957          415 LYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDE-NMVAHVSDFGISKLL  479 (481)
Q Consensus       415 l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~-~~~~kl~Dfgl~~~~  479 (481)
                      +.......++..+..++.+++++++|+|    ..+++|+|++|.||+++. ++.++++|||.+...
T Consensus        82 ~~~~~~~~~~~~~~~~~~~l~~~l~~lh----~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~  143 (215)
T cd00180          82 LKENEGKLSEDEILRILLQILEGLEYLH----SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLL  143 (215)
T ss_pred             HHhccCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEc
Confidence            8764345788999999999999999999    578999999999999999 899999999998754

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.58  E-value=2.6e-15  Score=144.84  Aligned_cols=133  Identities=24%  Similarity=0.375  Sum_probs=108.8

Q ss_pred             ccccccceeeeeccC-CcceEEEEEeccc--------hhhhhhhhHHHHHhhhhc---cCccceeecccCCCCcccc---
Q 039957          342 LAGSFGSVYKGTISD-GTDVAIKIFNLQR--------ERAFRSFNSECEVLRNVR---HQNLIKILSSCSTPDFKFM---  406 (481)
Q Consensus       342 ~~g~~g~vy~~~l~~-g~~vavK~l~~~~--------~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~~---  406 (481)
                      +.|+||.|+.+.... ...|.+|.+.+++        .+.......|+++|+.++   |+||++++.+|.+.++-|+   
T Consensus       570 G~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te  649 (772)
T KOG1152|consen  570 GEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYYLETE  649 (772)
T ss_pred             cccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeEEEec
Confidence            789999999998764 4567888776543        233446788999999998   9999999999999887664   


Q ss_pred             ---cCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          407 ---PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       407 ---~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                         ++-+|.+++.-+. ..+..++-.|..||+.|+++||    +.+|||||||-+||.+|.+|.+|+.|||-|...
T Consensus       650 ~hg~gIDLFd~IE~kp-~m~E~eAk~IFkQV~agi~hlh----~~~ivhrdikdenvivd~~g~~klidfgsaa~~  720 (772)
T KOG1152|consen  650 VHGEGIDLFDFIEFKP-RMDEPEAKLIFKQVVAGIKHLH----DQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYT  720 (772)
T ss_pred             CCCCCcchhhhhhccC-ccchHHHHHHHHHHHhcccccc----ccCceecccccccEEEecCCeEEEeeccchhhh
Confidence               4567888876443 4556677789999999999999    789999999999999999999999999987543

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.56  E-value=6.3e-15  Score=126.66  Aligned_cols=127  Identities=24%  Similarity=0.488  Sum_probs=103.3

Q ss_pred             ccccccceeeee-ccCCcceEEEEEeccchhhhhhhhHHHHHhhhhc-cCccceeecccCCCC-------cccccCCChh
Q 039957          342 LAGSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVR-HQNLIKILSSCSTPD-------FKFMPNGSLE  412 (481)
Q Consensus       342 ~~g~~g~vy~~~-l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-------~~~~~~g~l~  412 (481)
                      +.|.|..|+.|. +.+...+.+|.++.-.   .+.+.+|+.+|..++ |+||+++++...++.       |||+.+.+..
T Consensus        47 GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk  123 (338)
T KOG0668|consen   47 GRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFK  123 (338)
T ss_pred             cCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHH
Confidence            789999999997 4566778889886543   345778999999998 999999999887764       7888888776


Q ss_pred             HHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCC-CCcEEEccccCcccC
Q 039957          413 KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDE-NMVAHVSDFGISKLL  479 (481)
Q Consensus       413 ~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~-~~~~kl~Dfgl~~~~  479 (481)
                      ....    .++.........++..||+|.|    +.||+|||+||+|+++|. .-+.|+.|+|+|.++
T Consensus       124 ~ly~----tl~d~dIryY~~elLkALdyCH----S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY  183 (338)
T KOG0668|consen  124 QLYP----TLTDYDIRYYIYELLKALDYCH----SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  183 (338)
T ss_pred             HHhh----hhchhhHHHHHHHHHHHHhHHH----hcCcccccCCcceeeechhhceeeeeecchHhhc
Confidence            5432    1333444567889999999999    799999999999999997 578999999999875

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.55  E-value=2.2e-14  Score=141.41  Aligned_cols=135  Identities=30%  Similarity=0.386  Sum_probs=106.4

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccchhhhhhhhHHHHHhhhhc-c-----CccceeecccCCCCcccc----cCC
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVR-H-----QNLIKILSSCSTPDFKFM----PNG  409 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~l~~~~~~~~~~~~----~~g  409 (481)
                      .|+|.||.|-++.. .++..||+|+++... ....+-..|+.+|..++ |     -|+|++++++...+.-++    -.-
T Consensus       194 LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL~~  272 (586)
T KOG0667|consen  194 LGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELLST  272 (586)
T ss_pred             ecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhhhh
Confidence            47899999999985 458999999987542 33345567888998887 3     489999999877653222    246


Q ss_pred             ChhHHhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCC--CCcEEEccccCcccCC
Q 039957          410 SLEKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDE--NMVAHVSDFGISKLLG  480 (481)
Q Consensus       410 ~l~~~l~~~~-~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~--~~~~kl~Dfgl~~~~~  480 (481)
                      +|++++.... ..++......|+.+|+.||.+||    ..+|||+||||+||||-+  ...+||.|||.|....
T Consensus       273 NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~----~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~  342 (586)
T KOG0667|consen  273 NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH----ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFES  342 (586)
T ss_pred             hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeeccCChhheeeccCCcCceeEEecccccccC
Confidence            7888887633 34677888899999999999999    678999999999999965  3589999999987643

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.55  E-value=1.2e-14  Score=149.73  Aligned_cols=132  Identities=20%  Similarity=0.269  Sum_probs=85.7

Q ss_pred             hhccccccceeeeecc-C----CcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecc------cCCC-----Cc
Q 039957          340 ISLAGSFGSVYKGTIS-D----GTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSS------CSTP-----DF  403 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~-~----g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~------~~~~-----~~  403 (481)
                      ..++|+||.||+|... +    +..+|+|++......  +.+..+  .+....+.+++.+...      +...     .+
T Consensus       139 ~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~LV~  214 (566)
T PLN03225        139 KLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEYWLVW  214 (566)
T ss_pred             EEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccccCCceEEEE
Confidence            4478999999999865 4    688999986532211  111111  1111111222211111      1111     15


Q ss_pred             ccccCCChhHHhhcCCCcc-------------------CHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCC
Q 039957          404 KFMPNGSLEKRLYSHNYFL-------------------DILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDE  464 (481)
Q Consensus       404 ~~~~~g~l~~~l~~~~~~~-------------------~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~  464 (481)
                      +|+++|+|.+++.......                   .......|+.++++||+|+|    +.+|+||||||+|||+++
T Consensus       215 ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH----~~gIiHRDLKP~NILl~~  290 (566)
T PLN03225        215 RYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH----STGIVHRDVKPQNIIFSE  290 (566)
T ss_pred             EecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH----HCCEEeCcCCHHHEEEeC
Confidence            7899999998876432111                   11224468999999999999    678999999999999996


Q ss_pred             -CCcEEEccccCcccC
Q 039957          465 -NMVAHVSDFGISKLL  479 (481)
Q Consensus       465 -~~~~kl~Dfgl~~~~  479 (481)
                       ++.+||+|||+|+.+
T Consensus       291 ~~~~~KL~DFGlA~~l  306 (566)
T PLN03225        291 GSGSFKIIDLGAAADL  306 (566)
T ss_pred             CCCcEEEEeCCCcccc
Confidence             589999999999754

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.54  E-value=3.2e-14  Score=128.79  Aligned_cols=127  Identities=23%  Similarity=0.359  Sum_probs=99.8

Q ss_pred             ccccccceeeeeccCCcceEEEEEeccchh--------hhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccC
Q 039957          342 LAGSFGSVYKGTISDGTDVAIKIFNLQRER--------AFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPN  408 (481)
Q Consensus       342 ~~g~~g~vy~~~l~~g~~vavK~l~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~  408 (481)
                      +.|++|.||+|.. +|..+++|........        ....+..|++.+..++|+++.....++...+     ++|+++
T Consensus         5 ~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G   83 (211)
T PRK14879          5 KRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIEG   83 (211)
T ss_pred             ccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCC
Confidence            6799999999986 6778888875432211        1234677899999999988775554443322     679999


Q ss_pred             CChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          409 GSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       409 g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ++|.+.+....    + .+..++.+++.+++++|    ..+++|||++|+||+++ ++.++|.|||.++..
T Consensus        84 ~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH----~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~  144 (211)
T PRK14879         84 EPLKDLINSNG----M-EELELSREIGRLVGKLH----SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFS  144 (211)
T ss_pred             cCHHHHHHhcc----H-HHHHHHHHHHHHHHHHH----hCCcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence            99998876432    2 78899999999999999    67899999999999999 889999999998753

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.54  E-value=3.3e-16  Score=150.90  Aligned_cols=203  Identities=30%  Similarity=0.481  Sum_probs=128.6

Q ss_pred             EEEeeCCcCccccChhh-hcCCCCccEEEccCccceeecchhccccccCceeecccCcceecCcccccCCCCCCEEEccc
Q 039957           41 NLNLGGNRLSGHLPSMI-GHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLM  119 (481)
Q Consensus        41 ~L~L~~N~l~~~~p~~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  119 (481)
                      .|.|++-+++ ..|... ...+..-...||+.|++. .+|..++.+..|+.+.|..|.+. .+|..+.++..|++|||+.
T Consensus        54 ~l~Ls~rrlk-~fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~  130 (722)
T KOG0532|consen   54 RLLLSGRRLK-EFPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSS  130 (722)
T ss_pred             ccccccchhh-cCCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhcc
Confidence            4555555555 344221 134555566677777765 66666666666777777777666 4566666666666666655


Q ss_pred             ccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEccCCceeecCCcccccCCCCCeEecc
Q 039957          120 NNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLG  199 (481)
Q Consensus       120 N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~  199 (481)
                      |+++.                                 +|..++.+  -|+.|-+++|+++ .+|..++.+..|..||.+
T Consensus       131 NqlS~---------------------------------lp~~lC~l--pLkvli~sNNkl~-~lp~~ig~~~tl~~ld~s  174 (722)
T KOG0532|consen  131 NQLSH---------------------------------LPDGLCDL--PLKVLIVSNNKLT-SLPEEIGLLPTLAHLDVS  174 (722)
T ss_pred             chhhc---------------------------------CChhhhcC--cceeEEEecCccc-cCCcccccchhHHHhhhh
Confidence            55554                                 34444443  2566666666665 566666666667777777


Q ss_pred             cccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCcCcccC
Q 039957          200 FNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSI  279 (481)
Q Consensus       200 ~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~  279 (481)
                      .|++. .+|..++.+.+|+.|.+..|++.. +|..++.|+ |..||+++|+++ .+|-+|..|+.|++|-|.+|.+. ..
T Consensus       175 ~nei~-slpsql~~l~slr~l~vrRn~l~~-lp~El~~Lp-Li~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SP  249 (722)
T KOG0532|consen  175 KNEIQ-SLPSQLGYLTSLRDLNVRRNHLED-LPEELCSLP-LIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SP  249 (722)
T ss_pred             hhhhh-hchHHhhhHHHHHHHHHhhhhhhh-CCHHHhCCc-eeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CC
Confidence            77765 566667777777777777777664 455555544 677888888877 56777888888888888888876 56


Q ss_pred             Ccchhccc
Q 039957          280 PSSLWSLG  287 (481)
Q Consensus       280 p~~~~~l~  287 (481)
                      |..++-..
T Consensus       250 PAqIC~kG  257 (722)
T KOG0532|consen  250 PAQICEKG  257 (722)
T ss_pred             hHHHHhcc
Confidence            66655443

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.53  E-value=3.2e-14  Score=124.50  Aligned_cols=125  Identities=18%  Similarity=0.169  Sum_probs=92.3

Q ss_pred             ccccccceeeeeccCCcceEEEEEeccch---h-hhhhhhHHHHHhhhhc-cCccceeecccCC-CCcccccCCChhHHh
Q 039957          342 LAGSFGSVYKGTISDGTDVAIKIFNLQRE---R-AFRSFNSECEVLRNVR-HQNLIKILSSCST-PDFKFMPNGSLEKRL  415 (481)
Q Consensus       342 ~~g~~g~vy~~~l~~g~~vavK~l~~~~~---~-~~~~~~~e~~~l~~l~-h~niv~l~~~~~~-~~~~~~~~g~l~~~l  415 (481)
                      .++.||+||.+.- ++..++.+.+.....   . ....+.+|++++.++. ++++++++++... ..++|+.+.+|....
T Consensus        11 ~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~~~~lvmeyI~G~~L~~~~   89 (218)
T PRK12274         11 KSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWDGRHLDRSYLAGAAMYQRP   89 (218)
T ss_pred             cCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEcCEEEEEeeecCccHHhhh
Confidence            5789999996655 455666555544321   1 1224788999999995 4778888775221 236789988886543


Q ss_pred             hcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCC-CCCCeeeCCCCcEEEccccCcccC
Q 039957          416 YSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDL-KPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       416 ~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dl-k~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ..        ....+..+++++++++|    ..+|||||| ||+|||+++++.++|.|||+|+..
T Consensus        90 ~~--------~~~~~~~qi~~~L~~lH----~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~  142 (218)
T PRK12274         90 PR--------GDLAYFRAARRLLQQLH----RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRG  142 (218)
T ss_pred             hh--------hhHHHHHHHHHHHHHHH----HCcCccCCCCCcceEEEcCCCCEEEEECCCceec
Confidence            21        12356788999999999    688999999 799999999999999999999854

>smart00090 RIO RIO-like kinase

Probab=99.53  E-value=3.5e-14  Score=129.92  Aligned_cols=136  Identities=17%  Similarity=0.148  Sum_probs=98.3

Q ss_pred             hhhccccccceeeee--ccCCcceEEEEEeccchh------------------------hhhhhhHHHHHhhhhccCc--
Q 039957          339 TISLAGSFGSVYKGT--ISDGTDVAIKIFNLQRER------------------------AFRSFNSECEVLRNVRHQN--  390 (481)
Q Consensus       339 ~l~~~g~~g~vy~~~--l~~g~~vavK~l~~~~~~------------------------~~~~~~~e~~~l~~l~h~n--  390 (481)
                      ...+.|++|.||+|.  ..+|..||+|.+......                        ....+..|...+.++.+..  
T Consensus        34 ~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~i~  113 (237)
T smart00090       34 GCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAGVP  113 (237)
T ss_pred             CeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            334789999999998  668999999988653210                        0112457888888887533  


Q ss_pred             cceeecccCC-CCcccccCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCC-eeeCCCCCCCeeeCCCCcE
Q 039957          391 LIKILSSCST-PDFKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAP-IIHCDLKPTSILLDENMVA  468 (481)
Q Consensus       391 iv~l~~~~~~-~~~~~~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~-i~H~dlk~~nill~~~~~~  468 (481)
                      +.+.+++... -.+||++++++....... ...+..+...++.+++.+++|+|    ..+ |+|||+||+||+++ ++++
T Consensus       114 ~p~~~~~~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH----~~g~iiH~Dikp~NIli~-~~~i  187 (237)
T smart00090      114 VPKPIAWRRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLY----KEGELVHGDLSEYNILVH-DGKV  187 (237)
T ss_pred             CCeeeEecCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHH----hcCCEEeCCCChhhEEEE-CCCE
Confidence            3344433211 126789988886654322 22344456789999999999999    577 99999999999999 8899


Q ss_pred             EEccccCcccCC
Q 039957          469 HVSDFGISKLLG  480 (481)
Q Consensus       469 kl~Dfgl~~~~~  480 (481)
                      ++.|||.|+...
T Consensus       188 ~LiDFg~a~~~~  199 (237)
T smart00090      188 VIIDVSQSVELD  199 (237)
T ss_pred             EEEEChhhhccC
Confidence            999999998653

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.53  E-value=3.3e-15  Score=146.48  Aligned_cols=134  Identities=29%  Similarity=0.446  Sum_probs=113.4

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHH
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKR  414 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~  414 (481)
                      .++|.||.|||+... .+..+|+|.+++.....+....+|+.+++.++|+|||.++|.+...+     +||+.+|++.+.
T Consensus        23 vgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdi  102 (829)
T KOG0576|consen   23 VGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDI  102 (829)
T ss_pred             ecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccce
Confidence            478999999999854 58889999999887777778889999999999999999999876554     789999999886


Q ss_pred             hhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          415 LYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       415 l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      -+. ...++..+...+.....+|+.|+|    +.+=+|||||..|||+++.|.+|++|||.+-.+
T Consensus       103 y~~-TgplselqiayvcRetl~gl~ylh----s~gk~hRdiKGanilltd~gDvklaDfgvsaqi  162 (829)
T KOG0576|consen  103 YHV-TGPLSELQIAYVCRETLQGLKYLH----SQGKIHRDIKGANILLTDEGDVKLADFGVSAQI  162 (829)
T ss_pred             eee-cccchhHHHHHHHhhhhccchhhh----cCCcccccccccceeecccCceeecccCchhhh
Confidence            553 344555555566678889999999    788899999999999999999999999997554

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.52  E-value=5.3e-14  Score=125.87  Aligned_cols=130  Identities=18%  Similarity=0.164  Sum_probs=96.0

Q ss_pred             hhhccccccceeeeeccCCcceEEEEEeccchh----------------------hhhhhhHHHHHhhhhccCc--ccee
Q 039957          339 TISLAGSFGSVYKGTISDGTDVAIKIFNLQRER----------------------AFRSFNSECEVLRNVRHQN--LIKI  394 (481)
Q Consensus       339 ~l~~~g~~g~vy~~~l~~g~~vavK~l~~~~~~----------------------~~~~~~~e~~~l~~l~h~n--iv~l  394 (481)
                      ...+.|++|.||++...+|..++||.+......                      .......|...+.++.+++  +.+.
T Consensus        21 ~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v~~~  100 (198)
T cd05144          21 NQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPVPKP  100 (198)
T ss_pred             CccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCCCce
Confidence            344689999999999888999999987543210                      0112456777888887763  4444


Q ss_pred             ecccCCC-CcccccCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 039957          395 LSSCSTP-DFKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDF  473 (481)
Q Consensus       395 ~~~~~~~-~~~~~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Df  473 (481)
                      ++.+... .++|++++++.+....       ....+++.++++++.++|    ..+|+|||+||+||++++++.++|+||
T Consensus       101 ~~~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh----~~gi~H~Dl~p~Nill~~~~~~~liDf  169 (198)
T cd05144         101 IDWNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAY----KHGIIHGDLSEFNILVDDDEKIYIIDW  169 (198)
T ss_pred             eecCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHH----HCCCCcCCCCcccEEEcCCCcEEEEEC
Confidence            4432111 2678999988765321       234568899999999999    578999999999999999999999999


Q ss_pred             cCcccC
Q 039957          474 GISKLL  479 (481)
Q Consensus       474 gl~~~~  479 (481)
                      |.|...
T Consensus       170 g~~~~~  175 (198)
T cd05144         170 PQMVST  175 (198)
T ss_pred             CccccC
Confidence            999654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.51  E-value=4.5e-14  Score=142.73  Aligned_cols=137  Identities=27%  Similarity=0.413  Sum_probs=112.5

Q ss_pred             hhhccccccceeeee-ccCCcceEEEEEeccchhhhhhhhHHHHHhhhh-ccCccceeecccCCCC----------cccc
Q 039957          339 TISLAGSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD----------FKFM  406 (481)
Q Consensus       339 ~l~~~g~~g~vy~~~-l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~----------~~~~  406 (481)
                      ...+.|.+|.||+++ ..+|..+|+|+.+..... .++...|..++... .|||++..+|++.-.+          +|||
T Consensus        25 evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC  103 (953)
T KOG0587|consen   25 EVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFC  103 (953)
T ss_pred             EEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeecc
Confidence            345789999999998 456888999998765433 34566677777765 6999999999875432          7899


Q ss_pred             cCCChhHHhhc-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          407 PNGSLEKRLYS-HNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       407 ~~g~l~~~l~~-~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      .+||.-+.... .+..++|.....|...+.+|+++||    ...++|||||..|||++.++.+|++|||++..+.
T Consensus       104 ~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH----~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQld  174 (953)
T KOG0587|consen  104 GGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH----NNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  174 (953)
T ss_pred             CCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh----hcceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence            99999988765 3566788888889999999999999    5679999999999999999999999999987653

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.51  E-value=4.8e-14  Score=126.37  Aligned_cols=124  Identities=19%  Similarity=0.271  Sum_probs=94.5

Q ss_pred             ccccccceeeeeccCCcceEEEEEeccch--------hhhhhhhHHHHHhhhhccCccce--eecccCCC---CcccccC
Q 039957          342 LAGSFGSVYKGTISDGTDVAIKIFNLQRE--------RAFRSFNSECEVLRNVRHQNLIK--ILSSCSTP---DFKFMPN  408 (481)
Q Consensus       342 ~~g~~g~vy~~~l~~g~~vavK~l~~~~~--------~~~~~~~~e~~~l~~l~h~niv~--l~~~~~~~---~~~~~~~  408 (481)
                      ++|++|.||+|. .+|..+++|.......        ....++.+|++++.+++|+++..  ++......   -++|+++
T Consensus         3 g~G~~~~vy~~~-~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g   81 (199)
T TIGR03724         3 AKGAEAIIYLGD-FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEG   81 (199)
T ss_pred             CCCceEEEEEee-cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECC
Confidence            579999999998 4678899997543211        11245677999999998876543  33322221   1679999


Q ss_pred             CChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          409 GSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       409 g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +++.+.+.....        .++.+++.+++++|    +.+++|||++|.||+++ ++.+++.|||+++..
T Consensus        82 ~~l~~~~~~~~~--------~~~~~i~~~l~~lH----~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        82 KPLKDVIEEGND--------ELLREIGRLVGKLH----KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             ccHHHHHhhcHH--------HHHHHHHHHHHHHH----HCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            999887653211        78999999999999    68899999999999999 899999999998864

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.49  E-value=7.9e-16  Score=148.31  Aligned_cols=183  Identities=25%  Similarity=0.348  Sum_probs=143.5

Q ss_pred             CCCCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCce
Q 039957           11 NLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLII   90 (481)
Q Consensus        11 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~   90 (481)
                      .+..-...||+.|++. .+|..+..+..|+.|.|..|.+. .+|..+. .+..|++|||+.|+++ .+|..++.++ |+.
T Consensus        73 ~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~-~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkv  147 (722)
T KOG0532|consen   73 DLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAIC-NLEALTFLDLSSNQLS-HLPDGLCDLP-LKV  147 (722)
T ss_pred             cccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhh-hhhHHHHhhhccchhh-cCChhhhcCc-cee
Confidence            4455567788888887 56777888888888888888887 7888776 7888888888888887 6777777775 888


Q ss_pred             eecccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCcc
Q 039957           91 LDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQ  170 (481)
Q Consensus        91 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~  170 (481)
                      |-+++|+++ .+|..++.+..|..||.+.|++..++         +.+..+.+|+.|++..|++. .+|++...+  .|.
T Consensus       148 li~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~slp---------sql~~l~slr~l~vrRn~l~-~lp~El~~L--pLi  214 (722)
T KOG0532|consen  148 LIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQSLP---------SQLGYLTSLRDLNVRRNHLE-DLPEELCSL--PLI  214 (722)
T ss_pred             EEEecCccc-cCCcccccchhHHHhhhhhhhhhhch---------HHhhhHHHHHHHHHhhhhhh-hCCHHHhCC--cee
Confidence            888888887 57778888888888888888887663         44677788888888888887 467777755  488


Q ss_pred             EEEccCCceeecCCcccccCCCCCeEecccccceecCCcCCcC
Q 039957          171 RFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGT  213 (481)
Q Consensus       171 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~  213 (481)
                      +||+|.|+++ .+|-.|.+|+.|++|-|.+|.++ ..|..++.
T Consensus       215 ~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~  255 (722)
T KOG0532|consen  215 RLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICE  255 (722)
T ss_pred             eeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHHh
Confidence            8888888888 68888888888888888888887 45555543

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.49  E-value=7.9e-14  Score=143.67  Aligned_cols=128  Identities=20%  Similarity=0.288  Sum_probs=97.8

Q ss_pred             hhhhccccccceeeeeccCCcceEEEEEecc--ch------hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cc
Q 039957          338 ETISLAGSFGSVYKGTISDGTDVAIKIFNLQ--RE------RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FK  404 (481)
Q Consensus       338 ~~l~~~g~~g~vy~~~l~~g~~vavK~l~~~--~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~  404 (481)
                      ....++|+||.||++..... .+++|.....  ..      ...+.+.+|++++.+++|++++....++....     +|
T Consensus       338 ~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E  416 (535)
T PRK09605        338 DHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVME  416 (535)
T ss_pred             cceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEE
Confidence            34558899999999986544 3444432111  11      12245778999999999999887665554432     68


Q ss_pred             cccCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          405 FMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       405 ~~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      |+++++|.+++.         .+.+++.+++++++|+|    ..+|+|||+||+||++ +++.++|+|||+|+...
T Consensus       417 ~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH----~~giiHrDlkp~NILl-~~~~~~liDFGla~~~~  478 (535)
T PRK09605        417 YIGGKDLKDVLE---------GNPELVRKVGEIVAKLH----KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYSD  478 (535)
T ss_pred             ecCCCcHHHHHH---------HHHHHHHHHHHHHHHHH----hCCCccCCCChHHEEE-ECCcEEEEeCcccccCC
Confidence            999999988764         45678999999999999    6789999999999999 67899999999998653

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.47  E-value=9e-14  Score=136.58  Aligned_cols=130  Identities=25%  Similarity=0.317  Sum_probs=99.9

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccchhhhhhhhHHHHHhhh-hccCccceeecccCCCC-----cccccCCChhH
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQRERAFRSFNSECEVLRN-VRHQNLIKILSSCSTPD-----FKFMPNGSLEK  413 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~-----~~~~~~g~l~~  413 (481)
                      .+.|+|+++-.+.. +++...+||++...    ..+..+|+.++.. -.|+|++++.+.|.+..     ++++.+|.+.+
T Consensus       330 ~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~  405 (612)
T KOG0603|consen  330 LGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLR  405 (612)
T ss_pred             cCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHH
Confidence            35688888877764 45788889988655    2233456655544 46999999999887764     56777887777


Q ss_pred             HhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeee-CCCCcEEEccccCcccCC
Q 039957          414 RLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILL-DENMVAHVSDFGISKLLG  480 (481)
Q Consensus       414 ~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill-~~~~~~kl~Dfgl~~~~~  480 (481)
                      .+.......  .++..|+++++.|++|||    +.+|||||+||+|||+ ++.+++||+|||.++...
T Consensus       406 ri~~~~~~~--~e~~~w~~~lv~Av~~LH----~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~  467 (612)
T KOG0603|consen  406 RIRSKPEFC--SEASQWAAELVSAVDYLH----EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE  467 (612)
T ss_pred             HHHhcchhH--HHHHHHHHHHHHHHHHHH----hcCeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence            665433222  567789999999999999    6889999999999999 588999999999998764

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.44  E-value=3.3e-13  Score=120.80  Aligned_cols=124  Identities=14%  Similarity=0.149  Sum_probs=95.2

Q ss_pred             hccccccceeeeeccCCcceEEEEEeccchhh---hhh------hhHHHHHhhhhccCccceeecccCCC----------
Q 039957          341 SLAGSFGSVYKGTISDGTDVAIKIFNLQRERA---FRS------FNSECEVLRNVRHQNLIKILSSCSTP----------  401 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~g~~vavK~l~~~~~~~---~~~------~~~e~~~l~~l~h~niv~l~~~~~~~----------  401 (481)
                      ...|+||.||.... ++..+++|.+.......   ...      +.+|+..+.+++|+++..+..++...          
T Consensus        39 l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~  117 (232)
T PRK10359         39 FRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHT  117 (232)
T ss_pred             ecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccccccccCC
Confidence            35799999998655 57789999986543221   122      57889999999999999877663321          


Q ss_pred             ---CcccccCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          402 ---DFKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       402 ---~~~~~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                         .+||+++.+|.++..     .+  +  ....+++.++..+|    ..+++|||+||+||++++++ +++.|||..+.
T Consensus       118 ~~lvmEyi~G~tL~~~~~-----~~--~--~~~~~i~~~l~~lH----~~gi~H~Dikp~Nili~~~g-i~liDfg~~~~  183 (232)
T PRK10359        118 YIMLIEYIEGVELNDMPE-----IS--E--DVKAKIKASIESLH----QHGMVSGDPHKGNFIVSKNG-LRIIDLSGKRC  183 (232)
T ss_pred             eEEEEEEECCccHHHhhh-----cc--H--HHHHHHHHHHHHHH----HcCCccCCCChHHEEEeCCC-EEEEECCCccc
Confidence               257899999977632     11  1  24568999999999    67899999999999999988 99999998876


Q ss_pred             C
Q 039957          479 L  479 (481)
Q Consensus       479 ~  479 (481)
                      .
T Consensus       184 ~  184 (232)
T PRK10359        184 T  184 (232)
T ss_pred             c
Confidence            5

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.41  E-value=5.9e-13  Score=132.53  Aligned_cols=182  Identities=35%  Similarity=0.475  Sum_probs=95.7

Q ss_pred             cccCceeecccCcceecCcccccCCC-CCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhh
Q 039957           85 ATKLIILDLGFNTFSGHIPNTFGNLR-HLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIG  163 (481)
Q Consensus        85 l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~  163 (481)
                      ++.++.|++.+|.++ .+|...+.+. +|+.|++++|++..++         ..+..++.|+.|++++|+++. +|...+
T Consensus       115 ~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~~l~---------~~~~~l~~L~~L~l~~N~l~~-l~~~~~  183 (394)
T COG4886         115 LTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIESLP---------SPLRNLPNLKNLDLSFNDLSD-LPKLLS  183 (394)
T ss_pred             ccceeEEecCCcccc-cCccccccchhhcccccccccchhhhh---------hhhhccccccccccCCchhhh-hhhhhh
Confidence            344555555555544 2333333342 4555555555544431         123344455555555555542 222221


Q ss_pred             hcccCccEEEccCCceeecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCe
Q 039957          164 NFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNL  243 (481)
Q Consensus       164 ~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~  243 (481)
                      .. +.|+.|++++|++. .+|........|+++++++|.+. ..+..+.++.++..+.+.+|++.. .+..+..++.++.
T Consensus       184 ~~-~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~-~~~~~~~l~~l~~  259 (394)
T COG4886         184 NL-SNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED-LPESIGNLSNLET  259 (394)
T ss_pred             hh-hhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeee-ccchhccccccce
Confidence            21 34555555555555 34444444444666666666432 344555566666666666665543 2555666666777


Q ss_pred             eecCCCeeeecCCcccccCCCCCcEEcCCCcCcccCCcch
Q 039957          244 LHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSL  283 (481)
Q Consensus       244 L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~  283 (481)
                      |++++|+++...+  +..+.+++.|++++|.+....|...
T Consensus       260 L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~  297 (394)
T COG4886         260 LDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLIA  297 (394)
T ss_pred             ecccccccccccc--ccccCccCEEeccCccccccchhhh
Confidence            7777777764332  6777777777777777765555443

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.40  E-value=1.1e-12  Score=116.17  Aligned_cols=131  Identities=19%  Similarity=0.223  Sum_probs=86.7

Q ss_pred             ccccccceeeeeccCCcceEEEEEeccchh--hhhhh----------------------hHHHHHhhhhccCc--cceee
Q 039957          342 LAGSFGSVYKGTISDGTDVAIKIFNLQRER--AFRSF----------------------NSECEVLRNVRHQN--LIKIL  395 (481)
Q Consensus       342 ~~g~~g~vy~~~l~~g~~vavK~l~~~~~~--~~~~~----------------------~~e~~~l~~l~h~n--iv~l~  395 (481)
                      ++|++|.||++...+|..||||.+......  ....+                      ..|...+.++++..  +.+.+
T Consensus         6 g~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~   85 (187)
T cd05119           6 GTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVPKPI   85 (187)
T ss_pred             ccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCCceE
Confidence            679999999999888999999987653211  11111                      23444455544332  22333


Q ss_pred             cccCC-CCcccccCCChhHH-hhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 039957          396 SSCST-PDFKFMPNGSLEKR-LYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDF  473 (481)
Q Consensus       396 ~~~~~-~~~~~~~~g~l~~~-l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Df  473 (481)
                      ++... -.++|++++.+... +....  .. .+..+++.+++.+++++|.   +.+|+|||+||+||+++ ++.++++||
T Consensus        86 ~~~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~---~~~ivH~Dl~p~Nili~-~~~~~liDf  158 (187)
T cd05119          86 DLNRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYR---EAGLVHGDLSEYNILVD-DGKVYIIDV  158 (187)
T ss_pred             ecCCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhh---ccCcCcCCCChhhEEEE-CCcEEEEEC
Confidence            22111 12678888544321 11110  11 4567889999999999993   27899999999999999 999999999


Q ss_pred             cCcccC
Q 039957          474 GISKLL  479 (481)
Q Consensus       474 gl~~~~  479 (481)
                      |.|...
T Consensus       159 g~a~~~  164 (187)
T cd05119         159 PQAVEI  164 (187)
T ss_pred             cccccc
Confidence            999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.39  E-value=7.4e-13  Score=116.88  Aligned_cols=132  Identities=22%  Similarity=0.365  Sum_probs=94.1

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccchhhhhhhhHHHH-HhhhhccCccceeec-ccCCCC-----cccccCCChh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECE-VLRNVRHQNLIKILS-SCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~~~~~~~~e~~-~l~~l~h~niv~l~~-~~~~~~-----~~~~~~g~l~  412 (481)
                      -+.|.||.+..+... ....+++|.+...... .++|.+|-. .+---.|.||+.-++ .+...+     .||+|.|+|.
T Consensus        32 lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt-~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~  110 (378)
T KOG1345|consen   32 LGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT-QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLR  110 (378)
T ss_pred             hcccceeeEEeeeccCCceEEEeeccCcchhh-HHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchhh
Confidence            378999999888764 3566788876544322 234555543 112225888887554 333433     4789999999


Q ss_pred             HHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeC-C-CCcEEEccccCcccC
Q 039957          413 KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLD-E-NMVAHVSDFGISKLL  479 (481)
Q Consensus       413 ~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~-~-~~~~kl~Dfgl~~~~  479 (481)
                      +-+...+  +.....-+|+.|++.|++|||    +..+||||||.+|||+- . ..++|+||||+.+..
T Consensus       111 snv~~~G--igE~~~K~v~~ql~SAi~fMH----sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~  173 (378)
T KOG1345|consen  111 SNVEAAG--IGEANTKKVFAQLLSAIEFMH----SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV  173 (378)
T ss_pred             hhcCccc--ccHHHHHHHHHHHHHHHHHhh----ccchhhcccccceEEEecCCccEEEeeeccccccc
Confidence            8876543  333455679999999999999    68899999999999993 3 369999999997754

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.39  E-value=6.3e-13  Score=132.33  Aligned_cols=201  Identities=32%  Similarity=0.445  Sum_probs=153.1

Q ss_pred             EEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccc-cCceeecccCcceecCcccccCCCCCCEEEccc
Q 039957           41 NLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNAT-KLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLM  119 (481)
Q Consensus        41 ~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  119 (481)
                      .++++.|.+...+.. +. .++.++.|++.+|.++ .+|.....+. +|+.|++++|++. .+|..++.+++|+.|++++
T Consensus        97 ~l~~~~~~~~~~~~~-~~-~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~  172 (394)
T COG4886          97 SLDLNLNRLRSNISE-LL-ELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSF  172 (394)
T ss_pred             eeeccccccccCchh-hh-cccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCC
Confidence            578888887533333 33 4678888888888887 5666666664 8888899988888 4556788889999999999


Q ss_pred             ccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEccCCceeecCCcccccCCCCCeEecc
Q 039957          120 NNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLG  199 (481)
Q Consensus       120 N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~  199 (481)
                      |+++.++..         ...++.|+.|++++|+++ .+|...... ..|+++.+++|.+. ..+..+.++.++..+.++
T Consensus       173 N~l~~l~~~---------~~~~~~L~~L~ls~N~i~-~l~~~~~~~-~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~  240 (394)
T COG4886         173 NDLSDLPKL---------LSNLSNLNNLDLSGNKIS-DLPPEIELL-SALEELDLSNNSII-ELLSSLSNLKNLSGLELS  240 (394)
T ss_pred             chhhhhhhh---------hhhhhhhhheeccCCccc-cCchhhhhh-hhhhhhhhcCCcce-ecchhhhhcccccccccC
Confidence            988876432         125678888999999988 455544332 45899999999644 466778888889999999


Q ss_pred             cccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeeeecCCcccc
Q 039957          200 FNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLA  260 (481)
Q Consensus       200 ~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~  260 (481)
                      +|++. ..+..++.++.++.+++++|.++...+  +..+..++.|++++|.+...+|....
T Consensus       241 ~n~~~-~~~~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~~  298 (394)
T COG4886         241 NNKLE-DLPESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLIAL  298 (394)
T ss_pred             Cceee-eccchhccccccceecccccccccccc--ccccCccCEEeccCccccccchhhhc
Confidence            99886 347778888889999999999986544  88889999999999999876665443

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.38  E-value=2.7e-13  Score=126.07  Aligned_cols=133  Identities=26%  Similarity=0.288  Sum_probs=102.0

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccch---hhhhhhhHHHHHhhhh-ccCccceeecccCCCC-----cccccCCC
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRE---RAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD-----FKFMPNGS  410 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----~~~~~~g~  410 (481)
                      -+.|+||.|..+.-. ....+|||+++...-   ...+--..|-.+|+-. +-|.++++..++...+     +||+.+|+
T Consensus       357 lGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGGD  436 (683)
T KOG0696|consen  357 LGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGGD  436 (683)
T ss_pred             eccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCch
Confidence            378999999888654 346789998876432   1122123344455543 5788999988888776     78999999


Q ss_pred             hhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          411 LEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       411 l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      |.=++.+-+..-+ ..+.-+|..||-||=|||    +.+|+.||+|-.||++|.+|++||+|||++|-
T Consensus       437 LMyhiQQ~GkFKE-p~AvFYAaEiaigLFFLh----~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE  499 (683)
T KOG0696|consen  437 LMYHIQQVGKFKE-PVAVFYAAEIAIGLFFLH----SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  499 (683)
T ss_pred             hhhHHHHhcccCC-chhhhhhHHHHHHhhhhh----cCCeeeeeccccceEeccCCceEeeecccccc
Confidence            9988876443333 455668999999999999    78999999999999999999999999999874

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.37  E-value=7.5e-13  Score=119.57  Aligned_cols=115  Identities=27%  Similarity=0.404  Sum_probs=87.6

Q ss_pred             CCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----------cccccCCChhHHhhcCCCcc
Q 039957          356 DGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----------FKFMPNGSLEKRLYSHNYFL  422 (481)
Q Consensus       356 ~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----------~~~~~~g~l~~~l~~~~~~~  422 (481)
                      .+..|++|......  ....++..+|..++..+.|+|+++++.++.-..           +|||. +++...++   ..+
T Consensus        40 ~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~-~nl~~vi~---~el  115 (369)
T KOG0665|consen   40 LGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMD-ANLCQVIL---MEL  115 (369)
T ss_pred             ccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhh-hHHHHHHH---Hhc
Confidence            36778888764331  233455677899999999999999998876543           23442 45554443   223


Q ss_pred             CHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          423 DILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       423 ~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      +=...-.|..|+..|++|+|    +.+|+|||+||+||++..++.+||.|||+|+.
T Consensus       116 DH~tis~i~yq~~~~ik~lh----s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~  167 (369)
T KOG0665|consen  116 DHETISYILYQMLCGIKHLH----SAGIIHRDLKPSNIVVNSDCTLKILDFGLART  167 (369)
T ss_pred             chHHHHHHHHHHHHHHHHHH----hcceeecccCcccceecchhheeeccchhhcc
Confidence            44456678999999999999    78899999999999999999999999999975

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.37  E-value=4e-12  Score=108.24  Aligned_cols=126  Identities=21%  Similarity=0.256  Sum_probs=98.5

Q ss_pred             ccccccceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhhhhcc--CccceeecccCCCC-----cccccCCChhHH
Q 039957          342 LAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRH--QNLIKILSSCSTPD-----FKFMPNGSLEKR  414 (481)
Q Consensus       342 ~~g~~g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~-----~~~~~~g~l~~~  414 (481)
                      +.|.++.+|++.... ..+++|.......  ...+..|++.+..+++  ..+++++++....+     ++|++++.+...
T Consensus         7 ~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~   83 (155)
T cd05120           7 KGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV   83 (155)
T ss_pred             ccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC
Confidence            578899999998754 6788888754332  3467889999999987  47888887766533     456766666433


Q ss_pred             hhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          415 LYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       415 l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                              ++..+..++.+++++++++|... ..+++|+|++|+||++++.+.+++.|||.++..
T Consensus        84 --------~~~~~~~~~~~~~~~l~~lh~~~-~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          84 --------SEEEKEDIAEQLAELLAKLHQLP-LLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             --------CHHHHHHHHHHHHHHHHHHhCCC-ceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence                    45667788999999999999644 367999999999999999999999999998764

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.37  E-value=1.4e-12  Score=125.73  Aligned_cols=134  Identities=23%  Similarity=0.284  Sum_probs=108.9

Q ss_pred             hccccccceeeeeccCCcceEEEEEec--cchhhhhhhhHHHHHhhhhc-cCccceeecccCCCCcccc--cC--CChhH
Q 039957          341 SLAGSFGSVYKGTISDGTDVAIKIFNL--QRERAFRSFNSECEVLRNVR-HQNLIKILSSCSTPDFKFM--PN--GSLEK  413 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~g~~vavK~l~~--~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~--~~--g~l~~  413 (481)
                      .|+|+...||++.-.+...+|+|+...  .+.+....|..|+..|.+++ |.+||++++|-...++-||  +-  -+|.+
T Consensus       369 iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~Gd~DL~k  448 (677)
T KOG0596|consen  369 IGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECGDIDLNK  448 (677)
T ss_pred             hcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecccccHHH
Confidence            478999999999988888888876543  34556678999999999996 8999999999887777775  33  46778


Q ss_pred             HhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          414 RLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       414 ~l~~~~-~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      ++.+.. ...+| .+..+-.++..|+.++|    ..+|||.|+||.|.|+ =.|.+||.|||+|+.+.
T Consensus       449 iL~k~~~~~~~~-~lk~ywkqML~aV~~IH----~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~  510 (677)
T KOG0596|consen  449 ILKKKKSIDPDW-FLKFYWKQMLLAVKTIH----QHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQ  510 (677)
T ss_pred             HHHhccCCCchH-HHHHHHHHHHHHHHHHH----HhceeecCCCcccEEE-EeeeEEeeeechhcccC
Confidence            887644 33446 55678899999999999    6789999999999987 35889999999999875

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.35  E-value=4e-12  Score=116.57  Aligned_cols=126  Identities=17%  Similarity=0.187  Sum_probs=92.2

Q ss_pred             cccccceeeeeccCCcceEEEEEeccc--------h-----hhhhhhhHHHHHhhhhccCcc--ceeecccCCC------
Q 039957          343 AGSFGSVYKGTISDGTDVAIKIFNLQR--------E-----RAFRSFNSECEVLRNVRHQNL--IKILSSCSTP------  401 (481)
Q Consensus       343 ~g~~g~vy~~~l~~g~~vavK~l~~~~--------~-----~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~~------  401 (481)
                      .|+.|++|.+... +..+++|.+....        .     .....+.+|++++.+++|+++  ++.++++...      
T Consensus        42 ~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~  120 (239)
T PRK01723         42 AKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYR  120 (239)
T ss_pred             CCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCccee
Confidence            6888999988775 6678888774311        0     112346779999999998875  5555543221      


Q ss_pred             ---CcccccC-CChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcc
Q 039957          402 ---DFKFMPN-GSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK  477 (481)
Q Consensus       402 ---~~~~~~~-g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~  477 (481)
                         -++|+++ +++.+++...  .++.    ..+.+|++++.++|    ..+|+|||+||+|||++.+++++|+|||.++
T Consensus       121 ~~lV~e~l~G~~~L~~~l~~~--~l~~----~~~~~i~~~l~~lH----~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~  190 (239)
T PRK01723        121 ADILIERIEGARDLVALLQEA--PLSE----EQWQAIGQLIARFH----DAGVYHADLNAHNILLDPDGKFWLIDFDRGE  190 (239)
T ss_pred             eeEEEEecCCCCCHHHHHhcC--CCCH----HHHHHHHHHHHHHH----HCCCCCCCCCchhEEEcCCCCEEEEECCCcc
Confidence               1457786 6888877543  2222    23568899999999    6889999999999999999999999999987


Q ss_pred             cC
Q 039957          478 LL  479 (481)
Q Consensus       478 ~~  479 (481)
                      ..
T Consensus       191 ~~  192 (239)
T PRK01723        191 LR  192 (239)
T ss_pred             cC
Confidence            64

>PLN03150 hypothetical protein; Provisional

Probab=99.33  E-value=2.1e-12  Score=134.70  Aligned_cols=86  Identities=36%  Similarity=0.652  Sum_probs=49.8

Q ss_pred             CCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeecccCcceecCcccccCCCCCCEEEcc
Q 039957           39 IRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLL  118 (481)
Q Consensus        39 L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  118 (481)
                      ++.|+|++|.++|.+|..+. .+++|+.|+|++|+++|.+|..+..+++|+.|+|++|+++|.+|+.++++++|++|+|+
T Consensus       420 v~~L~L~~n~L~g~ip~~i~-~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        420 IDGLGLDNQGLRGFIPNDIS-KLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEECCCCCccccCCHHHh-CCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            45555555555555555554 45555555555555555555555555555555555555555555555555555555555


Q ss_pred             cccCccc
Q 039957          119 MNNLTTE  125 (481)
Q Consensus       119 ~N~l~~~  125 (481)
                      +|++++.
T Consensus       499 ~N~l~g~  505 (623)
T PLN03150        499 GNSLSGR  505 (623)
T ss_pred             CCccccc
Confidence            5555543

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.31  E-value=1.2e-12  Score=121.23  Aligned_cols=140  Identities=19%  Similarity=0.328  Sum_probs=106.8

Q ss_pred             hhhhhccccccceeeeeccC------CcceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC------c
Q 039957          337 LETISLAGSFGSVYKGTISD------GTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD------F  403 (481)
Q Consensus       337 L~~l~~~g~~g~vy~~~l~~------g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~  403 (481)
                      +..+.-+|.||.+|+|.+.+      .+.|-||..+... .-....+..|...+..+.|||+.++.+.|.+..      |
T Consensus       288 l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y  367 (563)
T KOG1024|consen  288 LSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLY  367 (563)
T ss_pred             chhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEE
Confidence            44566789999999996532      3445566543322 223345677888888899999999999886642      3


Q ss_pred             ccccCCChhHHhh-----cCC--CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCc
Q 039957          404 KFMPNGSLEKRLY-----SHN--YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGIS  476 (481)
Q Consensus       404 ~~~~~g~l~~~l~-----~~~--~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~  476 (481)
                      .++.-|.|..++.     +..  ..+.-.+...+|.|+|.|++|||    .++|||.||-++|.++|+...+|++|-.++
T Consensus       368 ~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh----~~~ViHkDiAaRNCvIdd~LqVkltDsaLS  443 (563)
T KOG1024|consen  368 PATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH----NHGVIHKDIAARNCVIDDQLQVKLTDSALS  443 (563)
T ss_pred             eccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH----hcCcccchhhhhcceehhheeEEeccchhc
Confidence            4667799998887     221  23444567789999999999999    788999999999999999999999999998


Q ss_pred             ccCC
Q 039957          477 KLLG  480 (481)
Q Consensus       477 ~~~~  480 (481)
                      |.+.
T Consensus       444 RDLF  447 (563)
T KOG1024|consen  444 RDLF  447 (563)
T ss_pred             cccC
Confidence            8753

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.30  E-value=1.2e-11  Score=119.26  Aligned_cols=136  Identities=26%  Similarity=0.326  Sum_probs=103.2

Q ss_pred             hhhhccccccceeeeeccCC--cceEEEEEeccchhhhhhhhHHHHHhhhhcc----Cccceeeccc-CCCCcccc----
Q 039957          338 ETISLAGSFGSVYKGTISDG--TDVAIKIFNLQRERAFRSFNSECEVLRNVRH----QNLIKILSSC-STPDFKFM----  406 (481)
Q Consensus       338 ~~l~~~g~~g~vy~~~l~~g--~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h----~niv~l~~~~-~~~~~~~~----  406 (481)
                      ....++|+||.||.+.....  ..+|+|............+..|+.++..+..    .++..+.... ....+.||    
T Consensus        23 ~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l  102 (322)
T KOG1164|consen   23 GKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSL  102 (322)
T ss_pred             eeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEec
Confidence            34457899999999985443  4677887655433333367788888888763    4777777766 35556654    


Q ss_pred             cCCChhHHhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCC-----CcEEEccccCcc
Q 039957          407 PNGSLEKRLYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDEN-----MVAHVSDFGISK  477 (481)
Q Consensus       407 ~~g~l~~~l~~~-~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~-----~~~kl~Dfgl~~  477 (481)
                      -+.+|.+..... ....+....++||.|+..+|+++|    +.+++||||||.|+.++..     ..+.+.|||+|+
T Consensus       103 ~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH----~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar  175 (322)
T KOG1164|consen  103 LGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH----SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR  175 (322)
T ss_pred             cCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH----hcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence            467787765433 356778899999999999999999    6889999999999999764     469999999998

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.28  E-value=6.2e-12  Score=117.83  Aligned_cols=127  Identities=26%  Similarity=0.359  Sum_probs=104.3

Q ss_pred             hccccccceeeeecc----CCcceEEEEEeccchhhhhhhhHHHHHhhhhc-cCccceeecccCCCC-----cccccCCC
Q 039957          341 SLAGSFGSVYKGTIS----DGTDVAIKIFNLQRERAFRSFNSECEVLRNVR-HQNLIKILSSCSTPD-----FKFMPNGS  410 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~----~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-----~~~~~~g~  410 (481)
                      .+.|.|++||+++..    ....||+|.+......  .....|++++..+. +.||+++.+++...+     ++|++.-+
T Consensus        44 igeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~  121 (418)
T KOG1167|consen   44 IGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDR  121 (418)
T ss_pred             ccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCccC
Confidence            478999999999864    3577999988765433  34778999998875 889999999887765     67888888


Q ss_pred             hhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCC-CCcEEEccccCcc
Q 039957          411 LEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDE-NMVAHVSDFGISK  477 (481)
Q Consensus       411 l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~-~~~~kl~Dfgl~~  477 (481)
                      ..++...    ++..+...+...+..||+++|    ..+||||||||+|+|.+. .++-.|.|||+|.
T Consensus       122 f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h----~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~  181 (418)
T KOG1167|consen  122 FRDLYRS----LSLAEIRWYLRNLLKALAHLH----KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ  181 (418)
T ss_pred             HHHHHhc----CCHHHHHHHHHHHHHHhhhhh----ccCccccCCCccccccccccCCceEEechhHH
Confidence            8777653    445667778889999999999    688999999999999987 5889999999986

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.27  E-value=3.3e-12  Score=115.91  Aligned_cols=134  Identities=20%  Similarity=0.249  Sum_probs=102.1

Q ss_pred             hhccccccceeeeecc-CCcceEEEEEeccch---hhhhhhhHHHHHhhh-hccCccceeecccCCCC-----cccccCC
Q 039957          340 ISLAGSFGSVYKGTIS-DGTDVAIKIFNLQRE---RAFRSFNSECEVLRN-VRHQNLIKILSSCSTPD-----FKFMPNG  409 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~-----~~~~~~g  409 (481)
                      +.+.|+|..|..+.+. ..+.+|+|.++..-.   ........|-.+..+ -+||.+|.+..++....     .||+++|
T Consensus       257 vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~gg  336 (593)
T KOG0695|consen  257 VIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGG  336 (593)
T ss_pred             eecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCc
Confidence            4478999998888764 467788887765422   222334445555544 46999999998887654     4799999


Q ss_pred             ChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          410 SLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       410 ~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      +|.-++... ..+....+.-+...|.-||.|||    +++|+.||+|-.|||+|.+|++|+.|||++|-
T Consensus       337 dlmfhmqrq-rklpeeharfys~ei~lal~flh----~rgiiyrdlkldnvlldaeghikltdygmcke  400 (593)
T KOG0695|consen  337 DLMFHMQRQ-RKLPEEHARFYSAEICLALNFLH----ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE  400 (593)
T ss_pred             ceeeehhhh-hcCcHHHhhhhhHHHHHHHHHHh----hcCeeeeeccccceEEccCCceeecccchhhc
Confidence            998776543 34555555567778999999999    78999999999999999999999999999874

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.27  E-value=3.5e-12  Score=109.48  Aligned_cols=113  Identities=28%  Similarity=0.366  Sum_probs=40.8

Q ss_pred             ccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeecccCcceecCcccccCCCCC
Q 039957           33 IFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHL  112 (481)
Q Consensus        33 ~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  112 (481)
                      +.+..++++|+|++|+|+ .+. .++..+.+|+.|+|++|.|+.. + .+..++.|++|++++|+|+.+.+.....+++|
T Consensus        15 ~~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~~l-~-~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L   90 (175)
T PF14580_consen   15 YNNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQITKL-E-GLPGLPRLKTLDLSNNRISSISEGLDKNLPNL   90 (175)
T ss_dssp             -----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S-CHHHHHH-TT-
T ss_pred             cccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCccc-c-CccChhhhhhcccCCCCCCccccchHHhCCcC
Confidence            556667888888888887 554 3433578888999999988743 3 47778889999999999885433222468899


Q ss_pred             CEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccce
Q 039957          113 SVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGG  156 (481)
Q Consensus       113 ~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~  156 (481)
                      ++|++++|+|..+...       ..+..+++|+.|+|.+|+++.
T Consensus        91 ~~L~L~~N~I~~l~~l-------~~L~~l~~L~~L~L~~NPv~~  127 (175)
T PF14580_consen   91 QELYLSNNKISDLNEL-------EPLSSLPKLRVLSLEGNPVCE  127 (175)
T ss_dssp             -EEE-TTS---SCCCC-------GGGGG-TT--EEE-TT-GGGG
T ss_pred             CEEECcCCcCCChHHh-------HHHHcCCCcceeeccCCcccc
Confidence            9999999988876332       346678888889999888863

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.25  E-value=7.7e-13  Score=132.00  Aligned_cols=249  Identities=26%  Similarity=0.286  Sum_probs=108.5

Q ss_pred             CCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeecccCcceecCcccccCCCCCCE
Q 039957           35 NISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSV  114 (481)
Q Consensus        35 ~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  114 (481)
                      .+..++.+++..|.+. .+-..+. .+.+|+.|++.+|+|.++. ..+..+++|++|++++|.|+.+.+  +..++.|+.
T Consensus        70 ~l~~l~~l~l~~n~i~-~~~~~l~-~~~~l~~l~l~~n~i~~i~-~~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~  144 (414)
T KOG0531|consen   70 SLTSLKELNLRQNLIA-KILNHLS-KLKSLEALDLYDNKIEKIE-NLLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKE  144 (414)
T ss_pred             HhHhHHhhccchhhhh-hhhcccc-cccceeeeeccccchhhcc-cchhhhhcchheeccccccccccc--hhhccchhh
Confidence            3444455555555554 2222222 3555555555555554222 224445555555555555554322  444455555


Q ss_pred             EEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEccCCceeecCCcccccCCCCC
Q 039957          115 LSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLI  194 (481)
Q Consensus       115 L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~  194 (481)
                      |++++|.|+.+.          .+..+..|+.+++++|++...-+.....+ .+++.+++.+|.+..  ...+..+..+.
T Consensus       145 L~l~~N~i~~~~----------~~~~l~~L~~l~l~~n~i~~ie~~~~~~~-~~l~~l~l~~n~i~~--i~~~~~~~~l~  211 (414)
T KOG0531|consen  145 LNLSGNLISDIS----------GLESLKSLKLLDLSYNRIVDIENDELSEL-ISLEELDLGGNSIRE--IEGLDLLKKLV  211 (414)
T ss_pred             heeccCcchhcc----------CCccchhhhcccCCcchhhhhhhhhhhhc-cchHHHhccCCchhc--ccchHHHHHHH
Confidence            555555555441          12234455555555555543322101111 234445555554431  11222233333


Q ss_pred             eEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCc
Q 039957          195 YLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNK  274 (481)
Q Consensus       195 ~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~  274 (481)
                      .+++..|.++..-+  +..+..                      ..|+.+++++|++.. .+..+..+..+..|++.+|+
T Consensus       212 ~~~l~~n~i~~~~~--l~~~~~----------------------~~L~~l~l~~n~i~~-~~~~~~~~~~l~~l~~~~n~  266 (414)
T KOG0531|consen  212 LLSLLDNKISKLEG--LNELVM----------------------LHLRELYLSGNRISR-SPEGLENLKNLPVLDLSSNR  266 (414)
T ss_pred             HhhcccccceeccC--cccchh----------------------HHHHHHhcccCcccc-ccccccccccccccchhhcc
Confidence            33444444432211  111111                      024555555555542 22334445555555555555


Q ss_pred             CcccCCcchhccccCcEEEccCcccCCC---CCC-ccccCCcCcEEEccCCeeeeecc
Q 039957          275 LTSSIPSSLWSLGYILEINLSSNLLNDS---LPS-NVQKLKVLRVLDLSRNQLSGDIP  328 (481)
Q Consensus       275 l~~~~p~~~~~l~~L~~L~l~~N~l~~~---~p~-~~~~l~~L~~L~l~~N~l~~~~p  328 (481)
                      +...-.  +.....+..+....|.+...   ... .....+.++...+..|.+....+
T Consensus       267 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (414)
T KOG0531|consen  267 ISNLEG--LERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISS  322 (414)
T ss_pred             cccccc--ccccchHHHhccCcchhcchhhhhccccccccccccccccccCccccccc
Confidence            542211  12223333344444443311   111 13455667777777777765443

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.23  E-value=3.5e-12  Score=109.49  Aligned_cols=130  Identities=25%  Similarity=0.313  Sum_probs=51.8

Q ss_pred             hhCCCCCCeeeCcCCcccccCChhcc-CCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhc-cccc
Q 039957            9 IGNLQNLKSLFLGANNLSGLIPPMIF-NISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSI-TNAT   86 (481)
Q Consensus         9 ~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~   86 (481)
                      +.+..++++|+|++|+|+.+.  .+. .+.+|+.|+|++|.|+ .++. +. .++.|++|++++|+|+. ++..+ ..++
T Consensus        15 ~~n~~~~~~L~L~~n~I~~Ie--~L~~~l~~L~~L~Ls~N~I~-~l~~-l~-~L~~L~~L~L~~N~I~~-i~~~l~~~lp   88 (175)
T PF14580_consen   15 YNNPVKLRELNLRGNQISTIE--NLGATLDKLEVLDLSNNQIT-KLEG-LP-GLPRLKTLDLSNNRISS-ISEGLDKNLP   88 (175)
T ss_dssp             -----------------------S--TT-TT--EEE-TTS--S---TT------TT--EEE--SS---S--CHHHHHH-T
T ss_pred             ccccccccccccccccccccc--chhhhhcCCCEEECCCCCCc-cccC-cc-ChhhhhhcccCCCCCCc-cccchHHhCC
Confidence            455567899999999998653  355 5789999999999998 6664 43 68999999999999985 44444 5789


Q ss_pred             cCceeecccCcceecCc-ccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEc
Q 039957           87 KLIILDLGFNTFSGHIP-NTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLIL  149 (481)
Q Consensus        87 ~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L  149 (481)
                      +|+.|+|++|+|...-. ..+..+++|++|+|.+|.++..  ..|+..   -+..+|+|+.||-
T Consensus        89 ~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~--~~YR~~---vi~~lP~Lk~LD~  147 (175)
T PF14580_consen   89 NLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK--KNYRLF---VIYKLPSLKVLDG  147 (175)
T ss_dssp             T--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS--TTHHHH---HHHH-TT-SEETT
T ss_pred             cCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccch--hhHHHH---HHHHcChhheeCC
Confidence            99999999999975322 4577899999999999998865  223221   2344666777663

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.23  E-value=9.8e-13  Score=117.74  Aligned_cols=141  Identities=25%  Similarity=0.310  Sum_probs=94.3

Q ss_pred             eccCcchhCCCCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhc
Q 039957            3 GQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSI   82 (481)
Q Consensus         3 g~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~   82 (481)
                      |.+-.++.-.+.|+++|||+|.|+ .+.++..-++.++.|++|+|.|. .+.. +. .+++|+.||||+|.++ .+..+-
T Consensus       274 G~~~~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~n-La-~L~~L~~LDLS~N~Ls-~~~Gwh  348 (490)
T KOG1259|consen  274 GSALVSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQN-LA-ELPQLQLLDLSGNLLA-ECVGWH  348 (490)
T ss_pred             CceEEecchHhhhhhccccccchh-hhhhhhhhccceeEEecccccee-eehh-hh-hcccceEeecccchhH-hhhhhH
Confidence            344444555566777788887776 34566667777778888888776 4444 32 4777778888877776 455555


Q ss_pred             cccccCceeecccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCcccee
Q 039957           83 TNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGI  157 (481)
Q Consensus        83 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~  157 (481)
                      ..+.+.+.|.|+.|.|...  ..++.|-+|..||++.|+|.....       ..++++++.|+.+.|.+|.+.+.
T Consensus       349 ~KLGNIKtL~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~lde-------V~~IG~LPCLE~l~L~~NPl~~~  414 (490)
T KOG1259|consen  349 LKLGNIKTLKLAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDE-------VNHIGNLPCLETLRLTGNPLAGS  414 (490)
T ss_pred             hhhcCEeeeehhhhhHhhh--hhhHhhhhheeccccccchhhHHH-------hcccccccHHHHHhhcCCCcccc
Confidence            6677777777777776532  346667777777777777766532       24567777777777777777643

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.22  E-value=5.2e-11  Score=103.64  Aligned_cols=134  Identities=27%  Similarity=0.364  Sum_probs=97.2

Q ss_pred             hccccccceeeee-ccCCcceEEEEEeccchhhhhhhhHHHHHhhhhcc-CccceeecccCCCCccc--c--cCCChhHH
Q 039957          341 SLAGSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRH-QNLIKILSSCSTPDFKF--M--PNGSLEKR  414 (481)
Q Consensus       341 ~~~g~~g~vy~~~-l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~--~--~~g~l~~~  414 (481)
                      .++|+||.+|.|. +.+|..||+|.-...  ........|..+-+.+++ ..|..+.-+..+..+..  |  -+-+|.+.
T Consensus        23 iGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLLGPsLEdL  100 (341)
T KOG1163|consen   23 IGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLLGPSLEDL  100 (341)
T ss_pred             ecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeeccCccHHHH
Confidence            3789999999997 678999999975332  223445667777777764 34444444444444432  2  35677766


Q ss_pred             hhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeC---CCCcEEEccccCcccCC
Q 039957          415 LYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLD---ENMVAHVSDFGISKLLG  480 (481)
Q Consensus       415 l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~---~~~~~kl~Dfgl~~~~~  480 (481)
                      ..-.....+....+-.|-|+..-++|+|    .++.+||||||+|.|..   ....+.+.|||+||.+.
T Consensus       101 fnfC~R~ftmkTvLMLaDQml~RiEyvH----~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen  101 FNFCSRRFTMKTVLMLADQMLSRIEYVH----LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             HHHHhhhhhHHhHHHHHHHHHHHHHHHH----hhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence            5444445677788889999999999999    56699999999999985   35689999999999764

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.22  E-value=3.6e-11  Score=119.92  Aligned_cols=132  Identities=18%  Similarity=0.240  Sum_probs=89.9

Q ss_pred             ccccccceeeeeccCCcceEEEEEeccchhhh----------------------------------------hhhhHHHH
Q 039957          342 LAGSFGSVYKGTISDGTDVAIKIFNLQRERAF----------------------------------------RSFNSECE  381 (481)
Q Consensus       342 ~~g~~g~vy~~~l~~g~~vavK~l~~~~~~~~----------------------------------------~~~~~e~~  381 (481)
                      ++|++|.||+|++.+|..||||..........                                        -+|..|.+
T Consensus       126 asaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~Ea~  205 (437)
T TIGR01982       126 AAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRREAA  205 (437)
T ss_pred             eeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHHHHH
Confidence            67999999999999999999998854321000                                        02444555


Q ss_pred             Hhhhhc----cCccceeecccC---CC---CcccccCCChhHHhhcCCCccCHHHHHHHHHHHHH-HHHHHhcCCCCCCe
Q 039957          382 VLRNVR----HQNLIKILSSCS---TP---DFKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGS-TLEYLHHGHSSAPI  450 (481)
Q Consensus       382 ~l~~l~----h~niv~l~~~~~---~~---~~~~~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~-~l~~lH~~~~~~~i  450 (481)
                      .+.+++    +..-+.+...+.   +.   .+||++++++.+.........   .+.+++..+++ .+..+|    ..++
T Consensus       206 n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~----~~g~  278 (437)
T TIGR01982       206 NASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVL----RDGF  278 (437)
T ss_pred             HHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHH----hCCc
Confidence            555443    222233322222   11   278999999987654321112   24557777766 467788    5789


Q ss_pred             eeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          451 IHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       451 ~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      +|+|+||.||++++++.+++.|||+++.+.
T Consensus       279 ~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       279 FHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             eeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            999999999999999999999999998764

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PLN03150 hypothetical protein; Provisional

Probab=99.20  E-value=2.3e-11  Score=126.87  Aligned_cols=113  Identities=32%  Similarity=0.448  Sum_probs=99.8

Q ss_pred             CCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeeeecCCcccccCCCCCcEEcC
Q 039957          192 GLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLG  271 (481)
Q Consensus       192 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls  271 (481)
                      .++.|+|++|.+.|.+|..++.+++|+.|+|++|.+.|.+|..++.+++|+.|+|++|+++|.+|..++.+++|+.|+++
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            37789999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCcCcccCCcchhcc-ccCcEEEccCcccCCCCC
Q 039957          272 SNKLTSSIPSSLWSL-GYILEINLSSNLLNDSLP  304 (481)
Q Consensus       272 ~N~l~~~~p~~~~~l-~~L~~L~l~~N~l~~~~p  304 (481)
                      +|+++|.+|..+..+ ..+..+++.+|......|
T Consensus       499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p  532 (623)
T PLN03150        499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP  532 (623)
T ss_pred             CCcccccCChHHhhccccCceEEecCCccccCCC
Confidence            999999999988764 456788888887544444

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.19  E-value=2.3e-11  Score=131.59  Aligned_cols=88  Identities=16%  Similarity=0.291  Sum_probs=66.7

Q ss_pred             hcc-CccceeecccCCC------------CcccccCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeee
Q 039957          386 VRH-QNLIKILSSCSTP------------DFKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH  452 (481)
Q Consensus       386 l~h-~niv~l~~~~~~~------------~~~~~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H  452 (481)
                      ++| +||++++++|...            .+||+ .++|.+++......+++.++..++.||++||+|+|    +.+|||
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH----~~gIvH  103 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAH----SQGIVV  103 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHH----hCCeee
Confidence            344 4666666665221            13455 57999999765566889999999999999999999    678999


Q ss_pred             CCCCCCCeeeCC-------------------CCcEEEccccCccc
Q 039957          453 CDLKPTSILLDE-------------------NMVAHVSDFGISKL  478 (481)
Q Consensus       453 ~dlk~~nill~~-------------------~~~~kl~Dfgl~~~  478 (481)
                      |||||+|||++.                   ++.+|++|||+++.
T Consensus       104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~  148 (793)
T PLN00181        104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRR  148 (793)
T ss_pred             ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccc
Confidence            999999999954                   45666777777653

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.16  E-value=9.6e-12  Score=109.89  Aligned_cols=125  Identities=28%  Similarity=0.542  Sum_probs=103.9

Q ss_pred             ccccceeeeeccCCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHHhh
Q 039957          344 GSFGSVYKGTISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRLY  416 (481)
Q Consensus       344 g~~g~vy~~~l~~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~l~  416 (481)
                      ...|..|+|.+. |+.+.+|++...+  .+..++|..|+..++...||||+.++|.|.++.     ..|||.|+|+..++
T Consensus       201 ~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlh  279 (448)
T KOG0195|consen  201 SHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLH  279 (448)
T ss_pred             CCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHh
Confidence            456888999874 6777778776654  345678999999999999999999999998875     45999999999999


Q ss_pred             cCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 039957          417 SHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVS  471 (481)
Q Consensus       417 ~~~-~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~  471 (481)
                      +.. ...+-.++.+.|.++|+|++|||+.  ++-|..--+.++.+++|++.++||+
T Consensus       280 e~t~vvvd~sqav~faldiargmaflhsl--ep~ipr~~lns~hvmidedltaris  333 (448)
T KOG0195|consen  280 EQTSVVVDHSQAVRFALDIARGMAFLHSL--EPMIPRFYLNSKHVMIDEDLTARIS  333 (448)
T ss_pred             cCccEEEecchHHHHHHHHHhhHHHHhhc--chhhhhhhcccceEEecchhhhhee
Confidence            743 4567778999999999999999974  3556667899999999999999886

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.14  E-value=3.4e-12  Score=127.36  Aligned_cols=217  Identities=30%  Similarity=0.359  Sum_probs=129.5

Q ss_pred             CCCccEEEccCccceeecchhccccccCceeecccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCC
Q 039957           61 LPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTN  140 (481)
Q Consensus        61 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~  140 (481)
                      +..++.+++..|.+.. +-..+..+++|+.|++..|.|..+ ...+..+++|++|++++|+|+.+.          .+..
T Consensus        71 l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i~----------~l~~  138 (414)
T KOG0531|consen   71 LTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKLE----------GLST  138 (414)
T ss_pred             hHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhc-ccchhhhhcchheecccccccccc----------chhh
Confidence            4455555555555542 223345555555555555555532 222445555555555555555441          1233


Q ss_pred             CCCCcEEEccCCccceeCChhhhhcccCccEEEccCCceeecCCcccccCCCCCeEecccccceecCC-cCCcCCCCCCe
Q 039957          141 CRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIP-TSIGTLKQLQG  219 (481)
Q Consensus       141 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~  219 (481)
                      ++.|+.|++++|.|+..                           ..+..+.+|+.+++++|++....+ . ...+.+++.
T Consensus       139 l~~L~~L~l~~N~i~~~---------------------------~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~  190 (414)
T KOG0531|consen  139 LTLLKELNLSGNLISDI---------------------------SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEE  190 (414)
T ss_pred             ccchhhheeccCcchhc---------------------------cCCccchhhhcccCCcchhhhhhhhh-hhhccchHH
Confidence            33444555555544321                           123336667777777777764333 2 456677777


Q ss_pred             eecCCCcCCCCCCccccCccCCCeeecCCCeeeecCCcccccCC--CCCcEEcCCCcCcccCCcchhccccCcEEEccCc
Q 039957          220 FFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLT--SLRELDLGSNKLTSSIPSSLWSLGYILEINLSSN  297 (481)
Q Consensus       220 l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~--~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N  297 (481)
                      +++.+|.+..  ...+..+..+..+++..|.++...+  +..+.  +|+.+++++|.+. .++..+..+..+..+++.+|
T Consensus       191 l~l~~n~i~~--i~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n  265 (414)
T KOG0531|consen  191 LDLGGNSIRE--IEGLDLLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSN  265 (414)
T ss_pred             HhccCCchhc--ccchHHHHHHHHhhcccccceeccC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhc
Confidence            7777777653  3344445556666888888874432  22233  3899999999997 44456677888999999999


Q ss_pred             ccCCCCCCccccCCcCcEEEccCCeee
Q 039957          298 LLNDSLPSNVQKLKVLRVLDLSRNQLS  324 (481)
Q Consensus       298 ~l~~~~p~~~~~l~~L~~L~l~~N~l~  324 (481)
                      ++...  ..+.....+..+....|++.
T Consensus       266 ~~~~~--~~~~~~~~~~~~~~~~~~~~  290 (414)
T KOG0531|consen  266 RISNL--EGLERLPKLSELWLNDNKLA  290 (414)
T ss_pred             ccccc--ccccccchHHHhccCcchhc
Confidence            98754  33555667788888888876

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.14  E-value=2.3e-10  Score=110.43  Aligned_cols=131  Identities=37%  Similarity=0.549  Sum_probs=106.4

Q ss_pred             cccccceeeeeccCCcceEEEEEeccchh---hhhhhhHHHHHhhhhccC-ccceeecccCCCC-----cccccCCChhH
Q 039957          343 AGSFGSVYKGTISDGTDVAIKIFNLQRER---AFRSFNSECEVLRNVRHQ-NLIKILSSCSTPD-----FKFMPNGSLEK  413 (481)
Q Consensus       343 ~g~~g~vy~~~l~~g~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~-----~~~~~~g~l~~  413 (481)
                      .|.|+.||++...  ..+++|.+......   ....+.+|...++.+.|+ +++++...+....     ++|+.++++.+
T Consensus        10 ~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~   87 (384)
T COG0515          10 EGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLED   87 (384)
T ss_pred             CCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHH
Confidence            6888999999866  67888887654432   356788899999999988 7999988775443     45888999986


Q ss_pred             HhhcCC--CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCC-cEEEccccCcccC
Q 039957          414 RLYSHN--YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENM-VAHVSDFGISKLL  479 (481)
Q Consensus       414 ~l~~~~--~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~-~~kl~Dfgl~~~~  479 (481)
                      .+....  ..........++.+++.+++|+|    ..+++|||+||+||+++..+ .+|++|||.++.+
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H----~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~  152 (384)
T COG0515          88 LLKKIGRKGPLSESEALFILAQILSALEYLH----SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLL  152 (384)
T ss_pred             HHHhcccccCCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHeeecCCCCeEEEeccCcceec
Confidence            665433  25677888899999999999999    57799999999999999988 7999999998743

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.14  E-value=1.1e-11  Score=111.09  Aligned_cols=204  Identities=19%  Similarity=0.198  Sum_probs=114.7

Q ss_pred             ccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeeccc-CcceecCcccccCCCC
Q 039957           33 IFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGF-NTFSGHIPNTFGNLRH  111 (481)
Q Consensus        33 ~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~  111 (481)
                      +.-+.+|+.+.+|.+.-. .|-.... .-|.|+++...+..+. ..| ++...+.+....-+. ...+|..-......+.
T Consensus       210 l~~f~~l~~~~~s~~~~~-~i~~~~~-~kptl~t~~v~~s~~~-~~~-~l~pe~~~~D~~~~E~~t~~G~~~~~~dTWq~  285 (490)
T KOG1259|consen  210 LNAFRNLKTLKFSALSTE-NIVDIEL-LKPTLQTICVHNTTIQ-DVP-SLLPETILADPSGSEPSTSNGSALVSADTWQE  285 (490)
T ss_pred             hHHhhhhheeeeeccchh-heeceee-cCchhheeeeeccccc-ccc-cccchhhhcCccCCCCCccCCceEEecchHhh
Confidence            334455666666666543 2322222 3466777776655443 111 111222222111111 1112223333444566


Q ss_pred             CCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEccCCceeecCCcccccCC
Q 039957          112 LSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLR  191 (481)
Q Consensus       112 L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~  191 (481)
                      |+++|||+|.|+.+..+         ..-.+.++.|++|+|.++..-  .+..+ ++|+.||||+|.++ .+..+-.++.
T Consensus       286 LtelDLS~N~I~~iDES---------vKL~Pkir~L~lS~N~i~~v~--nLa~L-~~L~~LDLS~N~Ls-~~~Gwh~KLG  352 (490)
T KOG1259|consen  286 LTELDLSGNLITQIDES---------VKLAPKLRRLILSQNRIRTVQ--NLAEL-PQLQLLDLSGNLLA-ECVGWHLKLG  352 (490)
T ss_pred             hhhccccccchhhhhhh---------hhhccceeEEeccccceeeeh--hhhhc-ccceEeecccchhH-hhhhhHhhhc
Confidence            77777777777665322         234566777777777776432  23333 46777777777776 3445556677


Q ss_pred             CCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCC-CccccCccCCCeeecCCCeeeecC
Q 039957          192 GLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYV-PHNLCHLEMLNLLHLGGNKLSGHI  255 (481)
Q Consensus       192 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~  255 (481)
                      +++.|.|+.|.+..  -+.++.+-+|..|++++|++.... -..+++++.|+++.|.+|.+++.+
T Consensus       353 NIKtL~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v  415 (490)
T KOG1259|consen  353 NIKTLKLAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV  415 (490)
T ss_pred             CEeeeehhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence            77778888877642  234566667777888888776533 246778888888999999887543

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.13  E-value=7.4e-12  Score=117.69  Aligned_cols=210  Identities=21%  Similarity=0.228  Sum_probs=114.6

Q ss_pred             CCCCCCeeeCcCCcccccCC-hhccCCcCCCEEEeeCCcCccccC-hhhhcCCCCccEEEccCccceeecchh-cccccc
Q 039957           11 NLQNLKSLFLGANNLSGLIP-PMIFNISTIRNLNLGGNRLSGHLP-SMIGHSLPNIKYLELGDNNLIGTIPNS-ITNATK   87 (481)
Q Consensus        11 ~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~   87 (481)
                      ++.+|+...|.+....-... .....+++++.||||+|-+..--| ..+...||+|+.|+|+.|++.-...+. -..+++
T Consensus       119 n~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~  198 (505)
T KOG3207|consen  119 NLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSH  198 (505)
T ss_pred             hHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhh
Confidence            45566666776666542111 345567777777777776652111 122335777777777777765332221 134566


Q ss_pred             CceeecccCcceec-CcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCC-hhhhhc
Q 039957           88 LIILDLGFNTFSGH-IPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILP-PSIGNF  165 (481)
Q Consensus        88 L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~~  165 (481)
                      |+.|.|+.|.++-. +-.....+|+|+.|+|+.|....+...        +-.-+..|+.|||++|++-.... ...+.+
T Consensus       199 lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~--------~~~i~~~L~~LdLs~N~li~~~~~~~~~~l  270 (505)
T KOG3207|consen  199 LKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKAT--------STKILQTLQELDLSNNNLIDFDQGYKVGTL  270 (505)
T ss_pred             hheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecc--------hhhhhhHHhhccccCCcccccccccccccc
Confidence            77777777766521 122244567777777777753222111        11234557777777777653211 223333


Q ss_pred             ccCccEEEccCCceeec-CCcc-----cccCCCCCeEecccccceecC-CcCCcCCCCCCeeecCCCcCCC
Q 039957          166 STSLQRFSASECKLKGT-IPKE-----IGHLRGLIYLSLGFNDLNGTI-PTSIGTLKQLQGFFLPETNLQG  229 (481)
Q Consensus       166 ~~~L~~L~l~~n~l~~~-~p~~-----~~~l~~L~~L~l~~N~l~~~~-p~~~~~l~~L~~l~l~~n~l~~  229 (481)
                       +.|+.|+++.|.++.. .|+.     ...+++|++|++..|++...- -..+..+++|+.+....|.+..
T Consensus       271 -~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~  340 (505)
T KOG3207|consen  271 -PGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNK  340 (505)
T ss_pred             -cchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcccccccc
Confidence             4566777777766532 2222     234677888888888875211 1233445666666666666653

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=99.13  E-value=5.9e-11  Score=83.86  Aligned_cols=61  Identities=39%  Similarity=0.587  Sum_probs=39.9

Q ss_pred             CCccEEEccCccceeecchhccccccCceeecccCcceecCcccccCCCCCCEEEcccccC
Q 039957           62 PNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNL  122 (481)
Q Consensus        62 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l  122 (481)
                      |+|++|++++|+++...+.+|.++++|++|++++|.++.+.|.+|.++++|++|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            4566666666666655556666666666666666666666666666666666666666653

...

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.09  E-value=1e-11  Score=116.80  Aligned_cols=186  Identities=21%  Similarity=0.178  Sum_probs=90.1

Q ss_pred             ccccCceeecccCcceecCc--ccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChh
Q 039957           84 NATKLIILDLGFNTFSGHIP--NTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPS  161 (481)
Q Consensus        84 ~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~  161 (481)
                      ++.+|+.+.|.+.... ..+  .....+++++.|||+.|-+....+.      ..-...+++|+.|+|+.|++.-.....
T Consensus       119 n~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v------~~i~eqLp~Le~LNls~Nrl~~~~~s~  191 (505)
T KOG3207|consen  119 NLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPV------LKIAEQLPSLENLNLSSNRLSNFISSN  191 (505)
T ss_pred             hHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHH------HHHHHhcccchhcccccccccCCcccc
Confidence            3445555555544433 122  2344555555555555554433111      112234555666666666554222211


Q ss_pred             hhhcccCccEEEccCCceee-cCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCC-CccccCcc
Q 039957          162 IGNFSTSLQRFSASECKLKG-TIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYV-PHNLCHLE  239 (481)
Q Consensus       162 ~~~~~~~L~~L~l~~n~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~-p~~~~~l~  239 (481)
                      .....+.+++|.++.|.++- .+-.....+++|+.|+|..|...+........+..|+.|+|++|++.... -...+.++
T Consensus       192 ~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~  271 (505)
T KOG3207|consen  192 TTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLP  271 (505)
T ss_pred             chhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccccccccccccccc
Confidence            11122456666666666652 11122344566777777766433333333444556666666666654322 12344556


Q ss_pred             CCCeeecCCCeeeec-CCcc-----cccCCCCCcEEcCCCcCc
Q 039957          240 MLNLLHLGGNKLSGH-IPPC-----LASLTSLRELDLGSNKLT  276 (481)
Q Consensus       240 ~L~~L~L~~N~l~~~-~p~~-----~~~l~~L~~L~ls~N~l~  276 (481)
                      .|+.|+++.+.+..+ .|++     ...+++|++|+++.|++.
T Consensus       272 ~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~  314 (505)
T KOG3207|consen  272 GLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR  314 (505)
T ss_pred             chhhhhccccCcchhcCCCccchhhhcccccceeeecccCccc
Confidence            666666666655432 2222     234456666666666653

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=99.05  E-value=1.5e-10  Score=81.80  Aligned_cols=59  Identities=34%  Similarity=0.569  Sum_probs=29.4

Q ss_pred             CCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeecccCc
Q 039957           38 TIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNT   97 (481)
Q Consensus        38 ~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~   97 (481)
                      +|++|++++|+++ .+|...+..+++|++|++++|+++...|.+|.++++|++|++++|+
T Consensus         2 ~L~~L~l~~n~l~-~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~   60 (61)
T PF13855_consen    2 NLESLDLSNNKLT-EIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN   60 (61)
T ss_dssp             TESEEEETSSTES-EECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred             cCcEEECCCCCCC-ccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence            3445555555554 3444333345555555555555554444455555555555555554

...

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.04  E-value=1.7e-09  Score=98.68  Aligned_cols=135  Identities=21%  Similarity=0.312  Sum_probs=94.2

Q ss_pred             hccccccceeeee-ccCCcceEEEEEeccchhhhhhhhHHHHHhhhhc-cCccceeecccCCCCcc--c--ccCCChhHH
Q 039957          341 SLAGSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVR-HQNLIKILSSCSTPDFK--F--MPNGSLEKR  414 (481)
Q Consensus       341 ~~~g~~g~vy~~~-l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~--~--~~~g~l~~~  414 (481)
                      .+.|+||+.+.|+ +-.+..||+|.--...  ...+...|-..-..+. -+.|..++-+-.++-+.  .  +-+-||.+.
T Consensus        36 IGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLLGPSLEDL  113 (449)
T KOG1165|consen   36 IGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLLGPSLEDL  113 (449)
T ss_pred             cccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhhCcCHHHH
Confidence            3789999999997 6678999999643221  1223444554444443 45555544332222221  1  235677776


Q ss_pred             hhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCC-----CCcEEEccccCcccCCC
Q 039957          415 LYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDE-----NMVAHVSDFGISKLLGE  481 (481)
Q Consensus       415 l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~-----~~~~kl~Dfgl~~~~~~  481 (481)
                      ..-.+...+......||.|+..-++|+|    +...|.|||||+|.|+..     ...+.+.|||+||.+.|
T Consensus       114 FD~CgR~FSvKTV~miA~Qmi~rie~vH----~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD  181 (449)
T KOG1165|consen  114 FDLCGRRFSVKTVAMIAKQMITRIEYVH----EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD  181 (449)
T ss_pred             HHHhcCcccHHhHHHHHHHHHHHHHHHH----hcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence            6555666788889999999999999999    567999999999999964     35789999999998753

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.02  E-value=8e-10  Score=102.56  Aligned_cols=135  Identities=22%  Similarity=0.267  Sum_probs=95.3

Q ss_pred             hhhccccccceeeeecc-CCcceEEEEEeccchhhhhhhhHHHHHhhhhccC------ccceeecccCCCC-----cccc
Q 039957          339 TISLAGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQ------NLIKILSSCSTPD-----FKFM  406 (481)
Q Consensus       339 ~l~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~------niv~l~~~~~~~~-----~~~~  406 (481)
                      .+-++|.||.|-+.... .+..||+|+++.- .+..+....|+++++++.+.      ..|.+.+++...+     ||.+
T Consensus        95 ~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell  173 (415)
T KOG0671|consen   95 DLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL  173 (415)
T ss_pred             hhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc
Confidence            34478999999888643 3688999977532 22334456789999998421      2445545543322     2222


Q ss_pred             cCCChhHHhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCC--------------------C
Q 039957          407 PNGSLEKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDE--------------------N  465 (481)
Q Consensus       407 ~~g~l~~~l~~~~-~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~--------------------~  465 (481)
                       +.|+++.+.... ..........|+.|+.++++|||    +.+++|-|+||+|||+-+                    +
T Consensus       174 -G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh----~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks  248 (415)
T KOG0671|consen  174 -GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH----DLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKS  248 (415)
T ss_pred             -ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH----hcceeecCCChheEEEeccceEEEeccCCccceeccCCC
Confidence             348888887633 34667788899999999999999    688999999999999721                    3


Q ss_pred             CcEEEccccCcccC
Q 039957          466 MVAHVSDFGISKLL  479 (481)
Q Consensus       466 ~~~kl~Dfgl~~~~  479 (481)
                      ..+||.|||-|..-
T Consensus       249 ~~I~vIDFGsAtf~  262 (415)
T KOG0671|consen  249 TAIKVIDFGSATFD  262 (415)
T ss_pred             cceEEEecCCccee
Confidence            46799999988753

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.02  E-value=2.3e-11  Score=111.46  Aligned_cols=144  Identities=18%  Similarity=0.165  Sum_probs=69.2

Q ss_pred             ccccCceeecccCcceecCccc----ccCCCCCCEEEcccccCccccCCCc-----cccccccCCCCCCCcEEEccCCcc
Q 039957           84 NATKLIILDLGFNTFSGHIPNT----FGNLRHLSVLSLLMNNLTTESSSAY-----QWSFLSSLTNCRYLVYLILSGNPL  154 (481)
Q Consensus        84 ~l~~L~~L~Ls~N~l~~~~p~~----~~~l~~L~~L~L~~N~l~~~~~~~~-----~~~~~~~l~~l~~L~~L~Ls~N~l  154 (481)
                      .+++|++||||.|.|....+..    +.+...|++|.|.+|.+........     .........+-++|+++..+.|++
T Consensus        90 ~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrl  169 (382)
T KOG1909|consen   90 GCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRL  169 (382)
T ss_pred             cCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeecccc
Confidence            4456666666666665333333    3345666666666665543211110     000111223345666677676666


Q ss_pred             ceeCC----hhhhhcccCccEEEccCCceee----cCCcccccCCCCCeEecccccceec----CCcCCcCCCCCCeeec
Q 039957          155 GGILP----PSIGNFSTSLQRFSASECKLKG----TIPKEIGHLRGLIYLSLGFNDLNGT----IPTSIGTLKQLQGFFL  222 (481)
Q Consensus       155 ~~~~p----~~~~~~~~~L~~L~l~~n~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~l~l  222 (481)
                      ...-.    ..|... +.|+.+.+..|.|..    .+...+..+++|++|||..|.++..    +...+..+++|+.+++
T Consensus       170 en~ga~~~A~~~~~~-~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l  248 (382)
T KOG1909|consen  170 ENGGATALAEAFQSH-PTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNL  248 (382)
T ss_pred             ccccHHHHHHHHHhc-cccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecc
Confidence            43211    112222 356666666665531    1122355666666666666666521    2233444445555555


Q ss_pred             CCCcCC
Q 039957          223 PETNLQ  228 (481)
Q Consensus       223 ~~n~l~  228 (481)
                      +++.+.
T Consensus       249 ~dcll~  254 (382)
T KOG1909|consen  249 GDCLLE  254 (382)
T ss_pred             cccccc
Confidence            555444

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=99.00  E-value=2.9e-10  Score=121.42  Aligned_cols=271  Identities=23%  Similarity=0.252  Sum_probs=135.1

Q ss_pred             CCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCc--CccccChhhhcCCCCccEEEccCccceeecchhccccccCce
Q 039957           13 QNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNR--LSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLII   90 (481)
Q Consensus        13 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~--l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~   90 (481)
                      ...+...+.+|++..+ +... ..+.|+.|-+.+|.  +. .++..++..++.|++|||++|.=-+.+|..++.+.+|++
T Consensus       523 ~~~rr~s~~~~~~~~~-~~~~-~~~~L~tLll~~n~~~l~-~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~Lry  599 (889)
T KOG4658|consen  523 NSVRRMSLMNNKIEHI-AGSS-ENPKLRTLLLQRNSDWLL-EISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRY  599 (889)
T ss_pred             hheeEEEEeccchhhc-cCCC-CCCccceEEEeecchhhh-hcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhc
Confidence            4566667777766533 2222 23367777777775  43 566666666777777777777655677777777777777


Q ss_pred             eecccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCcc--ceeCChhhhhcccC
Q 039957           91 LDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPL--GGILPPSIGNFSTS  168 (481)
Q Consensus        91 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l--~~~~p~~~~~~~~~  168 (481)
                      |+|++..++ .+|..+++|..|.+|++.++.-....+        .....+++|++|.+..-..  +...-..+..+ .+
T Consensus       600 L~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~--------~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~L-e~  669 (889)
T KOG4658|consen  600 LDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIP--------GILLELQSLRVLRLPRSALSNDKLLLKELENL-EH  669 (889)
T ss_pred             ccccCCCcc-ccchHHHHHHhhheecccccccccccc--------chhhhcccccEEEeeccccccchhhHHhhhcc-cc
Confidence            777777777 577777777777777777665332211        1223466677776654431  11111122221 23


Q ss_pred             ccEEEccCCceeecCCcccccCCCCC----eEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCcc-----
Q 039957          169 LQRFSASECKLKGTIPKEIGHLRGLI----YLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLE-----  239 (481)
Q Consensus       169 L~~L~l~~n~l~~~~p~~~~~l~~L~----~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~-----  239 (481)
                      |+.+.......  .+-..+..+..|.    .+.+..+... ..+.++..+.+|+.|.+.++..........+...     
T Consensus       670 L~~ls~~~~s~--~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f  746 (889)
T KOG4658|consen  670 LENLSITISSV--LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCF  746 (889)
T ss_pred             hhhheeecchh--HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCchhhcccccccchhhhH
Confidence            33333322221  0001112222222    2222222221 3445566666777777666655432222221111     


Q ss_pred             -CCCeeecCCCeeeecCCcccccCCCCCcEEcCCCcCcccCCcchhccccCcEEEccCcccC
Q 039957          240 -MLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLN  300 (481)
Q Consensus       240 -~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  300 (481)
                       ++..+...+...- ..+......++|+.|++..+.....+.+....+..+..+.+..+.+.
T Consensus       747 ~~l~~~~~~~~~~~-r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~  807 (889)
T KOG4658|consen  747 PNLSKVSILNCHML-RDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLE  807 (889)
T ss_pred             HHHHHHHhhccccc-cccchhhccCcccEEEEecccccccCCCHHHHhhhcccEEecccccc
Confidence             1111111111110 11222234467777777766655555444444444444444444433

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=98.99  E-value=8.3e-10  Score=116.53  Aligned_cols=133  Identities=27%  Similarity=0.364  Sum_probs=94.0

Q ss_pred             hhhhhccccccceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhhhhc---cCccceeecccCCCC-----cccccC
Q 039957          337 LETISLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVR---HQNLIKILSSCSTPD-----FKFMPN  408 (481)
Q Consensus       337 L~~l~~~g~~g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~-----~~~~~~  408 (481)
                      .+.+.|.|+||.||+|+..+|+.||+|.-.....  + +|---.+++.+++   -+.|..+..++...+     .+|.+.
T Consensus       702 I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~--W-EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~  778 (974)
T KOG1166|consen  702 ISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP--W-EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPY  778 (974)
T ss_pred             EEeeeccccceEEEEeecCCCcEEEEEeecCCCc--e-eeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeecccc
Confidence            3445689999999999988899999997644321  1 1111123334444   112222222222222     568899


Q ss_pred             CChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeC-------CCCcEEEccccCcc
Q 039957          409 GSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLD-------ENMVAHVSDFGISK  477 (481)
Q Consensus       409 g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~-------~~~~~kl~Dfgl~~  477 (481)
                      |+|.+++. .....+|.-.+.+++++++-++.||    ..+|||+||||.|.||.       +....+|.|||.+-
T Consensus       779 Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH----~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si  849 (974)
T KOG1166|consen  779 GTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLH----AMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI  849 (974)
T ss_pred             ccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHH----hcceecccCCcceeEeecccCCCCcccceEEEecccce
Confidence            99999886 5556788889999999999999999    67899999999999993       23578999999864

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.98  E-value=1.7e-09  Score=103.38  Aligned_cols=117  Identities=26%  Similarity=0.351  Sum_probs=87.7

Q ss_pred             cccccceeeeecc-CCcceEEEEEeccchhhhhhhhHHHHHhhhhc-----c---CccceeecccCCCC---------cc
Q 039957          343 AGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECEVLRNVR-----H---QNLIKILSSCSTPD---------FK  404 (481)
Q Consensus       343 ~g~~g~vy~~~l~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~l~~~~~~~~---------~~  404 (481)
                      =|.|.+||.+... ..+.||+|+.+.++ ...+....|+.+|.+++     |   .+||++++.|....         ||
T Consensus        88 WGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfE  166 (590)
T KOG1290|consen   88 WGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFE  166 (590)
T ss_pred             ccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEeh
Confidence            4889999999754 46789999876543 23445678999999875     2   37999999886543         34


Q ss_pred             cccCCChhHHhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCC
Q 039957          405 FMPNGSLEKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDE  464 (481)
Q Consensus       405 ~~~~g~l~~~l~~~~-~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~  464 (481)
                      |+ +-.|.+++.... ..+.....-+|+.||..||.|||..|   +|+|-||||+|||+..
T Consensus       167 vL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec---gIIHTDlKPENvLl~~  223 (590)
T KOG1290|consen  167 VL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC---GIIHTDLKPENVLLCS  223 (590)
T ss_pred             hh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc---CccccCCCcceeeeec
Confidence            44 456666665433 23566778899999999999999866   6999999999999843

>cd05151 ChoK Choline Kinase (ChoK)

Probab=98.95  E-value=2.2e-09  Score=93.43  Aligned_cols=125  Identities=16%  Similarity=0.166  Sum_probs=85.3

Q ss_pred             cccccceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccc-eeecccCCCC---cccccCCChhHHhhcC
Q 039957          343 AGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLI-KILSSCSTPD---FKFMPNGSLEKRLYSH  418 (481)
Q Consensus       343 ~g~~g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~---~~~~~~g~l~~~l~~~  418 (481)
                      .|..+.+|++... |..+++|....... ....+..|..++..+.+..++ +++.+.....   ++|+++.++.+.-   
T Consensus         8 ~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~~~~lv~e~i~G~~l~~~~---   82 (170)
T cd05151           8 GGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDPETGVLITEFIEGSELLTED---   82 (170)
T ss_pred             CcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeCCCCeEEEEecCCCcccccc---
Confidence            4677889998764 67799998654321 123456788888888665544 4444433222   6788887775430   


Q ss_pred             CCccCHHHHHHHHHHHHHHHHHHhcCCC-CCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          419 NYFLDILERLNIMIDVGSTLEYLHHGHS-SAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       419 ~~~~~~~~~~~i~~~ia~~l~~lH~~~~-~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                            .....++.+++++++.||.... ...++|+|++|.||+++ ++.+++.|||.|..-
T Consensus        83 ------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~  137 (170)
T cd05151          83 ------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN  137 (170)
T ss_pred             ------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence                  1123456789999999995321 12369999999999999 678999999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=98.93  E-value=2.9e-11  Score=110.76  Aligned_cols=44  Identities=27%  Similarity=0.374  Sum_probs=23.9

Q ss_pred             cCCCCCCCcEEEccCCccceeCChhhhhc---ccCccEEEccCCcee
Q 039957          137 SLTNCRYLVYLILSGNPLGGILPPSIGNF---STSLQRFSASECKLK  180 (481)
Q Consensus       137 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~---~~~L~~L~l~~n~l~  180 (481)
                      .|..+++|++||||+|-|...-+..+..+   ..+|++|.|.+|.+.
T Consensus        87 aL~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg  133 (382)
T KOG1909|consen   87 ALLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLG  133 (382)
T ss_pred             HHhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCC
Confidence            34455566777777776654444444322   234566666666553

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=98.91  E-value=3e-09  Score=102.39  Aligned_cols=134  Identities=22%  Similarity=0.315  Sum_probs=96.9

Q ss_pred             ccccccceeeeec-cCCcceEEEEEeccchhhhhhhhHHHHHhhhhcc------CccceeecccCCCCcccc----cCCC
Q 039957          342 LAGSFGSVYKGTI-SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRH------QNLIKILSSCSTPDFKFM----PNGS  410 (481)
Q Consensus       342 ~~g~~g~vy~~~l-~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h------~niv~l~~~~~~~~~~~~----~~g~  410 (481)
                      +.|-|+.|.+|.. ..|+.||||++...... .+.=..|+++|.++..      .+.++++..|...+.-.|    -.-.
T Consensus       441 GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~LslN  519 (752)
T KOG0670|consen  441 GKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPLSLN  519 (752)
T ss_pred             ccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhhhch
Confidence            6788999998874 35889999999764322 3344568888888742      245566655544431111    1235


Q ss_pred             hhHHhhcC--CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCC-CcEEEccccCcccCC
Q 039957          411 LEKRLYSH--NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDEN-MVAHVSDFGISKLLG  480 (481)
Q Consensus       411 l~~~l~~~--~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~-~~~kl~Dfgl~~~~~  480 (481)
                      |.+.+..-  ...+.......+|.|+--||..|.    .-+|+|.||||.|||+.+. ...||||||-|....
T Consensus       520 LRevLKKyG~nvGL~ikaVRsYaqQLflALklLK----~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~  588 (752)
T KOG0670|consen  520 LREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK----KCGVLHADIKPDNILVNESKNILKLCDFGSASFAS  588 (752)
T ss_pred             HHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH----hcCeeecccCccceEeccCcceeeeccCccccccc
Confidence            66666542  234666778889999999999998    5689999999999999985 788999999988764

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=98.87  E-value=1.7e-09  Score=111.46  Aligned_cols=98  Identities=28%  Similarity=0.381  Sum_probs=80.5

Q ss_pred             hhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCe
Q 039957          376 FNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPI  450 (481)
Q Consensus       376 ~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i  450 (481)
                      +..|..+-..++|+|++..+..+....     +||+++ +|...+... ..+...++-.+..|+.+|+.|+|    +.+|
T Consensus       368 i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h----~~Gi  441 (601)
T KOG0590|consen  368 ITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLH----SMGL  441 (601)
T ss_pred             hhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHH----hcCc
Confidence            445666677789999987665554432     689998 999887653 34666788889999999999999    6889


Q ss_pred             eeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          451 IHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       451 ~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .|||+|++|++++.+|.+||+|||.+...
T Consensus       442 ahrdlK~enll~~~~g~lki~Dfg~~~vf  470 (601)
T KOG0590|consen  442 AHRDLKLENLLVTENGILKIIDFGAASVF  470 (601)
T ss_pred             eeccCccccEEEecCCceEEeecCcceee
Confidence            99999999999999999999999998654

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.81  E-value=4e-09  Score=112.81  Aligned_cols=204  Identities=22%  Similarity=0.276  Sum_probs=139.8

Q ss_pred             ccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCcc--ceeecchhccccccCceeecccCcceecCcccccCCC
Q 039957           33 IFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNN--LIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLR  110 (481)
Q Consensus        33 ~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~--l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  110 (481)
                      ..+....+...+-+|.+. .++...  ..+.|++|-+..|.  +....+..|..++.|++|||++|.=-+.+|..+++|-
T Consensus       519 ~~~~~~~rr~s~~~~~~~-~~~~~~--~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li  595 (889)
T KOG4658|consen  519 VKSWNSVRRMSLMNNKIE-HIAGSS--ENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELV  595 (889)
T ss_pred             ccchhheeEEEEeccchh-hccCCC--CCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhh
Confidence            344578899999999987 677665  35689999999996  5545555688999999999999987778999999999


Q ss_pred             CCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEccCCcee--ecCCcccc
Q 039957          111 HLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLK--GTIPKEIG  188 (481)
Q Consensus       111 ~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~--~~~p~~~~  188 (481)
                      +|++|++++..++.+|         .++.+++.|.+||+..+.....+|.....+ .+|++|.+-.-...  ...-..+.
T Consensus       596 ~LryL~L~~t~I~~LP---------~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L-~~Lr~L~l~~s~~~~~~~~l~el~  665 (889)
T KOG4658|consen  596 HLRYLDLSDTGISHLP---------SGLGNLKKLIYLNLEVTGRLESIPGILLEL-QSLRVLRLPRSALSNDKLLLKELE  665 (889)
T ss_pred             hhhcccccCCCccccc---------hHHHHHHhhheeccccccccccccchhhhc-ccccEEEeeccccccchhhHHhhh
Confidence            9999999999988653         567899999999999988766666655555 68999988765422  12223345


Q ss_pred             cCCCCCeEecccccceecCCcCCcCCCCCC----eeecCCCcCCCCCCccccCccCCCeeecCCCeee
Q 039957          189 HLRGLIYLSLGFNDLNGTIPTSIGTLKQLQ----GFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLS  252 (481)
Q Consensus       189 ~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~----~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~  252 (481)
                      ++.+|+.+.......  .+-..+..+.+|.    .+.+..+.. ...+..+..+..|+.|.+.++.++
T Consensus       666 ~Le~L~~ls~~~~s~--~~~e~l~~~~~L~~~~~~l~~~~~~~-~~~~~~~~~l~~L~~L~i~~~~~~  730 (889)
T KOG4658|consen  666 NLEHLENLSITISSV--LLLEDLLGMTRLRSLLQSLSIEGCSK-RTLISSLGSLGNLEELSILDCGIS  730 (889)
T ss_pred             cccchhhheeecchh--HhHhhhhhhHHHHHHhHhhhhccccc-ceeecccccccCcceEEEEcCCCc
Confidence            556666555533222  1111122333332    222222221 234455666777777777777665

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=98.73  E-value=4.5e-08  Score=99.10  Aligned_cols=133  Identities=16%  Similarity=0.172  Sum_probs=81.6

Q ss_pred             ccccccceeeeeccC-CcceEEEEEeccchh------------------------------h----h------hhhhHHH
Q 039957          342 LAGSFGSVYKGTISD-GTDVAIKIFNLQRER------------------------------A----F------RSFNSEC  380 (481)
Q Consensus       342 ~~g~~g~vy~~~l~~-g~~vavK~l~~~~~~------------------------------~----~------~~~~~e~  380 (481)
                      ++|++|.||+|.+.+ |..||||........                              .    .      -++..|.
T Consensus       128 asaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~~Ea  207 (537)
T PRK04750        128 ASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLMREA  207 (537)
T ss_pred             cCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHHHHH
Confidence            679999999999987 999999998643100                              0    0      1234455


Q ss_pred             HHhhhhc----cCcccee---e-cccCCC--CcccccCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCe
Q 039957          381 EVLRNVR----HQNLIKI---L-SSCSTP--DFKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPI  450 (481)
Q Consensus       381 ~~l~~l~----h~niv~l---~-~~~~~~--~~~~~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i  450 (481)
                      ..+.+++    +...+.+   + ++|...  .+||+.|+.+.+.-.-.....+   +..++...++.  |+++.. ..++
T Consensus       208 ~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d---~~~la~~~v~~--~~~Qif-~~Gf  281 (537)
T PRK04750        208 ANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTD---MKLLAERGVEV--FFTQVF-RDGF  281 (537)
T ss_pred             HHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCC---HHHHHHHHHHH--HHHHHH-hCCe
Confidence            5555443    3333332   2 233332  2789999999764211111111   12233332222  222222 4689


Q ss_pred             eeCCCCCCCeeeCCCC----cEEEccccCcccCC
Q 039957          451 IHCDLKPTSILLDENM----VAHVSDFGISKLLG  480 (481)
Q Consensus       451 ~H~dlk~~nill~~~~----~~kl~Dfgl~~~~~  480 (481)
                      +|+|+||.||+++.++    .+++.|||++..+.
T Consensus       282 fHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        282 FHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             eeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence            9999999999999888    99999999987664

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=98.71  E-value=1.6e-08  Score=99.78  Aligned_cols=94  Identities=32%  Similarity=0.500  Sum_probs=83.9

Q ss_pred             hhhhccCccceeecccCCCC-----cccccCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCC
Q 039957          383 LRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKP  457 (481)
Q Consensus       383 l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~  457 (481)
                      ++.+.|.|+.+++|.|..+.     .+|+..|+|.+.+.......+|.-....+.+|++|++|+|.   ++--.|+.+++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~---s~i~~hg~l~s   77 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHN---SPIGYHGALKS   77 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhc---Ccceeeeeecc
Confidence            35678999999999998775     46999999999999888889999999999999999999995   33339999999


Q ss_pred             CCeeeCCCCcEEEccccCcccC
Q 039957          458 TSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       458 ~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +|.++|....+|++|||+..+.
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~   99 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLL   99 (484)
T ss_pred             ccceeeeeEEEEechhhhcccc
Confidence            9999999999999999998765

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=98.68  E-value=2.4e-08  Score=93.37  Aligned_cols=49  Identities=33%  Similarity=0.430  Sum_probs=40.2

Q ss_pred             CHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeee--CCC--CcEEEccccCc
Q 039957          423 DILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILL--DEN--MVAHVSDFGIS  476 (481)
Q Consensus       423 ~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill--~~~--~~~kl~Dfgl~  476 (481)
                      .|..+ -|..|+.+|+.|||    .++|.|||+|+.|||+  |+|  -...|+|||.|
T Consensus       340 ~r~~~-~~laQlLEav~hL~----~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCc  392 (598)
T KOG4158|consen  340 YRTGR-VILAQLLEAVTHLH----KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCC  392 (598)
T ss_pred             hHHHH-HHHHHHHHHHHHHH----HccchhhcccccceEEEecCCCCcEEEEccccee
Confidence            34444 47789999999999    6889999999999998  444  45689999986

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.60  E-value=3.4e-07  Score=83.29  Aligned_cols=136  Identities=22%  Similarity=0.260  Sum_probs=97.2

Q ss_pred             ccccccceeeeeccCCcceEEEEEeccch-hhhhhhhHHHHHhhhhccC--ccceeecccCCCC--------cccccCCC
Q 039957          342 LAGSFGSVYKGTISDGTDVAIKIFNLQRE-RAFRSFNSECEVLRNVRHQ--NLIKILSSCSTPD--------FKFMPNGS  410 (481)
Q Consensus       342 ~~g~~g~vy~~~l~~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~~~--------~~~~~~g~  410 (481)
                      ..|..+.+|++...+|..+++|....... .....+..|.+++..+++.  .+.++++++....        ++|+++++
T Consensus         7 ~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~   86 (223)
T cd05154           7 SGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRV   86 (223)
T ss_pred             CCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEe
Confidence            35778899999877778899998654332 1345678899998888763  3456676665521        56788887


Q ss_pred             hhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCC---------------------------------------------
Q 039957          411 LEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGH---------------------------------------------  445 (481)
Q Consensus       411 l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~---------------------------------------------  445 (481)
                      +.+....  ...+..++..++.++++++.++|+..                                             
T Consensus        87 l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (223)
T cd05154          87 LRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWL  164 (223)
T ss_pred             cCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHH
Confidence            7664421  23456677778888888888888521                                             


Q ss_pred             -------CCCCeeeCCCCCCCeeeCC--CCcEEEccccCcccC
Q 039957          446 -------SSAPIIHCDLKPTSILLDE--NMVAHVSDFGISKLL  479 (481)
Q Consensus       446 -------~~~~i~H~dlk~~nill~~--~~~~kl~Dfgl~~~~  479 (481)
                             ....++|+|+.+.||++++  ++.+.|.||+.+..-
T Consensus       165 ~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g  207 (223)
T cd05154         165 EAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG  207 (223)
T ss_pred             HhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence                   0245799999999999998  677899999988753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.59  E-value=1.3e-09  Score=108.78  Aligned_cols=122  Identities=26%  Similarity=0.270  Sum_probs=54.8

Q ss_pred             EEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeecccCcceecCccc-ccCCCCCCEEEccc
Q 039957           41 NLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNT-FGNLRHLSVLSLLM  119 (481)
Q Consensus        41 ~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~L~~  119 (481)
                      ..+.+.|++. .+...+- -++.|+.|||++|+++..-  .+..+++|++|||++|.+.. +|.. ..+. .|..|.+++
T Consensus       168 ~a~fsyN~L~-~mD~SLq-ll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~-vp~l~~~gc-~L~~L~lrn  241 (1096)
T KOG1859|consen  168 TASFSYNRLV-LMDESLQ-LLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRH-VPQLSMVGC-KLQLLNLRN  241 (1096)
T ss_pred             hhhcchhhHH-hHHHHHH-HHHHhhhhccchhhhhhhH--HHHhcccccccccccchhcc-ccccchhhh-hheeeeecc
Confidence            3344444443 3333332 3455555555555554221  44555555555555555552 2221 1122 255555555


Q ss_pred             ccCccccCCCccccccccCCCCCCCcEEEccCCccceeCCh-hhhhcccCccEEEccCCce
Q 039957          120 NNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPP-SIGNFSTSLQRFSASECKL  179 (481)
Q Consensus       120 N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~-~~~~~~~~L~~L~l~~n~l  179 (481)
                      |.++.+          ..+.++++|+.||+++|-+.+.-.- .++.+ ..|+.|+|.+|.+
T Consensus       242 N~l~tL----------~gie~LksL~~LDlsyNll~~hseL~pLwsL-s~L~~L~LeGNPl  291 (1096)
T KOG1859|consen  242 NALTTL----------RGIENLKSLYGLDLSYNLLSEHSELEPLWSL-SSLIVLWLEGNPL  291 (1096)
T ss_pred             cHHHhh----------hhHHhhhhhhccchhHhhhhcchhhhHHHHH-HHHHHHhhcCCcc
Confidence            555544          2234555555555555555432111 11222 2455555555544

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=98.57  E-value=3.1e-07  Score=80.60  Aligned_cols=130  Identities=18%  Similarity=0.194  Sum_probs=81.1

Q ss_pred             cccccceeeeeccC-------CcceEEEEEeccc------------hhhh----------hh----hhHHHHHhhhhccC
Q 039957          343 AGSFGSVYKGTISD-------GTDVAIKIFNLQR------------ERAF----------RS----FNSECEVLRNVRHQ  389 (481)
Q Consensus       343 ~g~~g~vy~~~l~~-------g~~vavK~l~~~~------------~~~~----------~~----~~~e~~~l~~l~h~  389 (481)
                      .|.-+.||.|.-.+       +..+|||......            ...+          ..    ...|...|.+++..
T Consensus         7 ~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~rl~~~   86 (197)
T cd05146           7 TGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKRMQKA   86 (197)
T ss_pred             cCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHHHHHc
Confidence            46667788886543       4789999775321            0000          01    12577778777643


Q ss_pred             --ccceeecccCCC-CcccccCCChhH-HhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCC
Q 039957          390 --NLIKILSSCSTP-DFKFMPNGSLEK-RLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDEN  465 (481)
Q Consensus       390 --niv~l~~~~~~~-~~~~~~~g~l~~-~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~  465 (481)
                        .+.+.+++.... .|||+.++.+.. .+.+  ..++..+..++..++++++.+++|   ..+|||+|+++.||+++ +
T Consensus        87 Gv~vP~pi~~~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs~~NIL~~-~  160 (197)
T cd05146          87 GIPCPEVVVLKKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLSEYNMLWH-D  160 (197)
T ss_pred             CCCCCeEEEecCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEE-C
Confidence              444455431111 267876544422 2222  123333455677899999999943   56899999999999997 4


Q ss_pred             CcEEEccccCccc
Q 039957          466 MVAHVSDFGISKL  478 (481)
Q Consensus       466 ~~~kl~Dfgl~~~  478 (481)
                      +.+.+.|||.|-.
T Consensus       161 ~~v~iIDF~qav~  173 (197)
T cd05146         161 GKVWFIDVSQSVE  173 (197)
T ss_pred             CcEEEEECCCcee
Confidence            7899999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=98.56  E-value=1.5e-07  Score=87.19  Aligned_cols=133  Identities=24%  Similarity=0.383  Sum_probs=78.7

Q ss_pred             ccccccceeeeeccC-CcceEEEEEeccchh---hhhhhhHHHHHhhhhc----------cCccceeecccC---CCC--
Q 039957          342 LAGSFGSVYKGTISD-GTDVAIKIFNLQRER---AFRSFNSECEVLRNVR----------HQNLIKILSSCS---TPD--  402 (481)
Q Consensus       342 ~~g~~g~vy~~~l~~-g~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~----------h~niv~l~~~~~---~~~--  402 (481)
                      +.|+++.||.++... |..+|+|.+......   ..+.+.+|.-....+.          |..++.-++...   .+.  
T Consensus        21 ~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~~~~~  100 (288)
T PF14531_consen   21 GKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGKPPFF  100 (288)
T ss_dssp             EEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS-SEE
T ss_pred             ccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCCCcce
Confidence            568999999999764 899999988654322   2334444443333211          211111111000   000  


Q ss_pred             --------c------ccc--cCCChhHHhh---cC-C--CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCe
Q 039957          403 --------F------KFM--PNGSLEKRLY---SH-N--YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSI  460 (481)
Q Consensus       403 --------~------~~~--~~g~l~~~l~---~~-~--~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~ni  460 (481)
                              +      ..+  ..++|.+.+.   .. .  ..+....|+.+..|+.+.+++||    +.+|||+||||+|+
T Consensus       101 ~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh----~~GlVHgdi~~~nf  176 (288)
T PF14531_consen  101 ERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH----SYGLVHGDIKPENF  176 (288)
T ss_dssp             EECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH----HTTEEEST-SGGGE
T ss_pred             ecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh----hcceEecccceeeE
Confidence                    1      112  2356655432   21 1  23445678889999999999999    67899999999999


Q ss_pred             eeCCCCcEEEccccCccc
Q 039957          461 LLDENMVAHVSDFGISKL  478 (481)
Q Consensus       461 ll~~~~~~kl~Dfgl~~~  478 (481)
                      +++++|.++++||+-...
T Consensus       177 ll~~~G~v~Lg~F~~~~r  194 (288)
T PF14531_consen  177 LLDQDGGVFLGDFSSLVR  194 (288)
T ss_dssp             EE-TTS-EEE--GGGEEE
T ss_pred             EEcCCCCEEEcChHHHee
Confidence            999999999999987654

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=98.55  E-value=2.5e-08  Score=98.74  Aligned_cols=133  Identities=25%  Similarity=0.293  Sum_probs=95.1

Q ss_pred             ccccccceeeeec---c-CCcceEEEEEeccch--hhhhhhhHHHHHhhhhc-cCccceeecccCCCC-----cccccCC
Q 039957          342 LAGSFGSVYKGTI---S-DGTDVAIKIFNLQRE--RAFRSFNSECEVLRNVR-HQNLIKILSSCSTPD-----FKFMPNG  409 (481)
Q Consensus       342 ~~g~~g~vy~~~l---~-~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-----~~~~~~g  409 (481)
                      +.|.||.|+.+.-   . .|..+|+|.+.....  +.......|..++..++ |+.+|++...+....     ..|..+|
T Consensus         3 g~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg   82 (612)
T KOG0603|consen    3 GQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGG   82 (612)
T ss_pred             CcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccc
Confidence            3466776664431   1 256677776654331  22225566788888887 999999876665543     3477889


Q ss_pred             ChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          410 SLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       410 ~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ++...+...........+. ....+|-|++++|    ..+|++||+|++||++|.+|++|+.|||++|..
T Consensus        83 ~lft~l~~~~~f~~~~~~~-~~aelaLald~lh----~l~iiyrd~k~enilld~~Ghi~~tdfglske~  147 (612)
T KOG0603|consen   83 DLFTRLSKEVMFDELDVAF-YLAELALALDHLH----KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEA  147 (612)
T ss_pred             hhhhccccCCchHHHHHHH-HHHHHHHHHhhcc----hhHHHHhcccccceeecccCccccCCchhhhHh
Confidence            9998887655444333333 4456777999999    688999999999999999999999999998864

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.54  E-value=1.1e-09  Score=109.27  Aligned_cols=128  Identities=29%  Similarity=0.397  Sum_probs=99.6

Q ss_pred             CCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecch-hccccccCcee
Q 039957           13 QNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPN-SITNATKLIIL   91 (481)
Q Consensus        13 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L   91 (481)
                      ..|.+.+.++|++. ....++.-++.|+.|||++|+++ ... .+ ..++.|++|||+.|+++ .+|. +...+. |+.|
T Consensus       164 n~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~-~v~-~L-r~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L  237 (1096)
T KOG1859|consen  164 NKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFT-KVD-NL-RRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLL  237 (1096)
T ss_pred             hhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhh-hhH-HH-Hhcccccccccccchhc-cccccchhhhh-heee
Confidence            35788899999997 45678888999999999999997 343 44 37999999999999998 4443 344555 9999


Q ss_pred             ecccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccc
Q 039957           92 DLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLG  155 (481)
Q Consensus        92 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~  155 (481)
                      .+++|.++..  ..+.+|.+|+.||+++|-|.+-....+       +..+..|+.|.|.||.+-
T Consensus       238 ~lrnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~p-------LwsLs~L~~L~LeGNPl~  292 (1096)
T KOG1859|consen  238 NLRNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEP-------LWSLSSLIVLWLEGNPLC  292 (1096)
T ss_pred             eecccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhH-------HHHHHHHHHHhhcCCccc
Confidence            9999998854  347899999999999998887644333       344567888999999874

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.50  E-value=8.1e-07  Score=75.49  Aligned_cols=123  Identities=20%  Similarity=0.303  Sum_probs=81.1

Q ss_pred             cccccceeeeeccCCcceEEEEEeccc---hh-----hhhhhhHHHHHhhhhccCccc--eeecccCCC---CcccccCC
Q 039957          343 AGSFGSVYKGTISDGTDVAIKIFNLQR---ER-----AFRSFNSECEVLRNVRHQNLI--KILSSCSTP---DFKFMPNG  409 (481)
Q Consensus       343 ~g~~g~vy~~~l~~g~~vavK~l~~~~---~~-----~~~~~~~e~~~l~~l~h~niv--~l~~~~~~~---~~~~~~~g  409 (481)
                      .|+-..+|.+.+. |.++.+|.--.+.   ..     .......|..++++++-..|.  -++.+-...   .+||+++.
T Consensus         6 ~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~   84 (204)
T COG3642           6 QGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGE   84 (204)
T ss_pred             CCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCCh
Confidence            4555666666443 3344455321111   11     123456688888887754443  222222221   27899888


Q ss_pred             ChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          410 SLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       410 ~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+.+.+...        +..++..|.+-+.-||    ..+|||+|+.++||++.++. +.+.|||+++.-
T Consensus        85 ~lkd~l~~~--------~~~~~r~vG~~vg~lH----~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          85 LLKDALEEA--------RPDLLREVGRLVGKLH----KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             hHHHHHHhc--------chHHHHHHHHHHHHHH----hcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence            888777543        4667788888999999    67899999999999998766 999999999864

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.50  E-value=9e-09  Score=82.05  Aligned_cols=109  Identities=21%  Similarity=0.317  Sum_probs=80.4

Q ss_pred             CCCeeeCcCCcccccCChhccC---CcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCce
Q 039957           14 NLKSLFLGANNLSGLIPPMIFN---ISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLII   90 (481)
Q Consensus        14 ~L~~L~L~~N~l~~~~p~~~~~---l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~   90 (481)
                      .+..+||+.+++.. ++++...   ...|+..+|++|.+. ..|..+...++.++.|+|++|+|+ .+|..+..++.|+.
T Consensus        28 E~h~ldLssc~lm~-i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~  104 (177)
T KOG4579|consen   28 ELHFLDLSSCQLMY-IADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRS  104 (177)
T ss_pred             HhhhcccccchhhH-HHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhh
Confidence            35667888888753 4554444   444566688888887 677777666778888888888887 67777888888888


Q ss_pred             eecccCcceecCcccccCCCCCCEEEcccccCcccc
Q 039957           91 LDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTES  126 (481)
Q Consensus        91 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  126 (481)
                      |++++|.+. ..|..|..|.+|-.|+..+|.+..++
T Consensus       105 lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~eid  139 (177)
T KOG4579|consen  105 LNLRFNPLN-AEPRVIAPLIKLDMLDSPENARAEID  139 (177)
T ss_pred             cccccCccc-cchHHHHHHHhHHHhcCCCCccccCc
Confidence            888888887 56677777888888888777776654

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=98.45  E-value=3.1e-07  Score=80.24  Aligned_cols=59  Identities=22%  Similarity=0.135  Sum_probs=52.2

Q ss_pred             CChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          409 GSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       409 g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      |+|.+++......+++.++..|+.+|++||+|+|+    .+      ||+||+++.++.+|+  ||+++..
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~----~~------kp~Nil~~~~~~~~~--fG~~~~~   59 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHR----QA------KSGNILLTWDGLLKL--DGSVAFK   59 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh----cC------CcccEeEcCccceee--ccceEee
Confidence            78889887656678999999999999999999994    33      999999999999999  9998764

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.41  E-value=3.7e-08  Score=88.74  Aligned_cols=201  Identities=23%  Similarity=0.252  Sum_probs=105.1

Q ss_pred             CCCCccEEEccCcccee--ecchhccccccCceeecccCcceecCcccccCCCCCCEEEcccccCccccCCCcccccccc
Q 039957           60 SLPNIKYLELGDNNLIG--TIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSS  137 (481)
Q Consensus        60 ~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~  137 (481)
                      ..+.++.|||..|+|+.  .+-..+.+++.|++|+|+.|.+...+...-..+.+|++|-|.+..+.-...       -+.
T Consensus        69 ~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~-------~s~  141 (418)
T KOG2982|consen   69 SVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQS-------TSS  141 (418)
T ss_pred             HhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhh-------hhh
Confidence            44566666666666652  122234566667777777776664433222345566666665544432211       133


Q ss_pred             CCCCCCCcEEEccCCccceeCC--hhhhhcccCccEEEccCC---------ceeecCCcccccCCCCCeEecccccceec
Q 039957          138 LTNCRYLVYLILSGNPLGGILP--PSIGNFSTSLQRFSASEC---------KLKGTIPKEIGHLRGLIYLSLGFNDLNGT  206 (481)
Q Consensus       138 l~~l~~L~~L~Ls~N~l~~~~p--~~~~~~~~~L~~L~l~~n---------~l~~~~p~~~~~l~~L~~L~l~~N~l~~~  206 (481)
                      +..++.++.|.+|.|.++...-  +....+.+.+.++....|         ++...       ++++..+.+..|.+...
T Consensus       142 l~~lP~vtelHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~-------Fpnv~sv~v~e~PlK~~  214 (418)
T KOG2982|consen  142 LDDLPKVTELHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRI-------FPNVNSVFVCEGPLKTE  214 (418)
T ss_pred             hhcchhhhhhhhccchhhhhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhh-------cccchheeeecCcccch
Confidence            4566667777777775432211  111122233444443333         22222       23444555555555321


Q ss_pred             -CCcCCcCCCCCCeeecCCCcCCCCCC-ccccCccCCCeeecCCCeeeecCCc------ccccCCCCCcEEcCCCcCc
Q 039957          207 -IPTSIGTLKQLQGFFLPETNLQGYVP-HNLCHLEMLNLLHLGGNKLSGHIPP------CLASLTSLRELDLGSNKLT  276 (481)
Q Consensus       207 -~p~~~~~l~~L~~l~l~~n~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~------~~~~l~~L~~L~ls~N~l~  276 (481)
                       ....+...+.+..|+|+.|++..+.. ..+.++++|..|.+++|.+......      -++++++++.|+=+  +++
T Consensus       215 s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d~l~~~err~llIaRL~~v~vLNGs--kIs  290 (418)
T KOG2982|consen  215 SSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSDPLRGGERRFLLIARLTKVQVLNGS--KIS  290 (418)
T ss_pred             hhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCcccccccCCcceEEEEeeccceEEecCc--ccc
Confidence             22334445556667777777765432 3556677777777888776532221      35678888877644  554

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.40  E-value=5.6e-08  Score=87.60  Aligned_cols=110  Identities=24%  Similarity=0.215  Sum_probs=71.4

Q ss_pred             CCCccEEEccCccceeecc-hhc-cccccCceeecccCccee--cCcccccCCCCCCEEEcccccCccccCCCccccccc
Q 039957           61 LPNIKYLELGDNNLIGTIP-NSI-TNATKLIILDLGFNTFSG--HIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLS  136 (481)
Q Consensus        61 l~~L~~L~L~~N~l~~~~p-~~~-~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~  136 (481)
                      +..++.|-+.++.|...-. ..| ..++.++.+||..|.|+.  .+..-+.+||.|++|+|+.|.+....         .
T Consensus        44 ~ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I---------~  114 (418)
T KOG2982|consen   44 LRALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDI---------K  114 (418)
T ss_pred             ccchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCcc---------c
Confidence            3445566666665542211 123 456889999999999983  34445779999999999999997541         2


Q ss_pred             cC-CCCCCCcEEEccCCccceeCChhhhhcccCccEEEccCCce
Q 039957          137 SL-TNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKL  179 (481)
Q Consensus       137 ~l-~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l  179 (481)
                      ++ ..+.+|+.|-|.+..+.-.--.++..-.+.++.|.+|.|.+
T Consensus       115 ~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~  158 (418)
T KOG2982|consen  115 SLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSL  158 (418)
T ss_pred             cCcccccceEEEEEcCCCCChhhhhhhhhcchhhhhhhhccchh
Confidence            22 24567899999887775333333333335567777777743

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.36  E-value=1.6e-06  Score=75.84  Aligned_cols=123  Identities=24%  Similarity=0.308  Sum_probs=72.2

Q ss_pred             eeeeeccCCcceEEEEEeccch-------------h-------------hhhhhhHHHHHhhhhccC--ccceeecccCC
Q 039957          349 VYKGTISDGTDVAIKIFNLQRE-------------R-------------AFRSFNSECEVLRNVRHQ--NLIKILSSCST  400 (481)
Q Consensus       349 vy~~~l~~g~~vavK~l~~~~~-------------~-------------~~~~~~~e~~~l~~l~h~--niv~l~~~~~~  400 (481)
                      ||.|.-++|..+|+|+......             +             .......|...|.++...  ++.+++.+-..
T Consensus         2 Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~~~   81 (188)
T PF01163_consen    2 VYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYNRN   81 (188)
T ss_dssp             EEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEETT
T ss_pred             EEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEeCC
Confidence            7888888899999998754210             0             011244577888887755  34445443221


Q ss_pred             C-Cccccc--CCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcc
Q 039957          401 P-DFKFMP--NGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK  477 (481)
Q Consensus       401 ~-~~~~~~--~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~  477 (481)
                      . .|||++  +..+.. +.+..  .+......+..++.+.+..++|   ..+|||+|+.+.||+++++ .+.+.|||-|.
T Consensus        82 ~ivME~I~~~G~~~~~-l~~~~--~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iIDf~qav  154 (188)
T PF01163_consen   82 VIVMEYIGEDGVPLPR-LKDVD--LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYIIDFGQAV  154 (188)
T ss_dssp             EEEEE--EETTEEGGC-HHHCG--GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE--GTTEE
T ss_pred             EEEEEecCCCccchhh-HHhcc--ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEEecCcce
Confidence            1 278887  444433 33221  1112334566777776666543   5789999999999999988 99999999875


Q ss_pred             c
Q 039957          478 L  478 (481)
Q Consensus       478 ~  478 (481)
                      .
T Consensus       155 ~  155 (188)
T PF01163_consen  155 D  155 (188)
T ss_dssp             E
T ss_pred             e
Confidence            4

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=98.35  E-value=2.4e-07  Score=97.20  Aligned_cols=130  Identities=22%  Similarity=0.273  Sum_probs=94.3

Q ss_pred             ccccccceeeeeccCCcceEEEEEeccc-hhhhhhhhHHHHH--hhhhccCccceeecccCCCCccccc----CCChhHH
Q 039957          342 LAGSFGSVYKGTISDGTDVAIKIFNLQR-ERAFRSFNSECEV--LRNVRHQNLIKILSSCSTPDFKFMP----NGSLEKR  414 (481)
Q Consensus       342 ~~g~~g~vy~~~l~~g~~vavK~l~~~~-~~~~~~~~~e~~~--l~~l~h~niv~l~~~~~~~~~~~~~----~g~l~~~  414 (481)
                      +++.|-.+.+++...|. |.||.+-... .-..+.|.+++.-  ..-.++||.+.+.-.-......||.    .-+|++.
T Consensus        32 GstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvkhnLyDR  110 (1431)
T KOG1240|consen   32 GSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVKHNLYDR  110 (1431)
T ss_pred             CchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHhhhhhhh
Confidence            67788889999888887 7888875544 2334555554443  3446899988765443333334543    2456665


Q ss_pred             hhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcc
Q 039957          415 LYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK  477 (481)
Q Consensus       415 l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~  477 (481)
                      +. -+.++...+...||.|+..|+.-.|    ..+|+|+|||.+|||++...=+.++||.--|
T Consensus       111 lS-TRPFL~~iEKkWiaFQLL~al~qcH----~~gVcHGDIKsENILiTSWNW~~LtDFAsFK  168 (1431)
T KOG1240|consen  111 LS-TRPFLVLIEKKWIAFQLLKALSQCH----KLGVCHGDIKSENILITSWNWLYLTDFASFK  168 (1431)
T ss_pred             hc-cchHHHHHHHHHHHHHHHHHHHHHH----HcCccccccccceEEEeeechhhhhcccccC
Confidence            54 2345667788889999999999999    6889999999999999999999999997543

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.28  E-value=3.8e-06  Score=71.13  Aligned_cols=131  Identities=21%  Similarity=0.270  Sum_probs=80.8

Q ss_pred             cccccceeeeeccCCcceEEEEE-eccc-h------hhhhhhhHHHHHhhhhccCccceeeccc--CCCC---cccccC-
Q 039957          343 AGSFGSVYKGTISDGTDVAIKIF-NLQR-E------RAFRSFNSECEVLRNVRHQNLIKILSSC--STPD---FKFMPN-  408 (481)
Q Consensus       343 ~g~~g~vy~~~l~~g~~vavK~l-~~~~-~------~~~~~~~~e~~~l~~l~h~niv~l~~~~--~~~~---~~~~~~-  408 (481)
                      .|+-+.|+++..+ |....+|.- .... .      -...+..+|...+.+++--.|.--.-++  ...+   +||+++ 
T Consensus        17 QGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~   95 (229)
T KOG3087|consen   17 QGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGA   95 (229)
T ss_pred             ccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccch
Confidence            4666677887653 555555532 2111 1      1123456788888887654433211112  1122   566665 


Q ss_pred             CChhHHhhcCCCccCHHHH-HHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCC---CcEEEccccCccc
Q 039957          409 GSLEKRLYSHNYFLDILER-LNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDEN---MVAHVSDFGISKL  478 (481)
Q Consensus       409 g~l~~~l~~~~~~~~~~~~-~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~---~~~kl~Dfgl~~~  478 (481)
                      -++.+++......-...+. ...+..|.+.+.-||    ...|+|+|+..+||++..+   ..+.+.|||++..
T Consensus        96 ~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH----~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   96 STVKDFILSTMEDESEDEGLAELARRIGELIGKLH----DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             hHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh----hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            3666666543222222222 578889999999999    5779999999999998654   3568999999754

>PRK15386 type III secretion protein GogB; Provisional

Probab=98.26  E-value=2.5e-06  Score=82.49  Aligned_cols=77  Identities=17%  Similarity=0.233  Sum_probs=45.6

Q ss_pred             cCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeecccC-cceecCcccccCCCCC
Q 039957           34 FNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFN-TFSGHIPNTFGNLRHL  112 (481)
Q Consensus        34 ~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L  112 (481)
                      ..+.+++.|++++|.++ .+|. +   -++|++|.++++.-...+|+.+  ..+|+.|++++| .+. .+|.      +|
T Consensus        49 ~~~~~l~~L~Is~c~L~-sLP~-L---P~sLtsL~Lsnc~nLtsLP~~L--P~nLe~L~Ls~Cs~L~-sLP~------sL  114 (426)
T PRK15386         49 EEARASGRLYIKDCDIE-SLPV-L---PNELTEITIENCNNLTTLPGSI--PEGLEKLTVCHCPEIS-GLPE------SV  114 (426)
T ss_pred             HHhcCCCEEEeCCCCCc-ccCC-C---CCCCcEEEccCCCCcccCCchh--hhhhhheEccCccccc-cccc------cc
Confidence            34667778888877776 6662 2   2357777777643334556544  246777777776 443 3442      35


Q ss_pred             CEEEcccccCcc
Q 039957          113 SVLSLLMNNLTT  124 (481)
Q Consensus       113 ~~L~L~~N~l~~  124 (481)
                      +.|+++.|....
T Consensus       115 e~L~L~~n~~~~  126 (426)
T PRK15386        115 RSLEIKGSATDS  126 (426)
T ss_pred             ceEEeCCCCCcc
Confidence            666666555443

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.20  E-value=7.3e-06  Score=76.17  Aligned_cols=125  Identities=14%  Similarity=0.066  Sum_probs=81.1

Q ss_pred             eeeeeccCCcceEEEEEeccchh-hh----------hhhhHHHHHhhhhccCccc--eeecccCCC----------Cccc
Q 039957          349 VYKGTISDGTDVAIKIFNLQRER-AF----------RSFNSECEVLRNVRHQNLI--KILSSCSTP----------DFKF  405 (481)
Q Consensus       349 vy~~~l~~g~~vavK~l~~~~~~-~~----------~~~~~e~~~l~~l~h~niv--~l~~~~~~~----------~~~~  405 (481)
                      |.+..+ +|..+.||........ ..          ..+.+|...+.++....|.  ..+++....          -+++
T Consensus        38 vvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~  116 (268)
T PRK15123         38 TLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITED  116 (268)
T ss_pred             EEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEee
Confidence            445443 5677888876432210 01          1366788877777543332  333343211          1456


Q ss_pred             ccCC-ChhHHhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCC-------CCcEEEccccCc
Q 039957          406 MPNG-SLEKRLYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDE-------NMVAHVSDFGIS  476 (481)
Q Consensus       406 ~~~g-~l~~~l~~~-~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~-------~~~~kl~Dfgl~  476 (481)
                      +++- ++.+++... ....+...+..++.++|+.+.-||    ..+|+|+|++++|||++.       ++.+.+.||+.+
T Consensus       117 l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH----~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~  192 (268)
T PRK15123        117 LAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH----AAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRA  192 (268)
T ss_pred             CCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH----HCcCccCCCChhhEEEeccccCCCCCceEEEEECCcc
Confidence            7664 677776421 122334566789999999999999    688999999999999975       578999999988


Q ss_pred             cc
Q 039957          477 KL  478 (481)
Q Consensus       477 ~~  478 (481)
                      +.
T Consensus       193 ~~  194 (268)
T PRK15123        193 QI  194 (268)
T ss_pred             cc
Confidence            54

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.19  E-value=5.4e-08  Score=77.71  Aligned_cols=81  Identities=25%  Similarity=0.333  Sum_probs=36.2

Q ss_pred             CcEEEccCCccceeCChhhhhcccCccEEEccCCceeecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecC
Q 039957          144 LVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLP  223 (481)
Q Consensus       144 L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~  223 (481)
                      |+..+|++|.+. ..|+.|....+.++.+++++|.++ .+|.+++.++.|+.+++++|.+. ..|..+..+.++..|+..
T Consensus        55 l~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~  131 (177)
T KOG4579|consen   55 LTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSP  131 (177)
T ss_pred             EEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCC
Confidence            444444444443 233333332233445555555554 34444555555555555555554 233333334444444444


Q ss_pred             CCcC
Q 039957          224 ETNL  227 (481)
Q Consensus       224 ~n~l  227 (481)
                      +|.+
T Consensus       132 ~na~  135 (177)
T KOG4579|consen  132 ENAR  135 (177)
T ss_pred             CCcc
Confidence            4443

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=98.13  E-value=2e-06  Score=55.55  Aligned_cols=37  Identities=32%  Similarity=0.467  Sum_probs=16.9

Q ss_pred             cCceeecccCcceecCcccccCCCCCCEEEcccccCcc
Q 039957           87 KLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTT  124 (481)
Q Consensus        87 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  124 (481)
                      +|++|++++|+|+. +|..+++|++|++|++++|+++.
T Consensus         2 ~L~~L~l~~N~i~~-l~~~l~~l~~L~~L~l~~N~i~~   38 (44)
T PF12799_consen    2 NLEELDLSNNQITD-LPPELSNLPNLETLNLSNNPISD   38 (44)
T ss_dssp             T-SEEEETSSS-SS-HGGHGTTCTTSSEEEETSSCCSB
T ss_pred             cceEEEccCCCCcc-cCchHhCCCCCCEEEecCCCCCC
Confidence            34455555555542 33345555555555555555443

...

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=98.12  E-value=2.4e-06  Score=55.25  Aligned_cols=36  Identities=31%  Similarity=0.673  Sum_probs=16.5

Q ss_pred             CCCEEEeeCCcCccccChhhhcCCCCccEEEccCccce
Q 039957           38 TIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLI   75 (481)
Q Consensus        38 ~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~   75 (481)
                      +|++|++++|+|+ .+|+.+. .+++|++|++++|+++
T Consensus         2 ~L~~L~l~~N~i~-~l~~~l~-~l~~L~~L~l~~N~i~   37 (44)
T PF12799_consen    2 NLEELDLSNNQIT-DLPPELS-NLPNLETLNLSNNPIS   37 (44)
T ss_dssp             T-SEEEETSSS-S-SHGGHGT-TCTTSSEEEETSSCCS
T ss_pred             cceEEEccCCCCc-ccCchHh-CCCCCCEEEecCCCCC
Confidence            4455555555554 4444333 4555555555555544

...

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=98.11  E-value=1e-05  Score=81.37  Aligned_cols=117  Identities=15%  Similarity=0.240  Sum_probs=86.8

Q ss_pred             ccCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCCcccccC---CChhHHhhcCCCccCHHHHHHH
Q 039957          354 ISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPDFKFMPN---GSLEKRLYSHNYFLDILERLNI  430 (481)
Q Consensus       354 l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~---g~l~~~l~~~~~~~~~~~~~~i  430 (481)
                      -.++.+|.|...+...........+.+..+..+|||||++++......+.-|+.-   ..+..++...+    .......
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~Pl~~~lk~l~----~~~v~~G  109 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRPLETVLKELG----KEEVCLG  109 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccccHHHHHHHhH----HHHHHHH
Confidence            3467888888877655433344566778899999999999998887766555522   23444444321    2334456


Q ss_pred             HHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcc
Q 039957          431 MIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK  477 (481)
Q Consensus       431 ~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~  477 (481)
                      +.+|+.||.|||+.|   .++|+++.-..|++++.|+-||++|.++.
T Consensus       110 l~qIl~AL~FL~~d~---~lvHgNv~~~SVfVn~~GeWkLggle~v~  153 (690)
T KOG1243|consen  110 LFQILAALSFLNDDC---NLVHGNVCKDSVFVNESGEWKLGGLELVS  153 (690)
T ss_pred             HHHHHHHHHHHhccC---CeeeccEeeeeEEEcCCCcEEEeeeEEEe
Confidence            778999999999754   69999999999999999999999998864

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.00  E-value=3.4e-05  Score=75.46  Aligned_cols=129  Identities=20%  Similarity=0.262  Sum_probs=94.9

Q ss_pred             cceeeeec-cCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC---------cccccC-CChhHHh
Q 039957          347 GSVYKGTI-SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD---------FKFMPN-GSLEKRL  415 (481)
Q Consensus       347 g~vy~~~l-~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---------~~~~~~-g~l~~~l  415 (481)
                      ...||++- -||..+.+|+++..+.........-++.+.++.|.|+|++...+....         |.|.|+ ++|++.-
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~  369 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY  369 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence            45688874 489999999996554433333445678899999999999887765322         345554 7777654


Q ss_pred             hcC--------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          416 YSH--------------NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       416 ~~~--------------~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ...              +........+.++.|++.||.++|    +.|...+-+.+.+||++++++++|+..|..-++
T Consensus       370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH----ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl  443 (655)
T KOG3741|consen  370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH----SSGLACKTLDLKKILVTGKMRIRISGCGIMDVL  443 (655)
T ss_pred             ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH----hcCceeecccHhHeEeeCcceEEEecccceeee
Confidence            321              112334566788999999999999    567888999999999999999999988876554

>PRK15386 type III secretion protein GogB; Provisional

Probab=97.94  E-value=2.6e-05  Score=75.51  Aligned_cols=58  Identities=12%  Similarity=0.145  Sum_probs=35.8

Q ss_pred             CCCCccEEEccCccceeecchhccccccCceeecccCcceecCcccccCCCCCCEEEcccc-cCc
Q 039957           60 SLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMN-NLT  123 (481)
Q Consensus        60 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~  123 (481)
                      .+.++++|++++|.++ .+|.   -..+|+.|+++++.--..+|+.+  .++|++|++++| ++.
T Consensus        50 ~~~~l~~L~Is~c~L~-sLP~---LP~sLtsL~Lsnc~nLtsLP~~L--P~nLe~L~Ls~Cs~L~  108 (426)
T PRK15386         50 EARASGRLYIKDCDIE-SLPV---LPNELTEITIENCNNLTTLPGSI--PEGLEKLTVCHCPEIS  108 (426)
T ss_pred             HhcCCCEEEeCCCCCc-ccCC---CCCCCcEEEccCCCCcccCCchh--hhhhhheEccCccccc
Confidence            3677888888888776 4452   23458888887643223556544  246777777766 443

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=97.93  E-value=2.9e-06  Score=87.82  Aligned_cols=135  Identities=24%  Similarity=0.389  Sum_probs=93.2

Q ss_pred             ccccccceeeeeccCC--cceEEEEEeccc--hhhhhhhhHHHHHhhhhc-cCccceeecccCCCC-----cccccCCCh
Q 039957          342 LAGSFGSVYKGTISDG--TDVAIKIFNLQR--ERAFRSFNSECEVLRNVR-HQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       342 ~~g~~g~vy~~~l~~g--~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      +.|.++.+-.......  ..+++|......  .....+...|..+-.++. |.|++..++....++     .+|..+|++
T Consensus        29 g~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~  108 (601)
T KOG0590|consen   29 GKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSL  108 (601)
T ss_pred             cccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCccccccc
Confidence            3666666655443222  334455443322  222334445666666666 999999998877765     357788888


Q ss_pred             hHHh-hcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCC-cEEEccccCcccC
Q 039957          412 EKRL-YSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENM-VAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l-~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~-~~kl~Dfgl~~~~  479 (481)
                      .+.+ +.+....+....-.+..++..++.|+|.   ..+++|||+||+|.+++..+ ..|++|||+|..+
T Consensus       109 f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~---~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~  175 (601)
T KOG0590|consen  109 FSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP---ENGVTHRDIKPSNSLLDESGSALKIADFGLATAY  175 (601)
T ss_pred             ccccccCCccCCCCcchhhhhhhhccCccccCc---ccccccCCCCCccchhccCCCcccCCCchhhccc
Confidence            8877 4332133334455678899999999994   35699999999999999999 9999999999765

>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification]

Probab=97.91  E-value=5.3e-07  Score=80.39  Aligned_cols=45  Identities=29%  Similarity=0.464  Sum_probs=32.6

Q ss_pred             ccCCCCCCCcEEEccCCccceeCChhhhhc---ccCccEEEccCCcee
Q 039957          136 SSLTNCRYLVYLILSGNPLGGILPPSIGNF---STSLQRFSASECKLK  180 (481)
Q Consensus       136 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~---~~~L~~L~l~~n~l~  180 (481)
                      +.+-+|++|+..+||+|.|....|+.++.+   .+.|.+|.+++|.+.
T Consensus        86 ~aLlkcp~l~~v~LSDNAfg~~~~e~L~d~is~~t~l~HL~l~NnGlG  133 (388)
T COG5238          86 KALLKCPRLQKVDLSDNAFGSEFPEELGDLISSSTDLVHLKLNNNGLG  133 (388)
T ss_pred             HHHhcCCcceeeeccccccCcccchHHHHHHhcCCCceeEEeecCCCC
Confidence            456678888888888888887777666543   345777777777654

>PRK09902 hypothetical protein; Provisional

Probab=97.89  E-value=9e-05  Score=65.40  Aligned_cols=131  Identities=15%  Similarity=0.058  Sum_probs=86.7

Q ss_pred             ccccccceeeeeccCCcceEEEEEeccc------hhhhhhhhHHHHHhhhhccCcc--ceeecccCC--CC--------c
Q 039957          342 LAGSFGSVYKGTISDGTDVAIKIFNLQR------ERAFRSFNSECEVLRNVRHQNL--IKILSSCST--PD--------F  403 (481)
Q Consensus       342 ~~g~~g~vy~~~l~~g~~vavK~l~~~~------~~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~--~~--------~  403 (481)
                      ..|+...|++-.+ +|..+-+|+.....      .-....|.+|...+.++....+  .+.. ++..  ..        .
T Consensus        27 ~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         27 RRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT  104 (216)
T ss_pred             CCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence            3467777777654 34467788764221      1123568899998888864433  3333 2221  11        1


Q ss_pred             cccc-CCChhHHhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCc--EEEccccCccc
Q 039957          404 KFMP-NGSLEKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMV--AHVSDFGISKL  478 (481)
Q Consensus       404 ~~~~-~g~l~~~l~~~~-~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~--~kl~Dfgl~~~  478 (481)
                      +-++ --+|.+++.+.. ...+...+..+..+||++++-||    +.++.|+|+.+.||+++.++.  +++.||.-++.
T Consensus       105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH----~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH----SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH----HCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            1122 257777765432 23455667889999999999999    678999999999999986666  99999987654

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=97.89  E-value=3.2e-05  Score=69.35  Aligned_cols=100  Identities=21%  Similarity=0.280  Sum_probs=69.4

Q ss_pred             hhhHHHHHhhhhccCcc--ceeecccCCCC---------cccccC-CChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHh
Q 039957          375 SFNSECEVLRNVRHQNL--IKILSSCSTPD---------FKFMPN-GSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLH  442 (481)
Q Consensus       375 ~~~~e~~~l~~l~h~ni--v~l~~~~~~~~---------~~~~~~-g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH  442 (481)
                      ...+|...+.+++...|  .+.+++.....         .+++++ -+|.+++.+... .+-..+..++.++++.++-||
T Consensus        57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~lH  135 (206)
T PF06293_consen   57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKLH  135 (206)
T ss_pred             HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHHH
Confidence            45567666666653333  34444433211         245565 467777654211 344567789999999999999


Q ss_pred             cCCCCCCeeeCCCCCCCeeeCCCC---cEEEccccCcccC
Q 039957          443 HGHSSAPIIHCDLKPTSILLDENM---VAHVSDFGISKLL  479 (481)
Q Consensus       443 ~~~~~~~i~H~dlk~~nill~~~~---~~kl~Dfgl~~~~  479 (481)
                          ..+|+|+|+++.|||++.+.   .+.+.||+-++.-
T Consensus       136 ----~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  136 ----DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             ----HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence                68899999999999999876   8999999987753

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification]

Probab=97.89  E-value=1.7e-05  Score=68.04  Aligned_cols=108  Identities=28%  Similarity=0.427  Sum_probs=76.5

Q ss_pred             CCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeecccCcceecCcccccCCCCCCEEEc
Q 039957           38 TIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSL  117 (481)
Q Consensus        38 ~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  117 (481)
                      .=++++|.+.++. .+.. ++.-+.+...+||++|.+. .+ ..|..++.|.+|.|++|+|+.+-|.--.-+++|..|.|
T Consensus        20 ~e~e~~LR~lkip-~ien-lg~~~d~~d~iDLtdNdl~-~l-~~lp~l~rL~tLll~nNrIt~I~p~L~~~~p~l~~L~L   95 (233)
T KOG1644|consen   20 RERELDLRGLKIP-VIEN-LGATLDQFDAIDLTDNDLR-KL-DNLPHLPRLHTLLLNNNRITRIDPDLDTFLPNLKTLIL   95 (233)
T ss_pred             ccccccccccccc-chhh-ccccccccceecccccchh-hc-ccCCCccccceEEecCCcceeeccchhhhccccceEEe
Confidence            3456777776664 2222 3334567788888888875 22 34777888888888888888777766556778888888


Q ss_pred             ccccCccccCCCccccccccCCCCCCCcEEEccCCccce
Q 039957          118 LMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGG  156 (481)
Q Consensus       118 ~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~  156 (481)
                      .+|+|..+..       +..+..+++|++|.+-+|+++.
T Consensus        96 tnNsi~~l~d-------l~pLa~~p~L~~Ltll~Npv~~  127 (233)
T KOG1644|consen   96 TNNSIQELGD-------LDPLASCPKLEYLTLLGNPVEH  127 (233)
T ss_pred             cCcchhhhhh-------cchhccCCccceeeecCCchhc
Confidence            8888877632       2446778888888888887763

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=97.85  E-value=1.2e-05  Score=84.63  Aligned_cols=40  Identities=43%  Similarity=0.648  Sum_probs=37.7

Q ss_pred             HHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          435 GSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       435 a~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      +.+++|+|    +.+|||||+||.|.++..-|++|+.|||+.|.
T Consensus       153 vla~Eylh----~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~  192 (1205)
T KOG0606|consen  153 VLAVEYLH----SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKK  192 (1205)
T ss_pred             hHHhHhhc----cCCeecCCCCCCcceeeecccccccchhhhhh
Confidence            56899999    78999999999999999999999999999875

>KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification]

Probab=97.83  E-value=2.9e-05  Score=66.65  Aligned_cols=132  Identities=20%  Similarity=0.176  Sum_probs=93.3

Q ss_pred             CCCCeeeCcCCcccccCChhcc-CCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCcee
Q 039957           13 QNLKSLFLGANNLSGLIPPMIF-NISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIIL   91 (481)
Q Consensus        13 ~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L   91 (481)
                      ..=+.++|.+.++..+..  ++ -+.+...+||++|.+. .++. +. .++.|.+|.|++|+|+.+-|.--..+++|..|
T Consensus        19 ~~e~e~~LR~lkip~ien--lg~~~d~~d~iDLtdNdl~-~l~~-lp-~l~rL~tLll~nNrIt~I~p~L~~~~p~l~~L   93 (233)
T KOG1644|consen   19 VRERELDLRGLKIPVIEN--LGATLDQFDAIDLTDNDLR-KLDN-LP-HLPRLHTLLLNNNRITRIDPDLDTFLPNLKTL   93 (233)
T ss_pred             ccccccccccccccchhh--ccccccccceecccccchh-hccc-CC-CccccceEEecCCcceeeccchhhhccccceE
Confidence            345778888888764322  11 2345778999999985 4443 32 58899999999999997777766777889999


Q ss_pred             ecccCcceecC-cccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCcc
Q 039957           92 DLGFNTFSGHI-PNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPL  154 (481)
Q Consensus        92 ~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l  154 (481)
                      .|.+|+|...- -.-+..++.|++|.+-+|..+...  .|+.   --+..+++|++||.++=.-
T Consensus        94 ~LtnNsi~~l~dl~pLa~~p~L~~Ltll~Npv~~k~--~YR~---yvl~klp~l~~LDF~kVt~  152 (233)
T KOG1644|consen   94 ILTNNSIQELGDLDPLASCPKLEYLTLLGNPVEHKK--NYRL---YVLYKLPSLRTLDFQKVTR  152 (233)
T ss_pred             EecCcchhhhhhcchhccCCccceeeecCCchhccc--Ccee---EEEEecCcceEeehhhhhH
Confidence            99999887321 112667889999999999887652  2221   1245788899999876543

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	481
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		1e-24
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		1e-24
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		5e-17
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-16
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-15
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-15
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		5e-14
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-13
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		9e-13
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		9e-13
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		9e-13
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-12
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-12
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-12
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		4e-12
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-12
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-12
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		5e-12
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		5e-12
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		5e-12
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		5e-12
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		7e-12
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		4e-10
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		3e-09
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		8e-12
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-11
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-11
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		4e-11
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		5e-11
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		6e-11
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		9e-11
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-10
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-10
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		3e-10
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-10
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		4e-10
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-10
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		6e-10
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		6e-10
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		7e-10
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		7e-10
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		7e-10
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		7e-10
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-10
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		7e-10
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		8e-10
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-09
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-09
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-09
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-09
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-09
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-09
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-09
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-09
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-09
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-09
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-09
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-09
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-09
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-09
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-09
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-09
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-09
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-09
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-09
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-09
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-09
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-09
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-09
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		3e-09
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-09
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-09
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-09
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		4e-09
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		4e-09
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		4e-09
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		4e-09
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		4e-09
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		4e-09
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		4e-09
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		4e-09
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		4e-09
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		4e-09
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		4e-09
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		4e-09
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		4e-09
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		5e-09
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		5e-09
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		5e-09
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		5e-09
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		5e-09
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		5e-09
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		5e-09
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		5e-09
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		5e-09
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		6e-09
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		6e-09
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		6e-09
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		7e-09
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		7e-09
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		9e-09
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-08
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-08
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-08
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-08
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-08
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-08
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-08
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-08
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		3e-08
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-08
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-08
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-08
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		4e-08
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		4e-08
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		4e-08
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		4e-08
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		4e-08
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		4e-08
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		4e-08
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		4e-08
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		4e-08
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		4e-08
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-08
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		5e-08
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		5e-08
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		5e-08
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-08
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		5e-08
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		5e-08
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		6e-08
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-08
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		6e-08
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		6e-08
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		7e-08
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		7e-08
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		8e-08
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		9e-08
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-07
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-07
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-07
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-07
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-07
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-07
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-07
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-07
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-07
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-07
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		3e-07
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-07
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		5e-07
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		8e-07
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		9e-07
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		9e-07
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		9e-07
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		9e-07
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-06
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-06
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-06
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-06
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-06
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-06
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-06
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-06
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-06
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-06
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-06
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-06
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-06
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-06
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-06
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-06
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-06
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-06
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-06
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-06
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-06
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-06
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-06
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-06
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-06
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-06
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		3e-06
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-06
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-06
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-06
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-06
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-06
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-06
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-06
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		3e-06
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-06
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-06
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-06
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-06
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-06
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-06
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-06
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		4e-06
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		4e-06
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-06
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-06
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-06
3a4o_X	286	Lyn Kinase Domain Length = 286		4e-06
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-06
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		4e-06
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		4e-06
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		4e-06
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		4e-06
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		4e-06
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-06
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		5e-06
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		5e-06
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		5e-06
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		5e-06
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		6e-06
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		6e-06
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		6e-06
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		6e-06
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		6e-06
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		6e-06
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		6e-06
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		6e-06
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		6e-06
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		6e-06
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		6e-06
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		7e-06
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		7e-06
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		7e-06
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		7e-06
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-06
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		7e-06
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		7e-06
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		7e-06
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-06
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		7e-06
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		7e-06
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		7e-06
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		7e-06
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		7e-06
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		7e-06
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		7e-06
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		8e-06
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		8e-06
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-06
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		8e-06
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		8e-06
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		8e-06
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		8e-06
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		8e-06
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		8e-06
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		8e-06
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		9e-06
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		9e-06
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		9e-06
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		9e-06
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		9e-06
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		9e-06
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-05
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-05
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-05
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-05
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-05
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-05
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-05
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-05
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-05
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-05
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-05
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-05
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-05
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-05
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-05
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-05
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-05
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-05
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-05
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-05
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-05
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-05
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-05
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		3e-05
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-05
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		4e-05
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		5e-05
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		5e-05
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-05
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-05
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-05
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		8e-05
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		9e-05
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-04
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-04
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-04
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-04
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-04
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-04
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-04
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-04
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-04
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-04
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-04
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-04
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-04
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-04
2z62_A	276	Crystal Structure Of The Tv3 Hybrid Of Human Tlr4 A		1e-04
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-04
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-04
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-04
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-04
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-04
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-04
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-04
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-04
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-04
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-04
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-04
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-04
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-04
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-04
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-04
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-04
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-04
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-04
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-04
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-04
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-04
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-04
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-04
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-04
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-04
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-04
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-04
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-04
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-04
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-04
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-04
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-04
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-04
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-04
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-04
3ul8_A	279	Crystal Structure Of The Tv3 Mutant V134l Length =		2e-04
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-04
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-04
4g8a_A	635	Crystal Structure Of Human Tlr4 Polymorphic Variant		2e-04
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-04
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-04
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-04
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-04
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-04
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-04
3fxi_A	605	Crystal Structure Of The Human Tlr4-Human Md-2-E.Co		3e-04
2z63_A	570	Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 A		3e-04
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-04
3ul9_A	278	Structure Of The Tv3 Mutant M41e Length = 278		3e-04
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-04
2z64_A	599	Crystal Structure Of Mouse Tlr4 And Mouse Md-2 Comp		3e-04
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-04
3vq1_A	606	Crystal Structure Of Mouse Tlr4MD-2LIPID IVA COMPLE		3e-04
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-04
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-04
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-04
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		4e-04
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		4e-04
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		4e-04
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		4e-04
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		5e-04
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		5e-04
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		5e-04
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		5e-04
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		5e-04
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		5e-04
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		6e-04
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		6e-04
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		6e-04
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		6e-04
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		6e-04
3ula_A	279	Crystal Structure Of The Tv3 Mutant F63w-Md-2-Erito		6e-04
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		6e-04
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		6e-04
3ul7_A	278	Crystal Structure Of The Tv3 Mutant F63w Length = 2		6e-04
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-04
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		7e-04
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		7e-04
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		7e-04
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		7e-04
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		7e-04
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		7e-04
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		7e-04
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		7e-04
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		7e-04
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		7e-04
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		7e-04
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		7e-04
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		7e-04
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		7e-04
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		8e-04
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		8e-04
3zyj_A	440	Netring1 In Complex With Ngl1 Length = 440		8e-04
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		8e-04
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		8e-04
2wfh_A	193	The Human Slit 2 Dimerization Domain D4 Length = 19		8e-04
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		8e-04
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		8e-04
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		8e-04
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		9e-04
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		9e-04
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		9e-04
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		9e-04
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		9e-04
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		9e-04
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		9e-04

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 110/388 (28%), Positives = 163/388 (42%), Gaps = 50/388 (12%)
Query: 1   MTGQIPTE-IGNLQNLKSLFLGANNLSGLIPPMIFNIS-TIRNLNLGGNRLSGH-LPSMI 57
            +G++P + +  ++ LK L L  N  SG +P  + N+S ++  L+L  N  SG  LP++ 
Sbjct: 327 FSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLC 386
Query: 58  GHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSL 117
            +    ++ L L +N   G IP +++N ++L+ L L FN  SG IP++ G+L  L  L L
Sbjct: 387 QNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKL 446
Query: 118 LMNNLTTESSSAYQW----------------SFLSSLTNCRYLVYLILSGNPLGGILPPS 161
            +N L  E      +                   S L+NC  L ++ LS N L G +P  
Sbjct: 447 WLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKW 506
Query: 162 IGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSI---------- 211
           IG    +L     S     G IP E+G  R LI+L L  N  NGTIP ++          
Sbjct: 507 IGRLE-NLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAAN 565
Query: 212 -------------GTLKQLQGFFLPETNL---QGYVPXXXXXXXXXXXXXXXXXKLSGHI 255
                        G  K+  G      NL   QG                       GH 
Sbjct: 566 FIAGKRYVYIKNDGMKKECHG----AGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHT 621
Query: 256 PPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEIXXXXXXXXXXXXXXVQKLKVLRV 315
            P   +  S+  LD+  N L+  IP  + S+ Y+  +              V  L+ L +
Sbjct: 622 SPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNI 681
Query: 316 LDLSRNQLSGDIPSTIGALVDLETISLA 343
           LDLS N+L G IP  + AL  L  I L+
Sbjct: 682 LDLSSNKLDGRIPQAMSALTMLTEIDLS 709

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 110/388 (28%), Positives = 163/388 (42%), Gaps = 50/388 (12%)
Query: 1   MTGQIPTE-IGNLQNLKSLFLGANNLSGLIPPMIFNIS-TIRNLNLGGNRLSGH-LPSMI 57
            +G++P + +  ++ LK L L  N  SG +P  + N+S ++  L+L  N  SG  LP++ 
Sbjct: 330 FSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLC 389
Query: 58  GHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSL 117
            +    ++ L L +N   G IP +++N ++L+ L L FN  SG IP++ G+L  L  L L
Sbjct: 390 QNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKL 449
Query: 118 LMNNLTTESSSAYQW----------------SFLSSLTNCRYLVYLILSGNPLGGILPPS 161
            +N L  E      +                   S L+NC  L ++ LS N L G +P  
Sbjct: 450 WLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKW 509
Query: 162 IGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSI---------- 211
           IG    +L     S     G IP E+G  R LI+L L  N  NGTIP ++          
Sbjct: 510 IGRLE-NLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAAN 568
Query: 212 -------------GTLKQLQGFFLPETNL---QGYVPXXXXXXXXXXXXXXXXXKLSGHI 255
                        G  K+  G      NL   QG                       GH 
Sbjct: 569 FIAGKRYVYIKNDGMKKECHG----AGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHT 624
Query: 256 PPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEIXXXXXXXXXXXXXXVQKLKVLRV 315
            P   +  S+  LD+  N L+  IP  + S+ Y+  +              V  L+ L +
Sbjct: 625 SPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNI 684
Query: 316 LDLSRNQLSGDIPSTIGALVDLETISLA 343
           LDLS N+L G IP  + AL  L  I L+
Sbjct: 685 LDLSSNKLDGRIPQAMSALTMLTEIDLS 712

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 56/146 (38%), Positives = 78/146 (53%), Gaps = 12/146 (8%)
Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRERAFR-SFNSECEVLRNVRHQNLIKILSSCSTPD 402
           G FG VYKG ++DGT VA+K    +R +     F +E E++    H+NL+++   C TP 
Sbjct: 49  GGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 108
Query: 403 -----FKFMPNGS----LEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHC 453
                + +M NGS    L +R  S    LD  +R  I +     L YLH  H    IIH 
Sbjct: 109 ERLLVYPYMANGSVASCLRERPESQPP-LDWPKRQRIALGSARGLAYLH-DHCDPKIIHR 166
Query: 454 DLKPTSILLDENMVAHVSDFGISKLL 479
           D+K  +ILLDE   A V DFG++KL+
Sbjct: 167 DVKAANILLDEEFEAVVGDFGLAKLM 192

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/146 (37%), Positives = 77/146 (52%), Gaps = 12/146 (8%)
Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRERAFR-SFNSECEVLRNVRHQNLIKILSSCSTPD 402
           G FG VYKG ++DG  VA+K    +R +     F +E E++    H+NL+++   C TP 
Sbjct: 41  GGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 100
Query: 403 -----FKFMPNGS----LEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHC 453
                + +M NGS    L +R  S    LD  +R  I +     L YLH  H    IIH 
Sbjct: 101 ERLLVYPYMANGSVASCLRERPESQPP-LDWPKRQRIALGSARGLAYLHD-HCDPKIIHR 158
Query: 454 DLKPTSILLDENMVAHVSDFGISKLL 479
           D+K  +ILLDE   A V DFG++KL+
Sbjct: 159 DVKAANILLDEEFEAVVGDFGLAKLM 184

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/142 (37%), Positives = 76/142 (53%), Gaps = 12/142 (8%)
Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD- 402
           G FG VYKG + DG  VA+K    +  +    F +E E L   RH +L+ ++  C   + 
Sbjct: 50  GVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE 109
Query: 403 ----FKFMPNGSLEKRLYSHN---YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDL 455
               +K+M NG+L++ LY  +     +   +RL I I     L YLH    +  IIH D+
Sbjct: 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH----TRAIIHRDV 165
Query: 456 KPTSILLDENMVAHVSDFGISK 477
           K  +ILLDEN V  ++DFGISK
Sbjct: 166 KSINILLDENFVPKITDFGISK 187

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/142 (37%), Positives = 76/142 (53%), Gaps = 12/142 (8%)
Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD- 402
           G FG VYKG + DG  VA+K    +  +    F +E E L   RH +L+ ++  C   + 
Sbjct: 50  GVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE 109
Query: 403 ----FKFMPNGSLEKRLYSHN---YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDL 455
               +K+M NG+L++ LY  +     +   +RL I I     L YLH    +  IIH D+
Sbjct: 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH----TRAIIHRDV 165
Query: 456 KPTSILLDENMVAHVSDFGISK 477
           K  +ILLDEN V  ++DFGISK
Sbjct: 166 KSINILLDENFVPKITDFGISK 187

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 48/145 (33%), Positives = 79/145 (54%), Gaps = 12/145 (8%)
Query: 343 AGSFGSVYKGTISDGTDVAIKIFNLQRERAFR--SFNSECEVLRNVRHQNLIKILSSCST 400
           AGSFG+V++     G+DVA+KI   Q   A R   F  E  +++ +RH N++  + + + 
Sbjct: 47  AGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ 105
Query: 401 PD-----FKFMPNGSLEKRLYSH--NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHC 453
           P       +++  GSL + L+       LD   RL++  DV   + YLH+   + PI+H 
Sbjct: 106 PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN--RNPPIVHR 163
Query: 454 DLKPTSILLDENMVAHVSDFGISKL 478
           DLK  ++L+D+     V DFG+S+L
Sbjct: 164 DLKSPNLLVDKKYTVKVCDFGLSRL 188

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 79/145 (54%), Gaps = 12/145 (8%)
Query: 343 AGSFGSVYKGTISDGTDVAIKIFNLQRERAFR--SFNSECEVLRNVRHQNLIKILSSCST 400
           AGSFG+V++     G+DVA+KI   Q   A R   F  E  +++ +RH N++  + + + 
Sbjct: 47  AGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ 105
Query: 401 PD-----FKFMPNGSLEKRLYSH--NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHC 453
           P       +++  GSL + L+       LD   RL++  DV   + YLH+   + PI+H 
Sbjct: 106 PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN--RNPPIVHR 163
Query: 454 DLKPTSILLDENMVAHVSDFGISKL 478
           +LK  ++L+D+     V DFG+S+L
Sbjct: 164 NLKSPNLLVDKKYTVKVCDFGLSRL 188

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 49/145 (33%), Positives = 77/145 (53%), Gaps = 16/145 (11%)
Query: 344 GSFGSVYKGTISDGTDVAIK----IFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCS 399
           G FG VYKG +++ T VA+K    + ++  E   + F+ E +V+   +H+NL+++L   S
Sbjct: 42  GGFGVVYKGYVNNTT-VAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSS 100
Query: 400 TPD-----FKFMPNGSLEKRLYSHNYF--LDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
             D     + +MPNGSL  RL   +    L    R  I     + + +LH  H     IH
Sbjct: 101 DGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH----IH 156
Query: 453 CDLKPTSILLDENMVAHVSDFGISK 477
            D+K  +ILLDE   A +SDFG+++
Sbjct: 157 RDIKSANILLDEAFTAKISDFGLAR 181

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 49/145 (33%), Positives = 77/145 (53%), Gaps = 16/145 (11%)
Query: 344 GSFGSVYKGTISDGTDVAIK----IFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCS 399
           G FG VYKG +++ T VA+K    + ++  E   + F+ E +V+   +H+NL+++L   S
Sbjct: 42  GGFGVVYKGYVNNTT-VAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSS 100
Query: 400 TPD-----FKFMPNGSLEKRLYSHNYF--LDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
             D     + +MPNGSL  RL   +    L    R  I     + + +LH  H     IH
Sbjct: 101 DGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH----IH 156
Query: 453 CDLKPTSILLDENMVAHVSDFGISK 477
            D+K  +ILLDE   A +SDFG+++
Sbjct: 157 RDIKSANILLDEAFTAKISDFGLAR 181

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 49/145 (33%), Positives = 77/145 (53%), Gaps = 16/145 (11%)
Query: 344 GSFGSVYKGTISDGTDVAIK----IFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCS 399
           G FG VYKG +++ T VA+K    + ++  E   + F+ E +V+   +H+NL+++L   S
Sbjct: 36  GGFGVVYKGYVNNTT-VAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSS 94
Query: 400 TPD-----FKFMPNGSLEKRLYSHNYF--LDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
             D     + +MPNGSL  RL   +    L    R  I     + + +LH  H     IH
Sbjct: 95  DGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH----IH 150
Query: 453 CDLKPTSILLDENMVAHVSDFGISK 477
            D+K  +ILLDE   A +SDFG+++
Sbjct: 151 RDIKSANILLDEAFTAKISDFGLAR 175

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 81/169 (47%), Gaps = 13/169 (7%)
Query: 314 RVLDLSRNQLSGDIPSTIGALVDLETISLAGSFGSVYKGTISDGTDVAIKIFNLQR--ER 371
           R+  L R   S D     G +   + I  +GSFG+VYKG      DVA+K+ N+     +
Sbjct: 18  RMKTLGRRDSSDDWEIPDGQITVGQRIG-SGSFGTVYKGKWH--GDVAVKMLNVTAPTPQ 74
Query: 372 AFRSFNSECEVLRNVRHQNLIKILSSCSTPDFKFMPNGSLEKRLYSHNYFLDILERLNIM 431
             ++F +E  VLR  RH N++  +   + P    +        LY H + ++    +  +
Sbjct: 75  QLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKL 134
Query: 432 IDVGST----LEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGIS 476
           ID+       ++YLH    +  IIH DLK  +I L E++   + DFG++
Sbjct: 135 IDIARQTAQGMDYLH----AKSIIHRDLKSNNIFLHEDLTVKIGDFGLA 179

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 81/169 (47%), Gaps = 13/169 (7%)
Query: 314 RVLDLSRNQLSGDIPSTIGALVDLETISLAGSFGSVYKGTISDGTDVAIKIFNLQR--ER 371
           R+  L R   S D     G +   + I  +GSFG+VYKG      DVA+K+ N+     +
Sbjct: 18  RMKTLGRRDSSDDWEIPDGQITVGQRIG-SGSFGTVYKGKWH--GDVAVKMLNVTAPTPQ 74
Query: 372 AFRSFNSECEVLRNVRHQNLIKILSSCSTPDFKFMPNGSLEKRLYSHNYFLDILERLNIM 431
             ++F +E  VLR  RH N++  +   + P    +        LY H + ++    +  +
Sbjct: 75  QLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKL 134
Query: 432 IDVGST----LEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGIS 476
           ID+       ++YLH    +  IIH DLK  +I L E++   + DFG++
Sbjct: 135 IDIARQTAQGMDYLH----AKSIIHRDLKSNNIFLHEDLTVKIGDFGLA 179

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 81/169 (47%), Gaps = 13/169 (7%)
Query: 314 RVLDLSRNQLSGDIPSTIGALVDLETISLAGSFGSVYKGTISDGTDVAIKIFNLQR--ER 371
           R+  L R   S D     G +   + I  +GSFG+VYKG      DVA+K+ N+     +
Sbjct: 10  RMKTLGRRDSSDDWEIPDGQITVGQRIG-SGSFGTVYKGKWH--GDVAVKMLNVTAPTPQ 66
Query: 372 AFRSFNSECEVLRNVRHQNLIKILSSCSTPDFKFMPNGSLEKRLYSHNYFLDILERLNIM 431
             ++F +E  VLR  RH N++  +   + P    +        LY H + ++    +  +
Sbjct: 67  QLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKL 126
Query: 432 IDVGST----LEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGIS 476
           ID+       ++YLH    +  IIH DLK  +I L E++   + DFG++
Sbjct: 127 IDIARQTAQGMDYLH----AKSIIHRDLKSNNIFLHEDLTVKIGDFGLA 171

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 81/169 (47%), Gaps = 13/169 (7%)
Query: 314 RVLDLSRNQLSGDIPSTIGALVDLETISLAGSFGSVYKGTISDGTDVAIKIFNLQR--ER 371
           R+  L R   S D     G +   + I  +GSFG+VYKG      DVA+K+ N+     +
Sbjct: 17  RMKTLGRRDSSDDWEIPDGQITVGQRIG-SGSFGTVYKGKWH--GDVAVKMLNVTAPTPQ 73
Query: 372 AFRSFNSECEVLRNVRHQNLIKILSSCSTPDFKFMPNGSLEKRLYSHNYFLDILERLNIM 431
             ++F +E  VLR  RH N++  +   + P    +        LY H + ++    +  +
Sbjct: 74  QLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKL 133
Query: 432 IDVGST----LEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGIS 476
           ID+       ++YLH    +  IIH DLK  +I L E++   + DFG++
Sbjct: 134 IDIARQTAQGMDYLH----AKSIIHRDLKSNNIFLHEDLTVKIGDFGLA 178

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 71/140 (50%), Gaps = 12/140 (8%)
Query: 343 AGSFGSVYKGTISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCST 400
           +GSFG+VYKG      DVA+K+ N+     +  ++F +E  VLR  RH N++  +   + 
Sbjct: 18  SGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 75
Query: 401 PDFKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGST----LEYLHHGHSSAPIIHCDLK 456
           P    +        LY H + ++    +  +ID+       ++YLH    +  IIH DLK
Sbjct: 76  PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH----AKSIIHRDLK 131
Query: 457 PTSILLDENMVAHVSDFGIS 476
             +I L E++   + DFG++
Sbjct: 132 SNNIFLHEDLTVKIGDFGLA 151

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 71/140 (50%), Gaps = 12/140 (8%)
Query: 343 AGSFGSVYKGTISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCST 400
           +GSFG+VYKG      DVA+K+ N+     +  ++F +E  VLR  RH N++  +   + 
Sbjct: 18  SGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 75
Query: 401 PDFKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGST----LEYLHHGHSSAPIIHCDLK 456
           P    +        LY H + ++    +  +ID+       ++YLH    +  IIH DLK
Sbjct: 76  PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH----AKSIIHRDLK 131
Query: 457 PTSILLDENMVAHVSDFGIS 476
             +I L E++   + DFG++
Sbjct: 132 SNNIFLHEDLTVKIGDFGLA 151

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 71/140 (50%), Gaps = 12/140 (8%)
Query: 343 AGSFGSVYKGTISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCST 400
           +GSFG+VYKG      DVA+K+ N+     +  ++F +E  VLR  RH N++  +   + 
Sbjct: 23  SGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 80
Query: 401 PDFKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGST----LEYLHHGHSSAPIIHCDLK 456
           P    +        LY H + ++    +  +ID+       ++YLH    +  IIH DLK
Sbjct: 81  PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH----AKSIIHRDLK 136
Query: 457 PTSILLDENMVAHVSDFGIS 476
             +I L E++   + DFG++
Sbjct: 137 SNNIFLHEDLTVKIGDFGLA 156

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 71/140 (50%), Gaps = 12/140 (8%)
Query: 343 AGSFGSVYKGTISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCST 400
           +GSFG+VYKG      DVA+K+ N+     +  ++F +E  VLR  RH N++  +   + 
Sbjct: 18  SGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 75
Query: 401 PDFKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGST----LEYLHHGHSSAPIIHCDLK 456
           P    +        LY H + ++    +  +ID+       ++YLH    +  IIH DLK
Sbjct: 76  PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH----AKSIIHRDLK 131
Query: 457 PTSILLDENMVAHVSDFGIS 476
             +I L E++   + DFG++
Sbjct: 132 SNNIFLHEDLTVKIGDFGLA 151

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 71/140 (50%), Gaps = 12/140 (8%)
Query: 343 AGSFGSVYKGTISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCST 400
           +GSFG+VYKG      DVA+K+ N+     +  ++F +E  VLR  RH N++  +   + 
Sbjct: 23  SGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 80
Query: 401 PDFKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGST----LEYLHHGHSSAPIIHCDLK 456
           P    +        LY H + ++    +  +ID+       ++YLH    +  IIH DLK
Sbjct: 81  PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH----AKSIIHRDLK 136
Query: 457 PTSILLDENMVAHVSDFGIS 476
             +I L E++   + DFG++
Sbjct: 137 SNNIFLHEDLTVKIGDFGLA 156

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 71/140 (50%), Gaps = 12/140 (8%)
Query: 343 AGSFGSVYKGTISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCST 400
           +GSFG+VYKG      DVA+K+ N+     +  ++F +E  VLR  RH N++  +   + 
Sbjct: 20  SGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 77
Query: 401 PDFKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGST----LEYLHHGHSSAPIIHCDLK 456
           P    +        LY H + ++    +  +ID+       ++YLH    +  IIH DLK
Sbjct: 78  PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH----AKSIIHRDLK 133
Query: 457 PTSILLDENMVAHVSDFGIS 476
             +I L E++   + DFG++
Sbjct: 134 SNNIFLHEDLTVKIGDFGLA 153

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 103/209 (49%), Gaps = 13/209 (6%)
Query: 1   MTGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHS 60
           + G IP  I  L  L  L++   N+SG IP  +  I T+  L+   N LSG LP  I  S
Sbjct: 89  LVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSIS-S 147
Query: 61  LPNIKYLELGDNNLIGTIPNSITNATKLII-LDLGFNTFSGHIPNTFGNLRHLSVLSLLM 119
           LPN+  +    N + G IP+S  + +KL   + +  N  +G IP TF NL +L+ + L  
Sbjct: 148 LPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSR 206
Query: 120 NNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKL 179
           N L  ++S  +      S  N + +    L+ N L   L   +G  S +L        ++
Sbjct: 207 NMLEGDASVLF-----GSDKNTQKIH---LAKNSLAFDL-GKVG-LSKNLNGLDLRNNRI 256
Query: 180 KGTIPKEIGHLRGLIYLSLGFNDLNGTIP 208
            GT+P+ +  L+ L  L++ FN+L G IP
Sbjct: 257 YGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 71/246 (28%), Positives = 102/246 (41%), Gaps = 16/246 (6%)
Query: 39  IRNLNLGGNRLSGHLPSMIGHSLPNIKYLEL----GDNNLIGTIPNSITNATKLIILDLG 94
           + NL+L G  L    P  I  SL N+ YL      G NNL+G IP +I   T+L  L + 
Sbjct: 52  VNNLDLSGLNLPKPYP--IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYIT 109
Query: 95  FNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPL 154
               SG IP+    ++ L  L    N L+     +     +SSL N   LV +   GN +
Sbjct: 110 HTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPS-----ISSLPN---LVGITFDGNRI 161
Query: 155 GGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTL 214
            G +P S G+FS      + S  +L G IP    +L  L ++ L  N L G      G+ 
Sbjct: 162 SGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSD 220
Query: 215 KQLQGFFLPETNLQGYVPXXXXXXXXXXXXXXXXXKLSGHIPPCLASLTSLRELDLGSNK 274
           K  Q   L + +L  +                   ++ G +P  L  L  L  L++  N 
Sbjct: 221 KNTQKIHLAKNSL-AFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNN 279
Query: 275 LTSSIP 280
           L   IP
Sbjct: 280 LCGEIP 285

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 69/247 (27%), Positives = 104/247 (42%), Gaps = 15/247 (6%)
Query: 136 SSLTNCRYLVYLILSG-NPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLI 194
           SSL N  YL +L + G N L G +PP+I    T L     +   + G IP  +  ++ L+
Sbjct: 70  SSLANLPYLNFLYIGGINNLVGPIPPAIAKL-TQLHYLYITHTNVSGAIPDFLSQIKTLV 128
Query: 195 YLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPXXX-XXXXXXXXXXXXXXKLSG 253
            L   +N L+GT+P SI +L  L G       + G +P                  +L+G
Sbjct: 129 TLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTG 188
Query: 254 HIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEIXXXXXXXXXXXXXXVQKLKVL 313
            IPP  A+L +L  +DL  N L     S L+      +               V   K L
Sbjct: 189 KIPPTFANL-NLAFVDLSRNMLEGDA-SVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNL 246
Query: 314 RVLDLSRNQLSGDIPSTIGALVDLETISLAGSFGSVYKGTISDGTDVAIKIFNLQRERAF 373
             LDL  N++ G +P  +  L  L ++++  SF ++  G I  G        NLQR    
Sbjct: 247 NGLDLRNNRIYGTLPQGLTQLKFLHSLNV--SFNNLC-GEIPQGG-------NLQRFDVS 296
Query: 374 RSFNSEC 380
              N++C
Sbjct: 297 AYANNKC 303

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 48/145 (33%), Positives = 75/145 (51%), Gaps = 16/145 (11%)
Query: 344 GSFGSVYKGTISDGTDVAIK----IFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCS 399
           G FG VYKG +++ T VA+K    + ++  E   + F+ E +V    +H+NL+++L   S
Sbjct: 33  GGFGVVYKGYVNNTT-VAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLGFSS 91
Query: 400 TPD-----FKFMPNGSLEKRLYSHNYF--LDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
             D     + + PNGSL  RL   +    L    R  I     + + +LH  H     IH
Sbjct: 92  DGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHH----IH 147
Query: 453 CDLKPTSILLDENMVAHVSDFGISK 477
            D+K  +ILLDE   A +SDFG+++
Sbjct: 148 RDIKSANILLDEAFTAKISDFGLAR 172

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 69/140 (49%), Gaps = 12/140 (8%)
Query: 343 AGSFGSVYKGTISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCST 400
           +GSFG+VYKG      DVA+K+ N+     +  ++F +E  VLR  RH N++  +   + 
Sbjct: 34  SGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 91
Query: 401 PDFKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGST----LEYLHHGHSSAPIIHCDLK 456
           P    +        LY H +  +    +  +ID+       ++YLH    +  IIH DLK
Sbjct: 92  PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH----AKSIIHRDLK 147
Query: 457 PTSILLDENMVAHVSDFGIS 476
             +I L E+    + DFG++
Sbjct: 148 SNNIFLHEDNTVKIGDFGLA 167

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 69/140 (49%), Gaps = 12/140 (8%)
Query: 343 AGSFGSVYKGTISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCST 400
           +GSFG+VYKG      DVA+K+ N+     +  ++F +E  VLR  RH N++  +   + 
Sbjct: 34  SGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 91
Query: 401 PDFKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGST----LEYLHHGHSSAPIIHCDLK 456
           P    +        LY H +  +    +  +ID+       ++YLH    +  IIH DLK
Sbjct: 92  PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH----AKSIIHRDLK 147
Query: 457 PTSILLDENMVAHVSDFGIS 476
             +I L E+    + DFG++
Sbjct: 148 SNNIFLHEDNTVKIGDFGLA 167

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 69/140 (49%), Gaps = 12/140 (8%)
Query: 343 AGSFGSVYKGTISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCST 400
           +GSFG+VYKG      DVA+K+ N+     +  ++F +E  VLR  RH N++  +   + 
Sbjct: 22  SGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 79
Query: 401 PDFKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGST----LEYLHHGHSSAPIIHCDLK 456
           P    +        LY H +  +    +  +ID+       ++YLH    +  IIH DLK
Sbjct: 80  PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH----AKSIIHRDLK 135
Query: 457 PTSILLDENMVAHVSDFGIS 476
             +I L E+    + DFG++
Sbjct: 136 SNNIFLHEDNTVKIGDFGLA 155

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 83/167 (49%), Gaps = 18/167 (10%)
Query: 327 IPSTIGALVDLETISLAGSFGSVYKGT-ISDGTDVAIKIFNL-------QRERAFRSFNS 378
           +P+     ++ E     G FG V+KG  + D + VAIK   L       +    F+ F  
Sbjct: 13  LPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQR 72
Query: 379 ECEVLRNVRHQNLIKILSSCSTPD---FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVG 435
           E  ++ N+ H N++K+      P     +F+P G L  RL    + +    +L +M+D+ 
Sbjct: 73  EVFIMSNLNHPNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIA 132
Query: 436 STLEYLHHGHSSAPIIHCDLKPTSIL---LDEN--MVAHVSDFGISK 477
             +EY+   + + PI+H DL+  +I    LDEN  + A V+DFG+S+
Sbjct: 133 LGIEYMQ--NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ 177

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 69/140 (49%), Gaps = 12/140 (8%)
Query: 343 AGSFGSVYKGTISDGTDVAIKIFNL--QRERAFRSFNSECEVLRNVRHQNLIKILSSCST 400
           +GSFG+VYKG      DVA+KI  +       F++F +E  VLR  RH N++  +   + 
Sbjct: 46  SGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK 103
Query: 401 PDF----KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLK 456
            +     ++    SL K L+       + + ++I       ++YLH    +  IIH D+K
Sbjct: 104 DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH----AKNIIHRDMK 159
Query: 457 PTSILLDENMVAHVSDFGIS 476
             +I L E +   + DFG++
Sbjct: 160 SNNIFLHEGLTVKIGDFGLA 179

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 82/167 (49%), Gaps = 18/167 (10%)
Query: 327 IPSTIGALVDLETISLAGSFGSVYKGT-ISDGTDVAIKIFNL-------QRERAFRSFNS 378
           +P+     ++ E     G FG V+KG  + D + VAIK   L       +    F+ F  
Sbjct: 13  LPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQR 72
Query: 379 ECEVLRNVRHQNLIKILSSCSTPD---FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVG 435
           E  ++ N+ H N++K+      P     +F+P G L  RL    + +    +L +M+D+ 
Sbjct: 73  EVFIMSNLNHPNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIA 132
Query: 436 STLEYLHHGHSSAPIIHCDLKPTSIL---LDEN--MVAHVSDFGISK 477
             +EY+   + + PI+H DL+  +I    LDEN  + A V+DFG S+
Sbjct: 133 LGIEYMQ--NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ 177

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 78/155 (50%), Gaps = 14/155 (9%)
Query: 335 VDLETISLAGSFGSVYKGT--ISDGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQ 389
           + +E I  +G  G V  G   +    DV + I  L+    ER  R F SE  ++    H 
Sbjct: 51  IHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHP 110
Query: 390 NLIKILSSCSTPDF-----KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHG 444
           N+I++    +         ++M NGSL+  L +H+    I++ + ++  VG+ + YL   
Sbjct: 111 NIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL--- 167
Query: 445 HSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
            S    +H DL   ++L+D N+V  VSDFG+S++L
Sbjct: 168 -SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 78/155 (50%), Gaps = 14/155 (9%)
Query: 335 VDLETISLAGSFGSVYKGT--ISDGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQ 389
           + +E I  +G  G V  G   +    DV + I  L+    ER  R F SE  ++    H 
Sbjct: 51  IHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHP 110
Query: 390 NLIKILSSCSTPDF-----KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHG 444
           N+I++    +         ++M NGSL+  L +H+    I++ + ++  VG+ + YL   
Sbjct: 111 NIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL--- 167
Query: 445 HSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
            S    +H DL   ++L+D N+V  VSDFG+S++L
Sbjct: 168 -SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 82/167 (49%), Gaps = 18/167 (10%)
Query: 327 IPSTIGALVDLETISLAGSFGSVYKGT-ISDGTDVAIKIFNL-------QRERAFRSFNS 378
           +P+     ++ E     G FG V+KG  + D + VAIK   L       +    F+ F  
Sbjct: 13  LPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQR 72
Query: 379 ECEVLRNVRHQNLIKILSSCSTPD---FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVG 435
           E  ++ N+ H N++K+      P     +F+P G L  RL    + +    +L +M+D+ 
Sbjct: 73  EVFIMSNLNHPNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIA 132
Query: 436 STLEYLHHGHSSAPIIHCDLKPTSIL---LDEN--MVAHVSDFGISK 477
             +EY+   + + PI+H DL+  +I    LDEN  + A V+DF +S+
Sbjct: 133 LGIEYMQ--NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ 177

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 76/148 (51%), Gaps = 14/148 (9%)
Query: 343 AGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFR---SFNSECEVLRNVRHQNLIKILSSC 398
            G+FG V  G     G  VA+KI N Q+ R+         E + L+  RH ++IK+    
Sbjct: 21  VGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI 80
Query: 399 STP-DF----KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHC 453
           STP DF    +++  G L   +  H   ++ +E   +   + S ++Y H       ++H 
Sbjct: 81  STPTDFFMVMEYVSGGELFDYICKHGR-VEEMEARRLFQQILSAVDYCH----RHMVVHR 135
Query: 454 DLKPTSILLDENMVAHVSDFGISKLLGE 481
           DLKP ++LLD +M A ++DFG+S ++ +
Sbjct: 136 DLKPENVLLDAHMNAKIADFGLSNMMSD 163

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 76/148 (51%), Gaps = 14/148 (9%)
Query: 343 AGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFR---SFNSECEVLRNVRHQNLIKILSSC 398
            G+FG V  G     G  VA+KI N Q+ R+         E + L+  RH ++IK+    
Sbjct: 21  VGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI 80
Query: 399 STP-DF----KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHC 453
           STP DF    +++  G L   +  H   ++ +E   +   + S ++Y H       ++H 
Sbjct: 81  STPTDFFMVMEYVSGGELFDYICKHGR-VEEMEARRLFQQILSAVDYCH----RHMVVHR 135
Query: 454 DLKPTSILLDENMVAHVSDFGISKLLGE 481
           DLKP ++LLD +M A ++DFG+S ++ +
Sbjct: 136 DLKPENVLLDAHMNAKIADFGLSNMMSD 163

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 80/157 (50%), Gaps = 14/157 (8%)
Query: 335 VDLETISLAGSFGSVYKGTIS----DGTDVAIKIFNL-QRERAFRSFNSECEVLRNVRHQ 389
           + ++ +  AG FG V  G +         VAIK   +   E+  R F  E  ++    H 
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 390 NLIKI--LSSCSTPDF---KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHG 444
           N+I++  + + S P     ++M NGSL+  L  H+    +++ + ++  + S ++YL   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL--- 163
Query: 445 HSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
            S    +H DL   +IL++ N+V  VSDFG+S++L +
Sbjct: 164 -SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLED 199

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 80/157 (50%), Gaps = 14/157 (8%)
Query: 335 VDLETISLAGSFGSVYKGTIS----DGTDVAIKIFNL-QRERAFRSFNSECEVLRNVRHQ 389
           + ++ +  AG FG V  G +         VAIK   +   E+  R F  E  ++    H 
Sbjct: 35  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 94
Query: 390 NLIKI--LSSCSTPDF---KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHG 444
           N+I++  + + S P     ++M NGSL+  L  H+    +++ + ++  + S ++YL   
Sbjct: 95  NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL--- 151
Query: 445 HSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
            S    +H DL   +IL++ N+V  VSDFG+S++L +
Sbjct: 152 -SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED 187

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 80/157 (50%), Gaps = 14/157 (8%)
Query: 335 VDLETISLAGSFGSVYKGTIS----DGTDVAIKIFNL-QRERAFRSFNSECEVLRNVRHQ 389
           + ++ +  AG FG V  G +         VAIK   +   E+  R F  E  ++    H 
Sbjct: 18  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 77
Query: 390 NLIKI--LSSCSTPDF---KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHG 444
           N+I++  + + S P     ++M NGSL+  L  H+    +++ + ++  + S ++YL   
Sbjct: 78  NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL--- 134
Query: 445 HSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
            S    +H DL   +IL++ N+V  VSDFG+S++L +
Sbjct: 135 -SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED 170

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 81/159 (50%), Gaps = 14/159 (8%)
Query: 333 ALVDLETISLAGSFGSVYKGTIS----DGTDVAIKIFNL-QRERAFRSFNSECEVLRNVR 387
           + V +E +  AG FG V +G +       + VAIK       ER  R F SE  ++    
Sbjct: 14  SYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFE 73
Query: 388 HQNLIKI--LSSCSTPDF---KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLH 442
           H N+I++  + + S P     +FM NG+L+  L  ++    +++ + ++  + S + YL 
Sbjct: 74  HPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYL- 132
Query: 443 HGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
              +    +H DL   +IL++ N+V  VSDFG+S+ L E
Sbjct: 133 ---AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEE 168

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 80/157 (50%), Gaps = 14/157 (8%)
Query: 335 VDLETISLAGSFGSVYKGTIS----DGTDVAIKIFNL-QRERAFRSFNSECEVLRNVRHQ 389
           + ++ +  AG FG V  G +         VAIK   +   E+  R F  E  ++    H 
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 390 NLIKI--LSSCSTPDF---KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHG 444
           N+I++  + + S P     ++M NGSL+  L  H+    +++ + ++  + S ++YL   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL--- 163
Query: 445 HSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
            S    +H DL   +IL++ N+V  VSDFG+S++L +
Sbjct: 164 -SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED 199

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 80/157 (50%), Gaps = 14/157 (8%)
Query: 335 VDLETISLAGSFGSVYKGTIS----DGTDVAIKIFNL-QRERAFRSFNSECEVLRNVRHQ 389
           + ++ +  AG FG V  G +         VAIK   +   E+  R F  E  ++    H 
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 390 NLIKI--LSSCSTPDF---KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHG 444
           N+I++  + + S P     ++M NGSL+  L  H+    +++ + ++  + S ++YL   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL--- 163
Query: 445 HSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
            S    +H DL   +IL++ N+V  VSDFG+S++L +
Sbjct: 164 -SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED 199

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 80/157 (50%), Gaps = 14/157 (8%)
Query: 335 VDLETISLAGSFGSVYKGTIS----DGTDVAIKIFNL-QRERAFRSFNSECEVLRNVRHQ 389
           + ++ +  AG FG V  G +         VAIK   +   E+  R F  E  ++    H 
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 390 NLIKI--LSSCSTPDF---KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHG 444
           N+I++  + + S P     ++M NGSL+  L  H+    +++ + ++  + S ++YL   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL--- 163
Query: 445 HSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
            S    +H DL   +IL++ N+V  VSDFG+S++L +
Sbjct: 164 -SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED 199

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 80/157 (50%), Gaps = 14/157 (8%)
Query: 335 VDLETISLAGSFGSVYKGTIS----DGTDVAIKIFNL-QRERAFRSFNSECEVLRNVRHQ 389
           + ++ +  AG FG V  G +         VAIK   +   E+  R F  E  ++    H 
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 390 NLIKI--LSSCSTPDF---KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHG 444
           N+I++  + + S P     ++M NGSL+  L  H+    +++ + ++  + S ++YL   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL--- 163
Query: 445 HSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
            S    +H DL   +IL++ N+V  VSDFG+S++L +
Sbjct: 164 -SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED 199

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 80/157 (50%), Gaps = 14/157 (8%)
Query: 335 VDLETISLAGSFGSVYKGTIS----DGTDVAIKIFNL-QRERAFRSFNSECEVLRNVRHQ 389
           + ++ +  AG FG V  G +         VAIK   +   E+  R F  E  ++    H 
Sbjct: 45  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 104
Query: 390 NLIKI--LSSCSTPDF---KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHG 444
           N+I++  + + S P     ++M NGSL+  L  H+    +++ + ++  + S ++YL   
Sbjct: 105 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL--- 161
Query: 445 HSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
            S    +H DL   +IL++ N+V  VSDFG+S++L +
Sbjct: 162 -SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED 197

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 81/159 (50%), Gaps = 14/159 (8%)
Query: 333 ALVDLETISLAGSFGSVYKGTIS----DGTDVAIKIFNL-QRERAFRSFNSECEVLRNVR 387
           + V +E +  AG FG V +G +       + VAIK       ER  R F SE  ++    
Sbjct: 16  SYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFE 75
Query: 388 HQNLIKI--LSSCSTPDF---KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLH 442
           H N+I++  + + S P     +FM NG+L+  L  ++    +++ + ++  + S + YL 
Sbjct: 76  HPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYL- 134
Query: 443 HGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
              +    +H DL   +IL++ N+V  VSDFG+S+ L E
Sbjct: 135 ---AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEE 170

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 74/141 (52%), Gaps = 10/141 (7%)
Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPDF 403
           G FG V+ GT +  T VAIK        +  +F  E +V++ +RH+ L+++ +  S    
Sbjct: 29  GCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKIRHEKLVQLYAVVSEEPI 87
Query: 404 ----KFMPNGSLEKRLYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPT 458
               ++M  GSL   L      +L + + +++   + S + Y+   +     +H DL+  
Sbjct: 88  YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN----YVHRDLRAA 143
Query: 459 SILLDENMVAHVSDFGISKLL 479
           +IL+ EN+V  V+DFG+++L+
Sbjct: 144 NILVGENLVCKVADFGLARLI 164

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 80/157 (50%), Gaps = 14/157 (8%)
Query: 335 VDLETISLAGSFGSVYKGTIS----DGTDVAIKIFNL-QRERAFRSFNSECEVLRNVRHQ 389
           + ++ +  AG FG V  G +         VAIK   +   E+  R F  E  ++    H 
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 390 NLIKI--LSSCSTPDF---KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHG 444
           N+I++  + + S P     ++M NGSL+  L  H+    +++ + ++  + S ++YL   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL--- 163
Query: 445 HSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
            S    +H DL   +IL++ N+V  VSDFG++++L +
Sbjct: 164 -SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLED 199

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 74/141 (52%), Gaps = 10/141 (7%)
Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPDF 403
           G FG V+ GT +  T VAIK        +  +F  E +V++ +RH+ L+++ +  S    
Sbjct: 19  GCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI 77
Query: 404 ----KFMPNGSLEKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPT 458
               ++M  GSL   L      +L + + +++   + S + Y+   +     +H DL+  
Sbjct: 78  XIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN----YVHRDLRAA 133
Query: 459 SILLDENMVAHVSDFGISKLL 479
           +IL+ EN+V  V+DFG+++L+
Sbjct: 134 NILVGENLVCKVADFGLARLI 154

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 74/141 (52%), Gaps = 10/141 (7%)
Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPDF 403
           G FG V+ GT +  T VAIK        +  +F  E +V++ +RH+ L+++ +  S    
Sbjct: 22  GCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI 80
Query: 404 ----KFMPNGSLEKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPT 458
               ++M  GSL   L      +L + + +++   + S + Y+   +     +H DL+  
Sbjct: 81  YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN----YVHRDLRAA 136
Query: 459 SILLDENMVAHVSDFGISKLL 479
           +IL+ EN+V  V+DFG+++L+
Sbjct: 137 NILVGENLVCKVADFGLARLI 157

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 75/144 (52%), Gaps = 16/144 (11%)
Query: 344 GSFGSVYKGTISDGTDVAIKIF---NLQRERAFRSFNSECEVLRNVRHQNLIKILSSCST 400
           G FG V+ GT +  T VAIK     N+  E    +F  E +V++ +RH+ L+++ +  S 
Sbjct: 196 GCFGEVWMGTWNGTTRVAIKTLKPGNMSPE----AFLQEAQVMKKLRHEKLVQLYAVVSE 251
Query: 401 PDF----KFMPNGSLEKRLYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDL 455
                  ++M  GSL   L      +L + + +++   + S + Y+   +     +H DL
Sbjct: 252 EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN----YVHRDL 307
Query: 456 KPTSILLDENMVAHVSDFGISKLL 479
           +  +IL+ EN+V  V+DFG+ +L+
Sbjct: 308 RAANILVGENLVCKVADFGLGRLI 331

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 70/149 (46%), Gaps = 16/149 (10%)
Query: 343 AGSFGSV---YKGTISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSS 397
            G+FGSV       + D T   + +  LQ   E   R F  E E+L++++H N++K    
Sbjct: 23  KGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGV 82
Query: 398 CSTPD-------FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPI 450
           C +          +F+P GSL + L  H   +D ++ L     +   +EYL     +   
Sbjct: 83  CYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYL----GTKRY 138
Query: 451 IHCDLKPTSILLDENMVAHVSDFGISKLL 479
           IH DL   +IL++      + DFG++K+L
Sbjct: 139 IHRDLATRNILVENENRVKIGDFGLTKVL 167

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 74/141 (52%), Gaps = 10/141 (7%)
Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPDF 403
           G FG V+ GT +  T VAIK        +  +F  E +V++ +RH+ L+++ +  S    
Sbjct: 29  GCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI 87
Query: 404 ----KFMPNGSLEKRLYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPT 458
               ++M  GSL   L      +L + + +++   + S + Y+   +     +H DL+  
Sbjct: 88  YIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN----YVHRDLRAA 143
Query: 459 SILLDENMVAHVSDFGISKLL 479
           +IL+ EN+V  V+DFG+++L+
Sbjct: 144 NILVGENLVCKVADFGLARLI 164

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 74/141 (52%), Gaps = 10/141 (7%)
Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPDF 403
           G FG V+ GT +  T VAIK        +  +F  E +V++ +RH+ L+++ +  S    
Sbjct: 29  GCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI 87
Query: 404 ----KFMPNGSLEKRLYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPT 458
               ++M  GSL   L      +L + + +++   + S + Y+   +     +H DL+  
Sbjct: 88  YIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN----YVHRDLRAA 143
Query: 459 SILLDENMVAHVSDFGISKLL 479
           +IL+ EN+V  V+DFG+++L+
Sbjct: 144 NILVGENLVCKVADFGLARLI 164

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 74/141 (52%), Gaps = 10/141 (7%)
Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPDF 403
           G FG V+ GT +  T VAIK        +  +F  E +V++ +RH+ L+++ +  S    
Sbjct: 18  GCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI 76
Query: 404 ----KFMPNGSLEKRLYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPT 458
               ++M  GSL   L      +L + + +++   + S + Y+   +     +H DL+  
Sbjct: 77  YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN----YVHRDLRAA 132
Query: 459 SILLDENMVAHVSDFGISKLL 479
           +IL+ EN+V  V+DFG+++L+
Sbjct: 133 NILVGENLVCKVADFGLARLI 153

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 74/141 (52%), Gaps = 10/141 (7%)
Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPDF 403
           G FG V+ GT +  T VAIK        +  +F  E +V++ +RH+ L+++ +  S    
Sbjct: 29  GCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI 87
Query: 404 ----KFMPNGSLEKRLYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPT 458
               ++M  GSL   L      +L + + +++   + S + Y+   +     +H DL+  
Sbjct: 88  YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN----YVHRDLRAA 143
Query: 459 SILLDENMVAHVSDFGISKLL 479
           +IL+ EN+V  V+DFG+++L+
Sbjct: 144 NILVGENLVCKVADFGLARLI 164

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 74/141 (52%), Gaps = 10/141 (7%)
Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPDF 403
           G FG V+ GT +  T VAIK        +  +F  E +V++ +RH+ L+++ +  S    
Sbjct: 20  GCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI 78
Query: 404 ----KFMPNGSLEKRLYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPT 458
               ++M  GSL   L      +L + + +++   + S + Y+   +     +H DL+  
Sbjct: 79  YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN----YVHRDLRAA 134
Query: 459 SILLDENMVAHVSDFGISKLL 479
           +IL+ EN+V  V+DFG+++L+
Sbjct: 135 NILVGENLVCKVADFGLARLI 155

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 74/141 (52%), Gaps = 10/141 (7%)
Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPDF 403
           G FG V+ GT +  T VAIK        +  +F  E +V++ +RH+ L+++ +  S    
Sbjct: 29  GCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI 87
Query: 404 ----KFMPNGSLEKRLYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPT 458
               ++M  GSL   L      +L + + +++   + S + Y+   +     +H DL+  
Sbjct: 88  YIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN----YVHRDLRAA 143
Query: 459 SILLDENMVAHVSDFGISKLL 479
           +IL+ EN+V  V+DFG+++L+
Sbjct: 144 NILVGENLVCKVADFGLARLI 164

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 79/157 (50%), Gaps = 14/157 (8%)
Query: 335 VDLETISLAGSFGSVYKGTIS----DGTDVAIKIFNL-QRERAFRSFNSECEVLRNVRHQ 389
           + ++ +  AG FG V  G +         VAIK   +   E+  R F  E  ++    H 
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 390 NLIKI--LSSCSTPDF---KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHG 444
           N+I++  + + S P     ++M NGSL+  L  H+    +++ + ++  + S ++YL   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL--- 163
Query: 445 HSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
            S    +H DL   +IL++ N+V  VSDFG+ ++L +
Sbjct: 164 -SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED 199

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 76/148 (51%), Gaps = 15/148 (10%)
Query: 343 AGSFGSVYKG---TISDGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILS 396
           AG FG VYKG   T S   +V + I  L+    E+    F  E  ++    H N+I++  
Sbjct: 54  AGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEG 113
Query: 397 SCSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPII 451
             S         ++M NG+L+K L   +    +L+ + ++  + + ++YL    ++   +
Sbjct: 114 VISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL----ANMNYV 169
Query: 452 HCDLKPTSILLDENMVAHVSDFGISKLL 479
           H DL   +IL++ N+V  VSDFG+S++L
Sbjct: 170 HRDLAARNILVNSNLVCKVSDFGLSRVL 197

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 74/141 (52%), Gaps = 10/141 (7%)
Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPDF 403
           G FG V+ GT +  T VAIK        +  +F  E +V++ +RH+ L+++ +  S    
Sbjct: 278 GCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI 336
Query: 404 ----KFMPNGSLEKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPT 458
               ++M  GSL   L      +L + + +++   + S + Y+   +     +H DL+  
Sbjct: 337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN----YVHRDLRAA 392
Query: 459 SILLDENMVAHVSDFGISKLL 479
           +IL+ EN+V  V+DFG+++L+
Sbjct: 393 NILVGENLVCKVADFGLARLI 413

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 79/157 (50%), Gaps = 14/157 (8%)
Query: 335 VDLETISLAGSFGSVYKGTIS----DGTDVAIKIFNL-QRERAFRSFNSECEVLRNVRHQ 389
           + ++ +  AG FG V  G +         VAIK   +   E+  R F  E  ++    H 
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 390 NLIKI--LSSCSTPDF---KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHG 444
           N+I++  + + S P     + M NGSL+  L  H+    +++ + ++  + S ++YL   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL--- 163
Query: 445 HSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
            S    +H DL   +IL++ N+V  VSDFG+S++L +
Sbjct: 164 -SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLED 199

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 74/141 (52%), Gaps = 10/141 (7%)
Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPDF 403
           G FG V+ GT +  T VAIK        +  +F  E +V++ +RH+ L+++ +  S    
Sbjct: 195 GCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI 253
Query: 404 ----KFMPNGSLEKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPT 458
               ++M  GSL   L      +L + + +++   + S + Y+   +     +H DL+  
Sbjct: 254 YIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN----YVHRDLRAA 309
Query: 459 SILLDENMVAHVSDFGISKLL 479
           +IL+ EN+V  V+DFG+++L+
Sbjct: 310 NILVGENLVCKVADFGLARLI 330

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 74/141 (52%), Gaps = 10/141 (7%)
Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPDF 403
           G FG V+ GT +  T VAIK        +  +F  E +V++ +RH+ L+++ +  S    
Sbjct: 195 GCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI 253
Query: 404 ----KFMPNGSLEKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPT 458
               ++M  GSL   L      +L + + +++   + S + Y+   +     +H DL+  
Sbjct: 254 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN----YVHRDLRAA 309
Query: 459 SILLDENMVAHVSDFGISKLL 479
           +IL+ EN+V  V+DFG+++L+
Sbjct: 310 NILVGENLVCKVADFGLARLI 330

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 74/141 (52%), Gaps = 10/141 (7%)
Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPDF 403
           G FG V+ GT +  T VAIK        +  +F  E +V++ +RH+ L+++ +  S    
Sbjct: 195 GCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI 253
Query: 404 ----KFMPNGSLEKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPT 458
               ++M  GSL   L      +L + + +++   + S + Y+   +     +H DL+  
Sbjct: 254 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN----YVHRDLRAA 309
Query: 459 SILLDENMVAHVSDFGISKLL 479
           +IL+ EN+V  V+DFG+++L+
Sbjct: 310 NILVGENLVCKVADFGLARLI 330

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 69/149 (46%), Gaps = 16/149 (10%)
Query: 343 AGSFGSV---YKGTISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSS 397
            G+FGSV       + D T   + +  LQ   E   R F  E E+L++++H N++K    
Sbjct: 38  KGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGV 97
Query: 398 CSTPD-------FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPI 450
           C +          +++P GSL   L  H   +D ++ L     +   +EYL     +   
Sbjct: 98  CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL----GTKRY 153
Query: 451 IHCDLKPTSILLDENMVAHVSDFGISKLL 479
           IH DL   +IL++      + DFG++K+L
Sbjct: 154 IHRDLATRNILVENENRVKIGDFGLTKVL 182

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 79/157 (50%), Gaps = 14/157 (8%)
Query: 335 VDLETISLAGSFGSVYKGTIS----DGTDVAIKIFNL-QRERAFRSFNSECEVLRNVRHQ 389
           + ++ +  AG FG V  G +         VAIK   +   E+  R F  E  ++    H 
Sbjct: 18  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 77
Query: 390 NLIKI--LSSCSTPDF---KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHG 444
           N+I++  + + S P     + M NGSL+  L  H+    +++ + ++  + S ++YL   
Sbjct: 78  NIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL--- 134
Query: 445 HSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
            S    +H DL   +IL++ N+V  VSDFG+S++L +
Sbjct: 135 -SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED 170

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 74/141 (52%), Gaps = 10/141 (7%)
Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPDF 403
           G FG V+ GT +  T VAIK        +  +F  E +V++ +RH+ L+++ +  S    
Sbjct: 26  GCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI 84
Query: 404 ----KFMPNGSLEKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPT 458
               ++M  GSL   L      +L + + +++   + S + Y+   +     +H DL+  
Sbjct: 85  YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMN----YVHRDLRAA 140
Query: 459 SILLDENMVAHVSDFGISKLL 479
           +IL+ EN+V  V+DFG+++L+
Sbjct: 141 NILVGENLVCKVADFGLARLI 161

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 79/157 (50%), Gaps = 14/157 (8%)
Query: 335 VDLETISLAGSFGSVYKGTIS----DGTDVAIKIFNL-QRERAFRSFNSECEVLRNVRHQ 389
           + ++ +  AG FG V  G +         VAIK   +   E+  R F  E  ++    H 
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 390 NLIKI--LSSCSTPDF---KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHG 444
           N+I++  + + S P     + M NGSL+  L  H+    +++ + ++  + S ++YL   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL--- 163
Query: 445 HSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
            S    +H DL   +IL++ N+V  VSDFG+S++L +
Sbjct: 164 -SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED 199

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 68/136 (50%), Gaps = 15/136 (11%)
Query: 347 GSVYKGTISDGTDVAIKIFNLQ--RERAFRSFNSECEVLRNVRHQNLIKILSSCSTPDFK 404
           G ++KG    G D+ +K+  ++    R  R FN EC  LR   H N++ +L +C +P   
Sbjct: 24  GELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82
Query: 405 -------FMPNGSLEKRLYS-HNYFLDILERLNIMIDVGSTLEYLHHGHSSAPII-HCDL 455
                  +MP GSL   L+   N+ +D  + +   +D+   + +L   H+  P+I    L
Sbjct: 83  HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFL---HTLEPLIPRHAL 139
Query: 456 KPTSILLDENMVAHVS 471
              S+++DE+M A +S
Sbjct: 140 NSRSVMIDEDMTARIS 155

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 69/149 (46%), Gaps = 16/149 (10%)
Query: 343 AGSFGSV---YKGTISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSS 397
            G+FGSV       + D T   + +  LQ   E   R F  E E+L++++H N++K    
Sbjct: 38  KGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGV 97
Query: 398 CSTPD-------FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPI 450
           C +          +++P GSL   L  H   +D ++ L     +   +EYL     +   
Sbjct: 98  CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL----GTKRY 153
Query: 451 IHCDLKPTSILLDENMVAHVSDFGISKLL 479
           IH DL   +IL++      + DFG++K+L
Sbjct: 154 IHRDLATRNILVENENRVKIGDFGLTKVL 182

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 74/141 (52%), Gaps = 10/141 (7%)
Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPDF 403
           G FG V+ GT +  T VAIK        +  +F  E +V++ +RH+ L+++ +  S    
Sbjct: 26  GCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI 84
Query: 404 ----KFMPNGSLEKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPT 458
               ++M  GSL   L      +L + + +++   + S + Y+   +     +H DL+  
Sbjct: 85  YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMN----YVHRDLRAA 140
Query: 459 SILLDENMVAHVSDFGISKLL 479
           +IL+ EN+V  V+DFG+++L+
Sbjct: 141 NILVGENLVCKVADFGLARLI 161

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 84/170 (49%), Gaps = 15/170 (8%)
Query: 321 NQLSGDIPSTIGA-LVDLETISLAGSFGSVYKG--TISDGTDVAIKIFNLQR---ERAFR 374
           NQ   +    I A  + +E +   G FG V  G   +    ++ + I  L+    ++  R
Sbjct: 1   NQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRR 60
Query: 375 SFNSECEVLRNVRHQNLIK---ILSSCSTPDF--KFMPNGSLEKRLYSHNYFLDILERLN 429
            F SE  ++    H N+I    +++ C       ++M NGSL+  L  ++    +++ + 
Sbjct: 61  DFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVG 120
Query: 430 IMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
           ++  +GS ++YL    S    +H DL   +IL++ N+V  VSDFG+S++L
Sbjct: 121 MLRGIGSGMKYL----SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVL 166

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 69/149 (46%), Gaps = 16/149 (10%)
Query: 343 AGSFGSV---YKGTISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSS 397
            G+FGSV       + D T   + +  LQ   E   R F  E E+L++++H N++K    
Sbjct: 51  KGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGV 110
Query: 398 CSTPD-------FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPI 450
           C +          +++P GSL   L  H   +D ++ L     +   +EYL     +   
Sbjct: 111 CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL----GTKRY 166
Query: 451 IHCDLKPTSILLDENMVAHVSDFGISKLL 479
           IH DL   +IL++      + DFG++K+L
Sbjct: 167 IHRDLATRNILVENENRVKIGDFGLTKVL 195

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 69/149 (46%), Gaps = 16/149 (10%)
Query: 343 AGSFGSV---YKGTISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSS 397
            G+FGSV       + D T   + +  LQ   E   R F  E E+L++++H N++K    
Sbjct: 20  KGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGV 79
Query: 398 CSTPD-------FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPI 450
           C +          +++P GSL   L  H   +D ++ L     +   +EYL     +   
Sbjct: 80  CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL----GTKRY 135
Query: 451 IHCDLKPTSILLDENMVAHVSDFGISKLL 479
           IH DL   +IL++      + DFG++K+L
Sbjct: 136 IHRDLATRNILVENENRVKIGDFGLTKVL 164

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 73/141 (51%), Gaps = 10/141 (7%)
Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPDF 403
           G FG V+ GT +  T VAIK        +  +F  E +V++ +RH+ L+++ +  S    
Sbjct: 29  GCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI 87
Query: 404 ----KFMPNGSLEKRLYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPT 458
               ++M  GSL   L      +L + + +++   + S + Y+   +     +H DL   
Sbjct: 88  YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN----YVHRDLAAA 143
Query: 459 SILLDENMVAHVSDFGISKLL 479
           +IL+ EN+V  V+DFG+++L+
Sbjct: 144 NILVGENLVCKVADFGLARLI 164

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 69/149 (46%), Gaps = 16/149 (10%)
Query: 343 AGSFGSV---YKGTISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSS 397
            G+FGSV       + D T   + +  LQ   E   R F  E E+L++++H N++K    
Sbjct: 27  KGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGV 86
Query: 398 CSTPD-------FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPI 450
           C +          +++P GSL   L  H   +D ++ L     +   +EYL     +   
Sbjct: 87  CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL----GTKRY 142
Query: 451 IHCDLKPTSILLDENMVAHVSDFGISKLL 479
           IH DL   +IL++      + DFG++K+L
Sbjct: 143 IHRDLATRNILVENENRVKIGDFGLTKVL 171

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 67/141 (47%), Gaps = 10/141 (7%)
Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCST--P 401
           G FG V  G      DVAIK+   +   +   F  E +V+ N+ H+ L+++   C+   P
Sbjct: 35  GQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP 93
Query: 402 DF---KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPT 458
            F   ++M NG L   L    +     + L +  DV   +EYL     S   +H DL   
Sbjct: 94  IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE----SKQFLHRDLAAR 149
Query: 459 SILLDENMVAHVSDFGISKLL 479
           + L+++  V  VSDFG+S+ +
Sbjct: 150 NCLVNDQGVVKVSDFGLSRYV 170

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 67/141 (47%), Gaps = 10/141 (7%)
Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCST--P 401
           G FG V  G      DVAIK+   +   +   F  E +V+ N+ H+ L+++   C+   P
Sbjct: 35  GQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP 93
Query: 402 DF---KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPT 458
            F   ++M NG L   L    +     + L +  DV   +EYL     S   +H DL   
Sbjct: 94  IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE----SKQFLHRDLAAR 149
Query: 459 SILLDENMVAHVSDFGISKLL 479
           + L+++  V  VSDFG+S+ +
Sbjct: 150 NCLVNDQGVVKVSDFGLSRYV 170

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 69/149 (46%), Gaps = 16/149 (10%)
Query: 343 AGSFGSV---YKGTISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSS 397
            G+FGSV       + D T   + +  LQ   E   R F  E E+L++++H N++K    
Sbjct: 20  KGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGV 79
Query: 398 CSTPD-------FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPI 450
           C +          +++P GSL   L  H   +D ++ L     +   +EYL     +   
Sbjct: 80  CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL----GTKRY 135
Query: 451 IHCDLKPTSILLDENMVAHVSDFGISKLL 479
           IH DL   +IL++      + DFG++K+L
Sbjct: 136 IHRDLATRNILVENENRVKIGDFGLTKVL 164

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 69/149 (46%), Gaps = 16/149 (10%)
Query: 343 AGSFGSV---YKGTISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSS 397
            G+FGSV       + D T   + +  LQ   E   R F  E E+L++++H N++K    
Sbjct: 20  KGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGV 79
Query: 398 CSTPD-------FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPI 450
           C +          +++P GSL   L  H   +D ++ L     +   +EYL     +   
Sbjct: 80  CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL----GTKRY 135
Query: 451 IHCDLKPTSILLDENMVAHVSDFGISKLL 479
           IH DL   +IL++      + DFG++K+L
Sbjct: 136 IHRDLATRNILVENENRVKIGDFGLTKVL 164

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 69/149 (46%), Gaps = 16/149 (10%)
Query: 343 AGSFGSV---YKGTISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSS 397
            G+FGSV       + D T   + +  LQ   E   R F  E E+L++++H N++K    
Sbjct: 18  KGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGV 77
Query: 398 CSTPD-------FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPI 450
           C +          +++P GSL   L  H   +D ++ L     +   +EYL     +   
Sbjct: 78  CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL----GTKRY 133
Query: 451 IHCDLKPTSILLDENMVAHVSDFGISKLL 479
           IH DL   +IL++      + DFG++K+L
Sbjct: 134 IHRDLATRNILVENENRVKIGDFGLTKVL 162

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 67/141 (47%), Gaps = 10/141 (7%)
Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCST--P 401
           G FG V  G      DVAIK+   +   +   F  E +V+ N+ H+ L+++   C+   P
Sbjct: 26  GQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP 84
Query: 402 DF---KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPT 458
            F   ++M NG L   L    +     + L +  DV   +EYL     S   +H DL   
Sbjct: 85  IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE----SKQFLHRDLAAR 140
Query: 459 SILLDENMVAHVSDFGISKLL 479
           + L+++  V  VSDFG+S+ +
Sbjct: 141 NCLVNDQGVVKVSDFGLSRYV 161

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 84/170 (49%), Gaps = 15/170 (8%)
Query: 321 NQLSGDIPSTIGA-LVDLETISLAGSFGSVYKG--TISDGTDVAIKIFNLQR---ERAFR 374
           NQ   +    I A  + +E +   G FG V  G   +    ++ + I  L+    ++  R
Sbjct: 16  NQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRR 75
Query: 375 SFNSECEVLRNVRHQNLIK---ILSSCSTPDF--KFMPNGSLEKRLYSHNYFLDILERLN 429
            F SE  ++    H N+I    +++ C       ++M NGSL+  L  ++    +++ + 
Sbjct: 76  DFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVG 135
Query: 430 IMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
           ++  +GS ++YL    S    +H DL   +IL++ N+V  VSDFG+S++L
Sbjct: 136 MLRGIGSGMKYL----SDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVL 181

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 69/149 (46%), Gaps = 16/149 (10%)
Query: 343 AGSFGSV---YKGTISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSS 397
            G+FGSV       + D T   + +  LQ   E   R F  E E+L++++H N++K    
Sbjct: 26  KGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGV 85
Query: 398 CSTPD-------FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPI 450
           C +          +++P GSL   L  H   +D ++ L     +   +EYL     +   
Sbjct: 86  CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL----GTKRY 141
Query: 451 IHCDLKPTSILLDENMVAHVSDFGISKLL 479
           IH DL   +IL++      + DFG++K+L
Sbjct: 142 IHRDLATRNILVENENRVKIGDFGLTKVL 170

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 69/149 (46%), Gaps = 16/149 (10%)
Query: 343 AGSFGSV---YKGTISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSS 397
            G+FGSV       + D T   + +  LQ   E   R F  E E+L++++H N++K    
Sbjct: 23  KGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGV 82
Query: 398 CSTPD-------FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPI 450
           C +          +++P GSL   L  H   +D ++ L     +   +EYL     +   
Sbjct: 83  CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL----GTKRY 138
Query: 451 IHCDLKPTSILLDENMVAHVSDFGISKLL 479
           IH DL   +IL++      + DFG++K+L
Sbjct: 139 IHRDLATRNILVENENRVKIGDFGLTKVL 167

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 69/149 (46%), Gaps = 16/149 (10%)
Query: 343 AGSFGSV---YKGTISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSS 397
            G+FGSV       + D T   + +  LQ   E   R F  E E+L++++H N++K    
Sbjct: 25  KGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGV 84
Query: 398 CSTPD-------FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPI 450
           C +          +++P GSL   L  H   +D ++ L     +   +EYL     +   
Sbjct: 85  CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL----GTKRY 140
Query: 451 IHCDLKPTSILLDENMVAHVSDFGISKLL 479
           IH DL   +IL++      + DFG++K+L
Sbjct: 141 IHRDLATRNILVENENRVKIGDFGLTKVL 169

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 69/149 (46%), Gaps = 16/149 (10%)
Query: 343 AGSFGSV---YKGTISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSS 397
            G+FGSV       + D T   + +  LQ   E   R F  E E+L++++H N++K    
Sbjct: 19  KGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGV 78
Query: 398 CSTPD-------FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPI 450
           C +          +++P GSL   L  H   +D ++ L     +   +EYL     +   
Sbjct: 79  CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL----GTKRY 134
Query: 451 IHCDLKPTSILLDENMVAHVSDFGISKLL 479
           IH DL   +IL++      + DFG++K+L
Sbjct: 135 IHRDLATRNILVENENRVKIGDFGLTKVL 163

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 69/149 (46%), Gaps = 16/149 (10%)
Query: 343 AGSFGSV---YKGTISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSS 397
            G+FGSV       + D T   + +  LQ   E   R F  E E+L++++H N++K    
Sbjct: 24  KGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGV 83
Query: 398 CSTPD-------FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPI 450
           C +          +++P GSL   L  H   +D ++ L     +   +EYL     +   
Sbjct: 84  CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL----GTKRY 139
Query: 451 IHCDLKPTSILLDENMVAHVSDFGISKLL 479
           IH DL   +IL++      + DFG++K+L
Sbjct: 140 IHRDLATRNILVENENRVKIGDFGLTKVL 168

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 38/141 (26%), Positives = 73/141 (51%), Gaps = 10/141 (7%)
Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD- 402
           G FG V+ GT +  T VAIK        +  +F  E +V++ +RH+ L+++ +  S    
Sbjct: 29  GCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI 87
Query: 403 ---FKFMPNGSLEKRLYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPT 458
               ++M  G L   L      +L + + +++   + S + Y+   +     +H DL+  
Sbjct: 88  YIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN----YVHRDLRAA 143
Query: 459 SILLDENMVAHVSDFGISKLL 479
           +IL+ EN+V  V+DFG+++L+
Sbjct: 144 NILVGENLVCKVADFGLARLI 164

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 72/148 (48%), Gaps = 14/148 (9%)
Query: 343 AGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFR---SFNSECEVLRNVRHQNLIKILSSC 398
            G+FG V  G     G  VA+KI N Q+ R+         E + L+  RH ++IK+    
Sbjct: 26  VGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI 85
Query: 399 STPDFKFM-----PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHC 453
           STP   FM       G L   +   N  LD  E   +   + S ++Y H       ++H 
Sbjct: 86  STPSDIFMVMEYVSGGELFDYI-CKNGRLDEKESRRLFQQILSGVDYCHRHM----VVHR 140
Query: 454 DLKPTSILLDENMVAHVSDFGISKLLGE 481
           DLKP ++LLD +M A ++DFG+S ++ +
Sbjct: 141 DLKPENVLLDAHMNAKIADFGLSNMMSD 168

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 67/141 (47%), Gaps = 10/141 (7%)
Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCST--P 401
           G FG V  G      DVAIK+   +   +   F  E +V+ N+ H+ L+++   C+   P
Sbjct: 20  GQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP 78
Query: 402 DF---KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPT 458
            F   ++M NG L   L    +     + L +  DV   +EYL     S   +H DL   
Sbjct: 79  IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL----ESKQFLHRDLAAR 134
Query: 459 SILLDENMVAHVSDFGISKLL 479
           + L+++  V  VSDFG+S+ +
Sbjct: 135 NCLVNDQGVVKVSDFGLSRYV 155

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 70/149 (46%), Gaps = 16/149 (10%)
Query: 343 AGSFGSV---YKGTISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSS 397
            G+FGSV       + D T   + +  LQ   E   R F  E E+L++++H N++K    
Sbjct: 23  KGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGV 82
Query: 398 CSTPD-------FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPI 450
           C +          +++P GSL   L +H   +D ++ L     +   +EYL     +   
Sbjct: 83  CYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYL----GTKRY 138
Query: 451 IHCDLKPTSILLDENMVAHVSDFGISKLL 479
           IH DL   +IL++      + DFG++K+L
Sbjct: 139 IHRDLATRNILVENENRVKIGDFGLTKVL 167

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 77/158 (48%), Gaps = 14/158 (8%)
Query: 332 GALVDLETISLAGSFGSVYKGTIS--DGTDVAIKIFNLQ---RERAFRSFNSECEVLRNV 386
            + + +E +  AG FG V  G +      DVA+ I  L+    E+  R F  E  ++   
Sbjct: 42  ASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQF 101
Query: 387 RHQNLIKILSSCSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYL 441
            H N++ +    +         +FM NG+L+  L  H+    +++ + ++  + + + YL
Sbjct: 102 DHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYL 161
Query: 442 HHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
               +    +H DL   +IL++ N+V  VSDFG+S+++
Sbjct: 162 ----ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVI 195

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 38/141 (26%), Positives = 73/141 (51%), Gaps = 10/141 (7%)
Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPDF 403
           G FG V+ GT +  T VAIK        +  +F  E +V++ +RH+ L+++ +  S    
Sbjct: 29  GCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI 87
Query: 404 ----KFMPNGSLEKRLYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPT 458
               ++M  G L   L      +L + + +++   + S + Y+   +     +H DL+  
Sbjct: 88  YIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN----YVHRDLRAA 143
Query: 459 SILLDENMVAHVSDFGISKLL 479
           +IL+ EN+V  V+DFG+++L+
Sbjct: 144 NILVGENLVCKVADFGLARLI 164

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 67/141 (47%), Gaps = 10/141 (7%)
Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCST--P 401
           G FG V  G      DVAIK+   +   +   F  E +V+ N+ H+ L+++   C+   P
Sbjct: 20  GQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP 78
Query: 402 DF---KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPT 458
            F   ++M NG L   L    +     + L +  DV   +EYL     S   +H DL   
Sbjct: 79  IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL----ESKQFLHRDLAAR 134
Query: 459 SILLDENMVAHVSDFGISKLL 479
           + L+++  V  VSDFG+S+ +
Sbjct: 135 NCLVNDQGVVKVSDFGLSRYV 155

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 41/158 (25%), Positives = 80/158 (50%), Gaps = 14/158 (8%)
Query: 332 GALVDLETISLAGSFGSVYKG--TISDGTDVAIKIFNLQR---ERAFRSFNSECEVLRNV 386
            + + +E +   G FG V  G   +    ++ + I  L+    ++  R F SE  ++   
Sbjct: 7   ASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQF 66
Query: 387 RHQNLIK---ILSSCSTPDF--KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYL 441
            H N+I    +++ C       ++M NGSL+  L  ++    +++ + ++  +GS ++YL
Sbjct: 67  DHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYL 126
Query: 442 HHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
               S    +H DL   +IL++ N+V  VSDFG+S++L
Sbjct: 127 ----SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVL 160

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 82/159 (51%), Gaps = 14/159 (8%)
Query: 333 ALVDLETISLAGSFGSVYKG--TISDGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVR 387
           + V +E +  AG FG V  G   +    ++ + I  L+    E+  R F SE  ++    
Sbjct: 33  SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 92
Query: 388 HQNLIKI--LSSCSTPDF---KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLH 442
           H N+I +  + + STP     +FM NGSL+  L  ++    +++ + ++  + + ++YL 
Sbjct: 93  HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL- 151
Query: 443 HGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
              +    +H DL   +IL++ N+V  VSDFG+S+ L +
Sbjct: 152 ---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 187

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 67/141 (47%), Gaps = 10/141 (7%)
Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCST--P 401
           G FG V  G      DVAIK+   +   +   F  E +V+ N+ H+ L+++   C+   P
Sbjct: 19  GQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP 77
Query: 402 DF---KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPT 458
            F   ++M NG L   L    +     + L +  DV   +EYL     S   +H DL   
Sbjct: 78  IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL----ESKQFLHRDLAAR 133
Query: 459 SILLDENMVAHVSDFGISKLL 479
           + L+++  V  VSDFG+S+ +
Sbjct: 134 NCLVNDQGVVKVSDFGLSRYV 154

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 67/141 (47%), Gaps = 10/141 (7%)
Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCST--P 401
           G FG V  G      DVAIK+   +   +   F  E +V+ N+ H+ L+++   C+   P
Sbjct: 15  GQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP 73
Query: 402 DF---KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPT 458
            F   ++M NG L   L    +     + L +  DV   +EYL     S   +H DL   
Sbjct: 74  IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL----ESKQFLHRDLAAR 129
Query: 459 SILLDENMVAHVSDFGISKLL 479
           + L+++  V  VSDFG+S+ +
Sbjct: 130 NCLVNDQGVVKVSDFGLSRYV 150

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 70/143 (48%), Gaps = 12/143 (8%)
Query: 344 GSFGSVYKGTISDGT-DVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCS-TP 401
           G +G VY G     +  VA+K    +       F  E  V++ ++H NL+++L  C+  P
Sbjct: 43  GQYGEVYVGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTLEP 101
Query: 402 DF----KFMPNGSLEKRLYSHNYF-LDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLK 456
            F    ++MP G+L   L   N   +  +  L +   + S +EYL   +     IH DL 
Sbjct: 102 PFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEKKN----FIHRDLA 157
Query: 457 PTSILLDENMVAHVSDFGISKLL 479
             + L+ EN V  V+DFG+S+L+
Sbjct: 158 ARNCLVGENHVVKVADFGLSRLM 180

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 66/144 (45%), Gaps = 14/144 (9%)
Query: 343 AGSFGSVYKGTISDGTDVAIKIFNLQRERAF--RSFNSECEVLRNVRHQNLIKILSSC-- 398
           +G FG V+ G   +   VAIK     RE A     F  E EV+  + H  L+++   C  
Sbjct: 17  SGQFGLVHLGYWLNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 399 STP---DFKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDL 455
             P    F+FM +G L   L +          L + +DV   + YL      A +IH DL
Sbjct: 74  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE----ASVIHRDL 129
Query: 456 KPTSILLDENMVAHVSDFGISKLL 479
              + L+ EN V  VSDFG+++ +
Sbjct: 130 AARNCLVGENQVIKVSDFGMTRFV 153

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 73/157 (46%), Gaps = 27/157 (17%)
Query: 344 GSFGSVYKGTI------SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSS 397
           G+FG V+           D   VA+K      + A + F+ E E+L N++H++++K    
Sbjct: 24  GAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGV 83
Query: 398 CSTPD-----FKFMPNGSLEKRLYSHNYFLDIL------------ERLNIMIDVGSTLEY 440
           C   D     F++M +G L K L +H     ++            + L+I   + + + Y
Sbjct: 84  CVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVY 143
Query: 441 LHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK 477
           L    +S   +H DL   + L+ EN++  + DFG+S+
Sbjct: 144 L----ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR 176

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 66/144 (45%), Gaps = 14/144 (9%)
Query: 343 AGSFGSVYKGTISDGTDVAIKIFNLQRERAF--RSFNSECEVLRNVRHQNLIKILSSC-- 398
           +G FG V+ G   +   VAIK     RE A     F  E EV+  + H  L+++   C  
Sbjct: 20  SGQFGLVHLGYWLNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 76
Query: 399 STP---DFKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDL 455
             P    F+FM +G L   L +          L + +DV   + YL      A +IH DL
Sbjct: 77  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE----ACVIHRDL 132
Query: 456 KPTSILLDENMVAHVSDFGISKLL 479
              + L+ EN V  VSDFG+++ +
Sbjct: 133 AARNCLVGENQVIKVSDFGMTRFV 156

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 69/149 (46%), Gaps = 16/149 (10%)
Query: 343 AGSFGSV---YKGTISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSS 397
            G+FGSV       + D T   + +  LQ   E   R F  E E+L++++H N++K    
Sbjct: 21  KGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGV 80
Query: 398 CSTPD-------FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPI 450
           C +          +++P GSL   L  H   +D ++ L     +   +EYL     +   
Sbjct: 81  CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL----GTKRY 136
Query: 451 IHCDLKPTSILLDENMVAHVSDFGISKLL 479
           IH +L   +IL++      + DFG++K+L
Sbjct: 137 IHRNLATRNILVENENRVKIGDFGLTKVL 165

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 66/144 (45%), Gaps = 14/144 (9%)
Query: 343 AGSFGSVYKGTISDGTDVAIKIFNLQRERAF--RSFNSECEVLRNVRHQNLIKILSSC-- 398
           +G FG V+ G   +   VAIK     RE A     F  E EV+  + H  L+++   C  
Sbjct: 17  SGQFGLVHLGYWLNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 399 STP---DFKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDL 455
             P    F+FM +G L   L +          L + +DV   + YL      A +IH DL
Sbjct: 74  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE----ACVIHRDL 129
Query: 456 KPTSILLDENMVAHVSDFGISKLL 479
              + L+ EN V  VSDFG+++ +
Sbjct: 130 AARNCLVGENQVIKVSDFGMTRFV 153

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 66/144 (45%), Gaps = 14/144 (9%)
Query: 343 AGSFGSVYKGTISDGTDVAIKIFNLQRERAF--RSFNSECEVLRNVRHQNLIKILSSC-- 398
           +G FG V+ G   +   VAIK     RE A     F  E EV+  + H  L+++   C  
Sbjct: 15  SGQFGLVHLGYWLNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 399 STP---DFKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDL 455
             P    F+FM +G L   L +          L + +DV   + YL      A +IH DL
Sbjct: 72  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE----ACVIHRDL 127
Query: 456 KPTSILLDENMVAHVSDFGISKLL 479
              + L+ EN V  VSDFG+++ +
Sbjct: 128 AARNCLVGENQVIKVSDFGMTRFV 151

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 70/143 (48%), Gaps = 12/143 (8%)
Query: 344 GSFGSVYKGTISDGT-DVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCS-TP 401
           G FG VY+G     +  VA+K    +       F  E  V++ ++H NL+++L  C+  P
Sbjct: 22  GQFGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 80
Query: 402 DF----KFMPNGSLEKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLK 456
            F    +FM  G+L   L   N   +  +  L +   + S +EYL   +     IH DL 
Sbjct: 81  PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN----FIHRDLA 136
Query: 457 PTSILLDENMVAHVSDFGISKLL 479
             + L+ EN +  V+DFG+S+L+
Sbjct: 137 ARNCLVGENHLVKVADFGLSRLM 159

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 71/143 (49%), Gaps = 12/143 (8%)
Query: 344 GSFGSVYKGTISDGT-DVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCS-TP 401
           G +G VY+G     +  VA+K    +       F  E  V++ ++H NL+++L  C+  P
Sbjct: 25  GQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 83
Query: 402 DF----KFMPNGSLEKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLK 456
            F    +FM  G+L   L   N   ++ +  L +   + S +EYL   +     IH DL 
Sbjct: 84  PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----FIHRDLA 139
Query: 457 PTSILLDENMVAHVSDFGISKLL 479
             + L+ EN +  V+DFG+S+L+
Sbjct: 140 ARNCLVGENHLVKVADFGLSRLM 162

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 71/155 (45%), Gaps = 25/155 (16%)
Query: 344 GSFGSVYKGTI--SDGT--DVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSS 397
           G FGSV +G +   DGT   VA+K   L    +R    F SE   +++  H N+I++L  
Sbjct: 45  GEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGV 104
Query: 398 C------STPD----FKFMPNGSLE-----KRLYSHNYFLDILERLNIMIDVGSTLEYLH 442
           C        P       FM  G L       RL +    + +   L  M+D+   +EYL 
Sbjct: 105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL- 163
Query: 443 HGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK 477
              S+   +H DL   + +L ++M   V+DFG+SK
Sbjct: 164 ---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK 195

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 71/143 (49%), Gaps = 12/143 (8%)
Query: 344 GSFGSVYKGTISDGT-DVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCS-TP 401
           G +G VY+G     +  VA+K    +       F  E  V++ ++H NL+++L  C+  P
Sbjct: 29  GQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 87
Query: 402 DF----KFMPNGSLEKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLK 456
            F    +FM  G+L   L   N   ++ +  L +   + S +EYL   +     IH DL 
Sbjct: 88  PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----FIHRDLA 143
Query: 457 PTSILLDENMVAHVSDFGISKLL 479
             + L+ EN +  V+DFG+S+L+
Sbjct: 144 ARNCLVGENHLVKVADFGLSRLM 166

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 71/143 (49%), Gaps = 12/143 (8%)
Query: 344 GSFGSVYKGTISDGT-DVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCS-TP 401
           G +G VY+G     +  VA+K    +       F  E  V++ ++H NL+++L  C+  P
Sbjct: 26  GQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 84
Query: 402 DF----KFMPNGSLEKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLK 456
            F    +FM  G+L   L   N   ++ +  L +   + S +EYL   +     IH DL 
Sbjct: 85  PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----FIHRDLA 140
Query: 457 PTSILLDENMVAHVSDFGISKLL 479
             + L+ EN +  V+DFG+S+L+
Sbjct: 141 ARNCLVGENHLVKVADFGLSRLM 163

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 71/143 (49%), Gaps = 12/143 (8%)
Query: 344 GSFGSVYKGTISDGT-DVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCS-TP 401
           G +G VY+G     +  VA+K    +       F  E  V++ ++H NL+++L  C+  P
Sbjct: 29  GQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 87
Query: 402 DF----KFMPNGSLEKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLK 456
            F    +FM  G+L   L   N   ++ +  L +   + S +EYL   +     IH DL 
Sbjct: 88  PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----FIHRDLA 143
Query: 457 PTSILLDENMVAHVSDFGISKLL 479
             + L+ EN +  V+DFG+S+L+
Sbjct: 144 ARNCLVGENHLVKVADFGLSRLM 166

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 71/143 (49%), Gaps = 12/143 (8%)
Query: 344 GSFGSVYKGTISDGT-DVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCS-TP 401
           G +G VY+G     +  VA+K    +       F  E  V++ ++H NL+++L  C+  P
Sbjct: 25  GQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 83
Query: 402 DF----KFMPNGSLEKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLK 456
            F    +FM  G+L   L   N   ++ +  L +   + S +EYL   +     IH DL 
Sbjct: 84  PFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----FIHRDLA 139
Query: 457 PTSILLDENMVAHVSDFGISKLL 479
             + L+ EN +  V+DFG+S+L+
Sbjct: 140 ARNCLVGENHLVKVADFGLSRLM 162

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 71/143 (49%), Gaps = 12/143 (8%)
Query: 344 GSFGSVYKGTISDGT-DVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCS-TP 401
           G +G VY+G     +  VA+K    +       F  E  V++ ++H NL+++L  C+  P
Sbjct: 29  GQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 87
Query: 402 DF----KFMPNGSLEKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLK 456
            F    +FM  G+L   L   N   ++ +  L +   + S +EYL   +     IH DL 
Sbjct: 88  PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----FIHRDLA 143
Query: 457 PTSILLDENMVAHVSDFGISKLL 479
             + L+ EN +  V+DFG+S+L+
Sbjct: 144 ARNCLVGENHLVKVADFGLSRLM 166

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 71/143 (49%), Gaps = 12/143 (8%)
Query: 344 GSFGSVYKGTISDGT-DVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCS-TP 401
           G +G VY+G     +  VA+K    +       F  E  V++ ++H NL+++L  C+  P
Sbjct: 28  GQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 86
Query: 402 DF----KFMPNGSLEKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLK 456
            F    +FM  G+L   L   N   ++ +  L +   + S +EYL   +     IH DL 
Sbjct: 87  PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----FIHRDLA 142
Query: 457 PTSILLDENMVAHVSDFGISKLL 479
             + L+ EN +  V+DFG+S+L+
Sbjct: 143 ARNCLVGENHLVKVADFGLSRLM 165

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 71/143 (49%), Gaps = 12/143 (8%)
Query: 344 GSFGSVYKGTISDGT-DVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCS-TP 401
           G +G VY+G     +  VA+K    +       F  E  V++ ++H NL+++L  C+  P
Sbjct: 26  GQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 84
Query: 402 DF----KFMPNGSLEKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLK 456
            F    +FM  G+L   L   N   ++ +  L +   + S +EYL   +     IH DL 
Sbjct: 85  PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----FIHRDLA 140
Query: 457 PTSILLDENMVAHVSDFGISKLL 479
             + L+ EN +  V+DFG+S+L+
Sbjct: 141 ARNCLVGENHLVKVADFGLSRLM 163

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 71/143 (49%), Gaps = 12/143 (8%)
Query: 344 GSFGSVYKGTISDGT-DVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCS-TP 401
           G +G VY+G     +  VA+K    +       F  E  V++ ++H NL+++L  C+  P
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 82
Query: 402 DF----KFMPNGSLEKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLK 456
            F    +FM  G+L   L   N   ++ +  L +   + S +EYL   +     IH DL 
Sbjct: 83  PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----FIHRDLA 138
Query: 457 PTSILLDENMVAHVSDFGISKLL 479
             + L+ EN +  V+DFG+S+L+
Sbjct: 139 ARNCLVGENHLVKVADFGLSRLM 161

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 71/143 (49%), Gaps = 12/143 (8%)
Query: 344 GSFGSVYKGTISDGT-DVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCS-TP 401
           G +G VY+G     +  VA+K    +       F  E  V++ ++H NL+++L  C+  P
Sbjct: 29  GQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 87
Query: 402 DF----KFMPNGSLEKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLK 456
            F    +FM  G+L   L   N   ++ +  L +   + S +EYL   +     IH DL 
Sbjct: 88  PFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----FIHRDLA 143
Query: 457 PTSILLDENMVAHVSDFGISKLL 479
             + L+ EN +  V+DFG+S+L+
Sbjct: 144 ARNCLVGENHLVKVADFGLSRLM 166

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 71/143 (49%), Gaps = 12/143 (8%)
Query: 344 GSFGSVYKGTISDGT-DVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCS-TP 401
           G +G VY+G     +  VA+K    +       F  E  V++ ++H NL+++L  C+  P
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 82
Query: 402 DF----KFMPNGSLEKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLK 456
            F    +FM  G+L   L   N   ++ +  L +   + S +EYL   +     IH DL 
Sbjct: 83  PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----FIHRDLA 138
Query: 457 PTSILLDENMVAHVSDFGISKLL 479
             + L+ EN +  V+DFG+S+L+
Sbjct: 139 ARNCLVGENHLVKVADFGLSRLM 161

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 71/143 (49%), Gaps = 12/143 (8%)
Query: 344 GSFGSVYKGTISDGT-DVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCS-TP 401
           G +G VY+G     +  VA+K    +       F  E  V++ ++H NL+++L  C+  P
Sbjct: 37  GQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 95
Query: 402 DF----KFMPNGSLEKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLK 456
            F    +FM  G+L   L   N   ++ +  L +   + S +EYL   +     IH DL 
Sbjct: 96  PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----FIHRDLA 151
Query: 457 PTSILLDENMVAHVSDFGISKLL 479
             + L+ EN +  V+DFG+S+L+
Sbjct: 152 ARNCLVGENHLVKVADFGLSRLM 174

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 77/166 (46%), Gaps = 19/166 (11%)
Query: 325 GDIPSTIGALVDLETISLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLR 384
           G + STI   + L+     G FG V++G    G +VA+KIF+ + ER   S+  E E+ +
Sbjct: 1   GAMGSTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER---SWFREAEIYQ 56
Query: 385 NV--RHQNLIKILSSCSTPDFKFMPNGSLEKRLYSHNYFLDILERLNIMID--------V 434
            V  RH+N++  +++    D        L    + H    D L R  + ++         
Sbjct: 57  TVMLRHENILGFIAA-DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALST 115
Query: 435 GSTLEYLHH---GHSSAPII-HCDLKPTSILLDENMVAHVSDFGIS 476
            S L +LH    G    P I H DLK  +IL+ +N    ++D G++
Sbjct: 116 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 161

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 74/147 (50%), Gaps = 14/147 (9%)
Query: 343 AGSFGSVYKGT-ISDGTDV----AIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILS 396
           +G+FG+VYKG  + +G  V    AIKI N     +A   F  E  ++ ++ H +L+++L 
Sbjct: 48  SGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLG 107
Query: 397 SCSTPDFKF----MPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
            C +P  +     MP+G L + ++ H   +     LN  + +   + YL        ++H
Sbjct: 108 VCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR----LVH 163
Query: 453 CDLKPTSILLDENMVAHVSDFGISKLL 479
            DL   ++L+       ++DFG+++LL
Sbjct: 164 RDLAARNVLVKSPNHVKITDFGLARLL 190

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 71/143 (49%), Gaps = 12/143 (8%)
Query: 344 GSFGSVYKGTISDGT-DVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCS-TP 401
           G +G VY+G     +  VA+K    +       F  E  V++ ++H NL+++L  C+  P
Sbjct: 26  GQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 84
Query: 402 DF----KFMPNGSLEKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLK 456
            F    +FM  G+L   L   N   ++ +  L +   + S +EYL   +     IH DL 
Sbjct: 85  PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----FIHRDLA 140
Query: 457 PTSILLDENMVAHVSDFGISKLL 479
             + L+ EN +  V+DFG+S+L+
Sbjct: 141 ARNCLVGENHLVKVADFGLSRLM 163

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 69/149 (46%), Gaps = 24/149 (16%)
Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTP 401
           G FG VY G      +VAI++ +++R  E   ++F  E    R  RH+N++  + +C +P
Sbjct: 44  GRFGQVYHGRWH--GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP 101
Query: 402 DFKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLE----------YLHHGHSSAPII 451
                P+ ++   L        ++    I++DV  T +          YLH    +  I+
Sbjct: 102 -----PHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH----AKGIL 152
Query: 452 HCDLKPTSILLDENMVAHVSDFGISKLLG 480
           H DLK  ++  D   V  ++DFG+  + G
Sbjct: 153 HKDLKSKNVFYDNGKVV-ITDFGLFSISG 180

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 70/143 (48%), Gaps = 12/143 (8%)
Query: 344 GSFGSVYKGTISDGT-DVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCS-TP 401
           G +G VY+G     +  VA+K    +       F  E  V++ ++H NL+++L  C+  P
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 82
Query: 402 DF----KFMPNGSLEKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLK 456
            F    +FM  G+L   L   N   +  +  L +   + S +EYL   +     IH DL 
Sbjct: 83  PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN----FIHRDLA 138
Query: 457 PTSILLDENMVAHVSDFGISKLL 479
             + L+ EN +  V+DFG+S+L+
Sbjct: 139 ARNCLVGENHLVKVADFGLSRLM 161

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 81/159 (50%), Gaps = 14/159 (8%)
Query: 333 ALVDLETISLAGSFGSVYKG--TISDGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVR 387
           + V +E +  AG FG V  G   +    ++ + I  L+    E+  R F SE  ++    
Sbjct: 7   SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 66
Query: 388 HQNLIKI--LSSCSTPDF---KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLH 442
           H N+I +  + + STP     +FM NGSL+  L  ++    +++ + ++  + + ++YL 
Sbjct: 67  HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL- 125
Query: 443 HGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
              +    +H  L   +IL++ N+V  VSDFG+S+ L +
Sbjct: 126 ---ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLED 161

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 70/143 (48%), Gaps = 12/143 (8%)
Query: 344 GSFGSVYKGTISDGT-DVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCS-TP 401
           G +G VY+G     +  VA+K    +       F  E  V++ ++H NL+++L  C+  P
Sbjct: 22  GQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 80
Query: 402 DF----KFMPNGSLEKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLK 456
            F    +FM  G+L   L   N   +  +  L +   + S +EYL   +     IH DL 
Sbjct: 81  PFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN----FIHRDLA 136
Query: 457 PTSILLDENMVAHVSDFGISKLL 479
             + L+ EN +  V+DFG+S+L+
Sbjct: 137 ARNCLVGENHLVKVADFGLSRLM 159

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 70/143 (48%), Gaps = 12/143 (8%)
Query: 344 GSFGSVYKGTISDGT-DVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCS-TP 401
           G +G VY+G     +  VA+K    +       F  E  V++ ++H NL+++L  C+  P
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 82
Query: 402 DF----KFMPNGSLEKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLK 456
            F    +FM  G+L   L   N   +  +  L +   + S +EYL   +     IH DL 
Sbjct: 83  PFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN----FIHRDLA 138
Query: 457 PTSILLDENMVAHVSDFGISKLL 479
             + L+ EN +  V+DFG+S+L+
Sbjct: 139 ARNCLVGENHLVKVADFGLSRLM 161

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 70/143 (48%), Gaps = 12/143 (8%)
Query: 344 GSFGSVYKGTISDGT-DVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCS-TP 401
           G +G VY+G     +  VA+K    +       F  E  V++ ++H NL+++L  C+  P
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 82
Query: 402 DF----KFMPNGSLEKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLK 456
            F    +FM  G+L   L   N   +  +  L +   + S +EYL   +     IH DL 
Sbjct: 83  PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN----FIHRDLA 138
Query: 457 PTSILLDENMVAHVSDFGISKLL 479
             + L+ EN +  V+DFG+S+L+
Sbjct: 139 ARNCLVGENHLVKVADFGLSRLM 161

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 65/142 (45%), Gaps = 10/142 (7%)
Query: 343 AGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSC--ST 400
           +G FG V+ G   +   VAIK    +   +   F  E EV+  + H  L+++   C    
Sbjct: 37  SGQFGLVHLGYWLNKDKVAIKTIK-EGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLEQA 95
Query: 401 P---DFKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKP 457
           P    F+FM +G L   L +          L + +DV   + YL      A +IH DL  
Sbjct: 96  PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE----ACVIHRDLAA 151
Query: 458 TSILLDENMVAHVSDFGISKLL 479
            + L+ EN V  VSDFG+++ +
Sbjct: 152 RNCLVGENQVIKVSDFGMTRFV 173

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 70/143 (48%), Gaps = 12/143 (8%)
Query: 344 GSFGSVYKGTISDGT-DVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCS-TP 401
           G +G VY+G     +  VA+K    +       F  E  V++ ++H NL+++L  C+  P
Sbjct: 22  GQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 80
Query: 402 DF----KFMPNGSLEKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLK 456
            F    +FM  G+L   L   N   +  +  L +   + S +EYL   +     IH DL 
Sbjct: 81  PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN----FIHRDLA 136
Query: 457 PTSILLDENMVAHVSDFGISKLL 479
             + L+ EN +  V+DFG+S+L+
Sbjct: 137 ARNCLVGENHLVKVADFGLSRLM 159

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 70/143 (48%), Gaps = 12/143 (8%)
Query: 344 GSFGSVYKGTISDGT-DVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCS-TP 401
           G +G VY+G     +  VA+K    +       F  E  V++ ++H NL+++L  C+  P
Sbjct: 29  GQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 87
Query: 402 DF----KFMPNGSLEKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLK 456
            F    +FM  G+L   L   N   +  +  L +   + S +EYL   +     IH DL 
Sbjct: 88  PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN----FIHRDLA 143
Query: 457 PTSILLDENMVAHVSDFGISKLL 479
             + L+ EN +  V+DFG+S+L+
Sbjct: 144 ARNCLVGENHLVKVADFGLSRLM 166

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 70/143 (48%), Gaps = 12/143 (8%)
Query: 344 GSFGSVYKGTISDGT-DVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCS-TP 401
           G +G VY+G     +  VA+K    +       F  E  V++ ++H NL+++L  C+  P
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 82
Query: 402 DF----KFMPNGSLEKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLK 456
            F    +FM  G+L   L   N   +  +  L +   + S +EYL   +     IH DL 
Sbjct: 83  PFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN----FIHRDLA 138
Query: 457 PTSILLDENMVAHVSDFGISKLL 479
             + L+ EN +  V+DFG+S+L+
Sbjct: 139 ARNCLVGENHLVKVADFGLSRLM 161

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 73/150 (48%), Gaps = 19/150 (12%)
Query: 337 LETISLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILS 396
           L+TI   G FG V  G    G  VA+K   ++ +   ++F +E  V+  +RH NL+++L 
Sbjct: 17  LQTIG-KGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLG 72
Query: 397 SCSTPD------FKFMPNGSLEKRLYSHNYFL---DILERLNIMIDVGSTLEYLHHGHSS 447
                        ++M  GSL   L S    +   D L  L   +DV   +EYL   +  
Sbjct: 73  VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL--LKFSLDVCEAMEYLEGNN-- 128
Query: 448 APIIHCDLKPTSILLDENMVAHVSDFGISK 477
              +H DL   ++L+ E+ VA VSDFG++K
Sbjct: 129 --FVHRDLAARNVLVSEDNVAKVSDFGLTK 156

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 83/170 (48%), Gaps = 15/170 (8%)
Query: 321 NQLSGDIPSTIGA-LVDLETISLAGSFGSVYKGTIS----DGTDVAIKIFNL-QRERAFR 374
           NQ   +    I A  + +E +  AG FG V  G +         VAIK   +   E+  R
Sbjct: 9   NQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRR 68
Query: 375 SFNSECEVLRNVRHQNLIKI--LSSCSTPDF---KFMPNGSLEKRLYSHNYFLDILERLN 429
            F  E  ++    H N+I +  + + S P     ++M NGSL+  L  ++    +++ + 
Sbjct: 69  DFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVG 128
Query: 430 IMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
           ++  + + ++YL    S    +H DL   +IL++ N+V  VSDFG+S++L
Sbjct: 129 MLRGISAGMKYL----SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL 174

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 73/150 (48%), Gaps = 19/150 (12%)
Query: 337 LETISLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILS 396
           L+TI   G FG V  G    G  VA+K   ++ +   ++F +E  V+  +RH NL+++L 
Sbjct: 26  LQTIG-KGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLG 81
Query: 397 SCSTPD------FKFMPNGSLEKRLYSHNYFL---DILERLNIMIDVGSTLEYLHHGHSS 447
                        ++M  GSL   L S    +   D L  L   +DV   +EYL   +  
Sbjct: 82  VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL--LKFSLDVCEAMEYLEGNN-- 137
Query: 448 APIIHCDLKPTSILLDENMVAHVSDFGISK 477
              +H DL   ++L+ E+ VA VSDFG++K
Sbjct: 138 --FVHRDLAARNVLVSEDNVAKVSDFGLTK 165

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 73/150 (48%), Gaps = 19/150 (12%)
Query: 337 LETISLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILS 396
           L+TI   G FG V  G    G  VA+K   ++ +   ++F +E  V+  +RH NL+++L 
Sbjct: 11  LQTIG-KGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLG 66
Query: 397 SCSTPD------FKFMPNGSLEKRLYSHNYFL---DILERLNIMIDVGSTLEYLHHGHSS 447
                        ++M  GSL   L S    +   D L  L   +DV   +EYL   +  
Sbjct: 67  VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL--LKFSLDVCEAMEYLEGNN-- 122
Query: 448 APIIHCDLKPTSILLDENMVAHVSDFGISK 477
              +H DL   ++L+ E+ VA VSDFG++K
Sbjct: 123 --FVHRDLAARNVLVSEDNVAKVSDFGLTK 150

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 74/147 (50%), Gaps = 14/147 (9%)
Query: 343 AGSFGSVYKGT-ISDGTDV----AIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILS 396
           +G+FG+VYKG  + +G  V    AIKI N     +A   F  E  ++ ++ H +L+++L 
Sbjct: 25  SGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLG 84
Query: 397 SCSTPDFKF----MPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
            C +P  +     MP+G L + ++ H   +     LN  + +   + YL        ++H
Sbjct: 85  VCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR----LVH 140
Query: 453 CDLKPTSILLDENMVAHVSDFGISKLL 479
            DL   ++L+       ++DFG+++LL
Sbjct: 141 RDLAARNVLVKSPNHVKITDFGLARLL 167

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 75/164 (45%), Gaps = 19/164 (11%)
Query: 327 IPSTIGALVDLETISLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNV 386
           +  TI   + L+     G FG V++G    G +VA+KIF+ + ER   S+  E E+ + V
Sbjct: 23  VQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER---SWFREAEIYQTV 78
Query: 387 --RHQNLIKILSSCSTPDFKFMPNGSLEKRLYSHNYFLDILERLNIMID--------VGS 436
             RH+N++  +++    D        L    + H    D L R  + ++          S
Sbjct: 79  MLRHENILGFIAA-DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTAS 137
Query: 437 TLEYLHH---GHSSAPII-HCDLKPTSILLDENMVAHVSDFGIS 476
            L +LH    G    P I H DLK  +IL+ +N    ++D G++
Sbjct: 138 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 181

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 73/150 (48%), Gaps = 19/150 (12%)
Query: 337 LETISLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILS 396
           L+TI   G FG V  G    G  VA+K   ++ +   ++F +E  V+  +RH NL+++L 
Sbjct: 198 LQTIG-KGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLG 253
Query: 397 SCSTPD------FKFMPNGSLEKRLYSHNYFL---DILERLNIMIDVGSTLEYLHHGHSS 447
                        ++M  GSL   L S    +   D L  L   +DV   +EYL   +  
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL--LKFSLDVCEAMEYLEGNN-- 309
Query: 448 APIIHCDLKPTSILLDENMVAHVSDFGISK 477
              +H DL   ++L+ E+ VA VSDFG++K
Sbjct: 310 --FVHRDLAARNVLVSEDNVAKVSDFGLTK 337

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 75/164 (45%), Gaps = 19/164 (11%)
Query: 327 IPSTIGALVDLETISLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNV 386
           +  TI   + L+     G FG V++G    G +VA+KIF+ + ER   S+  E E+ + V
Sbjct: 36  VQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER---SWFREAEIYQTV 91
Query: 387 --RHQNLIKILSSCSTPDFKFMPNGSLEKRLYSHNYFLDILERLNIMID--------VGS 436
             RH+N++  +++    D        L    + H    D L R  + ++          S
Sbjct: 92  MLRHENILGFIAA-DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTAS 150
Query: 437 TLEYLHH---GHSSAPII-HCDLKPTSILLDENMVAHVSDFGIS 476
            L +LH    G    P I H DLK  +IL+ +N    ++D G++
Sbjct: 151 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 194

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 65/144 (45%), Gaps = 14/144 (9%)
Query: 343 AGSFGSVYKGTISDGTDVAIKIFNLQRERAF--RSFNSECEVLRNVRHQNLIKILSSC-- 398
           +G FG V+ G   +   VAIK     RE A     F  E EV+  + H  L+++   C  
Sbjct: 18  SGQFGLVHLGYWLNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 399 STPDF---KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDL 455
             P     +FM +G L   L +          L + +DV   + YL      A +IH DL
Sbjct: 75  QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE----ACVIHRDL 130
Query: 456 KPTSILLDENMVAHVSDFGISKLL 479
              + L+ EN V  VSDFG+++ +
Sbjct: 131 AARNCLVGENQVIKVSDFGMTRFV 154

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 71/143 (49%), Gaps = 12/143 (8%)
Query: 344 GSFGSVYKGTISDGT-DVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCS-TP 401
           G +G VY+G     +  VA+K    +       F  E  V++ ++H NL+++L  C+  P
Sbjct: 270 GQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 328
Query: 402 DF----KFMPNGSLEKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLK 456
            F    +FM  G+L   L   N   ++ +  L +   + S +EYL   +     IH +L 
Sbjct: 329 PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----FIHRNLA 384
Query: 457 PTSILLDENMVAHVSDFGISKLL 479
             + L+ EN +  V+DFG+S+L+
Sbjct: 385 ARNCLVGENHLVKVADFGLSRLM 407

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 70/160 (43%), Gaps = 30/160 (18%)
Query: 344 GSFGSVYKGTI------SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSS 397
           G+FG V+           D   VA+K        A + F  E E+L N++H++++K    
Sbjct: 26  GAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGV 85
Query: 398 CSTPD-----FKFMPNGSLEKRLYSHNYFLDIL---------------ERLNIMIDVGST 437
           C   D     F++M +G L K L +H     IL               + L+I   + S 
Sbjct: 86  CGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASG 145
Query: 438 LEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK 477
           + YL    +S   +H DL   + L+  N++  + DFG+S+
Sbjct: 146 MVYL----ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 181

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 66/142 (46%), Gaps = 10/142 (7%)
Query: 343 AGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCST-- 400
           +G FG V  G      DVA+K+   +   +   F  E + +  + H  L+K    CS   
Sbjct: 18  SGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEY 76
Query: 401 PDF---KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKP 457
           P +   +++ NG L   L SH   L+  + L +  DV   + +L     S   IH DL  
Sbjct: 77  PIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL----ESHQFIHRDLAA 132
Query: 458 TSILLDENMVAHVSDFGISKLL 479
            + L+D ++   VSDFG+++ +
Sbjct: 133 RNCLVDRDLCVKVSDFGMTRYV 154

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 12/143 (8%)
Query: 344 GSFGSVYKGTISDGT-DVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCS-TP 401
           G +G VY+G     +  VA+K    +       F  E  V++ ++H NL+++L  C+  P
Sbjct: 231 GQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 289
Query: 402 DF----KFMPNGSLEKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLK 456
            F    +FM  G+L   L   N   +  +  L +   + S +EYL   +     IH +L 
Sbjct: 290 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN----FIHRNLA 345
Query: 457 PTSILLDENMVAHVSDFGISKLL 479
             + L+ EN +  V+DFG+S+L+
Sbjct: 346 ARNCLVGENHLVKVADFGLSRLM 368

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 74/161 (45%), Gaps = 19/161 (11%)
Query: 330 TIGALVDLETISLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNV--R 387
           TI   + L+     G FG V++G    G +VA+KIF+ + ER   S+  E E+ + V  R
Sbjct: 3   TIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER---SWFREAEIYQTVMLR 58
Query: 388 HQNLIKILSSCSTPDFKFMPNGSLEKRLYSHNYFLDILERLNIMID--------VGSTLE 439
           H+N++  +++    D        L    + H    D L R  + ++          S L 
Sbjct: 59  HENILGFIAA-DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLA 117
Query: 440 YLHH---GHSSAPII-HCDLKPTSILLDENMVAHVSDFGIS 476
           +LH    G    P I H DLK  +IL+ +N    ++D G++
Sbjct: 118 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 158

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 74/161 (45%), Gaps = 19/161 (11%)
Query: 330 TIGALVDLETISLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNV--R 387
           TI   + L+     G FG V++G    G +VA+KIF+ + ER   S+  E E+ + V  R
Sbjct: 1   TIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER---SWFREAEIYQTVMLR 56
Query: 388 HQNLIKILSSCSTPDFKFMPNGSLEKRLYSHNYFLDILERLNIMID--------VGSTLE 439
           H+N++  +++    D        L    + H    D L R  + ++          S L 
Sbjct: 57  HENILGFIAA-DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLA 115
Query: 440 YLHH---GHSSAPII-HCDLKPTSILLDENMVAHVSDFGIS 476
           +LH    G    P I H DLK  +IL+ +N    ++D G++
Sbjct: 116 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 156

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 69/147 (46%), Gaps = 19/147 (12%)
Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNV--RHQNLIKILSSCSTP 401
           G FG V++G    G +VA+KIF+ + ER   S+  E E+ + V  RH+N++  +++    
Sbjct: 14  GRFGEVWRGKWR-GEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIAA-DNK 68
Query: 402 DFKFMPNGSLEKRLYSHNYFLDILERLNIMID--------VGSTLEYLHH---GHSSAPI 450
           D        L    + H    D L R  + ++          S L +LH    G    P 
Sbjct: 69  DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA 128
Query: 451 I-HCDLKPTSILLDENMVAHVSDFGIS 476
           I H DLK  +IL+ +N    ++D G++
Sbjct: 129 IAHRDLKSKNILVKKNGTCCIADLGLA 155

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 67/147 (45%), Gaps = 15/147 (10%)
Query: 344 GSFGSV---YKGTISDGTDVAIKIFN---LQRERAFRSFNSECEVLRNVRHQNLIKILSS 397
           GSFG V   Y  T   G  VA+KI N   L +         E   LR +RH ++IK+   
Sbjct: 24  GSFGKVKLAYHTTT--GQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDV 81
Query: 398 CSTPDFKFMPNGSLEKRLYSHNYFLDIL---ERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
             + D   M        L+ +    D +   E       + S +EY H       I+H D
Sbjct: 82  IKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR----HKIVHRD 137
Query: 455 LKPTSILLDENMVAHVSDFGISKLLGE 481
           LKP ++LLDE++   ++DFG+S ++ +
Sbjct: 138 LKPENLLLDEHLNVKIADFGLSNIMTD 164

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 67/147 (45%), Gaps = 15/147 (10%)
Query: 344 GSFGSV---YKGTISDGTDVAIKIFN---LQRERAFRSFNSECEVLRNVRHQNLIKILSS 397
           GSFG V   Y  T   G  VA+KI N   L +         E   LR +RH ++IK+   
Sbjct: 19  GSFGKVKLAYHTTT--GQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDV 76
Query: 398 CSTPDFKFMPNGSLEKRLYSHNYFLDIL---ERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
             + D   M        L+ +    D +   E       + S +EY H       I+H D
Sbjct: 77  IKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR----HKIVHRD 132
Query: 455 LKPTSILLDENMVAHVSDFGISKLLGE 481
           LKP ++LLDE++   ++DFG+S ++ +
Sbjct: 133 LKPENLLLDEHLNVKIADFGLSNIMTD 159

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 38/137 (27%), Positives = 64/137 (46%), Gaps = 17/137 (12%)
Query: 347 GSVYKGTISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPDFK 404
           G ++KG    G D+ +K+  ++    R  R FN EC  LR   H N++ +L +C +P   
Sbjct: 24  GELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82
Query: 405 -------FMPNGSLEKRLYS-HNYFLDILERLNIMIDVGSTLEYLHHGHSSAPII--HCD 454
                  + P GSL   L+   N+ +D  + +   +D      +L   H+  P+I  H  
Sbjct: 83  HPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFL---HTLEPLIPRHA- 138
Query: 455 LKPTSILLDENMVAHVS 471
           L   S+ +DE+  A +S
Sbjct: 139 LNSRSVXIDEDXTARIS 155

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 67/147 (45%), Gaps = 15/147 (10%)
Query: 344 GSFGSV---YKGTISDGTDVAIKIFN---LQRERAFRSFNSECEVLRNVRHQNLIKILSS 397
           GSFG V   Y  T   G  VA+KI N   L +         E   LR +RH ++IK+   
Sbjct: 25  GSFGKVKLAYHTTT--GQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDV 82
Query: 398 CSTPDFKFMPNGSLEKRLYSHNYFLDIL---ERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
             + D   M        L+ +    D +   E       + S +EY H       I+H D
Sbjct: 83  IKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR----HKIVHRD 138
Query: 455 LKPTSILLDENMVAHVSDFGISKLLGE 481
           LKP ++LLDE++   ++DFG+S ++ +
Sbjct: 139 LKPENLLLDEHLNVKIADFGLSNIMTD 165

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 46/146 (31%), Positives = 68/146 (46%), Gaps = 16/146 (10%)
Query: 344 GSFGSVY-KGTISDGTDVAIKIFNLQ---RERAFRSFNSECEVLRNVRHQNLIKILSSCS 399
           GSF +V     ++   + AIKI   +   +E        E +V+  + H   +K L  C 
Sbjct: 48  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK-LYFCF 106
Query: 400 TPDFK------FMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHC 453
             D K      +  NG L K +     F +   R     ++ S LEYLH       IIH 
Sbjct: 107 QDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH----GKGIIHR 161
Query: 454 DLKPTSILLDENMVAHVSDFGISKLL 479
           DLKP +ILL+E+M   ++DFG +K+L
Sbjct: 162 DLKPENILLNEDMHIQITDFGTAKVL 187

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 67/147 (45%), Gaps = 15/147 (10%)
Query: 344 GSFGSV---YKGTISDGTDVAIKIFN---LQRERAFRSFNSECEVLRNVRHQNLIKILSS 397
           GSFG V   Y  T   G  VA+KI N   L +         E   LR +RH ++IK+   
Sbjct: 15  GSFGKVKLAYHTTT--GQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDV 72
Query: 398 CSTPDFKFMPNGSLEKRLYSHNYFLDIL---ERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
             + D   M        L+ +    D +   E       + S +EY H       I+H D
Sbjct: 73  IKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK----IVHRD 128
Query: 455 LKPTSILLDENMVAHVSDFGISKLLGE 481
           LKP ++LLDE++   ++DFG+S ++ +
Sbjct: 129 LKPENLLLDEHLNVKIADFGLSNIMTD 155

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/155 (25%), Positives = 79/155 (50%), Gaps = 15/155 (9%)
Query: 335 VDLETISL-----AGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQ 389
           V  ET+ L     AG FG V+ G  +  T VA+K    Q   +  +F +E  +++ ++HQ
Sbjct: 18  VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQ 76
Query: 390 NLIKILSSCSTPDF----KFMPNGSLEKRLYSHNYF-LDILERLNIMIDVGSTLEYLHHG 444
            L+++ +  +        ++M NGSL   L + +   L I + L++   +   + ++   
Sbjct: 77  RLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 136
Query: 445 HSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
           +     IH DL+  +IL+ + +   ++DFG+++L+
Sbjct: 137 N----YIHRDLRAANILVSDTLSCKIADFGLARLI 167

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/155 (25%), Positives = 79/155 (50%), Gaps = 15/155 (9%)
Query: 335 VDLETISL-----AGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQ 389
           V  ET+ L     AG FG V+ G  +  T VA+K    Q   +  +F +E  +++ ++HQ
Sbjct: 10  VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQ 68
Query: 390 NLIKILSSCSTPDF----KFMPNGSLEKRLYSHNYF-LDILERLNIMIDVGSTLEYLHHG 444
            L+++ +  +        ++M NGSL   L + +   L I + L++   +   + ++   
Sbjct: 69  RLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 445 HSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
           +     IH DL+  +IL+ + +   ++DFG+++L+
Sbjct: 129 N----YIHRDLRAANILVSDTLSCKIADFGLARLI 159

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/143 (23%), Positives = 73/143 (51%), Gaps = 11/143 (7%)
Query: 343 AGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           AG FG V+ G  ++ T VA+K        + ++F  E  +++ ++H  L+++ +  +  +
Sbjct: 22  AGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEE 80
Query: 403 -----FKFMPNGSLEKRLYSHNYFLDILERL-NIMIDVGSTLEYLHHGHSSAPIIHCDLK 456
                 +FM  GSL   L S      +L +L +    +   + Y+   +     IH DL+
Sbjct: 81  PIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN----YIHRDLR 136
Query: 457 PTSILLDENMVAHVSDFGISKLL 479
             ++L+ E+++  ++DFG+++++
Sbjct: 137 AANVLVSESLMCKIADFGLARVI 159

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/155 (25%), Positives = 79/155 (50%), Gaps = 15/155 (9%)
Query: 335 VDLETISL-----AGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQ 389
           V  ET+ L     AG FG V+ G  +  T VA+K    Q   +  +F +E  +++ ++HQ
Sbjct: 16  VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQ 74
Query: 390 NLIKILSSCSTPDF----KFMPNGSLEKRLYSHNYF-LDILERLNIMIDVGSTLEYLHHG 444
            L+++ +  +        ++M NGSL   L + +   L I + L++   +   + ++   
Sbjct: 75  RLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 134
Query: 445 HSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
           +     IH DL+  +IL+ + +   ++DFG+++L+
Sbjct: 135 N----YIHRDLRAANILVSDTLSCKIADFGLARLI 165

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/155 (25%), Positives = 79/155 (50%), Gaps = 15/155 (9%)
Query: 335 VDLETISL-----AGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQ 389
           V  ET+ L     AG FG V+ G  +  T VA+K    Q   +  +F +E  +++ ++HQ
Sbjct: 20  VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQ 78
Query: 390 NLIKILSSCSTPDF----KFMPNGSLEKRLYSHNYF-LDILERLNIMIDVGSTLEYLHHG 444
            L+++ +  +        ++M NGSL   L + +   L I + L++   +   + ++   
Sbjct: 79  RLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 138
Query: 445 HSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
           +     IH DL+  +IL+ + +   ++DFG+++L+
Sbjct: 139 N----YIHRDLRAANILVSDTLSCKIADFGLARLI 169

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/155 (25%), Positives = 79/155 (50%), Gaps = 15/155 (9%)
Query: 335 VDLETISL-----AGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQ 389
           V  ET+ L     AG FG V+ G  +  T VA+K    Q   +  +F +E  +++ ++HQ
Sbjct: 12  VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQ 70
Query: 390 NLIKILSSCSTPDF----KFMPNGSLEKRLYSHNYF-LDILERLNIMIDVGSTLEYLHHG 444
            L+++ +  +        ++M NGSL   L + +   L I + L++   +   + ++   
Sbjct: 71  RLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 130
Query: 445 HSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
           +     IH DL+  +IL+ + +   ++DFG+++L+
Sbjct: 131 N----YIHRDLRAANILVSDTLSCKIADFGLARLI 161

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 80/157 (50%), Gaps = 15/157 (9%)
Query: 335 VDLETISL-----AGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQ 389
           V  ET+ L     AG FG V+ G  +  T VA+K    Q   +  +F +E  +++ ++HQ
Sbjct: 16  VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQ 74
Query: 390 NLIKILSSCSTPDF----KFMPNGSLEKRLYSHNYF-LDILERLNIMIDVGSTLEYLHHG 444
            L+++ +  +        ++M NGSL   L + +   L I + L++   +   + ++   
Sbjct: 75  RLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 134
Query: 445 HSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
           +     IH DL+  +IL+ + +   ++DFG+++L+ +
Sbjct: 135 N----YIHRDLRAANILVSDTLSCKIADFGLARLIED 167

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/155 (25%), Positives = 79/155 (50%), Gaps = 15/155 (9%)
Query: 335 VDLETISL-----AGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQ 389
           V  ET+ L     AG FG V+ G  +  T VA+K    Q   +  +F +E  +++ ++HQ
Sbjct: 19  VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQ 77
Query: 390 NLIKILSSCSTPDF----KFMPNGSLEKRLYSHNYF-LDILERLNIMIDVGSTLEYLHHG 444
            L+++ +  +        ++M NGSL   L + +   L I + L++   +   + ++   
Sbjct: 78  RLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 137
Query: 445 HSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
           +     IH DL+  +IL+ + +   ++DFG+++L+
Sbjct: 138 N----YIHRDLRAANILVSDTLSCKIADFGLARLI 168

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 68/148 (45%), Gaps = 16/148 (10%)
Query: 344 GSFGSVYKGTISDGTD-VAIKIFNL-QRERAFRSFNS----ECEVLRNVRHQNLIKILSS 397
           G F +VYK    +    VAIK   L  R  A    N     E ++L+ + H N+I +L +
Sbjct: 21  GQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDA 80
Query: 398 CSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
                     F FM    LE  +  ++  L        M+     LEYLH       I+H
Sbjct: 81  FGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW----ILH 135
Query: 453 CDLKPTSILLDENMVAHVSDFGISKLLG 480
            DLKP ++LLDEN V  ++DFG++K  G
Sbjct: 136 RDLKPNNLLLDENGVLKLADFGLAKSFG 163

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/142 (24%), Positives = 74/142 (52%), Gaps = 10/142 (7%)
Query: 343 AGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           AG FG V+ G  +  T VA+K    Q   +  +F +E  +++ ++HQ L+++ +  +   
Sbjct: 24  AGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP 82
Query: 403 F----KFMPNGSLEKRLYSHNYF-LDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKP 457
                ++M NGSL   L + +   L I + L++   +   + ++   +     IH DL+ 
Sbjct: 83  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN----YIHRDLRA 138
Query: 458 TSILLDENMVAHVSDFGISKLL 479
            +IL+ + +   ++DFG+++L+
Sbjct: 139 ANILVSDTLSCKIADFGLARLI 160

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/142 (24%), Positives = 74/142 (52%), Gaps = 10/142 (7%)
Query: 343 AGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           AG FG V+ G  +  T VA+K    Q   +  +F +E  +++ ++HQ L+++ +  +   
Sbjct: 23  AGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP 81
Query: 403 F----KFMPNGSLEKRLYSHNYF-LDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKP 457
                ++M NGSL   L + +   L I + L++   +   + ++   +     IH DL+ 
Sbjct: 82  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN----YIHRDLRA 137
Query: 458 TSILLDENMVAHVSDFGISKLL 479
            +IL+ + +   ++DFG+++L+
Sbjct: 138 ANILVSDTLSCKIADFGLARLI 159

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/142 (24%), Positives = 74/142 (52%), Gaps = 10/142 (7%)
Query: 343 AGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           AG FG V+ G  +  T VA+K    Q   +  +F +E  +++ ++HQ L+++ +  +   
Sbjct: 23  AGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP 81
Query: 403 F----KFMPNGSLEKRLYSHNYF-LDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKP 457
                ++M NGSL   L + +   L I + L++   +   + ++   +     IH DL+ 
Sbjct: 82  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN----YIHRDLRA 137
Query: 458 TSILLDENMVAHVSDFGISKLL 479
            +IL+ + +   ++DFG+++L+
Sbjct: 138 ANILVSDTLSCKIADFGLARLI 159

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/155 (25%), Positives = 79/155 (50%), Gaps = 15/155 (9%)
Query: 335 VDLETISL-----AGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQ 389
           V  ET+ L     AG FG V+ G  +  T VA+K    Q   +  +F +E  +++ ++HQ
Sbjct: 15  VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQ 73
Query: 390 NLIKILSSCSTPDF----KFMPNGSLEKRLYSHNYF-LDILERLNIMIDVGSTLEYLHHG 444
            L+++ +  +        ++M NGSL   L + +   L I + L++   +   + ++   
Sbjct: 74  RLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 133
Query: 445 HSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
           +     IH DL+  +IL+ + +   ++DFG+++L+
Sbjct: 134 N----YIHRDLRAANILVSDTLSCKIADFGLARLI 164

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 21/152 (13%)
Query: 344 GSFGSV----YKGTISDGTD--VAIKIFNLQRERAFRS-FNSECEVLRNVRHQNLIKILS 396
           G FG V    Y  T +DGT   VA+K          RS +  E ++LR + H+++IK   
Sbjct: 42  GHFGKVSLYCYDPT-NDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKG 100
Query: 397 SCSTPD-------FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAP 449
            C            +++P GSL   L  H+  + + + L     +   + YLH  H    
Sbjct: 101 CCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLHAQH---- 154
Query: 450 IIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
            IH DL   ++LLD + +  + DFG++K + E
Sbjct: 155 YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/142 (24%), Positives = 74/142 (52%), Gaps = 10/142 (7%)
Query: 343 AGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           AG FG V+ G  +  T VA+K    Q   +  +F +E  +++ ++HQ L+++ +  +   
Sbjct: 18  AGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP 76
Query: 403 F----KFMPNGSLEKRLYSHNYF-LDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKP 457
                ++M NGSL   L + +   L I + L++   +   + ++   +     IH DL+ 
Sbjct: 77  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN----YIHRDLRA 132
Query: 458 TSILLDENMVAHVSDFGISKLL 479
            +IL+ + +   ++DFG+++L+
Sbjct: 133 ANILVSDTLSCKIADFGLARLI 154

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/159 (24%), Positives = 68/159 (42%), Gaps = 29/159 (18%)
Query: 344 GSFGSVYKGTI------SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSS 397
           G+FG V+           D   VA+K      E A + F  E E+L  ++HQ++++    
Sbjct: 52  GAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGV 111
Query: 398 CSTPD-----FKFMPNGSLEKRLYSHNYFLDIL--------------ERLNIMIDVGSTL 438
           C+        F++M +G L + L SH     +L              + L +   V + +
Sbjct: 112 CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGM 171
Query: 439 EYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK 477
            YL   H     +H DL   + L+ + +V  + DFG+S+
Sbjct: 172 VYLAGLH----FVHRDLATRNCLVGQGLVVKIGDFGMSR 206

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 67/148 (45%), Gaps = 10/148 (6%)
Query: 335 VDLETISLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKI 394
           +++E +   G+FG V K       DVAIK    + ER  ++F  E   L  V H N++K+
Sbjct: 11  IEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKL 67
Query: 395 LSSCSTP---DFKFMPNGSLEKRLYSHN--YFLDILERLNIMIDVGSTLEYLHHGHSSAP 449
             +C  P     ++   GSL   L+      +      ++  +     + YLH     A 
Sbjct: 68  YGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA- 126
Query: 450 IIHCDLKPTSILLDE-NMVAHVSDFGIS 476
           +IH DLKP ++LL     V  + DFG +
Sbjct: 127 LIHRDLKPPNLLLVAGGTVLKICDFGTA 154

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 67/148 (45%), Gaps = 10/148 (6%)
Query: 335 VDLETISLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKI 394
           +++E +   G+FG V K       DVAIK    + ER  ++F  E   L  V H N++K+
Sbjct: 10  IEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKL 66
Query: 395 LSSCSTP---DFKFMPNGSLEKRLYSHN--YFLDILERLNIMIDVGSTLEYLHHGHSSAP 449
             +C  P     ++   GSL   L+      +      ++  +     + YLH     A 
Sbjct: 67  YGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA- 125
Query: 450 IIHCDLKPTSILLDE-NMVAHVSDFGIS 476
           +IH DLKP ++LL     V  + DFG +
Sbjct: 126 LIHRDLKPPNLLLVAGGTVLKICDFGTA 153

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/159 (24%), Positives = 68/159 (42%), Gaps = 29/159 (18%)
Query: 344 GSFGSVYKGTI------SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSS 397
           G+FG V+           D   VA+K      E A + F  E E+L  ++HQ++++    
Sbjct: 23  GAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGV 82
Query: 398 CSTPD-----FKFMPNGSLEKRLYSHNYFLDIL--------------ERLNIMIDVGSTL 438
           C+        F++M +G L + L SH     +L              + L +   V + +
Sbjct: 83  CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGM 142
Query: 439 EYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK 477
            YL   H     +H DL   + L+ + +V  + DFG+S+
Sbjct: 143 VYLAGLH----FVHRDLATRNCLVGQGLVVKIGDFGMSR 177

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 73/159 (45%), Gaps = 29/159 (18%)
Query: 344 GSFGSVYKGTIS-DG--TDVAIK-IFNLQRERAFRSFNSECEVLRNV-RHQNLIKILSSC 398
           G+FG V K  I  DG   D AIK +     +   R F  E EVL  +  H N+I +L +C
Sbjct: 26  GNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC 85
Query: 399 STPDF-----KFMPNGSL-----EKRLYSHNYFLDIL----------ERLNIMIDVGSTL 438
               +     ++ P+G+L     + R+   +    I           + L+   DV   +
Sbjct: 86  EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGM 145
Query: 439 EYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK 477
           +YL    S    IH DL   +IL+ EN VA ++DFG+S+
Sbjct: 146 DYL----SQKQFIHRDLAARNILVGENYVAKIADFGLSR 180

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/141 (24%), Positives = 69/141 (48%), Gaps = 10/141 (7%)
Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPDF 403
           G FG V+ GT +  T VAIK        +  SF  E ++++ ++H  L+++ +  S    
Sbjct: 20  GQFGEVWMGTWNGNTKVAIKTLK-PGTMSPESFLEEAQIMKKLKHDKLVQLYAVVSEEPI 78
Query: 404 ----KFMPNGSLEKRLYS-HNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPT 458
               ++M  GSL   L       L +   +++   V + + Y+   +     IH DL+  
Sbjct: 79  YIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN----YIHRDLRSA 134
Query: 459 SILLDENMVAHVSDFGISKLL 479
           +IL+   ++  ++DFG+++L+
Sbjct: 135 NILVGNGLICKIADFGLARLI 155

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 73/159 (45%), Gaps = 29/159 (18%)
Query: 344 GSFGSVYKGTIS-DG--TDVAIK-IFNLQRERAFRSFNSECEVLRNV-RHQNLIKILSSC 398
           G+FG V K  I  DG   D AIK +     +   R F  E EVL  +  H N+I +L +C
Sbjct: 36  GNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC 95
Query: 399 STPDF-----KFMPNGSL-----EKRLYSHNYFLDIL----------ERLNIMIDVGSTL 438
               +     ++ P+G+L     + R+   +    I           + L+   DV   +
Sbjct: 96  EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGM 155
Query: 439 EYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK 477
           +YL    S    IH DL   +IL+ EN VA ++DFG+S+
Sbjct: 156 DYL----SQKQFIHRDLAARNILVGENYVAKIADFGLSR 190

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 67/145 (46%), Gaps = 14/145 (9%)
Query: 344 GSFGSVY-KGTISDGTDVAIKIFNLQ---RERAFRSFNSECEVLRNVRHQNLIKILSSCS 399
           GSF +V     ++   + AIKI   +   +E        E +V+  + H   +K+  +  
Sbjct: 46  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 105
Query: 400 TPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
             +       +  NG L K +     F +   R     ++ S LEYLH       IIH D
Sbjct: 106 DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH----GKGIIHRD 160
Query: 455 LKPTSILLDENMVAHVSDFGISKLL 479
           LKP +ILL+E+M   ++DFG +K+L
Sbjct: 161 LKPENILLNEDMHIQITDFGTAKVL 185

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 67/145 (46%), Gaps = 14/145 (9%)
Query: 344 GSFGSVY-KGTISDGTDVAIKIFNLQ---RERAFRSFNSECEVLRNVRHQNLIKILSSCS 399
           GSF +V     ++   + AIKI   +   +E        E +V+  + H   +K+  +  
Sbjct: 43  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 102
Query: 400 TPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
             +       +  NG L K +     F +   R     ++ S LEYLH       IIH D
Sbjct: 103 DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH----GKGIIHRD 157
Query: 455 LKPTSILLDENMVAHVSDFGISKLL 479
           LKP +ILL+E+M   ++DFG +K+L
Sbjct: 158 LKPENILLNEDMHIQITDFGTAKVL 182

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/112 (24%), Positives = 57/112 (50%), Gaps = 11/112 (9%)
Query: 375 SFNSECEVLRNVRHQNLIKILSSCSTPD-------FKFMPNGSLEKRLYSHNYFLDILER 427
               E E+LRN+ H+N++K    C+           +F+P+GSL++ L  +   +++ ++
Sbjct: 69  DLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQ 128
Query: 428 LNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
           L   + +   ++YL     S   +H DL   ++L++      + DFG++K +
Sbjct: 129 LKYAVQICKGMDYL----GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/159 (24%), Positives = 68/159 (42%), Gaps = 29/159 (18%)
Query: 344 GSFGSVYKGTI------SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSS 397
           G+FG V+           D   VA+K      E A + F  E E+L  ++HQ++++    
Sbjct: 29  GAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGV 88
Query: 398 CSTPD-----FKFMPNGSLEKRLYSHNYFLDIL--------------ERLNIMIDVGSTL 438
           C+        F++M +G L + L SH     +L              + L +   V + +
Sbjct: 89  CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGM 148
Query: 439 EYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK 477
            YL   H     +H DL   + L+ + +V  + DFG+S+
Sbjct: 149 VYLAGLH----FVHRDLATRNCLVGQGLVVKIGDFGMSR 183

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 67/145 (46%), Gaps = 14/145 (9%)
Query: 344 GSFGSVY-KGTISDGTDVAIKIFNLQ---RERAFRSFNSECEVLRNVRHQNLIKILSSCS 399
           GSF +V     ++   + AIKI   +   +E        E +V+  + H   +K+  +  
Sbjct: 44  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 103
Query: 400 TPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
             +       +  NG L K +     F +   R     ++ S LEYLH       IIH D
Sbjct: 104 DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH----GKGIIHRD 158
Query: 455 LKPTSILLDENMVAHVSDFGISKLL 479
           LKP +ILL+E+M   ++DFG +K+L
Sbjct: 159 LKPENILLNEDMHIQITDFGTAKVL 183

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 14/148 (9%)
Query: 343 AGSFGSVYKG-TISDGTDVAIKIFNLQ-RE----RAFRSFNSECEVLRNVRHQNLIKILS 396
           +G+FG+VYKG  I +G  V I +  ++ RE    +A +    E  V+ +V + ++ ++L 
Sbjct: 59  SGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRLLG 118
Query: 397 SCSTPDFKF----MPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
            C T   +     MP G L   +  H   +     LN  + +   + YL        ++H
Sbjct: 119 ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR----LVH 174
Query: 453 CDLKPTSILLDENMVAHVSDFGISKLLG 480
            DL   ++L+       ++DFG++KLLG
Sbjct: 175 RDLAARNVLVKTPQHVKITDFGLAKLLG 202

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 67/145 (46%), Gaps = 14/145 (9%)
Query: 344 GSFGSVY-KGTISDGTDVAIKIFNLQ---RERAFRSFNSECEVLRNVRHQNLIKILSSCS 399
           GSF +V     ++   + AIKI   +   +E        E +V+  + H   +K+  +  
Sbjct: 43  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 102
Query: 400 TPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
             +       +  NG L K +     F +   R     ++ S LEYLH       IIH D
Sbjct: 103 DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH----GKGIIHRD 157
Query: 455 LKPTSILLDENMVAHVSDFGISKLL 479
           LKP +ILL+E+M   ++DFG +K+L
Sbjct: 158 LKPENILLNEDMHIQITDFGTAKVL 182

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 67/145 (46%), Gaps = 14/145 (9%)
Query: 344 GSFGSVY-KGTISDGTDVAIKIFNLQ---RERAFRSFNSECEVLRNVRHQNLIKILSSCS 399
           GSF +V     ++   + AIKI   +   +E        E +V+  + H   +K+  +  
Sbjct: 43  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 102
Query: 400 TPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
             +       +  NG L K +     F +   R     ++ S LEYLH       IIH D
Sbjct: 103 DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH----GKGIIHRD 157
Query: 455 LKPTSILLDENMVAHVSDFGISKLL 479
           LKP +ILL+E+M   ++DFG +K+L
Sbjct: 158 LKPENILLNEDMHIQITDFGTAKVL 182

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/112 (24%), Positives = 57/112 (50%), Gaps = 11/112 (9%)
Query: 375 SFNSECEVLRNVRHQNLIKILSSCSTPD-------FKFMPNGSLEKRLYSHNYFLDILER 427
               E E+LRN+ H+N++K    C+           +F+P+GSL++ L  +   +++ ++
Sbjct: 57  DLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQ 116
Query: 428 LNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
           L   + +   ++YL     S   +H DL   ++L++      + DFG++K +
Sbjct: 117 LKYAVQICKGMDYL----GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 164

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 68/163 (41%), Gaps = 16/163 (9%)
Query: 325 GDIPSTIGALVDLETISL--AGSFGSVYKGTISDGTDV-AIKIF---NLQRERAFRSFNS 378
            ++P     + D + +     G FG+VY         + A+K+     L++E        
Sbjct: 4   AEMPKRKFTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRR 63
Query: 379 ECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMID 433
           E E+  ++RH N++++ +            +F P G L K L  H  F D       M +
Sbjct: 64  EIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRF-DEQRSATFMEE 122
Query: 434 VGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGIS 476
           +   L Y H       +IH D+KP ++L+       ++DFG S
Sbjct: 123 LADALHYCH----ERKVIHRDIKPENLLMGYKGELKIADFGWS 161

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 67/145 (46%), Gaps = 14/145 (9%)
Query: 344 GSFGSVY-KGTISDGTDVAIKIFNLQ---RERAFRSFNSECEVLRNVRHQNLIKILSSCS 399
           GSF +V     ++   + AIKI   +   +E        E +V+  + H   +K+  +  
Sbjct: 43  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 102
Query: 400 TPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
             +       +  NG L K +     F +   R     ++ S LEYLH       IIH D
Sbjct: 103 DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH----GKGIIHRD 157
Query: 455 LKPTSILLDENMVAHVSDFGISKLL 479
           LKP +ILL+E+M   ++DFG +K+L
Sbjct: 158 LKPENILLNEDMHIQITDFGTAKVL 182

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 67/145 (46%), Gaps = 14/145 (9%)
Query: 344 GSFGSVY-KGTISDGTDVAIKIFNLQ---RERAFRSFNSECEVLRNVRHQNLIKILSSCS 399
           GSF +V     ++   + AIKI   +   +E        E +V+  + H   +K+  +  
Sbjct: 44  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 103
Query: 400 TPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
             +       +  NG L K +     F +   R     ++ S LEYLH       IIH D
Sbjct: 104 DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH----GKGIIHRD 158
Query: 455 LKPTSILLDENMVAHVSDFGISKLL 479
           LKP +ILL+E+M   ++DFG +K+L
Sbjct: 159 LKPENILLNEDMHIQITDFGTAKVL 183

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 67/145 (46%), Gaps = 14/145 (9%)
Query: 344 GSFGSVY-KGTISDGTDVAIKIFNLQ---RERAFRSFNSECEVLRNVRHQNLIKILSSCS 399
           GSF +V     ++   + AIKI   +   +E        E +V+  + H   +K+  +  
Sbjct: 41  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 100
Query: 400 TPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
             +       +  NG L K +     F +   R     ++ S LEYLH       IIH D
Sbjct: 101 DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH----GKGIIHRD 155
Query: 455 LKPTSILLDENMVAHVSDFGISKLL 479
           LKP +ILL+E+M   ++DFG +K+L
Sbjct: 156 LKPENILLNEDMHIQITDFGTAKVL 180

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 67/145 (46%), Gaps = 14/145 (9%)
Query: 344 GSFGSVY-KGTISDGTDVAIKIFNLQ---RERAFRSFNSECEVLRNVRHQNLIKILSSCS 399
           GSF +V     ++   + AIKI   +   +E        E +V+  + H   +K+  +  
Sbjct: 41  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 100
Query: 400 TPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
             +       +  NG L K +     F +   R     ++ S LEYLH       IIH D
Sbjct: 101 DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH----GKGIIHRD 155
Query: 455 LKPTSILLDENMVAHVSDFGISKLL 479
           LKP +ILL+E+M   ++DFG +K+L
Sbjct: 156 LKPENILLNEDMHIQITDFGTAKVL 180

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 67/145 (46%), Gaps = 14/145 (9%)
Query: 344 GSFGSVY-KGTISDGTDVAIKIFNLQ---RERAFRSFNSECEVLRNVRHQNLIKILSSCS 399
           GSF +V     ++   + AIKI   +   +E        E +V+  + H   +K+  +  
Sbjct: 43  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 102
Query: 400 TPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
             +       +  NG L K +     F +   R     ++ S LEYLH       IIH D
Sbjct: 103 DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH----GKGIIHRD 157
Query: 455 LKPTSILLDENMVAHVSDFGISKLL 479
           LKP +ILL+E+M   ++DFG +K+L
Sbjct: 158 LKPENILLNEDMHIQITDFGTAKVL 182

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 67/145 (46%), Gaps = 14/145 (9%)
Query: 344 GSFGSVY-KGTISDGTDVAIKIFNLQ---RERAFRSFNSECEVLRNVRHQNLIKILSSCS 399
           GSF +V     ++   + AIKI   +   +E        E +V+  + H   +K+  +  
Sbjct: 41  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 100
Query: 400 TPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
             +       +  NG L K +     F +   R     ++ S LEYLH       IIH D
Sbjct: 101 DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH----GKGIIHRD 155
Query: 455 LKPTSILLDENMVAHVSDFGISKLL 479
           LKP +ILL+E+M   ++DFG +K+L
Sbjct: 156 LKPENILLNEDMHIQITDFGTAKVL 180

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 61/143 (42%), Gaps = 14/143 (9%)
Query: 343 AGSFGSVYKGTISDGTDV-AIKIF---NLQRERAFRSFNSECEVLRNVRHQNLIKILSSC 398
            G FG+VY         + A+K+     L++E        E E+  ++RH N++++ +  
Sbjct: 25  KGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF 84
Query: 399 STPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHC 453
                     +F P G L K L  H  F D       M ++   L Y H       +IH 
Sbjct: 85  HDRKRIYLMLEFAPRGELYKELQKHGRF-DEQRSATFMEELADALHYCH----ERKVIHR 139
Query: 454 DLKPTSILLDENMVAHVSDFGIS 476
           D+KP ++L+       ++DFG S
Sbjct: 140 DIKPENLLMGYKGELKIADFGWS 162

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 67/145 (46%), Gaps = 14/145 (9%)
Query: 344 GSFGS-VYKGTISDGTDVAIKIFNLQ---RERAFRSFNSECEVLRNVRHQNLIKILSSCS 399
           GSF + V    ++   + AIKI   +   +E        E +V+  + H   +K+  +  
Sbjct: 41  GSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 100
Query: 400 TPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
             +       +  NG L K +     F +   R     ++ S LEYLH       IIH D
Sbjct: 101 DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH----GKGIIHRD 155
Query: 455 LKPTSILLDENMVAHVSDFGISKLL 479
           LKP +ILL+E+M   ++DFG +K+L
Sbjct: 156 LKPENILLNEDMHIQITDFGTAKVL 180

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 67/145 (46%), Gaps = 14/145 (9%)
Query: 344 GSFGSVY-KGTISDGTDVAIKIFNLQ---RERAFRSFNSECEVLRNVRHQNLIKILSSCS 399
           GSF +V     ++   + AIKI   +   +E        E +V+  + H   +K+  +  
Sbjct: 43  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 102
Query: 400 TPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
             +       +  NG L K +     F +   R     ++ S LEYLH       IIH D
Sbjct: 103 DDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRF-YTAEIVSALEYLH----GKGIIHRD 157
Query: 455 LKPTSILLDENMVAHVSDFGISKLL 479
           LKP +ILL+E+M   ++DFG +K+L
Sbjct: 158 LKPENILLNEDMHIQITDFGTAKVL 182

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 67/145 (46%), Gaps = 14/145 (9%)
Query: 344 GSFGSVY-KGTISDGTDVAIKIFNLQ---RERAFRSFNSECEVLRNVRHQNLIKILSSCS 399
           GSF +V     ++   + AIKI   +   +E        E +V+  + H   +K+  +  
Sbjct: 40  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 99
Query: 400 TPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
             +       +  NG L K +     F +   R     ++ S LEYLH       IIH D
Sbjct: 100 DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH----GKGIIHRD 154
Query: 455 LKPTSILLDENMVAHVSDFGISKLL 479
           LKP +ILL+E+M   ++DFG +K+L
Sbjct: 155 LKPENILLNEDMHIQITDFGTAKVL 179

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 67/145 (46%), Gaps = 14/145 (9%)
Query: 344 GSFGSVY-KGTISDGTDVAIKIFNLQ---RERAFRSFNSECEVLRNVRHQNLIKILSSCS 399
           GSF +V     ++   + AIKI   +   +E        E +V+  + H   +K+  +  
Sbjct: 40  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 99
Query: 400 TPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
             +       +  NG L K +     F +   R     ++ S LEYLH       IIH D
Sbjct: 100 DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH----GKGIIHRD 154
Query: 455 LKPTSILLDENMVAHVSDFGISKLL 479
           LKP +ILL+E+M   ++DFG +K+L
Sbjct: 155 LKPENILLNEDMHIQITDFGTAKVL 179

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/142 (24%), Positives = 69/142 (48%), Gaps = 10/142 (7%)
Query: 343 AGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           AG FG V+  T +  T VA+K        +  +F +E  V++ ++H  L+K+ +  +   
Sbjct: 25  AGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEP 83
Query: 403 F----KFMPNGSLEKRLYSHNYFLDILERL-NIMIDVGSTLEYLHHGHSSAPIIHCDLKP 457
                +FM  GSL   L S       L +L +    +   + ++   +     IH DL+ 
Sbjct: 84  IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN----YIHRDLRA 139
Query: 458 TSILLDENMVAHVSDFGISKLL 479
            +IL+  ++V  ++DFG+++++
Sbjct: 140 ANILVSASLVCKIADFGLARVI 161

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 67/145 (46%), Gaps = 14/145 (9%)
Query: 344 GSFGSVY-KGTISDGTDVAIKIFNLQ---RERAFRSFNSECEVLRNVRHQNLIKILSSCS 399
           GSF +V     ++   + AIKI   +   +E        E +V+  + H   +K+  +  
Sbjct: 21  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 80
Query: 400 TPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
             +       +  NG L K +     F +   R     ++ S LEYLH       IIH D
Sbjct: 81  DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH----GKGIIHRD 135
Query: 455 LKPTSILLDENMVAHVSDFGISKLL 479
           LKP +ILL+E+M   ++DFG +K+L
Sbjct: 136 LKPENILLNEDMHIQITDFGTAKVL 160

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/143 (22%), Positives = 73/143 (51%), Gaps = 11/143 (7%)
Query: 343 AGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           AG FG V+ G  ++ T VA+K        + ++F  E  +++ ++H  L+++ +  +  +
Sbjct: 23  AGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTREE 81
Query: 403 -----FKFMPNGSLEKRLYSHNYFLDILERL-NIMIDVGSTLEYLHHGHSSAPIIHCDLK 456
                 ++M  GSL   L S      +L +L +    +   + Y+   +     IH DL+
Sbjct: 82  PIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN----YIHRDLR 137
Query: 457 PTSILLDENMVAHVSDFGISKLL 479
             ++L+ E+++  ++DFG+++++
Sbjct: 138 AANVLVSESLMCKIADFGLARVI 160

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 74/163 (45%), Gaps = 22/163 (13%)
Query: 331 IGALVDLETISLAGSFGSVYKGT-ISDGTDVAIKIFN---LQRERAFRSFNSECEVLRNV 386
           IG  +  ET+   GSFG V   T       VA+K  +   L++         E   L+ +
Sbjct: 8   IGPYIIRETLG-EGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL 66
Query: 387 RHQNLIKILSSCSTPDFKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGS--------TL 438
           RH ++IK+    +TP    M        L+ +     I+E+  +  D G          +
Sbjct: 67  RHPHIIKLYDVITTPTDIVMVIEYAGGELFDY-----IVEKKRMTEDEGRRFFQQIICAI 121
Query: 439 EYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
           EY H       I+H DLKP ++LLD+N+   ++DFG+S ++ +
Sbjct: 122 EYCHRHK----IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 74/158 (46%), Gaps = 39/158 (24%)
Query: 344 GSFGSVYKGTISD-GTDVAIKIF------NLQRERAFRSFNSECEVLRNVRHQNLIKILS 396
           GS+G V K    D G  VAIK F       + ++ A R    E ++L+ +RH+NL+ +L 
Sbjct: 36  GSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR----EIKLLKQLRHENLVNLLE 91
Query: 397 SCSTPDFKFMPNGSLEKRLYSHNYFLD--ILERLNIM---IDVGSTLEYLH--------- 442
            C             +KR Y    F+D  IL+ L +    +D     +YL          
Sbjct: 92  VCKK-----------KKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFC 140
Query: 443 HGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG 480
           H H+   IIH D+KP +IL+ ++ V  + DFG ++ L 
Sbjct: 141 HSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLA 175

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 67/145 (46%), Gaps = 14/145 (9%)
Query: 344 GSFGSVY-KGTISDGTDVAIKIFNLQ---RERAFRSFNSECEVLRNVRHQNLIKILSSCS 399
           GSF +V     ++   + AIKI   +   +E        E +V+  + H   +K+  +  
Sbjct: 25  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 84
Query: 400 TPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
             +       +  NG L K +     F +   R     ++ S LEYLH       IIH D
Sbjct: 85  DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH----GKGIIHRD 139
Query: 455 LKPTSILLDENMVAHVSDFGISKLL 479
           LKP +ILL+E+M   ++DFG +K+L
Sbjct: 140 LKPENILLNEDMHIQITDFGTAKVL 164

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/155 (24%), Positives = 79/155 (50%), Gaps = 15/155 (9%)
Query: 335 VDLETISL-----AGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQ 389
           V  ET+ L     AG FG V+ G  +  T VA+K    Q   +  +F +E  +++ ++HQ
Sbjct: 6   VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQ 64
Query: 390 NLIKILSSCSTPDF----KFMPNGSLEKRLYSHNYF-LDILERLNIMIDVGSTLEYLHHG 444
            L+++ +  +        ++M NGSL   L + +   L I + L++   +   + ++   
Sbjct: 65  RLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 124
Query: 445 HSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
           +     IH +L+  +IL+ + +   ++DFG+++L+
Sbjct: 125 N----YIHRNLRAANILVSDTLSCKIADFGLARLI 155

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 67/145 (46%), Gaps = 14/145 (9%)
Query: 344 GSFGSVY-KGTISDGTDVAIKIFNLQ---RERAFRSFNSECEVLRNVRHQNLIKILSSCS 399
           GSF +V     ++   + AIKI   +   +E        E +V+  + H   +K+  +  
Sbjct: 18  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 77
Query: 400 TPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
             +       +  NG L K +     F +   R     ++ S LEYLH       IIH D
Sbjct: 78  DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH----GKGIIHRD 132
Query: 455 LKPTSILLDENMVAHVSDFGISKLL 479
           LKP +ILL+E+M   ++DFG +K+L
Sbjct: 133 LKPENILLNEDMHIQITDFGTAKVL 157

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 67/145 (46%), Gaps = 14/145 (9%)
Query: 344 GSFGSVY-KGTISDGTDVAIKIFNLQ---RERAFRSFNSECEVLRNVRHQNLIKILSSCS 399
           GSF +V     ++   + AIKI   +   +E        E +V+  + H   +K+  +  
Sbjct: 19  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 78
Query: 400 TPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
             +       +  NG L K +     F +   R     ++ S LEYLH       IIH D
Sbjct: 79  DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH----GKGIIHRD 133
Query: 455 LKPTSILLDENMVAHVSDFGISKLL 479
           LKP +ILL+E+M   ++DFG +K+L
Sbjct: 134 LKPENILLNEDMHIQITDFGTAKVL 158

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 67/145 (46%), Gaps = 14/145 (9%)
Query: 344 GSFGSVY-KGTISDGTDVAIKIFNLQ---RERAFRSFNSECEVLRNVRHQNLIKILSSCS 399
           GSF +V     ++   + AIKI   +   +E        E +V+  + H   +K+  +  
Sbjct: 20  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 79
Query: 400 TPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
             +       +  NG L K +     F +   R     ++ S LEYLH       IIH D
Sbjct: 80  DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH----GKGIIHRD 134
Query: 455 LKPTSILLDENMVAHVSDFGISKLL 479
           LKP +ILL+E+M   ++DFG +K+L
Sbjct: 135 LKPENILLNEDMHIQITDFGTAKVL 159

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 37/141 (26%), Positives = 65/141 (46%), Gaps = 11/141 (7%)
Query: 344 GSFGSVYKGTI-SDGTDVAIKIFNLQRERAFRS-FNSECEVLRNVRHQNLIKILSSCSTP 401
           G+FG V+ G + +D T VA+K          ++ F  E  +L+   H N+++++  C+  
Sbjct: 125 GNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK 184
Query: 402 D-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLK 456
                  + +  G     L +    L +   L ++ D  + +EYL     S   IH DL 
Sbjct: 185 QPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL----ESKCCIHRDLA 240
Query: 457 PTSILLDENMVAHVSDFGISK 477
             + L+ E  V  +SDFG+S+
Sbjct: 241 ARNCLVTEKNVLKISDFGMSR 261

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 35/142 (24%), Positives = 69/142 (48%), Gaps = 10/142 (7%)
Query: 343 AGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           AG FG V+  T +  T VA+K        +  +F +E  V++ ++H  L+K+ +  +   
Sbjct: 198 AGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEP 256
Query: 403 F----KFMPNGSLEKRLYSHNYFLDILERL-NIMIDVGSTLEYLHHGHSSAPIIHCDLKP 457
                +FM  GSL   L S       L +L +    +   + ++   +     IH DL+ 
Sbjct: 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN----YIHRDLRA 312
Query: 458 TSILLDENMVAHVSDFGISKLL 479
            +IL+  ++V  ++DFG+++++
Sbjct: 313 ANILVSASLVCKIADFGLARVI 334

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 74/162 (45%), Gaps = 21/162 (12%)
Query: 333 ALVDLETISLAGSFGSVYKGTISDGTDVAIKIFNLQRE----RAFRSFNSECEVLRNVRH 388
           A + LE I   G FG VY+     G +VA+K      +    +   +   E ++   ++H
Sbjct: 7   AELTLEEIIGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65
Query: 389 QNLIKILSSC-STPD----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHH 443
            N+I +   C   P+     +F   G L + L       DIL  +N  + +   + YLH 
Sbjct: 66  PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDIL--VNWAVQIARGMNYLHD 123
Query: 444 GHSSAPIIHCDLKPTSILLDE--------NMVAHVSDFGISK 477
             +  PIIH DLK ++IL+ +        N +  ++DFG+++
Sbjct: 124 -EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 37/141 (26%), Positives = 65/141 (46%), Gaps = 11/141 (7%)
Query: 344 GSFGSVYKGTI-SDGTDVAIKIFNLQRERAFRS-FNSECEVLRNVRHQNLIKILSSCSTP 401
           G+FG V+ G + +D T VA+K          ++ F  E  +L+   H N+++++  C+  
Sbjct: 125 GNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK 184
Query: 402 D-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLK 456
                  + +  G     L +    L +   L ++ D  + +EYL     S   IH DL 
Sbjct: 185 QPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL----ESKCCIHRDLA 240
Query: 457 PTSILLDENMVAHVSDFGISK 477
             + L+ E  V  +SDFG+S+
Sbjct: 241 ARNCLVTEKNVLKISDFGMSR 261

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 65/149 (43%), Gaps = 19/149 (12%)
Query: 344 GSFGSVYKGTIS----DGTDVAIKIFN---LQRERAFRSFNSECEVLRNVRHQNLIKILS 396
           GSFG V +G           VA+K      L +  A   F  E   + ++ H+NLI++  
Sbjct: 23  GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG 82
Query: 397 SCSTPDFKFM----PNGSLEKRLYSH--NYFLDILERLNIMIDVGSTLEYLHHGHSSAPI 450
              TP  K +    P GSL  RL  H  ++ L  L R  + +  G  + YL     S   
Sbjct: 83  VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG--MGYL----ESKRF 136
Query: 451 IHCDLKPTSILLDENMVAHVSDFGISKLL 479
           IH DL   ++LL    +  + DFG+ + L
Sbjct: 137 IHRDLAARNLLLATRDLVKIGDFGLMRAL 165

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 65/149 (43%), Gaps = 19/149 (12%)
Query: 344 GSFGSVYKGTIS----DGTDVAIKIFN---LQRERAFRSFNSECEVLRNVRHQNLIKILS 396
           GSFG V +G           VA+K      L +  A   F  E   + ++ H+NLI++  
Sbjct: 29  GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG 88
Query: 397 SCSTPDFKFM----PNGSLEKRLYSH--NYFLDILERLNIMIDVGSTLEYLHHGHSSAPI 450
              TP  K +    P GSL  RL  H  ++ L  L R  + +  G  + YL     S   
Sbjct: 89  VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG--MGYL----ESKRF 142
Query: 451 IHCDLKPTSILLDENMVAHVSDFGISKLL 479
           IH DL   ++LL    +  + DFG+ + L
Sbjct: 143 IHRDLAARNLLLATRDLVKIGDFGLMRAL 171

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 65/149 (43%), Gaps = 19/149 (12%)
Query: 344 GSFGSVYKGTIS----DGTDVAIKIFN---LQRERAFRSFNSECEVLRNVRHQNLIKILS 396
           GSFG V +G           VA+K      L +  A   F  E   + ++ H+NLI++  
Sbjct: 19  GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG 78
Query: 397 SCSTPDFKFM----PNGSLEKRLYSH--NYFLDILERLNIMIDVGSTLEYLHHGHSSAPI 450
              TP  K +    P GSL  RL  H  ++ L  L R  + +  G  + YL     S   
Sbjct: 79  VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG--MGYL----ESKRF 132
Query: 451 IHCDLKPTSILLDENMVAHVSDFGISKLL 479
           IH DL   ++LL    +  + DFG+ + L
Sbjct: 133 IHRDLAARNLLLATRDLVKIGDFGLMRAL 161

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 65/149 (43%), Gaps = 19/149 (12%)
Query: 344 GSFGSVYKGTIS----DGTDVAIKIFN---LQRERAFRSFNSECEVLRNVRHQNLIKILS 396
           GSFG V +G           VA+K      L +  A   F  E   + ++ H+NLI++  
Sbjct: 29  GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG 88
Query: 397 SCSTPDFKFM----PNGSLEKRLYSH--NYFLDILERLNIMIDVGSTLEYLHHGHSSAPI 450
              TP  K +    P GSL  RL  H  ++ L  L R  + +  G  + YL     S   
Sbjct: 89  VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG--MGYL----ESKRF 142
Query: 451 IHCDLKPTSILLDENMVAHVSDFGISKLL 479
           IH DL   ++LL    +  + DFG+ + L
Sbjct: 143 IHRDLAARNLLLATRDLVKIGDFGLMRAL 171

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 34/145 (23%), Positives = 67/145 (46%), Gaps = 15/145 (10%)
Query: 344 GSFGSVYKGTI--SDGTDVAIKIFNLQRER---AFRSFNSECEVLRNVRHQNLIKILSSC 398
           G FG VY GT+  +DG  +   + +L R         F +E  ++++  H N++ +L  C
Sbjct: 59  GHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC 118
Query: 399 STPD------FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
              +        +M +G L   + +  +   + + +   + V   ++YL    +S   +H
Sbjct: 119 LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL----ASKKFVH 174
Query: 453 CDLKPTSILLDENMVAHVSDFGISK 477
            DL   + +LDE     V+DFG+++
Sbjct: 175 RDLAARNCMLDEKFTVKVADFGLAR 199

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 70/148 (47%), Gaps = 14/148 (9%)
Query: 343 AGSFGSVYKG-TISDGTDVAIKIFNLQ-RE----RAFRSFNSECEVLRNVRHQNLIKILS 396
           +G+FG+VYKG  I +G  V I +   + RE    +A +    E  V+ +V + ++ ++L 
Sbjct: 29  SGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLG 88
Query: 397 SCSTPD----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
            C T       + MP G L   +  H   +     LN  + +   + YL        ++H
Sbjct: 89  ICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR----LVH 144
Query: 453 CDLKPTSILLDENMVAHVSDFGISKLLG 480
            DL   ++L+       ++DFG++KLLG
Sbjct: 145 RDLAARNVLVKTPQHVKITDFGLAKLLG 172

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 34/145 (23%), Positives = 67/145 (46%), Gaps = 15/145 (10%)
Query: 344 GSFGSVYKGTI--SDGTDVAIKIFNLQRER---AFRSFNSECEVLRNVRHQNLIKILSSC 398
           G FG VY GT+  +DG  +   + +L R         F +E  ++++  H N++ +L  C
Sbjct: 60  GHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC 119
Query: 399 STPD------FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
              +        +M +G L   + +  +   + + +   + V   ++YL    +S   +H
Sbjct: 120 LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL----ASKKFVH 175
Query: 453 CDLKPTSILLDENMVAHVSDFGISK 477
            DL   + +LDE     V+DFG+++
Sbjct: 176 RDLAARNCMLDEKFTVKVADFGLAR 200

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 70/148 (47%), Gaps = 14/148 (9%)
Query: 343 AGSFGSVYKG-TISDGTDVAIKIFNLQ-RE----RAFRSFNSECEVLRNVRHQNLIKILS 396
           +G+FG+VYKG  I +G  V I +   + RE    +A +    E  V+ +V + ++ ++L 
Sbjct: 27  SGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLG 86
Query: 397 SCSTPD----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
            C T       + MP G L   +  H   +     LN  + +   + YL        ++H
Sbjct: 87  ICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR----LVH 142
Query: 453 CDLKPTSILLDENMVAHVSDFGISKLLG 480
            DL   ++L+       ++DFG++KLLG
Sbjct: 143 RDLAARNVLVKTPQHVKITDFGLAKLLG 170

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 34/145 (23%), Positives = 67/145 (46%), Gaps = 15/145 (10%)
Query: 344 GSFGSVYKGTI--SDGTDVAIKIFNLQRER---AFRSFNSECEVLRNVRHQNLIKILSSC 398
           G FG VY GT+  +DG  +   + +L R         F +E  ++++  H N++ +L  C
Sbjct: 33  GHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC 92
Query: 399 STPD------FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
              +        +M +G L   + +  +   + + +   + V   ++YL    +S   +H
Sbjct: 93  LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL----ASKKFVH 148
Query: 453 CDLKPTSILLDENMVAHVSDFGISK 477
            DL   + +LDE     V+DFG+++
Sbjct: 149 RDLAARNCMLDEKFTVKVADFGLAR 173

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 70/148 (47%), Gaps = 14/148 (9%)
Query: 343 AGSFGSVYKG-TISDGTDVAIKIFNLQ-RE----RAFRSFNSECEVLRNVRHQNLIKILS 396
           +G+FG+VYKG  I +G  V I +   + RE    +A +    E  V+ +V + ++ ++L 
Sbjct: 28  SGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLG 87
Query: 397 SCSTPD----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
            C T       + MP G L   +  H   +     LN  + +   + YL        ++H
Sbjct: 88  ICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR----LVH 143
Query: 453 CDLKPTSILLDENMVAHVSDFGISKLLG 480
            DL   ++L+       ++DFG++KLLG
Sbjct: 144 RDLAARNVLVKTPQHVKITDFGLAKLLG 171

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 34/145 (23%), Positives = 67/145 (46%), Gaps = 15/145 (10%)
Query: 344 GSFGSVYKGTI--SDGTDVAIKIFNLQRER---AFRSFNSECEVLRNVRHQNLIKILSSC 398
           G FG VY GT+  +DG  +   + +L R         F +E  ++++  H N++ +L  C
Sbjct: 40  GHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC 99
Query: 399 STPD------FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
              +        +M +G L   + +  +   + + +   + V   ++YL    +S   +H
Sbjct: 100 LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL----ASKKFVH 155
Query: 453 CDLKPTSILLDENMVAHVSDFGISK 477
            DL   + +LDE     V+DFG+++
Sbjct: 156 RDLAARNCMLDEKFTVKVADFGLAR 180

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 65/149 (43%), Gaps = 19/149 (12%)
Query: 344 GSFGSVYKGTIS----DGTDVAIKIFN---LQRERAFRSFNSECEVLRNVRHQNLIKILS 396
           GSFG V +G           VA+K      L +  A   F  E   + ++ H+NLI++  
Sbjct: 19  GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG 78
Query: 397 SCSTPDFKFM----PNGSLEKRLYSH--NYFLDILERLNIMIDVGSTLEYLHHGHSSAPI 450
              TP  K +    P GSL  RL  H  ++ L  L R  + +  G  + YL     S   
Sbjct: 79  VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG--MGYL----ESKRF 132
Query: 451 IHCDLKPTSILLDENMVAHVSDFGISKLL 479
           IH DL   ++LL    +  + DFG+ + L
Sbjct: 133 IHRDLAARNLLLATRDLVKIGDFGLMRAL 161

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 65/149 (43%), Gaps = 19/149 (12%)
Query: 344 GSFGSVYKGTIS----DGTDVAIKIFN---LQRERAFRSFNSECEVLRNVRHQNLIKILS 396
           GSFG V +G           VA+K      L +  A   F  E   + ++ H+NLI++  
Sbjct: 23  GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG 82
Query: 397 SCSTPDFKFM----PNGSLEKRLYSH--NYFLDILERLNIMIDVGSTLEYLHHGHSSAPI 450
              TP  K +    P GSL  RL  H  ++ L  L R  + +  G  + YL     S   
Sbjct: 83  VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG--MGYL----ESKRF 136
Query: 451 IHCDLKPTSILLDENMVAHVSDFGISKLL 479
           IH DL   ++LL    +  + DFG+ + L
Sbjct: 137 IHRDLAARNLLLATRDLVKIGDFGLMRAL 165

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 70/148 (47%), Gaps = 14/148 (9%)
Query: 343 AGSFGSVYKG-TISDGTDVAIKIFNLQ-RE----RAFRSFNSECEVLRNVRHQNLIKILS 396
           +G+FG+VYKG  I +G  V I +   + RE    +A +    E  V+ +V + ++ ++L 
Sbjct: 32  SGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLG 91
Query: 397 SCSTPD----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
            C T       + MP G L   +  H   +     LN  + +   + YL        ++H
Sbjct: 92  ICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR----LVH 147
Query: 453 CDLKPTSILLDENMVAHVSDFGISKLLG 480
            DL   ++L+       ++DFG++KLLG
Sbjct: 148 RDLAARNVLVKTPQHVKITDFGLAKLLG 175

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 34/145 (23%), Positives = 67/145 (46%), Gaps = 15/145 (10%)
Query: 344 GSFGSVYKGTI--SDGTDVAIKIFNLQRER---AFRSFNSECEVLRNVRHQNLIKILSSC 398
           G FG VY GT+  +DG  +   + +L R         F +E  ++++  H N++ +L  C
Sbjct: 38  GHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC 97
Query: 399 STPD------FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
              +        +M +G L   + +  +   + + +   + V   ++YL    +S   +H
Sbjct: 98  LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL----ASKKFVH 153
Query: 453 CDLKPTSILLDENMVAHVSDFGISK 477
            DL   + +LDE     V+DFG+++
Sbjct: 154 RDLAARNCMLDEKFTVKVADFGLAR 178

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 70/148 (47%), Gaps = 14/148 (9%)
Query: 343 AGSFGSVYKG-TISDGTDVAIKIFNLQ-RE----RAFRSFNSECEVLRNVRHQNLIKILS 396
           +G+FG+VYKG  I +G  V I +   + RE    +A +    E  V+ +V + ++ ++L 
Sbjct: 26  SGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLG 85
Query: 397 SCSTPD----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
            C T       + MP G L   +  H   +     LN  + +   + YL        ++H
Sbjct: 86  ICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR----LVH 141
Query: 453 CDLKPTSILLDENMVAHVSDFGISKLLG 480
            DL   ++L+       ++DFG++KLLG
Sbjct: 142 RDLAARNVLVKTPQHVKITDFGLAKLLG 169

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 34/145 (23%), Positives = 67/145 (46%), Gaps = 15/145 (10%)
Query: 344 GSFGSVYKGTI--SDGTDVAIKIFNLQRER---AFRSFNSECEVLRNVRHQNLIKILSSC 398
           G FG VY GT+  +DG  +   + +L R         F +E  ++++  H N++ +L  C
Sbjct: 41  GHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC 100
Query: 399 STPD------FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
              +        +M +G L   + +  +   + + +   + V   ++YL    +S   +H
Sbjct: 101 LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL----ASKKFVH 156
Query: 453 CDLKPTSILLDENMVAHVSDFGISK 477
            DL   + +LDE     V+DFG+++
Sbjct: 157 RDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 66/142 (46%), Gaps = 22/142 (15%)
Query: 349 VYKGTISDGTDVAIKIFNLQRER--------AFRSFNSECEVLRNVR-HQNLIKILSSCS 399
           V++ T   G + A+KI  +  ER           +   E  +LR V  H ++I ++ S  
Sbjct: 114 VHRAT---GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE 170
Query: 400 TPDFKF-----MPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
           +  F F     M  G L   L +    L   E  +IM  +   + +LH  +    I+H D
Sbjct: 171 SSSFMFLVFDLMRKGELFDYL-TEKVALSEKETRSIMRSLLEAVSFLHANN----IVHRD 225
Query: 455 LKPTSILLDENMVAHVSDFGIS 476
           LKP +ILLD+NM   +SDFG S
Sbjct: 226 LKPENILLDDNMQIRLSDFGFS 247

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 65/149 (43%), Gaps = 19/149 (12%)
Query: 344 GSFGSVYKGTIS----DGTDVAIKIFN---LQRERAFRSFNSECEVLRNVRHQNLIKILS 396
           GSFG V +G           VA+K      L +  A   F  E   + ++ H+NLI++  
Sbjct: 19  GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG 78
Query: 397 SCSTPDFKFM----PNGSLEKRLYSH--NYFLDILERLNIMIDVGSTLEYLHHGHSSAPI 450
              TP  K +    P GSL  RL  H  ++ L  L R  + +  G  + YL     S   
Sbjct: 79  VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG--MGYL----ESKRF 132
Query: 451 IHCDLKPTSILLDENMVAHVSDFGISKLL 479
           IH DL   ++LL    +  + DFG+ + L
Sbjct: 133 IHRDLAARNLLLATRDLVKIGDFGLMRAL 161

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 70/148 (47%), Gaps = 14/148 (9%)
Query: 343 AGSFGSVYKG-TISDGTDVAIKIFNLQ-RE----RAFRSFNSECEVLRNVRHQNLIKILS 396
           +G+FG+VYKG  I +G  V I +   + RE    +A +    E  V+ +V + ++ ++L 
Sbjct: 26  SGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLG 85
Query: 397 SCSTPD----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
            C T       + MP G L   +  H   +     LN  + +   + YL        ++H
Sbjct: 86  ICLTSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR----LVH 141
Query: 453 CDLKPTSILLDENMVAHVSDFGISKLLG 480
            DL   ++L+       ++DFG++KLLG
Sbjct: 142 RDLAARNVLVKTPQHVKITDFGLAKLLG 169

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 70/148 (47%), Gaps = 14/148 (9%)
Query: 343 AGSFGSVYKG-TISDGTDVAIKIFNLQ-RE----RAFRSFNSECEVLRNVRHQNLIKILS 396
           +G+FG+VYKG  I +G  V I +   + RE    +A +    E  V+ +V + ++ ++L 
Sbjct: 32  SGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLG 91
Query: 397 SCSTPDFKF----MPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
            C T   +     MP G L   +  H   +     LN  + +   + YL        ++H
Sbjct: 92  ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR----LVH 147
Query: 453 CDLKPTSILLDENMVAHVSDFGISKLLG 480
            DL   ++L+       ++DFG++KLLG
Sbjct: 148 RDLAARNVLVKTPQHVKITDFGLAKLLG 175

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 70/148 (47%), Gaps = 14/148 (9%)
Query: 343 AGSFGSVYKG-TISDGTDVAIKIFNLQ-RE----RAFRSFNSECEVLRNVRHQNLIKILS 396
           +G+FG+VYKG  I +G  V I +   + RE    +A +    E  V+ +V + ++ ++L 
Sbjct: 28  SGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLG 87
Query: 397 SCSTPDFKF----MPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
            C T   +     MP G L   +  H   +     LN  + +   + YL        ++H
Sbjct: 88  ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR----LVH 143
Query: 453 CDLKPTSILLDENMVAHVSDFGISKLLG 480
            DL   ++L+       ++DFG++KLLG
Sbjct: 144 RDLAARNVLVKTPQHVKITDFGLAKLLG 171

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 34/145 (23%), Positives = 67/145 (46%), Gaps = 15/145 (10%)
Query: 344 GSFGSVYKGTI--SDGTDVAIKIFNLQRER---AFRSFNSECEVLRNVRHQNLIKILSSC 398
           G FG VY GT+  +DG  +   + +L R         F +E  ++++  H N++ +L  C
Sbjct: 39  GHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC 98
Query: 399 STPD------FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
              +        +M +G L   + +  +   + + +   + V   ++YL    +S   +H
Sbjct: 99  LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL----ASKKFVH 154
Query: 453 CDLKPTSILLDENMVAHVSDFGISK 477
            DL   + +LDE     V+DFG+++
Sbjct: 155 RDLAARNCMLDEKFTVKVADFGLAR 179

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 70/148 (47%), Gaps = 14/148 (9%)
Query: 343 AGSFGSVYKG-TISDGTDVAIKIFNLQ-RE----RAFRSFNSECEVLRNVRHQNLIKILS 396
           +G+FG+VYKG  I +G  V I +   + RE    +A +    E  V+ +V + ++ ++L 
Sbjct: 27  SGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLG 86
Query: 397 SCSTPDFKF----MPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
            C T   +     MP G L   +  H   +     LN  + +   + YL        ++H
Sbjct: 87  ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR----LVH 142
Query: 453 CDLKPTSILLDENMVAHVSDFGISKLLG 480
            DL   ++L+       ++DFG++KLLG
Sbjct: 143 RDLAARNVLVKTPQHVKITDFGLAKLLG 170

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 72/144 (50%), Gaps = 12/144 (8%)
Query: 343 AGSFGSVYKGTISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIK---ILSS 397
            G FG   K T  +  +V + +  L R  E   R+F  E +V+R + H N++K   +L  
Sbjct: 20  KGCFGQAIKVTHRETGEVMV-MKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK 78
Query: 398 CSTPDF--KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDL 455
               +F  +++  G+L   + S +      +R++   D+ S + YLH    S  IIH DL
Sbjct: 79  DKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH----SMNIIHRDL 134
Query: 456 KPTSILLDENMVAHVSDFGISKLL 479
              + L+ EN    V+DFG+++L+
Sbjct: 135 NSHNCLVRENKNVVVADFGLARLM 158

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 70/148 (47%), Gaps = 14/148 (9%)
Query: 343 AGSFGSVYKG-TISDGTDVAIKIFNLQ-RE----RAFRSFNSECEVLRNVRHQNLIKILS 396
           +G+FG+VYKG  I +G  V I +   + RE    +A +    E  V+ +V + ++ ++L 
Sbjct: 28  SGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLG 87
Query: 397 SCSTPDFKF----MPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
            C T   +     MP G L   +  H   +     LN  + +   + YL        ++H
Sbjct: 88  ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR----LVH 143
Query: 453 CDLKPTSILLDENMVAHVSDFGISKLLG 480
            DL   ++L+       ++DFG++KLLG
Sbjct: 144 RDLAARNVLVKTPQHVKITDFGLAKLLG 171

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 70/148 (47%), Gaps = 14/148 (9%)
Query: 343 AGSFGSVYKG-TISDGTDVAIKIFNLQ-RE----RAFRSFNSECEVLRNVRHQNLIKILS 396
           +G+FG+VYKG  I +G  V I +   + RE    +A +    E  V+ +V + ++ ++L 
Sbjct: 32  SGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLG 91
Query: 397 SCSTPDFKF----MPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
            C T   +     MP G L   +  H   +     LN  + +   + YL        ++H
Sbjct: 92  ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR----LVH 147
Query: 453 CDLKPTSILLDENMVAHVSDFGISKLLG 480
            DL   ++L+       ++DFG++KLLG
Sbjct: 148 RDLAARNVLVKTPQHVKITDFGLAKLLG 175

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 78/165 (47%), Gaps = 21/165 (12%)
Query: 327 IPSTIGALVDLETISLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNV 386
           +  T+   + L      G +G V++G+   G +VA+KIF+ + E+   S+  E E+   V
Sbjct: 31  VQRTVARQITLLECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEK---SWFRETELYNTV 86
Query: 387 --RHQNLIKILSSCSTPDFK---------FMPNGSLEKRLYSHNYFLDILERLNIMIDVG 435
             RH+N++  ++S  T             +   GSL    Y     LD +  L I++ + 
Sbjct: 87  MLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYD--YLQLTTLDTVSCLRIVLSIA 144
Query: 436 STLEYLH---HGHSSAPII-HCDLKPTSILLDENMVAHVSDFGIS 476
           S L +LH    G    P I H DLK  +IL+ +N    ++D G++
Sbjct: 145 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA 189

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 34/145 (23%), Positives = 67/145 (46%), Gaps = 15/145 (10%)
Query: 344 GSFGSVYKGTI--SDGTDVAIKIFNLQRER---AFRSFNSECEVLRNVRHQNLIKILSSC 398
           G FG VY GT+  +DG  +   + +L R         F +E  ++++  H N++ +L  C
Sbjct: 41  GHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC 100
Query: 399 STPD------FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
              +        +M +G L   + +  +   + + +   + V   ++YL    +S   +H
Sbjct: 101 LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL----ASKKFVH 156
Query: 453 CDLKPTSILLDENMVAHVSDFGISK 477
            DL   + +LDE     V+DFG+++
Sbjct: 157 RDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 70/148 (47%), Gaps = 14/148 (9%)
Query: 343 AGSFGSVYKG-TISDGTDVAIKIFNLQ-RE----RAFRSFNSECEVLRNVRHQNLIKILS 396
           +G+FG+VYKG  I +G  V I +   + RE    +A +    E  V+ +V + ++ ++L 
Sbjct: 25  SGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLG 84
Query: 397 SCSTPD----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
            C T       + MP G L   +  H   +     LN  + +   + YL        ++H
Sbjct: 85  ICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR----LVH 140
Query: 453 CDLKPTSILLDENMVAHVSDFGISKLLG 480
            DL   ++L+       ++DFG++KLLG
Sbjct: 141 RDLAARNVLVKTPQHVKITDFGLAKLLG 168

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 34/145 (23%), Positives = 67/145 (46%), Gaps = 15/145 (10%)
Query: 344 GSFGSVYKGTI--SDGTDVAIKIFNLQRER---AFRSFNSECEVLRNVRHQNLIKILSSC 398
           G FG VY GT+  +DG  +   + +L R         F +E  ++++  H N++ +L  C
Sbjct: 36  GHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC 95
Query: 399 STPD------FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
              +        +M +G L   + +  +   + + +   + V   ++YL    +S   +H
Sbjct: 96  LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL----ASKKFVH 151
Query: 453 CDLKPTSILLDENMVAHVSDFGISK 477
            DL   + +LDE     V+DFG+++
Sbjct: 152 RDLAARNCMLDEKFTVKVADFGLAR 176

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 34/145 (23%), Positives = 67/145 (46%), Gaps = 15/145 (10%)
Query: 344 GSFGSVYKGTI--SDGTDVAIKIFNLQRER---AFRSFNSECEVLRNVRHQNLIKILSSC 398
           G FG VY GT+  +DG  +   + +L R         F +E  ++++  H N++ +L  C
Sbjct: 40  GHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC 99
Query: 399 STPD------FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
              +        +M +G L   + +  +   + + +   + V   ++YL    +S   +H
Sbjct: 100 LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL----ASKKFVH 155
Query: 453 CDLKPTSILLDENMVAHVSDFGISK 477
            DL   + +LDE     V+DFG+++
Sbjct: 156 RDLAARNCMLDEKFTVKVADFGLAR 180

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 35/141 (24%), Positives = 68/141 (48%), Gaps = 10/141 (7%)
Query: 343 AGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           AG FG V+  T +  T VA+K        +  +F +E  V++ ++H  L+K+ +  +   
Sbjct: 192 AGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEP 250
Query: 403 F----KFMPNGSLEKRLYSHNYFLDILERL-NIMIDVGSTLEYLHHGHSSAPIIHCDLKP 457
                +FM  GSL   L S       L +L +    +   + ++   +     IH DL+ 
Sbjct: 251 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN----YIHRDLRA 306
Query: 458 TSILLDENMVAHVSDFGISKL 478
            +IL+  ++V  ++DFG++++
Sbjct: 307 ANILVSASLVCKIADFGLARV 327

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 70/148 (47%), Gaps = 14/148 (9%)
Query: 343 AGSFGSVYKG-TISDGTDVAIKIFNLQ-RE----RAFRSFNSECEVLRNVRHQNLIKILS 396
           +G+FG+VYKG  I +G  V I +   + RE    +A +    E  V+ +V + ++ ++L 
Sbjct: 28  SGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLG 87
Query: 397 SCSTPDFKF----MPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
            C T   +     MP G L   +  H   +     LN  + +   + YL        ++H
Sbjct: 88  ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR----LVH 143
Query: 453 CDLKPTSILLDENMVAHVSDFGISKLLG 480
            DL   ++L+       ++DFG++KLLG
Sbjct: 144 RDLAARNVLVKTPQHVKITDFGLAKLLG 171

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 70/148 (47%), Gaps = 14/148 (9%)
Query: 343 AGSFGSVYKG-TISDGTDVAIKIFNLQ-RE----RAFRSFNSECEVLRNVRHQNLIKILS 396
           +G+FG+VYKG  I +G  V I +   + RE    +A +    E  V+ +V + ++ ++L 
Sbjct: 25  SGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLG 84
Query: 397 SCSTPDFKF----MPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
            C T   +     MP G L   +  H   +     LN  + +   + YL        ++H
Sbjct: 85  ICLTSTVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR----LVH 140
Query: 453 CDLKPTSILLDENMVAHVSDFGISKLLG 480
            DL   ++L+       ++DFG++KLLG
Sbjct: 141 RDLAARNVLVKTPQHVKITDFGLAKLLG 168

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 70/148 (47%), Gaps = 14/148 (9%)
Query: 343 AGSFGSVYKG-TISDGTDVAIKIFNLQ-RE----RAFRSFNSECEVLRNVRHQNLIKILS 396
           +G+FG+VYKG  I +G  V I +   + RE    +A +    E  V+ +V + ++ ++L 
Sbjct: 31  SGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLG 90
Query: 397 SCSTPDFKF----MPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
            C T   +     MP G L   +  H   +     LN  + +   + YL        ++H
Sbjct: 91  ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR----LVH 146
Query: 453 CDLKPTSILLDENMVAHVSDFGISKLLG 480
            DL   ++L+       ++DFG++KLLG
Sbjct: 147 RDLAARNVLVKTPQHVKITDFGLAKLLG 174

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 70/148 (47%), Gaps = 14/148 (9%)
Query: 343 AGSFGSVYKG-TISDGTDVAIKIFNLQ-RE----RAFRSFNSECEVLRNVRHQNLIKILS 396
           +G+FG+VYKG  I +G  V I +   + RE    +A +    E  V+ +V + ++ ++L 
Sbjct: 25  SGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLG 84
Query: 397 SCSTPDFKF----MPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
            C T   +     MP G L   +  H   +     LN  + +   + YL        ++H
Sbjct: 85  ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR----LVH 140
Query: 453 CDLKPTSILLDENMVAHVSDFGISKLLG 480
            DL   ++L+       ++DFG++KLLG
Sbjct: 141 RDLAARNVLVKTPQHVKITDFGLAKLLG 168

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 70/148 (47%), Gaps = 14/148 (9%)
Query: 343 AGSFGSVYKG-TISDGTDVAIKIFNLQ-RE----RAFRSFNSECEVLRNVRHQNLIKILS 396
           +G+FG+VYKG  I +G  V I +   + RE    +A +    E  V+ +V + ++ ++L 
Sbjct: 25  SGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLG 84
Query: 397 SCSTPDFKF----MPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
            C T   +     MP G L   +  H   +     LN  + +   + YL        ++H
Sbjct: 85  ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR----LVH 140
Query: 453 CDLKPTSILLDENMVAHVSDFGISKLLG 480
            DL   ++L+       ++DFG++KLLG
Sbjct: 141 RDLAARNVLVKTPQHVKITDFGLAKLLG 168

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 70/148 (47%), Gaps = 14/148 (9%)
Query: 343 AGSFGSVYKG-TISDGTDVAIKIFNLQ-RE----RAFRSFNSECEVLRNVRHQNLIKILS 396
           +G+FG+VYKG  I +G  V I +   + RE    +A +    E  V+ +V + ++ ++L 
Sbjct: 22  SGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLG 81
Query: 397 SCSTPDFKF----MPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
            C T   +     MP G L   +  H   +     LN  + +   + YL        ++H
Sbjct: 82  ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMNYLEDRR----LVH 137
Query: 453 CDLKPTSILLDENMVAHVSDFGISKLLG 480
            DL   ++L+       ++DFG++KLLG
Sbjct: 138 RDLAARNVLVKTPQHVKITDFGLAKLLG 165

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 70/148 (47%), Gaps = 14/148 (9%)
Query: 343 AGSFGSVYKG-TISDGTDVAIKIFNLQ-RE----RAFRSFNSECEVLRNVRHQNLIKILS 396
           +G+FG+VYKG  I +G  V I +   + RE    +A +    E  V+ +V + ++ ++L 
Sbjct: 50  SGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLG 109
Query: 397 SCSTPDFKF----MPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
            C T   +     MP G L   +  H   +     LN  + +   + YL        ++H
Sbjct: 110 ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR----LVH 165
Query: 453 CDLKPTSILLDENMVAHVSDFGISKLLG 480
            DL   ++L+       ++DFG++KLLG
Sbjct: 166 RDLAARNVLVKTPQHVKITDFGLAKLLG 193

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 38/155 (24%), Positives = 78/155 (50%), Gaps = 15/155 (9%)
Query: 335 VDLETISL-----AGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQ 389
           V  ET+ L     AG  G V+ G  +  T VA+K    Q   +  +F +E  +++ ++HQ
Sbjct: 10  VPRETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQ 68
Query: 390 NLIKILSSCSTPDF----KFMPNGSLEKRLYSHNYF-LDILERLNIMIDVGSTLEYLHHG 444
            L+++ +  +        ++M NGSL   L + +   L I + L++   +   + ++   
Sbjct: 69  RLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 445 HSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
           +     IH DL+  +IL+ + +   ++DFG+++L+
Sbjct: 129 N----YIHRDLRAANILVSDTLSCKIADFGLARLI 159

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 70/148 (47%), Gaps = 14/148 (9%)
Query: 343 AGSFGSVYKG-TISDGTDVAIKIFNLQ-RE----RAFRSFNSECEVLRNVRHQNLIKILS 396
           +G+FG+VYKG  I +G  V I +   + RE    +A +    E  V+ +V + ++ ++L 
Sbjct: 35  SGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLG 94
Query: 397 SCSTPDFKF----MPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
            C T   +     MP G L   +  H   +     LN  + +   + YL        ++H
Sbjct: 95  ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR----LVH 150
Query: 453 CDLKPTSILLDENMVAHVSDFGISKLLG 480
            DL   ++L+       ++DFG++KLLG
Sbjct: 151 RDLAARNVLVKTPQHVKITDFGLAKLLG 178

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 70/148 (47%), Gaps = 14/148 (9%)
Query: 343 AGSFGSVYKG-TISDGTDVAIKIFNLQ-RE----RAFRSFNSECEVLRNVRHQNLIKILS 396
           +G+FG+VYKG  I +G  V I +   + RE    +A +    E  V+ +V + ++ ++L 
Sbjct: 25  SGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLG 84
Query: 397 SCSTPDFKF----MPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
            C T   +     MP G L   +  H   +     LN  + +   + YL        ++H
Sbjct: 85  ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR----LVH 140
Query: 453 CDLKPTSILLDENMVAHVSDFGISKLLG 480
            DL   ++L+       ++DFG++KLLG
Sbjct: 141 RDLAARNVLVKTPQHVKITDFGLAKLLG 168

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 72/146 (49%), Gaps = 14/146 (9%)
Query: 343 AGSFGSVYKGTISDGTDV-AIKIFNLQR--ER-AFRSFNSECEVLRNVRHQNLIKILSSC 398
            GSFG V     +D   + A+K  N Q+  ER   R+   E ++++ + H  L+ +  S 
Sbjct: 25  KGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF 84
Query: 399 STPDFKFMP-----NGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHC 453
              +  FM       G L   L  + +F +   +L I  ++   L+YL +      IIH 
Sbjct: 85  QDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFI-CELVMALDYLQNQR----IIHR 139
Query: 454 DLKPTSILLDENMVAHVSDFGISKLL 479
           D+KP +ILLDE+   H++DF I+ +L
Sbjct: 140 DMKPDNILLDEHGHVHITDFNIAAML 165

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 73/159 (45%), Gaps = 29/159 (18%)
Query: 344 GSFGSVYKGTIS-DG--TDVAIK-IFNLQRERAFRSFNSECEVLRNV-RHQNLIKILSSC 398
           G+FG V K  I  DG   D AIK +     +   R F  E EVL  +  H N+I +L +C
Sbjct: 33  GNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC 92
Query: 399 STPDF-----KFMPNGSL-----EKRLYSHNYFLDIL----------ERLNIMIDVGSTL 438
               +     ++ P+G+L     + R+   +    I           + L+   DV   +
Sbjct: 93  EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGM 152
Query: 439 EYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK 477
           +YL    S    IH +L   +IL+ EN VA ++DFG+S+
Sbjct: 153 DYL----SQKQFIHRNLAARNILVGENYVAKIADFGLSR 187

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 70/148 (47%), Gaps = 14/148 (9%)
Query: 343 AGSFGSVYKG-TISDGTDVAIKIFNLQ-RE----RAFRSFNSECEVLRNVRHQNLIKILS 396
           +G+FG+VYKG  I +G  V I +   + RE    +A +    E  V+ +V + ++ ++L 
Sbjct: 19  SGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLG 78
Query: 397 SCSTPDFKF----MPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
            C T   +     MP G L   +  H   +     LN  + +   + YL        ++H
Sbjct: 79  ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR----LVH 134
Query: 453 CDLKPTSILLDENMVAHVSDFGISKLLG 480
            DL   ++L+       ++DFG++KLLG
Sbjct: 135 RDLAARNVLVKTPQHVKITDFGLAKLLG 162

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 70/148 (47%), Gaps = 20/148 (13%)
Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRER------AFRSFNSECEVLRNVRHQNLIKIL-- 395
           G++G VYK   S G  VA+K   L  E       A R    E  +L+ + H N++ ++  
Sbjct: 32  GTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR----EISLLKELHHPNIVSLIDV 87
Query: 396 ---SSCSTPDFKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
                C T  F+FM    L+K L  +   L   +   I I +   L  + H H    I+H
Sbjct: 88  IHSERCLTLVFEFM-EKDLKKVLDENKTGL---QDSQIKIYLYQLLRGVAHCHQHR-ILH 142
Query: 453 CDLKPTSILLDENMVAHVSDFGISKLLG 480
            DLKP ++L++ +    ++DFG+++  G
Sbjct: 143 RDLKPQNLLINSDGALKLADFGLARAFG 170

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 70/148 (47%), Gaps = 20/148 (13%)
Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRER------AFRSFNSECEVLRNVRHQNLIKIL-- 395
           G++G VYK   S G  VA+K   L  E       A R    E  +L+ + H N++ ++  
Sbjct: 32  GTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR----EISLLKELHHPNIVSLIDV 87
Query: 396 ---SSCSTPDFKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
                C T  F+FM    L+K L  +   L   +   I I +   L  + H H    I+H
Sbjct: 88  IHSERCLTLVFEFM-EKDLKKVLDENKTGL---QDSQIKIYLYQLLRGVAHCHQHR-ILH 142
Query: 453 CDLKPTSILLDENMVAHVSDFGISKLLG 480
            DLKP ++L++ +    ++DFG+++  G
Sbjct: 143 RDLKPQNLLINSDGALKLADFGLARAFG 170

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 73/148 (49%), Gaps = 21/148 (14%)
Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNV--RHQNLIKILSSCSTP 401
           G +G V++G+   G +VA+KIF+ + E+   S+  E E+   V  RH+N++  ++S  T 
Sbjct: 19  GRYGEVWRGSWQ-GENVAVKIFSSRDEK---SWFRETELYNTVMLRHENILGFIASDMTS 74
Query: 402 DFK---------FMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLH---HGHSSAP 449
                       +   GSL    Y     LD +  L I++ + S L +LH    G    P
Sbjct: 75  RHSSTQLWLITHYHEMGSLYD--YLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP 132
Query: 450 II-HCDLKPTSILLDENMVAHVSDFGIS 476
            I H DLK  +IL+ +N    ++D G++
Sbjct: 133 AIAHRDLKSKNILVKKNGQCCIADLGLA 160

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 73/148 (49%), Gaps = 21/148 (14%)
Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNV--RHQNLIKILSSCSTP 401
           G +G V++G+   G +VA+KIF+ + E+   S+  E E+   V  RH+N++  ++S  T 
Sbjct: 19  GRYGEVWRGSWQ-GENVAVKIFSSRDEK---SWFRETELYNTVMLRHENILGFIASDMTS 74
Query: 402 DFK---------FMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLH---HGHSSAP 449
                       +   GSL    Y     LD +  L I++ + S L +LH    G    P
Sbjct: 75  RHSSTQLWLITHYHEMGSLYD--YLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP 132
Query: 450 II-HCDLKPTSILLDENMVAHVSDFGIS 476
            I H DLK  +IL+ +N    ++D G++
Sbjct: 133 AIAHRDLKSKNILVKKNGQCCIADLGLA 160

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 70/163 (42%), Gaps = 26/163 (15%)
Query: 336 DLETISL--AGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQ--- 389
           D E I++   G+FG V K   + D    AIK      E    +  SE  +L ++ HQ   
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQYVV 65
Query: 390 ----------NLIKILSSCSTP-----DFKFMPNGSLEKRLYSHNYFLDILERLNIMIDV 434
                     N +K +++           ++  NG+L   ++S N      E   +   +
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQI 125
Query: 435 GSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK 477
              L Y+H    S  IIH DLKP +I +DE+    + DFG++K
Sbjct: 126 LEALSYIH----SQGIIHRDLKPMNIFIDESRNVKIGDFGLAK 164

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 21/152 (13%)
Query: 344 GSFGSV----YKGTISDGTD--VAIKIFNLQRERAFRS-FNSECEVLRNVRHQNLIKILS 396
           G FG V    Y  T +DGT   VA+K          RS +  E ++LR + H+++IK   
Sbjct: 25  GHFGKVSLYCYDPT-NDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKG 83
Query: 397 SCSTPDFK-------FMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAP 449
            C     K       ++P GSL   L  H+  + + + L     +   + YLH  H    
Sbjct: 84  CCEDQGEKSLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLHAQH---- 137
Query: 450 IIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
            IH +L   ++LLD + +  + DFG++K + E
Sbjct: 138 YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPE 169

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 21/152 (13%)
Query: 344 GSFGSV----YKGTISDGTD--VAIKIFNLQRERAFRS-FNSECEVLRNVRHQNLIKILS 396
           G FG V    Y  T +DGT   VA+K          RS +  E ++LR + H+++IK   
Sbjct: 25  GHFGKVSLYCYDPT-NDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKG 83
Query: 397 SCSTPDFK-------FMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAP 449
            C     K       ++P GSL   L  H+  + + + L     +   + YLH  H    
Sbjct: 84  CCEDQGEKSLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLHSQH---- 137
Query: 450 IIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
            IH +L   ++LLD + +  + DFG++K + E
Sbjct: 138 YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPE 169

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/145 (22%), Positives = 67/145 (46%), Gaps = 15/145 (10%)
Query: 344 GSFGSVYKGTI--SDGTDVAIKIFNLQRER---AFRSFNSECEVLRNVRHQNLIKILSSC 398
           G FG VY GT+  +DG  +   + +L R         F +E  ++++  H N++ +L  C
Sbjct: 46  GHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC 105
Query: 399 STPD------FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
              +        +M +G L   + +  +   + + +   + V   +++L    +S   +H
Sbjct: 106 LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL----ASKKFVH 161
Query: 453 CDLKPTSILLDENMVAHVSDFGISK 477
            DL   + +LDE     V+DFG+++
Sbjct: 162 RDLAARNCMLDEKFTVKVADFGLAR 186

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/145 (22%), Positives = 67/145 (46%), Gaps = 15/145 (10%)
Query: 344 GSFGSVYKGTI--SDGTDVAIKIFNLQRER---AFRSFNSECEVLRNVRHQNLIKILSSC 398
           G FG VY GT+  +DG  +   + +L R         F +E  ++++  H N++ +L  C
Sbjct: 100 GHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC 159
Query: 399 STPD------FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
              +        +M +G L   + +  +   + + +   + V   +++L    +S   +H
Sbjct: 160 LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL----ASKKFVH 215
Query: 453 CDLKPTSILLDENMVAHVSDFGISK 477
            DL   + +LDE     V+DFG+++
Sbjct: 216 RDLAARNCMLDEKFTVKVADFGLAR 240

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/145 (22%), Positives = 67/145 (46%), Gaps = 15/145 (10%)
Query: 344 GSFGSVYKGTI--SDGTDVAIKIFNLQRER---AFRSFNSECEVLRNVRHQNLIKILSSC 398
           G FG VY GT+  +DG  +   + +L R         F +E  ++++  H N++ +L  C
Sbjct: 42  GHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC 101
Query: 399 STPD------FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
              +        +M +G L   + +  +   + + +   + V   +++L    +S   +H
Sbjct: 102 LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL----ASKKFVH 157
Query: 453 CDLKPTSILLDENMVAHVSDFGISK 477
            DL   + +LDE     V+DFG+++
Sbjct: 158 RDLAARNCMLDEKFTVKVADFGLAR 182

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/145 (22%), Positives = 67/145 (46%), Gaps = 15/145 (10%)
Query: 344 GSFGSVYKGTI--SDGTDVAIKIFNLQRER---AFRSFNSECEVLRNVRHQNLIKILSSC 398
           G FG VY GT+  +DG  +   + +L R         F +E  ++++  H N++ +L  C
Sbjct: 41  GHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC 100
Query: 399 STPD------FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
              +        +M +G L   + +  +   + + +   + V   +++L    +S   +H
Sbjct: 101 LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL----ASKKFVH 156
Query: 453 CDLKPTSILLDENMVAHVSDFGISK 477
            DL   + +LDE     V+DFG+++
Sbjct: 157 RDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 343 AGSFGSVYKG-TISDGTDVAIKIFNLQ-RE----RAFRSFNSECEVLRNVRHQNLIKILS 396
           +G+FG+VYKG  I +G  V I +   + RE    +A +    E  V+ +V + ++ ++L 
Sbjct: 27  SGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLG 86
Query: 397 SCSTPD----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
            C T       + MP G L   +  H   +     LN  + +   + YL        ++H
Sbjct: 87  ICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR----LVH 142
Query: 453 CDLKPTSILLDENMVAHVSDFGISKLLG 480
            DL   ++L+       ++DFG +KLLG
Sbjct: 143 RDLAARNVLVKTPQHVKITDFGRAKLLG 170

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/145 (22%), Positives = 67/145 (46%), Gaps = 15/145 (10%)
Query: 344 GSFGSVYKGTI--SDGTDVAIKIFNLQRER---AFRSFNSECEVLRNVRHQNLIKILSSC 398
           G FG VY GT+  +DG  +   + +L R         F +E  ++++  H N++ +L  C
Sbjct: 42  GHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC 101
Query: 399 STPD------FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
              +        +M +G L   + +  +   + + +   + V   +++L    +S   +H
Sbjct: 102 LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL----ASKKFVH 157
Query: 453 CDLKPTSILLDENMVAHVSDFGISK 477
            DL   + +LDE     V+DFG+++
Sbjct: 158 RDLAARNCMLDEKFTVKVADFGLAR 182

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 343 AGSFGSVYKG-TISDGTDVAIKIFNLQ-RE----RAFRSFNSECEVLRNVRHQNLIKILS 396
           +G+FG+VYKG  I +G  V I +   + RE    +A +    E  V+ +V + ++ ++L 
Sbjct: 27  SGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLG 86
Query: 397 SCSTPD----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
            C T       + MP G L   +  H   +     LN  + +   + YL        ++H
Sbjct: 87  ICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR----LVH 142
Query: 453 CDLKPTSILLDENMVAHVSDFGISKLLG 480
            DL   ++L+       ++DFG +KLLG
Sbjct: 143 RDLAARNVLVKTPQHVKITDFGRAKLLG 170

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/145 (22%), Positives = 67/145 (46%), Gaps = 15/145 (10%)
Query: 344 GSFGSVYKGTI--SDGTDVAIKIFNLQRER---AFRSFNSECEVLRNVRHQNLIKILSSC 398
           G FG VY GT+  +DG  +   + +L R         F +E  ++++  H N++ +L  C
Sbjct: 41  GHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC 100
Query: 399 STPD------FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
              +        +M +G L   + +  +   + + +   + V   +++L    +S   +H
Sbjct: 101 LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL----ASKKFVH 156
Query: 453 CDLKPTSILLDENMVAHVSDFGISK 477
            DL   + +LDE     V+DFG+++
Sbjct: 157 RDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 69/153 (45%), Gaps = 23/153 (15%)
Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRN--VRHQNLIKIL--SSCS 399
           G +G+VYKG++ D   VA+K+F+    +   +F +E  + R   + H N+ + +      
Sbjct: 24  GRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNIYRVPLMEHDNIARFIVGDERV 79
Query: 400 TPD--------FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHH-----GHS 446
           T D         ++ PNGSL K L  H    D +    +   V   L YLH       H 
Sbjct: 80  TADGRMEYLLVMEYYPNGSLXKYLSLHTS--DWVSSCRLAHSVTRGLAYLHTELPRGDHY 137
Query: 447 SAPIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
              I H DL   ++L+  +    +SDFG+S  L
Sbjct: 138 KPAISHRDLNSRNVLVKNDGTCVISDFGLSMRL 170

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 343 AGSFGSVYKG-TISDGTDVAIKIFNLQ-RE----RAFRSFNSECEVLRNVRHQNLIKILS 396
           +G+FG+VYKG  I +G  V I +   + RE    +A +    E  V+ +V + ++ ++L 
Sbjct: 29  SGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLG 88
Query: 397 SCSTPD----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
            C T       + MP G L   +  H   +     LN  + +   + YL        ++H
Sbjct: 89  ICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR----LVH 144
Query: 453 CDLKPTSILLDENMVAHVSDFGISKLLG 480
            DL   ++L+       ++DFG +KLLG
Sbjct: 145 RDLAARNVLVKTPQHVKITDFGRAKLLG 172

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/145 (22%), Positives = 67/145 (46%), Gaps = 15/145 (10%)
Query: 344 GSFGSVYKGTI--SDGTDVAIKIFNLQRER---AFRSFNSECEVLRNVRHQNLIKILSSC 398
           G FG VY GT+  +DG  +   + +L R         F +E  ++++  H N++ +L  C
Sbjct: 39  GHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC 98
Query: 399 STPD------FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
              +        +M +G L   + +  +   + + +   + V   +++L    +S   +H
Sbjct: 99  LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL----ASKKFVH 154
Query: 453 CDLKPTSILLDENMVAHVSDFGISK 477
            DL   + +LDE     V+DFG+++
Sbjct: 155 RDLAARNCMLDEKFTVKVADFGLAR 179

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 343 AGSFGSVYKG-TISDGTDVAIKIFNLQ-RE----RAFRSFNSECEVLRNVRHQNLIKILS 396
           +G+FG+VYKG  I +G  V I +   + RE    +A +    E  V+ +V + ++ ++L 
Sbjct: 32  SGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLG 91
Query: 397 SCSTPDFKF----MPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
            C T   +     MP G L   +  H   +     LN  + +   + YL        ++H
Sbjct: 92  ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR----LVH 147
Query: 453 CDLKPTSILLDENMVAHVSDFGISKLLG 480
            DL   ++L+       ++DFG +KLLG
Sbjct: 148 RDLAARNVLVKTPQHVKITDFGRAKLLG 175

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 343 AGSFGSVYKG-TISDGTDVAIKIFNLQ-RE----RAFRSFNSECEVLRNVRHQNLIKILS 396
           +G+FG+VYKG  I +G  V I +   + RE    +A +    E  V+ +V + ++ ++L 
Sbjct: 27  SGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLG 86
Query: 397 SCSTPDFKF----MPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
            C T   +     MP G L   +  H   +     LN  + +   + YL        ++H
Sbjct: 87  ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR----LVH 142
Query: 453 CDLKPTSILLDENMVAHVSDFGISKLLG 480
            DL   ++L+       ++DFG +KLLG
Sbjct: 143 RDLAARNVLVKTPQHVKITDFGRAKLLG 170

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 343 AGSFGSVYKG-TISDGTDVAIKIFNLQ-RE----RAFRSFNSECEVLRNVRHQNLIKILS 396
           +G+FG+VYKG  I +G  V I +   + RE    +A +    E  V+ +V + ++ ++L 
Sbjct: 25  SGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLG 84
Query: 397 SCSTPDFKF----MPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
            C T   +     MP G L   +  H   +     LN  + +   + YL        ++H
Sbjct: 85  ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR----LVH 140
Query: 453 CDLKPTSILLDENMVAHVSDFGISKLLG 480
            DL   ++L+       ++DFG +KLLG
Sbjct: 141 RDLAARNVLVKTPQHVKITDFGRAKLLG 168

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/130 (26%), Positives = 60/130 (46%), Gaps = 13/130 (10%)
Query: 360 VAIKIFNL---QRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL 411
           VAIK   +   ++E   + F  E      + HQN++ ++      D      +++   +L
Sbjct: 39  VAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTL 98
Query: 412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVS 471
            + + SH   L +   +N        L+ + H H    I+H D+KP +IL+D N    + 
Sbjct: 99  SEYIESHGP-LSVDTAINF---TNQILDGIKHAHD-MRIVHRDIKPQNILIDSNKTLKIF 153
Query: 472 DFGISKLLGE 481
           DFGI+K L E
Sbjct: 154 DFGIAKALSE 163

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 77/155 (49%), Gaps = 25/155 (16%)
Query: 340 ISLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEV--LRNVRHQNLIKILSS 397
           +   G FG V+K  + +   VA+KIF +Q ++   S+ +E EV  L  ++H+N+++ + +
Sbjct: 31  VKARGRFGCVWKAQLLNEY-VAVKIFPIQDKQ---SWQNEYEVYSLPGMKHENILQFIGA 86
Query: 398 ---CSTPDFK------FMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHH----- 443
               ++ D        F   GSL   L ++   +   E  +I   +   L YLH      
Sbjct: 87  EKRGTSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGL 144
Query: 444 --GHSSAPIIHCDLKPTSILLDENMVAHVSDFGIS 476
             GH  A I H D+K  ++LL  N+ A ++DFG++
Sbjct: 145 KDGHKPA-ISHRDIKSKNVLLKNNLTACIADFGLA 178

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/158 (25%), Positives = 71/158 (44%), Gaps = 22/158 (13%)
Query: 331 IGALVDLETISLAGSFGSVYKGT-ISDGTDVAIKIFNLQR------ERAFRSFNSECEVL 383
           IG    L+TI   G+F  V     I  G +VA+KI +  +      ++ FR    E  ++
Sbjct: 6   IGNYRLLKTIG-KGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR----EVRIM 60
Query: 384 RNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTL 438
           + + H N++K+     T        ++   G +   L +H +  +   R      + S +
Sbjct: 61  KVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFR-QIVSAV 119
Query: 439 EYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGIS 476
           +Y H       I+H DLK  ++LLD +M   ++DFG S
Sbjct: 120 QYCHQKF----IVHRDLKAENLLLDADMNIKIADFGFS 153

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 72/165 (43%), Gaps = 22/165 (13%)
Query: 324 SGDIPSTIGALVDLETISLAGSFGSVYKGT-ISDGTDVAIKIFNLQR------ERAFRSF 376
           S D    IG    L+TI   G+F  V     I  G +VA+KI +  +      ++ FR  
Sbjct: 6   SADEQPHIGNYRLLKTIG-KGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-- 62
Query: 377 NSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIM 431
             E  +++ + H N++K+     T        ++   G +   L +H    +   R    
Sbjct: 63  --EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR 120
Query: 432 IDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGIS 476
             + S ++Y H       I+H DLK  ++LLD +M   ++DFG S
Sbjct: 121 -QIVSAVQYCHQKF----IVHRDLKAENLLLDADMNIKIADFGFS 160

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 72/165 (43%), Gaps = 22/165 (13%)
Query: 324 SGDIPSTIGALVDLETISLAGSFGSVYKGT-ISDGTDVAIKIFNLQR------ERAFRSF 376
           S D    IG    L+TI   G+F  V     I  G +VA+KI +  +      ++ FR  
Sbjct: 6   SADEQPHIGNYRLLKTIG-KGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-- 62
Query: 377 NSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIM 431
             E  +++ + H N++K+     T        ++   G +   L +H    +   R    
Sbjct: 63  --EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR 120
Query: 432 IDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGIS 476
             + S ++Y H       I+H DLK  ++LLD +M   ++DFG S
Sbjct: 121 -QIVSAVQYCHQKF----IVHRDLKAENLLLDADMNIKIADFGFS 160

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 72/165 (43%), Gaps = 22/165 (13%)
Query: 324 SGDIPSTIGALVDLETISLAGSFGSVYKGT-ISDGTDVAIKIFNLQR------ERAFRSF 376
           S D    IG    L+TI   G+F  V     I  G +VA+KI +  +      ++ FR  
Sbjct: 6   SADEQPHIGNYRLLKTIG-KGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-- 62
Query: 377 NSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIM 431
             E  +++ + H N++K+     T        ++   G +   L +H    +   R    
Sbjct: 63  --EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR 120
Query: 432 IDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGIS 476
             + S ++Y H       I+H DLK  ++LLD +M   ++DFG S
Sbjct: 121 -QIVSAVQYCHQKF----IVHRDLKAENLLLDADMNIKIADFGFS 160

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 69/152 (45%), Gaps = 21/152 (13%)
Query: 344 GSFGSV----YKGTISDGTD--VAIKIFNLQRERAFRS-FNSECEVLRNVRHQNLIKILS 396
           G FG V    Y  T +DGT   VA+K          RS +  E E+LR + H++++K   
Sbjct: 20  GHFGKVSLYCYDPT-NDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKG 78
Query: 397 SCSTPDFK-------FMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAP 449
            C     K       ++P GSL  R Y   + + + + L     +   + YLH  H    
Sbjct: 79  CCEDQGEKSVQLVMEYVPLGSL--RDYLPRHCVGLAQLLLFAQQICEGMAYLHAQH---- 132
Query: 450 IIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
            IH  L   ++LLD + +  + DFG++K + E
Sbjct: 133 YIHRALAARNVLLDNDRLVKIGDFGLAKAVPE 164

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 69/152 (45%), Gaps = 21/152 (13%)
Query: 344 GSFGSV----YKGTISDGTD--VAIKIFNLQRERAFRS-FNSECEVLRNVRHQNLIKILS 396
           G FG V    Y  T +DGT   VA+K          RS +  E E+LR + H++++K   
Sbjct: 19  GHFGKVSLYCYDPT-NDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKG 77
Query: 397 SCSTPDFK-------FMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAP 449
            C     K       ++P GSL  R Y   + + + + L     +   + YLH  H    
Sbjct: 78  CCEDQGEKSVQLVMEYVPLGSL--RDYLPRHCVGLAQLLLFAQQICEGMAYLHAQH---- 131
Query: 450 IIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
            IH  L   ++LLD + +  + DFG++K + E
Sbjct: 132 YIHRALAARNVLLDNDRLVKIGDFGLAKAVPE 163

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 34/142 (23%), Positives = 65/142 (45%), Gaps = 12/142 (8%)
Query: 344 GSFGSVYK-GTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           G FG V+K    + G  +A KI   +  +      +E  V+  + H NLI++  +  + +
Sbjct: 100 GRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKN 159
Query: 403 -----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKP 457
                 +++  G L  R+   +Y L  L+ +  M  +   + ++H  +    I+H DLKP
Sbjct: 160 DIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY----ILHLDLKP 215
Query: 458 TSILLDENMVAHVS--DFGISK 477
            +IL        +   DFG+++
Sbjct: 216 ENILCVNRDAKQIKIIDFGLAR 237

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 79/171 (46%), Gaps = 27/171 (15%)
Query: 324 SGDIPSTIGALVDLETISLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVL 383
           SG +P   G+L  LE I   G FG V+K  + +   VA+KIF LQ ++   S+ SE E+ 
Sbjct: 9   SGLVPR--GSLQLLE-IKARGRFGCVWKAQLMNDF-VAVKIFPLQDKQ---SWQSEREIF 61
Query: 384 RN--VRHQNLIKILSSCSTPD---------FKFMPNGSLEKRLYSHNYFLDILERLNIMI 432
               ++H+NL++ +++                F   GSL    Y     +   E  ++  
Sbjct: 62  STPGMKHENLLQFIAAEKRGSNLEVELWLITAFHDKGSLTD--YLKGNIITWNELCHVAE 119
Query: 433 DVGSTLEYLHH------GHSSAP-IIHCDLKPTSILLDENMVAHVSDFGIS 476
            +   L YLH       G    P I H D K  ++LL  ++ A ++DFG++
Sbjct: 120 TMSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLA 170

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 74/165 (44%), Gaps = 27/165 (16%)
Query: 330 TIGALVDLETISLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNV--R 387
           T+   V L      G +G V++G +  G  VA+KIF+ + E+   S+  E E+   V  R
Sbjct: 5   TVARQVALVECVGKGRYGEVWRG-LWHGESVAVKIFSSRDEQ---SWFRETEIYNTVLLR 60
Query: 388 HQNLIKILSSCSTPDFKFMPNGSLEKRLYSHNY----FLDILER--------LNIMIDVG 435
           H N++  ++S  T       N S +  L +H +      D L+R        L + +   
Sbjct: 61  HDNILGFIASDMTSR-----NSSTQLWLITHYHEHGSLYDFLQRQTLEPHLALRLAVSAA 115
Query: 436 STLEYLH---HGHSSAPII-HCDLKPTSILLDENMVAHVSDFGIS 476
             L +LH    G    P I H D K  ++L+  N+   ++D G++
Sbjct: 116 CGLAHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLA 160

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/148 (25%), Positives = 70/148 (47%), Gaps = 16/148 (10%)
Query: 343 AGSFGSVYKGT-ISDGTD----VAIKIFNLQRER-AFRSFNSECEVLRNVRHQNLIKILS 396
           +G FG+V+KG  I +G      V IK+   +  R +F++       + ++ H +++++L 
Sbjct: 23  SGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLG 82
Query: 397 SCSTPDFK----FMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLH-HGHSSAPII 451
            C     +    ++P GSL   +  H   L     LN  + +   + YL  HG     ++
Sbjct: 83  LCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG-----MV 137
Query: 452 HCDLKPTSILLDENMVAHVSDFGISKLL 479
           H +L   ++LL       V+DFG++ LL
Sbjct: 138 HRNLAARNVLLKSPSQVQVADFGVADLL 165

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 75/158 (47%), Gaps = 37/158 (23%)
Query: 344 GSFGSVYKGTISD-GTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           GSFG VY+  + D G  VAIK   + + +AF+  N E +++R + H N++++        
Sbjct: 31  GSFGVVYQAKLCDSGELVAIK--KVLQGKAFK--NRELQIMRKLDHCNIVRL-------R 79
Query: 403 FKFMPNGSLEKRLYSH---NYFLDILERLN-----------------IMIDVGSTLEYLH 442
           + F  +G  +  +Y +   +Y  + + R+                   M  +  +L Y+H
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 443 HGHSSAPIIHCDLKPTSILLD-ENMVAHVSDFGISKLL 479
               S  I H D+KP ++LLD +  V  + DFG +K L
Sbjct: 140 ----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 72/165 (43%), Gaps = 22/165 (13%)
Query: 324 SGDIPSTIGALVDLETISLAGSFGSVYKGT-ISDGTDVAIKIFNLQR------ERAFRSF 376
           S D    IG    L+TI   G+F  V     I  G +VA++I +  +      ++ FR  
Sbjct: 6   SADEQPHIGNYRLLKTIG-KGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR-- 62
Query: 377 NSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIM 431
             E  +++ + H N++K+     T        ++   G +   L +H    +   R    
Sbjct: 63  --EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR 120
Query: 432 IDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGIS 476
             + S ++Y H       I+H DLK  ++LLD +M   ++DFG S
Sbjct: 121 -QIVSAVQYCHQKF----IVHRDLKAENLLLDADMNIKIADFGFS 160

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 75/158 (47%), Gaps = 37/158 (23%)
Query: 344 GSFGSVYKGTISD-GTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           GSFG VY+  + D G  VAIK   + + +AF+  N E +++R + H N++++        
Sbjct: 31  GSFGVVYQAKLCDSGELVAIK--KVLQGKAFK--NRELQIMRKLDHCNIVRL-------R 79
Query: 403 FKFMPNGSLEKRLYSH---NYFLDILERLN-----------------IMIDVGSTLEYLH 442
           + F  +G  +  +Y +   +Y  + + R+                   M  +  +L Y+H
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 443 HGHSSAPIIHCDLKPTSILLD-ENMVAHVSDFGISKLL 479
               S  I H D+KP ++LLD +  V  + DFG +K L
Sbjct: 140 ----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 72/165 (43%), Gaps = 22/165 (13%)
Query: 324 SGDIPSTIGALVDLETISLAGSFGSVYKGT-ISDGTDVAIKIFNLQR------ERAFRSF 376
           S D    IG    L+TI   G+F  V     I  G +VA++I +  +      ++ FR  
Sbjct: 6   SADEQPHIGNYRLLKTIG-KGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR-- 62
Query: 377 NSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIM 431
             E  +++ + H N++K+     T        ++   G +   L +H    +   R    
Sbjct: 63  --EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR 120
Query: 432 IDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGIS 476
             + S ++Y H       I+H DLK  ++LLD +M   ++DFG S
Sbjct: 121 -QIVSAVQYCHQKF----IVHRDLKAENLLLDADMNIKIADFGFS 160

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/148 (25%), Positives = 70/148 (47%), Gaps = 16/148 (10%)
Query: 343 AGSFGSVYKGT-ISDGTD----VAIKIFNLQRER-AFRSFNSECEVLRNVRHQNLIKILS 396
           +G FG+V+KG  I +G      V IK+   +  R +F++       + ++ H +++++L 
Sbjct: 41  SGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLG 100
Query: 397 SCSTPDFK----FMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLH-HGHSSAPII 451
            C     +    ++P GSL   +  H   L     LN  + +   + YL  HG     ++
Sbjct: 101 LCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG-----MV 155
Query: 452 HCDLKPTSILLDENMVAHVSDFGISKLL 479
           H +L   ++LL       V+DFG++ LL
Sbjct: 156 HRNLAARNVLLKSPSQVQVADFGVADLL 183

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 77/169 (45%), Gaps = 25/169 (14%)
Query: 318 LSRNQLSGDIPSTIGALVDLETISLAGSFGSVYKGTISDGTDVAI-KIFNLQRERAFRSF 376
           ++R+    D    IG L D       G+FG VYK    + + +A  K+ + + E     +
Sbjct: 29  VTRDLNPEDFWEIIGELGD-------GAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY 81
Query: 377 NSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRLYSHNYFLDILER---- 427
             E ++L +  H N++K+L +    +      +F   G+++  +         LER    
Sbjct: 82  MVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE-------LERPLTE 134
Query: 428 LNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGIS 476
             I +    TL+ L++ H +  IIH DLK  +IL   +    ++DFG+S
Sbjct: 135 SQIQVVCKQTLDALNYLHDNK-IIHRDLKAGNILFTLDGDIKLADFGVS 182

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 77/169 (45%), Gaps = 25/169 (14%)
Query: 318 LSRNQLSGDIPSTIGALVDLETISLAGSFGSVYKGTISDGTDVAI-KIFNLQRERAFRSF 376
           ++R+    D    IG L D       G+FG VYK    + + +A  K+ + + E     +
Sbjct: 29  VTRDLNPEDFWEIIGELGD-------GAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY 81
Query: 377 NSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRLYSHNYFLDILER---- 427
             E ++L +  H N++K+L +    +      +F   G+++  +         LER    
Sbjct: 82  MVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE-------LERPLTE 134
Query: 428 LNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGIS 476
             I +    TL+ L++ H +  IIH DLK  +IL   +    ++DFG+S
Sbjct: 135 SQIQVVCKQTLDALNYLHDNK-IIHRDLKAGNILFTLDGDIKLADFGVS 182

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 75/158 (47%), Gaps = 37/158 (23%)
Query: 344 GSFGSVYKGTISD-GTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           GSFG VY+  + D G  VAIK   + +++ F+  N E +++R + H N++++        
Sbjct: 36  GSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVRL-------R 84
Query: 403 FKFMPNGSLEKRLYSH---NYFLDILERLN-----------------IMIDVGSTLEYLH 442
           + F  +G  +  +Y +   +Y  + + R+                   M  +  +L Y+H
Sbjct: 85  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 144
Query: 443 HGHSSAPIIHCDLKPTSILLD-ENMVAHVSDFGISKLL 479
               S  I H D+KP ++LLD +  V  + DFG +K L
Sbjct: 145 ----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 178

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 68/147 (46%), Gaps = 14/147 (9%)
Query: 343 AGSFGSVYKGT-ISDGTDVAIKI-FNLQRE----RAFRSFNSECEVLRNVRHQNLIKILS 396
           +G+FG+VYKG  I DG +V I +   + RE    +A +    E  V+  V    + ++L 
Sbjct: 27  SGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRLLG 86
Query: 397 SCSTPDFKF----MPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
            C T   +     MP G L   +  +   L   + LN  + +   + YL        ++H
Sbjct: 87  ICLTSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLE----DVRLVH 142
Query: 453 CDLKPTSILLDENMVAHVSDFGISKLL 479
            DL   ++L+       ++DFG+++LL
Sbjct: 143 RDLAARNVLVKSPNHVKITDFGLARLL 169

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 69/163 (42%), Gaps = 26/163 (15%)
Query: 336 DLETISL--AGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQ--- 389
           D E I++   G+FG V K   + D    AIK      E    +  SE  +L ++ HQ   
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQYVV 65
Query: 390 ----------NLIKILSSCSTP-----DFKFMPNGSLEKRLYSHNYFLDILERLNIMIDV 434
                     N +K +++           ++  N +L   ++S N      E   +   +
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQI 125
Query: 435 GSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK 477
              L Y+H    S  IIH DLKP +I +DE+    + DFG++K
Sbjct: 126 LEALSYIH----SQGIIHRDLKPMNIFIDESRNVKIGDFGLAK 164

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 75/158 (47%), Gaps = 37/158 (23%)
Query: 344 GSFGSVYKGTISD-GTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           GSFG VY+  + D G  VAIK   + +++ F+  N E +++R + H N++++        
Sbjct: 110 GSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVRL-------R 158
Query: 403 FKFMPNGSLEKRLYSH---NYFLDILERLN-----------------IMIDVGSTLEYLH 442
           + F  +G  +  +Y +   +Y  + + R+                   M  +  +L Y+H
Sbjct: 159 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 218
Query: 443 HGHSSAPIIHCDLKPTSILLD-ENMVAHVSDFGISKLL 479
               S  I H D+KP ++LLD +  V  + DFG +K L
Sbjct: 219 ----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 252

>pdb|2Z62|A Chain A, Crystal Structure Of The Tv3 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 276

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 76/174 (43%), Gaps = 22/174 (12%)
Query: 61  LPNIKY--LELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLL 118
           +PNI Y  +EL    +   +P S  N      LDL FN        +F +   L VL L 
Sbjct: 7   VPNITYQCMELNFYKIPDNLPFSTKN------LDLSFNPLRHLGSYSFFSFPELQVLDLS 60
Query: 119 MNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFS--TSLQRFSASE 176
              + T    AYQ     SL+   +L  LIL+GNP+  +   ++G FS  +SLQ+  A E
Sbjct: 61  RCEIQTIEDGAYQ-----SLS---HLSTLILTGNPIQSL---ALGAFSGLSSLQKLVAVE 109
Query: 177 CKLKGTIPKEIGHLRGLIYLSLGFNDLNG-TIPTSIGTLKQLQGFFLPETNLQG 229
             L       IGHL+ L  L++  N +    +P     L  L+   L    +Q 
Sbjct: 110 TNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS 163

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 77/169 (45%), Gaps = 25/169 (14%)
Query: 318 LSRNQLSGDIPSTIGALVDLETISLAGSFGSVYKGTISDGTDVAI-KIFNLQRERAFRSF 376
           ++R+    D    IG L D       G+FG VYK    + + +A  K+ + + E     +
Sbjct: 29  VTRDLNPEDFWEIIGELGD-------GAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY 81
Query: 377 NSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRLYSHNYFLDILER---- 427
             E ++L +  H N++K+L +    +      +F   G+++  +         LER    
Sbjct: 82  MVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE-------LERPLTE 134
Query: 428 LNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGIS 476
             I +    TL+ L++ H +  IIH DLK  +IL   +    ++DFG+S
Sbjct: 135 SQIQVVCKQTLDALNYLHDNK-IIHRDLKAGNILFTLDGDIKLADFGVS 182

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/115 (26%), Positives = 57/115 (49%), Gaps = 13/115 (11%)
Query: 375 SFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLN 429
           S  +E  VLR ++H+N++ +     +P+      + +  G L  R+    ++ +  +   
Sbjct: 66  SIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTE-KDAST 124
Query: 430 IMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILL---DENMVAHVSDFGISKLLGE 481
           ++  V   + YLH       I+H DLKP ++L    DE     +SDFG+SK+ G+
Sbjct: 125 LIRQVLDAVYYLHR----MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGK 175

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 72/166 (43%), Gaps = 22/166 (13%)
Query: 323 LSGDIPSTIGALVDLETISLAGSFGSVYKGT-ISDGTDVAIKIFNLQR------ERAFRS 375
           +  D    IG    L+TI   G+F  V     I  G +VAIKI +  +      ++ FR 
Sbjct: 3   MGSDEQPHIGNYRLLKTIG-KGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR- 60
Query: 376 FNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNI 430
              E  +++ + H N++K+     T        ++   G +   L +H    +   R   
Sbjct: 61  ---EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKF 117
Query: 431 MIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGIS 476
              + S ++Y H       I+H DLK  ++LLD +M   ++DFG S
Sbjct: 118 R-QIVSAVQYCHQKR----IVHRDLKAENLLLDADMNIKIADFGFS 158

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 73/151 (48%), Gaps = 23/151 (15%)
Query: 344 GSFGSVYKGTISD-GTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKI----LSSC 398
           GSFG VY+  + D G  VAIK   + +++ F+  N E +++R + H N++++     SS 
Sbjct: 35  GSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVRLRYFFYSSG 90
Query: 399 STPD-------FKFMPNGSLE-KRLYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAP 449
              D         ++P       R YS     L ++     M  +  +L Y+H    S  
Sbjct: 91  EKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH----SFG 146
Query: 450 IIHCDLKPTSILLD-ENMVAHVSDFGISKLL 479
           I H D+KP ++LLD +  V  + DFG +K L
Sbjct: 147 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 177

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 75/158 (47%), Gaps = 37/158 (23%)
Query: 344 GSFGSVYKGTISD-GTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           GSFG VY+  + D G  VAIK   + +++ F+  N E +++R + H N++++        
Sbjct: 59  GSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVRLR------- 107
Query: 403 FKFMPNGSLEKRLYSH---NYFLDILERLN-----------------IMIDVGSTLEYLH 442
           + F  +G  +  +Y +   +Y  + + R+                   M  +  +L Y+H
Sbjct: 108 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 167
Query: 443 HGHSSAPIIHCDLKPTSILLD-ENMVAHVSDFGISKLL 479
               S  I H D+KP ++LLD +  V  + DFG +K L
Sbjct: 168 ----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 201

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 73/151 (48%), Gaps = 23/151 (15%)
Query: 344 GSFGSVYKGTISD-GTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKI----LSSC 398
           GSFG VY+  + D G  VAIK   + + +AF+  N E +++R + H N++++     SS 
Sbjct: 31  GSFGVVYQAKLCDSGELVAIK--KVLQGKAFK--NRELQIMRKLDHCNIVRLRYFFYSSG 86
Query: 399 STPD-------FKFMPNGSLE-KRLYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAP 449
              D         ++P       R YS     L ++     M  +  +L Y+H    S  
Sbjct: 87  EKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH----SFG 142
Query: 450 IIHCDLKPTSILLD-ENMVAHVSDFGISKLL 479
           I H D+KP ++LLD +  V  + DFG +K L
Sbjct: 143 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 73/151 (48%), Gaps = 23/151 (15%)
Query: 344 GSFGSVYKGTISD-GTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKI----LSSC 398
           GSFG VY+  + D G  VAIK   + +++ F+  N E +++R + H N++++     SS 
Sbjct: 32  GSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVRLRYFFYSSG 87
Query: 399 STPD-------FKFMPNGSLE-KRLYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAP 449
              D         ++P       R YS     L ++     M  +  +L Y+H    S  
Sbjct: 88  EKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH----SFG 143
Query: 450 IIHCDLKPTSILLD-ENMVAHVSDFGISKLL 479
           I H D+KP ++LLD +  V  + DFG +K L
Sbjct: 144 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 174

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 73/151 (48%), Gaps = 23/151 (15%)
Query: 344 GSFGSVYKGTISD-GTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKI----LSSC 398
           GSFG VY+  + D G  VAIK   + +++ F+  N E +++R + H N++++     SS 
Sbjct: 31  GSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVRLRYFFYSSG 86
Query: 399 STPD-------FKFMPNGSLE-KRLYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAP 449
              D         ++P       R YS     L ++     M  +  +L Y+H    S  
Sbjct: 87  EKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH----SFG 142
Query: 450 IIHCDLKPTSILLD-ENMVAHVSDFGISKLL 479
           I H D+KP ++LLD +  V  + DFG +K L
Sbjct: 143 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 73/151 (48%), Gaps = 23/151 (15%)
Query: 344 GSFGSVYKGTISD-GTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKI----LSSC 398
           GSFG VY+  + D G  VAIK   + +++ F+  N E +++R + H N++++     SS 
Sbjct: 31  GSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVRLRYFFYSSG 86
Query: 399 STPD-------FKFMPNGSLE-KRLYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAP 449
              D         ++P       R YS     L ++     M  +  +L Y+H    S  
Sbjct: 87  EKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH----SFG 142
Query: 450 IIHCDLKPTSILLD-ENMVAHVSDFGISKLL 479
           I H D+KP ++LLD +  V  + DFG +K L
Sbjct: 143 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 75/158 (47%), Gaps = 37/158 (23%)
Query: 344 GSFGSVYKGTISD-GTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           GSFG VY+  + D G  VAIK   + +++ F+  N E +++R + H N++++        
Sbjct: 44  GSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVRL-------R 92
Query: 403 FKFMPNGSLEKRLYSH---NYFLDILERLN-----------------IMIDVGSTLEYLH 442
           + F  +G  +  +Y +   +Y  + + R+                   M  +  +L Y+H
Sbjct: 93  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 152
Query: 443 HGHSSAPIIHCDLKPTSILLD-ENMVAHVSDFGISKLL 479
               S  I H D+KP ++LLD +  V  + DFG +K L
Sbjct: 153 ----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 186

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 75/158 (47%), Gaps = 37/158 (23%)
Query: 344 GSFGSVYKGTISD-GTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           GSFG VY+  + D G  VAIK   + +++ F+  N E +++R + H N++++        
Sbjct: 69  GSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVRLR------- 117
Query: 403 FKFMPNGSLEKRLYSH---NYFLDILERLN-----------------IMIDVGSTLEYLH 442
           + F  +G  +  +Y +   +Y  + + R+                   M  +  +L Y+H
Sbjct: 118 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 177
Query: 443 HGHSSAPIIHCDLKPTSILLD-ENMVAHVSDFGISKLL 479
               S  I H D+KP ++LLD +  V  + DFG +K L
Sbjct: 178 ----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 211

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 75/158 (47%), Gaps = 37/158 (23%)
Query: 344 GSFGSVYKGTISD-GTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           GSFG VY+  + D G  VAIK   + +++ F+  N E +++R + H N++++        
Sbjct: 65  GSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVRLR------- 113
Query: 403 FKFMPNGSLEKRLYSH---NYFLDILERLN-----------------IMIDVGSTLEYLH 442
           + F  +G  +  +Y +   +Y  + + R+                   M  +  +L Y+H
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 173
Query: 443 HGHSSAPIIHCDLKPTSILLD-ENMVAHVSDFGISKLL 479
               S  I H D+KP ++LLD +  V  + DFG +K L
Sbjct: 174 ----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 73/151 (48%), Gaps = 23/151 (15%)
Query: 344 GSFGSVYKGTISD-GTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKI----LSSC 398
           GSFG VY+  + D G  VAIK   + +++ F+  N E +++R + H N++++     SS 
Sbjct: 31  GSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVRLRYFFYSSG 86
Query: 399 STPD-------FKFMPNGSLE-KRLYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAP 449
              D         ++P       R YS     L ++     M  +  +L Y+H    S  
Sbjct: 87  EKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH----SFG 142
Query: 450 IIHCDLKPTSILLD-ENMVAHVSDFGISKLL 479
           I H D+KP ++LLD +  V  + DFG +K L
Sbjct: 143 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 73/151 (48%), Gaps = 23/151 (15%)
Query: 344 GSFGSVYKGTISD-GTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKI----LSSC 398
           GSFG VY+  + D G  VAIK   + +++ F+  N E +++R + H N++++     SS 
Sbjct: 31  GSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVRLRYFFYSSG 86
Query: 399 STPD-------FKFMPNGSLE-KRLYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAP 449
              D         ++P       R YS     L ++     M  +  +L Y+H    S  
Sbjct: 87  EKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH----SFG 142
Query: 450 IIHCDLKPTSILLD-ENMVAHVSDFGISKLL 479
           I H D+KP ++LLD +  V  + DFG +K L
Sbjct: 143 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 73/144 (50%), Gaps = 9/144 (6%)
Query: 344 GSFGSVYKG-TISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           G++G VY G  +S+   +AIK    +  R  +  + E  + ++++H+N+++ L S S   
Sbjct: 19  GTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG 78
Query: 403 F-----KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKP 457
           F     + +P GSL   L S    L   E+  I       LE L + H +  I+H D+K 
Sbjct: 79  FIKIFMEQVPGGSLSALLRSKWGPLKDNEQ-TIGFYTKQILEGLKYLHDNQ-IVHRDIKG 136
Query: 458 TSILLDE-NMVAHVSDFGISKLLG 480
            ++L++  + V  +SDFG SK L 
Sbjct: 137 DNVLINTYSGVLKISDFGTSKRLA 160

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 75/158 (47%), Gaps = 37/158 (23%)
Query: 344 GSFGSVYKGTISD-GTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           GSFG VY+  + D G  VAIK   + +++ F+  N E +++R + H N++++        
Sbjct: 65  GSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVRLR------- 113
Query: 403 FKFMPNGSLEKRLYSH---NYFLDILERLN-----------------IMIDVGSTLEYLH 442
           + F  +G  +  +Y +   +Y  + + R+                   M  +  +L Y+H
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 173
Query: 443 HGHSSAPIIHCDLKPTSILLD-ENMVAHVSDFGISKLL 479
               S  I H D+KP ++LLD +  V  + DFG +K L
Sbjct: 174 ----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 75/158 (47%), Gaps = 37/158 (23%)
Query: 344 GSFGSVYKGTISD-GTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           GSFG VY+  + D G  VAIK   + +++ F+  N E +++R + H N++++        
Sbjct: 43  GSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVRL-------R 91
Query: 403 FKFMPNGSLEKRLYSH---NYFLDILERLN-----------------IMIDVGSTLEYLH 442
           + F  +G  +  +Y +   +Y  + + R+                   M  +  +L Y+H
Sbjct: 92  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 151
Query: 443 HGHSSAPIIHCDLKPTSILLD-ENMVAHVSDFGISKLL 479
               S  I H D+KP ++LLD +  V  + DFG +K L
Sbjct: 152 ----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 185

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 75/158 (47%), Gaps = 37/158 (23%)
Query: 344 GSFGSVYKGTISD-GTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           GSFG VY+  + D G  VAIK   + +++ F+  N E +++R + H N++++        
Sbjct: 67  GSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVRLR------- 115
Query: 403 FKFMPNGSLEKRLYSH---NYFLDILERLN-----------------IMIDVGSTLEYLH 442
           + F  +G  +  +Y +   +Y  + + R+                   M  +  +L Y+H
Sbjct: 116 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 175
Query: 443 HGHSSAPIIHCDLKPTSILLD-ENMVAHVSDFGISKLL 479
               S  I H D+KP ++LLD +  V  + DFG +K L
Sbjct: 176 ----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 209

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 73/151 (48%), Gaps = 23/151 (15%)
Query: 344 GSFGSVYKGTISD-GTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKI----LSSC 398
           GSFG VY+  + D G  VAIK   + +++ F+  N E +++R + H N++++     SS 
Sbjct: 43  GSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVRLRYFFYSSG 98
Query: 399 STPD-------FKFMPNGSLE-KRLYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAP 449
              D         ++P       R YS     L ++     M  +  +L Y+H    S  
Sbjct: 99  EKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH----SFG 154
Query: 450 IIHCDLKPTSILLD-ENMVAHVSDFGISKLL 479
           I H D+KP ++LLD +  V  + DFG +K L
Sbjct: 155 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 185

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/142 (26%), Positives = 65/142 (45%), Gaps = 14/142 (9%)
Query: 344 GSFGSVYKGTISDGTDV-AIKI-FNLQRERA--FRSFNSECEVLRNVRHQNLIKILSSCS 399
           G FG+VY         + A+K+ F  Q E+A        E E+  ++RH N++++     
Sbjct: 23  GKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 82
Query: 400 TPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
                    ++ P G++ + L   + F D       + ++ + L Y H    S  +IH D
Sbjct: 83  DATRVYLILEYAPLGTVYRELQKLSRF-DEQRTATYITELANALSYCH----SKRVIHRD 137
Query: 455 LKPTSILLDENMVAHVSDFGIS 476
           +KP ++LL  N    ++DFG S
Sbjct: 138 IKPENLLLGSNGELKIADFGWS 159

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/112 (29%), Positives = 57/112 (50%), Gaps = 12/112 (10%)
Query: 377 NSECEVLRNVRHQNLIKILSSCSTPDF----KFMPNGSLEKRLYSHNYFLDILERLNIMI 432
            +E E+L+ + H  +IKI +     D+    + M  G L  ++  +    +   +L    
Sbjct: 62  ETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL-YFY 120
Query: 433 DVGSTLEYLHHGHSSAPIIHCDLKPTSILL---DENMVAHVSDFGISKLLGE 481
            +   ++YLH       IIH DLKP ++LL   +E+ +  ++DFG SK+LGE
Sbjct: 121 QMLLAVQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 168

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/151 (25%), Positives = 73/151 (48%), Gaps = 21/151 (13%)
Query: 344 GSFGSVYKG-TISDGTDVAIKIFNLQRERAFRSFN-SECEVLRNVRHQNLIKILSSCSTP 401
           G++ +VYKG   + G  VA+K   L  E    S    E  +++ ++H+N++++     T 
Sbjct: 16  GTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTE 75
Query: 402 D-----FKFMPNGSLEKRLYSHNY-------FLDILERLNIMIDVGSTLEYLHHGHSSAP 449
           +     F+FM N  L+K + S           L++++     +  G  L + H       
Sbjct: 76  NKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG--LAFCHENK---- 128
Query: 450 IIHCDLKPTSILLDENMVAHVSDFGISKLLG 480
           I+H DLKP ++L+++     + DFG+++  G
Sbjct: 129 ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 75/158 (47%), Gaps = 37/158 (23%)
Query: 344 GSFGSVYKGTISD-GTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           GSFG VY+  + D G  VAIK   + +++ F+  N E +++R + H N++++        
Sbjct: 39  GSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVRL-------R 87
Query: 403 FKFMPNGSLEKRLYSH---NYFLDILERLN-----------------IMIDVGSTLEYLH 442
           + F  +G  +  +Y +   +Y  + + R+                   M  +  +L Y+H
Sbjct: 88  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 147
Query: 443 HGHSSAPIIHCDLKPTSILLD-ENMVAHVSDFGISKLL 479
               S  I H D+KP ++LLD +  V  + DFG +K L
Sbjct: 148 ----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 181

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/112 (29%), Positives = 57/112 (50%), Gaps = 12/112 (10%)
Query: 377 NSECEVLRNVRHQNLIKILSSCSTPDF----KFMPNGSLEKRLYSHNYFLDILERLNIMI 432
            +E E+L+ + H  +IKI +     D+    + M  G L  ++  +    +   +L    
Sbjct: 63  ETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL-YFY 121
Query: 433 DVGSTLEYLHHGHSSAPIIHCDLKPTSILL---DENMVAHVSDFGISKLLGE 481
            +   ++YLH       IIH DLKP ++LL   +E+ +  ++DFG SK+LGE
Sbjct: 122 QMLLAVQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 169

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/112 (29%), Positives = 57/112 (50%), Gaps = 12/112 (10%)
Query: 377 NSECEVLRNVRHQNLIKILSSCSTPDF----KFMPNGSLEKRLYSHNYFLDILERLNIMI 432
            +E E+L+ + H  +IKI +     D+    + M  G L  ++  +    +   +L    
Sbjct: 69  ETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL-YFY 127
Query: 433 DVGSTLEYLHHGHSSAPIIHCDLKPTSILL---DENMVAHVSDFGISKLLGE 481
            +   ++YLH       IIH DLKP ++LL   +E+ +  ++DFG SK+LGE
Sbjct: 128 QMLLAVQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 175

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/112 (29%), Positives = 57/112 (50%), Gaps = 12/112 (10%)
Query: 377 NSECEVLRNVRHQNLIKILSSCSTPDF----KFMPNGSLEKRLYSHNYFLDILERLNIMI 432
            +E E+L+ + H  +IKI +     D+    + M  G L  ++  +    +   +L    
Sbjct: 63  ETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL-YFY 121
Query: 433 DVGSTLEYLHHGHSSAPIIHCDLKPTSILL---DENMVAHVSDFGISKLLGE 481
            +   ++YLH       IIH DLKP ++LL   +E+ +  ++DFG SK+LGE
Sbjct: 122 QMLLAVQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 169

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 75/158 (47%), Gaps = 37/158 (23%)
Query: 344 GSFGSVYKGTISD-GTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           GSFG VY+  + D G  VAIK   + +++ F+  N E +++R + H N++++        
Sbjct: 50  GSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVRL-------R 98
Query: 403 FKFMPNGSLEKRLYSH---NYFLDILERLN-----------------IMIDVGSTLEYLH 442
           + F  +G  +  +Y +   +Y  + + R+                   M  +  +L Y+H
Sbjct: 99  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 158
Query: 443 HGHSSAPIIHCDLKPTSILLD-ENMVAHVSDFGISKLL 479
               S  I H D+KP ++LLD +  V  + DFG +K L
Sbjct: 159 ----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 192

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 71/164 (43%), Gaps = 22/164 (13%)
Query: 325 GDIPSTIGALVDLETISLAGSFGSVYKGT-ISDGTDVAIKIFNLQR------ERAFRSFN 377
            D    IG    L+TI   G+F  V     I  G +VAIKI +  +      ++ FR   
Sbjct: 8   ADEQPHIGNYRLLKTIG-KGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR--- 63
Query: 378 SECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMI 432
            E  +++ + H N++K+     T        ++   G +   L +H    +   R     
Sbjct: 64  -EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR- 121
Query: 433 DVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGIS 476
            + S ++Y H       I+H DLK  ++LLD +M   ++DFG S
Sbjct: 122 QIVSAVQYCHQKR----IVHRDLKAENLLLDADMNIKIADFGFS 161

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/112 (29%), Positives = 57/112 (50%), Gaps = 12/112 (10%)
Query: 377 NSECEVLRNVRHQNLIKILSSCSTPDF----KFMPNGSLEKRLYSHNYFLDILERLNIMI 432
            +E E+L+ + H  +IKI +     D+    + M  G L  ++  +    +   +L    
Sbjct: 63  ETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL-YFY 121
Query: 433 DVGSTLEYLHHGHSSAPIIHCDLKPTSILL---DENMVAHVSDFGISKLLGE 481
            +   ++YLH       IIH DLKP ++LL   +E+ +  ++DFG SK+LGE
Sbjct: 122 QMLLAVQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 169

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/142 (26%), Positives = 65/142 (45%), Gaps = 14/142 (9%)
Query: 344 GSFGSVYKGTISDGTDV-AIKI-FNLQRERA--FRSFNSECEVLRNVRHQNLIKILSSCS 399
           G FG+VY         + A+K+ F  Q E+A        E E+  ++RH N++++     
Sbjct: 23  GKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 82
Query: 400 TPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
                    ++ P G++ + L   + F D       + ++ + L Y H    S  +IH D
Sbjct: 83  DATRVYLILEYAPLGTVYRELQKLSRF-DEQRTATYITELANALSYCH----SKRVIHRD 137
Query: 455 LKPTSILLDENMVAHVSDFGIS 476
           +KP ++LL  N    ++DFG S
Sbjct: 138 IKPENLLLGSNGELKIADFGWS 159

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/112 (29%), Positives = 57/112 (50%), Gaps = 12/112 (10%)
Query: 377 NSECEVLRNVRHQNLIKILSSCSTPDF----KFMPNGSLEKRLYSHNYFLDILERLNIMI 432
            +E E+L+ + H  +IKI +     D+    + M  G L  ++  +    +   +L    
Sbjct: 202 ETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL-YFY 260
Query: 433 DVGSTLEYLHHGHSSAPIIHCDLKPTSILL---DENMVAHVSDFGISKLLGE 481
            +   ++YLH       IIH DLKP ++LL   +E+ +  ++DFG SK+LGE
Sbjct: 261 QMLLAVQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 308

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 73/144 (50%), Gaps = 9/144 (6%)
Query: 344 GSFGSVYKG-TISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           G++G VY G  +S+   +AIK    +  R  +  + E  + ++++H+N+++ L S S   
Sbjct: 33  GTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG 92
Query: 403 F-----KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKP 457
           F     + +P GSL   L S    L   E+  I       LE L + H +  I+H D+K 
Sbjct: 93  FIKIFMEQVPGGSLSALLRSKWGPLKDNEQ-TIGFYTKQILEGLKYLHDNQ-IVHRDIKG 150
Query: 458 TSILLDE-NMVAHVSDFGISKLLG 480
            ++L++  + V  +SDFG SK L 
Sbjct: 151 DNVLINTYSGVLKISDFGTSKRLA 174

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/112 (29%), Positives = 57/112 (50%), Gaps = 12/112 (10%)
Query: 377 NSECEVLRNVRHQNLIKILSSCSTPDF----KFMPNGSLEKRLYSHNYFLDILERLNIMI 432
            +E E+L+ + H  +IKI +     D+    + M  G L  ++  +    +   +L    
Sbjct: 188 ETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL-YFY 246
Query: 433 DVGSTLEYLHHGHSSAPIIHCDLKPTSILL---DENMVAHVSDFGISKLLGE 481
            +   ++YLH       IIH DLKP ++LL   +E+ +  ++DFG SK+LGE
Sbjct: 247 QMLLAVQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 294

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/142 (26%), Positives = 63/142 (44%), Gaps = 14/142 (9%)
Query: 344 GSFGSVYKGTISDGTDV-AIKI-FNLQRERA--FRSFNSECEVLRNVRHQNLIKILSSCS 399
           G FG+VY         + A+K+ F  Q E+A        E E+  ++RH N++++     
Sbjct: 24  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 83
Query: 400 TPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
                    ++ P G + K L   + F D       + ++ + L Y H    S  +IH D
Sbjct: 84  DATRVYLILEYAPRGEVYKELQKLSKF-DEQRTATYITELANALSYCH----SKRVIHRD 138
Query: 455 LKPTSILLDENMVAHVSDFGIS 476
           +KP ++LL       ++DFG S
Sbjct: 139 IKPENLLLGSAGELKIADFGWS 160

>pdb|3UL8|A Chain A, Crystal Structure Of The Tv3 Mutant V134l Length = 279

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 76/174 (43%), Gaps = 22/174 (12%)
Query: 61  LPNIKY--LELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLL 118
           +PNI Y  +EL    +   +P S  N      LDL FN        +F +   L VL L 
Sbjct: 9   VPNITYQCMELNFYKIPDNLPFSTKN------LDLSFNPLRHLGSYSFFSFPELQVLDLS 62
Query: 119 MNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFS--TSLQRFSASE 176
              + T    AYQ     SL+   +L  LIL+GNP+  +   ++G FS  +SLQ+  A E
Sbjct: 63  RCEIQTIEDGAYQ-----SLS---HLSTLILTGNPIQSL---ALGAFSGLSSLQKLVALE 111
Query: 177 CKLKGTIPKEIGHLRGLIYLSLGFNDLNG-TIPTSIGTLKQLQGFFLPETNLQG 229
             L       IGHL+ L  L++  N +    +P     L  L+   L    +Q 
Sbjct: 112 TNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS 165

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 74/165 (44%), Gaps = 24/165 (14%)
Query: 329 STIGALVDLETISLAGSFG-SVYKGTISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRN 385
            ++   V L+ I   GSFG ++   +  DG    IK  N+ R   +       E  VL N
Sbjct: 21  QSMEKYVRLQKIG-EGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLAN 79
Query: 386 VRHQNLIKILSSCSTPDFKFMPNGSLEKRLYSHNYFLDILERLN----IMIDVGSTLEY- 440
           ++H N+++   S       F  NGSL   +  +    D+ +R+N    ++      L++ 
Sbjct: 80  MKHPNIVQYRES-------FEENGSLYI-VMDYCEGGDLFKRINAQKGVLFQEDQILDWF 131
Query: 441 ------LHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
                 L H H    I+H D+K  +I L ++    + DFGI+++L
Sbjct: 132 VQICLALKHVHDRK-ILHRDIKSQNIFLTKDGTVQLGDFGIARVL 175

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 67/156 (42%), Gaps = 26/156 (16%)
Query: 344 GSFGSVYKGTI--SDGTDVAIKIFNLQRE----RAFRSFNSECEVLRNVRHQNLIKILSS 397
           G FGSV +  +   DG+ V + +  L+ +         F  E   ++   H ++ K++  
Sbjct: 34  GEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGV 93
Query: 398 CSTPDFK-----------FMPNGSLEK-----RLYSHNYFLDILERLNIMIDVGSTLEYL 441
                 K           FM +G L       R+  + + L +   +  M+D+   +EYL
Sbjct: 94  SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYL 153
Query: 442 HHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK 477
               SS   IH DL   + +L E+M   V+DFG+S+
Sbjct: 154 ----SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185

>pdb|4G8A|A Chain A, Crystal Structure Of Human Tlr4 Polymorphic Variant D299g And T399i In Complex With Md-2 And Lps Length = 635

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 78/172 (45%), Gaps = 18/172 (10%)
Query: 61  LPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMN 120
           +PNI Y  +  N     IP+++  +TK   LDL FN        +F +   L VL L   
Sbjct: 31  VPNITYQCMELN--FYKIPDNLPFSTK--NLDLSFNPLRHLGSYSFFSFPELQVLDLSRC 86
Query: 121 NLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFS--TSLQRFSASECK 178
            + T    AYQ     SL+   +L  LIL+GNP+  +   ++G FS  +SLQ+  A E  
Sbjct: 87  EIQTIEDGAYQ-----SLS---HLSTLILTGNPIQSL---ALGAFSGLSSLQKLVAVETN 135
Query: 179 LKGTIPKEIGHLRGLIYLSLGFNDLNG-TIPTSIGTLKQLQGFFLPETNLQG 229
           L       IGHL+ L  L++  N +    +P     L  L+   L    +Q 
Sbjct: 136 LASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS 187

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 62/140 (44%), Gaps = 12/140 (8%)
Query: 344 GSFGSVYKGTISD-GTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           G+FG VYK    + G   A K+   + E     +  E E+L    H  ++K+L +     
Sbjct: 22  GAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDG 81
Query: 403 -----FKFMPNGSLEKRLYSHNYFLDI-LERLNIMIDVGSTLEYLHHGHSSAPIIHCDLK 456
                 +F P G+++  +      LD  L    I +     LE L+  HS   IIH DLK
Sbjct: 82  KLWIMIEFCPGGAVDAIMLE----LDRGLTEPQIQVVCRQMLEALNFLHSKR-IIHRDLK 136
Query: 457 PTSILLDENMVAHVSDFGIS 476
             ++L+       ++DFG+S
Sbjct: 137 AGNVLMTLEGDIRLADFGVS 156

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 37/142 (26%), Positives = 63/142 (44%), Gaps = 14/142 (9%)
Query: 344 GSFGSVYKGTISDGTDV-AIKI-FNLQRERA--FRSFNSECEVLRNVRHQNLIKILSSCS 399
           G FG+VY         + A+K+ F  Q E+A        E E+  ++RH N++++     
Sbjct: 24  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 83
Query: 400 TPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
                    ++ P G + K L   + F D       + ++ + L Y H    S  +IH D
Sbjct: 84  DATRVYLILEYAPRGEVYKELQKLSKF-DEQRTATYITELANALSYCH----SKRVIHRD 138
Query: 455 LKPTSILLDENMVAHVSDFGIS 476
           +KP ++LL       ++DFG S
Sbjct: 139 IKPENLLLGSAGELKIADFGWS 160

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/146 (24%), Positives = 63/146 (43%), Gaps = 12/146 (8%)
Query: 343 AGSFGSVYKGTI---SDGTDVAIKIFNLQRERA-FRSFNSECEVLRNVRHQNLIKILSSC 398
            G+FGSV +G         DVAIK+     E+A       E +++  + +  +++++  C
Sbjct: 20  CGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC 79
Query: 399 STPD----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
                    +    G L K L      + +     ++  V   ++YL   +     +H D
Sbjct: 80  QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN----FVHRD 135
Query: 455 LKPTSILLDENMVAHVSDFGISKLLG 480
           L   ++LL     A +SDFG+SK LG
Sbjct: 136 LAARNVLLVNRHYAKISDFGLSKALG 161

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 71/153 (46%), Gaps = 17/153 (11%)
Query: 337 LETISLAGSFGSVYKGTISDGTDVAIKIFNLQRERAF--RSFNSECEVLRNVRHQNLIKI 394
           LE I   G++G VYK   + G   A+K   L++E      +   E  +L+ ++H N++K+
Sbjct: 7   LEKIG-EGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL 65
Query: 395 LSSCSTPDFKFMPNGSLEKRLYSHNYFLDILE-------RLNIMIDVGSTLEYLHHGHSS 447
                T     +    L++ L      LD+ E         + ++ + + + Y H     
Sbjct: 66  YDVIHTKKRLVLVFEHLDQDLKK---LLDVCEGGLESVTAKSFLLQLLNGIAYCH----D 118
Query: 448 APIIHCDLKPTSILLDENMVAHVSDFGISKLLG 480
             ++H DLKP ++L++      ++DFG+++  G
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFG 151

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 71/153 (46%), Gaps = 17/153 (11%)
Query: 337 LETISLAGSFGSVYKGTISDGTDVAIKIFNLQRERAF--RSFNSECEVLRNVRHQNLIKI 394
           LE I   G++G VYK   + G   A+K   L++E      +   E  +L+ ++H N++K+
Sbjct: 7   LEKIG-EGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL 65
Query: 395 LSSCSTPDFKFMPNGSLEKRLYSHNYFLDILE-------RLNIMIDVGSTLEYLHHGHSS 447
                T     +    L++ L      LD+ E         + ++ + + + Y H     
Sbjct: 66  YDVIHTKKRLVLVFEHLDQDLKK---LLDVCEGGLESVTAKSFLLQLLNGIAYCH----D 118
Query: 448 APIIHCDLKPTSILLDENMVAHVSDFGISKLLG 480
             ++H DLKP ++L++      ++DFG+++  G
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFG 151

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 71/153 (46%), Gaps = 17/153 (11%)
Query: 337 LETISLAGSFGSVYKGTISDGTDVAIKIFNLQRERAF--RSFNSECEVLRNVRHQNLIKI 394
           LE I   G++G VYK   + G   A+K   L++E      +   E  +L+ ++H N++K+
Sbjct: 7   LEKIG-EGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL 65
Query: 395 LSSCSTPDFKFMPNGSLEKRLYSHNYFLDILE-------RLNIMIDVGSTLEYLHHGHSS 447
                T     +    L++ L      LD+ E         + ++ + + + Y H     
Sbjct: 66  YDVIHTKKRLVLVFEHLDQDLKK---LLDVCEGGLESVTAKSFLLQLLNGIAYCH----D 118
Query: 448 APIIHCDLKPTSILLDENMVAHVSDFGISKLLG 480
             ++H DLKP ++L++      ++DFG+++  G
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFG 151

>pdb|3FXI|A Chain A, Crystal Structure Of The Human Tlr4-Human Md-2-E.Coli Lps Ra Complex Length = 605

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 78/172 (45%), Gaps = 18/172 (10%)
Query: 61  LPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMN 120
           +PNI Y  +  N     IP+++  +TK   LDL FN        +F +   L VL L   
Sbjct: 7   VPNITYQCMELN--FYKIPDNLPFSTK--NLDLSFNPLRHLGSYSFFSFPELQVLDLSRC 62
Query: 121 NLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFS--TSLQRFSASECK 178
            + T    AYQ     SL+   +L  LIL+GNP+  +   ++G FS  +SLQ+  A E  
Sbjct: 63  EIQTIEDGAYQ-----SLS---HLSTLILTGNPIQSL---ALGAFSGLSSLQKLVAVETN 111
Query: 179 LKGTIPKEIGHLRGLIYLSLGFNDLNG-TIPTSIGTLKQLQGFFLPETNLQG 229
           L       IGHL+ L  L++  N +    +P     L  L+   L    +Q 
Sbjct: 112 LASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS 163

>pdb|2Z63|A Chain A, Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 570

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 78/172 (45%), Gaps = 18/172 (10%)
Query: 61  LPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMN 120
           +PNI Y  +  N     IP+++  +TK   LDL FN        +F +   L VL L   
Sbjct: 7   VPNITYQCMELN--FYKIPDNLPFSTK--NLDLSFNPLRHLGSYSFFSFPELQVLDLSRC 62
Query: 121 NLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFS--TSLQRFSASECK 178
            + T    AYQ     SL+   +L  LIL+GNP+  +   ++G FS  +SLQ+  A E  
Sbjct: 63  EIQTIEDGAYQ-----SLS---HLSTLILTGNPIQSL---ALGAFSGLSSLQKLVAVETN 111
Query: 179 LKGTIPKEIGHLRGLIYLSLGFNDLNG-TIPTSIGTLKQLQGFFLPETNLQG 229
           L       IGHL+ L  L++  N +    +P     L  L+   L    +Q 
Sbjct: 112 LASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS 163

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/148 (25%), Positives = 62/148 (41%), Gaps = 16/148 (10%)
Query: 344 GSFGSV---YKGTISDGTDVAIKIFNLQRE--RAFRSFNSECEVLRNVRHQNLIKILSSC 398
           G+FGSV       + D T   + +  LQ       R F  E ++L+ +    ++K     
Sbjct: 34  GNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVS 93
Query: 399 STPD-------FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPII 451
             P         +++P+G L   L  H   LD    L     +   +EYL     S   +
Sbjct: 94  YGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL----GSRRCV 149
Query: 452 HCDLKPTSILLDENMVAHVSDFGISKLL 479
           H DL   +IL++      ++DFG++KLL
Sbjct: 150 HRDLAARNILVESEAHVKIADFGLAKLL 177

>pdb|3UL9|A Chain A, Structure Of The Tv3 Mutant M41e Length = 278

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 79/172 (45%), Gaps = 18/172 (10%)
Query: 61  LPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMN 120
           +PNI Y +  + N    IP+++  +TK   LDL FN        +F +   L VL L   
Sbjct: 8   VPNITY-QCEELNFY-KIPDNLPFSTK--NLDLSFNPLRHLGSYSFFSFPELQVLDLSRC 63
Query: 121 NLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFS--TSLQRFSASECK 178
            + T    AYQ     SL+   +L  LIL+GNP+  +   ++G FS  +SLQ+  A E  
Sbjct: 64  EIQTIEDGAYQ-----SLS---HLSTLILTGNPIQSL---ALGAFSGLSSLQKLVAVETN 112
Query: 179 LKGTIPKEIGHLRGLIYLSLGFNDLNG-TIPTSIGTLKQLQGFFLPETNLQG 229
           L       IGHL+ L  L++  N +    +P     L  L+   L    +Q 
Sbjct: 113 LASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS 164

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/148 (25%), Positives = 62/148 (41%), Gaps = 16/148 (10%)
Query: 344 GSFGSV---YKGTISDGTDVAIKIFNLQRE--RAFRSFNSECEVLRNVRHQNLIKILSSC 398
           G+FGSV       + D T   + +  LQ       R F  E ++L+ +    ++K     
Sbjct: 22  GNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVS 81
Query: 399 STPD-------FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPII 451
             P         +++P+G L   L  H   LD    L     +   +EYL     S   +
Sbjct: 82  YGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL----GSRRCV 137
Query: 452 HCDLKPTSILLDENMVAHVSDFGISKLL 479
           H DL   +IL++      ++DFG++KLL
Sbjct: 138 HRDLAARNILVESEAHVKIADFGLAKLL 165

>pdb|2Z64|A Chain A, Crystal Structure Of Mouse Tlr4 And Mouse Md-2 Complex Length = 599

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/143 (34%), Positives = 64/143 (44%), Gaps = 17/143 (11%)
Query: 61  LPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMN 120
           +PNI Y +  D  L   +P+ I ++TK I  DL FN        +F N   L  L L   
Sbjct: 6   VPNITY-QCMDQKL-SKVPDDIPSSTKNI--DLSFNPLKILKSYSFSNFSELQWLDLSRC 61
Query: 121 NLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFS--TSLQRFSASECK 178
            + T    A  W  L  L+N      LIL+GNP+    P   G+FS  TSL+   A E K
Sbjct: 62  EIETIEDKA--WHGLHHLSN------LILTGNPIQSFSP---GSFSGLTSLENLVAVETK 110
Query: 179 LKGTIPKEIGHLRGLIYLSLGFN 201
           L       IG L  L  L++  N
Sbjct: 111 LASLESFPIGQLITLKKLNVAHN 133

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 62/140 (44%), Gaps = 12/140 (8%)
Query: 344 GSFGSVYKGTISD-GTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           G+FG VYK    + G   A K+   + E     +  E E+L    H  ++K+L +     
Sbjct: 30  GAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDG 89
Query: 403 -----FKFMPNGSLEKRLYSHNYFLDI-LERLNIMIDVGSTLEYLHHGHSSAPIIHCDLK 456
                 +F P G+++  +      LD  L    I +     LE L+  HS   IIH DLK
Sbjct: 90  KLWIMIEFCPGGAVDAIMLE----LDRGLTEPQIQVVCRQMLEALNFLHSKR-IIHRDLK 144
Query: 457 PTSILLDENMVAHVSDFGIS 476
             ++L+       ++DFG+S
Sbjct: 145 AGNVLMTLEGDIRLADFGVS 164

>pdb|3VQ1|A Chain A, Crystal Structure Of Mouse Tlr4MD-2LIPID IVA COMPLEX Length = 606

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/143 (34%), Positives = 64/143 (44%), Gaps = 17/143 (11%)
Query: 61  LPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMN 120
           +PNI Y +  D  L   +P+ I ++TK I  DL FN        +F N   L  L L   
Sbjct: 11  VPNITY-QCMDQKL-SKVPDDIPSSTKNI--DLSFNPLKILKSYSFSNFSELQWLDLSRC 66
Query: 121 NLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFS--TSLQRFSASECK 178
            + T    A  W  L  L+N      LIL+GNP+    P   G+FS  TSL+   A E K
Sbjct: 67  EIETIEDKA--WHGLHHLSN------LILTGNPIQSFSP---GSFSGLTSLENLVAVETK 115
Query: 179 LKGTIPKEIGHLRGLIYLSLGFN 201
           L       IG L  L  L++  N
Sbjct: 116 LASLESFPIGQLITLKKLNVAHN 138

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/148 (25%), Positives = 62/148 (41%), Gaps = 16/148 (10%)
Query: 344 GSFGSV---YKGTISDGTDVAIKIFNLQRE--RAFRSFNSECEVLRNVRHQNLIKILSSC 398
           G+FGSV       + D T   + +  LQ       R F  E ++L+ +    ++K     
Sbjct: 21  GNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVS 80
Query: 399 STPD-------FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPII 451
             P         +++P+G L   L  H   LD    L     +   +EYL     S   +
Sbjct: 81  YGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL----GSRRCV 136
Query: 452 HCDLKPTSILLDENMVAHVSDFGISKLL 479
           H DL   +IL++      ++DFG++KLL
Sbjct: 137 HRDLAARNILVESEAHVKIADFGLAKLL 164

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 67/144 (46%), Gaps = 15/144 (10%)
Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQ---RERAFRSFNSECEVL-RNVRHQNLIKILSSC 398
           GSFG V      ++    A+K+   +   +++  +   SE  VL +NV+H  L+ +  S 
Sbjct: 49  GSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF 108
Query: 399 STPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHC 453
            T D       ++  G L   L     FL+   R     ++ S L YLH    S  I++ 
Sbjct: 109 QTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH----SLNIVYR 163
Query: 454 DLKPTSILLDENMVAHVSDFGISK 477
           DLKP +ILLD      ++DFG+ K
Sbjct: 164 DLKPENILLDSQGHIVLTDFGLCK 187

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/131 (24%), Positives = 60/131 (45%), Gaps = 20/131 (15%)
Query: 357 GTDVAIKIFNLQR------ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKF 405
           G +VA+KI +  +      ++ FR    E  +++ + H N++K+     T        ++
Sbjct: 40  GREVAVKIIDKTQLNPTSLQKLFR----EVRIMKILNHPNIVKLFEVIETEKTLYLVMEY 95
Query: 406 MPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDEN 465
              G +   L +H    +   R      + S ++Y H  +    I+H DLK  ++LLD +
Sbjct: 96  ASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKY----IVHRDLKAENLLLDGD 150
Query: 466 MVAHVSDFGIS 476
           M   ++DFG S
Sbjct: 151 MNIKIADFGFS 161

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 38/148 (25%), Positives = 62/148 (41%), Gaps = 16/148 (10%)
Query: 344 GSFGSV---YKGTISDGTDVAIKIFNLQRE--RAFRSFNSECEVLRNVRHQNLIKILSSC 398
           G+FGSV       + D T   + +  LQ       R F  E ++L+ +    ++K     
Sbjct: 18  GNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVS 77
Query: 399 STPD-------FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPII 451
             P         +++P+G L   L  H   LD    L     +   +EYL     S   +
Sbjct: 78  YGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL----GSRRCV 133
Query: 452 HCDLKPTSILLDENMVAHVSDFGISKLL 479
           H DL   +IL++      ++DFG++KLL
Sbjct: 134 HRDLAARNILVESEAHVKIADFGLAKLL 161

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 35/144 (24%), Positives = 68/144 (47%), Gaps = 16/144 (11%)
Query: 344 GSFGSVYKG-TISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCST 400
           G+F  V +   I  G + A KI N ++   R  +    E  + R ++H N++++  S S 
Sbjct: 15  GAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE 74
Query: 401 PDFKFM-----PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDL 455
             F ++       G L + + +  Y+ +     +    +   LE ++H H +  I+H DL
Sbjct: 75  EGFHYLVFDLVTGGELFEDIVAREYYSEA----DASHCIQQILESVNHCHLNG-IVHRDL 129
Query: 456 KPTSILL---DENMVAHVSDFGIS 476
           KP ++LL    +     ++DFG++
Sbjct: 130 KPENLLLASKSKGAAVKLADFGLA 153

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 80/151 (52%), Gaps = 24/151 (15%)
Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKI----LSSCS 399
           GSFG V++  + +  +VAIK   + +++ F+  N E +++R V+H N++ +     S+  
Sbjct: 51  GSFGVVFQAKLVESDEVAIK--KVLQDKRFK--NRELQIMRIVKHPNVVDLKAFFYSNGD 106
Query: 400 TPDFKFMPNGSLE---KRLY-SHNYFLDILERLNI------MIDVGSTLEYLHHGHSSAP 449
             D  F+ N  LE   + +Y +  ++  + + + +      M  +  +L Y+H    S  
Sbjct: 107 KKDEVFL-NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH----SIG 161
Query: 450 IIHCDLKPTSILLD-ENMVAHVSDFGISKLL 479
           I H D+KP ++LLD  + V  + DFG +K+L
Sbjct: 162 ICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 70/155 (45%), Gaps = 25/155 (16%)
Query: 344 GSFGSVYKGTIS----DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKIL- 395
           G+FG VY+G +S    D + + + +  L     E+    F  E  ++  + HQN+++ + 
Sbjct: 42  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVRCIG 101
Query: 396 -SSCSTPDF---KFMPNGSLEKRLY------SHNYFLDILERLNIMIDVGSTLEYLHHGH 445
            S  S P F   + M  G L+  L       S    L +L+ L++  D+    +YL   H
Sbjct: 102 VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH 161
Query: 446 SSAPIIHCDLKPTSILLD---ENMVAHVSDFGISK 477
                IH D+   + LL       VA + DFG+++
Sbjct: 162 ----FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 192

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 35/144 (24%), Positives = 68/144 (47%), Gaps = 16/144 (11%)
Query: 344 GSFGSVYKG-TISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCST 400
           G+F  V +   I  G + A KI N ++   R  +    E  + R ++H N++++  S S 
Sbjct: 15  GAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE 74
Query: 401 PDFKFM-----PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDL 455
             F ++       G L + + +  Y+ +     +    +   LE ++H H +  I+H DL
Sbjct: 75  EGFHYLVFDLVTGGELFEDIVAREYYSEA----DASHCIQQILESVNHCHLNG-IVHRDL 129
Query: 456 KPTSILL---DENMVAHVSDFGIS 476
           KP ++LL    +     ++DFG++
Sbjct: 130 KPENLLLASKSKGAAVKLADFGLA 153

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 70/137 (51%), Gaps = 12/137 (8%)
Query: 344 GSFGSVYKGTI-SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           GS G V   T+ S G  VA+K  +L++++      +E  ++R+ +H+N++++ +S    D
Sbjct: 35  GSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD 94
Query: 403 -----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKP 457
                 +F+  G+L   + +H   ++  +   + + V   L  LH    +  +IH D+K 
Sbjct: 95  ELWVVMEFLEGGALTD-IVTHTR-MNEEQIAAVCLAVLQALSVLH----AQGVIHRDIKS 148
Query: 458 TSILLDENMVAHVSDFG 474
            SILL  +    +SDFG
Sbjct: 149 DSILLTHDGRVKLSDFG 165

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 70/155 (45%), Gaps = 25/155 (16%)
Query: 344 GSFGSVYKGTIS----DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKIL- 395
           G+FG VY+G +S    D + + + +  L     E+    F  E  ++  + HQN+++ + 
Sbjct: 56  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVRCIG 115
Query: 396 -SSCSTPDF---KFMPNGSLEKRLY------SHNYFLDILERLNIMIDVGSTLEYLHHGH 445
            S  S P F   + M  G L+  L       S    L +L+ L++  D+    +YL   H
Sbjct: 116 VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH 175
Query: 446 SSAPIIHCDLKPTSILLD---ENMVAHVSDFGISK 477
                IH D+   + LL       VA + DFG+++
Sbjct: 176 ----FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 84/176 (47%), Gaps = 30/176 (17%)
Query: 320 RNQLSGDIPSTIGALVDLETISLAGSFGSVYKGTI-SDGTDVAIKIF------NLQRERA 372
           R +++           DL+ +  +G++G+V        G  VAIK         L  +RA
Sbjct: 13  RQEVTKTAWEVRAVYRDLQPVG-SGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRA 71
Query: 373 FRSFNSECEVLRNVRHQNLIKILSSCSTPD---------FKFMP-NGSLEKRLYSHNYFL 422
           +R    E  +L+++RH+N+I +L    TPD         +  MP  G+   +L  H    
Sbjct: 72  YR----ELRLLKHMRHENVIGLLD-VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLG 126
Query: 423 DILERLNIMI-DVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK 477
           +  +R+  ++  +   L Y+H    +A IIH DLKP ++ ++E+    + DFG+++
Sbjct: 127 E--DRIQFLVYQMLKGLRYIH----AAGIIHRDLKPGNLAVNEDCELKILDFGLAR 176

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 70/137 (51%), Gaps = 12/137 (8%)
Query: 344 GSFGSVYKGTI-SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           GS G V   T+ S G  VA+K  +L++++      +E  ++R+ +H+N++++ +S    D
Sbjct: 31  GSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD 90
Query: 403 -----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKP 457
                 +F+  G+L   + +H   ++  +   + + V   L  LH    +  +IH D+K 
Sbjct: 91  ELWVVMEFLEGGALTD-IVTHTR-MNEEQIAAVCLAVLQALSVLH----AQGVIHRDIKS 144
Query: 458 TSILLDENMVAHVSDFG 474
            SILL  +    +SDFG
Sbjct: 145 DSILLTHDGRVKLSDFG 161

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 68/155 (43%), Gaps = 25/155 (16%)
Query: 344 GSFGSVYKGTIS------DGTDVAIKIF-NLQRERAFRSFNSECEVLRNVRHQNLIKIL- 395
           G+FG VY+G +S          VA+K    +  E+    F  E  ++    HQN+++ + 
Sbjct: 56  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVRCIG 115
Query: 396 -SSCSTPDF---KFMPNGSLEKRLY------SHNYFLDILERLNIMIDVGSTLEYLHHGH 445
            S  S P F   + M  G L+  L       S    L +L+ L++  D+    +YL   H
Sbjct: 116 VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH 175
Query: 446 SSAPIIHCDLKPTSILLD---ENMVAHVSDFGISK 477
                IH D+   + LL       VA + DFG+++
Sbjct: 176 ----FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 69/155 (44%), Gaps = 25/155 (16%)
Query: 344 GSFGSVYKGTIS----DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKIL- 395
           G+FG VY+G +S    D + + + +  L     E+    F  E  ++    HQN+++ + 
Sbjct: 33  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIG 92
Query: 396 -SSCSTPDF---KFMPNGSLEKRLY------SHNYFLDILERLNIMIDVGSTLEYLHHGH 445
            S  S P F   + M  G L+  L       S    L +L+ L++  D+    +YL   H
Sbjct: 93  VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH 152
Query: 446 SSAPIIHCDLKPTSILLD---ENMVAHVSDFGISK 477
                IH D+   + LL       VA + DFG+++
Sbjct: 153 ----FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 183

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 67/152 (44%), Gaps = 21/152 (13%)
Query: 343 AGSFGSVY-KGTISDGTDVAIKIFNLQRERA-FRSFNSECEVLRNVRHQNLIKILSSCST 400
           +G+FG V+     S G +  IK  N  R +       +E EVL+++ H N+IKI      
Sbjct: 32  SGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFE- 90
Query: 401 PDFKFM-------PNGSLEKRLYSHNYFLDILER---LNIMIDVGSTLEYLHHGHSSAPI 450
            D+  M         G L +R+ S       L       +M  + + L Y H  H    +
Sbjct: 91  -DYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH----V 145
Query: 451 IHCDLKPTSILLDE---NMVAHVSDFGISKLL 479
           +H DLKP +IL  +   +    + DFG+++L 
Sbjct: 146 VHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 41/169 (24%), Positives = 70/169 (41%), Gaps = 39/169 (23%)
Query: 344 GSFGSVYKGT------ISDGTDVAIKIFNLQRERAFRS-FNSECEVLRNVRHQNLIKILS 396
           G+FG V++            T VA+K+   +     ++ F  E  ++    + N++K+L 
Sbjct: 58  GAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLG 117
Query: 397 SCSTPD-----FKFMPNGSLEKRLYS----------HNYF-------------LDILERL 428
            C+        F++M  G L + L S          H+               L   E+L
Sbjct: 118 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQL 177
Query: 429 NIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK 477
            I   V + + YL    S    +H DL   + L+ ENMV  ++DFG+S+
Sbjct: 178 CIARQVAAGMAYL----SERKFVHRDLATRNCLVGENMVVKIADFGLSR 222

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 70/137 (51%), Gaps = 12/137 (8%)
Query: 344 GSFGSVYKGTI-SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           GS G V   T+ S G  VA+K  +L++++      +E  ++R+ +H+N++++ +S    D
Sbjct: 42  GSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD 101
Query: 403 -----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKP 457
                 +F+  G+L   + +H   ++  +   + + V   L  LH    +  +IH D+K 
Sbjct: 102 ELWVVMEFLEGGALTD-IVTHTR-MNEEQIAAVCLAVLQALSVLH----AQGVIHRDIKS 155
Query: 458 TSILLDENMVAHVSDFG 474
            SILL  +    +SDFG
Sbjct: 156 DSILLTHDGRVKLSDFG 172

>pdb|3ULA|A Chain A, Crystal Structure Of The Tv3 Mutant F63w-Md-2-Eritoran Complex Length = 279

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 87/221 (39%), Gaps = 68/221 (30%)
Query: 61  LPNIKY--LELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLL 118
           +PNI Y  +EL    +   +P S  N      LDL +N        +F +   L VL L 
Sbjct: 9   VPNITYQCMELNFYKIPDNLPFSTKN------LDLSWNPLRHLGSYSFFSFPELQVLDLS 62
Query: 119 MNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFS--TSLQRFSASE 176
              + T    AYQ     SL+   +L  LIL+GNP+  +   ++G FS  +SLQ+  A E
Sbjct: 63  RCEIQTIEDGAYQ-----SLS---HLSTLILTGNPIQSL---ALGAFSGLSSLQKLVAVE 111
Query: 177 CKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPXXXX 236
             L       IGHL+ L  L++  N               +Q F LPE            
Sbjct: 112 TNLASLENFPIGHLKTLKELNVAHN--------------LIQSFKLPEY----------- 146
Query: 237 XXXXXXXXXXXXXKLSGHIPPCLASLTSLRELDLGSNKLTS 277
                                  ++LT+L  LDL SNK+ S
Sbjct: 147 ----------------------FSNLTNLEHLDLSSNKIQS 165

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 69/155 (44%), Gaps = 25/155 (16%)
Query: 344 GSFGSVYKGTIS----DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKIL- 395
           G+FG VY+G +S    D + + + +  L     E+    F  E  ++    HQN+++ + 
Sbjct: 59  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIG 118
Query: 396 -SSCSTPDF---KFMPNGSLEKRLY------SHNYFLDILERLNIMIDVGSTLEYLHHGH 445
            S  S P F   + M  G L+  L       S    L +L+ L++  D+    +YL   H
Sbjct: 119 VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH 178
Query: 446 SSAPIIHCDLKPTSILLD---ENMVAHVSDFGISK 477
                IH D+   + LL       VA + DFG+++
Sbjct: 179 ----FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 209

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 69/155 (44%), Gaps = 25/155 (16%)
Query: 344 GSFGSVYKGTIS----DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKIL- 395
           G+FG VY+G +S    D + + + +  L     E+    F  E  ++    HQN+++ + 
Sbjct: 82  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIG 141
Query: 396 -SSCSTPDF---KFMPNGSLEKRLY------SHNYFLDILERLNIMIDVGSTLEYLHHGH 445
            S  S P F   + M  G L+  L       S    L +L+ L++  D+    +YL   H
Sbjct: 142 VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH 201
Query: 446 SSAPIIHCDLKPTSILLD---ENMVAHVSDFGISK 477
                IH D+   + LL       VA + DFG+++
Sbjct: 202 ----FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232

>pdb|3UL7|A Chain A, Crystal Structure Of The Tv3 Mutant F63w Length = 278

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 87/221 (39%), Gaps = 68/221 (30%)
Query: 61  LPNIKY--LELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLL 118
           +PNI Y  +EL    +   +P S  N      LDL +N        +F +   L VL L 
Sbjct: 8   VPNITYQCMELNFYKIPDNLPFSTKN------LDLSWNPLRHLGSYSFFSFPELQVLDLS 61
Query: 119 MNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFS--TSLQRFSASE 176
              + T    AYQ     SL+   +L  LIL+GNP+  +   ++G FS  +SLQ+  A E
Sbjct: 62  RCEIQTIEDGAYQ-----SLS---HLSTLILTGNPIQSL---ALGAFSGLSSLQKLVAVE 110
Query: 177 CKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPXXXX 236
             L       IGHL+ L  L++  N               +Q F LPE            
Sbjct: 111 TNLASLENFPIGHLKTLKELNVAHN--------------LIQSFKLPEY----------- 145
Query: 237 XXXXXXXXXXXXXKLSGHIPPCLASLTSLRELDLGSNKLTS 277
                                  ++LT+L  LDL SNK+ S
Sbjct: 146 ----------------------FSNLTNLEHLDLSSNKIQS 164

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 74/160 (46%), Gaps = 20/160 (12%)
Query: 336 DLETISL--AGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLI 392
           D E I++   G+FG V K   + D    AIK      E+   +  SE  +L ++ HQ ++
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVXLLASLNHQYVV 65
Query: 393 KILSSCSTPDFKFMPNGSLEKR-------LYSHNYFL-DIL--ERLNIMID-----VGST 437
           +  ++         P  +++K+        Y  N  L D++  E LN   D         
Sbjct: 66  RYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQI 125
Query: 438 LEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK 477
           LE L + HS   IIH +LKP +I +DE+    + DFG++K
Sbjct: 126 LEALSYIHSQG-IIHRNLKPXNIFIDESRNVKIGDFGLAK 164

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 66/137 (48%), Gaps = 12/137 (8%)
Query: 344 GSFGSVYKG-TISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           G+ G+VY    ++ G +VAI+  NLQ++       +E  V+R  ++ N++  L S    D
Sbjct: 31  GASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD 90
Query: 403 -----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKP 457
                 +++  GSL   +      +D  +   +  +    LE+LH    S  +IH D+K 
Sbjct: 91  ELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH----SNQVIHRDIKS 144
Query: 458 TSILLDENMVAHVSDFG 474
            +ILL  +    ++DFG
Sbjct: 145 DNILLGMDGSVKLTDFG 161

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 33/123 (26%), Positives = 61/123 (49%), Gaps = 11/123 (8%)
Query: 357 GTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL 411
           G  VA+K  +L++++      +E  ++R+  H N++ + SS    D      +F+  G+L
Sbjct: 70  GKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGAL 129
Query: 412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVS 471
              + +H   ++  +   + + V   L YLH    +  +IH D+K  SILL  +    +S
Sbjct: 130 TD-IVTHTR-MNEEQIATVCLSVLRALSYLH----NQGVIHRDIKSDSILLTSDGRIKLS 183
Query: 472 DFG 474
           DFG
Sbjct: 184 DFG 186

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 70/137 (51%), Gaps = 12/137 (8%)
Query: 344 GSFGSVYKGTI-SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           GS G V   T+ S G  VA+K  +L++++      +E  ++R+ +H+N++++ +S    D
Sbjct: 85  GSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD 144
Query: 403 -----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKP 457
                 +F+  G+L   + +H   ++  +   + + V   L  LH    +  +IH D+K 
Sbjct: 145 ELWVVMEFLEGGALTD-IVTHTR-MNEEQIAAVCLAVLQALSVLH----AQGVIHRDIKS 198
Query: 458 TSILLDENMVAHVSDFG 474
            SILL  +    +SDFG
Sbjct: 199 DSILLTHDGRVKLSDFG 215

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 69/155 (44%), Gaps = 25/155 (16%)
Query: 344 GSFGSVYKGTIS----DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKIL- 395
           G+FG VY+G +S    D + + + +  L     E+    F  E  ++    HQN+++ + 
Sbjct: 41  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIG 100
Query: 396 -SSCSTPDF---KFMPNGSLEKRLY------SHNYFLDILERLNIMIDVGSTLEYLHHGH 445
            S  S P F   + M  G L+  L       S    L +L+ L++  D+    +YL   H
Sbjct: 101 VSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH 160
Query: 446 SSAPIIHCDLKPTSILLD---ENMVAHVSDFGISK 477
                IH D+   + LL       VA + DFG+++
Sbjct: 161 ----FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 69/155 (44%), Gaps = 25/155 (16%)
Query: 344 GSFGSVYKGTIS----DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKIL- 395
           G+FG VY+G +S    D + + + +  L     E+    F  E  ++    HQN+++ + 
Sbjct: 58  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIG 117
Query: 396 -SSCSTPDF---KFMPNGSLEKRLY------SHNYFLDILERLNIMIDVGSTLEYLHHGH 445
            S  S P F   + M  G L+  L       S    L +L+ L++  D+    +YL   H
Sbjct: 118 VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH 177
Query: 446 SSAPIIHCDLKPTSILLD---ENMVAHVSDFGISK 477
                IH D+   + LL       VA + DFG+++
Sbjct: 178 ----FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 208

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 70/137 (51%), Gaps = 12/137 (8%)
Query: 344 GSFGSVYKGTI-SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           GS G V   T+ S G  VA+K  +L++++      +E  ++R+ +H+N++++ +S    D
Sbjct: 40  GSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD 99
Query: 403 -----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKP 457
                 +F+  G+L   + +H   ++  +   + + V   L  LH    +  +IH D+K 
Sbjct: 100 ELWVVMEFLEGGALTD-IVTHTR-MNEEQIAAVCLAVLQALSVLH----AQGVIHRDIKS 153
Query: 458 TSILLDENMVAHVSDFG 474
            SILL  +    +SDFG
Sbjct: 154 DSILLTHDGRVKLSDFG 170

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 66/137 (48%), Gaps = 12/137 (8%)
Query: 344 GSFGSVYKG-TISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           G+ G+VY    ++ G +VAI+  NLQ++       +E  V+R  ++ N++  L S    D
Sbjct: 31  GASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD 90
Query: 403 -----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKP 457
                 +++  GSL   +      +D  +   +  +    LE+LH    S  +IH D+K 
Sbjct: 91  ELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH----SNQVIHRDIKS 144
Query: 458 TSILLDENMVAHVSDFG 474
            +ILL  +    ++DFG
Sbjct: 145 DNILLGMDGSVKLTDFG 161

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 66/137 (48%), Gaps = 12/137 (8%)
Query: 344 GSFGSVYKG-TISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           G+ G+VY    ++ G +VAI+  NLQ++       +E  V+R  ++ N++  L S    D
Sbjct: 31  GASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD 90
Query: 403 -----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKP 457
                 +++  GSL   +      +D  +   +  +    LE+LH    S  +IH D+K 
Sbjct: 91  ELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH----SNQVIHRDIKS 144
Query: 458 TSILLDENMVAHVSDFG 474
            +ILL  +    ++DFG
Sbjct: 145 DNILLGMDGSVKLTDFG 161

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 69/155 (44%), Gaps = 25/155 (16%)
Query: 344 GSFGSVYKGTIS----DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKIL- 395
           G+FG VY+G +S    D + + + +  L     E+    F  E  ++    HQN+++ + 
Sbjct: 42  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIG 101
Query: 396 -SSCSTPDF---KFMPNGSLEKRLY------SHNYFLDILERLNIMIDVGSTLEYLHHGH 445
            S  S P F   + M  G L+  L       S    L +L+ L++  D+    +YL   H
Sbjct: 102 VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH 161
Query: 446 SSAPIIHCDLKPTSILLD---ENMVAHVSDFGISK 477
                IH D+   + LL       VA + DFG+++
Sbjct: 162 ----FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 192

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 69/155 (44%), Gaps = 25/155 (16%)
Query: 344 GSFGSVYKGTIS----DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKIL- 395
           G+FG VY+G +S    D + + + +  L     E+    F  E  ++    HQN+++ + 
Sbjct: 41  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIG 100
Query: 396 -SSCSTPDF---KFMPNGSLEKRLY------SHNYFLDILERLNIMIDVGSTLEYLHHGH 445
            S  S P F   + M  G L+  L       S    L +L+ L++  D+    +YL   H
Sbjct: 101 VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH 160
Query: 446 SSAPIIHCDLKPTSILLD---ENMVAHVSDFGISK 477
                IH D+   + LL       VA + DFG+++
Sbjct: 161 ----FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 66/146 (45%), Gaps = 14/146 (9%)
Query: 343 AGSFGSVY-KGTISDGTDVAIKIFNLQ---RERAFRSFNSECEVLRNVRHQNLIKILSSC 398
            GSFG V+   +  +G   A+K+   +   R +     N E  +L  V H  +I++  + 
Sbjct: 16  TGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF 75
Query: 399 STPDFKFM-----PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHC 453
                 FM       G L   L     F + + +     +V   LEYLH    S  II+ 
Sbjct: 76  QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF-YAAEVCLALEYLH----SKDIIYR 130
Query: 454 DLKPTSILLDENMVAHVSDFGISKLL 479
           DLKP +ILLD+N    ++DFG +K +
Sbjct: 131 DLKPENILLDKNGHIKITDFGFAKYV 156

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 69/155 (44%), Gaps = 25/155 (16%)
Query: 344 GSFGSVYKGTIS----DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKIL- 395
           G+FG VY+G +S    D + + + +  L     E+    F  E  ++    HQN+++ + 
Sbjct: 56  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIG 115
Query: 396 -SSCSTPDF---KFMPNGSLEKRLY------SHNYFLDILERLNIMIDVGSTLEYLHHGH 445
            S  S P F   + M  G L+  L       S    L +L+ L++  D+    +YL   H
Sbjct: 116 VSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH 175
Query: 446 SSAPIIHCDLKPTSILLD---ENMVAHVSDFGISK 477
                IH D+   + LL       VA + DFG+++
Sbjct: 176 ----FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 69/155 (44%), Gaps = 25/155 (16%)
Query: 344 GSFGSVYKGTIS----DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKIL- 395
           G+FG VY+G +S    D + + + +  L     E+    F  E  ++    HQN+++ + 
Sbjct: 48  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIG 107
Query: 396 -SSCSTPDF---KFMPNGSLEKRLY------SHNYFLDILERLNIMIDVGSTLEYLHHGH 445
            S  S P F   + M  G L+  L       S    L +L+ L++  D+    +YL   H
Sbjct: 108 VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH 167
Query: 446 SSAPIIHCDLKPTSILLD---ENMVAHVSDFGISK 477
                IH D+   + LL       VA + DFG+++
Sbjct: 168 ----FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 198

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 42/171 (24%), Positives = 74/171 (43%), Gaps = 16/171 (9%)
Query: 317 DLSRNQLSGDIPSTIGALVDLETISL--AGSFGSVYKGTISDGTDV-AIKI-FNLQRERA 372
           +L+  Q + +      AL D E       G FG+VY         + A+K+ F  Q E+A
Sbjct: 16  ELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKA 75
Query: 373 --FRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRLYSHNYFLDIL 425
                   E E+  ++RH N++++              ++ P G++ + L   + F D  
Sbjct: 76  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQ 134
Query: 426 ERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGIS 476
                + ++ + L Y H    S  +IH D+KP ++LL       ++DFG S
Sbjct: 135 RTATYITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWS 181

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 67/147 (45%), Gaps = 20/147 (13%)
Query: 344 GSFGSVYKGTISDGTDV----AIKIFNLQ----RERAFRSFNSECEVLRNVRHQNLIKIL 395
           GSFG V+      G+D     A+K+        R+R       E ++L  V H  ++K+ 
Sbjct: 35  GSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRV--RTKMERDILVEVNHPFIVKLH 92
Query: 396 SSCSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPI 450
            +  T         F+  G L  RL     F +   +   + ++   L++LH    S  I
Sbjct: 93  YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF-YLAELALALDHLH----SLGI 147
Query: 451 IHCDLKPTSILLDENMVAHVSDFGISK 477
           I+ DLKP +ILLDE     ++DFG+SK
Sbjct: 148 IYRDLKPENILLDEEGHIKLTDFGLSK 174

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 66/137 (48%), Gaps = 12/137 (8%)
Query: 344 GSFGSVYKG-TISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           G+ G+VY    ++ G +VAI+  NLQ++       +E  V+R  ++ N++  L S    D
Sbjct: 32  GASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD 91
Query: 403 -----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKP 457
                 +++  GSL   +      +D  +   +  +    LE+LH    S  +IH D+K 
Sbjct: 92  ELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH----SNQVIHRDIKS 145
Query: 458 TSILLDENMVAHVSDFG 474
            +ILL  +    ++DFG
Sbjct: 146 DNILLGMDGSVKLTDFG 162

>pdb|3ZYJ|A Chain A, Netring1 In Complex With Ngl1 Length = 440

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 40/120 (33%), Positives = 58/120 (48%), Gaps = 4/120 (3%)
Query: 12  LQNLKSLFLGANNLSGLIPPMIFN-ISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELG 70
           L  LK L+L  N +   IP   FN I ++R L+LG  +   ++       L N++YL L 
Sbjct: 135 LSKLKELWLRNNPIES-IPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLA 193
Query: 71  DNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAY 130
             NL   IPN +T   KL  LDL  N  S   P +F  L HL  L ++ + +     +A+
Sbjct: 194 MCNL-REIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAF 251

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 71/163 (43%), Gaps = 16/163 (9%)
Query: 325 GDIPSTIGALVDLETISL--AGSFGSVYKGTISDGTDV-AIKI-FNLQRERA--FRSFNS 378
           G + S   AL D E       G FG+VY         + A+K+ F  Q E+A        
Sbjct: 1   GAMGSRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 60
Query: 379 ECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMID 433
           E E+  ++RH N++++              ++ P G++ + L   + F D       + +
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITE 119
Query: 434 VGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGIS 476
           + + L Y H    S  +IH D+KP ++LL       ++DFG S
Sbjct: 120 LANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWS 158

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 67/147 (45%), Gaps = 20/147 (13%)
Query: 344 GSFGSVYKGTISDGTDV----AIKIFNLQ----RERAFRSFNSECEVLRNVRHQNLIKIL 395
           GSFG V+      G+D     A+K+        R+R       E ++L  V H  ++K+ 
Sbjct: 36  GSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRV--RTKMERDILVEVNHPFIVKLH 93
Query: 396 SSCSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPI 450
            +  T         F+  G L  RL     F +   +   + ++   L++LH    S  I
Sbjct: 94  YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF-YLAELALALDHLH----SLGI 148
Query: 451 IHCDLKPTSILLDENMVAHVSDFGISK 477
           I+ DLKP +ILLDE     ++DFG+SK
Sbjct: 149 IYRDLKPENILLDEEGHIKLTDFGLSK 175

>pdb|2WFH|A Chain A, The Human Slit 2 Dimerization Domain D4 Length = 193

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 58/109 (53%), Gaps = 11/109 (10%)
Query: 49  LSGHLPSMIGHSLPNIKYLELGD--NNLIGTIPN-SITNATKLIILDLGFNTFSGHIPNT 105
           L G+  +++   L N K+L L D  NN I T+ N S +N T+L+ L L +N      P T
Sbjct: 38  LDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRT 97
Query: 106 FGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPL 154
           F  L+ L +LSL  N+++     A+  + LS+L+      +L +  NPL
Sbjct: 98  FDGLKSLRLLSLHGNDISVVPEGAF--NDLSALS------HLAIGANPL 138

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 69/155 (44%), Gaps = 25/155 (16%)
Query: 344 GSFGSVYKGTIS----DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKIL- 395
           G+FG VY+G +S    D + + + +  L     E+    F  E  ++    HQN+++ + 
Sbjct: 68  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIG 127
Query: 396 -SSCSTPDF---KFMPNGSLEKRLY------SHNYFLDILERLNIMIDVGSTLEYLHHGH 445
            S  S P F   + M  G L+  L       S    L +L+ L++  D+    +YL   H
Sbjct: 128 VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH 187
Query: 446 SSAPIIHCDLKPTSILLD---ENMVAHVSDFGISK 477
                IH D+   + LL       VA + DFG+++
Sbjct: 188 ----FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 218

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 38/142 (26%), Positives = 68/142 (47%), Gaps = 14/142 (9%)
Query: 344 GSFGSVYKGTISDGTDV-AIKI-FNLQRERA--FRSFNSECEVLRNVRHQNLIKILSSC- 398
           G FG+VY     +   + A+K+ F  Q E+A        E E+  ++RH N++++     
Sbjct: 19  GKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 78
Query: 399 -STPDF---KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
            ST  +   ++ P G++ + L   + F D       + ++ + L Y H    S  +IH D
Sbjct: 79  DSTRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALSYCH----SKKVIHRD 133
Query: 455 LKPTSILLDENMVAHVSDFGIS 476
           +KP ++LL       ++DFG S
Sbjct: 134 IKPENLLLGSAGELKIADFGWS 155

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 67/156 (42%), Gaps = 32/156 (20%)
Query: 344 GSFGSVYKGT-ISDGTDVAIK---IFNLQRERAFRSFNSECEVLRNVRHQNLIKILSS-- 397
           G F  VY+   + DG  VA+K   IF+L   +A      E ++L+ + H N+IK  +S  
Sbjct: 43  GQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI 102
Query: 398 -----------CSTPDF-KFMPNGSLEKRLYSHNYFLDILER--LNIMIDVGSTLEYLHH 443
                          D  + + +   +KRL        I ER      + + S LE++H 
Sbjct: 103 EDNELNIVLELADAGDLSRMIKHFKKQKRL--------IPERTVWKYFVQLCSALEHMH- 153
Query: 444 GHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
              S  ++H D+KP ++ +    V  + D G+ +  
Sbjct: 154 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 186

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 35/146 (23%), Positives = 63/146 (43%), Gaps = 12/146 (8%)
Query: 343 AGSFGSVYKGTI---SDGTDVAIKIFNLQRERA-FRSFNSECEVLRNVRHQNLIKILSSC 398
            G+FGSV +G         DVAIK+     E+A       E +++  + +  +++++  C
Sbjct: 346 CGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC 405
Query: 399 STPD----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
                    +    G L K L      + +     ++  V   ++YL   +     +H +
Sbjct: 406 QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN----FVHRN 461
Query: 455 LKPTSILLDENMVAHVSDFGISKLLG 480
           L   ++LL     A +SDFG+SK LG
Sbjct: 462 LAARNVLLVNRHYAKISDFGLSKALG 487

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 75/164 (45%), Gaps = 34/164 (20%)
Query: 344 GSFGSVY--------KGTISDGTDVAIKIFNLQR-ERAFRSFNSECEVLRNV-RHQNLIK 393
           G+FG V         K   +  T VA+K+      E+      SE E+++ + +H+N+I 
Sbjct: 80  GAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIIN 139
Query: 394 ILSSCSTPD-----FKFMPNGSLEKRL---------YSHNYFLDILERLN------IMID 433
           +L +C+         ++   G+L + L         YS+N   +  E+L+          
Sbjct: 140 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQ 199
Query: 434 VGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK 477
           V   +EYL    +S   IH DL   ++L+ E+ V  ++DFG+++
Sbjct: 200 VARGMEYL----ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 34/145 (23%), Positives = 65/145 (44%), Gaps = 15/145 (10%)
Query: 344 GSFGSVYKGTISDGTD----VAIK-IFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSC 398
           G FG VY G   D        AIK +  +   +   +F  E  ++R + H N++ ++   
Sbjct: 32  GHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIM 91
Query: 399 STPD------FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
             P+        +M +G L + + S      + + ++  + V   +EYL    +    +H
Sbjct: 92  LPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL----AEQKFVH 147
Query: 453 CDLKPTSILLDENMVAHVSDFGISK 477
            DL   + +LDE+    V+DFG+++
Sbjct: 148 RDLAARNCMLDESFTVKVADFGLAR 172

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 36/142 (25%), Positives = 64/142 (45%), Gaps = 14/142 (9%)
Query: 344 GSFGSVYKGTISDGTDV-AIKI-FNLQRERA--FRSFNSECEVLRNVRHQNLIKILSSCS 399
           G FG+VY         + A+K+ F  Q E+A        E E+  ++RH N++++     
Sbjct: 23  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 82
Query: 400 TPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
                    ++ P G++ + L   + F D       + ++ + L Y H    S  +IH D
Sbjct: 83  DATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALSYCH----SKRVIHRD 137
Query: 455 LKPTSILLDENMVAHVSDFGIS 476
           +KP ++LL       ++DFG S
Sbjct: 138 IKPENLLLGSAGELKIADFGWS 159

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 42/171 (24%), Positives = 74/171 (43%), Gaps = 16/171 (9%)
Query: 317 DLSRNQLSGDIPSTIGALVDLETISL--AGSFGSVYKGTISDGTDV-AIKI-FNLQRERA 372
           +L+  Q + +      AL D E       G FG+VY         + A+K+ F  Q E+A
Sbjct: 7   ELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKA 66
Query: 373 --FRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRLYSHNYFLDIL 425
                   E E+  ++RH N++++              ++ P G++ + L   + F D  
Sbjct: 67  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQ 125
Query: 426 ERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGIS 476
                + ++ + L Y H    S  +IH D+KP ++LL       ++DFG S
Sbjct: 126 RTATYITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWS 172

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 69/155 (44%), Gaps = 25/155 (16%)
Query: 344 GSFGSVYKGTIS----DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKIL- 395
           G+FG VY+G +S    D + + + +  L     E+    F  E  ++    HQN+++ + 
Sbjct: 42  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIG 101
Query: 396 -SSCSTPDF---KFMPNGSLEKRLY------SHNYFLDILERLNIMIDVGSTLEYLHHGH 445
            S  S P F   + M  G L+  L       S    L +L+ L++  D+    +YL   H
Sbjct: 102 VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH 161
Query: 446 SSAPIIHCDLKPTSILLD---ENMVAHVSDFGISK 477
                IH D+   + LL       VA + DFG+++
Sbjct: 162 ----FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQ 192

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 71/163 (43%), Gaps = 16/163 (9%)
Query: 325 GDIPSTIGALVDLETISL--AGSFGSVYKGTISDGTDV-AIKI-FNLQRERA--FRSFNS 378
           G + S   AL D E       G FG+VY         + A+K+ F  Q E+A        
Sbjct: 1   GPLGSRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 60
Query: 379 ECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMID 433
           E E+  ++RH N++++              ++ P G++ + L   + F D       + +
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITE 119
Query: 434 VGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGIS 476
           + + L Y H    S  +IH D+KP ++LL       ++DFG S
Sbjct: 120 LANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWS 158

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	481
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-83
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-83
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	9e-74
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-72
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-69
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	9e-66
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-61
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-56
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-44
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	5e-41
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-52
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-51
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-45
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-40
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-38
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-24
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-49
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-49
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-45
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-42
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-40
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-33
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-28
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	9e-18
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	8e-10
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-43
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-42
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-37
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-37
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	5e-33
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-22
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	7e-17
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	5e-15
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	6e-05
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-04
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-39
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-38
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-38
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-37
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	6e-37
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-30
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	6e-28
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-21
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-16
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-11
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-39
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-38
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-36
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-35
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-31
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	7e-38
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	5e-37
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-36
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	5e-33
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-28
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-20
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-36
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	5e-36
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	5e-33
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-05
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	8e-36
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-35
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	9e-35
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-34
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-34
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-32
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-31
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-30
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-26
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-14
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-34
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	4e-33
1o6v_A	466	Internalin A; bacterial infection, extracellular r	7e-33
1o6v_A	466	Internalin A; bacterial infection, extracellular r	4e-31
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-30
1o6v_A	466	Internalin A; bacterial infection, extracellular r	9e-22
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-21
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-32
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	5e-32
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	6e-32
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	8e-32
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-31
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-31
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-31
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	8e-31
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-30
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-30
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	5e-24
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-06
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	5e-04
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-30
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	4e-28
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	4e-18
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-08
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	8e-07
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	8e-30
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-29
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-15
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	8e-15
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-29
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-28
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	9e-28
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-23
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	5e-28
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	4e-23
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-19
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	9e-28
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-27
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-16
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	4e-15
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-27
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-25
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-10
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-04
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-26
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-25
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-25
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-23
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	6e-09
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-26
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	9e-26
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-25
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-17
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-17
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-15
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-14
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	5e-26
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	5e-25
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-24
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-24
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-22
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	6e-26
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-25
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	8e-26
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-25
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-25
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-19
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	5e-17
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-15
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-24
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-22
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-21
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-19
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	7e-15
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-21
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-21
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-21
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-19
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	9e-17
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-21
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	3e-21
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-19
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	8e-17
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	6e-21
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	6e-20
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	5e-14
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	9e-21
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	9e-21
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-20
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-20
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-20
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-20
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-20
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-20
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-19
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-11
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-20
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-20
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-20
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	3e-20
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	7e-18
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-20
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	4e-20
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	4e-20
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	4e-20
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	5e-20
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	5e-20
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	6e-20
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	6e-20
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	6e-20
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	7e-20
3pls_A	298	Macrophage-stimulating protein receptor; protein k	9e-20
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	9e-20
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-19
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-19
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-19
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-19
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-19
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-19
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-19
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-19
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-19
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	4e-19
2a19_B	284	Interferon-induced, double-stranded RNA-activated	4e-19
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-19
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	5e-19
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	5e-19
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	7e-19
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-18
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-18
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-18
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-16
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-15
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	4e-10
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-06
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-05
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-18
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-18
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-18
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-18
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-18
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-18
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-18
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	4e-18
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	6e-18
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	8e-18
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	8e-18
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	9e-18
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-17
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-17
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	6e-17
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	7e-17
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	8e-17
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-15
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-12
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	9e-17
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-15
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-11
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-05
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-16
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-16
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-10
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-08
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-05
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-16
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	4e-16
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	5e-16
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-15
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-10
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-07
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-15
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-15
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-15
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-15
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-15
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-15
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-12
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-15
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-15
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-15
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	4e-15
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-14
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-14
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	8e-14
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-06
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-15
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	5e-15
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	6e-15
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-14
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-09
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	7e-09
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	7e-15
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	7e-15
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	7e-15
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	9e-15
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	9e-15
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-14
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-14
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-14
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-14
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-14
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-14
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	5e-12
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	5e-11
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-10
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-09
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-08
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-06
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-14
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-14
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-14
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-14
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-14
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	4e-14
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-14
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	6e-14
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	7e-14
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	8e-14
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	8e-14
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-13
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-13
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-13
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	2e-13
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	7e-13
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	4e-12
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	9e-10
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	2e-08
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-13
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-13
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-13
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-13
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-13
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-13
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-13
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-13
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	4e-13
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	4e-13
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	6e-13
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	7e-13
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	8e-13
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	8e-13
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	9e-13
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-12
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-12
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-12
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-12
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	4e-11
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	8e-11
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-12
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-12
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-12
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	3e-12
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	3e-12
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-12
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	4e-12
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	5e-12
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	7e-12
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	7e-10
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-07
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	6e-07
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-06
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	8e-06
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	7e-12
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-11
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-11
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-11
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-11
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-11
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-11
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-11
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	5e-10
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-09
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	5e-09
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-11
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-11
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-11
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-11
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-11
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	5e-11
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	6e-11
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	6e-11
3niz_A	311	Rhodanese family protein; structural genomics, str	6e-11
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	7e-11
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	3e-07
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	3e-07
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	8e-11
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-10
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	4e-10
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-09
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-07
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-07
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-04
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	9e-11
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-10
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-10
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-07
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-06
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-04
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-10
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-10
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-10
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-10
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-10
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-10
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-10
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-10
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-10
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	4e-10
3o0g_A	292	Cell division protein kinase 5; kinase activator c	4e-10
3aln_A	327	Dual specificity mitogen-activated protein kinase;	4e-10
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	4e-10
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	4e-09
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-07
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	5e-06
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	3e-05
3bhy_A	283	Death-associated protein kinase 3; death associate	5e-10
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	6e-10
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	8e-10
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	8e-10
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-09
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-09
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-09
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-09
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	5e-09
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	6e-09
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	9e-09
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	1e-07
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-08
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-08
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-08
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	1e-08
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	5e-06
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-08
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-08
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-08
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	3e-08
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-05
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-08
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	4e-08
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	4e-08
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-08
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	4e-08
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	1e-04
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	7e-04
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	4e-08
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	5e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	6e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	5e-04
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	7e-04
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	9e-08
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	9e-08
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	3e-07
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	4e-06
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	3e-05
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	4e-04
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	9e-08
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	1e-07
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	4e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	7e-04
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-07
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-07
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	9e-05
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-07
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-07
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-07
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-07
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-07
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-07
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-07
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-07
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-07
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-07
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	4e-07
3e6j_A	229	Variable lymphocyte receptor diversity region; var	4e-07
3e6j_A	229	Variable lymphocyte receptor diversity region; var	6e-07
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	4e-07
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	5e-07
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	7e-04
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	5e-07
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	8e-07
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-06
3m19_A	251	Variable lymphocyte receptor A diversity region; a	5e-06
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-05
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-05
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-04
3m19_A	251	Variable lymphocyte receptor A diversity region; a	4e-04
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-05
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-06
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-06
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-06
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-06
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-06
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-06
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	4e-06
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	5e-05
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	5e-06
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	9e-06
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	9e-06
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	9e-06
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	7e-04
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	1e-05
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	9e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-05
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-05
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-05
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	6e-04
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-05
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-05
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	5e-05
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	6e-05
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	7e-05
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	8e-05
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-04
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-04
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-04
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-04
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-04
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	6e-04
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	8e-04

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  272 bits (699), Expect = 1e-83
 Identities = 109/346 (31%), Positives = 154/346 (44%), Gaps = 14/346 (4%)

Query: 2   TGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSL 61
           +  IP  +G+   L+ L +  N LSG     I   + ++ LN+  N+  G +P      L
Sbjct: 213 STGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP---LPL 268

Query: 62  PNIKYLELGDNNLIGTIPNSIT-NATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMN 120
            +++YL L +N   G IP+ ++     L  LDL  N F G +P  FG+   L  L+L  N
Sbjct: 269 KSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSN 328

Query: 121 NLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLK 180
           N + E           +L   R L  L LS N   G LP S+ N S SL     S     
Sbjct: 329 NFSGELPM-------DTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFS 381

Query: 181 GTIPKEIGH--LRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHL 238
           G I   +       L  L L  N   G IP ++    +L    L    L G +P +L  L
Sbjct: 382 GPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSL 441

Query: 239 EMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNL 298
             L  L L  N L G IP  L  + +L  L L  N LT  IPS L +   +  I+LS+N 
Sbjct: 442 SKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNR 501

Query: 299 LNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAG 344
           L   +P  + +L+ L +L LS N  SG+IP+ +G    L  + L  
Sbjct: 502 LTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNT 547

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  271 bits (696), Expect = 3e-83
 Identities = 100/336 (29%), Positives = 163/336 (48%), Gaps = 13/336 (3%)

Query: 2   TGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSL 61
           +G     I     LK L + +N   G IPP    + +++ L+L  N+ +G +P  +  + 
Sbjct: 236 SGDFSRAISTCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGAC 293

Query: 62  PNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIP-NTFGNLRHLSVLSLLMN 120
             +  L+L  N+  G +P    + + L  L L  N FSG +P +T   +R L VL L  N
Sbjct: 294 DTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFN 353

Query: 121 NLTTESSSAYQWSFLSSLTNCRY-LVYLILSGNPLGGILPPSIGNFS-TSLQRFSASECK 178
             +             SLTN    L+ L LS N   G + P++      +LQ        
Sbjct: 354 EFSG--------ELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNG 405

Query: 179 LKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHL 238
             G IP  + +   L+ L L FN L+GTIP+S+G+L +L+   L    L+G +P  L ++
Sbjct: 406 FTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYV 465

Query: 239 EMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNL 298
           + L  L L  N L+G IP  L++ T+L  + L +N+LT  IP  +  L  +  + LS+N 
Sbjct: 466 KTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNS 525

Query: 299 LNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGAL 334
            + ++P+ +   + L  LDL+ N  +G IP+ +   
Sbjct: 526 FSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ 561

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  246 bits (630), Expect = 9e-74
 Identities = 106/352 (30%), Positives = 162/352 (46%), Gaps = 23/352 (6%)

Query: 1   MTGQIPTEI---GNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMI 57
           ++G              LK L +  N +SG +   +     +  L++  N  S  +P  +
Sbjct: 163 ISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-L 219

Query: 58  GHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSL 117
           G     +++L++  N L G    +I+  T+L +L++  N F G IP     L+ L  LSL
Sbjct: 220 GD-CSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSL 276

Query: 118 LMNNLTTESSSAYQWSFLSSLT-NCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASE 176
             N  T              L+  C  L  L LSGN   G +PP  G+ S  L+  + S 
Sbjct: 277 AENKFT--------GEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCS-LLESLALSS 327

Query: 177 CKLKGTIPKE-IGHLRGLIYLSLGFNDLNGTIPTSIGTLK-QLQGFFLPETNLQGYVPHN 234
               G +P + +  +RGL  L L FN+ +G +P S+  L   L    L   N  G +  N
Sbjct: 328 NNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPN 387

Query: 235 LCHLEMLNL--LHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEI 292
           LC      L  L+L  N  +G IPP L++ + L  L L  N L+ +IPSSL SL  + ++
Sbjct: 388 LCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDL 447

Query: 293 NLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAG 344
            L  N+L   +P  +  +K L  L L  N L+G+IPS +    +L  ISL+ 
Sbjct: 448 KLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSN 499

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  241 bits (618), Expect = 5e-72
 Identities = 94/346 (27%), Positives = 153/346 (44%), Gaps = 17/346 (4%)

Query: 1   MTGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHS 60
            TG+IP  + N   L SL L  N LSG IP  + ++S +R+L L  N L G +P  +   
Sbjct: 406 FTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELM-Y 464

Query: 61  LPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMN 120
           +  ++ L L  N+L G IP+ ++N T L  + L  N  +G IP   G L +L++L L  N
Sbjct: 465 VKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNN 524

Query: 121 NLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLK 180
           + +         +  + L +CR L++L L+ N   G +P ++   S  +         + 
Sbjct: 525 SFSG--------NIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAAN-----FIA 571

Query: 181 GTIPKEIGHLRGL--IYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHL 238
           G     I +       + +    +  G     +  L       +      G+      + 
Sbjct: 572 GKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNN 631

Query: 239 EMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNL 298
             +  L +  N LSG+IP  + S+  L  L+LG N ++ SIP  +  L  +  ++LSSN 
Sbjct: 632 GSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNK 691

Query: 299 LNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAG 344
           L+  +P  +  L +L  +DLS N LSG IP   G            
Sbjct: 692 LDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM-GQFETFPPAKFLN 736

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  235 bits (602), Expect = 1e-69
 Identities = 102/350 (29%), Positives = 158/350 (45%), Gaps = 17/350 (4%)

Query: 2   TGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIF-NISTIRNLNLGGNRLSGHLPSMIGHS 60
            G IP     L++L+ L L  N  +G IP  +     T+  L+L GN   G +P   G  
Sbjct: 260 VGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGS- 316

Query: 61  LPNIKYLELGDNNLIGTIP-NSITNATKLIILDLGFNTFSGHIPNTFGNLR-HLSVLSLL 118
              ++ L L  NN  G +P +++     L +LDL FN FSG +P +  NL   L  L L 
Sbjct: 317 CSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLS 376

Query: 119 MNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECK 178
            NN +         +  ++L        L L  N   G +PP++ N S  L     S   
Sbjct: 377 SNNFSGPILPNLCQNPKNTLQ------ELYLQNNGFTGKIPPTLSNCS-ELVSLHLSFNY 429

Query: 179 LKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHL 238
           L GTIP  +G L  L  L L  N L G IP  +  +K L+   L   +L G +P  L + 
Sbjct: 430 LSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNC 489

Query: 239 EMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNL 298
             LN + L  N+L+G IP  +  L +L  L L +N  + +IP+ L     ++ ++L++NL
Sbjct: 490 TNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNL 549

Query: 299 LNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAGSFGS 348
            N ++P+ + K        ++ N ++G     I      +    AG+   
Sbjct: 550 FNGTIPAAMFKQS----GKIAANFIAGKRYVYIKNDGMKKECHGAGNLLE 595

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  224 bits (574), Expect = 9e-66
 Identities = 92/352 (26%), Positives = 149/352 (42%), Gaps = 25/352 (7%)

Query: 3   GQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIG-HSL 61
             + + + +L  L+SLFL  ++++G +       +++ +L+L  N LSG + ++    S 
Sbjct: 67  SAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSRNSLSGPVTTLTSLGSC 125

Query: 62  PNIKYLELGDNNLIGTIPNSI-TNATKLIILDLGFNTFSGHIPNTF---GNLRHLSVLSL 117
             +K+L +  N L      S       L +LDL  N+ SG     +        L  L++
Sbjct: 126 SGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAI 185

Query: 118 LMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASEC 177
             N ++ +            ++ C  L +L +S N     + P +G+ S +LQ    S  
Sbjct: 186 SGNKISGD----------VDVSRCVNLEFLDVSSNNFSTGI-PFLGDCS-ALQHLDISGN 233

Query: 178 KLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCH 237
           KL G   + I     L  L++  N   G IP     LK LQ   L E    G +P  L  
Sbjct: 234 KLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSG 291

Query: 238 -LEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIP-SSLWSLGYILEINLS 295
             + L  L L GN   G +PP   S + L  L L SN  +  +P  +L  +  +  ++LS
Sbjct: 292 ACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLS 351

Query: 296 SNLLNDSLPSNVQKLKV-LRVLDLSRNQLSGDIPSTIG--ALVDLETISLAG 344
            N  +  LP ++  L   L  LDLS N  SG I   +       L+ + L  
Sbjct: 352 FNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQN 403

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  212 bits (543), Expect = 2e-61
 Identities = 82/344 (23%), Positives = 150/344 (43%), Gaps = 24/344 (6%)

Query: 11  NLQNLKSLFLGANNLS---GLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYL 67
               + S+ L +  L+     +   + +++ + +L L  + ++G +         ++  L
Sbjct: 48  RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGF--KCSASLTSL 105

Query: 68  ELGDNNLIGTIP--NSITNATKLIILDLGFNTFSGHIP-NTFGNLRHLSVLSLLMNNLTT 124
           +L  N+L G +    S+ + + L  L++  NT       +    L  L VL L  N+++ 
Sbjct: 106 DLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISG 165

Query: 125 ESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIP 184
            +              C  L +L +SGN + G +   +     +L+    S       IP
Sbjct: 166 ANVVG-----WVLSDGCGELKHLAISGNKISGDVD--VSRC-VNLEFLDVSSNNFSTGIP 217

Query: 185 KEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPH-NLCHLEMLNL 243
             +G    L +L +  N L+G    +I T  +L+   +      G +P   L  L+ L+ 
Sbjct: 218 -FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLS- 275

Query: 244 LHLGGNKLSGHIPPCLA-SLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDS 302
             L  NK +G IP  L+ +  +L  LDL  N    ++P    S   +  + LSSN  +  
Sbjct: 276 --LAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGE 333

Query: 303 LPSNV-QKLKVLRVLDLSRNQLSGDIPSTIGAL-VDLETISLAG 344
           LP +   K++ L+VLDLS N+ SG++P ++  L   L T+ L+ 
Sbjct: 334 LPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSS 377

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  190 bits (484), Expect = 1e-56
 Identities = 77/346 (22%), Positives = 125/346 (36%), Gaps = 87/346 (25%)

Query: 2   TGQIPTEIGNLQNLKSLFLGANNLSG--LIPPMIFNISTIRNLNLGG-NRLSGHLPSMIG 58
            G +         + +L L   NL     IP  + N+  +  L +GG N L G +P  I 
Sbjct: 39  LGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIA 98

Query: 59  HSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLL 118
             L  + YL +   N+ G IP+ ++    L+ LD  +N  SG +P +  +L +L  ++  
Sbjct: 99  -KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFD 157

Query: 119 MNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECK 178
            N ++                                G +P S G+FS      + S  +
Sbjct: 158 GNRIS--------------------------------GAIPDSYGSFSKLFTSMTISRNR 185

Query: 179 LKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHL 238
           L G IP    +L  L ++ L  N L G      G+ K  Q                    
Sbjct: 186 LTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQ-------------------- 224

Query: 239 EMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNL 298
                +HL  N L+  +   +    +L  LDL +N++  ++P  L               
Sbjct: 225 ----KIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGL--------------- 264

Query: 299 LNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAG 344
                     +LK L  L++S N L G+IP   G L   +  + A 
Sbjct: 265 ---------TQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYAN 300

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  157 bits (400), Expect = 1e-44
 Identities = 61/220 (27%), Positives = 94/220 (42%), Gaps = 10/220 (4%)

Query: 133 SFLSSLTNCRYLV----YLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGT--IPKE 186
                L N   L               G+L  +    +  +     S   L     IP  
Sbjct: 13  QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQ-TYRVNNLDLSGLNLPKPYPIPSS 71

Query: 187 IGHLRGLIYLSL-GFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLH 245
           + +L  L +L + G N+L G IP +I  L QL   ++  TN+ G +P  L  ++ L  L 
Sbjct: 72  LANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLD 131

Query: 246 LGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILE-INLSSNLLNDSLP 304
              N LSG +PP ++SL +L  +    N+++ +IP S  S   +   + +S N L   +P
Sbjct: 132 FSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIP 191

Query: 305 SNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAG 344
                L  L  +DLSRN L GD     G+  + + I LA 
Sbjct: 192 PTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAK 230

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  148 bits (375), Expect = 5e-41
 Identities = 52/201 (25%), Positives = 83/201 (41%), Gaps = 12/201 (5%)

Query: 2   TGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSL 61
           +G IP  +  ++ L +L    N LSG +PP I ++  +  +   GNR+SG +P   G   
Sbjct: 114 SGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFS 173

Query: 62  PNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNN 121
                + +  N L G IP +  N   L  +DL  N   G     FG+ ++   + L  N+
Sbjct: 174 KLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNS 232

Query: 122 LTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKG 181
           L  +         L  +   + L  L L  N + G LP  +      L   + S   L G
Sbjct: 233 LAFD---------LGKVGLSKNLNGLDLRNNRIYGTLPQGLTQL-KFLHSLNVSFNNLCG 282

Query: 182 TIPKEIGHLRGLIYLSLGFND 202
            IP+  G+L+     +   N 
Sbjct: 283 EIPQG-GNLQRFDVSAYANNK 302

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  186 bits (473), Expect = 2e-52
 Identities = 48/361 (13%), Positives = 114/361 (31%), Gaps = 28/361 (7%)

Query: 2   TGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSL 61
              I            +   +NN++  +   +  ++ +R   +G +              
Sbjct: 172 QKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAW--- 227

Query: 62  PNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNN 121
              +           T      N   L  +++        +P     L  + ++++  N 
Sbjct: 228 ---ENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNR 284

Query: 122 LTTESSSAYQWSFLSSLTNCRYLVYLILSGNPL-GGILPPSIGNFSTSLQRFSASECKLK 180
             +       W  L+       +  + +  N L    +  S+      L        +L+
Sbjct: 285 GISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKM-KKLGMLECLYNQLE 343

Query: 181 GTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPH-NLCHLE 239
           G +P   G    L  L+L +N +        G  +Q++        L+      +   + 
Sbjct: 344 GKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVS 402

Query: 240 MLNLLHLGGNKLSG-------HIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEI 292
           +++ +    N++          + P      ++  ++L +N+++        +   +  I
Sbjct: 403 VMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSI 462

Query: 293 NLSSNLLND-------SLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGA--LVDLETISLA 343
           NL  N+L +           N +   +L  +DL  N+L+  +     A  L  L  I L+
Sbjct: 463 NLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLS 521

Query: 344 G 344
            
Sbjct: 522 Y 522

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  182 bits (465), Expect = 3e-51
 Identities = 60/391 (15%), Positives = 126/391 (32%), Gaps = 64/391 (16%)

Query: 5   IPTEIGNLQNLKSLFLGANNLSGL-------------------IPPMIFNISTIRNLNLG 45
           +   +  L  L+  ++G +                              N+  + ++ + 
Sbjct: 198 VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVY 257

Query: 46  GNRLSGHLPSMIGHSLPNIKYLELGDNNLI--------GTIPNSITNATKLIILDLGFNT 97
                  LP+ +  +LP ++ + +  N  I                   K+ I+ +G+N 
Sbjct: 258 NCPNLTKLPTFLK-ALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNN 316

Query: 98  F-SGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGG 156
             +  +  +   ++ L +L  L N L            L +  +   L  L L+ N +  
Sbjct: 317 LKTFPVETSLQKMKKLGMLECLYNQLE---------GKLPAFGSEIKLASLNLAYNQITE 367

Query: 157 ILPPSIGNFSTSLQRFSASECKLKGTIPK--EIGHLRGLIYLSLGFNDLNG-------TI 207
           I P +   F+  ++  S +  KLK  IP   +   +  +  +   +N++          +
Sbjct: 368 I-PANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPL 425

Query: 208 PTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSG-------HIPPCLA 260
             +      +    L    +  +          L+ ++L GN L+               
Sbjct: 426 DPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFK 485

Query: 261 SLTSLRELDLGSNKLTSSIPS-SLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVL--- 316
           +   L  +DL  NKLT         +L Y++ I+LS N  +   P+       L+     
Sbjct: 486 NTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFS-KFPTQPLNSSTLKGFGIR 544

Query: 317 ---DLSRNQLSGDIPSTIGALVDLETISLAG 344
              D   N+   + P  I     L  + +  
Sbjct: 545 NQRDAQGNRTLREWPEGITLCPSLTQLQIGS 575

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  165 bits (421), Expect = 4e-45
 Identities = 48/359 (13%), Positives = 111/359 (30%), Gaps = 33/359 (9%)

Query: 2   TGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSL 61
             Q    + +   +  L L     SG +P  I  ++ +  L LG +    +        +
Sbjct: 70  GAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGI 129

Query: 62  PNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFS-----GHIPNTFGNLRHLSVLS 116
                 E      +      +    +    DL  +  +       I  +       + + 
Sbjct: 130 SANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIG 189

Query: 117 LLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASE 176
            L NN+T             ++     L    +  +P              S        
Sbjct: 190 QLSNNIT---------FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENS------EY 234

Query: 177 CKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFL--------PETNLQ 228
            +   T   +  +L+ L  + +        +PT +  L ++Q   +         +    
Sbjct: 235 AQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDD 294

Query: 229 GYVPHNLCHLEMLNLLHLGGNKL-SGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLG 287
                +    E + ++++G N L +  +   L  +  L  L+   N+L   +P +  S  
Sbjct: 295 WQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEI 353

Query: 288 YILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPST--IGALVDLETISLAG 344
            +  +NL+ N + +   +     + +  L  + N+L   IP+     ++  +  I  + 
Sbjct: 354 KLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSY 411

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  152 bits (387), Expect = 2e-40
 Identities = 58/341 (17%), Positives = 109/341 (31%), Gaps = 53/341 (15%)

Query: 2   TGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSL 61
           T  + T +  ++ L  L    N L G   P   +   + +LNL  N+++  +P+      
Sbjct: 319 TFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQITE-IPANFCGFT 376

Query: 62  PNIKYLELGDNNLIGTIPN--SITNATKLIILDLGFNTFSG-------HIPNTFGNLRHL 112
             ++ L    N L   IPN     + + +  +D  +N            +  T     ++
Sbjct: 377 EQVENLSFAHNKL-KYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINV 435

Query: 113 SVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGI-------LPPSIGNF 165
           S ++L  N ++               +    L  + L GN L  I          +  N 
Sbjct: 436 SSINLSNNQISKFPKE--------LFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKN- 486

Query: 166 STSLQRFSASECKLKGTIPKEI--GHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLP 223
           +  L        KL   +  +     L  L+ + L +N  +   PT       L+G    
Sbjct: 487 TYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKG---- 540

Query: 224 ETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSL 283
                           + N     GN+     P  +    SL +L +GSN +   +   +
Sbjct: 541 --------------FGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKI 585

Query: 284 WSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLS 324
                I  +++  N       S V       +  L  ++  
Sbjct: 586 --TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  146 bits (370), Expect = 3e-38
 Identities = 46/309 (14%), Positives = 101/309 (32%), Gaps = 27/309 (8%)

Query: 49  LSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSG----HIPN 104
           + G  P +  +S   +  L L      G +P++I   T+L +L LG +          P 
Sbjct: 68  MWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPK 127

Query: 105 TFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGN 164
                        +  +                  +   L+   ++ +P    +  S   
Sbjct: 128 GISANMSDEQKQKMRMHYQKTFVDY------DPREDFSDLIKDCINSDPQQKSIKKSSRI 181

Query: 165 FSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPE 224
            +    +       +   + K +  L  L    +G +             +  +      
Sbjct: 182 -TLKDTQIGQLSNNI-TFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSE-----Y 234

Query: 225 TNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTS------- 277
                       +L+ L  + +        +P  L +L  ++ +++  N+  S       
Sbjct: 235 AQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDD 294

Query: 278 -SIPSSLWSLGYILEINLSSN-LLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALV 335
               +       I  I +  N L    + +++QK+K L +L+   NQL G +P+  G+ +
Sbjct: 295 WQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEI 353

Query: 336 DLETISLAG 344
            L +++LA 
Sbjct: 354 KLASLNLAY 362

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  106 bits (266), Expect = 1e-24
 Identities = 28/255 (10%), Positives = 64/255 (25%), Gaps = 37/255 (14%)

Query: 92  DLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSG 151
           +   + +      +  +   ++ LSL     +             ++     L  L L  
Sbjct: 63  NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVP--------DAIGQLTELEVLALGS 114

Query: 152 NPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSI 211
           +                               PK I                  T     
Sbjct: 115 HGEKVNERLF---------------------GPKGISANMSDEQKQKMRMHYQKTFVDYD 153

Query: 212 G--TLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELD 269
                  L    +     Q  +  +         +    N ++  +   +  LT LR+  
Sbjct: 154 PREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFY 212

Query: 270 LGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPS 329
           +G++   +      W        N        +       LK L  +++        +P+
Sbjct: 213 MGNSPFVAENICEAWEN-----ENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPT 267

Query: 330 TIGALVDLETISLAG 344
            + AL +++ I++A 
Sbjct: 268 FLKALPEMQLINVAC 282

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  178 bits (454), Expect = 2e-49
 Identities = 64/361 (17%), Positives = 118/361 (32%), Gaps = 23/361 (6%)

Query: 1   MTGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHS 60
           ++           NL  L L +N++  +          +  L+L  N LS          
Sbjct: 85  LSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQ- 143

Query: 61  LPNIKYLELGDNNLIGTIPNSITNA--TKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLL 118
           L N++ L L +N +       +     + L  L+L  N      P  F  +  L  L L 
Sbjct: 144 LENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLN 203

Query: 119 MNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFS-TSLQRFSASEC 177
              L    +       L        +  L LS + L      +      T+L     S  
Sbjct: 204 NVQLGPSLTEK-----LCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYN 258

Query: 178 KLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQ---------GFFLPETNLQ 228
            L          L  L Y  L +N++      S+  L  ++            +   +L 
Sbjct: 259 NLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLP 318

Query: 229 GYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSL----W 284
                +   L+ L  L++  N + G        L +L+ L L ++  +    ++      
Sbjct: 319 KIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSL 378

Query: 285 SLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIP-STIGALVDLETISLA 343
           +   +  +NL+ N ++         L  L VLDL  N++  ++       L ++  I L+
Sbjct: 379 AHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLS 438

Query: 344 G 344
            
Sbjct: 439 Y 439

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  177 bits (452), Expect = 4e-49
 Identities = 84/360 (23%), Positives = 134/360 (37%), Gaps = 26/360 (7%)

Query: 4   QIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPN 63
           Q+P ++    N+  L L  N L  L        S + +L++G N +S   P +    LP 
Sbjct: 18  QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQK-LPM 74

Query: 64  IKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLT 123
           +K L L  N L      +    T L  L L  N+      N F   ++L  L L  N L+
Sbjct: 75  LKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLS 134

Query: 124 TESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFS-TSLQRFSASECKLKGT 182
           +             L N   L  L+LS N +  +    +  F+ +SL++   S  ++K  
Sbjct: 135 STKLGT-----QVQLEN---LQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEF 186

Query: 183 IPKEIGHLRGLIYLSLGFNDLNGTIPTSIG---TLKQLQGFFLPETNLQGYVPHNLCHLE 239
            P     +  L  L L    L  ++   +        ++   L  + L          L+
Sbjct: 187 SPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLK 246

Query: 240 MLNL--LHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSN 297
             NL  L L  N L+       A L  L    L  N +      SL  L  +  +NL  +
Sbjct: 247 WTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRS 306

Query: 298 LLNDSLPSNV---------QKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAGSFGS 348
               S+             Q LK L  L++  N + G   +    L++L+ +SL+ SF S
Sbjct: 307 FTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTS 366

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  165 bits (421), Expect = 6e-45
 Identities = 79/367 (21%), Positives = 123/367 (33%), Gaps = 31/367 (8%)

Query: 1   MTGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHL------- 53
           +          L  L+  FL  NN+  L    +  +  +R LNL  +     +       
Sbjct: 260 LNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPK 319

Query: 54  -PSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGH--IPNTFGNLR 110
                   L  +++L + DN++ G   N  T    L  L L  +  S       TF +L 
Sbjct: 320 IDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLA 379

Query: 111 H--LSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTS 168
           H  L +L+L  N ++   S A         +   +L  L L  N +G  L         +
Sbjct: 380 HSPLHILNLTKNKISKIESDA--------FSWLGHLEVLDLGLNEIGQELTGQEWRGLEN 431

Query: 169 LQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNG--TIPTSIGTLKQLQGFFLPETN 226
           +     S  K           +  L  L L    L    + P+    L+ L    L   N
Sbjct: 432 IFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNN 491

Query: 227 LQGYVPHNLCHLEMLNLLHLGGNKLS--------GHIPPCLASLTSLRELDLGSNKLTSS 278
           +       L  LE L +L L  N L+        G     L  L+ L  L+L SN     
Sbjct: 492 IANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEI 551

Query: 279 IPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIG-ALVDL 337
                  L  +  I+L  N LN    S       L+ L+L +N ++       G A  +L
Sbjct: 552 PVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNL 611

Query: 338 ETISLAG 344
             + +  
Sbjct: 612 TELDMRF 618

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  158 bits (402), Expect = 2e-42
 Identities = 69/312 (22%), Positives = 114/312 (36%), Gaps = 20/312 (6%)

Query: 42  LNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGH 101
            +    +L+  +P  +     NI  L L  N L      + T  ++L  LD+GFNT S  
Sbjct: 9   ADCSHLKLT-QVPDDL---PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKL 64

Query: 102 IPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPS 161
            P     L  L VL+L  N L+  S          +   C  L  L L  N +  I    
Sbjct: 65  EPELCQKLPMLKVLNLQHNELSQLSD--------KTFAFCTNLTELHLMSNSIQKIKNNP 116

Query: 162 IGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLK--QLQG 219
                 +L     S   L  T       L  L  L L  N +       +       L+ 
Sbjct: 117 FVKQ-KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKK 175

Query: 220 FFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLA---SLTSLRELDLGSNKLT 276
             L    ++ + P     +  L  L L   +L   +   L    + TS+R L L +++L+
Sbjct: 176 LELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLS 235

Query: 277 SSIPSSLWSLGY--ILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGAL 334
           ++  ++   L +  +  ++LS N LN     +   L  L    L  N +      ++  L
Sbjct: 236 TTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGL 295

Query: 335 VDLETISLAGSF 346
            ++  ++L  SF
Sbjct: 296 FNVRYLNLKRSF 307

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  154 bits (390), Expect = 1e-40
 Identities = 77/352 (21%), Positives = 123/352 (34%), Gaps = 33/352 (9%)

Query: 2   TGQIPTEIGNLQNLKSLFLG---------ANNLSGLIPPMIFNISTIRNLNLGGNRLSGH 52
                  +  L N++ L L            +L  +       +  + +LN+  N + G 
Sbjct: 285 QHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGI 344

Query: 53  LPSMIGHSLPNIKYLELGDNNL-IGTIPNSI---TNATKLIILDLGFNTFSGHIPNTFGN 108
             +M    L N+KYL L ++   + T+ N        + L IL+L  N  S    + F  
Sbjct: 345 KSNMFTG-LINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSW 403

Query: 109 LRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTS 168
           L HL VL L +N +  E +                +  + LS N    +   S      S
Sbjct: 404 LGHLEVLDLGLNEIGQELTG-------QEWRGLENIFEIYLSYNKYLQLTRNSFALV-PS 455

Query: 169 LQRFSASECKLKG--TIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGF------ 220
           LQR       LK   + P     LR L  L L  N++       +  L++L+        
Sbjct: 456 LQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNN 515

Query: 221 --FLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSS 278
              L +    G   + L  L  L++L+L  N            L  L+ +DLG N L + 
Sbjct: 516 LARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTL 575

Query: 279 IPSSLWSLGYILEINLSSNLLNDSLPSNVQK-LKVLRVLDLSRNQLSGDIPS 329
             S   +   +  +NL  NL+            + L  LD+  N       S
Sbjct: 576 PASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  132 bits (335), Expect = 2e-33
 Identities = 63/313 (20%), Positives = 99/313 (31%), Gaps = 32/313 (10%)

Query: 14  NLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNN 73
            L  L L  N +S +       +  +  L+LG N +   L       L NI  + L  N 
Sbjct: 382 PLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNK 441

Query: 74  LIGTIPNSITNATKLIILDLGFNTFSG--HIPNTFGNLRHLSVLSLLMNNLTTESSSAYQ 131
            +    NS      L  L L           P+ F  LR+L++L L  NN+   +     
Sbjct: 442 YLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDM-- 499

Query: 132 WSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLR 191
                 L     L  L L  N L  +                  +    G     +  L 
Sbjct: 500 ------LEGLEKLEILDLQHNNLARL-----------------WKHANPGGPIYFLKGLS 536

Query: 192 GLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKL 251
            L  L+L  N  +         L +L+   L   NL         +   L  L+L  N +
Sbjct: 537 HLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLI 596

Query: 252 SGHIPPCLA-SLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLND----SLPSN 306
           +         +  +L ELD+  N    +  S  W + +I E + +   L+     + P +
Sbjct: 597 TSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPH 656

Query: 307 VQKLKVLRVLDLS 319
                V      S
Sbjct: 657 YHGFPVRLFDTSS 669

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  117 bits (294), Expect = 4e-28
 Identities = 51/252 (20%), Positives = 83/252 (32%), Gaps = 17/252 (6%)

Query: 88  LIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYL 147
             + D      +    +   N+     L+L  N L    +        ++ T    L  L
Sbjct: 6   HEVADCSHLKLTQVPDDLPTNITV---LNLTHNQLRRLPA--------ANFTRYSQLTSL 54

Query: 148 ILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTI 207
            +  N +  + P         L+  +    +L     K       L  L L  N +    
Sbjct: 55  DVGFNTISKLEPELCQKL-PMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIK 113

Query: 208 PTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASL--TSL 265
                  K L    L    L          LE L  L L  NK+       L     +SL
Sbjct: 114 NNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSL 173

Query: 266 RELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQ---KLKVLRVLDLSRNQ 322
           ++L+L SN++    P    ++G +  + L++  L  SL   +        +R L LS +Q
Sbjct: 174 KKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQ 233

Query: 323 LSGDIPSTIGAL 334
           LS    +T   L
Sbjct: 234 LSTTSNTTFLGL 245

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 85.4 bits (212), Expect = 9e-18
 Identities = 37/178 (20%), Positives = 63/178 (35%), Gaps = 4/178 (2%)

Query: 193 LIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLS 252
                     L   +P  +     +    L    L+     N      L  L +G N +S
Sbjct: 6   HEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTIS 62

Query: 253 GHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKV 312
              P     L  L+ L+L  N+L+     +      + E++L SN +     +   K K 
Sbjct: 63  KLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKN 122

Query: 313 LRVLDLSRNQLSGDIPSTIGALVDLETISLAG-SFGSVYKGTISDGTDVAIKIFNLQR 369
           L  LDLS N LS     T   L +L+ + L+     ++    +    + ++K   L  
Sbjct: 123 LITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 60.0 bits (146), Expect = 8e-10
 Identities = 24/117 (20%), Positives = 42/117 (35%), Gaps = 1/117 (0%)

Query: 2   TGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSL 61
                    +L  LK + LG NNL+ L   +  N  ++++LNL  N ++     + G + 
Sbjct: 549 DEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAF 608

Query: 62  PNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIP-NTFGNLRHLSVLSL 117
            N+  L++  N    T  +       +          S H   NT  +     V   
Sbjct: 609 RNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYHGFPVRLF 665

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  163 bits (414), Expect = 1e-43
 Identities = 57/359 (15%), Positives = 108/359 (30%), Gaps = 37/359 (10%)

Query: 2   TGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSL 61
            G++P  IG L  LK L  G ++ +           T        +R+  H   M     
Sbjct: 336 KGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYD 395

Query: 62  PNIKYLELGDN-----NLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLS 116
             +   +L  +       +  I      + K   +    N  +  I      L  L ++ 
Sbjct: 396 QRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIY 454

Query: 117 LLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASE 176
              +  T                                     S  N    L       
Sbjct: 455 FANSPFT-------------YDNIAVDWEDANSDYAKQYENEELSWSNL-KDLTDVELYN 500

Query: 177 CKLKGTIPKEIGHLRGLIYLSLGFNDLNG---------TIPTSIGTLKQLQGFFLPETNL 227
           C     +P  +  L  L  L++  N              +     T  ++Q F++   NL
Sbjct: 501 CPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNL 560

Query: 228 QGY-VPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWS- 285
           + +    +L  +  L LL    NK+         +   L +L L  N++   IP    + 
Sbjct: 561 EEFPASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAF 617

Query: 286 LGYILEINLSSNLLNDSLPSNVQ--KLKVLRVLDLSRNQLSGDIPSTIGALVDLETISL 342
              +  +  S N L   +P+      + V+  +D S N++  +  +   ++ D + I+ 
Sbjct: 618 TDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINA 675

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  159 bits (403), Expect = 4e-42
 Identities = 49/362 (13%), Positives = 107/362 (29%), Gaps = 43/362 (11%)

Query: 2   TGQIPTEIGNLQNLKSLFLGANNLSGL---------IPPMIFNISTIRNLNLGGNRLSGH 52
             Q+P  + +L  L+SL +  N              +         I+   +G N L   
Sbjct: 504 MTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEF 563

Query: 53  LPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHL 112
             S     +  +  L+   N +      +     KL  L L +N       +       +
Sbjct: 564 PASASLQKMVKLGLLDCVHNKV--RHLEAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQV 621

Query: 113 SVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNF-----ST 167
             L    N L    +         +  +   +  +  S N +G     +I          
Sbjct: 622 EGLGFSHNKLKYIPNIF-------NAKSVYVMGSVDFSYNKIGSE-GRNISCSMDDYKGI 673

Query: 168 SLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDL-------NGTIPTSIGTLKQLQGF 220
           +    + S  +++    +       +  + L  N +             +      L   
Sbjct: 674 NASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTI 733

Query: 221 FLPETNLQGYVPH-NLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDL------GSN 273
            L    L           L  L+ + +  N  S   P    + + L+   +        N
Sbjct: 734 DLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGN 792

Query: 274 KLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQL-SGDIPSTIG 332
           ++    P+ + +   ++++ + SN +   +   +     L +LD++ N   S D+ S   
Sbjct: 793 RILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCP 849

Query: 333 AL 334
            +
Sbjct: 850 YI 851

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  145 bits (367), Expect = 2e-37
 Identities = 45/355 (12%), Positives = 109/355 (30%), Gaps = 27/355 (7%)

Query: 3   GQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLP 62
            Q   ++ N   +  L L      G +P  I  ++ ++ L+ G +  +          L 
Sbjct: 313 DQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELT 372

Query: 63  NIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNL 122
                E      +      +    +L + DL  +  + +       ++  S +SL    +
Sbjct: 373 PDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRN--PEMKPIKKDSRISLKDTQI 430

Query: 123 TTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGT 182
              + +        ++     L  +  + +P                +  ++   K    
Sbjct: 431 --GNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIA------VDWEDANSDYAKQYEN 482

Query: 183 IPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFL---------PETNLQGYVPH 233
                 +L+ L  + L        +P  +  L +LQ   +                 +  
Sbjct: 483 EELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLAD 542

Query: 234 NLCHLEMLNLLHLGGNKLSG-HIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEI 292
           +      + + ++G N L        L  +  L  LD   NK+      +  +   + ++
Sbjct: 543 DEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRH--LEAFGTNVKLTDL 600

Query: 293 NLSSNLLNDSLPSNV-QKLKVLRVLDLSRNQLSGDIPST--IGALVDLETISLAG 344
            L  N +   +P +       +  L  S N+L   IP+     ++  + ++  + 
Sbjct: 601 KLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSY 653

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  144 bits (365), Expect = 3e-37
 Identities = 53/341 (15%), Positives = 111/341 (32%), Gaps = 33/341 (9%)

Query: 3   GQIPTEIGNLQNLKSLFLGANNLSGLIPPM-IFNISTIRNLNLGGNRLSGHLPSMIGHSL 61
            ++  +      ++  ++G NNL        +  +  +  L+   N++  HL +      
Sbjct: 538 TRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLEAFGT--N 594

Query: 62  PNIKYLELGDNNLIGTIPNSI-TNATKLIILDLGFNTFSGHIPNTF--GNLRHLSVLSLL 118
             +  L+L  N +   IP        ++  L    N     IPN F   ++  +  +   
Sbjct: 595 VKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFS 652

Query: 119 MNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECK 178
            N + +E  +           N      + LS N +            + +     S   
Sbjct: 653 YNKIGSEGRNISCSMDDYKGIN---ASTVTLSYNEIQKFPTELFATG-SPISTIILSNNL 708

Query: 179 LK-------GTIPKEIGHLRGLIYLSLGFNDLNGTIPTSI--GTLKQLQGFFLPETNLQG 229
           +                +   L  + L FN L  ++       TL  L    +       
Sbjct: 709 MTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS 767

Query: 230 --YVPHNLCHLEMLNLLH---LGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLW 284
               P N   L+   + H     GN++    P  + +  SL +L +GSN +   +   L 
Sbjct: 768 FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKL- 825

Query: 285 SLGYILEINLSSN-LLNDSLPSNVQKLKV-LRVLDLSRNQL 323
               +  ++++ N  ++  + S    ++  + VL   + Q 
Sbjct: 826 -TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQD 865

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  131 bits (332), Expect = 5e-33
 Identities = 53/366 (14%), Positives = 98/366 (26%), Gaps = 44/366 (12%)

Query: 12  LQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGD 71
           L+ +     G N             S   N N   + + G  P +   +   +  L L  
Sbjct: 274 LKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELD-MWGDQPGVDLDNNGRVTGLSLAG 332

Query: 72  NNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQ 131
               G +P++I   T+L +L  G ++ +              +     + +       + 
Sbjct: 333 FGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFL 392

Query: 132 WSFLSSLTNCRYLVYLILSGNPLGGI----------------------LPPSIGNFSTSL 169
             +   L     L   I     +  I                      +  +I    T L
Sbjct: 393 -DYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRL-TKL 450

Query: 170 QRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQG 229
           Q    +                     +  +         S   LK L    L       
Sbjct: 451 QIIYFANSPFTYDNIAV-----DWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMT 505

Query: 230 YVPHNLCHLEMLNLLHLGGNKLSG---------HIPPCLASLTSLRELDLGSNKLTSSIP 280
            +P  L  L  L  L++  N+             +     +   ++   +G N L     
Sbjct: 506 QLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPA 565

Query: 281 S-SLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGA-LVDLE 338
           S SL  +  +  ++   N +   L +       L  L L  NQ+   IP    A    +E
Sbjct: 566 SASLQKMVKLGLLDCVHNKVR-HLEA-FGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVE 622

Query: 339 TISLAG 344
            +  + 
Sbjct: 623 GLGFSH 628

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  100 bits (250), Expect = 2e-22
 Identities = 35/321 (10%), Positives = 87/321 (27%), Gaps = 43/321 (13%)

Query: 58  GHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSL 117
             +L  I     G N    +   + T  +     +   + +         N   ++ LSL
Sbjct: 271 YKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSL 330

Query: 118 LMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASEC 177
                              ++     L  L    +          G+   +       + 
Sbjct: 331 AGFGAKGRVP--------DAIGQLTELKVLSFGTHSETV-SGRLFGDEELTPDMSEERKH 381

Query: 178 KLKGTIPKEIG----HLRGLIYLSLGFNDLNGTIPTSIGTLKQLQG-FFLPETNLQGYVP 232
           +++    K        L     L    N      P    +   L+       TN   ++ 
Sbjct: 382 RIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFIS 441

Query: 233 HNLCHLEMLNLLHLGGNKLSG-------------------HIPPCLASLTSLRELDLGSN 273
             +  L  L +++   +  +                    +     ++L  L +++L + 
Sbjct: 442 KAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNC 501

Query: 274 KLTSSIPSSLWSLGYILEINLSSNLLND---------SLPSNVQKLKVLRVLDLSRNQLS 324
              + +P  L+ L  +  +N++ N              L  +      +++  +  N L 
Sbjct: 502 PNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE 561

Query: 325 G-DIPSTIGALVDLETISLAG 344
                +++  +V L  +    
Sbjct: 562 EFPASASLQKMVKLGLLDCVH 582

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 82.6 bits (204), Expect = 7e-17
 Identities = 23/183 (12%), Positives = 52/183 (28%), Gaps = 25/183 (13%)

Query: 2   TGQIPTEIGNLQNLKSLFLGANNLSGL-------IPPMIFNISTIRNLNLGGNRLSGHLP 54
                        + ++ L  N ++ +             N   +  ++L  N+L+    
Sbjct: 686 QKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSD 745

Query: 55  SMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDL------GFNTFSGHIPNTFGN 108
                +LP +  +++   N   + P    N+++L    +        N      P     
Sbjct: 746 DFRATTLPYLSNMDV-SYNCFSSFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITT 804

Query: 109 LRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTS 168
              L  L +  N++               L        L ++ NP   I   S+  +  +
Sbjct: 805 CPSLIQLQIGSNDIRKVDE-----KLTPQLY------ILDIADNPNISIDVTSVCPYIEA 853

Query: 169 LQR 171
              
Sbjct: 854 GMY 856

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 76.8 bits (189), Expect = 5e-15
 Identities = 22/181 (12%), Positives = 55/181 (30%), Gaps = 7/181 (3%)

Query: 172 FSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYV 231
           F+            ++ +   +  LSL      G +P +IG L +L+       +     
Sbjct: 304 FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSG 363

Query: 232 PHNLCHLEMLNLLHLGGNKLSGHIPPC-LASLTSLRELDLGSNKLTS-----SIPSSLWS 285
                     ++     +++  H     L     L   DL  + +        I      
Sbjct: 364 RLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRI 423

Query: 286 LGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAGS 345
                +I   +N +   +   +Q+L  L+++  + +  + D  +      + +      +
Sbjct: 424 SLKDTQIGNLTNRIT-FISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYEN 482

Query: 346 F 346
            
Sbjct: 483 E 483

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 44.5 bits (105), Expect = 6e-05
 Identities = 14/76 (18%), Positives = 29/76 (38%), Gaps = 4/76 (5%)

Query: 1   MTGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRL-SGHLPSMIGH 59
           +  Q PT I    +L  L +G+N++   +   +     +  L++  N   S  + S+  +
Sbjct: 794 ILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKLT--PQLYILDIADNPNISIDVTSVCPY 850

Query: 60  SLPNIKYLELGDNNLI 75
               +  L       I
Sbjct: 851 IEAGMYVLLYDKTQDI 866

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 42.6 bits (100), Expect = 3e-04
 Identities = 22/163 (13%), Positives = 50/163 (30%), Gaps = 2/163 (1%)

Query: 249 NKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQ 308
            + + +I    A       LD  + +  S   ++          N   ++  D    ++ 
Sbjct: 262 KETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSL-NWNFNKELDMWGDQPGVDLD 320

Query: 309 KLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAGSFGSVYKGTISDGTDVAIKIFNLQ 368
               +  L L+     G +P  IG L +L+ +S      +V      D           +
Sbjct: 321 NNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERK 380

Query: 369 RERAFRSFNSECEVLRNVRHQNLIKILSSCSTPDFKFMPNGSL 411
                       +  + +   +L++   +   P+ K +   S 
Sbjct: 381 HRIRMHYKKMFLDYDQRLNLSDLLQDAIN-RNPEMKPIKKDSR 422

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  149 bits (379), Expect = 2e-39
 Identities = 74/375 (19%), Positives = 125/375 (33%), Gaps = 41/375 (10%)

Query: 2   TGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSL 61
                     L +L+ L     NL+ L    I ++ T++ LN+  N +          +L
Sbjct: 89  QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL 148

Query: 62  PNIKYLELGDNNLIGTIPNSITNATKL----IILDLGFNTFSGHIPNTFGNLRHLSVLSL 117
            N+++L+L  N +       +    ++    + LDL  N  +   P  F  +R L  L+L
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTL 207

Query: 118 LMNNLTTESSSAYQWSF-----------------------LSSLTNCRYLVYLILSGNPL 154
             N  +                                   S+L     L         L
Sbjct: 208 RNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 267

Query: 155 GGILPPSIGNFS--TSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIG 212
              L   I  F+  T++  FS     ++        +  G  +L L            + 
Sbjct: 268 DYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLK 325

Query: 213 TLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLS--GHIPPCLASLTSLRELDL 270
           +LK+L       T+ +G    +   L  L  L L  N LS  G         TSL+ LDL
Sbjct: 326 SLKRLT-----FTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDL 380

Query: 271 GSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNV-QKLKVLRVLDLSRNQLSGDIPS 329
             N +  ++ S+   L  +  ++   + L      +V   L+ L  LD+S          
Sbjct: 381 SFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNG 439

Query: 330 TIGALVDLETISLAG 344
               L  LE + +AG
Sbjct: 440 IFNGLSSLEVLKMAG 454

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  146 bits (371), Expect = 2e-38
 Identities = 58/330 (17%), Positives = 94/330 (28%), Gaps = 43/330 (13%)

Query: 3   GQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLP 62
             I      L N+ S  L +  +  +           ++L L   +            L 
Sbjct: 272 DDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTL----KLK 325

Query: 63  NIKYLELGDNNLIGTIPNSITNATKLIILDLGFN--TFSGHIPNTFGNLRHLSVLSLLMN 120
           ++K L     +  G    S  +   L  LDL  N  +F G    +      L  L L  N
Sbjct: 326 SLKRLTF--TSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFN 383

Query: 121 NLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLK 180
            + T           S+      L +L    + L  +   S+     +L     S    +
Sbjct: 384 GVIT---------MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR 434

Query: 181 GTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEM 240
                    L  L  L +  N                              P     L  
Sbjct: 435 VAFNGIFNGLSSLEVLKMAGNSFQENFL-----------------------PDIFTELRN 471

Query: 241 LNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLN 300
           L  L L   +L    P    SL+SL+ L++  N   S        L  +  ++ S N + 
Sbjct: 472 LTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM 531

Query: 301 DSLPSNVQKL-KVLRVLDLSRNQLSGDIPS 329
            S    +Q     L  L+L++N  +     
Sbjct: 532 TSKKQELQHFPSSLAFLNLTQNDFACTCEH 561

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  145 bits (369), Expect = 4e-38
 Identities = 73/377 (19%), Positives = 120/377 (31%), Gaps = 45/377 (11%)

Query: 2   TGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSL 61
                    +L +L +L L  N +  L       +S+++ L      L+      IGH L
Sbjct: 65  QTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGH-L 123

Query: 62  PNIKYLELGDNNLIGT-IPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSV----LS 116
             +K L +  N +    +P   +N T L  LDL  N            L  + +    L 
Sbjct: 124 KTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLD 183

Query: 117 LLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASE 176
           L +N +      A++            L  L L  N     +  +       L+      
Sbjct: 184 LSLNPMNFIQPGAFKEI---------RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVL 234

Query: 177 CKLKGTIPKE---IGHLRGLIYLSLGFNDLN------GTIPTSIGTLKQLQGFFLPETNL 227
            + +     E      L GL  L++    L         I      L  +  F L    +
Sbjct: 235 GEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTI 294

Query: 228 QGYVP----HNLCHLEMLN-------------LLHLGGNKLSGHIPPCLASLTSLRELDL 270
           +            HLE++N             L  L      G        L SL  LDL
Sbjct: 295 ERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDL 354

Query: 271 GSNKLT--SSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIP 328
             N L+       S +    +  ++LS N +  ++ SN   L+ L  LD   + L     
Sbjct: 355 SRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSE 413

Query: 329 -STIGALVDLETISLAG 344
            S   +L +L  + ++ 
Sbjct: 414 FSVFLSLRNLIYLDISH 430

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  142 bits (361), Expect = 4e-37
 Identities = 70/354 (19%), Positives = 115/354 (32%), Gaps = 32/354 (9%)

Query: 5   IPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNL---NLGGNRLS------GHLPS 55
           + T I  L  L+   L             F+ S +  L    +   RL+        +  
Sbjct: 217 MKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIID 276

Query: 56  MIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVL 115
           +    L N+    L    +      S         L+L    F         +L+ L+  
Sbjct: 277 LFNC-LTNVSSFSLVSVTIERVKDFS--YNFGWQHLELVNCKFGQFPTLKLKSLKRLTFT 333

Query: 116 SLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLG--GILPPSIGNFSTSLQRFS 173
           S    N               S  +   L +L LS N L   G    S    +TSL+   
Sbjct: 334 SNKGGNAF-------------SEVDLPSLEFLDLSRNGLSFKGCCSQSDFG-TTSLKYLD 379

Query: 174 ASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSI-GTLKQLQGFFLPETNLQGYVP 232
            S   +  T+      L  L +L    ++L      S+  +L+ L    +  T+ +    
Sbjct: 380 LSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFN 438

Query: 233 HNLCHLEMLNLLHLGGNKLSGHIPPC-LASLTSLRELDLGSNKLTSSIPSSLWSLGYILE 291
                L  L +L + GN    +  P     L +L  LDL   +L    P++  SL  +  
Sbjct: 439 GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV 498

Query: 292 INLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVD-LETISLAG 344
           +N+S N          + L  L+VLD S N +       +      L  ++L  
Sbjct: 499 LNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQ 552

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  142 bits (360), Expect = 6e-37
 Identities = 70/375 (18%), Positives = 116/375 (30%), Gaps = 47/375 (12%)

Query: 4   QIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPN 63
           +IP  +    + K+L L  N L  L     F+   ++ L+L    +           L +
Sbjct: 21  KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQS-LSH 77

Query: 64  IKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLT 123
           +  L L  N +      + +  + L  L       +       G+L+ L  L++  N + 
Sbjct: 78  LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 137

Query: 124 TESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFS---TSLQRFSASECKLK 180
           +              +N   L +L LS N +  I    +               S   + 
Sbjct: 138 SFKLP-------EYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190

Query: 181 GTIPKEIGHLRGLIYLSLGFNDLNGTIP-TSIGTLKQLQ------GFFLPETNLQGYVPH 233
              P     +R L  L+L  N  +  +  T I  L  L+      G F  E NL+ +   
Sbjct: 191 FIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKS 249

Query: 234 NLCHLEMLNLLHLGGNKLS---GHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYIL 290
            L  L  L +       L      I      LT++    L S  +      S        
Sbjct: 250 ALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY--NFGWQ 307

Query: 291 EINLSSNLLNDSLPSNVQKLKV-------------------LRVLDLSRNQLS--GDIPS 329
            + L +          ++ LK                    L  LDLSRN LS  G    
Sbjct: 308 HLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQ 367

Query: 330 TIGALVDLETISLAG 344
           +      L+ + L+ 
Sbjct: 368 SDFGTTSLKYLDLSF 382

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  122 bits (309), Expect = 3e-30
 Identities = 52/296 (17%), Positives = 96/296 (32%), Gaps = 23/296 (7%)

Query: 49  LSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGN 108
           +  +   +  +   + K L+L  N L      S  +  +L +LDL            + +
Sbjct: 15  MELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQS 74

Query: 109 LRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTS 168
           L HLS L L  N + + +  A         +    L  L+     L  +    IG+   +
Sbjct: 75  LSHLSTLILTGNPIQSLALGA--------FSGLSSLQKLVAVETNLASLENFPIGHL-KT 125

Query: 169 LQRFSASECKLKGT-IPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLP---E 224
           L+  + +   ++   +P+   +L  L +L L  N +     T +  L Q+    L     
Sbjct: 126 LKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLS 185

Query: 225 TNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPP-CLASLTSLRELDL------GSNKLTS 277
            N   ++         L+ L L  N  S ++   C+  L  L    L          L  
Sbjct: 186 LNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEK 245

Query: 278 SIPSSLWSLGYILEINLSSNLLNDSLPSNV---QKLKVLRVLDLSRNQLSGDIPST 330
              S+L  L  +         L+  L   +     L  +    L    +      +
Sbjct: 246 FDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS 301

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  116 bits (292), Expect = 6e-28
 Identities = 44/239 (18%), Positives = 83/239 (34%), Gaps = 14/239 (5%)

Query: 1   MTGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHS 60
             G          +LK L L  N +   +      +  + +L+   + L       +  S
Sbjct: 361 FKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS 419

Query: 61  LPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHI-PNTFGNLRHLSVLSLLM 119
           L N+ YL++   +            + L +L +  N+F  +  P+ F  LR+L+ L L  
Sbjct: 420 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 479

Query: 120 NNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKL 179
             L   S         ++  +   L  L +S N    +          SLQ    S   +
Sbjct: 480 CQLEQLSP--------TAFNSLSSLQVLNMSHNNFFSLDTFPYKCL-NSLQVLDYSLNHI 530

Query: 180 KGTIPKEIGHL-RGLIYLSLGFNDLNGTIPTS--IGTLKQLQGFFLPETNLQGYVPHNL 235
             +  +E+ H    L +L+L  ND   T      +  +K  +   +    ++   P + 
Sbjct: 531 MTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDK 589

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 97.4 bits (243), Expect = 1e-21
 Identities = 38/191 (19%), Positives = 71/191 (37%), Gaps = 6/191 (3%)

Query: 164 NFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLP 223
           N   S +    S   L+            L  L L   ++      +  +L  L    L 
Sbjct: 25  NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILT 84

Query: 224 ETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTS-SIPSS 282
              +Q         L  L  L      L+      +  L +L+EL++  N + S  +P  
Sbjct: 85  GNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144

Query: 283 LWSLGYILEINLSSNLLNDSLPSNVQKLKVLRV----LDLSRNQLSGDIPSTIGALVDLE 338
             +L  +  ++LSSN +     ++++ L  + +    LDLS N ++   P     +  L 
Sbjct: 145 FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LH 203

Query: 339 TISLAGSFGSV 349
            ++L  +F S+
Sbjct: 204 KLTLRNNFDSL 214

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 81.6 bits (202), Expect = 1e-16
 Identities = 25/168 (14%), Positives = 48/168 (28%), Gaps = 9/168 (5%)

Query: 1   MTGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIF-NISTIRNLNLGGNRLSGHLPSMIGH 59
                      L +L+ L +  N+      P IF  +  +  L+L   +L    P+    
Sbjct: 433 TRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS 492

Query: 60  SLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNL-RHLSVLSLL 118
            L +++ L +  NN              L +LD   N           +    L+ L+L 
Sbjct: 493 -LSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLT 551

Query: 119 MNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFS 166
            N+            ++           L++    +    P       
Sbjct: 552 QNDFACTCEHQSFLQWIKDQRQ------LLVEVERMECATPSDKQGMP 593

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 64.7 bits (158), Expect = 3e-11
 Identities = 19/115 (16%), Positives = 41/115 (35%), Gaps = 2/115 (1%)

Query: 2   TGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSL 61
               PT   +L +L+ L +  NN   L       +++++ L+   N +       + H  
Sbjct: 483 EQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFP 542

Query: 62  PNIKYLELGDNNLIGTIPNS--ITNATKLIILDLGFNTFSGHIPNTFGNLRHLSV 114
            ++ +L L  N+   T  +   +        L +         P+    +  LS+
Sbjct: 543 SSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMPVLSL 597

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  147 bits (374), Expect = 8e-39
 Identities = 53/347 (15%), Positives = 113/347 (32%), Gaps = 19/347 (5%)

Query: 4   QIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPN 63
           +IP  +    + + L    N L  +       +  +  L+L   ++   +      S   
Sbjct: 26  EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIY-WIHEDTFQSQHR 82

Query: 64  IKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLT 123
           +  L L  N LI     +++    L  L       S        N + L  L L  N+++
Sbjct: 83  LDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHIS 142

Query: 124 TESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNF-STSLQRFSASECKLKGT 182
           +          L        L  L    N +  +    + +    +    + +   +   
Sbjct: 143 SIK--------LPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA-G 193

Query: 183 IPKEIGHLRGLIYLSLGFNDLNGTIPTSIG--TLKQLQGFFLPETNLQGYVPHNLCHLEM 240
           I            L+ G       I   +   T++ L      + + +   P     L  
Sbjct: 194 IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCE 253

Query: 241 LNL--LHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNL 298
           +++  ++L  +             + L+ELDL +  L+  +PS L  L  + ++ LS+N 
Sbjct: 254 MSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANK 312

Query: 299 LNDSLPSNVQKLKVLRVLDLSRNQLSGDIPS-TIGALVDLETISLAG 344
             +    +      L  L +  N    ++ +  +  L +L  + L+ 
Sbjct: 313 FENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSH 359

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  145 bits (369), Expect = 4e-38
 Identities = 72/329 (21%), Positives = 115/329 (34%), Gaps = 35/329 (10%)

Query: 1   MTGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHS 60
                         L+ L L A +LS  +P  +  +ST++ L L  N+          + 
Sbjct: 266 FFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANKFENLCQISASN- 323

Query: 61  LPNIKYLELGDNNLIGTI-PNSITNATKLIILDLGFN--TFSGHIPNTFGNLRHLSVLSL 117
            P++ +L +  N     +    + N   L  LDL  +    S        NL HL  L+L
Sbjct: 324 FPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNL 383

Query: 118 LMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASEC 177
             N   +  + A  +     L        L L+   L      S       L+  + S  
Sbjct: 384 SYNEPLSLKTEA--FKECPQLE------LLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHS 435

Query: 178 KLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCH 237
            L  +  +    L  L +L+L  N           +L+                      
Sbjct: 436 LLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQ---------------------T 474

Query: 238 LEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSN 297
           L  L +L L    LS        SL  +  +DL  N+LTSS   +L  L   + +NL+SN
Sbjct: 475 LGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHL-KGIYLNLASN 533

Query: 298 LLNDSLPSNVQKLKVLRVLDLSRNQLSGD 326
            ++  LPS +  L   R ++L +N L   
Sbjct: 534 HISIILPSLLPILSQQRTINLRQNPLDCT 562

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  141 bits (357), Expect = 1e-36
 Identities = 72/378 (19%), Positives = 118/378 (31%), Gaps = 45/378 (11%)

Query: 2   TGQIPTEIGNLQNLKSLFLGANNLSGL-------------------------IPPMIFNI 36
           +     +    + LK L    N +  L                         I P  F+ 
Sbjct: 142 SSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDS 201

Query: 37  STIRNLNLGGNRLSGHLPSMIGHS-LPNIKYLELGDNNLIGTIPNSITN--ATKLIILDL 93
           +  ++LN GG +    +   + +S + ++      D +     P          +  ++L
Sbjct: 202 AVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINL 261

Query: 94  GFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNP 153
             + F     NTF     L  L L   +L+            S L     L  L+LS N 
Sbjct: 262 QKHYFFNISSNTFHCFSGLQELDLTATHLS---------ELPSGLVGLSTLKKLVLSANK 312

Query: 154 LGGILPPSIGNFSTSLQRFSASECKLKGTIPKE-IGHLRGLIYLSLGFNDLN--GTIPTS 210
              +   S  NF  SL   S      +  +    + +L  L  L L  +D+         
Sbjct: 313 FENLCQISASNF-PSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQ 371

Query: 211 IGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPP-CLASLTSLRELD 269
           +  L  LQ   L                  L LL L   +L          +L  L+ L+
Sbjct: 372 LRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLN 431

Query: 270 LGSNKLTSSIPSSLWSLGYILEINLSSNLL---NDSLPSNVQKLKVLRVLDLSRNQLSGD 326
           L  + L  S       L  +  +NL  N     N    +++Q L  L +L LS   LS  
Sbjct: 432 LSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSI 491

Query: 327 IPSTIGALVDLETISLAG 344
                 +L  +  + L+ 
Sbjct: 492 DQHAFTSLKMMNHVDLSH 509

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  137 bits (348), Expect = 3e-35
 Identities = 65/345 (18%), Positives = 120/345 (34%), Gaps = 18/345 (5%)

Query: 3   GQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFN--ISTIRNLNLGGNRLSGHLPSMI-GH 59
             I     +    +SL  G      +I   + N  I ++              P++  G 
Sbjct: 192 AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL 251

Query: 60  SLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLM 119
              +++ + L  +       N+    + L  LDL     S  +P+    L  L  L L  
Sbjct: 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSA 310

Query: 120 NNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKL 179
           N        +         +N   L +L + GN     L         +L+    S   +
Sbjct: 311 NKFENLCQIS--------ASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDI 362

Query: 180 K--GTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHN-LC 236
           +       ++ +L  L  L+L +N+       +     QL+   L  T L+     +   
Sbjct: 363 ETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQ 422

Query: 237 HLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSI---PSSLWSLGYILEIN 293
           +L +L +L+L  + L          L +L+ L+L  N          +SL +LG +  + 
Sbjct: 423 NLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILV 482

Query: 294 LSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLE 338
           LS   L+         LK++  +DLS N+L+      +  L  + 
Sbjct: 483 LSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY 527

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  127 bits (320), Expect = 1e-31
 Identities = 56/320 (17%), Positives = 104/320 (32%), Gaps = 20/320 (6%)

Query: 42  LNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGH 101
            N     L+  +P  +     + + LE   N L      + +    L  LDL        
Sbjct: 17  YNCENLGLN-EIPGTL---PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWI 72

Query: 102 IPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPS 161
             +TF +   L  L L  N L   + +A        L+  + L +L      +  I    
Sbjct: 73  HEDTFQSQHRLDTLVLTANPLIFMAETA--------LSGPKALKHLFFIQTGISSIDFIP 124

Query: 162 IGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFF 221
           + N   +L+        +      +      L  L    N ++      + +L+Q     
Sbjct: 125 LHN-QKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLS 183

Query: 222 LPETNLQ-GYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLA--SLTSLRELDLGSNKLTSS 278
           L         +        +   L+ GG +    I   L   ++ SL             
Sbjct: 184 LNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDI 243

Query: 279 IPSSLWSLG--YILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVD 336
            P+    L    +  INL  +   +   +       L+ LDL+   LS ++PS +  L  
Sbjct: 244 SPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLST 302

Query: 337 LETISLAG-SFGSVYKGTIS 355
           L+ + L+   F ++ + + S
Sbjct: 303 LKKLVLSANKFENLCQISAS 322

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  140 bits (354), Expect = 7e-38
 Identities = 53/143 (37%), Positives = 74/143 (51%), Gaps = 12/143 (8%)

Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD- 402
           G FG VYKG + DG  VA+K    +  +    F +E E L   RH +L+ ++  C   + 
Sbjct: 50  GVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE 109

Query: 403 ----FKFMPNGSLEKRLY---SHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDL 455
               +K+M NG+L++ LY        +   +RL I I     L YLH       IIH D+
Sbjct: 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR----AIIHRDV 165

Query: 456 KPTSILLDENMVAHVSDFGISKL 478
           K  +ILLDEN V  ++DFGISK 
Sbjct: 166 KSINILLDENFVPKITDFGISKK 188

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  137 bits (348), Expect = 5e-37
 Identities = 56/149 (37%), Positives = 77/149 (51%), Gaps = 14/149 (9%)

Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRERA---FRSFNSECEVLRNVRHQNLIKILSSCST 400
           G FG VYKG ++DGT VA+K   L+ ER       F +E E++    H+NL+++   C T
Sbjct: 41  GGFGKVYKGRLADGTLVAVK--RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT 98

Query: 401 PDFK-----FMPNGSLEKRLY---SHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
           P  +     +M NGS+   L         LD  +R  I +     L YLH  H    IIH
Sbjct: 99  PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHD-HCDPKIIH 157

Query: 453 CDLKPTSILLDENMVAHVSDFGISKLLGE 481
            D+K  +ILLDE   A V DFG++KL+  
Sbjct: 158 RDVKAANILLDEEFEAVVGDFGLAKLMDY 186

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  137 bits (347), Expect = 1e-36
 Identities = 82/338 (24%), Positives = 148/338 (43%), Gaps = 33/338 (9%)

Query: 7   TEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKY 66
               +L       L   +++ ++      + +I  L + G +++  +  +    L N++Y
Sbjct: 16  FPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-SIQGI--EYLTNLEY 70

Query: 67  LELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTES 126
           L L  N +    P  ++N  KL  L +G N  +    +   NL +L  L L  +N++   
Sbjct: 71  LNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISD-- 124

Query: 127 SSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKE 186
                   +S L N   +  L L  N         + N  T L   + +E K+K   P  
Sbjct: 125 --------ISPLANLTKMYSLNLGANHNLSD-LSPLSNM-TGLNYLTVTESKVKDVTP-- 172

Query: 187 IGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHL 246
           I +L  L  LSL +N +    P  + +L  L  F      +    P  + ++  LN L +
Sbjct: 173 IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKI 228

Query: 247 GGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSN 306
           G NK++   P  LA+L+ L  L++G+N+++    +++  L  +  +N+ SN ++D   S 
Sbjct: 229 GNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD--ISV 282

Query: 307 VQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAG 344
           +  L  L  L L+ NQL  +    IG L +L T+ L+ 
Sbjct: 283 LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQ 320

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  127 bits (321), Expect = 5e-33
 Identities = 76/339 (22%), Positives = 147/339 (43%), Gaps = 33/339 (9%)

Query: 6   PTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIK 65
                 L+++  L +    ++ +    I  ++ +  LNL GN+++   P  + + L  + 
Sbjct: 37  VVTQEELESITKLVVAGEKVASIQG--IEYLTNLEYLNLNGNQITDISP--LSN-LVKLT 91

Query: 66  YLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTE 125
            L +G N +  T  +++ N T L  L L  +  S  I     NL  +  L+L  N+  ++
Sbjct: 92  NLYIGTNKI--TDISALQNLTNLRELYLNEDNIS-DISP-LANLTKMYSLNLGANHNLSD 147

Query: 126 SSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPK 185
                    LS L+N   L YL ++ + +  +    I N  T L   S +  +++   P 
Sbjct: 148 ---------LSPLSNMTGLNYLTVTESKVKDV--TPIANL-TDLYSLSLNYNQIEDISP- 194

Query: 186 EIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLH 245
            +  L  L Y +   N +    P  +  + +L    +    +    P  L +L  L  L 
Sbjct: 195 -LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLE 249

Query: 246 LGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPS 305
           +G N++S      +  LT L+ L++GSN+++    S L +L  +  + L++N L +    
Sbjct: 250 IGTNQISD--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDME 305

Query: 306 NVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAG 344
            +  L  L  L LS+N ++ DI   + +L  +++   A 
Sbjct: 306 VIGGLTNLTTLFLSQNHIT-DIRP-LASLSKMDSADFAN 342

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  114 bits (289), Expect = 1e-28
 Identities = 65/293 (22%), Positives = 120/293 (40%), Gaps = 29/293 (9%)

Query: 7   TEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKY 66
           + + NL  L +L++G N ++ +    + N++ +R L L  + +S  +  +   +L  +  
Sbjct: 82  SPLSNLVKLTNLYIGTNKITDISA--LQNLTNLRELYLNEDNIS-DISPL--ANLTKMYS 136

Query: 67  LELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTES 126
           L LG N+ + +  + ++N T L  L +  +      P    NL  L  LSL  N +    
Sbjct: 137 LNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIED-- 191

Query: 127 SSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKE 186
                   +S L +   L Y     N +  I    + N  T L        K+    P  
Sbjct: 192 --------ISPLASLTSLHYFTAYVNQITDI--TPVANM-TRLNSLKIGNNKITDLSP-- 238

Query: 187 IGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHL 246
           + +L  L +L +G N +  +   ++  L +L+   +    +       L +L  LN L L
Sbjct: 239 LANLSQLTWLEIGTNQI--SDINAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFL 294

Query: 247 GGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLL 299
             N+L       +  LT+L  L L  N +T   P  L SL  +   + ++ ++
Sbjct: 295 NNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVI 345

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 91.8 bits (229), Expect = 1e-20
 Identities = 42/225 (18%), Positives = 88/225 (39%), Gaps = 24/225 (10%)

Query: 4   QIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPN 63
              + + N+  L  L +  + +  + P  I N++ + +L+L  N++   +  +   SL +
Sbjct: 146 SDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIED-ISPL--ASLTS 200

Query: 64  IKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLT 123
           + Y     N +    P  + N T+L  L +G N  +   P    NL  L+ L +  N ++
Sbjct: 201 LHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQIS 256

Query: 124 TESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTI 183
                      ++++ +   L  L +  N +  I    + N  + L     +  +L    
Sbjct: 257 D----------INAVKDLTKLKMLNVGSNQISDI--SVLNNL-SQLNSLFLNNNQLGNED 303

Query: 184 PKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQ 228
            + IG L  L  L L  N +    P  + +L ++         ++
Sbjct: 304 MEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  136 bits (344), Expect = 2e-36
 Identities = 50/287 (17%), Positives = 87/287 (30%), Gaps = 11/287 (3%)

Query: 4   QIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTI--RNLNLGGNRLSGHLPSMIGHSL 61
                  N  N +        L      ++ + +      L L    L    P      L
Sbjct: 47  HSAWRQANSNNPQIETRTGRALKAT-ADLLEDATQPGRVALELRSVPLP-QFPDQAFR-L 103

Query: 62  PNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNN 121
            +++++ +    L+  +P+++     L  L L  N     +P +  +L  L  LS+    
Sbjct: 104 SHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACP 161

Query: 122 -LTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLK 180
            LT                    L  L L    +   LP SI N   +L+        L 
Sbjct: 162 ELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRS-LPASIANL-QNLKSLKIRNSPLS 219

Query: 181 GTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEM 240
             +   I HL  L  L L         P   G    L+   L + +    +P ++  L  
Sbjct: 220 -ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQ 278

Query: 241 LNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLG 287
           L  L L G      +P  +A L +   + +  +           +  
Sbjct: 279 LEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARP 325

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  135 bits (341), Expect = 5e-36
 Identities = 54/322 (16%), Positives = 105/322 (32%), Gaps = 37/322 (11%)

Query: 5   IPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGH-SLPN 63
               +   Q   +      + +        N +  +     G  L      ++   + P 
Sbjct: 28  YHDVLSQWQRHYNADRNRWHSAWRQA----NSNNPQIETRTGRALK-ATADLLEDATQPG 82

Query: 64  IKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLT 123
              LEL    L    P+     + L  + +        +P+T      L  L+L  N L 
Sbjct: 83  RVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR 140

Query: 124 TESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTI 183
                    +  +S+ +   L  L +   P    LP  + +                   
Sbjct: 141 ---------ALPASIASLNRLRELSIRACPELTELPEPLASTD----------------A 175

Query: 184 PKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNL 243
             E   L  L  L L +  +  ++P SI  L+ L+   +  + L   +   + HL  L  
Sbjct: 176 SGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEE 233

Query: 244 LHLGGNKLSGHIPPCLASLTSLRELDL-GSNKLTSSIPSSLWSLGYILEINLSSNLLNDS 302
           L L G     + PP       L+ L L   + L  ++P  +  L  + +++L   +    
Sbjct: 234 LDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSR 292

Query: 303 LPSNVQKLKVLRVLDLSRNQLS 324
           LPS + +L    ++ +  +  +
Sbjct: 293 LPSLIAQLPANCIILVPPHLQA 314

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  126 bits (320), Expect = 5e-33
 Identities = 54/298 (18%), Positives = 100/298 (33%), Gaps = 32/298 (10%)

Query: 59  HSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLL 118
           H     + L    +  +    + ++   +    D      +    N      +  + +  
Sbjct: 9   HHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQAN----SNNPQIETRT 64

Query: 119 MNNLTTESSSAYQWSFLSSLTNCRY--LVYLILSGNPLGGILPPSIGNFSTSLQRFSASE 176
              L          +    L +      V L L   PL    P       + LQ  +   
Sbjct: 65  GRALK---------ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRL-SHLQHMTIDA 113

Query: 177 CKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLC 236
             L   +P  +    GL  L+L  N L   +P SI +L +L+   +        +P  L 
Sbjct: 114 AGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLA 171

Query: 237 ---------HLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLG 287
                     L  L  L L    +   +P  +A+L +L+ L + ++ L++ +  ++  L 
Sbjct: 172 STDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLP 229

Query: 288 YILEINLSSNLLNDSLPSNVQKLKVLRVLDLS-RNQLSGDIPSTIGALVDLETISLAG 344
            + E++L       + P        L+ L L   + L   +P  I  L  LE + L G
Sbjct: 230 KLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRG 286

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 44.6 bits (106), Expect = 4e-05
 Identities = 14/116 (12%), Positives = 30/116 (25%), Gaps = 8/116 (6%)

Query: 232 PHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILE 291
            H+  H      L+  G+         L+        D           +S        +
Sbjct: 5   HHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANS-----NNPQ 59

Query: 292 INLSSNLLNDSLPSNVQKLKV--LRVLDLSRNQLSGDIPSTIGALVDLETISLAGS 345
           I   +     +    ++         L+L    L    P     L  L+ +++  +
Sbjct: 60  IETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAA 114

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  133 bits (336), Expect = 8e-36
 Identities = 38/146 (26%), Positives = 66/146 (45%), Gaps = 13/146 (8%)

Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTP 401
              G ++KG    G D+ +K+  ++    R  R FN EC  LR   H N++ +L +C +P
Sbjct: 21  NHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP 79

Query: 402 DFK-------FMPNGSLEKRLYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHC 453
                     +MP GSL   L+   N+ +D  + +   +D+   + +LH       I   
Sbjct: 80  PAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT--LEPLIPRH 137

Query: 454 DLKPTSILLDENMVAHVSDFGISKLL 479
            L   S+++DE+M A +S   +    
Sbjct: 138 ALNSRSVMIDEDMTARISMADVKFSF 163

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  133 bits (337), Expect = 1e-35
 Identities = 45/145 (31%), Positives = 77/145 (53%), Gaps = 12/145 (8%)

Query: 343 AGSFGSVYKGTISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCST 400
           AGSFG+V++     G+DVA+KI   Q         F  E  +++ +RH N++  + + + 
Sbjct: 47  AGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ 105

Query: 401 PDF-----KFMPNGSLEKRLYSHN--YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHC 453
           P       +++  GSL + L+       LD   RL++  DV   + YLH+   + PI+H 
Sbjct: 106 PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN--RNPPIVHR 163

Query: 454 DLKPTSILLDENMVAHVSDFGISKL 478
           +LK  ++L+D+     V DFG+S+L
Sbjct: 164 NLKSPNLLVDKKYTVKVCDFGLSRL 188

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  130 bits (329), Expect = 9e-35
 Identities = 44/151 (29%), Positives = 73/151 (48%), Gaps = 18/151 (11%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRERA-------FRSFNSECEVLRNVRHQNLIKIL 395
           G FG V+KG  + D + VAIK   L            F+ F  E  ++ N+ H N++K+ 
Sbjct: 30  GGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLY 89

Query: 396 SSCSTPDF---KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
                P     +F+P G L  RL    + +    +L +M+D+   +EY+   + + PI+H
Sbjct: 90  GLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ--NQNPPIVH 147

Query: 453 CDLKPTSILLDE-----NMVAHVSDFGISKL 478
            DL+  +I L        + A V+DFG+S+ 
Sbjct: 148 RDLRSPNIFLQSLDENAPVCAKVADFGLSQQ 178

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  129 bits (327), Expect = 2e-34
 Identities = 42/155 (27%), Positives = 75/155 (48%), Gaps = 17/155 (10%)

Query: 335 VDLETISL-----AGSFGSVYKGTISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVR 387
           +    I++     +GSFG+VYKG      DVA+K+ N+     +  ++F +E  VLR  R
Sbjct: 21  IPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 78

Query: 388 HQNLIKILSSCSTPDF----KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHH 443
           H N++  +   + P      ++    SL   L++     ++ + ++I       ++YLH 
Sbjct: 79  HVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH- 137

Query: 444 GHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL 478
              +  IIH DLK  +I L E+    + DFG++  
Sbjct: 138 ---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATE 169

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  135 bits (342), Expect = 2e-34
 Identities = 65/363 (17%), Positives = 102/363 (28%), Gaps = 25/363 (6%)

Query: 4   QIPTEIGNLQNLKSLFLGANNLSGLIPPMIF-NISTIRNLNLGGNRLSGH-----LPSMI 57
            I  +      L  L L  N  S  I      N++ +    L                 I
Sbjct: 195 FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSI 254

Query: 58  GHSLPNIKYLELGD--NNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVL 115
              L ++   E      N              +  + L   +                 L
Sbjct: 255 MEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSL 312

Query: 116 SLLMNNLTTESSSAYQW-----------SFLSSLTNCRYLVYLILSGNPLGGILPPSIGN 164
           S++   L    +    +           S          L YL LS N L      S  +
Sbjct: 313 SIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSD 372

Query: 165 FS-TSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTS-IGTLKQLQGFFL 222
               SL+    S       +      L  L +L    + L      S   +L++L    +
Sbjct: 373 LGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDI 431

Query: 223 PETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPC-LASLTSLRELDLGSNKLTSSIPS 281
             TN +         L  LN L + GN    +      A+ T+L  LDL   +L      
Sbjct: 432 SYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWG 491

Query: 282 SLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETIS 341
              +L  +  +N+S N L     S+  +L  L  LD S N++             L   +
Sbjct: 492 VFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFN 551

Query: 342 LAG 344
           L  
Sbjct: 552 LTN 554

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  128 bits (323), Expect = 5e-32
 Identities = 68/380 (17%), Positives = 124/380 (32%), Gaps = 33/380 (8%)

Query: 4   QIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPN 63
           ++P +I +  + K++ L  N L  L      N S ++ L+L    +   +     H L +
Sbjct: 25  KVPDDIPS--STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIE-TIEDKAWHGLHH 81

Query: 64  IKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLT 123
           +  L L  N +    P S +  T L  L       +       G L  L  L++  N + 
Sbjct: 82  LSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIH 141

Query: 124 TESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNF---STSLQRFSASECKLK 180
           +    A    + S+LTN   LV++ LS N +  I    +               S   + 
Sbjct: 142 SCKLPA----YFSNLTN---LVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID 194

Query: 181 GTIPKEIGHLRGLIYLSLGFNDLNGTIP-TSIGTLKQLQGFFLPETNLQGY--------- 230
             I  +      L  L+L  N  +  I  T +  L  L    L     +           
Sbjct: 195 -FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPS 253

Query: 231 VPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYIL 290
           +   LC + +     L               L ++  + L    +       +       
Sbjct: 254 IMEGLCDVTIDE-FRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQ 310

Query: 291 EINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAG-SFGSV 349
            +++    L      +   L  L+ L L+ N+ S  I     AL  L  + L+  +    
Sbjct: 311 SLSIIRCQLKQFPTLD---LPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFS 365

Query: 350 YKGTISDGTDVAIKIFNLQR 369
              + SD    +++  +L  
Sbjct: 366 GCCSYSDLGTNSLRHLDLSF 385

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  125 bits (317), Expect = 4e-31
 Identities = 70/376 (18%), Positives = 120/376 (31%), Gaps = 44/376 (11%)

Query: 2   TGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSL 61
               P     L +L++L      L+ L    I  + T++ LN+  N +          +L
Sbjct: 93  QSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNL 152

Query: 62  PNIKYLELGDNNL---------------------------IGTIPNSITNATKLIILDLG 94
            N+ +++L  N +                           I  I +      KL  L L 
Sbjct: 153 TNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLR 212

Query: 95  FNTFSGHIP-NTFGNLRHLSVLSLLMNNLTTESS-SAYQWSFLSSLTNCRYLVYLILSGN 152
            N  S +I      NL  L V  L++     E +   ++ S +  L +        L+  
Sbjct: 213 GNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTID-EFRLTYT 271

Query: 153 PLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIG 212
                        + ++   S +   +     +++        LS+    L       + 
Sbjct: 272 NDFSDDIVKFHCLA-NVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQLKQFPTLDLP 328

Query: 213 TLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPC---LASLTSLRELD 269
            LK L       T  +G +      L  L+ L L  N LS     C        SLR LD
Sbjct: 329 FLKSLT-----LTMNKGSISFKKVALPSLSYLDLSRNALSF-SGCCSYSDLGTNSLRHLD 382

Query: 270 LGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNV-QKLKVLRVLDLSRNQLSGDIP 328
           L  N     + ++   L  +  ++   + L      +    L+ L  LD+S      D  
Sbjct: 383 LSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFD 441

Query: 329 STIGALVDLETISLAG 344
                L  L T+ +AG
Sbjct: 442 GIFLGLTSLNTLKMAG 457

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  122 bits (308), Expect = 5e-30
 Identities = 52/324 (16%), Positives = 93/324 (28%), Gaps = 38/324 (11%)

Query: 1   MTGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHS 60
                  +   L N+ ++ L   ++  L    +      ++L++   +L           
Sbjct: 273 DFSDDIVKFHCLANVSAMSLAGVSIKYL--EDVPKHFKWQSLSIIRCQLK----QFPTLD 326

Query: 61  LPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMN 120
           LP +K L L  N    +I         L  LDL  N  S     ++ +L   S+  L ++
Sbjct: 327 LPFLKSLTLTMNKG--SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLS 384

Query: 121 NLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLK 180
                  S       ++      L +L    + L  +   S       L     S    K
Sbjct: 385 FNGAIIMS-------ANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTK 437

Query: 181 GTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEM 240
                    L  L  L +  N                               +   +   
Sbjct: 438 IDFDGIFLGLTSLNTLKMAGNSFKDNTL-----------------------SNVFANTTN 474

Query: 241 LNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLN 300
           L  L L   +L         +L  L+ L++  N L     S    L  +  ++ S N + 
Sbjct: 475 LTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE 534

Query: 301 DSLPSNVQKLKVLRVLDLSRNQLS 324
            S        K L   +L+ N ++
Sbjct: 535 TSKGILQHFPKSLAFFNLTNNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  112 bits (281), Expect = 1e-26
 Identities = 60/315 (19%), Positives = 102/315 (32%), Gaps = 19/315 (6%)

Query: 8   EIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYL 67
           ++      +SL +    L         ++  +++L L  N+ S     +   +LP++ YL
Sbjct: 302 DVPKHFKWQSLSIIRCQLKQFPT---LDLPFLKSLTLTMNKGSISFKKV---ALPSLSYL 355

Query: 68  ELGDNNL--IGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTE 125
           +L  N L   G    S      L  LDL FN     +   F  L  L  L    + L   
Sbjct: 356 DLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRV 414

Query: 126 SSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPK 185
           +         S+  +   L+YL +S                TSL     +    K     
Sbjct: 415 TE-------FSAFLSLEKLLYLDISYTNTKIDFDGIFLGL-TSLNTLKMAGNSFKDNTLS 466

Query: 186 EI-GHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLL 244
            +  +   L +L L    L         TL +LQ   +   NL      +   L  L+ L
Sbjct: 467 NVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTL 526

Query: 245 HLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLP 304
               N++            SL   +L +N +   I      L ++ E       +     
Sbjct: 527 DCSFNRIETSKGILQHFPKSLAFFNLTNNSVA-CICEHQKFLQWVKEQKQFLVNVEQMTC 585

Query: 305 SNVQKLKVLRVLDLS 319
           +   ++    VLD +
Sbjct: 586 ATPVEMNTSLVLDFN 600

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 73.5 bits (181), Expect = 5e-14
 Identities = 28/165 (16%), Positives = 57/165 (34%), Gaps = 5/165 (3%)

Query: 181 GTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEM 240
           G++   I  +  +         L+  +P  I +    +   L    L+    ++  +   
Sbjct: 2   GSLNPCIEVVPNIT-YQCMDQKLS-KVPDDIPS--STKNIDLSFNPLKILKSYSFSNFSE 57

Query: 241 LNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLN 300
           L  L L   ++          L  L  L L  N + S  P S   L  +  +      L 
Sbjct: 58  LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117

Query: 301 DSLPSNVQKLKVLRVLDLSRNQLSG-DIPSTIGALVDLETISLAG 344
                 + +L  L+ L+++ N +    +P+    L +L  + L+ 
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSY 162

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  130 bits (328), Expect = 2e-34
 Identities = 42/157 (26%), Positives = 68/157 (43%), Gaps = 15/157 (9%)

Query: 334 LVDLETISL-----AGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRH 388
           ++D + I +      G+FG V K       DVAIK    + ER  ++F  E   L  V H
Sbjct: 4   MIDYKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNH 60

Query: 389 QNLIKILSSCSTPDF---KFMPNGSLEKRLYSHN--YFLDILERLNIMIDVGSTLEYLHH 443
            N++K+  +C  P     ++   GSL   L+      +      ++  +     + YLH 
Sbjct: 61  PNIVKLYGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHS 120

Query: 444 GHSSAPIIHCDLKPTSILLDENM-VAHVSDFGISKLL 479
                 +IH DLKP ++LL     V  + DFG +  +
Sbjct: 121 -MQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  129 bits (326), Expect = 7e-33
 Identities = 86/352 (24%), Positives = 147/352 (41%), Gaps = 36/352 (10%)

Query: 7   TEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKY 66
           T + NL NL  L L  N ++ + P  + N++ +  L L  N +S  + ++ G  L +++ 
Sbjct: 106 TPLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD-ISALSG--LTSLQQ 160

Query: 67  LELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTES 126
           L  G N +    P  + N T L  LD+  N  S    +    L +L  L    N ++   
Sbjct: 161 LSFG-NQVTDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISD-- 213

Query: 127 SSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKE 186
                   ++ L     L  L L+GN L  I   ++ +  T+L     +  ++    P  
Sbjct: 214 --------ITPLGILTNLDELSLNGNQLKDI--GTLASL-TNLTDLDLANNQISNLAP-- 260

Query: 187 IGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHL 246
           +  L  L  L LG N ++   P  +  L  L    L E  L+      + +L+ L  L L
Sbjct: 261 LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLED--ISPISNLKNLTYLTL 316

Query: 247 GGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSN 306
             N +S   P  ++SLT L+ L   +NK++    SSL +L  I  ++   N ++D   + 
Sbjct: 317 YFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISD--LTP 370

Query: 307 VQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAGSFGSVYKGTISDGT 358
           +  L  +  L L+    + + P    A V +       +   +   TISDG 
Sbjct: 371 LANLTRITQLGLNDQAWT-NAPVNYKANVSIPNTVKNVTGALIAPATISDGG 421

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  124 bits (313), Expect = 4e-31
 Identities = 86/341 (25%), Positives = 143/341 (41%), Gaps = 37/341 (10%)

Query: 4   QIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPN 63
           +    +  L NL  +    N L+ + P  + N++ + ++ +  N+++    + + + L N
Sbjct: 59  KSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD--ITPLAN-LTN 113

Query: 64  IKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLT 123
           +  L L +N +    P  + N T L  L+L  NT S    +    L  L  LS   N +T
Sbjct: 114 LTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLS-FGNQVT 168

Query: 124 TESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTI 183
                      L  L N   L  L +S N +  I    +    T+L+   A+  ++    
Sbjct: 169 D----------LKPLANLTTLERLDISSNKVSDI--SVLAKL-TNLESLIATNNQISDIT 215

Query: 184 PKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNL 243
           P  +G L  L  LSL  N L      ++ +L  L    L    +    P  L  L  L  
Sbjct: 216 P--LGILTNLDELSLNGNQL--KDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTE 269

Query: 244 LHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSL 303
           L LG N++S  I P LA LT+L  L+L  N+L    P  + +L  +  + L  N ++D  
Sbjct: 270 LKLGANQISN-ISP-LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDI- 324

Query: 304 PSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAG 344
            S V  L  L+ L    N++S    S++  L ++  +S   
Sbjct: 325 -SPVSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGH 362

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  121 bits (306), Expect = 3e-30
 Identities = 80/336 (23%), Positives = 136/336 (40%), Gaps = 37/336 (11%)

Query: 9   IGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLE 68
              L       LG  N++  +     ++  +  L      +       + + L N+  + 
Sbjct: 20  DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEY-LNNLTQIN 74

Query: 69  LGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSS 128
             +N L    P  + N TKL+ + +  N  +   P    NL +L+ L+L  N +T     
Sbjct: 75  FSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITD---- 126

Query: 129 AYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIG 188
                 +  L N   L  L LS N +  I   ++    TSLQ+ S           K + 
Sbjct: 127 ------IDPLKNLTNLNRLELSSNTISDI--SALSGL-TSLQQLSFGNQVTD---LKPLA 174

Query: 189 HLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGG 248
           +L  L  L +  N +  +  + +  L  L+        +       L  L  L+ L L G
Sbjct: 175 NLTTLERLDISSNKV--SDISVLAKLTNLESLIATNNQISDI--TPLGILTNLDELSLNG 230

Query: 249 NKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQ 308
           N+L       LASLT+L +LDL +N++++  P  L  L  + E+ L +N +++   S + 
Sbjct: 231 NQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNI--SPLA 284

Query: 309 KLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAG 344
            L  L  L+L+ NQL    P  I  L +L  ++L  
Sbjct: 285 GLTALTNLELNENQLEDISP--ISNLKNLTYLTLYF 318

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 96.6 bits (241), Expect = 9e-22
 Identities = 67/319 (21%), Positives = 111/319 (34%), Gaps = 76/319 (23%)

Query: 6   PTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIK 65
            + +  L NL+SL    N +S + P                              L N+ 
Sbjct: 192 ISVLAKLTNLESLIATNNQISDITPL---------------------------GILTNLD 224

Query: 66  YLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTE 125
            L L  N L      ++ + T L  LDL  N  S   P     L  L+ L L  N ++  
Sbjct: 225 ELSLNGNQL--KDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN- 279

Query: 126 SSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPK 185
                    +S L     L  L L+ N L  I                            
Sbjct: 280 ---------ISPLAGLTALTNLELNENQLEDI---------------------------S 303

Query: 186 EIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLH 245
            I +L+ L YL+L FN+++   P  + +L +LQ  F     +      +L +L  +N L 
Sbjct: 304 PISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLS 359

Query: 246 LGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPS 305
            G N++S   P  LA+LT + +L L     T++  +   ++   +   + +       P+
Sbjct: 360 AGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANV--SIPNTVKNVTGALIAPA 415

Query: 306 NVQKLKVLRVLDLSRNQLS 324
            +         D++ N  S
Sbjct: 416 TISDGGSYTEPDITWNLPS 434

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 95.4 bits (238), Expect = 2e-21
 Identities = 59/274 (21%), Positives = 103/274 (37%), Gaps = 31/274 (11%)

Query: 71  DNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAY 130
            +  I  I    T   + +   LG    +  +     +L  ++ L      + +      
Sbjct: 10  QDTPINQIFT-DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS------ 60

Query: 131 QWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHL 190
               +  +     L  +  S N L  I    + N  T L     +  ++    P  + +L
Sbjct: 61  ----IDGVEYLNNLTQINFSNNQLTDI--TPLKNL-TKLVDILMNNNQIADITP--LANL 111

Query: 191 RGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNK 250
             L  L+L  N +    P  +  L  L    L    +       L  L  L  L   GN+
Sbjct: 112 TNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQ 166

Query: 251 LSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKL 310
           ++   P  LA+LT+L  LD+ SNK++    S L  L  +  +  ++N ++D   + +  L
Sbjct: 167 VTDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDI--TPLGIL 220

Query: 311 KVLRVLDLSRNQLSGDIPSTIGALVDLETISLAG 344
             L  L L+ NQL      T+ +L +L  + LA 
Sbjct: 221 TNLDELSLNGNQLKD--IGTLASLTNLTDLDLAN 252

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  125 bits (315), Expect = 2e-32
 Identities = 37/153 (24%), Positives = 65/153 (42%), Gaps = 19/153 (12%)

Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPDF 403
           G FG V+K  +     VA+KIF +Q +++++    E   L  ++H+N+++ + +      
Sbjct: 35  GRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQ-NEYEVYSLPGMKHENILQFIGAEKRGTS 92

Query: 404 K---------FMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLH------HGHSSA 448
                     F   GSL   L      +   E  +I   +   L YLH            
Sbjct: 93  VDVDLWLITAFHEKGSLSDFL--KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKP 150

Query: 449 PIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
            I H D+K  ++LL  N+ A ++DFG++     
Sbjct: 151 AISHRDIKSKNVLLKNNLTACIADFGLALKFEA 183

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  123 bits (311), Expect = 5e-32
 Identities = 39/145 (26%), Positives = 67/145 (46%), Gaps = 10/145 (6%)

Query: 343 AGSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTP 401
            G FG   K T    G  + +K      E   R+F  E +V+R + H N++K +      
Sbjct: 20  KGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD 79

Query: 402 DF-----KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLK 456
                  +++  G+L   + S +      +R++   D+ S + YLH    S  IIH DL 
Sbjct: 80  KRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH----SMNIIHRDLN 135

Query: 457 PTSILLDENMVAHVSDFGISKLLGE 481
             + L+ EN    V+DFG+++L+ +
Sbjct: 136 SHNCLVRENKNVVVADFGLARLMVD 160

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  122 bits (308), Expect = 6e-32
 Identities = 37/166 (22%), Positives = 70/166 (42%), Gaps = 26/166 (15%)

Query: 335 VDLETISL-----AGSFGSVYKGTISDGTDVAIKIFNLQRE----RAFRSFNSECEVLRN 385
           +D   ++L      G FG VY+     G +VA+K      +    +   +   E ++   
Sbjct: 4   IDFAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAM 62

Query: 386 VRHQNLIKILSSCSTPDF-----KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEY 440
           ++H N+I +   C          +F   G L + L      +     +N  + +   + Y
Sbjct: 63  LKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL--SGKRIPPDILVNWAVQIARGMNY 120

Query: 441 LHHGHSSAPIIHCDLKPTSILLDE--------NMVAHVSDFGISKL 478
           LH   +  PIIH DLK ++IL+ +        N +  ++DFG+++ 
Sbjct: 121 LHD-EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE 165

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  122 bits (308), Expect = 1e-31
 Identities = 41/151 (27%), Positives = 70/151 (46%), Gaps = 21/151 (13%)

Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEV--LRNVRHQNLIKILSSCSTP 401
           G +G V++G+   G +VA+KIF     R  +S+  E E+     +RH+N++  ++S  T 
Sbjct: 19  GRYGEVWRGSW-QGENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFIASDMTS 74

Query: 402 DFK---------FMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLH----HGHSSA 448
                       +   GSL   L      LD +  L I++ + S L +LH          
Sbjct: 75  RHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP 132

Query: 449 PIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
            I H DLK  +IL+ +N    ++D G++ + 
Sbjct: 133 AIAHRDLKSKNILVKKNGQCCIADLGLAVMH 163

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  123 bits (310), Expect = 1e-31
 Identities = 44/167 (26%), Positives = 72/167 (43%), Gaps = 28/167 (16%)

Query: 335 VDLETISLA-----GSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEV--LRNVR 387
           +DL+ + L      G +G+VYKG++ D   VA+K+F+    +   +F +E  +  +  + 
Sbjct: 10  LDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNIYRVPLME 65

Query: 388 HQNLIKILSSCSTPDFK----------FMPNGSLEKRLYSHNYFLDILERLNIMIDVGST 437
           H N+ + +                   + PNGSL K L  H    D +    +   V   
Sbjct: 66  HDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRG 123

Query: 438 LEYLH-----HGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
           L YLH       H    I H DL   ++L+  +    +SDFG+S  L
Sbjct: 124 LAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRL 170

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  122 bits (308), Expect = 1e-31
 Identities = 37/156 (23%), Positives = 69/156 (44%), Gaps = 19/156 (12%)

Query: 335 VDLETISL-----AGSFGSVYKGTISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVR 387
           +  E + +      G FG VY G      +VAI++ +++R  E   ++F  E    R  R
Sbjct: 30  IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTR 87

Query: 388 HQNLIKILSSCSTPDF-----KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLH 442
           H+N++  + +C +P             +L   +      LD+ +   I  ++   + YLH
Sbjct: 88  HENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH 147

Query: 443 HGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL 478
               +  I+H DLK  ++  D   V  ++DFG+  +
Sbjct: 148 ----AKGILHKDLKSKNVFYDNGKV-VITDFGLFSI 178

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  120 bits (303), Expect = 8e-31
 Identities = 47/149 (31%), Positives = 72/149 (48%), Gaps = 16/149 (10%)

Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRERA----FRSFNSECEVLRNVRHQNLIKILSSCS 399
           G FG VYKG + + T VA+K      +       + F+ E +V+   +H+NL+++L   S
Sbjct: 42  GGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSS 100

Query: 400 TPDFK-----FMPNGSLEKRLYSHNYF--LDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
             D       +MPNGSL  RL   +    L    R  I     + + +LH        IH
Sbjct: 101 DGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN----HHIH 156

Query: 453 CDLKPTSILLDENMVAHVSDFGISKLLGE 481
            D+K  +ILLDE   A +SDFG+++   +
Sbjct: 157 RDIKSANILLDEAFTAKISDFGLARASEK 185

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  120 bits (303), Expect = 1e-30
 Identities = 42/184 (22%), Positives = 73/184 (39%), Gaps = 26/184 (14%)

Query: 316 LDLSRNQLSGDIPSTIGALVDLETISL-----AGSFGSVYKGTISDGTDVAIKIFNLQRE 370
           ++ S++  SG     +      + I +      G +G V+ G    G  VA+K+F    E
Sbjct: 15  IEQSQSSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEE 73

Query: 371 RAFRSFNSECEV--LRNVRHQNLIKILSSCSTPDFK---------FMPNGSLEKRLYSHN 419
               S+  E E+     +RH+N++  +++                +  NGSL   L   +
Sbjct: 74  A---SWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL--KS 128

Query: 420 YFLDILERLNIMIDVGSTLEYLH----HGHSSAPIIHCDLKPTSILLDENMVAHVSDFGI 475
             LD    L +     S L +LH           I H DLK  +IL+ +N    ++D G+
Sbjct: 129 TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 188

Query: 476 SKLL 479
           +   
Sbjct: 189 AVKF 192

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  124 bits (314), Expect = 1e-30
 Identities = 67/343 (19%), Positives = 120/343 (34%), Gaps = 20/343 (5%)

Query: 6   PTEIGNLQNLKSLFLGANNLSGLIPPMIF-NISTIRNLNLGGNRLSGHLPSMIGHSLPNI 64
            +    L+ L+ L LG+      I    F N+  +R L+LG +++   L       L ++
Sbjct: 41  ASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHL 99

Query: 65  KYLELGDNNLIGTI--PNSITNATKLIILDLGFNTFSG-HIPNTFGNLRHLSVLSLLMNN 121
             L L    L   +       N   L  LDL  N     ++  +FG L  L  +    N 
Sbjct: 100 FELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQ 159

Query: 122 LTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKG 181
           +            L  L   + L +  L+ N L   +    G      +        + G
Sbjct: 160 IFLVCEHE-----LEPLQG-KTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSG 213

Query: 182 TIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEML 241
                  +   +       N ++ +   S+     + G      N++    +    L   
Sbjct: 214 -------NGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARS 266

Query: 242 NL--LHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLL 299
           ++  L L    +         +L  L+ L+L  NK+      + + L  +  +NLS NLL
Sbjct: 267 SVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLL 326

Query: 300 NDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISL 342
            +   SN   L  +  +DL +N ++     T   L  L+T+ L
Sbjct: 327 GELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDL 369

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  104 bits (262), Expect = 5e-24
 Identities = 70/343 (20%), Positives = 130/343 (37%), Gaps = 31/343 (9%)

Query: 6   PTEIGNLQNLKSLFLGANNLSGLIPPMIFNI--STIRNLNLGGNRLSGHLPSMIGHSLPN 63
              +    ++     G +N+          +  S++R+L+L    +   L S +  +L +
Sbjct: 233 AFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVF-SLNSRVFETLKD 291

Query: 64  IKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLT 123
           +K L L  N +      +      L +L+L +N       + F  L  ++ + L  N++ 
Sbjct: 292 LKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIA 351

Query: 124 TESSSAYQW-----------SFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRF 172
                 +++           + L+++     +  + LSGN L      ++   + +    
Sbjct: 352 IIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLV-----TLPKINLTANLI 406

Query: 173 SASECKLKG-TIPKEIGHLRGLIYLSLGFNDLNGTIPTSI-GTLKQLQGFFLPETNLQGY 230
             SE +L+   I   +  +  L  L L  N  +             L+  FL E  LQ  
Sbjct: 407 HLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLA 466

Query: 231 VPHNLC-----HLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWS 285
               LC      L  L +L+L  N L+   P   + LT+LR L L SN+LT    + L  
Sbjct: 467 WETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDL-- 524

Query: 286 LGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIP 328
              +  +++S N L    P     L    VLD++ N+   +  
Sbjct: 525 PANLEILDISRNQLLAPNPDVFVSLS---VLDITHNKFICECE 564

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 50.2 bits (120), Expect = 1e-06
 Identities = 33/132 (25%), Positives = 57/132 (43%), Gaps = 11/132 (8%)

Query: 10  GNLQNLKSLFLGANNLSGL----IPPMIF-NISTIRNLNLGGNRLSGHLPSMIGHSLPNI 64
               +L+ LFLG N L       +   +F  +S ++ L L  N L+  LP  +   L  +
Sbjct: 448 SENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLN-SLPPGVFSHLTAL 506

Query: 65  KYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTT 124
           + L L ++N +  + ++      L ILD+  N      P+ F     LSVL +  N    
Sbjct: 507 RGLSL-NSNRLTVLSHN-DLPANLEILDISRNQLLAPNPDVF---VSLSVLDITHNKFIC 561

Query: 125 ESSSAYQWSFLS 136
           E   +   ++L+
Sbjct: 562 ECELSTFINWLN 573

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 41.7 bits (98), Expect = 5e-04
 Identities = 25/99 (25%), Positives = 45/99 (45%), Gaps = 6/99 (6%)

Query: 6   PTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIK 65
                 L +L+ L+L  N L+ L P +  +++ +R L+L  NRL+  L         N++
Sbjct: 473 WDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSH--NDLPANLE 529

Query: 66  YLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPN 104
            L++  N L+   P+   +   L +LD+  N F      
Sbjct: 530 ILDISRNQLLAPNPDVFVS---LSVLDITHNKFICECEL 565

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  123 bits (311), Expect = 2e-30
 Identities = 78/303 (25%), Positives = 123/303 (40%), Gaps = 54/303 (17%)

Query: 42  LNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGH 101
           LN+G + L+  LP  +     +I  L + DNNL  ++P        L  L++  N  +  
Sbjct: 45  LNVGESGLT-TLPDCLP---AHITTLVIPDNNLT-SLPALPPE---LRTLEVSGNQLT-S 95

Query: 102 IPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPS 161
           +P     L  LS+ S  + +L    S                L  L + GN L   LP  
Sbjct: 96  LPVLPPGLLELSIFSNPLTHLPALPSG---------------LCKLWIFGNQLTS-LPVL 139

Query: 162 IGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFF 221
                  LQ  S S+ +L  ++P     L     L    N L  ++P     L++L    
Sbjct: 140 PPG----LQELSVSDNQLA-SLPALPSELC---KLWAYNNQLT-SLPMLPSGLQELS--- 187

Query: 222 LPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPS 281
           + +  L   +P     L  L   +   N+L+  +P   A  + L+EL +  N+LT S+P 
Sbjct: 188 VSDNQLA-SLPTLPSELYKLWAYN---NRLT-SLP---ALPSGLKELIVSGNRLT-SLPV 238

Query: 282 SLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETIS 341
               L    E+ +S N L  SLP        L  L + RNQL+  +P ++  L    T++
Sbjct: 239 LPSELK---ELMVSGNRL-TSLPMLPSG---LLSLSVYRNQLT-RLPESLIHLSSETTVN 290

Query: 342 LAG 344
           L G
Sbjct: 291 LEG 293

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  116 bits (293), Expect = 4e-28
 Identities = 70/335 (20%), Positives = 115/335 (34%), Gaps = 77/335 (22%)

Query: 4   QIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPN 63
            +P  +    ++ +L +  NNL+ L P        +R L + GN+L+  LP +    L  
Sbjct: 54  TLPDCLPA--HITTLVIPDNNLTSL-PA---LPPELRTLEVSGNQLT-SLPVLPPG-LLE 105

Query: 64  IKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLT 123
           +        +L    P   +    L  L +  N  +  +P     L+ LSV     N L 
Sbjct: 106 LSIFSNPLTHL----PALPSG---LCKLWIFGNQLT-SLPVLPPGLQELSVSD---NQLA 154

Query: 124 TESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTI 183
                    S  +  +    L  L    N L   LP         LQ  S S+ +L  ++
Sbjct: 155 ---------SLPALPSE---LCKLWAYNNQLTS-LPMLPSG----LQELSVSDNQLA-SL 196

Query: 184 PKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNL 243
           P     L  L   +     L    P     LK+                           
Sbjct: 197 PTLPSELYKLWAYNNRLTSL----PALPSGLKE--------------------------- 225

Query: 244 LHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSL 303
           L + GN+L+  +P      + L+EL +  N+LT S+P     L   L +++  N L   L
Sbjct: 226 LIVSGNRLT-SLPV---LPSELKELMVSGNRLT-SLPMLPSGL---LSLSVYRNQLT-RL 276

Query: 304 PSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLE 338
           P ++  L     ++L  N LS      +  +    
Sbjct: 277 PESLIHLSSETTVNLEGNPLSERTLQALREITSAP 311

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 86.5 bits (214), Expect = 4e-18
 Identities = 50/291 (17%), Positives = 90/291 (30%), Gaps = 42/291 (14%)

Query: 4   QIPTEIGNLQNLKSLFLGANNLSGL----------------IPPMIFNISTIRNLNLGGN 47
            +P     L  L        +L  L                +P +   +   + L++  N
Sbjct: 95  SLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTSLPVLPPGL---QELSVSDN 151

Query: 48  RLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFG 107
           +L+  LP++       +  L   +N L  ++P   +    L  L +  N  +  +P    
Sbjct: 152 QLA-SLPALPS----ELCKLWAYNNQLT-SLPMLPSG---LQELSVSDNQLA-SLPTLPS 201

Query: 108 NLRHLSVLSLLMNNLTTESSS----AYQWSFLSSL-TNCRYLVYLILSGNPLGGILPPSI 162
            L  L   +  + +L    S         + L+SL      L  L++SGN L   LP   
Sbjct: 202 ELYKLWAYNNRLTSLPALPSGLKELIVSGNRLTSLPVLPSELKELMVSGNRLT-SLPMLP 260

Query: 163 GNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFL 222
                 L   S    +L   +P+ + HL     ++L  N L+     ++  +    G+  
Sbjct: 261 SG----LLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSG 315

Query: 223 PETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSN 273
           P                 L+L     + L        A            N
Sbjct: 316 PIIRFDMAGASAPRETRALHLAAA--DWLVPAREGEPAPADRWHMFGQEDN 364

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 55.7 bits (134), Expect = 2e-08
 Identities = 23/94 (24%), Positives = 36/94 (38%), Gaps = 8/94 (8%)

Query: 236 CHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLS 295
           C      +L++G + L+  +P CL     +  L +  N LT S+P+    L     + +S
Sbjct: 37  CLNNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPALPPEL---RTLEVS 89

Query: 296 SNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPS 329
            N L  SLP     L  L +       L      
Sbjct: 90  GNQLT-SLPVLPPGLLELSIFSNPLTHLPALPSG 122

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 50.7 bits (121), Expect = 8e-07
 Identities = 24/91 (26%), Positives = 42/91 (46%), Gaps = 16/91 (17%)

Query: 255 IPPCLASLTSLRELDLGSNKLTS---SIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLK 311
           +  CL        L++G + LT+    +P+ + +L       +  N L  SLP+   +  
Sbjct: 34  MRACL--NNGNAVLNVGESGLTTLPDCLPAHITTL------VIPDNNLT-SLPALPPE-- 82

Query: 312 VLRVLDLSRNQLSGDIPSTIGALVDLETISL 342
            LR L++S NQL+  +P     L++L   S 
Sbjct: 83  -LRTLEVSGNQLT-SLPVLPPGLLELSIFSN 111

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  119 bits (300), Expect = 8e-30
 Identities = 66/340 (19%), Positives = 123/340 (36%), Gaps = 25/340 (7%)

Query: 5   IPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNI 64
           I + +        + +               ++  + +    + +   LP+ +  S   +
Sbjct: 13  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 71

Query: 65  KYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTT 124
           + L L D  +      +   A  +  L +GFN      P+ F N+  L+VL L  N+L++
Sbjct: 72  ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS 131

Query: 125 ESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIP 184
                          N   L  L +S N L  I        +TSLQ    S  +L   + 
Sbjct: 132 LPRGI--------FHNTPKLTTLSMSNNNLERI-EDDTFQATTSLQNLQLSSNRLT-HVD 181

Query: 185 KEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLL 244
             +  +  L + ++ +N L     +++     ++       ++          L +L L 
Sbjct: 182 --LSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSINVVRGPVNVELTILKLQ 234

Query: 245 HLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLP 304
           H   N L+      L +   L E+DL  N+L   +      +  +  + +S+N L  +L 
Sbjct: 235 H---NNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALN 288

Query: 305 SNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAG 344
              Q +  L+VLDLS N L   +         LE + L  
Sbjct: 289 LYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDH 327

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  117 bits (295), Expect = 3e-29
 Identities = 64/336 (19%), Positives = 112/336 (33%), Gaps = 32/336 (9%)

Query: 11  NLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELG 70
            L N K +    + +  L   ++ +   +  LNL   ++   + +        I+ L + 
Sbjct: 43  TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYM- 100

Query: 71  DNNLIGTIPNSI-TNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSA 129
             N I  +P  +  N   L +L L  N  S      F N   L+ LS+  NNL       
Sbjct: 101 GFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDT 160

Query: 130 YQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGH 189
                         L  L LS N L  +    +     SL   + S   L       +  
Sbjct: 161 --------FQATTSLQNLQLSSNRLTHV---DLSLI-PSLFHANVSYNLL-----STLAI 203

Query: 190 LRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGN 249
              +  L    N +N  +        +L    L   NL       L +   L  + L  N
Sbjct: 204 PIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYN 258

Query: 250 KLSGHIPP-CLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQ 308
           +L   I       +  L  L + +N+L  ++      +  +  ++LS N L   +  N  
Sbjct: 259 ELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHL-LHVERNQP 315

Query: 309 KLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAG 344
           +   L  L L  N +   +   +     L+ ++L+ 
Sbjct: 316 QFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSH 348

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 76.6 bits (189), Expect = 3e-15
 Identities = 52/269 (19%), Positives = 95/269 (35%), Gaps = 52/269 (19%)

Query: 10  GNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLEL 69
            N   L +L +  NNL  +        ++++NL L  NRL+ H+       +P++ +  +
Sbjct: 138 HNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDL---SLIPSLFHANV 193

Query: 70  GDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSA 129
             N L     +++     +  LD   N+ +  +         L++L L  NNLT      
Sbjct: 194 SYNLL-----STLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNLTD----- 240

Query: 130 YQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGH 189
                 + L N   LV + LS N L  I+                               
Sbjct: 241 -----TAWLLNYPGLVEVDLSYNELEKIMYHPFVK------------------------- 270

Query: 190 LRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGN 249
           ++ L  L +  N L   +      +  L+   L   +L  +V  N    + L  L+L  N
Sbjct: 271 MQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHN 328

Query: 250 KLSGHIPPCLASLTSLRELDLGSNKLTSS 278
            +   +    ++  +L+ L L  N    +
Sbjct: 329 SIV-TLKL--STHHTLKNLTLSHNDWDCN 354

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 75.1 bits (185), Expect = 8e-15
 Identities = 44/252 (17%), Positives = 86/252 (34%), Gaps = 19/252 (7%)

Query: 95  FNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPL 154
           +N           +            ++  ++   Y      +L N      +    + +
Sbjct: 1   YNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNN---QKIVTFKNSTM 57

Query: 155 GGILPPSIGNFSTSLQRFSASECKLKGTIPKEI-GHLRGLIYLSLGFNDLNGTIPTSIGT 213
             + P ++ +    ++  + ++ +++  I      +   +  L +GFN +    P     
Sbjct: 58  RKL-PAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQN 115

Query: 214 LKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPP-CLASLTSLRELDLGS 272
           +  L    L   +L         +   L  L +  N L   I      + TSL+ L L S
Sbjct: 116 VPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSS 174

Query: 273 NKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIG 332
           N+LT    S + SL      N+S NLL     S +     +  LD S N ++  +     
Sbjct: 175 NRLTHVDLSLIPSL---FHANVSYNLL-----STLAIPIAVEELDASHNSIN-VVRG--P 223

Query: 333 ALVDLETISLAG 344
             V+L  + L  
Sbjct: 224 VNVELTILKLQH 235

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  117 bits (296), Expect = 1e-29
 Identities = 38/151 (25%), Positives = 71/151 (47%), Gaps = 21/151 (13%)

Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEV--LRNVRHQNLIKILSSCSTP 401
           G FG V++G    G +VA+KIF+ + ER   S+  E E+     +RH+N++  +++ +  
Sbjct: 53  GRFGEVWRGKW-RGEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIAADNKD 108

Query: 402 DFK---------FMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLH----HGHSSA 448
           +           +  +GSL   L  + Y + +   + + +   S L +LH          
Sbjct: 109 NGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP 166

Query: 449 PIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
            I H DLK  +IL+ +N    ++D G++   
Sbjct: 167 AIAHRDLKSKNILVKKNGTCCIADLGLAVRH 197

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  117 bits (295), Expect = 1e-28
 Identities = 82/344 (23%), Positives = 129/344 (37%), Gaps = 42/344 (12%)

Query: 4   QIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPN 63
            +P  I      + L LG N +  L      +   +  L L  N +S  +     ++L N
Sbjct: 25  AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFN 81

Query: 64  IKYLELGDNNLIGTIPNSI-TNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNL 122
           ++ L L  +N +  IP  + T  + L  LD+  N     +   F +L +L  L +  N+L
Sbjct: 82  LRTLGL-RSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDL 140

Query: 123 TTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGT 182
              S  A      S L +   L  L L    L  I        S                
Sbjct: 141 VYISHRA-----FSGLNS---LEQLTLEKCNLTSIPT---EALS---------------- 173

Query: 183 IPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLN 242
                 HL GLI L L   ++N     S   L +L+   +        +  N  +   L 
Sbjct: 174 ------HLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLT 227

Query: 243 LLHLGGNKLSGHIPPC-LASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLND 301
            L +    L+  +P   +  L  LR L+L  N +++   S L  L  + EI L    L  
Sbjct: 228 SLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA- 285

Query: 302 SLPSNV-QKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAG 344
            +     + L  LRVL++S NQL+    S   ++ +LET+ L  
Sbjct: 286 VVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDS 329

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  114 bits (288), Expect = 9e-28
 Identities = 77/320 (24%), Positives = 121/320 (37%), Gaps = 46/320 (14%)

Query: 11  NLQNLKSLFLGANNLSGLIPPMIF-NISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLEL 69
           +  +L+ L L  N +S  + P  F N+  +R L L  NRL   +P  +   L N+  L++
Sbjct: 54  SFPHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDI 111

Query: 70  GDNNLIGTIPNSI-TNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSS 128
              N I  + + +  +   L  L++G N         F  L  L  L+L   NLT+  + 
Sbjct: 112 -SENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTE 170

Query: 129 AYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFS--TSLQRFSASECKLKGTIPKE 186
           A     LS L     L+ L L    +  I      +F     L+    S      T+   
Sbjct: 171 A-----LSHLHG---LIVLRLRHLNINAIRD---YSFKRLYRLKVLEISHWPYLDTMTPN 219

Query: 187 IGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHL 246
             +   L  LS+   +L   +P                          + HL  L  L+L
Sbjct: 220 CLYGLNLTSLSITHCNLT-AVP-----------------------YLAVRHLVYLRFLNL 255

Query: 247 GGNKLSGHIPPC-LASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPS 305
             N +S  I    L  L  L+E+ L   +L    P +   L Y+  +N+S N L  +L  
Sbjct: 256 SYNPIS-TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEE 313

Query: 306 NV-QKLKVLRVLDLSRNQLS 324
           +V   +  L  L L  N L+
Sbjct: 314 SVFHSVGNLETLILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  101 bits (254), Expect = 2e-23
 Identities = 64/308 (20%), Positives = 112/308 (36%), Gaps = 19/308 (6%)

Query: 40  RNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFS 99
           R +     R    +P  I       + L+LG N +     +   +   L  L+L  N  S
Sbjct: 14  RAVLCHRKRFV-AVPEGI---PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS 69

Query: 100 GHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILP 159
              P  F NL +L  L L  N L             + L+N   L  L +S N +  +L 
Sbjct: 70  AVEPGAFNNLFNLRTLGLRSNRLKLIPLGV-----FTGLSN---LTKLDISENKIVILLD 121

Query: 160 PSIGNFS--TSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQL 217
                F    +L+     +  L     +    L  L  L+L   +L      ++  L  L
Sbjct: 122 ---YMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGL 178

Query: 218 QGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTS 277
               L   N+     ++   L  L +L +        + P      +L  L +    LT+
Sbjct: 179 IVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTA 238

Query: 278 SIPSSLWSLGYILEINLSSNLLNDSLPSNV-QKLKVLRVLDLSRNQLSGDIPSTIGALVD 336
               ++  L Y+  +NLS N +  ++  ++  +L  L+ + L   QL+   P     L  
Sbjct: 239 VPYLAVRHLVYLRFLNLSYNPI-STIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNY 297

Query: 337 LETISLAG 344
           L  ++++G
Sbjct: 298 LRVLNVSG 305

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  115 bits (289), Expect = 5e-28
 Identities = 76/387 (19%), Positives = 122/387 (31%), Gaps = 80/387 (20%)

Query: 4   QIPTEIGNLQNLKSLFLGANNLSGLIPPMIFN-------------ISTIRNLNLGGNRLS 50
           ++P E  N+++    +   +      PP                       L L    LS
Sbjct: 25  EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS 84

Query: 51  GHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPN------ 104
             LP       P+++ L     N +  +P    +   L++ +      S   P       
Sbjct: 85  -SLPE----LPPHLESLVA-SCNSLTELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGV 138

Query: 105 ---------TFGNLRHLSVLSLLMNNLTTESSSAY----------QWSFLSSLTNCRYLV 145
                       N   L ++ +  N+L                  Q   L  L N  +L 
Sbjct: 139 SNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLT 198

Query: 146 YLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNG 205
            +    N L   LP    +    L+   A    L      E+ +L  L  +    N L  
Sbjct: 199 AIYADNNSLKK-LPDLPLS----LESIVAGNNIL--EELPELQNLPFLTTIYADNNLLK- 250

Query: 206 TIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASL--- 262
           T+P    +L+ L       T+L    P     L  L++     + LS  +PP L  L   
Sbjct: 251 TLPDLPPSLEALNVRDNYLTDL----PELPQSLTFLDVSENIFSGLSE-LPPNLYYLNAS 305

Query: 263 -----------TSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLK 311
                       SL EL++ +NKL   +P+    L     +  S N L   +P   Q LK
Sbjct: 306 SNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRL---ERLIASFNHLA-EVPELPQNLK 360

Query: 312 VLRVLDLSRNQLSGDIPSTIGALVDLE 338
               L +  N L  + P    ++ DL 
Sbjct: 361 ---QLHVEYNPLR-EFPDIPESVEDLR 383

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  100 bits (251), Expect = 4e-23
 Identities = 64/317 (20%), Positives = 114/317 (35%), Gaps = 53/317 (16%)

Query: 8   EIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYL 67
           E+ NL  L +++   N+L  L         ++ ++  G N L   LP +   +LP +  +
Sbjct: 190 ELQNLPFLTAIYADNNSLKKLPD----LPLSLESIVAGNNILE-ELPEL--QNLPFLTTI 242

Query: 68  ELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESS 127
              DNNL+ T+P+   +   L + D         +P    +L  L V   + + L+    
Sbjct: 243 YA-DNNLLKTLPDLPPSLEALNVRDNYLTD----LPELPQSLTFLDVSENIFSGLSELPP 297

Query: 128 SAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEI 187
           +               L YL  S N +      S+ +   SL+  + S  KL   +P   
Sbjct: 298 N---------------LYYLNASSNEI-----RSLCDLPPSLEELNVSNNKLI-ELPALP 336

Query: 188 GHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLG 247
             L     L   FN L   +P     LKQL   + P       +P ++  L M + L   
Sbjct: 337 PRLE---RLIASFNHLA-EVPELPQNLKQLHVEYNPLREFP-DIPESVEDLRMNSHL--- 388

Query: 248 GNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNV 307
                  +P       +L++L + +N L    P    S+    ++ ++S  + D      
Sbjct: 389 -----AEVP---ELPQNLKQLHVETNPLRE-FPDIPESVE---DLRMNSERVVDPYEFAH 436

Query: 308 QKLKVLRVLDLSRNQLS 324
           +    L       +   
Sbjct: 437 ETTDKLEDDVFEHHHHH 453

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 89.7 bits (223), Expect = 2e-19
 Identities = 58/279 (20%), Positives = 94/279 (33%), Gaps = 26/279 (9%)

Query: 60  SLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLM 119
           S   ++      +NL   +P    N          ++ +  + P   G  R ++V  L  
Sbjct: 9   SNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRD 67

Query: 120 NNLTTESSSAYQWSFLSSL-TNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECK 178
                          LSSL     +L  L+ S N L   LP    +   SL   + +   
Sbjct: 68  CLDRQAHELELNNLGLSSLPELPPHLESLVASCNSL-TELPELPQSL-KSLLVDNNNLKA 125

Query: 179 LKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHL 238
           L    P        L YL +  N L   +P  +     L+   +   +L+  +P     L
Sbjct: 126 LSDLPPL-------LEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK-KLPDLPPSL 175

Query: 239 EMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNL 298
           E +   +   N+L     P L +L  L  +   +N L   +P    SL     I   +N+
Sbjct: 176 EFIAAGN---NQLE--ELPELQNLPFLTAIYADNNSLK-KLPDLPLSL---ESIVAGNNI 226

Query: 299 LNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDL 337
           L       +Q L  L  +    N L   +P    +L  L
Sbjct: 227 L--EELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEAL 262

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  115 bits (289), Expect = 9e-28
 Identities = 64/335 (19%), Positives = 112/335 (33%), Gaps = 30/335 (8%)

Query: 11  NLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELG 70
            L N K +    + +  L   ++ +   +  LNL   ++   + +        I+ L +G
Sbjct: 49  TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMG 107

Query: 71  DNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAY 130
            N +    P+   N   L +L L  N  S      F N   L+ LS+  NNL        
Sbjct: 108 FNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDT- 166

Query: 131 QWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHL 190
                        L  L LS N L  +    +     SL   + S   L       +   
Sbjct: 167 -------FQATTSLQNLQLSSNRLTHV---DLSLI-PSLFHANVSYNLL-----STLAIP 210

Query: 191 RGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNK 250
             +  L    N +N  +        +L    L   NL       L +   L  + L  N+
Sbjct: 211 IAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNE 265

Query: 251 LSGHIPP-CLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQK 309
           L   I       +  L  L + +N+L  ++      +  +  ++LS N L   +  N  +
Sbjct: 266 LE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQ 322

Query: 310 LKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAG 344
              L  L L  N +   +   +     L+ ++L+ 
Sbjct: 323 FDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSH 354

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  114 bits (286), Expect = 3e-27
 Identities = 66/340 (19%), Positives = 123/340 (36%), Gaps = 25/340 (7%)

Query: 5   IPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNI 64
           I + +        + +               ++  + +    + +   LP+ +  S   +
Sbjct: 19  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 77

Query: 65  KYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTT 124
           + L L D  +      +   A  +  L +GFN      P+ F N+  L+VL L  N+L++
Sbjct: 78  ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS 137

Query: 125 ESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIP 184
                          N   L  L +S N L  I        +TSLQ    S  +L   + 
Sbjct: 138 LPRGI--------FHNTPKLTTLSMSNNNLERI-EDDTFQATTSLQNLQLSSNRLT-HVD 187

Query: 185 KEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLL 244
             +  +  L + ++ +N L     +++     ++       ++          L +L L 
Sbjct: 188 --LSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSINVVRGPVNVELTILKLQ 240

Query: 245 HLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLP 304
           H   N L+      L +   L E+DL  N+L   +      +  +  + +S+N L  +L 
Sbjct: 241 H---NNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALN 294

Query: 305 SNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAG 344
              Q +  L+VLDLS N L   +         LE + L  
Sbjct: 295 LYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDH 333

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 81.5 bits (201), Expect = 1e-16
 Identities = 54/327 (16%), Positives = 104/327 (31%), Gaps = 43/327 (13%)

Query: 44  LGGNRLSGHLPSMIGHS--LPNIKYLELGDNNLIGTIPNSIT------NATKLIILDLGF 95
           +GG +     P    +     N++Y  +  +  I      +             I+    
Sbjct: 1   VGGQQRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKN 60

Query: 96  NTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLG 155
           +T          + R + +L+L    +    + A              +  L +  N + 
Sbjct: 61  STMRKLPAALLDSFRQVELLNLNDLQIEEIDTYA--------FAYAHTIQKLYMGFNAI- 111

Query: 156 GILPPSIGNFSTSLQRFSASECKLKGTIPKEI-GHLRGLIYLSLGFNDLNGTIPTSIGTL 214
             LPP +      L         L  ++P+ I  +   L  LS+  N+L      +    
Sbjct: 112 RYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQAT 170

Query: 215 KQLQGFFLPETNLQGYVPHNLCHLEMLNL----------------LHLGGNKLSGHIPPC 258
             LQ   L    L       +  L   N+                L    N ++  +   
Sbjct: 171 TSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSIN-VVRG- 228

Query: 259 LASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNV-QKLKVLRVLD 317
                 L  L L  N LT    + L +   ++E++LS N L + +  +   K++ L  L 
Sbjct: 229 -PVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNEL-EKIMYHPFVKMQRLERLY 284

Query: 318 LSRNQLSGDIPSTIGALVDLETISLAG 344
           +S N+L   +      +  L+ + L+ 
Sbjct: 285 ISNNRLV-ALNLYGQPIPTLKVLDLSH 310

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 76.9 bits (189), Expect = 4e-15
 Identities = 58/313 (18%), Positives = 100/313 (31%), Gaps = 77/313 (24%)

Query: 10  GNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLEL 69
            N   L +L +  NNL  +        ++++NL L  NRL+ H+       +P++ +  +
Sbjct: 144 HNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDL---SLIPSLFHANV 199

Query: 70  GDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSA 129
             N L     +++     +  LD   N+ +         L     L L  NNLT      
Sbjct: 200 SYNLL-----STLAIPIAVEELDASHNSINVVRGPVNVELTI---LKLQHNNLTD----- 246

Query: 130 YQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGH 189
                 + L N   LV + LS N L  I+                               
Sbjct: 247 -----TAWLLNYPGLVEVDLSYNELEKIMYHPFVK------------------------- 276

Query: 190 LRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGN 249
           ++ L  L +  N L   +      +  L+                        +L L  N
Sbjct: 277 MQRLERLYISNNRLV-ALNLYGQPIPTLK------------------------VLDLSHN 311

Query: 250 KLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSN-LLNDSLPSNVQ 308
            L  H+         L  L L  N + +   S+  +L     + LS N    +SL +  +
Sbjct: 312 HLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHTL---KNLTLSHNDWDCNSLRALFR 367

Query: 309 KLKVLRVLDLSRN 321
            +    V D  ++
Sbjct: 368 NVARPAVDDADQH 380

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  111 bits (279), Expect = 1e-27
 Identities = 51/288 (17%), Positives = 95/288 (32%), Gaps = 25/288 (8%)

Query: 57  IGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLS 116
           I  +    K  ++ D++L   + +   +A  +  LDL  N  S            L +L+
Sbjct: 5   IKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLN 64

Query: 117 LLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASE 176
           L  N L               L +   L  L L+ N +  +L         S++   A+ 
Sbjct: 65  LSSNVLYE----------TLDLESLSTLRTLDLNNNYVQELLVG------PSIETLHAAN 108

Query: 177 CKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQG-YVPHNL 235
             +   +       +G   + L  N +        G   ++Q   L    +         
Sbjct: 109 NNIS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELA 165

Query: 236 CHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLS 295
              + L  L+L  N +   +         L+ LDL SNKL   +     S   +  I+L 
Sbjct: 166 ASSDTLEHLNLQYNFIY-DVKG-QVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLR 222

Query: 296 SNLLNDSLPSNVQKLKVLRVLDLSRNQLSGD-IPSTIGALVDLETISL 342
           +N L   +   ++  + L   DL  N      +         ++T++ 
Sbjct: 223 NNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAK 269

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  105 bits (264), Expect = 2e-25
 Identities = 53/341 (15%), Positives = 106/341 (31%), Gaps = 28/341 (8%)

Query: 5   IPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNI 64
           I     N    K   +  ++L   +  +  +   ++ L+L GN LS    + +      +
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAP-FTKL 60

Query: 65  KYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTT 124
           + L L  N L       + + + L  LDL  N               +  L    NN++ 
Sbjct: 61  ELLNLSSNVL--YETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR 113

Query: 125 ESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKG-TI 183
            S S           N      + L+ N +  +     G   + +Q       ++     
Sbjct: 114 VSCSR-----GQGKKN------IYLANNKITMLRDLDEGCR-SRVQYLDLKLNEIDTVNF 161

Query: 184 PKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNL 243
            +       L +L+L +N +   +   +    +L+   L    L  ++         +  
Sbjct: 162 AELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTW 218

Query: 244 LHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSL 303
           + L  NKL   I   L    +L   DL  N          +S    ++  ++   +   L
Sbjct: 219 ISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQ-TVAKQTVK-KL 275

Query: 304 PSNVQKLKVLRVLDLSRNQLSGDIPSTIGA-LVDLETISLA 343
               ++   +  L         D+P+     L+ L      
Sbjct: 276 TGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALGHHHHH 316

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 61.5 bits (150), Expect = 1e-10
 Identities = 25/108 (23%), Positives = 47/108 (43%), Gaps = 7/108 (6%)

Query: 237 HLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSS 296
           +     +  +  + L   +     S  +++ELDL  N L+    + L     +  +NLSS
Sbjct: 8   NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67

Query: 297 NLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAG 344
           N+L +    +++ L  LR LDL+ N +       +     +ET+  A 
Sbjct: 68  NVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAAN 108

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 41.1 bits (97), Expect = 4e-04
 Identities = 12/115 (10%), Positives = 30/115 (26%), Gaps = 11/115 (9%)

Query: 4   QIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPN 63
            +  E  +   +  + L  N L   I   +     + + +L GN                
Sbjct: 205 FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGF----------HCGT 253

Query: 64  IKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLL 118
           ++     +  +      ++   T     +    T   +      +L       L+
Sbjct: 254 LRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLI 308

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  111 bits (278), Expect = 2e-26
 Identities = 53/360 (14%), Positives = 109/360 (30%), Gaps = 38/360 (10%)

Query: 6   PTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSG-------------- 51
             ++     L+ L L +N L   +   + ++ST+R L+L  N +                
Sbjct: 51  AADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVGPSIETLHAAN 108

Query: 52  -HLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSG-HIPNTFGNL 109
            ++  +        K + L +N +           +++  LDL  N     +      + 
Sbjct: 109 NNISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASS 168

Query: 110 RHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSL 169
             L  L+L  N +            +        L  L LS N L  +  P   +    +
Sbjct: 169 DTLEHLNLQYNFIYD----------VKGQVVFAKLKTLDLSSNKLAFM-GPEFQSA-AGV 216

Query: 170 QRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLN-GTIPTSIGTLKQLQGFFLPETNLQ 228
              S    KL   I K +   + L +  L  N  + GT+       +++Q   + +  ++
Sbjct: 217 TWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQ--TVAKQTVK 273

Query: 229 GYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLT----SSIPSSLW 284
                N     +  L H G         P    L +L+  +             +     
Sbjct: 274 KLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERE 333

Query: 285 SLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAG 344
           +     EI+         +     + +    L+  +  L   + +   A  +L+      
Sbjct: 334 NQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQA 393

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  108 bits (271), Expect = 1e-25
 Identities = 57/337 (16%), Positives = 103/337 (30%), Gaps = 25/337 (7%)

Query: 57  IGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLS 116
           I  +    K  ++ D++L   + +   +A  +  LDL  N  S            L +L+
Sbjct: 5   IKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLN 64

Query: 117 LLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASE 176
           L  N L               L +   L  L L+ N +  +L         S++   A+ 
Sbjct: 65  LSSNVLYE----------TLDLESLSTLRTLDLNNNYVQELLVG------PSIETLHAAN 108

Query: 177 CKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNL- 235
             +   +       +G   + L  N +        G   ++Q   L    +       L 
Sbjct: 109 NNIS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELA 165

Query: 236 CHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLS 295
              + L  L+L  N +   +         L+ LDL SNKL   +     S   +  I+L 
Sbjct: 166 ASSDTLEHLNLQYNFIY-DVKG-QVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLR 222

Query: 296 SNLLNDSLPSNVQKLKVLRVLDLSRNQLSGD-IPSTIGALVDLETISLAGSFGSVYKGTI 354
           +N L   +   ++  + L   DL  N      +         ++T++         +   
Sbjct: 223 NNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE 281

Query: 355 SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNL 391
                          E     F      L+   H  L
Sbjct: 282 ECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALL 318

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  107 bits (269), Expect = 3e-25
 Identities = 52/340 (15%), Positives = 104/340 (30%), Gaps = 26/340 (7%)

Query: 5   IPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNI 64
           I     N    K   +  ++L   +  +  +   ++ L+L GN LS    + +      +
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAP-FTKL 60

Query: 65  KYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTT 124
           + L L  N L       + + + L  LDL  N               +  L    NN++ 
Sbjct: 61  ELLNLSSNVL--YETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR 113

Query: 125 ESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKG-TI 183
            S S           N      + L+ N +  +     G   + +Q       ++     
Sbjct: 114 VSCSR-----GQGKKN------IYLANNKITMLRDLDEGCR-SRVQYLDLKLNEIDTVNF 161

Query: 184 PKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNL 243
            +       L +L+L +N +   +   +    +L+   L    L  ++         +  
Sbjct: 162 AELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTW 218

Query: 244 LHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSL 303
           + L  NKL   I   L    +L   DL  N          +S    ++  ++   +    
Sbjct: 219 ISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQ-TVAKQTVKKLT 276

Query: 304 PSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLA 343
             N ++  V  +                  L+ L+    A
Sbjct: 277 GQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHA 316

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  101 bits (252), Expect = 3e-23
 Identities = 44/321 (13%), Positives = 94/321 (29%), Gaps = 19/321 (5%)

Query: 8   EIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYL 67
                Q  K+++L  N ++ L        S ++ L+L  N +     + +  S   +++L
Sbjct: 115 SCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL 174

Query: 68  ELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESS 127
            L  N +   +   +    KL  LDL  N  +  +   F +   ++ +SL  N L     
Sbjct: 175 NLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV---- 227

Query: 128 SAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEI 187
                    +L   + L +  L GN           + +  +Q  +     +K    +  
Sbjct: 228 -----LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ--TVKKLTGQNE 280

Query: 188 GHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQG----YVPHNLCHLEMLNL 243
                      G              L  L+       + QG     +     +      
Sbjct: 281 EECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQRE 340

Query: 244 LHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSL 303
           +     +    I        +   L+     L   + +   +    L+  L   +    L
Sbjct: 341 IDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAE-LDGTLQQAVGQIEL 399

Query: 304 PSNVQKLKVLRVLDLSRNQLS 324
               ++   L++L     +  
Sbjct: 400 QHATEEQSPLQLLRAIVKRYE 420

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 57.2 bits (138), Expect = 6e-09
 Identities = 28/138 (20%), Positives = 50/138 (36%), Gaps = 10/138 (7%)

Query: 207 IPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLR 266
           I        + +   + +++L+  +         +  L L GN LS      LA  T L 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 267 ELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGD 326
            L+L SN L       L SL  +  ++L++N +       +     +  L  + N +S  
Sbjct: 62  LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-R 113

Query: 327 IPSTIGALVDLETISLAG 344
           +          + I LA 
Sbjct: 114 VSC--SRGQGKKNIYLAN 129

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  110 bits (278), Expect = 2e-26
 Identities = 66/357 (18%), Positives = 128/357 (35%), Gaps = 32/357 (8%)

Query: 11  NLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELG 70
           +L +L+ L L  N+LS L       +S+++ LNL GN       + +  +L N++ L +G
Sbjct: 72  SLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIG 131

Query: 71  DNNLIGTIP-NSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSA 129
           +      I        T L  L++   +   +   +  ++R +  L+L ++         
Sbjct: 132 NVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIF 191

Query: 130 YQWSFLSSLTNCRYLVYLILSGNPLGGI--LPPSIGNFSTSLQRFSASECKLKG------ 181
                LSS+       YL L    L      P  +   S+ +++ +     L        
Sbjct: 192 ADI--LSSVR------YLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNEL 243

Query: 182 -TIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLK--------QLQGFFLPETNLQGYVP 232
             + + I  L  + +     N L    P+    +          ++   +P+  L   + 
Sbjct: 244 LKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLS 303

Query: 233 HNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSI---PSSLWSLGYI 289
                LE +  + +  +K+          L SL  LDL  N +        +   +   +
Sbjct: 304 TVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSL 363

Query: 290 LEINLSSNLLND--SLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAG 344
             + LS N L         +  LK L  LD+SRN     +P +      +  ++L+ 
Sbjct: 364 QTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSS 419

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  109 bits (274), Expect = 9e-26
 Identities = 62/364 (17%), Positives = 128/364 (35%), Gaps = 35/364 (9%)

Query: 4   QIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPN 63
            IP+ +     +KSL L  N ++ +    +   + ++ L L  +R++  +     +SL +
Sbjct: 19  SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEGDAFYSLGS 75

Query: 64  IKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSG-HIPNTFGNLRHLSVLSLLMNNL 122
           +++L+L DN+L     +     + L  L+L  N +    + + F NL +L  L +     
Sbjct: 76  LEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVET 135

Query: 123 TTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGT 182
            +E          + LT+   L  L +    L      S+ +    +   +    +    
Sbjct: 136 FSEIRR----IDFAGLTS---LNELEIKALSLRNYQSQSLKSI-RDIHHLTLHLSESAFL 187

Query: 183 IPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGY----------VP 232
           +      L  + YL L   +L     + +   +                         + 
Sbjct: 188 LEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLL 247

Query: 233 HNLCHLEMLNLLHLGGNKL------SGHIPPCLASL--TSLRELDLGSNKLTSSIPSSLW 284
             +  L  +       N L         +   L  +   ++R L +    L   + +   
Sbjct: 248 RYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYS 307

Query: 285 SLGYILEINLSSNLLNDSLPSNV-QKLKVLRVLDLSRNQLSGDIPST---IGALVDLETI 340
            L  +  I + ++ +   +P +  Q LK L  LDLS N +  +        GA   L+T+
Sbjct: 308 LLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTL 366

Query: 341 SLAG 344
            L+ 
Sbjct: 367 VLSQ 370

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  107 bits (269), Expect = 3e-25
 Identities = 60/349 (17%), Positives = 119/349 (34%), Gaps = 21/349 (6%)

Query: 4   QIPTEIGNLQNLKSLFLGANNLSGLIPPMIF-NISTIRNLNLGGNRLSGHLPSMIGHSLP 62
            + +   NL NL++L +G       I  + F  ++++  L +    L  +  S    S+ 
Sbjct: 114 GVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR-NYQSQSLKSIR 172

Query: 63  NIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNL 122
           +I +L L  +     +       + +  L+L     +    +        S +  L    
Sbjct: 173 DIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRG 232

Query: 123 TTESSSAYQW--SFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFS-------TSLQRFS 173
           +  +  ++      L  +     + +   + N LG   P      S        +++R  
Sbjct: 233 SVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLH 292

Query: 174 ASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPH 233
             +  L   +      L  +  +++  + +     +    LK L+   L E  +      
Sbjct: 293 IPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLK 352

Query: 234 N---LCHLEMLNLLHLGGNKLS--GHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGY 288
           N         L  L L  N L         L +L +L  LD+  N     +P S      
Sbjct: 353 NSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHP-MPDSCQWPEK 411

Query: 289 ILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDL 337
           +  +NLSS  +   + + +   + L VLD+S N L       +  L +L
Sbjct: 412 MRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLD-SFSLFLPRLQEL 456

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 83.6 bits (207), Expect = 2e-17
 Identities = 49/290 (16%), Positives = 93/290 (32%), Gaps = 22/290 (7%)

Query: 10  GNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLEL 69
            +   L  L      LS +     F+  T+  L       S  +  +       I+ L +
Sbjct: 238 ESFNELLKLLRYILELSEVE----FDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHI 293

Query: 70  GDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSA 129
               L   +    +   K+  + +  +       +   +L+ L  L L  N +  E    
Sbjct: 294 PQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLK- 352

Query: 130 YQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFS--TSLQRFSASECKLKGTIPKEI 187
              +   +  +   L  L+LS N L   +  +        +L     S       +P   
Sbjct: 353 -NSACKGAWPS---LQTLVLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTFH-PMPDSC 406

Query: 188 GHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLG 247
                + +L+L    +   + T I   + L+   +   NL       L  L+ L +    
Sbjct: 407 QWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLD-SFSLFLPRLQELYI---S 459

Query: 248 GNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSN 297
            NKL   +P   +    L  + +  N+L S        L  + +I L +N
Sbjct: 460 RNKLK-TLPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTN 507

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 83.2 bits (206), Expect = 4e-17
 Identities = 57/338 (16%), Positives = 109/338 (32%), Gaps = 41/338 (12%)

Query: 11  NLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGH---------SL 61
            L +++ L L   NL+      +        +     R S                   L
Sbjct: 194 ILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILEL 253

Query: 62  PNIKYLELGDNNLIGTIPNSIT--------NATKLIILDLGFNTFSGHIPNTFGNLRHLS 113
             +++ +   N L    P+               +  L +        +   +  L  + 
Sbjct: 254 SEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVK 313

Query: 114 VLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFS--TSLQR 171
            +++  + +     S      L SL       +L LS N +      +        SLQ 
Sbjct: 314 RITVENSKVFLVPCSF--SQHLKSLE------FLDLSENLMVEEYLKNSACKGAWPSLQT 365

Query: 172 FSASECKLKGTIPKEIG---HLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQ 228
              S+  L+ ++ K       L+ L  L +  N  +  +P S    ++++   L  T ++
Sbjct: 366 LVLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR 423

Query: 229 GYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGY 288
             V    C  + L +L +  N L          L  L+EL +  NKL + +P +      
Sbjct: 424 -VVKT--CIPQTLEVLDVSNNNLD-SFS---LFLPRLQELYISRNKLKT-LPDA-SLFPV 474

Query: 289 ILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGD 326
           +L + +S N L         +L  L+ + L  N     
Sbjct: 475 LLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 512

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 77.5 bits (191), Expect = 2e-15
 Identities = 54/337 (16%), Positives = 95/337 (28%), Gaps = 59/337 (17%)

Query: 42  LNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGH 101
            +      +  +PS +      +K L+L  N +       +     L +L L  +  +  
Sbjct: 10  CDGRSRSFT-SIPSGL---TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTI 65

Query: 102 IPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPS 161
             + F +L  L  L L  N+L++ SSS               L YL L GNP   +   S
Sbjct: 66  EGDAFYSLGSLEHLDLSDNHLSSLSSSW--------FGPLSSLKYLNLMGNPYQTLGVTS 117

Query: 162 IGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFF 221
                                      +L  L  L +G  +    I              
Sbjct: 118 ------------------------LFPNLTNLQTLRIGNVETFSEIR------------- 140

Query: 222 LPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPS 281
                       +   L  LN L +    L  +    L S+  +  L L  ++    +  
Sbjct: 141 ----------RIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEI 190

Query: 282 SLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETIS 341
               L  +  + L    L     S +   +V   +     + S     +   L+ L    
Sbjct: 191 FADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYI 250

Query: 342 LAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNS 378
           L  S       T++   D      ++  E       +
Sbjct: 251 LELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVT 287

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 74.0 bits (182), Expect = 3e-14
 Identities = 52/281 (18%), Positives = 100/281 (35%), Gaps = 23/281 (8%)

Query: 8   EIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYL 67
           E  +           +    +         TIR L++    L   L ++    L  +K +
Sbjct: 257 EFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSL-LEKVKRI 315

Query: 68  ELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNT---FGNLRHLSVLSLLMNNLTT 124
            + ++ +     +   +   L  LDL  N             G    L  L L  N+L +
Sbjct: 316 TVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRS 375

Query: 125 ESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIP 184
              +      L +L N   L  L +S N     +P S       ++  + S   ++  + 
Sbjct: 376 MQKTG---EILLTLKN---LTSLDISRNTFH-PMPDSCQW-PEKMRFLNLSSTGIR-VVK 426

Query: 185 KEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLL 244
             I   + L  L +  N+L+ +       L +LQ  ++    L+  +P       +L ++
Sbjct: 427 TCI--PQTLEVLDVSNNNLD-SFSLF---LPRLQELYISRNKLK-TLPDAS-LFPVLLVM 478

Query: 245 HLGGNKLSGHIPP-CLASLTSLRELDLGSNKLTSSIPSSLW 284
            +  N+L   +P      LTSL+++ L +N    S P   +
Sbjct: 479 KISRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDY 518

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  109 bits (273), Expect = 6e-26
 Identities = 73/341 (21%), Positives = 110/341 (32%), Gaps = 20/341 (5%)

Query: 11  NLQNLKSLFLGANNLSGLIPPMIF-NISTIRNLNLGGNRL-SGHLPSMIGHSLPNIKYLE 68
            L +L  L L  N    L     F  ++ +  L L    L    L       L +++ L 
Sbjct: 77  GLSSLIILKLDYNQFLQL-ETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLV 135

Query: 69  LGDNNLIGTIPNSI-TNATKLIILDLGFNTFSGHIPNTFGNL--RHLSVLSLLMNNLTTE 125
           L DNN+    P S   N  +  +LDL FN           N   +H ++L L    L   
Sbjct: 136 LRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDM 195

Query: 126 SSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPK 185
           +     W    +      +  L LSGN     +      F  ++         L      
Sbjct: 196 NEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMA---KRFFDAIAGTKIQSLILS-NSYN 251

Query: 186 EIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLH 245
                    +         G   + + T   L    +    L   V  +   LE L L  
Sbjct: 252 MGSSFGHTNFKDPDNFTFKGLEASGVKTC-DLSKSKI--FALLKSVFSHFTDLEQLTL-- 306

Query: 246 LGGNKLSGHIPP-CLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLP 304
              N+++  I       LT L +L+L  N L S       +L  +  ++LS N +  +L 
Sbjct: 307 -AQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALG 363

Query: 305 SNV-QKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAG 344
                 L  L+ L L  NQL          L  L+ I L  
Sbjct: 364 DQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHT 404

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  107 bits (269), Expect = 2e-25
 Identities = 66/360 (18%), Positives = 124/360 (34%), Gaps = 39/360 (10%)

Query: 14  NLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNN 73
           ++  + L  N+++ L       +  ++ L +        + +     L ++  L+L  N 
Sbjct: 31  HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90

Query: 74  LIGTIPNSI-TNATKLIILDLGFNTFSGHI--PNTFGNLRHLSVLSLLMNNLTTESSSAY 130
               +          L +L L      G +   N F  L  L +L L  NN+     ++ 
Sbjct: 91  F-LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS- 148

Query: 131 QWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFS---------TSLQRFSASECKLKG 181
              F  ++        L L+ N +  I    + NF          +S+     +E  L  
Sbjct: 149 ---FFLNMRR---FHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGW 202

Query: 182 TIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQL-------------QGFFLPETNLQ 228
                      +  L L  N    ++                        G     TN +
Sbjct: 203 EKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFK 262

Query: 229 GYVPHNLCHLEMLNL--LHLGGNKLSGHIPPCL-ASLTSLRELDLGSNKLTSSIPSSLWS 285
                    LE   +    L  +K+   +   + +  T L +L L  N++     ++ W 
Sbjct: 263 DPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWG 321

Query: 286 LGYILEINLSSNLLNDSLPSNV-QKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAG 344
           L ++L++NLS N L  S+ S + + L  L VLDLS N +      +   L +L+ ++L  
Sbjct: 322 LTHLLKLNLSQNFL-GSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDT 380

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  109 bits (275), Expect = 8e-26
 Identities = 75/396 (18%), Positives = 127/396 (32%), Gaps = 59/396 (14%)

Query: 2   TGQIPTEIGNLQNLKSLFLGANNLSGL---------------------------IPPMIF 34
           + ++P    NL NL+ L L +N +  +                           I P  F
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF 197

Query: 35  NISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLEL------GDNNLIGTIPNSITNATKL 88
               +  L L  N  S ++       L  ++   L       + NL     +++     L
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257

Query: 89  IILDL---GFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLT------ 139
            I +      + +   I + F  L ++S  SL+   +      +Y +     L       
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFG-WQHLELVNCKF 316

Query: 140 ------NCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKL--KGTIPKEIGHLR 191
                   + L  L  + N  G            SL+    S   L  KG   +      
Sbjct: 317 GQFPTLKLKSLKRLTFTSNKGGNAFS---EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTT 373

Query: 192 GLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHN-LCHLEMLNLLHLGGNK 250
            L YL L FN +  T+ ++   L+QL+      +NL+     +    L  L  L +    
Sbjct: 374 SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 432

Query: 251 LSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEI-NLSSNLLNDSLPSNV-Q 308
                      L+SL  L +  N    +    +++    L   +LS   L   L      
Sbjct: 433 TRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFN 491

Query: 309 KLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAG 344
            L  L+VL+++ NQL          L  L+ I L  
Sbjct: 492 SLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHT 527

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  109 bits (273), Expect = 1e-25
 Identities = 74/365 (20%), Positives = 122/365 (33%), Gaps = 39/365 (10%)

Query: 11  NLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELG 70
            L +L+ L     NL+ L    I ++ T++ LN+  N +          +L N+++L+L 
Sbjct: 98  GLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLS 157

Query: 71  DN---------------------------NLIGTIPNSITNATKLIILDLGFNTFSGHIP 103
            N                           N +  I        +L  L L  N  S ++ 
Sbjct: 158 SNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVM 217

Query: 104 -NTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSI 162
                 L  L V  L++      +    +    S+L     L         L   L   I
Sbjct: 218 KTCIQGLAGLEVHRLVLGEF--RNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDII 275

Query: 163 GNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFL 222
             F+      S S   +     K+  +  G  +L L            + +LK+L     
Sbjct: 276 DLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLT---- 331

Query: 223 PETNLQGYVPHNLCHLEMLNLLHLGGNKLS--GHIPPCLASLTSLRELDLGSNKLTSSIP 280
             T+ +G    +   L  L  L L  N LS  G         TSL+ LDL  N +  ++ 
Sbjct: 332 -FTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMS 389

Query: 281 SSLWSLGYILEINLSSNLLNDSLPSNV-QKLKVLRVLDLSRNQLSGDIPSTIGALVDLET 339
           S+   L  +  ++   + L      +V   L+ L  LD+S              L  LE 
Sbjct: 390 SNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEV 449

Query: 340 ISLAG 344
           + +AG
Sbjct: 450 LKMAG 454

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  107 bits (269), Expect = 4e-25
 Identities = 75/375 (20%), Positives = 122/375 (32%), Gaps = 47/375 (12%)

Query: 4   QIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPN 63
           +IP  +    + K+L L  N L  L     F+   ++ L+L    +   +      SL +
Sbjct: 21  KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSH 77

Query: 64  IKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLT 123
           +  L L  N +      + +  + L  L       +       G+L+ L  L++  N + 
Sbjct: 78  LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 137

Query: 124 TESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFS---TSLQRFSASECKLK 180
           +         + S+LTN   L +L LS N +  I    +               S   + 
Sbjct: 138 SFKLP----EYFSNLTN---LEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190

Query: 181 GTIPKEIGHLRGLIYLSLGFNDLNGTIP-TSIGTLKQLQ------GFFLPETNLQGYVPH 233
             I         L  L+L  N  +  +  T I  L  L+      G F  E NL+ +   
Sbjct: 191 -FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKS 249

Query: 234 NLCHLEMLNLLHLGGNKLSG---HIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYIL 290
            L  L  L +       L      I      LT++    L S  +      S       L
Sbjct: 250 ALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHL 309

Query: 291 EI-------------------NLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLS--GDIPS 329
           E+                     +SN   ++       L  L  LDLSRN LS  G    
Sbjct: 310 ELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQ 367

Query: 330 TIGALVDLETISLAG 344
           +      L+ + L+ 
Sbjct: 368 SDFGTTSLKYLDLSF 382

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 89.0 bits (221), Expect = 4e-19
 Identities = 55/301 (18%), Positives = 97/301 (32%), Gaps = 24/301 (7%)

Query: 8   EIGNLQNLKSLFLGANNLSGL------IPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSL 61
           +   L+ L +L +    L+ L      I  +   ++ + + +L    +            
Sbjct: 247 DKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGW 306

Query: 62  PNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNN 121
            +++ +             S      L  L    N        +  +L  L  L L  N 
Sbjct: 307 QHLELVNCKFGQFPTLKLKS------LKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNG 358

Query: 122 LTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKG 181
           L+ +   +      +SL       YL LS N +  +   +       L+        LK 
Sbjct: 359 LSFKGCCSQSDFGTTSLK------YLDLSFNGVITM-SSNFLGL-EQLEHLDFQHSNLKQ 410

Query: 182 TIPKEI-GHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHN-LCHLE 239
                +   LR LIYL +               L  L+   +   + Q     +    L 
Sbjct: 411 MSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELR 470

Query: 240 MLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLL 299
            L  L L   +L    P    SL+SL+ L++ SN+L S        L  + +I L +N  
Sbjct: 471 NLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530

Query: 300 N 300
           +
Sbjct: 531 D 531

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 82.5 bits (204), Expect = 5e-17
 Identities = 59/276 (21%), Positives = 92/276 (33%), Gaps = 42/276 (15%)

Query: 12  LQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGD 71
               + L L               + +++ L    N+            LP++++L+L  
Sbjct: 303 NFGWQHLELVNCKFGQFPT---LKLKSLKRLTFTSNKGGNAFS---EVDLPSLEFLDLSR 356

Query: 72  NNL--IGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSA 129
           N L   G    S    T L  LDL FN     + + F  L  L  L    +NL   S   
Sbjct: 357 NGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEF- 414

Query: 130 YQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEI-G 188
              S   SL N   L+YL +S                +SL+    +    +     +I  
Sbjct: 415 ---SVFLSLRN---LIYLDISHTHTRVAFNGIFNGL-SSLEVLKMAGNSFQENFLPDIFT 467

Query: 189 HLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGG 248
            LR L +L L    L    PT+  +L  LQ                        +L++  
Sbjct: 468 ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ------------------------VLNMAS 503

Query: 249 NKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLW 284
           N+L          LTSL+++ L +N    S P   +
Sbjct: 504 NQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDY 539

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 78.2 bits (193), Expect = 1e-15
 Identities = 38/191 (19%), Positives = 71/191 (37%), Gaps = 6/191 (3%)

Query: 164 NFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLP 223
           N   S +    S   L+            L  L L   ++      +  +L  L    L 
Sbjct: 25  NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILT 84

Query: 224 ETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTS-SIPSS 282
              +Q         L  L  L      L+      +  L +L+EL++  N + S  +P  
Sbjct: 85  GNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144

Query: 283 LWSLGYILEINLSSNLLNDSLPSNVQKLKVLRV----LDLSRNQLSGDIPSTIGALVDLE 338
             +L  +  ++LSSN +     ++++ L  + +    LDLS N ++  I       + L 
Sbjct: 145 FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLH 203

Query: 339 TISLAGSFGSV 349
            ++L  +F S+
Sbjct: 204 KLTLRNNFDSL 214

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  105 bits (264), Expect = 1e-24
 Identities = 75/397 (18%), Positives = 118/397 (29%), Gaps = 61/397 (15%)

Query: 4   QIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPN 63
              +     +         N    L+   + N      L L    LS  LP  +    P 
Sbjct: 28  DYFSAWDKWEKQALPGENRNEAVSLLKECLIN--QFSELQLNRLNLS-SLPDNLP---PQ 81

Query: 64  IKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLT 123
           I  LE+  N LI ++P    +   L  LD   N  S  +P    +L+HL V +   N LT
Sbjct: 82  ITVLEITQNALI-SLPELPAS---LEYLDACDNRLS-TLPELPASLKHLDVDN---NQLT 133

Query: 124 TESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTI 183
                               L Y+    N L   LP    +    L+  S    +L   +
Sbjct: 134 ---------MLPELPAL---LEYINADNNQLTM-LPELPTS----LEVLSVRNNQLT-FL 175

Query: 184 PKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNL 243
           P+    L     L +  N L  ++P         +                    E    
Sbjct: 176 PELPESLE---ALDVSTNLLE-SLPAVPVRNHHSE--------------------ETEIF 211

Query: 244 LHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSL 303
                N+++ HIP  + SL     + L  N L+S I  SL       + +     +  S+
Sbjct: 212 FRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQ--TAQPDYHGPRIYFSM 268

Query: 304 PSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVD-LETISLAGSFGSVYKGTISDGTDVAI 362
               Q      + D        +  S +  +    E    A +F S +   +SD      
Sbjct: 269 SDGQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTF-SAFLDRLSDTVSARN 327

Query: 363 KIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCS 399
                ++  A+    S    LR            SC 
Sbjct: 328 TSGFREQVAAWLEKLSASAELRQQSFAVAADATESCE 364

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 95.0 bits (237), Expect = 4e-22
 Identities = 41/151 (27%), Positives = 68/151 (45%), Gaps = 16/151 (10%)

Query: 343 AGSFGSVYKGTI-----SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSS 397
            G+FGSV          + G  VA+K      E   R F  E E+L++++H N++K    
Sbjct: 20  KGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGV 79

Query: 398 CSTPDFK-------FMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPI 450
           C +   +       ++P GSL   L  H   +D ++ L     +   +EYL         
Sbjct: 80  CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR----Y 135

Query: 451 IHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
           IH DL   +IL++      + DFG++K+L +
Sbjct: 136 IHRDLATRNILVENENRVKIGDFGLTKVLPQ 166

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 94.7 bits (236), Expect = 1e-21
 Identities = 67/317 (21%), Positives = 100/317 (31%), Gaps = 34/317 (10%)

Query: 40  RNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFS 99
           R +      L   +P  +    P+   L+L +N +         N   L  L L  N  S
Sbjct: 34  RVVQCSDLGLE-KVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 89

Query: 100 GHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILP 159
              P  F  L  L  L L  N L              +L        L +  N +  +  
Sbjct: 90  KISPGAFAPLVKLERLYLSKNQLKELPEKM-----PKTLQ------ELRVHENEITKVRK 138

Query: 160 PSIGNFS--TSLQRFSASECKLK-GTIPKEI-GHLRGLIYLSLGFNDLNGTIPTSIGTLK 215
                F+    +         LK   I       ++ L Y+ +   ++  TIP   G   
Sbjct: 139 ---SVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPP 192

Query: 216 QLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKL 275
            L    L    +      +L  L  L  L L  N +S      LA+   LREL L +NKL
Sbjct: 193 SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL 252

Query: 276 TSSIPSSLWSLGYILEINLSSNLLND------SLPSNVQKLKVLRVLDLSRNQLSGDI-- 327
              +P  L    YI  + L +N ++         P    K      + L  N +      
Sbjct: 253 V-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQ 311

Query: 328 PSTIGALVDLETISLAG 344
           PST   +     + L  
Sbjct: 312 PSTFRCVYVRAAVQLGN 328

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 88.1 bits (219), Expect = 2e-19
 Identities = 64/299 (21%), Positives = 104/299 (34%), Gaps = 55/299 (18%)

Query: 11  NLQNLKSLFLGANNLSGLIPPMIF-NISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLEL 69
           NL+NL +L L  N +S  I P  F  +  +  L L  N+L   LP         ++ L +
Sbjct: 74  NLKNLHTLILINNKISK-ISPGAFAPLVKLERLYLSKNQLK-ELPE---KMPKTLQELRV 128

Query: 70  GDNNLIGTIPNSI-TNATKLIILDLGFN--TFSGHIPNTFGNLRHLSVLSLLMNNLTTES 126
              N I  +  S+     ++I+++LG N    SG     F  ++ LS + +   N+TT  
Sbjct: 129 -HENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIP 187

Query: 127 SSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKE 186
                     SLT       L L GN +  +      +                      
Sbjct: 188 QGL-----PPSLT------ELHLDGNKITKV---DAASLK-------------------- 213

Query: 187 IGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHL 246
              L  L  L L FN ++     S+     L+   L    L   VP  L   + + +++L
Sbjct: 214 --GLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYL 270

Query: 247 GGNKLSG------HIPPCLASLTSLRELDLGSNKLT-SSIPSSLWS-LGYILEINLSSN 297
             N +S         P       S   + L SN +    I  S +  +     + L + 
Sbjct: 271 HNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 74.7 bits (184), Expect = 7e-15
 Identities = 45/267 (16%), Positives = 90/267 (33%), Gaps = 60/267 (22%)

Query: 12  LQNLKSLFLGANNLSGLIPPMIF-NISTIRNLNLGGNRL-SGHLPSMIGHSLPNIKYLEL 69
            + L+ L +  N ++  +   +F  ++ +  + LG N L S  + +     +  + Y+ +
Sbjct: 120 PKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRI 178

Query: 70  GDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSA 129
            D N I TIP  +     L  L L  N  +     +   L +L+ L L  N+++   + +
Sbjct: 179 ADTN-ITTIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGS 235

Query: 130 YQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGH 189
                   L N  +L  L L+ N L                            +P  +  
Sbjct: 236 --------LANTPHLRELHLNNNKL--------------------------VKVPGGLAD 261

Query: 190 LRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGN 249
            + +  + L  N+++  I ++          F P                  + + L  N
Sbjct: 262 HKYIQVVYLHNNNIS-AIGSND---------FCPPGYNTK--------KASYSGVSLFSN 303

Query: 250 KLSGH-IPPCL-ASLTSLRELDLGSNK 274
            +    I P     +     + LG+ K
Sbjct: 304 PVQYWEIQPSTFRCVYVRAAVQLGNYK 330

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 93.9 bits (234), Expect = 1e-21
 Identities = 41/150 (27%), Positives = 60/150 (40%), Gaps = 15/150 (10%)

Query: 343 AGSFGSVYKGT----ISDGTDVAIKIFN---LQRERAFRSFNSECEVLRNVRHQNLIKIL 395
            GSFG V +G           VA+K      L +  A   F  E   + ++ H+NLI++ 
Sbjct: 28  DGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLY 87

Query: 396 SSCSTPDFK----FMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPII 451
               TP  K      P GSL  RL  H     +       + V   + YL     S   I
Sbjct: 88  GVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL----ESKRFI 143

Query: 452 HCDLKPTSILLDENMVAHVSDFGISKLLGE 481
           H DL   ++LL    +  + DFG+ + L +
Sbjct: 144 HRDLAARNLLLATRDLVKIGDFGLMRALPQ 173

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 94.4 bits (235), Expect = 1e-21
 Identities = 41/151 (27%), Positives = 69/151 (45%), Gaps = 16/151 (10%)

Query: 343 AGSFGSVYKGTI-----SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSS 397
            G+FGSV          + G  VA+K      E   R F  E E+L++++H N++K    
Sbjct: 51  KGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGV 110

Query: 398 CSTPDFK-------FMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPI 450
           C +   +       ++P GSL   L  H   +D ++ L     +   +EYL     +   
Sbjct: 111 CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL----GTKRY 166

Query: 451 IHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
           IH DL   +IL++      + DFG++K+L +
Sbjct: 167 IHRDLATRNILVENENRVKIGDFGLTKVLPQ 197

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 95.2 bits (237), Expect = 3e-21
 Identities = 70/286 (24%), Positives = 106/286 (37%), Gaps = 43/286 (15%)

Query: 62  PNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNN 121
                +     NL   +P+ I+  T+  +L+L  N       N+F +LRHL +L L  N+
Sbjct: 43  NQFSKVICVRKNLR-EVPDGISTNTR--LLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99

Query: 122 LTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKG 181
           + T    A      + L N   L  L L  N L  I     G F                
Sbjct: 100 IRTIEIGA-----FNGLAN---LNTLELFDNRLTTIPN---GAFV--------------- 133

Query: 182 TIPKEIGHLRGLIYLSLGFNDLNGTIPTSI-GTLKQLQGFFLPETNLQGYVPHN-LCHLE 239
                  +L  L  L L  N +  +IP+     +  L+   L E     Y+       L 
Sbjct: 134 -------YLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLS 185

Query: 240 MLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLL 299
            L  L+L    L   IP  L  L  L ELDL  N L++  P S   L ++ ++ +  + +
Sbjct: 186 NLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQI 243

Query: 300 NDSLPSNV-QKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAG 344
              +  N    L+ L  ++L+ N L+         L  LE I L  
Sbjct: 244 Q-VIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHH 288

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 89.8 bits (223), Expect = 1e-19
 Identities = 76/316 (24%), Positives = 113/316 (35%), Gaps = 68/316 (21%)

Query: 14  NLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNN 73
               +     NL   +P  I   +  R LNL  N++   +       L +++ L+L   N
Sbjct: 44  QFSKVICVRKNLRE-VPDGIS--TNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQL-SRN 98

Query: 74  LIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWS 133
            I TI                           F  L +L+ L L  N LTT  + A    
Sbjct: 99  HIRTIE-----------------------IGAFNGLANLNTLELFDNRLTTIPNGA---- 131

Query: 134 FLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEI-GHLRG 192
               L+    L  L L  NP+  I P    N   SL+R    E K    I +     L  
Sbjct: 132 -FVYLSK---LKELWLRNNPIESI-PSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSN 186

Query: 193 LIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLS 252
           L YL+L   +L   IP                          L  L  L+ L L GN LS
Sbjct: 187 LRYLNLAMCNLR-EIPN-------------------------LTPLIKLDELDLSGNHLS 220

Query: 253 GHIPP-CLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNV-QKL 310
             I P     L  L++L +  +++     ++  +L  ++EINL+ N L   LP ++   L
Sbjct: 221 -AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPL 278

Query: 311 KVLRVLDLSRNQLSGD 326
             L  + L  N  + +
Sbjct: 279 HHLERIHLHHNPWNCN 294

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 81.3 bits (201), Expect = 9e-17
 Identities = 63/267 (23%), Positives = 95/267 (35%), Gaps = 67/267 (25%)

Query: 11  NLQNLKSLFLGANNLSGLIPPMIF-NISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLEL 69
           +L++L+ L L  N++   I    F  ++ +  L L  NRL+  +P+     L  +K L L
Sbjct: 86  HLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWL 143

Query: 70  GDNNLIGTIPNSI-TNATKLIILDLGFNTFSGHIP-NTFGNLRHLSVLSLLMNNLTTESS 127
             NN I +IP+        L  LDLG      +I    F  L +L  L+L M NL     
Sbjct: 144 -RNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE--- 199

Query: 128 SAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEI 187
                  + +LT    L  L LSGN L  I P   G+F                      
Sbjct: 200 -------IPNLTPLIKLDELDLSGNHLSAIRP---GSFQ--------------------- 228

Query: 188 GHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLG 247
             L  L  L +  + +   I                         +   +L+ L  ++L 
Sbjct: 229 -GLMHLQKLWMIQSQIQ-VIE-----------------------RNAFDNLQSLVEINLA 263

Query: 248 GNKLSGHIPP-CLASLTSLRELDLGSN 273
            N L+  +P      L  L  + L  N
Sbjct: 264 HNNLT-LLPHDLFTPLHHLERIHLHHN 289

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 93.1 bits (232), Expect = 3e-21
 Identities = 35/154 (22%), Positives = 67/154 (43%), Gaps = 21/154 (13%)

Query: 343 AGSFGSVYKGT-----ISDGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKI 394
            G FG V          + G  VA+K   L+             E E+LRN+ H+N++K 
Sbjct: 31  EGHFGKVELCRYDPEGDNTGEQVAVKS--LKPESGGNHIADLKKEIEILRNLYHENIVKY 88

Query: 395 LSSCSTPDFK-------FMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSS 447
              C+            F+P+GSL++ L  +   +++ ++L   + +   ++YL      
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ-- 146

Query: 448 APIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
              +H DL   ++L++      + DFG++K +  
Sbjct: 147 --YVHRDLAARNVLVESEHQVKIGDFGLTKAIET 178

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 94.8 bits (236), Expect = 3e-21
 Identities = 63/286 (22%), Positives = 96/286 (33%), Gaps = 43/286 (15%)

Query: 62  PNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNN 121
                +      L   +P  I + T+   L+L  N       +TF +L HL VL L  N+
Sbjct: 54  NQFSKVVCTRRGLS-EVPQGIPSNTR--YLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110

Query: 122 LTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKG 181
           +      A      + L +   L  L L  N L  I     G F                
Sbjct: 111 IRQIEVGA-----FNGLAS---LNTLELFDNWLTVIPS---GAFE--------------- 144

Query: 182 TIPKEIGHLRGLIYLSLGFNDLNGTIPTSI-GTLKQLQGFFLPETNLQGYVPHN-LCHLE 239
                  +L  L  L L  N +  +IP+     +  L    L E     Y+       L 
Sbjct: 145 -------YLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLF 196

Query: 240 MLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLL 299
            L  L+LG   +   +P  L  L  L EL++  N      P S   L  + ++ + ++ +
Sbjct: 197 NLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQV 254

Query: 300 NDSLPSNV-QKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAG 344
              +  N    L  L  L+L+ N LS         L  L  + L  
Sbjct: 255 -SLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHH 299

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 90.6 bits (225), Expect = 1e-19
 Identities = 73/313 (23%), Positives = 110/313 (35%), Gaps = 68/313 (21%)

Query: 14  NLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNN 73
               +      LS  +P  I   S  R LNL  N +   + +     L +++ L+L   N
Sbjct: 55  QFSKVVCTRRGLSE-VPQGIP--SNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQL-GRN 109

Query: 74  LIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWS 133
            I  I                           F  L  L+ L L  N LT   S A    
Sbjct: 110 SIRQIE-----------------------VGAFNGLASLNTLELFDNWLTVIPSGA---- 142

Query: 134 FLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEI-GHLRG 192
               L+    L  L L  NP+  I P    N   SL R    E K    I +     L  
Sbjct: 143 -FEYLSK---LRELWLRNNPIESI-PSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFN 197

Query: 193 LIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLS 252
           L YL+LG  ++       +  L                       L  L  L + GN   
Sbjct: 198 LKYLNLGMCNI-----KDMPNLT---------------------PLVGLEELEMSGNHFP 231

Query: 253 GHIPP-CLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNV-QKL 310
             I P     L+SL++L + +++++    ++   L  ++E+NL+ N L+ SLP ++   L
Sbjct: 232 -EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPL 289

Query: 311 KVLRVLDLSRNQL 323
           + L  L L  N  
Sbjct: 290 RYLVELHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 81.7 bits (202), Expect = 8e-17
 Identities = 63/267 (23%), Positives = 95/267 (35%), Gaps = 67/267 (25%)

Query: 11  NLQNLKSLFLGANNLSGLIPPMIF-NISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLEL 69
           +L +L+ L LG N++   I    F  ++++  L L  N L+  +PS     L  ++ L L
Sbjct: 97  HLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWL 154

Query: 70  GDNNLIGTIPNSI-TNATKLIILDLGFNTFSGHIP-NTFGNLRHLSVLSLLMNNLTTESS 127
            +N  I +IP+        L+ LDLG      +I    F  L +L  L+L M N+     
Sbjct: 155 RNNP-IESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD--- 210

Query: 128 SAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEI 187
                  + +LT    L  L +SGN    I P   G+F                      
Sbjct: 211 -------MPNLTPLVGLEELEMSGNHFPEIRP---GSFH--------------------- 239

Query: 188 GHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLG 247
             L  L  L +  + ++  I                         +    L  L  L+L 
Sbjct: 240 -GLSSLKKLWVMNSQVS-LIE-----------------------RNAFDGLASLVELNLA 274

Query: 248 GNKLSGHIPP-CLASLTSLRELDLGSN 273
            N LS  +P      L  L EL L  N
Sbjct: 275 HNNLS-SLPHDLFTPLRYLVELHLHHN 300

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 92.0 bits (229), Expect = 6e-21
 Identities = 59/284 (20%), Positives = 98/284 (34%), Gaps = 40/284 (14%)

Query: 65  KYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTT 124
             +      L  ++P  I ++     L+L  N         F  L  L+ LSL  N L+ 
Sbjct: 10  TEIRCNSKGLT-SVPTGIPSSAT--RLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSF 66

Query: 125 ESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIP 184
           +   +      +SL       YL LS N +                           T+ 
Sbjct: 67  KGCCSQSDFGTTSLK------YLDLSFNGVI--------------------------TMS 94

Query: 185 KEIGHLRGLIYLSLGFNDLNGTIPTSI-GTLKQLQGFFLPETNLQGYVPHNLCHLEMLNL 243
                L  L +L    ++L      S+  +L+ L    +  T+ +         L  L +
Sbjct: 95  SNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEV 154

Query: 244 LHLGGNKLSGHIPP-CLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDS 302
           L + GN    +  P     L +L  LDL   +L    P++  SL  +  +N+S N    S
Sbjct: 155 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF-S 213

Query: 303 LPSNV-QKLKVLRVLDLSRNQLSGDIPSTIGALVD-LETISLAG 344
           L +   + L  L+VLD S N +       +      L  ++L  
Sbjct: 214 LDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQ 257

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 89.3 bits (222), Expect = 6e-20
 Identities = 60/298 (20%), Positives = 101/298 (33%), Gaps = 64/298 (21%)

Query: 4   QIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLS-GHLPSMIGHSLP 62
            +PT I    +   L L +N L  L   +   ++ +  L+L  N LS     S       
Sbjct: 21  SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78

Query: 63  NIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIP-NTFGNLRHLSVLSLLMNN 121
           ++KYL+L  N +I T+ ++     +L  LD   +        + F +LR+L  L +   +
Sbjct: 79  SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 137

Query: 122 LTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKG 181
                +        + L++   L  L ++GN       P    F+               
Sbjct: 138 TRVAFNGI-----FNGLSS---LEVLKMAGNSFQENFLP--DIFT--------------- 172

Query: 182 TIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEML 241
                   LR L +L L    L                       L     ++L  L++L
Sbjct: 173 -------ELRNLTFLDLSQCQL---------------------EQLSPTAFNSLSSLQVL 204

Query: 242 NLLHLGGNKLSGHIPPC-LASLTSLRELDLGSNKLTSSIPSSLWSLGYILE-INLSSN 297
           N   +  N     +       L SL+ LD   N + +S    L      L  +NL+ N
Sbjct: 205 N---MSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN 258

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 71.6 bits (176), Expect = 5e-14
 Identities = 31/145 (21%), Positives = 58/145 (40%), Gaps = 9/145 (6%)

Query: 11  NLQNLKSLFLGANNLSGLIPPMIF-NISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLEL 69
           +L+NL  L +   +   +    IF  +S++  L + GN    +    I   L N+ +L+L
Sbjct: 124 SLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 182

Query: 70  GDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSA 129
               L    P +  + + L +L++  N F       +  L  L VL   +N++ T     
Sbjct: 183 SQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQE 242

Query: 130 YQWSFLSSLTNCRYLVYLILSGNPL 154
                    ++   L +L L+ N  
Sbjct: 243 ----LQHFPSS---LAFLNLTQNDF 260

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 91.2 bits (227), Expect = 9e-21
 Identities = 34/147 (23%), Positives = 59/147 (40%), Gaps = 12/147 (8%)

Query: 343 AGSFGSVYKGT---ISDGTDVAIKIF-NLQRERAFRSFNSECEVLRNVRHQNLIKILSSC 398
            G+FGSV +G         DVAIK+      +        E +++  + +  +++++  C
Sbjct: 20  CGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC 79

Query: 399 STPDFK----FMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
                         G L K L      + +     ++  V   ++YL         +H D
Sbjct: 80  QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL----EEKNFVHRD 135

Query: 455 LKPTSILLDENMVAHVSDFGISKLLGE 481
           L   ++LL     A +SDFG+SK LG 
Sbjct: 136 LAARNVLLVNRHYAKISDFGLSKALGA 162

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 92.0 bits (229), Expect = 9e-21
 Identities = 37/151 (24%), Positives = 60/151 (39%), Gaps = 16/151 (10%)

Query: 343 AGSFGSVYKGTI-----SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSS 397
            G+FGSV          + G  VA+K          R F  E ++L+ +    ++K    
Sbjct: 33  KGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGV 92

Query: 398 CSTPDFK-------FMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPI 450
              P  +       ++P+G L   L  H   LD    L     +   +EYL         
Sbjct: 93  SYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR----C 148

Query: 451 IHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
           +H DL   +IL++      ++DFG++KLL  
Sbjct: 149 VHRDLAARNILVESEAHVKIADFGLAKLLPL 179

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 91.7 bits (228), Expect = 1e-20
 Identities = 40/153 (26%), Positives = 70/153 (45%), Gaps = 19/153 (12%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILS--SCS 399
           G+  +V++G     G   AIK+FN     R       E EVL+ + H+N++K+ +    +
Sbjct: 20  GATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET 79

Query: 400 TPDFKFM-----PNGSLEKRLYSHNYFLDILER--LNIMIDVGSTLEYLHHGHSSAPIIH 452
           T   K +     P GSL   L   +    + E   L ++ DV   + +L        I+H
Sbjct: 80  TTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG----IVH 135

Query: 453 CDLKPTSILL----DENMVAHVSDFGISKLLGE 481
            ++KP +I+     D   V  ++DFG ++ L +
Sbjct: 136 RNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 92.3 bits (230), Expect = 1e-20
 Identities = 39/159 (24%), Positives = 69/159 (43%), Gaps = 16/159 (10%)

Query: 335 VDLETISL-----AGSFGSVYKGTI-SDGTDVAIKIFNLQR-ERAFRSFNSECEVLRNVR 387
           ++ E + L      G+FG V+ G + +D T VA+K             F  E  +L+   
Sbjct: 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYS 170

Query: 388 HQNLIKILSSCSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLH 442
           H N+++++  C+         + +  G     L +    L +   L ++ D  + +EYL 
Sbjct: 171 HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE 230

Query: 443 HGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
               S   IH DL   + L+ E  V  +SDFG+S+   +
Sbjct: 231 ----SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 90.8 bits (226), Expect = 2e-20
 Identities = 34/148 (22%), Positives = 66/148 (44%), Gaps = 15/148 (10%)

Query: 343 AGSFGSVYKGTISDG----TDVAIKIFN-LQRERAFRSFNSECEVLRNVRHQNLIKILSS 397
            G FG VY GT+ D        A+K  N +        F +E  ++++  H N++ +L  
Sbjct: 35  RGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGI 94

Query: 398 CSTPD------FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPII 451
           C   +        +M +G L   + +  +   + + +   + V   ++YL    +S   +
Sbjct: 95  CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL----ASKKFV 150

Query: 452 HCDLKPTSILLDENMVAHVSDFGISKLL 479
           H DL   + +LDE     V+DFG+++ +
Sbjct: 151 HRDLAARNCMLDEKFTVKVADFGLARDM 178

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 92.8 bits (231), Expect = 2e-20
 Identities = 33/144 (22%), Positives = 69/144 (47%), Gaps = 10/144 (6%)

Query: 343 AGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           AG FG V+  T +  T VA+K        +  +F +E  V++ ++H  L+K+ +  +   
Sbjct: 198 AGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEP 256

Query: 403 F----KFMPNGSLEKRLYSHNY-FLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKP 457
                +FM  GSL   L S       + + ++    +   + ++         IH DL+ 
Sbjct: 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI----EQRNYIHRDLRA 312

Query: 458 TSILLDENMVAHVSDFGISKLLGE 481
            +IL+  ++V  ++DFG+++++ +
Sbjct: 313 ANILVSASLVCKIADFGLARVIED 336

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 90.8 bits (226), Expect = 2e-20
 Identities = 34/145 (23%), Positives = 60/145 (41%), Gaps = 16/145 (11%)

Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNL--IKILSSCS 399
           G    V++         AIK  NL+    +   S+ +E   L  ++  +   I++     
Sbjct: 39  GGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 98

Query: 400 TPDFKFM----PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLH-HGHSSAPIIHCD 454
           T  + +M     N  L   L       D  ER +   ++   +  +H HG     I+H D
Sbjct: 99  TDQYIYMVMECGNIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIHQHG-----IVHSD 152

Query: 455 LKPTSILLDENMVAHVSDFGISKLL 479
           LKP + L+ + M+  + DFGI+  +
Sbjct: 153 LKPANFLIVDGML-KLIDFGIANQM 176

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 91.3 bits (227), Expect = 2e-20
 Identities = 59/293 (20%), Positives = 103/293 (35%), Gaps = 44/293 (15%)

Query: 62  PNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNN 121
             +K L+L +N +     + +     L  L L  N  +    ++F +L  L  L L  N 
Sbjct: 52  EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNY 111

Query: 122 LTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKG 181
           L+  SSS         L++   L +L L GNP   +   S+ +  T LQ           
Sbjct: 112 LSNLSSSW-----FKPLSS---LTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFT 163

Query: 182 TIPKEI-GHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEM 240
            I ++    L  L  L +  +                        +LQ Y P +L  ++ 
Sbjct: 164 KIQRKDFAGLTFLEELEIDAS------------------------DLQSYEPKSLKSIQN 199

Query: 241 LNLLHLGGNKLSGHIPP-CLASLTSLRELDLGSNKLT----SSIPS----SLWSLGYILE 291
           ++ L L   +    +    +   +S+  L+L    L     S + +    SL        
Sbjct: 200 VSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRN 258

Query: 292 INLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAG 344
           + ++   L   +   + ++  L  L+ SRNQL          L  L+ I L  
Sbjct: 259 VKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHT 310

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 88.3 bits (219), Expect = 2e-19
 Identities = 56/290 (19%), Positives = 99/290 (34%), Gaps = 55/290 (18%)

Query: 11  NLQNLKSLFLGANNLSGLIPPMIF-NISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLEL 69
              NL++L L +N ++  I    F ++ ++ +L+L  N LS +L S     L ++ +L L
Sbjct: 74  RCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNL 131

Query: 70  GDNNLIGTIPNSI-TNATKLIILDLGFNTFSGHIP-NTFGNLRHLSVLSLLMNNLTTESS 127
             N        S+ ++ TKL IL +G       I    F  L  L  L +  ++L +   
Sbjct: 132 LGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEP 191

Query: 128 SAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEI 187
            +     L S+ N   + +LIL       +L                             
Sbjct: 192 KS-----LKSIQN---VSHLILHMKQHILLLE---IFVD--------------------- 219

Query: 188 GHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLG 247
                +  L L   DL+                    + L     ++L        + + 
Sbjct: 220 -VTSSVECLELRDTDLDT----------------FHFSELSTGETNSLIKKFTFRNVKIT 262

Query: 248 GNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSN 297
              L   +   L  ++ L EL+   N+L S        L  + +I L +N
Sbjct: 263 DESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTN 311

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 65.1 bits (159), Expect = 1e-11
 Identities = 25/152 (16%), Positives = 50/152 (32%), Gaps = 18/152 (11%)

Query: 11  NLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELG 70
            L  L+ L + A++L    P  + +I  + +L L   +    L  +      +++ LEL 
Sbjct: 172 GLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELR 230

Query: 71  DNNLIGTIPNSI--------TNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNL 122
           D +L     + +                + +   +    +      +  L  L    N L
Sbjct: 231 DTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQL 289

Query: 123 TTESSSAYQWSFLSSLTNCRYLVYLILSGNPL 154
            +     +       LT+   L  + L  NP 
Sbjct: 290 KSVPDGIFD-----RLTS---LQKIWLHTNPW 313

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 90.8 bits (226), Expect = 3e-20
 Identities = 38/149 (25%), Positives = 65/149 (43%), Gaps = 14/149 (9%)

Query: 343 AGSFGSVYKGTISDG-----TDVAIKIFNL-QRERAFRSFNSECEVLRNVRHQNLIKILS 396
           +G+FG+VYKG            VAIK        +A +    E  V+ +V + ++ ++L 
Sbjct: 25  SGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLG 84

Query: 397 SCSTPDFK----FMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
            C T   +     MP G L   +  H   +     LN  + +   + YL        ++H
Sbjct: 85  ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL----EDRRLVH 140

Query: 453 CDLKPTSILLDENMVAHVSDFGISKLLGE 481
            DL   ++L+       ++DFG++KLLG 
Sbjct: 141 RDLAARNVLVKTPQHVKITDFGLAKLLGA 169

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 90.1 bits (224), Expect = 3e-20
 Identities = 38/155 (24%), Positives = 62/155 (40%), Gaps = 24/155 (15%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           G+FG V K     D    AIK      E    +  SE  +L ++ HQ +++  ++     
Sbjct: 17  GAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERR 75

Query: 403 FK------------------FMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHG 444
                               +  NG+L   ++S N      E   +   +   L Y+H  
Sbjct: 76  NFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ 135

Query: 445 HSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
                IIH DLKP +I +DE+    + DFG++K +
Sbjct: 136 G----IIHRDLKPMNIFIDESRNVKIGDFGLAKNV 166

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 92.0 bits (229), Expect = 3e-20
 Identities = 43/142 (30%), Positives = 66/142 (46%), Gaps = 14/142 (9%)

Query: 343 AGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCST-- 400
            G FG V  G    G  VA+K   ++ +   ++F +E  V+  +RH NL+++L       
Sbjct: 203 KGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 259

Query: 401 PDF----KFMPNGSLEKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDL 455
                  ++M  GSL   L S     L     L   +DV   +EYL         +H DL
Sbjct: 260 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL----EGNNFVHRDL 315

Query: 456 KPTSILLDENMVAHVSDFGISK 477
              ++L+ E+ VA VSDFG++K
Sbjct: 316 AARNVLVSEDNVAKVSDFGLTK 337

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 90.5 bits (225), Expect = 3e-20
 Identities = 72/265 (27%), Positives = 116/265 (43%), Gaps = 24/265 (9%)

Query: 63  NIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNL 122
           +++ ++  D  L   +P  I+  T   +LDL  N  S    + F  L+HL  L L+ N +
Sbjct: 34  HLRVVQCSDLGLK-AVPKEISPDTT--LLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90

Query: 123 TTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGT 182
           +     A      S L     L  L +S N L  I P    N  +SL      + +++  
Sbjct: 91  SKIHEKA-----FSPLRK---LQKLYISKNHLVEIPP----NLPSSLVELRIHDNRIR-K 137

Query: 183 IPKEI-GHLRGLIYLSLGFNDL-NGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEM 240
           +PK +   LR +  + +G N L N           +L    + E  L   +P +L   E 
Sbjct: 138 VPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PET 194

Query: 241 LNLLHLGGNKLSGHIPP-CLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLL 299
           LN LHL  NK+   I    L   + L  L LG N++      SL  L  + E++L +N L
Sbjct: 195 LNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKL 253

Query: 300 NDSLPSNVQKLKVLRVLDLSRNQLS 324
              +P+ +  LK+L+V+ L  N ++
Sbjct: 254 -SRVPAGLPDLKLLQVVYLHTNNIT 277

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 83.5 bits (207), Expect = 7e-18
 Identities = 62/327 (18%), Positives = 111/327 (33%), Gaps = 52/327 (15%)

Query: 5   IPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNI 64
           +P EI    +   L L  N++S L       +  +  L L  N++S  +       L  +
Sbjct: 48  VPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKL 104

Query: 65  KYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTT 124
           + L +   N +  IP ++   + L+ L +  N         F  LR+++ + +  N L  
Sbjct: 105 QKLYI-SKNHLVEIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLEN 161

Query: 125 ESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIP 184
                  +  L        L YL +S   L GI      +   +L        K++  I 
Sbjct: 162 SGFEPGAFDGLK-------LNYLRISEAKLTGIPK----DLPETLNELHLDHNKIQ-AIE 209

Query: 185 KEI-GHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNL 243
            E       L  L LG N +                       ++      L  L     
Sbjct: 210 LEDLLRYSKLYRLGLGHNQI---------------------RMIENGSLSFLPTLRE--- 245

Query: 244 LHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYIL------EINLSSN 297
           LHL  NKLS  +P  L  L  L+ + L +N +T    +    +G+ +       I+L +N
Sbjct: 246 LHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNN 304

Query: 298 LL-NDSLPSNV-QKLKVLRVLDLSRNQ 322
            +    +     + +     +     +
Sbjct: 305 PVPYWEVQPATFRCVTDRLAIQFGNYK 331

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 89.2 bits (222), Expect = 3e-20
 Identities = 41/146 (28%), Positives = 63/146 (43%), Gaps = 14/146 (9%)

Query: 343 AGSFGSVYKGTISDGTDVAIKIF--NLQRERAFRSFNSECEVLRNVRHQNLIKILSSCST 400
           +G FG V+ G   +   VAIK        E  F     E EV+  + H  L+++   C  
Sbjct: 18  SGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE---EAEVMMKLSHPKLVQLYGVCLE 74

Query: 401 PD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDL 455
                   +FM +G L   L +          L + +DV   + YL      A +IH DL
Sbjct: 75  QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL----EEACVIHRDL 130

Query: 456 KPTSILLDENMVAHVSDFGISKLLGE 481
              + L+ EN V  VSDFG+++ + +
Sbjct: 131 AARNCLVGENQVIKVSDFGMTRFVLD 156

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 91.0 bits (226), Expect = 4e-20
 Identities = 34/145 (23%), Positives = 60/145 (41%), Gaps = 16/145 (11%)

Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNL--IKILSSCS 399
           G    V++         AIK  NL+    +   S+ +E   L  ++  +   I++     
Sbjct: 67  GGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 126

Query: 400 TPDFKFM----PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLH-HGHSSAPIIHCD 454
           T  + +M     N  L   L       D  ER +   ++   +  +H HG     I+H D
Sbjct: 127 TDQYIYMVMECGNIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIHQHG-----IVHSD 180

Query: 455 LKPTSILLDENMVAHVSDFGISKLL 479
           LKP + L+ + M+  + DFGI+  +
Sbjct: 181 LKPANFLIVDGML-KLIDFGIANQM 204

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 90.1 bits (224), Expect = 4e-20
 Identities = 33/149 (22%), Positives = 65/149 (43%), Gaps = 14/149 (9%)

Query: 343 AGSFGSVYKGTISDG-----TDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILS 396
           +G FG+V+KG            V IK+   +   ++F++       + ++ H +++++L 
Sbjct: 23  SGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLG 82

Query: 397 SCSTPDFK----FMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
            C     +    ++P GSL   +  H   L     LN  + +   + YL        ++H
Sbjct: 83  LCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYL----EEHGMVH 138

Query: 453 CDLKPTSILLDENMVAHVSDFGISKLLGE 481
            +L   ++LL       V+DFG++ LL  
Sbjct: 139 RNLAARNVLLKSPSQVQVADFGVADLLPP 167

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 89.2 bits (222), Expect = 4e-20
 Identities = 42/160 (26%), Positives = 70/160 (43%), Gaps = 21/160 (13%)

Query: 335 VDLETISL-----AGSFGSVYKGTISDGTDVAIKIFN---LQRERAFRSFNSECEVLRNV 386
           +  E I+L     +G FG V  G      DVA+K+     +  +     F  E + +  +
Sbjct: 5   LKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDE----FFQEAQTMMKL 60

Query: 387 RHQNLIKILSSCSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYL 441
            H  L+K    CS         +++ NG L   L SH   L+  + L +  DV   + +L
Sbjct: 61  SHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL 120

Query: 442 HHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
                S   IH DL   + L+D ++   VSDFG+++ + +
Sbjct: 121 ----ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 91.1 bits (226), Expect = 5e-20
 Identities = 41/154 (26%), Positives = 72/154 (46%), Gaps = 21/154 (13%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILS--SCS 399
           G+  +V++G     G   AIK+FN     R       E EVL+ + H+N++K+ +    +
Sbjct: 20  GATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET 79

Query: 400 TPDFKFM-----PNGSLEKRLYSHNYFLDILER--LNIMIDVGSTLEYLH-HGHSSAPII 451
           T   K +     P GSL   L   +    + E   L ++ DV   + +L  +G     I+
Sbjct: 80  TTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG-----IV 134

Query: 452 HCDLKPTSILL----DENMVAHVSDFGISKLLGE 481
           H ++KP +I+     D   V  ++DFG ++ L +
Sbjct: 135 HRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 90.6 bits (225), Expect = 5e-20
 Identities = 33/148 (22%), Positives = 66/148 (44%), Gaps = 15/148 (10%)

Query: 343 AGSFGSVYKGTISDG----TDVAIKIFN-LQRERAFRSFNSECEVLRNVRHQNLIKILSS 397
            G FG VY GT+ D        A+K  N +        F +E  ++++  H N++ +L  
Sbjct: 99  RGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGI 158

Query: 398 CSTPD------FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPII 451
           C   +        +M +G L   + +  +   + + +   + V   +++L    +S   +
Sbjct: 159 CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL----ASKKFV 214

Query: 452 HCDLKPTSILLDENMVAHVSDFGISKLL 479
           H DL   + +LDE     V+DFG+++ +
Sbjct: 215 HRDLAARNCMLDEKFTVKVADFGLARDM 242

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 91.9 bits (228), Expect = 6e-20
 Identities = 33/147 (22%), Positives = 59/147 (40%), Gaps = 12/147 (8%)

Query: 343 AGSFGSVYKGTISDG---TDVAIKIF-NLQRERAFRSFNSECEVLRNVRHQNLIKILSSC 398
            G+FGSV +G         DVAIK+      +        E +++  + +  +++++  C
Sbjct: 346 CGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC 405

Query: 399 STPDFK----FMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
                         G L K L      + +     ++  V   ++YL         +H +
Sbjct: 406 QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL----EEKNFVHRN 461

Query: 455 LKPTSILLDENMVAHVSDFGISKLLGE 481
           L   ++LL     A +SDFG+SK LG 
Sbjct: 462 LAARNVLLVNRHYAKISDFGLSKALGA 488

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 89.8 bits (223), Expect = 6e-20
 Identities = 34/145 (23%), Positives = 60/145 (41%), Gaps = 16/145 (11%)

Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNL--IKILSSCS 399
           G    V++         AIK  NL+    +   S+ +E   L  ++  +   I++     
Sbjct: 20  GGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 79

Query: 400 TPDFKFM----PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLH-HGHSSAPIIHCD 454
           T  + +M     N  L   L       D  ER +   ++   +  +H HG     I+H D
Sbjct: 80  TDQYIYMVMECGNIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIHQHG-----IVHSD 133

Query: 455 LKPTSILLDENMVAHVSDFGISKLL 479
           LKP + L+ + M+  + DFGI+  +
Sbjct: 134 LKPANFLIVDGML-KLIDFGIANQM 157

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 91.0 bits (226), Expect = 6e-20
 Identities = 39/144 (27%), Positives = 74/144 (51%), Gaps = 10/144 (6%)

Query: 343 AGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
            G FG V+ GT +  T VAIK        +  +F  E +V++ +RH+ L+++ +  S   
Sbjct: 194 QGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP 252

Query: 403 F----KFMPNGSLEKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKP 457
                ++M  GSL   L      +L + + +++   + S + Y+         +H DL+ 
Sbjct: 253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV----ERMNYVHRDLRA 308

Query: 458 TSILLDENMVAHVSDFGISKLLGE 481
            +IL+ EN+V  V+DFG+++L+ +
Sbjct: 309 ANILVGENLVCKVADFGLARLIED 332

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 89.3 bits (222), Expect = 7e-20
 Identities = 44/151 (29%), Positives = 75/151 (49%), Gaps = 18/151 (11%)

Query: 343 AGSFGSVYKGTI----SDGTDVAIKIFN---LQRERAFRSFNSECEVLRNVRHQNLIKIL 395
           +G  G V  G +         VAIK       +R+R  R F SE  ++    H N+I++ 
Sbjct: 59  SGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR--RDFLSEASIMGQFDHPNIIRLE 116

Query: 396 SSCSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPI 450
              +         ++M NGSL+  L +H+    I++ + ++  VG+ + YL    S    
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL----SDLGY 172

Query: 451 IHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
           +H DL   ++L+D N+V  VSDFG+S++L +
Sbjct: 173 VHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 88.5 bits (220), Expect = 9e-20
 Identities = 34/148 (22%), Positives = 66/148 (44%), Gaps = 15/148 (10%)

Query: 343 AGSFGSVYKGTISDG----TDVAIKIFN-LQRERAFRSFNSECEVLRNVRHQNLIKILSS 397
            G FG VY G   D        AIK  + +   +   +F  E  ++R + H N++ ++  
Sbjct: 31  KGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGI 90

Query: 398 CSTPD------FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPII 451
              P+        +M +G L + + S      + + ++  + V   +EYL    +    +
Sbjct: 91  MLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL----AEQKFV 146

Query: 452 HCDLKPTSILLDENMVAHVSDFGISKLL 479
           H DL   + +LDE+    V+DFG+++ +
Sbjct: 147 HRDLAARNCMLDESFTVKVADFGLARDI 174

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 88.5 bits (220), Expect = 9e-20
 Identities = 33/148 (22%), Positives = 62/148 (41%), Gaps = 14/148 (9%)

Query: 343 AGSFGSVYKGTI---SDGTDVAIKIF--NLQRERAFRSFNSECEVLRNVRHQNLIKILSS 397
           +G+FG+V KG          VA+KI               +E  V++ + +  +++++  
Sbjct: 27  SGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGI 86

Query: 398 CSTPD----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHC 453
           C         +    G L K L  + + +     + ++  V   ++YL      +  +H 
Sbjct: 87  CEAESWMLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYL----EESNFVHR 141

Query: 454 DLKPTSILLDENMVAHVSDFGISKLLGE 481
           DL   ++LL     A +SDFG+SK L  
Sbjct: 142 DLAARNVLLVTQHYAKISDFGLSKALRA 169

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 88.1 bits (219), Expect = 1e-19
 Identities = 40/147 (27%), Positives = 66/147 (44%), Gaps = 16/147 (10%)

Query: 343 AGSFGSVYKGTISDGTDVAIKIFN---LQRERAFRSFNSECEVLRNVRHQNLIKILSSCS 399
            G FG V  G      DVAIK+     +  +     F  E +V+ N+ H+ L+++   C+
Sbjct: 34  TGQFGVVKYGKWRGQYDVAIKMIKEGSMSED----EFIEEAKVMMNLSHEKLVQLYGVCT 89

Query: 400 TPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
                    ++M NG L   L    +     + L +  DV   +EYL     S   +H D
Sbjct: 90  KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL----ESKQFLHRD 145

Query: 455 LKPTSILLDENMVAHVSDFGISKLLGE 481
           L   + L+++  V  VSDFG+S+ + +
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLD 172

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 89.8 bits (223), Expect = 1e-19
 Identities = 37/148 (25%), Positives = 67/148 (45%), Gaps = 17/148 (11%)

Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD 402
           G+ G++    + D  DVA+K    +          E ++LR    H N+I+   +     
Sbjct: 35  GAEGTIVYRGMFDNRDVAVKRILPECFSFAD---REVQLLRESDEHPNVIRYFCTEKDRQ 91

Query: 403 FKFMP----NGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPT 458
           F+++       +L++ +   ++    LE + ++    S L +LH    S  I+H DLKP 
Sbjct: 92  FQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH----SLNIVHRDLKPH 147

Query: 459 SILLDE-----NMVAHVSDFGISKLLGE 481
           +IL+        + A +SDFG+ K L  
Sbjct: 148 NILISMPNAHGKIKAMISDFGLCKKLAV 175

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 87.7 bits (218), Expect = 2e-19
 Identities = 41/145 (28%), Positives = 69/145 (47%), Gaps = 13/145 (8%)

Query: 344 GSFGSVYKGTISD-GTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           G++G VY G        +AIK    +  R  +  + E  + ++++H+N+++ L S S   
Sbjct: 33  GTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG 92

Query: 403 F-----KFMPNGSLEKRLYSHNYFLDILERL--NIMIDVGSTLEYLHHGHSSAPIIHCDL 455
           F     + +P GSL   L S    L   E+        +   L+YLH       I+H D+
Sbjct: 93  FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ----IVHRDI 148

Query: 456 KPTSILLD-ENMVAHVSDFGISKLL 479
           K  ++L++  + V  +SDFG SK L
Sbjct: 149 KGDNVLINTYSGVLKISDFGTSKRL 173

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 87.3 bits (217), Expect = 2e-19
 Identities = 35/161 (21%), Positives = 61/161 (37%), Gaps = 18/161 (11%)

Query: 335 VDLETISL-----AGSFGSVYKGTISDG----TDVAIKIFNL-QRERAFRSFNSECEVLR 384
           +  E I L      G FG V++G           VAIK       +     F  E   +R
Sbjct: 12  IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR 71

Query: 385 NVRHQNLIKILSSCSTPDF----KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEY 440
              H +++K++   +        +    G L   L    Y LD+   +     + + L Y
Sbjct: 72  QFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 131

Query: 441 LHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
           L     S   +H D+   ++L+  N    + DFG+S+ + +
Sbjct: 132 L----ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 88.2 bits (219), Expect = 2e-19
 Identities = 34/149 (22%), Positives = 58/149 (38%), Gaps = 17/149 (11%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           G F  V     + DG   A+K      ++       E ++ R   H N++++++ C    
Sbjct: 40  GGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRER 99

Query: 403 ---------FKFMPNGSLE---KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPI 450
                      F   G+L    +RL     FL   + L +++ +   LE +H    +   
Sbjct: 100 GAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH----AKGY 155

Query: 451 IHCDLKPTSILLDENMVAHVSDFGISKLL 479
            H DLKPT+ILL +     + D G     
Sbjct: 156 AHRDLKPTNILLGDEGQPVLMDLGSMNQA 184

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 89.9 bits (223), Expect = 2e-19
 Identities = 40/147 (27%), Positives = 74/147 (50%), Gaps = 16/147 (10%)

Query: 343 AGSFGSVYKGTISDGTDVAIKIF---NLQRERAFRSFNSECEVLRNVRHQNLIKILSSCS 399
            G FG V+ GT +  T VAIK      +  E     F  E +V++ +RH+ L+++ +  S
Sbjct: 277 QGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA----FLQEAQVMKKLRHEKLVQLYAVVS 332

Query: 400 TPDF----KFMPNGSLEKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
                   ++M  GSL   L      +L + + +++   + S + Y+         +H D
Sbjct: 333 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV----ERMNYVHRD 388

Query: 455 LKPTSILLDENMVAHVSDFGISKLLGE 481
           L+  +IL+ EN+V  V+DFG+++L+ +
Sbjct: 389 LRAANILVGENLVCKVADFGLARLIED 415

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 86.9 bits (216), Expect = 3e-19
 Identities = 35/147 (23%), Positives = 76/147 (51%), Gaps = 16/147 (10%)

Query: 343 AGSFGSVYKGTISDGTDVAIKIFN---LQRERAFRSFNSECEVLRNVRHQNLIKILSSCS 399
           AG FG V+ G  +  T VA+K      +  +    +F +E  +++ ++HQ L+++ +  +
Sbjct: 23  AGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD----AFLAEANLMKQLQHQRLVRLYAVVT 78

Query: 400 T-PDF---KFMPNGSLEKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
             P +   ++M NGSL   L + +   L I + L++   +   + ++         IH D
Sbjct: 79  QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI----EERNYIHRD 134

Query: 455 LKPTSILLDENMVAHVSDFGISKLLGE 481
           L+  +IL+ + +   ++DFG+++L+ +
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIED 161

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 87.8 bits (218), Expect = 3e-19
 Identities = 38/149 (25%), Positives = 65/149 (43%), Gaps = 14/149 (9%)

Query: 343 AGSFGSVYKGTISDG-----TDVAIKIFNL-QRERAFRSFNSECEVLRNVRHQNLIKILS 396
           +G+FG+VYKG            VAIK        +A +    E  V+ +V + ++ ++L 
Sbjct: 25  SGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLG 84

Query: 397 SCSTPDFK----FMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
            C T   +     MP G L   +  H   +     LN  + +   + YL        ++H
Sbjct: 85  ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL----EDRRLVH 140

Query: 453 CDLKPTSILLDENMVAHVSDFGISKLLGE 481
            DL   ++L+       ++DFG++KLLG 
Sbjct: 141 RDLAARNVLVKTPQHVKITDFGLAKLLGA 169

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 88.2 bits (219), Expect = 3e-19
 Identities = 44/162 (27%), Positives = 77/162 (47%), Gaps = 19/162 (11%)

Query: 335 VDLETISL-----AGSFGSVYKGTI----SDGTDVAIKIFNLQR-ERAFRSFNSECEVLR 384
           +D   IS+     AG FG V  G +         VAIK   +   E+  R F  E  ++ 
Sbjct: 42  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101

Query: 385 NVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLE 439
              H N+I++    +         ++M NGSL+  L  H+    +++ + ++  + S ++
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMK 161

Query: 440 YLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
           YL    S    +H DL   +IL++ N+V  VSDFG+ ++L +
Sbjct: 162 YL----SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED 199

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 86.5 bits (215), Expect = 4e-19
 Identities = 32/148 (21%), Positives = 61/148 (41%), Gaps = 13/148 (8%)

Query: 343 AGSFGSVYKGT----ISDGTDVAIKIFNL-QRERAFRSFNSECEVLRNVRHQNLIKILSS 397
            G FG VY+G       +  +VA+K             F SE  +++N+ H +++K++  
Sbjct: 22  EGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGI 81

Query: 398 CSTPD----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHC 453
                     +  P G L   L  +   L +L  +   + +   + YL     S   +H 
Sbjct: 82  IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL----ESINCVHR 137

Query: 454 DLKPTSILLDENMVAHVSDFGISKLLGE 481
           D+   +IL+       + DFG+S+ + +
Sbjct: 138 DIAVRNILVASPECVKLGDFGLSRYIED 165

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 86.2 bits (214), Expect = 4e-19
 Identities = 37/159 (23%), Positives = 60/159 (37%), Gaps = 31/159 (19%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           G FG V+K     DG    IK      E+A R    E + L  + H N++         D
Sbjct: 22  GGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNIVHYNGCWDGFD 77

Query: 403 FK---------------------FMPNGSLEKRLYSHN-YFLDILERLNIMIDVGSTLEY 440
           +                      F   G+LE+ +       LD +  L +   +   ++Y
Sbjct: 78  YDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDY 137

Query: 441 LHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
           +H       +I+ DLKP++I L +     + DFG+   L
Sbjct: 138 IHSKK----LINRDLKPSNIFLVDTKQVKIGDFGLVTSL 172

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 87.0 bits (216), Expect = 5e-19
 Identities = 42/165 (25%), Positives = 79/165 (47%), Gaps = 24/165 (14%)

Query: 335 VDLETISL-----AGSFGSVYKG-----TISDGTDVAIKIFN---LQRERAFRSFNSECE 381
           +    ++      AG FG VYKG     +      VAIK       +++R    F  E  
Sbjct: 41  IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR--VDFLGEAG 98

Query: 382 VLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGS 436
           ++    H N+I++    S         ++M NG+L+K L   +    +L+ + ++  + +
Sbjct: 99  IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAA 158

Query: 437 TLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
            ++YL    ++   +H DL   +IL++ N+V  VSDFG+S++L +
Sbjct: 159 GMKYL----ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 86.6 bits (215), Expect = 5e-19
 Identities = 34/148 (22%), Positives = 61/148 (41%), Gaps = 16/148 (10%)

Query: 344 GSFGSVYKGT-ISDGTDVAIK---IFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCS 399
           G F  VY+   + DG  VA+K   IF+L   +A      E ++L+ + H N+IK  +S  
Sbjct: 43  GQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI 102

Query: 400 TPDF-----KFMPNGSLE---KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPII 451
             +      +    G L    K        +         + + S LE++H       ++
Sbjct: 103 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR----VM 158

Query: 452 HCDLKPTSILLDENMVAHVSDFGISKLL 479
           H D+KP ++ +    V  + D G+ +  
Sbjct: 159 HRDIKPANVFITATGVVKLGDLGLGRFF 186

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 87.9 bits (218), Expect = 5e-19
 Identities = 47/188 (25%), Positives = 77/188 (40%), Gaps = 33/188 (17%)

Query: 319 SRNQLSGDIPSTIGALVDLETISLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNS 378
           SR     +   ++  LV  E I   GS G+V       G  VA+K   +           
Sbjct: 1   SRIANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIAL---M 57

Query: 379 ECEVLR-NVRHQNLIKILSSCSTPDFKFMP----NGSLEKRLYSHNYFLDILERL----- 428
           E ++L  +  H N+I+   S +T  F ++     N +L+  + S N   + L+       
Sbjct: 58  EIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNP 117

Query: 429 -NIMIDVGSTLEYLH-HGHSSAPIIHCDLKPTSILLD-------------ENMVAHVSDF 473
            +++  + S + +LH        IIH DLKP +IL+              EN+   +SDF
Sbjct: 118 ISLLRQIASGVAHLHSLK-----IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 172

Query: 474 GISKLLGE 481
           G+ K L  
Sbjct: 173 GLCKKLDS 180

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 86.2 bits (214), Expect = 7e-19
 Identities = 39/154 (25%), Positives = 65/154 (42%), Gaps = 23/154 (14%)

Query: 343 AGSFGSVYKGTI-----SDGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKI 394
            G FG V            G  VA+K   L+     +    +  E ++LR + H+++IK 
Sbjct: 41  EGHFGKVSLYCYDPTNDGTGEMVAVKA--LKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98

Query: 395 LSSCSTPDFK-------FMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSS 447
              C             ++P GSL   L  H+  + + + L     +   + YLH  H  
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLHAQH-- 154

Query: 448 APIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
              IH DL   ++LLD + +  + DFG++K + E
Sbjct: 155 --YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 85.0 bits (211), Expect = 1e-18
 Identities = 43/142 (30%), Positives = 66/142 (46%), Gaps = 14/142 (9%)

Query: 343 AGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
            G FG V  G    G  VA+K   ++ +   ++F +E  V+  +RH NL+++L       
Sbjct: 31  KGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 87

Query: 403 ------FKFMPNGSLEKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDL 455
                  ++M  GSL   L S     L     L   +DV   +EYL         +H DL
Sbjct: 88  GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL----EGNNFVHRDL 143

Query: 456 KPTSILLDENMVAHVSDFGISK 477
              ++L+ E+ VA VSDFG++K
Sbjct: 144 AARNVLVSEDNVAKVSDFGLTK 165

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 85.4 bits (212), Expect = 1e-18
 Identities = 43/156 (27%), Positives = 67/156 (42%), Gaps = 25/156 (16%)

Query: 343 AGSFGSVYKGTISDG----TDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILS 396
            G FGSV +G +         VA+K   L    +R    F SE   +++  H N+I++L 
Sbjct: 44  EGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLG 103

Query: 397 SCSTPD----------FKFMPNGSL-----EKRLYSHNYFLDILERLNIMIDVGSTLEYL 441
            C                FM  G L       RL +    + +   L  M+D+   +EYL
Sbjct: 104 VCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL 163

Query: 442 HHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK 477
               S+   +H DL   + +L ++M   V+DFG+SK
Sbjct: 164 ----SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK 195

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 87.2 bits (216), Expect = 1e-18
 Identities = 65/379 (17%), Positives = 124/379 (32%), Gaps = 47/379 (12%)

Query: 5   IPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNI 64
           I  E GN+  LK L L   +L       I +++  + L + G              L + 
Sbjct: 107 ICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKED---PEGLQDF 163

Query: 65  KYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSG------------------------ 100
               L          + I + +   + +L  +                            
Sbjct: 164 NTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLS 223

Query: 101 ------------HIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLI 148
                               + H +V    ++N+  +    ++  F  S T+ + L    
Sbjct: 224 NLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFR-DFDYSGTSLKALSIHQ 282

Query: 149 LSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIP 208
           +  +  G      I    +++   + +    +         +   ++L    N L  T+ 
Sbjct: 283 VVSDVFG-FPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVF 341

Query: 209 TSIGTLKQLQGFFLPETNLQ--GYVPHNLCHLEMLNLLHLGGNKLSGHIPPCL-ASLTSL 265
            + G L +L+   L    L+    +      ++ L  L +  N +S        +   SL
Sbjct: 342 ENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSL 401

Query: 266 RELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSG 325
             L++ SN LT +I   L     I  ++L SN +  S+P  V KL+ L+ L+++ NQL  
Sbjct: 402 LSLNMSSNILTDTIFRCLPPR--IKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKS 458

Query: 326 DIPSTIGALVDLETISLAG 344
                   L  L+ I L  
Sbjct: 459 VPDGIFDRLTSLQKIWLHT 477

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 81.4 bits (201), Expect = 1e-16
 Identities = 54/346 (15%), Positives = 106/346 (30%), Gaps = 24/346 (6%)

Query: 6   PTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIK 65
            ++I +L  L+ L +  N +  L   +      +  L+L  N+L   +     H   N+K
Sbjct: 38  TSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISC---HPTVNLK 93

Query: 66  YLELGDNNLIG-TIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTT 124
           +L+L  N      I     N ++L  L L              +L    VL +L      
Sbjct: 94  HLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGE 153

Query: 125 ESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQR-----FSASECKL 179
           +         L        L  +  +      IL  S+   +             ++C  
Sbjct: 154 K----EDPEGLQDFNT-ESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSY 208

Query: 180 KGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQ--------LQGFFLPETNLQGYV 231
             +I  ++     L  L+L   +        I  L          +    L         
Sbjct: 209 FLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDF 268

Query: 232 PHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILE 291
            ++   L+ L++  +  +             +++   +   +            +   L 
Sbjct: 269 DYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLH 328

Query: 292 INLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDL 337
           ++ S+NLL D++  N   L  L  L L  NQL  ++         +
Sbjct: 329 LDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQM 373

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 78.4 bits (193), Expect = 1e-15
 Identities = 52/300 (17%), Positives = 104/300 (34%), Gaps = 25/300 (8%)

Query: 7   TEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKY 66
           + I  +          + L+ L      +  T+ N+    N     +  ++ H+   + Y
Sbjct: 195 SNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFI-RILQLVWHT--TVWY 251

Query: 67  LELGDNNLIG-----TIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNN 121
             + +  L G         S T+   L I  +  + F       +    ++++ +  ++ 
Sbjct: 252 FSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSG 311

Query: 122 LTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKG 181
                      S +S         +L  S N L   +  + G+  T L+       +LK 
Sbjct: 312 TRMVHMLC--PSKISPFL------HLDFSNNLLTDTVFENCGHL-TELETLILQMNQLK- 361

Query: 182 TIPKEIG---HLRGLIYLSLGFNDLNGTIPTSI-GTLKQLQGFFLPETNLQGYVPHNLCH 237
            + K       ++ L  L +  N ++           K L    +    L   +   L  
Sbjct: 362 ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPP 421

Query: 238 LEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSN 297
              + +L L  NK+   IP  +  L +L+EL++ SN+L S        L  + +I L +N
Sbjct: 422 R--IKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 60.6 bits (147), Expect = 4e-10
 Identities = 55/323 (17%), Positives = 91/323 (28%), Gaps = 36/323 (11%)

Query: 42  LNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGH 101
           ++   N L  H+P  +         L +  N +     + I + +KL IL +  N     
Sbjct: 5   VDRSKNGLI-HVPKDLS---QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYL 60

Query: 102 IPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPS 161
             + F   + L  L L  N L   S             N   L +L LS N    +  P 
Sbjct: 61  DISVFKFNQELEYLDLSHNKLVKISC--------HPTVN---LKHLDLSFNAFDAL--PI 107

Query: 162 IGNFS--TSLQRFSASECKLKGTIPKEIGHLRGLIYL---------SLGFNDLNGTIPTS 210
              F   + L+    S   L+ +    I HL     L               L      S
Sbjct: 108 CKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTES 167

Query: 211 IGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDL 270
           +  +      F    ++      NL    +  +L          I   L +   L  L L
Sbjct: 168 LHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTL 227

Query: 271 GSNKLT----SSIPSSLWSLG----YILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQ 322
            + + T      I   +W        I  + L   L       +   LK L +  +  + 
Sbjct: 228 NNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDV 287

Query: 323 LSGDIPSTIGALVDLETISLAGS 345
                        ++   +   S
Sbjct: 288 FGFPQSYIYEIFSNMNIKNFTVS 310

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 48.7 bits (116), Expect = 3e-06
 Identities = 24/113 (21%), Positives = 45/113 (39%), Gaps = 5/113 (4%)

Query: 11  NLQNLKSLFLGANNLSGLIPPMIF-NISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLEL 69
            +++L+ L +  N++S            ++ +LN+  N L+  +   +    P IK L+L
Sbjct: 372 QMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL---PPRIKVLDL 428

Query: 70  GDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNL 122
             N +  +IP  +     L  L++  N         F  L  L  + L  N  
Sbjct: 429 HSNKI-KSIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 45.6 bits (108), Expect = 3e-05
 Identities = 22/84 (26%), Positives = 38/84 (45%), Gaps = 5/84 (5%)

Query: 242 NLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLND 301
            L+    N L  H+P  L+       L++  N ++    S + SL  +  + +S N +  
Sbjct: 3   FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ- 58

Query: 302 SLPSNV-QKLKVLRVLDLSRNQLS 324
            L  +V +  + L  LDLS N+L 
Sbjct: 59  YLDISVFKFNQELEYLDLSHNKLV 82

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 84.7 bits (210), Expect = 2e-18
 Identities = 35/151 (23%), Positives = 61/151 (40%), Gaps = 16/151 (10%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNL--QRERAFRSFNSECEVLRNVRHQNLIKILSSCST 400
           GSF +VYKG       +VA          +   + F  E E+L+ ++H N+++   S  +
Sbjct: 37  GSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWES 96

Query: 401 PDFK---------FMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPII 451
                         M +G+L+  L         + R +    +   L++LH    + PII
Sbjct: 97  TVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLR-SWCRQILKGLQFLHT--RTPPII 153

Query: 452 HCDLKPTSILLD-ENMVAHVSDFGISKLLGE 481
           H DLK  +I +        + D G++ L   
Sbjct: 154 HRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 85.1 bits (211), Expect = 2e-18
 Identities = 37/156 (23%), Positives = 64/156 (41%), Gaps = 26/156 (16%)

Query: 344 GSFGSVYKGTISDG----TDVAIKIF--NLQRERAFRSFNSECEVLRNVRHQNLIKILSS 397
           G FGSV +  +         VA+K+   ++        F  E   ++   H ++ K++  
Sbjct: 34  GEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGV 93

Query: 398 CSTPD-----------FKFMPNGSL-----EKRLYSHNYFLDILERLNIMIDVGSTLEYL 441
                             FM +G L       R+  + + L +   +  M+D+   +EYL
Sbjct: 94  SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYL 153

Query: 442 HHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK 477
               SS   IH DL   + +L E+M   V+DFG+S+
Sbjct: 154 ----SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 84.2 bits (209), Expect = 2e-18
 Identities = 34/152 (22%), Positives = 59/152 (38%), Gaps = 14/152 (9%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCST 400
           GS+G   K    SDG  +  K  +     E   +   SE  +LR ++H N+++       
Sbjct: 17  GSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID 76

Query: 401 PDFK-------FMPNGSLEKRLYSH---NYFLDILERLNIMIDVGSTLEYLHHGHSSA-P 449
                      +   G L   +        +LD    L +M  +   L+  H        
Sbjct: 77  RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHT 136

Query: 450 IIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
           ++H DLKP ++ LD      + DFG++++L  
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARILNH 168

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 87.2 bits (216), Expect = 2e-18
 Identities = 34/161 (21%), Positives = 61/161 (37%), Gaps = 18/161 (11%)

Query: 335 VDLETISL-----AGSFGSVYKGTISDG----TDVAIKIFNLQ-RERAFRSFNSECEVLR 384
           +  E I L      G FG V++G           VAIK       +     F  E   +R
Sbjct: 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMR 446

Query: 385 NVRHQNLIKILSSCSTPDF----KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEY 440
              H +++K++   +        +    G L   L    + LD+   +     + + L Y
Sbjct: 447 QFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAY 506

Query: 441 LHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
           L     S   +H D+   ++L+  N    + DFG+S+ + +
Sbjct: 507 L----ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 543

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 85.1 bits (211), Expect = 3e-18
 Identities = 35/147 (23%), Positives = 61/147 (41%), Gaps = 13/147 (8%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCST 400
           GSFG         DG    IK  N+ R   +       E  VL N++H N+++   S   
Sbjct: 35  GSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE 94

Query: 401 PDF-----KFMPNGSLEKRLYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
                    +   G L KR+ +         + L+  + +   L+++H       I+H D
Sbjct: 95  NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK----ILHRD 150

Query: 455 LKPTSILLDENMVAHVSDFGISKLLGE 481
           +K  +I L ++    + DFGI+++L  
Sbjct: 151 IKSQNIFLTKDGTVQLGDFGIARVLNS 177

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 83.8 bits (208), Expect = 3e-18
 Identities = 42/160 (26%), Positives = 73/160 (45%), Gaps = 23/160 (14%)

Query: 335 VDLETISL-----AGSFGSVYKGTISDG-TDVAIKIFN---LQRERAFRSFNSECEVLRN 385
           ++   I++      G +G VY+G        VA+K      ++ E     F  E  V++ 
Sbjct: 10  MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE----EFLKEAAVMKE 65

Query: 386 VRHQNLIKILSSCSTPD-----FKFMPNGSLEKRLYSHN-YFLDILERLNIMIDVGSTLE 439
           ++H NL+++L  C+         +FM  G+L   L   N   +  +  L +   + S +E
Sbjct: 66  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 125

Query: 440 YLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
           YL         IH DL   + L+ EN +  V+DFG+S+L+
Sbjct: 126 YL----EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 161

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 86.4 bits (214), Expect = 3e-18
 Identities = 40/149 (26%), Positives = 68/149 (45%), Gaps = 18/149 (12%)

Query: 343 AGSFGSVYKGTI-SDGTDVAIKIF---NLQRERAFRSFNSECEVLRNVRHQNLIKILSSC 398
            G +G VY+G        VA+K      ++ E     F  E  V++ ++H NL+++L  C
Sbjct: 230 GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE----EFLKEAAVMKEIKHPNLVQLLGVC 285

Query: 399 STPD-----FKFMPNGSLEKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
           +         +FM  G+L   L   N   +  +  L +   + S +EYL         IH
Sbjct: 286 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL----EKKNFIH 341

Query: 453 CDLKPTSILLDENMVAHVSDFGISKLLGE 481
            +L   + L+ EN +  V+DFG+S+L+  
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTG 370

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 83.8 bits (208), Expect = 4e-18
 Identities = 29/145 (20%), Positives = 56/145 (38%), Gaps = 14/145 (9%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFN---LQRERAFRSFNSECEVLRNVRHQNLIKILSSCS 399
           G F   ++ +        A KI     L +       + E  + R++ HQ+++       
Sbjct: 26  GGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE 85

Query: 400 TPDFKFM-----PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
             DF F+        SL +         +   R   +  +    +YLH       +IH D
Sbjct: 86  DNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLHRNR----VIHRD 140

Query: 455 LKPTSILLDENMVAHVSDFGISKLL 479
           LK  ++ L+E++   + DFG++  +
Sbjct: 141 LKLGNLFLNEDLEVKIGDFGLATKV 165

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 83.2 bits (206), Expect = 6e-18
 Identities = 31/157 (19%), Positives = 58/157 (36%), Gaps = 25/157 (15%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTP 401
           G FG V++     D  + AIK   L   E A      E + L  + H  +++  ++    
Sbjct: 16  GGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEK 75

Query: 402 DFK-----------------FMPNGSLEKRLYSHNYFLDILER--LNIMIDVGSTLEYLH 442
           +                        +L+  +       +      L+I + +   +E+LH
Sbjct: 76  NTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH 135

Query: 443 HGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
                  ++H DLKP++I    + V  V DFG+   +
Sbjct: 136 SKG----LMHRDLKPSNIFFTMDDVVKVGDFGLVTAM 168

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 82.6 bits (205), Expect = 8e-18
 Identities = 31/145 (21%), Positives = 61/145 (42%), Gaps = 14/145 (9%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFN---LQRERAFRSFNSECEVLRNVRHQNLIKILSSCS 399
           G FG+VY          +A+K+     L++         E E+  ++RH N++++     
Sbjct: 20  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 79

Query: 400 TPDFKFM-----PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
                ++     P G++ + L   + F +       + ++ + L Y H       +IH D
Sbjct: 80  DATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-TYITELANALSYCHSKR----VIHRD 134

Query: 455 LKPTSILLDENMVAHVSDFGISKLL 479
           +KP ++LL       ++DFG S   
Sbjct: 135 IKPENLLLGSAGELKIADFGWSVHA 159

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 85.5 bits (211), Expect = 8e-18
 Identities = 40/160 (25%), Positives = 62/160 (38%), Gaps = 30/160 (18%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQ-----RERAFRSFNSECEVLRNVRHQNLIKIL-- 395
           G FG V +      G  VAIK    +     RER       E ++++ + H N++     
Sbjct: 25  GGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL----EIQIMKKLNHPNVVSAREV 80

Query: 396 ----SSCSTPDFKFM-----PNGSLEKRLYSH--NYFLDILERLNIMIDVGSTLEYLHHG 444
                  +  D   +       G L K L        L       ++ D+ S L YLH  
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140

Query: 445 HSSAPIIHCDLKPTSILLD---ENMVAHVSDFGISKLLGE 481
                IIH DLKP +I+L    + ++  + D G +K L +
Sbjct: 141 R----IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ 176

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 83.1 bits (206), Expect = 9e-18
 Identities = 29/145 (20%), Positives = 56/145 (38%), Gaps = 14/145 (9%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFN---LQRERAFRSFNSECEVLRNVRHQNLIKILSSCS 399
           G F   ++ +        A KI     L +       + E  + R++ HQ+++       
Sbjct: 52  GGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE 111

Query: 400 TPDFKFM-----PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
             DF F+        SL +         +   R   +  +    +YLH       +IH D
Sbjct: 112 DNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLHRNR----VIHRD 166

Query: 455 LKPTSILLDENMVAHVSDFGISKLL 479
           LK  ++ L+E++   + DFG++  +
Sbjct: 167 LKLGNLFLNEDLEVKIGDFGLATKV 191

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 82.1 bits (203), Expect = 2e-17
 Identities = 30/145 (20%), Positives = 54/145 (37%), Gaps = 17/145 (11%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           GSFG V++      G   A+K   L+  R       E      +    ++ +  +     
Sbjct: 69  GSFGEVHRMKDKQTGFQCAVKKVRLEVFRV-----EELVACAGLSSPRIVPLYGAVREGP 123

Query: 403 F-----KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKP 457
           +     + +  GSL + +       +       +      LEYLH    +  I+H D+K 
Sbjct: 124 WVNIFMELLEGGSLGQLIKQMGCLPEDRAL-YYLGQALEGLEYLH----TRRILHGDVKA 178

Query: 458 TSILLDEN-MVAHVSDFGISKLLGE 481
            ++LL  +   A + DFG +  L  
Sbjct: 179 DNVLLSSDGSRAALCDFGHALCLQP 203

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 80.8 bits (200), Expect = 3e-17
 Identities = 29/160 (18%), Positives = 60/160 (37%), Gaps = 25/160 (15%)

Query: 343 AGSFGSVYKGT--------ISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKI 394
            G+F  ++KG             T+V +K+ +        SF     ++  + H++L+  
Sbjct: 18  QGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLN 77

Query: 395 LSSCSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAP 449
              C   D      +F+  GSL+  L  +   ++IL +L +   + + + +L        
Sbjct: 78  YGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFL----EENT 133

Query: 450 IIHCDL--------KPTSILLDENMVAHVSDFGISKLLGE 481
           +IH ++        +             +SD GIS  +  
Sbjct: 134 LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP 173

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 79.9 bits (198), Expect = 6e-17
 Identities = 35/144 (24%), Positives = 62/144 (43%), Gaps = 14/144 (9%)

Query: 344 GSFGSVYKG-TISDGTDVAIKIFN---LQRERAFRSFNSECEVLRNVRHQNLIKILSSCS 399
           G FG+VY      +   +A+K+     L++E        E E+  ++RH N++++ +   
Sbjct: 25  GKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH 84

Query: 400 TPDFKFM-----PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
                ++     P G L K L  H  F +       M ++   L Y H       +IH D
Sbjct: 85  DRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA-TFMEELADALHYCHERK----VIHRD 139

Query: 455 LKPTSILLDENMVAHVSDFGISKL 478
           +KP ++L+       ++DFG S  
Sbjct: 140 IKPENLLMGYKGELKIADFGWSVH 163

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 79.9 bits (198), Expect = 7e-17
 Identities = 33/145 (22%), Positives = 70/145 (48%), Gaps = 13/145 (8%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFN---LQRERAFRSFNSECEVLRNVRHQNLIKILSSCS 399
           GSF  VY+   I  G +VAIK+ +   + +    +   +E ++   ++H +++++ +   
Sbjct: 22  GSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE 81

Query: 400 TPDFKFM-----PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
             ++ ++      NG + + L +        E  + M  + + + YLH       I+H D
Sbjct: 82  DSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG----ILHRD 137

Query: 455 LKPTSILLDENMVAHVSDFGISKLL 479
           L  +++LL  NM   ++DFG++  L
Sbjct: 138 LTLSNLLLTRNMNIKIADFGLATQL 162

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 79.7 bits (197), Expect = 8e-17
 Identities = 54/276 (19%), Positives = 86/276 (31%), Gaps = 62/276 (22%)

Query: 71  DNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAY 130
               +  +P  I  A++   + L  N  S     +F   R+L++L L  N L    ++A 
Sbjct: 19  PQQGLQAVPVGIPAASQ--RIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA- 75

Query: 131 QWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHL 190
                + L     L  L LS N     + P+          F                 L
Sbjct: 76  ----FTGLAL---LEQLDLSDNAQLRSVDPAT---------FH---------------GL 104

Query: 191 RGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNK 250
             L  L L    L                       L   +   L  L+ L   +L  N 
Sbjct: 105 GRLHTLHLDRCGL---------------------QELGPGLFRGLAALQYL---YLQDNA 140

Query: 251 LSGHIPP-CLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNV-Q 308
           L   +P      L +L  L L  N+++S    +   L  +  + L  N +   +  +  +
Sbjct: 141 LQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFR 198

Query: 309 KLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAG 344
            L  L  L L  N LS      +  L  L+ + L  
Sbjct: 199 DLGRLMTLYLFANNLSALPTEALAPLRALQYLRLND 234

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 76.2 bits (188), Expect = 1e-15
 Identities = 48/240 (20%), Positives = 77/240 (32%), Gaps = 40/240 (16%)

Query: 62  PNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNN 121
              + + L  N +      S      L IL L  N  +      F  L  L  L L  N 
Sbjct: 32  AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91

Query: 122 LTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFS--TSLQRFSASECKL 179
                         ++      L  L L    L  + P   G F    +LQ     +  L
Sbjct: 92  QLRSVDP-------ATFHGLGRLHTLHLDRCGLQELGP---GLFRGLAALQYLYLQDNAL 141

Query: 180 KGTIPKEI-GHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHL 238
           +  +P +    L  L +L L  N ++ ++P                             L
Sbjct: 142 Q-ALPDDTFRDLGNLTHLFLHGNRIS-SVP-----------------------ERAFRGL 176

Query: 239 EMLNLLHLGGNKLSGHIPP-CLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSN 297
             L+ L L  N+++ H+ P     L  L  L L +N L++    +L  L  +  + L+ N
Sbjct: 177 HSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 66.2 bits (162), Expect = 2e-12
 Identities = 45/196 (22%), Positives = 72/196 (36%), Gaps = 19/196 (9%)

Query: 11  NLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELG 70
             +NL  L+L +N L+ +       ++ +  L+L  N     +     H L  +  L L 
Sbjct: 54  ACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL- 112

Query: 71  DNNLIGTIPNSI-TNATKLIILDLGFNTFSGHIP-NTFGNLRHLSVLSLLMNNLTTESSS 128
           D   +  +   +      L  L L  N     +P +TF +L +L+ L L  N +++    
Sbjct: 113 DRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPER 171

Query: 129 AYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFS--TSLQRFSASECKLKGTIPKE 186
           A        L +   L  L+L  N +  + P     F     L         L   +P E
Sbjct: 172 A-----FRGLHS---LDRLLLHQNRVAHVHP---HAFRDLGRLMTLYLFANNLS-ALPTE 219

Query: 187 I-GHLRGLIYLSLGFN 201
               LR L YL L  N
Sbjct: 220 ALAPLRALQYLRLNDN 235

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 81.3 bits (201), Expect = 9e-17
 Identities = 62/337 (18%), Positives = 107/337 (31%), Gaps = 46/337 (13%)

Query: 8   EIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYL 67
           ++    NL  L   +N L+ L    +  ++ +  LN   N+L+     +     P + YL
Sbjct: 80  DLSQNTNLTYLACDSNKLTNLD---VTPLTKLTYLNCDTNKLT----KLDVSQNPLLTYL 132

Query: 68  ELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESS 127
                N +  I   +++ T+L  LD   N     +         L+ L    N +T    
Sbjct: 133 NC-ARNTLTEID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITE--- 184

Query: 128 SAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEI 187
                     ++  + L  L    N +  +    +      L     S  KL   I   +
Sbjct: 185 --------LDVSQNKLLNRLNCDTNNITKL---DLNQN-IQLTFLDCSSNKLT-EID--V 229

Query: 188 GHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLG 247
             L  L Y     N L   +   + TL +L      +T+L      +   L         
Sbjct: 230 TPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGC- 285

Query: 248 GNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNV 307
             K+       +   T L  LD  +  +T    S    L   + + L++  L   L   V
Sbjct: 286 -RKIK---ELDVTHNTQLYLLDCQAAGITELDLSQNPKL---VYLYLNNTELT-ELD--V 335

Query: 308 QKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAG 344
                L+ L      +  D  S +G +  L     A 
Sbjct: 336 SHNTKLKSLSCVNAHIQ-DFSS-VGKIPALNNNFEAE 370

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 78.2 bits (193), Expect = 1e-15
 Identities = 65/348 (18%), Positives = 110/348 (31%), Gaps = 54/348 (15%)

Query: 13  QNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDN 72
            N  S    A  +          ++T+ +L+   + ++  +  +    L  +  L    N
Sbjct: 18  DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTGI--EKLTGLTKLICTSN 74

Query: 73  NLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQW 132
           N I T+   ++  T L  L    N  + ++      L  L+ L+   N LT         
Sbjct: 75  N-ITTLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLTK-------- 120

Query: 133 SFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRG 192
                ++    L YL  + N L  I    + +  T L        K       ++     
Sbjct: 121 ---LDVSQNPLLTYLNCARNTLTEI---DVSHN-TQLTELDCHLNKK--ITKLDVTPQTQ 171

Query: 193 LIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLS 252
           L  L   FN +       +   K L        N+      +L     L  L    NKL+
Sbjct: 172 LTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNITK---LDLNQNIQLTFLDCSSNKLT 225

Query: 253 GHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGY-------ILEINLSSNL------- 298
             I   +  LT L   D   N LT    S+L  L         +LEI+L+ N        
Sbjct: 226 -EID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQA 282

Query: 299 --LNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAG 344
                    +V     L +LD     ++ ++   +     L  + L  
Sbjct: 283 EGCRKIKELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNN 327

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 64.7 bits (158), Expect = 2e-11
 Identities = 58/344 (16%), Positives = 100/344 (29%), Gaps = 53/344 (15%)

Query: 9   IGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLE 68
           +  L  L  L    N L+ L    +     +  LN   N L+     +       +  L+
Sbjct: 102 VTPLTKLTYLNCDTNKLTKL---DVSQNPLLTYLNCARNTLT----EIDVSHNTQLTELD 154

Query: 69  LGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTT-ESS 127
              N  I  +   +T  T+L  LD  FN  +          + L+ L+   NN+T  + +
Sbjct: 155 CHLNKKITKLD--VTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNITKLDLN 209

Query: 128 SAYQWSFLS---------SLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECK 178
              Q +FL           +T    L Y   S NPL  +    +    + L      +  
Sbjct: 210 QNIQLTFLDCSSNKLTEIDVTPLTQLTYFDCSVNPLTEL---DVSTL-SKLTTLHCIQTD 265

Query: 179 LKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHL 238
           L   I   + H   LIY               +    QL         +          L
Sbjct: 266 LL-EID--LTHNTQLIYFQA--EGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKL 320

Query: 239 EMLNL------------------LHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIP 280
             L L                  L      +       +  + +L        +  +   
Sbjct: 321 VYLYLNNTELTELDVSHNTKLKSLSCVNAHIQD--FSSVGKIPALNNNFEAEGQTITMPK 378

Query: 281 SSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLS 324
            +L +    L I +S +LL+        +     V D + N ++
Sbjct: 379 ETLTNN--SLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTIT 420

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 45.4 bits (108), Expect = 3e-05
 Identities = 27/162 (16%), Positives = 53/162 (32%), Gaps = 13/162 (8%)

Query: 7   TEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKY 66
            EI    N + ++  A     +    + + + +  L+     ++     +     P + Y
Sbjct: 267 LEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT----ELDLSQNPKLVY 322

Query: 67  LELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTES 126
           L L +  L   +   +++ TKL  L            ++ G +  L+          T  
Sbjct: 323 LYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQD--FSSVGKIPALNNNFEAEGQTITMP 377

Query: 127 SSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTS 168
                    +SLT       L   GNP+  I P   G +  +
Sbjct: 378 KETLT---NNSLTIAVSPDLLDQFGNPM-NIEPGDGGVYDQA 415

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 78.1 bits (193), Expect = 3e-16
 Identities = 41/157 (26%), Positives = 63/157 (40%), Gaps = 27/157 (17%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRS---------FNSECEVLRNV-RHQNLI 392
           G    V +        + A+KI ++    +F +            E ++LR V  H N+I
Sbjct: 28  GVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNII 87

Query: 393 KILSSCSTPDFKF-----MPNGSLEKRLYSHNYFLDILER--LNIMIDVGSTLEYLH-HG 444
           ++  +  T  F F     M  G L   L          E+    IM  +   +  LH   
Sbjct: 88  QLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLS---EKETRKIMRALLEVICALHKLN 144

Query: 445 HSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
                I+H DLKP +ILLD++M   ++DFG S  L  
Sbjct: 145 -----IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 176

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 77.7 bits (192), Expect = 3e-16
 Identities = 63/227 (27%), Positives = 95/227 (41%), Gaps = 21/227 (9%)

Query: 78  IPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSS 137
           IP+++  +TK   LDL FN        +F +   L VL L    + T    AY      S
Sbjct: 22  IPDNLPFSTK--NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAY-----QS 74

Query: 138 LTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLS 197
           L++   L  LIL+GNP+   L     +  +SLQ+  A E  L       IGHL+ L  L+
Sbjct: 75  LSH---LSTLILTGNPIQS-LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 130

Query: 198 LGFNDLNGTIPTSIGT---LKQLQGFFLPE---TNLQGYVPHNLCHLEMLNL-LHLGGNK 250
           +  N +  +          L  L+   L      ++       L  + +LNL L L  N 
Sbjct: 131 VAHNLIQ-SFK-LPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188

Query: 251 LSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSN 297
           ++  I P       L+EL L +N+L S        L  + +I L +N
Sbjct: 189 MN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 60.0 bits (146), Expect = 3e-10
 Identities = 52/272 (19%), Positives = 92/272 (33%), Gaps = 66/272 (24%)

Query: 5   IPTEIGNLQNLKSLFLGANNLSGLIPPMIF-NISTIRNLNLGGNRLSGHLPSMIGHSLPN 63
           +P       + K+L L  N L  L     F +   ++ L+L    +   +      SL +
Sbjct: 26  LPF------STKNLDLSFNPLRHL-GSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSH 77

Query: 64  IKYLELGDNNLIGTIPNSI-TNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNL 122
           +  L L  N +  ++     +  + L  L       +       G+L+ L  L++  N +
Sbjct: 78  LSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI 136

Query: 123 TTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGT 182
            +     Y     S+LTN   L +L LS N +   +  +       +   + S       
Sbjct: 137 QSFKLPEY----FSNLTN---LEHLDLSSNKI-QSIYCTDLRVLHQMPLLNLS------- 181

Query: 183 IPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLN 242
                        L L  N +N  I    G  K+++                      L 
Sbjct: 182 -------------LDLSLNPMN-FIQP--GAFKEIR----------------------LK 203

Query: 243 LLHLGGNKLSGHIPP-CLASLTSLRELDLGSN 273
            L L  N+L   +P      LTSL+++ L +N
Sbjct: 204 ELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 54.6 bits (132), Expect = 2e-08
 Identities = 32/156 (20%), Positives = 57/156 (36%), Gaps = 18/156 (11%)

Query: 5   IPTEI-GNLQNLKSLFLGANNLSGLIPPMIFNI-STIRNLNLGGNRLSGHLPSM-IGHSL 61
           +       L +L+ L     NL+ L          T++ LN+  N +           +L
Sbjct: 91  LALGAFSGLSSLQKLVAVETNLASL-ENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNL 148

Query: 62  PNIKYLELGDNNLIGTIPNSITNATKLII----LDLGFNTFSGHIPNTFGNLRHLSVLSL 117
            N+++L+L  N +       +    ++ +    LDL  N  +   P  F  +  L  L+L
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLKELAL 207

Query: 118 LMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNP 153
             N L +     +    L+SL        + L  NP
Sbjct: 208 DTNQLKSVPDGIFD--RLTSLQ------KIWLHTNP 235

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 45.0 bits (107), Expect = 3e-05
 Identities = 18/82 (21%), Positives = 31/82 (37%), Gaps = 4/82 (4%)

Query: 263 TSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNV-QKLKVLRVLDLSRN 321
            S + LDL  N L      S +S   +  ++LS   +  ++     Q L  L  L L+ N
Sbjct: 28  FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGN 86

Query: 322 QLSGDIPSTI-GALVDLETISL 342
            +   +       L  L+ +  
Sbjct: 87  PIQ-SLALGAFSGLSSLQKLVA 107

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 78.6 bits (194), Expect = 3e-16
 Identities = 33/153 (21%), Positives = 59/153 (38%), Gaps = 20/153 (13%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVR-HQNLIKILSSCSTP 401
           G F  VY+   +  G + A+K      E   R+   E   ++ +  H N+++  S+ S  
Sbjct: 39  GGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG 98

Query: 402 DFKFMPNGSLEKRL---YSHNYFLDILER------------LNIMIDVGSTLEYLHHGHS 446
             +    G  E  L         ++ L++            L I       ++++H    
Sbjct: 99  K-EESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR--Q 155

Query: 447 SAPIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
             PIIH DLK  ++LL       + DFG +  +
Sbjct: 156 KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTI 188

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 78.1 bits (193), Expect = 4e-16
 Identities = 32/150 (21%), Positives = 54/150 (36%), Gaps = 20/150 (13%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNL------QRERAFRSFNSECEVLRNV-RHQNLIKIL 395
           GS+G V+K     DG   A+K           R R       E      V +H   +++ 
Sbjct: 68  GSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLA----EVGSHEKVGQHPCCVRLE 123

Query: 396 SSCSTPDFKFMPN----GSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPII 451
            +       ++       SL++   +    L   +    + D    L +LH       ++
Sbjct: 124 QAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG----LV 179

Query: 452 HCDLKPTSILLDENMVAHVSDFGISKLLGE 481
           H D+KP +I L       + DFG+   LG 
Sbjct: 180 HLDVKPANIFLGPRGRCKLGDFGLLVELGT 209

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 79.8 bits (196), Expect = 5e-16
 Identities = 57/271 (21%), Positives = 97/271 (35%), Gaps = 50/271 (18%)

Query: 72  NNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQ 131
           +  I  I        + I  +L   + +     T   L  +  +    +++ +       
Sbjct: 8   STPIKQIFP-DDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIKS------- 57

Query: 132 WSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLR 191
              +  +     +  L L+GN L  I P  + N   +L      E K+K      +  L+
Sbjct: 58  ---VQGIQYLPNVTKLFLNGNKLTDIKP--LTNL-KNLGWLFLDENKIKDLSS--LKDLK 109

Query: 192 GLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKL 251
            L  LSL  N +                     +++ G     L HL  L  L+LG NK+
Sbjct: 110 KLKSLSLEHNGI---------------------SDING-----LVHLPQLESLYLGNNKI 143

Query: 252 SGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLK 311
           +  I   L+ LT L  L L  N+++      L  L  +  + LS N ++D     +  LK
Sbjct: 144 T-DITV-LSRLTKLDTLSLEDNQISDI--VPLAGLTKLQNLYLSKNHISD--LRALAGLK 197

Query: 312 VLRVLDLSRNQLSGDIPSTIGALVDLETISL 342
            L VL+L   +      +    LV   T+  
Sbjct: 198 NLDVLELFSQECLNKPINHQSNLVVPNTVKN 228

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 77.5 bits (190), Expect = 2e-15
 Identities = 45/287 (15%), Positives = 93/287 (32%), Gaps = 28/287 (9%)

Query: 11  NLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELG 70
                    L   +++  +      +++I  +    + +   +  +    LPN+  L L 
Sbjct: 19  AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQGI--QYLPNVTKLFLN 73

Query: 71  DNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAY 130
            N  +  I   +TN   L  L L  N     + +   +L+ L  LSL  N ++       
Sbjct: 74  GNK-LTDIKP-LTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGISD------ 123

Query: 131 QWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHL 190
               ++ L +   L  L L  N +  I    +    T L   S  + ++   I   +  L
Sbjct: 124 ----INGLVHLPQLESLYLGNNKITDI--TVLSRL-TKLDTLSLEDNQIS-DIV-PLAGL 174

Query: 191 RGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNK 250
             L  L L  N +  +   ++  LK L    L          ++  +L + N +      
Sbjct: 175 TKLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGS 232

Query: 251 LSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSN 297
           L    P  ++      + ++  +    +   S      +      + 
Sbjct: 233 L--VTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKAR 277

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 62.8 bits (152), Expect = 1e-10
 Identities = 44/203 (21%), Positives = 73/203 (35%), Gaps = 26/203 (12%)

Query: 7   TEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKY 66
             I  L N+  LFL  N L+ + P  + N+  +  L L  N++   L S+    L  +K 
Sbjct: 59  QGIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIK-DLSSL--KDLKKLKS 113

Query: 67  LELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTES 126
           L L  N  I  I   + +  +L  L LG N  +  I      L  L  LSL  N ++   
Sbjct: 114 LSLEHNG-ISDING-LVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQISD-- 167

Query: 127 SSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKE 186
                   +  L     L  L LS N +  +   ++     +L        +        
Sbjct: 168 --------IVPLAGLTKLQNLYLSKNHISDL--RALAGL-KNLDVLELFSQECLNKPINH 216

Query: 187 IGHLRGLIYLSLGFNDLNGTIPT 209
             +L     +     + +G++ T
Sbjct: 217 QSNLVVPNTV----KNTDGSLVT 235

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 53.2 bits (127), Expect = 1e-07
 Identities = 26/146 (17%), Positives = 56/146 (38%), Gaps = 11/146 (7%)

Query: 9   IGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLE 68
           + +L  L+SL+LG N ++ +    +  ++ +  L+L  N++S  +  +    L  ++ L 
Sbjct: 127 LVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQIS-DIVPL--AGLTKLQNLY 181

Query: 69  LGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSS 128
           L  N++  +   ++     L +L+L          N   NL   + +     +L T    
Sbjct: 182 LSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTP--- 236

Query: 129 AYQWSFLSSLTNCRYLVYLILSGNPL 154
               S            +L    N +
Sbjct: 237 -EIISDDGDYEKPNVKWHLPEFTNEV 261

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 78.7 bits (194), Expect = 1e-15
 Identities = 32/151 (21%), Positives = 61/151 (40%), Gaps = 21/151 (13%)

Query: 344 GSFGSVYKG--TISDGTDVAIKIFNLQRERAFRS-FNSECEVLRNVRHQNLIKILSSCST 400
           G  G +Y       +G  V +K      +   ++   +E + L  V H ++++I +    
Sbjct: 91  GGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEH 150

Query: 401 PDFKFMPNG----------SLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPI 450
            D    P G          SL++        L + E +  ++++   L YLH    S  +
Sbjct: 151 TDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLH----SIGL 203

Query: 451 IHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
           ++ DLKP +I+L E  +  + D G    +  
Sbjct: 204 VYNDLKPENIMLTEEQLK-LIDLGAVSRINS 233

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 77.8 bits (192), Expect = 1e-15
 Identities = 41/157 (26%), Positives = 68/157 (43%), Gaps = 27/157 (17%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFN--------LQRERAFRSFNSECEVLRNVRHQNLIKI 394
           G+ G V           VAI+I +         +      +  +E E+L+ + H  +IKI
Sbjct: 146 GACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKI 205

Query: 395 LSSCSTPD----FKFMPNGSLEKRLYSHNYFLDILERL--NIMIDVGSTLEYLH-HGHSS 447
            +     D     + M  G L  ++  +       E         +   ++YLH +G   
Sbjct: 206 KNFFDAEDYYIVLELMEGGELFDKVVGNKRL---KEATCKLYFYQMLLAVQYLHENG--- 259

Query: 448 APIIHCDLKPTSILL---DENMVAHVSDFGISKLLGE 481
             IIH DLKP ++LL   +E+ +  ++DFG SK+LGE
Sbjct: 260 --IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 294

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 76.6 bits (189), Expect = 1e-15
 Identities = 36/169 (21%), Positives = 67/169 (39%), Gaps = 30/169 (17%)

Query: 335 VDLETISL-----AGSFGSVYKGTISDG------TDVAIKIFN-LQRERAFRSFNSECEV 382
           V  E I++      GSFG VY+G           T VAIK  N     R    F +E  V
Sbjct: 22  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 81

Query: 383 LRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRLYSH---------NYFLDILERL 428
           ++     +++++L   S         + M  G L+  L S               + + +
Sbjct: 82  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141

Query: 429 NIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK 477
            +  ++   + YL    ++   +H DL   + ++ E+    + DFG+++
Sbjct: 142 QMAGEIADGMAYL----NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 76.6 bits (189), Expect = 1e-15
 Identities = 39/172 (22%), Positives = 70/172 (40%), Gaps = 34/172 (19%)

Query: 335 VDLETISL-----AGSFGSVYKGTISDG------TDVAIKIFNLQRERAFRSFNSECEVL 383
           +    I L      G+FG V+     +         VA+K      E A + F  E E+L
Sbjct: 38  IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELL 97

Query: 384 RNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRLYSHNYF--------------LDI 424
             ++HQ++++    C+        F++M +G L + L SH                 L +
Sbjct: 98  TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 157

Query: 425 LERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGIS 476
            + L +   V + + YL    +    +H DL   + L+ + +V  + DFG+S
Sbjct: 158 GQLLAVASQVAAGMVYL----AGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 76.6 bits (189), Expect = 1e-15
 Identities = 42/157 (26%), Positives = 69/157 (43%), Gaps = 27/157 (17%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFN--------LQRERAFRSFNSECEVLRNVRHQNLIKI 394
           G+ G V           VAIKI +         +      +  +E E+L+ + H  +IKI
Sbjct: 21  GACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKI 80

Query: 395 LSSCSTPDF----KFMPNGSLEKRLYSHNYFLDILERL--NIMIDVGSTLEYLH-HGHSS 447
            +     D+    + M  G L  ++  +       E         +   ++YLH +G   
Sbjct: 81  KNFFDAEDYYIVLELMEGGELFDKVVGNKRL---KEATCKLYFYQMLLAVQYLHENG--- 134

Query: 448 APIIHCDLKPTSILL---DENMVAHVSDFGISKLLGE 481
             IIH DLKP ++LL   +E+ +  ++DFG SK+LGE
Sbjct: 135 --IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 169

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 76.5 bits (188), Expect = 2e-15
 Identities = 50/258 (19%), Positives = 76/258 (29%), Gaps = 20/258 (7%)

Query: 101 HIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPP 160
              +       +  LSL    +      +        +     L  L L    + G  PP
Sbjct: 54  TEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPP 113

Query: 161 SIGNFS-TSLQRFSASECKLKGTIPKEIGHL-----RGLIYLSLGFNDLNGTIPTSIGTL 214
            +   +   L   +             +  L      GL  LS+            +   
Sbjct: 114 PLLEATGPDLNILNLRNVSWAT-RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVF 172

Query: 215 KQLQ-------GFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRE 267
             L                +    P     L++L L + G    SG      A+   L+ 
Sbjct: 173 PALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQG 232

Query: 268 LDLGSNKLTSSIPSSLWSLGYILE-INLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGD 326
           LDL  N L  +  +        L  +NLS   L   +P  +     L VLDLS N+L   
Sbjct: 233 LDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGL-KQVPKGL--PAKLSVLDLSYNRLDR- 288

Query: 327 IPSTIGALVDLETISLAG 344
            PS    L  +  +SL G
Sbjct: 289 NPS-PDELPQVGNLSLKG 305

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 66.5 bits (162), Expect = 3e-12
 Identities = 55/283 (19%), Positives = 91/283 (32%), Gaps = 25/283 (8%)

Query: 10  GNLQNLKSLFLGANNLSGLIPPM-IFNISTIRNLNLGGNRLSGHLPSMIGH--SLPNIKY 66
           G  ++L+ L    +  + L     I    +++ L +   R+   +         +  ++ 
Sbjct: 40  GGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQE 99

Query: 67  LELGDNNLIGTIPNSITNAT--KLIILDLGFNTFSGH--IPNTFGNLRHLSVLSLLMNNL 122
           L L +  + GT P  +  AT   L IL+L   +++                +  L +   
Sbjct: 100 LTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQA 159

Query: 123 TTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPS---IGNFSTSLQRFSASECKL 179
            + + S  Q     +L+       L LS NP  G              +LQ  +     +
Sbjct: 160 HSLNFSCEQVRVFPALS------TLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGM 213

Query: 180 K---GTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGT-LKQLQGFFLPETNLQGYVPHNL 235
           +   G           L  L L  N L             QL    L  T L+  VP  L
Sbjct: 214 ETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGL 272

Query: 236 CHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSS 278
                L++L L  N+L     P    L  +  L L  N    S
Sbjct: 273 --PAKLSVLDLSYNRLDR--NPSPDELPQVGNLSLKGNPFLDS 311

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 76.1 bits (188), Expect = 2e-15
 Identities = 43/173 (24%), Positives = 72/173 (41%), Gaps = 35/173 (20%)

Query: 335 VDLETISL-----AGSFGSVYKGTI------SDGTDVAIKIFNLQRERAFRSFNSECEVL 383
           +    I L      G+FG V+           D   VA+K        A + F  E E+L
Sbjct: 12  IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELL 71

Query: 384 RNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRLYSH---------------NYFLD 423
            N++H++++K    C   D     F++M +G L K L +H                  L 
Sbjct: 72  TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 131

Query: 424 ILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGIS 476
           + + L+I   + S + YL    +S   +H DL   + L+  N++  + DFG+S
Sbjct: 132 LSQMLHIASQIASGMVYL----ASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 76.2 bits (188), Expect = 2e-15
 Identities = 39/169 (23%), Positives = 67/169 (39%), Gaps = 30/169 (17%)

Query: 335 VDLETISL-----AGSFGSVYKGTISDG------TDVAIKIFN-LQRERAFRSFNSECEV 382
           V  + I+L      G+FG VY+G +S          VA+K    +  E+    F  E  +
Sbjct: 27  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 86

Query: 383 LRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRLYSH------NYFLDILERLNIM 431
           +    HQN+++ +             + M  G L+  L            L +L+ L++ 
Sbjct: 87  ISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 146

Query: 432 IDVGSTLEYLHHGHSSAPIIHCDLKPTSILLD---ENMVAHVSDFGISK 477
            D+    +YL         IH D+   + LL       VA + DFG+++
Sbjct: 147 RDIACGCQYL----EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 76.3 bits (188), Expect = 3e-15
 Identities = 43/156 (27%), Positives = 65/156 (41%), Gaps = 26/156 (16%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQR--------ERAFRSFNSECEVLRNVR-HQNLIK 393
           G    V +    + G + A+KI  +          E    +   E  +LR V  H ++I 
Sbjct: 105 GVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT 164

Query: 394 ILSSCSTPDFKF-----MPNGSLEKRLYSHNYFLDILER--LNIMIDVGSTLEYLH-HGH 445
           ++ S  +  F F     M  G L   L          E+   +IM  +   + +LH +  
Sbjct: 165 LIDSYESSSFMFLVFDLMRKGELFDYLTEKVALS---EKETRSIMRSLLEAVSFLHANN- 220

Query: 446 SSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
               I+H DLKP +ILLD+NM   +SDFG S  L  
Sbjct: 221 ----IVHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 76.8 bits (189), Expect = 4e-15
 Identities = 67/356 (18%), Positives = 112/356 (31%), Gaps = 33/356 (9%)

Query: 4   QIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPN 63
            +P ++      K+L L  N++S L  P I  +S +R L L  NR+   L   +     +
Sbjct: 45  HVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQD 101

Query: 64  IKYLELGDNNLIGTIPNSITNATKLIILDLGFNTF-SGHIPNTFGNLRHLSVLSLLMNNL 122
           ++YL++  N L   I         L  LDL FN F    +   FGNL  L+ L L     
Sbjct: 102 LEYLDVSHNRL-QNISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKF 158

Query: 123 TTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGT 182
                       LS +        L L    + G    S+   +T++         L   
Sbjct: 159 RQLDLLPVAHLHLSCI-------LLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSV 211

Query: 183 IPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNL--------------- 227
                  +  L +L L    LN      + T            N+               
Sbjct: 212 QVNMS--VNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKL 269

Query: 228 -QGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSL 286
            Q + P  + +L + NL  +              +L SL    + +     S  +     
Sbjct: 270 FQFFWPRPVEYLNIYNL-TITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVF 328

Query: 287 GYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISL 342
             +    LS +                  L+ ++N  +  +      L  L+T+ L
Sbjct: 329 AEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLIL 384

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 75.3 bits (185), Expect = 1e-14
 Identities = 49/317 (15%), Positives = 91/317 (28%), Gaps = 25/317 (7%)

Query: 10  GNLQNLKSLFLGANNLSGLIPPMIF-NISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLE 68
             + +L+ L L  N+   L     F N++ +  L L   +        + H   +   L+
Sbjct: 118 CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLD 177

Query: 69  LGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSS 128
           L   ++ G    S+       +L L F+  S        ++  L  L L    L  E+  
Sbjct: 178 LVSYHIKGGETESLQI-PNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQ 236

Query: 129 AYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNF--STSLQRFSASECKLKGTIPKE 186
                          L+ + L            +  F     ++  +     +   I +E
Sbjct: 237 RLMTFLSELTRGPT-LLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDRE 295

Query: 187 IGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHL 246
                     SL    +            + Q F   +  L             +N+  L
Sbjct: 296 EFTYSETALKSLMIEHV------------KNQVFLFSKEALY-------SVFAEMNIKML 336

Query: 247 GGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSN 306
             +        C  S +S   L+   N  T S+     +L  +  + L  N L  +    
Sbjct: 337 SISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGL-KNFFKV 395

Query: 307 VQKLKVLRVLDLSRNQL 323
               K +  L+     L
Sbjct: 396 ALMTKNMSSLETLDVSL 412

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 75.3 bits (185), Expect = 1e-14
 Identities = 67/372 (18%), Positives = 115/372 (30%), Gaps = 41/372 (11%)

Query: 8   EIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRN-LNLGGNRLSGHLPSMIGHSLPNIKY 66
           E GNL  L  L L A     L    + ++      L+L    + G     +      + +
Sbjct: 141 EFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLH 200

Query: 67  LELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTES 126
           L    N+L     N   N   L  L L     +                   + N+T + 
Sbjct: 201 LVFHPNSLFSVQVNMSVN--ALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQH 258

Query: 127 SSAYQWSFLSSLTN--CRYLVYLILSGNPLGGI--------------------------- 157
                   +        R + YL +    +                              
Sbjct: 259 IETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFL 318

Query: 158 -LPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQ 216
               ++ +    +     S                   +L+   N    ++     TLK+
Sbjct: 319 FSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKR 378

Query: 217 LQGFFLPETNLQ--GYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASL-TSLRELDLGSN 273
           LQ   L    L+    V     ++  L  L +  N L+ H      +   S+  L+L SN
Sbjct: 379 LQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSN 438

Query: 274 KLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIP-STIG 332
            LT S+   L     +L  +L +N +  S+P +V  L+ L+ L+++ NQL   +P     
Sbjct: 439 MLTGSVFRCLPPKVKVL--DLHNNRI-MSIPKDVTHLQALQELNVASNQLK-SVPDGVFD 494

Query: 333 ALVDLETISLAG 344
            L  L+ I L  
Sbjct: 495 RLTSLQYIWLHD 506

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 72.6 bits (178), Expect = 8e-14
 Identities = 49/303 (16%), Positives = 91/303 (30%), Gaps = 25/303 (8%)

Query: 6   PTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSL--PN 63
                 L N+K        L   +  +     T+ N+ L     +      +        
Sbjct: 219 ALGHLQLSNIKLNDENCQRLMTFLSELTRG-PTLLNVTLQHIETTWKCSVKLFQFFWPRP 277

Query: 64  IKYLELGDNNLIGTIPNSITNATK-----LIILDLGFNTFSGHIPNTFGNLRHLSVLSLL 118
           ++YL + +  +   I       ++     L+I  +    F       +     +++  L 
Sbjct: 278 VEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLS 337

Query: 119 MNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECK 178
           +++              SS T      +L  + N     +          LQ        
Sbjct: 338 ISDTPFIHMVCPPS--PSSFT------FLNFTQNVFTDSVFQGCSTL-KRLQTLILQRNG 388

Query: 179 LKGTIPKEIGHLRGLIYLSLGFNDLN----GTIPTSIGTLKQLQGFFLPETNLQGYVPHN 234
           LK    K     + +  L      LN         +    + +    L    L G V   
Sbjct: 389 LK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRC 447

Query: 235 LCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINL 294
           L     + +L L  N++   IP  +  L +L+EL++ SN+L S        L  +  I L
Sbjct: 448 L--PPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWL 504

Query: 295 SSN 297
             N
Sbjct: 505 HDN 507

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 49.5 bits (118), Expect = 2e-06
 Identities = 34/157 (21%), Positives = 55/157 (35%), Gaps = 17/157 (10%)

Query: 1   MTGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHS 60
            T  +      L+ L++L L  N L      +      + +L      L+  L S     
Sbjct: 365 FTDSVFQGCSTLKRLQTLILQRNGLKNF-FKVALMTKNMSSLETLDVSLNS-LNSHAYDR 422

Query: 61  L----PNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLS 116
                 +I  L L  N L G++   +    K+ +LDL  N     IP    +L+ L  L+
Sbjct: 423 TCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELN 479

Query: 117 LLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNP 153
           +  N L +     +             L Y+ L  NP
Sbjct: 480 VASNQLKSVPDGVFD--------RLTSLQYIWLHDNP 508

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 75.9 bits (186), Expect = 4e-15
 Identities = 17/178 (9%), Positives = 37/178 (20%), Gaps = 44/178 (24%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFN---LQRERAFRSFNSECEVLRNVRHQNLIKILSSC- 398
           G    V+    +    D A+K+F              +        +  ++  +      
Sbjct: 73  GDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRR 132

Query: 399 ---------------------------STPDFKFMP--------NGSLEKRLYSHNYFLD 423
                                             MP          S    +Y       
Sbjct: 133 LLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEG 192

Query: 424 ILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
           IL    +   +      L        ++H    P ++ +  +    + D      +G 
Sbjct: 193 ILALHILTAQLIRLAANLQSKG----LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT 246

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 75.0 bits (185), Expect = 5e-15
 Identities = 46/160 (28%), Positives = 69/160 (43%), Gaps = 29/160 (18%)

Query: 343 AGSFGSVYKGTISDG---TDVAIKIFN-LQRERAFRSFNSECEVLRNV-RHQNLIKILSS 397
            G+FG V K  I       D AIK       +   R F  E EVL  +  H N+I +L +
Sbjct: 35  EGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGA 94

Query: 398 CSTPD-----FKFMPNGSL-----EKRLYSHNYF----------LDILERLNIMIDVGST 437
           C          ++ P+G+L     + R+   +            L   + L+   DV   
Sbjct: 95  CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARG 154

Query: 438 LEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK 477
           ++YL    S    IH DL   +IL+ EN VA ++DFG+S+
Sbjct: 155 MDYL----SQKQFIHRDLAARNILVGENYVAKIADFGLSR 190

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 74.7 bits (184), Expect = 6e-15
 Identities = 60/314 (19%), Positives = 111/314 (35%), Gaps = 54/314 (17%)

Query: 11  NLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELG 70
            L N   +  G +N++  +     ++  I  L+  G  ++  +  +    L N+  LEL 
Sbjct: 17  ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEGV--QYLNNLIGLELK 71

Query: 71  DNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAY 130
           DN  I  +   + N TK+  L+L  N    ++      L+ +  L L    +T       
Sbjct: 72  DNQ-ITDLAP-LKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQITD------ 121

Query: 131 QWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHL 190
               ++ L     L  L L  N +  I P                           +  L
Sbjct: 122 ----VTPLAGLSNLQVLYLDLNQITNISP---------------------------LAGL 150

Query: 191 RGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNK 250
             L YLS+G   ++   P  +  L +L      +  +    P  L  L  L  +HL  N+
Sbjct: 151 TNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQ 206

Query: 251 LSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKL 310
           +S   P  LA+ ++L  + L +  +T+       +L  ++   +         P+ +   
Sbjct: 207 ISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNL--VVPNVVKGPSGAPIAPATISDN 262

Query: 311 KVLRVLDLSRNQLS 324
                 +L+ N  S
Sbjct: 263 GTYASPNLTWNLTS 276

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 72.8 bits (179), Expect = 2e-14
 Identities = 47/237 (19%), Positives = 97/237 (40%), Gaps = 27/237 (11%)

Query: 108 NLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFST 167
            L +   ++   +N+T             +  +   +  L   G  +  I    +     
Sbjct: 17  ALANAIKIAAGKSNVTD----------TVTQADLDGITTLSAFGTGVTTI--EGVQYL-N 63

Query: 168 SLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNL 227
           +L      + ++    P  + +L  +  L L  N L     ++I  L+ ++   L  T +
Sbjct: 64  NLIGLELKDNQITDLAP--LKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQI 119

Query: 228 QGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLG 287
               P  L  L  L +L+L  N+++ +I P LA LT+L+ L +G+ +++    + L +L 
Sbjct: 120 TDVTP--LAGLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVSDL--TPLANLS 173

Query: 288 YILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAG 344
            +  +    N ++D   S +  L  L  + L  NQ+S D+   +    +L  ++L  
Sbjct: 174 KLTTLKADDNKISDI--SPLASLPNLIEVHLKNNQIS-DVSP-LANTSNLFIVTLTN 226

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 42/211 (19%), Positives = 76/211 (36%), Gaps = 24/211 (11%)

Query: 7   TEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKY 66
             +  L NL  L L  N ++ L P  + N++ I  L L GN L  ++ ++    L +IK 
Sbjct: 57  EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVSAI--AGLQSIKT 111

Query: 67  LELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTES 126
           L+L     I  +   +   + L +L L  N  + +I      L +L  LS+    ++   
Sbjct: 112 LDLTSTQ-ITDVTP-LAGLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVSD-- 165

Query: 127 SSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKE 186
                   L+ L N   L  L    N +  I    + +   +L        ++    P  
Sbjct: 166 --------LTPLANLSKLTTLKADDNKISDI--SPLASL-PNLIEVHLKNNQISDVSP-- 212

Query: 187 IGHLRGLIYLSLGFNDLNGTIPTSIGTLKQL 217
           + +   L  ++L    +          L   
Sbjct: 213 LANTSNLFIVTLTNQTITNQPVFYNNNLVVP 243

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 55.8 bits (135), Expect = 7e-09
 Identities = 37/205 (18%), Positives = 72/205 (35%), Gaps = 24/205 (11%)

Query: 7   TEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKY 66
             + NL  +  L L  N L  +    I  + +I+ L+L   +++  +  +    L N++ 
Sbjct: 79  APLKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQITD-VTPL--AGLSNLQV 133

Query: 67  LELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTES 126
           L L  N +    P  +   T L  L +G    S   P    NL  L+ L    N ++   
Sbjct: 134 LYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISD-- 187

Query: 127 SSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKE 186
                   +S L +   L+ + L  N +  +    + N  ++L   + +   +       
Sbjct: 188 --------ISPLASLPNLIEVHLKNNQISDV--SPLANT-SNLFIVTLTNQTITNQPVFY 236

Query: 187 IGHLRGLIYLSLGFNDLNGTIPTSI 211
             +L     +           P +I
Sbjct: 237 NNNLVVPNVVKG--PSGAPIAPATI 259

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 75.1 bits (185), Expect = 7e-15
 Identities = 39/169 (23%), Positives = 67/169 (39%), Gaps = 30/169 (17%)

Query: 335 VDLETISL-----AGSFGSVYKGTISDG------TDVAIKIFN-LQRERAFRSFNSECEV 382
           V  + I+L      G+FG VY+G +S          VA+K    +  E+    F  E  +
Sbjct: 68  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 127

Query: 383 LRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRLYSH------NYFLDILERLNIM 431
           +    HQN+++ +             + M  G L+  L            L +L+ L++ 
Sbjct: 128 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 187

Query: 432 IDVGSTLEYLHHGHSSAPIIHCDLKPTSILLD---ENMVAHVSDFGISK 477
            D+    +YL         IH D+   + LL       VA + DFG+++
Sbjct: 188 RDIACGCQYL----EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 74.3 bits (183), Expect = 7e-15
 Identities = 39/147 (26%), Positives = 65/147 (44%), Gaps = 28/147 (19%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           GS G V        G  VA+K+ +L++++      +E  ++R+ +H N++++  S    +
Sbjct: 56  GSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGE 115

Query: 403 F-----KFMPNGSLEKRLYSHNYFLDILE--RLN------IMIDVGSTLEYLHHGHSSAP 449
                 +F+  G+L           DI+   RLN      +   V   L YLH       
Sbjct: 116 ELWVLMEFLQGGAL----------TDIVSQVRLNEEQIATVCEAVLQALAYLHAQG---- 161

Query: 450 IIHCDLKPTSILLDENMVAHVSDFGIS 476
           +IH D+K  SILL  +    +SDFG  
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFC 188

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 75.0 bits (184), Expect = 7e-15
 Identities = 24/181 (13%), Positives = 49/181 (27%), Gaps = 49/181 (27%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNL----------------QRERAFRSFNSECEVLRNV 386
               +  + T    G    + +                    R R  R   ++ +   ++
Sbjct: 84  EDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHL 143

Query: 387 RHQNLIKILSSCSTPDFKFMPNGSLEKRLYSHNYFL------------------------ 422
           R      ++        K +     E+ ++  + F                         
Sbjct: 144 RFIFPFDLVKDPQKK--KMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHK 201

Query: 423 --DILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG 480
                 RL + + V   L  LHH      ++H  L+P  I+LD+     ++ F      G
Sbjct: 202 SLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257

Query: 481 E 481
            
Sbjct: 258 A 258

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 73.8 bits (182), Expect = 9e-15
 Identities = 33/174 (18%), Positives = 64/174 (36%), Gaps = 36/174 (20%)

Query: 335 VDLETISL-----AGSFGSVYKGTISDG------TDVAIKIFN-LQRERAFRSFNSECEV 382
           + L  +          FG VYKG +           VAIK             F  E  +
Sbjct: 6   ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAML 65

Query: 383 LRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRLYSH---------------NYFL 422
              ++H N++ +L   +        F +  +G L + L                     L
Sbjct: 66  RARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSAL 125

Query: 423 DILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGIS 476
           +  + ++++  + + +EYL    SS  ++H DL   ++L+ + +   +SD G+ 
Sbjct: 126 EPPDFVHLVAQIAAGMEYL----SSHHVVHKDLATRNVLVYDKLNVKISDLGLF 175

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 73.8 bits (182), Expect = 9e-15
 Identities = 40/164 (24%), Positives = 67/164 (40%), Gaps = 33/164 (20%)

Query: 343 AGSFGSVYKGTI------SDGTDVAIKIFN-LQRERAFRSFNSECEVLRNV-RHQNLIKI 394
            G+FG V +         +    VA+K+          R+  SE ++L ++  H N++ +
Sbjct: 37  RGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96

Query: 395 LSSCSTPD------FKFMPNGSL-----EKRLYSHNY----------FLDILERLNIMID 433
           L +C+ P        +F   G+L      KR     Y          FL +   +     
Sbjct: 97  LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQ 156

Query: 434 VGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK 477
           V   +E+L    +S   IH DL   +ILL E  V  + DFG+++
Sbjct: 157 VAKGMEFL----ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 74.4 bits (183), Expect = 1e-14
 Identities = 34/164 (20%), Positives = 69/164 (42%), Gaps = 33/164 (20%)

Query: 344 GSFGSVYKGTISDGTDVAIKIFN---LQRERAFRSFNS--------------ECEVLRNV 386
           G F  +      D    A+K +    L+++R F   N+              E +++ ++
Sbjct: 42  GKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI 100

Query: 387 RHQNLIKILSSCSTPD-----FKFMPNGSLEKRLYSHNYF-------LDILERLNIMIDV 434
           +++  +      +  D     +++M N S+ K               + I     I+  V
Sbjct: 101 KNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSV 160

Query: 435 GSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL 478
            ++  Y+H+  +   I H D+KP++IL+D+N    +SDFG S+ 
Sbjct: 161 LNSFSYIHNEKN---ICHRDVKPSNILMDKNGRVKLSDFGESEY 201

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 73.4 bits (181), Expect = 1e-14
 Identities = 36/151 (23%), Positives = 67/151 (44%), Gaps = 20/151 (13%)

Query: 343 AGSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTP 401
           +G+F  V+       G   A+K           S  +E  VL+ ++H+N++ +     + 
Sbjct: 19  SGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYEST 78

Query: 402 DFKFM-----PNGSLEKRLYSHNYFLDILERL--NIMIDVGSTLEYLH-HGHSSAPIIHC 453
              ++       G L  R+     +    E+    ++  V S ++YLH +G     I+H 
Sbjct: 79  THYYLVMQLVSGGELFDRILERGVY---TEKDASLVIQQVLSAVKYLHENG-----IVHR 130

Query: 454 DLKPTSILL---DENMVAHVSDFGISKLLGE 481
           DLKP ++L    +EN    ++DFG+SK+   
Sbjct: 131 DLKPENLLYLTPEENSKIMITDFGLSKMEQN 161

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 74.2 bits (182), Expect = 1e-14
 Identities = 27/160 (16%), Positives = 50/160 (31%), Gaps = 30/160 (18%)

Query: 344 GSFGSVYKGTISDGTD------VAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSS 397
           G+F  VY+ T  D  D        +K+        F       E L+       +K  S+
Sbjct: 76  GAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSA 135

Query: 398 CSTPD-----FKFMPNGSL----EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSA 448
               +      +    G+L         +    +     ++  + +   +E +H      
Sbjct: 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH----DC 191

Query: 449 PIIHCDLKPTSILLDENMVAH-----------VSDFGISK 477
            IIH D+KP + +L    +             + D G S 
Sbjct: 192 EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 73.0 bits (180), Expect = 1e-14
 Identities = 33/150 (22%), Positives = 54/150 (36%), Gaps = 20/150 (13%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           GS+G V            A K            F  E E+++++ H N+I++  +     
Sbjct: 20  GSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNT 79

Query: 403 FKFM-----PNGSLEKRLYSHNYFLDILER--LNIMIDVGSTLEYLH-HGHSSAPIIHCD 454
             ++       G L +R+     F    E     IM DV S + Y H        + H D
Sbjct: 80  DIYLVMELCTGGELFERVVHKRVF---RESDAARIMKDVLSAVAYCHKLN-----VAHRD 131

Query: 455 LKPTSILL---DENMVAHVSDFGISKLLGE 481
           LKP + L      +    + DFG++     
Sbjct: 132 LKPENFLFLTDSPDSPLKLIDFGLAARFKP 161

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 74.3 bits (182), Expect = 1e-14
 Identities = 26/180 (14%), Positives = 50/180 (27%), Gaps = 47/180 (26%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNL----------------QRERAFRSFNSECEVLRNV 386
               +  + T    G    + +                    R R  R   ++ +   ++
Sbjct: 89  EDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHL 148

Query: 387 RHQNLIKILSSCSTPD----------------FKFMP--NGSLE------KRLYSHNYFL 422
           R      ++                       F   P    +L+          S +  L
Sbjct: 149 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSL 208

Query: 423 DILERLNIMIDVGSTLEYLH-HGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
               RL + + V   L  LH +G     ++H  L+P  I+LD+     ++ F      G 
Sbjct: 209 VHHARLQLTLQVIRLLASLHHYG-----LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 263

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 71.1 bits (175), Expect = 1e-14
 Identities = 26/151 (17%), Positives = 52/151 (34%), Gaps = 14/151 (9%)

Query: 7   TEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKY 66
           T I    N+K L +   + +   P  I  +S +  L + G  ++      +   L ++  
Sbjct: 60  TGIEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSG-LTSLTL 116

Query: 67  LELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTES 126
           L++  +    +I   I    K+  +DL +N     I      L  L  L++  + +    
Sbjct: 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHD-- 173

Query: 127 SSAYQWSFLSSLTNCRYLVYLILSGNPLGGI 157
                      + +   L  L      +GG 
Sbjct: 174 --------YRGIEDFPKLNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 63.8 bits (156), Expect = 5e-12
 Identities = 27/155 (17%), Positives = 66/155 (42%), Gaps = 8/155 (5%)

Query: 190 LRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGN 249
            +  +   LG +         + +L  +    +  T+L G     + +   +  L +   
Sbjct: 22  FKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTG-----IEYAHNIKDLTINNI 76

Query: 250 KLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQK 309
             + +  P ++ L++L  L +    +TS    +L  L  +  +++S +  +DS+ + +  
Sbjct: 77  HAT-NYNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINT 134

Query: 310 LKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAG 344
           L  +  +DLS N    DI   +  L +L+++++  
Sbjct: 135 LPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQF 168

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 61.1 bits (149), Expect = 5e-11
 Identities = 27/172 (15%), Positives = 59/172 (34%), Gaps = 17/172 (9%)

Query: 8   EIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYL 67
               + +L  + L   N++ L    I     I++L +     +    + I   L N++ L
Sbjct: 39  TEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHATN--YNPIS-GLSNLERL 93

Query: 68  ELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESS 127
            +   ++      +++  T L +LD+  +     I      L  ++ + L  N   T+  
Sbjct: 94  RIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD-- 151

Query: 128 SAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKL 179
                  +  L     L  L +  + +       I +F   L +  A    +
Sbjct: 152 -------IMPLKTLPELKSLNIQFDGVHDYRG--IEDF-PKLNQLYAFSQTI 193

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 58.4 bits (142), Expect = 4e-10
 Identities = 23/158 (14%), Positives = 53/158 (33%), Gaps = 8/158 (5%)

Query: 144 LVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDL 203
           L Y+ L+   +  +    I     +++  + +        P  I  L  L  L +   D+
Sbjct: 46  LTYITLANINVTDLTG--IEYA-HNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDV 100

Query: 204 NGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLT 263
                 ++  L  L    +  +     +   +  L  +N + L  N     I P L +L 
Sbjct: 101 TSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLP 159

Query: 264 SLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLND 301
            L+ L++  + +       +     + ++   S  +  
Sbjct: 160 ELKSLNIQFDGVHDY--RGIEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 56.9 bits (138), Expect = 1e-09
 Identities = 31/216 (14%), Positives = 64/216 (29%), Gaps = 40/216 (18%)

Query: 62  PNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNN 121
              K    G      T   +      L  + L     +  +        ++  L++   +
Sbjct: 20  STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINNIH 77

Query: 122 LTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKG 181
            T        ++ +S L+N   L  L + G  +     P++    TSL     S      
Sbjct: 78  ATN-------YNPISGLSN---LERLRIMGKDVTSDKIPNLSGL-TSLTLLDISHSAHDD 126

Query: 182 TIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEML 241
           +I  +I  L  +  + L +N     I   + TL +L+                       
Sbjct: 127 SILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELK----------------------- 162

Query: 242 NLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTS 277
             L++  + +  +    +     L +L   S  +  
Sbjct: 163 -SLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 53.8 bits (130), Expect = 1e-08
 Identities = 25/191 (13%), Positives = 59/191 (30%), Gaps = 20/191 (10%)

Query: 11  NLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELG 70
             +   +  LG ++ + +       ++++  + L    ++  L  +      NIK L + 
Sbjct: 21  TFKAYLNGLLGQSSTANITEA---QMNSLTYITLANINVT-DLTGI--EYAHNIKDLTIN 74

Query: 71  DNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAY 130
           + +   T  N I+  + L  L +     +         L  L++L +  +          
Sbjct: 75  NIHA--TNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSI---- 128

Query: 131 QWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHL 190
               L+ +     +  + LS N     + P +      L+  +     +       I   
Sbjct: 129 ----LTKINTLPKVNSIDLSYNGAITDIMP-LKTL-PELKSLNIQFDGVHDYRG--IEDF 180

Query: 191 RGLIYLSLGFN 201
             L  L     
Sbjct: 181 PKLNQLYAFSQ 191

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 46.5 bits (111), Expect = 4e-06
 Identities = 18/99 (18%), Positives = 34/99 (34%), Gaps = 4/99 (4%)

Query: 2   TGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSL 61
           T      +  L +L  L +  +     I   I  +  + +++L  N     +  +    L
Sbjct: 101 TSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKT--L 158

Query: 62  PNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSG 100
           P +K L +  + +       I +  KL  L     T  G
Sbjct: 159 PELKSLNIQFDGV--HDYRGIEDFPKLNQLYAFSQTIGG 195

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 73.1 bits (180), Expect = 2e-14
 Identities = 36/147 (24%), Positives = 66/147 (44%), Gaps = 28/147 (19%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           G+ G+VY    ++ G +VAI+  NLQ++       +E  V+R  ++ N++  L S    D
Sbjct: 31  GASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD 90

Query: 403 F-----KFMPNGSLEKRLYSHNYFLDILE--RLN------IMIDVGSTLEYLHHGHSSAP 449
                 +++  GSL           D++    ++      +  +    LE+LH       
Sbjct: 91  ELWVVMEYLAGGSL----------TDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---- 136

Query: 450 IIHCDLKPTSILLDENMVAHVSDFGIS 476
           +IH D+K  +ILL  +    ++DFG  
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFC 163

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 72.7 bits (179), Expect = 2e-14
 Identities = 40/161 (24%), Positives = 66/161 (40%), Gaps = 42/161 (26%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRSFNS------ECEVLRNVRHQNLIKILS 396
           GS+G V +          A+KI    +++  R  N       E ++LR +RH+N+I+++ 
Sbjct: 16  GSYGKVKEVLDSETLCRRAVKILK--KKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVD 73

Query: 397 --SCSTPDFKFM-----PNGSLE-------KRLY---SHNYFLDILERLNIMIDVGSTLE 439
                     +M       G  E       KR     +H YF  ++            LE
Sbjct: 74  VLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLI----------DGLE 123

Query: 440 YLH-HGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
           YLH  G     I+H D+KP ++LL       +S  G+++ L
Sbjct: 124 YLHSQG-----IVHKDIKPGNLLLTTGGTLKISALGVAEAL 159

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 72.2 bits (178), Expect = 3e-14
 Identities = 32/152 (21%), Positives = 70/152 (46%), Gaps = 22/152 (14%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCST 400
           G+F  V +    + G + A KI N ++   R F+    E  + R ++H N++++  S   
Sbjct: 17  GAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 76

Query: 401 PDFKFM-----PNGSLEKRLYSHNYFLDILER--LNIMIDVGSTLEYLH-HGHSSAPIIH 452
             F ++       G L + + +  ++    E    + +  +  ++ Y H +G     I+H
Sbjct: 77  ESFHYLVFDLVTGGELFEDIVAREFY---SEADASHCIQQILESIAYCHSNG-----IVH 128

Query: 453 CDLKPTSILL---DENMVAHVSDFGISKLLGE 481
            +LKP ++LL    +     ++DFG++  + +
Sbjct: 129 RNLKPENLLLASKAKGAAVKLADFGLAIEVND 160

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 72.0 bits (177), Expect = 4e-14
 Identities = 35/149 (23%), Positives = 58/149 (38%), Gaps = 30/149 (20%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           G+FG VYK      G   A K+   + E     +  E E+L    H  ++K+L +     
Sbjct: 30  GAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDG 89

Query: 403 -----FKFMPNGSLEKRLYSHNYFLDILERLN----------IMIDVGSTLEYLHHGHSS 447
                 +F P G++            I+  L+          +   +   L +LH     
Sbjct: 90  KLWIMIEFCPGGAV----------DAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR-- 137

Query: 448 APIIHCDLKPTSILLDENMVAHVSDFGIS 476
             IIH DLK  ++L+       ++DFG+S
Sbjct: 138 --IIHRDLKAGNVLMTLEGDIRLADFGVS 164

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 71.5 bits (176), Expect = 4e-14
 Identities = 34/156 (21%), Positives = 64/156 (41%), Gaps = 40/156 (25%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQR-----ERAFRSFNSECEVLRNVRHQNLIKILSS 397
           G++G V           VA+KI +++R     E   +    E  + + + H+N++K    
Sbjct: 18  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----EICINKMLNHENVVKFYGH 73

Query: 398 CSTPDFKFM-----PNGSLEKRLYSH---------NYFLDILERLNIMIDVGSTLEYLH- 442
               + +++       G L  R+             +F  ++          + + YLH 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----------AGVVYLHG 123

Query: 443 HGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL 478
            G     I H D+KP ++LLDE     +SDFG++ +
Sbjct: 124 IG-----ITHRDIKPENLLLDERDNLKISDFGLATV 154

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 72.3 bits (178), Expect = 4e-14
 Identities = 41/169 (24%), Positives = 65/169 (38%), Gaps = 39/169 (23%)

Query: 344 GSFGSVYKGTISDG------TDVAIKIFNLQ-RERAFRSFNSECEVLRNVRHQNLIKILS 396
           G FG V K T          T VA+K+          R   SE  VL+ V H ++IK+  
Sbjct: 34  GEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYG 93

Query: 397 SCSTPD-----FKFMPNGSL-----EKRLYSHNYF------------------LDILERL 428
           +CS         ++   GSL     E R     Y                   L + + +
Sbjct: 94  ACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLI 153

Query: 429 NIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK 477
           +    +   ++YL    +   ++H DL   +IL+ E     +SDFG+S+
Sbjct: 154 SFAWQISQGMQYL----AEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 73.3 bits (180), Expect = 4e-14
 Identities = 46/157 (29%), Positives = 68/157 (43%), Gaps = 40/157 (25%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQR-------ERAFRSFNSECEVLRNVRHQNLIKIL 395
           G+FG V  G     G  VA+KI N Q+        +  R    E + L+  RH ++IK+ 
Sbjct: 27  GTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR----EIQNLKLFRHPHIIKLY 82

Query: 396 SSCSTPDFKFM-----PNGSLEKRLYSH---------NYFLDILERLNIMIDVGSTLEYL 441
              STP   FM       G L   +  +           F  IL          S ++Y 
Sbjct: 83  QVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQIL----------SGVDYC 132

Query: 442 HHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL 478
           H       ++H DLKP ++LLD +M A ++DFG+S +
Sbjct: 133 HRHM----VVHRDLKPENVLLDAHMNAKIADFGLSNM 165

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 72.0 bits (177), Expect = 6e-14
 Identities = 32/152 (21%), Positives = 70/152 (46%), Gaps = 22/152 (14%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCST 400
           G+F  V +    + G + A KI N ++   R F+    E  + R ++H N++++  S   
Sbjct: 40  GAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 99

Query: 401 PDFKFM-----PNGSLEKRLYSHNYFLDILER--LNIMIDVGSTLEYLH-HGHSSAPIIH 452
             F ++       G L + + +  ++    E    + +  +  ++ Y H +G     I+H
Sbjct: 100 ESFHYLVFDLVTGGELFEDIVAREFY---SEADASHCIQQILESIAYCHSNG-----IVH 151

Query: 453 CDLKPTSILL---DENMVAHVSDFGISKLLGE 481
            +LKP ++LL    +     ++DFG++  + +
Sbjct: 152 RNLKPENLLLASKAKGAAVKLADFGLAIEVND 183

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 70.7 bits (174), Expect = 7e-14
 Identities = 47/155 (30%), Positives = 67/155 (43%), Gaps = 40/155 (25%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQR-------ERAFRSFNSECEVLRNVRHQNLIKIL 395
           G+FG V  G     G  VA+KI N Q+        +  R    E + L+  RH ++IK+ 
Sbjct: 22  GTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR----EIQNLKLFRHPHIIKLY 77

Query: 396 SSCSTPDFKFM-----PNGSLEKRLYSH---------NYFLDILERLNIMIDVGSTLEYL 441
              STP   FM       G L   +  H           F  IL          S ++Y 
Sbjct: 78  QVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQIL----------SAVDYC 127

Query: 442 HHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGIS 476
           H       ++H DLKP ++LLD +M A ++DFG+S
Sbjct: 128 HRHM----VVHRDLKPENVLLDAHMNAKIADFGLS 158

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 71.6 bits (176), Expect = 8e-14
 Identities = 52/226 (23%), Positives = 82/226 (36%), Gaps = 58/226 (25%)

Query: 294 LSSNLLNDSLPSNVQKLKVLRVLD-------LSRNQLSGDIPSTIGALVDLETISLAGSF 346
           L S LL D L  N    ++  +L+         RN +       IG           G+F
Sbjct: 13  LPSELLLDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIE--YVRDIGE----------GAF 60

Query: 347 GSVYKGTISDG------TDVAIKIFN-LQRERAFRSFNSECEVLRNVRHQNLIKILSSCS 399
           G V++            T VA+K+            F  E  ++    + N++K+L  C+
Sbjct: 61  GRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120

Query: 400 TPD-----FKFMPNGSLEKRLYSH-----------------------NYFLDILERLNIM 431
                   F++M  G L + L S                           L   E+L I 
Sbjct: 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIA 180

Query: 432 IDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK 477
             V + + YL    S    +H DL   + L+ ENMV  ++DFG+S+
Sbjct: 181 RQVAAGMAYL----SERKFVHRDLATRNCLVGENMVVKIADFGLSR 222

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 70.7 bits (174), Expect = 8e-14
 Identities = 38/152 (25%), Positives = 63/152 (41%), Gaps = 22/152 (14%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCST 400
           GSFG V K        + A+K+ N      +   +   E E+L+ + H N++K+      
Sbjct: 33  GSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED 92

Query: 401 PDFKFM-----PNGSLEKRLYSHNYFLDILER--LNIMIDVGSTLEYLH-HGHSSAPIIH 452
               ++       G L   +     F    E     I+  V S + Y+H H      I+H
Sbjct: 93  SSSFYIVGELYTGGELFDEIIKRKRF---SEHDAARIIKQVFSGITYMHKHN-----IVH 144

Query: 453 CDLKPTSILL---DENMVAHVSDFGISKLLGE 481
            DLKP +ILL   +++    + DFG+S    +
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 70.8 bits (174), Expect = 1e-13
 Identities = 34/156 (21%), Positives = 64/156 (41%), Gaps = 40/156 (25%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQR-----ERAFRSFNSECEVLRNVRHQNLIKILSS 397
           G++G V           VA+KI +++R     E   +    E  + + + H+N++K    
Sbjct: 18  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----EICINKMLNHENVVKFYGH 73

Query: 398 CSTPDFKFM-----PNGSLEKRLYSH---------NYFLDILERLNIMIDVGSTLEYLH- 442
               + +++       G L  R+             +F  ++          + + YLH 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----------AGVVYLHG 123

Query: 443 HGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL 478
            G     I H D+KP ++LLDE     +SDFG++ +
Sbjct: 124 IG-----ITHRDIKPENLLLDERDNLKISDFGLATV 154

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 70.4 bits (173), Expect = 1e-13
 Identities = 35/164 (21%), Positives = 61/164 (37%), Gaps = 34/164 (20%)

Query: 343 AGSFGSVYKGTISD------GTDVAIKIFNLQ-RERAFRSFNSECEVLRNV-RHQNLIKI 394
           AG+FG V + T            VA+K+           +  SE +VL  +  H N++ +
Sbjct: 33  AGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNL 92

Query: 395 LSSCSTPD-----FKFMPNGSL-----------------EKRLYSHNYFLDILERLNIMI 432
           L +C+         ++   G L                    +      LD+ + L+   
Sbjct: 93  LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSY 152

Query: 433 DVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGIS 476
            V   + +L    +S   IH DL   +ILL    +  + DFG++
Sbjct: 153 QVAKGMAFL----ASKNCIHRDLAARNILLTHGRITKICDFGLA 192

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 35/164 (21%), Positives = 68/164 (41%), Gaps = 34/164 (20%)

Query: 344 GSFGSVYKGTISD--------GTDVAIKIFN-LQRERAFRSFNSECEVLRNV-RHQNLIK 393
           G+FG V                  VA+K+      E+      SE E+++ + +H+N+I 
Sbjct: 46  GAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIN 105

Query: 394 ILSSCSTPD-----FKFMPNGSL-----EKRLYSHNYF----------LDILERLNIMID 433
           +L +C+         ++   G+L      +R     Y           +   + ++    
Sbjct: 106 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQ 165

Query: 434 VGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK 477
           +   +EYL    +S   IH DL   ++L+ EN V  ++DFG+++
Sbjct: 166 LARGMEYL----ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 71.5 bits (176), Expect = 2e-13
 Identities = 62/323 (19%), Positives = 104/323 (32%), Gaps = 63/323 (19%)

Query: 37  STIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNL----IGTIPNSITNATKLIILD 92
             I++L++    LS    + +   L   + + L D  L       I +++     L  L+
Sbjct: 3   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62

Query: 93  LGFNTFSG----------HIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCR 142
           L  N                P+       +  LSL    LT            S+L    
Sbjct: 63  LRSNELGDVGVHCVLQGLQTPSC-----KIQKLSLQNCCLTGAGCGV----LSSTLRTLP 113

Query: 143 YLVYLILSGNPLGG----ILPPSIGNFSTSLQRFSASECKLKGTIPKEIG----HLRGLI 194
            L  L LS N LG     +L   + +    L++     C L     + +           
Sbjct: 114 TLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFK 173

Query: 195 YLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLS-- 252
            L++  ND+N      +    +                 + C LE L    L    ++  
Sbjct: 174 ELTVSNNDINEAGVRVLCQGLK----------------DSPCQLEALK---LESCGVTSD 214

Query: 253 --GHIPPCLASLTSLRELDLGSNKLTSS-----IPSSLWSLGYILEINLSSNLLND---- 301
               +   +AS  SLREL LGSNKL         P  L     +  + +    +      
Sbjct: 215 NCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCG 274

Query: 302 SLPSNVQKLKVLRVLDLSRNQLS 324
            L   ++  + L+ L L+ N+L 
Sbjct: 275 DLCRVLRAKESLKELSLAGNELG 297

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 69.2 bits (170), Expect = 7e-13
 Identities = 63/351 (17%), Positives = 108/351 (30%), Gaps = 61/351 (17%)

Query: 12  LQNLKSLFLGANNLS----GLIPPMIFNISTIRNLNLGGNRLSG----HLPSMIGHSLPN 63
           LQ  + + L    L+      I   +     +  LNL  N L       +   +      
Sbjct: 27  LQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCK 86

Query: 64  IKYLELGDNNL----IGTIPNSITNATKLIILDLGFNTFSG----HIPNTFGNLR-HLSV 114
           I+ L L +  L     G + +++     L  L L  N         +     + +  L  
Sbjct: 87  IQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEK 146

Query: 115 LSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGG----ILPPSIGNFSTSLQ 170
           L L   +L+  S         S L        L +S N +      +L   + +    L+
Sbjct: 147 LQLEYCSLSAASCEP----LASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLE 202

Query: 171 RFSASECKLK----GTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETN 226
                 C +       +   +     L  L+LG N L               G       
Sbjct: 203 ALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV------------GM----AE 246

Query: 227 LQGYVPHNLCHLEMLNLLHLGGNKLS----GHIPPCLASLTSLRELDLGSNKLTSS---- 278
           L   + H    L  L    +    ++    G +   L +  SL+EL L  N+L       
Sbjct: 247 LCPGLLHPSSRLRTLW---IWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARL 303

Query: 279 IPSSLWSLGYILE-INLSSNLLND----SLPSNVQKLKVLRVLDLSRNQLS 324
           +  +L   G  LE + + S            S + + + L  L +S N+L 
Sbjct: 304 LCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLE 354

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 66.9 bits (164), Expect = 4e-12
 Identities = 65/349 (18%), Positives = 119/349 (34%), Gaps = 61/349 (17%)

Query: 14  NLKSLFLGANNLS----GLIPPMIFNISTIRNLNLGGNRLSG----HLPSMIGHSLPNIK 65
            ++ L L    L+    G++   +  + T++ L+L  N L       L   +      ++
Sbjct: 86  KIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLE 145

Query: 66  YLELGDNNL----IGTIPNSITNATKLIILDLGFNTFSG----HIPNTFG-NLRHLSVLS 116
            L+L   +L       + + +        L +  N  +      +      +   L  L 
Sbjct: 146 KLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALK 205

Query: 117 LLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGI----LPPSIGNFSTSLQRF 172
           L    +T+++           + +   L  L L  N LG +    L P + + S+ L+  
Sbjct: 206 LESCGVTSDNCRD----LCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTL 261

Query: 173 SASECKLK----GTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQ 228
              EC +     G + + +     L  LSL  N+L       +                 
Sbjct: 262 WIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCET-------------- 307

Query: 229 GYVPHNLCHLEMLNLLHLGGNKLSG----HIPPCLASLTSLRELDLGSNKLTSS----IP 280
             +    C LE L +        +     H    LA    L EL + +N+L  +    + 
Sbjct: 308 --LLEPGCQLESLWV---KSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELC 362

Query: 281 SSLWSLGYILE-INLSSNLLND----SLPSNVQKLKVLRVLDLSRNQLS 324
             L   G +L  + L+   ++D    SL + +     LR LDLS N L 
Sbjct: 363 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 59.6 bits (145), Expect = 9e-10
 Identities = 55/322 (17%), Positives = 96/322 (29%), Gaps = 57/322 (17%)

Query: 14  NLKSLFLGANNLS----GLIPPMIFNISTIRNLNLGGNRLSG----HLPSMIGHSLPNIK 65
            L+ L L   +LS      +  ++      + L +  N ++      L   +  S   ++
Sbjct: 143 RLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLE 202

Query: 66  YLELGDNNL----IGTIPNSITNATKLIILDLGFNTFSGH-----IPNTFGNLRHLSVLS 116
            L+L    +       +   + +   L  L LG N           P        L  L 
Sbjct: 203 ALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLW 262

Query: 117 LLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGG----ILPPSIGNFSTSLQRF 172
           +    +T +            L     L  L L+GN LG     +L  ++      L+  
Sbjct: 263 IWECGITAKGCGD----LCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESL 318

Query: 173 SASECKLKGTIPKEIG----HLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQ 228
               C                 R L+ L +  N L       +                 
Sbjct: 319 WVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQG-------------- 364

Query: 229 GYVPHNLCHLEMLNLLHLGGNKLS----GHIPPCLASLTSLRELDLGSNKLTSS----IP 280
             +      L +L L       +S      +   L +  SLRELDL +N L  +    + 
Sbjct: 365 --LGQPGSVLRVLWL---ADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLV 419

Query: 281 SSLWSLGYILE-INLSSNLLND 301
            S+   G +LE + L     ++
Sbjct: 420 ESVRQPGCLLEQLVLYDIYWSE 441

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 55.4 bits (134), Expect = 2e-08
 Identities = 55/263 (20%), Positives = 78/263 (29%), Gaps = 45/263 (17%)

Query: 86  TKLIILDLGFNTFS-GHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYL 144
             +  LD+     S          L+   V+ L    LT            S+L     L
Sbjct: 3   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKD----ISSALRVNPAL 58

Query: 145 VYLILSGNPLGG----ILPPSIGNFSTSLQRFSASECKLKGT----IPKEIGHLRGLIYL 196
             L L  N LG      +   +   S  +Q+ S   C L G     +   +  L  L  L
Sbjct: 59  AELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQEL 118

Query: 197 SLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLS---- 252
            L  N L          L+ L    L             C LE L    L    LS    
Sbjct: 119 HLSDNLLGDA------GLQLLCEGLL----------DPQCRLEKLQ---LEYCSLSAASC 159

Query: 253 GHIPPCLASLTSLRELDLGSNKLTSS----IPSSLWSLGYILE-INLSSNLLND----SL 303
             +   L +    +EL + +N +  +    +   L      LE + L S  +       L
Sbjct: 160 EPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDL 219

Query: 304 PSNVQKLKVLRVLDLSRNQLSGD 326
              V     LR L L  N+L   
Sbjct: 220 CGIVASKASLRELALGSNKLGDV 242

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 42/156 (26%), Positives = 63/156 (40%), Gaps = 39/156 (25%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQR-------ERAFRSFNSECEVLRNVRHQNLIKIL 395
           GSFG V   T       VA+K  + Q         R  R    E   L+ +RH ++IK+ 
Sbjct: 20  GSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVER----EISYLKLLRHPHIIKLY 75

Query: 396 SSCSTPDFKFM----PNGSLEKRLYSH---------NYFLDILERLNIMIDVGSTLEYLH 442
              +TP    M      G L   +             +F  I+            +EY H
Sbjct: 76  DVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQII----------CAIEYCH 125

Query: 443 HGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL 478
                  I+H DLKP ++LLD+N+   ++DFG+S +
Sbjct: 126 RHK----IVHRDLKPENLLLDDNLNVKIADFGLSNI 157

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 70.5 bits (173), Expect = 2e-13
 Identities = 37/178 (20%), Positives = 73/178 (41%), Gaps = 39/178 (21%)

Query: 335 VDLETISL-----AGSFGSVYKGTI--------SDGTDVAIKIFN-LQRERAFRSFNSEC 380
           +  + + L      G+FG V             +  T VA+K+      E+      SE 
Sbjct: 66  LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEM 125

Query: 381 EVLRNV-RHQNLIKILSSCSTPD-----FKFMPNGSL-----EKRLYSHNYFLDILER-- 427
           E+++ + +H+N+I +L +C+         ++   G+L      +R     Y  +      
Sbjct: 126 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 185

Query: 428 --------LNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK 477
                   ++    V   +EYL    +S   IH DL   ++L+ E+ V  ++DFG+++
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYL----ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 70.1 bits (172), Expect = 3e-13
 Identities = 37/164 (22%), Positives = 67/164 (40%), Gaps = 34/164 (20%)

Query: 344 GSFGSVYKGTISD--------GTDVAIKIFN-LQRERAFRSFNSECEVLRNV-RHQNLIK 393
           G FG V                  VA+K+      E+      SE E+++ + +H+N+I 
Sbjct: 92  GCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIN 151

Query: 394 ILSSCSTPD-----FKFMPNGSL-----EKRLYSHNYFLDILER----------LNIMID 433
           +L +C+         ++   G+L      +R     Y  DI             ++    
Sbjct: 152 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQ 211

Query: 434 VGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK 477
           +   +EYL    +S   IH DL   ++L+ EN V  ++DFG+++
Sbjct: 212 LARGMEYL----ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 251

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 70.5 bits (173), Expect = 3e-13
 Identities = 36/152 (23%), Positives = 65/152 (42%), Gaps = 21/152 (13%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFN---LQRERAFRSFNSECEVLRNVRHQNLIKILSSCS 399
           GSFG V        G + A+K+ +   ++++    S   E ++L+ + H N++K+     
Sbjct: 37  GSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFE 96

Query: 400 TPDFKFM-----PNGSLEKRLYSHNYFLDILERL--NIMIDVGSTLEYLHHGHSSAPIIH 452
              + ++       G L   + S   F    E     I+  V S + Y+H       I+H
Sbjct: 97  DKGYFYLVGEVYTGGELFDEIISRKRF---SEVDAARIIRQVLSGITYMH----KNKIVH 149

Query: 453 CDLKPTSILL---DENMVAHVSDFGISKLLGE 481
            DLKP ++LL    ++    + DFG+S     
Sbjct: 150 RDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 69.9 bits (171), Expect = 3e-13
 Identities = 27/144 (18%), Positives = 50/144 (34%), Gaps = 15/144 (10%)

Query: 343 AGSFGSVYKGT-ISDGTDVAIKIFNL--QRERAFRSFNSECEVLRNVRHQNLIKILSSCS 399
                +V        G  V ++  NL             E  V +   H N++   ++  
Sbjct: 37  FEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFI 96

Query: 400 TPD-----FKFMPNGSLEKRLYSHNYFLDILERL--NIMIDVGSTLEYLHHGHSSAPIIH 452
             +       FM  GS  K L   ++   + E     I+  V   L+Y+HH       +H
Sbjct: 97  ADNELWVVTSFMAYGSA-KDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG----YVH 151

Query: 453 CDLKPTSILLDENMVAHVSDFGIS 476
             +K + IL+  +   ++S    +
Sbjct: 152 RSVKASHILISVDGKVYLSGLRSN 175

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 69.4 bits (170), Expect = 3e-13
 Identities = 32/158 (20%), Positives = 55/158 (34%), Gaps = 40/158 (25%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFN--------LQRERAFRSFNSECEVLRNVRHQNLIKI 394
           G+FG V+         +V +K              +        E  +L  V H N+IK+
Sbjct: 35  GAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKV 94

Query: 395 LSSCSTPDFKFM----------------PNGSLEKRLYSHNYFLDILERLNIMIDVGSTL 438
           L       F  +                 +  L++ L S+  F  ++          S +
Sbjct: 95  LDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASY-IFRQLV----------SAV 143

Query: 439 EYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGIS 476
            YL        IIH D+K  +I++ E+    + DFG +
Sbjct: 144 GYLRLKD----IIHRDIKDENIVIAEDFTIKLIDFGSA 177

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 69.6 bits (171), Expect = 3e-13
 Identities = 32/160 (20%), Positives = 63/160 (39%), Gaps = 30/160 (18%)

Query: 343 AGSFGSVYKGTISD------GTDVAIKIFNLQ-RERAFRSFNSECEVLRNV-RHQNLIKI 394
           AG+FG V + T            VA+K+           +  SE +++ ++ +H+N++ +
Sbjct: 56  AGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNL 115

Query: 395 LSSCSTPD-----FKFMPNGSL-------------EKRLYSHNYFLDILERLNIMIDVGS 436
           L +C+         ++   G L             +      N      + L+    V  
Sbjct: 116 LGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQ 175

Query: 437 TLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGIS 476
            + +L    +S   IH D+   ++LL    VA + DFG++
Sbjct: 176 GMAFL----ASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 211

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 70.1 bits (172), Expect = 4e-13
 Identities = 37/151 (24%), Positives = 62/151 (41%), Gaps = 20/151 (13%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCST 400
           GSFG V K        + A+K+ N      +   +   E E+L+ + H N++K+      
Sbjct: 33  GSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED 92

Query: 401 PDFKFM-----PNGSLEKRLYSHNYFLDILER--LNIMIDVGSTLEYLHHGHSSAPIIHC 453
               ++       G L   +     F    E     I+  V S + Y+H       I+H 
Sbjct: 93  SSSFYIVGELYTGGELFDEIIKRKRFS---EHDAARIIKQVFSGITYMH----KHNIVHR 145

Query: 454 DLKPTSILL---DENMVAHVSDFGISKLLGE 481
           DLKP +ILL   +++    + DFG+S    +
Sbjct: 146 DLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 69.3 bits (170), Expect = 4e-13
 Identities = 38/154 (24%), Positives = 65/154 (42%), Gaps = 39/154 (25%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQR------ERAFRSFNSECEVLRNVRHQNLIKILS 396
           G+F  V     I  G +VAIKI +  +      ++ FR    E  +++ + H N++K+  
Sbjct: 26  GNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR----EVRIMKILNHPNIVKLFE 81

Query: 397 SCSTPDFKFM-----PNGSLEKRLYSH---------NYFLDILERLNIMIDVGSTLEYLH 442
              T    ++       G +   L +H         + F  I+          S ++Y H
Sbjct: 82  VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIV----------SAVQYCH 131

Query: 443 HGHSSAPIIHCDLKPTSILLDENMVAHVSDFGIS 476
                  I+H DLK  ++LLD +M   ++DFG S
Sbjct: 132 QKR----IVHRDLKAENLLLDADMNIKIADFGFS 161

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 69.3 bits (170), Expect = 6e-13
 Identities = 29/150 (19%), Positives = 65/150 (43%), Gaps = 22/150 (14%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCST 400
           G+F  V +   +  G + A  I N ++   R  +    E  + R ++H N++++  S S 
Sbjct: 22  GAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE 81

Query: 401 PDFKFM-----PNGSLEKRLYSHNYFLDILER--LNIMIDVGSTLEYLH-HGHSSAPIIH 452
               ++       G L + + +  Y+    E    + +  +   + + H  G     ++H
Sbjct: 82  EGHHYLIFDLVTGGELFEDIVAREYY---SEADASHCIQQILEAVLHCHQMG-----VVH 133

Query: 453 CDLKPTSILL---DENMVAHVSDFGISKLL 479
            +LKP ++LL    +     ++DFG++  +
Sbjct: 134 RNLKPENLLLASKLKGAAVKLADFGLAIEV 163

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 69.3 bits (170), Expect = 7e-13
 Identities = 35/151 (23%), Positives = 59/151 (39%), Gaps = 20/151 (13%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCST 400
           G++G V          + AIKI         +      E  VL+ + H N++K+      
Sbjct: 48  GAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED 107

Query: 401 PDFKFM-----PNGSLEKRLYSHNYFLDILER--LNIMIDVGSTLEYLHHGHSSAPIIHC 453
               ++       G L   +     F    E     I+  V S + YLH       I+H 
Sbjct: 108 KRNYYLVMECYKGGELFDEIIHRMKFN---EVDAAVIIKQVLSGVTYLH----KHNIVHR 160

Query: 454 DLKPTSILL---DENMVAHVSDFGISKLLGE 481
           DLKP ++LL   +++ +  + DFG+S +   
Sbjct: 161 DLKPENLLLESKEKDALIKIVDFGLSAVFEN 191

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 68.5 bits (168), Expect = 8e-13
 Identities = 35/165 (21%), Positives = 62/165 (37%), Gaps = 41/165 (24%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKI-----FNLQRERAFRSFNSECEVLRNVRHQNLIKILSS 397
           G F  V +      G   A+KI     F      +      E  +   ++H +++++L +
Sbjct: 35  GPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLET 94

Query: 398 CSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLN------------IMIDVGSTLEY 440
            S+       F+FM    L           +I++R +             M  +   L Y
Sbjct: 95  YSSDGMLYMVFEFMDGADL---------CFEIVKRADAGFVYSEAVASHYMRQILEALRY 145

Query: 441 LH-HGHSSAPIIHCDLKPTSILL---DENMVAHVSDFGISKLLGE 481
            H +      IIH D+KP  +LL   + +    +  FG++  LGE
Sbjct: 146 CHDNN-----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE 185

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 68.5 bits (168), Expect = 8e-13
 Identities = 36/155 (23%), Positives = 53/155 (34%), Gaps = 38/155 (24%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFN---LQRERAFRSFNSECEVLRNVRHQNLIKILSSCS 399
           G+FG             VA+K         E   R    E    R++RH N+++      
Sbjct: 31  GNFGVARLMRDKLTKELVAVKYIERGAAIDENVQR----EIINHRSLRHPNIVRFKEVIL 86

Query: 400 TPDFKFM-----PNGSLEKRLYSH---------NYFLDILERLNIMIDVGSTLEYLHHGH 445
           TP    +       G L +R+ +           +F  +L          S + Y H   
Sbjct: 87  TPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLL----------SGVSYCHSMQ 136

Query: 446 SSAPIIHCDLKPTSILLDENMVAH--VSDFGISKL 478
               I H DLK  + LLD +      + DFG SK 
Sbjct: 137 ----ICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 67.7 bits (166), Expect = 9e-13
 Identities = 40/178 (22%), Positives = 71/178 (39%), Gaps = 56/178 (31%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFN---LQRERAFRSFNS--------------------- 378
           GS+G V      +D T  A+K+ +   L R+  F                          
Sbjct: 24  GSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQV 83

Query: 379 --ECEVLRNVRHQNLIKILSSCSTPD-------FKFMPNGSL-----EKRL---YSHNYF 421
             E  +L+ + H N++K++     P+       F+ +  G +      K L    +  YF
Sbjct: 84  YQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYF 143

Query: 422 LDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
            D++            +EYLH+      IIH D+KP+++L+ E+    ++DFG+S   
Sbjct: 144 QDLI----------KGIEYLHYQK----IIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 68.1 bits (167), Expect = 1e-12
 Identities = 32/169 (18%), Positives = 60/169 (35%), Gaps = 39/169 (23%)

Query: 343 AGSFGSVYKGTISDG------TDVAIKIFNLQ-RERAFRSFNSECEVLRNV-RHQNLIKI 394
           +G+FG V   T            VA+K+   +       +  SE +++  +  H+N++ +
Sbjct: 55  SGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNL 114

Query: 395 LSSCSTPD-----FKFMPNGSLEKRLYSH----------------------NYFLDILER 427
           L +C+        F++   G L   L S                          L   + 
Sbjct: 115 LGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDL 174

Query: 428 LNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGIS 476
           L     V   +E+L         +H DL   ++L+    V  + DFG++
Sbjct: 175 LCFAYQVAKGMEFL----EFKSCVHRDLAARNVLVTHGKVVKICDFGLA 219

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 68.7 bits (168), Expect = 1e-12
 Identities = 32/147 (21%), Positives = 62/147 (42%), Gaps = 14/147 (9%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           G+FG V++ T  + G + A K      E    +   E + +  +RH  L+ +  +    +
Sbjct: 168 GAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN 227

Query: 403 -----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLH-HGHSSAPIIHCDLK 456
                ++FM  G L +++   +  +   E +  M  V   L ++H +       +H DLK
Sbjct: 228 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN-----YVHLDLK 282

Query: 457 PTSILLDENMVAHV--SDFGISKLLGE 481
           P +I+        +   DFG++  L  
Sbjct: 283 PENIMFTTKRSNELKLIDFGLTAHLDP 309

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 33/147 (22%), Positives = 62/147 (42%), Gaps = 14/147 (9%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           G+FG V++    + G     K  N        +  +E  ++  + H  LI +  +     
Sbjct: 62  GAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY 121

Query: 403 -----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLH-HGHSSAPIIHCDLK 456
                 +F+  G L  R+ + +Y +   E +N M      L+++H H      I+H D+K
Sbjct: 122 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS-----IVHLDIK 176

Query: 457 PTSILLDENMVAHV--SDFGISKLLGE 481
           P +I+ +    + V   DFG++  L  
Sbjct: 177 PENIMCETKKASSVKIIDFGLATKLNP 203

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 66.7 bits (163), Expect = 2e-12
 Identities = 49/201 (24%), Positives = 75/201 (37%), Gaps = 12/201 (5%)

Query: 144 LVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDL 203
            + +      L  + PP +            SE  L       +     L  L+L   +L
Sbjct: 12  HLEVNCDKRNLTAL-PPDL---PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL 67

Query: 204 NGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPP-CLASL 262
              +    GTL  L    L    LQ  +P     L  L +L +  N+L+  +P   L  L
Sbjct: 68  T-KLQVD-GTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLT-SLPLGALRGL 123

Query: 263 TSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNV-QKLKVLRVLDLSRN 321
             L+EL L  N+L +  P  L     + +++L++N L   LP+ +   L+ L  L L  N
Sbjct: 124 GELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQEN 182

Query: 322 QLSGDIPSTIGALVDLETISL 342
            L   IP        L    L
Sbjct: 183 SLYT-IPKGFFGSHLLPFAFL 202

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 62.8 bits (153), Expect = 4e-11
 Identities = 53/229 (23%), Positives = 73/229 (31%), Gaps = 43/229 (18%)

Query: 71  DNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAY 130
           D   +  +P  +   T   IL L  N        T      L+ L+L    LT       
Sbjct: 18  DKRNLTALPPDLPKDTT--ILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK------ 69

Query: 131 QWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEI-GH 189
               L        L  L LS N L  +  P +G    +L     S  +L  ++P      
Sbjct: 70  ----LQVDGTLPVLGTLDLSHNQLQSL--PLLGQTLPALTVLDVSFNRLT-SLPLGALRG 122

Query: 190 LRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGN 249
           L  L  L L  N+L  T+P          G   P   L+               L L  N
Sbjct: 123 LGELQELYLKGNELK-TLPP---------GLLTPTPKLE--------------KLSLANN 158

Query: 250 KLSGHIPP-CLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSN 297
            L+  +P   L  L +L  L L  N L  +IP   +    +    L  N
Sbjct: 159 NLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 62.0 bits (151), Expect = 8e-11
 Identities = 48/197 (24%), Positives = 71/197 (36%), Gaps = 16/197 (8%)

Query: 5   IPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNI 64
           +P ++   ++   L L  N L       +   + +  LNL    L+  L   +  +LP +
Sbjct: 25  LPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ--VDGTLPVL 79

Query: 65  KYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTT 124
             L+L  N L  ++P        L +LD+ FN  +         L  L  L L  N L T
Sbjct: 80  GTLDLSHNQL-QSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKT 138

Query: 125 ESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIP 184
                     L+       L  L L+ N L   LP  + N   +L      E  L  TIP
Sbjct: 139 LPPGL-----LTPTPK---LEKLSLANNNLTE-LPAGLLNGLENLDTLLLQENSLY-TIP 188

Query: 185 KEIGHLRGLIYLSLGFN 201
           K       L +  L  N
Sbjct: 189 KGFFGSHLLPFAFLHGN 205

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 66.9 bits (164), Expect = 2e-12
 Identities = 36/150 (24%), Positives = 62/150 (41%), Gaps = 26/150 (17%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRSFNSECEVL-RNVRHQNLIKILSSCSTP 401
           GS+    +    +   + A+KI +  +         E E+L R  +H N+I +       
Sbjct: 33  GSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EIEILLRYGQHPNIITLKDVYDDG 88

Query: 402 DFKF-----MPNGSLEKRLYSHNYFLDILER--LNIMIDVGSTLEYLH-HGHSSAPIIHC 453
            + +     M  G L  ++    +F    ER    ++  +  T+EYLH  G     ++H 
Sbjct: 89  KYVYVVTELMKGGELLDKILRQKFFS---EREASAVLFTITKTVEYLHAQG-----VVHR 140

Query: 454 DLKPTSILL----DENMVAHVSDFGISKLL 479
           DLKP++IL            + DFG +K L
Sbjct: 141 DLKPSNILYVDESGNPESIRICDFGFAKQL 170

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 66.5 bits (163), Expect = 2e-12
 Identities = 33/146 (22%), Positives = 56/146 (38%), Gaps = 12/146 (8%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKI--FNLQRERAFRS-FNSECEVLRNVRHQNLIKILSSCS 399
           G   +VY          VAIK      + +      F  E      + HQN++ ++    
Sbjct: 22  GGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDE 81

Query: 400 TPDFKFMP----NGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDL 455
             D  ++      G         +  L +   +N    +   +++ H       I+H D+
Sbjct: 82  EDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR----IVHRDI 137

Query: 456 KPTSILLDENMVAHVSDFGISKLLGE 481
           KP +IL+D N    + DFGI+K L E
Sbjct: 138 KPQNILIDSNKTLKIFDFGIAKALSE 163

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 66.5 bits (163), Expect = 3e-12
 Identities = 34/151 (22%), Positives = 61/151 (40%), Gaps = 24/151 (15%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVR-HQNLIKILSSCSTP 401
           GSF    K          A+KI + + E   +    E   L+    H N++K+       
Sbjct: 22  GSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEVFHDQ 78

Query: 402 D-----FKFMPNGSLEKRLYSHNYFLDILER--LNIMIDVGSTLEYLH-HGHSSAPIIHC 453
                  + +  G L +R+    +F    E     IM  + S + ++H  G     ++H 
Sbjct: 79  LHTFLVMELLNGGELFERIKKKKHFS---ETEASYIMRKLVSAVSHMHDVG-----VVHR 130

Query: 454 DLKPTSILL---DENMVAHVSDFGISKLLGE 481
           DLKP ++L    ++N+   + DFG ++L   
Sbjct: 131 DLKPENLLFTDENDNLEIKIIDFGFARLKPP 161

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 66.8 bits (163), Expect = 3e-12
 Identities = 44/275 (16%), Positives = 87/275 (31%), Gaps = 46/275 (16%)

Query: 4   QIPTEIGNLQNLKSLFLGANNLSGLIPPMIF-NISTIRNLNLGGNRLSGHLPSMIGHSLP 62
           +IP+++   +N   L      L   I    F     +  + +  N +   + + +  +LP
Sbjct: 23  EIPSDL--PRNAIELRFVLTKLRV-IQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLP 79

Query: 63  NIKYLELGDNNLIGTIPNSI-TNATKLIILDLGFNTFSGHIPN-TFGNLRHLSVLSLLMN 120
            +  + +   N +  I      N   L  L +       H+P+    +     +L +  N
Sbjct: 80  KLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDN 138

Query: 121 N-LTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKL 179
             + T   ++        L+     V L L+ N +  I   S  N +   +   +    L
Sbjct: 139 INIHTIERNS-----FVGLSF--ESVILWLNKNGIQEI-HNSAFNGTQLDELNLSDNNNL 190

Query: 180 KGTIPKEI-GHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHL 238
           +  +P ++     G + L +    +                      +L  Y   NL  L
Sbjct: 191 E-ELPNDVFHGASGPVILDISRTRI---------------------HSLPSYGLENLKKL 228

Query: 239 EMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSN 273
              +  +L          P L  L +L E  L   
Sbjct: 229 RARSTYNL-------KKLPTLEKLVALMEASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 66.8 bits (163), Expect = 3e-12
 Identities = 57/307 (18%), Positives = 97/307 (31%), Gaps = 69/307 (22%)

Query: 40  RNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFS 99
           R      ++++  +PS +     N   L      L      + +    L  +++  N   
Sbjct: 12  RVFLCQESKVT-EIPSDL---PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVL 67

Query: 100 GHIP-NTFGNLRHLSVLSLL-MNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGI 157
             I  + F NL  L  + +   NNL   +  A       +L N   L YL++S   +  +
Sbjct: 68  EVIEADVFSNLPKLHEIRIEKANNLLYINPEA-----FQNLPN---LQYLLISNTGIKHL 119

Query: 158 LPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQL 217
                 +   SLQ                       + L +  N    TI     +   L
Sbjct: 120 PD---VHKIHSLQ----------------------KVLLDIQDNINIHTIER--NSFVGL 152

Query: 218 QGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDL-GSNKLT 276
                                    +L L  N +   I     + T L EL+L  +N L 
Sbjct: 153 SF--------------------ESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE 191

Query: 277 SSIPSSLWSLGYILEINLSSNLLNDSLPSNV-QKLKVLRVLDLSRNQLSGDIPSTIGALV 335
                        + +++S   ++ SLPS   + LK LR       +    +P+ +  LV
Sbjct: 192 ELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLK---KLPT-LEKLV 246

Query: 336 DLETISL 342
            L   SL
Sbjct: 247 ALMEASL 253

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 66.8 bits (163), Expect = 3e-12
 Identities = 48/183 (26%), Positives = 81/183 (44%), Gaps = 42/183 (22%)

Query: 318 LSRNQLSGDIPSTIGALVDLETISL--AGSFGSVYKGT-ISDGTDVAIKIFNLQRERAFR 374
           L++ Q  G++        D E IS   AG+ G V+K +    G  +A K+ +L+ + A R
Sbjct: 21  LTQKQKVGELKDD-----DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIR 75

Query: 375 SFNSECEVLRNVRHQNLIKILSSCSTP---DFK--------------FMPNGSLEKRLYS 417
           +     +++R       +++L  C++P    F                M  GSL++ L  
Sbjct: 76  N-----QIIRE------LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK 124

Query: 418 HNYFL-DILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGIS 476
                  IL +  + I V   L YL   H    I+H D+KP++IL++      + DFG+S
Sbjct: 125 AGRIPEQILGK--VSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVS 179

Query: 477 KLL 479
             L
Sbjct: 180 GQL 182

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 65.8 bits (161), Expect = 4e-12
 Identities = 42/151 (27%), Positives = 63/151 (41%), Gaps = 29/151 (19%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNL-QRERAFRSFNSECEVLRNVRHQNLIKILSSCSTP 401
           GSFG V+KG        VAIKI +L + E        E  VL       + K   S    
Sbjct: 33  GSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD 92

Query: 402 DF-----KFMPNGSLEKRLYSHNYFLDILE--RLN------IMIDVGSTLEYLHHGHSSA 448
                  +++  GS           LD+LE   L+      I+ ++   L+YLH      
Sbjct: 93  TKLWIIMEYLGGGSA----------LDLLEPGPLDETQIATILREILKGLDYLHSEK--- 139

Query: 449 PIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
             IH D+K  ++LL E+    ++DFG++  L
Sbjct: 140 -KIHRDIKAANVLLSEHGEVKLADFGVAGQL 169

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 65.8 bits (161), Expect = 5e-12
 Identities = 37/139 (26%), Positives = 60/139 (43%), Gaps = 12/139 (8%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           GS+GSVYK      G  VAIK   ++ +   +    E  +++     +++K   S     
Sbjct: 40  GSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHVVKYYGSYFKNT 97

Query: 403 F-----KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKP 457
                 ++   GS+   +   N  L   E   I+      LEYLH        IH D+K 
Sbjct: 98  DLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR----KIHRDIKA 153

Query: 458 TSILLDENMVAHVSDFGIS 476
            +ILL+    A ++DFG++
Sbjct: 154 GNILLNTEGHAKLADFGVA 172

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 65.1 bits (159), Expect = 7e-12
 Identities = 55/272 (20%), Positives = 97/272 (35%), Gaps = 50/272 (18%)

Query: 71  DNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAY 130
               I  I +      + I  +L   + +     T   L  +  +    +++ +      
Sbjct: 10  VPTPIKQIFS-DDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIKS------ 60

Query: 131 QWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHL 190
               +  +     +  L L+GN L  I P                           + +L
Sbjct: 61  ----VQGIQYLPNVTKLFLNGNKLTDIKP---------------------------LANL 89

Query: 191 RGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNK 250
           + L +L L  N +     +S+  LK+L+   L    +     + L HL  L  L+LG NK
Sbjct: 90  KNLGWLFLDENKV--KDLSSLKDLKKLKSLSLEHNGIS--DINGLVHLPQLESLYLGNNK 145

Query: 251 LSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKL 310
           ++  I   L+ LT L  L L  N+++      L  L  +  + LS N ++D     +  L
Sbjct: 146 IT-DITV-LSRLTKLDTLSLEDNQISD--IVPLAGLTKLQNLYLSKNHISD--LRALAGL 199

Query: 311 KVLRVLDLSRNQLSGDIPSTIGALVDLETISL 342
           K L VL+L   +      +    LV   T+  
Sbjct: 200 KNLDVLELFSQECLNKPINHQSNLVVPNTVKN 231

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 58.9 bits (143), Expect = 7e-10
 Identities = 47/292 (16%), Positives = 94/292 (32%), Gaps = 52/292 (17%)

Query: 11  NLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELG 70
                    L   +++  +      +++I  +    + +   +  +    LPN+  L L 
Sbjct: 22  AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQGI--QYLPNVTKLFLN 76

Query: 71  DNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAY 130
            N  +  I   + N   L  L L  N     + +   +L+ L  LSL  N ++       
Sbjct: 77  GNK-LTDIKP-LANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGISD------ 126

Query: 131 QWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHL 190
               ++ L +   L  L L  N +  I                             +  L
Sbjct: 127 ----INGLVHLPQLESLYLGNNKITDITV---------------------------LSRL 155

Query: 191 RGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNK 250
             L  LSL  N +  +    +  L +LQ  +L + ++       L  L+ L++L L   +
Sbjct: 156 TKLDTLSLEDNQI--SDIVPLAGLTKLQNLYLSKNHISDLRA--LAGLKNLDVLELFSQE 211

Query: 251 LSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDS 302
                    ++L     +      L +  P  +   G   + N+  +L   +
Sbjct: 212 CLNKPINHQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKPNVKWHLPEFT 261

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 51.6 bits (124), Expect = 2e-07
 Identities = 38/147 (25%), Positives = 56/147 (38%), Gaps = 21/147 (14%)

Query: 9   IGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIG-HSLPNIKYL 67
           I  L N+  LFL  N L+ + P  + N+  +  L L  N++      +     L  +K L
Sbjct: 64  IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVK----DLSSLKDLKKLKSL 117

Query: 68  ELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESS 127
            L  N  I  I   + +  +L  L LG N  +  I      L  L  LSL  N ++    
Sbjct: 118 SLEHNG-ISDING-LVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQISD--- 170

Query: 128 SAYQWSFLSSLTNCRYLVYLILSGNPL 154
                  +  L     L  L LS N +
Sbjct: 171 -------IVPLAGLTKLQNLYLSKNHI 190

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 50.1 bits (120), Expect = 6e-07
 Identities = 38/148 (25%), Positives = 62/148 (41%), Gaps = 19/148 (12%)

Query: 7   TEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKY 66
             + NL+NL  LFL  N +  L    + ++  +++L+L  N +S  +  +    LP ++ 
Sbjct: 84  KPLANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGIS-DINGL--VHLPQLES 138

Query: 67  LELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTES 126
           L LG+N +  T    ++  TKL  L L  N  S  I      L  L  L L  N+++   
Sbjct: 139 LYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHISD-- 192

Query: 127 SSAYQWSFLSSLTNCRYLVYLILSGNPL 154
                   L +L   + L  L L     
Sbjct: 193 --------LRALAGLKNLDVLELFSQEC 212

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 40/210 (19%), Positives = 76/210 (36%), Gaps = 24/210 (11%)

Query: 9   IGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLE 68
              L ++  +    +++  +    I  +  +  L L GN+L+  +  +   +L N+ +L 
Sbjct: 42  QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLT-DIKPL--ANLKNLGWLF 96

Query: 69  LGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSS 128
           L +N  +  + + + +  KL  L L  N  S  I     +L  L  L L  N +T     
Sbjct: 97  LDENK-VKDLSS-LKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITD---- 148

Query: 129 AYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIG 188
                 ++ L+    L  L L  N +  I    +    T LQ    S+  +  +  + + 
Sbjct: 149 ------ITVLSRLTKLDTLSLEDNQISDI--VPLAGL-TKLQNLYLSKNHI--SDLRALA 197

Query: 189 HLRGLIYLSLGFNDLNGTIPTSIGTLKQLQ 218
            L+ L  L L   +           L    
Sbjct: 198 GLKNLDVLELFSQECLNKPINHQSNLVVPN 227

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 46.6 bits (111), Expect = 8e-06
 Identities = 23/119 (19%), Positives = 51/119 (42%), Gaps = 7/119 (5%)

Query: 9   IGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLE 68
           + +L  L+SL+LG N ++ +    +  ++ +  L+L  N++S  +  +    L  ++ L 
Sbjct: 130 LVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQIS-DIVPL--AGLTKLQNLY 184

Query: 69  LGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESS 127
           L  N++  +   ++     L +L+L          N   NL   + +     +L T   
Sbjct: 185 LSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEI 241

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 65.5 bits (160), Expect = 7e-12
 Identities = 38/142 (26%), Positives = 60/142 (42%), Gaps = 14/142 (9%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRERA---FRSFNSECEVLRNVRHQNLIKILSSCS 399
           GSFG+VY    + +   VAIK  +   +++   ++    E   L+ +RH N I+      
Sbjct: 65  GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 124

Query: 400 TPDF-----KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
                    ++   GS    L  H   L  +E   +       L YLH    S  +IH D
Sbjct: 125 REHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH----SHNMIHRD 179

Query: 455 LKPTSILLDENMVAHVSDFGIS 476
           +K  +ILL E  +  + DFG +
Sbjct: 180 VKAGNILLSEPGLVKLGDFGSA 201

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 64.2 bits (157), Expect = 1e-11
 Identities = 42/147 (28%), Positives = 67/147 (45%), Gaps = 14/147 (9%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFN---LQRERAFRSFNSECEVLRNVRHQNLIKILSSCS 399
           GSF +V     ++   + AIKI     + +E        E +V+  + H   +K+  +  
Sbjct: 41  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 100

Query: 400 TPDF-----KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
             +       +  NG L K +     F +   R     ++ S LEYLH       IIH D
Sbjct: 101 DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGKG----IIHRD 155

Query: 455 LKPTSILLDENMVAHVSDFGISKLLGE 481
           LKP +ILL+E+M   ++DFG +K+L  
Sbjct: 156 LKPENILLNEDMHIQITDFGTAKVLSP 182

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 63.8 bits (156), Expect = 2e-11
 Identities = 37/156 (23%), Positives = 60/156 (38%), Gaps = 27/156 (17%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTP 401
           G+FG V+     S G +  IK  N  R +       +E EVL+++ H N+IKI       
Sbjct: 33  GAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDY 92

Query: 402 DFKFM-----PNGSL-----EKRLYSHNYFLDILER--LNIMIDVGSTLEYLH-HGHSSA 448
              ++       G L       +           E     +M  + + L Y H       
Sbjct: 93  HNMYIVMETCEGGELLERIVSAQARGKAL----SEGYVAELMKQMMNALAYFHSQH---- 144

Query: 449 PIIHCDLKPTSILL---DENMVAHVSDFGISKLLGE 481
            ++H DLKP +IL      +    + DFG+++L   
Sbjct: 145 -VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 64.7 bits (158), Expect = 2e-11
 Identities = 35/148 (23%), Positives = 66/148 (44%), Gaps = 16/148 (10%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           G FG V+K    + G  +A KI   +  +      +E  V+  + H NLI++  +  + +
Sbjct: 100 GRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKN 159

Query: 403 -----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLH-HGHSSAPIIHCDLK 456
                 +++  G L  R+   +Y L  L+ +  M  +   + ++H        I+H DLK
Sbjct: 160 DIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY-----ILHLDLK 214

Query: 457 PTSILL---DENMVAHVSDFGISKLLGE 481
           P +IL    D   +  + DFG+++    
Sbjct: 215 PENILCVNRDAKQIK-IIDFGLARRYKP 241

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 37/160 (23%), Positives = 63/160 (39%), Gaps = 39/160 (24%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRSFNSECEVLRNV-RHQNLIK-----ILS 396
           G++G VYKG  +  G   AIK+ ++  +        E  +L+    H+N+       I  
Sbjct: 35  GTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATYYGAFIKK 93

Query: 397 SCSTPDFK------FMPNGSLEKRLYSHNYFLDILERLN-----------IMIDVGSTLE 439
           +    D +      F   GS+           D+++              I  ++   L 
Sbjct: 94  NPPGMDDQLWLVMEFCGAGSV----------TDLIKNTKGNTLKEEWIAYICREILRGLS 143

Query: 440 YLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
           +LH       +IH D+K  ++LL EN    + DFG+S  L
Sbjct: 144 HLHQHK----VIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 31/150 (20%), Positives = 61/150 (40%), Gaps = 24/150 (16%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQ------RERAFRSFNSECEVLRNV-RHQNLIKIL 395
           G FGSV+K     DG   AIK            + A R    E      + +H ++++  
Sbjct: 22  GEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALR----EVYAHAVLGQHSHVVRYF 77

Query: 396 SSCSTPDF-----KFMPNGSLEKRLYSHNYFLDIL---ERLNIMIDVGSTLEYLHHGHSS 447
           S+ +  D      ++   GSL   +  +   +      E  ++++ VG  L Y+H     
Sbjct: 78  SAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS-- 135

Query: 448 APIIHCDLKPTSILLDENMVAHVSDFGISK 477
             ++H D+KP++I +    + + +     +
Sbjct: 136 --LVHMDIKPSNIFISRTSIPNAASEEGDE 163

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 36/151 (23%), Positives = 63/151 (41%), Gaps = 22/151 (14%)

Query: 343 AGSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTP 401
            G+   VY+          A+K+     ++      +E  VL  + H N+IK+     TP
Sbjct: 63  RGATSIVYRCKQKGTQKPYALKVLKKTVDKK--IVRTEIGVLLRLSHPNIIKLKEIFETP 120

Query: 402 DFKFM-----PNGSLEKRLYSHNYFLDILER--LNIMIDVGSTLEYLH-HGHSSAPIIHC 453
               +       G L  R+    Y+    ER   + +  +   + YLH +G     I+H 
Sbjct: 121 TEISLVLELVTGGELFDRIVEKGYY---SERDAADAVKQILEAVAYLHENG-----IVHR 172

Query: 454 DLKPTSILL---DENMVAHVSDFGISKLLGE 481
           DLKP ++L      +    ++DFG+SK++  
Sbjct: 173 DLKPENLLYATPAPDAPLKIADFGLSKIVEH 203

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 64.5 bits (157), Expect = 2e-11
 Identities = 39/149 (26%), Positives = 55/149 (36%), Gaps = 14/149 (9%)

Query: 11  NLQNLKSLFLGANNLSGLIPPMIF-NISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLEL 69
            L NL SL L  N+L+  I    F  +  +R L+L  N L   L   +   L  ++ L L
Sbjct: 62  RLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLL 119

Query: 70  GDNNLIGTIPNSI-TNATKLIILDLGFNTFSGHIPNTFGN---LRHLSVLSLLMNNLTTE 125
             NN I  +  +   +  +L  L L  N  S        +   L  L +L L  N L   
Sbjct: 120 -YNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKL 178

Query: 126 SSSAYQWSFLSSLTNCRYLVYLILSGNPL 154
             +      L +         L L  NPL
Sbjct: 179 PLTDL--QKLPAWV----KNGLYLHNNPL 201

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 59.9 bits (145), Expect = 5e-10
 Identities = 30/114 (26%), Positives = 47/114 (41%), Gaps = 9/114 (7%)

Query: 237 HLEMLNLLHLGGNKLSGHIPPC-LASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLS 295
            L  L+ L L  N L+  I       + +LR LDL SN L +        L  +  + L 
Sbjct: 62  RLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLY 120

Query: 296 SNLLNDSLPSNV-QKLKVLRVLDLSRNQLSGDIP----STIGALVDLETISLAG 344
           +N +   +  N  + +  L+ L LS+NQ+S   P         L  L  + L+ 
Sbjct: 121 NNHI-VVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSS 172

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 58.7 bits (142), Expect = 1e-09
 Identities = 37/164 (22%), Positives = 65/164 (39%), Gaps = 11/164 (6%)

Query: 5   IPTEIGNLQNLKSLFLGANNLSGLIPPMIF-NISTIRNLNLGGNRLSGHLPSMIGHSLPN 63
           +P  + +      L L  NNLS L        ++ + +L L  N L+  + S     +PN
Sbjct: 33  VPQSLPS--YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPN 89

Query: 64  IKYLELGDNNLIGTIPNSI-TNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNL 122
           ++YL+L  +N + T+   + ++   L +L L  N       N F ++  L  L L  N +
Sbjct: 90  LRYLDL-SSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQI 148

Query: 123 TTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFS 166
           +            + L     L+ L LS N L  +    +    
Sbjct: 149 SRFPVELI--KDGNKLPK---LMLLDLSSNKLKKLPLTDLQKLP 187

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 56.8 bits (137), Expect = 5e-09
 Identities = 39/177 (22%), Positives = 60/177 (33%), Gaps = 14/177 (7%)

Query: 29  IPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSI-TNATK 87
           +P  +   S    L+L  N LS          L N+  L L  N+ +  I +        
Sbjct: 33  VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNH-LNFISSEAFVPVPN 89

Query: 88  LIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYL 147
           L  LDL  N         F +L+ L VL L  N++     +A        +     L  L
Sbjct: 90  LRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNA-----FEDMAQ---LQKL 141

Query: 148 ILSGNPLGGILPPSIGNFS--TSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFND 202
            LS N +       I + +    L     S  KLK     ++  L   +   L  ++
Sbjct: 142 YLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 64.7 bits (158), Expect = 2e-11
 Identities = 37/162 (22%), Positives = 69/162 (42%), Gaps = 31/162 (19%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKI-------------FNLQRERAFRSFNSECEVLRNVRHQ 389
           G++G V      +  ++ AIK+              N   E+      +E  +L+++ H 
Sbjct: 47  GAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHP 106

Query: 390 NLIKILSSCSTPDFKFM-----PNGSLEKRLYSHNYFLDILER--LNIMIDVGSTLEYLH 442
           N+IK+        + ++       G L +++ + + F    E    NIM  + S + YLH
Sbjct: 107 NIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFD---ECDAANIMKQILSGICYLH 163

Query: 443 HGHSSAPIIHCDLKPTSILL---DENMVAHVSDFGISKLLGE 481
                  I+H D+KP +ILL   +  +   + DFG+S    +
Sbjct: 164 ----KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK 201

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 63.5 bits (155), Expect = 3e-11
 Identities = 39/155 (25%), Positives = 66/155 (42%), Gaps = 29/155 (18%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQ----RERAFRSFNSECEVLRNVR-HQNLIKILSS 397
           G+   V     +    + A+KI   Q    R R FR    E E+L   + H+N+++++  
Sbjct: 24  GAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFR----EVEMLYQCQGHRNVLELIEF 79

Query: 398 CSTPD-----FKFMPNGSLEKRLYSHNYFLDILER--LNIMIDVGSTLEYLH-HGHSSAP 449
               D     F+ M  GS+   ++   +F    E     ++ DV S L++LH  G     
Sbjct: 80  FEEEDRFYLVFEKMRGGSILSHIHKRRHFN---ELEASVVVQDVASALDFLHNKG----- 131

Query: 450 IIHCDLKPTSILL---DENMVAHVSDFGISKLLGE 481
           I H DLKP +IL    ++     + DF +   +  
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 63.5 bits (155), Expect = 3e-11
 Identities = 39/156 (25%), Positives = 57/156 (36%), Gaps = 29/156 (18%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQR----------ERAFRSFNSECEVLRNVRHQ--N 390
           G FGSVY G  +SD   VAIK     R           R       E  +L+ V      
Sbjct: 54  GGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM----EVVLLKKVSSGFSG 109

Query: 391 LIKILSSCSTPDFKFM------PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHG 444
           +I++L     PD   +      P   L   +      L      +    V   + + H+ 
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNC 168

Query: 445 HSSAPIIHCDLKPTSILLDEN-MVAHVSDFGISKLL 479
                ++H D+K  +IL+D N     + DFG   LL
Sbjct: 169 G----VLHRDIKDENILIDLNRGELKLIDFGSGALL 200

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 63.5 bits (155), Expect = 3e-11
 Identities = 34/144 (23%), Positives = 60/144 (41%), Gaps = 12/144 (8%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTP 401
           G+   V           VAIK  NL++ + +      E + +    H N++   +S    
Sbjct: 26  GATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK 85

Query: 402 DF-----KFMPNGSL----EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
           D      K +  GS+    +  +    +   +L+   I   +   LE L + H +   IH
Sbjct: 86  DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG-QIH 144

Query: 453 CDLKPTSILLDENMVAHVSDFGIS 476
            D+K  +ILL E+    ++DFG+S
Sbjct: 145 RDVKAGNILLGEDGSVQIADFGVS 168

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 63.9 bits (156), Expect = 3e-11
 Identities = 39/151 (25%), Positives = 69/151 (45%), Gaps = 24/151 (15%)

Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKIL----SSCS 399
           GSFG V++  + +  +VAIK     +    R    E +++R V+H N++ +     S+  
Sbjct: 51  GSFGVVFQAKLVESDEVAIKKVLQDKRFKNR----ELQIMRIVKHPNVVDLKAFFYSNGD 106

Query: 400 TPDFK-------FMPNGSLEKRLYSHNYFLDILERLNI---MIDVGSTLEYLHHGHSSAP 449
             D         ++P  ++ +    +      +  L I   M  +  +L Y+H    S  
Sbjct: 107 KKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH----SIG 161

Query: 450 IIHCDLKPTSILLDENM-VAHVSDFGISKLL 479
           I H D+KP ++LLD    V  + DFG +K+L
Sbjct: 162 ICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 63.6 bits (155), Expect = 5e-11
 Identities = 41/152 (26%), Positives = 70/152 (46%), Gaps = 25/152 (16%)

Query: 344 GSFGSVYKGTISD-GTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKIL----SSC 398
           GSFG VY+  + D G  VAIK     +    R    E +++R + H N++++     SS 
Sbjct: 65  GSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVRLRYFFYSSG 120

Query: 399 STPD-------FKFMPNGSLEKRLYSHNYFLDILERLNI---MIDVGSTLEYLHHGHSSA 448
              D         ++P  ++ +    ++     L  + +   M  +  +L Y+H    S 
Sbjct: 121 EKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH----SF 175

Query: 449 PIIHCDLKPTSILLDENM-VAHVSDFGISKLL 479
            I H D+KP ++LLD +  V  + DFG +K L
Sbjct: 176 GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 62.3 bits (152), Expect = 6e-11
 Identities = 33/148 (22%), Positives = 57/148 (38%), Gaps = 16/148 (10%)

Query: 344 GSFGSVYKGTISD---GTDVAIKI--FNLQRERAFRS-FNSECEVLRNVRHQNLIKILSS 397
           G  G VY+    D      VA+K+    L  +  FR+    E      ++  +++ I   
Sbjct: 45  GGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDF 102

Query: 398 CSTPDFKF--MP--NGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHC 453
                  +  M   NG     +      L     + I+  +GS L+  H         H 
Sbjct: 103 GEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG----ATHR 158

Query: 454 DLKPTSILLDENMVAHVSDFGISKLLGE 481
           D+KP +IL+  +  A++ DFGI+    +
Sbjct: 159 DVKPENILVSADDFAYLVDFGIASATTD 186

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 62.7 bits (153), Expect = 6e-11
 Identities = 36/157 (22%), Positives = 55/157 (35%), Gaps = 27/157 (17%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRS------FNSECEVLRNVRHQNLIKILS 396
           G F  V K    S G + A K    ++ RA R          E  +LR V H N+I +  
Sbjct: 23  GQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHD 82

Query: 397 SCSTPD-----FKFMPNGSLEKRLYSHNYFLDILER--LNIMIDVGSTLEYLH-HGHSSA 448
                       + +  G L   L          E    + +  +   + YLH       
Sbjct: 83  VYENRTDVVLILELVSGGELFDFLAQKESL---SEEEATSFIKQILDGVNYLHTKK---- 135

Query: 449 PIIHCDLKPTSILL----DENMVAHVSDFGISKLLGE 481
            I H DLKP +I+L           + DFG++  + +
Sbjct: 136 -IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 62.2 bits (152), Expect = 6e-11
 Identities = 37/148 (25%), Positives = 67/148 (45%), Gaps = 20/148 (13%)

Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRER------AFRSFNSECEVLRNVRHQNLIKILSS 397
           G++G VYK   S G  VA+K   L  E       A R    E  +L+ + H N++ ++  
Sbjct: 32  GTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR----EISLLKELHHPNIVSLIDV 87

Query: 398 CSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
             +       F+FM    L+K L  +   L   +    +  +   + + H       I+H
Sbjct: 88  IHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR----ILH 142

Query: 453 CDLKPTSILLDENMVAHVSDFGISKLLG 480
            DLKP ++L++ +    ++DFG+++  G
Sbjct: 143 RDLKPQNLLINSDGALKLADFGLARAFG 170

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 63.2 bits (153), Expect = 7e-11
 Identities = 44/310 (14%), Positives = 91/310 (29%), Gaps = 24/310 (7%)

Query: 34  FNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDL 93
            ++    +++     LS      +         L + D   +     +     +   + L
Sbjct: 242 HDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWL 301

Query: 94  GFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNP 153
             +  +  + +         + +   +             +         L    LS   
Sbjct: 302 -CDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEK 360

Query: 154 LGGILPPSIGNFS--TSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSI 211
              +L   + +      L+  +         + + +  L         F+ L    P   
Sbjct: 361 ST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRA 419

Query: 212 GTLKQLQGFFLPETNLQGYVPH----------------NLCHLEMLNLLHLGGNKLSGHI 255
             L  L+  FL E ++                      +L  L ++  L L  N+L   +
Sbjct: 420 AYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVLCHLEQLLLVTHLDLSHNRLR-AL 478

Query: 256 PPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLND-SLPSNVQKLKVLR 314
           PP LA+L  L  L    N L +     + +L  + E+ L +N L   +    +     L 
Sbjct: 479 PPALAALRCLEVLQASDNALEN--VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLV 536

Query: 315 VLDLSRNQLS 324
           +L+L  N L 
Sbjct: 537 LLNLQGNSLC 546

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 51.7 bits (123), Expect = 3e-07
 Identities = 30/154 (19%), Positives = 51/154 (33%), Gaps = 37/154 (24%)

Query: 1   MTGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHS 60
              +         +++ L L   +L+ L    +  +  + +L+L  NRL   LP  +   
Sbjct: 429 FLLENSVLKMEYADVRVLHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLR-ALPPALAA- 484

Query: 61  LPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMN 120
           L  ++ L+   +N +  +                             NL  L  L L  N
Sbjct: 485 LRCLEVLQA-SDNALENVDG-------------------------VANLPRLQELLLCNN 518

Query: 121 NLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPL 154
            L          + +  L +C  LV L L GN L
Sbjct: 519 RLQQ-------SAAIQPLVSCPRLVLLNLQGNSL 545

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 51.7 bits (123), Expect = 3e-07
 Identities = 32/225 (14%), Positives = 69/225 (30%), Gaps = 14/225 (6%)

Query: 125 ESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRF---SASECKLKG 181
           E+  + +W          ++    L    L   LP        +                
Sbjct: 280 EAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPE 339

Query: 182 TIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEML 241
              ++      L    L        + + + + K+LQ            +   +  L+ L
Sbjct: 340 CWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPL 398

Query: 242 NLLHLGGNKLSGHIPPCLASLTSLRELDLG--SNKLTSSIPSSLWSLGYILEINLSSNLL 299
                     S      L ++  +R   L    +K              +  ++L+   L
Sbjct: 399 LYEKETLQYFST-----LKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL 453

Query: 300 NDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAG 344
             ++  ++++L ++  LDLS N+L   +P  + AL  LE +  + 
Sbjct: 454 --TVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASD 495

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 61.5 bits (150), Expect = 8e-11
 Identities = 51/159 (32%), Positives = 72/159 (45%), Gaps = 10/159 (6%)

Query: 189 HLRGLIYLSLGFNDLNGTIPTSI-GTLKQLQGFFLPETNLQGYVPHNL-CHLEMLNLLHL 246
            L  L  L L  N L  T+P  I   LK L+  ++ +  LQ  +P  +   L  L  L L
Sbjct: 59  RLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQA-LPIGVFDQLVNLAELRL 116

Query: 247 GGNKLSGHIPP-CLASLTSLRELDLGSNKLTSSIPSSLW-SLGYILEINLSSNLLNDSLP 304
             N+L   +PP    SLT L  L LG N+L S +P  ++  L  + E+ L +N L   +P
Sbjct: 117 DRNQLK-SLPPRVFDSLTKLTYLSLGYNELQS-LPKGVFDKLTSLKELRLYNNQLK-RVP 173

Query: 305 SNV-QKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISL 342
                KL  L+ L L  NQL         +L  L+ + L
Sbjct: 174 EGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQL 212

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 60.8 bits (148), Expect = 1e-10
 Identities = 43/145 (29%), Positives = 58/145 (40%), Gaps = 13/145 (8%)

Query: 11  NLQNLKSLFLGANNLSGLIPPMIF-NISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLEL 69
            L+NL++L++  N L  L P  +F  +  +  L L  N+L   LP  +  SL  + YL L
Sbjct: 83  ELKNLETLWVTDNKLQAL-PIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSL 140

Query: 70  GDNNLIGTIPNSI-TNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSS 128
           G N L  ++P  +    T L  L L  N         F  L  L  L L  N L      
Sbjct: 141 GYNEL-QSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEG 199

Query: 129 AYQWSFLSSLTNCRYLVYLILSGNP 153
           A+    L  L        L L  NP
Sbjct: 200 AF--DSLEKLK------MLQLQENP 216

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 59.6 bits (145), Expect = 4e-10
 Identities = 46/163 (28%), Positives = 64/163 (39%), Gaps = 14/163 (8%)

Query: 11  NLQNLKSLFLGANNLSGLIPPMIFN-ISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLEL 69
            L  L+ L+L  N L  L P  IF  +  +  L +  N+L   LP  +   L N+  L L
Sbjct: 59  RLTKLRLLYLNDNKLQTL-PAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRL 116

Query: 70  GDNNLIGTIPNSI-TNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSS 128
            D N + ++P  +  + TKL  L LG+N         F  L  L  L L  N L      
Sbjct: 117 -DRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEG 175

Query: 129 AYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQR 171
           A+       LT    L  L L  N L  + P    +    L+ 
Sbjct: 176 AF-----DKLTE---LKTLKLDNNQLKRV-PEGAFDSLEKLKM 209

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 58.1 bits (141), Expect = 1e-09
 Identities = 59/224 (26%), Positives = 85/224 (37%), Gaps = 41/224 (18%)

Query: 77  TIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLS 136
            IP++I   TK   LDL  N  S      F  L  L +L L  N L T  +  +      
Sbjct: 30  AIPSNIPADTK--KLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIF-----K 82

Query: 137 SLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEI-GHLRGLIY 195
            L N   L  L ++ N L   LP  + +   +L        +LK ++P  +   L  L Y
Sbjct: 83  ELKN---LETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTY 137

Query: 196 LSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLC-HLEMLNLLHLGGNKLSGH 254
           LSLG+N              +LQ            +P  +   L  L  L L  N+L   
Sbjct: 138 LSLGYN--------------ELQ-----------SLPKGVFDKLTSLKELRLYNNQLK-R 171

Query: 255 IPPCL-ASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSN 297
           +P      LT L+ L L +N+L      +  SL  +  + L  N
Sbjct: 172 VPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 51.5 bits (124), Expect = 2e-07
 Identities = 36/118 (30%), Positives = 52/118 (44%), Gaps = 4/118 (3%)

Query: 5   IPTEI-GNLQNLKSLFLGANNLSGLIPPMIF-NISTIRNLNLGGNRLSGHLPSMIGHSLP 62
           +P  +   L NL  L L  N L  L PP +F +++ +  L+LG N L   LP  +   L 
Sbjct: 100 LPIGVFDQLVNLAELRLDRNQLKSL-PPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLT 157

Query: 63  NIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMN 120
           ++K L L +N L      +    T+L  L L  N         F +L  L +L L  N
Sbjct: 158 SLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 51.1 bits (123), Expect = 2e-07
 Identities = 36/104 (34%), Positives = 47/104 (45%), Gaps = 10/104 (9%)

Query: 244 LHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTS---SIPSSLWSLGYILEINLSSNLLN 300
           L L  NKLS         LT LR L L  NKL +    I   L +L     + ++ N L 
Sbjct: 42  LDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLET---LWVTDNKLQ 98

Query: 301 DSLPSNV-QKLKVLRVLDLSRNQLSGDIPSTI-GALVDLETISL 342
            +LP  V  +L  L  L L RNQL   +P  +  +L  L  +SL
Sbjct: 99  -ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSL 140

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 43.0 bits (102), Expect = 1e-04
 Identities = 25/82 (30%), Positives = 44/82 (53%), Gaps = 4/82 (4%)

Query: 263 TSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNV-QKLKVLRVLDLSRN 321
              ++LDL SNKL+S    +   L  +  + L+ N L  +LP+ + ++LK L  L ++ N
Sbjct: 37  ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDN 95

Query: 322 QLSGDIPSTI-GALVDLETISL 342
           +L   +P  +   LV+L  + L
Sbjct: 96  KLQ-ALPIGVFDQLVNLAELRL 116

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 61.9 bits (151), Expect = 9e-11
 Identities = 30/150 (20%), Positives = 63/150 (42%), Gaps = 21/150 (14%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFN---LQRERAFRSFNSECEVLRNVRHQNLIKILSSCS 399
           G FG V++    S       K        +    +    E  +L   RH+N++ +  S  
Sbjct: 16  GEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKK----EISILNIARHRNILHLHESFE 71

Query: 400 TPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLH-HGHSSAPIIHC 453
           + +     F+F+    + +R+ +  + L+  E ++ +  V   L++LH H      I H 
Sbjct: 72  SMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN-----IGHF 126

Query: 454 DLKPTSILL--DENMVAHVSDFGISKLLGE 481
           D++P +I+     +    + +FG ++ L  
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKP 156

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 62.4 bits (152), Expect = 1e-10
 Identities = 36/156 (23%), Positives = 54/156 (34%), Gaps = 25/156 (16%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRERAFR------SFNSECEVLRNVRHQNLIKILS 396
           G F  V K    S G + A K    ++ RA R          E  +LR V H N+I +  
Sbjct: 23  GQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHD 82

Query: 397 SCSTPDFKFM-----PNGSLEKRLYSHNYFLDILER--LNIMIDVGSTLEYLHHGHSSAP 449
                    +       G L   L          E    + +  +   + YLH       
Sbjct: 83  VYENRTDVVLILELVSGGELFDFLAQKESL---SEEEATSFIKQILDGVNYLHTKK---- 135

Query: 450 IIHCDLKPTSILL----DENMVAHVSDFGISKLLGE 481
           I H DLKP +I+L           + DFG++  + +
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 61.2 bits (149), Expect = 1e-10
 Identities = 34/192 (17%), Positives = 68/192 (35%), Gaps = 20/192 (10%)

Query: 135 LSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLI 194
           +         V   L    +  ++        + +Q F+     ++      +     L 
Sbjct: 12  VFPDPGLANAVKQNLGKQSVTDLVS--QKEL-SGVQNFNGDNSNIQSLAG--MQFFTNLK 66

Query: 195 YLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNL--LHLGGNKLS 252
            L L  N +  +  + +  L +L+   +    L+     NL  +    L  L L  N+L 
Sbjct: 67  ELHLSHNQI--SDLSPLKDLTKLEELSVNRNRLK-----NLNGIPSACLSRLFLDNNELR 119

Query: 253 GHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKV 312
                 L  L +L  L + +NKL S     L  L  +  ++L  N + +     + +LK 
Sbjct: 120 -DTDS-LIHLKNLEILSIRNNKLKS--IVMLGFLSKLEVLDLHGNEITN--TGGLTRLKK 173

Query: 313 LRVLDLSRNQLS 324
           +  +DL+  +  
Sbjct: 174 VNWIDLTGQKCV 185

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 51.6 bits (124), Expect = 2e-07
 Identities = 36/146 (24%), Positives = 59/146 (40%), Gaps = 20/146 (13%)

Query: 9   IGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLE 68
           +    NLK L L  N +S L P  + +++ +  L++  NRL     ++ G     +  L 
Sbjct: 59  MQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLK----NLNGIPSACLSRLF 112

Query: 69  LGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSS 128
           L +N L     +S+ +   L IL +  N     I    G L  L VL L  N +T     
Sbjct: 113 LDNNEL--RDTDSLIHLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEITN---- 164

Query: 129 AYQWSFLSSLTNCRYLVYLILSGNPL 154
                    LT  + + ++ L+G   
Sbjct: 165 ------TGGLTRLKKVNWIDLTGQKC 184

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 48.1 bits (115), Expect = 2e-06
 Identities = 38/197 (19%), Positives = 65/197 (32%), Gaps = 25/197 (12%)

Query: 7   TEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKY 66
                L N     LG  +++ L+      +S ++N N   + +   L  M      N+K 
Sbjct: 13  FPDPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLAGM--QFFTNLKE 67

Query: 67  LELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTES 126
           L L  N  I  +   + + TKL  L +  N            L     L L  N L    
Sbjct: 68  LHLSHNQ-ISDLSP-LKDLTKLEELSVNRNRLKNLNGIPSACLSR---LFLDNNELRD-- 120

Query: 127 SSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKE 186
                     SL + + L  L +  N L  I    +G   + L+       ++  T    
Sbjct: 121 --------TDSLIHLKNLEILSIRNNKLKSI--VMLGFL-SKLEVLDLHGNEI--TNTGG 167

Query: 187 IGHLRGLIYLSLGFNDL 203
           +  L+ + ++ L     
Sbjct: 168 LTRLKKVNWIDLTGQKC 184

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 25/118 (21%), Positives = 46/118 (38%), Gaps = 10/118 (8%)

Query: 9   IGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLE 68
           + +L  L+ L +  N L  L        + +  L L  N L     S+    L N++ L 
Sbjct: 81  LKDLTKLEELSVNRNRLKNLNG---IPSACLSRLFLDNNELR-DTDSL--IHLKNLEILS 134

Query: 69  LGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTES 126
           + +N  + +I   +   +KL +LDL  N  +         L+ ++ + L       E 
Sbjct: 135 IRNNK-LKSIVM-LGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQKCVNEP 188

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 61.4 bits (150), Expect = 1e-10
 Identities = 34/148 (22%), Positives = 69/148 (46%), Gaps = 20/148 (13%)

Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRER------AFRSFNSECEVLRNVRHQNLIKILSS 397
           G++G VYK   + G   A+K   L++E         R    E  +L+ ++H N++K+   
Sbjct: 13  GTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR----EISILKELKHSNIVKLYDV 68

Query: 398 CSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
             T       F+ +    L+K L      L+ +   + ++ + + + Y H       ++H
Sbjct: 69  IHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR----VLH 123

Query: 453 CDLKPTSILLDENMVAHVSDFGISKLLG 480
            DLKP ++L++      ++DFG+++  G
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFG 151

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 61.9 bits (151), Expect = 1e-10
 Identities = 37/158 (23%), Positives = 59/158 (37%), Gaps = 34/158 (21%)

Query: 344 GSFGSVYKGTISDGTDVAIK-IFNLQRE--------------RAFRSFNSECEVLRNVRH 388
           GS+G+V  G  S+G  VAIK +FN   +              R  R    E  +L +  H
Sbjct: 33  GSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR----EIRLLNHFHH 88

Query: 389 QNLIKIL---SSCSTPDFK-------FMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTL 438
            N++ +         P           M    L + ++     +        M  +   L
Sbjct: 89  PNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGL 147

Query: 439 EYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGIS 476
             LH     A ++H DL P +ILL +N    + DF ++
Sbjct: 148 HVLH----EAGVVHRDLHPGNILLADNNDITICDFNLA 181

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 61.2 bits (149), Expect = 2e-10
 Identities = 35/163 (21%), Positives = 62/163 (38%), Gaps = 44/163 (26%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRSFNSECEVL-RNVRHQNLIKILSSCSTP 401
           G  G V +      G   A+K+      +A +    E +   +     +++ IL      
Sbjct: 40  GVNGKVLECFHRRTGQKCALKLLY-DSPKARQ----EVDHHWQASGGPHIVCILDVYENM 94

Query: 402 D---------FKFMPNGSLEKRLYSHNYFLDILERLN----------IMIDVGSTLEYLH 442
                      + M  G L         F  I ER +          IM D+G+ +++LH
Sbjct: 95  HHGKRCLLIIMECMEGGEL---------FSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 145

Query: 443 -HGHSSAPIIHCDLKPTSILL---DENMVAHVSDFGISKLLGE 481
            H      I H D+KP ++L    +++ V  ++DFG +K   +
Sbjct: 146 SHN-----IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ 183

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 61.0 bits (149), Expect = 2e-10
 Identities = 36/149 (24%), Positives = 63/149 (42%), Gaps = 21/149 (14%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRER------AFRSFNSECEVLRNVRHQNLIKILS 396
           GS+G V+K      G  VAIK F    +       A R    E  +L+ ++H NL+ +L 
Sbjct: 14  GSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR----EIRMLKQLKHPNLVNLLE 69

Query: 397 SCSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPII 451
                      F++  + ++   L  +   +      +I       + + H        I
Sbjct: 70  VFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH----KHNCI 124

Query: 452 HCDLKPTSILLDENMVAHVSDFGISKLLG 480
           H D+KP +IL+ ++ V  + DFG ++LL 
Sbjct: 125 HRDVKPENILITKHSVIKLCDFGFARLLT 153

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 61.8 bits (150), Expect = 2e-10
 Identities = 34/148 (22%), Positives = 65/148 (43%), Gaps = 27/148 (18%)

Query: 344 GSFGSVYKGT-ISDGTDVAIK-IFNLQRE-----RAFRSFNSECEVLRNVRHQNLIKILS 396
           GS+G V +     +   VAIK I  +  +     R  R    E  +L  + H +++K+L 
Sbjct: 64  GSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR----EIAILNRLNHDHVVKVLD 119

Query: 397 SCSTPD----------FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHS 446
                D           +   +   +K   +  Y  ++  +  ++ ++   ++Y+H    
Sbjct: 120 IVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKT-LLYNLLVGVKYVH---- 173

Query: 447 SAPIIHCDLKPTSILLDENMVAHVSDFG 474
           SA I+H DLKP + L++++    V DFG
Sbjct: 174 SAGILHRDLKPANCLVNQDCSVKVCDFG 201

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 60.3 bits (147), Expect = 2e-10
 Identities = 36/161 (22%), Positives = 65/161 (40%), Gaps = 25/161 (15%)

Query: 336 DLETISL--AGSFGSVYKGT-ISDGTDVAIKIFNLQRERA-FRSFNSECEV-LRNVRHQN 390
           DLE I     G++G V K   +  G  +A+K           +    + ++ +R V    
Sbjct: 8   DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPF 67

Query: 391 LIKILSSCSTPDFK---------FMPNGSLE---KRLYSHNYFLDILERLNIMIDVGSTL 438
            +    +     F+          M + SL+   K++      +       I + +   L
Sbjct: 68  TVTFYGAL----FREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKAL 122

Query: 439 EYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
           E+LH   S   +IH D+KP+++L++      + DFGIS  L
Sbjct: 123 EHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL 160

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 60.4 bits (147), Expect = 3e-10
 Identities = 34/154 (22%), Positives = 58/154 (37%), Gaps = 23/154 (14%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFN------LQRERAFRSFNSECEVLRNVR----HQNLI 392
           G FG+V+ G  ++D   VAIK+                +   E  +L  V     H  +I
Sbjct: 42  GGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVI 101

Query: 393 KILSSCSTPDFKFM------PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHS 446
           ++L    T +   +      P   L   +       +   R      V + +++ H    
Sbjct: 102 RLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSR-CFFGQVVAAIQHCHSRG- 159

Query: 447 SAPIIHCDLKPTSILLD-ENMVAHVSDFGISKLL 479
              ++H D+K  +IL+D     A + DFG   LL
Sbjct: 160 ---VVHRDIKDENILIDLRRGCAKLIDFGSGALL 190

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 60.3 bits (147), Expect = 3e-10
 Identities = 30/150 (20%), Positives = 61/150 (40%), Gaps = 16/150 (10%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKI--FNLQRERAFRS-FNSECEVLRNVRHQNLIKIL-SSC 398
           G    V+    + D  DVA+K+   +L R+ +F   F  E +    + H  ++ +  +  
Sbjct: 23  GGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGE 82

Query: 399 STPDFKFMP-------NGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPII 451
           +      +P       +G   + +      +     + ++ D    L + H       II
Sbjct: 83  AETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG----II 138

Query: 452 HCDLKPTSILLDENMVAHVSDFGISKLLGE 481
           H D+KP +I++       V DFGI++ + +
Sbjct: 139 HRDVKPANIMISATNAVKVMDFGIARAIAD 168

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 60.3 bits (147), Expect = 3e-10
 Identities = 40/149 (26%), Positives = 68/149 (45%), Gaps = 21/149 (14%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRER------AFRSFNSECEVLRNVRHQNLIKILS 396
           GS+G V K      G  VAIK F    +       A R    E ++L+ +RH+NL+ +L 
Sbjct: 36  GSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR----EIKLLKQLRHENLVNLLE 91

Query: 397 SCSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPII 451
            C         F+F+ + ++   L      LD       +  + + + + H  +    II
Sbjct: 92  VCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN----II 146

Query: 452 HCDLKPTSILLDENMVAHVSDFGISKLLG 480
           H D+KP +IL+ ++ V  + DFG ++ L 
Sbjct: 147 HRDIKPENILVSQSGVVKLCDFGFARTLA 175

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 60.3 bits (147), Expect = 4e-10
 Identities = 33/157 (21%), Positives = 54/157 (34%), Gaps = 27/157 (17%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRS------FNSECEVLRNVRHQNLIKILS 396
           G F  V K    S G   A K    +R ++ R          E  +L+ ++H N+I +  
Sbjct: 22  GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 81

Query: 397 SCSTPD-----FKFMPNGSLEKRLYSHNYFLDILER--LNIMIDVGSTLEYLH-HGHSSA 448
                       + +  G L   L          E      +  + + + YLH       
Sbjct: 82  VYENKTDVILILELVAGGELFDFLAEKESL---TEEEATEFLKQILNGVYYLHSLQ---- 134

Query: 449 PIIHCDLKPTSILL----DENMVAHVSDFGISKLLGE 481
            I H DLKP +I+L           + DFG++  +  
Sbjct: 135 -IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 59.8 bits (146), Expect = 4e-10
 Identities = 34/149 (22%), Positives = 69/149 (46%), Gaps = 21/149 (14%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRER------AFRSFNSECEVLRNVRHQNLIKILS 396
           G++G+V+K         VA+K   L  +       A R    E  +L+ ++H+N++++  
Sbjct: 13  GTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR----EICLLKELKHKNIVRLHD 68

Query: 397 SCSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPII 451
              +       F+F     L+K   S N  LD     + +  +   L + H  +    ++
Sbjct: 69  VLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN----VL 123

Query: 452 HCDLKPTSILLDENMVAHVSDFGISKLLG 480
           H DLKP ++L++ N    +++FG+++  G
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFG 152

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 60.0 bits (146), Expect = 4e-10
 Identities = 40/163 (24%), Positives = 69/163 (42%), Gaps = 28/163 (17%)

Query: 336 DLETISL--AGSFGSVYKGT-ISDGTDVAIKIFNL-QRERAFRSFNSECEV-LRNVRHQN 390
           DL+ +     G++GSV K      G  +A+K       E+  +    + +V +R+     
Sbjct: 23  DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPY 82

Query: 391 LIKILSSCSTPDFK---------FMPNGSLEKRLYSHNYFLD---ILERL--NIMIDVGS 436
           +++   +     F+          M + S +K  Y + Y +    I E +   I +    
Sbjct: 83  IVQFYGAL----FREGDCWICMELM-STSFDK-FYKYVYSVLDDVIPEEILGKITLATVK 136

Query: 437 TLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
            L +L        IIH D+KP++ILLD +    + DFGIS  L
Sbjct: 137 ALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 58.5 bits (142), Expect = 4e-10
 Identities = 37/153 (24%), Positives = 59/153 (38%), Gaps = 16/153 (10%)

Query: 5   IPTEIGNLQNLKSLFLGANNLSGLIPPMIF-NISTIRNLNLGGNRLSGHLPSMIGHSLPN 63
           IP  I   Q    L L  N  + L    IF  +  +R +N   N+++  +          
Sbjct: 26  IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASG 82

Query: 64  IKYLELGDNNLIGTIPNSI-TNATKLIILDLGFNTFSGHIPN-TFGNLRHLSVLSLLMNN 121
           +  + L  N L   + + +      L  L L  N  +  + N +F  L  + +LSL  N 
Sbjct: 83  VNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQ 140

Query: 122 LTTESSSAYQWSFLSSLTNCRYLVYLILSGNPL 154
           +TT +  A+    L SL+       L L  NP 
Sbjct: 141 ITTVAPGAF--DTLHSLS------TLNLLANPF 165

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 55.8 bits (135), Expect = 4e-09
 Identities = 25/110 (22%), Positives = 46/110 (41%), Gaps = 4/110 (3%)

Query: 237 HLEMLNLLHLGGNKLSGHIPP-CLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLS 295
            L  L  ++   NK++  I        + + E+ L SN+L +        L  +  + L 
Sbjct: 55  KLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLR 113

Query: 296 SNLLNDSLPSNV-QKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAG 344
           SN +   + ++    L  +R+L L  NQ++   P     L  L T++L  
Sbjct: 114 SNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLA 162

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 50.8 bits (122), Expect = 2e-07
 Identities = 23/102 (22%), Positives = 47/102 (46%), Gaps = 5/102 (4%)

Query: 244 LHLGGNKLSGHIPP--CLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLND 301
           L L  N+ +  +        L  LR+++  +NK+T     +      + EI L+SN L +
Sbjct: 37  LRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRL-E 94

Query: 302 SLPSNV-QKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISL 342
           ++   + + L+ L+ L L  N+++     +   L  +  +SL
Sbjct: 95  NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSL 136

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 46.6 bits (111), Expect = 5e-06
 Identities = 30/144 (20%), Positives = 47/144 (32%), Gaps = 13/144 (9%)

Query: 29  IPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSI-TNATK 87
           IP  I        L L  N  +    + I   LP ++ +    NN I  I       A+ 
Sbjct: 26  IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINF-SNNKITDIEEGAFEGASG 82

Query: 88  LIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYL 147
           +  + L  N         F  L  L  L L  N +T   + +        L++   +  L
Sbjct: 83  VNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDS-----FIGLSS---VRLL 134

Query: 148 ILSGNPLGGILPPSIGNFSTSLQR 171
            L  N +  +  P   +   SL  
Sbjct: 135 SLYDNQITTV-APGAFDTLHSLST 157

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 44.3 bits (105), Expect = 3e-05
 Identities = 23/110 (20%), Positives = 43/110 (39%), Gaps = 2/110 (1%)

Query: 189 HLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGG 248
            L  L  ++   N +      +      +    L    L+         LE L  L L  
Sbjct: 55  KLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRS 114

Query: 249 NKLSGHIPP-CLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSN 297
           N+++  +       L+S+R L L  N++T+  P +  +L  +  +NL +N
Sbjct: 115 NRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 59.1 bits (144), Expect = 5e-10
 Identities = 36/157 (22%), Positives = 53/157 (33%), Gaps = 27/157 (17%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRERAFR------SFNSECEVLRNVRHQNLIKILS 396
           G F  V K      G + A K    +R  + R          E  +LR +RH N+I +  
Sbjct: 16  GQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHD 75

Query: 397 SCSTPD-----FKFMPNGSLEKRLYSHNYFLDILER--LNIMIDVGSTLEYLH-HGHSSA 448
                       + +  G L   L          E      +  +   + YLH       
Sbjct: 76  IFENKTDVVLILELVSGGELFDFLAEKESL---TEDEATQFLKQILDGVHYLHSKR---- 128

Query: 449 PIIHCDLKPTSILL----DENMVAHVSDFGISKLLGE 481
            I H DLKP +I+L      N    + DFGI+  +  
Sbjct: 129 -IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 164

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 59.6 bits (145), Expect = 6e-10
 Identities = 33/161 (20%), Positives = 54/161 (33%), Gaps = 37/161 (22%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQ-NLIKILSSCS 399
           G F  V +    S G + A K    +R  +        E  VL   +    +I +     
Sbjct: 40  GKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99

Query: 400 TPD-----FKFMPNGSLEKRLYSHNYFLDILERL----------NIMIDVGSTLEYLH-H 443
                    ++   G +         F   L  L           ++  +   + YLH +
Sbjct: 100 NTSEIILILEYAAGGEI---------FSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN 150

Query: 444 GHSSAPIIHCDLKPTSILL---DENMVAHVSDFGISKLLGE 481
                 I+H DLKP +ILL          + DFG+S+ +G 
Sbjct: 151 N-----IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH 186

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 59.2 bits (144), Expect = 8e-10
 Identities = 32/156 (20%), Positives = 64/156 (41%), Gaps = 23/156 (14%)

Query: 344 GSFGSVYKGTISD-GTDVAIK-IFNLQRERAFRSFNSECEVLRNVRHQNLIKILS---SC 398
           G+FG+V  G     G  VAIK +         R      + L  + H N++++ S   + 
Sbjct: 34  GTFGTVQLGKEKSTGMSVAIKKVI-QDPRFRNREL-QIMQDLAVLHHPNIVQLQSYFYTL 91

Query: 399 STPDFK---------FMPNGSLEKRLYSHNYFLDILERLNI---MIDVGSTLEYLHHGHS 446
              D +         ++P+ +L +   ++         + I   +  +  ++  LH    
Sbjct: 92  GERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHL--P 148

Query: 447 SAPIIHCDLKPTSILLD-ENMVAHVSDFGISKLLGE 481
           S  + H D+KP ++L++  +    + DFG +K L  
Sbjct: 149 SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP 184

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 59.6 bits (145), Expect = 8e-10
 Identities = 39/148 (26%), Positives = 65/148 (43%), Gaps = 20/148 (13%)

Query: 344 GSFGSVY----KGTISDGTDVAIKIFN---LQRERAFRSFNSECEVLRNVRHQNLIKILS 396
           GSFG V       T       A+K  N          R+   E ++++ + H  L+ +  
Sbjct: 26  GSFGKVCIVQKNDT---KKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82

Query: 397 SCSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPII 451
           S    +        +  G L   L  + +F +   +L I  ++   L+YL +      II
Sbjct: 83  SFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC-ELVMALDYLQNQR----II 137

Query: 452 HCDLKPTSILLDENMVAHVSDFGISKLL 479
           H D+KP +ILLDE+   H++DF I+ +L
Sbjct: 138 HRDMKPDNILLDEHGHVHITDFNIAAML 165

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 58.7 bits (142), Expect = 1e-09
 Identities = 36/189 (19%), Positives = 57/189 (30%), Gaps = 58/189 (30%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRERAF-----RSFNSECEVLRNVRHQNLIKILSS 397
           GS+G V            AIKI N  + R           +E  +++ + H N+ ++   
Sbjct: 37  GSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEV 96

Query: 398 CSTPD-----FKFMPNGSLEKRLYSHNYFLDILERL------------------------ 428
                      +    G L  +L            +                        
Sbjct: 97  YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHG 156

Query: 429 ---------------NIMIDVGSTLEYLH-HGHSSAPIIHCDLKPTSILL--DENMVAHV 470
                          NIM  + S L YLH  G     I H D+KP + L   +++    +
Sbjct: 157 FRESLDFVQREKLISNIMRQIFSALHYLHNQG-----ICHRDIKPENFLFSTNKSFEIKL 211

Query: 471 SDFGISKLL 479
            DFG+SK  
Sbjct: 212 VDFGLSKEF 220

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 57.5 bits (140), Expect = 2e-09
 Identities = 36/150 (24%), Positives = 68/150 (45%), Gaps = 22/150 (14%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRER------AFRSFNSECEVLRNVRHQNLIKILS 396
           G++G VYK      G  VA+K   L  E       A R    E  +L+ + H N++K+L 
Sbjct: 14  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR----EISLLKELNHPNIVKLLD 69

Query: 397 SCSTPD-----FKFMPNGSLEKRLYSHNY-FLDILERLNIMIDVGSTLEYLHHGHSSAPI 450
              T +     F+F+    L+K + +     + +    + +  +   L + H       +
Sbjct: 70  VIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR----V 124

Query: 451 IHCDLKPTSILLDENMVAHVSDFGISKLLG 480
           +H DLKP ++L++      ++DFG+++  G
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFG 154

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 57.4 bits (139), Expect = 3e-09
 Identities = 34/158 (21%), Positives = 60/158 (37%), Gaps = 22/158 (13%)

Query: 336 DLETISL--AGSFGSVYKGT-ISDGTDVAIKIFNLQR-ERAFRSFNSECEVL-RNVRHQN 390
           DLE +    +G+ G V+K      G  +A+K       +   +    + +V+ ++     
Sbjct: 26  DLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPY 85

Query: 391 LIKILSSCSTPDFK---------FMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYL 441
           +++   +                 M     EK        +       + + +   L YL
Sbjct: 86  IVQCFGTF----ITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYL 140

Query: 442 HHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL 479
              H    +IH D+KP++ILLDE     + DFGIS  L
Sbjct: 141 KEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRL 175

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 56.8 bits (138), Expect = 5e-09
 Identities = 44/142 (30%), Positives = 63/142 (44%), Gaps = 16/142 (11%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRERAFR-SFNS----ECEVLRNVRHQNLIKILSS 397
           G F +VYK    +    VAIK   L      +   N     E ++L+ + H N+I +L +
Sbjct: 21  GQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDA 80

Query: 398 CSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
                     F FM    LE  +  ++  L        M+     LEYLH       I+H
Sbjct: 81  FGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW----ILH 135

Query: 453 CDLKPTSILLDENMVAHVSDFG 474
            DLKP ++LLDEN V  ++DFG
Sbjct: 136 RDLKPNNLLLDENGVLKLADFG 157

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 57.0 bits (138), Expect = 6e-09
 Identities = 32/163 (19%), Positives = 57/163 (34%), Gaps = 44/163 (26%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRSFNSECEVLRNV-RHQNLIKILSSCSTP 401
           G  G V +          A+K+      +A R    E E+     +  ++++I+      
Sbjct: 73  GINGKVLQIFNKRTQEKFALKMLQ-DCPKARR----EVELHWRASQCPHIVRIVDVYENL 127

Query: 402 D---------FKFMPNGSLEKRLYSHNYFLDILERLN----------IMIDVGSTLEYLH 442
                      + +  G L         F  I +R +          IM  +G  ++YLH
Sbjct: 128 YAGRKCLLIVMECLDGGEL---------FSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 178

Query: 443 -HGHSSAPIIHCDLKPTSILL---DENMVAHVSDFGISKLLGE 481
                   I H D+KP ++L      N +  ++DFG +K    
Sbjct: 179 SIN-----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 55.0 bits (133), Expect = 9e-09
 Identities = 36/288 (12%), Positives = 70/288 (24%), Gaps = 100/288 (34%)

Query: 37  STIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFN 96
            + + L L    L   +PS    +LPNI  + +  +  +  +                  
Sbjct: 31  PSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLE----------------- 72

Query: 97  TFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGG 156
                  ++F NL  ++ + +      T            +L     L +L +    L  
Sbjct: 73  ------SHSFYNLSKVTHIEIRNTRNLTYIDP-------DALKELPLLKFLGIFNTGL-- 117

Query: 157 ILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQ 216
                           +             +        L +  N    +IP        
Sbjct: 118 ----------KMFPDLTK------------VYSTDIFFILEITDNPYMTSIPV------- 148

Query: 217 LQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLT 276
               F    N                 L L  N  +  +     + T L  + L  NK  
Sbjct: 149 --NAFQGLCNE-------------TLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYL 192

Query: 277 SSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLS 324
           + I    +         + S                  +LD+S+  ++
Sbjct: 193 TVIDKDAFG-------GVYSGP---------------SLLDVSQTSVT 218

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 51.9 bits (125), Expect = 1e-07
 Identities = 40/241 (16%), Positives = 73/241 (30%), Gaps = 41/241 (17%)

Query: 14  NLKSLFLGANNLSGLIPPMIF-NISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDN 72
           + ++L L   +L   IP   F N+  I  + +  +     L S   ++L  + ++E+ + 
Sbjct: 32  STQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNT 90

Query: 73  NLIGTIPNSI-TNATKLIILDLGFNTFSGHIPNT--FGNLRHLSVLSLLMNN-LTTESSS 128
             +  I          L  L +         P+     +     +L +  N  +T+   +
Sbjct: 91  RNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVN 149

Query: 129 AYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFS-TSLQRFSASECKLKGTIPKEI 187
           A        L N    + L L  N    +       F+ T L     ++ K    I K+ 
Sbjct: 150 A-----FQGLCN--ETLTLKLYNNGFTSV---QGYAFNGTKLDAVYLNKNKYLTVIDKDA 199

Query: 188 --GHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLH 245
             G   G   L +    +                     T L      +L  L   N   
Sbjct: 200 FGGVYSGPSLLDVSQTSV---------------------TALPSKGLEHLKELIARNTWT 238

Query: 246 L 246
           L
Sbjct: 239 L 239

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 55.7 bits (135), Expect = 1e-08
 Identities = 33/148 (22%), Positives = 67/148 (45%), Gaps = 20/148 (13%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRE-----RAFRSFNSECEVLRNVRHQNLIKILSS 397
           G++ +VYKG        VA+K   L+ E      A R    E  +L++++H N++ +   
Sbjct: 13  GTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR----EVSLLKDLKHANIVTLHDI 68

Query: 398 CSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
             T       F+++    L++ L      +++      +  +   L Y H       ++H
Sbjct: 69  IHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK----VLH 123

Query: 453 CDLKPTSILLDENMVAHVSDFGISKLLG 480
            DLKP ++L++E     ++DFG+++   
Sbjct: 124 RDLKPQNLLINERGELKLADFGLARAKS 151

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 32/149 (21%), Positives = 60/149 (40%), Gaps = 23/149 (15%)

Query: 343 AGSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLI-KILSSCST 400
            G+FG +  G  +     VAIK+     +      + E    + +   + I ++      
Sbjct: 19  CGNFGELRLGKNLYTNEYVAIKL--EPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPC 76

Query: 401 PDFKFM------PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
             +  M      P  SLE      +    +   L I I + S +EY+H    S  +I+ D
Sbjct: 77  GKYNAMVLELLGP--SLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH----SKNLIYRD 130

Query: 455 LKPTSILL------DENMVAHVSDFGISK 477
           +KP + L+       + ++ H+ DF ++K
Sbjct: 131 VKPENFLIGRPGNKTQQVI-HIIDFALAK 158

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 55.9 bits (135), Expect = 1e-08
 Identities = 33/159 (20%), Positives = 59/159 (37%), Gaps = 45/159 (28%)

Query: 344 GSFGSVYKGT-ISDGTDVAIK-IFNLQRE-----RAFRSFNSECEVLRNVRHQNLIKIL- 395
           GS+G VY     +   +VAIK +  +  +     R  R    E  +L  ++   +I++  
Sbjct: 37  GSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR----EITILNRLKSDYIIRLYD 92

Query: 396 --SSCSTPDFK-------FMPNGSLEKRLYSHN--------YFL-DILERLNIMIDVGST 437
                    F           +  L+K   +            L ++L            
Sbjct: 93  LIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLL----------LG 141

Query: 438 LEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGIS 476
             ++H     + IIH DLKP + LL+++    V DFG++
Sbjct: 142 ENFIH----ESGIIHRDLKPANCLLNQDCSVKVCDFGLA 176

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 54/342 (15%), Positives = 115/342 (33%), Gaps = 63/342 (18%)

Query: 15  LKSLFLGANNLSG----LIPPMIFNISTIRNLNLGGNRLSG----HLPSMIGHSLPNIKY 66
           ++   L  + ++      +  ++    +++ + L GN +       L   I     +++ 
Sbjct: 6   IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASK-KDLEI 64

Query: 67  LELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTES 126
            E  D    G + + I  A +L++  L                  L  + L  N     +
Sbjct: 65  AEFSDIF-TGRVKDEIPEALRLLLQALLKCP-------------KLHTVRLSDNAFGPTA 110

Query: 127 SSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKE 186
                   +  L+    L +L L  N LG   P +    + +LQ  + +         K+
Sbjct: 111 QEP----LIDFLSKHTPLEHLYLHNNGLG---PQAGAKIARALQELAVN---------KK 154

Query: 187 IGHLRGLIYLSLGFNDLNG----TIPTSIGTLKQLQGFFLPETNL-----QGYVPHNLCH 237
             +   L  +  G N L          +  + + L    + +  +     +  +   L +
Sbjct: 155 AKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAY 214

Query: 238 LEMLNLLHLGGNKLSG----HIPPCLASLTSLRELDLGSNKLTS----SIPSSLWSLG-- 287
            + L +L L  N  +      +   L S  +LREL L    L++    ++  +   L   
Sbjct: 215 CQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENI 274

Query: 288 YILEINLSSNLLNDS-----LPSNVQKLKVLRVLDLSRNQLS 324
            +  + L  N +             +K+  L  L+L+ N+ S
Sbjct: 275 GLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 47.8 bits (114), Expect = 5e-06
 Identities = 39/286 (13%), Positives = 74/286 (25%), Gaps = 55/286 (19%)

Query: 64  IKYLELGDNNL----IGTIPNSITNATKLIILDLGFNTFSG----HIPNTFGNLRHLSVL 115
           I+   L  + +      ++   +     +  + L  NT        +     + + L + 
Sbjct: 6   IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65

Query: 116 SLLMNNLTTESSSAYQ--WSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFS 173
                          +     L +L  C  L  + LS N  G      + +F        
Sbjct: 66  EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDF-------- 117

Query: 174 ASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPH 233
                        +     L +L L  N L               G  +     +  V  
Sbjct: 118 -------------LSKHTPLEHLYLHNNGL-----GPQA------GAKIARALQELAVNK 153

Query: 234 NLCHLEMLNLLHLGGNKLSG----HIPPCLASLTSLRELDLGSNKLTSS-----IPSSLW 284
              +   L  +  G N+L             S   L  + +  N +        +   L 
Sbjct: 154 KAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLA 213

Query: 285 SLGYILEINLSSNLLND----SLPSNVQKLKVLRVLDLSRNQLSGD 326
               +  ++L  N        +L   ++    LR L L+   LS  
Sbjct: 214 YCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSAR 259

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 55.3 bits (134), Expect = 2e-08
 Identities = 38/153 (24%), Positives = 71/153 (46%), Gaps = 25/153 (16%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRER-----AFRSFNSECEVLRNVRHQNLIKILSS 397
           G++ +VYKG   + G  VA+K   L  E      A R    E  +++ ++H+N++++   
Sbjct: 16  GTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR----EISLMKELKHENIVRLYDV 71

Query: 398 CSTPD-----FKFMPNGSLEKRLYSHNYF-----LDILERLNIMIDVGSTLEYLHHGHSS 447
             T +     F+FM N  L+K + S         L++         +   L + H     
Sbjct: 72  IHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK-- 128

Query: 448 APIIHCDLKPTSILLDENMVAHVSDFGISKLLG 480
             I+H DLKP ++L+++     + DFG+++  G
Sbjct: 129 --ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 55.1 bits (133), Expect = 2e-08
 Identities = 31/160 (19%), Positives = 63/160 (39%), Gaps = 32/160 (20%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           G FG +Y     +     A  +  ++ +     F+ E +  + V  ++ IK        D
Sbjct: 48  GGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFS-ELKFYQRVAKKDCIKKWIERKQLD 106

Query: 403 FKFMPN----GSLEKRLYSHNYFL---------DILER---------LNIMIDVGSTLEY 440
           +  +P     G  E +  S+ + +          I  +         L + I +   LEY
Sbjct: 107 YLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEY 166

Query: 441 LHHGHSSAPIIHCDLKPTSILL---DENMVAHVSDFGISK 477
           +H        +H D+K  ++LL   + + V +++D+G+S 
Sbjct: 167 IHENE----YVHGDIKAANLLLGYKNPDQV-YLADYGLSY 201

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 54.7 bits (132), Expect = 3e-08
 Identities = 42/170 (24%), Positives = 73/170 (42%), Gaps = 41/170 (24%)

Query: 335 VDLETISLAGSFGSVYKGTISD-GTDVAIK----IFNLQRE--RAFRSFNSECEVLRNVR 387
            +L+ I  +G+ G V     +    +VAIK     F  Q    RA+R    E  +++ V 
Sbjct: 28  QNLKPIG-SGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR----ELVLMKCVN 82

Query: 388 HQNLIKIL----SSCSTPDFK-------FMP---NGSLEKRLYS--HNYFLDILERLNIM 431
           H+N+I +L       S  +F+        M       ++  L     +Y L  +      
Sbjct: 83  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC---- 138

Query: 432 IDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
                 +++LH    SA IIH DLKP++I++  +    + DFG+++  G 
Sbjct: 139 -----GIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 52.8 bits (127), Expect = 3e-08
 Identities = 37/150 (24%), Positives = 55/150 (36%), Gaps = 37/150 (24%)

Query: 5   IPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNI 64
           +   +  L+  K L L  NN           I  I +L+                 + N+
Sbjct: 40  MDATLSTLKACKHLALSTNN-----------IEKISSLS----------------GMENL 72

Query: 65  KYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTT 124
           + L LG  NLI  I N    A  L  L + +N  +  +      L +L VL +  N +T 
Sbjct: 73  RILSLG-RNLIKKIENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITN 129

Query: 125 ESSSAYQWSFLSSLTNCRYLVYLILSGNPL 154
                  W  +  L     L  L+L+GNPL
Sbjct: 130 -------WGEIDKLAALDKLEDLLLAGNPL 152

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 44.7 bits (106), Expect = 2e-05
 Identities = 33/124 (26%), Positives = 57/124 (45%), Gaps = 27/124 (21%)

Query: 244 LHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLN--- 300
           LH     +   +   L++L + + L L +N +   I SSL  +  +  ++L  NL+    
Sbjct: 30  LHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIKKIE 86

Query: 301 --DSLP----------------SNVQKLKVLRVLDLSRNQLS--GDIPSTIGALVDLETI 340
             D++                 S ++KL  LRVL +S N+++  G+I   + AL  LE +
Sbjct: 87  NLDAVADTLEELWISYNQIASLSGIEKLVNLRVLYMSNNKITNWGEI-DKLAALDKLEDL 145

Query: 341 SLAG 344
            LAG
Sbjct: 146 LLAG 149

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 54.2 bits (131), Expect = 3e-08
 Identities = 42/157 (26%), Positives = 65/157 (41%), Gaps = 43/157 (27%)

Query: 344 GSFGSVYKGT-ISDGTDVAIK-IFNLQRE----RAFRSFNSECEVLRNVRHQNLIKIL-- 395
           G++G V       +   VAIK I   + +    R  R    E ++L   RH+N+I I   
Sbjct: 38  GAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGINDI 93

Query: 396 -SSCSTPDFK-------FMPNGSLEKRLYS-------HNYFL-DILERLNIMIDVGSTLE 439
             + +    K        M    L K L +         YFL  IL            L+
Sbjct: 94  IRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQIL----------RGLK 142

Query: 440 YLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGIS 476
           Y+H    SA ++H DLKP+++LL+      + DFG++
Sbjct: 143 YIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLA 175

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 53.8 bits (130), Expect = 4e-08
 Identities = 33/159 (20%), Positives = 57/159 (35%), Gaps = 44/159 (27%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRSFNSECEVL-RNVRHQNLIKILSSCSTP 401
           G  G V +          A+K+      +A R    E E+  R  +  ++++I+      
Sbjct: 29  GINGKVLQIFNKRTQEKFALKMLQ-DCPKARR----EVELHWRASQCPHIVRIVDVYENL 83

Query: 402 DFK---------FMPNGSLEKRLYSHNYFLDILERLN----------IMIDVGSTLEYLH 442
                        +  G L         F  I +R +          IM  +G  ++YLH
Sbjct: 84  YAGRKCLLIVMECLDGGEL---------FSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 134

Query: 443 -HGHSSAPIIHCDLKPTSILL---DENMVAHVSDFGISK 477
                   I H D+KP ++L      N +  ++DFG +K
Sbjct: 135 SIN-----IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 54.5 bits (131), Expect = 4e-08
 Identities = 41/159 (25%), Positives = 74/159 (46%), Gaps = 36/159 (22%)

Query: 344 GSFGSVYKGTISD-GTDVAIK-IFN-LQRE----RAFRSFNSECEVLRNVRHQNLIKILS 396
           G+ G V     +    +VAIK +    Q +    RA+R    E  +++ V H+N+I +L+
Sbjct: 73  GAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR----ELVLMKCVNHKNIISLLN 128

Query: 397 SCSTPDFKFMPNGSLE--KRLYSHNYFLD------ILERLN------IMIDVGSTLEYLH 442
                   F P  +LE  + +Y     +D      I   L+      ++  +   +++LH
Sbjct: 129 -------VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 181

Query: 443 HGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
               SA IIH DLKP++I++  +    + DFG+++  G 
Sbjct: 182 ----SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 54.2 bits (131), Expect = 4e-08
 Identities = 39/157 (24%), Positives = 71/157 (45%), Gaps = 40/157 (25%)

Query: 344 GSFGSVYKGT-ISDGTDVAIK-IFN-LQRE----RAFRSFNSECEVLRNVRHQNLIKIL- 395
           G++GSV        G  VAIK +    Q E    RA+R    E  +L++++H+N+I +L 
Sbjct: 35  GAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR----ELLLLKHMQHENVIGLLD 90

Query: 396 ---SSCSTPDFK-------FMP---NGSLEKRLYS--HNYFLDILERLNIMIDVGSTLEY 440
               + S  +F        FM       +  +       Y +  + +          L+Y
Sbjct: 91  VFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLK---------GLKY 141

Query: 441 LHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK 477
           +H    SA ++H DLKP ++ ++E+    + DFG+++
Sbjct: 142 IH----SAGVVHRDLKPGNLAVNEDCELKILDFGLAR 174

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 52.3 bits (126), Expect = 4e-08
 Identities = 30/103 (29%), Positives = 53/103 (51%), Gaps = 9/103 (8%)

Query: 244 LHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSL 303
           L+L GN+ +  +P  L++   L  +DL +N++++    S  ++  +L + LS N L   +
Sbjct: 36  LYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-CI 93

Query: 304 PSNV-QKLKVLRVLDLSRNQLSGDIPSTIGA---LVDLETISL 342
           P      LK LR+L L  N +S  +P   GA   L  L  +++
Sbjct: 94  PPRTFDGLKSLRLLSLHGNDISV-VPE--GAFNDLSALSHLAI 133

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 41.9 bits (99), Expect = 1e-04
 Identities = 18/63 (28%), Positives = 32/63 (50%), Gaps = 3/63 (4%)

Query: 263 TSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNV-QKLKVLRVLDLSRN 321
             + EL L  N+ T  +P  L +  ++  I+LS+N ++ +L +     +  L  L LS N
Sbjct: 31  RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYN 88

Query: 322 QLS 324
           +L 
Sbjct: 89  RLR 91

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 39.6 bits (93), Expect = 7e-04
 Identities = 25/95 (26%), Positives = 44/95 (46%), Gaps = 5/95 (5%)

Query: 4   QIPTEIGNLQNLKSLFLGANNLSGLIPPMIF-NISTIRNLNLGGNRLSGHLPSMIGHSLP 62
            +P E+ N ++L  + L  N +S L     F N++ +  L L  NRL   +P      L 
Sbjct: 45  LVPKELSNYKHLTLIDLSNNRISTL-SNQSFSNMTQLLTLILSYNRLRC-IPPRTFDGLK 102

Query: 63  NIKYLELGDNNLIGTIPNSI-TNATKLIILDLGFN 96
           +++ L L  N++   +P     + + L  L +G N
Sbjct: 103 SLRLLSLHGNDI-SVVPEGAFNDLSALSHLAIGAN 136

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 53.7 bits (129), Expect = 4e-08
 Identities = 19/77 (24%), Positives = 34/77 (44%), Gaps = 6/77 (7%)

Query: 405 FMPNGSLEKRLYSHNY--FLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILL 462
                +L+  +         +    L+I I +   +E+LH    S  ++H DLKP++I  
Sbjct: 142 LCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH----SKGLMHRDLKPSNIFF 197

Query: 463 DENMVAHVSDFGISKLL 479
             + V  V DFG+   +
Sbjct: 198 TMDDVVKVGDFGLVTAM 214

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 53.4 bits (129), Expect = 5e-08
 Identities = 36/154 (23%), Positives = 67/154 (43%), Gaps = 27/154 (17%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRER------AFRSFNSECEVLRNVRHQNLIKILS 396
           G++G VYK         VAIK   L+ E       A R    E  +L+ ++H+N+I++ S
Sbjct: 45  GTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR----EVSLLKELQHRNIIELKS 100

Query: 397 SCSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPII 451
                      F++  N  L K+    N  + +    + +  + + + + H        +
Sbjct: 101 VIHHNHRLHLIFEYAEN-DL-KKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR----CL 154

Query: 452 HCDLKPTSILLDENMVAH-----VSDFGISKLLG 480
           H DLKP ++LL  +  +      + DFG+++  G
Sbjct: 155 HRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 53.6 bits (128), Expect = 6e-08
 Identities = 26/94 (27%), Positives = 38/94 (40%), Gaps = 2/94 (2%)

Query: 231 VPHNLCHLEMLNLLHLGGNKLSGHIPP-CLASLTSLRELDLGSNKLTSSIPSSLWSLGYI 289
             H+L   E L  L++   +   H+    L  L  LR L +  + L    P +      +
Sbjct: 23  SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82

Query: 290 LEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQL 323
             +NLS N L  SL     +   L+ L LS N L
Sbjct: 83  SRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 52.0 bits (124), Expect = 2e-07
 Identities = 22/96 (22%), Positives = 37/96 (38%), Gaps = 10/96 (10%)

Query: 60  SLPNIKYLELGDNNLIGTIPN-SITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLL 118
              N+  L + +   +  +    +    +L  L +  +      P+ F     LS L+L 
Sbjct: 29  GAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88

Query: 119 MNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPL 154
            N L +       W  +  L+    L  L+LSGNPL
Sbjct: 89  FNALES-----LSWKTVQGLS----LQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 48.6 bits (115), Expect = 2e-06
 Identities = 14/78 (17%), Positives = 27/78 (34%), Gaps = 3/78 (3%)

Query: 249 NKLSGHIPPCLASLTSLRELDLGSNKLTSSIPS-SLWSLGYILEINLSSNLLNDSLPSNV 307
              +      L    +L EL + + +    +    L  LG +  + +  + L   +  + 
Sbjct: 17  RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL-RFVAPDA 75

Query: 308 -QKLKVLRVLDLSRNQLS 324
                 L  L+LS N L 
Sbjct: 76  FHFTPRLSRLNLSFNALE 93

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 48.2 bits (114), Expect = 3e-06
 Identities = 17/95 (17%), Positives = 30/95 (31%), Gaps = 3/95 (3%)

Query: 5   IPTEIGNLQNLKSLFLGANNLSGLIPPMIF-NISTIRNLNLGGNRLSGHLPSMIGHSLPN 63
               +   +NL  L++        +       +  +RNL +  + L   +     H  P 
Sbjct: 23  SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPR 81

Query: 64  IKYLELGDNNLIGTIPNSITNATKLIILDLGFNTF 98
           +  L L  N L  ++         L  L L  N  
Sbjct: 82  LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 41.3 bits (96), Expect = 5e-04
 Identities = 17/93 (18%), Positives = 31/93 (33%), Gaps = 9/93 (9%)

Query: 77  TIPNSITNATKLIILDLGFNTFSGHIPN-TFGNLRHLSVLSLLMNNLTTESSSAYQWSFL 135
              + +  A  L  L +       H+       L  L  L+++ + L   +  A+   F 
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF--HFT 79

Query: 136 SSLTNCRYLVYLILSGNPLGGILPPSIGNFSTS 168
             L+       L LS N L  +   ++   S  
Sbjct: 80  PRLS------RLNLSFNALESLSWKTVQGLSLQ 106

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 40.9 bits (95), Expect = 7e-04
 Identities = 18/96 (18%), Positives = 32/96 (33%), Gaps = 2/96 (2%)

Query: 182 TIPKEIGHLRGLIYLSLGFNDLNGTIPT-SIGTLKQLQGFFLPETNLQGYVPHNLCHLEM 240
                +     L  L +        +    +  L +L+   + ++ L+   P        
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81

Query: 241 LNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLT 276
           L+ L+L  N L   +        SL+EL L  N L 
Sbjct: 82  LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 52.0 bits (125), Expect = 9e-08
 Identities = 27/112 (24%), Positives = 48/112 (42%), Gaps = 5/112 (4%)

Query: 11  NLQNLKSLFLGANNLSGLIPPMIFN-ISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLEL 69
             + L+ + L  N +S L  P  F  + ++ +L L GN+++  LP  +   L +++ L L
Sbjct: 54  PYKKLRRIDLSNNQISEL-APDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLL 111

Query: 70  GDNNLIGTIPNSI-TNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMN 120
             N +   +      +   L +L L  N        TF  LR +  + L  N
Sbjct: 112 NANKI-NCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 51.6 bits (124), Expect = 9e-08
 Identities = 35/152 (23%), Positives = 55/152 (36%), Gaps = 30/152 (19%)

Query: 196 LSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLC-HLEMLNLLHLGGNKLSGH 254
           + L  N +    P +    K+L+   L    +   +  +    L  LN L L GNK++  
Sbjct: 37  IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT-E 94

Query: 255 IPP-CLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNV-QKLKV 312
           +P      L SL+ L L +NK+                           L  +  Q L  
Sbjct: 95  LPKSLFEGLFSLQLLLLNANKIN-------------------------CLRVDAFQDLHN 129

Query: 313 LRVLDLSRNQLSGDIPSTIGALVDLETISLAG 344
           L +L L  N+L      T   L  ++T+ LA 
Sbjct: 130 LNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQ 161

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 50.0 bits (120), Expect = 3e-07
 Identities = 32/151 (21%), Positives = 52/151 (34%), Gaps = 37/151 (24%)

Query: 29  IPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIP--------- 79
           IP  +    TI  + L  N +   +P         ++ ++L  NN I  +          
Sbjct: 26  IPTNLP--ETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDL-SNNQISELAPDAFQGLRS 81

Query: 80  --------NSIT--------NATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLT 123
                   N IT            L +L L  N  +    + F +L +L++LSL  N L 
Sbjct: 82  LNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ 141

Query: 124 TESSSAYQWSFLSSLTNCRYLVYLILSGNPL 154
           T +         S L     +  + L+ NP 
Sbjct: 142 TIAKGT-----FSPLRA---IQTMHLAQNPF 164

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 46.9 bits (112), Expect = 4e-06
 Identities = 24/111 (21%), Positives = 40/111 (36%), Gaps = 4/111 (3%)

Query: 189 HLRGLIYLSLGFNDLNGTIPTSI-GTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLG 247
             + L  + L  N ++  +       L+ L    L    +          L  L LL L 
Sbjct: 54  PYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLN 112

Query: 248 GNKLSGHIPP-CLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSN 297
            NK++  +       L +L  L L  NKL +    +   L  I  ++L+ N
Sbjct: 113 ANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 44.3 bits (105), Expect = 3e-05
 Identities = 19/84 (22%), Positives = 39/84 (46%), Gaps = 4/84 (4%)

Query: 263 TSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNV-QKLKVLRVLDLSRN 321
            ++ E+ L  N +    P +      +  I+LS+N +   L  +  Q L+ L  L L  N
Sbjct: 32  ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQI-SELAPDAFQGLRSLNSLVLYGN 90

Query: 322 QLSGDIPSTI-GALVDLETISLAG 344
           +++ ++P ++   L  L+ + L  
Sbjct: 91  KIT-ELPKSLFEGLFSLQLLLLNA 113

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 40.8 bits (96), Expect = 4e-04
 Identities = 36/174 (20%), Positives = 53/174 (30%), Gaps = 37/174 (21%)

Query: 77  TIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLS 136
            IP ++        + L  NT     P  F   + L  + L  N ++  +  A       
Sbjct: 25  EIPTNLPETIT--EIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDA-----FQ 77

Query: 137 SLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYL 196
            L +   L  L+L GN +   LP S+  F                        L  L  L
Sbjct: 78  GLRS---LNSLVLYGNKITE-LPKSL--FE----------------------GLFSLQLL 109

Query: 197 SLGFNDLNGTIPTSI-GTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGN 249
            L  N +N  +       L  L    L +  LQ         L  +  +HL  N
Sbjct: 110 LLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 52.5 bits (127), Expect = 9e-08
 Identities = 41/152 (26%), Positives = 66/152 (43%), Gaps = 24/152 (15%)

Query: 344 GSFGSVY----KGTISDGTDVAIKIFN---LQRERAFRSFNSECEVLRNVRHQNLIKILS 396
           GSFG V+    +     G   A+K+     + R +     N E  +L  V H  +I++  
Sbjct: 17  GSFGRVHLIRSRHN---GRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73

Query: 397 SCSTPDF-----KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPII 451
           +            ++  G L   L     F + + +     +V   LEYLH       II
Sbjct: 74  TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA-EVCLALEYLHSKD----II 128

Query: 452 HCDLKPTSILLDENMVAHV--SDFGISKLLGE 481
           + DLKP +ILLD+N   H+  +DFG +K + +
Sbjct: 129 YRDLKPENILLDKN--GHIKITDFGFAKYVPD 158

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 50.8 bits (122), Expect = 1e-07
 Identities = 26/120 (21%), Positives = 43/120 (35%), Gaps = 11/120 (9%)

Query: 35  NISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLG 94
           N    R L+L G ++   +   +G +L     ++  DN  I  +        +L  L + 
Sbjct: 17  NAVRDRELDLRGYKIP--VIENLGATLDQFDAIDFSDNE-IRKLDG-FPLLRRLKTLLVN 72

Query: 95  FNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPL 154
            N            L  L+ L L  N+L            L  L + + L YL +  NP+
Sbjct: 73  NNRICRIGEGLDQALPDLTELILTNNSLVE-------LGDLDPLASLKSLTYLCILRNPV 125

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 43.1 bits (102), Expect = 4e-05
 Identities = 22/113 (19%), Positives = 40/113 (35%), Gaps = 6/113 (5%)

Query: 234 NLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEIN 293
              +      L L G K+   I    A+L     +D   N++          L  +  + 
Sbjct: 14  QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLL 70

Query: 294 LSSNLLNDSLPSNVQKLKVLRVLDLSRNQLS--GDIPSTIGALVDLETISLAG 344
           +++N +        Q L  L  L L+ N L   GD+   + +L  L  + +  
Sbjct: 71  VNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILR 122

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 39.6 bits (93), Expect = 7e-04
 Identities = 24/141 (17%), Positives = 50/141 (35%), Gaps = 11/141 (7%)

Query: 7   TEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIG-HSLPNIK 65
            +  N    + L L    +  +I  +   +     ++   N +      + G   L  +K
Sbjct: 13  AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR----KLDGFPLLRRLK 67

Query: 66  YLELGDNNLIGTIPNSITNATKLIILDLGFNTFS--GHIPNTFGNLRHLSVLSLLMNNLT 123
            L + +N +             L  L L  N+    G + +   +L+ L+ L +L N +T
Sbjct: 68  TLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRNPVT 126

Query: 124 TESSSAYQWSFLSSLTNCRYL 144
            +    Y+   +  +   R L
Sbjct: 127 NKKH--YRLYVIYKVPQVRVL 145

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 52.8 bits (127), Expect = 1e-07
 Identities = 27/163 (16%), Positives = 57/163 (34%), Gaps = 35/163 (21%)

Query: 344 GSFGSVYKGTISDGTDVAIKIFN---LQRERAFRSFNSECEVLRNVRHQNLIKILSSCST 400
           G FG +Y   ++    V         ++       F  E +  +       I+       
Sbjct: 46  GGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFT-ELKFYQRAAKPEQIQKWIRTRK 104

Query: 401 PDFKFMPN----GSLEKRLYSHNYFL---------DILER----------LNIMIDVGST 437
             +  +P     G  +K   S+ + +          I E           L + + +   
Sbjct: 105 LKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDI 164

Query: 438 LEYLHHGHSSAPIIHCDLKPTSILL---DENMVAHVSDFGISK 477
           LEY+H        +H D+K +++LL   + + V ++ D+G++ 
Sbjct: 165 LEYIHEHE----YVHGDIKASNLLLNYKNPDQV-YLVDYGLAY 202

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 50.5 bits (121), Expect = 1e-07
 Identities = 26/120 (21%), Positives = 44/120 (36%), Gaps = 9/120 (7%)

Query: 35  NISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLG 94
             + +R L L   + +      +     N+++L L  N  + ++ N +    KL  L+L 
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSL-INVGLISVSN-LPKLPKLKKLELS 79

Query: 95  FNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPL 154
            N   G +      L +L+ L+L  N L          S L  L     L  L L    +
Sbjct: 80  ENRIFGGLDMLAEKLPNLTHLNLSGNKLK-------DISTLEPLKKLECLKSLDLFNCEV 132

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 42.0 bits (99), Expect = 9e-05
 Identities = 31/139 (22%), Positives = 47/139 (33%), Gaps = 13/139 (9%)

Query: 11  NLQNLKSLFL-GANNLSGLIPPMIFNISTIRNLNLGGNRLS--GHLPSMIGHSLPNIKYL 67
               ++ L L    +  G I  +      +  L+L    L    +LP      LP +K L
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLPK-----LPKLKKL 76

Query: 68  ELGDNNLIGTIPNSITNATKLIILDLGFNTFS--GHIPNTFGNLRHLSVLSLLMNNLTTE 125
           EL +N + G +         L  L+L  N       +      L  L  L L    +T  
Sbjct: 77  ELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNCEVTNL 135

Query: 126 SSSAYQWSFLSSLTNCRYL 144
           +   Y+ S    L    YL
Sbjct: 136 ND--YRESVFKLLPQLTYL 152

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 52.7 bits (127), Expect = 1e-07
 Identities = 38/158 (24%), Positives = 68/158 (43%), Gaps = 43/158 (27%)

Query: 344 GSFGSVYKGTISD-GTDVAIK----IFNLQRE--RAFRSFNSECEVLRNVRHQNLIKIL- 395
           G++GSV     +  G  VA+K     F       R +R    E  +L++++H+N+I +L 
Sbjct: 40  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIGLLD 95

Query: 396 ---SSCSTPDFK-------FMPNGSLEKRLYS-------HNYFLDILERLNIMIDVGSTL 438
               + S  +F         M    L   +           + +  + R          L
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQILR---------GL 145

Query: 439 EYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGIS 476
           +Y+H    SA IIH DLKP+++ ++E+    + DFG++
Sbjct: 146 KYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLA 179

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 52.6 bits (127), Expect = 1e-07
 Identities = 34/150 (22%), Positives = 65/150 (43%), Gaps = 27/150 (18%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRER------AFRSFNSECEVLRNVRHQNLIKILS 396
           G+FG V+K      G  VA+K   ++ E+      A R    E ++L+ ++H+N++ ++ 
Sbjct: 28  GTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR----EIKILQLLKHENVVNLIE 83

Query: 397 SCSTPDFKFMPNGS------------LEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHG 444
            C T    +                 L   L +      + E   +M  + + L Y+H  
Sbjct: 84  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN 143

Query: 445 HSSAPIIHCDLKPTSILLDENMVAHVSDFG 474
                I+H D+K  ++L+  + V  ++DFG
Sbjct: 144 K----ILHRDMKAANVLITRDGVLKLADFG 169

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 52.7 bits (127), Expect = 1e-07
 Identities = 41/159 (25%), Positives = 71/159 (44%), Gaps = 43/159 (27%)

Query: 343 AGSFGSVYKGTISD-GTDVAIK-IFN-LQRE----RAFRSFNSECEVLRNVRHQNLIKIL 395
           +G++G+V        G  VAIK ++   Q E    RA+R    E  +L+++RH+N+I +L
Sbjct: 35  SGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLKHMRHENVIGLL 90

Query: 396 ----SSCSTPDFK-------FMPNGSLEKRLYS-------HNYFLDILERLNIMIDVGST 437
                  +  DF        FM    L K +           + +  + +          
Sbjct: 91  DVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQFLVYQMLK---------G 140

Query: 438 LEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGIS 476
           L Y+H    +A IIH DLKP ++ ++E+    + DFG++
Sbjct: 141 LRYIH----AAGIIHRDLKPGNLAVNEDCELKILDFGLA 175

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 53.2 bits (128), Expect = 1e-07
 Identities = 39/147 (26%), Positives = 65/147 (44%), Gaps = 21/147 (14%)

Query: 344 GSFGSVY----KGTISDGTDVAIKIFN----LQRERAFRSFNSECEVLRNVRHQNLIKIL 395
           G+FG V     K T   G   A+KI      + ++       +E  VL+N RH  L  + 
Sbjct: 159 GTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEV-AHTLTENRVLQNSRHPFLTALK 214

Query: 396 SSCSTPDF-----KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPI 450
            S  T D      ++   G L   L     F +   R     ++ S L+YLH   +   +
Sbjct: 215 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-EIVSALDYLHSEKN---V 270

Query: 451 IHCDLKPTSILLDENMVAHVSDFGISK 477
           ++ DLK  +++LD++    ++DFG+ K
Sbjct: 271 VYRDLKLENLMLDKDGHIKITDFGLCK 297

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 52.1 bits (125), Expect = 1e-07
 Identities = 14/144 (9%), Positives = 37/144 (25%), Gaps = 20/144 (13%)

Query: 343 AGSFGSVYKGTISD---GTDVAIKI--FNLQRERAFRS-FNSECEVLRNVRHQNLIKILS 396
                  ++    D      VA+                  S    L  +    + ++L 
Sbjct: 41  GVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLD 98

Query: 397 SCSTPDFKFM-----PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPII 451
              T     +       GSL++   +       +  +  M  + +  +  H     A + 
Sbjct: 99  VVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHR----AGVA 151

Query: 452 HCDLKPTSILLDENMVAHVSDFGI 475
                P+ + +  +    ++    
Sbjct: 152 LSIDHPSRVRVSIDGDVVLAYPAT 175

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 52.2 bits (126), Expect = 1e-07
 Identities = 39/157 (24%), Positives = 65/157 (41%), Gaps = 43/157 (27%)

Query: 344 GSFGSVYKGT-ISDGTDVAIK-IFNLQRE----RAFRSFNSECEVLRNVRHQNLIKIL-- 395
           G++G V   T    G  VAIK I    +     R  R    E ++L++ +H+N+I I   
Sbjct: 22  GAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR----EIKILKHFKHENIITIFNI 77

Query: 396 -SSCSTPDFK-------FMPNGSLEKRLYS-------HNYFL-DILERLNIMIDVGSTLE 439
               S  +F         M    L + + +         YF+   L            ++
Sbjct: 78  QRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYFIYQTL----------RAVK 126

Query: 440 YLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGIS 476
            LH     + +IH DLKP+++L++ N    V DFG++
Sbjct: 127 VLH----GSNVIHRDLKPSNLLINSNCDLKVCDFGLA 159

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 34/161 (21%), Positives = 60/161 (37%), Gaps = 42/161 (26%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRE----RAFRSFNSECEVLRNVRHQNLIKILSSC 398
           G  G V+          VAIK   L        A R    E +++R + H N++K+    
Sbjct: 22  GGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR----EIKIIRRLDHDNIVKVF--- 74

Query: 399 STPDFKFMPNGSLEKRLYSHNYFLDI----------LERL------------NIMIDVGS 436
              +        L   + S      +          L  +              M  +  
Sbjct: 75  ---EILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLR 131

Query: 437 TLEYLHHGHSSAPIIHCDLKPTSILLD-ENMVAHVSDFGIS 476
            L+Y+H    SA ++H DLKP ++ ++ E++V  + DFG++
Sbjct: 132 GLKYIH----SANVLHRDLKPANLFINTEDLVLKIGDFGLA 168

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 52.3 bits (126), Expect = 2e-07
 Identities = 38/150 (25%), Positives = 63/150 (42%), Gaps = 20/150 (13%)

Query: 344 GSFGSVY----KGTISDGTDVAIKIFNLQ---RERAFRSFNSECEVLRNVRHQNLIKILS 396
           GSFG V     K +   G   A+KI + Q   + +      +E  +L+ V    L+K+  
Sbjct: 52  GSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108

Query: 397 SCSTPDF-----KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPII 451
           S           +++  G +   L     F +   R      +  T EYLH       +I
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-QIVLTFEYLHSLD----LI 163

Query: 452 HCDLKPTSILLDENMVAHVSDFGISKLLGE 481
           + DLKP ++L+D+     V+DFG +K +  
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 51.6 bits (124), Expect = 2e-07
 Identities = 29/149 (19%), Positives = 56/149 (37%), Gaps = 23/149 (15%)

Query: 343 AGSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLI-KILSSCST 400
            GSFG +++GT + +   VAIK    + +        E    + +     I  +      
Sbjct: 20  EGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFGQE 77

Query: 401 PDFKFM------PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
                +      P  SLE  L        +         + + ++ +H       +++ D
Sbjct: 78  GLHNVLVIDLLGP--SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH----EKSLVYRD 131

Query: 455 LKPTSILL------DENMVAHVSDFGISK 477
           +KP + L+      + NM+ +V DFG+ K
Sbjct: 132 IKPDNFLIGRPNSKNANMI-YVVDFGMVK 159

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 37/154 (24%), Positives = 66/154 (42%), Gaps = 42/154 (27%)

Query: 344 GSFGSVYKGT-ISDGTDVAIK-IFN-LQRE----RAFRSFNSECEVLRNVR-HQNLIKIL 395
           G++G V+K      G  VA+K IF+  Q      R FR    E  +L  +  H+N++ +L
Sbjct: 20  GAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR----EIMILTELSGHENIVNLL 75

Query: 396 SSCSTPDFK-------FMPNGSLEKRLYS-------HNYFL-DILERLNIMIDVGSTLEY 440
           +     + +       +M    L   + +         Y +  ++            ++Y
Sbjct: 76  NVLRADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQYVVYQLI----------KVIKY 124

Query: 441 LHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFG 474
           LH    S  ++H D+KP++ILL+      V+DFG
Sbjct: 125 LH----SGGLLHRDMKPSNILLNAECHVKVADFG 154

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 51.3 bits (123), Expect = 4e-07
 Identities = 33/183 (18%), Positives = 62/183 (33%), Gaps = 55/183 (30%)

Query: 344 GSFGSVYKGTISD-GTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           GSFG V +    + G   A+K          R    E ++++ + H N+IK++    T  
Sbjct: 18  GSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----ELDIMKVLDHVNIIKLVDYFYTTG 73

Query: 403 FKFMPNGSLEKRLYSHNYFLDILER--------------LNIMID-VGSTL--------- 438
            +                  + +                LN++++ V  TL         
Sbjct: 74  DEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIR 133

Query: 439 ---------------------EYLHHGHSSAPIIHCDLKPTSILLD-ENMVAHVSDFGIS 476
                                 ++H    S  I H D+KP ++L++ ++    + DFG +
Sbjct: 134 SGRSIPMNLISIYIYQLFRAVGFIH----SLGICHRDIKPQNLLVNSKDNTLKLCDFGSA 189

Query: 477 KLL 479
           K L
Sbjct: 190 KKL 192

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 50.1 bits (120), Expect = 4e-07
 Identities = 42/137 (30%), Positives = 61/137 (44%), Gaps = 9/137 (6%)

Query: 207 IPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLR 266
           IPT+   L       L +  +    P     L  L  L+LG N+L         SLT L 
Sbjct: 38  IPTNAQILY------LHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLT 91

Query: 267 ELDLGSNKLTSSIPSSLW-SLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSG 325
            LDLG+N+LT  +PS+++  L ++ E+ +  N L   LP  +++L  L  L L +NQL  
Sbjct: 92  VLDLGTNQLTV-LPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKS 149

Query: 326 DIPSTIGALVDLETISL 342
                   L  L    L
Sbjct: 150 IPHGAFDRLSSLTHAYL 166

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 49.3 bits (118), Expect = 6e-07
 Identities = 45/150 (30%), Positives = 71/150 (47%), Gaps = 18/150 (12%)

Query: 5   IPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNI 64
           IPT      N + L+L  N ++ L P +  ++  ++ L LG N+L   LP  +  SL  +
Sbjct: 38  IPT------NAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-LPVGVFDSLTQL 90

Query: 65  KYLELGDNNLIGTIPNSITNA-TKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLT 123
             L+LG N L   +P+++ +    L  L +  N  +  +P     L HL+ L+L  N L 
Sbjct: 91  TVLDLGTNQL-TVLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLK 148

Query: 124 TESSSAYQWSFLSSLTNCRYLVYLILSGNP 153
           +    A+    LSSLT      +  L GNP
Sbjct: 149 SIPHGAF--DRLSSLT------HAYLFGNP 170

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 50.9 bits (122), Expect = 4e-07
 Identities = 68/356 (19%), Positives = 122/356 (34%), Gaps = 64/356 (17%)

Query: 11  NLQNLKSLFLGANNLS-----GLIPPMIFNISTIRNLNLGGNRLS----GHLPSMIGHSL 61
               + SL L  NNL       LI       +++ +LNL GN L       L  ++    
Sbjct: 20  IPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIP 79

Query: 62  PNIKYLELGDNNLIGTIPNSITNA-----TKLIILDLGFNTFSG----HIPNTFGNL-RH 111
            N+  L L  N L     + +          + +LDLG+N FS          F NL   
Sbjct: 80  ANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPAS 139

Query: 112 LSVLSLLMNNLTTESSSAYQWSFLSSLTNC-RYLVYLILSGNPLG----GILPPSIGNFS 166
           ++ L+L  N+L  +SS       +  L      +  L L GN L       L   + +  
Sbjct: 140 ITSLNLRGNDLGIKSSDE----LIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIP 195

Query: 167 TSLQRFSASECKLKGTIPKEIGHL-----RGLIYLSLGFNDLNGTIPTSIGTLKQLQGFF 221
            S+     S   L      E+ ++       ++ L+L  N L+G    ++  LK      
Sbjct: 196 ASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKD----- 250

Query: 222 LPETNLQGYVPHNLCHLEMLNLLHLGGNKLSG----HIPPCLASLTSLRELDLGSNKLTS 277
                       +L HL+ + L +     +S      +     ++  +  +D    ++  
Sbjct: 251 ------------SLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHP 298

Query: 278 S----IPSSLWSLGYILE-INLSSNLL-----NDSLPSNVQKLKVLRVLDLSRNQL 323
           S    I + +  L    +  +L +  L     + +   ++     LR    +   L
Sbjct: 299 SHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPL 354

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 50.7 bits (120), Expect = 5e-07
 Identities = 27/161 (16%), Positives = 59/161 (36%), Gaps = 15/161 (9%)

Query: 181 GTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQL--QGFFLPETNLQGYVPHNLCHL 238
             +   +  +  L  L +   +           LK L      LP++ ++  +  +L +L
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNL 221

Query: 239 EMLNLLHLGGNKLSGHIPPCLASL------TSLRELDLGSNKLTSSIPSSLWS---LGYI 289
           E L L     +            L       +L+ L +   +  + +         L  +
Sbjct: 222 EKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQL 281

Query: 290 LEINLSSNLLNDS----LPSNVQKLKVLRVLDLSRNQLSGD 326
             +++S+ +L D     L  +V K+K L+ +++  N LS +
Sbjct: 282 ETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 40.7 bits (94), Expect = 7e-04
 Identities = 22/131 (16%), Positives = 47/131 (35%), Gaps = 17/131 (12%)

Query: 12  LQNLKSLFLGANNLSGLIPPMIF--NISTIRNLNL--------GGNRLSGHLPSMIGHSL 61
             NLKSL + +  L   +   I   ++  +  L L            ++   P       
Sbjct: 192 RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRF 251

Query: 62  PNIKYLELGDNNLIGTIPNSITNA---TKLIILDLGFNTFSG----HIPNTFGNLRHLSV 114
           PN+K+L + D      +      +    +L  +D+     +      + +    ++HL  
Sbjct: 252 PNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKF 311

Query: 115 LSLLMNNLTTE 125
           +++  N L+ E
Sbjct: 312 INMKYNYLSDE 322

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 50.4 bits (121), Expect = 5e-07
 Identities = 40/147 (27%), Positives = 70/147 (47%), Gaps = 21/147 (14%)

Query: 343 AGSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLI-KILSSCST 400
           +GSFG +Y GT I+ G +VAIK+  ++ +      + E ++ + ++    I  I    + 
Sbjct: 19  SGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAE 76

Query: 401 PDFKFM------PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
            D+  M      P  SLE      +    +   L +   + S +EY+H    S   IH D
Sbjct: 77  GDYNVMVMELLGP--SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH----SKNFIHRD 130

Query: 455 LKPTSILL----DENMVAHVSDFGISK 477
           +KP + L+      N+V ++ DFG++K
Sbjct: 131 VKPDNFLMGLGKKGNLV-YIIDFGLAK 156

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 50.0 bits (120), Expect = 8e-07
 Identities = 34/149 (22%), Positives = 67/149 (44%), Gaps = 37/149 (24%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNL-QRERAFRSFNSECEVLRNVR-HQNLIKILSSCST 400
           G +  V++   I++   V +KI    ++++  R    E ++L N+R   N+I +      
Sbjct: 47  GKYSEVFEAINITNNEKVVVKILKPVKKKKIKR----EIKILENLRGGPNIITLADIVKD 102

Query: 401 PD-------FKFMPNGSLEKRLYSH------NYFL-DILERLNIMIDVGSTLEYLHHGHS 446
           P        F+ + N    K+LY         +++ +IL+           L+Y H    
Sbjct: 103 PVSRTPALVFEHVNNTDF-KQLYQTLTDYDIRFYMYEILK----------ALDYCH---- 147

Query: 447 SAPIIHCDLKPTSILLD-ENMVAHVSDFG 474
           S  I+H D+KP ++++D E+    + D+G
Sbjct: 148 SMGIMHRDVKPHNVMIDHEHRKLRLIDWG 176

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 44/167 (26%), Positives = 66/167 (39%), Gaps = 18/167 (10%)

Query: 5   IPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNI 64
           IP       + + L L +  L+ L       ++ +  LNL  N+L   L + +   L  +
Sbjct: 33  IPA------DTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTEL 85

Query: 65  KYLELGDNNLIGTIPNSI-TNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLT 123
             L L +N L  ++P  +  + T+L  L LG N         F  L  L  L L  N L 
Sbjct: 86  GTLGLANNQL-ASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ 144

Query: 124 TESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQ 170
           +  + A+       LTN   L  L LS N L  + P    +    LQ
Sbjct: 145 SIPAGAF-----DKLTN---LQTLSLSTNQLQSV-PHGAFDRLGKLQ 182

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 46.6 bits (111), Expect = 5e-06
 Identities = 25/81 (30%), Positives = 33/81 (40%), Gaps = 2/81 (2%)

Query: 244 LHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSL 303
           L L    L+         LT L  L+L  N+L +        L  +  + L++N L  SL
Sbjct: 40  LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-SL 98

Query: 304 PSNV-QKLKVLRVLDLSRNQL 323
           P  V   L  L  L L  NQL
Sbjct: 99  PLGVFDHLTQLDKLYLGGNQL 119

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 45.5 bits (108), Expect = 1e-05
 Identities = 47/169 (27%), Positives = 67/169 (39%), Gaps = 32/169 (18%)

Query: 178 KLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSI-GTLKQLQGFFLPETNLQGYVPHNL- 235
            L          L  L +L+L +N L  T+   +   L +L    L    L   +P  + 
Sbjct: 46  GLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANNQLA-SLPLGVF 103

Query: 236 CHLEMLNLLHLGGNKLSGHIPP-CLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINL 294
            HL  L+ L+LGGN+L   +P      LT L+EL L +N+L                   
Sbjct: 104 DHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQ------------------ 144

Query: 295 SSNLLNDSLPSNV-QKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISL 342
                  S+P+    KL  L+ L LS NQL          L  L+TI+L
Sbjct: 145 -------SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITL 186

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 45.5 bits (108), Expect = 2e-05
 Identities = 36/111 (32%), Positives = 49/111 (44%), Gaps = 5/111 (4%)

Query: 12  LQNLKSLFLGANNLSGLIPPMIFNIST-IRNLNLGGNRLSGHLPSMIGHSLPNIKYLELG 70
           L  L +L L  N L+ L P  +F+  T +  L LGGN+L   LPS +   L  +K L L 
Sbjct: 82  LTELGTLGLANNQLASL-PLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRL- 138

Query: 71  DNNLIGTIPNSI-TNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMN 120
           + N + +IP       T L  L L  N         F  L  L  ++L  N
Sbjct: 139 NTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 42.8 bits (101), Expect = 1e-04
 Identities = 56/228 (24%), Positives = 77/228 (33%), Gaps = 73/228 (32%)

Query: 77  TIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLS 136
           ++P+ I   T+   LDL     +     TF  L  L+ L+L  N L T S+  +      
Sbjct: 28  SVPSGIPADTE--KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDD---- 81

Query: 137 SLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYL 196
            LT    L  L L+ N L   LP  + +  T L                          L
Sbjct: 82  -LTE---LGTLGLANNQLAS-LPLGVFDHLTQLD------------------------KL 112

Query: 197 SLGFNDLNGTIPTSIGTLKQLQGFFLPE------TNLQGYVPHNLCHLEMLNLLHLGGNK 250
            LG N              QL+   LP       T L+               L L  N+
Sbjct: 113 YLGGN--------------QLKS--LPSGVFDRLTKLK--------------ELRLNTNQ 142

Query: 251 LSGHIPP-CLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSN 297
           L   IP      LT+L+ L L +N+L S    +   LG +  I L  N
Sbjct: 143 LQS-IPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 41.2 bits (97), Expect = 4e-04
 Identities = 19/63 (30%), Positives = 29/63 (46%), Gaps = 2/63 (3%)

Query: 263 TSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNV-QKLKVLRVLDLSRN 321
               +LDL S  L +   ++   L  +  +NL  N L  +L + V   L  L  L L+ N
Sbjct: 35  ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANN 93

Query: 322 QLS 324
           QL+
Sbjct: 94  QLA 96

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 50.3 bits (120), Expect = 1e-06
 Identities = 39/155 (25%), Positives = 66/155 (42%), Gaps = 27/155 (17%)

Query: 344 GSFGSVY----KGTISDGTDVAIKIFN---LQRERAFRSFNSECEVLRNVRHQN---LIK 393
           G FG VY      T   G   A+K  +   ++ ++      +E  +L  V   +   ++ 
Sbjct: 200 GGFGEVYGCRKADT---GKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256

Query: 394 ILSSCSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSA 448
           +  +  TPD        M  G L   L  H  F +   R     ++   LE++H    + 
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA-EIILGLEHMH----NR 311

Query: 449 PIIHCDLKPTSILLDENMVAHV--SDFGISKLLGE 481
            +++ DLKP +ILLDE+   HV  SD G++    +
Sbjct: 312 FVVYRDLKPANILLDEH--GHVRISDLGLACDFSK 344

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 47.4 bits (113), Expect = 1e-06
 Identities = 23/120 (19%), Positives = 43/120 (35%), Gaps = 9/120 (7%)

Query: 35  NISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLG 94
             S ++ L L  +R +      +      +++L   +   + +I N +    KL  L+L 
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVG-LTSIAN-LPKLNKLKKLELS 72

Query: 95  FNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPL 154
            N  SG +        +L+ L+L  N +          S +  L     L  L L    +
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKIK-------DLSTIEPLKKLENLKSLDLFNCEV 125

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 43.9 bits (104), Expect = 2e-05
 Identities = 24/112 (21%), Positives = 46/112 (41%), Gaps = 5/112 (4%)

Query: 234 NLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEIN 293
               ++ L L +   N+  G +         L  L   +  LTS   ++L  L  + ++ 
Sbjct: 15  TPSDVKELVLDNSRSNE--GKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLE 70

Query: 294 LSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSG-DIPSTIGALVDLETISLAG 344
           LS N ++  L    +K   L  L+LS N++        +  L +L+++ L  
Sbjct: 71  LSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFN 122

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 49.1 bits (118), Expect = 1e-06
 Identities = 35/157 (22%), Positives = 61/157 (38%), Gaps = 25/157 (15%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRER-AFRSFNSEC--EV-----LRNVRHQNLIKI 394
           G++G+VYK      G  VA+K   +                EV     L    H N++++
Sbjct: 20  GAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRL 79

Query: 395 LSSCSTPD----------FKFMPNGSLEKRLYSHN-YFLDILERLNIMIDVGSTLEYLHH 443
           +  C+T            F+ +    L   L       L      ++M      L++LH 
Sbjct: 80  MDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA 138

Query: 444 GHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG 480
                 I+H DLKP +IL+       ++DFG++++  
Sbjct: 139 NC----IVHRDLKPENILVTSGGTVKLADFGLARIYS 171

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 49.1 bits (116), Expect = 1e-06
 Identities = 28/184 (15%), Positives = 54/184 (29%), Gaps = 54/184 (29%)

Query: 344 GSFGSVYKGTISDGTDVAIKI--------FNLQRERAFRSFNSECEVLRNV--------- 386
           G FG V++  I+D T VAIKI         N   ++ F     E  + + +         
Sbjct: 31  GVFGEVFQT-IADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCN 89

Query: 387 RHQNLIKILSSC-------------------STPDFKFMPNGSLEKRLY----------- 416
           R +  I + S                     +       P+   + +L+           
Sbjct: 90  RTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGID 149

Query: 417 ---SHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDF 473
                     +    +I+  + ++L             H DL   ++LL +  +  +   
Sbjct: 150 LEQMRTKLSSLATAKSILHQLTASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYT 206

Query: 474 GISK 477
              K
Sbjct: 207 LNGK 210

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 30/161 (18%), Positives = 65/161 (40%), Gaps = 43/161 (26%)

Query: 344 GSFGSVY----KGTISDGTDVAIKIFN----LQRERAFRSFNSECEVLRNVRHQNLIKIL 395
           G+FG V     K T       A+K+ +    ++R  +   F  E +++       ++++ 
Sbjct: 80  GAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSDSAF-FWEERDIMAFANSPWVVQLF 135

Query: 396 SSCSTPDF-----KFMPNGSLEKRLYSHNYFLDILERLNIMIDVG--------STLEYLH 442
            +     +     ++MP G L          ++++   ++               L+ +H
Sbjct: 136 YAFQDDRYLYMVMEYMPGGDL----------VNLMSNYDVPEKWARFYTAEVVLALDAIH 185

Query: 443 HGHSSAPIIHCDLKPTSILLDENMVAHV--SDFGISKLLGE 481
               S   IH D+KP ++LLD++   H+  +DFG    + +
Sbjct: 186 ----SMGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNK 220

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 36/153 (23%), Positives = 62/153 (40%), Gaps = 24/153 (15%)

Query: 344 GSFGSVY----KGTISDGTDVAIKIFN---LQRERAFRSFNSECEVLRNVRHQNLIKILS 396
           G FG V     + T   G   A K      +++ +      +E ++L  V  + ++ +  
Sbjct: 195 GGFGEVCACQVRAT---GKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251

Query: 397 SCSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMI-DVGSTLEYLHHGHSSAPI 450
           +  T D        M  G L+  +Y          R      ++   LE LH       I
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH----RERI 307

Query: 451 IHCDLKPTSILLDENMVAHV--SDFGISKLLGE 481
           ++ DLKP +ILLD++   H+  SD G++  + E
Sbjct: 308 VYRDLKPENILLDDH--GHIRISDLGLAVHVPE 338

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 48.6 bits (116), Expect = 3e-06
 Identities = 36/164 (21%), Positives = 59/164 (35%), Gaps = 47/164 (28%)

Query: 344 GSFGSVY----KGTISDGTDVAIKIFN----LQR-ERAFRSFNSECEVLRNVRHQNLIKI 394
           G+FG V     K         A+KI N    L+R E A   F  E +VL N   + +  +
Sbjct: 85  GAFGEVAVVKLKNA---DKVFAMKILNKWEMLKRAETAC--FREERDVLVNGDSKWITTL 139

Query: 395 LSSCSTPDF-----KFMPNGSLEKRLYSHNYFLDILERLNIMID----------VGSTLE 439
             +    +       +   G L     +       L +    +           +   ++
Sbjct: 140 HYAFQDDNNLYLVMDYYVGGDL----LTL------LSKFEDRLPEEMARFYLAEMVIAID 189

Query: 440 YLHHGHSSAPIIHCDLKPTSILLDENMVAHV--SDFGISKLLGE 481
            +H        +H D+KP +IL+D N   H+  +DFG    L E
Sbjct: 190 SVH----QLHYVHRDIKPDNILMDMN--GHIRLADFGSCLKLME 227

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 48.0 bits (115), Expect = 3e-06
 Identities = 32/155 (20%), Positives = 57/155 (36%), Gaps = 35/155 (22%)

Query: 344 GSFGSVYKGTISDGTD--VAIKIFNLQRER------AFRSFNSECEV-----LRNVRHQN 390
           G++G V+K          VA+K   +Q           R      EV     L    H N
Sbjct: 22  GAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR------EVAVLRHLETFEHPN 75

Query: 391 LIKILSSCSTPD----------FKFMPNGSLEKRLYSH-NYFLDILERLNIMIDVGSTLE 439
           ++++   C+             F+ +    L   L       +      ++M  +   L+
Sbjct: 76  VVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 134

Query: 440 YLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFG 474
           +LH       ++H DLKP +IL+  +    ++DFG
Sbjct: 135 FLHSHR----VVHRDLKPQNILVTSSGQIKLADFG 165

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 46.6 bits (111), Expect = 4e-06
 Identities = 47/141 (33%), Positives = 65/141 (46%), Gaps = 16/141 (11%)

Query: 207 IPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLR 266
           IP     L       L   +L+         L  L  L+LGGNKL          LTSL 
Sbjct: 26  IPAQTTYLD------LETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLT 79

Query: 267 ELDLGSNKLTSSIPSSLW-SLGYILEINLSSNLLNDSLPSNV-QKLKVLRVLDLSRNQLS 324
            L+L +N+L S +P+ ++  L  + E+ L++N L  SLP  V  KL  L+ L L +NQL 
Sbjct: 80  YLNLSTNQLQS-LPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLK 137

Query: 325 GDIPSTIGA---LVDLETISL 342
             +P   G    L  L+ I L
Sbjct: 138 S-VPD--GVFDRLTSLQYIWL 155

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 43.5 bits (103), Expect = 5e-05
 Identities = 44/151 (29%), Positives = 68/151 (45%), Gaps = 15/151 (9%)

Query: 5   IPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNI 64
           +PT I        L L  N+L  L   +   ++++  L LGGN+L   LP+ + + L ++
Sbjct: 22  VPTGIPA--QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS-LPNGVFNKLTSL 78

Query: 65  KYLELGDNNLIGTIPNSITNA-TKLIILDLGFNTFSGHIPN-TFGNLRHLSVLSLLMNNL 122
            YL L  N L  ++PN + +  T+L  L L  N     +P+  F  L  L  L L  N L
Sbjct: 79  TYLNLSTNQL-QSLPNGVFDKLTQLKELALNTNQLQS-LPDGVFDKLTQLKDLRLYQNQL 136

Query: 123 TTESSSAYQWSFLSSLTNCRYLVYLILSGNP 153
            +     +    L+SL       Y+ L  NP
Sbjct: 137 KSVPDGVF--DRLTSLQ------YIWLHDNP 159

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 47.7 bits (113), Expect = 5e-06
 Identities = 35/146 (23%), Positives = 63/146 (43%), Gaps = 19/146 (13%)

Query: 343 AGSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLI-KILSSCST 400
           +GSFG +Y GT I    +VAIK+     +        E ++ R ++    I  +      
Sbjct: 17  SGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVE 74

Query: 401 PDFKFM------PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
            D+  +      P  SLE      +  L +   L +   + + +E++H    S   +H D
Sbjct: 75  GDYNVLVMDLLGP--SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH----SKSFLHRD 128

Query: 455 LKPTSILLDENMVAH---VSDFGISK 477
           +KP + L+     A+   + DFG++K
Sbjct: 129 IKPDNFLMGLGRRANQVYIIDFGLAK 154

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 46.8 bits (112), Expect = 9e-06
 Identities = 40/149 (26%), Positives = 66/149 (44%), Gaps = 26/149 (17%)

Query: 344 GSFGSV----YKGTISDGTDVAIKIFN----LQRERAFRSFNSECEVLRNVRHQNLIKIL 395
           G+FG V     K T   G   A+KI      + ++       +E  VL+N RH  L  + 
Sbjct: 16  GTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEV-AHTVTESRVLQNTRHPFLTALK 71

Query: 396 SSCSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPI 450
            +  T D      ++   G L   L     F +   R     ++ S LEYLH    S  +
Sbjct: 72  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA-EIVSALEYLH----SRDV 126

Query: 451 IHCDLKPTSILLDENMVAHV--SDFGISK 477
           ++ D+K  +++LD++   H+  +DFG+ K
Sbjct: 127 VYRDIKLENLMLDKD--GHIKITDFGLCK 153

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 47.0 bits (112), Expect = 9e-06
 Identities = 34/159 (21%), Positives = 58/159 (36%), Gaps = 45/159 (28%)

Query: 344 GSFGSVY----KGTISDGTDVAIKIFN----LQRERAFRSFNSECEVLRNVRHQNLIKIL 395
           G+F  V     K T   G   A+KI N    L+R      F  E +VL N   + + ++ 
Sbjct: 72  GAFSEVAVVKMKQT---GQVYAMKIMNKWDMLKRGEV-SCFREERDVLVNGDRRWITQLH 127

Query: 396 SSCSTPDF-----KFMPNGSLEKRLYSHNYFLDILERLNIMID----------VGSTLEY 440
            +    ++     ++   G L     +       L +    I           +   ++ 
Sbjct: 128 FAFQDENYLYLVMEYYVGGDL----LTL------LSKFGERIPAEMARFYLAEIVMAIDS 177

Query: 441 LHHGHSSAPIIHCDLKPTSILLDENMVAHV--SDFGISK 477
           +H        +H D+KP +ILLD     H+  +DFG   
Sbjct: 178 VH----RLGYVHRDIKPDNILLDRC--GHIRLADFGSCL 210

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 44.9 bits (107), Expect = 9e-06
 Identities = 33/101 (32%), Positives = 44/101 (43%), Gaps = 4/101 (3%)

Query: 244 LHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLW-SLGYILEINLSSNLLNDS 302
           L L  NKL          LT L +L L  N++  S+P  ++  L  +  + L  N L  S
Sbjct: 33  LELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ-S 90

Query: 303 LPSNV-QKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISL 342
           LP+ V  KL  L+ L L  NQL          L  L+ I L
Sbjct: 91  LPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWL 131

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 39.6 bits (93), Expect = 7e-04
 Identities = 36/127 (28%), Positives = 53/127 (41%), Gaps = 15/127 (11%)

Query: 29  IPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNA-TK 87
           +P  I   S+   L L  N+L   LP  +   L  +  L L  N +  ++P+ + +  TK
Sbjct: 22  VPTGIP--SSATRLELESNKLQS-LPHGVFDKLTQLTKLSLSQNQI-QSLPDGVFDKLTK 77

Query: 88  LIILDLGFNTFSGHIPN-TFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVY 146
           L IL L  N     +PN  F  L  L  L+L  N L +     +    L+SL        
Sbjct: 78  LTILYLHENKLQS-LPNGVFDKLTQLKELALDTNQLKSVPDGIF--DRLTSLQ------K 128

Query: 147 LILSGNP 153
           + L  NP
Sbjct: 129 IWLHTNP 135

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 45.0 bits (107), Expect = 1e-05
 Identities = 35/119 (29%), Positives = 48/119 (40%), Gaps = 10/119 (8%)

Query: 37  STIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFN 96
                L L  N L       +   LP++  LEL  N L G  PN+   A+ +  L LG N
Sbjct: 29  LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88

Query: 97  TFSGHIPN-TFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPL 154
                I N  F  L  L  L+L  N ++     ++    L+SLT       L L+ NP 
Sbjct: 89  KIK-EISNKMFLGLHQLKTLNLYDNQISCVMPGSF--EHLNSLT------SLNLASNPF 138

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 42.3 bits (100), Expect = 9e-05
 Identities = 27/113 (23%), Positives = 44/113 (38%), Gaps = 34/113 (30%)

Query: 237 HLEMLNLLHLGGNKLSGHIPPCL-ASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLS 295
            L  L  L L  N+L+G I P      + ++EL LG NK+                    
Sbjct: 52  RLPHLVKLELKRNQLTG-IEPNAFEGASHIQELQLGENKIK------------------- 91

Query: 296 SNLLNDSLPSNV-QKLKVLRVLDLSRNQLSGDIPSTIGA---LVDLETISLAG 344
                  + + +   L  L+ L+L  NQ+S  +    G+   L  L +++LA 
Sbjct: 92  ------EISNKMFLGLHQLKTLNLYDNQISC-VMP--GSFEHLNSLTSLNLAS 135

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 47.2 bits (111), Expect = 1e-05
 Identities = 51/361 (14%), Positives = 108/361 (29%), Gaps = 113/361 (31%)

Query: 136 SSLTNCRYLVYLILSGNP------LGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGH 189
            +++    L + +LS         +  +L     N+   +     +E +    + +    
Sbjct: 59  DAVSGTLRLFWTLLSKQEEMVQKFVEEVLRI---NYKFLMSPI-KTEQRQPSMMTRMYIE 114

Query: 190 LRGLIYLSLG-FNDLNGTIPTSIGTLK----QLQGFFLPETNLQGYVPHNLCHLEMLNLL 244
            R  +Y     F   N +       L+    +L+    P  N+               L+
Sbjct: 115 QRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELR----PAKNV---------------LI 155

Query: 245 H-LGGNKLSGHIPPCLASLTSLRE-------------LDLGSNKLTSSIPSSLWSLGYIL 290
             + G   SG     +A                    L+L +     ++   L  L Y +
Sbjct: 156 DGVLG---SGK--TWVALDV-CLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQI 209

Query: 291 EINLSSNLLN-DSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAGSFGSV 349
           + N +S   +  ++   +  ++     +L R   S    +    L+ L            
Sbjct: 210 DPNWTSRSDHSSNIKLRIHSIQ----AELRRLLKSKPYEN---CLLVL------------ 250

Query: 350 YKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPDFKFMPNG 409
                    +V       Q  +A+ +FN  C++L   R + +   LS+ +T         
Sbjct: 251 ------L--NV-------QNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHI------ 289

Query: 410 SLEKRL--YSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMV 467
           SL+      + +    +L            L+YL       P       P  +    +++
Sbjct: 290 SLDHHSMTLTPDEVKSLL------------LKYLDCRPQDLPREVLTTNPRRL----SII 333

Query: 468 A 468
           A
Sbjct: 334 A 334

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 46.4 bits (109), Expect = 2e-05
 Identities = 80/492 (16%), Positives = 144/492 (29%), Gaps = 160/492 (32%)

Query: 9   IGNLQNLKSLFLGANNLSGLIPPMI-----FNISTIRNLNLGGNRLSGHLPSMIGHSLPN 63
           + N  + +++      L   I P        + +    ++     L   L S        
Sbjct: 189 LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSK------- 241

Query: 64  IKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLT 123
             Y             N       L++L    N  +    N F       +L      LT
Sbjct: 242 -PY------------ENC------LLVLL---NVQNAKAWNAFNL--SCKIL------LT 271

Query: 124 TESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPP-SIGNFSTSLQRFSASECKLKGT 182
           T         FLS+ T        I   +    + P          L      +C+ +  
Sbjct: 272 TRFKQVTD--FLSAATTTH-----ISLDHHSMTLTPDEVKSLLLKYL------DCRPQ-D 317

Query: 183 IPKEI--GHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEM 240
           +P+E+   + R    LS+            I    +                  L   + 
Sbjct: 318 LPREVLTTNPR---RLSI------------IAESIR----------------DGLATWD- 345

Query: 241 LNLLHLGGNKLSGHIPPCLASLTS--LREL--DLG----SNKLTSSIPSSLW-------- 284
            N  H+  +KL+  I   L  L     R++   L     S  + + + S +W        
Sbjct: 346 -NWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDV 404

Query: 285 ----------SLG---------YILEINLSSNLLNDSLPSN----VQKLKVLRVL---DL 318
                     SL           I  I L   +  ++  +     V    + +     DL
Sbjct: 405 MVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDL 464

Query: 319 SRNQLSGDIPSTIGA-LVDLETISLAGSFGSVY------KGTI-SDGT--DVAIKIFN-L 367
               L     S IG  L ++E       F  V+      +  I  D T  + +  I N L
Sbjct: 465 IPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTL 524

Query: 368 QRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPDFKFMPNGSLEKRLYSHNYFLDILER 427
           Q+ + ++ +  + +       + +  IL         F+P   +E+ L    Y  D+L R
Sbjct: 525 QQLKFYKPYICDND---PKYERLVNAIL--------DFLPK--IEENLICSKY-TDLL-R 569

Query: 428 LNIMIDVGSTLE 439
           + +M +  +  E
Sbjct: 570 IALMAEDEAIFE 581

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 45.6 bits (109), Expect = 2e-05
 Identities = 34/150 (22%), Positives = 68/150 (45%), Gaps = 24/150 (16%)

Query: 344 GSFGSVY---KGTISDGTDV-AIKIFN----LQRERAFRSFNSECEVLRNVRHQNLIKIL 395
           G +G V+   K T ++   + A+K+      ++  +      +E  +L  V+H  ++ ++
Sbjct: 28  GGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLI 87

Query: 396 SSCSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLH-HGHSSAP 449
            +  T        +++  G L  +L     F++      +  ++   L +LH  G     
Sbjct: 88  YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLA-EISMALGHLHQKG----- 141

Query: 450 IIHCDLKPTSILLDENMVAHV--SDFGISK 477
           II+ DLKP +I+L+     HV  +DFG+ K
Sbjct: 142 IIYRDLKPENIMLNHQ--GHVKLTDFGLCK 169

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 45.0 bits (107), Expect = 2e-05
 Identities = 45/146 (30%), Positives = 64/146 (43%), Gaps = 15/146 (10%)

Query: 11  NLQNLKSLFLGANNLSGLIPPMIFN-ISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLEL 69
            L NL  L L  N L  L P  +F+ ++ ++ L L  N+L   LP  +   L N+ YL L
Sbjct: 83  ELTNLTYLILTGNQLQSL-PNGVFDKLTNLKELVLVENQLQS-LPDGVFDKLTNLTYLNL 140

Query: 70  GDNNLIGTIPNSITNA-TKLIILDLGFNTFSGHIPN-TFGNLRHLSVLSLLMNNLTTESS 127
             N L  ++P  + +  T L  LDL +N     +P   F  L  L  L L  N L +   
Sbjct: 141 AHNQL-QSLPKGVFDKLTNLTELDLSYNQLQS-LPEGVFDKLTQLKDLRLYQNQLKSVPD 198

Query: 128 SAYQWSFLSSLTNCRYLVYLILSGNP 153
             +    L+SL       Y+ L  NP
Sbjct: 199 GVF--DRLTSLQ------YIWLHDNP 216

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 40.8 bits (96), Expect = 6e-04
 Identities = 47/159 (29%), Positives = 58/159 (36%), Gaps = 34/159 (21%)

Query: 189 HLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGG 248
            L  L YL L  N L          L  L+   L E  LQ         L  L  L+L  
Sbjct: 83  ELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAH 142

Query: 249 NKLSGHIPPCL-ASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNV 307
           N+L   +P  +   LT+L ELDL  N+L                          SLP  V
Sbjct: 143 NQLQS-LPKGVFDKLTNLTELDLSYNQLQ-------------------------SLPEGV 176

Query: 308 -QKLKVLRVLDLSRNQLSGDIPSTIGA---LVDLETISL 342
             KL  L+ L L +NQL   +P   G    L  L+ I L
Sbjct: 177 FDKLTQLKDLRLYQNQLKS-VPD--GVFDRLTSLQYIWL 212

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 45.3 bits (107), Expect = 2e-05
 Identities = 29/111 (26%), Positives = 44/111 (39%), Gaps = 10/111 (9%)

Query: 373 FRSFNSECEVLRNVRHQNLIKILSSCSTPDFKFMPNGSL------EKRLYSHNYFLDILE 426
           FR        +     + L  I SS S+    F+   SL      E     +  FL +  
Sbjct: 135 FRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEH 194

Query: 427 RLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK 477
            +     V   +E+L    +S   IH DL   +ILL E  V  + DFG+++
Sbjct: 195 LICYSFQVAKGMEFL----ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 241

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 44.5 bits (105), Expect = 4e-05
 Identities = 30/149 (20%), Positives = 52/149 (34%), Gaps = 23/149 (15%)

Query: 343 AGSFGSVYKGTI------SDGTDVAIKIFNLQ-RERAFRSFNSECEVLRNV-RHQNLIKI 394
            G+FG V +         +    VA+K+          R+  SE ++L ++  H N++ +
Sbjct: 32  RGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91

Query: 395 LSSCSTPD------FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSA 448
           L +C+ P        +F   G+L   L S           N  +   +       G    
Sbjct: 92  LGACTKPGGPLMVIVEFCKFGNLSTYLRSKR---------NEFVPYKTKGARFRQGKDYV 142

Query: 449 PIIHCDLKPTSILLDENMVAHVSDFGISK 477
             I  DLK     +  +  +  S F   K
Sbjct: 143 GAIPVDLKRRLDSITSSQSSASSGFVEEK 171

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 44.8 bits (106), Expect = 5e-05
 Identities = 37/151 (24%), Positives = 64/151 (42%), Gaps = 26/151 (17%)

Query: 344 GSFGSVY----KGTISDGTDVAIKIFN---LQRERAFRSFNSECEVLRNVRHQNLIKILS 396
           G FG V+    K T   G   A K  N   L++ + ++    E ++L  V  + ++ +  
Sbjct: 196 GGFGEVFACQMKAT---GKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252

Query: 397 SCSTPD-----FKFMPNGSLEKRLYSHNYFLDIL--ERLNIMI-DVGSTLEYLHHGHSSA 448
           +  T          M  G +   +Y+ +         R       + S LE+LH      
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH----QR 308

Query: 449 PIIHCDLKPTSILLDENMVAHV--SDFGISK 477
            II+ DLKP ++LLD++   +V  SD G++ 
Sbjct: 309 NIIYRDLKPENVLLDDD--GNVRISDLGLAV 337

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 44.6 bits (105), Expect = 6e-05
 Identities = 37/150 (24%), Positives = 58/150 (38%), Gaps = 27/150 (18%)

Query: 344 GSFGSV----YKGTISDGTDVAIKIFN----LQRERAFRSFNSECEVL-RNVRHQNLIKI 394
           GSFG V     KGT       A+KI      +Q +        E  VL    +   L ++
Sbjct: 352 GSFGKVMLSERKGT---DELYAVKILKKDVVIQDDDV-ECTMVEKRVLALPGKPPFLTQL 407

Query: 395 LSSCSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAP 449
            S   T D      +++  G L   +     F +         ++   L +L     S  
Sbjct: 408 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA-EIAIGLFFLQ----SKG 462

Query: 450 IIHCDLKPTSILLDENMVAHV--SDFGISK 477
           II+ DLK  +++LD     H+  +DFG+ K
Sbjct: 463 IIYRDLKLDNVMLDSE--GHIKIADFGMCK 490

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 44.0 bits (104), Expect = 7e-05
 Identities = 23/165 (13%), Positives = 54/165 (32%), Gaps = 37/165 (22%)

Query: 343 AGSFGSVYKGT---------ISDGTDVAIKI----FNLQRERAFRSFNSECEVLRNVRHQ 389
             + G +Y+                  ++K+      L  E+ F    ++   +   +  
Sbjct: 52  RDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKL 111

Query: 390 NLIKIL-------SSCSTPDFKFM------PNGSLEKRL-YSHNYFLDILERLNIMIDVG 435
               +L              ++F+         SL+  L  S  + L     L +   + 
Sbjct: 112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR--SLQSALDVSPKHVLSERSVLQVACRLL 169

Query: 436 STLEYLHHGHSSAPIIHCDLKPTSILL---DENMVAHVSDFGISK 477
             LE+LH        +H ++   +I +   D++ V  ++ +G + 
Sbjct: 170 DALEFLHENE----YVHGNVTAENIFVDPEDQSQV-TLAGYGFAF 209

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 43.9 bits (104), Expect = 8e-05
 Identities = 43/163 (26%), Positives = 63/163 (38%), Gaps = 41/163 (25%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQ------NLIKILS 396
           GSFG V K         VA+K+     +R  R    E  +L ++R Q      N+I +L 
Sbjct: 108 GSFGQVVKAYDHKVHQHVALKMVR-NEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLE 166

Query: 397 SCSTPDFKF-----MPNGSLEKRLYSHNYFLDILERLN-----------IMIDVGSTLEY 440
           +     F F     M    L   LY      +++++                 +   L+ 
Sbjct: 167 N-----FTFRNHICMTFELLSMNLY------ELIKKNKFQGFSLPLVRKFAHSILQCLDA 215

Query: 441 LHHGHSSAPIIHCDLKPTSILLDENMVAH--VSDFGISKLLGE 481
           LH       IIHCDLKP +ILL +   +   V DFG S    +
Sbjct: 216 LH----KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ 254

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 43.6 bits (103), Expect = 1e-04
 Identities = 32/155 (20%), Positives = 58/155 (37%), Gaps = 33/155 (21%)

Query: 344 GSFGSVYKG---TISDGTDVAIKIFNLQRERAFRSFNSECEV--LRNVRHQNLIKILSSC 398
           G++G VYK       D  D A+K      E    S ++  E+  LR ++H N+I +    
Sbjct: 32  GTYGHVYKAKRKDGKDDKDYALKQI----EGTGISMSACREIALLRELKHPNVISLQKVF 87

Query: 399 STPD-------FKFMPNGSLEKRLYSHNYFLDILERLNI--------MIDVGSTLEYLHH 443
            +         F +  +  L   +  H       + + +        +  +   + YLH 
Sbjct: 88  LSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 146

Query: 444 GHSSAPIIHCDLKPTSILLDENMVAH----VSDFG 474
                 ++H DLKP +IL+           ++D G
Sbjct: 147 NW----VLHRDLKPANILVMGEGPERGRVKIADMG 177

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 43.5 bits (103), Expect = 1e-04
 Identities = 33/168 (19%), Positives = 63/168 (37%), Gaps = 47/168 (27%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVR-----------HQNL 391
           G F +V+    + + T VA+KI     +    +   E ++L+ V              ++
Sbjct: 30  GHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHI 88

Query: 392 IKILSSCSTPDFKFM-PNGS-----LEKRLYSHNYFLDILERLN-----------IMIDV 434
           +K+L       F    PNG       E  +   N  L ++++             I   +
Sbjct: 89  LKLLDH-----FNHKGPNGVHVVMVFE--VLGEN-LLALIKKYEHRGIPLIYVKQISKQL 140

Query: 435 GSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAH------VSDFGIS 476
              L+Y+H       IIH D+KP ++L++            ++D G +
Sbjct: 141 LLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 42.9 bits (102), Expect = 1e-04
 Identities = 45/151 (29%), Positives = 70/151 (46%), Gaps = 26/151 (17%)

Query: 344 GSFGSVY---KGTISDGTDV-AIKIFN----LQRERAFRSFNSECEVLRNVRHQNLIKIL 395
           GSFG V+   K + SD   + A+K+        R+R       E ++L  V H  ++K+ 
Sbjct: 35  GSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRV--RTKMERDILVEVNHPFIVKLH 92

Query: 396 SSCSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLH-HGHSSAP 449
            +  T         F+  G L  RL     F +   +  +  ++   L++LH  G     
Sbjct: 93  YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELALALDHLHSLG----- 146

Query: 450 IIHCDLKPTSILLDENMVAHV--SDFGISKL 478
           II+ DLKP +ILLDE    H+  +DFG+SK 
Sbjct: 147 IIYRDLKPENILLDEE--GHIKLTDFGLSKE 175

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 39/151 (25%), Positives = 68/151 (45%), Gaps = 25/151 (16%)

Query: 344 GSFGSVY---KGTISDGTDV-AIKIFN----LQRERAFRSFNSECEVLRNVRHQNLIKIL 395
           G++G V+   K +  D   + A+K+      +Q+ +      +E +VL ++R    +  L
Sbjct: 65  GAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTL 124

Query: 396 SSC-STPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLH-HGHSSA 448
                T         ++  G L   L     F +   ++ +  ++   LE+LH  G    
Sbjct: 125 HYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG-EIVLALEHLHKLG---- 179

Query: 449 PIIHCDLKPTSILLDENMVAHV--SDFGISK 477
            II+ D+K  +ILLD N   HV  +DFG+SK
Sbjct: 180 -IIYRDIKLENILLDSN--GHVVLTDFGLSK 207

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 41.8 bits (99), Expect = 4e-04
 Identities = 38/151 (25%), Positives = 60/151 (39%), Gaps = 29/151 (19%)

Query: 344 GSFGSV----YKGTISDGTDVAIKIFN----LQRERAFRSFNSECEVL-RNVRHQNLIKI 394
           GSFG V    +K T       AIK       L  +        E  VL     H  L  +
Sbjct: 28  GSFGKVFLAEFKKT---NQFFAIKALKKDVVLMDDDV-ECTMVEKRVLSLAWEHPFLTHM 83

Query: 395 LSSCSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLH-HGHSSA 448
             +  T +      +++  G L   + S + F           ++   L++LH  G    
Sbjct: 84  FCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAA-EIILGLQFLHSKG---- 138

Query: 449 PIIHCDLKPTSILLDENMVAHV--SDFGISK 477
            I++ DLK  +ILLD++   H+  +DFG+ K
Sbjct: 139 -IVYRDLKLDNILLDKD--GHIKIADFGMCK 166

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 41.4 bits (97), Expect = 6e-04
 Identities = 43/322 (13%), Positives = 96/322 (29%), Gaps = 42/322 (13%)

Query: 106 FGNLRHLSV---LSLLMNNLTTESSSAYQWSFLSSLT-NCRYLVYLILSGNPLGGILPPS 161
           F  +R + +         NL  +    Y + ++ +++ +  +L  + L    +       
Sbjct: 65  FPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLEL 124

Query: 162 IGNFSTSLQRFSASECKLKGT--IPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTL----K 215
           I     + +    S C+   T  +       R L  L L  +D++      +        
Sbjct: 125 IAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYT 184

Query: 216 QLQGFFLPETNLQ------GYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELD 269
            L    +     +        +     +L+ L L      +    +   L     L EL 
Sbjct: 185 SLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATL---LQRAPQLEELG 241

Query: 270 LGS------NKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQL 323
            G         + S +  +L     +  ++   + +   LP+       L  L+LS   +
Sbjct: 242 TGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATV 301

Query: 324 SGD-IPSTIGALVDLETISLAGSFGSVYKGTISDGTDVAIKIF-----NLQRERAFRSFN 377
               +   +     L+ + +                D  +++      +L+  R F S  
Sbjct: 302 QSYDLVKLLCQCPKLQRLWVLDYI-----------EDAGLEVLASTCKDLRELRVFPSEP 350

Query: 378 SECEVLRNVRHQNLIKILSSCS 399
              E    +  Q L+ +   C 
Sbjct: 351 FVMEPNVALTEQGLVSVSMGCP 372

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 40.7 bits (96), Expect = 8e-04
 Identities = 44/150 (29%), Positives = 66/150 (44%), Gaps = 27/150 (18%)

Query: 344 GSFGSVY----KGTISDGTDVAIKIF---NLQRERAFRSFNSECEVL-RNVRHQNLIKIL 395
           GSFG V     K         A+K+     + +++  +   SE  VL +NV+H  L+ + 
Sbjct: 49  GSFGKVLLARHKAE---EVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105

Query: 396 SSCSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLH-HGHSSAP 449
            S  T D       ++  G L   L     FL+   R     ++ S L YLH        
Sbjct: 106 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAA-EIASALGYLHSLN----- 159

Query: 450 IIHCDLKPTSILLDENMVAHV--SDFGISK 477
           I++ DLKP +ILLD     H+  +DFG+ K
Sbjct: 160 IVYRDLKPENILLDSQ--GHIVLTDFGLCK 187

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	481
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	100.0
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	100.0
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.98
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.97
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.97
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.97
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.97
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.97
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.97
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.97
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.97
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.97
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.97
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.97
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.97
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.97
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.97
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.97
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.96
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.96
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	99.96
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.96
4aoj_A	329	High affinity nerve growth factor receptor; transf	99.96
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	99.96
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.96
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.95
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.95
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.95
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	99.95
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	99.94
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.94
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	99.94
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.94
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.94
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.94
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.94
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	99.94
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	99.94
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	99.94
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	99.93
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.93
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.93
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.93
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.93
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	99.93
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.92
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	99.92
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.92
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.92
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.92
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.92
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.92
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.92
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.91
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.91
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.91
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.91
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.91
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.91
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.9
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.9
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.9
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	99.9
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	99.89
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.89
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	99.89
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.88
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	99.88
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.88
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.87
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.87
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.87
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.87
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.87
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.86
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.86
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.86
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.86
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.86
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.86
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.86
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.86
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.86
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.86
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.85
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.85
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	99.85
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.85
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.85
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.85
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.85
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.85
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.85
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.85
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.85
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.85
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.84
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.84
3niz_A	311	Rhodanese family protein; structural genomics, str	99.84
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.84
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.84
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.84
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.84
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.84
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.84
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.84
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.84
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.84
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.84
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.84
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.84
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.84
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.84
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.84
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.84
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.84
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.84
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.84
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.84
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.84
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.84
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.84
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.84
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.84
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.84
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.83
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.83
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.83
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.83
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.83
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.83
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.83
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.83
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.83
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.83
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.83
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.83
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.83
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.83
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.83
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.83
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.83
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.83
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.83
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.83
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.83
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.83
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.83
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.83
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.83
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.83
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.83
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.83
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.83
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.83
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.83
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.83
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.82
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.82
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.82
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.82
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.82
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.82
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.82
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.82
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.82
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.82
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.82
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.82
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.82
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.82
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.82
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.82
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.82
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.82
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.82
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.82
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.82
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.82
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.82
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.82
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.82
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.82
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.82
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.82
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.82
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.82
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.82
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.82
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.81
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.81
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.81
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.81
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.81
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.81
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.81
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.81
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.81
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.81
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.81
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.81
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.81
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.81
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.81
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.81
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.81
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.81
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.81
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.81
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.8
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.8
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.8
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.8
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.8
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.8
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.8
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.8
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.8
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.8
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.8
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.8
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.8
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.8
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.8
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.8
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.8
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.8
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.8
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.8
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.8
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.8
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.8
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.8
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.8
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.79
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.79
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.79
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.79
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.79
3bhy_A	283	Death-associated protein kinase 3; death associate	99.79
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.79
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.79
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.79
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.79
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.79
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.79
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.79
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.79
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.79
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.79
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.79
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.79
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.79
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.79
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.79
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.79
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.79
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.79
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.79
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.79
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.79
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.79
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.79
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.79
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.79
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.79
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.79
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.78
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.78
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.78
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.78
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.78
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.78
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.78
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.78
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.78
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.78
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.78
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.78
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.78
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.78
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.78
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.78
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.78
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.78
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.78
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.78
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.78
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.77
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.77
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.77
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.77
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.77
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.77
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.77
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.77
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.77
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.77
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.77
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.76
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.76
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.76
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.76
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.76
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.76
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.76
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.76
3uqc_A	286	Probable conserved transmembrane protein; structur	99.76
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.76
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.75
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.75
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.75
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.75
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.75
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.75
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.75
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.74
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.74
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.74
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.74
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.74
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.73
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.73
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.73
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.73
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.73
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.72
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.72
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.72
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.71
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.71
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.71
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.71
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.7
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.69
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.69
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.68
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.68
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.67
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.67
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.65
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.63
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.62
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.62
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.62
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.61
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.57
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.56
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.55
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.54
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.51
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.48
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.4
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.39
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.38
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.37
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.35
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.33
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	99.18
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	99.14
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.98
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.91
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.74
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.72
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	98.71
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.7
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.63
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.61
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.44
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.93
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	97.74
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.71
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	97.71
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.48
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	97.4
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.38
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.13
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.08
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.05
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.95
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	96.9
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	96.84
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	96.08
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	95.79
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	95.02
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	94.5
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	94.09
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	92.7
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	91.69
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	88.94
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	87.71
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	87.7
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	86.67
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	82.81
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	82.64
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	80.19

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=2.8e-47  Score=409.03  Aligned_cols=343  Identities=32%  Similarity=0.462  Sum_probs=217.6

Q ss_pred             eeccCcchhCC-CCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecch
Q 039957            2 TGQIPTEIGNL-QNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPN   80 (481)
Q Consensus         2 ~g~lp~~~~~l-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~   80 (481)
                      +|.+|..+..+ ++|++|+|++|++++.+|..|.++++|++|++++|+++|.+|...+..+++|++|++++|++++.+|.
T Consensus       282 ~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~  361 (768)
T 3rgz_A          282 TGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPE  361 (768)
T ss_dssp             EESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCT
T ss_pred             CCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccH
Confidence            46777776664 77777777777777777777777777777777777777777766334677777777777777777777


Q ss_pred             hccccc-cCceeecccCcceecCcccccC--CCCCCEEEcccccCccccCCCcc----------------ccccccCCCC
Q 039957           81 SITNAT-KLIILDLGFNTFSGHIPNTFGN--LRHLSVLSLLMNNLTTESSSAYQ----------------WSFLSSLTNC  141 (481)
Q Consensus        81 ~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~--l~~L~~L~L~~N~l~~~~~~~~~----------------~~~~~~l~~l  141 (481)
                      .+..++ +|++|++++|.+++.+|..+..  +++|++|++++|++++..+..+.                ...+..+.++
T Consensus       362 ~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l  441 (768)
T 3rgz_A          362 SLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSL  441 (768)
T ss_dssp             THHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGC
T ss_pred             HHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcC
Confidence            666655 5555555555555544444443  44455555555444433111100                0011234455


Q ss_pred             CCCcEEEccCCccceeCChhhhhcccCccEEEccCCceeecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeee
Q 039957          142 RYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFF  221 (481)
Q Consensus       142 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~  221 (481)
                      ++|++|++++|.+++.+|..+..+ ++|++|++++|++++.+|..+.++++|++|++++|++++.+|..++.+++|+.|+
T Consensus       442 ~~L~~L~L~~n~l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  520 (768)
T 3rgz_A          442 SKLRDLKLWLNMLEGEIPQELMYV-KTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILK  520 (768)
T ss_dssp             TTCCEEECCSSCCCSCCCGGGGGC-TTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEE
T ss_pred             CCCCEEECCCCcccCcCCHHHcCC-CCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEE
Confidence            566666666666666666655554 4566666666666666666666666666666666666666666666666666666


Q ss_pred             cCCCcCCCCCCccccCccCCCeeecCCCeeeecCCccc------------------------------------------
Q 039957          222 LPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCL------------------------------------------  259 (481)
Q Consensus       222 l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~------------------------------------------  259 (481)
                      +++|++++.+|..++.+++|+.|++++|+++|.+|..+                                          
T Consensus       521 L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  600 (768)
T 3rgz_A          521 LSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIR  600 (768)
T ss_dssp             CCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCC
T ss_pred             CCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcccccccccccccccccccccccccccccccc
Confidence            66666666666666666666666666666665555432                                          


Q ss_pred             ----------------------------ccCCCCCcEEcCCCcCcccCCcchhccccCcEEEccCcccCCCCCCccccCC
Q 039957          260 ----------------------------ASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLK  311 (481)
Q Consensus       260 ----------------------------~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~  311 (481)
                                                  ..+++|+.||+++|+++|.+|..+..++.|+.|++++|.+++.+|..+..++
T Consensus       601 ~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~  680 (768)
T 3rgz_A          601 SEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLR  680 (768)
T ss_dssp             GGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCT
T ss_pred             chhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCC
Confidence                                        2235566677777777777777777777777777777777777777777777


Q ss_pred             cCcEEEccCCeeeeeccccccccCChhhhhcccc
Q 039957          312 VLRVLDLSRNQLSGDIPSTIGALVDLETISLAGS  345 (481)
Q Consensus       312 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~~~g~  345 (481)
                      .|+.|||++|+++|.+|..++.++.|++++++++
T Consensus       681 ~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N  714 (768)
T 3rgz_A          681 GLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNN  714 (768)
T ss_dssp             TCCEEECCSSCCEECCCGGGGGCCCCSEEECCSS
T ss_pred             CCCEEECCCCcccCcCChHHhCCCCCCEEECcCC
Confidence            7777777777777777777777777777766654

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=1.7e-46  Score=402.89  Aligned_cols=342  Identities=33%  Similarity=0.553  Sum_probs=277.9

Q ss_pred             CeeccCcchhCCCCCCeeeCcCCcccccCChhccCC-cCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecc
Q 039957            1 MTGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNI-STIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIP   79 (481)
Q Consensus         1 ~~g~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p   79 (481)
                      ++|.+|..  .+++|++|+|++|++++.+|..+... ++|++|++++|++++.+|..+. .+++|++|++++|++++.+|
T Consensus       259 l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~-~l~~L~~L~L~~n~l~~~ip  335 (768)
T 3rgz_A          259 FVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFG-SCSLLESLALSSNNFSGELP  335 (768)
T ss_dssp             CEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGG-GCTTCCEEECCSSEEEEECC
T ss_pred             ccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHh-cCCCccEEECCCCcccCcCC
Confidence            35677765  89999999999999999999998876 9999999999999999999887 79999999999999998988


Q ss_pred             hh-ccccccCceeecccCcceecCcccccCCC-CCCEEEcccccCccccCCCcc------------------ccccccCC
Q 039957           80 NS-ITNATKLIILDLGFNTFSGHIPNTFGNLR-HLSVLSLLMNNLTTESSSAYQ------------------WSFLSSLT  139 (481)
Q Consensus        80 ~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~~~~~~------------------~~~~~~l~  139 (481)
                      .. +..+++|++|++++|.+++.+|..+.+++ +|++|++++|++++..+..+.                  ...+..+.
T Consensus       336 ~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~  415 (768)
T 3rgz_A          336 MDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLS  415 (768)
T ss_dssp             HHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGG
T ss_pred             HHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHh
Confidence            76 99999999999999999999999999998 999999999999864322111                  02334566


Q ss_pred             CCCCCcEEEccCCccceeCChhhhhcccCccEEEccCCceeecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCe
Q 039957          140 NCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQG  219 (481)
Q Consensus       140 ~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~  219 (481)
                      ++++|++|+|++|++++.+|..++.+ ++|+.|++++|.+++.+|..+..+++|++|++++|++++.+|..+..+++|+.
T Consensus       416 ~l~~L~~L~Ls~N~l~~~~p~~l~~l-~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~  494 (768)
T 3rgz_A          416 NCSELVSLHLSFNYLSGTIPSSLGSL-SKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNW  494 (768)
T ss_dssp             GCTTCCEEECCSSEEESCCCGGGGGC-TTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCE
T ss_pred             cCCCCCEEECcCCcccCcccHHHhcC-CCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCE
Confidence            67777777777777777777777766 46777777777777777777777778888888888887777777888888888


Q ss_pred             eecCCCcCCCCCCccccCccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCcCcccCCcchh---------------
Q 039957          220 FFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLW---------------  284 (481)
Q Consensus       220 l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~---------------  284 (481)
                      |++++|++++.+|..++.+++|+.|++++|++++.+|..+..+++|+.|++++|+++|.+|..++               
T Consensus       495 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~  574 (768)
T 3rgz_A          495 ISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKR  574 (768)
T ss_dssp             EECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCE
T ss_pred             EEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcccccc
Confidence            88888888877888888888888888888888888888888888888888888887776665442               


Q ss_pred             -------------------------------------------------------ccccCcEEEccCcccCCCCCCcccc
Q 039957          285 -------------------------------------------------------SLGYILEINLSSNLLNDSLPSNVQK  309 (481)
Q Consensus       285 -------------------------------------------------------~l~~L~~L~l~~N~l~~~~p~~~~~  309 (481)
                                                                             .++.|+.|++++|++++.+|..++.
T Consensus       575 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~  654 (768)
T 3rgz_A          575 YVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGS  654 (768)
T ss_dssp             EEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGG
T ss_pred             ccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhc
Confidence                                                                   2355677888888888888888888


Q ss_pred             CCcCcEEEccCCeeeeeccccccccCChhhhhccccc
Q 039957          310 LKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAGSF  346 (481)
Q Consensus       310 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~~~g~~  346 (481)
                      ++.|+.|+|++|+++|.+|..++.+++|+.|+++++.
T Consensus       655 l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~  691 (768)
T 3rgz_A          655 MPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNK  691 (768)
T ss_dssp             CTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSC
T ss_pred             cccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCc
Confidence            8888888888888888888888888888888877653

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=1.9e-43  Score=371.12  Aligned_cols=306  Identities=19%  Similarity=0.278  Sum_probs=235.5

Q ss_pred             cccccCChhccCCcCCCEEEeeCCcCccc-----------------cChhhh-cCCCCccEEEccCccceeecchhcccc
Q 039957           24 NLSGLIPPMIFNISTIRNLNLGGNRLSGH-----------------LPSMIG-HSLPNIKYLELGDNNLIGTIPNSITNA   85 (481)
Q Consensus        24 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-----------------~p~~~~-~~l~~L~~L~L~~N~l~~~~p~~~~~l   85 (481)
                      ++++ +|+.|.++++|++|+|++|+++|.                 +|+.++ ..+++|++|+|++|++.+.+|..|.++
T Consensus       194 ~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l  272 (636)
T 4eco_A          194 NITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKAL  272 (636)
T ss_dssp             EEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTC
T ss_pred             CCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcC
Confidence            3445 678888888899999998888875                 787764 158888899998888888888888888


Q ss_pred             ccCceeecccCc-cee-cCcccccCC------CCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCcccee
Q 039957           86 TKLIILDLGFNT-FSG-HIPNTFGNL------RHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGI  157 (481)
Q Consensus        86 ~~L~~L~Ls~N~-l~~-~~p~~~~~l------~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~  157 (481)
                      ++|++|++++|+ +++ .+|..++.+      ++|++|++++|+++.++..       ..+.++++|++|++++|+++|.
T Consensus       273 ~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~~ip~~-------~~l~~l~~L~~L~L~~N~l~g~  345 (636)
T 4eco_A          273 PEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVE-------TSLQKMKKLGMLECLYNQLEGK  345 (636)
T ss_dssp             SSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCSSCCCH-------HHHTTCTTCCEEECCSCCCEEE
T ss_pred             CCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCCccCch-------hhhccCCCCCEEeCcCCcCccc
Confidence            889999998888 888 788888776      8888888888888854320       0356778888888888888888


Q ss_pred             CChhhhhcccCccEEEccCCceeecCCcccccCCC-CCeEecccccceecCCcCCcCCC--CCCeeecCCCcCCCCCCcc
Q 039957          158 LPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRG-LIYLSLGFNDLNGTIPTSIGTLK--QLQGFFLPETNLQGYVPHN  234 (481)
Q Consensus       158 ~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~-L~~L~l~~N~l~~~~p~~~~~l~--~L~~l~l~~n~l~~~~p~~  234 (481)
                      +| .+..+ ++|++|++++|+++ .+|..+..+++ |++|++++|.++ .+|..+..++  +|+.|++++|.+++..|..
T Consensus       346 ip-~~~~l-~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~  421 (636)
T 4eco_A          346 LP-AFGSE-IKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKN  421 (636)
T ss_dssp             CC-CCEEE-EEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCS
T ss_pred             hh-hhCCC-CCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhh
Confidence            88 67665 57888888888888 77878888888 888888888887 6777776654  7888888888888887777


Q ss_pred             cc-------CccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCcCcccCCcchhc-c-------ccCcEEEccCccc
Q 039957          235 LC-------HLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWS-L-------GYILEINLSSNLL  299 (481)
Q Consensus       235 ~~-------~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~-l-------~~L~~L~l~~N~l  299 (481)
                      +.       .+.+|+.|++++|+++..++..+..+++|++|++++|+++ .+|..... .       +.|+.|++++|++
T Consensus       422 l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l  500 (636)
T 4eco_A          422 FDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKL  500 (636)
T ss_dssp             SCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCC
T ss_pred             hcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCccEEECcCCcC
Confidence            77       6677888888888887554455566778888888888887 44444332 2       2777888888887


Q ss_pred             CCCCCCccc--cCCcCcEEEccCCeeeeeccccccccCChhhhhccc
Q 039957          300 NDSLPSNVQ--KLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAG  344 (481)
Q Consensus       300 ~~~~p~~~~--~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~~~g  344 (481)
                      + .+|..+.  .+++|+.|++++|++++ +|..+..+++|+.|++++
T Consensus       501 ~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~  545 (636)
T 4eco_A          501 T-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRN  545 (636)
T ss_dssp             C-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCS
T ss_pred             C-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCC
Confidence            7 4666665  77778888888888876 677777777787777754

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=2.4e-43  Score=370.29  Aligned_cols=329  Identities=18%  Similarity=0.304  Sum_probs=291.1

Q ss_pred             eeccCcchhCCCCCCeeeCcCCccccc-----------------CChhcc--CCcCCCEEEeeCCcCccccChhhhcCCC
Q 039957            2 TGQIPTEIGNLQNLKSLFLGANNLSGL-----------------IPPMIF--NISTIRNLNLGGNRLSGHLPSMIGHSLP   62 (481)
Q Consensus         2 ~g~lp~~~~~l~~L~~L~L~~N~l~~~-----------------~p~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~~l~   62 (481)
                      +| ||.+|+++++|++|+|++|++++.                 +|+.+.  ++++|++|+|++|++.|.+|..++ .++
T Consensus       196 ~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~-~l~  273 (636)
T 4eco_A          196 TF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLK-ALP  273 (636)
T ss_dssp             EE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTT-TCS
T ss_pred             cc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHh-cCC
Confidence            57 999999999999999999999996                 899999  999999999999999999999887 899


Q ss_pred             CccEEEccCcc-cee-ecchhcccc------ccCceeecccCcceecCcc--cccCCCCCCEEEcccccCccccCCCccc
Q 039957           63 NIKYLELGDNN-LIG-TIPNSITNA------TKLIILDLGFNTFSGHIPN--TFGNLRHLSVLSLLMNNLTTESSSAYQW  132 (481)
Q Consensus        63 ~L~~L~L~~N~-l~~-~~p~~~~~l------~~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~~~~~~~  132 (481)
                      +|++|++++|+ +++ .+|..++.+      ++|++|++++|+++ .+|.  .|+++++|++|++++|++++.-+     
T Consensus       274 ~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-----  347 (636)
T 4eco_A          274 EMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-----  347 (636)
T ss_dssp             SCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-----
T ss_pred             CCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-----
Confidence            99999999998 998 899999887      99999999999999 7888  99999999999999999994311     


Q ss_pred             cccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEccCCceeecCCcccccCC--CCCeEecccccceecCCcC
Q 039957          133 SFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLR--GLIYLSLGFNDLNGTIPTS  210 (481)
Q Consensus       133 ~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~--~L~~L~l~~N~l~~~~p~~  210 (481)
                          .+..+++|++|+|++|+++ .+|..+..+..+|++|++++|.++ .+|..+..+.  +|++|++++|.+++.+|..
T Consensus       348 ----~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~  421 (636)
T 4eco_A          348 ----AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKN  421 (636)
T ss_dssp             ----CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCS
T ss_pred             ----hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhh
Confidence                3567789999999999998 788888887433999999999999 7888887755  8999999999999999988


Q ss_pred             Cc-------CCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeeeecCCcccccCC-------CCCcEEcCCCcCc
Q 039957          211 IG-------TLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLT-------SLRELDLGSNKLT  276 (481)
Q Consensus       211 ~~-------~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-------~L~~L~ls~N~l~  276 (481)
                      +.       .+++|+.|++++|+++...+..+..+++|+.|++++|+++..++..+....       +|+.|++++|+++
T Consensus       422 l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~  501 (636)
T 4eco_A          422 FDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT  501 (636)
T ss_dssp             SCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCCC
T ss_pred             hcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEECcCCcCC
Confidence            88       788999999999999976555667789999999999999954444444433       8999999999998


Q ss_pred             ccCCcchh--ccccCcEEEccCcccCCCCCCccccCCcCcEEEc------cCCeeeeeccccccccCChhhhhccccc
Q 039957          277 SSIPSSLW--SLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDL------SRNQLSGDIPSTIGALVDLETISLAGSF  346 (481)
Q Consensus       277 ~~~p~~~~--~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l------~~N~l~~~~p~~~~~l~~L~~l~~~g~~  346 (481)
                       .+|..+.  .++.|+.|++++|++++ +|..+..+++|++|++      ++|++.+.+|..++.+++|+.|+++++.
T Consensus       502 -~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~  577 (636)
T 4eco_A          502 -KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSND  577 (636)
T ss_dssp             -BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSC
T ss_pred             -ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCc
Confidence             7888886  89999999999999988 8889999999999999      5678888999999999999999988764

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=1.4e-42  Score=351.09  Aligned_cols=327  Identities=19%  Similarity=0.163  Sum_probs=250.8

Q ss_pred             CCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceee
Q 039957           13 QNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILD   92 (481)
Q Consensus        13 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~   92 (481)
                      ++|++|+|++|+++++.|..|.++++|++|++++|.+.+.++...+..+++|++|+|++|++++..|..|.++++|++|+
T Consensus        30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~  109 (455)
T 3v47_A           30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT  109 (455)
T ss_dssp             TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred             CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence            68999999999999999999999999999999999998777665555899999999999999988899999999999999


Q ss_pred             cccCcceecCccc--ccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcc-cCc
Q 039957           93 LGFNTFSGHIPNT--FGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFS-TSL  169 (481)
Q Consensus        93 Ls~N~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~-~~L  169 (481)
                      |++|.+++..|..  |+.+++|++|++++|+++++.+..       .+.++++|++|++++|++++..|..+..+. ..+
T Consensus       110 L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~-------~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L  182 (455)
T 3v47_A          110 LTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS-------FFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHF  182 (455)
T ss_dssp             CTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCG-------GGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEE
T ss_pred             CCCCCCCccccCcccccCcccCCEEECCCCccCccCccc-------ccCCCCcccEEeCCCCcccccChhhhhccccccc
Confidence            9999999866555  999999999999999998874322       156788999999999999988887776542 245


Q ss_pred             cEEEccCCceeecCCcc--------cccCCCCCeEecccccceecCCcCC------------------------------
Q 039957          170 QRFSASECKLKGTIPKE--------IGHLRGLIYLSLGFNDLNGTIPTSI------------------------------  211 (481)
Q Consensus       170 ~~L~l~~n~l~~~~p~~--------~~~l~~L~~L~l~~N~l~~~~p~~~------------------------------  211 (481)
                      +.+++++|.+.+..+..        +..+++|++|++++|++++..|..+                              
T Consensus       183 ~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~  262 (455)
T 3v47_A          183 TLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFK  262 (455)
T ss_dssp             EEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSC
T ss_pred             cccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhc
Confidence            55555555554332222        1133445555555554443322211                              


Q ss_pred             -------cC--CCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCcCcccCCcc
Q 039957          212 -------GT--LKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSS  282 (481)
Q Consensus       212 -------~~--l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~  282 (481)
                             ..  .++|+.+++++|.+.+..|..+..+++|+.|++++|++++..|..|..+++|++|++++|++++..|..
T Consensus       263 ~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~  342 (455)
T 3v47_A          263 DPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRM  342 (455)
T ss_dssp             CCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGG
T ss_pred             cCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhH
Confidence                   11  256778888888888777777888888888888888888777777888888888888888887777777


Q ss_pred             hhccccCcEEEccCcccCCCCCCccccCCcCcEEEccCCeeeeeccccccccCChhhhhccccc
Q 039957          283 LWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAGSF  346 (481)
Q Consensus       283 ~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~~~g~~  346 (481)
                      +..++.|++|++++|++++..|..+..+++|++|++++|++++..+..+..+++|++|+++++.
T Consensus       343 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~  406 (455)
T 3v47_A          343 FENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNP  406 (455)
T ss_dssp             GTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred             hcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCC
Confidence            7788888888888888877777778888888888888888887666677778888888777653

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=1.5e-41  Score=355.91  Aligned_cols=340  Identities=19%  Similarity=0.171  Sum_probs=276.3

Q ss_pred             eccCcchhCCCCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhc
Q 039957            3 GQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSI   82 (481)
Q Consensus         3 g~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~   82 (481)
                      +..|..|.++++|++|+|++|+++++.|.+|.++++|++|+|++|++++..|..+. .+++|++|++++|++++..|..|
T Consensus        46 ~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~-~l~~L~~L~L~~n~l~~~~~~~~  124 (606)
T 3vq2_A           46 ILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFS-GLTSLENLVAVETKLASLESFPI  124 (606)
T ss_dssp             EECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSST-TCTTCCEEECTTSCCCCSSSSCC
T ss_pred             EeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcC-CcccCCEEEccCCcccccccccc
Confidence            44455788899999999999999888888888999999999999998865576665 78899999999998887777788


Q ss_pred             cccccCceeecccCccee-cCcccccCCCCCCEEEcccccCccccCCCcccc-------------------cc-------
Q 039957           83 TNATKLIILDLGFNTFSG-HIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWS-------------------FL-------  135 (481)
Q Consensus        83 ~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~-------------------~~-------  135 (481)
                      +++++|++|++++|.+++ .+|..|+++++|++|++++|+++++++..+...                   .+       
T Consensus       125 ~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~  204 (606)
T 3vq2_A          125 GQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI  204 (606)
T ss_dssp             TTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC
T ss_pred             CCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCCcceeCcccccCc
Confidence            888899999999998876 568888899999999888888877644322100                   00       


Q ss_pred             --------------------------------------------------------------------------------
Q 039957          136 --------------------------------------------------------------------------------  135 (481)
Q Consensus       136 --------------------------------------------------------------------------------  135 (481)
                                                                                                      
T Consensus       205 ~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~l  284 (606)
T 3vq2_A          205 KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCL  284 (606)
T ss_dssp             EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGSCGGG
T ss_pred             eeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccccccC
Confidence                                                                                            


Q ss_pred             ----------------ccCCCCCCCcEEEccCCccceeCCh--------------------hhhhcccCccEEEccCCce
Q 039957          136 ----------------SSLTNCRYLVYLILSGNPLGGILPP--------------------SIGNFSTSLQRFSASECKL  179 (481)
Q Consensus       136 ----------------~~l~~l~~L~~L~Ls~N~l~~~~p~--------------------~~~~~~~~L~~L~l~~n~l  179 (481)
                                      +.+..+++|++|++++|.+ +.+|.                    .++.+ ++|++|++++|.+
T Consensus       285 ~~L~~L~l~~~~~~~l~~l~~~~~L~~L~l~~n~l-~~lp~~~l~~L~~L~l~~n~~~~~~~~~~l-~~L~~L~ls~n~l  362 (606)
T 3vq2_A          285 ANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQL-KQFPTLDLPFLKSLTLTMNKGSISFKKVAL-PSLSYLDLSRNAL  362 (606)
T ss_dssp             TTCSEEEEESCCCCCCCCCCTTCCCSEEEEESCCC-SSCCCCCCSSCCEEEEESCSSCEECCCCCC-TTCCEEECCSSCE
T ss_pred             CCCCEEEecCccchhhhhccccccCCEEEcccccC-cccccCCCCccceeeccCCcCccchhhccC-CCCCEEECcCCcc
Confidence                            0122233455555555554 23331                    12222 5789999999999


Q ss_pred             eec--CCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCC-ccccCccCCCeeecCCCeeeecCC
Q 039957          180 KGT--IPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVP-HNLCHLEMLNLLHLGGNKLSGHIP  256 (481)
Q Consensus       180 ~~~--~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p  256 (481)
                      ++.  +|..+..+++|++|++++|.+++ +|..+..+++|+.|++++|++.+..| ..+..+++|+.|++++|++++..|
T Consensus       363 ~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~  441 (606)
T 3vq2_A          363 SFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFD  441 (606)
T ss_dssp             EEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCT
T ss_pred             CCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccch
Confidence            876  48888999999999999999885 66889999999999999999998877 688899999999999999999889


Q ss_pred             cccccCCCCCcEEcCCCcCcc-cCCcchhccccCcEEEccCcccCCCCCCccccCCcCcEEEccCCeeeeeccccccccC
Q 039957          257 PCLASLTSLRELDLGSNKLTS-SIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALV  335 (481)
Q Consensus       257 ~~~~~l~~L~~L~ls~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~  335 (481)
                      ..|..+++|++|++++|++++ .+|..+..++.|++|++++|.+++..|..+..+++|++|++++|++++..|..++.++
T Consensus       442 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  521 (606)
T 3vq2_A          442 GIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLY  521 (606)
T ss_dssp             TTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCT
T ss_pred             hhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCC
Confidence            999999999999999999987 4788899999999999999999988888899999999999999999988899999999


Q ss_pred             Chhhhhccccc
Q 039957          336 DLETISLAGSF  346 (481)
Q Consensus       336 ~L~~l~~~g~~  346 (481)
                      +|+.|+++++.
T Consensus       522 ~L~~L~l~~N~  532 (606)
T 3vq2_A          522 SLSTLDCSFNR  532 (606)
T ss_dssp             TCCEEECTTSC
T ss_pred             cCCEEECCCCc
Confidence            99999988764

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=1.8e-41  Score=362.59  Aligned_cols=328  Identities=18%  Similarity=0.263  Sum_probs=283.9

Q ss_pred             eeccCcchhCCCCCCeeeCcCCcccc-----------------cCChhcc--CCcCCCEEEeeCCcCccccChhhhcCCC
Q 039957            2 TGQIPTEIGNLQNLKSLFLGANNLSG-----------------LIPPMIF--NISTIRNLNLGGNRLSGHLPSMIGHSLP   62 (481)
Q Consensus         2 ~g~lp~~~~~l~~L~~L~L~~N~l~~-----------------~~p~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~~l~   62 (481)
                      +| ||.+|+++++|++|+|++|++++                 .+|+.+.  ++++|++|+|++|++.+.+|..+. .++
T Consensus       438 ~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~-~L~  515 (876)
T 4ecn_A          438 TF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLY-DLP  515 (876)
T ss_dssp             EE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGG-GCS
T ss_pred             cc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHh-CCC
Confidence            45 99999999999999999999998                 3888877  999999999999999999998887 799


Q ss_pred             CccEEEccCcc-cee-ecchhccccc-------cCceeecccCcceecCcc--cccCCCCCCEEEcccccCccccCCCcc
Q 039957           63 NIKYLELGDNN-LIG-TIPNSITNAT-------KLIILDLGFNTFSGHIPN--TFGNLRHLSVLSLLMNNLTTESSSAYQ  131 (481)
Q Consensus        63 ~L~~L~L~~N~-l~~-~~p~~~~~l~-------~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~~~~~~  131 (481)
                      +|++|+|++|+ +++ .+|..+..++       +|++|+|++|.++ .+|.  .|+++++|++|+|++|+++.++     
T Consensus       516 ~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~~lp-----  589 (876)
T 4ecn_A          516 ELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVRHLE-----  589 (876)
T ss_dssp             SCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCCBCC-----
T ss_pred             CCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcccch-----
Confidence            99999999998 998 8998888777       9999999999999 7888  9999999999999999998553     


Q ss_pred             ccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEccCCceeecCCcccccCCC--CCeEecccccceecCCc
Q 039957          132 WSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRG--LIYLSLGFNDLNGTIPT  209 (481)
Q Consensus       132 ~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~--L~~L~l~~N~l~~~~p~  209 (481)
                           .+..+++|++|+|++|+++ .+|..+..+..+|+.|++++|.++ .+|..+..+..  |+.|++++|++.+.+|.
T Consensus       590 -----~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~  662 (876)
T 4ecn_A          590 -----AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRN  662 (876)
T ss_dssp             -----CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSS
T ss_pred             -----hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCcccc
Confidence                 3678899999999999999 788888887433999999999999 78888877654  99999999999887664


Q ss_pred             CC---c--CCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeeeecCCccccc-------CCCCCcEEcCCCcCcc
Q 039957          210 SI---G--TLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLAS-------LTSLRELDLGSNKLTS  277 (481)
Q Consensus       210 ~~---~--~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-------l~~L~~L~ls~N~l~~  277 (481)
                      ..   .  .+++|+.|++++|+++...+..+..+++|+.|+|++|+++..++..+..       +++|+.|++++|+++ 
T Consensus       663 l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-  741 (876)
T 4ecn_A          663 ISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-  741 (876)
T ss_dssp             CSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-
T ss_pred             chhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCCccChHHhccccccccccCCccEEECCCCCCc-
Confidence            32   2  3458999999999999644444568899999999999998443333332       238999999999998 


Q ss_pred             cCCcchh--ccccCcEEEccCcccCCCCCCccccCCcCcEEEccC------CeeeeeccccccccCChhhhhccccc
Q 039957          278 SIPSSLW--SLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSR------NQLSGDIPSTIGALVDLETISLAGSF  346 (481)
Q Consensus       278 ~~p~~~~--~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~------N~l~~~~p~~~~~l~~L~~l~~~g~~  346 (481)
                      .+|..+.  .++.|+.|++++|++++ +|..+..+++|+.|++++      |++.+.+|..+..+++|+.|+++++.
T Consensus       742 ~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~  817 (876)
T 4ecn_A          742 SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSND  817 (876)
T ss_dssp             CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSC
T ss_pred             cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCC
Confidence            7888887  89999999999999987 788899999999999976      78888999999999999999988764

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=1.3e-40  Score=348.77  Aligned_cols=339  Identities=20%  Similarity=0.173  Sum_probs=234.6

Q ss_pred             ccCcchhCCCCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhcc
Q 039957            4 QIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSIT   83 (481)
Q Consensus         4 ~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~   83 (481)
                      ..|..|+++++|++|+|++|+++++.|.+|.++++|++|+|++|++++..|..+. .+++|++|++++|++++..|..|.
T Consensus        48 ~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~-~l~~L~~L~L~~n~i~~l~~~~~~  126 (606)
T 3t6q_A           48 IQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALS-GPKALKHLFFIQTGISSIDFIPLH  126 (606)
T ss_dssp             ECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTS-SCTTCCEEECTTSCCSCGGGSCCT
T ss_pred             CChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhc-ccccccEeeccccCcccCCcchhc
Confidence            3455677777777777777777766677777777777777777777655455443 566666666666666554445555


Q ss_pred             ccccCceeecccCccee------------------------cCcccccCCCCCC--EEEcccccCccccCCCcccc----
Q 039957           84 NATKLIILDLGFNTFSG------------------------HIPNTFGNLRHLS--VLSLLMNNLTTESSSAYQWS----  133 (481)
Q Consensus        84 ~l~~L~~L~Ls~N~l~~------------------------~~p~~~~~l~~L~--~L~L~~N~l~~~~~~~~~~~----  133 (481)
                      ++++|++|++++|.+++                        ..|..|+.+++|+  .|++++|.++++++..+...    
T Consensus       127 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~  206 (606)
T 3t6q_A          127 NQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQS  206 (606)
T ss_dssp             TCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTTCEEEE
T ss_pred             cCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCccChhHhhhccccc
Confidence            55555555555555554                        4444444445554  44555555444433222100    


Q ss_pred             ---------------------------------------------------------------ccccCCCCCCCcEEEcc
Q 039957          134 ---------------------------------------------------------------FLSSLTNCRYLVYLILS  150 (481)
Q Consensus       134 ---------------------------------------------------------------~~~~l~~l~~L~~L~Ls  150 (481)
                                                                                     ....+..+++|++|+++
T Consensus       207 L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~  286 (606)
T 3t6q_A          207 LNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLT  286 (606)
T ss_dssp             EECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECT
T ss_pred             cccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEecc
Confidence                                                                           01125667889999999


Q ss_pred             CCccceeCChhhhhcccCccEEEccCCceeecCCcccccCCCCCeEecccccceecCCcC-CcCCCCCCeeecCCCcCCC
Q 039957          151 GNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTS-IGTLKQLQGFFLPETNLQG  229 (481)
Q Consensus       151 ~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~l~~L~~l~l~~n~l~~  229 (481)
                      +|.++ .+|+.+..+ ++|++|++++|.+++..|..+..+++|++|++++|.+.+.+|.. +..+++|+.|++++|.+++
T Consensus       287 ~n~l~-~lp~~l~~l-~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~  364 (606)
T 3t6q_A          287 ATHLS-ELPSGLVGL-STLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIET  364 (606)
T ss_dssp             TSCCS-CCCSSCCSC-TTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCE
T ss_pred             CCccC-CCChhhccc-ccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCcccc
Confidence            99888 577777766 57999999999998877888888888888888888887666544 7788888888888888877


Q ss_pred             CC--CccccCccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCcCcccCCcc-hhccccCcEEEccCcccCCCCCCc
Q 039957          230 YV--PHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSS-LWSLGYILEINLSSNLLNDSLPSN  306 (481)
Q Consensus       230 ~~--p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~l~~L~~L~l~~N~l~~~~p~~  306 (481)
                      ..  |..+..+++|+.|++++|++.+..|..|..+++|+.|++++|++++..|.. +..++.|++|++++|.+.+..|..
T Consensus       365 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~  444 (606)
T 3t6q_A          365 SDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQL  444 (606)
T ss_dssp             EEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTT
T ss_pred             ccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHH
Confidence            65  667778888888888888888777778888888888888888887665543 677778888888888887777777


Q ss_pred             cccCCcCcEEEccCCeeeee---ccccccccCChhhhhcccc
Q 039957          307 VQKLKVLRVLDLSRNQLSGD---IPSTIGALVDLETISLAGS  345 (481)
Q Consensus       307 ~~~l~~L~~L~l~~N~l~~~---~p~~~~~l~~L~~l~~~g~  345 (481)
                      +..+++|++|++++|++.+.   .+..+..+++|++|+++++
T Consensus       445 ~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n  486 (606)
T 3t6q_A          445 FDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFC  486 (606)
T ss_dssp             TTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTS
T ss_pred             HhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCC
Confidence            77777788888888877652   2355777777777777655

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=6.8e-41  Score=350.95  Aligned_cols=332  Identities=20%  Similarity=0.165  Sum_probs=281.0

Q ss_pred             ccCcchhCCCCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhcc
Q 039957            4 QIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSIT   83 (481)
Q Consensus         4 ~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~   83 (481)
                      .+|..+.  ++|++|+|++|+++++.+..|.++++|++|+|++|++++..|..+. .+++|++|+|++|++++..|.+|.
T Consensus        25 ~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~-~l~~L~~L~Ls~n~l~~~~p~~~~  101 (606)
T 3vq2_A           25 KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWH-GLHHLSNLILTGNPIQSFSPGSFS  101 (606)
T ss_dssp             SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTT-TCTTCCEEECTTCCCCCCCTTSST
T ss_pred             cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhh-chhhcCEeECCCCcccccChhhcC
Confidence            5676654  7899999999999999999999999999999999999965566665 899999999999999988899999


Q ss_pred             ccccCceeecccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhh
Q 039957           84 NATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIG  163 (481)
Q Consensus        84 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~  163 (481)
                      ++++|++|++++|.+++..|..|+++++|++|++++|.+++..       .+..+.++++|++|++++|++++..|..+.
T Consensus       102 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-------lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~  174 (606)
T 3vq2_A          102 GLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCK-------LPAYFSNLTNLVHVDLSYNYIQTITVNDLQ  174 (606)
T ss_dssp             TCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCC-------CCGGGGTCTTCCEEECCSSCCCEECTTTTH
T ss_pred             CcccCCEEEccCCccccccccccCCCCCCCEEeCCCCccccee-------chHhHhhcCCCCEEEccCCcceecChhhhh
Confidence            9999999999999999888899999999999999999998642       124567788888888888888877665443


Q ss_pred             hcc--------------------------cCccEEEccCCcee-------------------------------------
Q 039957          164 NFS--------------------------TSLQRFSASECKLK-------------------------------------  180 (481)
Q Consensus       164 ~~~--------------------------~~L~~L~l~~n~l~-------------------------------------  180 (481)
                      .+.                          .+|+.|++++|.++                                     
T Consensus       175 ~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~  254 (606)
T 3vq2_A          175 FLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSI  254 (606)
T ss_dssp             HHHHCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGG
T ss_pred             hhhccccccceeeccCCCcceeCcccccCceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHH
Confidence            321                          02333333333221                                     


Q ss_pred             -----------------------------------------------------------------ecCCc----------
Q 039957          181 -----------------------------------------------------------------GTIPK----------  185 (481)
Q Consensus       181 -----------------------------------------------------------------~~~p~----------  185 (481)
                                                                                       +.+|.          
T Consensus       255 ~~~l~~l~l~~l~l~~~~~~~~~~~~~~~l~~L~~L~l~~~~~~~l~~l~~~~~L~~L~l~~n~l~~lp~~~l~~L~~L~  334 (606)
T 3vq2_A          255 MEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLT  334 (606)
T ss_dssp             GTTGGGSEEEEEEECCCTTCCGGGGSCGGGTTCSEEEEESCCCCCCCCCCTTCCCSEEEEESCCCSSCCCCCCSSCCEEE
T ss_pred             hhhhhhccHhheeccccccccccccccccCCCCCEEEecCccchhhhhccccccCCEEEcccccCcccccCCCCccceee
Confidence                                                                             12221          


Q ss_pred             ----------ccccCCCCCeEecccccceec--CCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeeee
Q 039957          186 ----------EIGHLRGLIYLSLGFNDLNGT--IPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSG  253 (481)
Q Consensus       186 ----------~~~~l~~L~~L~l~~N~l~~~--~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~  253 (481)
                                .+..+++|++|++++|.+++.  +|..+..+++|+.|++++|.+.+ +|..+..+++|+.|++++|++.+
T Consensus       335 l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~  413 (606)
T 3vq2_A          335 LTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKR  413 (606)
T ss_dssp             EESCSSCEECCCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEES
T ss_pred             ccCCcCccchhhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCC
Confidence                      233456788888888888866  48889999999999999999987 56889999999999999999998


Q ss_pred             cCC-cccccCCCCCcEEcCCCcCcccCCcchhccccCcEEEccCcccCC-CCCCccccCCcCcEEEccCCeeeeeccccc
Q 039957          254 HIP-PCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLND-SLPSNVQKLKVLRVLDLSRNQLSGDIPSTI  331 (481)
Q Consensus       254 ~~p-~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~  331 (481)
                      ..| ..|..+++|++|++++|++++..|..+..++.|++|++++|.+.+ .+|..+..+++|++|++++|++++..|..+
T Consensus       414 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~  493 (606)
T 3vq2_A          414 VTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVF  493 (606)
T ss_dssp             TTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTT
T ss_pred             ccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhh
Confidence            887 789999999999999999999999999999999999999999998 479999999999999999999999999999


Q ss_pred             cccCChhhhhccccc
Q 039957          332 GALVDLETISLAGSF  346 (481)
Q Consensus       332 ~~l~~L~~l~~~g~~  346 (481)
                      +.+++|++|+++++.
T Consensus       494 ~~l~~L~~L~Ls~N~  508 (606)
T 3vq2_A          494 DTLHRLQLLNMSHNN  508 (606)
T ss_dssp             TTCTTCCEEECCSSC
T ss_pred             cccccCCEEECCCCc
Confidence            999999999998764

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=4.3e-41  Score=352.45  Aligned_cols=338  Identities=19%  Similarity=0.186  Sum_probs=222.3

Q ss_pred             ccCcchhCCCCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhcc
Q 039957            4 QIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSIT   83 (481)
Q Consensus         4 ~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~   83 (481)
                      .+|..+..  ++++|+|++|+|+++.|..|.++++|++|+|++|++++..|..+. .+++|++|+|++|++++..|.+|.
T Consensus        26 ~iP~~l~~--~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~-~l~~L~~L~Ls~n~l~~~~~~~~~  102 (606)
T 3t6q_A           26 EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQ-SQHRLDTLVLTANPLIFMAETALS  102 (606)
T ss_dssp             SCCTTSCT--TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTT-TCTTCCEEECTTCCCSEECTTTTS
T ss_pred             cCcCCCCC--cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhcc-CccccCeeeCCCCcccccChhhhc
Confidence            56766653  799999999999999999999999999999999999976677775 899999999999999999999999


Q ss_pred             ccccCceeecccCcceecCcccccCCCCCCEEEcccccCccccCCCcc-c---------------cccccCCCCCCCc--
Q 039957           84 NATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQ-W---------------SFLSSLTNCRYLV--  145 (481)
Q Consensus        84 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~---------------~~~~~l~~l~~L~--  145 (481)
                      ++++|++|++++|.+++..|..|+++++|++|++++|++++++...+. .               ..+..+..+++|+  
T Consensus       103 ~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l  182 (606)
T 3t6q_A          103 GPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNL  182 (606)
T ss_dssp             SCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSE
T ss_pred             ccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhccccee
Confidence            999999999999999998889999999999999999999986322210 0               0011233444555  


Q ss_pred             EEEccCCccceeCChhhhhc--------------------------------------------------ccCccEEEcc
Q 039957          146 YLILSGNPLGGILPPSIGNF--------------------------------------------------STSLQRFSAS  175 (481)
Q Consensus       146 ~L~Ls~N~l~~~~p~~~~~~--------------------------------------------------~~~L~~L~l~  175 (481)
                      .|++++|.+++..|..+...                                                  ..+++.++++
T Consensus       183 ~L~l~~n~l~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~  262 (606)
T 3t6q_A          183 SLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQ  262 (606)
T ss_dssp             EEECTTCCCCEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECT
T ss_pred             EEecCCCccCccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEee
Confidence            55666666555544332210                                                  0034555555


Q ss_pred             CCceeecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCe-----
Q 039957          176 ECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNK-----  250 (481)
Q Consensus       176 ~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~-----  250 (481)
                      +|.+++..+..|..+++|++|++++|+++ .+|..+..+++|++|++++|.+.+..|..+..+++|+.|++++|.     
T Consensus       263 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~  341 (606)
T 3t6q_A          263 KHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLEL  341 (606)
T ss_dssp             TCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBC
T ss_pred             cCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCccccc
Confidence            55555555555666666666666666665 455556666666666666666555555455555555555555554     


Q ss_pred             --------------------eeecC--CcccccCCCCCcEEcCCCcCcccCCcchhccccCcEEEccCcccCCCCCC-cc
Q 039957          251 --------------------LSGHI--PPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPS-NV  307 (481)
Q Consensus       251 --------------------l~~~~--p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~  307 (481)
                                          +++..  |..+..+++|++|++++|++++..|..+..++.|++|++++|.+.+..|. .+
T Consensus       342 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~  421 (606)
T 3t6q_A          342 GTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPF  421 (606)
T ss_dssp             CSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTT
T ss_pred             chhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhh
Confidence                                44333  44444555555555555555555555555555555555555555544332 25


Q ss_pred             ccCCcCcEEEccCCeeeeeccccccccCChhhhhcccc
Q 039957          308 QKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAGS  345 (481)
Q Consensus       308 ~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~~~g~  345 (481)
                      ..+++|++|++++|++.+..|..++.+++|++|+++++
T Consensus       422 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n  459 (606)
T 3t6q_A          422 QNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGN  459 (606)
T ss_dssp             TTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTC
T ss_pred             hCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCC
Confidence            55555555555555555555555555566666655544

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=1.6e-41  Score=362.82  Aligned_cols=330  Identities=18%  Similarity=0.222  Sum_probs=281.9

Q ss_pred             CeeccCcchhCCCCCCeeeC-cCCccccc---------------------------------------------------
Q 039957            1 MTGQIPTEIGNLQNLKSLFL-GANNLSGL---------------------------------------------------   28 (481)
Q Consensus         1 ~~g~lp~~~~~l~~L~~L~L-~~N~l~~~---------------------------------------------------   28 (481)
                      ++|.+|++|++|++|++|+| ++|.++|.                                                   
T Consensus       335 L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~  414 (876)
T 4ecn_A          335 AKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEM  414 (876)
T ss_dssp             CEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTS
T ss_pred             CCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccc
Confidence            47999999999999999999 77765444                                                   


Q ss_pred             -------------------------CChhccCCcCCCEEEeeCCcCcc-----------------ccChhh-hcCCCCcc
Q 039957           29 -------------------------IPPMIFNISTIRNLNLGGNRLSG-----------------HLPSMI-GHSLPNIK   65 (481)
Q Consensus        29 -------------------------~p~~~~~l~~L~~L~L~~N~l~~-----------------~~p~~~-~~~l~~L~   65 (481)
                                               +|..|.++++|++|+|++|+++|                 .+|+.+ +..+++|+
T Consensus       415 ~~i~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~  494 (876)
T 4ecn_A          415 KPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLT  494 (876)
T ss_dssp             CCCCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCC
T ss_pred             cccccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCC
Confidence                                     78889999999999999999997                 388876 23699999


Q ss_pred             EEEccCccceeecchhccccccCceeecccCc-cee-cCcccccCCC-------CCCEEEcccccCccccCCCccccccc
Q 039957           66 YLELGDNNLIGTIPNSITNATKLIILDLGFNT-FSG-HIPNTFGNLR-------HLSVLSLLMNNLTTESSSAYQWSFLS  136 (481)
Q Consensus        66 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~-~~p~~~~~l~-------~L~~L~L~~N~l~~~~~~~~~~~~~~  136 (481)
                      +|+|++|++.+.+|..|.++++|++|+|++|+ +++ .+|..|+.++       +|++|+|++|+++.++..       .
T Consensus       495 ~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~~ip~~-------~  567 (876)
T 4ecn_A          495 DVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPAS-------A  567 (876)
T ss_dssp             EEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCCBCCCH-------H
T ss_pred             EEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCCccCCh-------h
Confidence            99999999999999999999999999999998 998 8888777665       999999999999865320       1


Q ss_pred             cCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEccCCceeecCCcccccCCC-CCeEecccccceecCCcCCcCCC
Q 039957          137 SLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRG-LIYLSLGFNDLNGTIPTSIGTLK  215 (481)
Q Consensus       137 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~-L~~L~l~~N~l~~~~p~~~~~l~  215 (481)
                      .+.++++|++|+|++|+++ .+| .+..+ ++|+.|++++|+++ .+|..+..+++ |++|++++|.++ .+|..+..++
T Consensus       568 ~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L-~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~  642 (876)
T 4ecn_A          568 SLQKMVKLGLLDCVHNKVR-HLE-AFGTN-VKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKS  642 (876)
T ss_dssp             HHTTCTTCCEEECTTSCCC-BCC-CCCTT-SEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTC
T ss_pred             hhhcCCCCCEEECCCCCcc-cch-hhcCC-CcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccc
Confidence            4678899999999999999 777 77776 68999999999999 88989999999 999999999998 7888888775


Q ss_pred             C--CCeeecCCCcCCCCCCccc---c--CccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCcCcccCCcchhc---
Q 039957          216 Q--LQGFFLPETNLQGYVPHNL---C--HLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWS---  285 (481)
Q Consensus       216 ~--L~~l~l~~n~l~~~~p~~~---~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~---  285 (481)
                      .  |+.|++++|++.+.+|...   .  .+.+|+.|++++|+++..++..+..+++|+.|++++|+++ .+|..+..   
T Consensus       643 ~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~  721 (876)
T 4ecn_A          643 VYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLKPKD  721 (876)
T ss_dssp             SSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTT
T ss_pred             cCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCC-ccChHHhcccc
Confidence            5  9999999999998766433   2  3458999999999999544444558999999999999998 56655443   


Q ss_pred             -----cccCcEEEccCcccCCCCCCccc--cCCcCcEEEccCCeeeeeccccccccCChhhhhcccc
Q 039957          286 -----LGYILEINLSSNLLNDSLPSNVQ--KLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAGS  345 (481)
Q Consensus       286 -----l~~L~~L~l~~N~l~~~~p~~~~--~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~~~g~  345 (481)
                           ++.|+.|++++|+++ .+|..+.  .+++|+.|++++|++++ +|..+..+++|+.|+++++
T Consensus       722 ~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N  786 (876)
T 4ecn_A          722 GNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQ  786 (876)
T ss_dssp             SCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCC
T ss_pred             ccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCC
Confidence                 238999999999998 6788886  89999999999999997 7889999999999998763

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.4e-40  Score=336.69  Aligned_cols=312  Identities=22%  Similarity=0.218  Sum_probs=284.5

Q ss_pred             ccCcchhCCCCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhcc
Q 039957            4 QIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSIT   83 (481)
Q Consensus         4 ~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~   83 (481)
                      .+|..+.  +++++|+|++|+++++.|..|.++++|++|+|++|.+++..|..+. .+++|++|+|++|++++..+..|.
T Consensus        25 ~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~-~l~~L~~L~L~~n~l~~~~~~~~~  101 (477)
T 2id5_A           25 AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFN-NLFNLRTLGLRSNRLKLIPLGVFT  101 (477)
T ss_dssp             SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTT-TCTTCCEEECCSSCCCSCCTTSST
T ss_pred             cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhh-CCccCCEEECCCCcCCccCccccc
Confidence            4676553  5899999999999999999999999999999999999976677765 899999999999999977777899


Q ss_pred             ccccCceeecccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhh
Q 039957           84 NATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIG  163 (481)
Q Consensus        84 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~  163 (481)
                      ++++|++|+|++|.+++..|..|.++++|++|++++|.++++.+.        .+.++++|++|+|++|++++..+..+.
T Consensus       102 ~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~--------~~~~l~~L~~L~l~~n~l~~~~~~~l~  173 (477)
T 2id5_A          102 GLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHR--------AFSGLNSLEQLTLEKCNLTSIPTEALS  173 (477)
T ss_dssp             TCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTT--------SSTTCTTCCEEEEESCCCSSCCHHHHT
T ss_pred             CCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChh--------hccCCCCCCEEECCCCcCcccChhHhc
Confidence            999999999999999999999999999999999999999987543        467889999999999999976666677


Q ss_pred             hcccCccEEEccCCceeecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCe
Q 039957          164 NFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNL  243 (481)
Q Consensus       164 ~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~  243 (481)
                      .+ ++|+.|++++|.+.+..+..|..+++|++|++++|.+.+.+|.......+|+.|++++|+++...+..|..+++|+.
T Consensus       174 ~l-~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~  252 (477)
T 2id5_A          174 HL-HGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRF  252 (477)
T ss_dssp             TC-TTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCE
T ss_pred             cc-CCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCe
Confidence            76 68999999999999988889999999999999999988888888777789999999999999876678999999999


Q ss_pred             eecCCCeeeecCCcccccCCCCCcEEcCCCcCcccCCcchhccccCcEEEccCcccCCCCCCccccCCcCcEEEccCCee
Q 039957          244 LHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQL  323 (481)
Q Consensus       244 L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l  323 (481)
                      |++++|++++..+..|..+++|+.|++++|++++..|..|..++.|+.|++++|++++..+..|..+++|+.|++++|++
T Consensus       253 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l  332 (477)
T 2id5_A          253 LNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPL  332 (477)
T ss_dssp             EECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCE
T ss_pred             eECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCc
Confidence            99999999999999999999999999999999999999999999999999999999988888889999999999999999


Q ss_pred             eeec
Q 039957          324 SGDI  327 (481)
Q Consensus       324 ~~~~  327 (481)
                      .+.-
T Consensus       333 ~c~c  336 (477)
T 2id5_A          333 ACDC  336 (477)
T ss_dssp             ECSG
T ss_pred             cCcc
Confidence            8754

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.8e-40  Score=339.86  Aligned_cols=320  Identities=26%  Similarity=0.341  Sum_probs=215.3

Q ss_pred             ccCcchhCCCCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhcc
Q 039957            4 QIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSIT   83 (481)
Q Consensus         4 ~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~   83 (481)
                      .+|..+.  ++|++|+|++|+++++.|..|.++++|++|+|++|++++..|..+. .+++|++|+|++|+++ .+|..  
T Consensus        14 ~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~-~l~~L~~L~Ls~N~l~-~lp~~--   87 (520)
T 2z7x_B           14 HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFK-FNQELEYLDLSHNKLV-KISCH--   87 (520)
T ss_dssp             SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGT-TCTTCCEEECCSSCCC-EEECC--
T ss_pred             ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhh-cccCCCEEecCCCcee-ecCcc--
Confidence            4676665  7888888888888888778888888888888888888865566665 7888888888888887 45554  


Q ss_pred             ccccCceeecccCccee-cCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCC--cEEEccCCcc--ceeC
Q 039957           84 NATKLIILDLGFNTFSG-HIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYL--VYLILSGNPL--GGIL  158 (481)
Q Consensus        84 ~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L--~~L~Ls~N~l--~~~~  158 (481)
                      .+++|++|+|++|.+++ .+|..|+++++|++|++++|.+++..           +..+++|  ++|++++|.+  .+..
T Consensus        88 ~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~-----------~~~l~~L~L~~L~l~~n~l~~~~~~  156 (520)
T 2z7x_B           88 PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSS-----------VLPIAHLNISKVLLVLGETYGEKED  156 (520)
T ss_dssp             CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCGGG-----------GGGGTTSCEEEEEEEECTTTTSSCC
T ss_pred             ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccchhh-----------ccccccceeeEEEeecccccccccc
Confidence            78888888888888887 46788888888888888888876521           1122223  4444444444  3333


Q ss_pred             Chhhhhc-------------------------------------------------------------------------
Q 039957          159 PPSIGNF-------------------------------------------------------------------------  165 (481)
Q Consensus       159 p~~~~~~-------------------------------------------------------------------------  165 (481)
                      |..+..+                                                                         
T Consensus       157 ~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~  236 (520)
T 2z7x_B          157 PEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNS  236 (520)
T ss_dssp             TTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHH
T ss_pred             cccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCHHH
Confidence            3222221                                                                         


Q ss_pred             ---------ccCccEEEccCCceeecCCccc-----ccCCCCCeEecccccceecCC-----------------------
Q 039957          166 ---------STSLQRFSASECKLKGTIPKEI-----GHLRGLIYLSLGFNDLNGTIP-----------------------  208 (481)
Q Consensus       166 ---------~~~L~~L~l~~n~l~~~~p~~~-----~~l~~L~~L~l~~N~l~~~~p-----------------------  208 (481)
                               .++|++|++++|+++|.+|..+     +.+++|+.+++++|.+  .+|                       
T Consensus       237 ~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l  314 (520)
T 2z7x_B          237 FIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRM  314 (520)
T ss_dssp             HHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCC
T ss_pred             HHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCcc
Confidence                     1257777777777777777666     4455444444444444  122                       


Q ss_pred             --cC-CcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeeee--cCCcccccCCCCCcEEcCCCcCcccCCc-c
Q 039957          209 --TS-IGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSG--HIPPCLASLTSLRELDLGSNKLTSSIPS-S  282 (481)
Q Consensus       209 --~~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~ls~N~l~~~~p~-~  282 (481)
                        .. +..+++|+.|++++|++++..|..+..+++|+.|++++|++++  .+|..+..+++|++|++++|++++.+|. .
T Consensus       315 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~  394 (520)
T 2z7x_B          315 VHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGD  394 (520)
T ss_dssp             CCCCCCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCS
T ss_pred             ccccchhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccch
Confidence              00 1466677777777777777777777777777777777777765  3445677777777777777777764444 3


Q ss_pred             hhccccCcEEEccCcccCCCCCCccccCCcCcEEEccCCeeeeeccccccccCChhhhhcccc
Q 039957          283 LWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAGS  345 (481)
Q Consensus       283 ~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~~~g~  345 (481)
                      +..++.|++|++++|++++..|..+.  ++|++|++++|+++ .+|..+..+++|+.|+++++
T Consensus       395 ~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N  454 (520)
T 2z7x_B          395 CSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASN  454 (520)
T ss_dssp             CCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSS
T ss_pred             hccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCC
Confidence            56667777777777777665555443  56777777777776 56665667777777776655

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=6.8e-40  Score=340.83  Aligned_cols=335  Identities=20%  Similarity=0.214  Sum_probs=219.0

Q ss_pred             cCcchhCCCCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccc
Q 039957            5 IPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITN   84 (481)
Q Consensus         5 lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~   84 (481)
                      .|.+|.++++|++|+|++|+++++.|.+|.++++|++|+|++|++++..|..+. .+++|++|++++|++++..+..|++
T Consensus        44 ~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~n~l~~l~~~~~~~  122 (570)
T 2z63_A           44 GSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFS-GLSSLQKLVAVETNLASLENFPIGH  122 (570)
T ss_dssp             CTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTT-TCTTCCEEECTTSCCCCSTTCSCTT
T ss_pred             ChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhc-CccccccccccccccccCCCccccc
Confidence            355778888888888888888887778888888888888888888744444443 6788888888888877655556777


Q ss_pred             cccCceeecccCccee-cCcccccCCCCCCEEEcccccCccccCCCcc----------------------------c---
Q 039957           85 ATKLIILDLGFNTFSG-HIPNTFGNLRHLSVLSLLMNNLTTESSSAYQ----------------------------W---  132 (481)
Q Consensus        85 l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~----------------------------~---  132 (481)
                      +++|++|++++|.+++ .+|..|+++++|++|++++|.++++++..+.                            .   
T Consensus       123 l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~~L  202 (570)
T 2z63_A          123 LKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRL  202 (570)
T ss_dssp             CTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEE
T ss_pred             cccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCCCceecCHHHhccCcc
Confidence            8888888888887776 3577788888888888888777655322110                            0   


Q ss_pred             ----------------------------------------------------------------------cccccCCCCC
Q 039957          133 ----------------------------------------------------------------------SFLSSLTNCR  142 (481)
Q Consensus       133 ----------------------------------------------------------------------~~~~~l~~l~  142 (481)
                                                                                            ..+..+..++
T Consensus       203 ~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~  282 (570)
T 2z63_A          203 HKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLT  282 (570)
T ss_dssp             EEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGT
T ss_pred             eeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcC
Confidence                                                                                  0011223345


Q ss_pred             CCcEEEccCCccceeCChhhhhcccCccEEEccCCceeecCCcc--------------------cccCCCCCeEeccccc
Q 039957          143 YLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKE--------------------IGHLRGLIYLSLGFND  202 (481)
Q Consensus       143 ~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~--------------------~~~l~~L~~L~l~~N~  202 (481)
                      +|++|++++|.++ .+|+.+...  +|++|++++|.+. .+|..                    ...+++|++|++++|.
T Consensus       283 ~L~~L~l~~~~l~-~l~~~~~~~--~L~~L~l~~n~~~-~l~~~~l~~L~~L~l~~n~~~~~~~~~~~~~L~~L~l~~n~  358 (570)
T 2z63_A          283 NVSSFSLVSVTIE-RVKDFSYNF--GWQHLELVNCKFG-QFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNG  358 (570)
T ss_dssp             TCSEEEEESCEEC-SCCBCCSCC--CCSEEEEESCBCS-SCCBCBCSSCCEEEEESCBSCCBCCCCBCTTCCEEECCSSC
T ss_pred             cccEEEecCccch-hhhhhhccC--CccEEeeccCccc-ccCcccccccCEEeCcCCccccccccccCCCCCEEeCcCCc
Confidence            5666666666655 244433332  3444444444333 12211                    0345667777777777


Q ss_pred             ceecC--CcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeeeecCC-cccccCCCCCcEEcCCCcCcccC
Q 039957          203 LNGTI--PTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIP-PCLASLTSLRELDLGSNKLTSSI  279 (481)
Q Consensus       203 l~~~~--p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~ls~N~l~~~~  279 (481)
                      +++..  |..+..+++|+.|++++|.+.+..+. +..+++|+.|++++|.+.+..| ..+..+++|++|++++|.+++..
T Consensus       359 l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~  437 (570)
T 2z63_A          359 LSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAF  437 (570)
T ss_dssp             CBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECC
T ss_pred             cCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccc
Confidence            66543  55566677777777777776664444 6667777777777777766554 45666777777777777777666


Q ss_pred             CcchhccccCcEEEccCcccC-CCCCCccccCCcCcEEEccCCeeeeeccccccccCChhhhhcccc
Q 039957          280 PSSLWSLGYILEINLSSNLLN-DSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAGS  345 (481)
Q Consensus       280 p~~~~~l~~L~~L~l~~N~l~-~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~~~g~  345 (481)
                      |..+..++.|++|++++|.+. +.+|..+..+++|++|++++|++++..|..++.+++|++|+++++
T Consensus       438 ~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n  504 (570)
T 2z63_A          438 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASN  504 (570)
T ss_dssp             TTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             hhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCC
Confidence            767777777777777777765 456666777777777777777777666777777777777776654

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=2.6e-39  Score=343.50  Aligned_cols=330  Identities=23%  Similarity=0.250  Sum_probs=178.4

Q ss_pred             cchhCCCCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccc
Q 039957            7 TEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNAT   86 (481)
Q Consensus         7 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~   86 (481)
                      ..|+++++|++|+|++|+++++.|.+|.++++|++|+|++|+++ .+|...+..+++|++|+|++|++++..|..|.+++
T Consensus        43 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~  121 (680)
T 1ziw_A           43 ANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS-QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK  121 (680)
T ss_dssp             GGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCT
T ss_pred             HHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccC-ccChhhhccCCCCCEEECCCCccCccChhHccccC
Confidence            45677777777777777777777777777777777777777776 45543333677777777777777666666677777


Q ss_pred             cCceeecccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeC--------
Q 039957           87 KLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGIL--------  158 (481)
Q Consensus        87 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~--------  158 (481)
                      +|++|++++|.+++..|..|+++++|++|++++|.+++.++..+.      ...+++|++|++++|.+++..        
T Consensus       122 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~------~~~~~~L~~L~L~~n~l~~~~~~~~~~l~  195 (680)
T 1ziw_A          122 NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELD------IFANSSLKKLELSSNQIKEFSPGCFHAIG  195 (680)
T ss_dssp             TCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHG------GGTTCEESEEECTTCCCCCBCTTGGGGSS
T ss_pred             CCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhh------ccccccccEEECCCCcccccChhhhhhhh
Confidence            777777777777776666777777777777777776655332110      112234444444444444433        


Q ss_pred             -------------------------------------------Chhhhhcc-cCccEEEccCCceeecCCcccccCCCCC
Q 039957          159 -------------------------------------------PPSIGNFS-TSLQRFSASECKLKGTIPKEIGHLRGLI  194 (481)
Q Consensus       159 -------------------------------------------p~~~~~~~-~~L~~L~l~~n~l~~~~p~~~~~l~~L~  194 (481)
                                                                 |..+..+. ++|++|++++|++++..|..|+.+++|+
T Consensus       196 ~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~  275 (680)
T 1ziw_A          196 RLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLE  275 (680)
T ss_dssp             EECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred             hhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCcccccCccccc
Confidence                                                       33333321 1244444444444444444444444444


Q ss_pred             eEecccccceecCCcCCcCCCCCCeeecCCCcCCC-----CCCc----cccCccCCCeeecCCCeeeecCCcccccCCCC
Q 039957          195 YLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQG-----YVPH----NLCHLEMLNLLHLGGNKLSGHIPPCLASLTSL  265 (481)
Q Consensus       195 ~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~-----~~p~----~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  265 (481)
                      +|++++|.+++..|..|..+++|+.+++++|...+     .+|.    .|..+++|+.|++++|++++..|..|..+++|
T Consensus       276 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L  355 (680)
T 1ziw_A          276 YFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINL  355 (680)
T ss_dssp             EEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTC
T ss_pred             EeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChhHhccccCC
Confidence            44444444444444444444444444444433221     1111    44555666666666666666666666666666


Q ss_pred             CcEEcCCCcCcc--cCCcchhcc--ccCcEEEccCcccCCCCCCccccCCcCcEEEccCCeeeeecc-ccccccCChhhh
Q 039957          266 RELDLGSNKLTS--SIPSSLWSL--GYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIP-STIGALVDLETI  340 (481)
Q Consensus       266 ~~L~ls~N~l~~--~~p~~~~~l--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~l  340 (481)
                      ++|++++|.+..  ..+..+..+  +.|+.|++++|++++..|..+..+++|+.|++++|++.+.+| ..+..+++|+++
T Consensus       356 ~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L  435 (680)
T 1ziw_A          356 KYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEI  435 (680)
T ss_dssp             CEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEE
T ss_pred             cEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEE
Confidence            665555544221  111111111  234444444444444445555555555555555555554443 344555555555


Q ss_pred             hcc
Q 039957          341 SLA  343 (481)
Q Consensus       341 ~~~  343 (481)
                      +++
T Consensus       436 ~Ls  438 (680)
T 1ziw_A          436 YLS  438 (680)
T ss_dssp             ECC
T ss_pred             ecC
Confidence            443

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=1.5e-39  Score=337.37  Aligned_cols=324  Identities=24%  Similarity=0.293  Sum_probs=221.9

Q ss_pred             ccCcchhCCCCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhcc
Q 039957            4 QIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSIT   83 (481)
Q Consensus         4 ~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~   83 (481)
                      .+|..+.  ++|++|+|++|+++++.|..|.++++|++|+|++|++++..|..+. .+++|++|+|++|+++ .+|..  
T Consensus        45 ~ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~-~lp~~--  118 (562)
T 3a79_B           45 HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFL-FNQDLEYLDVSHNRLQ-NISCC--  118 (562)
T ss_dssp             SCCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTT-TCTTCCEEECTTSCCC-EECSC--
T ss_pred             cCCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhC-CCCCCCEEECCCCcCC-ccCcc--
Confidence            3676554  7899999999999888888899999999999999999865566665 7899999999999988 55555  


Q ss_pred             ccccCceeecccCcceec-CcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCcc--ceeCCh
Q 039957           84 NATKLIILDLGFNTFSGH-IPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPL--GGILPP  160 (481)
Q Consensus        84 ~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l--~~~~p~  160 (481)
                      .+++|++|+|++|++++. .|..|+++++|++|++++|+++...   +     ..+.++ +|++|++++|.+  ++..|.
T Consensus       119 ~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~~---~-----~~l~~L-~L~~L~L~~n~l~~~~~~~~  189 (562)
T 3a79_B          119 PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLD---L-----LPVAHL-HLSCILLDLVSYHIKGGETE  189 (562)
T ss_dssp             CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTTT---T-----GGGTTS-CEEEEEEEESSCCCCSSSCC
T ss_pred             ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccCc---h-----hhhhhc-eeeEEEeecccccccccCcc
Confidence            788999999999998873 4688999999999999999887531   1     112222 336666666666  444443


Q ss_pred             hhhhcc--------------------------------------------------------------------------
Q 039957          161 SIGNFS--------------------------------------------------------------------------  166 (481)
Q Consensus       161 ~~~~~~--------------------------------------------------------------------------  166 (481)
                      .+..+.                                                                          
T Consensus       190 ~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~  269 (562)
T 3a79_B          190 SLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKL  269 (562)
T ss_dssp             EEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHH
T ss_pred             cccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHH
Confidence            332210                                                                          


Q ss_pred             ------cCccEEEccCCceeecCCccc-----------------------------------------------------
Q 039957          167 ------TSLQRFSASECKLKGTIPKEI-----------------------------------------------------  187 (481)
Q Consensus       167 ------~~L~~L~l~~n~l~~~~p~~~-----------------------------------------------------  187 (481)
                            .+|++|++++|.++|.+|..+                                                     
T Consensus       270 ~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~~~  349 (562)
T 3a79_B          270 FQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCP  349 (562)
T ss_dssp             HHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCCCC
T ss_pred             HHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCcccccCc
Confidence                  156677777777776666554                                                     


Q ss_pred             ccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCC--CccccCccCCCeeecCCCeeee-cCCcccccCCC
Q 039957          188 GHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYV--PHNLCHLEMLNLLHLGGNKLSG-HIPPCLASLTS  264 (481)
Q Consensus       188 ~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~--p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~  264 (481)
                      ..+++|++|++++|++++.+|..+..+++|+.|++++|++++..  |..+..+++|+.|++++|++++ .++..+..+++
T Consensus       350 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~  429 (562)
T 3a79_B          350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAES  429 (562)
T ss_dssp             SSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTT
T ss_pred             cCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCccc
Confidence            45566677777777776666666777777777777777766532  3456666777777777777766 33334666677


Q ss_pred             CCcEEcCCCcCcccCCcchhccccCcEEEccCcccCCCCCCccccCCcCcEEEccCCeeeeeccccccccCChhhhhccc
Q 039957          265 LRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAG  344 (481)
Q Consensus       265 L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~~~g  344 (481)
                      |++|++++|++++.+|..+.  +.|++|++++|+++ .+|..+..+++|++|++++|+++...+..+..+++|+.+++++
T Consensus       430 L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~  506 (562)
T 3a79_B          430 ILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHD  506 (562)
T ss_dssp             CCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCS
T ss_pred             CCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecC
Confidence            77777777777665555443  56777777777776 4555555677777777777777743333366677777776665


Q ss_pred             c
Q 039957          345 S  345 (481)
Q Consensus       345 ~  345 (481)
                      +
T Consensus       507 N  507 (562)
T 3a79_B          507 N  507 (562)
T ss_dssp             C
T ss_pred             C
Confidence            5

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=9.6e-40  Score=330.27  Aligned_cols=320  Identities=20%  Similarity=0.252  Sum_probs=278.2

Q ss_pred             CCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeec-chhccccccCceeec
Q 039957           15 LKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTI-PNSITNATKLIILDL   93 (481)
Q Consensus        15 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L   93 (481)
                      -+.++.+++.++.+ |. +  .++|++|+|++|++++..|..+. .+++|++|++++|.+.+.+ |..|.++++|++|+|
T Consensus        12 ~~~~~c~~~~l~~l-p~-l--~~~l~~L~Ls~n~i~~~~~~~~~-~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~L   86 (455)
T 3v47_A           12 GYNAICINRGLHQV-PE-L--PAHVNYVDLSLNSIAELNETSFS-RLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKL   86 (455)
T ss_dssp             TTEEECCSSCCSSC-CC-C--CTTCCEEECCSSCCCEECTTTTS-SCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEEC
T ss_pred             ccccCcCCCCcccC-CC-C--CCccCEEEecCCccCcCChhHhc-cCccccEEECcCCcccceECcccccccccCCEEeC
Confidence            35688889988754 54 2  37899999999999976677775 8999999999999997555 678999999999999


Q ss_pred             ccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChh-hhhcccCccEE
Q 039957           94 GFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPS-IGNFSTSLQRF  172 (481)
Q Consensus        94 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~-~~~~~~~L~~L  172 (481)
                      ++|.+++..|..|+++++|++|++++|++++.....      ..+.++++|++|+|++|++++..|.. +..+ ++|++|
T Consensus        87 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~------~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l-~~L~~L  159 (455)
T 3v47_A           87 DYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSG------NFFKPLTSLEMLVLRDNNIKKIQPASFFLNM-RRFHVL  159 (455)
T ss_dssp             TTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHS------STTTTCTTCCEEECCSSBCCSCCCCGGGGGC-TTCCEE
T ss_pred             CCCccCccChhhccCcccCCEEeCCCCCCCccccCc------ccccCcccCCEEECCCCccCccCcccccCCC-CcccEE
Confidence            999999999999999999999999999998631111      23678899999999999999988877 5565 689999


Q ss_pred             EccCCceeecCCcccccC--CCCCeEecccccceecCCcC--------CcCCCCCCeeecCCCcCCCCCCccccC-----
Q 039957          173 SASECKLKGTIPKEIGHL--RGLIYLSLGFNDLNGTIPTS--------IGTLKQLQGFFLPETNLQGYVPHNLCH-----  237 (481)
Q Consensus       173 ~l~~n~l~~~~p~~~~~l--~~L~~L~l~~N~l~~~~p~~--------~~~l~~L~~l~l~~n~l~~~~p~~~~~-----  237 (481)
                      ++++|.+++..|..+..+  .+|+.|++++|.+.+..+..        +..+++|+.|++++|++.+..|..+..     
T Consensus       160 ~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~  239 (455)
T 3v47_A          160 DLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGT  239 (455)
T ss_dssp             ECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTC
T ss_pred             eCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhcccccc
Confidence            999999999989888876  78999999999998655543        336688999999999987655543322     


Q ss_pred             ----------------------------------ccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCcCcccCCcch
Q 039957          238 ----------------------------------LEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSL  283 (481)
Q Consensus       238 ----------------------------------l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~  283 (481)
                                                        .++|+.|++++|++++.+|..|..+++|++|++++|++++..|..+
T Consensus       240 ~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~  319 (455)
T 3v47_A          240 KIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAF  319 (455)
T ss_dssp             CEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTT
T ss_pred             ceeeEeeccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHh
Confidence                                              2579999999999999999999999999999999999999999999


Q ss_pred             hccccCcEEEccCcccCCCCCCccccCCcCcEEEccCCeeeeeccccccccCChhhhhccccc
Q 039957          284 WSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAGSF  346 (481)
Q Consensus       284 ~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~~~g~~  346 (481)
                      ..++.|++|++++|.+.+..|..+..+++|++|++++|++++..|..+..+++|++|+++++.
T Consensus       320 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  382 (455)
T 3v47_A          320 WGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQ  382 (455)
T ss_dssp             TTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred             cCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCc
Confidence            999999999999999998889999999999999999999999999999999999999998764

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=1.1e-38  Score=338.73  Aligned_cols=336  Identities=22%  Similarity=0.222  Sum_probs=222.5

Q ss_pred             eeccCcchhCCCC--CCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCcccee---
Q 039957            2 TGQIPTEIGNLQN--LKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIG---   76 (481)
Q Consensus         2 ~g~lp~~~~~l~~--L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~---   76 (481)
                      ++..|..|..++.  |++|+|++|++++..|..|..+++|++|++++|++++..|..+. .+++|++|++++|...+   
T Consensus       235 ~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~~~~~~~~~  313 (680)
T 1ziw_A          235 STTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLH-GLFNVRYLNLKRSFTKQSIS  313 (680)
T ss_dssp             CEECTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTT-TCTTCCEEECTTCBCCC---
T ss_pred             cccChhHhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhc-CCCCccEEeccchhhhcccc
Confidence            3455667777654  88888888888887778888888888888888888766666554 67888888887765432   


Q ss_pred             --ecc----hhccccccCceeecccCcceecCcccccCCCCCCEEEcccccCcc--ccCCCccccccccCCCCCCCcEEE
Q 039957           77 --TIP----NSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTT--ESSSAYQWSFLSSLTNCRYLVYLI  148 (481)
Q Consensus        77 --~~p----~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~~~~~~l~~l~~L~~L~  148 (481)
                        .+|    ..|..+++|++|++++|.+++..|..|.++++|++|++++|.++.  ++...|.     .+ ..+.|++|+
T Consensus       314 ~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~-----~~-~~~~L~~L~  387 (680)
T 1ziw_A          314 LASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFV-----SL-AHSPLHILN  387 (680)
T ss_dssp             ---CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTG-----GG-TTSCCCEEE
T ss_pred             cccccccChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhc-----cc-ccCcCceEE
Confidence              222    267788888888888888888888888888888888888886432  2222211     00 124566777


Q ss_pred             ccCCccceeCChhhhhcccCccEEEccCCceeecCC-cccccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcC
Q 039957          149 LSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIP-KEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNL  227 (481)
Q Consensus       149 Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l  227 (481)
                      +++|++++..|..+..+ ++|+.|++++|.+++.+| ..|.++++|++|++++|++.+..+..|..+++|+.|++++|.+
T Consensus       388 L~~n~l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l  466 (680)
T 1ziw_A          388 LTKNKISKIESDAFSWL-GHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVAL  466 (680)
T ss_dssp             CTTSCCCEECTTTTTTC-TTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCC
T ss_pred             CCCCCCCeEChhhhhCC-CCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccc
Confidence            77777776666666655 467777777777766554 4566677777777777777666666666666666666666665


Q ss_pred             C--CCCCccccCccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCcCcccCC--------cchhccccCcEEEccCc
Q 039957          228 Q--GYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIP--------SSLWSLGYILEINLSSN  297 (481)
Q Consensus       228 ~--~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p--------~~~~~l~~L~~L~l~~N  297 (481)
                      .  +..|..|..+++|+.|++++|++++.+|..|..+++|++|++++|++++..+        ..+..++.|++|++++|
T Consensus       467 ~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N  546 (680)
T 1ziw_A          467 KNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESN  546 (680)
T ss_dssp             BCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSS
T ss_pred             cccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCC
Confidence            5  4456666666666666666666666666666666666666666666654311        22555666666666666


Q ss_pred             ccCCCCCCccccCCcCcEEEccCCeeeeeccccccccCChhhhhcccc
Q 039957          298 LLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAGS  345 (481)
Q Consensus       298 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~~~g~  345 (481)
                      +++...+..|.++++|+.|++++|++++..+..|..+++|+.|+++++
T Consensus       547 ~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N  594 (680)
T 1ziw_A          547 GFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKN  594 (680)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred             CCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCC
Confidence            666444445666666666666666666555555666666666665554

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=2.6e-39  Score=350.66  Aligned_cols=271  Identities=21%  Similarity=0.218  Sum_probs=157.7

Q ss_pred             cCcchhCCCCCCeeeCcCCccc-ccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchh--
Q 039957            5 IPTEIGNLQNLKSLFLGANNLS-GLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNS--   81 (481)
Q Consensus         5 lp~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~--   81 (481)
                      .|..|.++++|++|+|++|... .+.|.+|.++++|++|+|++|++++..|..+. .+++|++|+|++|.+++.+|..  
T Consensus        40 ~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~n~l~~~~~~~~~  118 (844)
T 3j0a_A           40 TASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQ-GLFHLFELRLYFCGLSDAVLKDGY  118 (844)
T ss_dssp             CSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSC-SCSSCCCEECTTCCCSSCCSTTCC
T ss_pred             ChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHcc-CCcccCEeeCcCCCCCcccccCcc
Confidence            3455556666666666665333 22355566666666666666666544454443 5566666666666655544433  


Q ss_pred             ccccccCceeecccCcceecCc-ccccCCCCCCEEEcccccCccccCCCccc------------------cccccCCCCC
Q 039957           82 ITNATKLIILDLGFNTFSGHIP-NTFGNLRHLSVLSLLMNNLTTESSSAYQW------------------SFLSSLTNCR  142 (481)
Q Consensus        82 ~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~------------------~~~~~l~~l~  142 (481)
                      |.++++|++|+|++|.+++..+ ..|+++++|++|++++|.+++..+..+..                  ..+..+..++
T Consensus       119 ~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~  198 (844)
T 3j0a_A          119 FRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCM  198 (844)
T ss_dssp             CSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSS
T ss_pred             ccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCccccccccchhhcC
Confidence            5566666666666666655433 34566666666666666555442221110                  0001112222


Q ss_pred             ------CCcEEEccCCccceeCChhhhhc-------------------------------------ccCccEEEccCCce
Q 039957          143 ------YLVYLILSGNPLGGILPPSIGNF-------------------------------------STSLQRFSASECKL  179 (481)
Q Consensus       143 ------~L~~L~Ls~N~l~~~~p~~~~~~-------------------------------------~~~L~~L~l~~n~l  179 (481)
                            .|++|++++|.+++..|..+...                                     .++|+.|++++|.+
T Consensus       199 ~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l  278 (844)
T 3j0a_A          199 NPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFV  278 (844)
T ss_dssp             CTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCC
T ss_pred             CccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhccccCCccEEECCCCcc
Confidence                  26666666666554444333221                                     13566777777777


Q ss_pred             eecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeeeecCCccc
Q 039957          180 KGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCL  259 (481)
Q Consensus       180 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~  259 (481)
                      .+..|..|..+++|+.|++++|++++..|..|..+++|+.|++++|.+++..|..|..+++|+.|++++|++.+..+..|
T Consensus       279 ~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~  358 (844)
T 3j0a_A          279 FSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTF  358 (844)
T ss_dssp             CEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCS
T ss_pred             cccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhh
Confidence            66666667777777777777777776666677777777777777777776666677777777777777777766666666


Q ss_pred             ccCCCCCcEEcCCCcCc
Q 039957          260 ASLTSLRELDLGSNKLT  276 (481)
Q Consensus       260 ~~l~~L~~L~ls~N~l~  276 (481)
                      ..+++|++|++++|.++
T Consensus       359 ~~l~~L~~L~Ls~N~l~  375 (844)
T 3j0a_A          359 KFLEKLQTLDLRDNALT  375 (844)
T ss_dssp             CSCCCCCEEEEETCCSC
T ss_pred             cCCCCCCEEECCCCCCC
Confidence            66666666666666654

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=8.5e-39  Score=325.27  Aligned_cols=319  Identities=24%  Similarity=0.249  Sum_probs=289.0

Q ss_pred             CCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeecc
Q 039957           15 LKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLG   94 (481)
Q Consensus        15 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls   94 (481)
                      -+.++.++++++. +|..+  .+++++|+|++|++++..|..+. .+++|++|+|++|.+++..|..|.++++|++|+|+
T Consensus        13 ~~~v~c~~~~l~~-ip~~~--~~~l~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~   88 (477)
T 2id5_A           13 DRAVLCHRKRFVA-VPEGI--PTETRLLDLGKNRIKTLNQDEFA-SFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLR   88 (477)
T ss_dssp             TTEEECCSCCCSS-CCSCC--CTTCSEEECCSSCCCEECTTTTT-TCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CCEEEeCCCCcCc-CCCCC--CCCCcEEECCCCccceECHhHcc-CCCCCCEEECCCCccCEeChhhhhCCccCCEEECC
Confidence            4678999999985 45544  36899999999999965566665 89999999999999999999999999999999999


Q ss_pred             cCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEc
Q 039957           95 FNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSA  174 (481)
Q Consensus        95 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l  174 (481)
                      +|.+++..+..|.++++|++|+|++|+++++.+        ..+.++++|++|+|++|.+++..|..|..+ ++|++|++
T Consensus        89 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~--------~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l-~~L~~L~l  159 (477)
T 2id5_A           89 SNRLKLIPLGVFTGLSNLTKLDISENKIVILLD--------YMFQDLYNLKSLEVGDNDLVYISHRAFSGL-NSLEQLTL  159 (477)
T ss_dssp             SSCCCSCCTTSSTTCTTCCEEECTTSCCCEECT--------TTTTTCTTCCEEEECCTTCCEECTTSSTTC-TTCCEEEE
T ss_pred             CCcCCccCcccccCCCCCCEEECCCCccccCCh--------hHccccccCCEEECCCCccceeChhhccCC-CCCCEEEC
Confidence            999998888889999999999999999998744        346788999999999999999988888887 68999999


Q ss_pred             cCCceeecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeeeec
Q 039957          175 SECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGH  254 (481)
Q Consensus       175 ~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  254 (481)
                      ++|++++..+..+..+++|+.|++++|.+.+..+..|..+++|+.|++++|...+.+|.......+|+.|++++|++++.
T Consensus       160 ~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~  239 (477)
T 2id5_A          160 EKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAV  239 (477)
T ss_dssp             ESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSC
T ss_pred             CCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCccccc
Confidence            99999977667799999999999999999999899999999999999999998888887777777999999999999976


Q ss_pred             CCcccccCCCCCcEEcCCCcCcccCCcchhccccCcEEEccCcccCCCCCCccccCCcCcEEEccCCeeeeecccccccc
Q 039957          255 IPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGAL  334 (481)
Q Consensus       255 ~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l  334 (481)
                      .+..|..+++|+.|++++|++++..+..+..++.|++|++++|++++..|..|..+++|+.|++++|++++..+..|..+
T Consensus       240 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  319 (477)
T 2id5_A          240 PYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSV  319 (477)
T ss_dssp             CHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCG
T ss_pred             CHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCC
Confidence            66789999999999999999999889999999999999999999999999999999999999999999998888889999


Q ss_pred             CChhhhhccccc
Q 039957          335 VDLETISLAGSF  346 (481)
Q Consensus       335 ~~L~~l~~~g~~  346 (481)
                      ++|+.|+++++.
T Consensus       320 ~~L~~L~l~~N~  331 (477)
T 2id5_A          320 GNLETLILDSNP  331 (477)
T ss_dssp             GGCCEEECCSSC
T ss_pred             cccCEEEccCCC
Confidence            999999988764

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=5.5e-39  Score=332.50  Aligned_cols=148  Identities=22%  Similarity=0.281  Sum_probs=81.1

Q ss_pred             ccCCCCCeEecccccceecCC---cCCcCCCCCCeeecCCCcCCCCCC--ccccCccCCCeeecCCCeeeecCCcccccC
Q 039957          188 GHLRGLIYLSLGFNDLNGTIP---TSIGTLKQLQGFFLPETNLQGYVP--HNLCHLEMLNLLHLGGNKLSGHIPPCLASL  262 (481)
Q Consensus       188 ~~l~~L~~L~l~~N~l~~~~p---~~~~~l~~L~~l~l~~n~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  262 (481)
                      ..+++|++|++++|++++.+|   ..++.+++|+.|++++|++++..+  ..+..+++|+.|++++|+++ .+|..+..+
T Consensus       331 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~  409 (549)
T 2z81_A          331 QHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWP  409 (549)
T ss_dssp             HHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCC
T ss_pred             hcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhccc
Confidence            356667777777777665543   335666667777777776665432  34666667777777777766 355666666


Q ss_pred             CCCCcEEcCCCcCcccCCcchhccccCcEEEccCcccCCCCCCccccCCcCcEEEccCCeeeeeccccccccCChhhhhc
Q 039957          263 TSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISL  342 (481)
Q Consensus       263 ~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~~  342 (481)
                      ++|++|++++|+++. +|..+.  +.|++|++++|++++.+    ..+++|++|++++|+++ .+|. ...+++|++|++
T Consensus       410 ~~L~~L~Ls~N~l~~-l~~~~~--~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~L  480 (549)
T 2z81_A          410 EKMRFLNLSSTGIRV-VKTCIP--QTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKI  480 (549)
T ss_dssp             TTCCEEECTTSCCSC-CCTTSC--TTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEEC
T ss_pred             ccccEEECCCCCccc-ccchhc--CCceEEECCCCChhhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEec
Confidence            666666666666653 222211  23344444444433321    23455555555555555 3333 234555555555


Q ss_pred             ccc
Q 039957          343 AGS  345 (481)
Q Consensus       343 ~g~  345 (481)
                      +++
T Consensus       481 s~N  483 (549)
T 2z81_A          481 SRN  483 (549)
T ss_dssp             CSS
T ss_pred             CCC
Confidence            443

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=1e-38  Score=345.94  Aligned_cols=312  Identities=21%  Similarity=0.243  Sum_probs=269.4

Q ss_pred             ccCcchhCCCCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhcc
Q 039957            4 QIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSIT   83 (481)
Q Consensus         4 ~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~   83 (481)
                      .||.   -.++|++|||++|+|+++.|..|.++++|++|+|++|.+.+.+++..+..+++|++|+|++|.+++..|.+|.
T Consensus        18 ~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~   94 (844)
T 3j0a_A           18 QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQ   94 (844)
T ss_dssp             CCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSC
T ss_pred             CCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHcc
Confidence            4676   4578999999999999999999999999999999999777788554445899999999999999999999999


Q ss_pred             ccccCceeecccCcceecCccc--ccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChh
Q 039957           84 NATKLIILDLGFNTFSGHIPNT--FGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPS  161 (481)
Q Consensus        84 ~l~~L~~L~Ls~N~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~  161 (481)
                      ++++|++|+|++|.+++..|..  |+++++|++|+|++|.+++....       ..+.++++|++|+|++|.+++..|..
T Consensus        95 ~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~-------~~~~~L~~L~~L~Ls~N~i~~~~~~~  167 (844)
T 3j0a_A           95 GLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLH-------PSFGKLNSLKSIDFSSNQIFLVCEHE  167 (844)
T ss_dssp             SCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCC-------GGGGTCSSCCEEEEESSCCCCCCSGG
T ss_pred             CCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccc-------hhHhhCCCCCEEECCCCcCCeeCHHH
Confidence            9999999999999999877665  99999999999999999876321       34678999999999999999998888


Q ss_pred             hhhcc-cCccEEEccCCceeecCCcccccCCC------CCeEecccccceecCCcCCcC---------------------
Q 039957          162 IGNFS-TSLQRFSASECKLKGTIPKEIGHLRG------LIYLSLGFNDLNGTIPTSIGT---------------------  213 (481)
Q Consensus       162 ~~~~~-~~L~~L~l~~n~l~~~~p~~~~~l~~------L~~L~l~~N~l~~~~p~~~~~---------------------  213 (481)
                      +..+. ++|+.|+++.|.+.+..|..++.+.+      |++|++++|.+++..|..+..                     
T Consensus       168 l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~  247 (844)
T 3j0a_A          168 LEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGF  247 (844)
T ss_dssp             GHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSS
T ss_pred             cccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccc
Confidence            87652 47999999999999888887777665      899999999877655544322                     


Q ss_pred             -----------------CCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCcCc
Q 039957          214 -----------------LKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLT  276 (481)
Q Consensus       214 -----------------l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~  276 (481)
                                       .++|+.|++++|.+.+..|..|..+++|+.|++++|++++..|..|..+++|++|++++|+++
T Consensus       248 ~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~  327 (844)
T 3j0a_A          248 GFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG  327 (844)
T ss_dssp             SCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCS
T ss_pred             cccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCC
Confidence                             257888999999988888888888999999999999998888888989999999999999998


Q ss_pred             ccCCcchhccccCcEEEccCcccCCCCCCccccCCcCcEEEccCCeeee
Q 039957          277 SSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSG  325 (481)
Q Consensus       277 ~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~  325 (481)
                      +..|..+..++.|+.|++++|.+.+..+..|..+++|++|++++|.+++
T Consensus       328 ~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~  376 (844)
T 3j0a_A          328 ELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT  376 (844)
T ss_dssp             CCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCC
T ss_pred             ccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCc
Confidence            8888888889999999999999988777788888999999999998874

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=9.8e-39  Score=332.11  Aligned_cols=330  Identities=18%  Similarity=0.154  Sum_probs=269.8

Q ss_pred             ccCcchhCCCCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhcc
Q 039957            4 QIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSIT   83 (481)
Q Consensus         4 ~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~   83 (481)
                      ++|..+.  +++++|+|++|+++++.+.+|.++++|++|+|++|++++..|..+ ..+++|++|+|++|++++..|.+|.
T Consensus        21 ~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~-~~l~~L~~L~L~~n~l~~~~~~~~~   97 (570)
T 2z63_A           21 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAY-QSLSHLSTLILTGNPIQSLALGAFS   97 (570)
T ss_dssp             SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTT-TTCTTCCEEECTTCCCCEECTTTTT
T ss_pred             ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccc-cCchhCCEEeCcCCcCCccCHhhhc
Confidence            4676553  579999999999999999999999999999999999985445555 4899999999999999988889999


Q ss_pred             ccccCceeecccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhh
Q 039957           84 NATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIG  163 (481)
Q Consensus        84 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~  163 (481)
                      ++++|++|++++|.+++..+..|+++++|++|++++|.++++.       .+..+.++++|++|++++|++++..|..+.
T Consensus        98 ~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~-------lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~  170 (570)
T 2z63_A           98 GLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFK-------LPEYFSNLTNLEHLDLSSNKIQSIYCTDLR  170 (570)
T ss_dssp             TCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCC-------CCGGGGGCTTCCEEECTTSCCCEECGGGGH
T ss_pred             CccccccccccccccccCCCccccccccccEEecCCCccceec-------ChhhhcccCCCCEEeCcCCccceecHHHcc
Confidence            9999999999999999877778999999999999999998742       124467788888888888888876666555


Q ss_pred             hcccCc----cEEEccCCceeecC--------------------------------------------------------
Q 039957          164 NFSTSL----QRFSASECKLKGTI--------------------------------------------------------  183 (481)
Q Consensus       164 ~~~~~L----~~L~l~~n~l~~~~--------------------------------------------------------  183 (481)
                      .+ .+|    +.+++++|.+++..                                                        
T Consensus       171 ~l-~~L~~~~~~L~l~~n~l~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~  249 (570)
T 2z63_A          171 VL-HQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKS  249 (570)
T ss_dssp             HH-HTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTT
T ss_pred             ch-hccchhhhhcccCCCCceecCHHHhccCcceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchh
Confidence            44 234    45555555443322                                                        


Q ss_pred             -------------------------CcccccCCCCCeEecccccceecCCcCC---------------------------
Q 039957          184 -------------------------PKEIGHLRGLIYLSLGFNDLNGTIPTSI---------------------------  211 (481)
Q Consensus       184 -------------------------p~~~~~l~~L~~L~l~~N~l~~~~p~~~---------------------------  211 (481)
                                               |..+..+++|+.|++++|.++ .+|..+                           
T Consensus       250 ~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~~L~~L~l~~n~~~~l~~~~l~~L~  328 (570)
T 2z63_A          250 ALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLK  328 (570)
T ss_dssp             TTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCCCCSEEEEESCBCSSCCBCBCSSCC
T ss_pred             hhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccCCccEEeeccCcccccCcccccccC
Confidence                                     233344455566666555554 233222                           


Q ss_pred             ---------------cCCCCCCeeecCCCcCCCCC--CccccCccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCc
Q 039957          212 ---------------GTLKQLQGFFLPETNLQGYV--PHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNK  274 (481)
Q Consensus       212 ---------------~~l~~L~~l~l~~n~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~  274 (481)
                                     ..+++|+.|++++|++++..  |..+..+++|+.|++++|.+++..+. +..+++|+.|++++|.
T Consensus       329 ~L~l~~n~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~  407 (570)
T 2z63_A          329 RLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSN  407 (570)
T ss_dssp             EEEEESCBSCCBCCCCBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSE
T ss_pred             EEeCcCCccccccccccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCc
Confidence                           45678999999999998754  67888999999999999999976655 9999999999999999


Q ss_pred             CcccCC-cchhccccCcEEEccCcccCCCCCCccccCCcCcEEEccCCeee-eeccccccccCChhhhhccccc
Q 039957          275 LTSSIP-SSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLS-GDIPSTIGALVDLETISLAGSF  346 (481)
Q Consensus       275 l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~-~~~p~~~~~l~~L~~l~~~g~~  346 (481)
                      +.+..| ..+..++.|++|++++|.+.+..|..+..+++|++|++++|++. +.+|..+..+++|++|+++++.
T Consensus       408 l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~  481 (570)
T 2z63_A          408 LKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ  481 (570)
T ss_dssp             EESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSC
T ss_pred             cccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCc
Confidence            998776 57889999999999999999999999999999999999999998 6789999999999999998763

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.2e-38  Score=327.64  Aligned_cols=331  Identities=23%  Similarity=0.255  Sum_probs=269.6

Q ss_pred             eccCcchhCCCCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCcccee-ecchh
Q 039957            3 GQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIG-TIPNS   81 (481)
Q Consensus         3 g~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~-~~p~~   81 (481)
                      +..|..|.++++|++|+|++|+++++.|..|.++++|++|+|++|+++ .+|..   .+++|++|+|++|++++ .+|..
T Consensus        35 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~---~l~~L~~L~L~~N~l~~~~~p~~  110 (520)
T 2z7x_B           35 ELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH---PTVNLKHLDLSFNAFDALPICKE  110 (520)
T ss_dssp             CCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC---CCCCCSEEECCSSCCSSCCCCGG
T ss_pred             ccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc---ccCCccEEeccCCccccccchhh
Confidence            344578999999999999999999999999999999999999999998 78876   69999999999999987 47899


Q ss_pred             ccccccCceeecccCcceecCcccccCCCCC--CEEEcccccC--ccccCCCccccc-----------------------
Q 039957           82 ITNATKLIILDLGFNTFSGHIPNTFGNLRHL--SVLSLLMNNL--TTESSSAYQWSF-----------------------  134 (481)
Q Consensus        82 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L--~~L~L~~N~l--~~~~~~~~~~~~-----------------------  134 (481)
                      |+++++|++|++++|.+++   ..|..+++|  ++|++++|.+  ++..+..+....                       
T Consensus       111 ~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~  187 (520)
T 2z7x_B          111 FGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVK  187 (520)
T ss_dssp             GGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCT
T ss_pred             hccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccccccceEEEEeccCcchhhhhhhhhh
Confidence            9999999999999999986   467888888  9999999988  333222211100                       


Q ss_pred             -------------------------cccCCC---------------------------CCCCcEEEccCCccceeCChhh
Q 039957          135 -------------------------LSSLTN---------------------------CRYLVYLILSGNPLGGILPPSI  162 (481)
Q Consensus       135 -------------------------~~~l~~---------------------------l~~L~~L~Ls~N~l~~~~p~~~  162 (481)
                                               ++.+..                           .++|++|++++|+++|.+|..+
T Consensus       188 ~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~  267 (520)
T 2z7x_B          188 TVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRD  267 (520)
T ss_dssp             TCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCC
T ss_pred             cccceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccch
Confidence                                     000011                           1267888888888887777766


Q ss_pred             -----hhcccC--------------------------ccEEEccCCceeecCCcccccCCCCCeEecccccceecCCcCC
Q 039957          163 -----GNFSTS--------------------------LQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSI  211 (481)
Q Consensus       163 -----~~~~~~--------------------------L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~  211 (481)
                           ..+ +.                          ++.|++++|.+....  .+..+++|++|++++|++++.+|..+
T Consensus       268 ~~~~~~~l-~~L~~l~l~~n~~~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~  344 (520)
T 2z7x_B          268 FDYSGTSL-KALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENC  344 (520)
T ss_dssp             CCCCSCCC-CEEEEEEEEECCCCSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTC
T ss_pred             hhcccccC-ceeEeccccccceecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhh
Confidence                 333 33                          455555555443211  12678999999999999999899999


Q ss_pred             cCCCCCCeeecCCCcCCC--CCCccccCccCCCeeecCCCeeeecCC-cccccCCCCCcEEcCCCcCcccCCcchhcccc
Q 039957          212 GTLKQLQGFFLPETNLQG--YVPHNLCHLEMLNLLHLGGNKLSGHIP-PCLASLTSLRELDLGSNKLTSSIPSSLWSLGY  288 (481)
Q Consensus       212 ~~l~~L~~l~l~~n~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~  288 (481)
                      +.+++|+.|++++|++++  ..|..+..+++|+.|++++|++++.+| ..+..+++|++|++++|++++..|..+.  +.
T Consensus       345 ~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~  422 (520)
T 2z7x_B          345 GHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PR  422 (520)
T ss_dssp             CCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TT
T ss_pred             ccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--cc
Confidence            999999999999999997  556789999999999999999998444 4588999999999999999988877664  78


Q ss_pred             CcEEEccCcccCCCCCCccccCCcCcEEEccCCeeeeeccccccccCChhhhhccccc
Q 039957          289 ILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAGSF  346 (481)
Q Consensus       289 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~~~g~~  346 (481)
                      |+.|++++|+++ .+|..+..+++|++|++++|+++...+..+..+++|++++++++.
T Consensus       423 L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~  479 (520)
T 2z7x_B          423 IKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNP  479 (520)
T ss_dssp             CCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCC
Confidence            999999999998 678888899999999999999995444458999999999998774

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=4.2e-38  Score=326.56  Aligned_cols=316  Identities=21%  Similarity=0.240  Sum_probs=262.7

Q ss_pred             eccCcchhCCCCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceee-cchh
Q 039957            3 GQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGT-IPNS   81 (481)
Q Consensus         3 g~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~-~p~~   81 (481)
                      +..|.+|.++++|++|+|++|+++++.|++|.++++|++|+|++|+++ .+|..   .+++|++|+|++|++++. +|..
T Consensus        66 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~---~l~~L~~L~Ls~N~l~~l~~p~~  141 (562)
T 3a79_B           66 ELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC---PMASLRHLDLSFNDFDVLPVCKE  141 (562)
T ss_dssp             CCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC---CCTTCSEEECCSSCCSBCCCCGG
T ss_pred             ccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc---ccccCCEEECCCCCccccCchHh
Confidence            334578999999999999999999999999999999999999999998 78876   699999999999999873 4689


Q ss_pred             ccccccCceeecccCcceecCcccccCCCCC--CEEEcccccC--ccccCCCccccc-----------------c-ccCC
Q 039957           82 ITNATKLIILDLGFNTFSGHIPNTFGNLRHL--SVLSLLMNNL--TTESSSAYQWSF-----------------L-SSLT  139 (481)
Q Consensus        82 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L--~~L~L~~N~l--~~~~~~~~~~~~-----------------~-~~l~  139 (481)
                      |.++++|++|++++|.+++   ..|..+++|  ++|++++|.+  ++..+..+....                 + ..+.
T Consensus       142 ~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~  218 (562)
T 3a79_B          142 FGNLTKLTFLGLSAAKFRQ---LDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVN  218 (562)
T ss_dssp             GGGCTTCCEEEEECSBCCT---TTTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEES
T ss_pred             hcccCcccEEecCCCcccc---CchhhhhhceeeEEEeecccccccccCcccccccCcceEEEEecCccchhhhhhhccc
Confidence            9999999999999999986   346666666  9999999988  554332221100                 0 0000


Q ss_pred             -------------------------------------------------------CCCCCcEEEccCCccceeCChhhh-
Q 039957          140 -------------------------------------------------------NCRYLVYLILSGNPLGGILPPSIG-  163 (481)
Q Consensus       140 -------------------------------------------------------~l~~L~~L~Ls~N~l~~~~p~~~~-  163 (481)
                                                                             ..++|++|++++|.++|.+|..+. 
T Consensus       219 ~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~  298 (562)
T 3a79_B          219 ALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFT  298 (562)
T ss_dssp             SEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCC
T ss_pred             ccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEeccEeeccccchhhh
Confidence                                                                   012678888888888877776541 


Q ss_pred             ---------------------------------------------------hcccCccEEEccCCceeecCCcccccCCC
Q 039957          164 ---------------------------------------------------NFSTSLQRFSASECKLKGTIPKEIGHLRG  192 (481)
Q Consensus       164 ---------------------------------------------------~~~~~L~~L~l~~n~l~~~~p~~~~~l~~  192 (481)
                                                                         ...++|++|++++|++++.+|..+.++++
T Consensus       299 ~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~  378 (562)
T 3a79_B          299 YSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKR  378 (562)
T ss_dssp             CCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSSCCCTTTTTTCCSCSS
T ss_pred             cccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCcccccCccCCCCceEEECCCCccccchhhhhcccCC
Confidence                                                               12368999999999999989999999999


Q ss_pred             CCeEeccccccee--cCCcCCcCCCCCCeeecCCCcCCCCCC-ccccCccCCCeeecCCCeeeecCCcccccCCCCCcEE
Q 039957          193 LIYLSLGFNDLNG--TIPTSIGTLKQLQGFFLPETNLQGYVP-HNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELD  269 (481)
Q Consensus       193 L~~L~l~~N~l~~--~~p~~~~~l~~L~~l~l~~n~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  269 (481)
                      |++|++++|++++  .+|..+..+++|+.|++++|++++.+| ..+..+++|+.|++++|++++..|..+.  ++|+.|+
T Consensus       379 L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~  456 (562)
T 3a79_B          379 LQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLD  456 (562)
T ss_dssp             CCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEE
T ss_pred             CCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEE
Confidence            9999999999987  345789999999999999999998444 5688999999999999999987776654  7999999


Q ss_pred             cCCCcCcccCCcchhccccCcEEEccCcccCCCCCCccccCCcCcEEEccCCeeeeecc
Q 039957          270 LGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIP  328 (481)
Q Consensus       270 ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p  328 (481)
                      +++|+++ .+|..+..++.|++|++++|+++...+..+..+++|+.|++++|++.+..+
T Consensus       457 L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~  514 (562)
T 3a79_B          457 LHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP  514 (562)
T ss_dssp             CCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCCHH
T ss_pred             CCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCCcc
Confidence            9999998 677777799999999999999996444448999999999999999998655

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=4.6e-37  Score=323.41  Aligned_cols=339  Identities=19%  Similarity=0.188  Sum_probs=234.1

Q ss_pred             CcchhCCCCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhcccc
Q 039957            6 PTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNA   85 (481)
Q Consensus         6 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l   85 (481)
                      |.+|.++++|++|||++|+|+++.|.+|.++++|++|+|++|+|+ .+|...+..+++|++|+|++|++++..+..|+++
T Consensus        69 ~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~-~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L  147 (635)
T 4g8a_A           69 SYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHL  147 (635)
T ss_dssp             TTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC-EECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTC
T ss_pred             HHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCC-CCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcC
Confidence            356888888888888888888887888888888888888888887 5665554578888888888888887766778888


Q ss_pred             ccCceeecccCcceec-CcccccCCCCCCEEEcccccCccccCCCcccc-------------------c-----------
Q 039957           86 TKLIILDLGFNTFSGH-IPNTFGNLRHLSVLSLLMNNLTTESSSAYQWS-------------------F-----------  134 (481)
Q Consensus        86 ~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~-------------------~-----------  134 (481)
                      ++|++|+|++|.+++. .|..++.+++|++|++++|+++++.+..+...                   .           
T Consensus       148 ~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~~~  227 (635)
T 4g8a_A          148 KTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLH  227 (635)
T ss_dssp             TTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEE
T ss_pred             cccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccccchhhh
Confidence            8888888888888753 57778888888888888887766532211000                   0           


Q ss_pred             --------------------------------------------------------------------------------
Q 039957          135 --------------------------------------------------------------------------------  134 (481)
Q Consensus       135 --------------------------------------------------------------------------------  134 (481)
                                                                                                      
T Consensus       228 ~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~  307 (635)
T 4g8a_A          228 KLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTN  307 (635)
T ss_dssp             EEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTT
T ss_pred             hhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhcc
Confidence                                                                                            


Q ss_pred             -------------cccCCCCCCCcEEEccCCccceeCChhh-------------------hhcccCccEEEccCCceee-
Q 039957          135 -------------LSSLTNCRYLVYLILSGNPLGGILPPSI-------------------GNFSTSLQRFSASECKLKG-  181 (481)
Q Consensus       135 -------------~~~l~~l~~L~~L~Ls~N~l~~~~p~~~-------------------~~~~~~L~~L~l~~n~l~~-  181 (481)
                                   ...+.....|+.|++++|.+.+..+..+                   .. .++|+.++++.|.+.. 
T Consensus       308 l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~-l~~L~~L~ls~n~l~~~  386 (635)
T 4g8a_A          308 VSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVD-LPSLEFLDLSRNGLSFK  386 (635)
T ss_dssp             CSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCB-CTTCCEEECCSSCCBEE
T ss_pred             cccccccccccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCccccc-ccccccchhhccccccc
Confidence                         0000111234444454444432221111                   11 1456777777776642 


Q ss_pred             -cCCc-----------------------ccccCCCCCeEecccccceecCC-cCCcCCCCCCeeecCCCcCCCCCCcccc
Q 039957          182 -TIPK-----------------------EIGHLRGLIYLSLGFNDLNGTIP-TSIGTLKQLQGFFLPETNLQGYVPHNLC  236 (481)
Q Consensus       182 -~~p~-----------------------~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~l~l~~n~l~~~~p~~~~  236 (481)
                       ..+.                       .+..+++|+.++++.|......+ ..|..+++++.++++.|.+.+..+..+.
T Consensus       387 ~~~~~~~~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~  466 (635)
T 4g8a_A          387 GCCSQSDFGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFN  466 (635)
T ss_dssp             EECCHHHHSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTT
T ss_pred             cccccchhhhhhhhhhhccccccccccccccccccccchhhhhccccccccccccccccccccccccccccccccccccc
Confidence             2333                       34445555555555555443333 3456677777777778877777777777


Q ss_pred             CccCCCeeecCCCeee-ecCCcccccCCCCCcEEcCCCcCcccCCcchhccccCcEEEccCcccCCCCCCccccCCcCcE
Q 039957          237 HLEMLNLLHLGGNKLS-GHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRV  315 (481)
Q Consensus       237 ~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~  315 (481)
                      .++.++.|++++|.+. +.+|..|..+++|++|++++|++++..|..|.++++|++|++++|++++..|..|..+++|++
T Consensus       467 ~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~  546 (635)
T 4g8a_A          467 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQV  546 (635)
T ss_dssp             TCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCE
T ss_pred             cchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCE
Confidence            8888888888888643 456777888888888888888888878888888888888888888888777777888888888


Q ss_pred             EEccCCeeeeecccccccc-CChhhhhccccc
Q 039957          316 LDLSRNQLSGDIPSTIGAL-VDLETISLAGSF  346 (481)
Q Consensus       316 L~l~~N~l~~~~p~~~~~l-~~L~~l~~~g~~  346 (481)
                      ||+++|++++..|..+..+ .+|++|+++++.
T Consensus       547 L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np  578 (635)
T 4g8a_A          547 LDYSLNHIMTSKKQELQHFPSSLAFLNLTQND  578 (635)
T ss_dssp             EECTTSCCCBCCSSCTTCCCTTCCEEECTTCC
T ss_pred             EECCCCcCCCCCHHHHHhhhCcCCEEEeeCCC
Confidence            8888888888878877776 577777777653

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=2.1e-37  Score=320.68  Aligned_cols=332  Identities=23%  Similarity=0.272  Sum_probs=232.8

Q ss_pred             eccCcchhCCCCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCcccee-ecchh
Q 039957            3 GQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIG-TIPNS   81 (481)
Q Consensus         3 g~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~-~~p~~   81 (481)
                      +..|.+|+++++|++|+|++|++++..|.+|.++++|++|+|++|++++..|..+. .+++|++|++++|++++ ..|..
T Consensus        40 ~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~-~l~~L~~L~Ls~n~l~~~~~~~~  118 (549)
T 2z81_A           40 YIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFG-PLSSLKYLNLMGNPYQTLGVTSL  118 (549)
T ss_dssp             EECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHT-TCTTCCEEECTTCCCSSSCSSCS
T ss_pred             ccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhc-cCCCCcEEECCCCcccccchhhh
Confidence            33455667777777777777777766666777777777777777777643333343 56777777777776664 23455


Q ss_pred             ccccccCceeecccCc-ceecCcccccCCCCCCEEEcccccCccccCCCcccc-c--------------cc-cCCCCCC-
Q 039957           82 ITNATKLIILDLGFNT-FSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWS-F--------------LS-SLTNCRY-  143 (481)
Q Consensus        82 ~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~-~--------------~~-~l~~l~~-  143 (481)
                      +.++++|++|++++|. +....+..|+++++|++|++++|++++..+..+... .              +. .+..+++ 
T Consensus       119 ~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L  198 (549)
T 2z81_A          119 FPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSV  198 (549)
T ss_dssp             CTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTB
T ss_pred             hhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCcccccchhhHhhcccc
Confidence            6666666666666665 333333455555556666655555554322111000 0              00 0011233 


Q ss_pred             --------------------------------------------------------------------------------
Q 039957          144 --------------------------------------------------------------------------------  143 (481)
Q Consensus       144 --------------------------------------------------------------------------------  143 (481)
                                                                                                      
T Consensus       199 ~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~  278 (549)
T 2z81_A          199 RYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVS  278 (549)
T ss_dssp             SEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCC
T ss_pred             cEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhh
Confidence                                                                                            


Q ss_pred             ---------------------------------CcEEEccCCccceeCChhhhhcccCccEEEccCCceeecCCc---cc
Q 039957          144 ---------------------------------LVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPK---EI  187 (481)
Q Consensus       144 ---------------------------------L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~---~~  187 (481)
                                                       |++|++++|.++ .+|..++...++|++|++++|++++.+|.   .+
T Consensus       279 ~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~  357 (549)
T 2z81_A          279 ELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACK  357 (549)
T ss_dssp             CCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCT
T ss_pred             hhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhh
Confidence                                             333444444433 24545533236899999999999987653   47


Q ss_pred             ccCCCCCeEecccccceecCC--cCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeeeecCCcccccCCCC
Q 039957          188 GHLRGLIYLSLGFNDLNGTIP--TSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSL  265 (481)
Q Consensus       188 ~~l~~L~~L~l~~N~l~~~~p--~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  265 (481)
                      +.+++|++|++++|++++..+  ..+..+++|+.|++++|+++. +|..+..+++|+.|++++|++++ +|..+.  ++|
T Consensus       358 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~~~~~~~L~~L~Ls~N~l~~-l~~~~~--~~L  433 (549)
T 2z81_A          358 GAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHP-MPDSCQWPEKMRFLNLSSTGIRV-VKTCIP--QTL  433 (549)
T ss_dssp             TSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCCC-CCSCCCCCTTCCEEECTTSCCSC-CCTTSC--TTC
T ss_pred             hccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCcc-CChhhcccccccEEECCCCCccc-ccchhc--CCc
Confidence            889999999999999986543  458899999999999999994 78888999999999999999985 444432  689


Q ss_pred             CcEEcCCCcCcccCCcchhccccCcEEEccCcccCCCCCCccccCCcCcEEEccCCeeeeeccccccccCChhhhhcccc
Q 039957          266 RELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAGS  345 (481)
Q Consensus       266 ~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~~~g~  345 (481)
                      ++|++++|++++.+    ..++.|++|++++|+++ .+|. ...+++|++|++++|++++..|..+..+++|+.++++++
T Consensus       434 ~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N  507 (549)
T 2z81_A          434 EVLDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTN  507 (549)
T ss_dssp             SEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSS
T ss_pred             eEEECCCCChhhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCC
Confidence            99999999998753    47889999999999998 5666 467999999999999999998999999999999999877


Q ss_pred             c
Q 039957          346 F  346 (481)
Q Consensus       346 ~  346 (481)
                      .
T Consensus       508 ~  508 (549)
T 2z81_A          508 P  508 (549)
T ss_dssp             C
T ss_pred             C
Confidence            5

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=1.6e-36  Score=319.29  Aligned_cols=333  Identities=20%  Similarity=0.202  Sum_probs=268.5

Q ss_pred             ccCcchhCCCCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhcc
Q 039957            4 QIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSIT   83 (481)
Q Consensus         4 ~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~   83 (481)
                      +||..+.  +++++|||++|+|+++.|.+|.++++|++|+|++|+|+ .+|+..+..+++|++|+|++|+|++..+.+|.
T Consensus        45 ~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~-~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~  121 (635)
T 4g8a_A           45 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFS  121 (635)
T ss_dssp             SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCC-EECTTTTTTCTTCCEEECTTCCCCEECGGGGT
T ss_pred             ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCC-CcChhHhcCCCCCCEEEccCCcCCCCCHHHhc
Confidence            4665543  47999999999999999999999999999999999998 56655555899999999999999988888999


Q ss_pred             ccccCceeecccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhh
Q 039957           84 NATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIG  163 (481)
Q Consensus        84 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~  163 (481)
                      ++++|++|+|++|+++++.+..|+++++|++|++++|.++.+..       +..+..+++|++|+|++|++++..|..+.
T Consensus       122 ~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~-------~~~~~~l~~L~~L~L~~N~l~~~~~~~l~  194 (635)
T 4g8a_A          122 GLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKL-------PEYFSNLTNLEHLDLSSNKIQSIYCTDLR  194 (635)
T ss_dssp             TCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCC-------CGGGGGCTTCCEEECCSSCCCEECGGGGH
T ss_pred             CCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCC-------chhhccchhhhhhcccCcccccccccccc
Confidence            99999999999999999888899999999999999999987632       13456788899999999988776554432


Q ss_pred             hcc-----------------------------------------------------------------------------
Q 039957          164 NFS-----------------------------------------------------------------------------  166 (481)
Q Consensus       164 ~~~-----------------------------------------------------------------------------  166 (481)
                      .+.                                                                             
T Consensus       195 ~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~  274 (635)
T 4g8a_A          195 VLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA  274 (635)
T ss_dssp             HHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTT
T ss_pred             chhhhhhhhhhhhcccCcccccCcccccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccc
Confidence            210                                                                             


Q ss_pred             -----------------------------------------------------cCccEEEccCCceeecCCc--------
Q 039957          167 -----------------------------------------------------TSLQRFSASECKLKGTIPK--------  185 (481)
Q Consensus       167 -----------------------------------------------------~~L~~L~l~~n~l~~~~p~--------  185 (481)
                                                                           ..++.|++.+|.+.+..+.        
T Consensus       275 ~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l  354 (635)
T 4g8a_A          275 LEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRL  354 (635)
T ss_dssp             TGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEE
T ss_pred             cccccchhhhhhhhhhhcccccchhhhhhhhcccccccccccccccccccccchhhhhhhcccccccCcCcccchhhhhc
Confidence                                                                 0122333333333221111        


Q ss_pred             -----------ccccCCCCCeEecccccceec-------------------------CCcCCcCCCCCCeeecCCCcCCC
Q 039957          186 -----------EIGHLRGLIYLSLGFNDLNGT-------------------------IPTSIGTLKQLQGFFLPETNLQG  229 (481)
Q Consensus       186 -----------~~~~l~~L~~L~l~~N~l~~~-------------------------~p~~~~~l~~L~~l~l~~n~l~~  229 (481)
                                 ....+++|+++++++|.+...                         .+..+..+++|+.++++.++...
T Consensus       355 ~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~  434 (635)
T 4g8a_A          355 TFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQ  434 (635)
T ss_dssp             EEESCCSCCBCCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEES
T ss_pred             ccccccCCCCcccccccccccchhhccccccccccccchhhhhhhhhhhccccccccccccccccccccchhhhhccccc
Confidence                       112356777888888776421                         23445667777777877776655


Q ss_pred             CCC-ccccCccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCcC-cccCCcchhccccCcEEEccCcccCCCCCCcc
Q 039957          230 YVP-HNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKL-TSSIPSSLWSLGYILEINLSSNLLNDSLPSNV  307 (481)
Q Consensus       230 ~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l-~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~  307 (481)
                      ..+ ..|..+..++.++++.|.+.+..|..+..+++++.|++++|++ .+..|..+..++.|++|++++|++++..|..|
T Consensus       435 ~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f  514 (635)
T 4g8a_A          435 MSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAF  514 (635)
T ss_dssp             TTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTT
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHH
Confidence            444 4678899999999999999999999999999999999999985 45678899999999999999999999999999


Q ss_pred             ccCCcCcEEEccCCeeeeeccccccccCChhhhhccccc
Q 039957          308 QKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAGSF  346 (481)
Q Consensus       308 ~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~~~g~~  346 (481)
                      .++++|++|+|++|+|++..|..|..+++|++|+++++.
T Consensus       515 ~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~  553 (635)
T 4g8a_A          515 NSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH  553 (635)
T ss_dssp             TTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSC
T ss_pred             cCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCc
Confidence            999999999999999999999999999999999998764

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=1.5e-36  Score=300.61  Aligned_cols=306  Identities=21%  Similarity=0.166  Sum_probs=164.6

Q ss_pred             CCCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCcee
Q 039957           12 LQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIIL   91 (481)
Q Consensus        12 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L   91 (481)
                      ++++++|++++|.++.+.+..|..+++|++|++++|++++..+..+. .+++|++|+|++|++++..|..|..+++|++|
T Consensus        44 l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  122 (390)
T 3o6n_A           44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFA-YAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL  122 (390)
T ss_dssp             GCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTT-TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred             cCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhcc-CCCCcCEEECCCCCCCcCCHHHhcCCCCCCEE
Confidence            45566666666666655555556666666666666666533333332 56666666666666665555556666666666


Q ss_pred             ecccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccE
Q 039957           92 DLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQR  171 (481)
Q Consensus        92 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~  171 (481)
                      ++++|.++...+..|+++++|++|++++|.++++++        ..+.++++|++|++++|++++..   +..+ ++|+.
T Consensus       123 ~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~--------~~~~~l~~L~~L~l~~n~l~~~~---~~~l-~~L~~  190 (390)
T 3o6n_A          123 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIED--------DTFQATTSLQNLQLSSNRLTHVD---LSLI-PSLFH  190 (390)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCT--------TTTSSCTTCCEEECCSSCCSBCC---GGGC-TTCSE
T ss_pred             ECCCCccCcCCHHHhcCCCCCcEEECCCCccCccCh--------hhccCCCCCCEEECCCCcCCccc---cccc-cccce
Confidence            666666664444445666666666666666655432        22445556666666666665431   2222 34556


Q ss_pred             EEccCCceeecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCee
Q 039957          172 FSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKL  251 (481)
Q Consensus       172 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l  251 (481)
                      +++++|.+++.     ....+|++|++++|.+... |..  ..++|+.|++++|.+++.  ..+..+++|+.|++++|.+
T Consensus       191 L~l~~n~l~~~-----~~~~~L~~L~l~~n~l~~~-~~~--~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l  260 (390)
T 3o6n_A          191 ANVSYNLLSTL-----AIPIAVEELDASHNSINVV-RGP--VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNEL  260 (390)
T ss_dssp             EECCSSCCSEE-----ECCSSCSEEECCSSCCCEE-ECC--CCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCC
T ss_pred             eeccccccccc-----CCCCcceEEECCCCeeeec-ccc--ccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcC
Confidence            66666555431     2223455555555555533 211  124555555555555542  3455555555555555555


Q ss_pred             eecCCcccccCCCCCcEEcCCCcCcccCCcchhccccCcEEEccCcccCCCCCCccccCCcCcEEEccCCeeeeeccccc
Q 039957          252 SGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTI  331 (481)
Q Consensus       252 ~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~  331 (481)
                      ++..|..|..+++|+.|++++|++++ +|..+..++.|++|++++|++. .+|..+..+++|+.|++++|+++.. |  +
T Consensus       261 ~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~-~--~  335 (390)
T 3o6n_A          261 EKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--L  335 (390)
T ss_dssp             CEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--C
T ss_pred             CCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCcccee-C--c
Confidence            55555555555555555555555553 3334444555555555555554 2344455555555555555555432 1  3


Q ss_pred             cccCChhhhhcccc
Q 039957          332 GALVDLETISLAGS  345 (481)
Q Consensus       332 ~~l~~L~~l~~~g~  345 (481)
                      ..+++|+.|+++++
T Consensus       336 ~~~~~L~~L~l~~N  349 (390)
T 3o6n_A          336 STHHTLKNLTLSHN  349 (390)
T ss_dssp             CTTCCCSEEECCSS
T ss_pred             hhhccCCEEEcCCC
Confidence            44455555555443

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=6.1e-37  Score=293.78  Aligned_cols=253  Identities=29%  Similarity=0.456  Sum_probs=166.0

Q ss_pred             cCCCEEEeeCCcCcc--ccChhhhcCCCCccEEEccC-ccceeecchhccccccCceeecccCcceecCcccccCCCCCC
Q 039957           37 STIRNLNLGGNRLSG--HLPSMIGHSLPNIKYLELGD-NNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLS  113 (481)
Q Consensus        37 ~~L~~L~L~~N~l~~--~~p~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  113 (481)
                      .++++|+|++|.++|  .+|..+. .+++|++|++++ |.+.+.+|..|.++++|++|+|++|.+++.+|..|+++++|+
T Consensus        50 ~~l~~L~L~~~~l~~~~~~~~~l~-~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~  128 (313)
T 1ogq_A           50 YRVNNLDLSGLNLPKPYPIPSSLA-NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLV  128 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCGGGG-GCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCC
T ss_pred             ceEEEEECCCCCccCCcccChhHh-CCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCC
Confidence            356666666666665  5666554 466666666663 666666666666666666666666666666666666666666


Q ss_pred             EEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEccCCceeecCCcccccCCCC
Q 039957          114 VLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGL  193 (481)
Q Consensus       114 ~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L  193 (481)
                      +|++++|.+++..+        ..+..+++|++|+|++|++++.+|..++.+.+.|++|++++|++++.+|..+..++ |
T Consensus       129 ~L~Ls~N~l~~~~p--------~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L  199 (313)
T 1ogq_A          129 TLDFSYNALSGTLP--------PSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-L  199 (313)
T ss_dssp             EEECCSSEEESCCC--------GGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-C
T ss_pred             EEeCCCCccCCcCC--------hHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-c
Confidence            66666666664321        23445666666666666666666666666544666777777777666666666665 7


Q ss_pred             CeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCC
Q 039957          194 IYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSN  273 (481)
Q Consensus       194 ~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N  273 (481)
                      ++|++++|.+++.+|..+..+++|+.|++++|.+++.+|. +..+++|+.|++++|++++.+|..|..+++|++|++++|
T Consensus       200 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N  278 (313)
T 1ogq_A          200 AFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFN  278 (313)
T ss_dssp             SEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSS
T ss_pred             cEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCC
Confidence            7777777777666666666777777777777776655544 566677777777777777777777777777777777777


Q ss_pred             cCcccCCcchhccccCcEEEccCcc-cCC
Q 039957          274 KLTSSIPSSLWSLGYILEINLSSNL-LND  301 (481)
Q Consensus       274 ~l~~~~p~~~~~l~~L~~L~l~~N~-l~~  301 (481)
                      ++++.+|.. ..++.|+.+++++|+ +.+
T Consensus       279 ~l~~~ip~~-~~l~~L~~l~l~~N~~lc~  306 (313)
T 1ogq_A          279 NLCGEIPQG-GNLQRFDVSAYANNKCLCG  306 (313)
T ss_dssp             EEEEECCCS-TTGGGSCGGGTCSSSEEES
T ss_pred             cccccCCCC-ccccccChHHhcCCCCccC
Confidence            777766665 666777777777776 444

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=1.4e-36  Score=316.96  Aligned_cols=297  Identities=20%  Similarity=0.205  Sum_probs=222.5

Q ss_pred             eccCcc-hhCCCCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchh
Q 039957            3 GQIPTE-IGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNS   81 (481)
Q Consensus         3 g~lp~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~   81 (481)
                      +.+|.. |..+++|++|+|++|.++++.|..|.++++|++|+|++|.+++..|..+. .+++|++|+|++|.+++..+..
T Consensus        64 ~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~n~l~~l~~~~  142 (597)
T 3oja_B           64 RKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQ-NVPLLTVLVLERNDLSSLPRGI  142 (597)
T ss_dssp             SEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTT-TCTTCCEEECCSSCCCCCCTTT
T ss_pred             CCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHc-CCCCCCEEEeeCCCCCCCCHHH
Confidence            345544 56777777777777777777777777777777777777777754444443 6777777777777777655556


Q ss_pred             ccccccCceeecccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChh
Q 039957           82 ITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPS  161 (481)
Q Consensus        82 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~  161 (481)
                      |.++++|++|+|++|.+++..|..|+++++|++|++++|.+++++           +..+++|+.|++++|.+++...  
T Consensus       143 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-----------~~~l~~L~~L~l~~n~l~~l~~--  209 (597)
T 3oja_B          143 FHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD-----------LSLIPSLFHANVSYNLLSTLAI--  209 (597)
T ss_dssp             TTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC-----------GGGCTTCSEEECCSSCCSEEEC--
T ss_pred             hccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC-----------hhhhhhhhhhhcccCccccccC--
Confidence            677777777777777777777777777777777777777777652           2345667777787777765321  


Q ss_pred             hhhcccCccEEEccCCceeecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCC
Q 039957          162 IGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEML  241 (481)
Q Consensus       162 ~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L  241 (481)
                          ..+|+.|++++|.++...+..   .++|+.|++++|.+++  +..+..+++|+.|++++|.+.+..|..|..+++|
T Consensus       210 ----~~~L~~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  280 (597)
T 3oja_B          210 ----PIAVEELDASHNSINVVRGPV---NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRL  280 (597)
T ss_dssp             ----CTTCSEEECCSSCCCEEECSC---CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSC
T ss_pred             ----CchhheeeccCCccccccccc---CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCC
Confidence                246888888888877543322   2578888888888875  4678888888888888888888888888888888


Q ss_pred             CeeecCCCeeeecCCcccccCCCCCcEEcCCCcCcccCCcchhccccCcEEEccCcccCCCCCCccccCCcCcEEEccCC
Q 039957          242 NLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRN  321 (481)
Q Consensus       242 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N  321 (481)
                      +.|+|++|.+++. |..+..+++|+.|++++|.++ .+|..+..++.|+.|++++|.+.+..   +..++.|+.|++++|
T Consensus       281 ~~L~Ls~N~l~~l-~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~L~~L~l~~N  355 (597)
T 3oja_B          281 ERLYISNNRLVAL-NLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK---LSTHHTLKNLTLSHN  355 (597)
T ss_dssp             CEEECTTSCCCEE-ECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC---CCTTCCCSEEECCSS
T ss_pred             CEEECCCCCCCCC-CcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcC---hhhcCCCCEEEeeCC
Confidence            8888888888864 566677888888888888887 57777888888888888888887642   566778888888888


Q ss_pred             eeeeec
Q 039957          322 QLSGDI  327 (481)
Q Consensus       322 ~l~~~~  327 (481)
                      ++.+..
T Consensus       356 ~~~~~~  361 (597)
T 3oja_B          356 DWDCNS  361 (597)
T ss_dssp             CEEHHH
T ss_pred             CCCChh
Confidence            888653

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=2.6e-36  Score=305.79  Aligned_cols=306  Identities=26%  Similarity=0.382  Sum_probs=208.0

Q ss_pred             cCcchhCCCCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccc
Q 039957            5 IPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITN   84 (481)
Q Consensus         5 lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~   84 (481)
                      +| .+..+++|++|+|++|++++..|  +.++++|++|++++|++++ ++. +. .+++|++|++++|++++..+  +..
T Consensus        61 l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~~-~~-~l~~L~~L~L~~n~l~~~~~--~~~  132 (466)
T 1o6v_A           61 ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-ITP-LA-NLTNLTGLTLFNNQITDIDP--LKN  132 (466)
T ss_dssp             CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CGG-GT-TCTTCCEEECCSSCCCCCGG--GTT
T ss_pred             Cc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCcccc-Chh-hc-CCCCCCEEECCCCCCCCChH--HcC
Confidence            44 36777888888888888876544  7778888888888888874 443 43 67888888888887775433  777


Q ss_pred             cccCceeecccCcceecCc-------------------ccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCc
Q 039957           85 ATKLIILDLGFNTFSGHIP-------------------NTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLV  145 (481)
Q Consensus        85 l~~L~~L~Ls~N~l~~~~p-------------------~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~  145 (481)
                      +++|++|++++|.+++..+                   ..++++++|++|++++|.++.+          ..+..+++|+
T Consensus       133 l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~----------~~l~~l~~L~  202 (466)
T 1o6v_A          133 LTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDI----------SVLAKLTNLE  202 (466)
T ss_dssp             CTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCC----------GGGGGCTTCS
T ss_pred             CCCCCEEECCCCccCCChhhccCCcccEeecCCcccCchhhccCCCCCEEECcCCcCCCC----------hhhccCCCCC
Confidence            7888888888887765311                   1134445555555555555443          1234556666


Q ss_pred             EEEccCCccceeCChhhhhcccCccEEEccCCceeecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCC
Q 039957          146 YLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPET  225 (481)
Q Consensus       146 ~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n  225 (481)
                      +|++++|.+++..|  ++.+ ++|+.|++++|.+++.  ..+..+++|++|++++|.+++..|  +..+++|+.|++++|
T Consensus       203 ~L~l~~n~l~~~~~--~~~l-~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n  275 (466)
T 1o6v_A          203 SLIATNNQISDITP--LGIL-TNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGAN  275 (466)
T ss_dssp             EEECCSSCCCCCGG--GGGC-TTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSS
T ss_pred             EEEecCCccccccc--cccc-CCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCC
Confidence            77777776665443  3333 4677777777776642  356667777777777777765544  677777777777777


Q ss_pred             cCCCCCCccccCccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCcCcccCCcchhccccCcEEEccCcccCCCCCC
Q 039957          226 NLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPS  305 (481)
Q Consensus       226 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~  305 (481)
                      .+++..+  +..+++|+.|++++|++++..|  +..+++|+.|++++|++++..|  +..++.|+.|++++|.+++.  .
T Consensus       276 ~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~  347 (466)
T 1o6v_A          276 QISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--S  347 (466)
T ss_dssp             CCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--G
T ss_pred             ccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--h
Confidence            7776544  6677777777777777776443  6777778888888887776555  66777788888888877764  4


Q ss_pred             ccccCCcCcEEEccCCeeeeeccccccccCChhhhhcccc
Q 039957          306 NVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAGS  345 (481)
Q Consensus       306 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~~~g~  345 (481)
                      .+..+++|+.|++++|++++..|  +..+++|+.++++++
T Consensus       348 ~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n  385 (466)
T 1o6v_A          348 SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ  385 (466)
T ss_dssp             GGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCE
T ss_pred             hhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCC
Confidence            57777888888888888877665  677777777776654

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=1e-36  Score=292.15  Aligned_cols=249  Identities=27%  Similarity=0.389  Sum_probs=140.9

Q ss_pred             CCccEEEccCcccee--ecchhccccccCceeeccc-CcceecCcccccCCCCCCEEEcccccCccccCCCccccccccC
Q 039957           62 PNIKYLELGDNNLIG--TIPNSITNATKLIILDLGF-NTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSL  138 (481)
Q Consensus        62 ~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l  138 (481)
                      .++++|+|++|.+++  .+|..|.++++|++|++++ |.+++.+|..|+++++|++|++++|++++..+        ..+
T Consensus        50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p--------~~~  121 (313)
T 1ogq_A           50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIP--------DFL  121 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECC--------GGG
T ss_pred             ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCC--------HHH
Confidence            345555555555555  5555555555555555553 55555555555555555555555555553311        223


Q ss_pred             CCCCCCcEEEccCCccceeCChhhhhcccCccEEEccCCceeecCCcccccCC-CCCeEecccccceecCCcCCcCCCCC
Q 039957          139 TNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLR-GLIYLSLGFNDLNGTIPTSIGTLKQL  217 (481)
Q Consensus       139 ~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~-~L~~L~l~~N~l~~~~p~~~~~l~~L  217 (481)
                      .++++|++|+|++|.+++.+|..+..+ ++|++|++++|++++.+|..+..++ +|++|++++|++++.+|..+..++ |
T Consensus       122 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L  199 (313)
T 1ogq_A          122 SQIKTLVTLDFSYNALSGTLPPSISSL-PNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-L  199 (313)
T ss_dssp             GGCTTCCEEECCSSEEESCCCGGGGGC-TTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-C
T ss_pred             hCCCCCCEEeCCCCccCCcCChHHhcC-CCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-c
Confidence            445555555555555555555555554 3555555555555555555555555 555555555555555555555554 5


Q ss_pred             CeeecCCCcCCCCCCccccCccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCcCcccCCcchhccccCcEEEccCc
Q 039957          218 QGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSN  297 (481)
Q Consensus       218 ~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N  297 (481)
                      +.|++++|.+++..|..|..+++|+.|++++|++++.+|. +..+++|++|++++|++++.+|..+..++.|++|++++|
T Consensus       200 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N  278 (313)
T 1ogq_A          200 AFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFN  278 (313)
T ss_dssp             SEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSS
T ss_pred             cEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCC
Confidence            5555555555555555555555555555555555544433 555555555555555555555555555555555555555


Q ss_pred             ccCCCCCCccccCCcCcEEEccCCe
Q 039957          298 LLNDSLPSNVQKLKVLRVLDLSRNQ  322 (481)
Q Consensus       298 ~l~~~~p~~~~~l~~L~~L~l~~N~  322 (481)
                      ++++.+|.. ..+++|+.+++++|+
T Consensus       279 ~l~~~ip~~-~~l~~L~~l~l~~N~  302 (313)
T 1ogq_A          279 NLCGEIPQG-GNLQRFDVSAYANNK  302 (313)
T ss_dssp             EEEEECCCS-TTGGGSCGGGTCSSS
T ss_pred             cccccCCCC-ccccccChHHhcCCC
Confidence            555555554 455555555555555

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=2.8e-36  Score=298.57  Aligned_cols=297  Identities=21%  Similarity=0.212  Sum_probs=256.3

Q ss_pred             eccCcc-hhCCCCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchh
Q 039957            3 GQIPTE-IGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNS   81 (481)
Q Consensus         3 g~lp~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~   81 (481)
                      +.+|.. |..+++|++|+|++|+++++.+..|.++++|++|+|++|++++..|..+. .+++|++|++++|+++...+..
T Consensus        58 ~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~n~l~~l~~~~  136 (390)
T 3o6n_A           58 RKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQ-NVPLLTVLVLERNDLSSLPRGI  136 (390)
T ss_dssp             SEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTT-TCTTCCEEECCSSCCCCCCTTT
T ss_pred             hhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhc-CCCCCCEEECCCCccCcCCHHH
Confidence            456765 68899999999999999999888999999999999999999865555554 7999999999999998666666


Q ss_pred             ccccccCceeecccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChh
Q 039957           82 ITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPS  161 (481)
Q Consensus        82 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~  161 (481)
                      |..+++|++|++++|.+++..|..|+.+++|++|++++|.++.++           +..+++|+.|++++|.+++...  
T Consensus       137 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~-----------~~~l~~L~~L~l~~n~l~~~~~--  203 (390)
T 3o6n_A          137 FHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD-----------LSLIPSLFHANVSYNLLSTLAI--  203 (390)
T ss_dssp             TTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC-----------GGGCTTCSEEECCSSCCSEEEC--
T ss_pred             hcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccc-----------cccccccceeecccccccccCC--
Confidence            799999999999999999988989999999999999999998762           3456789999999999986422  


Q ss_pred             hhhcccCccEEEccCCceeecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCC
Q 039957          162 IGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEML  241 (481)
Q Consensus       162 ~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L  241 (481)
                          ..+|++|++++|.++.. |..  ..++|++|++++|.+++.  ..+..+++|+.|++++|.+++..|..|..+++|
T Consensus       204 ----~~~L~~L~l~~n~l~~~-~~~--~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L  274 (390)
T 3o6n_A          204 ----PIAVEELDASHNSINVV-RGP--VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRL  274 (390)
T ss_dssp             ----CSSCSEEECCSSCCCEE-ECC--CCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSC
T ss_pred             ----CCcceEEECCCCeeeec-ccc--ccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccC
Confidence                25799999999999865 332  247899999999999864  578899999999999999999889999999999


Q ss_pred             CeeecCCCeeeecCCcccccCCCCCcEEcCCCcCcccCCcchhccccCcEEEccCcccCCCCCCccccCCcCcEEEccCC
Q 039957          242 NLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRN  321 (481)
Q Consensus       242 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N  321 (481)
                      +.|++++|++++. |..+..+++|++|++++|+++ .+|..+..++.|++|++++|.++.. |  +..++.|+.|++++|
T Consensus       275 ~~L~L~~n~l~~~-~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~-~--~~~~~~L~~L~l~~N  349 (390)
T 3o6n_A          275 ERLYISNNRLVAL-NLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHN  349 (390)
T ss_dssp             CEEECCSSCCCEE-ECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSS
T ss_pred             CEEECCCCcCccc-CcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCcccee-C--chhhccCCEEEcCCC
Confidence            9999999999864 566788999999999999998 6777888999999999999999865 3  677889999999999


Q ss_pred             eeeeec
Q 039957          322 QLSGDI  327 (481)
Q Consensus       322 ~l~~~~  327 (481)
                      ++.+.-
T Consensus       350 ~~~~~~  355 (390)
T 3o6n_A          350 DWDCNS  355 (390)
T ss_dssp             CEEHHH
T ss_pred             Cccchh
Confidence            998753

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=3.2e-36  Score=314.27  Aligned_cols=308  Identities=20%  Similarity=0.157  Sum_probs=269.7

Q ss_pred             CCCCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCce
Q 039957           11 NLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLII   90 (481)
Q Consensus        11 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~   90 (481)
                      .+++++.|++++|.+..+.+..|.++++|++|+|++|.+++..|..+. .+++|++|+|++|.+++..|..|+++++|++
T Consensus        49 ~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~  127 (597)
T 3oja_B           49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFA-YAHTIQKLYMGFNAIRYLPPHVFQNVPLLTV  127 (597)
T ss_dssp             GGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTT-TCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred             cCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhc-CCCCCCEEECCCCcCCCCCHHHHcCCCCCCE
Confidence            467899999999999998888899999999999999999965555665 8999999999999999988999999999999


Q ss_pred             eecccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCcc
Q 039957           91 LDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQ  170 (481)
Q Consensus        91 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~  170 (481)
                      |+|++|.+++..+..|+++++|++|+|++|.++++++        ..+.++++|++|+|++|.+++..   +..+ ++|+
T Consensus       128 L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~--------~~~~~l~~L~~L~L~~N~l~~~~---~~~l-~~L~  195 (597)
T 3oja_B          128 LVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIED--------DTFQATTSLQNLQLSSNRLTHVD---LSLI-PSLF  195 (597)
T ss_dssp             EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCT--------TTTTTCTTCCEEECTTSCCSBCC---GGGC-TTCS
T ss_pred             EEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCCh--------hhhhcCCcCcEEECcCCCCCCcC---hhhh-hhhh
Confidence            9999999998777778999999999999999998754        34678899999999999998753   3333 6899


Q ss_pred             EEEccCCceeecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCe
Q 039957          171 RFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNK  250 (481)
Q Consensus       171 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~  250 (481)
                      .|++++|.+++.     ....+|+.|++++|.+....+..   .++|+.|++++|.+++  +..+..+++|+.|++++|.
T Consensus       196 ~L~l~~n~l~~l-----~~~~~L~~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~  265 (597)
T 3oja_B          196 HANVSYNLLSTL-----AIPIAVEELDASHNSINVVRGPV---NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNE  265 (597)
T ss_dssp             EEECCSSCCSEE-----ECCTTCSEEECCSSCCCEEECSC---CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSC
T ss_pred             hhhcccCccccc-----cCCchhheeeccCCccccccccc---CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCc
Confidence            999999998753     34568999999999998654433   2689999999999997  4788999999999999999


Q ss_pred             eeecCCcccccCCCCCcEEcCCCcCcccCCcchhccccCcEEEccCcccCCCCCCccccCCcCcEEEccCCeeeeecccc
Q 039957          251 LSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPST  330 (481)
Q Consensus       251 l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~  330 (481)
                      +++.+|..|..+++|+.|++++|++++ +|..+..++.|+.|++++|.+. .+|..+..+++|+.|++++|++.+..   
T Consensus       266 l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~---  340 (597)
T 3oja_B          266 LEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK---  340 (597)
T ss_dssp             CCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC---
T ss_pred             cCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcC---
Confidence            999999999999999999999999986 5777788999999999999998 57888899999999999999998653   


Q ss_pred             ccccCChhhhhccccc
Q 039957          331 IGALVDLETISLAGSF  346 (481)
Q Consensus       331 ~~~l~~L~~l~~~g~~  346 (481)
                      +..+++|+.|+++++.
T Consensus       341 ~~~~~~L~~L~l~~N~  356 (597)
T 3oja_B          341 LSTHHTLKNLTLSHND  356 (597)
T ss_dssp             CCTTCCCSEEECCSSC
T ss_pred             hhhcCCCCEEEeeCCC
Confidence            6677888888877653

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=1.9e-35  Score=288.04  Aligned_cols=305  Identities=24%  Similarity=0.390  Sum_probs=262.8

Q ss_pred             chhCCCCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhcccccc
Q 039957            8 EIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATK   87 (481)
Q Consensus         8 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~   87 (481)
                      .+..+++|++|++++|.+..+ | .+..+++|++|++++|+++ .+|. + ..+++|++|++++|.++. +| .+..+++
T Consensus        39 ~~~~l~~L~~L~l~~~~i~~~-~-~~~~~~~L~~L~l~~n~i~-~~~~-~-~~l~~L~~L~L~~n~i~~-~~-~~~~l~~  111 (347)
T 4fmz_A           39 TQEELESITKLVVAGEKVASI-Q-GIEYLTNLEYLNLNGNQIT-DISP-L-SNLVKLTNLYIGTNKITD-IS-ALQNLTN  111 (347)
T ss_dssp             CHHHHTTCSEEECCSSCCCCC-T-TGGGCTTCCEEECCSSCCC-CCGG-G-TTCTTCCEEECCSSCCCC-CG-GGTTCTT
T ss_pred             cchhcccccEEEEeCCccccc-h-hhhhcCCccEEEccCCccc-cchh-h-hcCCcCCEEEccCCcccC-ch-HHcCCCc
Confidence            356788999999999999865 4 4899999999999999998 5665 4 479999999999999985 44 6999999


Q ss_pred             CceeecccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhccc
Q 039957           88 LIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFST  167 (481)
Q Consensus        88 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~  167 (481)
                      |++|++++|.+++..+  +..+++|++|++++|......         ..+..+++|++|++++|.+.+..+  +..+ +
T Consensus       112 L~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~---------~~~~~l~~L~~L~l~~~~~~~~~~--~~~l-~  177 (347)
T 4fmz_A          112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDL---------SPLSNMTGLNYLTVTESKVKDVTP--IANL-T  177 (347)
T ss_dssp             CSEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCC---------GGGTTCTTCCEEECCSSCCCCCGG--GGGC-T
T ss_pred             CCEEECcCCcccCchh--hccCCceeEEECCCCCCcccc---------cchhhCCCCcEEEecCCCcCCchh--hccC-C
Confidence            9999999999996544  999999999999999654321         336788999999999999986543  5555 6


Q ss_pred             CccEEEccCCceeecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecC
Q 039957          168 SLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLG  247 (481)
Q Consensus       168 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~  247 (481)
                      +|++|++++|.+.+.. . +..+++|++|++++|.+.+..+  +..+++|+.|++++|.+++..+  +..+++|+.|+++
T Consensus       178 ~L~~L~l~~n~l~~~~-~-~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~  251 (347)
T 4fmz_A          178 DLYSLSLNYNQIEDIS-P-LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIG  251 (347)
T ss_dssp             TCSEEECTTSCCCCCG-G-GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECC
T ss_pred             CCCEEEccCCcccccc-c-ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECC
Confidence            8999999999998543 3 8889999999999999986554  8899999999999999997655  8899999999999


Q ss_pred             CCeeeecCCcccccCCCCCcEEcCCCcCcccCCcchhccccCcEEEccCcccCCCCCCccccCCcCcEEEccCCeeeeec
Q 039957          248 GNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDI  327 (481)
Q Consensus       248 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~  327 (481)
                      +|.+++.  +.+..+++|++|++++|++++.  ..+..++.|+.|++++|.+.+..|..+..+++|++|++++|++++..
T Consensus       252 ~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~  327 (347)
T 4fmz_A          252 TNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIR  327 (347)
T ss_dssp             SSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCG
T ss_pred             CCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCcccccc
Confidence            9999864  5789999999999999999864  45888999999999999999888888999999999999999999776


Q ss_pred             cccccccCChhhhhcccc
Q 039957          328 PSTIGALVDLETISLAGS  345 (481)
Q Consensus       328 p~~~~~l~~L~~l~~~g~  345 (481)
                      |  +..+++|++++++++
T Consensus       328 ~--~~~l~~L~~L~l~~N  343 (347)
T 4fmz_A          328 P--LASLSKMDSADFANQ  343 (347)
T ss_dssp             G--GGGCTTCSEESSSCC
T ss_pred             C--hhhhhccceeehhhh
Confidence            6  888999999998875

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=3.4e-35  Score=284.31  Aligned_cols=287  Identities=23%  Similarity=0.284  Sum_probs=231.8

Q ss_pred             CCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeecccCcceecCcccccCCCCCCEEEc
Q 039957           38 TIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSL  117 (481)
Q Consensus        38 ~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  117 (481)
                      +++.+++++|.++ .+|..++   ++|++|++++|++++..|..|.++++|++|++++|.+++..|..|+++++|++|++
T Consensus        34 ~l~~l~~~~~~l~-~ip~~~~---~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  109 (332)
T 2ft3_A           34 HLRVVQCSDLGLK-AVPKEIS---PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYI  109 (332)
T ss_dssp             ETTEEECCSSCCS-SCCSCCC---TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEEC
T ss_pred             cCCEEECCCCCcc-ccCCCCC---CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEEC
Confidence            6888888888887 7777653   67888888888888777778888888888888888888888888888888888888


Q ss_pred             ccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEccCCcee--ecCCcccccCCCCCe
Q 039957          118 LMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLK--GTIPKEIGHLRGLIY  195 (481)
Q Consensus       118 ~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~--~~~p~~~~~l~~L~~  195 (481)
                      ++|+++.++...         .  ++|++|++++|.+++..+..+..+ ++|+.|++++|.++  +..|..+..+ +|++
T Consensus       110 ~~n~l~~l~~~~---------~--~~L~~L~l~~n~i~~~~~~~~~~l-~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~  176 (332)
T 2ft3_A          110 SKNHLVEIPPNL---------P--SSLVELRIHDNRIRKVPKGVFSGL-RNMNCIEMGGNPLENSGFEPGAFDGL-KLNY  176 (332)
T ss_dssp             CSSCCCSCCSSC---------C--TTCCEEECCSSCCCCCCSGGGSSC-SSCCEEECCSCCCBGGGSCTTSSCSC-CCSC
T ss_pred             CCCcCCccCccc---------c--ccCCEEECCCCccCccCHhHhCCC-ccCCEEECCCCccccCCCCcccccCC-ccCE
Confidence            888888664322         1  578888888888886666666665 57888888888885  3667777777 8899


Q ss_pred             EecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCcC
Q 039957          196 LSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKL  275 (481)
Q Consensus       196 L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l  275 (481)
                      |++++|++++ +|..+.  ++|+.|++++|.+++..+..+..+++|+.|++++|++++..+..|..+++|+.|++++|++
T Consensus       177 L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  253 (332)
T 2ft3_A          177 LRISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKL  253 (332)
T ss_dssp             CBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCC
T ss_pred             EECcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcC
Confidence            9999998875 555554  6888899999999888888888889999999999999888777888889999999999998


Q ss_pred             cccCCcchhccccCcEEEccCcccCCCCCCcccc------CCcCcEEEccCCeee--eeccccccccCChhhhhcccc
Q 039957          276 TSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQK------LKVLRVLDLSRNQLS--GDIPSTIGALVDLETISLAGS  345 (481)
Q Consensus       276 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~------l~~L~~L~l~~N~l~--~~~p~~~~~l~~L~~l~~~g~  345 (481)
                      + .+|..+..++.|+.|++++|++++..+..|..      ...|+.+++++|++.  +..|.+|..+.+|+.++++++
T Consensus       254 ~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n  330 (332)
T 2ft3_A          254 S-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY  330 (332)
T ss_dssp             C-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC---
T ss_pred             e-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhcccc
Confidence            8 77888888899999999999998777766654      356889999999887  567788888888888877654

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=2e-35  Score=285.93  Aligned_cols=299  Identities=22%  Similarity=0.282  Sum_probs=250.2

Q ss_pred             eccCcchhCC------CCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCcccee
Q 039957            3 GQIPTEIGNL------QNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIG   76 (481)
Q Consensus         3 g~lp~~~~~l------~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~   76 (481)
                      ..+|..+...      .+++.+++++|.++. +|..+  .++|++|++++|++++..|..+. .+++|++|++++|++++
T Consensus        17 ~~lp~~~~~~cp~~c~c~l~~l~~~~~~l~~-ip~~~--~~~l~~L~l~~n~i~~~~~~~~~-~l~~L~~L~L~~n~l~~   92 (332)
T 2ft3_A           17 DSLPPTYSAMCPFGCHCHLRVVQCSDLGLKA-VPKEI--SPDTTLLDLQNNDISELRKDDFK-GLQHLYALVLVNNKISK   92 (332)
T ss_dssp             --------CCCCSSCEEETTEEECCSSCCSS-CCSCC--CTTCCEEECCSSCCCEECTTTTT-TCTTCCEEECCSSCCCE
T ss_pred             ccCCCcccCCCCCCCcccCCEEECCCCCccc-cCCCC--CCCCeEEECCCCcCCccCHhHhh-CCCCCcEEECCCCccCc
Confidence            3466655443      369999999999985 56555  36899999999999855555554 89999999999999999


Q ss_pred             ecchhccccccCceeecccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccce
Q 039957           77 TIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGG  156 (481)
Q Consensus        77 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~  156 (481)
                      ..|..|.++++|++|++++|.++. +|..+.  ++|++|++++|+++.++..        .+.++++|++|++++|.++.
T Consensus        93 ~~~~~~~~l~~L~~L~L~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~--------~~~~l~~L~~L~l~~n~l~~  161 (332)
T 2ft3_A           93 IHEKAFSPLRKLQKLYISKNHLVE-IPPNLP--SSLVELRIHDNRIRKVPKG--------VFSGLRNMNCIEMGGNPLEN  161 (332)
T ss_dssp             ECGGGSTTCTTCCEEECCSSCCCS-CCSSCC--TTCCEEECCSSCCCCCCSG--------GGSSCSSCCEEECCSCCCBG
T ss_pred             cCHhHhhCcCCCCEEECCCCcCCc-cCcccc--ccCCEEECCCCccCccCHh--------HhCCCccCCEEECCCCcccc
Confidence            989999999999999999999994 555554  8999999999999987543        35788999999999999963


Q ss_pred             --eCChhhhhcccCccEEEccCCceeecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCcc
Q 039957          157 --ILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHN  234 (481)
Q Consensus       157 --~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~  234 (481)
                        ..|..+..+  +|+.|++++|++++ +|..+.  ++|++|++++|.+++..+..+..+++|+.|++++|++++..+..
T Consensus       162 ~~~~~~~~~~l--~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~  236 (332)
T 2ft3_A          162 SGFEPGAFDGL--KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGS  236 (332)
T ss_dssp             GGSCTTSSCSC--CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTG
T ss_pred             CCCCcccccCC--ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhH
Confidence              666666665  79999999999995 666554  78999999999999888899999999999999999999988889


Q ss_pred             ccCccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCcCcccCCcchhcc------ccCcEEEccCcccC--CCCCCc
Q 039957          235 LCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSL------GYILEINLSSNLLN--DSLPSN  306 (481)
Q Consensus       235 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l------~~L~~L~l~~N~l~--~~~p~~  306 (481)
                      +..+++|+.|++++|+++ .+|..+..+++|++|++++|++++..+..|...      ..++.+++++|.+.  +..|..
T Consensus       237 ~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~  315 (332)
T 2ft3_A          237 LSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPAT  315 (332)
T ss_dssp             GGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGG
T ss_pred             hhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCccc
Confidence            999999999999999999 678889999999999999999998777777653      56899999999997  678888


Q ss_pred             cccCCcCcEEEccCCe
Q 039957          307 VQKLKVLRVLDLSRNQ  322 (481)
Q Consensus       307 ~~~l~~L~~L~l~~N~  322 (481)
                      |..++.|+.+++++|+
T Consensus       316 ~~~l~~L~~l~l~~n~  331 (332)
T 2ft3_A          316 FRCVTDRLAIQFGNYK  331 (332)
T ss_dssp             GTTBCCSTTEEC----
T ss_pred             ccccchhhhhhccccc
Confidence            9999999999999985

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=5.3e-35  Score=284.78  Aligned_cols=289  Identities=25%  Similarity=0.399  Sum_probs=250.4

Q ss_pred             ccCcchhCCCCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhcc
Q 039957            4 QIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSIT   83 (481)
Q Consensus         4 ~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~   83 (481)
                      .+| .+..+++|++|++++|+++++.+  +..+++|++|++++|.++ .+|. +. .+++|++|++++|++++..+  +.
T Consensus        58 ~~~-~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~-~~~~-~~-~l~~L~~L~l~~n~i~~~~~--~~  129 (347)
T 4fmz_A           58 SIQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT-DISA-LQ-NLTNLRELYLNEDNISDISP--LA  129 (347)
T ss_dssp             CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCGG-GT-TCTTCSEEECTTSCCCCCGG--GT
T ss_pred             cch-hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCccc-CchH-Hc-CCCcCCEEECcCCcccCchh--hc
Confidence            344 48899999999999999987644  999999999999999998 5653 44 79999999999999985544  89


Q ss_pred             ccccCceeecccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhh
Q 039957           84 NATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIG  163 (481)
Q Consensus        84 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~  163 (481)
                      .+++|++|++++|.....++ .+..+++|++|++++|.++..+.          +..+++|++|++++|.+++..+  +.
T Consensus       130 ~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~----------~~~l~~L~~L~l~~n~l~~~~~--~~  196 (347)
T 4fmz_A          130 NLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP----------IANLTDLYSLSLNYNQIEDISP--LA  196 (347)
T ss_dssp             TCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG----------GGGCTTCSEEECTTSCCCCCGG--GG
T ss_pred             cCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh----------hccCCCCCEEEccCCccccccc--cc
Confidence            99999999999997665544 49999999999999999987632          5678899999999999986533  55


Q ss_pred             hcccCccEEEccCCceeecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCe
Q 039957          164 NFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNL  243 (481)
Q Consensus       164 ~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~  243 (481)
                      .+ ++|+.+++++|.+++..+  +..+++|++|++++|.+++..+  +..+++|+.|++++|.+++.  ..+..+++|+.
T Consensus       197 ~l-~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~  269 (347)
T 4fmz_A          197 SL-TSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKM  269 (347)
T ss_dssp             GC-TTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCE
T ss_pred             CC-CccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCE
Confidence            55 689999999999986544  8899999999999999986544  88999999999999999874  56889999999


Q ss_pred             eecCCCeeeecCCcccccCCCCCcEEcCCCcCcccCCcchhccccCcEEEccCcccCCCCCCccccCCcCcEEEccCCee
Q 039957          244 LHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQL  323 (481)
Q Consensus       244 L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l  323 (481)
                      |++++|++++.  +.+..+++|+.|++++|++++..|..+..++.|++|++++|++++..|  +..+++|+.|++++|++
T Consensus       270 L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i  345 (347)
T 4fmz_A          270 LNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVI  345 (347)
T ss_dssp             EECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC--
T ss_pred             EEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhcc
Confidence            99999999875  568999999999999999999999999999999999999999998766  88999999999999998


Q ss_pred             e
Q 039957          324 S  324 (481)
Q Consensus       324 ~  324 (481)
                      +
T Consensus       346 ~  346 (347)
T 4fmz_A          346 K  346 (347)
T ss_dssp             -
T ss_pred             c
Confidence            6

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=2.2e-35  Score=297.12  Aligned_cols=259  Identities=20%  Similarity=0.165  Sum_probs=167.8

Q ss_pred             ccCcchhCCCCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhcc
Q 039957            4 QIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSIT   83 (481)
Q Consensus         4 ~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~   83 (481)
                      .-+.+++.+++|++|++++|.+++. | .+..+++|++|++++|++++ +|  +. .+++|++|++++|++++. |  ++
T Consensus        33 ~~~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~-~~--~~-~l~~L~~L~Ls~N~l~~~-~--~~  103 (457)
T 3bz5_A           33 TDTISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITT-LD--LS-QNTNLTYLACDSNKLTNL-D--VT  103 (457)
T ss_dssp             TSEEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSC-CC--CT-TCTTCSEEECCSSCCSCC-C--CT
T ss_pred             ccccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCe-Ec--cc-cCCCCCEEECcCCCCcee-e--cC
Confidence            3455788899999999999999875 5 68999999999999999985 55  43 789999999999999864 3  88


Q ss_pred             ccccCceeecccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhh
Q 039957           84 NATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIG  163 (481)
Q Consensus        84 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~  163 (481)
                      .+++|++|++++|++++. |  ++.+++|++|++++|++++++           +..+++|++|++++|...+.++  +.
T Consensus       104 ~l~~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l~-----------l~~l~~L~~L~l~~n~~~~~~~--~~  167 (457)
T 3bz5_A          104 PLTKLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEID-----------VSHNTQLTELDCHLNKKITKLD--VT  167 (457)
T ss_dssp             TCTTCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCCC-----------CTTCTTCCEEECTTCSCCCCCC--CT
T ss_pred             CCCcCCEEECCCCcCCee-c--CCCCCcCCEEECCCCccceec-----------cccCCcCCEEECCCCCcccccc--cc
Confidence            999999999999999974 4  889999999999999998762           2345556666666664433332  33


Q ss_pred             hcccCccEEEccCCceeecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCe
Q 039957          164 NFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNL  243 (481)
Q Consensus       164 ~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~  243 (481)
                      .+ ++|+.|++++|++++ +|  +..+++|+.|++++|++++.   .++.+++|+.|++++|++++ +|  +..+++|+.
T Consensus       168 ~l-~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~  237 (457)
T 3bz5_A          168 PQ-TQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTY  237 (457)
T ss_dssp             TC-TTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSE
T ss_pred             cC-CcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCE
Confidence            33 355666666666554 33  55555555556555555543   25555555555555555555 23  455555555


Q ss_pred             eecCCCeeeecCCcccccCC-------CCCcEEcCCCcCcccCCcchhccccCcEEEccCccc
Q 039957          244 LHLGGNKLSGHIPPCLASLT-------SLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLL  299 (481)
Q Consensus       244 L~L~~N~l~~~~p~~~~~l~-------~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l  299 (481)
                      |++++|++++.++..+..++       +|+.|++++|.+.+.+|  +..++.|+.|++++|..
T Consensus       238 L~l~~N~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~  298 (457)
T 3bz5_A          238 FDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQ  298 (457)
T ss_dssp             EECCSSCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTT
T ss_pred             EEeeCCcCCCcCHHHCCCCCEEeccCCCCCEEECCCCccCCccc--ccccccCCEEECCCCcc
Confidence            55555555554433333332       33344444444333333  23344444444444443

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=1.5e-34  Score=279.64  Aligned_cols=289  Identities=21%  Similarity=0.225  Sum_probs=231.8

Q ss_pred             cCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeecccCcceecCcccccCCCCCCEEE
Q 039957           37 STIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLS  116 (481)
Q Consensus        37 ~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  116 (481)
                      .+++.++++++.++ .+|..+.   ++|++|++++|++++..+..|.++++|++|++++|.+++..|..|+++++|++|+
T Consensus        31 c~l~~l~~~~~~l~-~lp~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  106 (330)
T 1xku_A           31 CHLRVVQCSDLGLE-KVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLY  106 (330)
T ss_dssp             EETTEEECTTSCCC-SCCCSCC---TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEE
T ss_pred             CCCeEEEecCCCcc-ccCccCC---CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEE
Confidence            36888888888887 6776543   6788888888888877777888888888888888888888788888888888888


Q ss_pred             cccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEccCCceee--cCCcccccCCCCC
Q 039957          117 LLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKG--TIPKEIGHLRGLI  194 (481)
Q Consensus       117 L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~--~~p~~~~~l~~L~  194 (481)
                      +++|+++.++...           .++|++|++++|.+++..+..+..+ ++|+.|++++|.++.  ..+..+..+++|+
T Consensus       107 Ls~n~l~~l~~~~-----------~~~L~~L~l~~n~l~~~~~~~~~~l-~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~  174 (330)
T 1xku_A          107 LSKNQLKELPEKM-----------PKTLQELRVHENEITKVRKSVFNGL-NQMIVVELGTNPLKSSGIENGAFQGMKKLS  174 (330)
T ss_dssp             CCSSCCSBCCSSC-----------CTTCCEEECCSSCCCBBCHHHHTTC-TTCCEEECCSSCCCGGGBCTTGGGGCTTCC
T ss_pred             CCCCcCCccChhh-----------cccccEEECCCCcccccCHhHhcCC-ccccEEECCCCcCCccCcChhhccCCCCcC
Confidence            8888888664322           1578888888888887666667666 578889998888853  6677888888999


Q ss_pred             eEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCc
Q 039957          195 YLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNK  274 (481)
Q Consensus       195 ~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~  274 (481)
                      +|++++|.++. +|..+.  ++|+.|++++|++++..|..|..+++|+.|++++|++++..+..|..+++|++|++++|+
T Consensus       175 ~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~  251 (330)
T 1xku_A          175 YIRIADTNITT-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNK  251 (330)
T ss_dssp             EEECCSSCCCS-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSC
T ss_pred             EEECCCCcccc-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCc
Confidence            99999998874 555544  788899999999888888888888999999999999988888888888999999999998


Q ss_pred             CcccCCcchhccccCcEEEccCcccCCCCCCcccc------CCcCcEEEccCCeeee--eccccccccCChhhhhcccc
Q 039957          275 LTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQK------LKVLRVLDLSRNQLSG--DIPSTIGALVDLETISLAGS  345 (481)
Q Consensus       275 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~------l~~L~~L~l~~N~l~~--~~p~~~~~l~~L~~l~~~g~  345 (481)
                      ++ .+|..+..++.|++|++++|++++..+..|..      ...++.+++++|++..  ..|..|..+.+++.++++++
T Consensus       252 l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N  329 (330)
T 1xku_A          252 LV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY  329 (330)
T ss_dssp             CS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC---
T ss_pred             Cc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEeccc
Confidence            88 77888888889999999999998777666643      3678889999998863  55677888888888877654

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=2.4e-34  Score=278.09  Aligned_cols=290  Identities=20%  Similarity=0.237  Sum_probs=244.9

Q ss_pred             CCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceee
Q 039957           13 QNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILD   92 (481)
Q Consensus        13 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~   92 (481)
                      .+++.++++++.++. +|..+.  +++++|++++|++++..+..+ ..+++|++|+|++|++++..|..|..+++|++|+
T Consensus        31 c~l~~l~~~~~~l~~-lp~~~~--~~l~~L~L~~n~i~~~~~~~~-~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  106 (330)
T 1xku_A           31 CHLRVVQCSDLGLEK-VPKDLP--PDTALLDLQNNKITEIKDGDF-KNLKNLHTLILINNKISKISPGAFAPLVKLERLY  106 (330)
T ss_dssp             EETTEEECTTSCCCS-CCCSCC--TTCCEEECCSSCCCCBCTTTT-TTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEE
T ss_pred             CCCeEEEecCCCccc-cCccCC--CCCeEEECCCCcCCEeChhhh-ccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEE
Confidence            478999999999985 455443  689999999999985444455 4899999999999999988899999999999999


Q ss_pred             cccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccce--eCChhhhhcccCcc
Q 039957           93 LGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGG--ILPPSIGNFSTSLQ  170 (481)
Q Consensus        93 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~--~~p~~~~~~~~~L~  170 (481)
                      +++|.++. +|..+.  ++|++|++++|.+++++.        ..+.++++|++|++++|.++.  ..+..+..+ ++|+
T Consensus       107 Ls~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~--------~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~~L~  174 (330)
T 1xku_A          107 LSKNQLKE-LPEKMP--KTLQELRVHENEITKVRK--------SVFNGLNQMIVVELGTNPLKSSGIENGAFQGM-KKLS  174 (330)
T ss_dssp             CCSSCCSB-CCSSCC--TTCCEEECCSSCCCBBCH--------HHHTTCTTCCEEECCSSCCCGGGBCTTGGGGC-TTCC
T ss_pred             CCCCcCCc-cChhhc--ccccEEECCCCcccccCH--------hHhcCCccccEEECCCCcCCccCcChhhccCC-CCcC
Confidence            99999984 565554  799999999999987643        235678899999999999964  667777776 6899


Q ss_pred             EEEccCCceeecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCe
Q 039957          171 RFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNK  250 (481)
Q Consensus       171 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~  250 (481)
                      +|++++|.++. +|..+.  ++|++|++++|++++..|..+..+++|+.|++++|.+++..+..+..+++|+.|++++|+
T Consensus       175 ~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~  251 (330)
T 1xku_A          175 YIRIADTNITT-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNK  251 (330)
T ss_dssp             EEECCSSCCCS-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSC
T ss_pred             EEECCCCcccc-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCc
Confidence            99999999984 665554  789999999999999889999999999999999999999888899999999999999999


Q ss_pred             eeecCCcccccCCCCCcEEcCCCcCcccCCcchhcc------ccCcEEEccCcccCC--CCCCccccCCcCcEEEccCCe
Q 039957          251 LSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSL------GYILEINLSSNLLND--SLPSNVQKLKVLRVLDLSRNQ  322 (481)
Q Consensus       251 l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l------~~L~~L~l~~N~l~~--~~p~~~~~l~~L~~L~l~~N~  322 (481)
                      ++ .+|..+..+++|++|++++|++++..+..|...      ..+..+++++|.+..  ..|..|..+..++.+++++|+
T Consensus       252 l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~  330 (330)
T 1xku_A          252 LV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK  330 (330)
T ss_dssp             CS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred             Cc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence            98 678889999999999999999998777776543      678899999999864  667889999999999999985

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=3.3e-34  Score=290.38  Aligned_cols=289  Identities=26%  Similarity=0.382  Sum_probs=246.5

Q ss_pred             cCcchhCCCCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecc-----
Q 039957            5 IPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIP-----   79 (481)
Q Consensus         5 lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p-----   79 (481)
                      +|. +..+++|++|++++|++++..|  +.++++|++|++++|+++ .+|. +. .+++|++|++++|.+++...     
T Consensus        83 ~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~-~~~~-~~-~l~~L~~L~l~~n~l~~~~~~~~l~  156 (466)
T 1o6v_A           83 ITP-LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQIT-DIDP-LK-NLTNLNRLELSSNTISDISALSGLT  156 (466)
T ss_dssp             CGG-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCGG-GT-TCTTCSEEEEEEEEECCCGGGTTCT
T ss_pred             chh-hhccccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCC-CChH-Hc-CCCCCCEEECCCCccCCChhhccCC
Confidence            444 8888999999999999987655  888999999999999887 4554 43 78889999998888765321     


Q ss_pred             --------------hhccccccCceeecccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCc
Q 039957           80 --------------NSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLV  145 (481)
Q Consensus        80 --------------~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~  145 (481)
                                    ..+.++++|++|++++|.+++.  ..+..+++|++|++++|.+++..+          +..+++|+
T Consensus       157 ~L~~L~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~----------~~~l~~L~  224 (466)
T 1o6v_A          157 SLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP----------LGILTNLD  224 (466)
T ss_dssp             TCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG----------GGGCTTCC
T ss_pred             cccEeecCCcccCchhhccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc----------ccccCCCC
Confidence                          1267788999999999999864  358999999999999999987632          45678999


Q ss_pred             EEEccCCccceeCChhhhhcccCccEEEccCCceeecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCC
Q 039957          146 YLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPET  225 (481)
Q Consensus       146 ~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n  225 (481)
                      +|++++|.+++.  +.+..+ ++|+.|++++|.+++..|  +..+++|++|++++|.+++..+  +..+++|+.|++++|
T Consensus       225 ~L~l~~n~l~~~--~~l~~l-~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n  297 (466)
T 1o6v_A          225 ELSLNGNQLKDI--GTLASL-TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNEN  297 (466)
T ss_dssp             EEECCSSCCCCC--GGGGGC-TTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSS
T ss_pred             EEECCCCCcccc--hhhhcC-CCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCC
Confidence            999999999864  456665 689999999999997654  8899999999999999987554  889999999999999


Q ss_pred             cCCCCCCccccCccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCcCcccCCcchhccccCcEEEccCcccCCCCCC
Q 039957          226 NLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPS  305 (481)
Q Consensus       226 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~  305 (481)
                      ++.+..+  +..+++|+.|++++|++++..|  +..+++|+.|++++|++++.  ..+..++.|+.|++++|++++..| 
T Consensus       298 ~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~-  370 (466)
T 1o6v_A          298 QLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP-  370 (466)
T ss_dssp             CCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG-
T ss_pred             cccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch-
Confidence            9998655  8899999999999999998765  78999999999999999875  478899999999999999998877 


Q ss_pred             ccccCCcCcEEEccCCeeeee
Q 039957          306 NVQKLKVLRVLDLSRNQLSGD  326 (481)
Q Consensus       306 ~~~~l~~L~~L~l~~N~l~~~  326 (481)
                       +..+++|+.|++++|++++.
T Consensus       371 -~~~l~~L~~L~l~~n~~~~~  390 (466)
T 1o6v_A          371 -LANLTRITQLGLNDQAWTNA  390 (466)
T ss_dssp             -GTTCTTCCEEECCCEEEECC
T ss_pred             -hhcCCCCCEEeccCCcccCC
Confidence             88999999999999999973

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=2.2e-34  Score=289.61  Aligned_cols=303  Identities=23%  Similarity=0.277  Sum_probs=156.3

Q ss_pred             eccCcchhCCCCCCeeeCcCCcccccCChhccCCcCC-------------CEEEeeCCcCccccChhhh-----------
Q 039957            3 GQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTI-------------RNLNLGGNRLSGHLPSMIG-----------   58 (481)
Q Consensus         3 g~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L-------------~~L~L~~N~l~~~~p~~~~-----------   58 (481)
                      |++|.+|+++++|++|++++|++++.+|..++++++|             ++|++++|.+++ +|....           
T Consensus        24 ~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp~~~~~L~~L~l~~n~  102 (454)
T 1jl5_A           24 TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LPELPPHLESLVASCNS  102 (454)
T ss_dssp             ----------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CCSCCTTCSEEECCSSC
T ss_pred             hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CCCCcCCCCEEEccCCc
Confidence            6788888888888888888888888888877776643             556666555552 332100           


Q ss_pred             -----cCCCCccEEEccCccceeecchhccccccCceeecccCcceecCcccccCCCCCCEEEcccccCccccCCCccc-
Q 039957           59 -----HSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQW-  132 (481)
Q Consensus        59 -----~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-  132 (481)
                           ...++|++|++++|++++ +|..   .++|++|++++|++++ +| +|+++++|++|++++|++++++...... 
T Consensus       103 l~~lp~~~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~lp~~~~~L~  176 (454)
T 1jl5_A          103 LTELPELPQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKKLPDLPPSLE  176 (454)
T ss_dssp             CSSCCCCCTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSCCCCCCTTCC
T ss_pred             CCccccccCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcccCCCccccc
Confidence                 012445555555555442 2211   1578888888888886 66 5888889999999998888764322100 


Q ss_pred             ---------cccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEccCCceeecCCcccccCCCCCeEecccccc
Q 039957          133 ---------SFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDL  203 (481)
Q Consensus       133 ---------~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l  203 (481)
                               ...+.+.++++|++|++++|++++ +|..    ..+|++|++++|.++ .+| .++.+++|++|++++|++
T Consensus       177 ~L~L~~n~l~~l~~~~~l~~L~~L~l~~N~l~~-l~~~----~~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l  249 (454)
T 1jl5_A          177 FIAAGNNQLEELPELQNLPFLTAIYADNNSLKK-LPDL----PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLL  249 (454)
T ss_dssp             EEECCSSCCSSCCCCTTCTTCCEEECCSSCCSS-CCCC----CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCC
T ss_pred             EEECcCCcCCcCccccCCCCCCEEECCCCcCCc-CCCC----cCcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcC
Confidence                     001134445555555555555553 2221    134556666666555 444 255566666666666666


Q ss_pred             eecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCcCcccCCcch
Q 039957          204 NGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSL  283 (481)
Q Consensus       204 ~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~  283 (481)
                      ++ +|..   +++|+.|++++|++++ +|..   +++|+.|++++|++++.. ..   .++|+.|++++|++++. +   
T Consensus       250 ~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l~-~~---~~~L~~L~l~~N~l~~i-~---  313 (454)
T 1jl5_A          250 KT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGLS-EL---PPNLYYLNASSNEIRSL-C---  313 (454)
T ss_dssp             SS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEES-CC---CTTCCEEECCSSCCSEE-C---
T ss_pred             Cc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCccc-Cc---CCcCCEEECcCCcCCcc-c---
Confidence            53 3322   2455555666555554 2322   245556666666655421 10   02333444444433321 1   


Q ss_pred             hcc-ccCcEEEccCcccCCCCCCccccCCcCcEEEccCCeeeeeccccccccCChhhhhccc
Q 039957          284 WSL-GYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAG  344 (481)
Q Consensus       284 ~~l-~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~~~g  344 (481)
                       .+ +.|++|++++|++++ +|..   +++|++|++++|++++ +|.   .+.+|++|++++
T Consensus       314 -~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~-lp~---~l~~L~~L~L~~  366 (454)
T 1jl5_A          314 -DLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAE-VPE---LPQNLKQLHVEY  366 (454)
T ss_dssp             -CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCS
T ss_pred             -CCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCcccc-ccc---hhhhccEEECCC
Confidence             11 355556666665554 3332   3455566666665552 333   244555555444

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=1.1e-33  Score=284.72  Aligned_cols=282  Identities=20%  Similarity=0.222  Sum_probs=241.2

Q ss_pred             cCcchhCCCCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccc
Q 039957            5 IPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITN   84 (481)
Q Consensus         5 lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~   84 (481)
                      +| +|+.+++|++|+|++|+++++ |  +..+++|++|++++|++++ +|  +. .+++|++|++++|++++ +|  +..
T Consensus        57 ~~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~-~~--~~-~l~~L~~L~L~~N~l~~-l~--~~~  125 (457)
T 3bz5_A           57 MT-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTN-LD--VT-PLTKLTYLNCDTNKLTK-LD--VSQ  125 (457)
T ss_dssp             CT-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSC-CC--CT-TCTTCCEEECCSSCCSC-CC--CTT
T ss_pred             Ch-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCce-ee--cC-CCCcCCEEECCCCcCCe-ec--CCC
Confidence            56 699999999999999999986 4  8999999999999999995 55  44 79999999999999987 44  899


Q ss_pred             cccCceeecccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhh
Q 039957           85 ATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGN  164 (481)
Q Consensus        85 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~  164 (481)
                      +++|++|++++|++++. +  ++.+++|++|++++|+..+..          .+..+++|++|++++|++++ +|  +..
T Consensus       126 l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~----------~~~~l~~L~~L~ls~n~l~~-l~--l~~  189 (457)
T 3bz5_A          126 NPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL----------DVTPQTQLTTLDCSFNKITE-LD--VSQ  189 (457)
T ss_dssp             CTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC----------CCTTCTTCCEEECCSSCCCC-CC--CTT
T ss_pred             CCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc----------ccccCCcCCEEECCCCccce-ec--ccc
Confidence            99999999999999984 3  899999999999999644321          25678899999999999997 44  555


Q ss_pred             cccCccEEEccCCceeecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCcc-----
Q 039957          165 FSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLE-----  239 (481)
Q Consensus       165 ~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~-----  239 (481)
                      + ++|+.|++++|++++.   .++.+++|++|++++|++++ +|  ++.+++|+.|++++|++++..+..+..++     
T Consensus       190 l-~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~l~~L~~L~l~  262 (457)
T 3bz5_A          190 N-KLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCI  262 (457)
T ss_dssp             C-TTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTTCTTCCEEECT
T ss_pred             C-CCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHHHCCCCCEEecc
Confidence            5 6899999999999975   48899999999999999997 55  88999999999999999998776666665     


Q ss_pred             --CCCeeecCCCeeeecCCcccccCCCCCcEEcCCCcCcccCCcc--------hhccccCcEEEccCcccCCCCCCcccc
Q 039957          240 --MLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSS--------LWSLGYILEINLSSNLLNDSLPSNVQK  309 (481)
Q Consensus       240 --~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~--------~~~l~~L~~L~l~~N~l~~~~p~~~~~  309 (481)
                        +|+.+++++|.+.+.+|  +..+++|+.|++++|...+.+|..        +..++.|++|++++|++++. +  +..
T Consensus       263 ~n~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~l~~l-~--l~~  337 (457)
T 3bz5_A          263 QTDLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTEL-D--VSH  337 (457)
T ss_dssp             TCCCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCCCSCC-C--CTT
T ss_pred             CCCCCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccCCCcceEechhhcccCCEEECCCCccccc-c--ccc
Confidence              56778888887766665  567899999999999987776643        45567889999999999984 3  889


Q ss_pred             CCcCcEEEccCCeeee
Q 039957          310 LKVLRVLDLSRNQLSG  325 (481)
Q Consensus       310 l~~L~~L~l~~N~l~~  325 (481)
                      ++.|+.|++++|++++
T Consensus       338 l~~L~~L~l~~N~l~~  353 (457)
T 3bz5_A          338 NTKLKSLSCVNAHIQD  353 (457)
T ss_dssp             CTTCSEEECCSSCCCB
T ss_pred             CCcCcEEECCCCCCCC
Confidence            9999999999999986

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=1.7e-36  Score=307.84  Aligned_cols=30  Identities=17%  Similarity=0.142  Sum_probs=26.4

Q ss_pred             hhhhhHHHHHhhhhccCccceeecccCCCC
Q 039957          373 FRSFNSECEVLRNVRHQNLIKILSSCSTPD  402 (481)
Q Consensus       373 ~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  402 (481)
                      .++|..|++.+++++|+|+|+++|||.+..
T Consensus       323 ~~eF~~Eve~L~~i~HrNLV~L~gyC~s~~  352 (487)
T 3oja_A          323 SETERLECERENQARQREIDALKEQYRTVI  352 (487)
T ss_dssp             --CHHHHHHHHHHHHHHHHHHHHHHTCCCC
T ss_pred             HHHHHHHHHHHhcccccchhhHHHHhcChH
Confidence            467999999999999999999999998865

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=7.3e-32  Score=271.21  Aligned_cols=282  Identities=25%  Similarity=0.319  Sum_probs=194.0

Q ss_pred             CCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceee
Q 039957           13 QNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILD   92 (481)
Q Consensus        13 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~   92 (481)
                      ++|++|++++|+++++ |..   .++|++|++++|++++ +|+ +. .+++|++|++++|++++ +|..+   .+|++|+
T Consensus       111 ~~L~~L~l~~n~l~~l-~~~---~~~L~~L~L~~n~l~~-lp~-~~-~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~  179 (454)
T 1jl5_A          111 QSLKSLLVDNNNLKAL-SDL---PPLLEYLGVSNNQLEK-LPE-LQ-NSSFLKIIDVDNNSLKK-LPDLP---PSLEFIA  179 (454)
T ss_dssp             TTCCEEECCSSCCSCC-CSC---CTTCCEEECCSSCCSS-CCC-CT-TCTTCCEEECCSSCCSC-CCCCC---TTCCEEE
T ss_pred             CCCcEEECCCCccCcc-cCC---CCCCCEEECcCCCCCC-Ccc-cC-CCCCCCEEECCCCcCcc-cCCCc---ccccEEE
Confidence            4455555555555432 111   1467777777777773 663 43 67777777777777764 44433   4777778


Q ss_pred             cccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEE
Q 039957           93 LGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRF  172 (481)
Q Consensus        93 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L  172 (481)
                      +++|.+++ +| .|+++++|++|++++|++++++..            .++|++|++++|.++ .+|. ++.+ ++|++|
T Consensus       180 L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~l~~~------------~~~L~~L~l~~n~l~-~lp~-~~~l-~~L~~L  242 (454)
T 1jl5_A          180 AGNNQLEE-LP-ELQNLPFLTAIYADNNSLKKLPDL------------PLSLESIVAGNNILE-ELPE-LQNL-PFLTTI  242 (454)
T ss_dssp             CCSSCCSS-CC-CCTTCTTCCEEECCSSCCSSCCCC------------CTTCCEEECCSSCCS-SCCC-CTTC-TTCCEE
T ss_pred             CcCCcCCc-Cc-cccCCCCCCEEECCCCcCCcCCCC------------cCcccEEECcCCcCC-cccc-cCCC-CCCCEE
Confidence            88887776 45 578888888888888888775432            247999999999998 5664 6665 689999


Q ss_pred             EccCCceeecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeee
Q 039957          173 SASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLS  252 (481)
Q Consensus       173 ~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~  252 (481)
                      ++++|++++ +|..   +++|++|++++|++++ +|..   +++|+.|++++|++++. |..   .++|+.|++++|+++
T Consensus       243 ~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l-~~~---~~~L~~L~l~~N~l~  310 (454)
T 1jl5_A          243 YADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGL-SEL---PPNLYYLNASSNEIR  310 (454)
T ss_dssp             ECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEE-SCC---CTTCCEEECCSSCCS
T ss_pred             ECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCcc-cCc---CCcCCEEECcCCcCC
Confidence            999999985 5543   4789999999999886 5543   37889999999998873 211   157888999999888


Q ss_pred             ecCCcccccCCCCCcEEcCCCcCcccCCcchhccccCcEEEccCcccCCCCCCccccCCcCcEEEccCCeeee--ecccc
Q 039957          253 GHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSG--DIPST  330 (481)
Q Consensus       253 ~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~--~~p~~  330 (481)
                      +. +..   .++|++|++++|++++ +|..   ++.|++|++++|+++. +|.   .+++|++|++++|++++  .+|..
T Consensus       311 ~i-~~~---~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~-lp~---~l~~L~~L~L~~N~l~~l~~ip~~  378 (454)
T 1jl5_A          311 SL-CDL---PPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAE-VPE---LPQNLKQLHVEYNPLREFPDIPES  378 (454)
T ss_dssp             EE-CCC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSSCCCCCTT
T ss_pred             cc-cCC---cCcCCEEECCCCcccc-cccc---CCcCCEEECCCCcccc-ccc---hhhhccEEECCCCCCCcCCCChHH
Confidence            63 211   2588899999999886 5554   4788899999998874 555   46788999999999988  67888


Q ss_pred             cccc-------------CChhhhhccccc
Q 039957          331 IGAL-------------VDLETISLAGSF  346 (481)
Q Consensus       331 ~~~l-------------~~L~~l~~~g~~  346 (481)
                      ++.+             .+|+.|+++++.
T Consensus       379 l~~L~~n~~~~~i~~~~~~L~~L~ls~N~  407 (454)
T 1jl5_A          379 VEDLRMNSHLAEVPELPQNLKQLHVETNP  407 (454)
T ss_dssp             CCEEECCC---------------------
T ss_pred             HHhhhhcccccccccccCcCCEEECCCCc
Confidence            8777             778888887654

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=100.00  E-value=3.9e-32  Score=259.77  Aligned_cols=249  Identities=24%  Similarity=0.291  Sum_probs=177.6

Q ss_pred             CeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceee--cchhccccccCceeec
Q 039957           16 KSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGT--IPNSITNATKLIILDL   93 (481)
Q Consensus        16 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~L   93 (481)
                      +.++.+++.++.+ |..+  .++|++|++++|+++ .+|..++..+++|++|+|++|+++..  .|..+..+++|++|++
T Consensus        10 ~~l~c~~~~l~~i-p~~~--~~~l~~L~L~~n~l~-~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L   85 (306)
T 2z66_A           10 TEIRCNSKGLTSV-PTGI--PSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDL   85 (306)
T ss_dssp             TEEECCSSCCSSC-CSCC--CTTCCEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEEC
T ss_pred             CEEEcCCCCcccC-CCCC--CCCCCEEECCCCccC-ccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEEC
Confidence            5788888888754 4433  267889999999987 67776555788999999999988733  3677778889999999


Q ss_pred             ccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEE
Q 039957           94 GFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFS  173 (481)
Q Consensus        94 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~  173 (481)
                      ++|.++. +|..|..+++|++|++++|.+++++..       ..+..+++|++|++++|.+++..|..+..+ ++|++|+
T Consensus        86 s~n~i~~-l~~~~~~l~~L~~L~l~~n~l~~~~~~-------~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l-~~L~~L~  156 (306)
T 2z66_A           86 SFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEF-------SVFLSLRNLIYLDISHTHTRVAFNGIFNGL-SSLEVLK  156 (306)
T ss_dssp             CSCSEEE-EEEEEETCTTCCEEECTTSEEESSTTT-------TTTTTCTTCCEEECTTSCCEECSTTTTTTC-TTCCEEE
T ss_pred             CCCcccc-ChhhcCCCCCCCEEECCCCcccccccc-------hhhhhccCCCEEECCCCcCCccchhhcccC-cCCCEEE
Confidence            9998884 566788889999999998888876431       235667778888888888877666666655 4677777


Q ss_pred             ccCCceee-cCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeee
Q 039957          174 ASECKLKG-TIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLS  252 (481)
Q Consensus       174 l~~n~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~  252 (481)
                      +++|.+++ .+|..+..+++|++|++++|++++..|..+..+++|+.|++++|.+++..+..+..+++|+.|++++|+++
T Consensus       157 l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  236 (306)
T 2z66_A          157 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM  236 (306)
T ss_dssp             CTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCC
T ss_pred             CCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCc
Confidence            77777765 45666777777777777777776666666666666666666666666655555666666666666666666


Q ss_pred             ecCCcccccCC-CCCcEEcCCCcCcc
Q 039957          253 GHIPPCLASLT-SLRELDLGSNKLTS  277 (481)
Q Consensus       253 ~~~p~~~~~l~-~L~~L~ls~N~l~~  277 (481)
                      +..|..+..++ +|++|++++|.+++
T Consensus       237 ~~~~~~~~~~~~~L~~L~L~~N~~~~  262 (306)
T 2z66_A          237 TSKKQELQHFPSSLAFLNLTQNDFAC  262 (306)
T ss_dssp             BCSSSSCCCCCTTCCEEECTTCCEEC
T ss_pred             ccCHHHHHhhhccCCEEEccCCCeec
Confidence            66666666553 56666666666653

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=100.00  E-value=1.3e-32  Score=263.08  Aligned_cols=248  Identities=21%  Similarity=0.185  Sum_probs=157.5

Q ss_pred             CCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeecccCcceec--CcccccCCCCCCEEE
Q 039957           39 IRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGH--IPNTFGNLRHLSVLS  116 (481)
Q Consensus        39 L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~  116 (481)
                      -+.++.+++.++ .+|..++   ++|++|++++|+++...+..|.++++|++|+|++|.++..  .|..+..+++|++|+
T Consensus         9 ~~~l~c~~~~l~-~ip~~~~---~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~   84 (306)
T 2z66_A            9 GTEIRCNSKGLT-SVPTGIP---SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLD   84 (306)
T ss_dssp             TTEEECCSSCCS-SCCSCCC---TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEE
T ss_pred             CCEEEcCCCCcc-cCCCCCC---CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEE
Confidence            357889999997 7887553   6899999999999865556688999999999999988743  367777888899999


Q ss_pred             cccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCC-hhhhhcccCccEEEccCCceeecCCcccccCCCCCe
Q 039957          117 LLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILP-PSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIY  195 (481)
Q Consensus       117 L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~  195 (481)
                      +++|.++.++         ..+..+++|++|++++|++++..+ ..+..+ ++|++|++++|.+++..|..+..+++|++
T Consensus        85 Ls~n~i~~l~---------~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l-~~L~~L~l~~n~l~~~~~~~~~~l~~L~~  154 (306)
T 2z66_A           85 LSFNGVITMS---------SNFLGLEQLEHLDFQHSNLKQMSEFSVFLSL-RNLIYLDISHTHTRVAFNGIFNGLSSLEV  154 (306)
T ss_dssp             CCSCSEEEEE---------EEEETCTTCCEEECTTSEEESSTTTTTTTTC-TTCCEEECTTSCCEECSTTTTTTCTTCCE
T ss_pred             CCCCccccCh---------hhcCCCCCCCEEECCCCcccccccchhhhhc-cCCCEEECCCCcCCccchhhcccCcCCCE
Confidence            9888887653         224567778888888887775443 334443 45666666666666655656666666666


Q ss_pred             Eeccccccee-cCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCc
Q 039957          196 LSLGFNDLNG-TIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNK  274 (481)
Q Consensus       196 L~l~~N~l~~-~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~  274 (481)
                      |++++|.+++ ..|..+..+++|+.|++++|++++..|..+..+++|+.|++++|++++..+..|..+++|++|++++|+
T Consensus       155 L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  234 (306)
T 2z66_A          155 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH  234 (306)
T ss_dssp             EECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSC
T ss_pred             EECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCC
Confidence            6666666654 345555555555555555555555445555555555555555555554444445555555555555555


Q ss_pred             CcccCCcchhccc-cCcEEEccCcccC
Q 039957          275 LTSSIPSSLWSLG-YILEINLSSNLLN  300 (481)
Q Consensus       275 l~~~~p~~~~~l~-~L~~L~l~~N~l~  300 (481)
                      +++..|..+..++ .|++|++++|.+.
T Consensus       235 l~~~~~~~~~~~~~~L~~L~L~~N~~~  261 (306)
T 2z66_A          235 IMTSKKQELQHFPSSLAFLNLTQNDFA  261 (306)
T ss_dssp             CCBCSSSSCCCCCTTCCEEECTTCCEE
T ss_pred             CcccCHHHHHhhhccCCEEEccCCCee
Confidence            5544444444432 4444444444443

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.98  E-value=6.7e-33  Score=270.53  Aligned_cols=279  Identities=20%  Similarity=0.211  Sum_probs=161.6

Q ss_pred             cCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeecccCcceecCcccccCCCCCCEEE
Q 039957           37 STIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLS  116 (481)
Q Consensus        37 ~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  116 (481)
                      +.....+.++|.++ .+|..++   ++|++|++++|++++..+..|.++++|++|++++|.+++..|..|+++++|++|+
T Consensus        31 ~~~~~c~~~~~~l~-~iP~~~~---~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  106 (353)
T 2z80_A           31 DRNGICKGSSGSLN-SIPSGLT---EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLD  106 (353)
T ss_dssp             CTTSEEECCSTTCS-SCCTTCC---TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred             CCCeEeeCCCCCcc-ccccccc---ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEE
Confidence            33344455555554 4444332   3455555555555544444455555555555555555544444555555555555


Q ss_pred             cccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCC-hhhhhcccCccEEEccCC-ceeecCCcccccCCCCC
Q 039957          117 LLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILP-PSIGNFSTSLQRFSASEC-KLKGTIPKEIGHLRGLI  194 (481)
Q Consensus       117 L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~~~~~L~~L~l~~n-~l~~~~p~~~~~l~~L~  194 (481)
                      +++|++++++..        .+.++++|++|++++|++++..+ ..+..+ ++|++|++++| .+....|..+.++++|+
T Consensus       107 Ls~n~l~~~~~~--------~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l-~~L~~L~l~~n~~~~~~~~~~~~~l~~L~  177 (353)
T 2z80_A          107 LSYNYLSNLSSS--------WFKPLSSLTFLNLLGNPYKTLGETSLFSHL-TKLQILRVGNMDTFTKIQRKDFAGLTFLE  177 (353)
T ss_dssp             CCSSCCSSCCHH--------HHTTCTTCSEEECTTCCCSSSCSSCSCTTC-TTCCEEEEEESSSCCEECTTTTTTCCEEE
T ss_pred             CCCCcCCcCCHh--------HhCCCccCCEEECCCCCCcccCchhhhccC-CCCcEEECCCCccccccCHHHccCCCCCC
Confidence            555555443211        12344455555555555543222 133333 34555555555 34444455566666666


Q ss_pred             eEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeeeecCCcccc---cCCCCCcEEcC
Q 039957          195 YLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLA---SLTSLRELDLG  271 (481)
Q Consensus       195 ~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~---~l~~L~~L~ls  271 (481)
                      +|++++|++++..|..+..+++|+.|++++|.+....+..+..+++|+.|++++|++++..+..+.   ..+.++.++++
T Consensus       178 ~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~  257 (353)
T 2z80_A          178 ELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFR  257 (353)
T ss_dssp             EEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEE
T ss_pred             EEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhccccc
Confidence            666666666666666666666666666666666543333344566677777777777655444332   34567778888


Q ss_pred             CCcCcc----cCCcchhccccCcEEEccCcccCCCCCCccccCCcCcEEEccCCeeeeecc
Q 039957          272 SNKLTS----SIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIP  328 (481)
Q Consensus       272 ~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p  328 (481)
                      ++.+++    .+|..+..++.|++|++++|+++...+..+..+++|++|++++|++.+..|
T Consensus       258 ~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~  318 (353)
T 2z80_A          258 NVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  318 (353)
T ss_dssp             SCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             cccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence            887765    367778888899999999999985444446889999999999999987654

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.97  E-value=4.6e-35  Score=296.45  Aligned_cols=333  Identities=22%  Similarity=0.213  Sum_probs=235.8

Q ss_pred             hhCCCCCCeeeCcCCcccc----cCChhccCCcCCCEEEeeCCcCccccChhhhcCCC----CccEEEccCcccee----
Q 039957            9 IGNLQNLKSLFLGANNLSG----LIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLP----NIKYLELGDNNLIG----   76 (481)
Q Consensus         9 ~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~----~L~~L~L~~N~l~~----   76 (481)
                      +..+++|++|+|++|+++.    .++..+..+++|++|+|++|.++...+..++..++    +|++|+|++|+++.    
T Consensus        24 ~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~  103 (461)
T 1z7x_W           24 LPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCG  103 (461)
T ss_dssp             HHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHH
T ss_pred             HhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHH
Confidence            6677888888888888764    34566777788888888888887544555554555    68888888888773    


Q ss_pred             ecchhccccccCceeecccCcceecCccccc-----CCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccC
Q 039957           77 TIPNSITNATKLIILDLGFNTFSGHIPNTFG-----NLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSG  151 (481)
Q Consensus        77 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~  151 (481)
                      .++..+..+++|++|++++|.++...+..+.     ..++|++|++++|+++......    +...+..+++|++|++++
T Consensus       104 ~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~----l~~~l~~~~~L~~L~L~~  179 (461)
T 1z7x_W          104 VLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEP----LASVLRAKPDFKELTVSN  179 (461)
T ss_dssp             HHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHH----HHHHHHHCTTCCEEECCS
T ss_pred             HHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHH----HHHHHhhCCCCCEEECcC
Confidence            5577788888888888888887755444333     3567888888888877642111    123345567888888888


Q ss_pred             CccceeCChhhhh----cccCccEEEccCCceeec----CCcccccCCCCCeEecccccceecC-----CcCCcCCCCCC
Q 039957          152 NPLGGILPPSIGN----FSTSLQRFSASECKLKGT----IPKEIGHLRGLIYLSLGFNDLNGTI-----PTSIGTLKQLQ  218 (481)
Q Consensus       152 N~l~~~~p~~~~~----~~~~L~~L~l~~n~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~-----p~~~~~l~~L~  218 (481)
                      |.++...+..+..    ..++|++|++++|.++..    ++..+..+++|++|++++|.++...     +..+..+++|+
T Consensus       180 n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~  259 (461)
T 1z7x_W          180 NDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLR  259 (461)
T ss_dssp             SBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCC
T ss_pred             CCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCce
Confidence            8887654444432    124788888888888753    4666777888888888888876432     23334577888


Q ss_pred             eeecCCCcCCCC----CCccccCccCCCeeecCCCeeeecCCccccc-----CCCCCcEEcCCCcCccc----CCcchhc
Q 039957          219 GFFLPETNLQGY----VPHNLCHLEMLNLLHLGGNKLSGHIPPCLAS-----LTSLRELDLGSNKLTSS----IPSSLWS  285 (481)
Q Consensus       219 ~l~l~~n~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-----l~~L~~L~ls~N~l~~~----~p~~~~~  285 (481)
                      .|++++|.++..    ++..+..+++|+.|++++|.+++..+..+..     .++|++|++++|.+++.    ++..+..
T Consensus       260 ~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~  339 (461)
T 1z7x_W          260 TLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQ  339 (461)
T ss_dssp             EEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHH
T ss_pred             EEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhh
Confidence            888888888764    4566667788888888888886544444433     26888888888888765    4556667


Q ss_pred             cccCcEEEccCcccCCCCCCcccc-----CCcCcEEEccCCeeee----eccccccccCChhhhhcccc
Q 039957          286 LGYILEINLSSNLLNDSLPSNVQK-----LKVLRVLDLSRNQLSG----DIPSTIGALVDLETISLAGS  345 (481)
Q Consensus       286 l~~L~~L~l~~N~l~~~~p~~~~~-----l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~l~~~g~  345 (481)
                      ++.|++|++++|.+.+..+..+..     .+.|++|++++|++++    .+|..+..+++|++|+++++
T Consensus       340 ~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N  408 (461)
T 1z7x_W          340 NRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNN  408 (461)
T ss_dssp             CSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSS
T ss_pred             CCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCC
Confidence            788888888888887654444432     5688888888888875    66777778888888887765

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.97  E-value=3.8e-32  Score=265.19  Aligned_cols=283  Identities=19%  Similarity=0.217  Sum_probs=230.4

Q ss_pred             hCCCCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCc
Q 039957           10 GNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLI   89 (481)
Q Consensus        10 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~   89 (481)
                      ..++.....++++|+++.+ |..+.  ++|++|++++|++++ +|...+..+++|++|++++|++++..|..|.++++|+
T Consensus        28 ~~C~~~~~c~~~~~~l~~i-P~~~~--~~L~~L~l~~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  103 (353)
T 2z80_A           28 LSCDRNGICKGSSGSLNSI-PSGLT--EAVKSLDLSNNRITY-ISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLE  103 (353)
T ss_dssp             CEECTTSEEECCSTTCSSC-CTTCC--TTCCEEECTTSCCCE-ECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred             CCCCCCeEeeCCCCCcccc-ccccc--ccCcEEECCCCcCcc-cCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCC
Confidence            3445566789999999864 55544  589999999999984 5553334799999999999999988888999999999


Q ss_pred             eeecccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCC-ccceeCChhhhhcccC
Q 039957           90 ILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGN-PLGGILPPSIGNFSTS  168 (481)
Q Consensus        90 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N-~l~~~~p~~~~~~~~~  168 (481)
                      +|++++|.+++..+..|+++++|++|++++|+++.++..       ..+.++++|++|++++| .+++..+..+..+ ++
T Consensus       104 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~-------~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l-~~  175 (353)
T 2z80_A          104 HLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGET-------SLFSHLTKLQILRVGNMDTFTKIQRKDFAGL-TF  175 (353)
T ss_dssp             EEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSS-------CSCTTCTTCCEEEEEESSSCCEECTTTTTTC-CE
T ss_pred             EEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCch-------hhhccCCCCcEEECCCCccccccCHHHccCC-CC
Confidence            999999999987777799999999999999999876541       23567889999999999 5777767777776 68


Q ss_pred             ccEEEccCCceeecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCcccc---CccCCCeee
Q 039957          169 LQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLC---HLEMLNLLH  245 (481)
Q Consensus       169 L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~---~l~~L~~L~  245 (481)
                      |++|++++|.+++..|..+..+++|++|++++|.+....+..+..+++|+.|++++|.+++..+..+.   ....++.++
T Consensus       176 L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~  255 (353)
T 2z80_A          176 LEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFT  255 (353)
T ss_dssp             EEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEE
T ss_pred             CCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhccc
Confidence            99999999999998899999999999999999998654444455688999999999999987665543   356678888


Q ss_pred             cCCCeeee----cCCcccccCCCCCcEEcCCCcCcccCCcchhccccCcEEEccCcccCCCCC
Q 039957          246 LGGNKLSG----HIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLP  304 (481)
Q Consensus       246 L~~N~l~~----~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p  304 (481)
                      ++++.+++    .+|..+..+++|+.|++++|+++...+..+..++.|++|++++|++.+..|
T Consensus       256 L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~  318 (353)
T 2z80_A          256 FRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  318 (353)
T ss_dssp             EESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             cccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence            88888775    367788999999999999999994444446899999999999999987544

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.97  E-value=1.9e-31  Score=252.25  Aligned_cols=224  Identities=22%  Similarity=0.189  Sum_probs=124.0

Q ss_pred             CEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeecccCcceecCcccccCCCCCCEEEccc
Q 039957           40 RNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLM  119 (481)
Q Consensus        40 ~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  119 (481)
                      +.++.+++.++ .+|..+   .++|++|++++|++++..+..|..+++|++|++++|.+++..|..|.++++|++|++++
T Consensus        14 ~~~~c~~~~l~-~ip~~~---~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~   89 (285)
T 1ozn_A           14 VTTSCPQQGLQ-AVPVGI---PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD   89 (285)
T ss_dssp             CEEECCSSCCS-SCCTTC---CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             eEEEcCcCCcc-cCCcCC---CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCC
Confidence            45555566555 455432   24566666666666655555566666666666666666665566666666666666666


Q ss_pred             cc-CccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEccCCceeecCCcccccCCCCCeEec
Q 039957          120 NN-LTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSL  198 (481)
Q Consensus       120 N~-l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l  198 (481)
                      |. ++.+.+        ..+..+++|++|++++|.+++..|..+..+ ++|++|++++|.+++..+..+..+++|++|++
T Consensus        90 n~~l~~~~~--------~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l-~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l  160 (285)
T 1ozn_A           90 NAQLRSVDP--------ATFHGLGRLHTLHLDRCGLQELGPGLFRGL-AALQYLYLQDNALQALPDDTFRDLGNLTHLFL  160 (285)
T ss_dssp             CTTCCCCCT--------TTTTTCTTCCEEECTTSCCCCCCTTTTTTC-TTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCccccCH--------HHhcCCcCCCEEECCCCcCCEECHhHhhCC-cCCCEEECCCCcccccCHhHhccCCCccEEEC
Confidence            64 544422        223445555555555555554444444443 34555555555555444444555556666666


Q ss_pred             ccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCcCc
Q 039957          199 GFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLT  276 (481)
Q Consensus       199 ~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~  276 (481)
                      ++|++++..+..|..+++|+.|++++|.+++..|..|..+++|+.|++++|++++.++..+..+++|+.|++++|.+.
T Consensus       161 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~  238 (285)
T 1ozn_A          161 HGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV  238 (285)
T ss_dssp             CSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEE
T ss_pred             CCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCcc
Confidence            666655544444555555555555555555555555555555555555555555544444555555555555555554

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.97  E-value=4.7e-31  Score=254.32  Aligned_cols=233  Identities=20%  Similarity=0.222  Sum_probs=154.6

Q ss_pred             cCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeecccCcceecCcccccCCCCCCEEE
Q 039957           37 STIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLS  116 (481)
Q Consensus        37 ~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  116 (481)
                      ++++.|+|++|.++ .+|..++ .+++|++|+|++|.++ .+|..+..+++|++|+|++|.++ .+|..|+++++|++|+
T Consensus        81 ~~l~~L~L~~n~l~-~lp~~l~-~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~  156 (328)
T 4fcg_A           81 PGRVALELRSVPLP-QFPDQAF-RLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELS  156 (328)
T ss_dssp             TTCCEEEEESSCCS-SCCSCGG-GGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEE
T ss_pred             cceeEEEccCCCch-hcChhhh-hCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEE
Confidence            44555555555554 4454444 3555555555555554 44555555555555555555555 3455555555555555


Q ss_pred             cccccCccccCCCc-cccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEccCCceeecCCcccccCCCCCe
Q 039957          117 LLMNNLTTESSSAY-QWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIY  195 (481)
Q Consensus       117 L~~N~l~~~~~~~~-~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~  195 (481)
                      +++|++.+..+..+ .......+.++++|++|+|++|.++ .+|..++.+ ++|++|++++|.+++ +|..+..+++|++
T Consensus       157 L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l-~~L~~L~L~~N~l~~-l~~~l~~l~~L~~  233 (328)
T 4fcg_A          157 IRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANL-QNLKSLKIRNSPLSA-LGPAIHHLPKLEE  233 (328)
T ss_dssp             EEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGC-TTCCEEEEESSCCCC-CCGGGGGCTTCCE
T ss_pred             CCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCC-CCCCEEEccCCCCCc-CchhhccCCCCCE
Confidence            55544333211111 0011122345677777777777777 667777766 478888888888874 6667888888888


Q ss_pred             EecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCcC
Q 039957          196 LSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKL  275 (481)
Q Consensus       196 L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l  275 (481)
                      |++++|.+.+.+|..++.+++|+.|++++|++.+.+|..+..+++|+.|++++|.+.+.+|..+..+++|+.+++..|.+
T Consensus       234 L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~  313 (328)
T 4fcg_A          234 LDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ  313 (328)
T ss_dssp             EECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGS
T ss_pred             EECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHH
Confidence            88888888888888888888888888888888888888888888888888888888888888888888888888887766


Q ss_pred             c
Q 039957          276 T  276 (481)
Q Consensus       276 ~  276 (481)
                      .
T Consensus       314 ~  314 (328)
T 4fcg_A          314 A  314 (328)
T ss_dssp             C
T ss_pred             H
Confidence            5

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.97  E-value=2.8e-30  Score=260.43  Aligned_cols=249  Identities=27%  Similarity=0.320  Sum_probs=152.1

Q ss_pred             CCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeecccCcceecCcccccCCCCCCEEEc
Q 039957           38 TIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSL  117 (481)
Q Consensus        38 ~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  117 (481)
                      ..+.++.+++.++ .+|..+.   +++++|+|++|++++..|..|.++++|++|+|++|.++++.|..|.++++|++|+|
T Consensus        55 ~~~~v~c~~~~l~-~iP~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L  130 (452)
T 3zyi_A           55 QFSKVVCTRRGLS-EVPQGIP---SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLEL  130 (452)
T ss_dssp             SSCEEECCSSCCS-SCCSCCC---TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred             CCcEEEECCCCcC-ccCCCCC---CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEEC
Confidence            3567777777776 6776543   57788888888888777778888888888888888888777778888888888888


Q ss_pred             ccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEccCC-ceeecCCcccccCCCCCeE
Q 039957          118 LMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASEC-KLKGTIPKEIGHLRGLIYL  196 (481)
Q Consensus       118 ~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n-~l~~~~p~~~~~l~~L~~L  196 (481)
                      ++|+++.++...        +..+++|++|+|++|++++..+..|..+ ++|++|++++| .+....+..|.++++|++|
T Consensus       131 ~~n~l~~~~~~~--------~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L  201 (452)
T 3zyi_A          131 FDNWLTVIPSGA--------FEYLSKLRELWLRNNPIESIPSYAFNRV-PSLMRLDLGELKKLEYISEGAFEGLFNLKYL  201 (452)
T ss_dssp             CSSCCSBCCTTT--------SSSCTTCCEEECCSCCCCEECTTTTTTC-TTCCEEECCCCTTCCEECTTTTTTCTTCCEE
T ss_pred             CCCcCCccChhh--------hcccCCCCEEECCCCCcceeCHhHHhcC-CcccEEeCCCCCCccccChhhccCCCCCCEE
Confidence            888877664432        4566677777777777765544444444 35556665552 3332222344555555555


Q ss_pred             ecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCcCc
Q 039957          197 SLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLT  276 (481)
Q Consensus       197 ~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~  276 (481)
                      ++++|++++. |                         .+..+++|+.|++++|++++..|..|..+++|+.|++++|+++
T Consensus       202 ~L~~n~l~~~-~-------------------------~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~  255 (452)
T 3zyi_A          202 NLGMCNIKDM-P-------------------------NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS  255 (452)
T ss_dssp             ECTTSCCSSC-C-------------------------CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCC
T ss_pred             ECCCCccccc-c-------------------------cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCc
Confidence            5555555422 2                         2344445555555555555555555555555555555555555


Q ss_pred             ccCCcchhccccCcEEEccCcccCCCCCCccccCCcCcEEEccCCeeee
Q 039957          277 SSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSG  325 (481)
Q Consensus       277 ~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~  325 (481)
                      +..|..|..++.|+.|++++|++++..+..+..+++|+.|++++|++.+
T Consensus       256 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C  304 (452)
T 3zyi_A          256 LIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNC  304 (452)
T ss_dssp             EECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEEC
T ss_pred             eECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCC
Confidence            5555555555555555555555555444555555566666666666554

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.97  E-value=3.7e-30  Score=258.65  Aligned_cols=249  Identities=26%  Similarity=0.303  Sum_probs=148.5

Q ss_pred             CCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeecccCcceecCcccccCCCCCCEEEc
Q 039957           38 TIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSL  117 (481)
Q Consensus        38 ~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  117 (481)
                      ..+.++.+++.++ .+|..+.   +++++|+|++|++++..+..|.++++|++|+|++|.++++.+..|.++++|++|+|
T Consensus        44 ~~~~v~c~~~~l~-~iP~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L  119 (440)
T 3zyj_A           44 QFSKVICVRKNLR-EVPDGIS---TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLEL  119 (440)
T ss_dssp             TSCEEECCSCCCS-SCCSCCC---TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEEC
T ss_pred             CCCEEEeCCCCcC-cCCCCCC---CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEEC
Confidence            3567778888887 7777653   57788888888888777778888888888888888888777778888888888888


Q ss_pred             ccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEccCC-ceeecCCcccccCCCCCeE
Q 039957          118 LMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASEC-KLKGTIPKEIGHLRGLIYL  196 (481)
Q Consensus       118 ~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n-~l~~~~p~~~~~l~~L~~L  196 (481)
                      ++|+++.++..        .+..+++|++|+|++|++++..+..|..+ ++|++|++++| .+....+..|.++++|++|
T Consensus       120 ~~n~l~~~~~~--------~~~~l~~L~~L~L~~N~i~~~~~~~~~~l-~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L  190 (440)
T 3zyj_A          120 FDNRLTTIPNG--------AFVYLSKLKELWLRNNPIESIPSYAFNRI-PSLRRLDLGELKRLSYISEGAFEGLSNLRYL  190 (440)
T ss_dssp             CSSCCSSCCTT--------TSCSCSSCCEEECCSCCCCEECTTTTTTC-TTCCEEECCCCTTCCEECTTTTTTCSSCCEE
T ss_pred             CCCcCCeeCHh--------HhhccccCceeeCCCCcccccCHHHhhhC-cccCEeCCCCCCCcceeCcchhhcccccCee
Confidence            88888766443        24566777777777777765555455544 45666666653 2332233345555555555


Q ss_pred             ecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCcCc
Q 039957          197 SLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLT  276 (481)
Q Consensus       197 ~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~  276 (481)
                      ++++|+++ .+| .+..+++|                        +.|+|++|++++..|..|..+++|+.|++++|+++
T Consensus       191 ~L~~n~l~-~~~-~~~~l~~L------------------------~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~  244 (440)
T 3zyj_A          191 NLAMCNLR-EIP-NLTPLIKL------------------------DELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ  244 (440)
T ss_dssp             ECTTSCCS-SCC-CCTTCSSC------------------------CEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCC
T ss_pred             cCCCCcCc-ccc-ccCCCccc------------------------CEEECCCCccCccChhhhccCccCCEEECCCCcee
Confidence            55555554 222 23444444                        44444444444444444444444444444444444


Q ss_pred             ccCCcchhccccCcEEEccCcccCCCCCCccccCCcCcEEEccCCeeee
Q 039957          277 SSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSG  325 (481)
Q Consensus       277 ~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~  325 (481)
                      +..+..|..+++|+.|++++|++++..+..+..+++|+.|++++|++.+
T Consensus       245 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C  293 (440)
T 3zyj_A          245 VIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNC  293 (440)
T ss_dssp             EECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEEC
T ss_pred             EEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccC
Confidence            4444444444444444444444444444444445555555555555543

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.97  E-value=1.4e-30  Score=251.10  Aligned_cols=226  Identities=22%  Similarity=0.226  Sum_probs=166.0

Q ss_pred             CCCccEEEccCccceeecchhccccccCceeecccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCC
Q 039957           61 LPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTN  140 (481)
Q Consensus        61 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~  140 (481)
                      .+++++|+|++|.++ .+|..+..+++|++|+|++|.++ .+|..|+++++|++|+|++|.++.++         ..+.+
T Consensus        80 ~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~~lp---------~~l~~  148 (328)
T 4fcg_A           80 QPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRALP---------ASIAS  148 (328)
T ss_dssp             STTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCCCCC---------GGGGG
T ss_pred             ccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccccCc---------HHHhc
Confidence            467777777777776 66666777777777777777777 67777777777777777777776442         33556


Q ss_pred             CCCCcEEEccCCccceeCChhhhh---------cccCccEEEccCCceeecCCcccccCCCCCeEecccccceecCCcCC
Q 039957          141 CRYLVYLILSGNPLGGILPPSIGN---------FSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSI  211 (481)
Q Consensus       141 l~~L~~L~Ls~N~l~~~~p~~~~~---------~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~  211 (481)
                      +++|++|+|++|++.+.+|..+..         + ++|++|++++|+++ .+|..+..+++|++|++++|++++ +|..+
T Consensus       149 l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l-~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l  225 (328)
T 4fcg_A          149 LNRLRELSIRACPELTELPEPLASTDASGEHQGL-VNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAI  225 (328)
T ss_dssp             CTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEES-TTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGG
T ss_pred             CcCCCEEECCCCCCccccChhHhhccchhhhccC-CCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-Cchhh
Confidence            777777777777777777766543         3 56777777777777 667777777777777777777774 55567


Q ss_pred             cCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCcCcccCCcchhccccCcE
Q 039957          212 GTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILE  291 (481)
Q Consensus       212 ~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~  291 (481)
                      ..+++|+.|++++|++.+.+|..+..+++|+.|++++|.+.+.+|..+..+++|++|++++|++.+.+|..+..++.++.
T Consensus       226 ~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~  305 (328)
T 4fcg_A          226 HHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCI  305 (328)
T ss_dssp             GGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCE
T ss_pred             ccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceE
Confidence            77777777777777777777777777777777777777777777777777777777777777777777777777777777


Q ss_pred             EEccCcccC
Q 039957          292 INLSSNLLN  300 (481)
Q Consensus       292 L~l~~N~l~  300 (481)
                      +++..|.+.
T Consensus       306 l~l~~~~~~  314 (328)
T 4fcg_A          306 ILVPPHLQA  314 (328)
T ss_dssp             EECCGGGSC
T ss_pred             EeCCHHHHH
Confidence            777766554

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.97  E-value=5.1e-32  Score=260.15  Aligned_cols=258  Identities=17%  Similarity=0.148  Sum_probs=160.9

Q ss_pred             CCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeec
Q 039957           14 NLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDL   93 (481)
Q Consensus        14 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L   93 (481)
                      .++.++++.+.+....+..+..+++|++|+|++|++++..|..+. .+++|++|+|++|++++..|  +..+++|++|++
T Consensus        11 ~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~L   87 (317)
T 3o53_A           11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLA-PFTKLELLNLSSNVLYETLD--LESLSTLRTLDL   87 (317)
T ss_dssp             EEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHT-TCTTCCEEECTTSCCEEEEE--ETTCTTCCEEEC
T ss_pred             ceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhh-CCCcCCEEECCCCcCCcchh--hhhcCCCCEEEC
Confidence            456667777777666666666677777777777777744344443 67777777777777776554  777777777777


Q ss_pred             ccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEE
Q 039957           94 GFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFS  173 (481)
Q Consensus        94 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~  173 (481)
                      ++|.+++..     ..++|++|++++|++++++..           .+++|++|++++|++++..+..+..+ ++|++|+
T Consensus        88 s~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~-----------~~~~L~~L~l~~N~l~~~~~~~~~~l-~~L~~L~  150 (317)
T 3o53_A           88 NNNYVQELL-----VGPSIETLHAANNNISRVSCS-----------RGQGKKNIYLANNKITMLRDLDEGCR-SRVQYLD  150 (317)
T ss_dssp             CSSEEEEEE-----ECTTCCEEECCSSCCSEEEEC-----------CCSSCEEEECCSSCCCSGGGBCTGGG-SSEEEEE
T ss_pred             cCCcccccc-----CCCCcCEEECCCCccCCcCcc-----------ccCCCCEEECCCCCCCCccchhhhcc-CCCCEEE
Confidence            777777533     236777777777777665321           24557777777777766555555554 4677777


Q ss_pred             ccCCceeecCCcccc-cCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeee
Q 039957          174 ASECKLKGTIPKEIG-HLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLS  252 (481)
Q Consensus       174 l~~n~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~  252 (481)
                      +++|.+++..|..+. .+++|++|++++|.+++..+  ...+++|+.|++++|++++.. ..+..+++|+.|++++|+++
T Consensus       151 Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~l~-~~~~~l~~L~~L~L~~N~l~  227 (317)
T 3o53_A          151 LKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFMG-PEFQSAAGVTWISLRNNKLV  227 (317)
T ss_dssp             CTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCEEC-GGGGGGTTCSEEECTTSCCC
T ss_pred             CCCCCCCcccHHHHhhccCcCCEEECCCCcCccccc--ccccccCCEEECCCCcCCcch-hhhcccCcccEEECcCCccc
Confidence            777777665555553 56667777777776664421  223566666666666666533 33556666666666666665


Q ss_pred             ecCCcccccCCCCCcEEcCCCcCc-ccCCcchhccccCcEEEcc
Q 039957          253 GHIPPCLASLTSLRELDLGSNKLT-SSIPSSLWSLGYILEINLS  295 (481)
Q Consensus       253 ~~~p~~~~~l~~L~~L~ls~N~l~-~~~p~~~~~l~~L~~L~l~  295 (481)
                      + +|..+..+++|+.|++++|.+. +.+|..+..++.|+.++++
T Consensus       228 ~-l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~  270 (317)
T 3o53_A          228 L-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ  270 (317)
T ss_dssp             E-ECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHH
T ss_pred             c-hhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECC
Confidence            3 3445556666666666666665 4455555555555555554

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.97  E-value=6.9e-30  Score=257.60  Aligned_cols=245  Identities=21%  Similarity=0.190  Sum_probs=182.5

Q ss_pred             ccEEEccCccceeecchhccccccCceeecccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCC
Q 039957           64 IKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRY  143 (481)
Q Consensus        64 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~  143 (481)
                      .+.++.+++.++ .+|..+.  ++|++|+|++|.++++.|..|.++++|++|+|++|+++++                  
T Consensus        56 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~------------------  114 (452)
T 3zyi_A           56 FSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQI------------------  114 (452)
T ss_dssp             SCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEE------------------
T ss_pred             CcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCc------------------
Confidence            455666666665 3444332  4566666666666666666666666666666666665554                  


Q ss_pred             CcEEEccCCccceeCChhhhhcccCccEEEccCCceeecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecC
Q 039957          144 LVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLP  223 (481)
Q Consensus       144 L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~  223 (481)
                                    .|..|..+ ++|++|++++|++++..+..|..+++|++|++++|+++...+..|..+++|+.|+++
T Consensus       115 --------------~~~~~~~l-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~  179 (452)
T 3zyi_A          115 --------------EVGAFNGL-ASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLG  179 (452)
T ss_dssp             --------------CTTTTTTC-TTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECC
T ss_pred             --------------ChhhccCc-ccCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCC
Confidence                          33333333 344555555555554444556667777777777777776666677777777777777


Q ss_pred             C-CcCCCCCCccccCccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCcCcccCCcchhccccCcEEEccCcccCCC
Q 039957          224 E-TNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDS  302 (481)
Q Consensus       224 ~-n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~  302 (481)
                      + +.+....+..|..+++|+.|++++|++++. | .+..+++|+.|++++|++++..|..|..++.|+.|++++|++++.
T Consensus       180 ~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~  257 (452)
T 3zyi_A          180 ELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLI  257 (452)
T ss_dssp             CCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEE
T ss_pred             CCCCccccChhhccCCCCCCEEECCCCccccc-c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceE
Confidence            7 344444455788899999999999999864 4 588999999999999999999999999999999999999999999


Q ss_pred             CCCccccCCcCcEEEccCCeeeeeccccccccCChhhhhccccc
Q 039957          303 LPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAGSF  346 (481)
Q Consensus       303 ~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~~~g~~  346 (481)
                      .|..|..+++|+.|++++|++++..+..+..+.+|+.|++.++.
T Consensus       258 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np  301 (452)
T 3zyi_A          258 ERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNP  301 (452)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSC
T ss_pred             CHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCC
Confidence            99999999999999999999998888889999999999988764

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.97  E-value=7.1e-30  Score=256.63  Aligned_cols=248  Identities=22%  Similarity=0.230  Sum_probs=212.5

Q ss_pred             CCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeec
Q 039957           14 NLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDL   93 (481)
Q Consensus        14 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L   93 (481)
                      ..+.++.+++.++. +|..+.  ++++.|+|++|++++..+..+ ..+++|++|+|++|++++..+..|.++++|++|+|
T Consensus        44 ~~~~v~c~~~~l~~-iP~~~~--~~l~~L~L~~n~i~~~~~~~~-~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L  119 (440)
T 3zyj_A           44 QFSKVICVRKNLRE-VPDGIS--TNTRLLNLHENQIQIIKVNSF-KHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLEL  119 (440)
T ss_dssp             TSCEEECCSCCCSS-CCSCCC--TTCSEEECCSCCCCEECTTTT-SSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEEC
T ss_pred             CCCEEEeCCCCcCc-CCCCCC--CCCcEEEccCCcCCeeCHHHh-hCCCCCCEEECCCCcCCccChhhccCCccCCEEEC
Confidence            46788889988875 455443  678999999999985555555 48999999999999999888889999999999999


Q ss_pred             ccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCc-cceeCChhhhhcccCccEE
Q 039957           94 GFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNP-LGGILPPSIGNFSTSLQRF  172 (481)
Q Consensus        94 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~-l~~~~p~~~~~~~~~L~~L  172 (481)
                      ++|++++..+..|..+++|++|+|++|.++.++..        .+.++++|++|+|++|. ++...+..|..+ ++|++|
T Consensus       120 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~--------~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l-~~L~~L  190 (440)
T 3zyj_A          120 FDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSY--------AFNRIPSLRRLDLGELKRLSYISEGAFEGL-SNLRYL  190 (440)
T ss_dssp             CSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTT--------TTTTCTTCCEEECCCCTTCCEECTTTTTTC-SSCCEE
T ss_pred             CCCcCCeeCHhHhhccccCceeeCCCCcccccCHH--------HhhhCcccCEeCCCCCCCcceeCcchhhcc-cccCee
Confidence            99999988788899999999999999999887543        35678899999999954 444444456665 689999


Q ss_pred             EccCCceeecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeee
Q 039957          173 SASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLS  252 (481)
Q Consensus       173 ~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~  252 (481)
                      ++++|+++ .+| .+..+++|++|++++|++++..|..|..+++|+.|++++|++++..+..|..+++|+.|+|++|+++
T Consensus       191 ~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~  268 (440)
T 3zyj_A          191 NLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT  268 (440)
T ss_dssp             ECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCC
T ss_pred             cCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCC
Confidence            99999998 455 4788999999999999999998999999999999999999999999999999999999999999999


Q ss_pred             ecCCcccccCCCCCcEEcCCCcCc
Q 039957          253 GHIPPCLASLTSLRELDLGSNKLT  276 (481)
Q Consensus       253 ~~~p~~~~~l~~L~~L~ls~N~l~  276 (481)
                      +..+..|..+++|+.|++++|.+.
T Consensus       269 ~~~~~~~~~l~~L~~L~L~~Np~~  292 (440)
T 3zyj_A          269 LLPHDLFTPLHHLERIHLHHNPWN  292 (440)
T ss_dssp             CCCTTTTSSCTTCCEEECCSSCEE
T ss_pred             ccChhHhccccCCCEEEcCCCCcc
Confidence            888888999999999999999875

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.97  E-value=1.7e-32  Score=263.46  Aligned_cols=258  Identities=20%  Similarity=0.168  Sum_probs=170.1

Q ss_pred             CCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeecccCcceecCcccccCCCCCCEEEc
Q 039957           38 TIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSL  117 (481)
Q Consensus        38 ~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  117 (481)
                      +++.++++.+.+. ..+..++..+++|++|+|++|++++..|..|..+++|++|+|++|.+++..|  |..+++|++|++
T Consensus        11 ~l~i~~ls~~~l~-~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~L   87 (317)
T 3o53_A           11 RYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDL   87 (317)
T ss_dssp             EEEEESCCTTTHH-HHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEEC
T ss_pred             ceeEeeccccchh-hhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEEC
Confidence            3455566677765 4444455566788888888888887777778888888888888888876554  777888888888


Q ss_pred             ccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEccCCceeecCCcccccCCCCCeEe
Q 039957          118 LMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLS  197 (481)
Q Consensus       118 ~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~  197 (481)
                      ++|++++++             ..++|++|++++|++++..+..+    ++|++|++++|++++..|..+..+++|++|+
T Consensus        88 s~n~l~~l~-------------~~~~L~~L~l~~n~l~~~~~~~~----~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~  150 (317)
T 3o53_A           88 NNNYVQELL-------------VGPSIETLHAANNNISRVSCSRG----QGKKNIYLANNKITMLRDLDEGCRSRVQYLD  150 (317)
T ss_dssp             CSSEEEEEE-------------ECTTCCEEECCSSCCSEEEECCC----SSCEEEECCSSCCCSGGGBCTGGGSSEEEEE
T ss_pred             cCCcccccc-------------CCCCcCEEECCCCccCCcCcccc----CCCCEEECCCCCCCCccchhhhccCCCCEEE
Confidence            888777652             12457777777777665433221    3455555555555544444444455555555


Q ss_pred             cccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccc-cCccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCcCc
Q 039957          198 LGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNL-CHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLT  276 (481)
Q Consensus       198 l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~  276 (481)
                      +++|.+                        ++..+..+ ..+++|+.|++++|++++..+  ...+++|++|++++|+++
T Consensus       151 Ls~N~l------------------------~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--~~~l~~L~~L~Ls~N~l~  204 (317)
T 3o53_A          151 LKLNEI------------------------DTVNFAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLA  204 (317)
T ss_dssp             CTTSCC------------------------CEEEGGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCC
T ss_pred             CCCCCC------------------------CcccHHHHhhccCcCCEEECCCCcCccccc--ccccccCCEEECCCCcCC
Confidence            555554                        44444443 245566666666666665422  223667777777777776


Q ss_pred             ccCCcchhccccCcEEEccCcccCCCCCCccccCCcCcEEEccCCeee-eeccccccccCChhhhhcc
Q 039957          277 SSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLS-GDIPSTIGALVDLETISLA  343 (481)
Q Consensus       277 ~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~-~~~p~~~~~l~~L~~l~~~  343 (481)
                      +. |..+..++.|+.|++++|+++. +|..+..+++|+.|++++|++. +..|..+..++.|+.+++.
T Consensus       205 ~l-~~~~~~l~~L~~L~L~~N~l~~-l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~  270 (317)
T 3o53_A          205 FM-GPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ  270 (317)
T ss_dssp             EE-CGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHH
T ss_pred             cc-hhhhcccCcccEEECcCCcccc-hhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECC
Confidence            43 3346777777777777777764 5667788888999999999988 6677888888888888765

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.97  E-value=5e-32  Score=259.57  Aligned_cols=252  Identities=21%  Similarity=0.157  Sum_probs=139.5

Q ss_pred             ccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccc-eeecchhcc-------ccccCceeecccCcceecCcc
Q 039957           33 IFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNL-IGTIPNSIT-------NATKLIILDLGFNTFSGHIPN  104 (481)
Q Consensus        33 ~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l-~~~~p~~~~-------~l~~L~~L~Ls~N~l~~~~p~  104 (481)
                      ++..++|+.|++++|.+  .+|..++..   |++|+|++|++ .+.+|..+.       ++++|++|+|++|.+++.+|.
T Consensus        39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~---L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~  113 (312)
T 1wwl_A           39 YGGGRSLEYLLKRVDTE--ADLGQFTDI---IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPP  113 (312)
T ss_dssp             EEEEEECTTHHHHCCTT--CCCHHHHHH---HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCC
T ss_pred             EccCCCceeEeeccccc--ccHHHHHHH---HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHH
Confidence            34444555555555555  455544421   55555555555 233444433       455555555555555555555


Q ss_pred             cc--cCCCCCCEEEcccccCccccCCCccccccccCC--CCCCCcEEEccCCccceeCChhhhhcccCccEEEccCCcee
Q 039957          105 TF--GNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLT--NCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLK  180 (481)
Q Consensus       105 ~~--~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~--~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~  180 (481)
                      .+  +.+++|++|++++|++++.+ ..+     ..+.  .+++|++|+|++|++++..|..++.+ ++|++|++++|++.
T Consensus       114 ~~~~~~l~~L~~L~Ls~N~l~~~~-~~~-----~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~Ls~N~l~  186 (312)
T 1wwl_A          114 PLLEATGPDLNILNLRNVSWATRD-AWL-----AELQQWLKPGLKVLSIAQAHSLNFSCEQVRVF-PALSTLDLSDNPEL  186 (312)
T ss_dssp             CSSSCCSCCCSEEEEESCBCSSSS-SHH-----HHHHTTCCTTCCEEEEESCSCCCCCTTTCCCC-SSCCEEECCSCTTC
T ss_pred             HHHHhcCCCccEEEccCCCCcchh-HHH-----HHHHHhhcCCCcEEEeeCCCCccchHHHhccC-CCCCEEECCCCCcC
Confidence            44  55555555555555555541 111     0000  11455666666666655555555554 35666666666554


Q ss_pred             ec--CCccc--ccCCCCCeEeccccccee---cCCcCCcCCCCCCeeecCCCcCCCCCC-ccccCccCCCeeecCCCeee
Q 039957          181 GT--IPKEI--GHLRGLIYLSLGFNDLNG---TIPTSIGTLKQLQGFFLPETNLQGYVP-HNLCHLEMLNLLHLGGNKLS  252 (481)
Q Consensus       181 ~~--~p~~~--~~l~~L~~L~l~~N~l~~---~~p~~~~~l~~L~~l~l~~n~l~~~~p-~~~~~l~~L~~L~L~~N~l~  252 (481)
                      +.  .|..+  ..+++|++|++++|++++   .....+..+++|+.|++++|++++..| ..+..+++|+.|++++|+++
T Consensus       187 ~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~  266 (312)
T 1wwl_A          187 GERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK  266 (312)
T ss_dssp             HHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS
T ss_pred             cchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC
Confidence            43  22223  556666666666666652   111223455666666666666666554 34455667777777777776


Q ss_pred             ecCCcccccCCCCCcEEcCCCcCcccCCcchhccccCcEEEccCcccCC
Q 039957          253 GHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLND  301 (481)
Q Consensus       253 ~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~  301 (481)
                       .+|..+.  ++|++|++++|++++. |. +..++.|++|++++|++++
T Consensus       267 -~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~  310 (312)
T 1wwl_A          267 -QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD  310 (312)
T ss_dssp             -SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred             -hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence             4555554  6677777777777654 44 6667777777777777654

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.97  E-value=2.1e-33  Score=284.17  Aligned_cols=317  Identities=21%  Similarity=0.203  Sum_probs=250.4

Q ss_pred             ccCcchhCCCCCCeeeCcCCcccccCChhcc-CCc----CCCEEEeeCCcCcc----ccChhhhcCCCCccEEEccCccc
Q 039957            4 QIPTEIGNLQNLKSLFLGANNLSGLIPPMIF-NIS----TIRNLNLGGNRLSG----HLPSMIGHSLPNIKYLELGDNNL   74 (481)
Q Consensus         4 ~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~----~L~~L~L~~N~l~~----~~p~~~~~~l~~L~~L~L~~N~l   74 (481)
                      .+|..+..+++|++|+|++|+++...+..+. .++    +|++|+|++|+++.    .+|..+. .+++|++|++++|.+
T Consensus        47 ~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~-~~~~L~~L~Ls~n~i  125 (461)
T 1z7x_W           47 DISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLR-TLPTLQELHLSDNLL  125 (461)
T ss_dssp             HHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTT-SCTTCCEEECCSSBC
T ss_pred             HHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHHHHc-cCCceeEEECCCCcC
Confidence            4567788999999999999999875554443 455    69999999999983    4576665 799999999999998


Q ss_pred             eeecchhccc-----cccCceeecccCcceec----CcccccCCCCCCEEEcccccCccccCCCccccccccCC-CCCCC
Q 039957           75 IGTIPNSITN-----ATKLIILDLGFNTFSGH----IPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLT-NCRYL  144 (481)
Q Consensus        75 ~~~~p~~~~~-----l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~-~l~~L  144 (481)
                      +...+..+..     .++|++|++++|.+++.    ++..+..+++|++|++++|.++......+    ...+. ..++|
T Consensus       126 ~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l----~~~l~~~~~~L  201 (461)
T 1z7x_W          126 GDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVL----CQGLKDSPCQL  201 (461)
T ss_dssp             HHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHH----HHHHHHSCCCC
T ss_pred             chHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHH----HHHHhcCCCCc
Confidence            7655554433     56899999999999874    46677889999999999999876422111    01111 34589


Q ss_pred             cEEEccCCcccee----CChhhhhcccCccEEEccCCceeecC-----CcccccCCCCCeEecccccceec----CCcCC
Q 039957          145 VYLILSGNPLGGI----LPPSIGNFSTSLQRFSASECKLKGTI-----PKEIGHLRGLIYLSLGFNDLNGT----IPTSI  211 (481)
Q Consensus       145 ~~L~Ls~N~l~~~----~p~~~~~~~~~L~~L~l~~n~l~~~~-----p~~~~~l~~L~~L~l~~N~l~~~----~p~~~  211 (481)
                      ++|++++|.+++.    ++..+..+ ++|++|++++|.++...     +..+..+++|++|++++|.++..    ++..+
T Consensus       202 ~~L~L~~n~l~~~~~~~l~~~l~~~-~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l  280 (461)
T 1z7x_W          202 EALKLESCGVTSDNCRDLCGIVASK-ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVL  280 (461)
T ss_dssp             CEEECTTSCCBTTHHHHHHHHHHHC-TTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHH
T ss_pred             eEEEccCCCCcHHHHHHHHHHHHhC-CCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHH
Confidence            9999999999863    45556655 68999999999987532     22334588999999999999864    57778


Q ss_pred             cCCCCCCeeecCCCcCCCCCCccccC-----ccCCCeeecCCCeeeec----CCcccccCCCCCcEEcCCCcCcccCCcc
Q 039957          212 GTLKQLQGFFLPETNLQGYVPHNLCH-----LEMLNLLHLGGNKLSGH----IPPCLASLTSLRELDLGSNKLTSSIPSS  282 (481)
Q Consensus       212 ~~l~~L~~l~l~~n~l~~~~p~~~~~-----l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~~~~p~~  282 (481)
                      ..+++|+.|++++|.+....+..+..     .++|+.|++++|.+++.    ++..+..+++|++|++++|.+++..+..
T Consensus       281 ~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~  360 (461)
T 1z7x_W          281 RAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRE  360 (461)
T ss_dssp             HHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHH
T ss_pred             hhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHH
Confidence            88999999999999987654444433     26899999999999865    4567778899999999999998765555


Q ss_pred             hhc-----cccCcEEEccCcccCC----CCCCccccCCcCcEEEccCCeeeee
Q 039957          283 LWS-----LGYILEINLSSNLLND----SLPSNVQKLKVLRVLDLSRNQLSGD  326 (481)
Q Consensus       283 ~~~-----l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~  326 (481)
                      +..     .+.|++|++++|.+++    .+|..+..+++|++|++++|++++.
T Consensus       361 l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~  413 (461)
T 1z7x_W          361 LCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA  413 (461)
T ss_dssp             HHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHH
T ss_pred             HHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHH
Confidence            543     5799999999999986    6788888999999999999999854

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.97  E-value=5e-30  Score=242.54  Aligned_cols=254  Identities=22%  Similarity=0.218  Sum_probs=163.7

Q ss_pred             cEEEccCccceeecchhccccccCceeecccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCC
Q 039957           65 KYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYL  144 (481)
Q Consensus        65 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L  144 (481)
                      ++++.+++.++ .+|..+  .++|++|++++|.+++..+..|..+++|++|++++|.++++.+        ..+.++++|
T Consensus        14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~--------~~~~~l~~L   82 (285)
T 1ozn_A           14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDA--------AAFTGLALL   82 (285)
T ss_dssp             CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECT--------TTTTTCTTC
T ss_pred             eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCH--------hhcCCccCC
Confidence            67888888886 455543  4678888888888888777888888888888888888877643        335667778


Q ss_pred             cEEEccCCc-cceeCChhhhhcccCccEEEccCCceeecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecC
Q 039957          145 VYLILSGNP-LGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLP  223 (481)
Q Consensus       145 ~~L~Ls~N~-l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~  223 (481)
                      ++|++++|. ++...|..+..+ ++|++|++++|.+++..|..+..+++|++|++++|++++..+..|..+++|+.|+++
T Consensus        83 ~~L~l~~n~~l~~~~~~~~~~l-~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~  161 (285)
T 1ozn_A           83 EQLDLSDNAQLRSVDPATFHGL-GRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLH  161 (285)
T ss_dssp             CEEECCSCTTCCCCCTTTTTTC-TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CEEeCCCCCCccccCHHHhcCC-cCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECC
Confidence            888888886 665555556554 467777777777766666666666777777777776665555556666666666666


Q ss_pred             CCcCCCCCCccccCccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCcCcccCCcchhccccCcEEEccCcccCCCC
Q 039957          224 ETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSL  303 (481)
Q Consensus       224 ~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~  303 (481)
                      +|++++..+..|..+++|+.|++++|++++..|..|..+++|+.|++++|++++..+..+..++.|++|++++|.+....
T Consensus       162 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~  241 (285)
T 1ozn_A          162 GNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC  241 (285)
T ss_dssp             SSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSG
T ss_pred             CCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCC
Confidence            66666655555666666666666666666666666666666666666666666554455555666666666666654322


Q ss_pred             CCccccCCcCcEEEccCCeeeeeccccc
Q 039957          304 PSNVQKLKVLRVLDLSRNQLSGDIPSTI  331 (481)
Q Consensus       304 p~~~~~l~~L~~L~l~~N~l~~~~p~~~  331 (481)
                      +.. .-...++.+..+.+.+.+..|..+
T Consensus       242 ~~~-~~~~~l~~~~~~~~~~~c~~p~~l  268 (285)
T 1ozn_A          242 RAR-PLWAWLQKFRGSSSEVPCSLPQRL  268 (285)
T ss_dssp             GGH-HHHHHHHHCCSEECCCBEEESGGG
T ss_pred             CcH-HHHHHHHhcccccCccccCCchHh
Confidence            210 011122333344555555555544

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.97  E-value=3.6e-29  Score=259.33  Aligned_cols=270  Identities=26%  Similarity=0.344  Sum_probs=226.6

Q ss_pred             CCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceee
Q 039957           13 QNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILD   92 (481)
Q Consensus        13 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~   92 (481)
                      .++++|++++|.++ .+|..+.  ++|++|++++|+|+ .+|.    .+++|++|+|++|++++ +|.   .+++|++|+
T Consensus        40 ~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~----~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~  107 (622)
T 3g06_A           40 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA----LPPELRTLEVSGNQLTS-LPV---LPPGLLELS  107 (622)
T ss_dssp             HCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC----CCTTCCEEEECSCCCSC-CCC---CCTTCCEEE
T ss_pred             CCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC----cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEE
Confidence            46899999999998 4566554  79999999999998 6776    47899999999999984 555   679999999


Q ss_pred             cccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEE
Q 039957           93 LGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRF  172 (481)
Q Consensus        93 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L  172 (481)
                      +++|.+++. |.   .+++|+.|++++|+++.++.            .+++|++|+|++|.+++ +|..    ..+|+.|
T Consensus       108 Ls~N~l~~l-~~---~l~~L~~L~L~~N~l~~lp~------------~l~~L~~L~Ls~N~l~~-l~~~----~~~L~~L  166 (622)
T 3g06_A          108 IFSNPLTHL-PA---LPSGLCKLWIFGNQLTSLPV------------LPPGLQELSVSDNQLAS-LPAL----PSELCKL  166 (622)
T ss_dssp             ECSCCCCCC-CC---CCTTCCEEECCSSCCSCCCC------------CCTTCCEEECCSSCCSC-CCCC----CTTCCEE
T ss_pred             CcCCcCCCC-CC---CCCCcCEEECCCCCCCcCCC------------CCCCCCEEECcCCcCCC-cCCc----cCCCCEE
Confidence            999999964 44   67899999999999998743            23789999999999986 3432    3579999


Q ss_pred             EccCCceeecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeee
Q 039957          173 SASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLS  252 (481)
Q Consensus       173 ~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~  252 (481)
                      ++++|.+++ +|   ..+++|+.|++++|.+++ +|..   +++|+.|++++|.++. +|..   +++|+.|++++|+++
T Consensus       167 ~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~~-l~~~---~~~L~~L~Ls~N~L~  234 (622)
T 3g06_A          167 WAYNNQLTS-LP---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLT  234 (622)
T ss_dssp             ECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSS-CCCC---CTTCCEEECCSSCCS
T ss_pred             ECCCCCCCC-Cc---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCcccc-cCCC---CCCCCEEEccCCccC
Confidence            999999995 66   457899999999999985 5543   4789999999999986 4433   478999999999999


Q ss_pred             ecCCcccccCCCCCcEEcCCCcCcccCCcchhccccCcEEEccCcccCCCCCCccccCCcCcEEEccCCeeeeecccccc
Q 039957          253 GHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIG  332 (481)
Q Consensus       253 ~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~  332 (481)
                      + +|   ..+++|+.|++++|+++ .+|.   .+++|+.|++++|.++ .+|..+.++++|+.|++++|++++..|..+.
T Consensus       235 ~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~  305 (622)
T 3g06_A          235 S-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALR  305 (622)
T ss_dssp             C-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHH
T ss_pred             c-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHH
Confidence            6 45   45689999999999998 4555   5688999999999998 6788999999999999999999998888776


Q ss_pred             ccCC
Q 039957          333 ALVD  336 (481)
Q Consensus       333 ~l~~  336 (481)
                      .+..
T Consensus       306 ~L~~  309 (622)
T 3g06_A          306 EITS  309 (622)
T ss_dssp             HHHH
T ss_pred             hccc
Confidence            5543

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.96  E-value=5.1e-31  Score=252.56  Aligned_cols=250  Identities=19%  Similarity=0.154  Sum_probs=210.6

Q ss_pred             CCCCccEEEccCccceeecchhccccccCceeecccCcc-eecCccccc-------CCCCCCEEEcccccCccccCCCcc
Q 039957           60 SLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTF-SGHIPNTFG-------NLRHLSVLSLLMNNLTTESSSAYQ  131 (481)
Q Consensus        60 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l-~~~~p~~~~-------~l~~L~~L~L~~N~l~~~~~~~~~  131 (481)
                      ..++|++|++++|.+  .+|..+...  |+.|+|++|.+ .+.+|..+.       ++++|++|++++|++++..+..+ 
T Consensus        41 ~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~-  115 (312)
T 1wwl_A           41 GGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPL-  115 (312)
T ss_dssp             EEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCS-
T ss_pred             cCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHH-
Confidence            567899999999999  777776655  99999999999 456777776       89999999999999997532221 


Q ss_pred             ccccccCCCCCCCcEEEccCCccceeCChhhhhcc----cCccEEEccCCceeecCCcccccCCCCCeEecccccceec-
Q 039957          132 WSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFS----TSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGT-  206 (481)
Q Consensus       132 ~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~----~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~-  206 (481)
                           .+..+++|++|+|++|++++. |..+..+.    ++|++|++++|++++..|..|+.+++|++|++++|++.+. 
T Consensus       116 -----~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  189 (312)
T 1wwl_A          116 -----LEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGER  189 (312)
T ss_dssp             -----SSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHH
T ss_pred             -----HHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcch
Confidence                 026789999999999999987 88777762    6899999999999988889999999999999999998765 


Q ss_pred             -CCcCC--cCCCCCCeeecCCCcCCCC---CCccccCccCCCeeecCCCeeeecCC-cccccCCCCCcEEcCCCcCcccC
Q 039957          207 -IPTSI--GTLKQLQGFFLPETNLQGY---VPHNLCHLEMLNLLHLGGNKLSGHIP-PCLASLTSLRELDLGSNKLTSSI  279 (481)
Q Consensus       207 -~p~~~--~~l~~L~~l~l~~n~l~~~---~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~ls~N~l~~~~  279 (481)
                       .|..+  ..+++|+.|++++|++++.   ....+..+++|+.|++++|++++.+| ..+..+++|++|++++|+++ .+
T Consensus       190 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~i  268 (312)
T 1wwl_A          190 GLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QV  268 (312)
T ss_dssp             HHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SC
T ss_pred             HHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hh
Confidence             33344  8899999999999999842   22345678899999999999998775 56777899999999999998 77


Q ss_pred             CcchhccccCcEEEccCcccCCCCCCccccCCcCcEEEccCCeeee
Q 039957          280 PSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSG  325 (481)
Q Consensus       280 p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~  325 (481)
                      |..+.  +.|++|++++|++++. |. +..+++|++|++++|++++
T Consensus       269 p~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~  310 (312)
T 1wwl_A          269 PKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD  310 (312)
T ss_dssp             CSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred             hhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence            77776  8899999999999876 66 8899999999999999875

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.96  E-value=4e-30  Score=261.02  Aligned_cols=234  Identities=19%  Similarity=0.179  Sum_probs=154.4

Q ss_pred             CCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeecccCcceecCcccccCCCCCCEEEc
Q 039957           38 TIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSL  117 (481)
Q Consensus        38 ~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  117 (481)
                      +|++|+|++|.+++..|..+. .+++|++|+|++|.+++..|  |..+++|++|+|++|.+++..+     .++|++|++
T Consensus        35 ~L~~L~Ls~n~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~L  106 (487)
T 3oja_A           35 NVKELDLSGNPLSQISAADLA-PFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLHA  106 (487)
T ss_dssp             GCCEEECCSSCCCCCCGGGGT-TCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEEC
T ss_pred             CccEEEeeCCcCCCCCHHHHh-CCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEEC
Confidence            677777777777644444443 67777777777777766555  6677777777777777765432     267777777


Q ss_pred             ccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEccCCceeecCCcccc-cCCCCCeE
Q 039957          118 LMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIG-HLRGLIYL  196 (481)
Q Consensus       118 ~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~-~l~~L~~L  196 (481)
                      ++|.+++++..           .+++|++|+|++|.+++..|..++.+ ++|+.|++++|.+++..|..+. .+++|++|
T Consensus       107 ~~N~l~~~~~~-----------~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L  174 (487)
T 3oja_A          107 ANNNISRVSCS-----------RGQGKKNIYLANNKITMLRDLDEGCR-SRVQYLDLKLNEIDTVNFAELAASSDTLEHL  174 (487)
T ss_dssp             CSSCCCCEEEC-----------CCSSCEEEECCSSCCCSGGGBCGGGG-SSEEEEECTTSCCCEEEGGGGGGGTTTCCEE
T ss_pred             cCCcCCCCCcc-----------ccCCCCEEECCCCCCCCCCchhhcCC-CCCCEEECCCCCCCCcChHHHhhhCCcccEE
Confidence            77777665321           23567777777777776666666655 4677777777777776666665 57777777


Q ss_pred             ecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCcCc
Q 039957          197 SLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLT  276 (481)
Q Consensus       197 ~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~  276 (481)
                      +|++|.+++..+  +..+++|+.|++++|.+++.+| .+..+++|+.|++++|.+++ +|..+..+++|+.|++++|.+.
T Consensus       175 ~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~  250 (487)
T 3oja_A          175 NLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFH  250 (487)
T ss_dssp             ECTTSCCCEEEC--CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBC
T ss_pred             ecCCCccccccc--cccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCc
Confidence            777777775532  3346777777777777776443 36677777777777777775 4556777777777777777776


Q ss_pred             -ccCCcchhccccCcEEEcc
Q 039957          277 -SSIPSSLWSLGYILEINLS  295 (481)
Q Consensus       277 -~~~p~~~~~l~~L~~L~l~  295 (481)
                       +.+|..+..++.++.++++
T Consensus       251 c~~~~~~~~~l~~L~~l~~~  270 (487)
T 3oja_A          251 CGTLRDFFSKNQRVQTVAKQ  270 (487)
T ss_dssp             HHHHHHHHTTCHHHHHHHHH
T ss_pred             CcchHHHHHhCCCCcEEecc
Confidence             5555666666666655554

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=99.96  E-value=4.3e-30  Score=242.57  Aligned_cols=135  Identities=30%  Similarity=0.523  Sum_probs=118.0

Q ss_pred             hccccccceeeeecc------CCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCC
Q 039957          341 SLAGSFGSVYKGTIS------DGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNG  409 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~------~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g  409 (481)
                      .|+|+||.||+|...      +|..||||.++.......++|.+|++++++++|||||+++|+|.+.+     +|||++|
T Consensus        21 lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G  100 (299)
T 4asz_A           21 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHG  100 (299)
T ss_dssp             EEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTC
T ss_pred             EeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCC
Confidence            478999999999853      46789999998766666678999999999999999999999998765     7899999


Q ss_pred             ChhHHhhcC------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcc
Q 039957          410 SLEKRLYSH------------NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK  477 (481)
Q Consensus       410 ~l~~~l~~~------------~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~  477 (481)
                      +|.++++..            ...++|.++.+|+.|||+||+|||    +++||||||||+|||+|+++.+||+|||+|+
T Consensus       101 ~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH----~~~iiHRDlKp~NILl~~~~~~Ki~DFGla~  176 (299)
T 4asz_A          101 DLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA----SQHFVHRDLATRNCLVGENLLVKIGDFGMSR  176 (299)
T ss_dssp             BHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGGCEEECCCSCHH
T ss_pred             cHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCccCHhhEEECCCCcEEECCcccce
Confidence            999999753            246899999999999999999999    5789999999999999999999999999997


Q ss_pred             cC
Q 039957          478 LL  479 (481)
Q Consensus       478 ~~  479 (481)
                      ..
T Consensus       177 ~~  178 (299)
T 4asz_A          177 DV  178 (299)
T ss_dssp             HH
T ss_pred             ec
Confidence            54

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=99.96  E-value=9.6e-30  Score=240.20  Aligned_cols=133  Identities=31%  Similarity=0.572  Sum_probs=117.8

Q ss_pred             hccccccceeeeeccCCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC----cccccCCChhHH
Q 039957          341 SLAGSFGSVYKGTISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----FKFMPNGSLEKR  414 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~~~~g~l~~~  414 (481)
                      .|+|+||.||+|.+..  .||||.++...  ....+.|.+|+.++++++|||||+++|+|....    +|||++|+|.++
T Consensus        44 iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~iVmEy~~gGsL~~~  121 (307)
T 3omv_A           44 IGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKH  121 (307)
T ss_dssp             CCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECCSSCBHHHH
T ss_pred             EeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECCeEEEEEEcCCCCCHHHH
Confidence            4899999999998643  59999886543  334567999999999999999999999997654    789999999999


Q ss_pred             hhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          415 LYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       415 l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ++.....++|.++.+|+.|||+||+|||    +.+||||||||+|||+|+++.+||+|||+|+..
T Consensus       122 l~~~~~~l~~~~~~~i~~qia~gL~yLH----~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  182 (307)
T 3omv_A          122 LHVQETKFQMFQLIDIARQTAQGMDYLH----AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVK  182 (307)
T ss_dssp             HHTSCCCCCHHHHHHHHHHHHHHHHHHH----HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred             HhhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCccCCccCHHHEEECCCCcEEEeeccCceec
Confidence            9876677999999999999999999999    578999999999999999999999999999865

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=99.96  E-value=1.1e-29  Score=243.14  Aligned_cols=135  Identities=28%  Similarity=0.497  Sum_probs=115.9

Q ss_pred             hccccccceeeeecc------CCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCC
Q 039957          341 SLAGSFGSVYKGTIS------DGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNG  409 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~------~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g  409 (481)
                      .|+|+||.||+|.+.      ++..||||.++.......+.|.+|++++++++|||||+++|+|.+.+     +|||++|
T Consensus        49 LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G  128 (329)
T 4aoj_A           49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHG  128 (329)
T ss_dssp             EEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTC
T ss_pred             EccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCC
Confidence            478999999999753      47889999998766666678999999999999999999999998765     7899999


Q ss_pred             ChhHHhhcCC--------------CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccC
Q 039957          410 SLEKRLYSHN--------------YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGI  475 (481)
Q Consensus       410 ~l~~~l~~~~--------------~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl  475 (481)
                      +|.++++...              ..++|.++++|+.|||+||+|||    +.+||||||||+|||+|+++.+||+|||+
T Consensus       129 ~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH----~~~iiHRDLKp~NILl~~~~~~Ki~DFGl  204 (329)
T 4aoj_A          129 DLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA----GLHFVHRDLATRNCLVGQGLVVKIGDFGM  204 (329)
T ss_dssp             BHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEETTTEEEECCCC-
T ss_pred             cHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh----cCCeecccccHhhEEECCCCcEEEccccc
Confidence            9999987532              35899999999999999999999    57899999999999999999999999999


Q ss_pred             cccC
Q 039957          476 SKLL  479 (481)
Q Consensus       476 ~~~~  479 (481)
                      |+.+
T Consensus       205 a~~~  208 (329)
T 4aoj_A          205 SRDI  208 (329)
T ss_dssp             ----
T ss_pred             ceec
Confidence            9865

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=99.96  E-value=2.2e-29  Score=238.67  Aligned_cols=135  Identities=23%  Similarity=0.413  Sum_probs=116.3

Q ss_pred             hccccccceeeeecc------CCcceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccC
Q 039957          341 SLAGSFGSVYKGTIS------DGTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPN  408 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~------~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~  408 (481)
                      .|+|+||.||+|.+.      ++..||||.+.... ....+.|.+|+.++++++|||||+++|+|...+     +|||++
T Consensus        34 lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~  113 (308)
T 4gt4_A           34 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSH  113 (308)
T ss_dssp             EEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSS
T ss_pred             eccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCC
Confidence            478999999999863      46789999986543 233467999999999999999999999998764     789999


Q ss_pred             CChhHHhhcC---------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 039957          409 GSLEKRLYSH---------------NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDF  473 (481)
Q Consensus       409 g~l~~~l~~~---------------~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Df  473 (481)
                      |+|.+++...               ...++|.++++|+.|||+||+|||    +.+||||||||+|||+|+++.+||+||
T Consensus       114 G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH----~~~iiHRDLK~~NILl~~~~~~Ki~DF  189 (308)
T 4gt4_A          114 GDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS----SHHVVHKDLATRNVLVYDKLNVKISDL  189 (308)
T ss_dssp             CBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGGCEEECCS
T ss_pred             CcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH----hCCCCCCCccccceEECCCCCEEECCc
Confidence            9999998642               135889999999999999999999    578999999999999999999999999


Q ss_pred             cCcccC
Q 039957          474 GISKLL  479 (481)
Q Consensus       474 gl~~~~  479 (481)
                      |+|+.+
T Consensus       190 Glar~~  195 (308)
T 4gt4_A          190 GLFREV  195 (308)
T ss_dssp             CCBCGG
T ss_pred             ccceec
Confidence            999864

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.96  E-value=8.5e-28  Score=249.04  Aligned_cols=255  Identities=26%  Similarity=0.345  Sum_probs=213.2

Q ss_pred             ccCcchhCCCCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhcc
Q 039957            4 QIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSIT   83 (481)
Q Consensus         4 ~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~   83 (481)
                      .+|..+.  ++|++|+|++|+|+.+ |.   .+++|++|+|++|+|+ .+|.    .+++|++|++++|++++ +|.   
T Consensus        54 ~lp~~l~--~~L~~L~L~~N~l~~l-p~---~l~~L~~L~Ls~N~l~-~lp~----~l~~L~~L~Ls~N~l~~-l~~---  118 (622)
T 3g06_A           54 TLPDCLP--AHITTLVIPDNNLTSL-PA---LPPELRTLEVSGNQLT-SLPV----LPPGLLELSIFSNPLTH-LPA---  118 (622)
T ss_dssp             CCCSCCC--TTCSEEEECSCCCSCC-CC---CCTTCCEEEECSCCCS-CCCC----CCTTCCEEEECSCCCCC-CCC---
T ss_pred             ccChhhC--CCCcEEEecCCCCCCC-CC---cCCCCCEEEcCCCcCC-cCCC----CCCCCCEEECcCCcCCC-CCC---
Confidence            5777665  7999999999999865 44   5789999999999998 6776    57999999999999985 444   


Q ss_pred             ccccCceeecccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhh
Q 039957           84 NATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIG  163 (481)
Q Consensus        84 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~  163 (481)
                      .+++|+.|++++|.+++ +|..   +++|++|++++|++++++.            .+++|+.|++++|.+++ +|.   
T Consensus       119 ~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~l~~------------~~~~L~~L~L~~N~l~~-l~~---  178 (622)
T 3g06_A          119 LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLASLPA------------LPSELCKLWAYNNQLTS-LPM---  178 (622)
T ss_dssp             CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSCCCC------------CCTTCCEEECCSSCCSC-CCC---
T ss_pred             CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCCcCC------------ccCCCCEEECCCCCCCC-Ccc---
Confidence            67899999999999996 5543   5999999999999998743            23579999999999986 452   


Q ss_pred             hcccCccEEEccCCceeecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCe
Q 039957          164 NFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNL  243 (481)
Q Consensus       164 ~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~  243 (481)
                       ..++|+.|++++|.+++ +|..   +++|+.|++++|.++ .+|..   +++|+.|++++|++++ +|   ..+++|+.
T Consensus       179 -~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~-~l~~~---~~~L~~L~Ls~N~L~~-lp---~~l~~L~~  245 (622)
T 3g06_A          179 -LPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTS-LP---VLPSELKE  245 (622)
T ss_dssp             -CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSC-CC---CCCTTCCE
T ss_pred             -cCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCccc-ccCCC---CCCCCEEEccCCccCc-CC---CCCCcCcE
Confidence             23689999999999985 5543   478999999999998 45543   4789999999999997 45   45588999


Q ss_pred             eecCCCeeeecCCcccccCCCCCcEEcCCCcCcccCCcchhccccCcEEEccCcccCCCCCCccccCC
Q 039957          244 LHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLK  311 (481)
Q Consensus       244 L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~  311 (481)
                      |++++|++++ +|.   .+++|+.|++++|+++ .+|..+..++.|+.|++++|.+++..|..+..++
T Consensus       246 L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~  308 (622)
T 3g06_A          246 LMVSGNRLTS-LPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT  308 (622)
T ss_dssp             EECCSSCCSC-CCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred             EECCCCCCCc-CCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence            9999999995 454   5689999999999999 7788999999999999999999988777665544

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.95  E-value=2.3e-27  Score=223.06  Aligned_cols=227  Identities=21%  Similarity=0.198  Sum_probs=127.8

Q ss_pred             eeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeecccC
Q 039957           17 SLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFN   96 (481)
Q Consensus        17 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N   96 (481)
                      +.+.++.+++. +|..+.  ++|++|++++|++++..+..+. .+++|++|++++|++++..+..|..+++|++|++++|
T Consensus        11 ~~~c~~~~l~~-ip~~l~--~~l~~L~ls~n~l~~~~~~~~~-~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n   86 (276)
T 2z62_A           11 TYQCMELNFYK-IPDNLP--FSTKNLDLSFNPLRHLGSYSFF-SFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN   86 (276)
T ss_dssp             EEECTTSCCSS-CCSSSC--TTCCEEECTTCCCCEECTTTTT-TCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred             eEEecCCCccc-cCCCCC--CCccEEECCCCcccccCHhHhc-cccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCC
Confidence            34555555543 344332  4577777777777643333443 6777777777777777666667777777777777777


Q ss_pred             cceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCcccee-CChhhhhcccCccEEEcc
Q 039957           97 TFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGI-LPPSIGNFSTSLQRFSAS  175 (481)
Q Consensus        97 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~-~p~~~~~~~~~L~~L~l~  175 (481)
                      .+++..|..|.++++|++|++++|+++++...+        +.++++|++|++++|.+++. +|..+..+ ++|++|+++
T Consensus        87 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~--------~~~l~~L~~L~l~~n~l~~~~l~~~~~~l-~~L~~L~Ls  157 (276)
T 2z62_A           87 PIQSLALGAFSGLSSLQKLVAVETNLASLENFP--------IGHLKTLKELNVAHNLIQSFKLPEYFSNL-TNLEHLDLS  157 (276)
T ss_dssp             CCCEECTTTTTTCTTCCEEECTTSCCCCSTTCC--------CTTCTTCCEEECCSSCCCCCCCCGGGGGC-TTCCEEECC
T ss_pred             ccCccChhhhcCCccccEEECCCCCccccCchh--------cccCCCCCEEECcCCccceecCchhhccC-CCCCEEECC
Confidence            777776677777777777777777776653322        45566666666666666542 34444443 345555555


Q ss_pred             CCceeecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeeeecC
Q 039957          176 ECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHI  255 (481)
Q Consensus       176 ~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  255 (481)
                      +|++++..+..+..+.+|+.+.+                    .+++++|.+++..+..+.. .+|+.|++++|++++.+
T Consensus       158 ~N~l~~~~~~~~~~l~~L~~l~l--------------------~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~  216 (276)
T 2z62_A          158 SNKIQSIYCTDLRVLHQMPLLNL--------------------SLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVP  216 (276)
T ss_dssp             SSCCCEECGGGGHHHHTCTTCCE--------------------EEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCC
T ss_pred             CCCCCcCCHHHhhhhhhccccce--------------------eeecCCCcccccCccccCC-CcccEEECCCCceeecC
Confidence            55554444444444433330000                    3444444444333333322 24555555555555544


Q ss_pred             CcccccCCCCCcEEcCCCcCcc
Q 039957          256 PPCLASLTSLRELDLGSNKLTS  277 (481)
Q Consensus       256 p~~~~~l~~L~~L~ls~N~l~~  277 (481)
                      +..|..+++|+.|++++|.++.
T Consensus       217 ~~~~~~l~~L~~L~l~~N~~~c  238 (276)
T 2z62_A          217 DGIFDRLTSLQKIWLHTNPWDC  238 (276)
T ss_dssp             TTTTTTCCSCCEEECCSSCBCC
T ss_pred             HhHhcccccccEEEccCCcccc
Confidence            4445555555555665555553

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.95  E-value=4.5e-27  Score=221.12  Aligned_cols=214  Identities=19%  Similarity=0.165  Sum_probs=172.2

Q ss_pred             ccCcchhCCCCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhcc
Q 039957            4 QIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSIT   83 (481)
Q Consensus         4 ~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~   83 (481)
                      .+|..+.  ++|++|+|++|+++++.+..|.++++|++|++++|++++..+..+ ..+++|++|++++|++++..+..|.
T Consensus        21 ~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~-~~l~~L~~L~L~~n~l~~~~~~~~~   97 (276)
T 2z62_A           21 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAY-QSLSHLSTLILTGNPIQSLALGAFS   97 (276)
T ss_dssp             SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTT-TTCTTCCEEECTTCCCCEECTTTTT
T ss_pred             ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHc-cCCcCCCEEECCCCccCccChhhhc
Confidence            4666553  579999999999999988899999999999999999985444445 4899999999999999988889999


Q ss_pred             ccccCceeecccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhh
Q 039957           84 NATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIG  163 (481)
Q Consensus        84 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~  163 (481)
                      ++++|++|++++|.+++..+..|+.+++|++|++++|.++.+.       .+..+.++++|++|+|++|++++..+..+.
T Consensus        98 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~-------l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  170 (276)
T 2z62_A           98 GLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFK-------LPEYFSNLTNLEHLDLSSNKIQSIYCTDLR  170 (276)
T ss_dssp             TCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCC-------CCGGGGGCTTCCEEECCSSCCCEECGGGGH
T ss_pred             CCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceec-------CchhhccCCCCCEEECCCCCCCcCCHHHhh
Confidence            9999999999999999888888999999999999999998742       124567889999999999999988777777


Q ss_pred             hcccCcc----EEEccCCceeecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCC
Q 039957          164 NFSTSLQ----RFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQG  229 (481)
Q Consensus       164 ~~~~~L~----~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~  229 (481)
                      .+ .+++    .|++++|.+++..+..+. ..+|++|++++|++++..+..|..+++|+.+++++|.+.+
T Consensus       171 ~l-~~L~~l~l~L~ls~n~l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c  238 (276)
T 2z62_A          171 VL-HQMPLLNLSLDLSLNPMNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC  238 (276)
T ss_dssp             HH-HTCTTCCEEEECCSSCCCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCC
T ss_pred             hh-hhccccceeeecCCCcccccCccccC-CCcccEEECCCCceeecCHhHhcccccccEEEccCCcccc
Confidence            65 3565    778888887765544443 3367777777777765555555666666666666666654

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=99.95  E-value=5.2e-28  Score=229.71  Aligned_cols=138  Identities=25%  Similarity=0.386  Sum_probs=114.6

Q ss_pred             hhhhccccccceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC---------cccccC
Q 039957          338 ETISLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD---------FKFMPN  408 (481)
Q Consensus       338 ~~l~~~g~~g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---------~~~~~~  408 (481)
                      +...|+|+||.||+|.. +|..||||++....... ..+..|+..+.+++|||||+++|+|...+         +|||++
T Consensus         8 ~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~-~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~   85 (303)
T 3hmm_A            8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH   85 (303)
T ss_dssp             EEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHH-HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred             EEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhh-HHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCC
Confidence            33458899999999987 68999999987543322 22345677778899999999999986532         689999


Q ss_pred             CChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCC----CCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          409 GSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGH----SSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       409 g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~----~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      |+|.++++..  .++|..+.+|+.++|+||+|||+.+    ..++||||||||+|||+|+++++||+|||+|+..
T Consensus        86 gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  158 (303)
T 3hmm_A           86 GSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             CBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             CcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence            9999999764  4889999999999999999999531    1358999999999999999999999999999764

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=99.95  E-value=9.3e-28  Score=229.54  Aligned_cols=134  Identities=27%  Similarity=0.414  Sum_probs=119.6

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHH
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKR  414 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~  414 (481)
                      .|+|+||.||+|.. .+|..||||++........+.+.+|+.++++++|||||++++++.+.+     +|||++|+|.++
T Consensus        82 iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~  161 (346)
T 4fih_A           82 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDI  161 (346)
T ss_dssp             EEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHH
T ss_pred             eecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHH
Confidence            37899999999985 468999999998766555667889999999999999999999988765     689999999998


Q ss_pred             hhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          415 LYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       415 l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      +...  .+++.+...++.||++||+|||    +.+||||||||+|||+++++.+||+|||+|+.+.
T Consensus       162 l~~~--~l~e~~~~~~~~qi~~aL~ylH----~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  221 (346)
T 4fih_A          162 VTHT--RMNEEQIAAVCLAVLQALSVLH----AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS  221 (346)
T ss_dssp             HHHS--CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             HHcC--CCCHHHHHHHHHHHHHHHHHHH----HCCcccccCCHHHEEECCCCCEEEecCcCceecC
Confidence            8753  4788899999999999999999    6789999999999999999999999999998753

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=99.94  E-value=1.9e-27  Score=227.80  Aligned_cols=136  Identities=26%  Similarity=0.437  Sum_probs=113.0

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      .|+|+||.||++.. .+|..||||.+....  ....+.+.+|++++++++|||||++++++.+.+     +||+++|+|.
T Consensus        32 lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~  111 (350)
T 4b9d_A           32 IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLF  111 (350)
T ss_dssp             C------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHH
T ss_pred             EecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHH
Confidence            37899999999985 468999999997653  234567889999999999999999999987765     6899999999


Q ss_pred             HHhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          413 KRLYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       413 ~~l~~~-~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      +++... ...++..+...|+.||+.||+|||    +.+||||||||+|||+++++.+||+|||+|+.+.
T Consensus       112 ~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH----~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  176 (350)
T 4b9d_A          112 KRINAQKGVLFQEDQILDWFVQICLALKHVH----DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN  176 (350)
T ss_dssp             HHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH----HTTCEETTCCGGGEEECTTCCEEECSTTEESCCC
T ss_pred             HHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeeccCCHHHEEECCCCCEEEcccccceeec
Confidence            999753 345677888899999999999999    6789999999999999999999999999998764

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.94  E-value=3.8e-27  Score=221.03  Aligned_cols=186  Identities=24%  Similarity=0.212  Sum_probs=119.3

Q ss_pred             CCCCcEEEccCCccceeCChhhhhcccCccEEEccCCceeecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCee
Q 039957          141 CRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGF  220 (481)
Q Consensus       141 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l  220 (481)
                      +++|++|++++|.+++.  +.+..+ ++|++|++++|.+++..|..+..+++|++|++++|++++..+..|..+++|+.|
T Consensus        62 l~~L~~L~l~~n~l~~~--~~l~~l-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  138 (272)
T 3rfs_A           62 LPNVRYLALGGNKLHDI--SALKEL-TNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYL  138 (272)
T ss_dssp             CTTCCEEECTTSCCCCC--GGGTTC-TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE
T ss_pred             CCCCcEEECCCCCCCCc--hhhcCC-CCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEE
Confidence            34444444444444431  233333 345555555555554444555666666666666666665555556666666666


Q ss_pred             ecCCCcCCCCCCccccCccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCcCcccCCcchhccccCcEEEccCcccC
Q 039957          221 FLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLN  300 (481)
Q Consensus       221 ~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  300 (481)
                      ++++|++++..+..|..+++|+.|++++|++++..+..|..+++|++|++++|++++..|..+..++.|+.|++++|.+.
T Consensus       139 ~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~  218 (272)
T 3rfs_A          139 NLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWD  218 (272)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred             ECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcc
Confidence            66666666666666667777777777777777666666677777777777777777666666677777777777777766


Q ss_pred             CCCCCccccCCcCcEEEccCCeeeeeccccccccCC
Q 039957          301 DSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVD  336 (481)
Q Consensus       301 ~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~  336 (481)
                      +.       ++.++.++++.|+++|.+|..++.+..
T Consensus       219 ~~-------~~~l~~l~~~~n~~~g~ip~~~~~~~~  247 (272)
T 3rfs_A          219 CT-------CPGIRYLSEWINKHSGVVRNSAGSVAP  247 (272)
T ss_dssp             CC-------TTTTHHHHHHHHHTGGGBBCTTSCBCG
T ss_pred             cc-------CcHHHHHHHHHHhCCCcccCcccccCC
Confidence            43       345777788888888888887766544

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=99.94  E-value=5e-27  Score=230.08  Aligned_cols=133  Identities=27%  Similarity=0.421  Sum_probs=119.0

Q ss_pred             ccccccceeeeec-cCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHHh
Q 039957          342 LAGSFGSVYKGTI-SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRL  415 (481)
Q Consensus       342 ~~g~~g~vy~~~l-~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~l  415 (481)
                      |.|+||.||+|.. .+|..||||.+........+.+.+|+.++++++|||||++++++...+     +|||++|+|.+++
T Consensus       160 G~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i  239 (423)
T 4fie_A          160 GEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV  239 (423)
T ss_dssp             EECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHH
T ss_pred             ccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHH
Confidence            7899999999985 468999999998766555667889999999999999999999988765     7899999999988


Q ss_pred             hcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          416 YSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       416 ~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      ...  .++..+...|+.+|++||+|||    +.+||||||||+|||++.+|.+||+|||+|+.+.
T Consensus       240 ~~~--~l~e~~~~~~~~qil~aL~ylH----~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~  298 (423)
T 4fie_A          240 THT--RMNEEQIAAVCLAVLQALSVLH----AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS  298 (423)
T ss_dssp             HHS--CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSTTTEEECTTCCEEECCCTTCEECC
T ss_pred             hcc--CCCHHHHHHHHHHHHHHHHHHH----HCCeecccCCHHHEEEcCCCCEEEecCccceECC
Confidence            754  4778889999999999999999    6789999999999999999999999999998653

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.94  E-value=9.4e-26  Score=211.31  Aligned_cols=202  Identities=26%  Similarity=0.306  Sum_probs=113.9

Q ss_pred             CCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeecccCcceecCcccccCCCCCCEEEcc
Q 039957           39 IRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLL  118 (481)
Q Consensus        39 L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  118 (481)
                      .+.+++++|+++ .+|..+.   +++++|++++|++++..+..|..+++|++|++++|.++...+..|.++++|++|+++
T Consensus        18 ~~~l~~~~~~l~-~ip~~~~---~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~   93 (270)
T 2o6q_A           18 KNSVDCSSKKLT-AIPSNIP---ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT   93 (270)
T ss_dssp             TTEEECTTSCCS-SCCSCCC---TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECC
T ss_pred             CCEEEccCCCCC-ccCCCCC---CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECC
Confidence            455666666665 4554432   455666666666655555556666666666666666665555555556666666666


Q ss_pred             cccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEccCCceeecCCcccccCCCCCeEec
Q 039957          119 MNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSL  198 (481)
Q Consensus       119 ~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l  198 (481)
                      +|.++.++...        +..+++|++|+|++|.+++                         ..|..|..+++|++|++
T Consensus        94 ~n~l~~~~~~~--------~~~l~~L~~L~l~~n~l~~-------------------------~~~~~~~~l~~L~~L~L  140 (270)
T 2o6q_A           94 DNKLQALPIGV--------FDQLVNLAELRLDRNQLKS-------------------------LPPRVFDSLTKLTYLSL  140 (270)
T ss_dssp             SSCCCCCCTTT--------TTTCSSCCEEECCSSCCCC-------------------------CCTTTTTTCTTCCEEEC
T ss_pred             CCcCCcCCHhH--------cccccCCCEEECCCCccCe-------------------------eCHHHhCcCcCCCEEEC
Confidence            66555443211        2334444444444444443                         33334444555555555


Q ss_pred             ccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCcCcc
Q 039957          199 GFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTS  277 (481)
Q Consensus       199 ~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~  277 (481)
                      ++|.+++..+..|..+++|+.|++++|.+++..+..|..+++|+.|++++|++++..+..|..+++|+.|++++|.+..
T Consensus       141 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c  219 (270)
T 2o6q_A          141 GYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDC  219 (270)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred             CCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeC
Confidence            5555554444445555556666666666655555556666666666666666666555566666777777777776653

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.94  E-value=1.3e-25  Score=210.47  Aligned_cols=204  Identities=25%  Similarity=0.258  Sum_probs=159.0

Q ss_pred             CccEEEccCccceeecchhccccccCceeecccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCC
Q 039957           63 NIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCR  142 (481)
Q Consensus        63 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~  142 (481)
                      +.+++++++|+++ .+|..+.  ++|+.|++++|++++..+..|.++++|++|++++|.++.++...        +.+++
T Consensus        17 ~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~--------~~~l~   85 (270)
T 2o6q_A           17 NKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGI--------FKELK   85 (270)
T ss_dssp             TTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTT--------TSSCT
T ss_pred             CCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhh--------hcCCC
Confidence            4566777777766 3444332  45667777777766665556666666666666666665543221        23344


Q ss_pred             CCcEEEccCCccceeCChhhhhcccCccEEEccCCceeecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeec
Q 039957          143 YLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFL  222 (481)
Q Consensus       143 ~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l  222 (481)
                                               +|++|++++|++++..+..|..+++|++|++++|++++..+..|..+++|+.|++
T Consensus        86 -------------------------~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L  140 (270)
T 2o6q_A           86 -------------------------NLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSL  140 (270)
T ss_dssp             -------------------------TCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             -------------------------CCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEEC
Confidence                                     4555555555555445556778899999999999999888888999999999999


Q ss_pred             CCCcCCCCCCccccCccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCcCcccCCcchhccccCcEEEccCcccCCC
Q 039957          223 PETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDS  302 (481)
Q Consensus       223 ~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~  302 (481)
                      ++|.+++..+..|..+++|+.|++++|++++..+..|..+++|++|++++|++++..+..+..++.|+.|++++|.+...
T Consensus       141 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  220 (270)
T 2o6q_A          141 GYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCT  220 (270)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCS
T ss_pred             CCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCC
Confidence            99999998888899999999999999999988888899999999999999999987777889999999999999998654

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=99.94  E-value=6.2e-27  Score=219.37  Aligned_cols=137  Identities=26%  Similarity=0.396  Sum_probs=115.0

Q ss_pred             hhccccccceeeeecc-CCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCC---------Cccccc
Q 039957          340 ISLAGSFGSVYKGTIS-DGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTP---------DFKFMP  407 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---------~~~~~~  407 (481)
                      ..|+|+||.||+|... ++..||+|.+....  ....+.|.+|+.++++++|||||+++++|...         .+|||+
T Consensus        33 ~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~  112 (290)
T 3fpq_A           33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMT  112 (290)
T ss_dssp             EEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred             EEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCC
Confidence            3589999999999854 58899999986543  23345789999999999999999999987542         268999


Q ss_pred             CCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCC-CCcEEEccccCcccC
Q 039957          408 NGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDE-NMVAHVSDFGISKLL  479 (481)
Q Consensus       408 ~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~-~~~~kl~Dfgl~~~~  479 (481)
                      +|+|.+++... ..+++..+..++.+|++||+|||+.  .++||||||||+|||+++ ++.+||+|||+|+..
T Consensus       113 gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH~~--~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~  182 (290)
T 3fpq_A          113 SGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTR--TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             SCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTS--SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC--CCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence            99999998753 4578889999999999999999942  235999999999999985 799999999999864

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.94  E-value=1.2e-26  Score=217.66  Aligned_cols=224  Identities=19%  Similarity=0.207  Sum_probs=123.3

Q ss_pred             CCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeecccCcceecCcccccCCCCCCEEEc
Q 039957           38 TIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSL  117 (481)
Q Consensus        38 ~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  117 (481)
                      ++..+++..+.+.......   .+++|+.|++++|.++. + ..+..+++|++|++++|.+++.  ..++.+++|++|++
T Consensus        20 ~l~~l~l~~~~~~~~~~~~---~l~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L   92 (272)
T 3rfs_A           20 ETIKANLKKKSVTDAVTQN---ELNSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLIL   92 (272)
T ss_dssp             HHHHHHHTCSCTTSEECHH---HHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEEC
T ss_pred             HHHHHHhcCcccccccccc---cccceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEEC
Confidence            4445566666665332221   46677777777777652 2 2466677777777777777652  35667777777777


Q ss_pred             ccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEccCCceeecCCcccccCCCCCeEe
Q 039957          118 LMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLS  197 (481)
Q Consensus       118 ~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~  197 (481)
                      ++|.++++++.        .+.++++|++|+|++|++++..+..+..+ ++|++|++++|++++..|..+..+++|++|+
T Consensus        93 ~~n~l~~~~~~--------~~~~l~~L~~L~L~~n~l~~~~~~~~~~l-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  163 (272)
T 3rfs_A           93 TGNQLQSLPNG--------VFDKLTNLKELVLVENQLQSLPDGVFDKL-TNLTYLNLAHNQLQSLPKGVFDKLTNLTELD  163 (272)
T ss_dssp             TTSCCCCCCTT--------TTTTCTTCCEEECTTSCCCCCCTTTTTTC-TTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCccCccChh--------HhcCCcCCCEEECCCCcCCccCHHHhccC-CCCCEEECCCCccCccCHHHhccCccCCEEE
Confidence            77766655332        23455666666666666665444444443 3455555555555544444455555555555


Q ss_pred             cccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCcCcc
Q 039957          198 LGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTS  277 (481)
Q Consensus       198 l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~  277 (481)
                      +++|++++..+..+..+++|+.|++++|++++..|..+..+++|+.|++++|.+.+.       +++|+.|+++.|+++|
T Consensus       164 l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g  236 (272)
T 3rfs_A          164 LSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSG  236 (272)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGG
T ss_pred             CCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCC
Confidence            555555544444445555555555555555554444455555555555555544322       2244445555555555


Q ss_pred             cCCcchh
Q 039957          278 SIPSSLW  284 (481)
Q Consensus       278 ~~p~~~~  284 (481)
                      .+|.+++
T Consensus       237 ~ip~~~~  243 (272)
T 3rfs_A          237 VVRNSAG  243 (272)
T ss_dssp             GBBCTTS
T ss_pred             cccCccc
Confidence            4444443

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=99.94  E-value=8.4e-27  Score=222.24  Aligned_cols=129  Identities=24%  Similarity=0.289  Sum_probs=113.5

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHH
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKR  414 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~  414 (481)
                      .|+|+||.||+|.. .+|..||||.++...     ...+|+.++++++|||||++++++.+.+     +|||++|+|.++
T Consensus        66 lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~  140 (336)
T 4g3f_A           66 VGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQL  140 (336)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHH
T ss_pred             eccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHH
Confidence            37899999999985 468999999987542     2346999999999999999999987765     689999999999


Q ss_pred             hhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCC-cEEEccccCcccC
Q 039957          415 LYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENM-VAHVSDFGISKLL  479 (481)
Q Consensus       415 l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~-~~kl~Dfgl~~~~  479 (481)
                      +... ..+++.+...|+.||++||+|||    +.+||||||||+|||++.++ ++||+|||+|+.+
T Consensus       141 l~~~-~~l~e~~~~~~~~qi~~aL~ylH----~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~  201 (336)
T 4g3f_A          141 IKQM-GCLPEDRALYYLGQALEGLEYLH----TRRILHGDVKADNVLLSSDGSRAALCDFGHALCL  201 (336)
T ss_dssp             HHHH-SSCCHHHHHHHHHHHHHHHHHHH----TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC
T ss_pred             HHHc-CCCCHHHHHHHHHHHHHHHHHHH----HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEc
Confidence            8754 35788999999999999999999    68899999999999999987 6999999999865

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=99.94  E-value=6.7e-27  Score=220.27  Aligned_cols=135  Identities=31%  Similarity=0.443  Sum_probs=117.9

Q ss_pred             hhccccccceeeeec-cCCcceEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCC
Q 039957          340 ISLAGSFGSVYKGTI-SDGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGS  410 (481)
Q Consensus       340 l~~~g~~g~vy~~~l-~~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~  410 (481)
                      ..|+|+||.||++.. .+|..||+|.+....   ....+.+.+|++++++++|||||++++++.+.+     +||+++|+
T Consensus        39 ~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~  118 (311)
T 4aw0_A           39 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE  118 (311)
T ss_dssp             EEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEE
T ss_pred             EEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCC
Confidence            348899999999985 568999999997543   233456889999999999999999999998775     68999999


Q ss_pred             hhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          411 LEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       411 l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      |.+++... ..++..+...++.||+.||+|||    +.+||||||||+|||+++++.+||+|||+|+.+
T Consensus       119 L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH----~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~  182 (311)
T 4aw0_A          119 LLKYIRKI-GSFDETCTRFYTAEIVSALEYLH----GKGIIHRDLKPENILLNEDMHIQITDFGTAKVL  182 (311)
T ss_dssp             HHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             HHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH----HCCCccCCCCHHHeEEcCCCCEEEEEcCCceec
Confidence            99998753 34677888899999999999999    678999999999999999999999999999875

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=99.94  E-value=7.3e-27  Score=225.33  Aligned_cols=136  Identities=29%  Similarity=0.472  Sum_probs=115.4

Q ss_pred             hhccccccceeeeecc------CCcceEEEEEeccch-hhhhhhhHHHHHhhhhcc-CccceeecccCCCC------ccc
Q 039957          340 ISLAGSFGSVYKGTIS------DGTDVAIKIFNLQRE-RAFRSFNSECEVLRNVRH-QNLIKILSSCSTPD------FKF  405 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~------~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~------~~~  405 (481)
                      ..|+|+||.||+|...      .++.||||.+..... ...+.|.+|++++.+++| ||||+++|+|...+      +||
T Consensus        71 ~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey  150 (353)
T 4ase_A           71 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEF  150 (353)
T ss_dssp             EEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEEC
T ss_pred             EEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEc
Confidence            3488999999999753      235799999875432 334678999999999975 89999999986542      689


Q ss_pred             ccCCChhHHhhcC---------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 039957          406 MPNGSLEKRLYSH---------------NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHV  470 (481)
Q Consensus       406 ~~~g~l~~~l~~~---------------~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl  470 (481)
                      |++|+|.++++..               ...++|.+++.|+.|||+||+|||    +.+||||||||+|||+++++.+||
T Consensus       151 ~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH----~~~iiHRDLK~~NILl~~~~~vKi  226 (353)
T 4ase_A          151 CKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA----SRKCIHRDLAARNILLSEKNVVKI  226 (353)
T ss_dssp             CTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGGCEEE
T ss_pred             CCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh----hCCeecCccCccceeeCCCCCEEE
Confidence            9999999998752               234789999999999999999999    678999999999999999999999


Q ss_pred             ccccCcccC
Q 039957          471 SDFGISKLL  479 (481)
Q Consensus       471 ~Dfgl~~~~  479 (481)
                      +|||+|+.+
T Consensus       227 ~DFGlar~~  235 (353)
T 4ase_A          227 CDFGLARDI  235 (353)
T ss_dssp             CCCGGGSCT
T ss_pred             Ccchhhhhc
Confidence            999999875

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=99.93  E-value=1.3e-26  Score=219.13  Aligned_cols=136  Identities=23%  Similarity=0.391  Sum_probs=110.5

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccch-hhhhhhhHHHHHhhhhccCccceeecccCCC-----------------
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQRE-RAFRSFNSECEVLRNVRHQNLIKILSSCSTP-----------------  401 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----------------  401 (481)
                      .|+|+||.||+|.. .+|..||||.+..... ...+.+.+|++++++++|||||++++++...                 
T Consensus        13 lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~i   92 (299)
T 4g31_A           13 LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYI   92 (299)
T ss_dssp             EEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEE
T ss_pred             EecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEE
Confidence            47899999999985 4689999999875443 3345788999999999999999999987432                 


Q ss_pred             CcccccCCChhHHhhcCC--CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          402 DFKFMPNGSLEKRLYSHN--YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       402 ~~~~~~~g~l~~~l~~~~--~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+||+++|+|.+++....  ...++.....|+.||++||+|||    +.+||||||||+|||++.++.+||+|||+|+.+
T Consensus        93 vmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH----~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~  168 (299)
T 4g31_A           93 QMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH----SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM  168 (299)
T ss_dssp             EEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEECCCCCC---
T ss_pred             EEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH----HCcCccccCcHHHeEECCCCcEEEccCccceec
Confidence            267999999999987643  23466778899999999999999    678999999999999999999999999999875


Q ss_pred             C
Q 039957          480 G  480 (481)
Q Consensus       480 ~  480 (481)
                      .
T Consensus       169 ~  169 (299)
T 4g31_A          169 D  169 (299)
T ss_dssp             -
T ss_pred             C
Confidence            3

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.93  E-value=1.4e-25  Score=206.14  Aligned_cols=196  Identities=17%  Similarity=0.136  Sum_probs=138.8

Q ss_pred             CCCEEEeeCCcCccccChhhhcCCCCccEEEccCcc-ceeecchhccccccCceeeccc-CcceecCcccccCCCCCCEE
Q 039957           38 TIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNN-LIGTIPNSITNATKLIILDLGF-NTFSGHIPNTFGNLRHLSVL  115 (481)
Q Consensus        38 ~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L  115 (481)
                      +|++|++++|+++ .+|...+..+++|++|++++|+ +++..+..|.++++|++|++++ |.+++..+..|.++++|++|
T Consensus        32 ~l~~L~l~~n~l~-~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L  110 (239)
T 2xwt_C           32 STQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL  110 (239)
T ss_dssp             TCCEEEEESCCCS-EECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred             cccEEEEeCCcce-EECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence            6778888888877 4444333467788888888886 7766666777788888888887 77877777777788888888


Q ss_pred             EcccccCccccCCCccccccccCCCCCCCc---EEEccCC-ccceeCChhhhhcccCcc-EEEccCCceeecCCcccccC
Q 039957          116 SLLMNNLTTESSSAYQWSFLSSLTNCRYLV---YLILSGN-PLGGILPPSIGNFSTSLQ-RFSASECKLKGTIPKEIGHL  190 (481)
Q Consensus       116 ~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~---~L~Ls~N-~l~~~~p~~~~~~~~~L~-~L~l~~n~l~~~~p~~~~~l  190 (481)
                      ++++|.+++++.          +..+++|+   +|++++| .+++..+..|..+ ++|+ .|++++|+++...+..|.. 
T Consensus       111 ~l~~n~l~~lp~----------~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l-~~L~~~L~l~~n~l~~i~~~~~~~-  178 (239)
T 2xwt_C          111 GIFNTGLKMFPD----------LTKVYSTDIFFILEITDNPYMTSIPVNAFQGL-CNETLTLKLYNNGFTSVQGYAFNG-  178 (239)
T ss_dssp             EEEEECCCSCCC----------CTTCCBCCSEEEEEEESCTTCCEECTTTTTTT-BSSEEEEECCSCCCCEECTTTTTT-
T ss_pred             eCCCCCCccccc----------cccccccccccEEECCCCcchhhcCcccccch-hcceeEEEcCCCCCcccCHhhcCC-
Confidence            888887776532          23444444   8888888 7776666666665 5688 8888888887433333444 


Q ss_pred             CCCCeEeccccc-ceecCCcCCcCC-CCCCeeecCCCcCCCCCCccccCccCCCeeecCCC
Q 039957          191 RGLIYLSLGFND-LNGTIPTSIGTL-KQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGN  249 (481)
Q Consensus       191 ~~L~~L~l~~N~-l~~~~p~~~~~l-~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N  249 (481)
                      ++|++|++++|+ +++..+..|..+ ++|+.|++++|++++..+.   .++.|+.|+++++
T Consensus       179 ~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~  236 (239)
T 2xwt_C          179 TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNT  236 (239)
T ss_dssp             CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC
T ss_pred             CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCc
Confidence            778888888884 776667777888 8888888888888765444   4566777777765

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.93  E-value=3.2e-25  Score=209.64  Aligned_cols=203  Identities=23%  Similarity=0.174  Sum_probs=106.6

Q ss_pred             ccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeecccCcceecCcccccCCCCC
Q 039957           33 IFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHL  112 (481)
Q Consensus        33 ~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  112 (481)
                      +.++++++++++++|.++ .+|..++   +++++|+|++|++++..|..|..+++|++|+|++|.+++..+.  +.+++|
T Consensus         6 ~~~l~~l~~l~~~~~~l~-~ip~~~~---~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L   79 (290)
T 1p9a_G            6 VSKVASHLEVNCDKRNLT-ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVL   79 (290)
T ss_dssp             EECSTTCCEEECTTSCCS-SCCSCCC---TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTC
T ss_pred             ccccCCccEEECCCCCCC-cCCCCCC---CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcC
Confidence            456666777777777776 5665442   4566666666666666566666666666666666666543321  455555


Q ss_pred             CEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEccCCceeecCCcccccCCC
Q 039957          113 SVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRG  192 (481)
Q Consensus       113 ~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~  192 (481)
                      ++|++++|+++.++.         .+..+++                         |++|++++|++++..|..|..+++
T Consensus        80 ~~L~Ls~N~l~~l~~---------~~~~l~~-------------------------L~~L~l~~N~l~~l~~~~~~~l~~  125 (290)
T 1p9a_G           80 GTLDLSHNQLQSLPL---------LGQTLPA-------------------------LTVLDVSFNRLTSLPLGALRGLGE  125 (290)
T ss_dssp             CEEECCSSCCSSCCC---------CTTTCTT-------------------------CCEEECCSSCCCCCCSSTTTTCTT
T ss_pred             CEEECCCCcCCcCch---------hhccCCC-------------------------CCEEECCCCcCcccCHHHHcCCCC
Confidence            555555555443311         1222333                         333333333333333344555555


Q ss_pred             CCeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeeeecCCcccccCCCCCcEEcCC
Q 039957          193 LIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGS  272 (481)
Q Consensus       193 L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~  272 (481)
                      |++|++++|++++..+..|..+++|+.|++++|++++..+..|..+++|+.|++++|+++ .+|..+..+.+|+.+++++
T Consensus       126 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~  204 (290)
T 1p9a_G          126 LQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHG  204 (290)
T ss_dssp             CCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCS
T ss_pred             CCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCC
Confidence            555555555555444444455555555555555555444444455555555555555555 3344444445555555555


Q ss_pred             CcCc
Q 039957          273 NKLT  276 (481)
Q Consensus       273 N~l~  276 (481)
                      |.+.
T Consensus       205 Np~~  208 (290)
T 1p9a_G          205 NPWL  208 (290)
T ss_dssp             CCBC
T ss_pred             CCcc
Confidence            5543

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.93  E-value=7.3e-25  Score=207.17  Aligned_cols=205  Identities=23%  Similarity=0.180  Sum_probs=143.4

Q ss_pred             ccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEccCCceeecCCc
Q 039957          106 FGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPK  185 (481)
Q Consensus       106 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~  185 (481)
                      ++++++++++++++|.++.++...           .+.+++|+|++|.+++..|..+..+ ++|+.|++++|.+++..+.
T Consensus         6 ~~~l~~l~~l~~~~~~l~~ip~~~-----------~~~l~~L~L~~N~l~~~~~~~~~~l-~~L~~L~L~~n~l~~~~~~   73 (290)
T 1p9a_G            6 VSKVASHLEVNCDKRNLTALPPDL-----------PKDTTILHLSENLLYTFSLATLMPY-TRLTQLNLDRAELTKLQVD   73 (290)
T ss_dssp             EECSTTCCEEECTTSCCSSCCSCC-----------CTTCCEEECTTSCCSEEEGGGGTTC-TTCCEEECTTSCCCEEECC
T ss_pred             ccccCCccEEECCCCCCCcCCCCC-----------CCCCCEEEcCCCcCCccCHHHhhcC-CCCCEEECCCCccCcccCC
Confidence            444555555555555555443211           1345556666666655555555554 4566666666666643322


Q ss_pred             ccccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeeeecCCcccccCCCC
Q 039957          186 EIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSL  265 (481)
Q Consensus       186 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  265 (481)
                        +.+++|++|++++|+++ .+|..+..+++|+.|++++|++++..|..|..+++|+.|++++|++++.++..|..+++|
T Consensus        74 --~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  150 (290)
T 1p9a_G           74 --GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKL  150 (290)
T ss_dssp             --SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTC
T ss_pred             --CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCC
Confidence              56677777777777776 566677777788888888888887777778888888888888888887777777888888


Q ss_pred             CcEEcCCCcCcccCCcchhccccCcEEEccCcccCCCCCCccccCCcCcEEEccCCeeeee
Q 039957          266 RELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGD  326 (481)
Q Consensus       266 ~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~  326 (481)
                      +.|++++|++++..+..+..++.|+.|++++|+++ .+|..+.....|+.+++++|++.+.
T Consensus       151 ~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~  210 (290)
T 1p9a_G          151 EKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCN  210 (290)
T ss_dssp             CEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred             CEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCc
Confidence            88888888888666666777888888888888887 4677777778899999999998754

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.93  E-value=1.5e-27  Score=233.33  Aligned_cols=259  Identities=17%  Similarity=0.152  Sum_probs=161.8

Q ss_pred             eeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccC----hhhhcCCC-CccEEEccCccceeecchhcccc-----c
Q 039957           17 SLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLP----SMIGHSLP-NIKYLELGDNNLIGTIPNSITNA-----T   86 (481)
Q Consensus        17 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p----~~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l-----~   86 (481)
                      .++|++|++++.+|..+...++|++|+|++|.+++..+    ..+ ..++ +|++|+|++|++++..+..+..+     +
T Consensus         2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l-~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~   80 (362)
T 3goz_A            2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAF-ANTPASVTSLNLSGNSLGFKNSDELVQILAAIPA   80 (362)
T ss_dssp             EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHH-HTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCT
T ss_pred             ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHH-HhCCCceeEEECcCCCCCHHHHHHHHHHHhccCC
Confidence            35778888888777766666668888888888874333    333 3567 78888888888877767666665     7


Q ss_pred             cCceeecccCcceecCcccccC----C-CCCCEEEcccccCccccCCCccccccccCCC-CCCCcEEEccCCccceeCCh
Q 039957           87 KLIILDLGFNTFSGHIPNTFGN----L-RHLSVLSLLMNNLTTESSSAYQWSFLSSLTN-CRYLVYLILSGNPLGGILPP  160 (481)
Q Consensus        87 ~L~~L~Ls~N~l~~~~p~~~~~----l-~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~-l~~L~~L~Ls~N~l~~~~p~  160 (481)
                      +|++|+|++|.+++..+..+..    + ++|++|++++|.++......+    ...+.. .++|++|+|++|.+++..+.
T Consensus        81 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l----~~~l~~~~~~L~~L~Ls~N~l~~~~~~  156 (362)
T 3goz_A           81 NVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEF----KQAFSNLPASITSLNLRGNDLGIKSSD  156 (362)
T ss_dssp             TCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHH----HHHHTTSCTTCCEEECTTSCGGGSCHH
T ss_pred             CccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHH----HHHHHhCCCceeEEEccCCcCCHHHHH
Confidence            8888888888887766664433    3 788888888888776532221    122333 25788888888888753333


Q ss_pred             h----hhhcccCccEEEccCCceeecCCcccc----cC-CCCCeEecccccceec----CCcCCcC-CCCCCeeecCCCc
Q 039957          161 S----IGNFSTSLQRFSASECKLKGTIPKEIG----HL-RGLIYLSLGFNDLNGT----IPTSIGT-LKQLQGFFLPETN  226 (481)
Q Consensus       161 ~----~~~~~~~L~~L~l~~n~l~~~~p~~~~----~l-~~L~~L~l~~N~l~~~----~p~~~~~-l~~L~~l~l~~n~  226 (481)
                      .    +.....+|++|++++|++++..+..++    .+ ++|++|++++|.++..    ++..+.. .++|+.|++++|.
T Consensus       157 ~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~  236 (362)
T 3goz_A          157 ELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNC  236 (362)
T ss_dssp             HHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSC
T ss_pred             HHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCC
Confidence            2    333333677888888877755554443    33 4777788887777642    3333433 3466667776666


Q ss_pred             CCCCCC----ccccCccCCCeeecCCCeeeecC-------CcccccCCCCCcEEcCCCcCcccCC
Q 039957          227 LQGYVP----HNLCHLEMLNLLHLGGNKLSGHI-------PPCLASLTSLRELDLGSNKLTSSIP  280 (481)
Q Consensus       227 l~~~~p----~~~~~l~~L~~L~L~~N~l~~~~-------p~~~~~l~~L~~L~ls~N~l~~~~p  280 (481)
                      +++..+    ..+..++.|+.|++++|.+.+..       +..+..+++|+.||+++|++....+
T Consensus       237 l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~  301 (362)
T 3goz_A          237 LHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHS  301 (362)
T ss_dssp             CCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGC
T ss_pred             CCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcch
Confidence            665433    22345566666666666643222       2244555666666666666654433

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=99.93  E-value=5.6e-26  Score=211.02  Aligned_cols=134  Identities=29%  Similarity=0.450  Sum_probs=109.8

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      .++|+||.||++.. .+|..||+|.+....   ......+.+|++++++++|||||++++++.+.+     +||+ +|+|
T Consensus        21 lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L   99 (275)
T 3hyh_A           21 LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNEL   99 (275)
T ss_dssp             EEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEH
T ss_pred             EecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCH
Confidence            47899999999985 468999999987543   223456889999999999999999999988765     6788 6899


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      .+++... ..++..+...++.||+.||+|||    +.+|+||||||+|||+++++.+||+|||+|+...
T Consensus       100 ~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH----~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~  163 (275)
T 3hyh_A          100 FDYIVQR-DKMSEQEARRFFQQIISAVEYCH----RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT  163 (275)
T ss_dssp             HHHHHHS-CSCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred             HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH----HCCcccccCChHHeEECCCCCEEEeecCCCeecC
Confidence            9988754 35788899999999999999999    6789999999999999999999999999998653

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.92  E-value=4.2e-26  Score=218.19  Aligned_cols=230  Identities=16%  Similarity=0.149  Sum_probs=183.4

Q ss_pred             CCCCeeeCcCCcccccCCh---hccCCcCCCEEEeeCCcCccccChhhh-cCCCCccEEEccCccceeecc----hhccc
Q 039957           13 QNLKSLFLGANNLSGLIPP---MIFNISTIRNLNLGGNRLSGHLPSMIG-HSLPNIKYLELGDNNLIGTIP----NSITN   84 (481)
Q Consensus        13 ~~L~~L~L~~N~l~~~~p~---~~~~l~~L~~L~L~~N~l~~~~p~~~~-~~l~~L~~L~L~~N~l~~~~p----~~~~~   84 (481)
                      ..++.|.+.++.++...-.   .+..+++|++|++++|++++..|..++ ..+++|++|+|++|++++..+    ..+..
T Consensus        64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~  143 (310)
T 4glp_A           64 LRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWL  143 (310)
T ss_dssp             CCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTB
T ss_pred             cceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhh
Confidence            3578888888877532111   133456799999999999988888763 479999999999999987655    44567


Q ss_pred             cccCceeecccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCCh---h
Q 039957           85 ATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPP---S  161 (481)
Q Consensus        85 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~---~  161 (481)
                      +++|++|+|++|.+++..|..|+.+++|++|+|++|++.+....+    ....+..+++|++|+|++|+++.. +.   .
T Consensus       144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~----~~~~~~~l~~L~~L~Ls~N~l~~l-~~~~~~  218 (310)
T 4glp_A          144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLM----AALCPHKFPAIQNLALRNTGMETP-TGVCAA  218 (310)
T ss_dssp             CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHH----TTSCTTSSCCCCSCBCCSSCCCCH-HHHHHH
T ss_pred             ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhh----HHHhhhcCCCCCEEECCCCCCCch-HHHHHH
Confidence            999999999999999999999999999999999999987531100    012235788999999999999732 22   2


Q ss_pred             -hhhcccCccEEEccCCceeecCCcccccC---CCCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccC
Q 039957          162 -IGNFSTSLQRFSASECKLKGTIPKEIGHL---RGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCH  237 (481)
Q Consensus       162 -~~~~~~~L~~L~l~~n~l~~~~p~~~~~l---~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~  237 (481)
                       +..+ ++|++|++++|++++..|..+..+   ++|++|++++|+++ .+|..+.  ++|+.|++++|++++. |. +..
T Consensus       219 l~~~l-~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~  292 (310)
T 4glp_A          219 LAAAG-VQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDE  292 (310)
T ss_dssp             HHHHT-CCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTS
T ss_pred             HHhcC-CCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhh
Confidence             2344 689999999999998888888776   69999999999999 6777775  7999999999999985 33 678


Q ss_pred             ccCCCeeecCCCeeee
Q 039957          238 LEMLNLLHLGGNKLSG  253 (481)
Q Consensus       238 l~~L~~L~L~~N~l~~  253 (481)
                      +++|+.|++++|+++.
T Consensus       293 l~~L~~L~L~~N~l~~  308 (310)
T 4glp_A          293 LPEVDNLTLDGNPFLV  308 (310)
T ss_dssp             CCCCSCEECSSTTTSC
T ss_pred             CCCccEEECcCCCCCC
Confidence            8999999999999863

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=99.92  E-value=2e-26  Score=217.01  Aligned_cols=135  Identities=29%  Similarity=0.361  Sum_probs=110.1

Q ss_pred             hhccccccceeeeecc----CCcceEEEEEeccch--hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccC
Q 039957          340 ISLAGSFGSVYKGTIS----DGTDVAIKIFNLQRE--RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPN  408 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~----~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~  408 (481)
                      ..|+|+||.||++...    .+..||+|.+.....  .....+.+|++++++++|||||++++++.+.+     +||+++
T Consensus        31 ~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~g  110 (304)
T 3ubd_A           31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRG  110 (304)
T ss_dssp             EEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEECCCTT
T ss_pred             EEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCC
Confidence            3489999999999742    367899999875432  23346788999999999999999999988765     789999


Q ss_pred             CChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          409 GSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       409 g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      |+|.+++... ..++..+...++.||+.||+|||    +.+||||||||+|||+++++++||+|||+|+..
T Consensus       111 g~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH----~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~  176 (304)
T 3ubd_A          111 GDLFTRLSKE-VMFTEEDVKFYLAELALALDHLH----SLGIIYRDLKPENILLDEEGHIKLTDFGLSKES  176 (304)
T ss_dssp             CEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred             CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH----HCCCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence            9999998753 35778888999999999999999    678999999999999999999999999999864

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.92  E-value=1.4e-25  Score=214.65  Aligned_cols=225  Identities=22%  Similarity=0.226  Sum_probs=184.0

Q ss_pred             CcCCCEEEeeCCcCccc----cChhhhcCCCCccEEEccCccceeecchhc--cccccCceeecccCcceecCc----cc
Q 039957           36 ISTIRNLNLGGNRLSGH----LPSMIGHSLPNIKYLELGDNNLIGTIPNSI--TNATKLIILDLGFNTFSGHIP----NT  105 (481)
Q Consensus        36 l~~L~~L~L~~N~l~~~----~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~--~~l~~L~~L~Ls~N~l~~~~p----~~  105 (481)
                      ...++.|.+.++.++..    ++...  .+++|++|++++|.+++..|..+  ..+++|++|+|++|.+++..|    ..
T Consensus        63 ~~~l~~l~l~~~~~~~~~~~~~~~~~--~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~  140 (310)
T 4glp_A           63 ALRVRRLTVGAAQVPAQLLVGALRVL--AYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQ  140 (310)
T ss_dssp             SCCCCEEEECSCCCBHHHHHHHHHHH--HHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHH
T ss_pred             hcceeEEEEeCCcCCHHHHHHHHHhc--ccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHH
Confidence            34578999999887631    12222  35779999999999999999988  999999999999999997655    45


Q ss_pred             ccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCcccee---CChh-hhhcccCccEEEccCCceee
Q 039957          106 FGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGI---LPPS-IGNFSTSLQRFSASECKLKG  181 (481)
Q Consensus       106 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~---~p~~-~~~~~~~L~~L~l~~n~l~~  181 (481)
                      +..+++|++|++++|.++++++        ..+..+++|++|+|++|++.+.   .+.. +..+ ++|++|++++|+++.
T Consensus       141 ~~~~~~L~~L~Ls~n~l~~~~~--------~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l-~~L~~L~Ls~N~l~~  211 (310)
T 4glp_A          141 QWLKPGLKVLSIAQAHSPAFSC--------EQVRAFPALTSLDLSDNPGLGERGLMAALCPHKF-PAIQNLALRNTGMET  211 (310)
T ss_dssp             TTBCSCCCEEEEECCSSCCCCT--------TSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSS-CCCCSCBCCSSCCCC
T ss_pred             hhhccCCCEEEeeCCCcchhhH--------HHhccCCCCCEEECCCCCCccchhhhHHHhhhcC-CCCCEEECCCCCCCc
Confidence            6789999999999999988754        3467889999999999998652   2222 2344 689999999999973


Q ss_pred             cCCc----ccccCCCCCeEecccccceecCCcCCcCC---CCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeeeec
Q 039957          182 TIPK----EIGHLRGLIYLSLGFNDLNGTIPTSIGTL---KQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGH  254 (481)
Q Consensus       182 ~~p~----~~~~l~~L~~L~l~~N~l~~~~p~~~~~l---~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  254 (481)
                       +|.    .+..+++|++|++++|++++..|..+..+   ++|+.|++++|+++. +|..+.  ++|+.|++++|++++.
T Consensus       212 -l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~~-lp~~~~--~~L~~L~Ls~N~l~~~  287 (310)
T 4glp_A          212 -PTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLEQ-VPKGLP--AKLRVLDLSSNRLNRA  287 (310)
T ss_dssp             -HHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCCS-CCSCCC--SCCSCEECCSCCCCSC
T ss_pred             -hHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCCc-hhhhhc--CCCCEEECCCCcCCCC
Confidence             333    35788999999999999998888888877   699999999999994 566664  7999999999999975


Q ss_pred             CCcccccCCCCCcEEcCCCcCcc
Q 039957          255 IPPCLASLTSLRELDLGSNKLTS  277 (481)
Q Consensus       255 ~p~~~~~l~~L~~L~ls~N~l~~  277 (481)
                       |. +..+++|+.|++++|+++.
T Consensus       288 -~~-~~~l~~L~~L~L~~N~l~~  308 (310)
T 4glp_A          288 -PQ-PDELPEVDNLTLDGNPFLV  308 (310)
T ss_dssp             -CC-TTSCCCCSCEECSSTTTSC
T ss_pred             -ch-hhhCCCccEEECcCCCCCC
Confidence             33 6888999999999999874

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.92  E-value=2.3e-26  Score=222.58  Aligned_cols=253  Identities=18%  Similarity=0.171  Sum_probs=152.4

Q ss_pred             CCeeeCcCCcccccCChhccCC--cCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceee-cchhccccccCcee
Q 039957           15 LKSLFLGANNLSGLIPPMIFNI--STIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGT-IPNSITNATKLIIL   91 (481)
Q Consensus        15 L~~L~L~~N~l~~~~p~~~~~l--~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L   91 (481)
                      ++.+|+++|.+.   |..+..+  ++++.|++++|.+++..+. ++ .+++|++|++++|.+++. +|..+..+++|++|
T Consensus        49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~-~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L  123 (336)
T 2ast_B           49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HF-SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNL  123 (336)
T ss_dssp             SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CC-CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEE
T ss_pred             heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hc-cCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEE
Confidence            677777777765   4556666  7777888888777755444 33 577788888887777655 66677777778888


Q ss_pred             ecccCcceecCcccccCCCCCCEEEcccc-cCccccCCCccccccccCCCCCCCcEEEccCC-cccee-CChhhhhcccC
Q 039957           92 DLGFNTFSGHIPNTFGNLRHLSVLSLLMN-NLTTESSSAYQWSFLSSLTNCRYLVYLILSGN-PLGGI-LPPSIGNFSTS  168 (481)
Q Consensus        92 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N-~l~~~-~p~~~~~~~~~  168 (481)
                      ++++|.+++..|..|+.+++|++|++++| .++...       .+..+.++++|++|++++| .+++. ++..+..+..+
T Consensus       124 ~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~-------l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~  196 (336)
T 2ast_B          124 SLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFA-------LQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSET  196 (336)
T ss_dssp             ECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHH-------HHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTT
T ss_pred             eCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHH-------HHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccC
Confidence            88877777777777777777777777777 455310       1122345666777777777 66643 34445444226


Q ss_pred             ccEEEccCC--cee-ecCCcccccCCCCCeEeccccc-ceecCCcCCcCCCCCCeeecCCCc-CCCCCCccccCccCCCe
Q 039957          169 LQRFSASEC--KLK-GTIPKEIGHLRGLIYLSLGFND-LNGTIPTSIGTLKQLQGFFLPETN-LQGYVPHNLCHLEMLNL  243 (481)
Q Consensus       169 L~~L~l~~n--~l~-~~~p~~~~~l~~L~~L~l~~N~-l~~~~p~~~~~l~~L~~l~l~~n~-l~~~~p~~~~~l~~L~~  243 (481)
                      |++|++++|  .++ +.+|..+..+++|++|++++|. +++..+..+..+++|+.|++++|. +.......+..+++|+.
T Consensus       197 L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~  276 (336)
T 2ast_B          197 ITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKT  276 (336)
T ss_dssp             CCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCE
T ss_pred             CCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCE
Confidence            777777776  343 3455555666666777766666 554555556666666666666653 11111113445555555


Q ss_pred             eecCCCeeeecCCcccccCC-CCCcEEcCCCcCcccCCcch
Q 039957          244 LHLGGNKLSGHIPPCLASLT-SLRELDLGSNKLTSSIPSSL  283 (481)
Q Consensus       244 L~L~~N~l~~~~p~~~~~l~-~L~~L~ls~N~l~~~~p~~~  283 (481)
                      |++++| +   ....+..+. +++.|++++|++++..|..+
T Consensus       277 L~l~~~-i---~~~~~~~l~~~l~~L~l~~n~l~~~~~~~~  313 (336)
T 2ast_B          277 LQVFGI-V---PDGTLQLLKEALPHLQINCSHFTTIARPTI  313 (336)
T ss_dssp             EECTTS-S---CTTCHHHHHHHSTTSEESCCCSCCTTCSSC
T ss_pred             EeccCc-c---CHHHHHHHHhhCcceEEecccCccccCCcc
Confidence            555555 1   122233332 25555555555555554443

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.92  E-value=1.9e-24  Score=198.60  Aligned_cols=205  Identities=16%  Similarity=0.194  Sum_probs=136.0

Q ss_pred             CccccChhhhcCCCCccEEEccCccceeecchhccccccCceeecccCc-ceecCcccccCCCCCCEEEccc-ccCcccc
Q 039957           49 LSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNT-FSGHIPNTFGNLRHLSVLSLLM-NNLTTES  126 (481)
Q Consensus        49 l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~  126 (481)
                      ++ .+|. +.   ++|++|++++|++++..+..|.++++|++|++++|. ++++.+..|.++++|++|++++ |+++.++
T Consensus        23 l~-~ip~-~~---~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~   97 (239)
T 2xwt_C           23 IQ-RIPS-LP---PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYID   97 (239)
T ss_dssp             CS-SCCC-CC---TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEEC
T ss_pred             cc-ccCC-CC---CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcC
Confidence            54 5665 32   367777777777776666677777777777777775 7666666777777777777776 7777664


Q ss_pred             CCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCcc---EEEccCC-ceeecCCcccccCCCCC-eEecccc
Q 039957          127 SSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQ---RFSASEC-KLKGTIPKEIGHLRGLI-YLSLGFN  201 (481)
Q Consensus       127 ~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~---~L~l~~n-~l~~~~p~~~~~l~~L~-~L~l~~N  201 (481)
                      ...        +.++++|++|++++|.+++ +|+ +..+ ++|+   .|++++| .+++..+..|.++++|+ +|++++|
T Consensus        98 ~~~--------f~~l~~L~~L~l~~n~l~~-lp~-~~~l-~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n  166 (239)
T 2xwt_C           98 PDA--------LKELPLLKFLGIFNTGLKM-FPD-LTKV-YSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNN  166 (239)
T ss_dssp             TTS--------EECCTTCCEEEEEEECCCS-CCC-CTTC-CBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSC
T ss_pred             HHH--------hCCCCCCCEEeCCCCCCcc-ccc-cccc-cccccccEEECCCCcchhhcCcccccchhcceeEEEcCCC
Confidence            333        3456677777777777765 444 4444 4565   7777777 77766666677777777 7777777


Q ss_pred             cceecCCcCCcCCCCCCeeecCCCc-CCCCCCccccCc-cCCCeeecCCCeeeecCCcccccCCCCCcEEcCCC
Q 039957          202 DLNGTIPTSIGTLKQLQGFFLPETN-LQGYVPHNLCHL-EMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSN  273 (481)
Q Consensus       202 ~l~~~~p~~~~~l~~L~~l~l~~n~-l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N  273 (481)
                      +++...+..|.. ++|+.|++++|+ +++..+..|..+ ++|+.|++++|++++.++.   .+++|+.|+++++
T Consensus       167 ~l~~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~  236 (239)
T 2xwt_C          167 GFTSVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNT  236 (239)
T ss_dssp             CCCEECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC
T ss_pred             CCcccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCc
Confidence            776333333433 677777777773 776666667777 7777777777777654333   4556777777665

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.92  E-value=6.2e-27  Score=228.96  Aligned_cols=266  Identities=16%  Similarity=0.145  Sum_probs=165.7

Q ss_pred             EEEeeCCcCccccChhhhcCCCCccEEEccCccceeecc----hhccccc-cCceeecccCcceecCcccccCC-----C
Q 039957           41 NLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIP----NSITNAT-KLIILDLGFNTFSGHIPNTFGNL-----R  110 (481)
Q Consensus        41 ~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p----~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l-----~  110 (481)
                      .++++.|.++|.+|..+. ..++|++|+|++|.+++..+    ..|..++ +|++|+|++|.+++..+..|..+     +
T Consensus         2 ~~~ls~n~~~~~~~~~~~-~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~   80 (362)
T 3goz_A            2 NYKLTLHPGSNPVEEFTS-IPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPA   80 (362)
T ss_dssp             EEECCCCTTCCHHHHHHT-SCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCT
T ss_pred             ccccccccchHHHHHHHh-CCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCC
Confidence            467888999887777664 45569999999999887666    6777787 89999999999888777777765     8


Q ss_pred             CCCEEEcccccCccccCCCccccccccCCCC-CCCcEEEccCCccceeCChhhhhc----ccCccEEEccCCceeec---
Q 039957          111 HLSVLSLLMNNLTTESSSAYQWSFLSSLTNC-RYLVYLILSGNPLGGILPPSIGNF----STSLQRFSASECKLKGT---  182 (481)
Q Consensus       111 ~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l-~~L~~L~Ls~N~l~~~~p~~~~~~----~~~L~~L~l~~n~l~~~---  182 (481)
                      +|++|+|++|.++......+    ...+..+ ++|++|+|++|++++..+..+...    .++|++|++++|.++..   
T Consensus        81 ~L~~L~Ls~n~l~~~~~~~l----~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~  156 (362)
T 3goz_A           81 NVTSLNLSGNFLSYKSSDEL----VKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSD  156 (362)
T ss_dssp             TCCEEECCSSCGGGSCHHHH----HHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHH
T ss_pred             CccEEECcCCcCChHHHHHH----HHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHH
Confidence            88888888888876532211    1123334 678888888888876555444432    23566777777666532   


Q ss_pred             -CCcccccCC-CCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCc-cCCCeeecCCCeeeec----C
Q 039957          183 -IPKEIGHLR-GLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHL-EMLNLLHLGGNKLSGH----I  255 (481)
Q Consensus       183 -~p~~~~~l~-~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l-~~L~~L~L~~N~l~~~----~  255 (481)
                       ++..+..++ +|++|++++|++++..+..+..                    .+... ++|+.|+|++|++++.    +
T Consensus       157 ~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~--------------------~l~~~~~~L~~L~Ls~N~i~~~~~~~l  216 (362)
T 3goz_A          157 ELIQILAAIPANVNSLNLRGNNLASKNCAELAK--------------------FLASIPASVTSLDLSANLLGLKSYAEL  216 (362)
T ss_dssp             HHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHH--------------------HHHTSCTTCCEEECTTSCGGGSCHHHH
T ss_pred             HHHHHHhcCCccccEeeecCCCCchhhHHHHHH--------------------HHHhCCCCCCEEECCCCCCChhHHHHH
Confidence             222233333 5555555555554333322211                    11122 3555666666655531    2


Q ss_pred             Cccccc-CCCCCcEEcCCCcCcccCCc----chhccccCcEEEccCcccCCCC-------CCccccCCcCcEEEccCCee
Q 039957          256 PPCLAS-LTSLRELDLGSNKLTSSIPS----SLWSLGYILEINLSSNLLNDSL-------PSNVQKLKVLRVLDLSRNQL  323 (481)
Q Consensus       256 p~~~~~-l~~L~~L~ls~N~l~~~~p~----~~~~l~~L~~L~l~~N~l~~~~-------p~~~~~l~~L~~L~l~~N~l  323 (481)
                      +..+.. .++|++|++++|++++..+.    .+..++.|++|++++|.+.+..       +..+..++.|+.||+++|++
T Consensus       217 ~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l  296 (362)
T 3goz_A          217 AYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEI  296 (362)
T ss_dssp             HHHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBC
T ss_pred             HHHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcC
Confidence            333444 34677777777766654332    2344566777777777654332       33566788899999999998


Q ss_pred             eeeccccc
Q 039957          324 SGDIPSTI  331 (481)
Q Consensus       324 ~~~~p~~~  331 (481)
                      ....+..+
T Consensus       297 ~~~~~~~~  304 (362)
T 3goz_A          297 HPSHSIPI  304 (362)
T ss_dssp             CGGGCHHH
T ss_pred             CCcchHHH
Confidence            86544443

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.92  E-value=4.8e-27  Score=231.89  Aligned_cols=247  Identities=17%  Similarity=0.225  Sum_probs=160.7

Q ss_pred             CChhccCCcCCCEEEeeCCcCccccChhh---hcCCCCccEEEccCc---cceeecchhc-------cccccCceeeccc
Q 039957           29 IPPMIFNISTIRNLNLGGNRLSGHLPSMI---GHSLPNIKYLELGDN---NLIGTIPNSI-------TNATKLIILDLGF   95 (481)
Q Consensus        29 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~---~~~l~~L~~L~L~~N---~l~~~~p~~~-------~~l~~L~~L~Ls~   95 (481)
                      ++..+..+++|++|+|++|+++...+..+   ...+++|++|+|++|   ++++.+|..+       ..+++|++|+|++
T Consensus        24 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~  103 (386)
T 2ca6_A           24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD  103 (386)
T ss_dssp             TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred             HHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCC
Confidence            44555556666666666666654322221   114566666666664   3333444433       4566666666666


Q ss_pred             Cccee----cCcccccCCCCCCEEEcccccCccccCCCccccccccCCCC---------CCCcEEEccCCccc-eeCC--
Q 039957           96 NTFSG----HIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNC---------RYLVYLILSGNPLG-GILP--  159 (481)
Q Consensus        96 N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l---------~~L~~L~Ls~N~l~-~~~p--  159 (481)
                      |.++.    .+|..+..+++|++|+|++|.++......+    ...+..+         ++|++|+|++|+++ +.+|  
T Consensus       104 n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l----~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l  179 (386)
T 2ca6_A          104 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKI----ARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEW  179 (386)
T ss_dssp             CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHH----HHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHH
T ss_pred             CcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHH----HHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHH
Confidence            66665    355566666677777776666653311111    1112222         56777777777776 2233  


Q ss_pred             -hhhhhcccCccEEEccCCcee--e---cCCcccccCCCCCeEecccccce----ecCCcCCcCCCCCCeeecCCCcCCC
Q 039957          160 -PSIGNFSTSLQRFSASECKLK--G---TIPKEIGHLRGLIYLSLGFNDLN----GTIPTSIGTLKQLQGFFLPETNLQG  229 (481)
Q Consensus       160 -~~~~~~~~~L~~L~l~~n~l~--~---~~p~~~~~l~~L~~L~l~~N~l~----~~~p~~~~~l~~L~~l~l~~n~l~~  229 (481)
                       ..+..+ ++|++|++++|+++  |   ..|..+..+++|++|+|++|.++    +.+|..+..+++|+.|++++|.+++
T Consensus       180 ~~~l~~~-~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~  258 (386)
T 2ca6_A          180 AKTFQSH-RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSA  258 (386)
T ss_dssp             HHHHHHC-TTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCH
T ss_pred             HHHHHhC-CCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCch
Confidence             233344 46778888887776  2   34446778888888888888885    5677778888888899998888876


Q ss_pred             C----CCccc--cCccCCCeeecCCCeeee----cCCccc-ccCCCCCcEEcCCCcCcccCC
Q 039957          230 Y----VPHNL--CHLEMLNLLHLGGNKLSG----HIPPCL-ASLTSLRELDLGSNKLTSSIP  280 (481)
Q Consensus       230 ~----~p~~~--~~l~~L~~L~L~~N~l~~----~~p~~~-~~l~~L~~L~ls~N~l~~~~p  280 (481)
                      .    ++..+  +.+++|+.|+|++|.+++    .+|..+ .++++|+.|++++|++++..+
T Consensus       259 ~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~  320 (386)
T 2ca6_A          259 RGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD  320 (386)
T ss_dssp             HHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred             hhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence            5    45555  348899999999999987    467766 668999999999999987664

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.92  E-value=3.5e-27  Score=246.22  Aligned_cols=331  Identities=12%  Similarity=0.043  Sum_probs=180.7

Q ss_pred             CCCeeeCcCCc-ccc-cCChhccCCcCCCEEEeeCCcCccc----cChhhhcCCCCccEEEccCccce----eecchhcc
Q 039957           14 NLKSLFLGANN-LSG-LIPPMIFNISTIRNLNLGGNRLSGH----LPSMIGHSLPNIKYLELGDNNLI----GTIPNSIT   83 (481)
Q Consensus        14 ~L~~L~L~~N~-l~~-~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~~l~~L~~L~L~~N~l~----~~~p~~~~   83 (481)
                      +|++|+|++|. ++. .++....++++|++|+|++|.+++.    ++... ..+++|++|++++|.++    +.++..+.
T Consensus       139 ~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~-~~~~~L~~L~L~~n~~~~~~~~~l~~~~~  217 (592)
T 3ogk_B          139 DLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELA-QHNTSLEVLNFYMTEFAKISPKDLETIAR  217 (592)
T ss_dssp             GCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHH-HHCCCCCEEECTTCCCSSCCHHHHHHHHH
T ss_pred             cCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHH-hcCCCccEEEeeccCCCccCHHHHHHHHh
Confidence            37777777765 211 1222234667777777777776543    22222 25677777777777765    33444556


Q ss_pred             ccccCceeecccCcceecCcccccCCCCCCEEEcccccCccccCCCc------------------cccccccCCCCCCCc
Q 039957           84 NATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAY------------------QWSFLSSLTNCRYLV  145 (481)
Q Consensus        84 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~------------------~~~~~~~l~~l~~L~  145 (481)
                      ++++|+.|++++|.+.+ +|..+.++++|++|+++.+.........+                  ....+..+..+++|+
T Consensus       218 ~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~l~~~~~~~~~L~  296 (592)
T 3ogk_B          218 NCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIR  296 (592)
T ss_dssp             HCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTTTGGGGGGGGGGCC
T ss_pred             hCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccchhHHHHHHhhcCCCc
Confidence            67777777777777764 55667777777777776422110000000                  000112233455566


Q ss_pred             EEEccCCccceeCChhhhhcccCccEEEccCCceeecCCcccccCCCCCeEecc-----------cccceec-CCcCCcC
Q 039957          146 YLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLG-----------FNDLNGT-IPTSIGT  213 (481)
Q Consensus       146 ~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~-----------~N~l~~~-~p~~~~~  213 (481)
                      +|+|++|.+++.....+....++|++|+++++...+.++..+..+++|++|+++           .|.++.. ++..+..
T Consensus       297 ~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~  376 (592)
T 3ogk_B          297 KLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQG  376 (592)
T ss_dssp             EEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHH
T ss_pred             EEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhh
Confidence            666666665433222211112456666666332222333333455666666666           2444322 1112234


Q ss_pred             CCCCCeeecCCCcCCCCCCccccC-ccCCCeeecC----CCeeeec-----CCcccccCCCCCcEEcCCCc--CcccCCc
Q 039957          214 LKQLQGFFLPETNLQGYVPHNLCH-LEMLNLLHLG----GNKLSGH-----IPPCLASLTSLRELDLGSNK--LTSSIPS  281 (481)
Q Consensus       214 l~~L~~l~l~~n~l~~~~p~~~~~-l~~L~~L~L~----~N~l~~~-----~p~~~~~l~~L~~L~ls~N~--l~~~~p~  281 (481)
                      +++|+.|+++.|.+++..+..+.. +++|+.|+++    .|.+++.     ++..+..+++|+.|++++|.  +++..+.
T Consensus       377 ~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~  456 (592)
T 3ogk_B          377 CQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLS  456 (592)
T ss_dssp             CTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHH
T ss_pred             CccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHH
Confidence            566677776666666554444443 6667777774    5566542     22235556777777776433  4444333


Q ss_pred             chh-ccccCcEEEccCcccCC-CCCCccccCCcCcEEEccCCeeeee-ccccccccCChhhhhccccc
Q 039957          282 SLW-SLGYILEINLSSNLLND-SLPSNVQKLKVLRVLDLSRNQLSGD-IPSTIGALVDLETISLAGSF  346 (481)
Q Consensus       282 ~~~-~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~-~p~~~~~l~~L~~l~~~g~~  346 (481)
                      .+. .++.|++|++++|.+++ .++..+..+++|++|++++|+++.. ++..+..+++|++|+++++.
T Consensus       457 ~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~  524 (592)
T 3ogk_B          457 YIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYR  524 (592)
T ss_dssp             HHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCB
T ss_pred             HHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCc
Confidence            333 26677777777777764 2344456677788888888877543 33444567777777776654

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.91  E-value=4.4e-24  Score=207.64  Aligned_cols=240  Identities=16%  Similarity=0.111  Sum_probs=149.3

Q ss_pred             CeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecc-hhccccccCce-eec
Q 039957           16 KSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIP-NSITNATKLII-LDL   93 (481)
Q Consensus        16 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~-L~L   93 (481)
                      ++++.++++++. +|..+  .+++++|+|++|+|+ .+|+..+..+++|++|+|++|++.+.+| .+|.++++|.. +++
T Consensus        12 ~~v~C~~~~Lt~-iP~~l--~~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~   87 (350)
T 4ay9_X           12 RVFLCQESKVTE-IPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE   87 (350)
T ss_dssp             TEEEEESTTCCS-CCTTC--CTTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEE
T ss_pred             CEEEecCCCCCc-cCcCc--CCCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcc
Confidence            567788888874 45544  357888888888887 6776555578888888888888766555 46778877664 566


Q ss_pred             ccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccC-CccceeCChhhhhcccCccEE
Q 039957           94 GFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSG-NPLGGILPPSIGNFSTSLQRF  172 (481)
Q Consensus        94 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~-N~l~~~~p~~~~~~~~~L~~L  172 (481)
                      ++|+++.+.|..|..+++|++|++++|+++.++...        .....++..|++.+ |++....+..|......++.|
T Consensus        88 ~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~--------~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L  159 (350)
T 4ay9_X           88 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVH--------KIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVIL  159 (350)
T ss_dssp             EETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCT--------TCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEE
T ss_pred             cCCcccccCchhhhhccccccccccccccccCCchh--------hcccchhhhhhhccccccccccccchhhcchhhhhh
Confidence            778888888888888888888888888887765433        22344566777755 456555455555544456667


Q ss_pred             EccCCceeecCCcccccCCCCCeEeccc-ccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCee
Q 039957          173 SASECKLKGTIPKEIGHLRGLIYLSLGF-NDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKL  251 (481)
Q Consensus       173 ~l~~n~l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l  251 (481)
                      ++++|+++. +|.......+|+.+++++ |.++...+..|..+++|+.|++++|+++...+..|.+++.|+.+++  +.+
T Consensus       160 ~L~~N~i~~-i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~--~~l  236 (350)
T 4ay9_X          160 WLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNL  236 (350)
T ss_dssp             ECCSSCCCE-ECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTTC--TTC
T ss_pred             ccccccccC-CChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhccC--CCc
Confidence            777777664 333333345566666653 4444333345566666666666666666554444444444433332  222


Q ss_pred             eecCCcccccCCCCCcEEcCC
Q 039957          252 SGHIPPCLASLTSLRELDLGS  272 (481)
Q Consensus       252 ~~~~p~~~~~l~~L~~L~ls~  272 (481)
                      + .+| .+..+++|+.+++++
T Consensus       237 ~-~lP-~l~~l~~L~~l~l~~  255 (350)
T 4ay9_X          237 K-KLP-TLEKLVALMEASLTY  255 (350)
T ss_dssp             C-CCC-CTTTCCSCCEEECSC
T ss_pred             C-cCC-CchhCcChhhCcCCC
Confidence            2 233 245555555555544

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.91  E-value=2.3e-26  Score=226.98  Aligned_cols=249  Identities=20%  Similarity=0.230  Sum_probs=143.0

Q ss_pred             ccChhhhcCCCCccEEEccCccceeecc----hhccccccCceeecccC---cceecCcccc-------cCCCCCCEEEc
Q 039957           52 HLPSMIGHSLPNIKYLELGDNNLIGTIP----NSITNATKLIILDLGFN---TFSGHIPNTF-------GNLRHLSVLSL  117 (481)
Q Consensus        52 ~~p~~~~~~l~~L~~L~L~~N~l~~~~p----~~~~~l~~L~~L~Ls~N---~l~~~~p~~~-------~~l~~L~~L~L  117 (481)
                      .++..+. .+++|++|+|++|+++...+    ..+..+++|++|+|++|   ++++.+|..+       ..+++|++|+|
T Consensus        23 ~l~~~l~-~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~L  101 (386)
T 2ca6_A           23 SVFAVLL-EDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRL  101 (386)
T ss_dssp             TTSHHHH-HCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEEC
T ss_pred             HHHHHHh-cCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEEC
Confidence            4566665 57888888888888876543    33667888888888885   4455556554       67778888888


Q ss_pred             ccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcc------------cCccEEEccCCcee-ecCC
Q 039957          118 LMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFS------------TSLQRFSASECKLK-GTIP  184 (481)
Q Consensus       118 ~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~------------~~L~~L~l~~n~l~-~~~p  184 (481)
                      ++|.++.....    .++..+..+++|++|+|++|.+++..+..+....            ++|++|++++|+++ +.+|
T Consensus       102 s~n~l~~~~~~----~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~  177 (386)
T 2ca6_A          102 SDNAFGPTAQE----PLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMK  177 (386)
T ss_dssp             CSCCCCTTTHH----HHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHH
T ss_pred             CCCcCCHHHHH----HHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHH
Confidence            88777652110    1123445667777777777777644333333221            34555555555554 2222


Q ss_pred             ---cccccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCC---CCCccccCccCCCeeecCCCeee----ec
Q 039957          185 ---KEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQG---YVPHNLCHLEMLNLLHLGGNKLS----GH  254 (481)
Q Consensus       185 ---~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~---~~p~~~~~l~~L~~L~L~~N~l~----~~  254 (481)
                         ..+..+++|++|++++|+++..                      +   ..|..+..+++|+.|+|++|.++    +.
T Consensus       178 ~l~~~l~~~~~L~~L~L~~n~l~~~----------------------g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~  235 (386)
T 2ca6_A          178 EWAKTFQSHRLLHTVKMVQNGIRPE----------------------GIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSA  235 (386)
T ss_dssp             HHHHHHHHCTTCCEEECCSSCCCHH----------------------HHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHH
T ss_pred             HHHHHHHhCCCcCEEECcCCCCCHh----------------------HHHHHHHHHhhcCCCccEEECcCCCCCcHHHHH
Confidence               2333444555555555544310                      1   22334455555556666666553    34


Q ss_pred             CCcccccCCCCCcEEcCCCcCccc----CCcchh--ccccCcEEEccCcccCC----CCCCcc-ccCCcCcEEEccCCee
Q 039957          255 IPPCLASLTSLRELDLGSNKLTSS----IPSSLW--SLGYILEINLSSNLLND----SLPSNV-QKLKVLRVLDLSRNQL  323 (481)
Q Consensus       255 ~p~~~~~l~~L~~L~ls~N~l~~~----~p~~~~--~l~~L~~L~l~~N~l~~----~~p~~~-~~l~~L~~L~l~~N~l  323 (481)
                      +|..+..+++|++|++++|.+++.    +|..+.  .++.|+.|++++|.+++    .+|..+ .++++|+.|++++|++
T Consensus       236 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l  315 (386)
T 2ca6_A          236 LAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF  315 (386)
T ss_dssp             HHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBS
T ss_pred             HHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcC
Confidence            455555666666666666666543    333442  25666666666666655    345555 4467777777777777


Q ss_pred             eeec
Q 039957          324 SGDI  327 (481)
Q Consensus       324 ~~~~  327 (481)
                      ++..
T Consensus       316 ~~~~  319 (386)
T 2ca6_A          316 SEED  319 (386)
T ss_dssp             CTTS
T ss_pred             Ccch
Confidence            6544

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.91  E-value=8.7e-27  Score=243.18  Aligned_cols=333  Identities=15%  Similarity=0.060  Sum_probs=199.6

Q ss_pred             CCCCCCeeeCcCCcccccCChhccCC--cCCCEEEeeCCc-Ccc-ccChhhhcCCCCccEEEccCccceee----cchhc
Q 039957           11 NLQNLKSLFLGANNLSGLIPPMIFNI--STIRNLNLGGNR-LSG-HLPSMIGHSLPNIKYLELGDNNLIGT----IPNSI   82 (481)
Q Consensus        11 ~l~~L~~L~L~~N~l~~~~p~~~~~l--~~L~~L~L~~N~-l~~-~~p~~~~~~l~~L~~L~L~~N~l~~~----~p~~~   82 (481)
                      .+++|++|+|++|.+++..+..+...  .+|++|+|++|. ++. .++... ..+++|++|+|++|.+++.    ++..+
T Consensus       110 ~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~-~~~~~L~~L~L~~~~~~~~~~~~l~~~~  188 (592)
T 3ogk_B          110 NLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIV-THCRKIKTLLMEESSFSEKDGKWLHELA  188 (592)
T ss_dssp             HCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHH-HHCTTCSEEECTTCEEECCCSHHHHHHH
T ss_pred             hCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHH-hhCCCCCEEECccccccCcchhHHHHHH
Confidence            56777777777777766555555553  337777777775 211 122222 2567788888888877655    34445


Q ss_pred             cccccCceeecccCcce----ecCcccccCCCCCCEEEcccccCccccCCC-------------c-----cccccccCCC
Q 039957           83 TNATKLIILDLGFNTFS----GHIPNTFGNLRHLSVLSLLMNNLTTESSSA-------------Y-----QWSFLSSLTN  140 (481)
Q Consensus        83 ~~l~~L~~L~Ls~N~l~----~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~-------------~-----~~~~~~~l~~  140 (481)
                      ..+++|++|++++|.++    +.++..+.++++|++|++++|.+.+++...             +     .......+..
T Consensus       189 ~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~  268 (592)
T 3ogk_B          189 QHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVF  268 (592)
T ss_dssp             HHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGGGHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCC
T ss_pred             hcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHHHHHHHhhhhHHHhhcccccccccchHHHHHHhhc
Confidence            66778888888888776    344555667788888888887766542100             0     0011123344


Q ss_pred             CCCCcEEEccCCccceeCChhhhhcccCccEEEccCCceeecCC-cccccCCCCCeEecccccceecCCcCCcCCCCCCe
Q 039957          141 CRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIP-KEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQG  219 (481)
Q Consensus       141 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~  219 (481)
                      +++|+.|+++++.. +.+|..+..+ ++|++|++++|.+++... ..+..+++|++|+++++...+.++..+..+++|+.
T Consensus       269 ~~~L~~L~l~~~~~-~~l~~~~~~~-~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~  346 (592)
T 3ogk_B          269 PRKLCRLGLSYMGP-NEMPILFPFA-AQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKR  346 (592)
T ss_dssp             CTTCCEEEETTCCT-TTGGGGGGGG-GGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCE
T ss_pred             cccccccCccccch-hHHHHHHhhc-CCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCE
Confidence            45555555554322 2334444443 467777777777654332 33566777777777733222333333456677888


Q ss_pred             eecCC-----------CcCCCCC-CccccCccCCCeeecCCCeeeecCCccccc-CCCCCcEEcC----CCcCccc----
Q 039957          220 FFLPE-----------TNLQGYV-PHNLCHLEMLNLLHLGGNKLSGHIPPCLAS-LTSLRELDLG----SNKLTSS----  278 (481)
Q Consensus       220 l~l~~-----------n~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~ls----~N~l~~~----  278 (481)
                      |++++           |.+++.. +.....+++|+.|+++.|++++..+..+.. +++|+.|+++    .|.+++.    
T Consensus       347 L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~  426 (592)
T 3ogk_B          347 LRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDN  426 (592)
T ss_dssp             EEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHH
T ss_pred             EEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHH
Confidence            88773           4444321 222344677888888777777665555554 7788888885    6667653    


Q ss_pred             -CCcchhccccCcEEEccCc--ccCCCCCCccc-cCCcCcEEEccCCeeee-eccccccccCChhhhhccccc
Q 039957          279 -IPSSLWSLGYILEINLSSN--LLNDSLPSNVQ-KLKVLRVLDLSRNQLSG-DIPSTIGALVDLETISLAGSF  346 (481)
Q Consensus       279 -~p~~~~~l~~L~~L~l~~N--~l~~~~p~~~~-~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~l~~~g~~  346 (481)
                       ++..+.+++.|+.|+++.+  .+++..+..+. .+++|+.|++++|++++ .++..+..+++|+.|+++++.
T Consensus       427 ~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~  499 (592)
T 3ogk_B          427 GVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCC  499 (592)
T ss_dssp             HHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCC
T ss_pred             HHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCC
Confidence             3334566778888888643  34443333333 36778888888888775 345555677888888877664

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.91  E-value=4.6e-24  Score=207.51  Aligned_cols=231  Identities=17%  Similarity=0.136  Sum_probs=186.0

Q ss_pred             ccCcchhCCCCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccE-EEccCccceeecchhc
Q 039957            4 QIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKY-LELGDNNLIGTIPNSI   82 (481)
Q Consensus         4 ~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~-L~L~~N~l~~~~p~~~   82 (481)
                      +||..+  .+++++|+|++|+|+.+.+.+|.++++|++|+|++|++.+.+|...+..++++++ +.++.|+++...|..|
T Consensus        23 ~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f  100 (350)
T 4ay9_X           23 EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAF  100 (350)
T ss_dssp             SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSB
T ss_pred             ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhh
Confidence            578766  3689999999999998888899999999999999999987888877778888775 6777899998889999


Q ss_pred             cccccCceeecccCcceecCcccccCCCCCCEEEccc-ccCccccCCCccccccccCCCC-CCCcEEEccCCccceeCCh
Q 039957           83 TNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLM-NNLTTESSSAYQWSFLSSLTNC-RYLVYLILSGNPLGGILPP  160 (481)
Q Consensus        83 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~~~~~~l~~l-~~L~~L~Ls~N~l~~~~p~  160 (481)
                      ..+++|++|++++|.+++..+..+....++..|++.. |+++.++...|        ..+ ..+++|+|++|+|+.+.+.
T Consensus       101 ~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f--------~~~~~~l~~L~L~~N~i~~i~~~  172 (350)
T 4ay9_X          101 QNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSF--------VGLSFESVILWLNKNGIQEIHNS  172 (350)
T ss_dssp             CCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSS--------TTSBSSCEEEECCSSCCCEECTT
T ss_pred             hhccccccccccccccccCCchhhcccchhhhhhhccccccccccccch--------hhcchhhhhhccccccccCCChh
Confidence            9999999999999999988888888888999999965 67887765443        333 4689999999999976555


Q ss_pred             hhhhcccCccEEEccC-CceeecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCcc
Q 039957          161 SIGNFSTSLQRFSASE-CKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLE  239 (481)
Q Consensus       161 ~~~~~~~~L~~L~l~~-n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~  239 (481)
                      .+. . .+++++++++ |.++...+..|..+++|++||+++|+++...+..|.++++|+.+++  ++++ .+| .+..++
T Consensus       173 ~f~-~-~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~--~~l~-~lP-~l~~l~  246 (350)
T 4ay9_X          173 AFN-G-TQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLP-TLEKLV  246 (350)
T ss_dssp             SST-T-EEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTTC--TTCC-CCC-CTTTCC
T ss_pred             hcc-c-cchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhccC--CCcC-cCC-CchhCc
Confidence            444 3 4799999985 6666444457899999999999999999666666666665555443  3344 455 478899


Q ss_pred             CCCeeecCCCe
Q 039957          240 MLNLLHLGGNK  250 (481)
Q Consensus       240 ~L~~L~L~~N~  250 (481)
                      +|+.++++++.
T Consensus       247 ~L~~l~l~~~~  257 (350)
T 4ay9_X          247 ALMEASLTYPS  257 (350)
T ss_dssp             SCCEEECSCHH
T ss_pred             ChhhCcCCCCc
Confidence            99999998764

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.91  E-value=5.6e-24  Score=203.02  Aligned_cols=210  Identities=24%  Similarity=0.323  Sum_probs=116.8

Q ss_pred             CCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeecc
Q 039957           15 LKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLG   94 (481)
Q Consensus        15 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls   94 (481)
                      +..+.+..+.++...+  +..+++|++|++++|.++ .+|. +. .+++|++|++++|++++..+  +..+++|++|+++
T Consensus        21 ~~~~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~-~l~~-~~-~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~   93 (308)
T 1h6u_A           21 AIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQ-YLNNLIGLELKDNQITDLAP--LKNLTKITELELS   93 (308)
T ss_dssp             HHHHHTTCSSTTSEEC--HHHHHTCCEEECTTSCCC-CCTT-GG-GCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECC
T ss_pred             HHHHHhCCCCcCceec--HHHcCCcCEEEeeCCCcc-Cchh-hh-ccCCCCEEEccCCcCCCChh--HccCCCCCEEEcc
Confidence            3344555555554322  445667777777777776 4553 33 56777777777777764433  6677777777777


Q ss_pred             cCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEc
Q 039957           95 FNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSA  174 (481)
Q Consensus        95 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l  174 (481)
                      +|.+++. | .|..+++|++|++++|++++++          .+..+++|++|++++|.+++..+  +..+ ++|+.|++
T Consensus        94 ~n~l~~~-~-~~~~l~~L~~L~l~~n~l~~~~----------~l~~l~~L~~L~l~~n~l~~~~~--l~~l-~~L~~L~l  158 (308)
T 1h6u_A           94 GNPLKNV-S-AIAGLQSIKTLDLTSTQITDVT----------PLAGLSNLQVLYLDLNQITNISP--LAGL-TNLQYLSI  158 (308)
T ss_dssp             SCCCSCC-G-GGTTCTTCCEEECTTSCCCCCG----------GGTTCTTCCEEECCSSCCCCCGG--GGGC-TTCCEEEC
T ss_pred             CCcCCCc-h-hhcCCCCCCEEECCCCCCCCch----------hhcCCCCCCEEECCCCccCcCcc--ccCC-CCccEEEc
Confidence            7776653 2 4666777777777777666542          13455666666666666654322  3332 34555555


Q ss_pred             cCCceeecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeeeec
Q 039957          175 SECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGH  254 (481)
Q Consensus       175 ~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  254 (481)
                      ++|.+++. +. +..+++|++|++++|++                        ++..+  +..+++|+.|++++|++++.
T Consensus       159 ~~n~l~~~-~~-l~~l~~L~~L~l~~n~l------------------------~~~~~--l~~l~~L~~L~L~~N~l~~~  210 (308)
T 1h6u_A          159 GNAQVSDL-TP-LANLSKLTTLKADDNKI------------------------SDISP--LASLPNLIEVHLKNNQISDV  210 (308)
T ss_dssp             CSSCCCCC-GG-GTTCTTCCEEECCSSCC------------------------CCCGG--GGGCTTCCEEECTTSCCCBC
T ss_pred             cCCcCCCC-hh-hcCCCCCCEEECCCCcc------------------------CcChh--hcCCCCCCEEEccCCccCcc
Confidence            55544432 21 44444444444444444                        43322  44455555555555555543


Q ss_pred             CCcccccCCCCCcEEcCCCcCc
Q 039957          255 IPPCLASLTSLRELDLGSNKLT  276 (481)
Q Consensus       255 ~p~~~~~l~~L~~L~ls~N~l~  276 (481)
                      .  .+..+++|+.|++++|+++
T Consensus       211 ~--~l~~l~~L~~L~l~~N~i~  230 (308)
T 1h6u_A          211 S--PLANTSNLFIVTLTNQTIT  230 (308)
T ss_dssp             G--GGTTCTTCCEEEEEEEEEE
T ss_pred             c--cccCCCCCCEEEccCCeee
Confidence            3  2555556666666666554

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.91  E-value=5e-25  Score=213.23  Aligned_cols=198  Identities=19%  Similarity=0.244  Sum_probs=120.8

Q ss_pred             CCCEEEeeCCcCccccChhhhcCC--CCccEEEccCccceeecchhccccccCceeecccCcceec-CcccccCCCCCCE
Q 039957           38 TIRNLNLGGNRLSGHLPSMIGHSL--PNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGH-IPNTFGNLRHLSV  114 (481)
Q Consensus        38 ~L~~L~L~~N~l~~~~p~~~~~~l--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~  114 (481)
                      .++.+++++|.+.   |..+. .+  ++++.|++++|.+.+..+. +..+++|++|++++|.+++. +|..+..+++|++
T Consensus        48 ~~~~l~l~~~~~~---~~~~~-~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~  122 (336)
T 2ast_B           48 LWQTLDLTGKNLH---PDVTG-RLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQN  122 (336)
T ss_dssp             TSSEEECTTCBCC---HHHHH-HHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSE
T ss_pred             hheeeccccccCC---HHHHH-hhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCE
Confidence            3677888887775   23333 34  6788888888887766555 45677888888888877755 6777777788888


Q ss_pred             EEcccccCccccCCCccccccccCCCCCCCcEEEccCC-cccee-CChhhhhcccCccEEEccCC-ceeec-CCcccccC
Q 039957          115 LSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGN-PLGGI-LPPSIGNFSTSLQRFSASEC-KLKGT-IPKEIGHL  190 (481)
Q Consensus       115 L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N-~l~~~-~p~~~~~~~~~L~~L~l~~n-~l~~~-~p~~~~~l  190 (481)
                      |++++|.++...        +..+..+++|++|+|++| .+++. ++..+..+ ++|++|++++| .+++. ++..+..+
T Consensus       123 L~L~~~~l~~~~--------~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~-~~L~~L~l~~~~~l~~~~~~~~~~~l  193 (336)
T 2ast_B          123 LSLEGLRLSDPI--------VNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC-SRLDELNLSWCFDFTEKHVQVAVAHV  193 (336)
T ss_dssp             EECTTCBCCHHH--------HHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHC-TTCCEEECCCCTTCCHHHHHHHHHHS
T ss_pred             EeCcCcccCHHH--------HHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcC-CCCCEEcCCCCCCcChHHHHHHHHhc
Confidence            888777765431        133455677777777777 56542 34444444 46777777777 66643 45556666


Q ss_pred             C-CCCeEeccccc--ce-ecCCcCCcCCCCCCeeecCCCc-CCCCCCccccCccCCCeeecCCC
Q 039957          191 R-GLIYLSLGFND--LN-GTIPTSIGTLKQLQGFFLPETN-LQGYVPHNLCHLEMLNLLHLGGN  249 (481)
Q Consensus       191 ~-~L~~L~l~~N~--l~-~~~p~~~~~l~~L~~l~l~~n~-l~~~~p~~~~~l~~L~~L~L~~N  249 (481)
                      + +|++|++++|.  ++ +.+|..+..+++|+.|++++|. +++..+..+..+++|+.|++++|
T Consensus       194 ~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~  257 (336)
T 2ast_B          194 SETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRC  257 (336)
T ss_dssp             CTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTC
T ss_pred             ccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCC
Confidence            6 66666666663  33 2334444445555555555554 34334444444444444444444

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.90  E-value=5.5e-24  Score=203.10  Aligned_cols=208  Identities=24%  Similarity=0.347  Sum_probs=142.8

Q ss_pred             EEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeecccCcceecCcccccCCCCCCEEEccccc
Q 039957           42 LNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNN  121 (481)
Q Consensus        42 L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~  121 (481)
                      +.+..+.++..++..   .+++|++|++++|.++. +| .+..+++|++|++++|.+++..+  |..+++|++|++++|.
T Consensus        24 ~~l~~~~~~~~~~~~---~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~   96 (308)
T 1h6u_A           24 IAAGKSNVTDTVTQA---DLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNP   96 (308)
T ss_dssp             HHTTCSSTTSEECHH---HHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCC
T ss_pred             HHhCCCCcCceecHH---HcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCc
Confidence            344555554333321   35667777777776653 33 46666777777777776665433  6666666666666666


Q ss_pred             CccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEccCCceeecCCcccccCCCCCeEecccc
Q 039957          122 LTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFN  201 (481)
Q Consensus       122 l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N  201 (481)
                      +++++          .+..+++|++|++++|++++                          +| .+..+++|++|++++|
T Consensus        97 l~~~~----------~~~~l~~L~~L~l~~n~l~~--------------------------~~-~l~~l~~L~~L~l~~n  139 (308)
T 1h6u_A           97 LKNVS----------AIAGLQSIKTLDLTSTQITD--------------------------VT-PLAGLSNLQVLYLDLN  139 (308)
T ss_dssp             CSCCG----------GGTTCTTCCEEECTTSCCCC--------------------------CG-GGTTCTTCCEEECCSS
T ss_pred             CCCch----------hhcCCCCCCEEECCCCCCCC--------------------------ch-hhcCCCCCCEEECCCC
Confidence            65541          23445555555555555543                          22 2556667777777777


Q ss_pred             cceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCcCcccCCc
Q 039957          202 DLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPS  281 (481)
Q Consensus       202 ~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~  281 (481)
                      .+++..+  +..+++|+.|++++|.+++..+  +..+++|+.|++++|++++..+  +..+++|++|++++|++++..| 
T Consensus       140 ~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~-  212 (308)
T 1h6u_A          140 QITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP-  212 (308)
T ss_dssp             CCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG-
T ss_pred             ccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc-
Confidence            7764433  6677777888888887776444  8888999999999999987544  8999999999999999986553 


Q ss_pred             chhccccCcEEEccCcccCC
Q 039957          282 SLWSLGYILEINLSSNLLND  301 (481)
Q Consensus       282 ~~~~l~~L~~L~l~~N~l~~  301 (481)
                       +..++.|+.|++++|++++
T Consensus       213 -l~~l~~L~~L~l~~N~i~~  231 (308)
T 1h6u_A          213 -LANTSNLFIVTLTNQTITN  231 (308)
T ss_dssp             -GTTCTTCCEEEEEEEEEEC
T ss_pred             -ccCCCCCCEEEccCCeeec
Confidence             8899999999999999976

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.90  E-value=1.7e-23  Score=193.64  Aligned_cols=177  Identities=23%  Similarity=0.296  Sum_probs=80.7

Q ss_pred             CCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeecccCcceecCcccccCCCCCCEEEcc
Q 039957           39 IRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLL  118 (481)
Q Consensus        39 L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  118 (481)
                      .++++++++.++ .+|..+.   +++++|+|++|++++..+..|..+++|++|+|++|.+++..|..|.++++|++|+++
T Consensus        16 ~~~l~~~~~~l~-~~p~~~~---~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~   91 (251)
T 3m19_A           16 KKEVDCQGKSLD-SVPSGIP---ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA   91 (251)
T ss_dssp             GTEEECTTCCCS-SCCSCCC---TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred             CeEEecCCCCcc-ccCCCCC---CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence            444555555554 4444332   345555555555554444455555555555555555555555555555555555555


Q ss_pred             cccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEccCCceeecCCcccccCCCCCeEec
Q 039957          119 MNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSL  198 (481)
Q Consensus       119 ~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l  198 (481)
                      +|++++++..        .+..+++|++|+|++|++++..+..+..+ ++|++|++++|++++..+..|..+++|++|++
T Consensus        92 ~n~l~~~~~~--------~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  162 (251)
T 3m19_A           92 NNQLASLPLG--------VFDHLTQLDKLYLGGNQLKSLPSGVFDRL-TKLKELRLNTNQLQSIPAGAFDKLTNLQTLSL  162 (251)
T ss_dssp             TSCCCCCCTT--------TTTTCTTCCEEECCSSCCCCCCTTTTTTC-TTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCcccccChh--------HhcccCCCCEEEcCCCcCCCcChhHhccC-CcccEEECcCCcCCccCHHHcCcCcCCCEEEC
Confidence            5555544221        12334444444444444443322222222 23444444444444333333444444444444


Q ss_pred             ccccceecCCcCCcCCCCCCeeecCCCcCC
Q 039957          199 GFNDLNGTIPTSIGTLKQLQGFFLPETNLQ  228 (481)
Q Consensus       199 ~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~  228 (481)
                      ++|++++..+..|..+++|+.|++++|.+.
T Consensus       163 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~  192 (251)
T 3m19_A          163 STNQLQSVPHGAFDRLGKLQTITLFGNQFD  192 (251)
T ss_dssp             CSSCCSCCCTTTTTTCTTCCEEECCSCCBC
T ss_pred             CCCcCCccCHHHHhCCCCCCEEEeeCCcee
Confidence            444444433334444444444444444443

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.90  E-value=2.1e-23  Score=193.05  Aligned_cols=180  Identities=24%  Similarity=0.285  Sum_probs=148.6

Q ss_pred             CCcEEEccCCccceeCChhhhhcccCccEEEccCCceeecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeec
Q 039957          143 YLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFL  222 (481)
Q Consensus       143 ~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l  222 (481)
                      ..++++++++.++ .+|..+.   +.++.|++++|.+++..|..|.++++|++|++++|.+++..|..|..+++|+.|++
T Consensus        15 ~~~~l~~~~~~l~-~~p~~~~---~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L   90 (251)
T 3m19_A           15 GKKEVDCQGKSLD-SVPSGIP---ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGL   90 (251)
T ss_dssp             GGTEEECTTCCCS-SCCSCCC---TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCeEEecCCCCcc-ccCCCCC---CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEEC
Confidence            3566777777776 3444332   46788888888888777777888888888888888888877778888888888888


Q ss_pred             CCCcCCCCCCccccCccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCcCcccCCcchhccccCcEEEccCcccCCC
Q 039957          223 PETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDS  302 (481)
Q Consensus       223 ~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~  302 (481)
                      ++|++++..+..|..+++|+.|++++|++++..+..|..+++|++|++++|++++..+..+..++.|++|++++|++++.
T Consensus        91 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  170 (251)
T 3m19_A           91 ANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSV  170 (251)
T ss_dssp             TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred             CCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCcc
Confidence            88888887778888888899999999998887777788889999999999999877777888888999999999999888


Q ss_pred             CCCccccCCcCcEEEccCCeeeee
Q 039957          303 LPSNVQKLKVLRVLDLSRNQLSGD  326 (481)
Q Consensus       303 ~p~~~~~l~~L~~L~l~~N~l~~~  326 (481)
                      .+..+..+++|+.|++++|++.+.
T Consensus       171 ~~~~~~~l~~L~~L~l~~N~~~c~  194 (251)
T 3m19_A          171 PHGAFDRLGKLQTITLFGNQFDCS  194 (251)
T ss_dssp             CTTTTTTCTTCCEEECCSCCBCTT
T ss_pred             CHHHHhCCCCCCEEEeeCCceeCC
Confidence            777888899999999999999865

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=99.90  E-value=7.8e-24  Score=207.74  Aligned_cols=134  Identities=27%  Similarity=0.384  Sum_probs=113.8

Q ss_pred             hhccccccceeeeec-cCCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCC-----------Cccc
Q 039957          340 ISLAGSFGSVYKGTI-SDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTP-----------DFKF  405 (481)
Q Consensus       340 l~~~g~~g~vy~~~l-~~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----------~~~~  405 (481)
                      ..|.|+||.||+|.. .+|..||||++....  ....+.+.+|++++++++|||||++++++...           .+||
T Consensus        61 ~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~  140 (398)
T 4b99_A           61 TIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDL  140 (398)
T ss_dssp             EEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEEC
T ss_pred             EEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeC
Confidence            348899999999985 578999999986543  23345678899999999999999999877542           1578


Q ss_pred             ccCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          406 MPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       406 ~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      |+ |+|.+++... ..+++.+...++.||++||+|||    +.+||||||||+|||++.++.+||+|||+|+.+
T Consensus       141 ~~-g~L~~~i~~~-~~l~~~~~~~~~~qil~al~ylH----~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~  208 (398)
T 4b99_A          141 ME-SDLHQIIHSS-QPLTLEHVRYFLYQLLRGLKYMH----SAQVIHRDLKPSNLLVNENCELKIGDFGMARGL  208 (398)
T ss_dssp             CS-EEHHHHHTSS-SCCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred             CC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH----HCcCcCCCcCccccccCCCCCEEEeecceeeec
Confidence            85 7899988754 46788899999999999999999    678999999999999999999999999999865

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=99.89  E-value=2.9e-23  Score=213.64  Aligned_cols=136  Identities=24%  Similarity=0.376  Sum_probs=120.0

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHH
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKR  414 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~  414 (481)
                      .|.|+||.||++.. .+|..||+|.+........+.+.+|+.++++++|||||++++++....     +|||++|+|.++
T Consensus       165 lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~  244 (573)
T 3uto_A          165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEK  244 (573)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHH
T ss_pred             EeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHH
Confidence            37899999999985 468999999997765555667889999999999999999999988765     689999999999


Q ss_pred             hhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCC--CcEEEccccCcccCC
Q 039957          415 LYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDEN--MVAHVSDFGISKLLG  480 (481)
Q Consensus       415 l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~--~~~kl~Dfgl~~~~~  480 (481)
                      +......++..+...++.||++||+|||    +.+|+||||||+|||++.+  +.+||+|||+|+.+.
T Consensus       245 i~~~~~~l~e~~~~~~~~qi~~al~ylH----~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~  308 (573)
T 3uto_A          245 VADEHNKMSEDEAVEYMRQVCKGLCHMH----ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD  308 (573)
T ss_dssp             HTCTTSCEEHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred             HHHhCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence            8766567888899999999999999999    6789999999999999854  899999999998764

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.89  E-value=2.2e-23  Score=213.35  Aligned_cols=186  Identities=25%  Similarity=0.320  Sum_probs=106.4

Q ss_pred             CCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeec
Q 039957           14 NLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDL   93 (481)
Q Consensus        14 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L   93 (481)
                      +|+.|+|++|++++ +|..+  .++|++|+|++|+|+ .+| .   .+++|++|+|++|+|++ +|. +..  +|++|+|
T Consensus        60 ~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~-~ip-~---~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~L  127 (571)
T 3cvr_A           60 QFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLP-E---LPASLEYLDACDNRLST-LPE-LPA--SLKHLDV  127 (571)
T ss_dssp             TCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCS-CCC-C---CCTTCCEEECCSSCCSC-CCC-CCT--TCCEEEC
T ss_pred             CccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCc-ccc-c---ccCCCCEEEccCCCCCC-cch-hhc--CCCEEEC
Confidence            66667777776665 34433  256667777777666 566 1   35666677777766665 444 443  6666666


Q ss_pred             ccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEE
Q 039957           94 GFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFS  173 (481)
Q Consensus        94 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~  173 (481)
                      ++|.+++ +|.   .+++|++|++++|.+++++.            .+++|++|+|++|++++ +|. +.   ++|+.|+
T Consensus       128 s~N~l~~-lp~---~l~~L~~L~Ls~N~l~~lp~------------~l~~L~~L~Ls~N~L~~-lp~-l~---~~L~~L~  186 (571)
T 3cvr_A          128 DNNQLTM-LPE---LPALLEYINADNNQLTMLPE------------LPTSLEVLSVRNNQLTF-LPE-LP---ESLEALD  186 (571)
T ss_dssp             CSSCCSC-CCC---CCTTCCEEECCSSCCSCCCC------------CCTTCCEEECCSSCCSC-CCC-CC---TTCCEEE
T ss_pred             CCCcCCC-CCC---cCccccEEeCCCCccCcCCC------------cCCCcCEEECCCCCCCC-cch-hh---CCCCEEE
Confidence            6666665 444   46666666666666665422            23456666666666665 444 32   4566666


Q ss_pred             ccCCceeecCCcccccCCCC-------CeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccC
Q 039957          174 ASECKLKGTIPKEIGHLRGL-------IYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCH  237 (481)
Q Consensus       174 l~~n~l~~~~p~~~~~l~~L-------~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~  237 (481)
                      +++|+|+ .+|. +..  +|       ++|+|++|+|+ .+|..+..+++|+.|++++|.+++.+|..++.
T Consensus       187 Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~  252 (571)
T 3cvr_A          187 VSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQ  252 (571)
T ss_dssp             CCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHH
T ss_pred             CcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHH
Confidence            6666666 4444 333  44       55555555555 34554555555555555555555555544444

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=99.89  E-value=4.1e-23  Score=211.60  Aligned_cols=135  Identities=24%  Similarity=0.285  Sum_probs=112.0

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccch---hhhhhhh---HHHHHhhhhccCccceeecccCCCC-----cccccC
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRE---RAFRSFN---SECEVLRNVRHQNLIKILSSCSTPD-----FKFMPN  408 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~---~~~~~~~---~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~  408 (481)
                      .|.|+||.||++... +|..||+|.+.....   .......   .++.+++.++|||||++++++.+.+     +||+++
T Consensus       197 LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~G  276 (689)
T 3v5w_A          197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNG  276 (689)
T ss_dssp             EEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             EecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCCC
Confidence            478999999999854 689999999975432   1112223   3356677789999999999998775     689999


Q ss_pred             CChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          409 GSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       409 g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      |+|.+++... ..++......++.+|+.||+|||    +.+||||||||+|||+|++|++||+|||+|+.+.
T Consensus       277 GdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH----~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          277 GDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMH----NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  343 (689)
T ss_dssp             CBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             CcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH----HCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence            9999998754 34677888899999999999999    6889999999999999999999999999998653

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.88  E-value=3.1e-25  Score=231.49  Aligned_cols=176  Identities=13%  Similarity=0.043  Sum_probs=76.3

Q ss_pred             cCccEEEccCCceeecC-CcccccCCCCCeEeccccccee-cCCcCCcCCCCCCeeecCC---------CcCCCCCCccc
Q 039957          167 TSLQRFSASECKLKGTI-PKEIGHLRGLIYLSLGFNDLNG-TIPTSIGTLKQLQGFFLPE---------TNLQGYVPHNL  235 (481)
Q Consensus       167 ~~L~~L~l~~n~l~~~~-p~~~~~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~l~l~~---------n~l~~~~p~~~  235 (481)
                      ++|++|++++|.+++.. +..+..+++|++|++++| +.. .++.....+++|+.|++..         +.+++.....+
T Consensus       289 ~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l  367 (594)
T 2p1m_B          289 SRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSV  367 (594)
T ss_dssp             TTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHH
T ss_pred             CCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHH
Confidence            46777777777655322 222345666667766666 321 1111122355566665522         23322111111


Q ss_pred             c-CccCCCeeecCCCeeeecCCcccc-cCCCCCcEEcC--C----CcCcccC-----CcchhccccCcEEEccCcccCCC
Q 039957          236 C-HLEMLNLLHLGGNKLSGHIPPCLA-SLTSLRELDLG--S----NKLTSSI-----PSSLWSLGYILEINLSSNLLNDS  302 (481)
Q Consensus       236 ~-~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~ls--~----N~l~~~~-----p~~~~~l~~L~~L~l~~N~l~~~  302 (481)
                      . .+++|+.|+++.|.+++..+..+. .+++|+.|+++  +    |.++...     +..+..++.|+.|++++ .+++.
T Consensus       368 ~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~  446 (594)
T 2p1m_B          368 SMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDK  446 (594)
T ss_dssp             HHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHH
T ss_pred             HHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHH
Confidence            1 245555555555555443333332 34555555555  2    3333111     11133444555555544 33222


Q ss_pred             CCCcccc-CCcCcEEEccCCeeeeeccccc-cccCChhhhhccc
Q 039957          303 LPSNVQK-LKVLRVLDLSRNQLSGDIPSTI-GALVDLETISLAG  344 (481)
Q Consensus       303 ~p~~~~~-l~~L~~L~l~~N~l~~~~p~~~-~~l~~L~~l~~~g  344 (481)
                      .+..+.. +++|+.|++++|.+++..+..+ ..+++|+.|++++
T Consensus       447 ~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~  490 (594)
T 2p1m_B          447 VFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRD  490 (594)
T ss_dssp             HHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEES
T ss_pred             HHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcC
Confidence            2222222 4445555555555443332222 3344555554443

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=99.88  E-value=6.2e-23  Score=199.14  Aligned_cols=131  Identities=21%  Similarity=0.292  Sum_probs=110.6

Q ss_pred             hhhccccccceeeeec----cCCcceEEEEEeccchhhhhhhhHHHHHhhhh-ccCccceeecccCCCC-----cccccC
Q 039957          339 TISLAGSFGSVYKGTI----SDGTDVAIKIFNLQRERAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD-----FKFMPN  408 (481)
Q Consensus       339 ~l~~~g~~g~vy~~~l----~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----~~~~~~  408 (481)
                      ...|+|+||.||+|..    ..+..||+|.+....  ....+.+|++++.++ +|||||++++++...+     +||+++
T Consensus        27 ~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g  104 (361)
T 4f9c_A           27 DKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEH  104 (361)
T ss_dssp             EEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCC
T ss_pred             EEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCc
Confidence            3458999999999964    246789999886543  234567899999988 6999999999887665     689999


Q ss_pred             CChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCC-CcEEEccccCcccC
Q 039957          409 GSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDEN-MVAHVSDFGISKLL  479 (481)
Q Consensus       409 g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~-~~~kl~Dfgl~~~~  479 (481)
                      |+|.+++.    .++..+...++.|+++||+|||    +.+||||||||+|||++.+ +.+||+|||+|+..
T Consensus       105 ~~L~~~~~----~l~~~~~~~~~~qll~al~ylH----~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~  168 (361)
T 4f9c_A          105 ESFLDILN----SLSFQEVREYMLNLFKALKRIH----QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT  168 (361)
T ss_dssp             CCHHHHHT----TCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             ccHHHHHc----CCCHHHHHHHHHHHHHHHHHHH----HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence            99999884    3677888899999999999999    6789999999999999886 89999999999754

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.88  E-value=5.7e-22  Score=177.97  Aligned_cols=180  Identities=24%  Similarity=0.259  Sum_probs=111.7

Q ss_pred             CeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeeccc
Q 039957           16 KSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGF   95 (481)
Q Consensus        16 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~   95 (481)
                      +.++.+++.++.+ |..+  .++|++|++++|+++ .+|...+..+++|++|++++|++++..+..|..+++|++|++++
T Consensus        10 ~~v~c~~~~l~~~-p~~~--~~~l~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~   85 (208)
T 2o6s_A           10 TTVECYSQGRTSV-PTGI--PAQTTYLDLETNSLK-SLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLST   85 (208)
T ss_dssp             TEEECCSSCCSSC-CSCC--CTTCSEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CEEEecCCCccCC-CCCC--CCCCcEEEcCCCccC-cCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCC
Confidence            4566667766643 3322  346777777777776 34444333677777777777777755555667777777777777


Q ss_pred             CcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEcc
Q 039957           96 NTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSAS  175 (481)
Q Consensus        96 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~  175 (481)
                      |.+++..+..|.++++|++|++++|+++++++.        .+..+++|++|+|++|++++..+..+..+ ++|++|+++
T Consensus        86 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~--------~~~~l~~L~~L~l~~N~l~~~~~~~~~~l-~~L~~L~l~  156 (208)
T 2o6s_A           86 NQLQSLPNGVFDKLTQLKELALNTNQLQSLPDG--------VFDKLTQLKDLRLYQNQLKSVPDGVFDRL-TSLQYIWLH  156 (208)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT--------TTTTCTTCCEEECCSSCCSCCCTTTTTTC-TTCCEEECC
T ss_pred             CcCCccCHhHhcCccCCCEEEcCCCcCcccCHh--------HhccCCcCCEEECCCCccceeCHHHhccC-CCccEEEec
Confidence            777766666667777777777777777665332        23456667777777776665444444444 456666666


Q ss_pred             CCceeecCCcccccCCCCCeEecccccceecCCcCCcCCC
Q 039957          176 ECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLK  215 (481)
Q Consensus       176 ~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~  215 (481)
                      +|.+.+       .+++|++|+++.|+++|.+|..++.++
T Consensus       157 ~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~~l~  189 (208)
T 2o6s_A          157 DNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSVA  189 (208)
T ss_dssp             SCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTSSBC
T ss_pred             CCCeec-------CCCCHHHHHHHHHhCCceeeccCcccc
Confidence            665543       234566666666666666666655544

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.87  E-value=2.6e-22  Score=180.18  Aligned_cols=181  Identities=20%  Similarity=0.186  Sum_probs=130.2

Q ss_pred             CCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeecccCcceecCcccccCCCCCCEEEcc
Q 039957           39 IRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLL  118 (481)
Q Consensus        39 L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  118 (481)
                      -+.++.+++.++ .+|..+   .++|++|++++|++++..+..|..+++|++|++++|++++..+..|..+++|++|+++
T Consensus         9 ~~~v~c~~~~l~-~~p~~~---~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls   84 (208)
T 2o6s_A            9 GTTVECYSQGRT-SVPTGI---PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLS   84 (208)
T ss_dssp             TTEEECCSSCCS-SCCSCC---CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCEEEecCCCcc-CCCCCC---CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECC
Confidence            367888888887 677654   4689999999999987777778899999999999999998777778889999999999


Q ss_pred             cccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEccCCceeecCCcccccCCCCCeEec
Q 039957          119 MNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSL  198 (481)
Q Consensus       119 ~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l  198 (481)
                      +|++++++..        .+..+++|++|+|++|++++..+..+..+ ++|++|++++|.+++..+..+..+++|++|++
T Consensus        85 ~n~l~~~~~~--------~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l  155 (208)
T 2o6s_A           85 TNQLQSLPNG--------VFDKLTQLKELALNTNQLQSLPDGVFDKL-TQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWL  155 (208)
T ss_dssp             SSCCCCCCTT--------TTTTCTTCCEEECCSSCCCCCCTTTTTTC-TTCCEEECCSSCCSCCCTTTTTTCTTCCEEEC
T ss_pred             CCcCCccCHh--------HhcCccCCCEEEcCCCcCcccCHhHhccC-CcCCEEECCCCccceeCHHHhccCCCccEEEe
Confidence            9988876432        24567788888888888876555445554 46777777777776555555666666777777


Q ss_pred             ccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCcc
Q 039957          199 GFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLE  239 (481)
Q Consensus       199 ~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~  239 (481)
                      ++|.+.+       .++.|+.|+++.|+++|.+|..++.++
T Consensus       156 ~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~~l~  189 (208)
T 2o6s_A          156 HDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSVA  189 (208)
T ss_dssp             CSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTSSBC
T ss_pred             cCCCeec-------CCCCHHHHHHHHHhCCceeeccCcccc
Confidence            6665543       234555566666666666665555443

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.87  E-value=2.7e-22  Score=191.70  Aligned_cols=135  Identities=29%  Similarity=0.430  Sum_probs=120.6

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHH
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKR  414 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~  414 (481)
                      -+.|+||.||++... +|..+|+|.+........+.+.+|+.++++++||||++++++|....     +||+++|+|.++
T Consensus        18 lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~   97 (310)
T 3s95_A           18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGI   97 (310)
T ss_dssp             EECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHH
T ss_pred             ecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHH
Confidence            478999999999864 58899999886655566678899999999999999999999987664     679999999999


Q ss_pred             hhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          415 LYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       415 l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +......+++.++.+++.++++||+|||    +.+|+||||||+||++++++.+||+|||+++..
T Consensus        98 l~~~~~~~~~~~~~~i~~qi~~al~~lH----~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  158 (310)
T 3s95_A           98 IKSMDSQYPWSQRVSFAKDIASGMAYLH----SMNIIHRDLNSHNCLVRENKNVVVADFGLARLM  158 (310)
T ss_dssp             HHHCCTTSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSTTSEEECTTSCEEECCCTTCEEC
T ss_pred             HHhccCCCCHHHHHHHHHHHHHHHHHHH----hCCccCCCCCcCeEEECCCCCEEEeecccceec
Confidence            9876667899999999999999999999    578999999999999999999999999999764

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.87  E-value=2e-22  Score=197.54  Aligned_cols=136  Identities=29%  Similarity=0.555  Sum_probs=113.8

Q ss_pred             hhccccccceeeeecc----CCcceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCC
Q 039957          340 ISLAGSFGSVYKGTIS----DGTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNG  409 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~----~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g  409 (481)
                      ..+.|+||.||+|...    ++..||+|.+.... ....+.+.+|+.++++++|+||++++++|...+     +||+++|
T Consensus        52 ~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  131 (373)
T 2qol_A           52 VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENG  131 (373)
T ss_dssp             EEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred             EEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCC
Confidence            4478999999999864    46789999987643 334467889999999999999999999998764     6799999


Q ss_pred             ChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          410 SLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       410 ~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +|.+++......+++.++.+|+.+|++||+|||    +.+|+||||||+|||+++++.+||+|||+++.+
T Consensus       132 sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  197 (373)
T 2qol_A          132 SLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS----DMGYVHRDLAARNILINSNLVCKVSDFGLGRVL  197 (373)
T ss_dssp             BHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence            999999876667899999999999999999999    578999999999999999999999999999865

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.87  E-value=5.2e-22  Score=190.70  Aligned_cols=136  Identities=39%  Similarity=0.683  Sum_probs=120.0

Q ss_pred             hhccccccceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHH
Q 039957          340 ISLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKR  414 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~  414 (481)
                      ..+.|+||.||+|...+|..||+|..........+.+.+|+.++++++||||++++++|...+     ++|+++|+|.++
T Consensus        46 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~  125 (321)
T 2qkw_B           46 LIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRH  125 (321)
T ss_dssp             CSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGG
T ss_pred             eeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHH
Confidence            457899999999998889999999887665555667889999999999999999999997764     678999999999


Q ss_pred             hhcCC---CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          415 LYSHN---YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       415 l~~~~---~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +....   ..++|..+.+++.++++||+|||    +.+|+||||||+||++++++.+||+|||+++..
T Consensus       126 l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  189 (321)
T 2qkw_B          126 LYGSDLPTMSMSWEQRLEICIGAARGLHYLH----TRAIIHRDVKSINILLDENFVPKITDFGISKKG  189 (321)
T ss_dssp             SSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCSTTEEECTTCCEEECCCTTCEEC
T ss_pred             HhccCCCccccCHHHHHHHHHHHHHHHHHhc----CCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence            86532   35889999999999999999999    578999999999999999999999999998753

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.87  E-value=2.4e-22  Score=205.72  Aligned_cols=188  Identities=24%  Similarity=0.304  Sum_probs=97.7

Q ss_pred             CccEEEccCccceeecchhccccccCceeecccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCC
Q 039957           63 NIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCR  142 (481)
Q Consensus        63 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~  142 (481)
                      +|++|+|++|++++ +|..+.  ++|++|+|++|.|+ .+|   ..+++|++|++++|+|++++.          +.+  
T Consensus        60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~ip~----------l~~--  120 (571)
T 3cvr_A           60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLSTLPE----------LPA--  120 (571)
T ss_dssp             TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSCCCC----------CCT--
T ss_pred             CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCCcch----------hhc--
Confidence            44444444444443 333221  34444444444444 233   224445555555554444322          111  


Q ss_pred             CCcEEEccCCccceeCChhhhhcccCccEEEccCCceeecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeec
Q 039957          143 YLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFL  222 (481)
Q Consensus       143 ~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l  222 (481)
                      +|++|+|++|.+++ +|.   . .++|+.|++++|++++ +|.   .+++|++|++++|++++ +|. |.  ++|+.|++
T Consensus       121 ~L~~L~Ls~N~l~~-lp~---~-l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~L  187 (571)
T 3cvr_A          121 SLKHLDVDNNQLTM-LPE---L-PALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDV  187 (571)
T ss_dssp             TCCEEECCSSCCSC-CCC---C-CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEEC
T ss_pred             CCCEEECCCCcCCC-CCC---c-CccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEEC
Confidence            44555555555544 333   1 2345555555555553 333   34455555555555554 444 43  55666666


Q ss_pred             CCCcCCCCCCccccCccCC-------CeeecCCCeeeecCCcccccCCCCCcEEcCCCcCcccCCcchhccc
Q 039957          223 PETNLQGYVPHNLCHLEML-------NLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLG  287 (481)
Q Consensus       223 ~~n~l~~~~p~~~~~l~~L-------~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~  287 (481)
                      ++|+++. +|. +..  +|       +.|+|++|+++ .+|..+..+++|+.|++++|++++.+|..+..+.
T Consensus       188 s~N~L~~-lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~  254 (571)
T 3cvr_A          188 STNLLES-LPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQT  254 (571)
T ss_dssp             CSSCCSS-CCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHH
T ss_pred             cCCCCCc-hhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhh
Confidence            6665553 333 333  44       77788888877 3566666678888888888888777777776654

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.86  E-value=5.8e-22  Score=190.66  Aligned_cols=136  Identities=32%  Similarity=0.533  Sum_probs=117.9

Q ss_pred             hhccccccceeeeecc----CCcceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCC
Q 039957          340 ISLAGSFGSVYKGTIS----DGTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNG  409 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~----~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g  409 (481)
                      ..+.|+||.||+|...    .+..||||.+.... ....+.+.+|+.++++++|+||++++++|....     +||+++|
T Consensus        56 ~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  135 (325)
T 3kul_A           56 IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENG  135 (325)
T ss_dssp             EEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTC
T ss_pred             EEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCC
Confidence            4478999999999864    23459999987543 334457889999999999999999999987654     6789999


Q ss_pred             ChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          410 SLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       410 ~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +|.+++......+++.++..++.++++||+|||    +.+|+||||||+||++++++.+||+|||+++.+
T Consensus       136 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  201 (325)
T 3kul_A          136 SLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS----DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL  201 (325)
T ss_dssp             BHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             cHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----HCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence            999999776667899999999999999999999    578999999999999999999999999999865

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.86  E-value=3.8e-22  Score=196.02  Aligned_cols=135  Identities=27%  Similarity=0.441  Sum_probs=118.3

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhH
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEK  413 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~  413 (481)
                      .+.|+||.||+|... ++..||+|.+.... ......+.+|++++++++||||++++++|...+     +||+++|+|.+
T Consensus       122 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~  201 (377)
T 3cbl_A          122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLT  201 (377)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHH
T ss_pred             eccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHH
Confidence            478999999999875 68899999986543 233457889999999999999999999997664     67999999999


Q ss_pred             HhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          414 RLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       414 ~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ++......+++....+++.+||+||+|||    +.+|+||||||+|||+++++.+||+|||+|+..
T Consensus       202 ~l~~~~~~~~~~~~~~~~~qi~~~l~~LH----~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~  263 (377)
T 3cbl_A          202 FLRTEGARLRVKTLLQMVGDAAAGMEYLE----SKCCIHRDLAARNCLVTEKNVLKISDFGMSREE  263 (377)
T ss_dssp             HHHHHGGGCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             HHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCcCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence            98866566889999999999999999999    578999999999999999999999999998754

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.86  E-value=6.5e-22  Score=197.11  Aligned_cols=135  Identities=22%  Similarity=0.255  Sum_probs=117.5

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccch---hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRE---RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      .+.|+||.||++... +|..+|+|.+.....   .....+..|+.++.+++|+||++++++|...+     +||+++|+|
T Consensus        82 LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L  161 (437)
T 4aw2_A           82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDL  161 (437)
T ss_dssp             EEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBH
T ss_pred             EEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcH
Confidence            478999999999875 478899999875322   22345788999999999999999999998765     689999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+++......+++..+..++.+|+.||+|||    +.+||||||||+|||+|.++++||+|||+|+.+
T Consensus       162 ~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH----~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~  225 (437)
T 4aw2_A          162 LTLLSKFEDRLPEEMARFYLAEMVIAIDSVH----QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL  225 (437)
T ss_dssp             HHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             HHHHHHccCCCCHHHHHHHHHHHHHHHHHHH----hCCeEecccCHHHeeEcCCCCEEEcchhhhhhc
Confidence            9999875567889999999999999999999    578999999999999999999999999999754

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.86  E-value=2.7e-22  Score=190.25  Aligned_cols=135  Identities=30%  Similarity=0.522  Sum_probs=117.6

Q ss_pred             hccccccceeeeec-----cCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCC-------CcccccC
Q 039957          341 SLAGSFGSVYKGTI-----SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTP-------DFKFMPN  408 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-----~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------~~~~~~~  408 (481)
                      -+.|+||.||++..     .+|..||+|.+........+.+.+|+.++++++|+||++++++|...       .++|+++
T Consensus        18 lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~   97 (295)
T 3ugc_A           18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPY   97 (295)
T ss_dssp             EEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTT
T ss_pred             eeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCC
Confidence            37899999999973     35789999998766555567788999999999999999999987543       2679999


Q ss_pred             CChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          409 GSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       409 g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      |+|.+++......+++..+.+++.++++||+|||    +.+|+||||||+||+++.++.+||+|||+++..
T Consensus        98 ~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~  164 (295)
T 3ugc_A           98 GSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG----TKRYIHRDLATRNILVENENRVKIGDFGLTKVL  164 (295)
T ss_dssp             CBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred             CCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHh----cCCcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence            9999999876667899999999999999999999    578999999999999999999999999999865

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.86  E-value=1.2e-21  Score=188.68  Aligned_cols=139  Identities=39%  Similarity=0.613  Sum_probs=118.2

Q ss_pred             hhccccccceeeeeccCCcceEEEEEeccchh-hhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhH
Q 039957          340 ISLAGSFGSVYKGTISDGTDVAIKIFNLQRER-AFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEK  413 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~~g~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~  413 (481)
                      ..+.|+||.||++...+|..||+|.+...... ....+.+|+.++++++|+||++++++|....     ++|+++|+|.+
T Consensus        37 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~  116 (326)
T 3uim_A           37 ILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVAS  116 (326)
T ss_dssp             EEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHH
T ss_pred             eEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHH
Confidence            44789999999999888999999998765432 2346788999999999999999999998765     67899999999


Q ss_pred             HhhcCC---CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          414 RLYSHN---YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       414 ~l~~~~---~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ++....   ..++|..+..|+.++++||+|||..+ .++|+||||||+||++++++.+||+|||+|+..
T Consensus       117 ~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~-~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  184 (326)
T 3uim_A          117 CLRERPESQPPLDWPKRQRIALGSARGLAYLHDHC-DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM  184 (326)
T ss_dssp             HHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSS-SSCEECCCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             HHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCC-CCCeEeCCCchhhEEECCCCCEEeccCcccccc
Confidence            987632   34899999999999999999999643 348999999999999999999999999999764

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.86  E-value=8.7e-24  Score=220.52  Aligned_cols=337  Identities=13%  Similarity=0.077  Sum_probs=212.7

Q ss_pred             Ccchh-CCCCCCeeeCcCC-ccccc-CChhccCCcCCCEEEeeCCcCccccChhh---hcCCCCccEEEccCcc--cee-
Q 039957            6 PTEIG-NLQNLKSLFLGAN-NLSGL-IPPMIFNISTIRNLNLGGNRLSGHLPSMI---GHSLPNIKYLELGDNN--LIG-   76 (481)
Q Consensus         6 p~~~~-~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~---~~~l~~L~~L~L~~N~--l~~-   76 (481)
                      +..+. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+   ...+++|++|++++|.  +.. 
T Consensus       122 ~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~  201 (594)
T 2p1m_B          122 LELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFS  201 (594)
T ss_dssp             HHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHH
T ss_pred             HHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccCCcCCHH
Confidence            34443 5788888888888 45432 34445578888888888888765333322   2246688888888886  221 


Q ss_pred             ecchhccccccCceeecccC-cceecCcccccCCCCCCEEEcccccC-------cccc----------------CCCccc
Q 039957           77 TIPNSITNATKLIILDLGFN-TFSGHIPNTFGNLRHLSVLSLLMNNL-------TTES----------------SSAYQW  132 (481)
Q Consensus        77 ~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~N~l-------~~~~----------------~~~~~~  132 (481)
                      .++..+..+++|++|++++| .+.+ +|..+..+++|++|+++.+..       .++.                ... ..
T Consensus       202 ~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~~~~L~~Ls~~~~~~-~~  279 (594)
T 2p1m_B          202 ALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAV-PA  279 (594)
T ss_dssp             HHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHHTCTTCCEEECCBTCC-GG
T ss_pred             HHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHHHHHHHhcCCCcccccCCcccc-hh
Confidence            12222345688888888887 4443 677777888888887654421       1000                000 00


Q ss_pred             cccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEccCCcee-ecCCcccccCCCCCeEeccc---------cc
Q 039957          133 SFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLK-GTIPKEIGHLRGLIYLSLGF---------ND  202 (481)
Q Consensus       133 ~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~-~~~p~~~~~l~~L~~L~l~~---------N~  202 (481)
                      .++..+..+++|++|+|++|.+++.....+....++|++|++++| +. ..++.....+++|++|+++.         +.
T Consensus       280 ~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~  358 (594)
T 2p1m_B          280 YLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVA  358 (594)
T ss_dssp             GGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSC
T ss_pred             hHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCC
Confidence            111222356889999999998765433332222368999999988 43 22333334588899998833         44


Q ss_pred             ceecCCcCCc-CCCCCCeeecCCCcCCCCCCcccc-CccCCCeeecC--C----CeeeecC-----CcccccCCCCCcEE
Q 039957          203 LNGTIPTSIG-TLKQLQGFFLPETNLQGYVPHNLC-HLEMLNLLHLG--G----NKLSGHI-----PPCLASLTSLRELD  269 (481)
Q Consensus       203 l~~~~p~~~~-~l~~L~~l~l~~n~l~~~~p~~~~-~l~~L~~L~L~--~----N~l~~~~-----p~~~~~l~~L~~L~  269 (481)
                      +++.....+. .+++|+.|.+..|.+++..+..+. .+++|+.|+++  +    |.++...     +..+..+++|+.|+
T Consensus       359 l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~  438 (594)
T 2p1m_B          359 LTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLS  438 (594)
T ss_dssp             CCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEE
T ss_pred             CCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEe
Confidence            4432222222 377888888888888765555554 47888899888  3    4554221     12356778899999


Q ss_pred             cCCCcCcccCCcchhc-cccCcEEEccCcccCCCCCCcc-ccCCcCcEEEccCCeeeeeccc-cccccCChhhhhccccc
Q 039957          270 LGSNKLTSSIPSSLWS-LGYILEINLSSNLLNDSLPSNV-QKLKVLRVLDLSRNQLSGDIPS-TIGALVDLETISLAGSF  346 (481)
Q Consensus       270 ls~N~l~~~~p~~~~~-l~~L~~L~l~~N~l~~~~p~~~-~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~l~~~g~~  346 (481)
                      +++ .++...+..+.. ++.|+.|++++|.+++..+..+ ..+++|+.|++++|+++..... .+..+++|+.|+++++.
T Consensus       439 L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~  517 (594)
T 2p1m_B          439 LSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCS  517 (594)
T ss_dssp             CCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSC
T ss_pred             ecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCC
Confidence            977 666554445544 7889999999988865444333 5678899999999988544333 44557888888887654

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.86  E-value=1.2e-21  Score=191.95  Aligned_cols=135  Identities=25%  Similarity=0.492  Sum_probs=115.0

Q ss_pred             hccccccceeeeecc--------CCcceEEEEEeccc-hhhhhhhhHHHHHhhhh-ccCccceeecccCCCC-----ccc
Q 039957          341 SLAGSFGSVYKGTIS--------DGTDVAIKIFNLQR-ERAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD-----FKF  405 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~--------~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----~~~  405 (481)
                      .+.|+||.||+|...        ++..||+|.+.... ....+.+.+|++++.++ +||||++++++|...+     +||
T Consensus        89 LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~  168 (370)
T 2psq_A           89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEY  168 (370)
T ss_dssp             ESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             EeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEc
Confidence            478999999999742        34569999986543 33456788999999999 8999999999987764     679


Q ss_pred             ccCCChhHHhhcCC---------------CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 039957          406 MPNGSLEKRLYSHN---------------YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHV  470 (481)
Q Consensus       406 ~~~g~l~~~l~~~~---------------~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl  470 (481)
                      +++|+|.+++....               ..+++.++.+++.+|++||+|||    +.+|+||||||+|||+++++.+||
T Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~~~~kl  244 (370)
T 2psq_A          169 ASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA----SQKCIHRDLAARNVLVTENNVMKI  244 (370)
T ss_dssp             CTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEECTTCCEEE
T ss_pred             CCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH----hCCeeccccchhhEEECCCCCEEE
Confidence            99999999987532               24788999999999999999999    578999999999999999999999


Q ss_pred             ccccCcccC
Q 039957          471 SDFGISKLL  479 (481)
Q Consensus       471 ~Dfgl~~~~  479 (481)
                      +|||+|+.+
T Consensus       245 ~DFG~a~~~  253 (370)
T 2psq_A          245 ADFGLARDI  253 (370)
T ss_dssp             CCCSSCEET
T ss_pred             ccccCCccc
Confidence            999999854

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.86  E-value=1.3e-21  Score=187.98  Aligned_cols=133  Identities=26%  Similarity=0.402  Sum_probs=117.8

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHH
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKR  414 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~  414 (481)
                      .++|+||.||+|... +|..||||.+........+.+.+|+.++++++|+||++++++|...+     +||+++|+|.++
T Consensus        53 lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~  132 (321)
T 2c30_A           53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDI  132 (321)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHH
T ss_pred             eccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHH
Confidence            378999999999865 68999999997665555567889999999999999999999887664     679999999998


Q ss_pred             hhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          415 LYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       415 l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +..  ..+++..+..++.++++||+|||    +.+|+||||||+||+++.++.+||+|||+++.+
T Consensus       133 l~~--~~l~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  191 (321)
T 2c30_A          133 VSQ--VRLNEEQIATVCEAVLQALAYLH----AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI  191 (321)
T ss_dssp             HTT--CCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             HHh--cCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEECCCCcEEEeeeeeeeec
Confidence            864  35889999999999999999999    578999999999999999999999999998764

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.86  E-value=1.1e-21  Score=192.10  Aligned_cols=135  Identities=25%  Similarity=0.441  Sum_probs=115.0

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHH
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKR  414 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~  414 (481)
                      .+.|+||.||++.. .+|..||+|.+........+.+.+|++++.+++|+||++++++|...+     +||+++|+|.++
T Consensus        97 lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~  176 (373)
T 2x4f_A           97 LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDR  176 (373)
T ss_dssp             CC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHH
T ss_pred             EecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHH
Confidence            47899999999985 468999999998765555667889999999999999999999998765     679999999999


Q ss_pred             hhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeee--CCCCcEEEccccCcccC
Q 039957          415 LYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILL--DENMVAHVSDFGISKLL  479 (481)
Q Consensus       415 l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill--~~~~~~kl~Dfgl~~~~  479 (481)
                      +......+++..+..++.+|++||+|||    +.+|+||||||+|||+  ++++.+||+|||+|+.+
T Consensus       177 l~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~  239 (373)
T 2x4f_A          177 IIDESYNLTELDTILFMKQICEGIRHMH----QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY  239 (373)
T ss_dssp             HHHTGGGCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEEC
T ss_pred             HHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccccCCHHHEEEecCCCCcEEEEeCCCceec
Confidence            8776667889999999999999999999    5789999999999999  67789999999999865

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.86  E-value=1.2e-21  Score=193.81  Aligned_cols=135  Identities=21%  Similarity=0.266  Sum_probs=117.5

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      .+.|+||.||++... +|..||+|.+....   ......+..|..++.+++|+||+++++++...+     +||+++|+|
T Consensus        69 lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L  148 (412)
T 2vd5_A           69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDL  148 (412)
T ss_dssp             EEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred             EeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcH
Confidence            378999999999864 68999999987532   223456788999999999999999999988765     679999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+++...+..+++..+..++.+|+.||+|||    +.+||||||||+|||+|+++++||+|||+|+.+
T Consensus       149 ~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH----~~giiHrDLKp~NILld~~g~vkL~DFGla~~~  212 (412)
T 2vd5_A          149 LTLLSKFGERIPAEMARFYLAEIVMAIDSVH----RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKL  212 (412)
T ss_dssp             HHHHHHHSSCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeecccCHHHeeecCCCCEEEeechhheec
Confidence            9999765556788889999999999999999    578999999999999999999999999999765

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.85  E-value=1.5e-21  Score=182.50  Aligned_cols=134  Identities=31%  Similarity=0.477  Sum_probs=118.8

Q ss_pred             hccccccceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHHh
Q 039957          341 SLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRL  415 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~l  415 (481)
                      .+.|+||.||++...++..||+|.+..... ..+.+.+|++++++++||||+++++++....     ++|+++|+|.+++
T Consensus        18 lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l   96 (269)
T 4hcu_A           18 IGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYL   96 (269)
T ss_dssp             EEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHH
T ss_pred             ecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHH
Confidence            378999999999987888899999875432 2356889999999999999999999988764     6799999999999


Q ss_pred             hcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          416 YSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       416 ~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ......+++..+..++.++++|++|||    +.+|+||||||+||++++++.+||+|||+++..
T Consensus        97 ~~~~~~~~~~~~~~i~~~i~~~l~~lH----~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  156 (269)
T 4hcu_A           97 RTQRGLFAAETLLGMCLDVCEGMAYLE----EACVIHRDLAARNCLVGENQVIKVSDFGMTRFV  156 (269)
T ss_dssp             HTTTTCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGB
T ss_pred             HhcCcccCHHHHHHHHHHHHHHHHHHH----hCCeecCCcchheEEEcCCCCEEeccccccccc
Confidence            776667899999999999999999999    578999999999999999999999999999864

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.85  E-value=1.6e-21  Score=185.15  Aligned_cols=133  Identities=28%  Similarity=0.430  Sum_probs=117.1

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHH
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKR  414 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~  414 (481)
                      .+.|+||.||++.. .+|..||+|.+........+.+.+|+.++++++||||+++++++...+     +||+++|+|.++
T Consensus        28 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~  107 (297)
T 3fxz_A           28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV  107 (297)
T ss_dssp             EEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHH
T ss_pred             eccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHH
Confidence            47899999999984 568999999987765555567888999999999999999999887664     679999999999


Q ss_pred             hhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          415 LYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       415 l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +...  .+++.....++.++++||+|||    +.+|+||||||+||+++.++.+||+|||+|+..
T Consensus       108 ~~~~--~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (297)
T 3fxz_A          108 VTET--CMDEGQIAAVCRECLQALEFLH----SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI  166 (297)
T ss_dssp             HHHS--CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             Hhhc--CCCHHHHHHHHHHHHHHHHHHH----hCCceeCCCCHHHEEECCCCCEEEeeCCCceec
Confidence            8754  4788899999999999999999    578999999999999999999999999998754

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=99.85  E-value=1.6e-21  Score=187.59  Aligned_cols=134  Identities=25%  Similarity=0.424  Sum_probs=116.2

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      -+.|+||.||+|.. .+|..||+|.+....  ....+.+.+|+.++++++||||+++++++....     +||+++|++.
T Consensus        23 lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~  102 (328)
T 3fe3_A           23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVF  102 (328)
T ss_dssp             EEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHH
T ss_pred             EeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHH
Confidence            37899999999985 578999999987543  233456788999999999999999999987765     6799999999


Q ss_pred             HHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          413 KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       413 ~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +++... ..++..+...++.++++||+|||    +.+|+||||||+||+++.++.+||+|||+|+..
T Consensus       103 ~~l~~~-~~l~~~~~~~~~~qi~~al~~lH----~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  164 (328)
T 3fe3_A          103 DYLVAH-GRMKEKEARSKFRQIVSAVQYCH----QKRIVHRDLKAENLLLDADMNIKIADFGFSNEF  164 (328)
T ss_dssp             HHHHHH-CCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGG
T ss_pred             HHHHHc-CCCCHHHHHHHHHHHHHHHHHHH----HCCEeccCCCHHHEEEcCCCCEEEeeccCceec
Confidence            988653 34778889999999999999999    578999999999999999999999999999754

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.85  E-value=1.2e-21  Score=197.11  Aligned_cols=136  Identities=24%  Similarity=0.452  Sum_probs=118.1

Q ss_pred             hhccccccceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC----cccccCCChhHHh
Q 039957          340 ISLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----FKFMPNGSLEKRL  415 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~~~~g~l~~~l  415 (481)
                      ..+.|+||.||+|...++..||||.+.... ...+.+.+|+.++++++|||||+++++|....    +||+++|+|.+++
T Consensus       195 ~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~lv~e~~~~g~L~~~l  273 (454)
T 1qcf_A          195 KLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFL  273 (454)
T ss_dssp             EEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEECCCTTCBHHHHH
T ss_pred             EcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEeCCccEEEEeecCCCcHHHHH
Confidence            347899999999998888899999987543 33567889999999999999999999987543    6799999999998


Q ss_pred             hcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          416 YSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       416 ~~~-~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      ... ....++..+.+++.+||+||+|||    +.+|+||||||+|||+++++.+||+|||+|+...
T Consensus       274 ~~~~~~~~~~~~~~~~~~qi~~~l~~LH----~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  335 (454)
T 1qcf_A          274 KSDEGSKQPLPKLIDFSAQIAEGMAFIE----QRNYIHRDLRAANILVSASLVCKIADFGLARVIE  335 (454)
T ss_dssp             HSHHHHTCCHHHHHHHHHHHHHHHHHHH----HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred             HhccCCCCCHHHHHHHHHHHHHHHHHHH----hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence            753 235678899999999999999999    5789999999999999999999999999998753

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.85  E-value=2.4e-21  Score=180.98  Aligned_cols=134  Identities=29%  Similarity=0.454  Sum_probs=117.9

Q ss_pred             hccccccceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHHh
Q 039957          341 SLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRL  415 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~l  415 (481)
                      -+.|+||.||++...++..||+|.+..... ..+.+.+|++++.+++||||++++++|....     ++|+++|+|.+++
T Consensus        16 lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l   94 (268)
T 3sxs_A           16 LGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYL   94 (268)
T ss_dssp             EEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHH
T ss_pred             eccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHH
Confidence            368999999999888888899999865432 2356888999999999999999999997764     6789999999998


Q ss_pred             hcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          416 YSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       416 ~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ......+++..+..++.++++|++|||    +.+|+||||||+||++++++.+||+|||+++..
T Consensus        95 ~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~  154 (268)
T 3sxs_A           95 RSHGKGLEPSQLLEMCYDVCEGMAFLE----SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYV  154 (268)
T ss_dssp             HHHGGGCCHHHHHHHHHHHHHHHHHHH----HTTEEESSCSGGGEEECTTCCEEECCTTCEEEC
T ss_pred             HHcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCcCcceEEECCCCCEEEccCccceec
Confidence            776556889999999999999999999    578999999999999999999999999998754

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.85  E-value=2.9e-21  Score=184.41  Aligned_cols=135  Identities=33%  Similarity=0.562  Sum_probs=112.3

Q ss_pred             hhccccccceeeeeccCCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          340 ISLAGSFGSVYKGTISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      .-+.|+||.||++.. .|..||+|.+....  ....+.+.+|++++++++|+||+++++++...+     +||+++|+|.
T Consensus        44 ~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~  122 (309)
T 3p86_A           44 KIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY  122 (309)
T ss_dssp             EEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHH
T ss_pred             EeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHH
Confidence            347899999999976 58889999986543  233456889999999999999999999987765     6799999999


Q ss_pred             HHhhcCCC--ccCHHHHHHHHHHHHHHHHHHhcCCCCCC--eeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          413 KRLYSHNY--FLDILERLNIMIDVGSTLEYLHHGHSSAP--IIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       413 ~~l~~~~~--~~~~~~~~~i~~~ia~~l~~lH~~~~~~~--i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +++.....  .+++..+..++.++++||+|||    +.+  |+||||||+||++++++.+||+|||+|+..
T Consensus       123 ~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  189 (309)
T 3p86_A          123 RLLHKSGAREQLDERRRLSMAYDVAKGMNYLH----NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK  189 (309)
T ss_dssp             HHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH----TSSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred             HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH----cCCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence            99876432  3788999999999999999999    456  999999999999999999999999998753

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.85  E-value=4.7e-21  Score=181.14  Aligned_cols=188  Identities=22%  Similarity=0.282  Sum_probs=107.6

Q ss_pred             CeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeeccc
Q 039957           16 KSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGF   95 (481)
Q Consensus        16 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~   95 (481)
                      ..+.+..+.+++..+  +..+++|+.|++++|.++ .+|. +. .+++|++|++++|++++..+  +..+++|++|++++
T Consensus        27 ~~~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~-~~~~-~~-~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~   99 (291)
T 1h6t_A           27 IKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQ-YLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDE   99 (291)
T ss_dssp             HHHHTTCSCTTSEEC--HHHHHTCCEEECTTSCCC-CCTT-GG-GCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCS
T ss_pred             HHHHhcCCCcccccc--hhhcCcccEEEccCCCcc-cChh-Hh-cCCCCCEEEccCCccCCCcc--cccCCCCCEEECCC
Confidence            334455555544322  345566666666666665 3443 32 46666666666666654433  56666666666666


Q ss_pred             CcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEcc
Q 039957           96 NTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSAS  175 (481)
Q Consensus        96 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~  175 (481)
                      |.+++. | .+..+++|++|++++|+++.+          ..+..+++|++|++++|++++.  +.+..+ ++|+.|+++
T Consensus       100 n~l~~~-~-~l~~l~~L~~L~L~~n~i~~~----------~~l~~l~~L~~L~l~~n~l~~~--~~l~~l-~~L~~L~L~  164 (291)
T 1h6t_A          100 NKVKDL-S-SLKDLKKLKSLSLEHNGISDI----------NGLVHLPQLESLYLGNNKITDI--TVLSRL-TKLDTLSLE  164 (291)
T ss_dssp             SCCCCG-G-GGTTCTTCCEEECTTSCCCCC----------GGGGGCTTCCEEECCSSCCCCC--GGGGGC-TTCSEEECC
T ss_pred             CcCCCC-h-hhccCCCCCEEECCCCcCCCC----------hhhcCCCCCCEEEccCCcCCcc--hhhccC-CCCCEEEcc
Confidence            666542 2 366666666666666666554          1234555666666666666543  344444 456666666


Q ss_pred             CCceeecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCC
Q 039957          176 ECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQG  229 (481)
Q Consensus       176 ~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~  229 (481)
                      +|++++..|  +..+++|++|++++|.+++ +| .+..+++|+.|++++|.+..
T Consensus       165 ~N~l~~~~~--l~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~i~~  214 (291)
T 1h6t_A          165 DNQISDIVP--LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECLN  214 (291)
T ss_dssp             SSCCCCCGG--GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEEEEEEC
T ss_pred             CCccccchh--hcCCCccCEEECCCCcCCC-Ch-hhccCCCCCEEECcCCcccC
Confidence            666664433  6666666666666666654 23 36666666666666666654

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.85  E-value=3.2e-21  Score=188.69  Aligned_cols=133  Identities=17%  Similarity=0.271  Sum_probs=110.5

Q ss_pred             hhccccccceeeee------ccCCcceEEEEEeccchhhhhhhhHHHHHhhhhc---cCccceeecccCCCC-----ccc
Q 039957          340 ISLAGSFGSVYKGT------ISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVR---HQNLIKILSSCSTPD-----FKF  405 (481)
Q Consensus       340 l~~~g~~g~vy~~~------l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~-----~~~  405 (481)
                      .-+.|+||.||+|.      ..++..||+|.+.....   ..+..|++++.+++   |+|++++++++...+     +||
T Consensus        72 ~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~  148 (365)
T 3e7e_A           72 LLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGEL  148 (365)
T ss_dssp             EEEECSSEEEEEEEC-------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECC
T ss_pred             EeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEec
Confidence            34789999999993      45688999999865432   34566666666665   999999999987664     689


Q ss_pred             ccCCChhHHhhc----CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCC-----------CCcEEE
Q 039957          406 MPNGSLEKRLYS----HNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDE-----------NMVAHV  470 (481)
Q Consensus       406 ~~~g~l~~~l~~----~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~-----------~~~~kl  470 (481)
                      +++|+|.+++..    ....+++..+..|+.+|++||+|||    +.+||||||||+|||++.           ++.+||
T Consensus       149 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH----~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl  224 (365)
T 3e7e_A          149 YSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH----DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLAL  224 (365)
T ss_dssp             CCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCSGGGEEECGGGTCC------CTTEEE
T ss_pred             cCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh----hCCeecCCCCHHHEEecccccCccccccccCCEEE
Confidence            999999999864    3456899999999999999999999    678999999999999998           899999


Q ss_pred             ccccCcccC
Q 039957          471 SDFGISKLL  479 (481)
Q Consensus       471 ~Dfgl~~~~  479 (481)
                      +|||+|+.+
T Consensus       225 ~DFG~a~~~  233 (365)
T 3e7e_A          225 IDLGQSIDM  233 (365)
T ss_dssp             CCCTTCEEG
T ss_pred             eeCchhhhh
Confidence            999999643

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.85  E-value=2.3e-21  Score=186.31  Aligned_cols=135  Identities=27%  Similarity=0.440  Sum_probs=112.1

Q ss_pred             hccccccceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC---------cccccCCCh
Q 039957          341 SLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD---------FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---------~~~~~~g~l  411 (481)
                      -+.|+||.||+|... +..||||++...... ...+..|+.++++++||||+++++++....         +||+++|+|
T Consensus        32 lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L  109 (322)
T 3soc_A           32 KARGRFGCVWKAQLL-NEYVAVKIFPIQDKQ-SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSL  109 (322)
T ss_dssp             EECSTTCEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBH
T ss_pred             ecccCceEEEEEEEC-CCEEEEEEeecCchH-HHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCH
Confidence            378999999999864 789999998654322 334556888999999999999999886532         578999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCC------CCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGH------SSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~------~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+++...  .++|..+.+++.++++||+|||..+      ..++|+||||||+|||+++++.+||+|||+|+.+
T Consensus       110 ~~~l~~~--~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~  181 (322)
T 3soc_A          110 SDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF  181 (322)
T ss_dssp             HHHHHHC--CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEE
T ss_pred             HHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCccccc
Confidence            9998764  3789999999999999999999320      0128999999999999999999999999999754

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.85  E-value=2.5e-21  Score=196.79  Aligned_cols=135  Identities=28%  Similarity=0.506  Sum_probs=118.0

Q ss_pred             hhccccccceeeeeccC-CcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhH
Q 039957          340 ISLAGSFGSVYKGTISD-GTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEK  413 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~~-g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~  413 (481)
                      ..+.|+||.||+|.... +..||||.+.... ...+.|.+|+.++++++|+||++++++|....     +||+++|+|.+
T Consensus       227 ~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~  305 (495)
T 1opk_A          227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD  305 (495)
T ss_dssp             ESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHH
T ss_pred             EecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHH
Confidence            34789999999998764 7889999986543 23467889999999999999999999997764     67999999999


Q ss_pred             HhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          414 RLYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       414 ~l~~~-~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ++... ...+++..+..++.+|++||+|||    +.+|+||||||+|||+++++.+||+|||+|+..
T Consensus       306 ~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH----~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  368 (495)
T 1opk_A          306 YLRECNRQEVSAVVLLYMATQISSAMEYLE----KKNFIHRNLAARNCLVGENHLVKVADFGLSRLM  368 (495)
T ss_dssp             HHHHSCTTTSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred             HHHhcCcCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCChhhEEECCCCcEEEeecccceec
Confidence            98763 345889999999999999999999    578999999999999999999999999999875

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.85  E-value=3.1e-21  Score=186.02  Aligned_cols=135  Identities=24%  Similarity=0.394  Sum_probs=112.9

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccch-hhhhhhhHHHHHhhhhccCccceeecccCCC-----------------
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRE-RAFRSFNSECEVLRNVRHQNLIKILSSCSTP-----------------  401 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----------------  401 (481)
                      -++|+||.||+|... +|..||||++..... ...+.+.+|+.++++++||||++++++|...                 
T Consensus        14 lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~   93 (332)
T 3qd2_B           14 MGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDE   93 (332)
T ss_dssp             EECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC------
T ss_pred             ecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccc
Confidence            378999999999865 789999999875442 3446788999999999999999999876321                 


Q ss_pred             ---------------------------------------------CcccccCCChhHHhhcCC--CccCHHHHHHHHHHH
Q 039957          402 ---------------------------------------------DFKFMPNGSLEKRLYSHN--YFLDILERLNIMIDV  434 (481)
Q Consensus       402 ---------------------------------------------~~~~~~~g~l~~~l~~~~--~~~~~~~~~~i~~~i  434 (481)
                                                                   .+||+++|+|.+++....  ...++..+.+++.++
T Consensus        94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi  173 (332)
T 3qd2_B           94 STDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQI  173 (332)
T ss_dssp             --------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHH
T ss_pred             cccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHH
Confidence                                                         156889999999987633  335667788999999


Q ss_pred             HHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          435 GSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       435 a~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ++||+|||    +.+|+||||||+||+++.++.+||+|||+|+.+
T Consensus       174 ~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~  214 (332)
T 3qd2_B          174 AEAVEFLH----SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM  214 (332)
T ss_dssp             HHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             HHHHHHHH----hCCeeecCCCcccEEEeCCCCEEEeecCccccc
Confidence            99999999    578999999999999999999999999999865

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.84  E-value=1.8e-21  Score=201.33  Aligned_cols=172  Identities=24%  Similarity=0.345  Sum_probs=91.3

Q ss_pred             hCCCCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCc
Q 039957           10 GNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLI   89 (481)
Q Consensus        10 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~   89 (481)
                      ..+++|+.|++++|.+..+ | .+..+++|+.|+|++|++++ +|. +. .+++|++|+|++|++++ +| .+..+++|+
T Consensus        40 ~~L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~-~~~-l~-~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~  112 (605)
T 1m9s_A           40 NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTD-IKP-LT-NLKNLGWLFLDENKIKD-LS-SLKDLKKLK  112 (605)
T ss_dssp             HHHTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCC-CGG-GG-GCTTCCEEECCSSCCCC-CT-TSTTCTTCC
T ss_pred             hcCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCC-Chh-hc-cCCCCCEEECcCCCCCC-Ch-hhccCCCCC
Confidence            4455555666666655543 2 35555666666666666553 332 22 45566666666665543 22 455555666


Q ss_pred             eeecccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCc
Q 039957           90 ILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSL  169 (481)
Q Consensus        90 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L  169 (481)
                      .|+|++|.+++.  ..|..+++|+.|+|++|.++++          ..+..+++|+.|+|++|.+++..|  +..+ ++|
T Consensus       113 ~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l----------~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l-~~L  177 (605)
T 1m9s_A          113 SLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI----------TVLSRLTKLDTLSLEDNQISDIVP--LAGL-TKL  177 (605)
T ss_dssp             EEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC----------GGGGSCTTCSEEECCSSCCCCCGG--GTTC-TTC
T ss_pred             EEEecCCCCCCC--ccccCCCccCEEECCCCccCCc----------hhhcccCCCCEEECcCCcCCCchh--hccC-CCC
Confidence            666666655542  2355556666666666655543          123445555566666665554433  4333 355


Q ss_pred             cEEEccCCceeecCCcccccCCCCCeEeccccccee
Q 039957          170 QRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNG  205 (481)
Q Consensus       170 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~  205 (481)
                      +.|+|++|.+++.  ..+..+++|+.|+|++|.+.+
T Consensus       178 ~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~  211 (605)
T 1m9s_A          178 QNLYLSKNHISDL--RALAGLKNLDVLELFSQECLN  211 (605)
T ss_dssp             CEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEEC
T ss_pred             CEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcC
Confidence            5555555555532  235555555555555555554

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.84  E-value=3.7e-21  Score=181.27  Aligned_cols=134  Identities=30%  Similarity=0.464  Sum_probs=115.4

Q ss_pred             hccccccceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHHh
Q 039957          341 SLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRL  415 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~l  415 (481)
                      .+.|+||.||++...++..||+|.+...... .+.+.+|++++.+++|+||++++++|....     ++|+++|+|.+++
T Consensus        32 lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l  110 (283)
T 3gen_A           32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL  110 (283)
T ss_dssp             CC---CEEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHH
T ss_pred             cCCCCCceEEEEEEcCCCeEEEEEecCCCCC-HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHH
Confidence            3689999999999888888999998754322 356888999999999999999999997764     6789999999998


Q ss_pred             hcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          416 YSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       416 ~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ......+++.++..++.++++||+|||    +.+|+||||||+||++++++.+||+|||+++..
T Consensus       111 ~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  170 (283)
T 3gen_A          111 REMRHRFQTQQLLEMCKDVCEAMEYLE----SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV  170 (283)
T ss_dssp             HCGGGCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGB
T ss_pred             HHhccCCCHHHHHHHHHHHHHHHHHHH----HCCccCCCCccceEEEcCCCCEEEccccccccc
Confidence            765566889999999999999999999    578999999999999999999999999999864

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.84  E-value=4.5e-21  Score=183.24  Aligned_cols=134  Identities=25%  Similarity=0.397  Sum_probs=114.5

Q ss_pred             hccccccceeeeeccCCcceEEEEEeccch--hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhH
Q 039957          341 SLAGSFGSVYKGTISDGTDVAIKIFNLQRE--RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEK  413 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~  413 (481)
                      .+.|+||.||++...+|..||+|.+.....  .....+.+|++++++++||||+++++++....     +||++ |++.+
T Consensus        29 lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~l~~  107 (311)
T 3niz_A           29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKK  107 (311)
T ss_dssp             EEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS-EEHHH
T ss_pred             ccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC-CCHHH
Confidence            378999999999988899999999865432  23356788999999999999999999998765     56787 58888


Q ss_pred             HhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          414 RLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       414 ~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+......+++..+..++.++++||+|||    +.+|+||||||+||+++.++.+||+|||+|+..
T Consensus       108 ~~~~~~~~~~~~~~~~~~~qi~~~l~~LH----~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~  169 (311)
T 3niz_A          108 VLDENKTGLQDSQIKIYLYQLLRGVAHCH----QHRILHRDLKPQNLLINSDGALKLADFGLARAF  169 (311)
T ss_dssp             HHHTCTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCEET
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCchHhEEECCCCCEEEccCcCceec
Confidence            87766666888999999999999999999    578999999999999999999999999999764

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.84  E-value=2e-21  Score=202.38  Aligned_cols=135  Identities=24%  Similarity=0.442  Sum_probs=118.4

Q ss_pred             hccccccceeeeecc---CCcceEEEEEeccch-hhhhhhhHHHHHhhhhccCccceeecccCCCC----cccccCCChh
Q 039957          341 SLAGSFGSVYKGTIS---DGTDVAIKIFNLQRE-RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----FKFMPNGSLE  412 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~---~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~~~~g~l~  412 (481)
                      .+.|+||.||+|...   ++..||||.+..... ...+.+.+|++++++++|+|||+++++|....    +||+++|+|.
T Consensus       344 LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~E~~~~g~L~  423 (613)
T 2ozo_A          344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLH  423 (613)
T ss_dssp             EEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESSSEEEEEECCTTCBHH
T ss_pred             EecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccCCeEEEEEeCCCCcHH
Confidence            378999999999764   456799999876432 34567889999999999999999999997654    6799999999


Q ss_pred             HHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          413 KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       413 ~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +++......+++..+..|+.+|++||+|||    +.+|+||||||+|||+++++.+||+|||+|+.+
T Consensus       424 ~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH----~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~  486 (613)
T 2ozo_A          424 KFLVGKREEIPVSNVAELLHQVSMGMKYLE----EKNFVHRNLAARNVLLVNRHYAKISDFGLSKAL  486 (613)
T ss_dssp             HHHTTCTTTSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred             HHHhhccCCCCHHHHHHHHHHHHHHHHHHH----HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence            999876667899999999999999999999    578999999999999999999999999999875

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.84  E-value=2.4e-21  Score=200.51  Aligned_cols=190  Identities=23%  Similarity=0.315  Sum_probs=96.7

Q ss_pred             CCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeecc
Q 039957           15 LKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLG   94 (481)
Q Consensus        15 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls   94 (481)
                      +..+.++.+.+....+  +..+++|+.|++++|.++ .+|. +. .+++|++|+|++|++++..|  +..+++|+.|+|+
T Consensus        23 l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~-~l~~-l~-~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls   95 (605)
T 1m9s_A           23 TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQ-YLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLD   95 (605)
T ss_dssp             HHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCC-CCTT-GG-GCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECC
T ss_pred             HHHHhccCCCcccccc--hhcCCCCCEEECcCCCCC-CChH-Hc-cCCCCCEEEeeCCCCCCChh--hccCCCCCEEECc
Confidence            4444555555544333  345555566666666554 3442 22 45555556655555554333  5555555555555


Q ss_pred             cCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEc
Q 039957           95 FNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSA  174 (481)
Q Consensus        95 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l  174 (481)
                      +|.+++ +| .|..+++|+.|+|++|.++.+          +.+..+++|+.|+|++|.+                    
T Consensus        96 ~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l----------~~l~~l~~L~~L~Ls~N~l--------------------  143 (605)
T 1m9s_A           96 ENKIKD-LS-SLKDLKKLKSLSLEHNGISDI----------NGLVHLPQLESLYLGNNKI--------------------  143 (605)
T ss_dssp             SSCCCC-CT-TSTTCTTCCEEECTTSCCCCC----------GGGGGCTTCSEEECCSSCC--------------------
T ss_pred             CCCCCC-Ch-hhccCCCCCEEEecCCCCCCC----------ccccCCCccCEEECCCCcc--------------------
Confidence            555553 12 355555555555555555443          1123344444444444444                    


Q ss_pred             cCCceeecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeeeec
Q 039957          175 SECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGH  254 (481)
Q Consensus       175 ~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  254 (481)
                           ++.  ..+..+++|+.|+|++|.+.+..|  +..+++|+.|+|++|.+++.  ..+..+++|+.|+|++|.+.+.
T Consensus       144 -----~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~  212 (605)
T 1m9s_A          144 -----TDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNK  212 (605)
T ss_dssp             -----CCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECC
T ss_pred             -----CCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCC
Confidence                 432  334455555555555555554433  55555555555555555543  2355556666666666666543

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.84  E-value=1.3e-21  Score=188.45  Aligned_cols=135  Identities=28%  Similarity=0.480  Sum_probs=111.0

Q ss_pred             hccccccceeeeec-cCCcc----eEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC----cccccCCC
Q 039957          341 SLAGSFGSVYKGTI-SDGTD----VAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----FKFMPNGS  410 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~----vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~~~~g~  410 (481)
                      .+.|+||.||+|.. .+|..    |++|.+.... ....+.+.+|+.++++++|+||++++++|....    ++|+++|+
T Consensus        23 lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~g~  102 (327)
T 3poz_A           23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGC  102 (327)
T ss_dssp             EEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSSEEEEEECCTTCB
T ss_pred             EeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCc
Confidence            47899999999985 34544    4777764432 234467889999999999999999999998765    56899999


Q ss_pred             hhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          411 LEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       411 l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      |.+++......+++..+.+++.++++||+|||    +.+|+||||||+|||++.++.+||+|||+|+.+
T Consensus       103 L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH----~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  167 (327)
T 3poz_A          103 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE----DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             HHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh----hCCeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence            99999876677899999999999999999999    578999999999999999999999999998754

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.84  E-value=5.8e-21  Score=187.64  Aligned_cols=136  Identities=23%  Similarity=0.392  Sum_probs=118.5

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHH
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKR  414 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~  414 (481)
                      .+.|+||.||+|... +|..+|+|.+..........+.+|+.++.+++|+||+++++++....     +||+++|+|.++
T Consensus        59 LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~  138 (387)
T 1kob_A           59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDR  138 (387)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHH
T ss_pred             EecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHH
Confidence            478999999999864 68899999987665444557889999999999999999999987764     679999999999


Q ss_pred             hhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCC--CCcEEEccccCcccCC
Q 039957          415 LYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDE--NMVAHVSDFGISKLLG  480 (481)
Q Consensus       415 l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~--~~~~kl~Dfgl~~~~~  480 (481)
                      +......+++.++..++.+|++||+|||    +.+|+||||||+|||++.  .+.+||+|||+|+.+.
T Consensus       139 l~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~  202 (387)
T 1kob_A          139 IAAEDYKMSEAEVINYMRQACEGLKHMH----EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN  202 (387)
T ss_dssp             TTCTTCCBCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred             HHhhcCCCCHHHHHHHHHHHHHHHHHHH----hCCeeecccchHHeEEecCCCCceEEEecccceecC
Confidence            8876667899999999999999999999    578999999999999974  5789999999998653

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.84  E-value=3e-21  Score=190.81  Aligned_cols=133  Identities=20%  Similarity=0.257  Sum_probs=114.6

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      .+.|+||.||++... +|..+|+|.+....   ......+..|+.+++.++|||||+++++|.+..     +||+++|+|
T Consensus        77 LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L  156 (410)
T 3v8s_A           77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL  156 (410)
T ss_dssp             EEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEH
T ss_pred             EEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            378999999999865 58899999986532   122345778999999999999999999998765     679999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+++...  .++...+..++.+|+.||+|||    +.+||||||||+|||+|.++++||+|||+|+.+
T Consensus       157 ~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH----~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~  218 (410)
T 3v8s_A          157 VNLMSNY--DVPEKWARFYTAEVVLALDAIH----SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM  218 (410)
T ss_dssp             HHHHHHC--CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             HHHHHcC--CCCHHHHHHHHHHHHHHHHHHH----HCCeEeccCCHHHeeECCCCCEEEeccceeEee
Confidence            9988754  4677888899999999999999    578999999999999999999999999999764

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.84  E-value=3.8e-21  Score=185.03  Aligned_cols=135  Identities=25%  Similarity=0.478  Sum_probs=113.9

Q ss_pred             hccccccceeeeec-cCCcc----eEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC----cccccCCC
Q 039957          341 SLAGSFGSVYKGTI-SDGTD----VAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----FKFMPNGS  410 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~----vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~~~~g~  410 (481)
                      .+.|+||.||+|.. .+|..    |++|.+.... ......+.+|+.++++++|+||++++++|....    ++|+++|+
T Consensus        21 lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~~  100 (325)
T 3kex_A           21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQLVTQYLPLGS  100 (325)
T ss_dssp             EECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBSSEEEEEECCTTCB
T ss_pred             eeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCccEEEEEeCCCCC
Confidence            47899999999985 34554    6677664332 233456788999999999999999999987554    57899999


Q ss_pred             hhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          411 LEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       411 l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      |.+++......+++..+..++.++++||+|||    +.+|+||||||+|||++.++.+||+|||+|+.+
T Consensus       101 L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  165 (325)
T 3kex_A          101 LLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE----EHGMVHRNLAARNVLLKSPSQVQVADFGVADLL  165 (325)
T ss_dssp             SHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHH----HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred             HHHHHHHccccCCHHHHHHHHHHHHHHHHHHH----hCCCCCCccchheEEECCCCeEEECCCCccccc
Confidence            99998876567888899999999999999999    578999999999999999999999999999865

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.84  E-value=5.7e-21  Score=183.31  Aligned_cols=134  Identities=22%  Similarity=0.369  Sum_probs=116.7

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHH
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKR  414 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~  414 (481)
                      -+.|+||.||++... +|..+|+|.+.... .....+.+|+.++..++||||+++++++...+     +||+++|+|.++
T Consensus        13 lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~   91 (321)
T 1tki_A           13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFER   91 (321)
T ss_dssp             EEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHH
T ss_pred             EecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHH
Confidence            378999999999854 57889999886543 23456788999999999999999999987664     679999999999


Q ss_pred             hhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCC--CCcEEEccccCcccC
Q 039957          415 LYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDE--NMVAHVSDFGISKLL  479 (481)
Q Consensus       415 l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~--~~~~kl~Dfgl~~~~  479 (481)
                      +......+++.++..++.++++||+|||    +.+|+||||||+||+++.  ++.+||+|||+++.+
T Consensus        92 l~~~~~~~~~~~~~~i~~qi~~al~~lH----~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~  154 (321)
T 1tki_A           92 INTSAFELNEREIVSYVHQVCEALQFLH----SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             HTSSSCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             HHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence            9776667889999999999999999999    578999999999999987  799999999999865

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.84  E-value=2.2e-20  Score=168.93  Aligned_cols=153  Identities=22%  Similarity=0.265  Sum_probs=100.9

Q ss_pred             EEEccCCceeecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCe
Q 039957          171 RFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNK  250 (481)
Q Consensus       171 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~  250 (481)
                      .++++++.++ .+|..+.  ++++.|++++|++++..+..|..+++|+.|++++|++++..|..|..+++|+.|+|++|+
T Consensus        15 ~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~   91 (220)
T 2v9t_B           15 IVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK   91 (220)
T ss_dssp             EEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSC
T ss_pred             EEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCc
Confidence            3444444444 2343332  355566666666655555556666666666666666666566666666666666777776


Q ss_pred             eeecCCcccccCCCCCcEEcCCCcCcccCCcchhccccCcEEEccCcccCCCCCCccccCCcCcEEEccCCeeeee
Q 039957          251 LSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGD  326 (481)
Q Consensus       251 l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~  326 (481)
                      +++..+..|..+++|++|++++|++++..|..|..++.|+.|++++|.+++..+..+..+++|+.|++++|++.+.
T Consensus        92 l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~  167 (220)
T 2v9t_B           92 ITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICD  167 (220)
T ss_dssp             CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred             CCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCC
Confidence            6665555666777777777777777766677777777777777777777777677777888888888888888764

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.84  E-value=2.8e-21  Score=189.23  Aligned_cols=136  Identities=25%  Similarity=0.495  Sum_probs=110.8

Q ss_pred             hhccccccceeeeeccC--C--cceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC------cccccC
Q 039957          340 ISLAGSFGSVYKGTISD--G--TDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD------FKFMPN  408 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~~--g--~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~~~~  408 (481)
                      ..++|+||.||+|...+  +  ..+|+|.+.... ....+.+.+|+.++++++||||++++++|...+      +||+++
T Consensus        96 ~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~  175 (373)
T 3c1x_A           96 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKH  175 (373)
T ss_dssp             EEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTT
T ss_pred             EeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCC
Confidence            44789999999998642  2  358889876432 334567889999999999999999999875432      579999


Q ss_pred             CChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          409 GSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       409 g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      |+|.+++.......++.+...++.+|++||+|||    +.+|+||||||+||++++++.+||+|||+|+.+
T Consensus       176 g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~  242 (373)
T 3c1x_A          176 GDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA----SKKFVHRDLAARNCMLDEKFTVKVADFGLARDM  242 (373)
T ss_dssp             CBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             CCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH----HCCEecCccchheEEECCCCCEEEeeccccccc
Confidence            9999999876667889999999999999999999    578999999999999999999999999999754

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.84  E-value=6.7e-21  Score=182.41  Aligned_cols=134  Identities=29%  Similarity=0.363  Sum_probs=115.5

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccch---hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRE---RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      .+.|+||.||++... +|..+|+|.+.....   ...+.+.+|+.+++.++||||+++++++....     +||+++|+|
T Consensus        14 lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L   93 (318)
T 1fot_A           14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGEL   93 (318)
T ss_dssp             EEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred             EeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCH
Confidence            378999999999864 689999999875432   23455778999999999999999999987765     679999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+++... ..+++..+..++.+|+.||+|||    +.+|+||||||+|||++.++++||+|||+|+..
T Consensus        94 ~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~  156 (318)
T 1fot_A           94 FSLLRKS-QRFPNPVAKFYAAEVCLALEYLH----SKDIIYRDLKPENILLDKNGHIKITDFGFAKYV  156 (318)
T ss_dssp             HHHHHHT-SSCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred             HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH----HCCccccCCChheEEEcCCCCEEEeecCcceec
Confidence            9998754 35678888999999999999999    678999999999999999999999999999764

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.84  E-value=7.7e-21  Score=179.68  Aligned_cols=189  Identities=22%  Similarity=0.276  Sum_probs=119.1

Q ss_pred             CCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeecccCcceecCcccccCCCCCCEEEc
Q 039957           38 TIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSL  117 (481)
Q Consensus        38 ~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  117 (481)
                      ++..+.+..+.+++..+..   .+++|++|++++|.+... + .+..+++|++|++++|.+++..+  +..+++|++|++
T Consensus        25 ~~~~~~l~~~~~~~~~~~~---~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l   97 (291)
T 1h6t_A           25 ETIKDNLKKKSVTDAVTQN---ELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFL   97 (291)
T ss_dssp             HHHHHHTTCSCTTSEECHH---HHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred             HHHHHHhcCCCcccccchh---hcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEEC
Confidence            3445556667666433322   467888888888888643 3 37788888888888888886554  888888888888


Q ss_pred             ccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEccCCceeecCCcccccCCCCCeEe
Q 039957          118 LMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLS  197 (481)
Q Consensus       118 ~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~  197 (481)
                      ++|.++.++          .+..+++|++|++++|++++.  +.+..+ ++|+.|++++|++++.  ..+..+++|++|+
T Consensus        98 ~~n~l~~~~----------~l~~l~~L~~L~L~~n~i~~~--~~l~~l-~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~  162 (291)
T 1h6t_A           98 DENKVKDLS----------SLKDLKKLKSLSLEHNGISDI--NGLVHL-PQLESLYLGNNKITDI--TVLSRLTKLDTLS  162 (291)
T ss_dssp             CSSCCCCGG----------GGTTCTTCCEEECTTSCCCCC--GGGGGC-TTCCEEECCSSCCCCC--GGGGGCTTCSEEE
T ss_pred             CCCcCCCCh----------hhccCCCCCEEECCCCcCCCC--hhhcCC-CCCCEEEccCCcCCcc--hhhccCCCCCEEE
Confidence            888887652          256677788888888877753  344444 4566666666666643  3455666666666


Q ss_pred             cccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeee
Q 039957          198 LGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLS  252 (481)
Q Consensus       198 l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~  252 (481)
                      +++|++++..|  +..+++|+.|++++|.+++. | .+..+++|+.|++++|+++
T Consensus       163 L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~  213 (291)
T 1h6t_A          163 LEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECL  213 (291)
T ss_dssp             CCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEE
T ss_pred             ccCCccccchh--hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCccc
Confidence            66666654333  55555555555555555442 1 2444455555555555444

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.84  E-value=2.4e-23  Score=214.13  Aligned_cols=188  Identities=18%  Similarity=0.148  Sum_probs=111.3

Q ss_pred             CCCCccEEEccCccceeecchhccccccCceeecccCc-------------ceecCcccccCCCCCCEEE-cccccCccc
Q 039957           60 SLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNT-------------FSGHIPNTFGNLRHLSVLS-LLMNNLTTE  125 (481)
Q Consensus        60 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-------------l~~~~p~~~~~l~~L~~L~-L~~N~l~~~  125 (481)
                      ..++|+.|+|++|+++ .+|..++++++|+.|++++|.             +.+.+|..++.+++|+.|+ ++.|.+.  
T Consensus       347 ~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~--  423 (567)
T 1dce_A          347 TDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD--  423 (567)
T ss_dssp             TTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH--
T ss_pred             cCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc--
Confidence            4567777777777775 667777777777777776654             3445555566666666665 4444332  


Q ss_pred             cCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEccCCceeecCCcccccCCCCCeEeccccccee
Q 039957          126 SSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNG  205 (481)
Q Consensus       126 ~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~  205 (481)
                                       .|..+.+++|.++...+       ..|+.|++++|.+++ +|. ++.+++|+.|+|++|.++ 
T Consensus       424 -----------------~L~~l~l~~n~i~~l~~-------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-  476 (567)
T 1dce_A          424 -----------------DLRSKFLLENSVLKMEY-------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-  476 (567)
T ss_dssp             -----------------HHHHHHHHHHHHHHHHH-------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-
T ss_pred             -----------------hhhhhhhhcccccccCc-------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-
Confidence                             13334455555543211       236666666666664 454 666666666666666665 


Q ss_pred             cCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeeeecC-CcccccCCCCCcEEcCCCcCcccC
Q 039957          206 TIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHI-PPCLASLTSLRELDLGSNKLTSSI  279 (481)
Q Consensus       206 ~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~ls~N~l~~~~  279 (481)
                      .+|..++.+++|+.|++++|++++ +| .++.+++|+.|+|++|++++.. |..|..+++|+.|++++|++++.+
T Consensus       477 ~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~  549 (567)
T 1dce_A          477 ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEE  549 (567)
T ss_dssp             CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSS
T ss_pred             ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCc
Confidence            556666666666666666666655 33 5555666666666666665554 555666666666666666655443

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.84  E-value=9.2e-21  Score=184.94  Aligned_cols=158  Identities=22%  Similarity=0.169  Sum_probs=88.0

Q ss_pred             CccEEEccCCceeecCCcccc-cCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeec
Q 039957          168 SLQRFSASECKLKGTIPKEIG-HLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHL  246 (481)
Q Consensus       168 ~L~~L~l~~n~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L  246 (481)
                      .++.|++++|++++..+..+. .+++|++|+|++|++++..+..|..+++|+.|+|++|++++..+..|..+++|+.|+|
T Consensus        40 ~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  119 (361)
T 2xot_A           40 YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLL  119 (361)
T ss_dssp             TCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred             CCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEEC
Confidence            345555555555544444444 5555555555555555555555555555555555555555555555555566666666


Q ss_pred             CCCeeeecCCcccccCCCCCcEEcCCCcCcccCCcch---hccccCcEEEccCcccCCCCCCccccCCc--CcEEEccCC
Q 039957          247 GGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSL---WSLGYILEINLSSNLLNDSLPSNVQKLKV--LRVLDLSRN  321 (481)
Q Consensus       247 ~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~---~~l~~L~~L~l~~N~l~~~~p~~~~~l~~--L~~L~l~~N  321 (481)
                      ++|++++..|..|..+++|+.|+|++|++++..+..+   ..++.|+.|++++|++++..+..+..++.  ++.|++++|
T Consensus       120 ~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N  199 (361)
T 2xot_A          120 YNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN  199 (361)
T ss_dssp             CSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSS
T ss_pred             CCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCC
Confidence            6666655555556666666666666666654333333   34556666666666665544445555554  356666666


Q ss_pred             eeee
Q 039957          322 QLSG  325 (481)
Q Consensus       322 ~l~~  325 (481)
                      ++.+
T Consensus       200 ~~~C  203 (361)
T 2xot_A          200 PLEC  203 (361)
T ss_dssp             CEEC
T ss_pred             CccC
Confidence            6654

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.84  E-value=4.5e-21  Score=181.22  Aligned_cols=135  Identities=24%  Similarity=0.424  Sum_probs=117.4

Q ss_pred             hccccccceeeeeccC-C-------cceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----ccccc
Q 039957          341 SLAGSFGSVYKGTISD-G-------TDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMP  407 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~-g-------~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~  407 (481)
                      .+.|+||.||++.... +       ..||+|.+........+.+.+|+.++++++|+||++++++|...+     +||++
T Consensus        16 lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   95 (289)
T 4fvq_A           16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVK   95 (289)
T ss_dssp             EEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEECCT
T ss_pred             eccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCC
Confidence            3689999999997543 3       469999987665555677889999999999999999999998764     67999


Q ss_pred             CCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCc--------EEEccccCcccC
Q 039957          408 NGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMV--------AHVSDFGISKLL  479 (481)
Q Consensus       408 ~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~--------~kl~Dfgl~~~~  479 (481)
                      +|+|.+++......+++..+.+++.++++||+|||    +.+|+||||||+||+++.++.        +||+|||+++..
T Consensus        96 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~  171 (289)
T 4fvq_A           96 FGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE----ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV  171 (289)
T ss_dssp             TCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTT
T ss_pred             CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHh----hCCeECCCcCcceEEEecCCcccccccceeeeccCcccccc
Confidence            99999999876666889999999999999999999    578999999999999998887        999999999764

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.84  E-value=2e-23  Score=214.68  Aligned_cols=204  Identities=20%  Similarity=0.176  Sum_probs=160.4

Q ss_pred             cCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCcc-------------ceeecchhccccccCceee-cccCcce
Q 039957           34 FNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNN-------------LIGTIPNSITNATKLIILD-LGFNTFS   99 (481)
Q Consensus        34 ~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~-------------l~~~~p~~~~~l~~L~~L~-Ls~N~l~   99 (481)
                      ..+++|+.|+|++|+++ .+|..++ .+++|+.|++++|.             +.+.+|..++.+++|+.|+ ++.|.+.
T Consensus       346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~-~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~  423 (567)
T 1dce_A          346 ATDEQLFRCELSVEKST-VLQSELE-SCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD  423 (567)
T ss_dssp             STTTTSSSCCCCHHHHH-HHHHHHH-HHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH
T ss_pred             ccCccceeccCChhhHH-hhHHHHH-HHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc
Confidence            45677777888888876 6777776 57777877776664             5677888899999999999 7777653


Q ss_pred             ecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEccCCce
Q 039957          100 GHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKL  179 (481)
Q Consensus       100 ~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l  179 (481)
                                 .|+.+.+++|.++.++.              ..|+.|+|++|.+++ +|. ++.+ ++|+.|++++|.+
T Consensus       424 -----------~L~~l~l~~n~i~~l~~--------------~~L~~L~Ls~n~l~~-lp~-~~~l-~~L~~L~Ls~N~l  475 (567)
T 1dce_A          424 -----------DLRSKFLLENSVLKMEY--------------ADVRVLHLAHKDLTV-LCH-LEQL-LLVTHLDLSHNRL  475 (567)
T ss_dssp             -----------HHHHHHHHHHHHHHHHH--------------TTCSEEECTTSCCSS-CCC-GGGG-TTCCEEECCSSCC
T ss_pred             -----------hhhhhhhhcccccccCc--------------cCceEEEecCCCCCC-CcC-cccc-ccCcEeecCcccc
Confidence                       34455667777776532              137888888888886 565 7766 5799999999998


Q ss_pred             eecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCC-CccccCccCCCeeecCCCeeeecCCcc
Q 039957          180 KGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYV-PHNLCHLEMLNLLHLGGNKLSGHIPPC  258 (481)
Q Consensus       180 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~~  258 (481)
                      + .+|..++.+++|++|+|++|++++ +| .++.+++|+.|++++|++++.. |..+..+++|+.|+|++|.+++.+|..
T Consensus       476 ~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~  552 (567)
T 1dce_A          476 R-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQ  552 (567)
T ss_dssp             C-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCT
T ss_pred             c-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHH
Confidence            8 788889999999999999999986 56 7889999999999999999887 889999999999999999998765532


Q ss_pred             ---cccCCCCCcEEc
Q 039957          259 ---LASLTSLRELDL  270 (481)
Q Consensus       259 ---~~~l~~L~~L~l  270 (481)
                         +..+++|+.|++
T Consensus       553 ~~l~~~lp~L~~L~l  567 (567)
T 1dce_A          553 ERLAEMLPSVSSILT  567 (567)
T ss_dssp             THHHHHCTTCSEEEC
T ss_pred             HHHHHHCcccCccCC
Confidence               334778888764

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.84  E-value=2.7e-21  Score=194.49  Aligned_cols=135  Identities=29%  Similarity=0.523  Sum_probs=116.3

Q ss_pred             hhccccccceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC----cccccCCChhHHh
Q 039957          340 ISLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----FKFMPNGSLEKRL  415 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~~~~g~l~~~l  415 (481)
                      ..+.|+||.||+|....+..||||.+.... ...+.+.+|++++++++||||++++++|....    +||+++|+|.+++
T Consensus       191 ~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~iv~e~~~~gsL~~~l  269 (452)
T 1fmk_A          191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFL  269 (452)
T ss_dssp             EEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCTTCBHHHHH
T ss_pred             eecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcCCceEEEehhhcCCCHHHHH
Confidence            347899999999998877889999987543 22456889999999999999999999987643    6799999999998


Q ss_pred             hcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          416 YSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       416 ~~~-~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ... ...+++.++.+++.+||+||+|||    +.+|+||||||+|||+++++.+||+|||+|+..
T Consensus       270 ~~~~~~~~~~~~~~~i~~qi~~~l~~LH----~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  330 (452)
T 1fmk_A          270 KGETGKYLRLPQLVDMAAQIASGMAYVE----RMNYVHRDLRAANILVGENLVCKVADFGLARLI  330 (452)
T ss_dssp             SHHHHTTCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred             HhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCChhhEEECCCCCEEECCCccceec
Confidence            752 345788999999999999999999    578999999999999999999999999999865

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.84  E-value=4.9e-21  Score=184.75  Aligned_cols=133  Identities=26%  Similarity=0.332  Sum_probs=114.6

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      .+.|+||.||++... +|..+|+|.+....   ......+..|+.++.+++||||+++++++...+     +||+++|+|
T Consensus        13 lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L   92 (337)
T 1o6l_A           13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL   92 (337)
T ss_dssp             EEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBH
T ss_pred             EecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcH
Confidence            378999999999854 68999999987542   223456778999999999999999999988765     679999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      ..++... ..++......++.+|+.||+|||    +.+|+||||||+|||++.++++||+|||+|+.
T Consensus        93 ~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~  154 (337)
T 1o6l_A           93 FFHLSRE-RVFTEERARFYGAEIVSALEYLH----SRDVVYRDIKLENLMLDKDGHIKITDFGLCKE  154 (337)
T ss_dssp             HHHHHHH-SCCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH----HCCeecCcCCHHHEEECCCCCEEEeeccchhh
Confidence            9988653 35678888999999999999999    57899999999999999999999999999985

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.84  E-value=6.3e-21  Score=191.66  Aligned_cols=132  Identities=33%  Similarity=0.491  Sum_probs=114.7

Q ss_pred             hccccccceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC------cccccCCChhHH
Q 039957          341 SLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD------FKFMPNGSLEKR  414 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~~~~g~l~~~  414 (481)
                      .+.|+||.||+|... |..||||.+....  ..+.+.+|+.++++++|+||++++++|....      +||+++|+|.++
T Consensus       201 lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~  277 (450)
T 1k9a_A          201 IGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDY  277 (450)
T ss_dssp             EEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHH
T ss_pred             ecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHH
Confidence            378999999999874 7899999987543  3467889999999999999999999876543      679999999999


Q ss_pred             hhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          415 LYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       415 l~~~~-~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +.... ..+++..+.+++.+||+||+|||    +.+|+||||||+|||+++++.+||+|||+|+..
T Consensus       278 l~~~~~~~~~~~~~~~~~~qi~~~l~~LH----~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  339 (450)
T 1k9a_A          278 LRSRGRSVLGGDCLLKFSLDVCEAMEYLE----GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA  339 (450)
T ss_dssp             HHHHCTTTCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             HHhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCCHhhEEECCCCCEEEeeCCCcccc
Confidence            87643 34688899999999999999999    578999999999999999999999999998754

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.84  E-value=2.4e-20  Score=168.70  Aligned_cols=155  Identities=19%  Similarity=0.184  Sum_probs=86.4

Q ss_pred             cEEEccCCccceeCChhhhhcccCccEEEccCCceeecCC-cccccCCCCCeEecccccceecCCcCCcCCCCCCeeecC
Q 039957          145 VYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIP-KEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLP  223 (481)
Q Consensus       145 ~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~  223 (481)
                      +.+++++|.++. +|..+.   ..+++|++++|++++..| ..|..+++|++|++++|+++                   
T Consensus        14 ~~l~~s~n~l~~-iP~~~~---~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~-------------------   70 (220)
T 2v70_A           14 TTVDCSNQKLNK-IPEHIP---QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-------------------   70 (220)
T ss_dssp             TEEECCSSCCSS-CCSCCC---TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCC-------------------
T ss_pred             CEeEeCCCCccc-CccCCC---CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCC-------------------
Confidence            356666666553 343332   234555555555554432 23444555555555555554                   


Q ss_pred             CCcCCCCCCccccCccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCcCcccCCcchhccccCcEEEccCcccCCCC
Q 039957          224 ETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSL  303 (481)
Q Consensus       224 ~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~  303 (481)
                           +..+..|..+++|+.|+|++|++++..|..|..+++|++|++++|++++..|..|..+++|++|++++|++++..
T Consensus        71 -----~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  145 (220)
T 2v70_A           71 -----DIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVA  145 (220)
T ss_dssp             -----EECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBC
T ss_pred             -----EECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEEC
Confidence                 444444555555555555555555555555555555555555555555555555555566666666666666656


Q ss_pred             CCccccCCcCcEEEccCCeeeeec
Q 039957          304 PSNVQKLKVLRVLDLSRNQLSGDI  327 (481)
Q Consensus       304 p~~~~~l~~L~~L~l~~N~l~~~~  327 (481)
                      |..|..+++|+.|++++|++.+..
T Consensus       146 ~~~~~~l~~L~~L~L~~N~l~c~c  169 (220)
T 2v70_A          146 PGAFDTLHSLSTLNLLANPFNCNC  169 (220)
T ss_dssp             TTTTTTCTTCCEEECCSCCEECSG
T ss_pred             HHHhcCCCCCCEEEecCcCCcCCC
Confidence            666667777777777777777643

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.84  E-value=3.9e-21  Score=187.53  Aligned_cols=135  Identities=29%  Similarity=0.499  Sum_probs=114.3

Q ss_pred             hccccccceeeeec------cCCcceEEEEEeccc-hhhhhhhhHHHHHhhhh-ccCccceeecccCCCC------cccc
Q 039957          341 SLAGSFGSVYKGTI------SDGTDVAIKIFNLQR-ERAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD------FKFM  406 (481)
Q Consensus       341 ~~~g~~g~vy~~~l------~~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~------~~~~  406 (481)
                      .+.|+||.||++..      .++..||||.+.... ....+.+.+|++++.++ +||||++++++|...+      +||+
T Consensus        30 lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~  109 (359)
T 3vhe_A           30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFC  109 (359)
T ss_dssp             EEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECC
T ss_pred             ecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEec
Confidence            47899999999963      346789999987543 23345688999999999 7899999999987653      5799


Q ss_pred             cCCChhHHhhcCCC-----------------------------------------------------------------c
Q 039957          407 PNGSLEKRLYSHNY-----------------------------------------------------------------F  421 (481)
Q Consensus       407 ~~g~l~~~l~~~~~-----------------------------------------------------------------~  421 (481)
                      ++|+|.+++.....                                                                 .
T Consensus       110 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (359)
T 3vhe_A          110 KFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDF  189 (359)
T ss_dssp             TTEEHHHHHHTTTTSBCSCC------------------------------------------------------CTTTTC
T ss_pred             CCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchhccc
Confidence            99999999875321                                                                 2


Q ss_pred             cCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          422 LDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       422 ~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +++..+.+++.++++||+|||    +.+|+||||||+||++++++.+||+|||+|+.+
T Consensus       190 l~~~~~~~~~~ql~~aL~~LH----~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  243 (359)
T 3vhe_A          190 LTLEHLICYSFQVAKGMEFLA----SRKCIHRDLAARNILLSEKNVVKICDFGLARDI  243 (359)
T ss_dssp             BCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCT
T ss_pred             cCHHHHHHHHHHHHHHHHHHH----HCCcccCCCChhhEEEcCCCcEEEEeccceeee
Confidence            788899999999999999999    578999999999999999999999999999864

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.84  E-value=6.9e-21  Score=183.28  Aligned_cols=135  Identities=30%  Similarity=0.532  Sum_probs=117.9

Q ss_pred             hccccccceeeeec-----cCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-------cccccC
Q 039957          341 SLAGSFGSVYKGTI-----SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-------FKFMPN  408 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-----~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-------~~~~~~  408 (481)
                      .+.|+||.||++..     .+|..||+|.+........+.+.+|+.++++++|+||+++++++...+       ++|+++
T Consensus        49 lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~  128 (326)
T 2w1i_A           49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPY  128 (326)
T ss_dssp             EECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTT
T ss_pred             eccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCC
Confidence            47899999999973     358899999987765555667889999999999999999999876542       578999


Q ss_pred             CChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          409 GSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       409 g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      |+|.+++......+++.++.+++.++++||+|||    +.+|+||||||+||++++++.+||+|||+++..
T Consensus       129 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~  195 (326)
T 2w1i_A          129 GSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG----TKRYIHRDLATRNILVENENRVKIGDFGLTKVL  195 (326)
T ss_dssp             CBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----hCCEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence            9999999876666899999999999999999999    578999999999999999999999999999765

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.84  E-value=2e-20  Score=169.17  Aligned_cols=152  Identities=23%  Similarity=0.302  Sum_probs=87.9

Q ss_pred             CEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeecccCcceecCcccccCCCCCCEEEccc
Q 039957           40 RNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLM  119 (481)
Q Consensus        40 ~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  119 (481)
                      +.+++++|.++ .+|..+.   ++|++|++++|++++..+..|..+++|++|+|++|+++++.|..|.++++|++|+|++
T Consensus        14 ~~v~c~~~~l~-~iP~~l~---~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~   89 (220)
T 2v9t_B           14 NIVDCRGKGLT-EIPTNLP---ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYG   89 (220)
T ss_dssp             TEEECTTSCCS-SCCSSCC---TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCS
T ss_pred             CEEEcCCCCcC-cCCCccC---cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCC
Confidence            45555666665 4555432   4566666666666655555666666666666666666666666666666666666666


Q ss_pred             ccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEccCCceeecCCcccccCCCCCeEecc
Q 039957          120 NNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLG  199 (481)
Q Consensus       120 N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~  199 (481)
                      |+++.++...        +..+++|++|+|++|++++..|..|..+ ++|+.|++++|++++..+..|..+++|++|+++
T Consensus        90 N~l~~l~~~~--------f~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  160 (220)
T 2v9t_B           90 NKITELPKSL--------FEGLFSLQLLLLNANKINCLRVDAFQDL-HNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLA  160 (220)
T ss_dssp             SCCCCCCTTT--------TTTCTTCCEEECCSSCCCCCCTTTTTTC-TTCCEEECCSSCCSCCCTTTTTTCTTCCEEECC
T ss_pred             CcCCccCHhH--------ccCCCCCCEEECCCCCCCEeCHHHcCCC-CCCCEEECCCCcCCEECHHHHhCCCCCCEEEeC
Confidence            6666553322        3445556666666666655555545444 345555555555555444555556666666666


Q ss_pred             cccce
Q 039957          200 FNDLN  204 (481)
Q Consensus       200 ~N~l~  204 (481)
                      +|.+.
T Consensus       161 ~N~~~  165 (220)
T 2v9t_B          161 QNPFI  165 (220)
T ss_dssp             SSCEE
T ss_pred             CCCcC
Confidence            66654

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.84  E-value=7.7e-21  Score=187.05  Aligned_cols=136  Identities=26%  Similarity=0.472  Sum_probs=115.6

Q ss_pred             hhccccccceeeeecc--------CCcceEEEEEeccc-hhhhhhhhHHHHHhhhh-ccCccceeecccCCCC-----cc
Q 039957          340 ISLAGSFGSVYKGTIS--------DGTDVAIKIFNLQR-ERAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD-----FK  404 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~--------~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----~~  404 (481)
                      ..+.|+||.||+|...        .+..||+|++.... ....+.+.+|++++.++ +|+||++++++|...+     +|
T Consensus        76 ~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e  155 (382)
T 3tt0_A           76 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVE  155 (382)
T ss_dssp             EEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             EEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEEE
Confidence            3478999999999742        23569999986543 33446788999999999 8999999999998764     67


Q ss_pred             cccCCChhHHhhcCC---------------CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEE
Q 039957          405 FMPNGSLEKRLYSHN---------------YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAH  469 (481)
Q Consensus       405 ~~~~g~l~~~l~~~~---------------~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~k  469 (481)
                      |+++|+|.+++....               ..+++..+.+|+.+|++||+|||    +.+|+||||||+|||+++++.+|
T Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~k  231 (382)
T 3tt0_A          156 YASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA----SKKCIHRDLAARNVLVTEDNVMK  231 (382)
T ss_dssp             CCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTCCEE
T ss_pred             ecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCcceEEEcCCCcEE
Confidence            999999999987532               34889999999999999999999    57899999999999999999999


Q ss_pred             EccccCcccC
Q 039957          470 VSDFGISKLL  479 (481)
Q Consensus       470 l~Dfgl~~~~  479 (481)
                      |+|||+|+..
T Consensus       232 L~DFG~a~~~  241 (382)
T 3tt0_A          232 IADFGLARDI  241 (382)
T ss_dssp             ECSCSCCCCS
T ss_pred             EcccCccccc
Confidence            9999999865

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.84  E-value=6.7e-21  Score=185.92  Aligned_cols=176  Identities=25%  Similarity=0.218  Sum_probs=94.1

Q ss_pred             CeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhc-CCCCccEEEccCccceeecchhccccccCceeecc
Q 039957           16 KSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGH-SLPNIKYLELGDNNLIGTIPNSITNATKLIILDLG   94 (481)
Q Consensus        16 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls   94 (481)
                      +++++++|+++. +|..+.  ..++.|+|++|+|++ ++...+. .+++|++|+|++|+|++..+..|.++++|++|+|+
T Consensus        21 ~~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~-l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls   96 (361)
T 2xot_A           21 NILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSR-LRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLS   96 (361)
T ss_dssp             TEEECCSSCCSS-CCSSCC--TTCSEEECCSSCCCE-ECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CEEEeCCCCcCc-cCccCC--CCCCEEECCCCCCCc-cChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECC
Confidence            456666666654 333332  235666666666653 3333332 46666666666666665555566666666666666


Q ss_pred             cCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhh---hhcccCccE
Q 039957           95 FNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSI---GNFSTSLQR  171 (481)
Q Consensus        95 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~---~~~~~~L~~  171 (481)
                      +|+|++..+..|.++++|++|+|++|+|+.+.+.        .+.++++|++|+|++|++++..+..+   ..+ ++|+.
T Consensus        97 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~--------~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l-~~L~~  167 (361)
T 2xot_A           97 SNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRN--------AFEDMAQLQKLYLSQNQISRFPVELIKDGNKL-PKLML  167 (361)
T ss_dssp             SSCCCEECTTTTTTCTTCCEEECCSSCCCEECTT--------TTTTCTTCCEEECCSSCCCSCCGGGTC----C-TTCCE
T ss_pred             CCcCCcCCHHHhCCCcCCCEEECCCCcccEECHH--------HhCCcccCCEEECCCCcCCeeCHHHhcCcccC-CcCCE
Confidence            6666665555666666666666666666655322        23455566666666666654222222   122 34555


Q ss_pred             EEccCCceeecCCcccccCCC--CCeEecccccce
Q 039957          172 FSASECKLKGTIPKEIGHLRG--LIYLSLGFNDLN  204 (481)
Q Consensus       172 L~l~~n~l~~~~p~~~~~l~~--L~~L~l~~N~l~  204 (481)
                      |++++|++++..+..+..++.  ++.|++++|.+.
T Consensus       168 L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~  202 (361)
T 2xot_A          168 LDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE  202 (361)
T ss_dssp             EECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred             EECCCCCCCccCHHHhhhccHhhcceEEecCCCcc
Confidence            555555555433334444443  245555555544

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.84  E-value=8e-21  Score=186.11  Aligned_cols=134  Identities=27%  Similarity=0.410  Sum_probs=115.7

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      .+.|+||.||++... +|..+|+|.+....   ....+.+.+|+.++.+++|||||+++++|....     ++|+++|+|
T Consensus        23 LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L  102 (384)
T 4fr4_A           23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDL  102 (384)
T ss_dssp             EECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEH
T ss_pred             EeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcH
Confidence            378999999999854 57889999986543   223456778999999999999999999988765     678999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ..++... ..+++..+..++.+|+.||+|||    +.+|+||||||+|||+++++.+||+|||+|+.+
T Consensus       103 ~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH----~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~  165 (384)
T 4fr4_A          103 RYHLQQN-VHFKEETVKLFICELVMALDYLQ----NQRIIHRDMKPDNILLDEHGHVHITDFNIAAML  165 (384)
T ss_dssp             HHHHHTT-CCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH----HCCceeccCcHHHeEECCCCCEEEeccceeeec
Confidence            9988753 45788899999999999999999    578999999999999999999999999999865

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.83  E-value=4.7e-21  Score=184.52  Aligned_cols=135  Identities=28%  Similarity=0.431  Sum_probs=117.9

Q ss_pred             hccccccceeeeec-----cCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-------cccccC
Q 039957          341 SLAGSFGSVYKGTI-----SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-------FKFMPN  408 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-----~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-------~~~~~~  408 (481)
                      .+.|+||.||++..     .++..||+|.+........+.+.+|++++++++|+||+++++++...+       +||+++
T Consensus        31 lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~  110 (327)
T 3lxl_A           31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPS  110 (327)
T ss_dssp             EEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTT
T ss_pred             ccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCC
Confidence            37899999999973     357889999997766555667899999999999999999999875432       678999


Q ss_pred             CChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          409 GSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       409 g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      |+|.+++......+++..+..++.++++||+|||    +.+|+||||||+||+++.++.+||+|||+++..
T Consensus       111 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH----~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  177 (327)
T 3lxl_A          111 GCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG----SRRCVHRDLAARNILVESEAHVKIADFGLAKLL  177 (327)
T ss_dssp             CBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred             CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----hCCccCCCCChhhEEECCCCCEEEcccccceec
Confidence            9999998765556889999999999999999999    578999999999999999999999999999864

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.83  E-value=1.8e-20  Score=176.88  Aligned_cols=136  Identities=32%  Similarity=0.529  Sum_probs=116.6

Q ss_pred             hhccccccceeeeec-cCCcceEEEEEeccchh-------hhhhhhHHHHHhhhhccCccceeecccCCCC---cccccC
Q 039957          340 ISLAGSFGSVYKGTI-SDGTDVAIKIFNLQRER-------AFRSFNSECEVLRNVRHQNLIKILSSCSTPD---FKFMPN  408 (481)
Q Consensus       340 l~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---~~~~~~  408 (481)
                      ..+.|+||.||++.. .++..||+|.+......       ..+.+.+|+.++++++|+||+++++++....   ++|+++
T Consensus        26 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~lv~e~~~~  105 (287)
T 4f0f_A           26 QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRMVMEFVPC  105 (287)
T ss_dssp             ECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTTEEEEECCTT
T ss_pred             ccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCCeEEEEecCC
Confidence            347899999999986 46889999998654321       1256788999999999999999999987765   679999


Q ss_pred             CChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCC--eeeCCCCCCCeeeCCCCc-----EEEccccCcccC
Q 039957          409 GSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAP--IIHCDLKPTSILLDENMV-----AHVSDFGISKLL  479 (481)
Q Consensus       409 g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~--i~H~dlk~~nill~~~~~-----~kl~Dfgl~~~~  479 (481)
                      |+|.+.+......+++..+..++.++++|++|||    +.+  |+||||||+||+++.++.     +||+|||+|+..
T Consensus       106 ~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~  179 (287)
T 4f0f_A          106 GDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ----NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS  179 (287)
T ss_dssp             CBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH----TSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCC
T ss_pred             CCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHH----hCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCccccc
Confidence            9999998877777899999999999999999999    456  999999999999988776     999999998754

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.83  E-value=8e-21  Score=180.03  Aligned_cols=134  Identities=26%  Similarity=0.405  Sum_probs=115.9

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      -+.|+||.||++.. .++..+|+|.+....   ....+.+.+|+.++.+++||||+++++++...+     +||+++|+|
T Consensus        19 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L   98 (294)
T 4eqm_A           19 LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTL   98 (294)
T ss_dssp             EEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBH
T ss_pred             EccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCH
Confidence            47899999999985 468899999885432   233457889999999999999999999987765     678999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+++... ..+++..+..++.++++||+|||    +.+|+||||||+||+++.++.+||+|||+|+.+
T Consensus        99 ~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  161 (294)
T 4eqm_A           99 SEYIESH-GPLSVDTAINFTNQILDGIKHAH----DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL  161 (294)
T ss_dssp             HHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC
T ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEEEeCCCcccc
Confidence            9998753 35788999999999999999999    578999999999999999999999999999865

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.83  E-value=9.9e-21  Score=179.72  Aligned_cols=136  Identities=25%  Similarity=0.486  Sum_probs=114.7

Q ss_pred             hhccccccceeeeeccCC----cceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC------cccccC
Q 039957          340 ISLAGSFGSVYKGTISDG----TDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD------FKFMPN  408 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~~g----~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~~~~  408 (481)
                      .-+.|+||.||+|...+.    ..+|+|.+.... ....+.+.+|+.++++++|+||++++++|...+      ++|+++
T Consensus        32 ~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~  111 (298)
T 3f66_A           32 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKH  111 (298)
T ss_dssp             EEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTT
T ss_pred             eeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCC
Confidence            347899999999985432    357888876533 334467889999999999999999999875443      678999


Q ss_pred             CChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          409 GSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       409 g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      |+|.+++.......++..+..++.++++||+|||    +.+|+||||||+||++++++.+||+|||+|+.+
T Consensus       112 ~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH----~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~  178 (298)
T 3f66_A          112 GDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA----SKKFVHRDLAARNCMLDEKFTVKVADFGLARDM  178 (298)
T ss_dssp             CBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred             CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----hCCccCCCCchheEEECCCCCEEECcccccccc
Confidence            9999999876667889999999999999999999    578999999999999999999999999999764

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.83  E-value=8.2e-21  Score=182.42  Aligned_cols=134  Identities=23%  Similarity=0.391  Sum_probs=113.9

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccch-hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhH
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRE-RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEK  413 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~  413 (481)
                      .+.|+||.||++... ++..||+|.+..... ...+.+.+|+.++++++|+||+++++++...+     +||+++|+|.+
T Consensus        15 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~   94 (323)
T 3tki_A           15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD   94 (323)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGG
T ss_pred             EecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHH
Confidence            478999999999854 688999999875443 23456788999999999999999999998765     67899999999


Q ss_pred             HhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          414 RLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       414 ~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ++... ..+++..+..++.++++||+|||    +.+|+||||||+||++++++.+||+|||+|+.+
T Consensus        95 ~l~~~-~~~~~~~~~~i~~qi~~aL~~LH----~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  155 (323)
T 3tki_A           95 RIEPD-IGMPEPDAQRFFHQLMAGVVYLH----GIGITHRDIKPENLLLDERDNLKISDFGLATVF  155 (323)
T ss_dssp             GSBTT-TBCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             HHhhc-CCCCHHHHHHHHHHHHHHHHHHH----HCCccccccchHHEEEeCCCCEEEEEeecccee
Confidence            88643 45788999999999999999999    578999999999999999999999999999754

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.83  E-value=8.8e-21  Score=177.01  Aligned_cols=134  Identities=30%  Similarity=0.455  Sum_probs=118.2

Q ss_pred             hccccccceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHHh
Q 039957          341 SLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRL  415 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~l  415 (481)
                      .+.|+||.||++...++..+|+|.+..... ..+.+.+|++++.+++||||+++++++...+     ++|+++|+|.+++
T Consensus        16 lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~   94 (267)
T 3t9t_A           16 IGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYL   94 (267)
T ss_dssp             EEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHH
T ss_pred             ecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHH
Confidence            368999999999987888999999875432 2356888999999999999999999987764     6789999999999


Q ss_pred             hcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          416 YSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       416 ~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ......+++..+.+++.++++|++|||    +.+|+||||||+||++++++.+||+|||+++..
T Consensus        95 ~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~  154 (267)
T 3t9t_A           95 RTQRGLFAAETLLGMCLDVCEGMAYLE----EACVIHRDLAARNCLVGENQVIKVSDFGMTRFV  154 (267)
T ss_dssp             HHTTTCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGB
T ss_pred             hhCcccCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCchheEEECCCCCEEEccccccccc
Confidence            876667889999999999999999999    578999999999999999999999999999764

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.83  E-value=1.3e-20  Score=183.42  Aligned_cols=136  Identities=25%  Similarity=0.360  Sum_probs=116.2

Q ss_pred             hhccccccceeeeecc-CCcceEEEEEeccchh------hhhhhhHHHHHhhhhccCccceeecccCCCC-----ccccc
Q 039957          340 ISLAGSFGSVYKGTIS-DGTDVAIKIFNLQRER------AFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMP  407 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~  407 (481)
                      ..+.|+||.||++... +|..+|+|.+......      ..+.+.+|+.++.+++||||+++++++....     +||++
T Consensus        19 ~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~   98 (361)
T 2yab_A           19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVS   98 (361)
T ss_dssp             EEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             EEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCC
Confidence            3478999999999854 6899999998764322      2356788999999999999999999987765     67899


Q ss_pred             CCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCC----cEEEccccCcccCC
Q 039957          408 NGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENM----VAHVSDFGISKLLG  480 (481)
Q Consensus       408 ~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~----~~kl~Dfgl~~~~~  480 (481)
                      +|+|.+++... ..+++..+..++.+|++||+|||    +.+|+||||||+||++++++    .+||+|||+|+.+.
T Consensus        99 gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH----~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~  170 (361)
T 2yab_A           99 GGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLH----TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE  170 (361)
T ss_dssp             SCBHHHHHTTC-SCCBHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECC
T ss_pred             CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcC
Confidence            99999998653 45788999999999999999999    57899999999999998876    79999999997653

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.83  E-value=8.2e-21  Score=184.41  Aligned_cols=133  Identities=26%  Similarity=0.363  Sum_probs=113.9

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc---hhhhhhhhHHHHHhhhh-ccCccceeecccCCCC-----cccccCCC
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD-----FKFMPNGS  410 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----~~~~~~g~  410 (481)
                      .+.|+||.||++... +|..+|+|.+....   ....+.+..|..++..+ +||||+++++++...+     +||+++|+
T Consensus        31 lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~  110 (353)
T 3txo_A           31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGD  110 (353)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCB
T ss_pred             EeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCc
Confidence            478999999999854 58899999987542   22344567788899887 6999999999988765     67999999


Q ss_pred             hhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          411 LEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       411 l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      |.+++... ..+++..+..++.+|+.||+|||    +.+||||||||+|||++.++++||+|||+|+.
T Consensus       111 L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH----~~givHrDlkp~NILl~~~g~ikL~DFG~a~~  173 (353)
T 3txo_A          111 LMFHIQKS-RRFDEARARFYAAEIISALMFLH----DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKE  173 (353)
T ss_dssp             HHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             HHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH----HCCCcccCCCHHHEEECCCCCEEEccccceee
Confidence            99988753 35788889999999999999999    57899999999999999999999999999985

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.83  E-value=7e-21  Score=181.09  Aligned_cols=135  Identities=26%  Similarity=0.510  Sum_probs=114.1

Q ss_pred             hccccccceeeeec-----cCCcceEEEEEeccch-hhhhhhhHHHHHhhhhccCccceeecccCCCC-------ccccc
Q 039957          341 SLAGSFGSVYKGTI-----SDGTDVAIKIFNLQRE-RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-------FKFMP  407 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-----~~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-------~~~~~  407 (481)
                      -+.|+||.||++..     .+|..||+|.+..... .....+.+|++++++++|+||+++++++...+       ++|++
T Consensus        29 lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~  108 (302)
T 4e5w_A           29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLP  108 (302)
T ss_dssp             EEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCT
T ss_pred             cCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCC
Confidence            37899999999973     4678999999875432 23456888999999999999999999987652       57899


Q ss_pred             CCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          408 NGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       408 ~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +|+|.+++......+++..+..++.++++||+|||    +.+|+||||||+||+++.++.+||+|||+++..
T Consensus       109 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  176 (302)
T 4e5w_A          109 SGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG----SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI  176 (302)
T ss_dssp             TCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             CCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhh----cCCcccCCCchheEEEcCCCCEEECcccccccc
Confidence            99999998665566889999999999999999999    578999999999999999999999999999764

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.83  E-value=1.3e-20  Score=178.92  Aligned_cols=136  Identities=25%  Similarity=0.450  Sum_probs=115.8

Q ss_pred             hhccccccceeeeeccC-C---cceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC------cccccC
Q 039957          340 ISLAGSFGSVYKGTISD-G---TDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD------FKFMPN  408 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~~-g---~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~~~~  408 (481)
                      ..+.|+||.||+|...+ +   ..+|+|.+.... ....+.+.+|+.++++++|+||+++++++...+      ++|+.+
T Consensus        28 ~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~  107 (298)
T 3pls_A           28 VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCH  107 (298)
T ss_dssp             EEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTT
T ss_pred             eeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccC
Confidence            34789999999998543 2   368999886533 234567889999999999999999999987553      468899


Q ss_pred             CChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          409 GSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       409 g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      |+|.+++.......++..+..++.++++||+|||    +.+|+||||||+||++++++.+||+|||+|+.+
T Consensus       108 ~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH----~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  174 (298)
T 3pls_A          108 GDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA----EQKFVHRDLAARNCMLDESFTVKVADFGLARDI  174 (298)
T ss_dssp             CBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred             CCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence            9999999876667889999999999999999999    578999999999999999999999999999754

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.83  E-value=6.5e-21  Score=180.11  Aligned_cols=134  Identities=24%  Similarity=0.442  Sum_probs=114.8

Q ss_pred             hccccccceeeeeccCCcceEEEEEeccch--hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhH
Q 039957          341 SLAGSFGSVYKGTISDGTDVAIKIFNLQRE--RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEK  413 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~  413 (481)
                      .+.|+||.||++...+|..+|+|.+.....  .....+.+|++++++++||||+++++++...+     +||++ |++.+
T Consensus        10 lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~   88 (288)
T 1ob3_A           10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD-QDLKK   88 (288)
T ss_dssp             EEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHH
T ss_pred             cccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecC-CCHHH
Confidence            368999999999887789999999865432  22356778999999999999999999987765     56776 48888


Q ss_pred             HhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          414 RLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       414 ~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ++......+++..+..++.++++||+|||    +.+|+||||||+||+++.++.+||+|||+|+..
T Consensus        89 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  150 (288)
T 1ob3_A           89 LLDVCEGGLESVTAKSFLLQLLNGIAYCH----DRRVLHRDLKPQNLLINREGELKIADFGLARAF  150 (288)
T ss_dssp             HHHTSTTCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHH
T ss_pred             HHHhcccCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEEcCCCCEEEeECcccccc
Confidence            88765566888999999999999999999    578999999999999999999999999998653

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.83  E-value=4.6e-21  Score=196.70  Aligned_cols=136  Identities=29%  Similarity=0.517  Sum_probs=118.1

Q ss_pred             hhccccccceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC----cccccCCChhHHh
Q 039957          340 ISLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----FKFMPNGSLEKRL  415 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~~~~g~l~~~l  415 (481)
                      ..+.|+||.||+|....+..||||.+..... ..+.|.+|++++++++|+||++++++|....    +||+++|+|.+++
T Consensus       274 ~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~lv~e~~~~gsL~~~l  352 (535)
T 2h8h_A          274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFL  352 (535)
T ss_dssp             EEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCTTEEHHHHH
T ss_pred             ecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEeeccceEeeehhcCCcHHHHH
Confidence            3478999999999987778899999875432 3457889999999999999999999987643    6799999999998


Q ss_pred             hcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          416 YSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       416 ~~~-~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      ... ...+++.++.+|+.+|++||+|||    +.+||||||||+|||+++++.+||+|||+++.+.
T Consensus       353 ~~~~~~~l~~~~~~~i~~qi~~~L~~LH----~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  414 (535)
T 2h8h_A          353 KGETGKYLRLPQLVDMAAQIASGMAYVE----RMNYVHRDLRAANILVGENLVCKVADFGLARLIE  414 (535)
T ss_dssp             SHHHHTTCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred             hhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence            752 245788999999999999999999    5789999999999999999999999999998753

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.83  E-value=6.1e-21  Score=179.59  Aligned_cols=136  Identities=24%  Similarity=0.400  Sum_probs=110.1

Q ss_pred             hhccccccceeeeeccC----CcceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC----cccccCCC
Q 039957          340 ISLAGSFGSVYKGTISD----GTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----FKFMPNGS  410 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~~----g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~~~~g~  410 (481)
                      ..+.|+||.||+|....    +..+|+|...... ....+.+.+|+.++++++||||+++++++....    ++|+++|+
T Consensus        22 ~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~lv~e~~~~~~  101 (281)
T 1mp8_A           22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGE  101 (281)
T ss_dssp             EEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEEEECCTTEE
T ss_pred             EeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEccCccEEEEecCCCCC
Confidence            34789999999998642    4568899876533 233456888999999999999999999986543    67899999


Q ss_pred             hhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          411 LEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       411 l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      |.+++......+++..+..++.++++||+|||    +.+|+||||||+||+++.++.+||+|||+|+..
T Consensus       102 L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (281)
T 1mp8_A          102 LRSFLQVRKYSLDLASLILYAYQLSTALAYLE----SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  166 (281)
T ss_dssp             HHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCeecccccHHHEEECCCCCEEECcccccccc
Confidence            99999876667899999999999999999999    578999999999999999999999999999764

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.83  E-value=5.1e-21  Score=185.48  Aligned_cols=135  Identities=29%  Similarity=0.490  Sum_probs=115.6

Q ss_pred             hccccccceeeeecc------CCcceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccC
Q 039957          341 SLAGSFGSVYKGTIS------DGTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPN  408 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~------~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~  408 (481)
                      .+.|+||.||++...      ++..||+|.+.... ....+.+.+|+.++++++|+||++++++|...+     ++|+++
T Consensus        55 lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~  134 (343)
T 1luf_A           55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAY  134 (343)
T ss_dssp             EEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred             eeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecCCC
Confidence            378999999999864      34789999987543 233467889999999999999999999987764     678999


Q ss_pred             CChhHHhhcCC-----------------------CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCC
Q 039957          409 GSLEKRLYSHN-----------------------YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDEN  465 (481)
Q Consensus       409 g~l~~~l~~~~-----------------------~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~  465 (481)
                      |+|.+++....                       ..+++.++..++.+|++||+|||    +.+|+||||||+||+++++
T Consensus       135 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH----~~~ivH~Dlkp~NIl~~~~  210 (343)
T 1luf_A          135 GDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS----ERKFVHRDLATRNCLVGEN  210 (343)
T ss_dssp             CBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGG
T ss_pred             CcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCcceEEECCC
Confidence            99999987531                       45788999999999999999999    5789999999999999999


Q ss_pred             CcEEEccccCcccC
Q 039957          466 MVAHVSDFGISKLL  479 (481)
Q Consensus       466 ~~~kl~Dfgl~~~~  479 (481)
                      +.+||+|||+++.+
T Consensus       211 ~~~kl~Dfg~~~~~  224 (343)
T 1luf_A          211 MVVKIADFGLSRNI  224 (343)
T ss_dssp             GCEEECCCSCHHHH
T ss_pred             CeEEEeecCCCccc
Confidence            99999999998643

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.83  E-value=1.2e-20  Score=181.02  Aligned_cols=137  Identities=31%  Similarity=0.436  Sum_probs=115.8

Q ss_pred             hhhccccccceeeeecc-CCcceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC-------cccccCC
Q 039957          339 TISLAGSFGSVYKGTIS-DGTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-------FKFMPNG  409 (481)
Q Consensus       339 ~l~~~g~~g~vy~~~l~-~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-------~~~~~~g  409 (481)
                      ...+.|+||.||+|... +|..||+|.+.... ....+.+.+|++++++++|+||+++++++....       +||+++|
T Consensus        15 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~   94 (319)
T 4euu_A           15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCG   94 (319)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTC
T ss_pred             EEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCC
Confidence            34478999999999865 48899999987543 233456778999999999999999999876543       5789999


Q ss_pred             ChhHHhhcCC--CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeee----CCCCcEEEccccCcccC
Q 039957          410 SLEKRLYSHN--YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILL----DENMVAHVSDFGISKLL  479 (481)
Q Consensus       410 ~l~~~l~~~~--~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill----~~~~~~kl~Dfgl~~~~  479 (481)
                      +|.+++....  ..+++..+..++.++++||+|||    +.+|+||||||+||++    ++++.+||+|||+|+.+
T Consensus        95 ~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~  166 (319)
T 4euu_A           95 SLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR----ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL  166 (319)
T ss_dssp             BHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred             CHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH----HCCEecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence            9999987633  23789999999999999999999    5789999999999999    88899999999999765

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.83  E-value=1.9e-20  Score=178.52  Aligned_cols=134  Identities=36%  Similarity=0.563  Sum_probs=115.4

Q ss_pred             hccccccceeeeeccCCcceEEEEEeccc----hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTISDGTDVAIKIFNLQR----ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~g~~vavK~l~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      .+.|+||.||+|.. ++..+|+|.+....    ....+.+.+|+.++++++||||+++++++...+     ++|+++|+|
T Consensus        39 lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L  117 (307)
T 2nru_A           39 MGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL  117 (307)
T ss_dssp             EEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred             cccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcH
Confidence            47899999999986 67889999886432    233456888999999999999999999987764     578999999


Q ss_pred             hHHhhc--CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          412 EKRLYS--HNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~--~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+++..  ....++|..+.+++.++++||+|||    +.+|+||||||+||++++++.+||+|||+++..
T Consensus       118 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH----~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~  183 (307)
T 2nru_A          118 LDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH----ENHHIHRDIKSANILLDEAFTAKISDFGLARAS  183 (307)
T ss_dssp             HHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh----cCCeecCCCCHHHEEEcCCCcEEEeeccccccc
Confidence            998864  2345889999999999999999999    578999999999999999999999999998754

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.83  E-value=9e-21  Score=186.40  Aligned_cols=133  Identities=21%  Similarity=0.281  Sum_probs=113.1

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc---hhhhhhhhHHHHHhhhh-ccCccceeecccCCCC-----cccccCCC
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD-----FKFMPNGS  410 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----~~~~~~g~  410 (481)
                      .+.|+||.||++... ++..+|+|.+....   ......+..|..++.++ +|||||++++++...+     +||+++|+
T Consensus        60 LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~  139 (396)
T 4dc2_A           60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGD  139 (396)
T ss_dssp             EEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCB
T ss_pred             EeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCc
Confidence            478999999999865 57889999987643   22334577888888886 8999999999988765     67999999


Q ss_pred             hhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          411 LEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       411 l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      |..++... ..+++..+..++.+|+.||+|||    +.+|+||||||+|||++.++++||+|||+|+.
T Consensus       140 L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH----~~givHrDLKp~NILl~~~g~ikL~DFGla~~  202 (396)
T 4dc2_A          140 LMFHMQRQ-RKLPEEHARFYSAEISLALNYLH----ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE  202 (396)
T ss_dssp             HHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             HHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH----HCCEEeccCCHHHEEECCCCCEEEeecceeee
Confidence            99988753 35788899999999999999999    57899999999999999999999999999985

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.83  E-value=8.5e-21  Score=181.38  Aligned_cols=134  Identities=22%  Similarity=0.233  Sum_probs=111.0

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc--hhhhhhhhHHHHHhhhh-ccCccceeecccCCCC-----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR--ERAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      -+.|+||.||+|... +|..||||++....  .........|+..+.++ +|+||++++++|....     +||+ +|++
T Consensus        65 LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L  143 (311)
T 3p1a_A           65 LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSL  143 (311)
T ss_dssp             EEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred             eccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-CCCH
Confidence            478999999999865 68999999876532  22233445566666555 8999999999997665     5677 7899


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+++......++|..+..|+.++++||+|||    +.+|+||||||+|||++.++.+||+|||+|+..
T Consensus       144 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~  207 (311)
T 3p1a_A          144 QQHCEAWGASLPEAQVWGYLRDTLLALAHLH----SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL  207 (311)
T ss_dssp             HHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCEecCCCCHHHEEECCCCCEEEccceeeeec
Confidence            9888766667899999999999999999999    578999999999999999999999999998765

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.83  E-value=1.2e-20  Score=182.97  Aligned_cols=134  Identities=27%  Similarity=0.354  Sum_probs=115.5

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccch---hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRE---RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      .+.|+||.||++... +|..||+|.+.....   ...+.+.+|+.++.+++||||+++++++....     +||+++|+|
T Consensus        49 lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L  128 (350)
T 1rdq_E           49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM  128 (350)
T ss_dssp             EEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBH
T ss_pred             eecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcH
Confidence            378999999999864 689999999865432   23456778999999999999999999987765     679999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+++... ..++...+..++.+|+.||+|||    +.+|+||||||+|||++.++.+||+|||+|+..
T Consensus       129 ~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~  191 (350)
T 1rdq_E          129 FSHLRRI-GRFSEPHARFYAAQIVLTFEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV  191 (350)
T ss_dssp             HHHHHHH-CCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH----HCCcccccCccceEEECCCCCEEEcccccceec
Confidence            9998753 34778889999999999999999    578999999999999999999999999999864

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.83  E-value=1.4e-20  Score=192.25  Aligned_cols=136  Identities=24%  Similarity=0.323  Sum_probs=116.9

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccch---hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRE---RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      .+.|+||.||++... +|..||+|.+.....   .....+.+|+.++.+++|+|||++++++...+     ++|+++|+|
T Consensus       192 LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L  271 (576)
T 2acx_A          192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDL  271 (576)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred             EeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcH
Confidence            478999999999864 689999999875432   23345778999999999999999999987765     679999999


Q ss_pred             hHHhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          412 EKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       412 ~~~l~~~~-~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      .+++.... ..+++..+..++.+|+.||+|||    +.+||||||||+|||++.++++||+|||+|+.+.
T Consensus       272 ~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH----~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~  337 (576)
T 2acx_A          272 KFHIYHMGQAGFPEARAVFYAAEICCGLEDLH----RERIVYRDLKPENILLDDHGHIRISDLGLAVHVP  337 (576)
T ss_dssp             HHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----HCCEeccCCchheEEEeCCCCeEEEecccceecc
Confidence            99887643 34788999999999999999999    5789999999999999999999999999998653

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.83  E-value=1.2e-20  Score=179.24  Aligned_cols=133  Identities=26%  Similarity=0.403  Sum_probs=109.4

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccch--------------------------hhhhhhhHHHHHhhhhccCccce
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQRE--------------------------RAFRSFNSECEVLRNVRHQNLIK  393 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~--------------------------~~~~~~~~e~~~l~~l~h~niv~  393 (481)
                      .+.|+||.||++.. .+|..||+|.+.....                          ...+.+.+|++++++++||||++
T Consensus        21 lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~  100 (298)
T 2zv2_A           21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVK  100 (298)
T ss_dssp             EEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCTTBCC
T ss_pred             EeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCCCCCe
Confidence            47899999999985 4688999999865421                          11346788999999999999999


Q ss_pred             eecccCCCC-------cccccCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCC
Q 039957          394 ILSSCSTPD-------FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENM  466 (481)
Q Consensus       394 l~~~~~~~~-------~~~~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~  466 (481)
                      +++++....       +||+++|++.++...  ..+++.++..++.++++||+|||    +.+|+||||||+||+++.++
T Consensus       101 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dlkp~Nil~~~~~  174 (298)
T 2zv2_A          101 LVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLH----YQKIIHRDIKPSNLLVGEDG  174 (298)
T ss_dssp             EEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTS
T ss_pred             EEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHEEECCCC
Confidence            999987532       678999999876543  45788999999999999999999    57899999999999999999


Q ss_pred             cEEEccccCcccC
Q 039957          467 VAHVSDFGISKLL  479 (481)
Q Consensus       467 ~~kl~Dfgl~~~~  479 (481)
                      .+||+|||+++.+
T Consensus       175 ~~kl~Dfg~~~~~  187 (298)
T 2zv2_A          175 HIKIADFGVSNEF  187 (298)
T ss_dssp             CEEECCCTTCEEC
T ss_pred             CEEEecCCCcccc
Confidence            9999999999764

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.83  E-value=1.1e-20  Score=182.68  Aligned_cols=134  Identities=25%  Similarity=0.330  Sum_probs=114.1

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc---hhhhhhhhHHHHHhhhh-ccCccceeecccCCCC-----cccccCCC
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD-----FKFMPNGS  410 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----~~~~~~g~  410 (481)
                      .+.|+||.||++... +|..||+|.+....   ......+..|..++.++ +||||+++++++...+     +||+++|+
T Consensus        25 lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~  104 (345)
T 1xjd_A           25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGD  104 (345)
T ss_dssp             EEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCB
T ss_pred             EeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCc
Confidence            478999999999864 58899999987543   22334567788888876 8999999999988765     67999999


Q ss_pred             hhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          411 LEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       411 l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      |.+++... ..+++..+..++.+|+.||+|||    +.+|+||||||+|||++.++++||+|||+|+..
T Consensus       105 L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  168 (345)
T 1xjd_A          105 LMYHIQSC-HKFDLSRATFYAAEIILGLQFLH----SKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN  168 (345)
T ss_dssp             HHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             HHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH----HCCeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence            99998753 35788899999999999999999    578999999999999999999999999999853

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.83  E-value=6.2e-21  Score=186.59  Aligned_cols=134  Identities=27%  Similarity=0.419  Sum_probs=112.5

Q ss_pred             hccccccceeeeecc------CCcceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccC
Q 039957          341 SLAGSFGSVYKGTIS------DGTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPN  408 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~------~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~  408 (481)
                      .+.|+||.||+|...      ++..||||.+.... ......+.+|+.++.+++|+||+++++++....     +||+++
T Consensus        79 LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~  158 (367)
T 3l9p_A           79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAG  158 (367)
T ss_dssp             CCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred             eeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCC
Confidence            478999999999843      45689999986432 334456888999999999999999999987764     678999


Q ss_pred             CChhHHhhcCC------CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCC---cEEEccccCccc
Q 039957          409 GSLEKRLYSHN------YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENM---VAHVSDFGISKL  478 (481)
Q Consensus       409 g~l~~~l~~~~------~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~---~~kl~Dfgl~~~  478 (481)
                      |+|.+++....      ..+++.++..++.+|++||+|||    +.+|+||||||+|||++.++   .+||+|||+|+.
T Consensus       159 g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~  233 (367)
T 3l9p_A          159 GDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE----ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD  233 (367)
T ss_dssp             EEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHH
T ss_pred             CCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH----hCCeeCCCCChhhEEEecCCCCceEEECCCccccc
Confidence            99999987522      35789999999999999999999    57899999999999999554   599999999864

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.83  E-value=2.3e-20  Score=179.52  Aligned_cols=134  Identities=25%  Similarity=0.373  Sum_probs=115.4

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccchh------hhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccC
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRER------AFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPN  408 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~  408 (481)
                      .+.|+||.||++... +|..+|+|.+......      ..+.+.+|+.++.+++||||+++++++....     +||+++
T Consensus        19 lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   98 (326)
T 2y0a_A           19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG   98 (326)
T ss_dssp             EECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred             EeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCC
Confidence            478999999999864 6899999998754321      2356788999999999999999999987765     678999


Q ss_pred             CChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCC----cEEEccccCcccC
Q 039957          409 GSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENM----VAHVSDFGISKLL  479 (481)
Q Consensus       409 g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~----~~kl~Dfgl~~~~  479 (481)
                      |+|.+++... ..+++..+..++.++++||+|||    +.+|+||||||+||++++++    .+||+|||+|+.+
T Consensus        99 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH----~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~  168 (326)
T 2y0a_A           99 GELFDFLAEK-ESLTEEEATEFLKQILNGVYYLH----SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI  168 (326)
T ss_dssp             CBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             CCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH----HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence            9999998653 45788999999999999999999    57899999999999999887    8999999999765

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.83  E-value=1.4e-20  Score=180.01  Aligned_cols=135  Identities=29%  Similarity=0.463  Sum_probs=115.0

Q ss_pred             hccccccceeeeec------cCCcceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccC
Q 039957          341 SLAGSFGSVYKGTI------SDGTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPN  408 (481)
Q Consensus       341 ~~~g~~g~vy~~~l------~~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~  408 (481)
                      .+.|+||.||++..      .++..||+|.+.... ....+.+.+|++++++++||||+++++++...+     ++|+++
T Consensus        31 lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~  110 (314)
T 2ivs_A           31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKY  110 (314)
T ss_dssp             EEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred             ecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeecCC
Confidence            47899999999975      235789999986543 334467888999999999999999999987764     678999


Q ss_pred             CChhHHhhcCC-----------------------CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCC
Q 039957          409 GSLEKRLYSHN-----------------------YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDEN  465 (481)
Q Consensus       409 g~l~~~l~~~~-----------------------~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~  465 (481)
                      |+|.+++....                       ..+++.++.+++.++++||+|||    +.+|+||||||+||+++++
T Consensus       111 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~dikp~NIli~~~  186 (314)
T 2ivs_A          111 GSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA----EMKLVHRDLAARNILVAEG  186 (314)
T ss_dssp             CBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEETT
T ss_pred             CCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH----HCCCcccccchheEEEcCC
Confidence            99999987532                       24788899999999999999999    5789999999999999999


Q ss_pred             CcEEEccccCcccC
Q 039957          466 MVAHVSDFGISKLL  479 (481)
Q Consensus       466 ~~~kl~Dfgl~~~~  479 (481)
                      +.+||+|||+++..
T Consensus       187 ~~~kl~Dfg~~~~~  200 (314)
T 2ivs_A          187 RKMKISDFGLSRDV  200 (314)
T ss_dssp             TEEEECCCTTCEEC
T ss_pred             CCEEEccccccccc
Confidence            99999999999754

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.83  E-value=5.5e-20  Score=166.35  Aligned_cols=154  Identities=18%  Similarity=0.207  Sum_probs=132.6

Q ss_pred             CEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChh-hhhcccCccEEEccCCceeecCCcccccCC
Q 039957          113 SVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPS-IGNFSTSLQRFSASECKLKGTIPKEIGHLR  191 (481)
Q Consensus       113 ~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~-~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~  191 (481)
                      +.+++++|.++.++...           .+.+++|+|++|++++..|.. |..+ ++|+.|++++|++++..|..|..++
T Consensus        14 ~~l~~s~n~l~~iP~~~-----------~~~~~~L~L~~N~l~~~~~~~~~~~l-~~L~~L~L~~N~i~~i~~~~~~~l~   81 (220)
T 2v70_A           14 TTVDCSNQKLNKIPEHI-----------PQYTAELRLNNNEFTVLEATGIFKKL-PQLRKINFSNNKITDIEEGAFEGAS   81 (220)
T ss_dssp             TEEECCSSCCSSCCSCC-----------CTTCSEEECCSSCCCEECCCCCGGGC-TTCCEEECCSSCCCEECTTTTTTCT
T ss_pred             CEeEeCCCCcccCccCC-----------CCCCCEEEcCCCcCCccCchhhhccC-CCCCEEECCCCcCCEECHHHhCCCC
Confidence            68999999999875422           235789999999999886644 5565 6899999999999988888999999


Q ss_pred             CCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeeeecCCcccccCCCCCcEEcC
Q 039957          192 GLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLG  271 (481)
Q Consensus       192 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls  271 (481)
                      +|++|++++|++++..+..|..+++|+.|++++|++++..|..|..+++|+.|+|++|++++..|..|..+++|+.|+++
T Consensus        82 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  161 (220)
T 2v70_A           82 GVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLL  161 (220)
T ss_dssp             TCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             CCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEec
Confidence            99999999999998888888899999999999999998888888888889999999998888888888888888888888


Q ss_pred             CCcCccc
Q 039957          272 SNKLTSS  278 (481)
Q Consensus       272 ~N~l~~~  278 (481)
                      +|.+...
T Consensus       162 ~N~l~c~  168 (220)
T 2v70_A          162 ANPFNCN  168 (220)
T ss_dssp             SCCEECS
T ss_pred             CcCCcCC
Confidence            8888754

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.83  E-value=7.8e-21  Score=184.38  Aligned_cols=135  Identities=28%  Similarity=0.388  Sum_probs=115.3

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      .+.|+||.||+|.. .+|..||+|.+....   ....+.+.+|+.++++++||||++++++|...+     +||++ |++
T Consensus        62 lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l  140 (348)
T 1u5q_A           62 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSA  140 (348)
T ss_dssp             EEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-EEH
T ss_pred             EccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-CCH
Confidence            37899999999985 578999999986543   233456889999999999999999999987664     56886 788


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      .+.+......+++..+..++.++++||+|||    +.+|+||||||+|||+++++.+||+|||+|+...
T Consensus       141 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~  205 (348)
T 1u5q_A          141 SDLLEVHKKPLQEVEIAAVTHGALQGLAYLH----SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA  205 (348)
T ss_dssp             HHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence            8877655567889999999999999999999    5789999999999999999999999999998653

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.83  E-value=2.1e-20  Score=188.18  Aligned_cols=134  Identities=32%  Similarity=0.525  Sum_probs=116.8

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccch---hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRE---RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      .+.|+||.||+|... +|..||+|.+.....   .....+.+|+.+++.++||||+++++++...+     +||+++|+|
T Consensus        24 LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L  103 (476)
T 2y94_A           24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGEL  103 (476)
T ss_dssp             EECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEH
T ss_pred             EeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcH
Confidence            478999999999864 689999999875432   22356788999999999999999999987765     679999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+++... ..+++.++..++.+|++||+|||    +.+|+||||||+|||+++++.+||+|||+|+..
T Consensus       104 ~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH----~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~  166 (476)
T 2y94_A          104 FDYICKN-GRLDEKESRRLFQQILSGVDYCH----RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM  166 (476)
T ss_dssp             HHHTTSS-SSCCHHHHHHHHHHHHHHHHHHH----TTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH----HCCCCcccccHHHEEEecCCCeEEEeccchhhc
Confidence            9998753 45788999999999999999999    678999999999999999999999999999865

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.83  E-value=1.6e-20  Score=181.86  Aligned_cols=133  Identities=22%  Similarity=0.282  Sum_probs=114.1

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc---hhhhhhhhHHHHHhhhh-ccCccceeecccCCCC-----cccccCCC
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD-----FKFMPNGS  410 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----~~~~~~g~  410 (481)
                      .++|+||.||++... +|..+|+|.+....   ....+.+..|..++.++ +||||+++++++....     +||+++|+
T Consensus        17 lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~   96 (345)
T 3a8x_A           17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGD   96 (345)
T ss_dssp             EEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             EEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCc
Confidence            378999999999865 58899999987543   22345577899999887 8999999999987765     67999999


Q ss_pred             hhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          411 LEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       411 l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      |.+++... ..+++..+..++.+|+.||+|||    +.+|+||||||+|||++.++++||+|||+|+.
T Consensus        97 L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~  159 (345)
T 3a8x_A           97 LMFHMQRQ-RKLPEEHARFYSAEISLALNYLH----ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE  159 (345)
T ss_dssp             HHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEECCGGGCBC
T ss_pred             HHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH----HCCceecCCCHHHEEECCCCCEEEEecccccc
Confidence            99988653 35788899999999999999999    57899999999999999999999999999985

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.83  E-value=1.4e-20  Score=182.43  Aligned_cols=136  Identities=24%  Similarity=0.446  Sum_probs=113.1

Q ss_pred             hhccccccceeeeec------cCCcceEEEEEeccc-hhhhhhhhHHHHHhhhh-ccCccceeecccCCCC-----cccc
Q 039957          340 ISLAGSFGSVYKGTI------SDGTDVAIKIFNLQR-ERAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD-----FKFM  406 (481)
Q Consensus       340 l~~~g~~g~vy~~~l------~~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----~~~~  406 (481)
                      ..+.|+||.||+|..      .++..||+|.+.... ....+.+.+|+.++.++ +||||++++++|...+     ++|+
T Consensus        52 ~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~  131 (344)
T 1rjb_A           52 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYC  131 (344)
T ss_dssp             EEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             eecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecC
Confidence            347899999999985      235679999987543 23345788999999999 8999999999987764     6789


Q ss_pred             cCCChhHHhhcCCC----------------------ccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCC
Q 039957          407 PNGSLEKRLYSHNY----------------------FLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDE  464 (481)
Q Consensus       407 ~~g~l~~~l~~~~~----------------------~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~  464 (481)
                      ++|+|.+++.....                      .+++..+..++.++++||+|||    +.+|+||||||+||+++.
T Consensus       132 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dikp~NIll~~  207 (344)
T 1rjb_A          132 CYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE----FKSCVHRDLAARNVLVTH  207 (344)
T ss_dssp             TTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH----HTTEEETTCSGGGEEEET
T ss_pred             CCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCChhhEEEcC
Confidence            99999999876432                      3688999999999999999999    578999999999999999


Q ss_pred             CCcEEEccccCcccC
Q 039957          465 NMVAHVSDFGISKLL  479 (481)
Q Consensus       465 ~~~~kl~Dfgl~~~~  479 (481)
                      ++.+||+|||+++.+
T Consensus       208 ~~~~kL~Dfg~~~~~  222 (344)
T 1rjb_A          208 GKVVKICDFGLARDI  222 (344)
T ss_dssp             TTEEEECCCGGGSCG
T ss_pred             CCcEEeCCCccCccc
Confidence            999999999999754

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.83  E-value=7.4e-21  Score=195.71  Aligned_cols=130  Identities=19%  Similarity=0.205  Sum_probs=100.9

Q ss_pred             cccccceeeee-ccCCcceEEEEEeccc----------hhhhhhhhHHHHHhhhh-ccCccceeecccCCCC-----ccc
Q 039957          343 AGSFGSVYKGT-ISDGTDVAIKIFNLQR----------ERAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD-----FKF  405 (481)
Q Consensus       343 ~g~~g~vy~~~-l~~g~~vavK~l~~~~----------~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----~~~  405 (481)
                      .|+.|....+. ...|..+++|.+....          ....++|.+|+++|+++ .|+||+++++++.+..     +||
T Consensus       244 ~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEy  323 (569)
T 4azs_A          244 AGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEK  323 (569)
T ss_dssp             --------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEEC
T ss_pred             cCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEec
Confidence            34444443332 2347889999986431          23346789999999998 6999999999998765     789


Q ss_pred             ccCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          406 MPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       406 ~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      ++||+|.+++...+ .++.   .+|+.||++||+|+|    +.+||||||||+|||+++++.+||+|||+|+...
T Consensus       324 v~G~~L~d~i~~~~-~l~~---~~I~~QIl~AL~ylH----~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~  390 (569)
T 4azs_A          324 LPGRLLSDMLAAGE-EIDR---EKILGSLLRSLAALE----KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTP  390 (569)
T ss_dssp             CCSEEHHHHHHTTC-CCCH---HHHHHHHHHHHHHHH----HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred             CCCCcHHHHHHhCC-CCCH---HHHHHHHHHHHHHHH----HCCceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence            99999999997643 3443   358999999999999    6889999999999999999999999999998753

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.83  E-value=1.5e-20  Score=181.25  Aligned_cols=133  Identities=22%  Similarity=0.293  Sum_probs=114.3

Q ss_pred             hhccccccceeeeec-cCCcceEEEEEeccchhhhhhhhHHHHHhhhh-ccCccceeecccCCCC-----cccccCCChh
Q 039957          340 ISLAGSFGSVYKGTI-SDGTDVAIKIFNLQRERAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       340 l~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      ..+.|+||.||+|.. .+|..||+|.+....  ..+.+..|+.++.++ +|+||+++++++...+     ++|+ +|+|.
T Consensus        16 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~   92 (330)
T 2izr_A           16 KIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLE   92 (330)
T ss_dssp             ECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHH
T ss_pred             EeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHH
Confidence            347899999999984 578999999886543  234678899999999 9999999999887664     5688 99999


Q ss_pred             HHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCc-----EEEccccCcccC
Q 039957          413 KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMV-----AHVSDFGISKLL  479 (481)
Q Consensus       413 ~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~-----~kl~Dfgl~~~~  479 (481)
                      +++......+++..+..|+.++++||+|||    +.+|+||||||+|||++.++.     +||+|||+|+.+
T Consensus        93 ~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH----~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~  160 (330)
T 2izr_A           93 DLFDLCDRTFSLKTVLMIAIQLISRMEYVH----SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY  160 (330)
T ss_dssp             HHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred             HHHHHcCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence            998865567899999999999999999999    578999999999999999887     999999999864

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.82  E-value=1.4e-20  Score=176.81  Aligned_cols=134  Identities=25%  Similarity=0.487  Sum_probs=115.9

Q ss_pred             hccccccceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC----cccccCCChhHHhh
Q 039957          341 SLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----FKFMPNGSLEKRLY  416 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~~~~g~l~~~l~  416 (481)
                      .+.|+||.||+|...++..||+|.+.... ...+.+.+|++++.+++|+||+++++++....    ++|+++|+|.+++.
T Consensus        21 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~l~   99 (279)
T 1qpc_A           21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLK   99 (279)
T ss_dssp             EEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCTTCBHHHHTT
T ss_pred             ecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcCCCcEEEEecCCCCCHHHHHh
Confidence            37899999999998778889999986543 23456888999999999999999999987654    57899999999986


Q ss_pred             cCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          417 SHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       417 ~~~-~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ... ..+++.++.+++.++++||+|||    +.+|+||||||+||++++++.+||+|||+++..
T Consensus       100 ~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  159 (279)
T 1qpc_A          100 TPSGIKLTINKLLDMAAQIAEGMAFIE----ERNYIHRDLRAANILVSDTLSCKIADFGLARLI  159 (279)
T ss_dssp             SHHHHTCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             cCCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence            532 25788999999999999999999    578999999999999999999999999999765

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.82  E-value=1.2e-20  Score=181.69  Aligned_cols=134  Identities=22%  Similarity=0.354  Sum_probs=107.9

Q ss_pred             hhccccccceeeeec----cCCcceEEEEEeccc----hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccc
Q 039957          340 ISLAGSFGSVYKGTI----SDGTDVAIKIFNLQR----ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFM  406 (481)
Q Consensus       340 l~~~g~~g~vy~~~l----~~g~~vavK~l~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~  406 (481)
                      ..+.|+||.||++..    .+|..+|+|.+....    ......+.+|+.++++++|+||+++++++...+     +||+
T Consensus        24 ~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~  103 (327)
T 3a62_A           24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYL  103 (327)
T ss_dssp             EEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred             EEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCC
Confidence            347899999999975    468899999987542    223445778999999999999999999987764     6789


Q ss_pred             cCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          407 PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       407 ~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      ++|+|.+++... ..++......++.+|+.||+|||    +.+|+||||||+|||++.++.+||+|||+|+.
T Consensus       104 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH----~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  170 (327)
T 3a62_A          104 SGGELFMQLERE-GIFMEDTACFYLAEISMALGHLH----QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE  170 (327)
T ss_dssp             TTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred             CCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHH----hCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence            999999988653 34677888899999999999999    57899999999999999999999999999875

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.82  E-value=2.8e-20  Score=179.65  Aligned_cols=135  Identities=25%  Similarity=0.494  Sum_probs=113.8

Q ss_pred             hccccccceeeeecc--------CCcceEEEEEeccc-hhhhhhhhHHHHHhhhh-ccCccceeecccCCCC-----ccc
Q 039957          341 SLAGSFGSVYKGTIS--------DGTDVAIKIFNLQR-ERAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD-----FKF  405 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~--------~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----~~~  405 (481)
                      .+.|+||.||++...        ++..||+|.+.... ....+.+.+|++++.++ +||||++++++|...+     ++|
T Consensus        43 lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~  122 (334)
T 2pvf_A           43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEY  122 (334)
T ss_dssp             EEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEEC
T ss_pred             EeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEEC
Confidence            478999999999752        46789999986543 23445688899999999 8999999999997764     678


Q ss_pred             ccCCChhHHhhcCC---------------CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 039957          406 MPNGSLEKRLYSHN---------------YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHV  470 (481)
Q Consensus       406 ~~~g~l~~~l~~~~---------------~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl  470 (481)
                      +++|+|.+++....               ..+++..+.+++.+|++||+|||    +.+|+||||||+||+++.++.+||
T Consensus       123 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~kL  198 (334)
T 2pvf_A          123 ASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA----SQKCIHRDLAARNVLVTENNVMKI  198 (334)
T ss_dssp             CTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEE
T ss_pred             CCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCccceEEEcCCCCEEE
Confidence            99999999987532               23788999999999999999999    578999999999999999999999


Q ss_pred             ccccCcccC
Q 039957          471 SDFGISKLL  479 (481)
Q Consensus       471 ~Dfgl~~~~  479 (481)
                      +|||+++..
T Consensus       199 ~Dfg~~~~~  207 (334)
T 2pvf_A          199 ADFGLARDI  207 (334)
T ss_dssp             CCCTTCEEC
T ss_pred             ccccccccc
Confidence            999999754

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.82  E-value=2e-21  Score=187.93  Aligned_cols=133  Identities=22%  Similarity=0.314  Sum_probs=105.1

Q ss_pred             hccccccceeeeeccCCcceEEEEEeccch--------hhhhhhhHHHHHhhhhc---------c---------------
Q 039957          341 SLAGSFGSVYKGTISDGTDVAIKIFNLQRE--------RAFRSFNSECEVLRNVR---------H---------------  388 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~g~~vavK~l~~~~~--------~~~~~~~~e~~~l~~l~---------h---------------  388 (481)
                      .++|+||.||+|.. +|..||+|.+.....        ...+.+.+|+.+++.++         |               
T Consensus        28 lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~  106 (336)
T 2vuw_A           28 IGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGS  106 (336)
T ss_dssp             EEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESS
T ss_pred             ecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCC
Confidence            37899999999987 789999999876432        12356788999988886         4               


Q ss_pred             --CccceeecccCC-------------CC-----cccccCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 039957          389 --QNLIKILSSCST-------------PD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSA  448 (481)
Q Consensus       389 --~niv~l~~~~~~-------------~~-----~~~~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~  448 (481)
                        |||+++++++..             ..     +||+++|++.+.+..  ..+++.....|+.||++||+|||+   +.
T Consensus       107 ~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~---~~  181 (336)
T 2vuw_A          107 YPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLAVAEA---SL  181 (336)
T ss_dssp             CCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHHHHHH---HH
T ss_pred             CcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHH---hC
Confidence              555555544432             22     678999987776643  356888999999999999999993   25


Q ss_pred             CeeeCCCCCCCeeeCCCC--------------------cEEEccccCcccC
Q 039957          449 PIIHCDLKPTSILLDENM--------------------VAHVSDFGISKLL  479 (481)
Q Consensus       449 ~i~H~dlk~~nill~~~~--------------------~~kl~Dfgl~~~~  479 (481)
                      +||||||||+|||++.++                    .+||+|||+|+..
T Consensus       182 ~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~  232 (336)
T 2vuw_A          182 RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLE  232 (336)
T ss_dssp             CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEE
T ss_pred             CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEec
Confidence            699999999999999887                    9999999999864

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.82  E-value=1.8e-20  Score=177.01  Aligned_cols=136  Identities=24%  Similarity=0.432  Sum_probs=117.6

Q ss_pred             hhccccccceeeeecc---CCcceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC----cccccCCCh
Q 039957          340 ISLAGSFGSVYKGTIS---DGTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----FKFMPNGSL  411 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~---~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~~~~g~l  411 (481)
                      ..+.|+||.||+|...   .+..||+|.+.... ....+.+.+|++++.+++||||+++++++....    ++|+++|+|
T Consensus        17 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L   96 (287)
T 1u59_A           17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPL   96 (287)
T ss_dssp             EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTEEH
T ss_pred             cccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecCCCcEEEEEeCCCCCH
Confidence            3478999999999753   56789999987643 334567889999999999999999999985543    678999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+++......+++..+.+++.++++||+|||    +.+|+||||||+||++++++.+||+|||+++.+
T Consensus        97 ~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~  160 (287)
T 1u59_A           97 HKFLVGKREEIPVSNVAELLHQVSMGMKYLE----EKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL  160 (287)
T ss_dssp             HHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             HHHHHhCCccCCHHHHHHHHHHHHHHHHHHH----HCCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence            9998766667899999999999999999999    578999999999999999999999999999765

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.82  E-value=2e-20  Score=181.94  Aligned_cols=137  Identities=23%  Similarity=0.405  Sum_probs=114.0

Q ss_pred             hhccccccceeeeec-cCCcceEEEEEeccch-----hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccC
Q 039957          340 ISLAGSFGSVYKGTI-SDGTDVAIKIFNLQRE-----RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPN  408 (481)
Q Consensus       340 l~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~  408 (481)
                      ..+.|+||.||++.. .+|..||+|.+.....     ...+.+.+|+.++.+++||||+++++++...+     +||+++
T Consensus        31 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g  110 (351)
T 3c0i_A           31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDG  110 (351)
T ss_dssp             EEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSS
T ss_pred             EEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCC
Confidence            347899999999985 4689999999865431     12456889999999999999999999887664     679999


Q ss_pred             CChhHHhhc---CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCc---EEEccccCcccCC
Q 039957          409 GSLEKRLYS---HNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMV---AHVSDFGISKLLG  480 (481)
Q Consensus       409 g~l~~~l~~---~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~---~kl~Dfgl~~~~~  480 (481)
                      |+|.+.+..   ....+++..+..++.+|++||+|||    +.+|+||||||+|||++.++.   +||+|||+++...
T Consensus       111 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH----~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~  184 (351)
T 3c0i_A          111 ADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH----DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG  184 (351)
T ss_dssp             CBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECC
T ss_pred             CCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH----HCCceeccCChHHeEEecCCCCCcEEEecCcceeEec
Confidence            999887754   2345788899999999999999999    578999999999999986554   9999999997653

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.82  E-value=2.2e-20  Score=179.05  Aligned_cols=134  Identities=25%  Similarity=0.435  Sum_probs=108.8

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccch-hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhH
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRE-RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEK  413 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~  413 (481)
                      .+.|+||.||+|... +|..||+|.+..... .....+.+|++++++++||||+++++++...+     +||++ |+|.+
T Consensus        13 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~   91 (317)
T 2pmi_A           13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKK   91 (317)
T ss_dssp             ------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHH
T ss_pred             ECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHH
Confidence            478999999999854 588999999876542 23356788999999999999999999998765     56887 69988


Q ss_pred             HhhcC-----CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          414 RLYSH-----NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       414 ~l~~~-----~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ++...     ...+++..+..++.+|++||+|||    +.+|+||||||+||+++.++.+||+|||+|+..
T Consensus        92 ~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH----~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  158 (317)
T 2pmi_A           92 YMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH----ENKILHRDLKPQNLLINKRGQLKLGDFGLARAF  158 (317)
T ss_dssp             HHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred             HHHhccccccccCCCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence            87642     234788889999999999999999    578999999999999999999999999999764

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.82  E-value=2.1e-20  Score=176.90  Aligned_cols=134  Identities=25%  Similarity=0.388  Sum_probs=113.1

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccch--hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRE--RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      .+.|+||.||++... +|..||+|.+.....  .....+.+|+.++++++|+||+++++++....     +||++ |++.
T Consensus        10 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~   88 (292)
T 3o0g_A           10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLK   88 (292)
T ss_dssp             EEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCS-EEHH
T ss_pred             ecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCC-CCHH
Confidence            368999999999864 588999999875432  23356788999999999999999999987665     56776 4666


Q ss_pred             HHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          413 KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       413 ~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +.+......+++..+..++.++++||+|||    +.+|+||||||+||+++.++.+||+|||+|+..
T Consensus        89 ~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH----~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~  151 (292)
T 3o0g_A           89 KYFDSCNGDLDPEIVKSFLFQLLKGLGFCH----SRNVLHRDLKPQNLLINRNGELKLANFGLARAF  151 (292)
T ss_dssp             HHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             HHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence            666555566889999999999999999999    578999999999999999999999999999764

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.82  E-value=3.1e-20  Score=181.17  Aligned_cols=135  Identities=24%  Similarity=0.463  Sum_probs=115.0

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      .+.|+||.||++... +|..+|+|.+....  ....+.+.+|+.++++++||||+++++++...+     +||+++|+|.
T Consensus        37 lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~  116 (362)
T 2bdw_A           37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELF  116 (362)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred             EecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHH
Confidence            478999999999854 68999999987543  233456888999999999999999999988765     6789999999


Q ss_pred             HHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCC---CcEEEccccCcccCC
Q 039957          413 KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDEN---MVAHVSDFGISKLLG  480 (481)
Q Consensus       413 ~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~---~~~kl~Dfgl~~~~~  480 (481)
                      +++... ..+++..+..++.+|++||+|||    +.+|+||||||+|||++.+   +.+||+|||+|+...
T Consensus       117 ~~l~~~-~~~~~~~~~~~~~qi~~al~~lH----~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~  182 (362)
T 2bdw_A          117 EDIVAR-EFYSEADASHCIQQILESIAYCH----SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  182 (362)
T ss_dssp             HHHTTC-SCCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred             HHHHHc-CCCCHHHHHHHHHHHHHHHHHHH----HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence            988754 45788999999999999999999    5789999999999999865   469999999997653

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.82  E-value=2e-20  Score=180.53  Aligned_cols=137  Identities=31%  Similarity=0.531  Sum_probs=114.4

Q ss_pred             hhhccccccceeeeeccC-----CcceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----ccccc
Q 039957          339 TISLAGSFGSVYKGTISD-----GTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMP  407 (481)
Q Consensus       339 ~l~~~g~~g~vy~~~l~~-----g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~  407 (481)
                      ...++|+||.||+|....     +..||+|.+.... ......+.+|+.++++++|+||+++++++...+     +||++
T Consensus        50 ~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  129 (333)
T 1mqb_A           50 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYME  129 (333)
T ss_dssp             EEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             cEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCC
Confidence            345789999999998642     2359999987543 233456888999999999999999999987764     67899


Q ss_pred             CCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          408 NGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       408 ~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +|+|.+++......+++.++.+++.++++||+|||    +.+|+||||||+||++++++.+||+|||+++..
T Consensus       130 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  197 (333)
T 1mqb_A          130 NGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA----NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL  197 (333)
T ss_dssp             TEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             CCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence            99999999876667899999999999999999999    578999999999999999999999999999764

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.82  E-value=1.6e-20  Score=179.43  Aligned_cols=135  Identities=27%  Similarity=0.430  Sum_probs=115.7

Q ss_pred             hccccccceeeeec------cCCcceEEEEEeccch-hhhhhhhHHHHHhhhh-ccCccceeecccCCCC-----ccccc
Q 039957          341 SLAGSFGSVYKGTI------SDGTDVAIKIFNLQRE-RAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD-----FKFMP  407 (481)
Q Consensus       341 ~~~g~~g~vy~~~l------~~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----~~~~~  407 (481)
                      .+.|+||.||++..      .++..||+|.+..... ...+.+.+|+.++.++ +||||++++++|...+     +||++
T Consensus        31 lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~  110 (313)
T 1t46_A           31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCC  110 (313)
T ss_dssp             EEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             hCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCC
Confidence            47899999999974      3467899999875433 3346688999999999 9999999999987765     67899


Q ss_pred             CCChhHHhhcCCC-----------------ccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 039957          408 NGSLEKRLYSHNY-----------------FLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHV  470 (481)
Q Consensus       408 ~g~l~~~l~~~~~-----------------~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl  470 (481)
                      +|+|.+++.....                 .+++.++.+++.++++||+|||    +.+|+||||||+||++++++.+||
T Consensus       111 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~kl  186 (313)
T 1t46_A          111 YGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA----SKNCIHRDLAARNILLTHGRITKI  186 (313)
T ss_dssp             TEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEEETTTEEEE
T ss_pred             CCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCccceEEEcCCCCEEE
Confidence            9999999875432                 4789999999999999999999    578999999999999999999999


Q ss_pred             ccccCcccC
Q 039957          471 SDFGISKLL  479 (481)
Q Consensus       471 ~Dfgl~~~~  479 (481)
                      +|||+++..
T Consensus       187 ~Dfg~~~~~  195 (313)
T 1t46_A          187 CDFGLARDI  195 (313)
T ss_dssp             CCCGGGSCT
T ss_pred             ccccccccc
Confidence            999999865

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.82  E-value=1.6e-20  Score=180.68  Aligned_cols=135  Identities=28%  Similarity=0.480  Sum_probs=111.6

Q ss_pred             hccccccceeeeec-cCCcce----EEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC----cccccCCC
Q 039957          341 SLAGSFGSVYKGTI-SDGTDV----AIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----FKFMPNGS  410 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~v----avK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~~~~g~  410 (481)
                      .+.|+||.||+|.. .++..+    ++|.+.... ....+.+.+|+.++++++||||++++++|....    ++|+++|+
T Consensus        23 lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~v~~~~~~g~  102 (327)
T 3lzb_A           23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGC  102 (327)
T ss_dssp             EEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSSEEEEECCCSSCB
T ss_pred             eeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCCceEEEEecCCCc
Confidence            47899999999984 455554    666654332 234457888999999999999999999988765    56889999


Q ss_pred             hhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          411 LEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       411 l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +.+++......+++..+..++.++++||+|||    +.+|+||||||+||+++.++.+||+|||+|+.+
T Consensus       103 L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A          103 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE----DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             HHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh----hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence            99999876667889999999999999999999    578999999999999999999999999999865

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.82  E-value=1.2e-19  Score=165.21  Aligned_cols=155  Identities=22%  Similarity=0.246  Sum_probs=122.2

Q ss_pred             ccEEEccCCceeecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCC
Q 039957          169 LQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGG  248 (481)
Q Consensus       169 L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~  248 (481)
                      .+.++.+++.++ .+|..+.  ++|++|++++|.+++..|..|..+++|+.|++++|+++...+..|..+++|+.|+|++
T Consensus        21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~   97 (229)
T 3e6j_A           21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT   97 (229)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence            445666666665 4554443  6777777777777777777777778888888888888776667778888888888888


Q ss_pred             CeeeecCCcccccCCCCCcEEcCCCcCcccCCcchhccccCcEEEccCcccCCCCCCccccCCcCcEEEccCCeeeeec
Q 039957          249 NKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDI  327 (481)
Q Consensus       249 N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~  327 (481)
                      |++++..+..|..+++|++|++++|+++ .+|..+..++.|+.|++++|++++..+..+..+++|+.|++++|++.+..
T Consensus        98 N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c  175 (229)
T 3e6j_A           98 NQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCEC  175 (229)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTB
T ss_pred             CcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCc
Confidence            8888777777888888888888888887 67888888888888999999888777777888999999999999988653

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.82  E-value=2.8e-20  Score=174.78  Aligned_cols=135  Identities=24%  Similarity=0.424  Sum_probs=117.6

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccch---hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQRE---RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      .++|+||.||++.. .+|..||+|.+.....   ...+.+.+|+.++.+++||||+++++++...+     +||+++|+|
T Consensus        19 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   98 (278)
T 3cok_A           19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEM   98 (278)
T ss_dssp             EEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEH
T ss_pred             ecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcH
Confidence            36899999999985 5689999999865432   22356788999999999999999999988765     578999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+++......+++..+..++.++++|++|||    +.+|+||||||+||++++++.+||+|||+++..
T Consensus        99 ~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~  162 (278)
T 3cok_A           99 NRYLKNRVKPFSENEARHFMHQIITGMLYLH----SHGILHRDLTLSNLLLTRNMNIKIADFGLATQL  162 (278)
T ss_dssp             HHHHHTCSSCCCHHHHHHHHHHHHHHHHHHH----HTTEECSSCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             HHHHhhccCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEEcCCCCEEEEeecceeec
Confidence            9998876667889999999999999999999    578999999999999999999999999998764

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.82  E-value=7.4e-20  Score=166.63  Aligned_cols=153  Identities=25%  Similarity=0.241  Sum_probs=88.7

Q ss_pred             CCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeecc
Q 039957           15 LKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLG   94 (481)
Q Consensus        15 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls   94 (481)
                      -+.++.++++++.+ |..+.  ++|++|+|++|++++..|..+. .+++|++|+|++|+++...+..|..+++|++|+|+
T Consensus        21 ~~~v~c~~~~l~~i-p~~~~--~~L~~L~Ls~n~i~~~~~~~~~-~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls   96 (229)
T 3e6j_A           21 GTTVDCRSKRHASV-PAGIP--TNAQILYLHDNQITKLEPGVFD-SLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLG   96 (229)
T ss_dssp             TTEEECTTSCCSSC-CSCCC--TTCSEEECCSSCCCCCCTTTTT-TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCEeEccCCCcCcc-CCCCC--CCCCEEEcCCCccCccCHHHhh-CccCCcEEECCCCCCCCcChhhcccCCCcCEEECC
Confidence            34566666666533 33222  5566666666666644444443 56666666666666655444555666666666666


Q ss_pred             cCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEc
Q 039957           95 FNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSA  174 (481)
Q Consensus        95 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l  174 (481)
                      +|++++..+..|..+++|++|+|++|+++.++         ..+..+++|++|+|++|++++..+..+..+ ++|+.|++
T Consensus        97 ~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~lp---------~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~l  166 (229)
T 3e6j_A           97 TNQLTVLPSAVFDRLVHLKELFMCCNKLTELP---------RGIERLTHLTHLALDQNQLKSIPHGAFDRL-SSLTHAYL  166 (229)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCCSCC---------TTGGGCTTCSEEECCSSCCCCCCTTTTTTC-TTCCEEEC
T ss_pred             CCcCCccChhHhCcchhhCeEeccCCcccccC---------cccccCCCCCEEECCCCcCCccCHHHHhCC-CCCCEEEe
Confidence            66666655555666666666666666666442         223455666666666666665444444444 45666666


Q ss_pred             cCCceee
Q 039957          175 SECKLKG  181 (481)
Q Consensus       175 ~~n~l~~  181 (481)
                      ++|.+..
T Consensus       167 ~~N~~~c  173 (229)
T 3e6j_A          167 FGNPWDC  173 (229)
T ss_dssp             TTSCBCT
T ss_pred             eCCCccC
Confidence            6666553

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.82  E-value=7.4e-21  Score=198.55  Aligned_cols=134  Identities=25%  Similarity=0.419  Sum_probs=115.6

Q ss_pred             hccccccceeeeecc---CCcceEEEEEeccch--hhhhhhhHHHHHhhhhccCccceeecccCCCC----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTIS---DGTDVAIKIFNLQRE--RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~---~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~~~~g~l  411 (481)
                      .+.|+||.||+|...   .+..||||++.....  ...+.+.+|++++.+++|+|||+++++|....    +||+++|+|
T Consensus       377 LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~lv~E~~~~g~L  456 (635)
T 4fl3_A          377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPL  456 (635)
T ss_dssp             EEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTEEH
T ss_pred             eccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEEEccCCCCH
Confidence            478999999999653   357899999875432  23467889999999999999999999997654    679999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+++... ..+++..+..|+.+|++||+|||    +.+||||||||+|||+++++.+||+|||+|+.+
T Consensus       457 ~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH----~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~  519 (635)
T 4fl3_A          457 NKYLQQN-RHVKDKNIIELVHQVSMGMKYLE----ESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL  519 (635)
T ss_dssp             HHHHHHC-TTCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHT
T ss_pred             HHHHhhC-CCCCHHHHHHHHHHHHHHHHHHH----HCCEeCCCCChHhEEEeCCCCEEEEEcCCcccc
Confidence            9998753 45788999999999999999999    578999999999999999999999999999765

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.82  E-value=1.2e-20  Score=181.42  Aligned_cols=136  Identities=26%  Similarity=0.485  Sum_probs=107.5

Q ss_pred             hhccccccceeeeeccCC----cceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----------
Q 039957          340 ISLAGSFGSVYKGTISDG----TDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----------  402 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~~g----~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----------  402 (481)
                      ..+.|+||.||+|.....    ..||+|.+....  ....+.+.+|++++++++|+||+++++++....           
T Consensus        30 ~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v  109 (323)
T 3qup_A           30 MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVI  109 (323)
T ss_dssp             EEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEE
T ss_pred             eecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEEE
Confidence            347899999999986543    279999886542  334567889999999999999999999886542           


Q ss_pred             cccccCCChhHHhhcC-----CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcc
Q 039957          403 FKFMPNGSLEKRLYSH-----NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK  477 (481)
Q Consensus       403 ~~~~~~g~l~~~l~~~-----~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~  477 (481)
                      ++|+++|+|.+++...     ...+++..+.+++.++++||+|||    +.+|+||||||+||++++++.+||+|||+|+
T Consensus       110 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH----~~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~  185 (323)
T 3qup_A          110 LPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS----SRNFIHRDLAARNCMLAEDMTVCVADFGLSR  185 (323)
T ss_dssp             EECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred             EEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH----cCCcccCCCCcceEEEcCCCCEEEeeccccc
Confidence            4688999999988642     225788999999999999999999    5789999999999999999999999999997


Q ss_pred             cC
Q 039957          478 LL  479 (481)
Q Consensus       478 ~~  479 (481)
                      ..
T Consensus       186 ~~  187 (323)
T 3qup_A          186 KI  187 (323)
T ss_dssp             --
T ss_pred             cc
Confidence            64

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.82  E-value=3.2e-20  Score=179.15  Aligned_cols=134  Identities=25%  Similarity=0.359  Sum_probs=114.3

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccch--------hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccc
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQRE--------RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFM  406 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~  406 (481)
                      .+.|+||.||++.. .+|..||+|.+.....        .....+.+|+.++++++|+||+++++++...+     ++|+
T Consensus        32 lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~  111 (335)
T 3dls_A           32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKH  111 (335)
T ss_dssp             CSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             EEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEeC
Confidence            37899999999984 5688999999876431        13346788999999999999999999998765     5677


Q ss_pred             cCC-ChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          407 PNG-SLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       407 ~~g-~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ..| ++.+++... ..+++..+..|+.++++||+|||    +.+|+||||||+||++++++.+||+|||+++.+
T Consensus       112 ~~g~~l~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~  180 (335)
T 3dls_A          112 GSGLDLFAFIDRH-PRLDEPLASYIFRQLVSAVGYLR----LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL  180 (335)
T ss_dssp             TTSCBHHHHHHTC-CCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH----hCCeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence            666 999888653 35788999999999999999999    578999999999999999999999999999765

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.82  E-value=7.1e-21  Score=177.12  Aligned_cols=171  Identities=22%  Similarity=0.268  Sum_probs=117.7

Q ss_pred             CCCCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCce
Q 039957           11 NLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLII   90 (481)
Q Consensus        11 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~   90 (481)
                      .+.+++.++++.|.++++.  .+..+++|++|++++|.++ .+| .+. .+++|++|+|++|++++..+  +..+++|++
T Consensus        17 ~l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~-~l~-~l~-~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~   89 (263)
T 1xeu_A           17 GLANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQ-SLA-GMQ-FFTNLKELHLSHNQISDLSP--LKDLTKLEE   89 (263)
T ss_dssp             HHHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCC-CCT-TGG-GCTTCCEEECCSSCCCCCGG--GTTCSSCCE
T ss_pred             HHHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcc-cch-HHh-hCCCCCEEECCCCccCCChh--hccCCCCCE
Confidence            4556677778888877553  4677788888888888886 566 343 57788888888888775544  777788888


Q ss_pred             eecccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCcc
Q 039957           91 LDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQ  170 (481)
Q Consensus        91 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~  170 (481)
                      |++++|++++. |. +.. ++|++|++++|+++++          +.+..+++|++|+|++|++++. + .+..+ ++|+
T Consensus        90 L~L~~N~l~~l-~~-~~~-~~L~~L~L~~N~l~~~----------~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l-~~L~  153 (263)
T 1xeu_A           90 LSVNRNRLKNL-NG-IPS-ACLSRLFLDNNELRDT----------DSLIHLKNLEILSIRNNKLKSI-V-MLGFL-SKLE  153 (263)
T ss_dssp             EECCSSCCSCC-TT-CCC-SSCCEEECCSSCCSBS----------GGGTTCTTCCEEECTTSCCCBC-G-GGGGC-TTCC
T ss_pred             EECCCCccCCc-Cc-ccc-CcccEEEccCCccCCC----------hhhcCcccccEEECCCCcCCCC-h-HHccC-CCCC
Confidence            88888887753 33 222 7778888888777765          2245677777777777777754 2 45554 4677


Q ss_pred             EEEccCCceeecCCcccccCCCCCeEecccccceec
Q 039957          171 RFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGT  206 (481)
Q Consensus       171 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~  206 (481)
                      .|++++|++++.  ..+..+++|++|++++|.+++.
T Consensus       154 ~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~  187 (263)
T 1xeu_A          154 VLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE  187 (263)
T ss_dssp             EEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred             EEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence            777777777654  4566677777777777776643

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.82  E-value=2.2e-20  Score=177.45  Aligned_cols=134  Identities=30%  Similarity=0.458  Sum_probs=108.4

Q ss_pred             hhccccccceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhhh--hccCccceeecccCCC---------CcccccC
Q 039957          340 ISLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRN--VRHQNLIKILSSCSTP---------DFKFMPN  408 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~---------~~~~~~~  408 (481)
                      ..+.|+||.||+|.. +|..||||.+....   ...+..|.+++..  ++||||+++++++...         .+||+++
T Consensus        15 ~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~   90 (301)
T 3q4u_A           15 CVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEM   90 (301)
T ss_dssp             EEEECSSEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTT
T ss_pred             eeccCCCcEEEEEEE-CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccC
Confidence            347899999999987 68899999986543   2334456665555  7999999999886432         1578999


Q ss_pred             CChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCC----CCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          409 GSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGH----SSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       409 g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~----~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      |+|.+++..  ..+++..+.+++.++++||+|||...    .+.+|+||||||+|||++.++.+||+|||+|+..
T Consensus        91 g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  163 (301)
T 3q4u_A           91 GSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMH  163 (301)
T ss_dssp             CBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             CCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeec
Confidence            999999864  35889999999999999999999321    0368999999999999999999999999998653

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.82  E-value=4.8e-20  Score=184.23  Aligned_cols=135  Identities=20%  Similarity=0.376  Sum_probs=113.7

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      .+.|+||.||++.. .+|..+|+|.+....  ....+.+.+|+.++++++||||+++++++...+     +||+++|+|.
T Consensus        19 LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~   98 (444)
T 3soa_A           19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELF   98 (444)
T ss_dssp             EEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHH
T ss_pred             eccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHH
Confidence            47899999999974 568999999987643  233456789999999999999999999988765     6789999999


Q ss_pred             HHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeC---CCCcEEEccccCcccCC
Q 039957          413 KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLD---ENMVAHVSDFGISKLLG  480 (481)
Q Consensus       413 ~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~---~~~~~kl~Dfgl~~~~~  480 (481)
                      +.+... ..++......++.+|++||+|||    +.+|+||||||+|||++   +++.+||+|||+|+...
T Consensus        99 ~~i~~~-~~~~e~~~~~i~~qil~aL~~lH----~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~  164 (444)
T 3soa_A           99 EDIVAR-EYYSEADASHCIQQILEAVLHCH----QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE  164 (444)
T ss_dssp             HHHHHC-SCCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred             HHHHHc-CCCCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence            988764 35788899999999999999999    57899999999999998   46889999999997653

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.82  E-value=9.7e-21  Score=190.24  Aligned_cols=135  Identities=26%  Similarity=0.308  Sum_probs=107.5

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      .+.|+||.||++.. .+|..||+|.+....   ......+..|+.++++++|+||++++++|...+     +||+++|+|
T Consensus       156 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L  235 (446)
T 4ejn_A          156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL  235 (446)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBH
T ss_pred             EeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcH
Confidence            47899999999985 468999999987542   223345678999999999999999999987664     689999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+++... ..+++..+..++.+|++||+|||.   ..+||||||||+|||++.++.+||+|||+|+..
T Consensus       236 ~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~  299 (446)
T 4ejn_A          236 FFHLSRE-RVFSEDRARFYGAEIVSALDYLHS---EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG  299 (446)
T ss_dssp             HHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhh---cCCEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence            9988653 357888999999999999999993   167999999999999999999999999999863

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.82  E-value=2.2e-20  Score=175.73  Aligned_cols=136  Identities=24%  Similarity=0.434  Sum_probs=116.0

Q ss_pred             hhccccccceeeeeccC----CcceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC----cccccCCC
Q 039957          340 ISLAGSFGSVYKGTISD----GTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----FKFMPNGS  410 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~~----g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~~~~g~  410 (481)
                      ..+.|+||.||+|....    +..||+|.+.... ....+.+.+|+.++++++||||+++++++....    ++|+++|+
T Consensus        19 ~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~~   98 (281)
T 3cc6_A           19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGE   98 (281)
T ss_dssp             EEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSSCEEEEECCTTCB
T ss_pred             EEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCEEEEecCCCCC
Confidence            34789999999997542    2459999887543 234567889999999999999999999987654    57899999


Q ss_pred             hhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          411 LEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       411 l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      |.+++......+++..+..++.++++||+|||    +.+|+||||||+||+++.++.+||+|||+++..
T Consensus        99 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  163 (281)
T 3cc6_A           99 LGHYLERNKNSLKVLTLVLYSLQICKAMAYLE----SINCVHRDIAVRNILVASPECVKLGDFGLSRYI  163 (281)
T ss_dssp             HHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred             HHHHHHhccccCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence            99998765566889999999999999999999    578999999999999999999999999998764

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.82  E-value=1.9e-20  Score=180.50  Aligned_cols=134  Identities=28%  Similarity=0.443  Sum_probs=114.2

Q ss_pred             hhccccccceeeeec-cCCcceEEEEEeccch---hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCC
Q 039957          340 ISLAGSFGSVYKGTI-SDGTDVAIKIFNLQRE---RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGS  410 (481)
Q Consensus       340 l~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~  410 (481)
                      ..+.|+||.||+|.. .+|..||+|.+.....   .....+.+|+.+++.++||||+++++++....     +||+ +|+
T Consensus        16 ~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~   94 (336)
T 3h4j_B           16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGE   94 (336)
T ss_dssp             EEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEE
T ss_pred             EEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCc
Confidence            347899999999985 5689999999865422   22346788999999999999999999998765     5788 689


Q ss_pred             hhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          411 LEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       411 l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +.+++... ..+++.++.+++.++++|++|||    +.+|+||||||+|||+++++.+||+|||+|+..
T Consensus        95 l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH----~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~  158 (336)
T 3h4j_B           95 LFDYIVEK-KRMTEDEGRRFFQQIICAIEYCH----RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM  158 (336)
T ss_dssp             HHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH----HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTT
T ss_pred             HHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCchhhEEEcCCCCEEEEEeccceec
Confidence            98887653 35788999999999999999999    578999999999999999999999999999865

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.82  E-value=2e-20  Score=176.78  Aligned_cols=134  Identities=31%  Similarity=0.550  Sum_probs=109.9

Q ss_pred             hhccccccceeeeeccCCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC----cccccCCChhH
Q 039957          340 ISLAGSFGSVYKGTISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----FKFMPNGSLEK  413 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~~~~g~l~~  413 (481)
                      ..++|+||.||++...  ..+|+|.+....  ....+.+.+|+.++++++|+||+++++++....    ++|+++|+|.+
T Consensus        31 ~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~lv~e~~~~~~L~~  108 (289)
T 3og7_A           31 RIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYH  108 (289)
T ss_dssp             EEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECCCEEEHHH
T ss_pred             EecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCCccEEEEEecCCCcHHH
Confidence            3478999999999753  359999986543  234467889999999999999999999876554    67899999999


Q ss_pred             HhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          414 RLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       414 ~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ++......+++.++.+++.++++||+|||    +.+|+||||||+||++++++.+||+|||+++..
T Consensus       109 ~l~~~~~~~~~~~~~~i~~qi~~~L~~lH----~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  170 (289)
T 3og7_A          109 HLHASETKFEMKKLIDIARQTARGMDYLH----AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEK  170 (289)
T ss_dssp             HHTTC---CCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred             HHhhccCCCCHHHHHHHHHHHHHHHHHHH----hCCcccccCccceEEECCCCCEEEccceecccc
Confidence            99776677899999999999999999999    578999999999999999999999999998754

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.82  E-value=5e-20  Score=175.67  Aligned_cols=135  Identities=27%  Similarity=0.445  Sum_probs=111.2

Q ss_pred             hccccccceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC---cccccCCChhHHhhc
Q 039957          341 SLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD---FKFMPNGSLEKRLYS  417 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---~~~~~~g~l~~~l~~  417 (481)
                      .+.|+||.||++... +..||+|.+...  ...+.+.+|+.++++++||||++++++|....   +||+++|+|.+++..
T Consensus        16 lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~lv~e~~~~~~L~~~l~~   92 (307)
T 2eva_A           16 VGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLNPVCLVMEYAEGGSLYNVLHG   92 (307)
T ss_dssp             EECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTTTTEEEEECCTTCBHHHHHHC
T ss_pred             eecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCcEEEEEcCCCCCHHHHHhc
Confidence            478999999999864 788999988643  23456888999999999999999999987653   679999999999876


Q ss_pred             CCC--ccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCc-EEEccccCcccC
Q 039957          418 HNY--FLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMV-AHVSDFGISKLL  479 (481)
Q Consensus       418 ~~~--~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~-~kl~Dfgl~~~~  479 (481)
                      ...  ..++...++++.++++||+|||+.+ ..+|+||||||+||+++.++. +||+|||+++..
T Consensus        93 ~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~-~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~  156 (307)
T 2eva_A           93 AEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ-PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI  156 (307)
T ss_dssp             SSSEECCCHHHHHHHHHHHHHHHHHHHTCS-SSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHHhCC-CCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence            432  4678889999999999999999533 278999999999999998876 899999998754

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.82  E-value=3.6e-20  Score=186.79  Aligned_cols=134  Identities=24%  Similarity=0.396  Sum_probs=104.7

Q ss_pred             hhccccccceeeeecc-CCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC----------cccc
Q 039957          340 ISLAGSFGSVYKGTIS-DGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----------FKFM  406 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----------~~~~  406 (481)
                      ..+.|+||.||++... +|..||+|++....  ....+.+.+|+.++++++|+|||+++++|....          +||+
T Consensus        60 ~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  139 (458)
T 3rp9_A           60 LIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA  139 (458)
T ss_dssp             C-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCC
T ss_pred             EeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEecc
Confidence            4478999999999754 68999999986532  233456889999999999999999999885432          3455


Q ss_pred             cCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          407 PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       407 ~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                       +|+|.+++... ..+++..+..++.+|++||+|||    +.+||||||||+|||++.++.+||+|||+|+..
T Consensus       140 -~~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH----~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  206 (458)
T 3rp9_A          140 -DSDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVH----SAGILHRDLKPANCLVNQDCSVKVCDFGLARTV  206 (458)
T ss_dssp             -SEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred             -ccchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHH----hCCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence             57888887643 45788899999999999999999    578999999999999999999999999999875

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.82  E-value=2.6e-20  Score=184.10  Aligned_cols=138  Identities=30%  Similarity=0.428  Sum_probs=116.0

Q ss_pred             hhhccccccceeeeecc-CCcceEEEEEeccch-hhhhhhhHHHHHhhhhccCccceeecccCCCC-------cccccCC
Q 039957          339 TISLAGSFGSVYKGTIS-DGTDVAIKIFNLQRE-RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-------FKFMPNG  409 (481)
Q Consensus       339 ~l~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-------~~~~~~g  409 (481)
                      ..-+.|+||.||+|... +|..||+|.+..... ...+.+.+|++++++++|+||+++++++...+       +||+++|
T Consensus        15 ~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g   94 (396)
T 4eut_A           15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCG   94 (396)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTE
T ss_pred             EEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCC
Confidence            34478999999999865 589999999875432 33456778999999999999999999886543       5789999


Q ss_pred             ChhHHhhcCC--CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeee----CCCCcEEEccccCcccCC
Q 039957          410 SLEKRLYSHN--YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILL----DENMVAHVSDFGISKLLG  480 (481)
Q Consensus       410 ~l~~~l~~~~--~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill----~~~~~~kl~Dfgl~~~~~  480 (481)
                      +|.+++....  ..+++..+..++.+|++||+|||    +.+|+||||||+||++    ++++.+||+|||+|+.+.
T Consensus        95 ~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~  167 (396)
T 4eut_A           95 SLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR----ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE  167 (396)
T ss_dssp             EHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECC
T ss_pred             CHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH----HCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEcc
Confidence            9999987532  23789999999999999999999    5789999999999999    788899999999998653

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.82  E-value=2.1e-20  Score=181.46  Aligned_cols=133  Identities=23%  Similarity=0.250  Sum_probs=113.5

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc---hhhhhhhhHHHHHhhhh-ccCccceeecccCCCC-----cccccCCC
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD-----FKFMPNGS  410 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----~~~~~~g~  410 (481)
                      .+.|+||.||++... +|..||+|.+....   ....+.+..|..++..+ +|++|+++.+++...+     +||+++|+
T Consensus        28 lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~  107 (353)
T 2i0e_A           28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGD  107 (353)
T ss_dssp             EEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCB
T ss_pred             EeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCc
Confidence            378999999999865 47889999987643   22344567788888887 7999999999887765     67999999


Q ss_pred             hhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          411 LEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       411 l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      |.+++... ..+++..+..++.+|+.||+|||    +.+|+||||||+|||++.++++||+|||+|+.
T Consensus       108 L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH----~~givHrDlkp~NIll~~~g~vkL~DFG~a~~  170 (353)
T 2i0e_A          108 LMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQ----SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  170 (353)
T ss_dssp             HHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH----HCCEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence            99998753 34788899999999999999999    57899999999999999999999999999985

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.82  E-value=3.1e-20  Score=177.89  Aligned_cols=135  Identities=24%  Similarity=0.312  Sum_probs=114.9

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCC---------CcccccCCC
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTP---------DFKFMPNGS  410 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---------~~~~~~~g~  410 (481)
                      .+.|+||.||++.. .+|..||+|.+........+.+.+|+.++++++|+||+++++++...         .++|+++|+
T Consensus        37 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~  116 (317)
T 2buj_A           37 LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGT  116 (317)
T ss_dssp             EEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCB
T ss_pred             ecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCc
Confidence            47899999999985 57899999998765555566788999999999999999999988521         157899999


Q ss_pred             hhHHhhc---CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          411 LEKRLYS---HNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       411 l~~~l~~---~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      |.+++..   ....+++.++.+++.++++||+|||    +.+|+||||||+||+++.++.+||+|||+++..
T Consensus       117 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH----~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          117 LWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH----AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             HHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            9998865   3456889999999999999999999    578999999999999999999999999987653

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.82  E-value=3.7e-20  Score=184.27  Aligned_cols=136  Identities=28%  Similarity=0.405  Sum_probs=112.9

Q ss_pred             hhccccccceeeeecc-CCcceEEEEEeccch--------hhhhhhhHHHHHhhhhccCccceeecccCCCC----cccc
Q 039957          340 ISLAGSFGSVYKGTIS-DGTDVAIKIFNLQRE--------RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----FKFM  406 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~~  406 (481)
                      .-++|+||.||+|... ++..||+|.+.....        .....+.+|+.++++++||||+++++++....    +||+
T Consensus       142 ~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~lv~e~~  221 (419)
T 3i6u_A          142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELM  221 (419)
T ss_dssp             EEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESSEEEEEEECC
T ss_pred             EEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecCceEEEEEcC
Confidence            3478999999999754 578999999875421        12235788999999999999999999986554    6799


Q ss_pred             cCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCC---CcEEEccccCcccCC
Q 039957          407 PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDEN---MVAHVSDFGISKLLG  480 (481)
Q Consensus       407 ~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~---~~~kl~Dfgl~~~~~  480 (481)
                      ++|+|.+++... ..+++.....++.++++||+|||    +.+|+||||||+|||++.+   +.+||+|||+|+.+.
T Consensus       222 ~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH----~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  293 (419)
T 3i6u_A          222 EGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLH----ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG  293 (419)
T ss_dssp             TTCBGGGGTSSS-CCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC
T ss_pred             CCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH----HCCccccCCChHhEEEecCCCcceEEEeecccceecC
Confidence            999999987643 45788999999999999999999    5789999999999999754   469999999998753

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.82  E-value=4.7e-20  Score=187.85  Aligned_cols=135  Identities=26%  Similarity=0.374  Sum_probs=116.4

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccch---hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRE---RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      .+.|+||.||++... +|..||+|.+.....   .....+..|+.++.+++||||+++++++....     ++|+++|+|
T Consensus       193 LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L  272 (543)
T 3c4z_A          193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDI  272 (543)
T ss_dssp             EEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBH
T ss_pred             EeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCH
Confidence            378999999999864 689999999875432   23356788999999999999999999887765     679999999


Q ss_pred             hHHhhcC---CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          412 EKRLYSH---NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~---~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+++...   ...+++..+..++.+|+.||+|||    +.+|+||||||+|||++.++++||+|||+|+.+
T Consensus       273 ~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH----~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~  339 (543)
T 3c4z_A          273 RYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH----QRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL  339 (543)
T ss_dssp             HHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             HHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH----HcCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence            9988753   345788899999999999999999    578999999999999999999999999999765

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.81  E-value=4e-20  Score=182.43  Aligned_cols=134  Identities=19%  Similarity=0.248  Sum_probs=115.6

Q ss_pred             hccc--cccceeeeecc-CCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCC
Q 039957          341 SLAG--SFGSVYKGTIS-DGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGS  410 (481)
Q Consensus       341 ~~~g--~~g~vy~~~l~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~  410 (481)
                      .+.|  +||.||++... +|..||+|.+....  ....+.+.+|+.++++++|+|||++++++...+     ++|+++|+
T Consensus        33 lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~  112 (389)
T 3gni_B           33 IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGS  112 (389)
T ss_dssp             EEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred             ccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCC
Confidence            3678  99999999865 68999999997653  233456788999999999999999999987765     67899999


Q ss_pred             hhHHhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          411 LEKRLYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       411 l~~~l~~~-~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      |.+++... ...+++..+..++.+|++||+|||    +.+|+||||||+|||++.++.+||+|||.+..
T Consensus       113 L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH----~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~  177 (389)
T 3gni_B          113 AKDLICTHFMDGMNELAIAYILQGVLKALDYIH----HMGYVHRSVKASHILISVDGKVYLSGLRSNLS  177 (389)
T ss_dssp             HHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             HHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEccccccee
Confidence            99998753 345788999999999999999999    57899999999999999999999999998753

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.81  E-value=2.8e-20  Score=174.66  Aligned_cols=135  Identities=23%  Similarity=0.346  Sum_probs=116.7

Q ss_pred             hhccccccceeeeecc-CCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhH
Q 039957          340 ISLAGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEK  413 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~  413 (481)
                      ..+.|+||.||++... ++..+|+|.+........+.+.+|++++++++|+||++++++|....     ++|+++|+|.+
T Consensus        16 ~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   95 (277)
T 3f3z_A           16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFE   95 (277)
T ss_dssp             EEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHH
T ss_pred             EEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHH
Confidence            3478999999999865 46789999987655555667889999999999999999999998765     67899999999


Q ss_pred             HhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeee---CCCCcEEEccccCcccC
Q 039957          414 RLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILL---DENMVAHVSDFGISKLL  479 (481)
Q Consensus       414 ~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill---~~~~~~kl~Dfgl~~~~  479 (481)
                      ++... ..+++..+.+++.++++|++|||    +.+|+||||||+||++   +.++.+||+|||+++.+
T Consensus        96 ~~~~~-~~~~~~~~~~i~~~i~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~  159 (277)
T 3f3z_A           96 RVVHK-RVFRESDAARIMKDVLSAVAYCH----KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF  159 (277)
T ss_dssp             HHHHH-CSCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             HHHHc-CCCCHHHHHHHHHHHHHHHHHHH----HCCccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence            87653 34788899999999999999999    5789999999999999   78899999999998754

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.81  E-value=7.5e-21  Score=181.78  Aligned_cols=138  Identities=20%  Similarity=0.348  Sum_probs=114.3

Q ss_pred             hhhhhccccccceeeeec-cCCcceEEEEEeccch---hhhhhhhHHHHHhhhhccCccceeecccCCC---------Cc
Q 039957          337 LETISLAGSFGSVYKGTI-SDGTDVAIKIFNLQRE---RAFRSFNSECEVLRNVRHQNLIKILSSCSTP---------DF  403 (481)
Q Consensus       337 L~~l~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---------~~  403 (481)
                      +....+.|+||.||++.. .+|..||+|.+.....   .....+.+|+.++.+++||||+++++++...         .+
T Consensus        16 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~   95 (311)
T 3ork_A           16 LGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVM   95 (311)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEE
Confidence            334457899999999985 5789999999876432   2345678899999999999999999887543         25


Q ss_pred             ccccCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          404 KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       404 ~~~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ||+++|+|.+++... ..+++.++.+++.++++||+|||    +.+|+||||||+||+++.++.+||+|||+++.+
T Consensus        96 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  166 (311)
T 3ork_A           96 EYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSH----QNGIIHRDVKPANIMISATNAVKVMDFGIARAI  166 (311)
T ss_dssp             ECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred             ecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH----HCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence            789999999998753 35788999999999999999999    578999999999999999999999999999754

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.81  E-value=4e-20  Score=179.53  Aligned_cols=133  Identities=24%  Similarity=0.399  Sum_probs=105.2

Q ss_pred             hhccccccceeeeecc-CCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhH
Q 039957          340 ISLAGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEK  413 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~  413 (481)
                      ..+.|+||.||++... ++..||+|.+....  ..+.+.+|++++.+++|+||++++++|...+     +||+++|+|.+
T Consensus        60 ~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~  137 (349)
T 2w4o_A           60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFD  137 (349)
T ss_dssp             EEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHH
T ss_pred             EEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHH
Confidence            3478999999999865 57889999987543  2345778999999999999999999998765     67999999999


Q ss_pred             HhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCC---CCcEEEccccCcccC
Q 039957          414 RLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDE---NMVAHVSDFGISKLL  479 (481)
Q Consensus       414 ~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~---~~~~kl~Dfgl~~~~  479 (481)
                      ++... ..+++.++..++.++++||+|||    +.+|+||||||+||+++.   ++.+||+|||+++..
T Consensus       138 ~l~~~-~~~~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~  201 (349)
T 2w4o_A          138 RIVEK-GYYSERDAADAVKQILEAVAYLH----ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV  201 (349)
T ss_dssp             HHTTC-SSCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred             HHHhc-CCCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence            88754 35788999999999999999999    578999999999999975   899999999998864

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.81  E-value=6e-20  Score=176.07  Aligned_cols=133  Identities=27%  Similarity=0.494  Sum_probs=113.5

Q ss_pred             hccccccceeeeec-----cCCcceEEEEEeccch-hhhhhhhHHHHHhhhhccCccceeecccCCCC-------ccccc
Q 039957          341 SLAGSFGSVYKGTI-----SDGTDVAIKIFNLQRE-RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-------FKFMP  407 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-----~~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-------~~~~~  407 (481)
                      .+.|+||.||++..     .+|..||+|.+..... ...+.+.+|++++++++|+||+++++++...+       ++|++
T Consensus        39 lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~  118 (318)
T 3lxp_A           39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVP  118 (318)
T ss_dssp             EEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCT
T ss_pred             ecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEeccc
Confidence            47899999977643     2578899999876532 33456889999999999999999999987632       67899


Q ss_pred             CCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          408 NGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       408 ~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +|+|.+++....  +++..+..++.++++||+|||    +.+|+||||||+||+++.++.+||+|||+++..
T Consensus       119 ~~~L~~~l~~~~--~~~~~~~~i~~~l~~~l~~LH----~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  184 (318)
T 3lxp_A          119 LGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH----AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  184 (318)
T ss_dssp             TCBHHHHGGGSC--CCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             CCcHHHHHhhCC--CCHHHHHHHHHHHHHHHHHHH----hCCccCCCCchheEEEcCCCCEEECCccccccc
Confidence            999999987543  788999999999999999999    578999999999999999999999999999765

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.81  E-value=6.9e-21  Score=187.10  Aligned_cols=135  Identities=19%  Similarity=0.181  Sum_probs=106.9

Q ss_pred             hhccccccceeeeec-cCCcceEEEEEecc---chhhhhhhhHHH---HHhhhhccCccceeecccCC-------C----
Q 039957          340 ISLAGSFGSVYKGTI-SDGTDVAIKIFNLQ---RERAFRSFNSEC---EVLRNVRHQNLIKILSSCST-------P----  401 (481)
Q Consensus       340 l~~~g~~g~vy~~~l-~~g~~vavK~l~~~---~~~~~~~~~~e~---~~l~~l~h~niv~l~~~~~~-------~----  401 (481)
                      ..+.|+||.||+|.. .+|..||||.+...   .....+.+.+|+   +.+++++|||||++++.+..       .    
T Consensus        80 ~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~  159 (377)
T 3byv_A           80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKK  159 (377)
T ss_dssp             EEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCS
T ss_pred             eeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCcc
Confidence            347899999999986 46899999998743   233446678898   56666789999998854431       1    


Q ss_pred             ------------------CcccccCCChhHHhhcCC------CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCC
Q 039957          402 ------------------DFKFMPNGSLEKRLYSHN------YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKP  457 (481)
Q Consensus       402 ------------------~~~~~~~g~l~~~l~~~~------~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~  457 (481)
                                        .+||+ +|+|.+++....      ..+++..+.+|+.+|++||+|||    +.+|+||||||
T Consensus       160 ~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~ivHrDikp  234 (377)
T 3byv_A          160 MIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH----HYGLVHTYLRP  234 (377)
T ss_dssp             EEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH----HTTEECSCCCG
T ss_pred             ccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH----hCCeecCCCCH
Confidence                              13456 689999887522      23446888899999999999999    57899999999


Q ss_pred             CCeeeCCCCcEEEccccCcccC
Q 039957          458 TSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       458 ~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +|||++.++.+||+|||+|+..
T Consensus       235 ~NIll~~~~~~kL~DFG~a~~~  256 (377)
T 3byv_A          235 VDIVLDQRGGVFLTGFEHLVRD  256 (377)
T ss_dssp             GGEEECTTCCEEECCGGGCEET
T ss_pred             HHEEEcCCCCEEEEechhheec
Confidence            9999999999999999999754

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.81  E-value=8.5e-20  Score=162.22  Aligned_cols=153  Identities=14%  Similarity=0.113  Sum_probs=85.3

Q ss_pred             cCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeecccCcceecCcccccCCCCCC
Q 039957           34 FNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLS  113 (481)
Q Consensus        34 ~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  113 (481)
                      ..+++|++|++++|.++ .+| .+. .+++|++|++++|.++  .+..+..+++|++|++++|.+++..|..|+.+++|+
T Consensus        41 ~~l~~L~~L~l~~n~i~-~l~-~l~-~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~  115 (197)
T 4ezg_A           41 AQMNSLTYITLANINVT-DLT-GIE-YAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT  115 (197)
T ss_dssp             HHHHTCCEEEEESSCCS-CCT-TGG-GCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCC
T ss_pred             hhcCCccEEeccCCCcc-ChH-HHh-cCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCC
Confidence            44555666666666665 445 232 4566666666666443  123455566666666666666655555566666666


Q ss_pred             EEEcccccCccccCCCccccccccCCCCCCCcEEEccCCc-cceeCChhhhhcccCccEEEccCCceeecCCcccccCCC
Q 039957          114 VLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNP-LGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRG  192 (481)
Q Consensus       114 ~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~-l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~  192 (481)
                      +|++++|+++...        +..+..+++|++|++++|. ++ .+| .+..+ ++|++|++++|.+++ ++ .+..+++
T Consensus       116 ~L~Ls~n~i~~~~--------~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l-~~L~~L~l~~n~i~~-~~-~l~~l~~  182 (197)
T 4ezg_A          116 LLDISHSAHDDSI--------LTKINTLPKVNSIDLSYNGAIT-DIM-PLKTL-PELKSLNIQFDGVHD-YR-GIEDFPK  182 (197)
T ss_dssp             EEECCSSBCBGGG--------HHHHTTCSSCCEEECCSCTBCC-CCG-GGGGC-SSCCEEECTTBCCCC-CT-TGGGCSS
T ss_pred             EEEecCCccCcHh--------HHHHhhCCCCCEEEccCCCCcc-ccH-hhcCC-CCCCEEECCCCCCcC-hH-HhccCCC
Confidence            6666666655421        1223455566666666665 33 233 34444 456666666666664 33 5667777


Q ss_pred             CCeEecccccce
Q 039957          193 LIYLSLGFNDLN  204 (481)
Q Consensus       193 L~~L~l~~N~l~  204 (481)
                      |++|++++|++.
T Consensus       183 L~~L~l~~N~i~  194 (197)
T 4ezg_A          183 LNQLYAFSQTIG  194 (197)
T ss_dssp             CCEEEECBC---
T ss_pred             CCEEEeeCcccC
Confidence            777777777765

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.81  E-value=5.1e-20  Score=176.08  Aligned_cols=135  Identities=30%  Similarity=0.556  Sum_probs=108.4

Q ss_pred             hccccccceeeeeccC----CcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC----------cc
Q 039957          341 SLAGSFGSVYKGTISD----GTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----------FK  404 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~----g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----------~~  404 (481)
                      .+.|+||.||+|....    +..||+|.+....  ....+.+.+|+.++++++||||+++++++....          ++
T Consensus        42 lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e  121 (313)
T 3brb_A           42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILP  121 (313)
T ss_dssp             EEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEE
T ss_pred             eeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEe
Confidence            4789999999997542    3579999886542  333456889999999999999999999886542          46


Q ss_pred             cccCCChhHHhhc-----CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          405 FMPNGSLEKRLYS-----HNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       405 ~~~~g~l~~~l~~-----~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      |+++|+|.+++..     ....+++..+.+++.++++||+|||    +.+|+||||||+||++++++.+||+|||+++.+
T Consensus       122 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~  197 (313)
T 3brb_A          122 FMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS----NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKI  197 (313)
T ss_dssp             CCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH----TTTCCCCCCSGGGEEECTTSCEEECSCSCC---
T ss_pred             cccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCcceEEEcCCCcEEEeecCcceec
Confidence            8899999998843     2346889999999999999999999    678999999999999999999999999999764

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.81  E-value=7.5e-20  Score=175.86  Aligned_cols=132  Identities=23%  Similarity=0.327  Sum_probs=112.0

Q ss_pred             hhccccccceeeeecc-CCcceEEEEEeccchhhhhhhhHHHHHhhhhc-cCccceeecccCCCC-----cccccCCChh
Q 039957          340 ISLAGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECEVLRNVR-HQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      ..+.|+||.||++... +|..||+|.+...   ....+.+|+.++.+++ ||||+++++++....     +||+++|+|.
T Consensus        18 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~   94 (325)
T 3kn6_A           18 PLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELF   94 (325)
T ss_dssp             CSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred             ccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHH
Confidence            3478999999999864 5889999998643   2345677999999997 999999999998765     6789999999


Q ss_pred             HHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCC---cEEEccccCcccC
Q 039957          413 KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENM---VAHVSDFGISKLL  479 (481)
Q Consensus       413 ~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~---~~kl~Dfgl~~~~  479 (481)
                      +++... ..+++.++..|+.++++||+|||    +.+|+||||||+||+++.++   .+||+|||+|+..
T Consensus        95 ~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH----~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~  159 (325)
T 3kn6_A           95 ERIKKK-KHFSETEASYIMRKLVSAVSHMH----DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK  159 (325)
T ss_dssp             HHHHHC-SCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred             HHHHhc-CCCCHHHHHHHHHHHHHHHHHHH----HCCCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence            998764 45788999999999999999999    57899999999999997655   8999999999754

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.81  E-value=3.1e-20  Score=178.54  Aligned_cols=134  Identities=24%  Similarity=0.435  Sum_probs=112.9

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccchh-hhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhH
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRER-AFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEK  413 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~  413 (481)
                      -+.|+||.||++... +|..||+|.+...... ....+.+|+.++++++|+||+++++++...+     +||++ |++.+
T Consensus        10 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~   88 (324)
T 3mtl_A           10 LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQ   88 (324)
T ss_dssp             EEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHH
T ss_pred             EcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCHHH
Confidence            368999999999865 6889999998654432 2335667999999999999999999987765     56776 68988


Q ss_pred             HhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          414 RLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       414 ~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ++......+++.....++.++++||+|||    +.+|+||||||+||+++.++.+||+|||+|+..
T Consensus        89 ~~~~~~~~~~~~~~~~~~~qi~~aL~~LH----~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~  150 (324)
T 3mtl_A           89 YLDDCGNIINMHNVKLFLFQLLRGLAYCH----RQKVLHRDLKPQNLLINERGELKLADFGLARAK  150 (324)
T ss_dssp             HHHHTTTCCCHHHHHHHHHHHHHHHHHHH----HTTEEESSCCGGGEEECTTCCEEECSSSEEECC
T ss_pred             HHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCccCCCcCHHHEEECCCCCEEEccCcccccc
Confidence            88776667889999999999999999999    578999999999999999999999999998754

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.81  E-value=6.3e-20  Score=178.99  Aligned_cols=132  Identities=26%  Similarity=0.284  Sum_probs=111.8

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHH
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKR  414 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~  414 (481)
                      .+.|+||.||++... +|..||+|.+.... ...+.+.+|+.++++++||||+++++++....     ++|+++|+|.++
T Consensus        28 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~  106 (361)
T 3uc3_A           28 IGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYER  106 (361)
T ss_dssp             ESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHH
T ss_pred             eccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHH
Confidence            378999999999865 68899999986543 22355778999999999999999999987765     679999999998


Q ss_pred             hhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCc--EEEccccCccc
Q 039957          415 LYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMV--AHVSDFGISKL  478 (481)
Q Consensus       415 l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~--~kl~Dfgl~~~  478 (481)
                      +... ..+++..+..++.++++||+|||    +.+|+||||||+||+++.++.  +||+|||+|+.
T Consensus       107 l~~~-~~~~~~~~~~i~~ql~~~L~~LH----~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~  167 (361)
T 3uc3_A          107 ICNA-GRFSEDEARFFFQQLLSGVSYCH----SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS  167 (361)
T ss_dssp             HHHH-SSCCHHHHHHHHHHHHHHHHHHH----HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred             HHhc-CCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence            8653 34788899999999999999999    578999999999999987765  99999999874

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.81  E-value=5.6e-20  Score=176.04  Aligned_cols=136  Identities=25%  Similarity=0.361  Sum_probs=114.5

Q ss_pred             hhhccccccceeeeec-cCCcceEEEEEeccchhhhhhhhHHHHHhhh-hccCccceeecccCCCC-----cccccCCCh
Q 039957          339 TISLAGSFGSVYKGTI-SDGTDVAIKIFNLQRERAFRSFNSECEVLRN-VRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       339 ~l~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      ...+.|+||.||++.. .+|..||+|.+..........+.+|++++.+ .+|+||+++++++...+     +||+++|+|
T Consensus        19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   98 (316)
T 2ac3_A           19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI   98 (316)
T ss_dssp             CCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred             ceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcH
Confidence            3457899999999984 4689999999876554445678889999988 47999999999987665     679999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCc---EEEccccCcccC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMV---AHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~---~kl~Dfgl~~~~  479 (481)
                      .+++... ..+++..+..++.+|++||+|||    +.+|+||||||+||+++.++.   +||+|||+++..
T Consensus        99 ~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~  164 (316)
T 2ac3_A           99 LSHIHKR-RHFNELEASVVVQDVASALDFLH----NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI  164 (316)
T ss_dssp             HHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred             HHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH----hCCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence            9998753 35788899999999999999999    578999999999999998765   999999998754

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.81  E-value=9.4e-21  Score=176.27  Aligned_cols=168  Identities=24%  Similarity=0.288  Sum_probs=102.2

Q ss_pred             CCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeecccCcceecCcccccCCCCCCE
Q 039957           35 NISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSV  114 (481)
Q Consensus        35 ~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  114 (481)
                      ++.++..+++++|.++ .++. +. .+++|++|++++|+++ .+| .+..+++|++|+|++|++++..|  |..+++|++
T Consensus        17 ~l~~l~~l~l~~~~i~-~~~~-~~-~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~   89 (263)
T 1xeu_A           17 GLANAVKQNLGKQSVT-DLVS-QK-ELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEE   89 (263)
T ss_dssp             HHHHHHHHHHTCSCTT-SEEC-HH-HHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCE
T ss_pred             HHHHHHHHHhcCCCcc-cccc-hh-hcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCE
Confidence            4566777788888887 4552 32 5788888888888876 444 57788888888888888886544  788888888


Q ss_pred             EEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEccCCceeecCCcccccCCCCC
Q 039957          115 LSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLI  194 (481)
Q Consensus       115 L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~  194 (481)
                      |++++|++++++..          .. ++|++|+|++|++++.  +.+..+ ++|+.|++++|++++. | .+..+++|+
T Consensus        90 L~L~~N~l~~l~~~----------~~-~~L~~L~L~~N~l~~~--~~l~~l-~~L~~L~Ls~N~i~~~-~-~l~~l~~L~  153 (263)
T 1xeu_A           90 LSVNRNRLKNLNGI----------PS-ACLSRLFLDNNELRDT--DSLIHL-KNLEILSIRNNKLKSI-V-MLGFLSKLE  153 (263)
T ss_dssp             EECCSSCCSCCTTC----------CC-SSCCEEECCSSCCSBS--GGGTTC-TTCCEEECTTSCCCBC-G-GGGGCTTCC
T ss_pred             EECCCCccCCcCcc----------cc-CcccEEEccCCccCCC--hhhcCc-ccccEEECCCCcCCCC-h-HHccCCCCC
Confidence            88888888776332          12 5677777777776642  234333 3455555555555532 2 344455555


Q ss_pred             eEecccccceecCCcCCcCCCCCCeeecCCCcC
Q 039957          195 YLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNL  227 (481)
Q Consensus       195 ~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l  227 (481)
                      +|++++|++++.  ..+..+++|+.|++++|.+
T Consensus       154 ~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~  184 (263)
T 1xeu_A          154 VLDLHGNEITNT--GGLTRLKKVNWIDLTGQKC  184 (263)
T ss_dssp             EEECTTSCCCBC--TTSTTCCCCCEEEEEEEEE
T ss_pred             EEECCCCcCcch--HHhccCCCCCEEeCCCCcc
Confidence            555555554432  2333333333333333333

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.81  E-value=3.4e-20  Score=178.02  Aligned_cols=135  Identities=24%  Similarity=0.433  Sum_probs=114.0

Q ss_pred             hccccccceeeeecc------CCcceEEEEEeccch-hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccC
Q 039957          341 SLAGSFGSVYKGTIS------DGTDVAIKIFNLQRE-RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPN  408 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~------~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~  408 (481)
                      .+.|+||.||+|...      ++..||+|.+..... .....+.+|+.++++++|+||+++++++...+     ++|+++
T Consensus        33 lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  112 (322)
T 1p4o_A           33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTR  112 (322)
T ss_dssp             EEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred             eccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCC
Confidence            478999999998753      367899999865432 33456888999999999999999999987764     678999


Q ss_pred             CChhHHhhcCC---------CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          409 GSLEKRLYSHN---------YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       409 g~l~~~l~~~~---------~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      |+|.+++....         ...++..+.+++.++++||+|||    +.+|+||||||+||++++++.+||+|||+++..
T Consensus       113 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~  188 (322)
T 1p4o_A          113 GDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN----ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI  188 (322)
T ss_dssp             CBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH----HTTCBCSCCSGGGEEECTTCCEEECCTTCCCGG
T ss_pred             CcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH----HCCCccCCCccceEEEcCCCeEEECcCcccccc
Confidence            99999886421         34588899999999999999999    578999999999999999999999999999754

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.81  E-value=3.1e-20  Score=176.64  Aligned_cols=133  Identities=26%  Similarity=0.419  Sum_probs=114.0

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHH
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKR  414 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~  414 (481)
                      .+.|+||.||++... +|..+|+|.+........+.+..|+.++.+++||||+++++++...+     ++|+++|++.++
T Consensus        27 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~  106 (302)
T 2j7t_A           27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAI  106 (302)
T ss_dssp             EECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHH
T ss_pred             eccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHH
Confidence            368999999999865 58899999987665555667888999999999999999999987764     578999999998


Q ss_pred             hhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcc
Q 039957          415 LYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK  477 (481)
Q Consensus       415 l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~  477 (481)
                      +......+++..+..++.++++||+|||    +.+|+||||||+||+++.++.+||+|||+++
T Consensus       107 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  165 (302)
T 2j7t_A          107 MLELDRGLTEPQIQVVCRQMLEALNFLH----SKRIIHRDLKAGNVLMTLEGDIRLADFGVSA  165 (302)
T ss_dssp             HHHHTSCCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCSGGGEEECTTSCEEECCCHHHH
T ss_pred             HHhhccCCCHHHHHHHHHHHHHHHHHHh----cCCcccCCCCHHHEEECCCCCEEEEECCCCc
Confidence            8765556889999999999999999999    5789999999999999999999999999864

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.81  E-value=8.1e-20  Score=172.27  Aligned_cols=137  Identities=29%  Similarity=0.428  Sum_probs=115.2

Q ss_pred             hhhccccccceeeeec-cCCcceEEEEEeccch-hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          339 TISLAGSFGSVYKGTI-SDGTDVAIKIFNLQRE-RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       339 ~l~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      ...+.|+||.||++.. .+|..+|+|.+..... ...+.+.+|++++++++||||+++++++....     +||+++|+|
T Consensus        28 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L  107 (285)
T 3is5_A           28 RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGEL  107 (285)
T ss_dssp             EEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBH
T ss_pred             ceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcH
Confidence            3447899999999985 4588999999876542 23456888999999999999999999987765     678999999


Q ss_pred             hHHhhc---CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeee---CCCCcEEEccccCcccC
Q 039957          412 EKRLYS---HNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILL---DENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~---~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill---~~~~~~kl~Dfgl~~~~  479 (481)
                      .+++..   ....+++..+.+|+.++++||+|||    +.+|+||||||+||++   +.++.+||+|||+|+.+
T Consensus       108 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH----~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          108 LERIVSAQARGKALSEGYVAELMKQMMNALAYFH----SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             HHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             HHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH----hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            998754   2356788999999999999999999    5789999999999999   45689999999999764

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.81  E-value=3.5e-20  Score=181.19  Aligned_cols=135  Identities=16%  Similarity=0.208  Sum_probs=109.1

Q ss_pred             hhccccccceeeeeccC------CcceEEEEEeccchhh-----------hhhhhHHHHHhhhhccCccceeecccCCC-
Q 039957          340 ISLAGSFGSVYKGTISD------GTDVAIKIFNLQRERA-----------FRSFNSECEVLRNVRHQNLIKILSSCSTP-  401 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~~------g~~vavK~l~~~~~~~-----------~~~~~~e~~~l~~l~h~niv~l~~~~~~~-  401 (481)
                      ..+.|+||.||+|....      +..||+|.+.......           ...+..|+..+.+++|+||+++++++... 
T Consensus        42 ~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~  121 (364)
T 3op5_A           42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDK  121 (364)
T ss_dssp             ECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEEEE
T ss_pred             EEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeeecc
Confidence            34789999999997654      4789999986543211           11233455567778899999999988653 


Q ss_pred             --------CcccccCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeC--CCCcEEEc
Q 039957          402 --------DFKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLD--ENMVAHVS  471 (481)
Q Consensus       402 --------~~~~~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~--~~~~~kl~  471 (481)
                              .++|+ +|+|.+++......+++..+.+|+.+|++||+|||    +.+|+||||||+|||++  .++.+||+
T Consensus       122 ~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH----~~~iiHrDlkp~Nill~~~~~~~~kl~  196 (364)
T 3op5_A          122 NGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIH----EHEYVHGDIKASNLLLNYKNPDQVYLV  196 (364)
T ss_dssp             TTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEEESSCTTCEEEC
T ss_pred             CCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----HCCeEEecCCHHHEEEecCCCCeEEEE
Confidence                    15788 99999998876667899999999999999999999    57899999999999999  88999999


Q ss_pred             cccCcccC
Q 039957          472 DFGISKLL  479 (481)
Q Consensus       472 Dfgl~~~~  479 (481)
                      |||+|+.+
T Consensus       197 DFG~a~~~  204 (364)
T 3op5_A          197 DYGLAYRY  204 (364)
T ss_dssp             CCTTCEES
T ss_pred             ECCcceec
Confidence            99999764

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.81  E-value=4.2e-20  Score=176.87  Aligned_cols=135  Identities=29%  Similarity=0.497  Sum_probs=114.1

Q ss_pred             hccccccceeeeec------cCCcceEEEEEeccch-hhhhhhhHHHHHhhhh-ccCccceeecccCCCC------cccc
Q 039957          341 SLAGSFGSVYKGTI------SDGTDVAIKIFNLQRE-RAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD------FKFM  406 (481)
Q Consensus       341 ~~~g~~g~vy~~~l------~~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~------~~~~  406 (481)
                      .+.|+||.||++..      .++..||+|.+..... ...+.+.+|+.++.++ +||||++++++|...+      ++|+
T Consensus        35 lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~  114 (316)
T 2xir_A           35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFC  114 (316)
T ss_dssp             EEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECC
T ss_pred             EcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcC
Confidence            47899999999963      3467899999875432 3345688899999999 6999999999987643      5789


Q ss_pred             cCCChhHHhhcCCC---------------ccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 039957          407 PNGSLEKRLYSHNY---------------FLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVS  471 (481)
Q Consensus       407 ~~g~l~~~l~~~~~---------------~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~  471 (481)
                      ++|+|.+++.....               .+++..+..++.++++||+|||    +.+|+||||||+||++++++.+||+
T Consensus       115 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~i~H~dikp~Nil~~~~~~~kl~  190 (316)
T 2xir_A          115 KFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA----SRKCIHRDLAARNILLSEKNVVKIC  190 (316)
T ss_dssp             TTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGGCEEEC
T ss_pred             CCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH----hCCcccccCccceEEECCCCCEEEC
Confidence            99999999876432               2788999999999999999999    5789999999999999999999999


Q ss_pred             cccCcccC
Q 039957          472 DFGISKLL  479 (481)
Q Consensus       472 Dfgl~~~~  479 (481)
                      |||+++.+
T Consensus       191 Dfg~~~~~  198 (316)
T 2xir_A          191 DFGLARDI  198 (316)
T ss_dssp             CCGGGSCT
T ss_pred             CCcccccc
Confidence            99999764

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.81  E-value=6.6e-20  Score=173.67  Aligned_cols=136  Identities=29%  Similarity=0.403  Sum_probs=114.9

Q ss_pred             hhccccccceeeeec-cCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhH
Q 039957          340 ISLAGSFGSVYKGTI-SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEK  413 (481)
Q Consensus       340 l~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~  413 (481)
                      +.+.|+||.||+|.. .++..||+|.+........+.+.+|+.++.+++|+||+++++++...+     ++|+++|+|.+
T Consensus        29 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~  108 (295)
T 2clq_A           29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSA  108 (295)
T ss_dssp             EEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHH
T ss_pred             EEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHH
Confidence            447899999999985 468899999987665555567889999999999999999999987654     57899999999


Q ss_pred             HhhcCC--CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCC-CCcEEEccccCcccC
Q 039957          414 RLYSHN--YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDE-NMVAHVSDFGISKLL  479 (481)
Q Consensus       414 ~l~~~~--~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~-~~~~kl~Dfgl~~~~  479 (481)
                      ++....  ...++.....++.++++||+|||    +.+|+||||||+||+++. ++.+||+|||+++..
T Consensus       109 ~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~  173 (295)
T 2clq_A          109 LLRSKWGPLKDNEQTIGFYTKQILEGLKYLH----DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL  173 (295)
T ss_dssp             HHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEETTTCCEEECCTTTCEES
T ss_pred             HHHhhccCCCccHHHHHHHHHHHHHHHHHHH----hCCEEccCCChhhEEEECCCCCEEEeeccccccc
Confidence            987642  34567888889999999999999    578999999999999988 899999999998764

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.81  E-value=1e-19  Score=175.73  Aligned_cols=135  Identities=28%  Similarity=0.451  Sum_probs=104.9

Q ss_pred             hccccccceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccC-----CC-----CcccccCCC
Q 039957          341 SLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCS-----TP-----DFKFMPNGS  410 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-----~~-----~~~~~~~g~  410 (481)
                      .+.|+||.||+|.. ++..||+|.+....... .....++..+..++|+||+++++.+.     ..     .+||+++|+
T Consensus        21 lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~-~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~   98 (336)
T 3g2f_A           21 IGRGRYGAVYKGSL-DERPVAVKVFSFANRQN-FINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGS   98 (336)
T ss_dssp             EEECSSEEEEEEEE-TTEEEEEEEEEGGGHHH-HHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCB
T ss_pred             cccCCCeEEEEEEE-CCeEEEEEEeeccchhh-HHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCc
Confidence            37899999999976 68899999987543221 11233444556689999999986432     11     167999999


Q ss_pred             hhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCC-----CCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          411 LEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHS-----SAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       411 l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~-----~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      |.+++....  .++..+.+++.+|++||+|||..+.     .++|+||||||+|||++.++.+||+|||+|+.+
T Consensus        99 L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~  170 (336)
T 3g2f_A           99 LXKYLSLHT--SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRL  170 (336)
T ss_dssp             HHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             HHHHHhhcc--cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeec
Confidence            999987543  4888999999999999999994210     118999999999999999999999999999754

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.80  E-value=3.6e-20  Score=180.32  Aligned_cols=134  Identities=25%  Similarity=0.312  Sum_probs=113.8

Q ss_pred             hccccccceeeeec----cCCcceEEEEEeccc----hhhhhhhhHHHHHhhhh-ccCccceeecccCCCC-----cccc
Q 039957          341 SLAGSFGSVYKGTI----SDGTDVAIKIFNLQR----ERAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD-----FKFM  406 (481)
Q Consensus       341 ~~~g~~g~vy~~~l----~~g~~vavK~l~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----~~~~  406 (481)
                      .+.|+||.||++..    .+|..||+|.+....    ....+.+..|++++.++ +|+||+++++++...+     +||+
T Consensus        62 lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~  141 (355)
T 1vzo_A           62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYI  141 (355)
T ss_dssp             EEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             eccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeecC
Confidence            37899999999986    368899999986432    23345677899999999 5999999999887654     6799


Q ss_pred             cCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          407 PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       407 ~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ++|+|.+++... ..+++.....++.+|++||+|||    +.+|+||||||+|||++.++.+||+|||+|+.+
T Consensus       142 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  209 (355)
T 1vzo_A          142 NGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLH----KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  209 (355)
T ss_dssp             CSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence            999999998753 35788899999999999999999    578999999999999999999999999998754

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.80  E-value=1.2e-19  Score=174.20  Aligned_cols=134  Identities=25%  Similarity=0.376  Sum_probs=115.2

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccchh------hhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccC
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRER------AFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPN  408 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~  408 (481)
                      .+.|+||.||++... +|..+|+|.+......      ..+.+.+|+.++.+++||||+++++++....     +||+++
T Consensus        20 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   99 (321)
T 2a2a_A           20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSG   99 (321)
T ss_dssp             EEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             eeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCC
Confidence            478999999999864 6889999998754322      2346788999999999999999999987765     678999


Q ss_pred             CChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCC----cEEEccccCcccC
Q 039957          409 GSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENM----VAHVSDFGISKLL  479 (481)
Q Consensus       409 g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~----~~kl~Dfgl~~~~  479 (481)
                      |+|.+++... ..+++..+..++.++++||+|||    +.+|+||||||+||+++.++    .+||+|||+++..
T Consensus       100 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH----~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~  169 (321)
T 2a2a_A          100 GELFDFLAQK-ESLSEEEATSFIKQILDGVNYLH----TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI  169 (321)
T ss_dssp             CBHHHHHHTC-SCEEHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred             CcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence            9999998753 45788899999999999999999    57899999999999999887    8999999999764

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.80  E-value=5.8e-20  Score=173.47  Aligned_cols=135  Identities=29%  Similarity=0.506  Sum_probs=116.7

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHH
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKR  414 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~  414 (481)
                      .+.|+||.||++... ++..+|+|.+.... ...+.+.+|+.++++++|+||+++++++....     ++|+++|+|.++
T Consensus        21 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~   99 (288)
T 3kfa_A           21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY   99 (288)
T ss_dssp             SGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHH
T ss_pred             cCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHH
Confidence            478999999999865 47889999986543 33456888999999999999999999987765     578999999999


Q ss_pred             hhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          415 LYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       415 l~~~-~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      +... ...+++..+..++.++++|++|||    +.+|+||||||+||++++++.+||+|||+++...
T Consensus       100 ~~~~~~~~~~~~~~~~i~~~i~~~l~~lH----~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~  162 (288)
T 3kfa_A          100 LRECNRQEVSAVVLLYMATQISSAMEYLE----KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT  162 (288)
T ss_dssp             HHHCCTTTSCHHHHHHHHHHHHHHHHHHH----HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred             HHhcccCCccHhHHHHHHHHHHHHHHHHH----HCCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence            8763 345789999999999999999999    5789999999999999999999999999998653

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.80  E-value=4.3e-20  Score=180.56  Aligned_cols=133  Identities=30%  Similarity=0.378  Sum_probs=105.4

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccch---hhhhhhhHHHHH-hhhhccCccceeecccCCCC-----cccccCCC
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRE---RAFRSFNSECEV-LRNVRHQNLIKILSSCSTPD-----FKFMPNGS  410 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~---~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~-----~~~~~~g~  410 (481)
                      .+.|+||.||++... ++..+|+|.+.....   .....+..|..+ ++.++||||+++++++...+     +||+++|+
T Consensus        46 lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~  125 (373)
T 2r5t_A           46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGE  125 (373)
T ss_dssp             EECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCB
T ss_pred             EeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCc
Confidence            378999999999865 578899999876432   223345566665 56789999999999988765     67999999


Q ss_pred             hhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          411 LEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       411 l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      |.+++... ..++......++.+|+.||+|||    +.+|+||||||+|||++.++++||+|||+|+.
T Consensus       126 L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH----~~givHrDlkp~NIll~~~g~ikL~DFG~a~~  188 (373)
T 2r5t_A          126 LFYHLQRE-RCFLEPRARFYAAEIASALGYLH----SLNIVYRDLKPENILLDSQGHIVLTDFGLCKE  188 (373)
T ss_dssp             HHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred             HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH----HCCceecCCCHHHEEECCCCCEEEeeCccccc
Confidence            99988753 34667788889999999999999    57899999999999999999999999999985

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.80  E-value=5.1e-20  Score=178.84  Aligned_cols=135  Identities=24%  Similarity=0.401  Sum_probs=116.1

Q ss_pred             hccccccceeeeeccCCcceEEEEEeccchhh-----------------hhhhhHHHHHhhhhccCccceeecccCCCC-
Q 039957          341 SLAGSFGSVYKGTISDGTDVAIKIFNLQRERA-----------------FRSFNSECEVLRNVRHQNLIKILSSCSTPD-  402 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~g~~vavK~l~~~~~~~-----------------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-  402 (481)
                      -+.|+||.||++.. +|..||+|.+.......                 .+.+.+|++++.+++|+||+++++++...+ 
T Consensus        39 lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~  117 (348)
T 2pml_X           39 LNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDE  117 (348)
T ss_dssp             EECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEESSSE
T ss_pred             EcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEeeCCe
Confidence            37899999999988 89999999987543221                 167889999999999999999999988765 


Q ss_pred             ----cccccCCChhHH------hhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 039957          403 ----FKFMPNGSLEKR------LYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVS  471 (481)
Q Consensus       403 ----~~~~~~g~l~~~------l~~~-~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~  471 (481)
                          +||+++|+|.++      +... ...+++..+..++.++++||+|||.   ..+|+||||||+||+++.++.+||+
T Consensus       118 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dl~p~Nil~~~~~~~kl~  194 (348)
T 2pml_X          118 VYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN---EKNICHRDVKPSNILMDKNGRVKLS  194 (348)
T ss_dssp             EEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TSCEECCCCCGGGEEECTTSCEEEC
T ss_pred             EEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc---cCCEeecCCChHhEEEcCCCcEEEe
Confidence                678999999998      5432 4568899999999999999999993   2789999999999999999999999


Q ss_pred             cccCcccC
Q 039957          472 DFGISKLL  479 (481)
Q Consensus       472 Dfgl~~~~  479 (481)
                      |||.++..
T Consensus       195 dfg~~~~~  202 (348)
T 2pml_X          195 DFGESEYM  202 (348)
T ss_dssp             CCTTCEEC
T ss_pred             cccccccc
Confidence            99999764

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.80  E-value=1e-19  Score=172.97  Aligned_cols=134  Identities=29%  Similarity=0.418  Sum_probs=115.1

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCC------------------
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTP------------------  401 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------------------  401 (481)
                      .+.|+||.||+|.. .+|..||+|.+... ....+.+.+|+.++++++||||++++++|...                  
T Consensus        14 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~l   92 (303)
T 1zy4_A           14 LGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFI   92 (303)
T ss_dssp             EEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEE
T ss_pred             eccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEE
Confidence            36899999999985 46899999998643 23346688899999999999999999876431                  


Q ss_pred             CcccccCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          402 DFKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       402 ~~~~~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+||+++|+|.+++.......++....+++.++++|++|||    +.+|+||||||+||++++++.+||+|||+++..
T Consensus        93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH----~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  166 (303)
T 1zy4_A           93 QMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH----SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNV  166 (303)
T ss_dssp             EEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTSCEEECCCCCCSCT
T ss_pred             EEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHH----hCCeecccCCHHhEEEcCCCCEEEeeCcchhhc
Confidence            15789999999999876667788899999999999999999    578999999999999999999999999999764

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.80  E-value=5.4e-20  Score=178.55  Aligned_cols=134  Identities=34%  Similarity=0.465  Sum_probs=111.1

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccch-----hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCC
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRE-----RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNG  409 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g  409 (481)
                      .+.|+||.||++... +|..||+|.+.....     ...+.+.+|+.++++++|+||+++++++....     ++|+++ 
T Consensus        18 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-   96 (346)
T 1ua2_A           18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-   96 (346)
T ss_dssp             EEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSE-
T ss_pred             EeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCCC-
Confidence            478999999999865 588999999865322     12346778999999999999999999987664     567774 


Q ss_pred             ChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          410 SLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       410 ~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ++.+++......+++..+..++.++++||+|||    +.+|+||||||+||++++++.+||+|||+|+.+
T Consensus        97 ~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (346)
T 1ua2_A           97 DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH----QHWILHRDLKPNNLLLDENGVLKLADFGLAKSF  162 (346)
T ss_dssp             EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred             CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH----HCCEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence            888888766666788889999999999999999    578999999999999999999999999999865

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.80  E-value=7.8e-20  Score=191.54  Aligned_cols=136  Identities=23%  Similarity=0.396  Sum_probs=116.6

Q ss_pred             hccccccceeeeeccC----CcceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTISD----GTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~----g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~~~~g~l  411 (481)
                      .+.|+||.||+|....    +..+|+|...... ....+.+.+|+.++++++||||+++++++....    +||+++|+|
T Consensus       398 LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~lv~E~~~~g~L  477 (656)
T 2j0j_A          398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGEL  477 (656)
T ss_dssp             EECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCTTCBH
T ss_pred             EeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCceEEEEEcCCCCcH
Confidence            4789999999998632    4568899876533 233467889999999999999999999986543    679999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      .+++......+++..+..++.++++||+|||    +.+|+||||||+|||++.++.+||+|||+|+...
T Consensus       478 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~  542 (656)
T 2j0j_A          478 RSFLQVRKFSLDLASLILYAYQLSTALAYLE----SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  542 (656)
T ss_dssp             HHHHHHTTTTCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred             HHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----hCCccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence            9999876667899999999999999999999    5789999999999999999999999999998653

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.80  E-value=1.3e-19  Score=172.82  Aligned_cols=136  Identities=26%  Similarity=0.415  Sum_probs=109.6

Q ss_pred             hhccccccceeeeec-cCCcceEEEEEeccch-----hhhhhhhHHHHHhhhhc---cCccceeecccCCCC--------
Q 039957          340 ISLAGSFGSVYKGTI-SDGTDVAIKIFNLQRE-----RAFRSFNSECEVLRNVR---HQNLIKILSSCSTPD--------  402 (481)
Q Consensus       340 l~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~-----~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~--------  402 (481)
                      ..+.|+||.||++.. .+|..||+|.+.....     .....+.+|++++++++   |+||++++++|....        
T Consensus        16 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~   95 (308)
T 3g33_A           16 EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVT   95 (308)
T ss_dssp             EECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEE
T ss_pred             EEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEE
Confidence            347899999999985 4688999999865331     11234567777777665   999999999886532        


Q ss_pred             --cccccCCChhHHhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          403 --FKFMPNGSLEKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       403 --~~~~~~g~l~~~l~~~~-~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                        ++|+. |+|.+++.... ..+++..+..++.++++||+|||    +.+|+||||||+||+++.++.+||+|||+|+..
T Consensus        96 lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH----~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  170 (308)
T 3g33_A           96 LVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH----ANCIVHRDLKPENILVTSGGTVKLADFGLARIY  170 (308)
T ss_dssp             EEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCTTTEEECTTSCEEECSCSCTTTS
T ss_pred             EEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEEcCCCCEEEeeCcccccc
Confidence              35665 79999887643 34889999999999999999999    577999999999999999999999999999865


Q ss_pred             C
Q 039957          480 G  480 (481)
Q Consensus       480 ~  480 (481)
                      .
T Consensus       171 ~  171 (308)
T 3g33_A          171 S  171 (308)
T ss_dssp             T
T ss_pred             C
Confidence            3

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.80  E-value=9.4e-20  Score=182.17  Aligned_cols=134  Identities=25%  Similarity=0.370  Sum_probs=113.0

Q ss_pred             hhccccccceeeeecc-CCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC----------cccc
Q 039957          340 ISLAGSFGSVYKGTIS-DGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----------FKFM  406 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----------~~~~  406 (481)
                      ..+.|+||.||+|... +|..||+|++....  ....+.+.+|+.++++++|+||+++++++....          +||+
T Consensus        33 ~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~  112 (432)
T 3n9x_A           33 LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA  112 (432)
T ss_dssp             EEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECC
T ss_pred             EEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecC
Confidence            3478999999999854 57889999986532  233456889999999999999999999886652          4566


Q ss_pred             cCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          407 PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       407 ~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      . |+|.+++... ..+++.....++.+|++||+|||    +.+|+||||||+|||+++++.+||+|||+|+..
T Consensus       113 ~-~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH----~~givHrDlkp~NILl~~~~~~kL~DFGla~~~  179 (432)
T 3n9x_A          113 D-SDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIH----ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTI  179 (432)
T ss_dssp             S-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             C-cCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH----HCCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence            5 6999888653 45788999999999999999999    578999999999999999999999999999865

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.80  E-value=1.1e-19  Score=169.68  Aligned_cols=133  Identities=28%  Similarity=0.520  Sum_probs=114.6

Q ss_pred             hccccccceeeeeccCCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCC--C-----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTP--D-----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~-----~~~~~~g~l  411 (481)
                      .+.|+||.||+|... |..+|+|.+....  ....+.+.+|+.++++++||||++++++|...  .     ++|+++|+|
T Consensus        18 lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L   96 (271)
T 3kmu_A           18 LNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSL   96 (271)
T ss_dssp             EEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBH
T ss_pred             hcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcH
Confidence            378999999999874 8889999987643  23345788999999999999999999998775  2     578999999


Q ss_pred             hHHhhcCCC-ccCHHHHHHHHHHHHHHHHHHhcCCCCCC--eeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          412 EKRLYSHNY-FLDILERLNIMIDVGSTLEYLHHGHSSAP--IIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       412 ~~~l~~~~~-~~~~~~~~~i~~~ia~~l~~lH~~~~~~~--i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      .+++..... .+++..+.+++.++++|++|||    +.+  |+||||||+||++++++.+||+|||++..
T Consensus        97 ~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~  162 (271)
T 3kmu_A           97 YNVLHEGTNFVVDQSQAVKFALDMARGMAFLH----TLEPLIPRHALNSRSVMIDEDMTARISMADVKFS  162 (271)
T ss_dssp             HHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT----TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred             HHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh----cCCCceecCCCccceEEEcCCcceeEEeccceee
Confidence            999986543 5899999999999999999999    455  99999999999999999999999998754

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.80  E-value=9.9e-21  Score=200.64  Aligned_cols=142  Identities=22%  Similarity=0.276  Sum_probs=61.3

Q ss_pred             ChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeecccCcceecCcccccCC
Q 039957           30 PPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNL  109 (481)
Q Consensus        30 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  109 (481)
                      |..|..++.|+.|+|++|++. .+|..++ .+++|++|+|++|.|+ .+|..|.++++|++|+|++|.|+ .+|..|++|
T Consensus       217 ~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~-~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l  292 (727)
T 4b8c_D          217 KDSKYDDQLWHALDLSNLQIF-NISANIF-KYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSC  292 (727)
T ss_dssp             -----CCCCCCEEECTTSCCS-CCCGGGG-GCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGG
T ss_pred             hhhhccCCCCcEEECCCCCCC-CCChhhc-CCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCC
Confidence            344444444444444444444 4444444 3444444444444444 44444444444444444444444 334444444


Q ss_pred             CCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEccCCceeecCC
Q 039957          110 RHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIP  184 (481)
Q Consensus       110 ~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p  184 (481)
                      ++|++|+|++|.|+.++         ..+.++++|++|+|++|.|++.+|..+.........+++++|.+++.+|
T Consensus       293 ~~L~~L~L~~N~l~~lp---------~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p  358 (727)
T 4b8c_D          293 FQLKYFYFFDNMVTTLP---------WEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLP  358 (727)
T ss_dssp             TTCSEEECCSSCCCCCC---------SSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCC
T ss_pred             CCCCEEECCCCCCCccC---------hhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCc
Confidence            44444444444444331         1233444444444444444444444443321112223444444444444

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.80  E-value=1e-19  Score=179.52  Aligned_cols=132  Identities=25%  Similarity=0.455  Sum_probs=104.5

Q ss_pred             hccccccceeeeec-cCCcceEEEEEecc--chhhhhhhhHHHHHhhhhc-cCccceeecccCCCC-------cccccCC
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQ--RERAFRSFNSECEVLRNVR-HQNLIKILSSCSTPD-------FKFMPNG  409 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-------~~~~~~g  409 (481)
                      .+.|+||.||+|.. .+|..||+|.+...  .......+.+|+.++.+++ |+||+++++++...+       ++|++ |
T Consensus        17 lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~   95 (388)
T 3oz6_A           17 LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-T   95 (388)
T ss_dssp             -------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-E
T ss_pred             eeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC-c
Confidence            47899999999975 46899999988543  2333456778999999997 999999999886443       56777 6


Q ss_pred             ChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          410 SLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       410 ~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +|.+++...  .+++..+..++.++++||+|||    +.+|+||||||+|||++.++.+||+|||+|+.+
T Consensus        96 ~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH----~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  159 (388)
T 3oz6_A           96 DLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLH----SGGLLHRDMKPSNILLNAECHVKVADFGLSRSF  159 (388)
T ss_dssp             EHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred             CHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH----hCCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence            888887653  5778888999999999999999    578999999999999999999999999999754

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.80  E-value=6.6e-20  Score=173.31  Aligned_cols=135  Identities=30%  Similarity=0.463  Sum_probs=108.5

Q ss_pred             hccccccceeeeecc--CCc--ceEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCCC----cccccCC
Q 039957          341 SLAGSFGSVYKGTIS--DGT--DVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----FKFMPNG  409 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~--~g~--~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~~~~g  409 (481)
                      .+.|+||.||+|...  ++.  .||+|.+....   ....+.+.+|+.++.+++|+||+++++++....    ++|+++|
T Consensus        26 lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~  105 (291)
T 1u46_A           26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLG  105 (291)
T ss_dssp             CC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCTTC
T ss_pred             ecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCCceeeEecccCC
Confidence            368999999999753  233  58999876532   234467889999999999999999999988765    5788999


Q ss_pred             ChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          410 SLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       410 ~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +|.+++......+++..+.+++.++++|++|||    +.+|+||||||+||+++.++.+||+|||+++..
T Consensus       106 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  171 (291)
T 1u46_A          106 SLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE----SKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  171 (291)
T ss_dssp             BHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             CHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHH----hCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence            999998765556888999999999999999999    578999999999999999999999999998765

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.80  E-value=1e-19  Score=171.31  Aligned_cols=132  Identities=26%  Similarity=0.463  Sum_probs=113.1

Q ss_pred             hhccccccceeeeecc-CCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCC----------------C-
Q 039957          340 ISLAGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCST----------------P-  401 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----------------~-  401 (481)
                      ..+.|+||.||++... +|..||+|.+....    ..+.+|+.++.+++|+||+++++++..                . 
T Consensus        18 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~   93 (284)
T 2a19_B           18 LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTK   93 (284)
T ss_dssp             EEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEE
T ss_pred             eeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcc
Confidence            3478999999999865 68999999986543    356789999999999999999987743                1 


Q ss_pred             ----CcccccCCChhHHhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCc
Q 039957          402 ----DFKFMPNGSLEKRLYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGIS  476 (481)
Q Consensus       402 ----~~~~~~~g~l~~~l~~~-~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~  476 (481)
                          .+||+++|+|.+++... ...+++..+.+++.++++||+|||    +.+|+||||||+||++++++.+||+|||++
T Consensus        94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  169 (284)
T 2a19_B           94 CLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH----SKKLINRDLKPSNIFLVDTKQVKIGDFGLV  169 (284)
T ss_dssp             EEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred             eEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeeccCCHHHEEEcCCCCEEECcchhh
Confidence                15789999999998653 346889999999999999999999    578999999999999999999999999998


Q ss_pred             ccC
Q 039957          477 KLL  479 (481)
Q Consensus       477 ~~~  479 (481)
                      +.+
T Consensus       170 ~~~  172 (284)
T 2a19_B          170 TSL  172 (284)
T ss_dssp             EES
T ss_pred             eec
Confidence            764

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.80  E-value=1.1e-19  Score=177.79  Aligned_cols=132  Identities=27%  Similarity=0.403  Sum_probs=106.0

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----------cccc
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----------FKFM  406 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----------~~~~  406 (481)
                      .+.|+||.||+|.. .+|..||+|.+....  ....+.+.+|+.++++++|+||+++++++....           ++|+
T Consensus        33 lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~  112 (367)
T 1cm8_A           33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM  112 (367)
T ss_dssp             C------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC
T ss_pred             eeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecC
Confidence            47899999999985 468999999985432  233456788999999999999999999886542           3566


Q ss_pred             cCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          407 PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       407 ~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                       +++|.+++...  .+++.....++.+|++||+|||    +.+|+||||||+||++++++.+||+|||+|+..
T Consensus       113 -~~~L~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH----~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  178 (367)
T 1cm8_A          113 -GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH----AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA  178 (367)
T ss_dssp             -SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             -CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----HCCccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence             78999888653  4778889999999999999999    578999999999999999999999999999864

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.80  E-value=1.1e-19  Score=171.31  Aligned_cols=135  Identities=24%  Similarity=0.402  Sum_probs=113.0

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc--hhhhhhhhHHHHHhhhh-ccCccceeecccCCCC-----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR--ERAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      .+.|+||.||++... +|..||+|.+....  ......+.+|+..+.++ +||||+++++++...+     +||+++|+|
T Consensus        19 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L   98 (289)
T 1x8b_A           19 IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSL   98 (289)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred             hcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcH
Confidence            368999999999865 68999999987542  22345677889889888 8999999999987665     678999999


Q ss_pred             hHHhhcC---CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCC-------------------CCcEE
Q 039957          412 EKRLYSH---NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDE-------------------NMVAH  469 (481)
Q Consensus       412 ~~~l~~~---~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~-------------------~~~~k  469 (481)
                      .+++...   ...+++..+.+|+.+|++||+|||    +.+|+||||||+||+++.                   ...+|
T Consensus        99 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH----~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~k  174 (289)
T 1x8b_A           99 ADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH----SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK  174 (289)
T ss_dssp             HHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEC--------------------CCCEE
T ss_pred             HHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH----hCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEE
Confidence            9998752   245788999999999999999999    578999999999999984                   44899


Q ss_pred             EccccCcccC
Q 039957          470 VSDFGISKLL  479 (481)
Q Consensus       470 l~Dfgl~~~~  479 (481)
                      |+|||.++..
T Consensus       175 l~Dfg~~~~~  184 (289)
T 1x8b_A          175 IGDLGHVTRI  184 (289)
T ss_dssp             ECCCTTCEET
T ss_pred             Eccccccccc
Confidence            9999998765

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.80  E-value=1.1e-19  Score=183.12  Aligned_cols=131  Identities=24%  Similarity=0.323  Sum_probs=106.8

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----------cccc
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----------FKFM  406 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----------~~~~  406 (481)
                      .+.|+||.||++.. .+|..||+|++....  ....+.+.+|+.+++.++|+||+++++++....           +||+
T Consensus        70 lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~  149 (464)
T 3ttj_A           70 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM  149 (464)
T ss_dssp             EEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECC
T ss_pred             eecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCC
Confidence            47899999999974 468899999987542  233456788999999999999999999886442           4677


Q ss_pred             cCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          407 PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       407 ~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +++ +.+.+..   .+++.++..++.++++||+|||    +.+|+||||||+|||++.++.+||+|||+|+..
T Consensus       150 ~~~-l~~~~~~---~l~~~~~~~~~~qil~aL~~lH----~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~  214 (464)
T 3ttj_A          150 DAN-LCQVIQM---ELDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (464)
T ss_dssp             SEE-HHHHHTS---CCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred             CCC-HHHHHhh---cCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence            654 6555543   3788889999999999999999    578999999999999999999999999999864

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.80  E-value=1.2e-19  Score=173.27  Aligned_cols=134  Identities=25%  Similarity=0.345  Sum_probs=114.3

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccch--hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRE--RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      .+.|+||.||++... +|..||+|.+.....  ...+.+.+|++++.+++|+||+++++++...+     ++|++++++.
T Consensus        11 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~   90 (311)
T 4agu_A           11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLH   90 (311)
T ss_dssp             EEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHH
T ss_pred             EeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHH
Confidence            368999999999865 589999998865432  23456778999999999999999999987664     6789999998


Q ss_pred             HHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          413 KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       413 ~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +++.. ...+++.....++.++++||+|||    +.+|+||||||+||+++.++.+||+|||+|+..
T Consensus        91 ~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  152 (311)
T 4agu_A           91 ELDRY-QRGVPEHLVKSITWQTLQAVNFCH----KHNCIHRDVKPENILITKHSVIKLCDFGFARLL  152 (311)
T ss_dssp             HHHHT-SSCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             HHHhh-hcCCCHHHHHHHHHHHHHHHHHHH----HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhc
Confidence            87654 345788899999999999999999    578999999999999999999999999999764

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.80  E-value=1.9e-19  Score=170.71  Aligned_cols=132  Identities=19%  Similarity=0.241  Sum_probs=113.3

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccchhhhhhhhHHHHHhhhh-ccCccceeecccCCCC-----cccccCCChhH
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQRERAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD-----FKFMPNGSLEK  413 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----~~~~~~g~l~~  413 (481)
                      .+.|+||.||+|.. .+|..||+|.+....  ..+.+.+|+..+.++ +|++++++++++....     ++|+ +|+|.+
T Consensus        18 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~   94 (298)
T 1csn_A           18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLED   94 (298)
T ss_dssp             EEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHH
T ss_pred             EeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHH
Confidence            47899999999984 578999999875432  335678899999998 7999999999887654     5688 999999


Q ss_pred             HhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCc-----EEEccccCcccC
Q 039957          414 RLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMV-----AHVSDFGISKLL  479 (481)
Q Consensus       414 ~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~-----~kl~Dfgl~~~~  479 (481)
                      ++......+++..+.+++.+|++||+|||    +.+|+||||||+||+++.++.     +||+|||+|+.+
T Consensus        95 ~l~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~  161 (298)
T 1csn_A           95 LLDLCGRKFSVKTVAMAAKQMLARVQSIH----EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  161 (298)
T ss_dssp             HHHHTTTCCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             HHHHhccCCCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence            99876666899999999999999999999    678999999999999988776     999999999764

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.80  E-value=1.1e-19  Score=177.54  Aligned_cols=135  Identities=24%  Similarity=0.313  Sum_probs=111.2

Q ss_pred             hhccccccceeeeeccCCcceEEEEEeccchh-----------hhhhhhHHHHHhhhhccCccceeecccCCC-----C-
Q 039957          340 ISLAGSFGSVYKGTISDGTDVAIKIFNLQRER-----------AFRSFNSECEVLRNVRHQNLIKILSSCSTP-----D-  402 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~~g~~vavK~l~~~~~~-----------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~-  402 (481)
                      ..+.|+||.||++...+|..||+|++......           ..+.+.+|+.++.+++|+||+++++++...     . 
T Consensus        29 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (362)
T 3pg1_A           29 FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHK  108 (362)
T ss_dssp             EEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCCE
T ss_pred             EeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCcce
Confidence            34789999999998878999999988543211           125678899999999999999999987321     1 


Q ss_pred             ----cccccCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          403 ----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       403 ----~~~~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                          ++|++ |++.+.+......+++..+..++.+|++||+|||    +.+|+||||||+||++++++.+||+|||+|+.
T Consensus       109 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~  183 (362)
T 3pg1_A          109 LYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH----EAGVVHRDLHPGNILLADNNDITICDFNLARE  183 (362)
T ss_dssp             EEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEECCTTC---
T ss_pred             EEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----HCcCEecCCChHHEEEcCCCCEEEEecCcccc
Confidence                45776 7888888776667899999999999999999999    57899999999999999999999999999974


Q ss_pred             C
Q 039957          479 L  479 (481)
Q Consensus       479 ~  479 (481)
                      .
T Consensus       184 ~  184 (362)
T 3pg1_A          184 D  184 (362)
T ss_dssp             -
T ss_pred             c
Confidence            3

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.80  E-value=1.8e-19  Score=170.65  Aligned_cols=135  Identities=20%  Similarity=0.253  Sum_probs=115.3

Q ss_pred             hhccccccceeeeecc-CCcceEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCC
Q 039957          340 ISLAGSFGSVYKGTIS-DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGS  410 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~  410 (481)
                      ..++|+||.||++... ++..+|+|.+....   ....+.+..|+.++++++|+||+++++++...+     +||+++++
T Consensus        22 ~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  101 (294)
T 2rku_A           22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS  101 (294)
T ss_dssp             EEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCB
T ss_pred             EEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCC
Confidence            3478999999999865 47889999886542   233456788999999999999999999998765     57899999


Q ss_pred             hhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          411 LEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       411 l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      |.+++... ..+++.++.+++.++++|++|||    +.+|+||||||+||++++++.+||+|||+++..
T Consensus       102 L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  165 (294)
T 2rku_A          102 LLELHKRR-KALTEPEARYYLRQIVLGCQYLH----RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV  165 (294)
T ss_dssp             HHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH----HCCccccCCChHhEEEcCCCCEEEEeccCceec
Confidence            99987643 35788999999999999999999    578999999999999999999999999998764

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.80  E-value=7.1e-20  Score=176.72  Aligned_cols=136  Identities=25%  Similarity=0.414  Sum_probs=113.7

Q ss_pred             hhccccccceeeeecc-CC-----cceEEEEEeccc-hhhhhhhhHHHHHhhhh-ccCccceeecccCCCC-----cccc
Q 039957          340 ISLAGSFGSVYKGTIS-DG-----TDVAIKIFNLQR-ERAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD-----FKFM  406 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~-~g-----~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----~~~~  406 (481)
                      ..+.|+||.||+|... .+     ..||+|.+.... ....+.+.+|+.++.++ +||||++++++|...+     ++|+
T Consensus        53 ~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~  132 (333)
T 2i1m_A           53 TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYC  132 (333)
T ss_dssp             EEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             EeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecC
Confidence            3478999999999853 23     469999886543 23345688999999999 8999999999997764     6789


Q ss_pred             cCCChhHHhhcC-------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 039957          407 PNGSLEKRLYSH-------------NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDF  473 (481)
Q Consensus       407 ~~g~l~~~l~~~-------------~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Df  473 (481)
                      ++|+|.+++...             ...+++..+..++.++++||+|||    +.+|+||||||+||++++++.+||+||
T Consensus       133 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dlkp~NIl~~~~~~~kl~Df  208 (333)
T 2i1m_A          133 CYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA----SKNCIHRDVAARNVLLTNGHVAKIGDF  208 (333)
T ss_dssp             TTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGCEEEGGGEEEBCCC
T ss_pred             CCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh----cCCcccCCcccceEEECCCCeEEECcc
Confidence            999999988642             234688899999999999999999    578999999999999999999999999


Q ss_pred             cCcccC
Q 039957          474 GISKLL  479 (481)
Q Consensus       474 gl~~~~  479 (481)
                      |+|+..
T Consensus       209 g~~~~~  214 (333)
T 2i1m_A          209 GLARDI  214 (333)
T ss_dssp             GGGCCG
T ss_pred             cccccc
Confidence            999754

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.80  E-value=1.4e-19  Score=170.06  Aligned_cols=134  Identities=23%  Similarity=0.383  Sum_probs=113.9

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccch---hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRE---RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      .+.|+||.||++... ++..+|+|.+.....   .....+.+|+.++++++|+||++++++|....     ++|+++|++
T Consensus        17 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l   96 (279)
T 3fdn_A           17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV   96 (279)
T ss_dssp             EEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEH
T ss_pred             EecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCcH
Confidence            368999999999754 567899999865432   22456788999999999999999999998765     678999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+++... ..+++..+..++.++++|++|||    +.+|+||||||+||+++.++.+||+|||++...
T Consensus        97 ~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH----~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~  159 (279)
T 3fdn_A           97 YRELQKL-SKFDEQRTATYITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWSVHA  159 (279)
T ss_dssp             HHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH----TTTCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH----hCCEecccCChHhEEEcCCCCEEEEeccccccC
Confidence            9988653 34788899999999999999999    678999999999999999999999999988653

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.80  E-value=2.1e-19  Score=177.06  Aligned_cols=133  Identities=23%  Similarity=0.328  Sum_probs=112.7

Q ss_pred             hhccccccceeeeeccCCcceEEEEEeccc--hhhhhhhhHHHHHhhhhc--cCccceeecccCCCC-----cccccCCC
Q 039957          340 ISLAGSFGSVYKGTISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVR--HQNLIKILSSCSTPD-----FKFMPNGS  410 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~-----~~~~~~g~  410 (481)
                      ..+.|+||.||++...+|..||||.+....  ......+.+|++++.+++  |+||+++++++...+     +| +.+|+
T Consensus        63 ~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~~  141 (390)
T 2zmd_A           63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNID  141 (390)
T ss_dssp             EEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSEE
T ss_pred             EEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCCC
Confidence            347899999999988778999999987543  334567889999999997  599999999987765     34 46789


Q ss_pred             hhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          411 LEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       411 l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      |.+++.... .+++.++..++.+|++||+|||    +.+|+||||||+|||++ ++.+||+|||+|+.+
T Consensus       142 L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH----~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~  204 (390)
T 2zmd_A          142 LNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH----QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM  204 (390)
T ss_dssp             HHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH----TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC
T ss_pred             HHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCHHHEEEE-CCeEEEEecCccccc
Confidence            999887643 5778889999999999999999    67899999999999996 589999999999865

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.79  E-value=1.8e-19  Score=173.98  Aligned_cols=135  Identities=20%  Similarity=0.253  Sum_probs=115.5

Q ss_pred             hhccccccceeeeecc-CCcceEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCC
Q 039957          340 ISLAGSFGSVYKGTIS-DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGS  410 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~  410 (481)
                      ..++|+||.||++... ++..+|+|.+....   ....+.+..|+.++++++|+||+++++++...+     +||+++++
T Consensus        48 ~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  127 (335)
T 2owb_A           48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS  127 (335)
T ss_dssp             EEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCB
T ss_pred             EEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCC
Confidence            3478999999999865 47889999886542   233456788999999999999999999998765     67899999


Q ss_pred             hhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          411 LEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       411 l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      |.+++... ..+++.++..++.++++||+|||    +.+|+||||||+||++++++.+||+|||+++..
T Consensus       128 L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~  191 (335)
T 2owb_A          128 LLELHKRR-KALTEPEARYYLRQIVLGCQYLH----RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV  191 (335)
T ss_dssp             HHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             HHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH----HCCCEecCCCchhEEEcCCCCEEEeeccCceec
Confidence            99987643 35788999999999999999999    578999999999999999999999999999764

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.79  E-value=6.5e-20  Score=172.26  Aligned_cols=132  Identities=33%  Similarity=0.490  Sum_probs=108.6

Q ss_pred             hccccccceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC------cccccCCChhHH
Q 039957          341 SLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD------FKFMPNGSLEKR  414 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~~~~g~l~~~  414 (481)
                      .+.|+||.||++.. .|..+|+|.+....  ..+.+.+|++++.+++|+|++++++++....      ++|+++|+|.++
T Consensus        29 lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~  105 (278)
T 1byg_A           29 IGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDY  105 (278)
T ss_dssp             EEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHH
T ss_pred             EecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHH
Confidence            36899999999986 48899999886432  3456888999999999999999999875442      578899999998


Q ss_pred             hhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          415 LYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       415 l~~~~-~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +.... ..+++..+.+++.++++|++|||    +.+|+||||||+||++++++.+||+|||+++..
T Consensus       106 l~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~  167 (278)
T 1byg_A          106 LRSRGRSVLGGDCLLKFSLDVCEAMEYLE----GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA  167 (278)
T ss_dssp             HHHHHHHHCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred             HHhcccccCCHHHHHHHHHHHHHHHHHHH----hCCccccCCCcceEEEeCCCcEEEeeccccccc
Confidence            87532 23678889999999999999999    578999999999999999999999999998754

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.79  E-value=2.3e-19  Score=173.39  Aligned_cols=133  Identities=29%  Similarity=0.413  Sum_probs=106.5

Q ss_pred             hccccccceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhh--hhccCccceeecccCCC----C-----cccccCC
Q 039957          341 SLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLR--NVRHQNLIKILSSCSTP----D-----FKFMPNG  409 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~--~l~h~niv~l~~~~~~~----~-----~~~~~~g  409 (481)
                      .+.|+||.||+|... |..||||.+.....   ..+..|.+++.  .++|+||+++++++...    .     +||+++|
T Consensus        45 lg~G~~g~V~~~~~~-~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g  120 (337)
T 3mdy_A           45 IGKGRYGEVWMGKWR-GEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENG  120 (337)
T ss_dssp             EEEETTEEEEEEEET-TEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTC
T ss_pred             eecCCCeEEEEEEEC-CceEEEEEEecccc---chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCC
Confidence            478999999999864 88999999864432   22333444444  45899999999987654    2     5789999


Q ss_pred             ChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCC----CCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          410 SLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGH----SSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       410 ~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~----~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +|.+++...  .+++..+.+++.++++||+|||..+    ..++|+||||||+||+++.++.+||+|||+|+.+
T Consensus       121 ~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~  192 (337)
T 3mdy_A          121 SLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKF  192 (337)
T ss_dssp             BHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             cHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceee
Confidence            999998754  4788999999999999999999420    0128999999999999999999999999999654

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.79  E-value=2.2e-19  Score=168.31  Aligned_cols=134  Identities=23%  Similarity=0.396  Sum_probs=115.2

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccch-hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhH
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRE-RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEK  413 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~  413 (481)
                      .+.|+||.||++... +|..||+|.+..... ...+.+.+|+.++++++|+||+++++++...+     +||+++|+|.+
T Consensus        15 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   94 (276)
T 2yex_A           15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD   94 (276)
T ss_dssp             EEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGG
T ss_pred             eecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHH
Confidence            368999999999864 688999999875432 33456788999999999999999999987664     57889999999


Q ss_pred             HhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          414 RLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       414 ~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ++.. ...+++.....++.++++||+|||    +.+|+||||||+||++++++.+||+|||.++.+
T Consensus        95 ~l~~-~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  155 (276)
T 2yex_A           95 RIEP-DIGMPEPDAQRFFHQLMAGVVYLH----GIGITHRDIKPENLLLDERDNLKISDFGLATVF  155 (276)
T ss_dssp             GSBT-TTBCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             HHhh-ccCCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCChHHEEEccCCCEEEeeCCCcccc
Confidence            8864 345788999999999999999999    578999999999999999999999999998753

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.79  E-value=2.7e-19  Score=168.46  Aligned_cols=134  Identities=27%  Similarity=0.387  Sum_probs=114.7

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccchh------hhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccC
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRER------AFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPN  408 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~  408 (481)
                      .+.|+||.||++... +|..+|+|.+......      ..+.+.+|+.++++++|+||+++++++....     ++|+++
T Consensus        13 lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   92 (283)
T 3bhy_A           13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSG   92 (283)
T ss_dssp             EEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred             hcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeecCC
Confidence            368999999999865 6899999998654321      2456788999999999999999999988765     678999


Q ss_pred             CChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCC----cEEEccccCcccC
Q 039957          409 GSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENM----VAHVSDFGISKLL  479 (481)
Q Consensus       409 g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~----~~kl~Dfgl~~~~  479 (481)
                      ++|.+++... ..+++..+..++.++++||+|||    +.+|+||||||+||++++++    .+||+|||+++..
T Consensus        93 ~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~  162 (283)
T 3bhy_A           93 GELFDFLAEK-ESLTEDEATQFLKQILDGVHYLH----SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI  162 (283)
T ss_dssp             CBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             CcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH----hCCccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence            9999988643 35788999999999999999999    57899999999999998877    8999999998764

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.79  E-value=2.3e-19  Score=173.23  Aligned_cols=135  Identities=24%  Similarity=0.340  Sum_probs=112.7

Q ss_pred             hhccccccceeeeec-cCCcceEEEEEeccchhhhhhhhHHHHHhhhhc-cCccceeecccCC-------CC------cc
Q 039957          340 ISLAGSFGSVYKGTI-SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVR-HQNLIKILSSCST-------PD------FK  404 (481)
Q Consensus       340 l~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~-------~~------~~  404 (481)
                      ..+.|+||.||++.. .+|..||+|.+........+.+.+|+.++.+++ |+||+++++++..       ..      ++
T Consensus        35 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e  114 (337)
T 3ll6_A           35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTE  114 (337)
T ss_dssp             EEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEE
T ss_pred             EEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEE
Confidence            347899999999985 468999999986655555667889999999996 9999999988731       11      34


Q ss_pred             cccCCChhHHhhc--CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCC--eeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          405 FMPNGSLEKRLYS--HNYFLDILERLNIMIDVGSTLEYLHHGHSSAP--IIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       405 ~~~~g~l~~~l~~--~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~--i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      |+. |+|.+++..  ....+++..+.+|+.+|++||+|||    +.+  |+||||||+||++++++.+||+|||+++..
T Consensus       115 ~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH----~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  188 (337)
T 3ll6_A          115 LCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH----RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTI  188 (337)
T ss_dssp             CCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH----TSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCC
T ss_pred             ecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH----hCCCCEEEccCCcccEEECCCCCEEEecCccceec
Confidence            664 899888764  3446899999999999999999999    455  999999999999999999999999999765

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.79  E-value=1.1e-19  Score=176.28  Aligned_cols=135  Identities=26%  Similarity=0.402  Sum_probs=110.7

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccc-----hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCC
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQR-----ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNG  409 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g  409 (481)
                      .+.|+||.||++.. .++..+|+|.+....     ....+.+.+|+.++++++||||++++++|...+     +||+++|
T Consensus        34 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg  113 (345)
T 3hko_A           34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGG  113 (345)
T ss_dssp             EEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred             eeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCCCCC
Confidence            37899999999985 457889999986542     233456888999999999999999999998765     6799999


Q ss_pred             ChhHHhhcC---------------------------------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCe
Q 039957          410 SLEKRLYSH---------------------------------------NYFLDILERLNIMIDVGSTLEYLHHGHSSAPI  450 (481)
Q Consensus       410 ~l~~~l~~~---------------------------------------~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i  450 (481)
                      +|.+++...                                       ....++.....|+.++++||+|||    +.+|
T Consensus       114 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH----~~~i  189 (345)
T 3hko_A          114 HLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH----NQGI  189 (345)
T ss_dssp             BHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH----HTTE
T ss_pred             cHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH----HCCc
Confidence            999987420                                       112245667789999999999999    5789


Q ss_pred             eeCCCCCCCeeeCCCC--cEEEccccCcccC
Q 039957          451 IHCDLKPTSILLDENM--VAHVSDFGISKLL  479 (481)
Q Consensus       451 ~H~dlk~~nill~~~~--~~kl~Dfgl~~~~  479 (481)
                      +||||||+||+++.++  .+||+|||+|+.+
T Consensus       190 vH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~  220 (345)
T 3hko_A          190 CHRDIKPENFLFSTNKSFEIKLVDFGLSKEF  220 (345)
T ss_dssp             ECCCCCGGGEEESCSSSCCEEECCCTTCEEG
T ss_pred             cccCCChhhEEEecCCCceEEEeeccccccc
Confidence            9999999999998766  8999999999753

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.79  E-value=2.3e-19  Score=188.59  Aligned_cols=133  Identities=23%  Similarity=0.250  Sum_probs=113.6

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc---hhhhhhhhHHHHHhhhh-ccCccceeecccCCCC-----cccccCCC
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD-----FKFMPNGS  410 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----~~~~~~g~  410 (481)
                      .+.|+||.||++... ++..||+|.+....   ....+.+..|..++..+ +|++|+++.+++...+     +||+++|+
T Consensus       349 LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~  428 (674)
T 3pfq_A          349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGD  428 (674)
T ss_dssp             SSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCB
T ss_pred             EccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCc
Confidence            478999999999864 57889999987542   22344567788888876 7999999999887765     68999999


Q ss_pred             hhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          411 LEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       411 l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      |.+++... ..+++..+..++.+|+.||+|||    +.+||||||||+|||+|+++++||+|||+|+.
T Consensus       429 L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH----~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~  491 (674)
T 3pfq_A          429 LMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQ----SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  491 (674)
T ss_dssp             HHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH----HTSEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred             HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH----hCCeEeccCChhhEEEcCCCcEEEeecceeec
Confidence            99998754 35788899999999999999999    57899999999999999999999999999985

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.79  E-value=2.2e-19  Score=171.48  Aligned_cols=135  Identities=23%  Similarity=0.433  Sum_probs=109.3

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      .+.|+||.||++.. .+|..||+|.+....   ......+.+|+.++.+++|+||+++++++...+     ++|+++|+|
T Consensus        40 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L  119 (310)
T 2wqm_A           40 IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDL  119 (310)
T ss_dssp             EECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBH
T ss_pred             ecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCH
Confidence            47899999999985 578999999987532   334456888999999999999999999987654     678999999


Q ss_pred             hHHhhc---CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          412 EKRLYS---HNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~---~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+++..   ....+++....+++.++++||+|||    +.+|+||||||+||+++.++.+||+|||+++..
T Consensus       120 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH----~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~  186 (310)
T 2wqm_A          120 SRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH----SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF  186 (310)
T ss_dssp             HHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred             HHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh----hCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence            998764   3456788899999999999999999    578999999999999999999999999998754

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.79  E-value=1.9e-19  Score=174.46  Aligned_cols=134  Identities=22%  Similarity=0.334  Sum_probs=112.9

Q ss_pred             hhccccccceeeeeccCCcceEEEEEeccc--hhhhhhhhHHHHHhhhhcc--CccceeecccCCCCccc----ccCCCh
Q 039957          340 ISLAGSFGSVYKGTISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRH--QNLIKILSSCSTPDFKF----MPNGSL  411 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~----~~~g~l  411 (481)
                      ..+.|+||.||++...++..||+|.+....  ......+.+|++++.+++|  +||+++++++......|    +.+|+|
T Consensus        16 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~~~~~L   95 (343)
T 3dbq_A           16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDL   95 (343)
T ss_dssp             EESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCSEEH
T ss_pred             EEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeCCCCCH
Confidence            347899999999988888999999987543  2334678899999999987  99999999988765222    467899


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+++... ..+++.++..++.++++||+|||    +.+|+||||||+|||++ ++.+||+|||+|+.+
T Consensus        96 ~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH----~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~  157 (343)
T 3dbq_A           96 NSWLKKK-KSIDPWERKSYWKNMLEAVHTIH----QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM  157 (343)
T ss_dssp             HHHHHHS-CCCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence            9988764 45788899999999999999999    57899999999999997 688999999999865

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.79  E-value=2.2e-19  Score=171.01  Aligned_cols=134  Identities=25%  Similarity=0.412  Sum_probs=112.6

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHH
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKR  414 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~  414 (481)
                      -+.|+||.||++... +|..||+|.+..........+.+|+.++.+++||||+++++++...+     +||+++|+|.++
T Consensus        17 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   96 (304)
T 2jam_A           17 LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDR   96 (304)
T ss_dssp             EEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHH
T ss_pred             ccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHH
Confidence            478999999999854 68999999987654444456888999999999999999999987765     578999999998


Q ss_pred             hhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeee---CCCCcEEEccccCcccC
Q 039957          415 LYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILL---DENMVAHVSDFGISKLL  479 (481)
Q Consensus       415 l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill---~~~~~~kl~Dfgl~~~~  479 (481)
                      +... ..+++.....++.++++|++|||    +.+|+||||||+||++   ++++.+||+|||+++..
T Consensus        97 l~~~-~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~  159 (304)
T 2jam_A           97 ILER-GVYTEKDASLVIQQVLSAVKYLH----ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME  159 (304)
T ss_dssp             HHHH-SCCCHHHHHHHHHHHHHHHHHHH----HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred             HHHc-CCCCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence            8643 34778899999999999999999    5789999999999999   78899999999998754

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.79  E-value=2.1e-19  Score=173.00  Aligned_cols=292  Identities=11%  Similarity=0.077  Sum_probs=171.4

Q ss_pred             eccCcchhC--CCCCCeeeCcCCcccccCChhccC-CcCCCEEEeeCCcCc--cccChhhhcCCCCccEEEccCccceee
Q 039957            3 GQIPTEIGN--LQNLKSLFLGANNLSGLIPPMIFN-ISTIRNLNLGGNRLS--GHLPSMIGHSLPNIKYLELGDNNLIGT   77 (481)
Q Consensus         3 g~lp~~~~~--l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~L~~N~l~--~~~p~~~~~~l~~L~~L~L~~N~l~~~   77 (481)
                      |.++..+..  +.+++.|.++++ +....-..+.. +++|++|||++|++.  ...+.    .++.++.+.+..|.   +
T Consensus        13 g~l~~~l~~~~~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~----~~~~~~~~~~~~~~---I   84 (329)
T 3sb4_A           13 GTLISMMTEEEANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAG----TYPNGKFYIYMANF---V   84 (329)
T ss_dssp             TCGGGGSCHHHHHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSS----SSGGGCCEEECTTE---E
T ss_pred             CcHHhhccchhhCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCccc----cccccccccccccc---c
Confidence            555555543  677999999875 22222223444 788999999999987  21111    23335666666663   3


Q ss_pred             cchhccc--------cccCceeecccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEc
Q 039957           78 IPNSITN--------ATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLIL  149 (481)
Q Consensus        78 ~p~~~~~--------l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L  149 (481)
                      .+.+|.+        +++|+.|+|.. .++.+.+.+|.++++|+.++++.|.++.+++.+|        ..+.++..+.+
T Consensus        85 ~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF--------~~~~~l~~l~~  155 (329)
T 3sb4_A           85 PAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEAL--------ADSVTAIFIPL  155 (329)
T ss_dssp             CTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSS--------CTTTCEEEECT
T ss_pred             CHHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhh--------cCCCceEEecC
Confidence            3456777        99999999988 8888888889999999999999999888876654        34556666665


Q ss_pred             cCCcc----ceeCChhhhhcccCcc-EEEccCCceeecCCccc----ccCCCCCeEecccccceecCCcCCcCCCCCCee
Q 039957          150 SGNPL----GGILPPSIGNFSTSLQ-RFSASECKLKGTIPKEI----GHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGF  220 (481)
Q Consensus       150 s~N~l----~~~~p~~~~~~~~~L~-~L~l~~n~l~~~~p~~~----~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l  220 (481)
                      ..+..    ....+..|..+ ..|+ .+.+....   .++..+    ....++..+.+.++-...........+++|+.+
T Consensus       156 ~~~~~~~~~~~i~~~~f~~~-~~L~~~i~~~~~~---~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l  231 (329)
T 3sb4_A          156 GSSDAYRFKNRWEHFAFIEG-EPLETTIQVGAMG---KLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSL  231 (329)
T ss_dssp             TCTHHHHTSTTTTTSCEEES-CCCEEEEEECTTC---CHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEE
T ss_pred             cchhhhhccccccccccccc-cccceeEEecCCC---cHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEE
Confidence            55322    11111222222 1233 23332211   111111    123344444444331110000001125566666


Q ss_pred             ecCCCcCCCCCCccccCccCCCeeecCCCeeeecCCcccccCCCCC-cEEcCCCcCcccCCcchhccccCcEEEccCccc
Q 039957          221 FLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLR-ELDLGSNKLTSSIPSSLWSLGYILEINLSSNLL  299 (481)
Q Consensus       221 ~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~-~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l  299 (481)
                      ++++|+++...+.+|.++.+|+.+++.+| ++.+.+.+|.++++|+ .+++.+ .++...+.+|.++..|+.+++++|.+
T Consensus       232 ~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i  309 (329)
T 3sb4_A          232 DISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKI  309 (329)
T ss_dssp             ECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCC
T ss_pred             ECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCcc
Confidence            66666666655666666666666666666 5556666666666676 666666 55555566666667777777766666


Q ss_pred             CCCCCCccccCCcCcEEE
Q 039957          300 NDSLPSNVQKLKVLRVLD  317 (481)
Q Consensus       300 ~~~~p~~~~~l~~L~~L~  317 (481)
                      +.+.+..|.++++|+.+.
T Consensus       310 ~~I~~~aF~~~~~L~~ly  327 (329)
T 3sb4_A          310 TTLGDELFGNGVPSKLIY  327 (329)
T ss_dssp             CEECTTTTCTTCCCCEEE
T ss_pred             CccchhhhcCCcchhhhc
Confidence            666666677777776664

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.79  E-value=2.2e-19  Score=175.38  Aligned_cols=135  Identities=32%  Similarity=0.472  Sum_probs=115.0

Q ss_pred             hhccccccceeeeecc-CCcceEEEEEeccch--------hhhhhhhHHHHHhhhh-ccCccceeecccCCCC-----cc
Q 039957          340 ISLAGSFGSVYKGTIS-DGTDVAIKIFNLQRE--------RAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD-----FK  404 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~--------~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----~~  404 (481)
                      ..++|+||.||++... +|..||||.+.....        ...+.+..|+.++.++ +|+||+++++++....     +|
T Consensus       101 ~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e  180 (365)
T 2y7j_A          101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFD  180 (365)
T ss_dssp             EEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEEC
T ss_pred             EEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEE
Confidence            3478999999999875 689999999865431        1234577899999998 7999999999987654     67


Q ss_pred             cccCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          405 FMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       405 ~~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      |+++|+|.+++... ..+++..+..++.+|++||+|||    +.+|+||||||+||++++++.+||+|||+++.+
T Consensus       181 ~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH----~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~  250 (365)
T 2y7j_A          181 LMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLH----ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHL  250 (365)
T ss_dssp             CCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             eCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEECCCCCEEEEecCccccc
Confidence            99999999988753 35788999999999999999999    578999999999999999999999999998764

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.79  E-value=1.9e-19  Score=173.20  Aligned_cols=135  Identities=34%  Similarity=0.551  Sum_probs=112.0

Q ss_pred             hhccccccceeeeecc-CCcc--eEEEEEeccc-hhhhhhhhHHHHHhhhh-ccCccceeecccCCCC-----cccccCC
Q 039957          340 ISLAGSFGSVYKGTIS-DGTD--VAIKIFNLQR-ERAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD-----FKFMPNG  409 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~-~g~~--vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----~~~~~~g  409 (481)
                      ..+.|+||.||++... +|..  +++|.+.... ....+.+.+|+.++.++ +||||+++++++...+     +||+++|
T Consensus        32 ~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~  111 (327)
T 1fvr_A           32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG  111 (327)
T ss_dssp             EEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred             eeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCC
Confidence            3478999999999864 4554  4888876432 33445688899999999 8999999999987665     6789999


Q ss_pred             ChhHHhhcCC---------------CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEcccc
Q 039957          410 SLEKRLYSHN---------------YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFG  474 (481)
Q Consensus       410 ~l~~~l~~~~---------------~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfg  474 (481)
                      +|.+++....               ..+++.++..++.++++||+|||    +.+|+||||||+||++++++.+||+|||
T Consensus       112 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~dlkp~NIl~~~~~~~kL~Dfg  187 (327)
T 1fvr_A          112 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS----QKQFIHRDLAARNILVGENYVAKIADFG  187 (327)
T ss_dssp             BHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECGGGCEEECCTT
T ss_pred             CHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH----hCCccCCCCccceEEEcCCCeEEEcccC
Confidence            9999987543               35788999999999999999999    5789999999999999999999999999


Q ss_pred             Cccc
Q 039957          475 ISKL  478 (481)
Q Consensus       475 l~~~  478 (481)
                      +++.
T Consensus       188 ~~~~  191 (327)
T 1fvr_A          188 LSRG  191 (327)
T ss_dssp             CEES
T ss_pred             cCcc
Confidence            9874

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.79  E-value=2.2e-19  Score=172.37  Aligned_cols=135  Identities=29%  Similarity=0.408  Sum_probs=111.0

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccch--------hhhhhhhHHHHHhhhhccCccceeecccCCCC----ccccc
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRE--------RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----FKFMP  407 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~~~  407 (481)
                      .+.|+||.||++... +|..||+|.+.....        .....+.+|++++.+++|+||+++++++....    ++|++
T Consensus        18 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~   97 (322)
T 2ycf_A           18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELME   97 (322)
T ss_dssp             EEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCT
T ss_pred             EecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCceEEEEecCC
Confidence            478999999999854 578999999865321        12345788999999999999999999987654    67899


Q ss_pred             CCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCC---cEEEccccCcccCC
Q 039957          408 NGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENM---VAHVSDFGISKLLG  480 (481)
Q Consensus       408 ~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~---~~kl~Dfgl~~~~~  480 (481)
                      +|+|.+++... ..+++.....++.+|++||+|||    +.+|+||||||+||+++.++   .+||+|||+++...
T Consensus        98 ~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  168 (322)
T 2ycf_A           98 GGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLH----ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG  168 (322)
T ss_dssp             TEETHHHHSTT-CCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECC
T ss_pred             CCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHEEEecCCCCCeEEEccCccceecc
Confidence            99999988643 45788899999999999999999    57899999999999998765   49999999998653

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.79  E-value=6.4e-20  Score=176.68  Aligned_cols=287  Identities=12%  Similarity=0.063  Sum_probs=196.0

Q ss_pred             CCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccce--eecchhccccccCceeecccCcceecCcccccC----
Q 039957           35 NISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLI--GTIPNSITNATKLIILDLGFNTFSGHIPNTFGN----  108 (481)
Q Consensus        35 ~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~----  108 (481)
                      .+.+++.|.++++- ...--..+...+++|++|||++|++.  ...+..+.   .+..+.+..|.   +.+.+|.+    
T Consensus        23 ~~~~l~~L~l~g~i-~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~~---~~~~~~~~~~~---I~~~aF~~~~~~   95 (329)
T 3sb4_A           23 EANSITHLTLTGKL-NAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTYP---NGKFYIYMANF---VPAYAFSNVVNG   95 (329)
T ss_dssp             HHHHCSEEEEEEEE-CHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSSSG---GGCCEEECTTE---ECTTTTEEEETT
T ss_pred             hhCceeEEEEeccc-cHHHHHHHHHhhccCeEEecCcceeEEecCcccccc---ccccccccccc---cCHHHhcccccc
Confidence            35678899998752 21111233323788999999999987  33333332   24555555553   44566777    


Q ss_pred             ----CCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEccCCce----e
Q 039957          109 ----LRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKL----K  180 (481)
Q Consensus       109 ----l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l----~  180 (481)
                          +++|+.++|.. +++.++..+        +.+|++|+.+++++|.++.+.+..|... ..+..+....+..    .
T Consensus        96 ~~~g~~~L~~l~L~~-~i~~I~~~a--------F~~~~~L~~l~l~~n~i~~i~~~aF~~~-~~l~~l~~~~~~~~~~~~  165 (329)
T 3sb4_A           96 VTKGKQTLEKVILSE-KIKNIEDAA--------FKGCDNLKICQIRKKTAPNLLPEALADS-VTAIFIPLGSSDAYRFKN  165 (329)
T ss_dssp             EEEECTTCCC-CBCT-TCCEECTTT--------TTTCTTCCEEEBCCSSCCEECTTSSCTT-TCEEEECTTCTHHHHTST
T ss_pred             cccccCCCcEEECCc-cccchhHHH--------hhcCcccceEEcCCCCccccchhhhcCC-CceEEecCcchhhhhccc
Confidence                99999999998 888886655        4678899999999999987777777664 3455665554322    1


Q ss_pred             ecCCcccccCCCCC-eEeccccc-ceecCCcCCcCCCCCCeeecCCCcCCCCCCccc-cCccCCCeeecCCCeeeecCCc
Q 039957          181 GTIPKEIGHLRGLI-YLSLGFND-LNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNL-CHLEMLNLLHLGGNKLSGHIPP  257 (481)
Q Consensus       181 ~~~p~~~~~l~~L~-~L~l~~N~-l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~  257 (481)
                      ..-+..|.++..|+ .+.+.... +...+...-....++..+.+.++- .......+ ..+++|+.+++++|+++.+.+.
T Consensus       166 ~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l-~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~  244 (329)
T 3sb4_A          166 RWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKL-DNADFKLIRDYMPNLVSLDISKTNATTIPDF  244 (329)
T ss_dssp             TTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECC-CHHHHHHHHHHCTTCCEEECTTBCCCEECTT
T ss_pred             cccccccccccccceeEEecCCCcHHHHHhhcccCccccceEEEeeee-cHHHHHHHHHhcCCCeEEECCCCCcceecHh
Confidence            12234466666666 44443321 111111111234455555554431 11111111 2367899999999999988888


Q ss_pred             ccccCCCCCcEEcCCCcCcccCCcchhccccCc-EEEccCcccCCCCCCccccCCcCcEEEccCCeeeeeccccccccCC
Q 039957          258 CLASLTSLRELDLGSNKLTSSIPSSLWSLGYIL-EINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVD  336 (481)
Q Consensus       258 ~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~-~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~  336 (481)
                      +|.++++|+.+++.+| ++...+.+|.++..|+ .+++.+ .++.+.+..|.++++|+.+++++|++....+.+|.++++
T Consensus       245 aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~  322 (329)
T 3sb4_A          245 TFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVP  322 (329)
T ss_dssp             TTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCC
T ss_pred             hhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcc
Confidence            9999999999999998 8778888899999999 999988 777777889999999999999999999888889999999


Q ss_pred             hhhhh
Q 039957          337 LETIS  341 (481)
Q Consensus       337 L~~l~  341 (481)
                      |+.++
T Consensus       323 L~~ly  327 (329)
T 3sb4_A          323 SKLIY  327 (329)
T ss_dssp             CCEEE
T ss_pred             hhhhc
Confidence            88764

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.79  E-value=1.6e-19  Score=172.60  Aligned_cols=133  Identities=29%  Similarity=0.380  Sum_probs=111.9

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHH
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKR  414 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~  414 (481)
                      .+.|+||.||+|... +|..||+|.+....  ....+.+|+.++.+++|+||+++++++...+     ++|+++|+|.++
T Consensus        37 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~  114 (314)
T 3com_A           37 LGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDI  114 (314)
T ss_dssp             CC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHH
T ss_pred             eccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHH
Confidence            468999999999865 58899999986542  3456788999999999999999999887654     678999999999


Q ss_pred             hhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          415 LYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       415 l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +......+++..+..++.++++|++|||    +.+|+||||||+||+++.++.+||+|||+++.+
T Consensus       115 ~~~~~~~~~~~~~~~i~~~i~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  175 (314)
T 3com_A          115 IRLRNKTLTEDEIATILQSTLKGLEYLH----FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQL  175 (314)
T ss_dssp             HHHHTCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             HHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCCcCCCcCHHHEEECCCCCEEEeecccchhh
Confidence            8754556889999999999999999999    578999999999999999999999999998654

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.79  E-value=5.7e-20  Score=174.76  Aligned_cols=136  Identities=28%  Similarity=0.409  Sum_probs=101.5

Q ss_pred             hhccccccceeeeecc-CCcceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          340 ISLAGSFGSVYKGTIS-DGTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~-~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      ..+.|+||.||++... +|..||+|.+.... ....+.+.+|+.++.+++||||+++++++...+     ++|+++|+|.
T Consensus        22 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~  101 (303)
T 2vwi_A           22 VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVL  101 (303)
T ss_dssp             ECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHH
T ss_pred             eeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchH
Confidence            3478999999999854 68899999886543 233456788999999999999999999887664     6789999999


Q ss_pred             HHhhc-------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          413 KRLYS-------HNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       413 ~~l~~-------~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +++..       ....+++..+..++.++++||+|||    +.+|+||||||+||++++++.+||+|||+++.+
T Consensus       102 ~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  171 (303)
T 2vwi_A          102 DIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH----KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFL  171 (303)
T ss_dssp             HHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCSGGGEEECTTCCEEECCCHHHHHC
T ss_pred             HHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH----hCCCCCCCCChhhEEEcCCCCEEEEeccchhee
Confidence            98863       2345789999999999999999999    578999999999999999999999999998653

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.79  E-value=1.5e-19  Score=171.06  Aligned_cols=135  Identities=24%  Similarity=0.406  Sum_probs=113.1

Q ss_pred             hhccccccceeeeec---cCCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC----cccccCCC
Q 039957          340 ISLAGSFGSVYKGTI---SDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----FKFMPNGS  410 (481)
Q Consensus       340 l~~~g~~g~vy~~~l---~~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~~~~g~  410 (481)
                      ..+.|+||.||++..   ..+..||+|.+....  ....+.+.+|++++++++|+||+++++++....    ++|+++|+
T Consensus        24 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~  103 (291)
T 1xbb_A           24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGP  103 (291)
T ss_dssp             EEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTEE
T ss_pred             ccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECCCCcEEEEEeCCCCC
Confidence            347899999999954   246789999986543  223457889999999999999999999985443    57899999


Q ss_pred             hhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          411 LEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       411 l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      |.+++... ..+++.....++.++++||+|||    +.+|+||||||+||+++.++.+||+|||+++..
T Consensus       104 L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH----~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  167 (291)
T 1xbb_A          104 LNKYLQQN-RHVKDKNIIELVHQVSMGMKYLE----ESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL  167 (291)
T ss_dssp             HHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             HHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHH----hCCeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence            99998764 34788899999999999999999    578999999999999999999999999998765

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.79  E-value=1.8e-19  Score=168.47  Aligned_cols=136  Identities=26%  Similarity=0.482  Sum_probs=107.7

Q ss_pred             hhccccccceeeeeccCCcceEEEEEeccch----hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCC
Q 039957          340 ISLAGSFGSVYKGTISDGTDVAIKIFNLQRE----RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGS  410 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~~g~~vavK~l~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~  410 (481)
                      ..+.|+||.||++... |..+|+|.+.....    ...+.+.+|+.++++++|+||++++++|...+     +||+++|+
T Consensus        14 ~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   92 (271)
T 3dtc_A           14 IIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGP   92 (271)
T ss_dssp             EEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEE
T ss_pred             eeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCC
Confidence            3478999999999864 88899998765432    22456788999999999999999999998765     67899999


Q ss_pred             hhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCC--------CCcEEEccccCcccC
Q 039957          411 LEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDE--------NMVAHVSDFGISKLL  479 (481)
Q Consensus       411 l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~--------~~~~kl~Dfgl~~~~  479 (481)
                      |.+++..  ..+++.....++.++++|++|||... ..+|+||||||+||++++        ++.+||+|||+++..
T Consensus        93 L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~-~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~  166 (271)
T 3dtc_A           93 LNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEA-IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW  166 (271)
T ss_dssp             HHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHSS-SSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC----
T ss_pred             HHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC-CCceeecCCchHHEEEecccccccccCcceEEccCCccccc
Confidence            9998854  35788899999999999999999533 234999999999999986        778999999999754

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.79  E-value=4.4e-20  Score=180.92  Aligned_cols=135  Identities=11%  Similarity=0.072  Sum_probs=96.1

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccch---hhhhhhhHHHHHhhhh--ccCccceeecccC---------------
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRE---RAFRSFNSECEVLRNV--RHQNLIKILSSCS---------------  399 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l--~h~niv~l~~~~~---------------  399 (481)
                      -+.|+||.||+|... +|..||+|.+.....   ...+.+..|+.++..+  +|||+++++..+.               
T Consensus        70 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~~~  149 (371)
T 3q60_A           70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFA  149 (371)
T ss_dssp             EEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSCSSS
T ss_pred             ccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCCCee
Confidence            478999999999854 689999999977542   2344566775544444  6999887543221               


Q ss_pred             --------------CCCcccccCCChhHHhhcCCCccCHHHH------HHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCC
Q 039957          400 --------------TPDFKFMPNGSLEKRLYSHNYFLDILER------LNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTS  459 (481)
Q Consensus       400 --------------~~~~~~~~~g~l~~~l~~~~~~~~~~~~------~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~n  459 (481)
                                    ...+||++ |+|.+++.......++..+      ..++.+|++||+|||    +.+||||||||+|
T Consensus       150 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH----~~~ivHrDikp~N  224 (371)
T 3q60_A          150 QLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ----SKGLVHGHFTPDN  224 (371)
T ss_dssp             BCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHH----HTTEEETTCSGGG
T ss_pred             eccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHH----HCCCccCcCCHHH
Confidence                          00156888 9999998764333455556      788899999999999    5789999999999


Q ss_pred             eeeCCCCcEEEccccCcccCC
Q 039957          460 ILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       460 ill~~~~~~kl~Dfgl~~~~~  480 (481)
                      ||++.++.+||+|||+|+...
T Consensus       225 Ill~~~~~~kL~DFG~a~~~~  245 (371)
T 3q60_A          225 LFIMPDGRLMLGDVSALWKVG  245 (371)
T ss_dssp             EEECTTSCEEECCGGGEEETT
T ss_pred             EEECCCCCEEEEecceeeecC
Confidence            999999999999999998653

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.79  E-value=1.9e-19  Score=168.83  Aligned_cols=134  Identities=31%  Similarity=0.540  Sum_probs=115.3

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccch---hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRE---RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      .+.|+||.||++... +|..||+|.+.....   ...+.+.+|+..+++++|+||+++++++...+     ++|+++++|
T Consensus        19 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   98 (276)
T 2h6d_A           19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGEL   98 (276)
T ss_dssp             EEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBH
T ss_pred             ecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcH
Confidence            368999999999865 689999999865432   23446788999999999999999999987765     578999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+++... ..+++....+++.++++|++|||    +.+|+||||||+||+++.++.+||+|||+++..
T Consensus        99 ~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~  161 (276)
T 2h6d_A           99 FDYICKH-GRVEEMEARRLFQQILSAVDYCH----RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM  161 (276)
T ss_dssp             HHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH----HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred             HHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH----HCCCccCCCChhhEEECCCCCEEEeeccccccc
Confidence            9988653 34788899999999999999999    578999999999999999999999999998765

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.79  E-value=3.3e-19  Score=167.87  Aligned_cols=134  Identities=24%  Similarity=0.461  Sum_probs=113.5

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      .+.|+||.||++... +|..+|+|.+....  ....+.+.+|+.++++++|+||+++++++....     ++|+++|++.
T Consensus        14 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   93 (284)
T 3kk8_A           14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELF   93 (284)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred             hcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHH
Confidence            468999999999854 58899999986543  233456788999999999999999999987765     5789999998


Q ss_pred             HHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCc---EEEccccCcccC
Q 039957          413 KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMV---AHVSDFGISKLL  479 (481)
Q Consensus       413 ~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~---~kl~Dfgl~~~~  479 (481)
                      +.+... ..+++..+..++.++++|++|||    +.+|+||||||+||+++.++.   +||+|||+++..
T Consensus        94 ~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~  158 (284)
T 3kk8_A           94 EDIVAR-EFYSEADASHCIQQILESIAYCH----SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  158 (284)
T ss_dssp             HHHHHH-SSCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             HHHHhc-CCCCHHHHHHHHHHHHHHHHHHH----HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence            887653 35788899999999999999999    578999999999999987655   999999998654

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.79  E-value=2.8e-19  Score=170.15  Aligned_cols=133  Identities=30%  Similarity=0.413  Sum_probs=115.2

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccch-hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhH
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQRE-RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEK  413 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~  413 (481)
                      .+.|+||.||+|.. .+|..||+|.+..... ...+.+.+|+.++.+++|+||+++++++....     ++|+++|+|.+
T Consensus        30 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~  109 (303)
T 3a7i_A           30 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD  109 (303)
T ss_dssp             EEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHH
T ss_pred             hcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHH
Confidence            36899999999975 4688999999876542 33467888999999999999999999887654     67899999999


Q ss_pred             HhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          414 RLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       414 ~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ++..  ..+++..+..++.++++||+|||    +.+|+||||||+||++++++.+||+|||+++.+
T Consensus       110 ~~~~--~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~  169 (303)
T 3a7i_A          110 LLEP--GPLDETQIATILREILKGLDYLH----SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL  169 (303)
T ss_dssp             HHTT--SCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             HHhc--CCCCHHHHHHHHHHHHHHHHHHH----HCCCccCCCChheEEECCCCCEEEeecccceec
Confidence            8864  35788999999999999999999    578999999999999999999999999998754

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.79  E-value=1.5e-19  Score=178.74  Aligned_cols=131  Identities=23%  Similarity=0.341  Sum_probs=108.7

Q ss_pred             hhccccccceeeeecc-CCcceEEEEEeccchhhhhhhhHHHHHhhh-hccCccceeecccCC----C-----CcccccC
Q 039957          340 ISLAGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECEVLRN-VRHQNLIKILSSCST----P-----DFKFMPN  408 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~----~-----~~~~~~~  408 (481)
                      ..+.|+||.||++... +|..||+|.+...     ..+.+|+.++.+ .+|+||+++++++..    .     .+||+++
T Consensus        69 ~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~g  143 (400)
T 1nxk_A           69 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG  143 (400)
T ss_dssp             EEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred             eeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCC
Confidence            3478999999999854 5889999998632     345678887754 589999999987753    1     2679999


Q ss_pred             CChhHHhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCC---CCcEEEccccCcccC
Q 039957          409 GSLEKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDE---NMVAHVSDFGISKLL  479 (481)
Q Consensus       409 g~l~~~l~~~~-~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~---~~~~kl~Dfgl~~~~  479 (481)
                      |+|.+++.... ..+++.++..|+.+|++||+|||    +.+||||||||+|||++.   ++.+||+|||+|+..
T Consensus       144 g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~  214 (400)
T 1nxk_A          144 GELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH----SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET  214 (400)
T ss_dssp             EEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----HCCccccCcCcceEEEecCCCCccEEEEeccccccc
Confidence            99999998643 45889999999999999999999    578999999999999998   789999999999864

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.79  E-value=2.6e-19  Score=168.69  Aligned_cols=134  Identities=25%  Similarity=0.406  Sum_probs=114.2

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccch---hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRE---RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      .+.|+||.||++... ++..||+|.+.....   .....+.+|+.++++++|+||+++++++...+     +||+++|+|
T Consensus        22 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L  101 (284)
T 2vgo_A           22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGEL  101 (284)
T ss_dssp             EEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEH
T ss_pred             ecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcH
Confidence            368999999999865 578899999865432   22356788999999999999999999987765     578899999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+++... ..+++.....++.++++|++|||    +.+|+||||||+||+++.++.+||+|||+++..
T Consensus       102 ~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~  164 (284)
T 2vgo_A          102 YKELQKH-GRFDEQRSATFMEELADALHYCH----ERKVIHRDIKPENLLMGYKGELKIADFGWSVHA  164 (284)
T ss_dssp             HHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH----HCCceecCCCHHHEEEcCCCCEEEecccccccC
Confidence            9988753 34788899999999999999999    678999999999999999999999999998653

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.79  E-value=2.4e-19  Score=174.40  Aligned_cols=134  Identities=25%  Similarity=0.426  Sum_probs=112.2

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccch--hhhhhhhHHHHHhhhhccCccceeecccCCCC-------------cc
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQRE--RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-------------FK  404 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-------------~~  404 (481)
                      .+.|+||.||++.. .+|..||+|.+.....  .....+.+|+.++++++|+||++++++|....             ++
T Consensus        25 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e  104 (351)
T 3mi9_A           25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFD  104 (351)
T ss_dssp             CSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEE
T ss_pred             EecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEe
Confidence            37899999999986 5689999998865432  22345678999999999999999999876531             45


Q ss_pred             cccCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          405 FMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       405 ~~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      |++ |++.+.+......+++.++..++.++++||+|||    +.+|+||||||+||++++++.+||+|||+|+.+
T Consensus       105 ~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH----~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~  174 (351)
T 3mi9_A          105 FCE-HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH----RNKILHRDMKAANVLITRDGVLKLADFGLARAF  174 (351)
T ss_dssp             CCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             ccC-CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH----HCCeeCCCCCHHHEEEcCCCCEEEccchhcccc
Confidence            776 5777777766567889999999999999999999    578999999999999999999999999999754

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.79  E-value=1.4e-19  Score=170.03  Aligned_cols=139  Identities=24%  Similarity=0.406  Sum_probs=112.1

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCC--C-----cccccCCC
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTP--D-----FKFMPNGS  410 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~-----~~~~~~g~  410 (481)
                      .+.|+||.||++... +|..+++|.+....  ....+.+.+|+.++++++|+||+++++++...  .     +||+++|+
T Consensus        14 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~   93 (279)
T 2w5a_A           14 IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGD   93 (279)
T ss_dssp             EEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEE
T ss_pred             ccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCC
Confidence            368999999999864 68899999987543  23345688899999999999999999977432  2     67899999


Q ss_pred             hhHHhhc---CCCccCHHHHHHHHHHHHHHHHHHhcCC-CCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          411 LEKRLYS---HNYFLDILERLNIMIDVGSTLEYLHHGH-SSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       411 l~~~l~~---~~~~~~~~~~~~i~~~ia~~l~~lH~~~-~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      |.+++..   ....+++..+.+++.++++||+|||... ...+|+||||||+||++++++.+||+|||+++..
T Consensus        94 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~  166 (279)
T 2w5a_A           94 LASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL  166 (279)
T ss_dssp             HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC
T ss_pred             HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheee
Confidence            9998865   2344889999999999999999999421 0122999999999999999999999999998754

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.79  E-value=1.8e-19  Score=175.82  Aligned_cols=134  Identities=25%  Similarity=0.303  Sum_probs=114.6

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhH
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEK  413 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~  413 (481)
                      .+.|+||.||++... +|..+|+|.+.... ....+.+.+|+.++.+++|+||+++++++...+     ++|+++|+|.+
T Consensus        41 lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~  120 (360)
T 3eqc_A           41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ  120 (360)
T ss_dssp             EEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHH
T ss_pred             ecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHH
Confidence            368999999999865 68899999987653 333457889999999999999999999887664     67999999999


Q ss_pred             HhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          414 RLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       414 ~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      ++... ..+++....+++.++++|++|||+   ..+|+||||||+||+++.++.+||+|||+++.
T Consensus       121 ~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  181 (360)
T 3eqc_A          121 VLKKA-GRIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ  181 (360)
T ss_dssp             HHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred             HHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCcc
Confidence            98753 347788899999999999999994   13799999999999999999999999999864

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.79  E-value=2.7e-19  Score=182.08  Aligned_cols=134  Identities=25%  Similarity=0.394  Sum_probs=109.7

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      .+.|+||.||++... ++..+|+|.+....  ......+.+|+.++++++||||++++++|....     +||+++|+|.
T Consensus        45 lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~  124 (494)
T 3lij_A           45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELF  124 (494)
T ss_dssp             EECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHH
T ss_pred             EecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHH
Confidence            478999999999864 68889999987543  223456788999999999999999999998765     6799999999


Q ss_pred             HHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCC---CCcEEEccccCcccC
Q 039957          413 KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDE---NMVAHVSDFGISKLL  479 (481)
Q Consensus       413 ~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~---~~~~kl~Dfgl~~~~  479 (481)
                      +.+... ..+++..+..|+.+|++||+|||    +.+||||||||+|||++.   ++.+||+|||+|+.+
T Consensus       125 ~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~  189 (494)
T 3lij_A          125 DEIIHR-MKFNEVDAAVIIKQVLSGVTYLH----KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF  189 (494)
T ss_dssp             HHHHHH-SSCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             HHHHHc-CCCCHHHHHHHHHHHHHHHHHHH----HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence            887643 35788899999999999999999    578999999999999976   456999999998764

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.79  E-value=3.6e-19  Score=168.22  Aligned_cols=135  Identities=25%  Similarity=0.385  Sum_probs=112.5

Q ss_pred             hhccccccceeeeecc-CCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCC---------Cccccc
Q 039957          340 ISLAGSFGSVYKGTIS-DGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTP---------DFKFMP  407 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---------~~~~~~  407 (481)
                      .-+.|+||.||+|... ++..||+|.+....  ....+.+.+|+.++++++|+||+++++++...         .++|++
T Consensus        33 ~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~  112 (290)
T 1t4h_A           33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMT  112 (290)
T ss_dssp             EEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCC
T ss_pred             eccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecC
Confidence            3478999999999864 57889999886543  23345688899999999999999999877532         157899


Q ss_pred             CCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCC--eeeCCCCCCCeeeC-CCCcEEEccccCcccC
Q 039957          408 NGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAP--IIHCDLKPTSILLD-ENMVAHVSDFGISKLL  479 (481)
Q Consensus       408 ~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~--i~H~dlk~~nill~-~~~~~kl~Dfgl~~~~  479 (481)
                      +|+|.+++... ..+++..+..++.++++||+|||    +.+  |+||||||+||+++ +++.+||+|||+++..
T Consensus       113 ~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH----~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~  182 (290)
T 1t4h_A          113 SGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLH----TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             SCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH----TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             CCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHH----cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence            99999998753 34788899999999999999999    455  99999999999998 7899999999998754

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.79  E-value=4.4e-19  Score=168.27  Aligned_cols=134  Identities=30%  Similarity=0.388  Sum_probs=114.5

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccch---------hhhhhhhHHHHHhhhhc-cCccceeecccCCCC-----cc
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRE---------RAFRSFNSECEVLRNVR-HQNLIKILSSCSTPD-----FK  404 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~---------~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-----~~  404 (481)
                      .+.|++|.||++... +|..||+|.+.....         ...+.+.+|++++.+++ ||||+++++++....     +|
T Consensus        25 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  104 (298)
T 1phk_A           25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFD  104 (298)
T ss_dssp             EEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEe
Confidence            368999999999864 688999999875431         22345778999999996 999999999987765     57


Q ss_pred             cccCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          405 FMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       405 ~~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      |+++|+|.+++... ..+++..+..++.++++||+|||    +.+|+||||||+||++++++.+||+|||+++.+
T Consensus       105 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  174 (298)
T 1phk_A          105 LMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALH----KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL  174 (298)
T ss_dssp             CCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             ccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence            89999999998753 35788899999999999999999    578999999999999999999999999998764

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.78  E-value=2.3e-19  Score=182.16  Aligned_cols=135  Identities=25%  Similarity=0.415  Sum_probs=115.3

Q ss_pred             hhccccccceeeeecc-CCcceEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCC
Q 039957          340 ISLAGSFGSVYKGTIS-DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGS  410 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~  410 (481)
                      ..+.|+||.||++... +|..||||.+....   ......+.+|+.++++++||||+++++++....     ++|+++|+
T Consensus        33 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~  112 (484)
T 3nyv_A           33 VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGE  112 (484)
T ss_dssp             EEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             EEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCC
Confidence            3478999999999864 68999999986543   233456888999999999999999999998765     57889999


Q ss_pred             hhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeee---CCCCcEEEccccCcccC
Q 039957          411 LEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILL---DENMVAHVSDFGISKLL  479 (481)
Q Consensus       411 l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill---~~~~~~kl~Dfgl~~~~  479 (481)
                      |.+++... ..+++..+..++.+|++||+|||    +.+|+||||||+|||+   +.++.+||+|||+|+.+
T Consensus       113 L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  179 (484)
T 3nyv_A          113 LFDEIISR-KRFSEVDAARIIRQVLSGITYMH----KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF  179 (484)
T ss_dssp             HHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred             HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence            99988754 45788899999999999999999    5789999999999999   46789999999998754

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.78  E-value=3.9e-19  Score=171.90  Aligned_cols=130  Identities=26%  Similarity=0.451  Sum_probs=109.3

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccchhhhhhhhHHHHHhhhh-ccCccceeecccCCCC-----cccccCCChhH
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD-----FKFMPNGSLEK  413 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----~~~~~~g~l~~  413 (481)
                      .+.|+||.||++... +|..+|+|.+....    ....+|++++.++ +||||+++++++...+     +||+++|+|.+
T Consensus        30 lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~  105 (342)
T 2qr7_A           30 IGVGSYSVCKRCIHKATNMEFAVKIIDKSK----RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLD  105 (342)
T ss_dssp             EEECSSEEEEEEEETTTTEEEEEEEEETTT----CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHH
T ss_pred             EeeCCCEEEEEEEECCCCCEEEEEEEEccc----CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHH
Confidence            478999999999864 68899999986543    2345688888887 7999999999988765     67899999999


Q ss_pred             HhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCC-C---CcEEEccccCcccC
Q 039957          414 RLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDE-N---MVAHVSDFGISKLL  479 (481)
Q Consensus       414 ~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~-~---~~~kl~Dfgl~~~~  479 (481)
                      ++... ..+++.+...++.+|++||+|||    +.+|+||||||+|||+.+ +   +.+||+|||+|+.+
T Consensus       106 ~i~~~-~~~~~~~~~~~~~qi~~al~~lH----~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~  170 (342)
T 2qr7_A          106 KILRQ-KFFSEREASAVLFTITKTVEYLH----AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL  170 (342)
T ss_dssp             HHHTC-TTCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred             HHHHc-CCCCHHHHHHHHHHHHHHHHHHH----HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence            88754 45788899999999999999999    578999999999999844 3   35999999999864

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.78  E-value=2.2e-19  Score=172.77  Aligned_cols=134  Identities=26%  Similarity=0.421  Sum_probs=110.0

Q ss_pred             hccccccceeeeec------cCCcceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccC
Q 039957          341 SLAGSFGSVYKGTI------SDGTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPN  408 (481)
Q Consensus       341 ~~~g~~g~vy~~~l------~~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~  408 (481)
                      .+.|+||.||+|..      .++..||+|.+.... ......+.+|+.++++++|+||+++++++....     ++|+++
T Consensus        38 lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  117 (327)
T 2yfx_A           38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAG  117 (327)
T ss_dssp             CC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred             EcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCC
Confidence            47899999999974      246789999986432 334456888999999999999999999988764     578999


Q ss_pred             CChhHHhhcCC------CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCC---CCcEEEccccCccc
Q 039957          409 GSLEKRLYSHN------YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDE---NMVAHVSDFGISKL  478 (481)
Q Consensus       409 g~l~~~l~~~~------~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~---~~~~kl~Dfgl~~~  478 (481)
                      |+|.+++....      ..+++..+.+++.++++||+|||    +.+|+||||||+||+++.   +..+||+|||+++.
T Consensus       118 ~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH----~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~  192 (327)
T 2yfx_A          118 GDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE----ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD  192 (327)
T ss_dssp             EEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHH
T ss_pred             CcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh----hCCeecCcCCHhHEEEecCCCcceEEECccccccc
Confidence            99999987643      34788999999999999999999    578999999999999984   45699999999863

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.78  E-value=3.4e-19  Score=170.72  Aligned_cols=132  Identities=25%  Similarity=0.416  Sum_probs=107.2

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCC--------------C---
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTP--------------D---  402 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------------~---  402 (481)
                      .+.|+||.||++... +|..||+|.+........+.+.+|+.++++++|+||+++++++...              .   
T Consensus        19 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~   98 (320)
T 2i6l_A           19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVY   98 (320)
T ss_dssp             CC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEE
T ss_pred             eccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCcee
Confidence            468999999999865 4889999998776656667788999999999999999999876321              1   


Q ss_pred             --cccccCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeC-CCCcEEEccccCcccC
Q 039957          403 --FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLD-ENMVAHVSDFGISKLL  479 (481)
Q Consensus       403 --~~~~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~-~~~~~kl~Dfgl~~~~  479 (481)
                        ++|++ |+|.+++..  ..+++.....++.++++||+|||    +.+|+||||||+||+++ +++.+||+|||+++..
T Consensus        99 lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~  171 (320)
T 2i6l_A           99 IVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIH----SANVLHRDLKPANLFINTEDLVLKIGDFGLARIM  171 (320)
T ss_dssp             EEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC
T ss_pred             EEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEEcCCCCeEEEccCcccccc
Confidence              46776 699988864  34778889999999999999999    57899999999999997 5689999999999865

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.78  E-value=3e-19  Score=172.17  Aligned_cols=134  Identities=29%  Similarity=0.436  Sum_probs=111.9

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccch--hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRE--RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      .+.|+||.||++... +|..||+|.+.....  ...+.+.+|+.++.+++|+||++++++|...+     ++|++++++.
T Consensus        33 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~  112 (331)
T 4aaa_A           33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILD  112 (331)
T ss_dssp             GGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHH
T ss_pred             EeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHH
Confidence            478999999999865 588999998865432  22345778999999999999999999987665     5788988888


Q ss_pred             HHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          413 KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       413 ~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ++... ...+++..+..++.++++||+|||    +.+|+||||||+||+++.++.+||+|||+++.+
T Consensus       113 ~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH----~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  174 (331)
T 4aaa_A          113 DLELF-PNGLDYQVVQKYLFQIINGIGFCH----SHNIIHRDIKPENILVSQSGVVKLCDFGFARTL  174 (331)
T ss_dssp             HHHHS-TTCCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred             HHHhh-ccCCCHHHHHHHHHHHHHHHHHHH----HCCEEccCcChheEEEcCCCcEEEEeCCCceee
Confidence            77553 345788999999999999999999    578999999999999999999999999999754

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.78  E-value=4.6e-19  Score=172.96  Aligned_cols=133  Identities=26%  Similarity=0.360  Sum_probs=111.4

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccchhhhhhhhHHHHHhhhhc-----cCccceeecccCCCC-----cccccCC
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVR-----HQNLIKILSSCSTPD-----FKFMPNG  409 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-----h~niv~l~~~~~~~~-----~~~~~~g  409 (481)
                      .+.|+||.||++.. .+|..||+|.+... ....+.+..|+.++.+++     |+||+++++++...+     ++|+ +|
T Consensus        43 lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~  120 (360)
T 3llt_A           43 MGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GP  120 (360)
T ss_dssp             EEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-CC
T ss_pred             EcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-CC
Confidence            37899999999986 46889999998643 233345677888888886     999999999887665     5678 89


Q ss_pred             ChhHHhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCC------------------------
Q 039957          410 SLEKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDE------------------------  464 (481)
Q Consensus       410 ~l~~~l~~~~-~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~------------------------  464 (481)
                      +|.+++.... ..+++.....++.+|++||+|||    +.+||||||||+|||+++                        
T Consensus       121 ~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (360)
T 3llt_A          121 SLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR----KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRT  196 (360)
T ss_dssp             BHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEE
T ss_pred             CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCCcccEEEccccccccccchhccccccccccccc
Confidence            9999987643 34788899999999999999999    678999999999999986                        


Q ss_pred             -CCcEEEccccCcccC
Q 039957          465 -NMVAHVSDFGISKLL  479 (481)
Q Consensus       465 -~~~~kl~Dfgl~~~~  479 (481)
                       ++.+||+|||+|+..
T Consensus       197 ~~~~~kl~DFG~a~~~  212 (360)
T 3llt_A          197 KSTGIKLIDFGCATFK  212 (360)
T ss_dssp             SCCCEEECCCTTCEET
T ss_pred             CCCCEEEEeccCceec
Confidence             789999999999754

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.78  E-value=1.9e-19  Score=175.91  Aligned_cols=132  Identities=25%  Similarity=0.365  Sum_probs=97.3

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----------cccc
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----------FKFM  406 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----------~~~~  406 (481)
                      .+.|+||.||+|.. .+|..||+|++....  ......+.+|+.++++++|+||+++++++....           ++|+
T Consensus        37 lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~  116 (367)
T 2fst_X           37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM  116 (367)
T ss_dssp             CC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC
T ss_pred             EeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc
Confidence            47899999999974 468999999986432  233456778999999999999999999886531           2344


Q ss_pred             cCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          407 PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       407 ~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                       +++|.+++..  ..+++..+..++.+|++||+|||    +.+|+||||||+||++++++.+||+|||+|+..
T Consensus       117 -~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH----~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~  182 (367)
T 2fst_X          117 -GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHT  182 (367)
T ss_dssp             -CEECC-------CCCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred             -CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence             6888887754  35788999999999999999999    578999999999999999999999999999764

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.78  E-value=5e-19  Score=170.52  Aligned_cols=128  Identities=22%  Similarity=0.427  Sum_probs=110.0

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccchhhhhhhhHHHHHhhhhc-cCccceeecccCCCC-------cccccCCCh
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVR-HQNLIKILSSCSTPD-------FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-------~~~~~~g~l  411 (481)
                      .+.|+||.||++.. .+|..||+|.+....   .+.+.+|+.++.+++ |+||+++++++....       ++|++++++
T Consensus        44 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l  120 (330)
T 3nsz_A           44 LGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF  120 (330)
T ss_dssp             EEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCH
T ss_pred             ecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhH
Confidence            47899999999974 568999999986432   346788999999997 999999999887632       678999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCC-cEEEccccCcccC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENM-VAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~-~~kl~Dfgl~~~~  479 (481)
                      .+++..    ++..++..++.++++||+|||    +.+|+||||||+|||++.++ .+||+|||+|+..
T Consensus       121 ~~~~~~----~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~  181 (330)
T 3nsz_A          121 KQLYQT----LTDYDIRFYMYEILKALDYCH----SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY  181 (330)
T ss_dssp             HHHGGG----CCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             HHHHHh----CCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence            988753    677888999999999999999    57899999999999999776 8999999999764

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.78  E-value=3.2e-19  Score=181.19  Aligned_cols=135  Identities=26%  Similarity=0.416  Sum_probs=114.4

Q ss_pred             hhccccccceeeeecc-CCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          340 ISLAGSFGSVYKGTIS-DGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      ..+.|+||.||++... +|..||+|.+....  ......+.+|+.++++++||||+++++++....     ++|+++|+|
T Consensus        29 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L  108 (486)
T 3mwu_A           29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL  108 (486)
T ss_dssp             EEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred             EEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcH
Confidence            3478999999999854 68899999986532  223456788999999999999999999998765     578999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeC---CCCcEEEccccCcccC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLD---ENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~---~~~~~kl~Dfgl~~~~  479 (481)
                      .+.+... ..+++..+..++.+|++||+|||    +.+||||||||+|||++   .++.+||+|||+|+.+
T Consensus       109 ~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH----~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  174 (486)
T 3mwu_A          109 FDEIIKR-KRFSEHDAARIIKQVFSGITYMH----KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (486)
T ss_dssp             HHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH----HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence            9887653 35788899999999999999999    57899999999999995   4678999999999865

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.78  E-value=2.2e-19  Score=171.36  Aligned_cols=134  Identities=22%  Similarity=0.282  Sum_probs=112.3

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccch---hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRE---RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      .+.|+||.||++... ++..||+|.+.....   ...+.+.+|+.++.+++|+||+++++++...+     +||+++++|
T Consensus        42 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L  121 (309)
T 2h34_A           42 VGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDL  121 (309)
T ss_dssp             EEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEH
T ss_pred             EcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCH
Confidence            478999999999864 688999999865432   22356888999999999999999999987654     578899999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+++... ..+++.++..++.++++||+|||    +.+|+||||||+||+++.++.+||+|||+++..
T Consensus       122 ~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~  184 (309)
T 2h34_A          122 AAMLRRQ-GPLAPPRAVAIVRQIGSALDAAH----AAGATHRDVKPENILVSADDFAYLVDFGIASAT  184 (309)
T ss_dssp             HHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH----HCcCCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence            9988753 35788999999999999999999    578999999999999999999999999998754

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.78  E-value=4.7e-19  Score=174.37  Aligned_cols=130  Identities=26%  Similarity=0.367  Sum_probs=106.2

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCC------------------
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTP------------------  401 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------------------  401 (481)
                      .+.|+||.||++.. .+|..||+|++....    ....+|++++++++|+||+++++++...                  
T Consensus        15 lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~   90 (383)
T 3eb0_A           15 LGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLG   90 (383)
T ss_dssp             EECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC------------------
T ss_pred             EEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCccccccccccccccccc
Confidence            47899999999975 578999999886432    2345799999999999999999987321                  


Q ss_pred             -------------------------CcccccCCChhHHhhc---CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeC
Q 039957          402 -------------------------DFKFMPNGSLEKRLYS---HNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHC  453 (481)
Q Consensus       402 -------------------------~~~~~~~g~l~~~l~~---~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~  453 (481)
                                               .+||++ |+|.+.+..   ....+++.....++.++++||+|||    +.+|+||
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~gi~H~  165 (383)
T 3eb0_A           91 GKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH----SLGICHR  165 (383)
T ss_dssp             -------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH----TTTEECS
T ss_pred             ccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCcCccC
Confidence                                     146777 577766653   4456888999999999999999999    6789999


Q ss_pred             CCCCCCeeeC-CCCcEEEccccCcccC
Q 039957          454 DLKPTSILLD-ENMVAHVSDFGISKLL  479 (481)
Q Consensus       454 dlk~~nill~-~~~~~kl~Dfgl~~~~  479 (481)
                      ||||+||+++ +++.+||+|||+|+.+
T Consensus       166 Dikp~Nil~~~~~~~~kl~Dfg~a~~~  192 (383)
T 3eb0_A          166 DIKPQNLLVNSKDNTLKLCDFGSAKKL  192 (383)
T ss_dssp             CCCGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             ccCHHHEEEcCCCCcEEEEECCCCccc
Confidence            9999999998 6899999999999864

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.78  E-value=2e-19  Score=174.50  Aligned_cols=134  Identities=18%  Similarity=0.197  Sum_probs=104.8

Q ss_pred             hhccccccceeeeecc----CCcceEEEEEeccchh-----------hhhhhhHHHHHhhhhccCccceeecccCC----
Q 039957          340 ISLAGSFGSVYKGTIS----DGTDVAIKIFNLQRER-----------AFRSFNSECEVLRNVRHQNLIKILSSCST----  400 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~----~g~~vavK~l~~~~~~-----------~~~~~~~e~~~l~~l~h~niv~l~~~~~~----  400 (481)
                      ..++|+||.||+|...    .+..+|+|........           ....+.+|+..+..++|+||+++++++..    
T Consensus        44 ~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~  123 (345)
T 2v62_A           44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKG  123 (345)
T ss_dssp             EC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEESSS
T ss_pred             eEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccccccCC
Confidence            3468999999999865    5678999988654321           11235567788889999999999998865    


Q ss_pred             CC-----cccccCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCC--cEEEccc
Q 039957          401 PD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENM--VAHVSDF  473 (481)
Q Consensus       401 ~~-----~~~~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~--~~kl~Df  473 (481)
                      ..     +||+ +|+|.+++.... .+++.++.+|+.+|++||+|||    +.+|+||||||+||+++.++  .+||+||
T Consensus       124 ~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~~~kL~Df  197 (345)
T 2v62_A          124 RSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIH----ENEYVHGDIKAANLLLGYKNPDQVYLADY  197 (345)
T ss_dssp             CEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEESSSTTSEEECCC
T ss_pred             CcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCcCHHHEEEccCCCCcEEEEeC
Confidence            22     5788 999999987544 6889999999999999999999    57899999999999999877  9999999


Q ss_pred             cCcccC
Q 039957          474 GISKLL  479 (481)
Q Consensus       474 gl~~~~  479 (481)
                      |+|+.+
T Consensus       198 g~a~~~  203 (345)
T 2v62_A          198 GLSYRY  203 (345)
T ss_dssp             TTCEES
T ss_pred             CCceec
Confidence            999754

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.78  E-value=5.2e-19  Score=170.16  Aligned_cols=135  Identities=21%  Similarity=0.319  Sum_probs=114.3

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccch--hhhhhhhHHHHHhhhhc-cCccceeecccCCCC-----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRE--RAFRSFNSECEVLRNVR-HQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      .+.|+||.||++... +|..||+|.+.....  .....+.+|+.++.+++ |+||+++++++....     +||+++|+|
T Consensus        37 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L  116 (327)
T 3lm5_A           37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEI  116 (327)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEG
T ss_pred             eCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcH
Confidence            478999999999854 689999999875432  22456788999999885 699999999987765     678999999


Q ss_pred             hHHhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCC---CCcEEEccccCcccC
Q 039957          412 EKRLYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDE---NMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~-~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~---~~~~kl~Dfgl~~~~  479 (481)
                      .+++... ...+++.++..++.++++||+|||    +.+|+||||||+||+++.   ++.+||+|||+|+..
T Consensus       117 ~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH----~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~  184 (327)
T 3lm5_A          117 FSLCLPELAEMVSENDVIRLIKQILEGVYYLH----QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI  184 (327)
T ss_dssp             GGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC
T ss_pred             HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----HCCeecCcCChHHEEEecCCCCCcEEEeeCcccccc
Confidence            9987643 356889999999999999999999    578999999999999998   789999999999764

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.78  E-value=4.8e-19  Score=180.65  Aligned_cols=135  Identities=26%  Similarity=0.429  Sum_probs=111.7

Q ss_pred             hhccccccceeeeecc-CCcceEEEEEeccch-------------hhhhhhhHHHHHhhhhccCccceeecccCCCC---
Q 039957          340 ISLAGSFGSVYKGTIS-DGTDVAIKIFNLQRE-------------RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD---  402 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---  402 (481)
                      ..+.|+||.||++... ++..+|+|.+.....             ...+.+.+|+.++++++||||++++++|....   
T Consensus        43 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  122 (504)
T 3q5i_A           43 KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFY  122 (504)
T ss_dssp             EEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             EecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence            3478999999999865 578899999865431             22356788999999999999999999998765   


Q ss_pred             --cccccCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCC---cEEEccccCcc
Q 039957          403 --FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENM---VAHVSDFGISK  477 (481)
Q Consensus       403 --~~~~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~---~~kl~Dfgl~~  477 (481)
                        +||+++|+|.+++... ..+++..+..|+.+|+.||+|||    +.+|+||||||+|||++.++   .+||+|||+|+
T Consensus       123 lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  197 (504)
T 3q5i_A          123 LVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLH----KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSS  197 (504)
T ss_dssp             EEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEESSTTCCSSEEECCCTTCE
T ss_pred             EEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH----HCCeEeCCCcHHHEEEecCCCCccEEEEECCCCE
Confidence              6789999999988653 35788999999999999999999    57899999999999998765   79999999997


Q ss_pred             cC
Q 039957          478 LL  479 (481)
Q Consensus       478 ~~  479 (481)
                      .+
T Consensus       198 ~~  199 (504)
T 3q5i_A          198 FF  199 (504)
T ss_dssp             EC
T ss_pred             Ec
Confidence            65

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.78  E-value=2.4e-19  Score=171.88  Aligned_cols=133  Identities=27%  Similarity=0.528  Sum_probs=111.0

Q ss_pred             hhccccccceeeeeccCCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          340 ISLAGSFGSVYKGTISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      ..+.|+||.||+|...  ..+++|.+....  ....+.+.+|+.++.+++|+||+++++++...+     ++|+++|+|.
T Consensus        40 ~lg~G~~g~V~~~~~~--~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~  117 (319)
T 2y4i_B           40 LIGKGRFGQVYHGRWH--GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLY  117 (319)
T ss_dssp             BCCCSSSSEEEEEEES--SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHH
T ss_pred             EeccCCceEEEEEEEc--CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHH
Confidence            3478999999999864  359999886543  233456788999999999999999999988765     5789999999


Q ss_pred             HHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          413 KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       413 ~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +++......+++..+.+++.++++||+|||    +.+|+||||||+||+++ ++.+||+|||+++..
T Consensus       118 ~~l~~~~~~~~~~~~~~i~~qi~~al~~lH----~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~  179 (319)
T 2y4i_B          118 SVVRDAKIVLDVNKTRQIAQEIVKGMGYLH----AKGILHKDLKSKNVFYD-NGKVVITDFGLFSIS  179 (319)
T ss_dssp             HHTTSSCCCCCSHHHHHHHHHHHHHHHHHH----HTTCCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence            999876667888999999999999999999    57899999999999998 689999999997654

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.78  E-value=1.5e-19  Score=175.81  Aligned_cols=130  Identities=13%  Similarity=0.203  Sum_probs=106.9

Q ss_pred             hhccccccceeeeecc---------CCcceEEEEEeccchhhhhhhhHHHHHhhhhccCcccee---------------e
Q 039957          340 ISLAGSFGSVYKGTIS---------DGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKI---------------L  395 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~---------~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l---------------~  395 (481)
                      ..+.|+||.||+|...         ++..||+|.+...     +.+.+|+.++.+++|+|++++               +
T Consensus        49 ~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~  123 (352)
T 2jii_A           49 FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCM  123 (352)
T ss_dssp             EEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCC
T ss_pred             EecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCccCccchh
Confidence            3478999999999865         3789999998643     467889999999999999984               3


Q ss_pred             cccCC-CC-----cccccCCChhHHhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCC--
Q 039957          396 SSCST-PD-----FKFMPNGSLEKRLYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENM--  466 (481)
Q Consensus       396 ~~~~~-~~-----~~~~~~g~l~~~l~~~-~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~--  466 (481)
                      +++.. ..     +||+ +|+|.+++... ...+++..+.+|+.+|++||+|||    +.+|+||||||+||++++++  
T Consensus       124 ~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dikp~NIl~~~~~~~  198 (352)
T 2jii_A          124 GFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH----ENEYVHGNVTAENIFVDPEDQS  198 (352)
T ss_dssp             EEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH----HTTCBCSCCCGGGEEEETTEEE
T ss_pred             hccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH----hCCccCCCCCHHHEEEcCCCCc
Confidence            34332 22     5788 99999998764 356889999999999999999999    57899999999999999998  


Q ss_pred             cEEEccccCcccC
Q 039957          467 VAHVSDFGISKLL  479 (481)
Q Consensus       467 ~~kl~Dfgl~~~~  479 (481)
                      .+||+|||+|+.+
T Consensus       199 ~~kl~Dfg~a~~~  211 (352)
T 2jii_A          199 QVTLAGYGFAFRY  211 (352)
T ss_dssp             EEEECCGGGCBCS
T ss_pred             eEEEecCcceeec
Confidence            9999999999764

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.78  E-value=5.5e-19  Score=172.68  Aligned_cols=132  Identities=27%  Similarity=0.381  Sum_probs=110.9

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC----------cccccC
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----------FKFMPN  408 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----------~~~~~~  408 (481)
                      .+.|+||.||++... ++..||+|.+.... ......+.+|+.++.+++|+||+++++++....          ++|+. 
T Consensus        35 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-  113 (364)
T 3qyz_A           35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-  113 (364)
T ss_dssp             EEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS-
T ss_pred             eecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccC-
Confidence            478999999999754 67889999987533 233456788999999999999999999886543          34555 


Q ss_pred             CChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          409 GSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       409 g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      |+|.+++...  .+++..+..++.++++||+|||    +.+|+||||||+||+++.++.+||+|||+|+..
T Consensus       114 ~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~  178 (364)
T 3qyz_A          114 TDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA  178 (364)
T ss_dssp             EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             cCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence            6898887653  4788899999999999999999    578999999999999999999999999999764

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.78  E-value=7e-19  Score=171.15  Aligned_cols=133  Identities=24%  Similarity=0.374  Sum_probs=111.5

Q ss_pred             hhccccccceeeeecc-CCcceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC----------ccccc
Q 039957          340 ISLAGSFGSVYKGTIS-DGTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----------FKFMP  407 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~-~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----------~~~~~  407 (481)
                      ..+.|+||.||+|... +|..||+|.+.... ......+.+|+.++++++|+||+++++++....          ++|+.
T Consensus        18 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~   97 (353)
T 2b9h_A           18 LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ   97 (353)
T ss_dssp             EEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS
T ss_pred             EEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccC
Confidence            3478999999999864 68899999986533 233456778999999999999999999876542          45665


Q ss_pred             CCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          408 NGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       408 ~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                       |+|.+++...  .+++..+..++.++++||+|||    +.+|+||||||+||+++.++.+||+|||+|+.+
T Consensus        98 -~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH----~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (353)
T 2b9h_A           98 -TDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLH----GSNVIHRDLKPSNLLINSNCDLKVCDFGLARII  162 (353)
T ss_dssp             -EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             -ccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence             6888887653  5788899999999999999999    578999999999999999999999999999764

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.78  E-value=2.2e-19  Score=172.95  Aligned_cols=133  Identities=26%  Similarity=0.424  Sum_probs=107.5

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccch--hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQRE--RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      .+.|+||.||++.. .+|..||+|.+.....  .....+.+|+.++++++|+||+++++++....     +||++ |+|.
T Consensus        42 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~L~  120 (329)
T 3gbz_A           42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLK  120 (329)
T ss_dssp             EEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS-EEHH
T ss_pred             EEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC-CCHH
Confidence            37899999999974 4688999999865432  23456778999999999999999999987765     56777 5999


Q ss_pred             HHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeee-----CCCCcEEEccccCcccC
Q 039957          413 KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILL-----DENMVAHVSDFGISKLL  479 (481)
Q Consensus       413 ~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill-----~~~~~~kl~Dfgl~~~~  479 (481)
                      +++.... .+++..+..|+.+|++||+|||    +.+|+||||||+|||+     ++++.+||+|||+|+.+
T Consensus       121 ~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH----~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~  187 (329)
T 3gbz_A          121 KYMDKNP-DVSMRVIKSFLYQLINGVNFCH----SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF  187 (329)
T ss_dssp             HHHHHCT-TCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred             HHHhhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence            8887543 4788899999999999999999    5789999999999999     45667999999998653

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.78  E-value=3.8e-19  Score=168.49  Aligned_cols=134  Identities=26%  Similarity=0.410  Sum_probs=110.9

Q ss_pred             hhhccccccceeeeec-cCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCC-C-----cccccCCCh
Q 039957          339 TISLAGSFGSVYKGTI-SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTP-D-----FKFMPNGSL  411 (481)
Q Consensus       339 ~l~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~-----~~~~~~g~l  411 (481)
                      ..-++|+||.||++.. .+|..||+|......  ....+..|+.++.+++|++++..++.|... +     ++|+ +|+|
T Consensus        15 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L   91 (296)
T 4hgt_A           15 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSL   91 (296)
T ss_dssp             EEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred             eeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCH
Confidence            3447899999999985 568899999865432  234578899999999999888777766432 2     5688 9999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeee---CCCCcEEEccccCcccC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILL---DENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill---~~~~~~kl~Dfgl~~~~  479 (481)
                      .+++......+++..+..++.++++||+|||    +.+|+||||||+||++   ++++.+||+|||+|+..
T Consensus        92 ~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH----~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~  158 (296)
T 4hgt_A           92 EDLFNFCSRKFSLKTVLLLADQMISRIEYIH----SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             HHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence            9998865667899999999999999999999    5789999999999999   78899999999999754

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.77  E-value=7.2e-19  Score=170.21  Aligned_cols=133  Identities=27%  Similarity=0.449  Sum_probs=110.7

Q ss_pred             hccccccceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhhh--hccCccceeecccCCCC---------cccccCC
Q 039957          341 SLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRN--VRHQNLIKILSSCSTPD---------FKFMPNG  409 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~---------~~~~~~g  409 (481)
                      .+.|+||.||++.. +|..||+|.+....   ...+..|.+++..  ++|+||+++++++....         ++|+++|
T Consensus        50 lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g  125 (342)
T 1b6c_B           50 IGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHG  125 (342)
T ss_dssp             EEEETTEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTC
T ss_pred             ecCCCCcEEEEEEE-cCccEEEEEeCchh---HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCC
Confidence            47899999999987 58899999986432   3456678887776  78999999999886653         5688999


Q ss_pred             ChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCC----CCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          410 SLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGH----SSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       410 ~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~----~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +|.+++...  .+++.++.+++.++++|++|||...    .+.+|+||||||+||++++++.+||+|||+++..
T Consensus       126 ~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~  197 (342)
T 1b6c_B          126 SLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  197 (342)
T ss_dssp             BHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEE
T ss_pred             cHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceec
Confidence            999998753  4788999999999999999999320    0367999999999999999999999999998653

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.77  E-value=6.8e-20  Score=194.24  Aligned_cols=223  Identities=21%  Similarity=0.162  Sum_probs=88.0

Q ss_pred             cCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeecccCcceecCcccccCCCCCCEEE
Q 039957           37 STIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLS  116 (481)
Q Consensus        37 ~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  116 (481)
                      ++++.|+|.+|.+.. .|..      .|+.++|++|.|.+              ++++.|.+. ..|+.|..++.|+.|+
T Consensus       173 ~~~~~l~L~~n~~~~-~~~~------~l~~l~Ls~~~i~~--------------~~~~~n~~~-~~~~~~~~l~~L~~L~  230 (727)
T 4b8c_D          173 PLTPKIELFANGKDE-ANQA------LLQHKKLSQYSIDE--------------DDDIENRMV-MPKDSKYDDQLWHALD  230 (727)
T ss_dssp             -----------------------------------------------------------------------CCCCCCEEE
T ss_pred             CccceEEeeCCCCCc-chhh------HhhcCccCcccccC--------------cccccccee-cChhhhccCCCCcEEE
Confidence            446667776766652 3322      23444455544432              233344444 4566666666666666


Q ss_pred             cccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEccCCceeecCCcccccCCCCCeE
Q 039957          117 LLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYL  196 (481)
Q Consensus       117 L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L  196 (481)
                      |++|.+..++.         .+.++++|++|+|++|.|+ .+|..++.+ ++|+.|+|++|+|+ .+|..|+.+++|++|
T Consensus       231 Ls~n~l~~l~~---------~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l-~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L  298 (727)
T 4b8c_D          231 LSNLQIFNISA---------NIFKYDFLTRLYLNGNSLT-ELPAEIKNL-SNLRVLDLSHNRLT-SLPAELGSCFQLKYF  298 (727)
T ss_dssp             CTTSCCSCCCG---------GGGGCCSCSCCBCTTSCCS-CCCGGGGGG-TTCCEEECTTSCCS-SCCSSGGGGTTCSEE
T ss_pred             CCCCCCCCCCh---------hhcCCCCCCEEEeeCCcCc-ccChhhhCC-CCCCEEeCcCCcCC-ccChhhcCCCCCCEE
Confidence            66666665432         2234566666667776666 566666655 46777777777766 556666667777777


Q ss_pred             ecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccC-CCeeecCCCeeeecCCcccccCCCCCcEEcCCC--
Q 039957          197 SLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEM-LNLLHLGGNKLSGHIPPCLASLTSLRELDLGSN--  273 (481)
Q Consensus       197 ~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N--  273 (481)
                      +|++|.|+ .+|..|+.+++|+.|+|++|.+++.+|..+..+.. +..++|++|.+++.+|..      |+.|+++.|  
T Consensus       299 ~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~l~~n~~  371 (727)
T 4b8c_D          299 YFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE------RRFIEINTDGE  371 (727)
T ss_dssp             ECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC-----------------
T ss_pred             ECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc------cceeEeecccc
Confidence            77777665 55666667777777777777776666665544322 123566667666666543      344555554  


Q ss_pred             ------cCcccCCcchhccccCcEEEccCcccC
Q 039957          274 ------KLTSSIPSSLWSLGYILEINLSSNLLN  300 (481)
Q Consensus       274 ------~l~~~~p~~~~~l~~L~~L~l~~N~l~  300 (481)
                            .+.+..+..+..+..+....++.|.+.
T Consensus       372 ~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~  404 (727)
T 4b8c_D          372 PQREYDSLQQSTEHLATDLAKRTFTVLSYNTLC  404 (727)
T ss_dssp             ------------------------------CCC
T ss_pred             cccccCCccccccchhhcccccceeeeeccccc
Confidence                  233333333334444444555555553

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.77  E-value=6.3e-19  Score=167.36  Aligned_cols=133  Identities=23%  Similarity=0.355  Sum_probs=111.0

Q ss_pred             hhhccccccceeeeec-cCCcceEEEEEeccchhhhhhhhHHHHHh-hhhccCccceeecccCC----CC-----ccccc
Q 039957          339 TISLAGSFGSVYKGTI-SDGTDVAIKIFNLQRERAFRSFNSECEVL-RNVRHQNLIKILSSCST----PD-----FKFMP  407 (481)
Q Consensus       339 ~l~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~~-----~~~~~  407 (481)
                      .+.+.|+||.||++.. .+|..||+|.+...     ..+.+|+.++ +..+|+||+++++++..    ..     ++|++
T Consensus        24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~   98 (299)
T 3m2w_A           24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD   98 (299)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCC
T ss_pred             cccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecC
Confidence            3457899999999985 46889999998532     3456788877 55689999999998764    21     67899


Q ss_pred             CCChhHHhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCC---CCcEEEccccCcccCC
Q 039957          408 NGSLEKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDE---NMVAHVSDFGISKLLG  480 (481)
Q Consensus       408 ~g~l~~~l~~~~-~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~---~~~~kl~Dfgl~~~~~  480 (481)
                      +|+|.+++.... ..+++..+..++.+++.||+|||    +.+|+||||||+||+++.   ++.+||+|||+|+...
T Consensus        99 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  171 (299)
T 3m2w_A           99 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH----SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT  171 (299)
T ss_dssp             SCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT
T ss_pred             CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc
Confidence            999999987643 46889999999999999999999    578999999999999998   7899999999997653

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.77  E-value=4.5e-19  Score=176.54  Aligned_cols=131  Identities=29%  Similarity=0.450  Sum_probs=105.3

Q ss_pred             hhccccccceeeeecc-CCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCC-----------Cccccc
Q 039957          340 ISLAGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTP-----------DFKFMP  407 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----------~~~~~~  407 (481)
                      ..+.|+||.||+|... +|..||||.+....    ....+|++++++++|+|||+++++|...           .++|++
T Consensus        61 ~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~  136 (420)
T 1j1b_A           61 VIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP  136 (420)
T ss_dssp             EEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCC
T ss_pred             EEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhccc
Confidence            3478999999999875 58999999885432    2345799999999999999999887421           145776


Q ss_pred             CCChhHHhh---cCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCC-CcEEEccccCcccC
Q 039957          408 NGSLEKRLY---SHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDEN-MVAHVSDFGISKLL  479 (481)
Q Consensus       408 ~g~l~~~l~---~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~-~~~kl~Dfgl~~~~  479 (481)
                      + ++.+.+.   .....+++.....++.+|++||+|||    +.+|+||||||+|||++.+ +.+||+|||+|+.+
T Consensus       137 ~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~  207 (420)
T 1j1b_A          137 E-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  207 (420)
T ss_dssp             E-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH----TTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             c-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH----HCCccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence            4 5555443   23456888899999999999999999    6889999999999999965 67899999999864

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.77  E-value=4.6e-19  Score=167.44  Aligned_cols=134  Identities=24%  Similarity=0.258  Sum_probs=102.1

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccchh--hhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQRER--AFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      -+.|+||.||++.. .+|..||+|.+......  ..+.+..+...++.++||||+++++++...+     +||++ |++.
T Consensus        15 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~   93 (290)
T 3fme_A           15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-TSLD   93 (290)
T ss_dssp             EEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS-EEHH
T ss_pred             cCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc-cchH
Confidence            36899999999985 57899999998654321  2223344445578889999999999987764     56776 5887


Q ss_pred             HHhhc---CCCccCHHHHHHHHHHHHHHHHHHhcCCCCC-CeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          413 KRLYS---HNYFLDILERLNIMIDVGSTLEYLHHGHSSA-PIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       413 ~~l~~---~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~-~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +++..   ....+++..+.+++.++++|++|||    +. +|+||||||+||+++.++.+||+|||+|+..
T Consensus        94 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           94 KFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH----SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             HHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH----HHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh----hcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            76643   4556889999999999999999999    44 8999999999999999999999999998764

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.77  E-value=4.1e-19  Score=176.12  Aligned_cols=132  Identities=25%  Similarity=0.363  Sum_probs=100.8

Q ss_pred             hccccccceeeeecc---CCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCC--CC-----cccccCCC
Q 039957          341 SLAGSFGSVYKGTIS---DGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCST--PD-----FKFMPNGS  410 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~---~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~-----~~~~~~g~  410 (481)
                      .+.|+||.||+|...   ++..||+|.+....  ....+.+|+.++++++|+||+++++++..  ..     ++|+. |+
T Consensus        29 lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-~~  105 (405)
T 3rgf_A           29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HD  105 (405)
T ss_dssp             CC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-EE
T ss_pred             eeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-CC
Confidence            478999999999854   47889999886432  23457789999999999999999998843  22     56765 57


Q ss_pred             hhHHhhc--------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeee----CCCCcEEEccccCccc
Q 039957          411 LEKRLYS--------HNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILL----DENMVAHVSDFGISKL  478 (481)
Q Consensus       411 l~~~l~~--------~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill----~~~~~~kl~Dfgl~~~  478 (481)
                      +.+.+..        ....+++..+..|+.+|+.||+|||    +.+|+||||||+|||+    +.++.+||+|||+|+.
T Consensus       106 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH----~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~  181 (405)
T 3rgf_A          106 LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH----ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL  181 (405)
T ss_dssp             HHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC-
T ss_pred             HHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH----hCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCcee
Confidence            7776642        1224788899999999999999999    5789999999999999    6789999999999976


Q ss_pred             C
Q 039957          479 L  479 (481)
Q Consensus       479 ~  479 (481)
                      +
T Consensus       182 ~  182 (405)
T 3rgf_A          182 F  182 (405)
T ss_dssp             -
T ss_pred             c
Confidence            4

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.77  E-value=5.2e-19  Score=167.58  Aligned_cols=133  Identities=26%  Similarity=0.418  Sum_probs=111.4

Q ss_pred             hhccccccceeeeec-cCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCC-C-----cccccCCChh
Q 039957          340 ISLAGSFGSVYKGTI-SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTP-D-----FKFMPNGSLE  412 (481)
Q Consensus       340 l~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~-----~~~~~~g~l~  412 (481)
                      ..+.|+||.||+|.. .+|..||+|.+.....  .+.+..|+.++.+++|++++..+.++... .     ++|+ +|+|.
T Consensus        16 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~   92 (296)
T 3uzp_A           16 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLE   92 (296)
T ss_dssp             EEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHH
T ss_pred             EEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHH
Confidence            347899999999985 5789999998765432  34678899999999999888777666432 2     5688 89999


Q ss_pred             HHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeee---CCCCcEEEccccCcccC
Q 039957          413 KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILL---DENMVAHVSDFGISKLL  479 (481)
Q Consensus       413 ~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill---~~~~~~kl~Dfgl~~~~  479 (481)
                      +++......+++..+.+++.++++||+|||    +.+|+||||||+||++   ++++.+||+|||+|+..
T Consensus        93 ~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  158 (296)
T 3uzp_A           93 DLFNFCSRKFSLKTVLLLADQMISRIEYIH----SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             HHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             HHHHhhccCCCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence            998765567899999999999999999999    5789999999999999   47899999999999764

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.77  E-value=9e-19  Score=171.54  Aligned_cols=131  Identities=24%  Similarity=0.319  Sum_probs=106.6

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----------cccc
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----------FKFM  406 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----------~~~~  406 (481)
                      .+.|+||.||++.. .+|..||+|.+....  ......+.+|+.++++++||||+++++++....           +||+
T Consensus        33 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~  112 (371)
T 2xrw_A           33 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM  112 (371)
T ss_dssp             EEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECC
T ss_pred             eEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcC
Confidence            47899999999975 468899999986532  233456788999999999999999999886542           4567


Q ss_pred             cCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          407 PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       407 ~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      + |++.+.+..   .+++.....++.+|++||+|||    +.+|+||||||+||+++.++.+||+|||+|+..
T Consensus       113 ~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH----~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~  177 (371)
T 2xrw_A          113 D-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  177 (371)
T ss_dssp             S-EEHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred             C-CCHHHHHhh---ccCHHHHHHHHHHHHHHHHHHH----HCCeecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence            6 578777753   3778889999999999999999    578999999999999999999999999999764

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ...

Probab=99.77  E-value=4.4e-19  Score=168.38  Aligned_cols=132  Identities=26%  Similarity=0.441  Sum_probs=109.4

Q ss_pred             ccccccceeeeecc-CCcceEEEEEeccch--hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhH
Q 039957          342 LAGSFGSVYKGTIS-DGTDVAIKIFNLQRE--RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEK  413 (481)
Q Consensus       342 ~~g~~g~vy~~~l~-~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~  413 (481)
                      +.|+||.||++... +|..||+|.+.....  .....+.+|+.++++++|+||+++++++...+     +||++ |+|.+
T Consensus        12 g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~L~~   90 (299)
T 2r3i_A           12 GEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKK   90 (299)
T ss_dssp             EECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHH
T ss_pred             ccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEEEccc-CCHHH
Confidence            67999999999865 689999998865432  23356788999999999999999999987665     56776 69988


Q ss_pred             HhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          414 RLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       414 ~l~~~~-~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      ++.... ..+++..+.+++.++++||+|||    +.+|+||||||+||+++.++.+||+|||+++.
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~  152 (299)
T 2r3i_A           91 FMDASALTGIPLPLIKSYLFQLLQGLAFCH----SHRVLHRDLKPQNLLINTEGAIKLADFGLARA  152 (299)
T ss_dssp             HHHHTTTTCCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEECSTTHHHH
T ss_pred             HHHhhhccCCCHHHHHHHHHHHHHHHHHHH----HCCccCCCCCHHHeEEcCCCCEEECcchhhhh
Confidence            876543 45788899999999999999999    57899999999999999999999999999864

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.77  E-value=1.1e-18  Score=166.07  Aligned_cols=135  Identities=25%  Similarity=0.390  Sum_probs=111.2

Q ss_pred             hhccccccceeeeecc-CCcceEEEEEeccch----hhhhhhhHHHHHhhhhccCccceeecccCCCC-------ccccc
Q 039957          340 ISLAGSFGSVYKGTIS-DGTDVAIKIFNLQRE----RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-------FKFMP  407 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-------~~~~~  407 (481)
                      ..+.|+||.||++... ++..+|+|.+.....    .....+.+|++++++++|+||+++++++...+       +||++
T Consensus        12 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~   91 (305)
T 2wtk_C           12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCV   91 (305)
T ss_dssp             EEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCS
T ss_pred             EEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhcc
Confidence            3478999999999864 578999999875432    23456888999999999999999999884322       56787


Q ss_pred             CCChhHHhhc-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          408 NGSLEKRLYS-HNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       408 ~g~l~~~l~~-~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +| +.+.+.. ....+++..+.+++.++++||+|||    +.+|+||||||+||+++.++.+||+|||+++..
T Consensus        92 ~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH----~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~  159 (305)
T 2wtk_C           92 CG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH----SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL  159 (305)
T ss_dssp             EE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence            66 6665554 3446788999999999999999999    578999999999999999999999999999764

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.76  E-value=1e-18  Score=171.09  Aligned_cols=132  Identities=26%  Similarity=0.383  Sum_probs=108.2

Q ss_pred             hhccccccceeeeec-cCCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----------ccc
Q 039957          340 ISLAGSFGSVYKGTI-SDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----------FKF  405 (481)
Q Consensus       340 l~~~g~~g~vy~~~l-~~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----------~~~  405 (481)
                      ..+.|+||.||+|.. .+|..||+|.+....  ......+.+|+.++++++|+||+++++++...+           ++|
T Consensus        49 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~  128 (371)
T 4exu_A           49 HVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPF  128 (371)
T ss_dssp             EEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEEC
T ss_pred             EEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEcc
Confidence            347899999999975 468999999986532  233456788999999999999999999886543           245


Q ss_pred             ccCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          406 MPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       406 ~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +. |++.+.+..   .+++..+..++.++++||+|||    +.+|+||||||+||++++++.+||+|||+|+..
T Consensus       129 ~~-~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  194 (371)
T 4exu_A          129 MQ-TDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIH----SAGVVHRDLKPGNLAVNEDCELKILDFGLARHA  194 (371)
T ss_dssp             CC-EEHHHHTTS---CCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred             cc-ccHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH----HCCCcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence            55 677776642   3788999999999999999999    578999999999999999999999999999754

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.76  E-value=2.3e-18  Score=152.88  Aligned_cols=151  Identities=17%  Similarity=0.201  Sum_probs=98.5

Q ss_pred             CccEEEccCCceeecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecC
Q 039957          168 SLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLG  247 (481)
Q Consensus       168 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~  247 (481)
                      +|+.|++++|.++ .+| .+..+++|++|++++|.++  .++.+..+++|+.|++++|.+++..|..++.+++|+.|+++
T Consensus        45 ~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls  120 (197)
T 4ezg_A           45 SLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDIS  120 (197)
T ss_dssp             TCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECC
T ss_pred             CccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEec
Confidence            4555555555555 344 4556666666666666543  23356666666777777766666666667777777777777


Q ss_pred             CCeeeecCCcccccCCCCCcEEcCCCcCcccCCcchhccccCcEEEccCcccCCCCCCccccCCcCcEEEccCCeeee
Q 039957          248 GNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSG  325 (481)
Q Consensus       248 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~  325 (481)
                      +|++++..|..+..+++|++|++++|++.+.+| .+..++.|+.|++++|.+++. + .+..+++|+.|++++|++.+
T Consensus       121 ~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~~-~-~l~~l~~L~~L~l~~N~i~~  195 (197)
T 4ezg_A          121 HSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDY-R-GIEDFPKLNQLYAFSQTIGG  195 (197)
T ss_dssp             SSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTBCCCCC-T-TGGGCSSCCEEEECBC----
T ss_pred             CCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCCCCcCh-H-HhccCCCCCEEEeeCcccCC
Confidence            777776666777777777777777777223444 567777777777777777653 3 57778888888888888753

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.76  E-value=9.7e-19  Score=168.17  Aligned_cols=134  Identities=27%  Similarity=0.395  Sum_probs=112.5

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccchhhhhhhhHHHHHhhhh-ccCccceeecccCCC------C-----ccccc
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQRERAFRSFNSECEVLRNV-RHQNLIKILSSCSTP------D-----FKFMP  407 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~------~-----~~~~~  407 (481)
                      .+.|+||.||+|.. .+|..||+|.+.... .....+.+|+.++.++ +|+||+++++++...      +     +||++
T Consensus        32 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~  110 (326)
T 2x7f_A           32 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCG  110 (326)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCT
T ss_pred             eccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCC
Confidence            46899999999986 468899999986543 2345678899999998 799999999988542      1     57899


Q ss_pred             CCChhHHhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          408 NGSLEKRLYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       408 ~g~l~~~l~~~-~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +|+|.+++... ...+++.....++.++++||+|||    +.+|+||||||+||++++++.+||+|||+++.+
T Consensus       111 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~  179 (326)
T 2x7f_A          111 AGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH----QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  179 (326)
T ss_dssp             TEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCSGGGEEECTTCCEEECCCTTTC--
T ss_pred             CCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH----HCCccccCCcHHHEEEcCCCCEEEeeCcCceec
Confidence            99999998753 245788889999999999999999    578999999999999999999999999998764

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.76  E-value=1.6e-18  Score=153.14  Aligned_cols=133  Identities=26%  Similarity=0.279  Sum_probs=101.2

Q ss_pred             CeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeeccc
Q 039957           16 KSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGF   95 (481)
Q Consensus        16 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~   95 (481)
                      +++++++|+++. +|..+..  +|++|++++|++++..+..++..+++|++|+|++|++++..|..|.++++|++|+|++
T Consensus        11 ~~l~~s~~~l~~-ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~   87 (192)
T 1w8a_A           11 TTVDCTGRGLKE-IPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCSS-CCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEcCCCCcCc-CccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence            678888888864 4554433  7888888888887544443334688888888888888888788888888888888888


Q ss_pred             CcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCC
Q 039957           96 NTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILP  159 (481)
Q Consensus        96 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p  159 (481)
                      |++++..|..|.++++|++|+|++|+++++.+        ..+..+++|++|+|++|.+++..+
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--------~~~~~l~~L~~L~L~~N~l~c~c~  143 (192)
T 1w8a_A           88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMP--------GSFEHLNSLTSLNLASNPFNCNCH  143 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECT--------TSSTTCTTCCEEECTTCCBCCSGG
T ss_pred             CcCCccCHHHhcCCCCCCEEECCCCcCCeeCH--------HHhhcCCCCCEEEeCCCCccCcCc
Confidence            88888888888888888888888888887643        335667788888888888876544

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.76  E-value=1.2e-18  Score=169.53  Aligned_cols=132  Identities=26%  Similarity=0.383  Sum_probs=109.3

Q ss_pred             hhccccccceeeeecc-CCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----------ccc
Q 039957          340 ISLAGSFGSVYKGTIS-DGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----------FKF  405 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----------~~~  405 (481)
                      ..+.|+||.||+|... +|..||+|.+....  ......+.+|+.++++++|+||+++++++....           ++|
T Consensus        31 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~  110 (353)
T 3coi_A           31 HVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPF  110 (353)
T ss_dssp             EEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEEC
T ss_pred             eEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEecc
Confidence            3478999999999854 68999999986532  223456788999999999999999999886643           345


Q ss_pred             ccCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          406 MPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       406 ~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +. |++.+++..   .+++..+..++.+|++||+|||    +.+|+||||||+||++++++.+||+|||+++..
T Consensus       111 ~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH----~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~  176 (353)
T 3coi_A          111 MQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIH----SAGVVHRDLKPGNLAVNEDCELKILDFGLARHA  176 (353)
T ss_dssp             CS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHH----HTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred             cc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence            55 677776642   4788899999999999999999    578999999999999999999999999999764

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.76  E-value=6.3e-19  Score=168.40  Aligned_cols=135  Identities=27%  Similarity=0.352  Sum_probs=109.5

Q ss_pred             hhccccccceeeeec-cCCcceEEEEEeccch------hhhhhhhHHHHHhhhh----ccCccceeecccCCCC-----c
Q 039957          340 ISLAGSFGSVYKGTI-SDGTDVAIKIFNLQRE------RAFRSFNSECEVLRNV----RHQNLIKILSSCSTPD-----F  403 (481)
Q Consensus       340 l~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~------~~~~~~~~e~~~l~~l----~h~niv~l~~~~~~~~-----~  403 (481)
                      ..+.|+||.||++.. .+|..||+|.+.....      .....+..|+.++.++    +|+||+++++++...+     +
T Consensus        38 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~  117 (312)
T 2iwi_A           38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVL  117 (312)
T ss_dssp             EEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEE
T ss_pred             EEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEE
Confidence            347899999999975 4688999999865432      2234567799999998    8999999999987654     4


Q ss_pred             cc-ccCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeC-CCCcEEEccccCcccC
Q 039957          404 KF-MPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLD-ENMVAHVSDFGISKLL  479 (481)
Q Consensus       404 ~~-~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~-~~~~~kl~Dfgl~~~~  479 (481)
                      +| +++++|.+++... ..+++..+.+++.++++||+|||    +.+|+||||||+||+++ +++.+||+|||+++..
T Consensus       118 e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~  190 (312)
T 2iwi_A          118 ERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCH----SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL  190 (312)
T ss_dssp             ECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH----HHTEECCCCSGGGEEEETTTTEEEECCCSSCEEC
T ss_pred             EecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCChhhEEEeCCCCeEEEEEcchhhhc
Confidence            55 7889999998753 35788999999999999999999    57899999999999999 7899999999998765

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.76  E-value=1.4e-18  Score=166.97  Aligned_cols=134  Identities=26%  Similarity=0.423  Sum_probs=109.4

Q ss_pred             hccccccceeeeec--cCCcceEEEEEeccch--hhhhhhhHHHHHhhhh---ccCccceeecccC-----CCC-----c
Q 039957          341 SLAGSFGSVYKGTI--SDGTDVAIKIFNLQRE--RAFRSFNSECEVLRNV---RHQNLIKILSSCS-----TPD-----F  403 (481)
Q Consensus       341 ~~~g~~g~vy~~~l--~~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~-----~~~-----~  403 (481)
                      .+.|+||.||++..  .+|..||+|.+.....  .....+.+|+++++++   +||||++++++|.     ...     +
T Consensus        19 lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~   98 (326)
T 1blx_A           19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVF   98 (326)
T ss_dssp             EEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEE
T ss_pred             ecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEE
Confidence            37899999999986  4678899998865432  2234566788777766   8999999999886     211     5


Q ss_pred             ccccCCChhHHhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          404 KFMPNGSLEKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       404 ~~~~~g~l~~~l~~~~-~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +|++ |+|.+++.... ..+++..+..++.++++||+|||    +.+|+||||||+||+++.++.+||+|||+++..
T Consensus        99 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~  170 (326)
T 1blx_A           99 EHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH----SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY  170 (326)
T ss_dssp             ECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEECSCCSCCCC
T ss_pred             ecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH----HCCceeccCCHHHeEEcCCCCEEEecCcccccc
Confidence            6777 79999887533 34788999999999999999999    578999999999999999999999999999764

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.76  E-value=5.7e-19  Score=186.58  Aligned_cols=133  Identities=23%  Similarity=0.362  Sum_probs=109.6

Q ss_pred             hhccccccceeeeecc--CCcceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC----------cccc
Q 039957          340 ISLAGSFGSVYKGTIS--DGTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----------FKFM  406 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~--~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----------~~~~  406 (481)
                      ..+.|+||.||++...  +|..|+||.+.... ......+..|+.++.+++||||++++++|...+          +||+
T Consensus        87 ~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~  166 (681)
T 2pzi_A           87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYV  166 (681)
T ss_dssp             EEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECC
T ss_pred             EEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeC
Confidence            3478999999999864  58899999876432 233456788999999999999999999886432          5789


Q ss_pred             cCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          407 PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       407 ~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      ++++|.+++..   .++|.++.+|+.+|++||+|+|    +.+||||||||+|||++++ .+||+|||+++...
T Consensus       167 ~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH----~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~  232 (681)
T 2pzi_A          167 GGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLH----SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN  232 (681)
T ss_dssp             CCEECC----C---CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred             CCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH----HCCCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence            99999887654   5889999999999999999999    5789999999999999986 99999999998653

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.76  E-value=1e-18  Score=164.71  Aligned_cols=131  Identities=11%  Similarity=0.068  Sum_probs=110.3

Q ss_pred             hhccccccceeeeecc-CCcceEEEEEeccch---hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCC
Q 039957          340 ISLAGSFGSVYKGTIS-DGTDVAIKIFNLQRE---RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGS  410 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~  410 (481)
                      ..+.|+||.||++... +|..||+|.+.....   ...+.+.+|+..+.+++|+||+++++++...+     +||+++++
T Consensus        38 ~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~  117 (286)
T 3uqc_A           38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGS  117 (286)
T ss_dssp             EEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEE
T ss_pred             EEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCC
Confidence            4478999999999865 489999999875432   23467888999999999999999999987664     67899999


Q ss_pred             hhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcc
Q 039957          411 LEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISK  477 (481)
Q Consensus       411 l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~  477 (481)
                      |.+++...   ....+..+|+.++++||+|||    +.+|+||||||+|||+++++.+||+++|...
T Consensus       118 L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH----~~givH~Dikp~NIll~~~g~~kl~~~~~~~  177 (286)
T 3uqc_A          118 LQEVADTS---PSPVGAIRAMQSLAAAADAAH----RAGVALSIDHPSRVRVSIDGDVVLAYPATMP  177 (286)
T ss_dssp             HHHHHTTC---CCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCSGGGEEEETTSCEEECSCCCCT
T ss_pred             HHHHHhcC---CChHHHHHHHHHHHHHHHHHH----HCCCccCCCCcccEEEcCCCCEEEEeccccC
Confidence            99998543   244567889999999999999    5789999999999999999999999887653

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.76  E-value=2.4e-18  Score=162.35  Aligned_cols=134  Identities=26%  Similarity=0.405  Sum_probs=113.1

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccch--hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRE--RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      .+.|+||.||++... ++..||+|.+.....  .....+.+|++++++++|+||+++++++....     ++|+++++|.
T Consensus        30 lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~  109 (287)
T 2wei_A           30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELF  109 (287)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred             EcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHH
Confidence            368999999999865 688999999865432  23456788999999999999999999987765     5788999999


Q ss_pred             HHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCC---CcEEEccccCcccC
Q 039957          413 KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDEN---MVAHVSDFGISKLL  479 (481)
Q Consensus       413 ~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~---~~~kl~Dfgl~~~~  479 (481)
                      +.+... ..+++..+.+++.++++||+|||    +.+|+||||||+||+++.+   +.+||+|||+++..
T Consensus       110 ~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH----~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~  174 (287)
T 2wei_A          110 DEIIKR-KRFSEHDAARIIKQVFSGITYMH----KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (287)
T ss_dssp             HHHHHH-SSCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred             HHHHhc-CCCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence            887643 35788999999999999999999    5789999999999999764   57999999998764

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.75  E-value=8.7e-19  Score=172.99  Aligned_cols=132  Identities=28%  Similarity=0.435  Sum_probs=104.7

Q ss_pred             hhccccccceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCC-----------CcccccC
Q 039957          340 ISLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTP-----------DFKFMPN  408 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----------~~~~~~~  408 (481)
                      ..+.|+||.||++....+..+|+|++....    ....+|++++++++|+||++++++|...           .+||+++
T Consensus        47 ~lG~G~~g~V~~a~~~~~~~~aikk~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~  122 (394)
T 4e7w_A           47 VIGNGSFGVVFQAKLVESDEVAIKKVLQDK----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE  122 (394)
T ss_dssp             EEEEETTEEEEEEEETTTEEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSE
T ss_pred             EEeeCCCeEEEEEEECCCCeEEEEEEecCc----chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCc
Confidence            447899999999998777679998875432    2234699999999999999999988432           1567776


Q ss_pred             CChhHHhh--cCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeC-CCCcEEEccccCcccC
Q 039957          409 GSLEKRLY--SHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLD-ENMVAHVSDFGISKLL  479 (481)
Q Consensus       409 g~l~~~l~--~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~-~~~~~kl~Dfgl~~~~  479 (481)
                      +.+.....  .....+++.....++.+|++||+|||    +.+|+||||||+|||++ .++.+||+|||+|+.+
T Consensus       123 ~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~  192 (394)
T 4e7w_A          123 TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH----SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL  192 (394)
T ss_dssp             EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH----HCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence            54333221  23446788889999999999999999    57899999999999999 7999999999999764

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.75  E-value=1.1e-18  Score=174.59  Aligned_cols=134  Identities=29%  Similarity=0.341  Sum_probs=104.7

Q ss_pred             hhhccccccceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhhhh-ccCccceeecccCCCC-----cccccCCChh
Q 039957          339 TISLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       339 ~l~~~g~~g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      ..-+.|+||.||.+...+|..||||++....   .+.+.+|++++.++ +|||||++++++....     +||+. |+|.
T Consensus        21 ~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~   96 (434)
T 2rio_A           21 KILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQ   96 (434)
T ss_dssp             EEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHH
T ss_pred             CeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHH
Confidence            3457899999976666679999999886532   23467899999886 8999999999887765     56775 7999


Q ss_pred             HHhhcCCCc------cCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCC-------------CCcEEEccc
Q 039957          413 KRLYSHNYF------LDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDE-------------NMVAHVSDF  473 (481)
Q Consensus       413 ~~l~~~~~~------~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~-------------~~~~kl~Df  473 (481)
                      +++......      ..+..+.+|+.+|++||+|||    +.+||||||||+|||++.             ++.+||+||
T Consensus        97 ~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DF  172 (434)
T 2rio_A           97 DLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH----SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF  172 (434)
T ss_dssp             HHHHTC------------CCHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCC
T ss_pred             HHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH----HCCccccCCChHhEEEecCcccccccccCCCceEEEEccc
Confidence            998754321      122245679999999999999    578999999999999965             458999999


Q ss_pred             cCcccCC
Q 039957          474 GISKLLG  480 (481)
Q Consensus       474 gl~~~~~  480 (481)
                      |+|+.+.
T Consensus       173 G~a~~~~  179 (434)
T 2rio_A          173 GLCKKLD  179 (434)
T ss_dssp             TTCEECC
T ss_pred             ccceecC
Confidence            9998653

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.75  E-value=9.1e-19  Score=174.67  Aligned_cols=132  Identities=28%  Similarity=0.418  Sum_probs=105.4

Q ss_pred             hhccccccceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhhhh-ccCccceeecccCCCC-----cccccCCChhH
Q 039957          340 ISLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD-----FKFMPNGSLEK  413 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----~~~~~~g~l~~  413 (481)
                      ..+.|+||.|+.....+|..||||++....   ...+.+|+++++++ +|||||++++++....     +||++ |+|.+
T Consensus        31 ~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~  106 (432)
T 3p23_A           31 VLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQE  106 (432)
T ss_dssp             EEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHH
T ss_pred             eeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHH
Confidence            447899999655545678999999986432   23467899999998 7999999999887665     45675 69999


Q ss_pred             HhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeC-----CCCcEEEccccCcccC
Q 039957          414 RLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLD-----ENMVAHVSDFGISKLL  479 (481)
Q Consensus       414 ~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~-----~~~~~kl~Dfgl~~~~  479 (481)
                      ++........+.++..++.+|++||+|||    +.+|+||||||+|||++     +...+||+|||+|+.+
T Consensus       107 ~l~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~  173 (432)
T 3p23_A          107 YVEQKDFAHLGLEPITLLQQTTSGLAHLH----SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL  173 (432)
T ss_dssp             HHHSSSCCCCSSCHHHHHHHHHHHHHHHH----HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred             HHHhcCCCccchhHHHHHHHHHHHHHHHH----HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence            98765544444566789999999999999    57899999999999994     3357889999999765

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.75  E-value=2.1e-18  Score=173.93  Aligned_cols=134  Identities=25%  Similarity=0.341  Sum_probs=108.7

Q ss_pred             hhhccccccceeeeec-cCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccce-eecccCCCC-----cccccCCCh
Q 039957          339 TISLAGSFGSVYKGTI-SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIK-ILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       339 ~l~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~-l~~~~~~~~-----~~~~~~g~l  411 (481)
                      ...+.|+||.||++.. .+|..||||.......  ...+..|+.++..++|.+.+. +..++...+     ++|+ +|+|
T Consensus        13 ~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL   89 (483)
T 3sv0_A           13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSL   89 (483)
T ss_dssp             CCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred             EEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCH
Confidence            3447899999999985 5689999998765432  345788999999998755444 433433333     5678 9999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeee---CCCCcEEEccccCcccC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILL---DENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill---~~~~~~kl~Dfgl~~~~  479 (481)
                      .+++......+++..+..|+.+|++||+|||    +.+||||||||+|||+   +.++.+||+|||+|+.+
T Consensus        90 ~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH----~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~  156 (483)
T 3sv0_A           90 EDLFNFCSRKLSLKTVLMLADQMINRVEFVH----SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY  156 (483)
T ss_dssp             HHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH----HCCEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence            9998765667899999999999999999999    5789999999999999   57899999999999864

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.75  E-value=1.9e-18  Score=165.76  Aligned_cols=136  Identities=26%  Similarity=0.313  Sum_probs=112.5

Q ss_pred             hhccccccceeeeec-cCCcceEEEEEeccchh------hhhhhhHHHHHhhhhc--cCccceeecccCCCC-----ccc
Q 039957          340 ISLAGSFGSVYKGTI-SDGTDVAIKIFNLQRER------AFRSFNSECEVLRNVR--HQNLIKILSSCSTPD-----FKF  405 (481)
Q Consensus       340 l~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~~------~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~-----~~~  405 (481)
                      ..+.|+||.||+|.. .+|..||+|.+......      ....+..|+.++.+++  |+|++++++++...+     ++|
T Consensus        50 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~  129 (320)
T 3a99_A           50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILER  129 (320)
T ss_dssp             ECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEEC
T ss_pred             EEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEc
Confidence            447899999999974 56889999998764321      2356778999999996  599999999998765     456


Q ss_pred             ccC-CChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeC-CCCcEEEccccCcccCC
Q 039957          406 MPN-GSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLD-ENMVAHVSDFGISKLLG  480 (481)
Q Consensus       406 ~~~-g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~-~~~~~kl~Dfgl~~~~~  480 (481)
                      +.. ++|.+++... ..+++..+..++.++++||+|||    +.+|+||||||+||+++ +++.+||+|||+++.+.
T Consensus       130 ~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~  201 (320)
T 3a99_A          130 PEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCH----NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK  201 (320)
T ss_dssp             CSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             CCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH----HCCcEeCCCCHHHEEEeCCCCCEEEeeCccccccc
Confidence            654 8999988653 35788899999999999999999    57899999999999999 68999999999987653

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.75  E-value=2.6e-18  Score=171.37  Aligned_cols=134  Identities=28%  Similarity=0.375  Sum_probs=109.3

Q ss_pred             hhccccccceeeeecc-CCcceEEEEEeccchhhhhhhhHHHHHhhhh------ccCccceeecccCCCC-----ccccc
Q 039957          340 ISLAGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECEVLRNV------RHQNLIKILSSCSTPD-----FKFMP  407 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l------~h~niv~l~~~~~~~~-----~~~~~  407 (481)
                      ..+.|+||.||+|... ++..||||.+.... ...+.+..|+.++..+      .|+||+++++++....     ++|+.
T Consensus       104 ~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~  182 (429)
T 3kvw_A          104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLS  182 (429)
T ss_dssp             EEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCC
T ss_pred             EcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccC
Confidence            3478999999999754 58899999986542 2334566788887776      4669999999887654     56775


Q ss_pred             CCChhHHhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCc--EEEccccCcccC
Q 039957          408 NGSLEKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMV--AHVSDFGISKLL  479 (481)
Q Consensus       408 ~g~l~~~l~~~~-~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~--~kl~Dfgl~~~~  479 (481)
                       |++.+++.... ..+++..+.+|+.+|++||+|||    +.+||||||||+|||++.++.  +||+|||+|+..
T Consensus       183 -~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~  252 (429)
T 3kvw_A          183 -MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH----KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE  252 (429)
T ss_dssp             -CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH----HHTEECSCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred             -CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEEccCCCcceEEeecccceec
Confidence             78988887643 34889999999999999999999    578999999999999999887  999999998654

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.75  E-value=3.4e-18  Score=163.43  Aligned_cols=134  Identities=22%  Similarity=0.336  Sum_probs=111.8

Q ss_pred             hhccccccceeeeeccCCcceEEEEEeccc--hhhhhhhhHHHHHhhhhcc--CccceeecccCCCCccc----ccCCCh
Q 039957          340 ISLAGSFGSVYKGTISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRH--QNLIKILSSCSTPDFKF----MPNGSL  411 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~----~~~g~l  411 (481)
                      ..+.|+||.||++...+|..+|+|.+....  ......+.+|++++.+++|  +||+++++++...+.-|    +.+|+|
T Consensus        35 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~~~~~L  114 (313)
T 3cek_A           35 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDL  114 (313)
T ss_dssp             EEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEECCCSEEH
T ss_pred             EecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEecCCCcH
Confidence            347899999999988889999999986543  2344678889999999974  99999999988766322    467899


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+++... ..+++..+..++.++++||+|||    +.+|+||||||+||++++ +.+||+|||+++.+
T Consensus       115 ~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~  176 (313)
T 3cek_A          115 NSWLKKK-KSIDPWERKSYWKNMLEAVHTIH----QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQM  176 (313)
T ss_dssp             HHHHHHC-SSCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEEET-TEEEECCCSSSCC-
T ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH----HCCceecCCCcccEEEEC-CeEEEeeccccccc
Confidence            9988754 35788899999999999999999    578999999999999965 89999999999864

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.74  E-value=3.1e-18  Score=176.86  Aligned_cols=136  Identities=27%  Similarity=0.383  Sum_probs=113.5

Q ss_pred             hhccccccceeeeec-cCCcceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCC------CC-----cccc
Q 039957          340 ISLAGSFGSVYKGTI-SDGTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCST------PD-----FKFM  406 (481)
Q Consensus       340 l~~~g~~g~vy~~~l-~~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~-----~~~~  406 (481)
                      ..+.|+||.||++.. .+|..||+|.+.... ....+.+.+|+.++.+++||||+++++++..      .+     ++|+
T Consensus        21 ~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~  100 (676)
T 3qa8_A           21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYC  100 (676)
T ss_dssp             CCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECC
T ss_pred             EEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeC
Confidence            447899999999986 468999999886542 3344568889999999999999999998755      21     6789


Q ss_pred             cCCChhHHhhcCC--CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCc---EEEccccCcccC
Q 039957          407 PNGSLEKRLYSHN--YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMV---AHVSDFGISKLL  479 (481)
Q Consensus       407 ~~g~l~~~l~~~~--~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~---~kl~Dfgl~~~~  479 (481)
                      ++|+|.+++....  ..+++..+..|+.++++||+|||    +.+|+||||||+||+++.++.   +||+|||+|+..
T Consensus       101 ~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH----s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~  174 (676)
T 3qa8_A          101 EGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH----ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL  174 (676)
T ss_dssp             SSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH----HTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBT
T ss_pred             CCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH----HCCCccCCCCHHHeEeecCCCceeEEEccccccccc
Confidence            9999999987633  24777888999999999999999    578999999999999987654   999999999865

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.74  E-value=1.3e-18  Score=163.22  Aligned_cols=126  Identities=14%  Similarity=0.166  Sum_probs=98.4

Q ss_pred             hhhccccccceeeeeccCCcceEEEEEeccch------------------hhhhhhhHHHHHhhhhccCccceeecccCC
Q 039957          339 TISLAGSFGSVYKGTISDGTDVAIKIFNLQRE------------------RAFRSFNSECEVLRNVRHQNLIKILSSCST  400 (481)
Q Consensus       339 ~l~~~g~~g~vy~~~l~~g~~vavK~l~~~~~------------------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  400 (481)
                      ...+.|+||.||+|...+|..||+|.+.....                  .....+.+|++++.+++  | +++.+++..
T Consensus        96 ~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~~  172 (282)
T 1zar_A           96 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYAW  172 (282)
T ss_dssp             EEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEEE
T ss_pred             CEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEec
Confidence            34478999999999987789999999864321                  12345788999999998  4 555554432


Q ss_pred             C----CcccccCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCc
Q 039957          401 P----DFKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGIS  476 (481)
Q Consensus       401 ~----~~~~~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~  476 (481)
                      .    .+||+++|+|.+ +..       .....++.++++|++|||    +.+|+||||||+|||++ ++.+||+|||+|
T Consensus       173 ~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH----~~giiHrDlkp~NILl~-~~~vkl~DFG~a  239 (282)
T 1zar_A          173 EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFY----HRGIVHGDLSQYNVLVS-EEGIWIIDFPQS  239 (282)
T ss_dssp             ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHH----HTTEECSCCSTTSEEEE-TTEEEECCCTTC
T ss_pred             cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHH----HCCCEeCCCCHHHEEEE-CCcEEEEECCCC
Confidence            2    268999999988 422       123469999999999999    67899999999999999 999999999999


Q ss_pred             ccCC
Q 039957          477 KLLG  480 (481)
Q Consensus       477 ~~~~  480 (481)
                      +...
T Consensus       240 ~~~~  243 (282)
T 1zar_A          240 VEVG  243 (282)
T ss_dssp             EETT
T ss_pred             eECC
Confidence            8653

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.74  E-value=1.6e-16  Score=156.34  Aligned_cols=264  Identities=13%  Similarity=0.087  Sum_probs=131.0

Q ss_pred             CCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceee
Q 039957           13 QNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILD   92 (481)
Q Consensus        13 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~   92 (481)
                      ..++.+.+.. .++.+.+.+|.++ +|+.+++..| ++ .++...|.. .+|+.+.+.. .++.+-+.+|.++++|+.++
T Consensus       113 ~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~-~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~  186 (401)
T 4fdw_A          113 KGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LK-SIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKAD  186 (401)
T ss_dssp             SSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CC-EECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEE
T ss_pred             CCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-cc-EECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeee
Confidence            3444444432 3444445555553 4555555544 43 444444433 3455555553 44444445555555555555


Q ss_pred             cccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEE
Q 039957           93 LGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRF  172 (481)
Q Consensus        93 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L  172 (481)
                      ++.|.++.+...+|. ..+|+.+.+.. .++.+...+        +.++++|+.+++..| ++.+-..            
T Consensus       187 l~~n~l~~I~~~aF~-~~~L~~l~lp~-~l~~I~~~a--------F~~~~~L~~l~l~~~-l~~I~~~------------  243 (401)
T 4fdw_A          187 LSKTKITKLPASTFV-YAGIEEVLLPV-TLKEIGSQA--------FLKTSQLKTIEIPEN-VSTIGQE------------  243 (401)
T ss_dssp             CTTSCCSEECTTTTT-TCCCSEEECCT-TCCEECTTT--------TTTCTTCCCEECCTT-CCEECTT------------
T ss_pred             cCCCcceEechhhEe-ecccCEEEeCC-chheehhhH--------hhCCCCCCEEecCCC-ccCcccc------------
Confidence            555555554444454 35555555542 244443322        234555555555543 3333333            


Q ss_pred             EccCCceeecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcCC-----CCCCccccCccCCCeeecC
Q 039957          173 SASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQ-----GYVPHNLCHLEMLNLLHLG  247 (481)
Q Consensus       173 ~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~-----~~~p~~~~~l~~L~~L~L~  247 (481)
                                   .|.+ .+|+.+.+. +.++...+..|.++++|+.+.+++|.+.     ...+.+|.++++|+.+++.
T Consensus       244 -------------aF~~-~~L~~i~lp-~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~  308 (401)
T 4fdw_A          244 -------------AFRE-SGITTVKLP-NGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP  308 (401)
T ss_dssp             -------------TTTT-CCCSEEEEE-TTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC
T ss_pred             -------------cccc-CCccEEEeC-CCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC
Confidence                         3333 344444442 2233333444444555555544444332     2334455555566666655


Q ss_pred             CCeeeecCCcccccCCCCCcEEcCCCcCcccCCcchhccccCcEEEccCcccCCCCCCccccCC-cCcEEEccCCee
Q 039957          248 GNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLK-VLRVLDLSRNQL  323 (481)
Q Consensus       248 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~-~L~~L~l~~N~l  323 (481)
                      + .++.+...+|.++++|+.+++..| ++..-+.+|.++ .|+.+.+++|.+....+..|..++ .++.+.+..+.+
T Consensus       309 ~-~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~  382 (401)
T 4fdw_A          309 E-SIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESV  382 (401)
T ss_dssp             T-TCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGH
T ss_pred             C-ceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHH
Confidence            3 355455556666666666666433 444455555555 666666666665555555555553 456666555443

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.74  E-value=5.5e-18  Score=146.42  Aligned_cols=138  Identities=21%  Similarity=0.199  Sum_probs=105.6

Q ss_pred             CCCCCCeeeCcCCccc-ccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCc
Q 039957           11 NLQNLKSLFLGANNLS-GLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLI   89 (481)
Q Consensus        11 ~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~   89 (481)
                      ..++|++|++++|+++ +.+|..+..+++|++|++++|.+++ + ..+. .+++|++|++++|++++.+|..+..+++|+
T Consensus        22 ~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~-~-~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~   98 (168)
T 2ell_A           22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS-V-SNLP-KLPKLKKLELSENRIFGGLDMLAEKLPNLT   98 (168)
T ss_dssp             CTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCC-C-SSCC-CCSSCCEEEEESCCCCSCCCHHHHHCTTCC
T ss_pred             CcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCC-h-hhhc-cCCCCCEEECcCCcCchHHHHHHhhCCCCC
Confidence            3477889999999887 6678888888899999999998874 3 4443 688888999998888877888888888888


Q ss_pred             eeecccCcceecC-cccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccce
Q 039957           90 ILDLGFNTFSGHI-PNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGG  156 (481)
Q Consensus        90 ~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~  156 (481)
                      +|++++|.+++.. +..|..+++|++|++++|.+++.+...     ...+..+++|++|++++|.+..
T Consensus        99 ~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~-----~~~~~~l~~L~~L~l~~n~~~~  161 (168)
T 2ell_A           99 HLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYR-----ESVFKLLPQLTYLDGYDREDQE  161 (168)
T ss_dssp             EEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHH-----HHHHTTCSSCCEETTEETTSCB
T ss_pred             EEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHH-----HHHHHhCccCcEecCCCCChhh
Confidence            8888888888643 267888888888888888887763200     0134567778888888887763

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.74  E-value=3.3e-18  Score=169.08  Aligned_cols=120  Identities=27%  Similarity=0.328  Sum_probs=96.1

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccchhhhhhhhHHHHHhhhhc--------cCccceeecccCC----CC-----
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVR--------HQNLIKILSSCST----PD-----  402 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~--------h~niv~l~~~~~~----~~-----  402 (481)
                      .+.|+||.||++.. .+|..||+|.+... ....+.+.+|+.++++++        |+||+++++++..    ..     
T Consensus        45 lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv  123 (397)
T 1wak_A           45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMV  123 (397)
T ss_dssp             EEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEE
T ss_pred             eeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEE
Confidence            47899999999974 46889999998654 233456788999999986        7889999998762    21     


Q ss_pred             cccccCCChhHHhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCC-CeeeCCCCCCCeeeCCCC
Q 039957          403 FKFMPNGSLEKRLYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSA-PIIHCDLKPTSILLDENM  466 (481)
Q Consensus       403 ~~~~~~g~l~~~l~~~-~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~-~i~H~dlk~~nill~~~~  466 (481)
                      ++|+ +|++.+++... ...+++..+..|+.+|++||+|||    +. +||||||||+|||++.++
T Consensus       124 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH----~~~givHrDikp~NIll~~~~  184 (397)
T 1wak_A          124 FEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH----TKCRIIHTDIKPENILLSVNE  184 (397)
T ss_dssp             ECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH----HTTCEECCCCSGGGEEECCCH
T ss_pred             Eecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH----HhCCEecCCCCHHHeeEeccc
Confidence            5677 56676665543 356889999999999999999999    45 899999999999999775

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.73  E-value=3e-18  Score=175.28  Aligned_cols=125  Identities=18%  Similarity=0.209  Sum_probs=97.1

Q ss_pred             hhccccccceeeeeccCCcceEEEEEeccch--------hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccc
Q 039957          340 ISLAGSFGSVYKGTISDGTDVAIKIFNLQRE--------RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFM  406 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~~g~~vavK~l~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~  406 (481)
                      +.++|+||.||++.. .+..+++|.......        ...+.+.+|++++++++|+||+++..++...+     +||+
T Consensus       343 ~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~  421 (540)
T 3en9_A          343 LIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYI  421 (540)
T ss_dssp             -----CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECC
T ss_pred             EEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECC
Confidence            457899999999954 467888887644221        11345789999999999999994444433322     6899


Q ss_pred             cCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          407 PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       407 ~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      ++|+|.+++..         +.+++.++++||+|||    +.+|+||||||+|||+++  .+||+|||+|+...
T Consensus       422 ~ggsL~~~l~~---------~~~i~~qi~~aL~~LH----~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~  480 (540)
T 3en9_A          422 NGKLAKDVIED---------NLDIAYKIGEIVGKLH----KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISN  480 (540)
T ss_dssp             CSEEHHHHSTT---------CTHHHHHHHHHHHHHH----HTTEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred             CCCCHHHHHHH---------HHHHHHHHHHHHHHHH----HCcCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence            99999999864         4679999999999999    578999999999999999  99999999998764

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.73  E-value=6.2e-18  Score=163.21  Aligned_cols=133  Identities=24%  Similarity=0.341  Sum_probs=110.4

Q ss_pred             hccccccceeeeec--cCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCc------cceeecccCCCC-----ccccc
Q 039957          341 SLAGSFGSVYKGTI--SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQN------LIKILSSCSTPD-----FKFMP  407 (481)
Q Consensus       341 ~~~g~~g~vy~~~l--~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~~-----~~~~~  407 (481)
                      .+.|+||.||++..  .+|..||+|.+... ....+.+.+|++++.+++|++      ++++++++...+     +||+ 
T Consensus        22 lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-   99 (339)
T 1z57_A           22 LGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-   99 (339)
T ss_dssp             EEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECC-
T ss_pred             EecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCC-
Confidence            47899999999974  36889999998653 233456788999999988775      888988886654     5788 


Q ss_pred             CCChhHHhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCC-------------------CCc
Q 039957          408 NGSLEKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDE-------------------NMV  467 (481)
Q Consensus       408 ~g~l~~~l~~~~-~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~-------------------~~~  467 (481)
                      ++++.+++.... ..+++..+.+++.++++||+|||    +.+|+||||||+||+++.                   ++.
T Consensus       100 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~  175 (339)
T 1z57_A          100 GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH----SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPD  175 (339)
T ss_dssp             CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCC
T ss_pred             CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH----HCCCcCCCCCHHHEEEeccccccccCCccccccccccCCC
Confidence            899999887643 35788899999999999999999    578999999999999988                   678


Q ss_pred             EEEccccCcccC
Q 039957          468 AHVSDFGISKLL  479 (481)
Q Consensus       468 ~kl~Dfgl~~~~  479 (481)
                      +||+|||+|+..
T Consensus       176 ~kl~Dfg~~~~~  187 (339)
T 1z57_A          176 IKVVDFGSATYD  187 (339)
T ss_dssp             EEECCCSSCEET
T ss_pred             ceEeeCcccccC
Confidence            999999998764

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.73  E-value=4.9e-18  Score=163.34  Aligned_cols=134  Identities=24%  Similarity=0.305  Sum_probs=107.7

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccch-hhhhhhhHHHH-HhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRE-RAFRSFNSECE-VLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~-~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      .+.|+||.||++... +|..||+|.+..... .....+..|+. .++.++|+||+++++++...+     +||++ |++.
T Consensus        30 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~  108 (327)
T 3aln_A           30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFD  108 (327)
T ss_dssp             EEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCS-EEHH
T ss_pred             eccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecC-CChH
Confidence            478999999999864 689999999875432 22334555555 677789999999999987765     56776 4776


Q ss_pred             HHhhc----CCCccCHHHHHHHHHHHHHHHHHHhcCCCCC-CeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          413 KRLYS----HNYFLDILERLNIMIDVGSTLEYLHHGHSSA-PIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       413 ~~l~~----~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~-~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +++..    ....+++..+.+++.++++|++|||+    . +|+||||||+||++++++.+||+|||+++.+
T Consensus       109 ~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~----~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          109 KFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE----NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             HHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH----HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             HHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc----cCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            66542    24567888999999999999999994    5 8999999999999999999999999999765

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.73  E-value=1.7e-17  Score=146.52  Aligned_cols=112  Identities=23%  Similarity=0.355  Sum_probs=59.3

Q ss_pred             CCCeeecCCCcCCCCCCc-cccCccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCcCcccCCcchhccccCcEEEc
Q 039957          216 QLQGFFLPETNLQGYVPH-NLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINL  294 (481)
Q Consensus       216 ~L~~l~l~~n~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l  294 (481)
                      +++.|++++|++++..+. .|..+++|+.|+|++|++++..|..|..+++|++|++++|++++..|..|..++.|++|++
T Consensus        30 ~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  109 (192)
T 1w8a_A           30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL  109 (192)
T ss_dssp             TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred             CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEEC
Confidence            344444444444433332 2444455555555555555544555555555555555555555555555555555555555


Q ss_pred             cCcccCCCCCCccccCCcCcEEEccCCeeeeec
Q 039957          295 SSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDI  327 (481)
Q Consensus       295 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~  327 (481)
                      ++|++++..|..+..+++|++|++++|++.+..
T Consensus       110 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c  142 (192)
T 1w8a_A          110 YDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC  142 (192)
T ss_dssp             CSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred             CCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcC
Confidence            555555555555666666666666666666543

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.73  E-value=7.4e-18  Score=161.32  Aligned_cols=135  Identities=24%  Similarity=0.293  Sum_probs=97.9

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccchh-h-hhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRER-A-FRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~-~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      .+.|+||.||++... +|..||+|.+...... . .+.+..+..++..++|+||+++++++...+     +||+ ++.+.
T Consensus        33 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~  111 (318)
T 2dyl_A           33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAE  111 (318)
T ss_dssp             C------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHH
T ss_pred             eeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHH
Confidence            368999999999865 6899999998754322 2 223334445677889999999999988765     4566 34444


Q ss_pred             HHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          413 KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       413 ~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .........+++..+.+++.++++||+|||+   ..+|+||||||+||+++.++.+||+|||+++.+
T Consensus       112 ~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  175 (318)
T 2dyl_A          112 KLKKRMQGPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRL  175 (318)
T ss_dssp             HHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred             HHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence            4433334567888999999999999999993   137999999999999999999999999998754

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.72  E-value=8.4e-18  Score=163.95  Aligned_cols=137  Identities=23%  Similarity=0.312  Sum_probs=99.5

Q ss_pred             hhccccccceeeeecc-CCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCC------------Ccccc
Q 039957          340 ISLAGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTP------------DFKFM  406 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------------~~~~~  406 (481)
                      ..+.|+||.||++... +|..||||.+.... .....+..++..+++++|+||++++++|...            .++|+
T Consensus        30 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~  108 (360)
T 3e3p_A           30 MAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV  108 (360)
T ss_dssp             ---------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECC
T ss_pred             EEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecc
Confidence            3478999999999864 68899999885432 2234456678888899999999999987431            14677


Q ss_pred             cCCChhHHhh---cCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCC-CCcEEEccccCcccCC
Q 039957          407 PNGSLEKRLY---SHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDE-NMVAHVSDFGISKLLG  480 (481)
Q Consensus       407 ~~g~l~~~l~---~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~-~~~~kl~Dfgl~~~~~  480 (481)
                      ++ ++...+.   ......++.....++.+++.|++|+|..  +.+|+||||||+|||++. ++.+||+|||+|+.+.
T Consensus       109 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~--~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~  183 (360)
T 3e3p_A          109 PD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP--SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS  183 (360)
T ss_dssp             SC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTST--TTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCC
T ss_pred             cc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCC--CCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecC
Confidence            75 4444333   2445677888899999999999999932  468999999999999997 8999999999998653

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.72  E-value=8.6e-18  Score=162.26  Aligned_cols=132  Identities=24%  Similarity=0.349  Sum_probs=106.0

Q ss_pred             hhhccccccceeeeecc-CCcceEEEEEeccchhhhhhhhHHH-HHhhhhccCccceeecccCCC---------Cccccc
Q 039957          339 TISLAGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSEC-EVLRNVRHQNLIKILSSCSTP---------DFKFMP  407 (481)
Q Consensus       339 ~l~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~~~~~~~~e~-~~l~~l~h~niv~l~~~~~~~---------~~~~~~  407 (481)
                      .+.+.|+||.||++... +|..||+|.+....     ....|+ ..+..++|+|++++++++...         .+||++
T Consensus        35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~  109 (336)
T 3fhr_A           35 QVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECME  109 (336)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEESSH-----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCT
T ss_pred             eeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccC
Confidence            34578999999999865 68999999986432     122233 345667899999999987541         167999


Q ss_pred             CCChhHHhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCC---CCcEEEccccCcccC
Q 039957          408 NGSLEKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDE---NMVAHVSDFGISKLL  479 (481)
Q Consensus       408 ~g~l~~~l~~~~-~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~---~~~~kl~Dfgl~~~~  479 (481)
                      +|+|.+++.... ..+++.++.+++.++++||+|||    +.+|+||||||+||+++.   ++.+||+|||+++..
T Consensus       110 gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH----~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~  181 (336)
T 3fhr_A          110 GGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH----SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET  181 (336)
T ss_dssp             TEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEEecCCCceEEEeccccceec
Confidence            999999987643 46889999999999999999999    578999999999999976   456999999999754

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.72  E-value=4.3e-17  Score=144.02  Aligned_cols=128  Identities=26%  Similarity=0.388  Sum_probs=104.7

Q ss_pred             CeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeeccc
Q 039957           16 KSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGF   95 (481)
Q Consensus        16 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~   95 (481)
                      +++++++|+++.+ |..+.  ++|++|+|++|+|+ .+|..+. .+++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus        13 ~~l~~~~~~l~~i-p~~~~--~~l~~L~L~~n~i~-~ip~~~~-~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~   87 (193)
T 2wfh_A           13 TVVRCSNKGLKVL-PKGIP--RDVTELYLDGNQFT-LVPKELS-NYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSY   87 (193)
T ss_dssp             TEEECTTSCCSSC-CSCCC--TTCCEEECCSSCCC-SCCGGGG-GCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CEEEcCCCCCCcC-CCCCC--CCCCEEECCCCcCc-hhHHHhh-cccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCC
Confidence            6788999988754 54442  57889999999997 7886665 788999999999999888888889999999999999


Q ss_pred             CcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccce
Q 039957           96 NTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGG  156 (481)
Q Consensus        96 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~  156 (481)
                      |+++++.|..|.++++|++|+|++|+++.++...        +..+++|++|+|++|.+..
T Consensus        88 N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~--------~~~l~~L~~L~L~~N~~~C  140 (193)
T 2wfh_A           88 NRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGA--------FNDLSALSHLAIGANPLYC  140 (193)
T ss_dssp             SCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTT--------TTTCTTCCEEECCSSCEEC
T ss_pred             CccCEeCHHHhCCCCCCCEEECCCCCCCeeChhh--------hhcCccccEEEeCCCCeec
Confidence            9999888888999999999999999988775433        4567788888888888864

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.71  E-value=8.4e-18  Score=166.92  Aligned_cols=136  Identities=18%  Similarity=0.132  Sum_probs=100.2

Q ss_pred             hhccccccceeeee-ccCCcceEEEEEeccch---hhhhhhhHHHHHhhhhcc-Cccceeecc-----------------
Q 039957          340 ISLAGSFGSVYKGT-ISDGTDVAIKIFNLQRE---RAFRSFNSECEVLRNVRH-QNLIKILSS-----------------  397 (481)
Q Consensus       340 l~~~g~~g~vy~~~-l~~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h-~niv~l~~~-----------------  397 (481)
                      +.++|+||.||+|. ..+|..||||.+.....   ...+.+.+|+.++..++| ++......+                 
T Consensus        85 ~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (413)
T 3dzo_A           85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKK  164 (413)
T ss_dssp             EEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC---
T ss_pred             ccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCc
Confidence            45789999999998 45789999999874332   234567889998888877 322211111                 


Q ss_pred             ----cCCCC----cc-----cccCCChhHHhh------cCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCC
Q 039957          398 ----CSTPD----FK-----FMPNGSLEKRLY------SHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPT  458 (481)
Q Consensus       398 ----~~~~~----~~-----~~~~g~l~~~l~------~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~  458 (481)
                          +....    +.     .+.+|+|.+++.      .....+++..+..|+.++++||+|||    +.+||||||||+
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~iiHrDiKp~  240 (413)
T 3dzo_A          165 MIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH----HYGLVHTYLRPV  240 (413)
T ss_dssp             ------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGG
T ss_pred             cccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCcccc
Confidence                00000    01     134678887773      22445778899999999999999999    578999999999


Q ss_pred             CeeeCCCCcEEEccccCcccC
Q 039957          459 SILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       459 nill~~~~~~kl~Dfgl~~~~  479 (481)
                      |||++.++.+||+|||+|+..
T Consensus       241 NILl~~~~~~kL~DFG~a~~~  261 (413)
T 3dzo_A          241 DIVLDQRGGVFLTGFEHLVRD  261 (413)
T ss_dssp             GEEECTTCCEEECCGGGCEET
T ss_pred             eEEEecCCeEEEEeccceeec
Confidence            999999999999999998764

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.71  E-value=2.7e-17  Score=161.73  Aligned_cols=136  Identities=26%  Similarity=0.344  Sum_probs=108.1

Q ss_pred             hhccccccceeeeecc-CCcceEEEEEeccchhhhhhhhHHHHHhhhhc-cC-----ccceeecccCCCC-----ccccc
Q 039957          340 ISLAGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECEVLRNVR-HQ-----NLIKILSSCSTPD-----FKFMP  407 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~l~~~~~~~~-----~~~~~  407 (481)
                      ..+.|+||.||+|... +|..||+|.+.... .....+..|+.++..++ |+     +++++.+++...+     +||++
T Consensus        61 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~  139 (382)
T 2vx3_A           61 LIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS  139 (382)
T ss_dssp             EEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCC
T ss_pred             EEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCC
Confidence            3478999999999854 67889999987432 23445667888888775 44     4888888876654     56775


Q ss_pred             CCChhHHhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeC--CCCcEEEccccCcccC
Q 039957          408 NGSLEKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLD--ENMVAHVSDFGISKLL  479 (481)
Q Consensus       408 ~g~l~~~l~~~~-~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~--~~~~~kl~Dfgl~~~~  479 (481)
                       |+|.+++.... ..+++..+..++.+++.||+|||..  ..+||||||||+|||++  +++.+||+|||+|+..
T Consensus       140 -~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~--~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~  211 (382)
T 2vx3_A          140 -YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP--ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL  211 (382)
T ss_dssp             -CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST--TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred             -CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC--CCCEEcCCCCcccEEEecCCCCcEEEEeccCceec
Confidence             69999887643 4578999999999999999999942  36899999999999994  5789999999999765

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.71  E-value=8.6e-18  Score=164.68  Aligned_cols=133  Identities=21%  Similarity=0.327  Sum_probs=108.0

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccchhhhhhhhHHHHHhhhhc-----------cCccceeecccCCCC------
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVR-----------HQNLIKILSSCSTPD------  402 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~~~~------  402 (481)
                      .+.|+||.||++.. .+|..||+|.+.... .....+.+|+.++.+++           |+||+++++++...+      
T Consensus        27 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  105 (373)
T 1q8y_A           27 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHV  105 (373)
T ss_dssp             EEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEE
T ss_pred             eeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceE
Confidence            47899999999985 568899999986432 23455778888888876           889999999876431      


Q ss_pred             ---cccccCCChhHHhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCC-CeeeCCCCCCCeeeC------CCCcEEEc
Q 039957          403 ---FKFMPNGSLEKRLYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSA-PIIHCDLKPTSILLD------ENMVAHVS  471 (481)
Q Consensus       403 ---~~~~~~g~l~~~l~~~-~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~-~i~H~dlk~~nill~------~~~~~kl~  471 (481)
                         ++|+ +++|.+++... ...+++..+.+++.+|++||+|||    +. +|+||||||+|||++      ..+.+||+
T Consensus       106 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH----~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~  180 (373)
T 1q8y_A          106 VMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH----RRCGIIHTDIKPENVLMEIVDSPENLIQIKIA  180 (373)
T ss_dssp             EEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH----HTTCEECSCCSGGGEEEEEEETTTTEEEEEEC
T ss_pred             EEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH----hcCCEEecCCChHHeEEeccCCCcCcceEEEc
Confidence               4566 88999988753 345788999999999999999999    45 899999999999994      45589999


Q ss_pred             cccCcccC
Q 039957          472 DFGISKLL  479 (481)
Q Consensus       472 Dfgl~~~~  479 (481)
                      |||+|+..
T Consensus       181 Dfg~a~~~  188 (373)
T 1q8y_A          181 DLGNACWY  188 (373)
T ss_dssp             CCTTCEET
T ss_pred             cccccccc
Confidence            99999764

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.71  E-value=8.6e-18  Score=142.10  Aligned_cols=131  Identities=20%  Similarity=0.195  Sum_probs=90.6

Q ss_pred             CCCCCeeeCcCCccc-ccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCce
Q 039957           12 LQNLKSLFLGANNLS-GLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLII   90 (481)
Q Consensus        12 l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~   90 (481)
                      .++|+.|++++|+++ +.+|..+..+++|++|++++|.+++.  ..+. .+++|++|++++|++++.+|..+..+++|++
T Consensus        16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~-~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~   92 (149)
T 2je0_A           16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLP-KLNKLKKLELSDNRVSGGLEVLAEKCPNLTH   92 (149)
T ss_dssp             GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCC-CCTTCCEEECCSSCCCSCTHHHHHHCTTCCE
T ss_pred             CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhh-cCCCCCEEECCCCcccchHHHHhhhCCCCCE
Confidence            366788888888887 66777777888888888888888743  3343 6778888888888887667777777778888


Q ss_pred             eecccCcceec-CcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEcc
Q 039957           91 LDLGFNTFSGH-IPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILS  150 (481)
Q Consensus        91 L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls  150 (481)
                      |++++|.+++. .+..++.+++|++|++++|.+++.+...     ...+..+++|++|+++
T Consensus        93 L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-----~~~~~~l~~L~~L~l~  148 (149)
T 2je0_A           93 LNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYR-----ENVFKLLPQLTYLDGY  148 (149)
T ss_dssp             EECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHH-----HHHHHHCTTCCEETTB
T ss_pred             EECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHH-----HHHHHHCCCcccccCC
Confidence            88888877763 3466777777777777777776653200     0123445566666654

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.70  E-value=3.1e-17  Score=159.45  Aligned_cols=134  Identities=22%  Similarity=0.317  Sum_probs=107.5

Q ss_pred             hhccccccceeeeecc-CC-cceEEEEEeccchhhhhhhhHHHHHhhhhccCc------cceeecccCCCC-----cccc
Q 039957          340 ISLAGSFGSVYKGTIS-DG-TDVAIKIFNLQRERAFRSFNSECEVLRNVRHQN------LIKILSSCSTPD-----FKFM  406 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~-~g-~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~~-----~~~~  406 (481)
                      ..+.|+||.||++... ++ ..||+|.+... ....+.+..|+.++.+++|++      ++.+.+++...+     +||+
T Consensus        26 ~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~  104 (355)
T 2eu9_A           26 NLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL  104 (355)
T ss_dssp             EEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECC
T ss_pred             EeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEecc
Confidence            3478999999999853 34 68999998643 233456778999999998876      777777766544     5677


Q ss_pred             cCCChhHHhhcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeee-------------------CCCC
Q 039957          407 PNGSLEKRLYSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILL-------------------DENM  466 (481)
Q Consensus       407 ~~g~l~~~l~~~~-~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill-------------------~~~~  466 (481)
                       +|++.+++.... ..+++.++.+++.+|++||+|||    +.+|+||||||+|||+                   +.++
T Consensus       105 -~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH----~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~  179 (355)
T 2eu9_A          105 -GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH----ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNT  179 (355)
T ss_dssp             -CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCC
T ss_pred             -CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEEecccccccccccccccccccCCC
Confidence             677777666533 46889999999999999999999    6789999999999999                   5689


Q ss_pred             cEEEccccCcccC
Q 039957          467 VAHVSDFGISKLL  479 (481)
Q Consensus       467 ~~kl~Dfgl~~~~  479 (481)
                      .+||+|||+|+..
T Consensus       180 ~~kl~Dfg~~~~~  192 (355)
T 2eu9_A          180 SIRVADFGSATFD  192 (355)
T ss_dssp             CEEECCCTTCEET
T ss_pred             cEEEeecCccccc
Confidence            9999999999754

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.69  E-value=1.1e-15  Score=150.35  Aligned_cols=246  Identities=13%  Similarity=0.123  Sum_probs=171.4

Q ss_pred             chhCCCCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhcccccc
Q 039957            8 EIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATK   87 (481)
Q Consensus         8 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~   87 (481)
                      +|.+. +|+.+++..| ++.+...+|.++ +|+.+.+.. .++ .++...|..+++|+.+++++|+++.+...+|. ..+
T Consensus       131 aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~-~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~  204 (401)
T 4fdw_A          131 AFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLE-QLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAG  204 (401)
T ss_dssp             TTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCC-EECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCC
T ss_pred             hcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-Ccc-EehHHHhhCcccCCeeecCCCcceEechhhEe-ecc
Confidence            57774 7999999876 888888999995 799999986 676 67777777899999999999999977777777 689


Q ss_pred             CceeecccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhccc
Q 039957           88 LIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFST  167 (481)
Q Consensus        88 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~  167 (481)
                      |+.+.+..+ ++.+...+|.++++|+.+++..| ++.+...+|        .+ .+|+.+.+. +.++.+-+..      
T Consensus       205 L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF--------~~-~~L~~i~lp-~~i~~I~~~a------  266 (401)
T 4fdw_A          205 IEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAF--------RE-SGITTVKLP-NGVTNIASRA------  266 (401)
T ss_dssp             CSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTT--------TT-CCCSEEEEE-TTCCEECTTT------
T ss_pred             cCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccc--------cc-CCccEEEeC-CCccEEChhH------
Confidence            999999854 88888999999999999999875 677765554        23 467777773 3344333334      


Q ss_pred             CccEEEccCCceeecCCcccccCCCCCeEecccccce-----ecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCC
Q 039957          168 SLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLN-----GTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLN  242 (481)
Q Consensus       168 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~-----~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~  242 (481)
                                         |.++++|+.+++.+|.+.     ...+..|.+|++|+.+.++ +.++.....+|.++.+|+
T Consensus       267 -------------------F~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~  326 (401)
T 4fdw_A          267 -------------------FYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVT  326 (401)
T ss_dssp             -------------------TTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCC
T ss_pred             -------------------hhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCcc
Confidence                               444444444444444332     3444556666666666665 335555556666666666


Q ss_pred             eeecCCCeeeecCCcccccCCCCCcEEcCCCcCcccCCcchhccc-cCcEEEccCccc
Q 039957          243 LLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLG-YILEINLSSNLL  299 (481)
Q Consensus       243 ~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~-~L~~L~l~~N~l  299 (481)
                      .+++..| ++.+.+.+|.++ +|+.+++++|.+....+..|.+++ .+..+.+..+.+
T Consensus       327 ~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~  382 (401)
T 4fdw_A          327 QLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESV  382 (401)
T ss_dssp             EEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGH
T ss_pred             EEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHH
Confidence            6666444 555556667776 777777777766655556666553 566666665544

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.69  E-value=1.5e-16  Score=138.59  Aligned_cols=133  Identities=25%  Similarity=0.286  Sum_probs=97.8

Q ss_pred             CCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeecc
Q 039957           15 LKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLG   94 (481)
Q Consensus        15 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls   94 (481)
                      .+.+++++|+++.+ |..+  .++|++|++++|+++ .+|...+..+++|++|++++|++++..+..|..+++|++|+++
T Consensus         9 ~~~l~~~~~~l~~~-p~~~--~~~l~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~   84 (177)
T 2o6r_A            9 GTEIRCNSKGLTSV-PTGI--PSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLH   84 (177)
T ss_dssp             TTEEECCSSCCSSC-CTTC--CTTCSEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCEEEecCCCCccC-CCCC--CCCCcEEEeCCCccc-EeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECC
Confidence            46788888888754 4333  367888888888887 4454443468888888888888887666677888888888888


Q ss_pred             cCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCC
Q 039957           95 FNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILP  159 (481)
Q Consensus        95 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p  159 (481)
                      +|.+++..+..|..+++|++|++++|++++++...        +..+++|++|+|++|.+.+..|
T Consensus        85 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~--------~~~l~~L~~L~l~~N~~~~~~~  141 (177)
T 2o6r_A           85 ENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGI--------FDRLTSLQKIWLHTNPWDCSCP  141 (177)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTT--------TTTCTTCCEEECCSSCBCCCHH
T ss_pred             CCCccccCHHHhhCCcccCEEECcCCcceEeCHHH--------hcCCcccCEEEecCCCeeccCc
Confidence            88888777777888888888888888887664322        3566778888888888776543

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.68  E-value=5.5e-17  Score=140.10  Aligned_cols=130  Identities=24%  Similarity=0.223  Sum_probs=66.5

Q ss_pred             CccEEEccCCcee-ecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeec
Q 039957          168 SLQRFSASECKLK-GTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHL  246 (481)
Q Consensus       168 ~L~~L~l~~n~l~-~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L  246 (481)
                      ++++|++++|.++ +.+|..+..+++|++|++++|.+++.  ..+..+++|+.|++++|.+++.+|..+..+++|+.|++
T Consensus        25 ~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  102 (168)
T 2ell_A           25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNL  102 (168)
T ss_dssp             SCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEEC
T ss_pred             cCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEec
Confidence            4555555555554 44555555555666666666655533  44555555555555555555544444444555555555


Q ss_pred             CCCeeeecCC-cccccCCCCCcEEcCCCcCcccCC---cchhccccCcEEEccCccc
Q 039957          247 GGNKLSGHIP-PCLASLTSLRELDLGSNKLTSSIP---SSLWSLGYILEINLSSNLL  299 (481)
Q Consensus       247 ~~N~l~~~~p-~~~~~l~~L~~L~ls~N~l~~~~p---~~~~~l~~L~~L~l~~N~l  299 (481)
                      ++|++++..+ ..+..+++|+.|++++|.+++..+   ..+..++.|++|++++|.+
T Consensus       103 s~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~  159 (168)
T 2ell_A          103 SGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDRED  159 (168)
T ss_dssp             BSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTS
T ss_pred             cCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCCh
Confidence            5555544221 445555555555555555553333   2344444444444444444

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.68  E-value=2.5e-16  Score=139.07  Aligned_cols=128  Identities=22%  Similarity=0.325  Sum_probs=84.3

Q ss_pred             eEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCc
Q 039957          195 YLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNK  274 (481)
Q Consensus       195 ~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~  274 (481)
                      ++++++|.++ .+|..+.  ++|+.|++++|+++ .+|..|..+++|+.|+|++|++++..+..|..+++|++|++++|+
T Consensus        14 ~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~   89 (193)
T 2wfh_A           14 VVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR   89 (193)
T ss_dssp             EEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence            4445555544 3333322  34555556665555 344566666666777777777766666667777777777777777


Q ss_pred             CcccCCcchhccccCcEEEccCcccCCCCCCccccCCcCcEEEccCCeeeee
Q 039957          275 LTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGD  326 (481)
Q Consensus       275 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~  326 (481)
                      +++..|..|..++.|+.|++++|.++...+..|..+++|+.|++++|++.+.
T Consensus        90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~  141 (193)
T 2wfh_A           90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCD  141 (193)
T ss_dssp             CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred             cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecC
Confidence            7766666677777777777777777766666677888888888888888764

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.67  E-value=4.5e-16  Score=135.56  Aligned_cols=132  Identities=23%  Similarity=0.221  Sum_probs=86.0

Q ss_pred             CeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCC
Q 039957          194 IYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSN  273 (481)
Q Consensus       194 ~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N  273 (481)
                      +.+++++|+++ .+|..+.  ++|+.|++++|++++..+..|..+++|+.|++++|++++..+..|..+++|++|++++|
T Consensus        10 ~~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   86 (177)
T 2o6r_A           10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN   86 (177)
T ss_dssp             TEEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence            34444444444 2232221  35555666666665555555666666677777777766655566667777777777777


Q ss_pred             cCcccCCcchhccccCcEEEccCcccCCCCCCccccCCcCcEEEccCCeeeeecc
Q 039957          274 KLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIP  328 (481)
Q Consensus       274 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p  328 (481)
                      ++++..+..+..++.|++|++++|.+++..+..+..+++|++|++++|++.+..|
T Consensus        87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  141 (177)
T 2o6r_A           87 KLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  141 (177)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             CccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence            7776666666677777777777777776666666778888888888888887554

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.67  E-value=7.9e-17  Score=136.11  Aligned_cols=109  Identities=20%  Similarity=0.252  Sum_probs=54.3

Q ss_pred             cCccEEEccCCcee-ecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeee
Q 039957          167 TSLQRFSASECKLK-GTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLH  245 (481)
Q Consensus       167 ~~L~~L~l~~n~l~-~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~  245 (481)
                      ++++.|++++|.++ +.+|..+..+++|++|++++|.+++.  ..+..+++|+.|++++|.+++.+|..+..+++|+.|+
T Consensus        17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~   94 (149)
T 2je0_A           17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN   94 (149)
T ss_dssp             GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred             ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence            34566666666655 45555555555555555555555533  4444455555555555555444444444444444444


Q ss_pred             cCCCeeeec-CCcccccCCCCCcEEcCCCcCcc
Q 039957          246 LGGNKLSGH-IPPCLASLTSLRELDLGSNKLTS  277 (481)
Q Consensus       246 L~~N~l~~~-~p~~~~~l~~L~~L~ls~N~l~~  277 (481)
                      +++|++++. .+..+..+++|++|++++|++++
T Consensus        95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~  127 (149)
T 2je0_A           95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTN  127 (149)
T ss_dssp             CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGG
T ss_pred             CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccc
Confidence            444444432 12344444444444444444443

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.65  E-value=2e-16  Score=137.63  Aligned_cols=110  Identities=17%  Similarity=0.170  Sum_probs=52.0

Q ss_pred             hhCCCCCCeeeCcCCcccccCChhccCCc-CCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhcccccc
Q 039957            9 IGNLQNLKSLFLGANNLSGLIPPMIFNIS-TIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATK   87 (481)
Q Consensus         9 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~   87 (481)
                      +..+.+|++|++++|+++.+ |. +..+. +|++|++++|++++ + ..+. .+++|++|++++|++++..+..|..+++
T Consensus        15 ~~~~~~L~~L~l~~n~l~~i-~~-~~~~~~~L~~L~Ls~N~l~~-~-~~l~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~   89 (176)
T 1a9n_A           15 YTNAVRDRELDLRGYKIPVI-EN-LGATLDQFDAIDFSDNEIRK-L-DGFP-LLRRLKTLLVNNNRICRIGEGLDQALPD   89 (176)
T ss_dssp             EECTTSCEEEECTTSCCCSC-CC-GGGGTTCCSEEECCSSCCCE-E-CCCC-CCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred             cCCcCCceEEEeeCCCCchh-HH-hhhcCCCCCEEECCCCCCCc-c-cccc-cCCCCCEEECCCCcccccCcchhhcCCC
Confidence            34445555555555555533 32 22222 55555555555543 2 2222 4555555555555555443333455555


Q ss_pred             CceeecccCcceecCcc--cccCCCCCCEEEcccccCcc
Q 039957           88 LIILDLGFNTFSGHIPN--TFGNLRHLSVLSLLMNNLTT  124 (481)
Q Consensus        88 L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~  124 (481)
                      |++|++++|.++. +|.  .+..+++|++|++++|.++.
T Consensus        90 L~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~l~~N~i~~  127 (176)
T 1a9n_A           90 LTELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVTN  127 (176)
T ss_dssp             CCEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGGG
T ss_pred             CCEEECCCCcCCc-chhhHhhhcCCCCCEEEecCCCCCC
Confidence            5555555555542 232  44455555555555555443

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.63  E-value=1.5e-16  Score=147.44  Aligned_cols=130  Identities=20%  Similarity=0.246  Sum_probs=93.1

Q ss_pred             hccccccceeeeec-cCCcc--eEEEEEeccchh------------------------hhhhhhHHHHHhhhhccCcc--
Q 039957          341 SLAGSFGSVYKGTI-SDGTD--VAIKIFNLQRER------------------------AFRSFNSECEVLRNVRHQNL--  391 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~--vavK~l~~~~~~------------------------~~~~~~~e~~~l~~l~h~ni--  391 (481)
                      .+.|+||.||+|.. .+|..  ||||.+......                        ....+..|+..+.+++|+++  
T Consensus        55 ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~  134 (258)
T 1zth_A           55 ISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAGVSV  134 (258)
T ss_dssp             EEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             EeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCCCCC
Confidence            47899999999987 68888  999987543111                        01246789999999988764  


Q ss_pred             ceeecccCC-CCcccccC-C----ChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCC
Q 039957          392 IKILSSCST-PDFKFMPN-G----SLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDEN  465 (481)
Q Consensus       392 v~l~~~~~~-~~~~~~~~-g----~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~  465 (481)
                      ..+++.... -.+||+.+ |    +|.+....    .++.....++.++++|++|||.   ..+||||||||+|||+++ 
T Consensus       135 p~~~~~~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~---~~givHrDlkp~NILl~~-  206 (258)
T 1zth_A          135 PQPYTYMKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQ---EAELVHADLSEYNIMYID-  206 (258)
T ss_dssp             CCEEEEETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHH---TSCEECSSCSTTSEEESS-
T ss_pred             CeEEEcCCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEEcC-
Confidence            333332100 12678842 4    56554332    1233456799999999999994   357999999999999998 


Q ss_pred             CcEEEccccCcccC
Q 039957          466 MVAHVSDFGISKLL  479 (481)
Q Consensus       466 ~~~kl~Dfgl~~~~  479 (481)
                       .++|+|||+|...
T Consensus       207 -~~~liDFG~a~~~  219 (258)
T 1zth_A          207 -KVYFIDMGQAVTL  219 (258)
T ss_dssp             -SEEECCCTTCEET
T ss_pred             -cEEEEECcccccC
Confidence             9999999999765

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.62  E-value=8.2e-18  Score=149.48  Aligned_cols=139  Identities=24%  Similarity=0.335  Sum_probs=112.3

Q ss_pred             chhCCCCCCeeeCcCCcccccCCh------hccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchh
Q 039957            8 EIGNLQNLKSLFLGANNLSGLIPP------MIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNS   81 (481)
Q Consensus         8 ~~~~l~~L~~L~L~~N~l~~~~p~------~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~   81 (481)
                      .+.....++.++++.+.+++..|.      .|..+++|++|++++|++++ +| .+. .+++|++|++++|+++ .+|..
T Consensus        13 ~~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~-~l~~L~~L~l~~n~l~-~l~~~   88 (198)
T 1ds9_A           13 IFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLS-GMENLRILSLGRNLIK-KIENL   88 (198)
T ss_dssp             HHHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHH-HHTTCCEEEEEEEEEC-SCSSH
T ss_pred             HHHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccc-cCCCCCEEECCCCCcc-cccch
Confidence            356678899999999999988887      88999999999999999984 77 554 6899999999999987 67777


Q ss_pred             ccccccCceeecccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCC
Q 039957           82 ITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILP  159 (481)
Q Consensus        82 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p  159 (481)
                      +..+++|++|++++|++++ +| .++.+++|++|++++|+++.++.       +..+..+++|++|++++|.+++..|
T Consensus        89 ~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~-------~~~l~~l~~L~~L~l~~N~l~~~~~  157 (198)
T 1ds9_A           89 DAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGE-------IDKLAALDKLEDLLLAGNPLYNDYK  157 (198)
T ss_dssp             HHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHH-------HHHHTTTTTCSEEEECSCHHHHHHH
T ss_pred             hhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhH-------HHHHhcCCCCCEEEecCCccccccc
Confidence            8888999999999999986 34 68888899999999998886532       1235667788888888888876544

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.62  E-value=7.9e-16  Score=133.84  Aligned_cols=136  Identities=20%  Similarity=0.235  Sum_probs=99.8

Q ss_pred             hhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeecccCcceecCcccccCCC
Q 039957           31 PMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLR  110 (481)
Q Consensus        31 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  110 (481)
                      ..+.++++|++|++++|+++ .+|. +....++|++|++++|++++.  ..|..+++|++|++++|.+++..|..|+.++
T Consensus        13 ~~~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~   88 (176)
T 1a9n_A           13 AQYTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALP   88 (176)
T ss_dssp             CEEECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCT
T ss_pred             HhcCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCC
Confidence            45778899999999999998 5665 333345999999999999865  5788999999999999999987667778999


Q ss_pred             CCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChh----hhhcccCccEEEccCCce
Q 039957          111 HLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPS----IGNFSTSLQRFSASECKL  179 (481)
Q Consensus       111 ~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~----~~~~~~~L~~L~l~~n~l  179 (481)
                      +|++|++++|.++.++..       ..+..+++|++|++++|.++. +|..    +..+ ++|+.|+++.|..
T Consensus        89 ~L~~L~L~~N~i~~~~~~-------~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l-~~L~~Ld~~~n~~  152 (176)
T 1a9n_A           89 DLTELILTNNSLVELGDL-------DPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKV-PQVRVLDFQKVKL  152 (176)
T ss_dssp             TCCEEECCSCCCCCGGGG-------GGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHC-TTCSEETTEECCH
T ss_pred             CCCEEECCCCcCCcchhh-------HhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHC-CccceeCCCcCCH
Confidence            999999999998765321       235567778888888887763 3332    3333 3444444444443

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.62  E-value=5.1e-18  Score=150.79  Aligned_cols=109  Identities=25%  Similarity=0.281  Sum_probs=65.8

Q ss_pred             ccCCcCCCEEEeeCCcCccccCh------hhhcCCCCccEEEccCccceeecchhccccccCceeecccCcceecCcccc
Q 039957           33 IFNISTIRNLNLGGNRLSGHLPS------MIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTF  106 (481)
Q Consensus        33 ~~~l~~L~~L~L~~N~l~~~~p~------~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  106 (481)
                      +.....++.++++.|.++|.+|.      .+. .+++|++|++++|++++ +| .+..+++|++|++++|.++ .+|..+
T Consensus        14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~-~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~   89 (198)
T 1ds9_A           14 FEERKSVVATEAEKVELHGMIPPIEKMDATLS-TLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLD   89 (198)
T ss_dssp             HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHH-HTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHH
T ss_pred             HHhcccccCcchheeEeccccCcHhhhhHHHh-cCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchh
Confidence            44455666666777777666654      444 56677777777776664 44 6666667777777777666 355555


Q ss_pred             cCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccc
Q 039957          107 GNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLG  155 (481)
Q Consensus       107 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~  155 (481)
                      ..+++|++|++++|++++++          .+..+++|++|++++|+++
T Consensus        90 ~~~~~L~~L~L~~N~l~~l~----------~~~~l~~L~~L~l~~N~i~  128 (198)
T 1ds9_A           90 AVADTLEELWISYNQIASLS----------GIEKLVNLRVLYMSNNKIT  128 (198)
T ss_dssp             HHHHHCSEEEEEEEECCCHH----------HHHHHHHSSEEEESEEECC
T ss_pred             hcCCcCCEEECcCCcCCcCC----------ccccCCCCCEEECCCCcCC
Confidence            55666666666666665542          1233445555555555554

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.61  E-value=2.3e-14  Score=141.31  Aligned_cols=309  Identities=11%  Similarity=0.035  Sum_probs=180.6

Q ss_pred             chhCCCCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhcccccc
Q 039957            8 EIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATK   87 (481)
Q Consensus         8 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~   87 (481)
                      +|.++++|+.+.+.. .++.+...+|.++++|+.+++..+ ++ .++...+....+|+.+.+..+ +...-..+|.++..
T Consensus        66 AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~~  141 (394)
T 4fs7_A           66 AFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VK-MIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCDF  141 (394)
T ss_dssp             TTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CC-EECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCCC
T ss_pred             HhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ce-EccchhhcccccchhhcccCc-eeeecceeeecccc
Confidence            577888888888864 477777788888888888888755 55 566666667777877776654 34344555655544


Q ss_pred             CceeecccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhccc
Q 039957           88 LIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFST  167 (481)
Q Consensus        88 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~  167 (481)
                      +.......  ...+...+|.++++|+.+.+..+ ++.+...+        +.++++|+.+++..| ++......|... .
T Consensus       142 ~~~~~~~~--~~~i~~~aF~~c~~L~~i~l~~~-~~~I~~~~--------F~~c~~L~~i~l~~~-~~~I~~~~F~~~-~  208 (394)
T 4fs7_A          142 KEITIPEG--VTVIGDEAFATCESLEYVSLPDS-METLHNGL--------FSGCGKLKSIKLPRN-LKIIRDYCFAEC-I  208 (394)
T ss_dssp             SEEECCTT--CCEECTTTTTTCTTCCEEECCTT-CCEECTTT--------TTTCTTCCBCCCCTT-CCEECTTTTTTC-T
T ss_pred             cccccCcc--ccccchhhhcccCCCcEEecCCc-cceecccc--------ccCCCCceEEEcCCC-ceEeCchhhccc-c
Confidence            33333222  22344566777777887777644 33443333        355666777777665 443334444443 3


Q ss_pred             CccEEEccCCceeecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecC
Q 039957          168 SLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLG  247 (481)
Q Consensus       168 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~  247 (481)
                      .|+.+.+..+...  +...+....+|+.+.+..+ ++......|..+..++.+.+..+.. ......|.....++.+...
T Consensus       209 ~L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~-~i~~~~F~~~~~l~~~~~~  284 (394)
T 4fs7_A          209 LLENMEFPNSLYY--LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKL-RIGGSLFYNCSGLKKVIYG  284 (394)
T ss_dssp             TCCBCCCCTTCCE--ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTC-EECSCTTTTCTTCCEEEEC
T ss_pred             ccceeecCCCceE--eehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcc-eeeccccccccccceeccC
Confidence            5665555544332  2223333455666655433 2333445566666666666655432 2344556666666666655


Q ss_pred             CCeeeecCCcccccCCCCCcEEcCCCcCcccCCcchhccccCcEEEccCcccCCCCCCccccCCcCcEEEccCCeeeeec
Q 039957          248 GNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDI  327 (481)
Q Consensus       248 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~  327 (481)
                      .+.+   ...+|..+.+|+.+.+..+ ++..-+.+|.++..|+.+++..+ ++.+-..+|.++.+|+.+++..| +....
T Consensus       285 ~~~i---~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~  358 (394)
T 4fs7_A          285 SVIV---PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIG  358 (394)
T ss_dssp             SSEE---CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEEC
T ss_pred             ceee---ccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEeh
Confidence            5442   2345666666666666543 44445556666666666666543 44444556666667777766655 55455


Q ss_pred             cccccccCChhhhhcc
Q 039957          328 PSTIGALVDLETISLA  343 (481)
Q Consensus       328 p~~~~~l~~L~~l~~~  343 (481)
                      ..+|.+|.+|+.+.+.
T Consensus       359 ~~aF~~C~~L~~i~lp  374 (394)
T 4fs7_A          359 ANAFQGCINLKKVELP  374 (394)
T ss_dssp             TTTBTTCTTCCEEEEE
T ss_pred             HHHhhCCCCCCEEEEC
Confidence            5666666666666554

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.57  E-value=6.8e-15  Score=127.02  Aligned_cols=104  Identities=28%  Similarity=0.344  Sum_probs=52.0

Q ss_pred             CEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeecccCcceecCcccccCCCCCCEEEccc
Q 039957           40 RNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLM  119 (481)
Q Consensus        40 ~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  119 (481)
                      +.+++++|+++ .+|..+   .++|++|+|++|+|++..|..|..+++|++|+|++|+|+++.+..|.++++|++|+|++
T Consensus        12 ~~l~~s~n~l~-~ip~~~---~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~   87 (170)
T 3g39_A           12 TTVDCSGKSLA-SVPTGI---PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND   87 (170)
T ss_dssp             TEEECTTSCCS-SCCSCC---CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CEEEeCCCCcC-ccCccC---CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence            44555555554 344433   14455555555555544455555555555555555555544444455555555555555


Q ss_pred             ccCccccCCCccccccccCCCCCCCcEEEccCCccc
Q 039957          120 NNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLG  155 (481)
Q Consensus       120 N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~  155 (481)
                      |+|+++++..        +..+++|++|+|++|.++
T Consensus        88 N~l~~~~~~~--------~~~l~~L~~L~L~~N~~~  115 (170)
T 3g39_A           88 NQLKSIPRGA--------FDNLKSLTHIWLLNNPWD  115 (170)
T ss_dssp             SCCCCCCTTT--------TTTCTTCCEEECCSSCBC
T ss_pred             CccCEeCHHH--------hcCCCCCCEEEeCCCCCC
Confidence            5555443221        334455555555555554

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.56  E-value=7.7e-15  Score=126.68  Aligned_cols=109  Identities=23%  Similarity=0.276  Sum_probs=93.9

Q ss_pred             CCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeec
Q 039957           14 NLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDL   93 (481)
Q Consensus        14 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L   93 (481)
                      ..+++++++|+++. +|..+  .++|++|+|++|+|++..|..+. .+++|++|+|++|+|++..+..|..+++|++|+|
T Consensus        10 ~~~~l~~s~n~l~~-ip~~~--~~~l~~L~L~~N~i~~~~~~~~~-~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L   85 (170)
T 3g39_A           10 SGTTVDCSGKSLAS-VPTGI--PTTTQVLYLYDNQITKLEPGVFD-RLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSL   85 (170)
T ss_dssp             ETTEEECTTSCCSS-CCSCC--CTTCSEEECCSSCCCCCCTTTTT-TCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCEEEeCCCCcCc-cCccC--CCCCcEEEcCCCcCCccChhhhc-CcccCCEEECCCCCcCccChhhccCCCCCCEEEC
Confidence            35789999999986 45544  37899999999999965566564 7999999999999999888888899999999999


Q ss_pred             ccCcceecCcccccCCCCCCEEEcccccCcccc
Q 039957           94 GFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTES  126 (481)
Q Consensus        94 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  126 (481)
                      ++|+|+++.+..|..+++|++|+|++|.++...
T Consensus        86 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c  118 (170)
T 3g39_A           86 NDNQLKSIPRGAFDNLKSLTHIWLLNNPWDCAC  118 (170)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred             CCCccCEeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence            999999888888999999999999999988753

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.55  E-value=1.4e-14  Score=125.48  Aligned_cols=104  Identities=23%  Similarity=0.287  Sum_probs=57.5

Q ss_pred             CEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeecccCcceecCcccccCCCCCCEEEccc
Q 039957           40 RNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLM  119 (481)
Q Consensus        40 ~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  119 (481)
                      +.+++++|+++ .+|..++   ++|++|+|++|+|++..|..|.++++|++|+|++|+|+++.+..|.++++|++|+|++
T Consensus        15 ~~l~~~~n~l~-~iP~~~~---~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~   90 (174)
T 2r9u_A           15 TLVNCQNIRLA-SVPAGIP---TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND   90 (174)
T ss_dssp             SEEECCSSCCS-SCCSCCC---TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             cEEEeCCCCCC-ccCCCcC---CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence            45555555554 4554432   4555555555555555555555556666666666666555444555566666666666


Q ss_pred             ccCccccCCCccccccccCCCCCCCcEEEccCCccc
Q 039957          120 NNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLG  155 (481)
Q Consensus       120 N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~  155 (481)
                      |+|++++..        .+..+++|++|+|++|.+.
T Consensus        91 N~l~~l~~~--------~~~~l~~L~~L~L~~N~~~  118 (174)
T 2r9u_A           91 NHLKSIPRG--------AFDNLKSLTHIYLYNNPWD  118 (174)
T ss_dssp             SCCCCCCTT--------TTTTCTTCSEEECCSSCBC
T ss_pred             CccceeCHH--------HhccccCCCEEEeCCCCcc
Confidence            665554322        1344555666666666655

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.54  E-value=1.6e-14  Score=125.10  Aligned_cols=108  Identities=23%  Similarity=0.268  Sum_probs=91.7

Q ss_pred             CCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeecc
Q 039957           15 LKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLG   94 (481)
Q Consensus        15 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls   94 (481)
                      -+.+++++|+++. +|..+.  ++|++|+|++|+|++..|..+. .+++|++|+|++|+|++..+..|..+++|++|+|+
T Consensus        14 ~~~l~~~~n~l~~-iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~   89 (174)
T 2r9u_A           14 QTLVNCQNIRLAS-VPAGIP--TDKQRLWLNNNQITKLEPGVFD-HLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLN   89 (174)
T ss_dssp             SSEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTT-TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CcEEEeCCCCCCc-cCCCcC--CCCcEEEeCCCCccccCHHHhc-CCcCCCEEECCCCCCCccChhHhCCcchhhEEECC
Confidence            3789999999975 565553  7899999999999865566664 79999999999999998777778999999999999


Q ss_pred             cCcceecCcccccCCCCCCEEEcccccCcccc
Q 039957           95 FNTFSGHIPNTFGNLRHLSVLSLLMNNLTTES  126 (481)
Q Consensus        95 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  126 (481)
                      +|+|++..+..|..+++|++|+|++|.+...+
T Consensus        90 ~N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~  121 (174)
T 2r9u_A           90 DNHLKSIPRGAFDNLKSLTHIYLYNNPWDCEC  121 (174)
T ss_dssp             SSCCCCCCTTTTTTCTTCSEEECCSSCBCTTB
T ss_pred             CCccceeCHHHhccccCCCEEEeCCCCccccc
Confidence            99999877777999999999999999988753

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.51  E-value=1.1e-12  Score=129.35  Aligned_cols=296  Identities=10%  Similarity=0.066  Sum_probs=220.3

Q ss_pred             cccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeecccCcceecCc
Q 039957           24 NLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIP  103 (481)
Q Consensus        24 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  103 (481)
                      .++.+-..+|.++++|+.+.+..+ ++ .+++..|..+++|+.+++.++ ++.+-..+|.++++|+.+.+..+ +..+..
T Consensus        58 ~VtsIg~~AF~~c~~L~~i~lp~~-i~-~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~  133 (394)
T 4fs7_A           58 DVVSIGYAAFQGCRKVTEIKIPST-VR-EIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGV  133 (394)
T ss_dssp             EEEEECTTTTTTCTTEEEEECCTT-CC-EECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECT
T ss_pred             eEeEhHHHHhhCCCCceEEEeCCC-cc-CcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecc
Confidence            456677788999999999999754 76 677777778899999999765 56566678999999998888754 555667


Q ss_pred             ccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEccCCceeecC
Q 039957          104 NTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTI  183 (481)
Q Consensus       104 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~  183 (481)
                      .+|.+...++.....  ....+..        ..+.++++|+.+.+.++. .......|..+ .+|+.+.+..+ ++..-
T Consensus       134 ~aF~~~~~~~~~~~~--~~~~i~~--------~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c-~~L~~i~l~~~-~~~I~  200 (394)
T 4fs7_A          134 EAFKGCDFKEITIPE--GVTVIGD--------EAFATCESLEYVSLPDSM-ETLHNGLFSGC-GKLKSIKLPRN-LKIIR  200 (394)
T ss_dssp             TTTTTCCCSEEECCT--TCCEECT--------TTTTTCTTCCEEECCTTC-CEECTTTTTTC-TTCCBCCCCTT-CCEEC
T ss_pred             eeeecccccccccCc--cccccch--------hhhcccCCCcEEecCCcc-ceeccccccCC-CCceEEEcCCC-ceEeC
Confidence            778777654443322  2223322        345788999999998764 33445556555 57999998876 55456


Q ss_pred             CcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeeeecCCcccccCC
Q 039957          184 PKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLT  263 (481)
Q Consensus       184 p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~  263 (481)
                      ...|.++..|+.+.+..+...  +...+.....|+.+.+..+ ++......|.....++.+.+..+... ....+|..+.
T Consensus       201 ~~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~  276 (394)
T 4fs7_A          201 DYCFAECILLENMEFPNSLYY--LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCS  276 (394)
T ss_dssp             TTTTTTCTTCCBCCCCTTCCE--ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCT
T ss_pred             chhhccccccceeecCCCceE--eehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcce-eecccccccc
Confidence            678899999999988776543  3444555678888888643 44455667888899999999887554 6678899999


Q ss_pred             CCCcEEcCCCcCcccCCcchhccccCcEEEccCcccCCCCCCccccCCcCcEEEccCCeeeeeccccccccCChhhhhcc
Q 039957          264 SLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLA  343 (481)
Q Consensus       264 ~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~~~  343 (481)
                      .++.+....+.+   ....|..+..|+.+.+..+ ++.+....|.++.+|+.+++..+ ++..-..+|.+|.+|+.+.+.
T Consensus       277 ~l~~~~~~~~~i---~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp  351 (394)
T 4fs7_A          277 GLKKVIYGSVIV---PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFP  351 (394)
T ss_dssp             TCCEEEECSSEE---CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCC
T ss_pred             ccceeccCceee---ccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEEC
Confidence            999998877653   3456788899999999765 65566778999999999999755 776678899999999999876


Q ss_pred             cc
Q 039957          344 GS  345 (481)
Q Consensus       344 g~  345 (481)
                      .+
T Consensus       352 ~~  353 (394)
T 4fs7_A          352 LS  353 (394)
T ss_dssp             TT
T ss_pred             cc
Confidence            44

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.48  E-value=7.1e-16  Score=150.30  Aligned_cols=38  Identities=24%  Similarity=0.282  Sum_probs=19.0

Q ss_pred             CccEEEccCCceeec----CCcccccCCCCCeEeccccccee
Q 039957          168 SLQRFSASECKLKGT----IPKEIGHLRGLIYLSLGFNDLNG  205 (481)
Q Consensus       168 ~L~~L~l~~n~l~~~----~p~~~~~l~~L~~L~l~~N~l~~  205 (481)
                      +|++|++++|.++..    ++..+...++|++|+|++|.|+.
T Consensus       212 ~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~  253 (372)
T 3un9_A          212 QLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSS  253 (372)
T ss_dssp             CCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCH
T ss_pred             CcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCH
Confidence            455555555555421    22233344566666666666553

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.40  E-value=7.1e-13  Score=128.29  Aligned_cols=105  Identities=19%  Similarity=0.203  Sum_probs=67.6

Q ss_pred             eeeCcCC-cccccCChhccCCcCCCEEEeeC-CcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeecc
Q 039957           17 SLFLGAN-NLSGLIPPMIFNISTIRNLNLGG-NRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLG   94 (481)
Q Consensus        17 ~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls   94 (481)
                      .++++++ ++++ +|. +..+++|++|+|++ |+|++..|..+ ..+++|++|+|++|+|++..|..|.++++|+.|+|+
T Consensus        12 ~v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~-~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~   88 (347)
T 2ifg_A           12 GLRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDL-RGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS   88 (347)
T ss_dssp             CEECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGS-CSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred             EEEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHh-ccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence            4566666 6664 455 66677777777774 77763333333 367777777777777776666667777777777777


Q ss_pred             cCcceecCcccccCCCCCCEEEcccccCccc
Q 039957           95 FNTFSGHIPNTFGNLRHLSVLSLLMNNLTTE  125 (481)
Q Consensus        95 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  125 (481)
                      +|+|++..+..|..++ |+.|+|.+|.+...
T Consensus        89 ~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~  118 (347)
T 2ifg_A           89 FNALESLSWKTVQGLS-LQELVLSGNPLHCS  118 (347)
T ss_dssp             SSCCSCCCSTTTCSCC-CCEEECCSSCCCCC
T ss_pred             CCccceeCHHHcccCC-ceEEEeeCCCccCC
Confidence            7777765555565555 67777776666654

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.39  E-value=4.7e-11  Score=117.52  Aligned_cols=311  Identities=11%  Similarity=0.134  Sum_probs=190.9

Q ss_pred             chhCCC-CCCeeeCcCCcccccCChhccCCcCCCEEEeeCCc---CccccChhhhcCCCCccEEEccCccceeecchhcc
Q 039957            8 EIGNLQ-NLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNR---LSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSIT   83 (481)
Q Consensus         8 ~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~---l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~   83 (481)
                      +|.+.+ .|+.+.+-. .++.+-..+|.++++|+.+.++.|.   ++ .+....|....+|+.+.+..+ ++.+...+|.
T Consensus        58 aF~~~~~~L~sI~iP~-svt~Ig~~AF~~C~~L~~i~~~~n~p~~l~-~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~  134 (394)
T 4gt6_A           58 VFCNYKYVLTSVQIPD-TVTEIGSNAFYNCTSLKRVTIQDNKPSCVK-KIGRQAFMFCSELTDIPILDS-VTEIDSEAFH  134 (394)
T ss_dssp             TTTTCCSCCCEEEECT-TCCEECTTTTTTCTTCCEEEEGGGCCCCCC-EECTTTTTTCTTCCBCGGGTT-CSEECTTTTT
T ss_pred             hccCCCCcCEEEEECC-CeeEEhHHHhhCCccCceEeecCCCCCeee-EechhhchhcccceeeccCCc-cceehhhhhh
Confidence            355553 477777754 3666667777777777777776654   44 455555556667777666654 4445556677


Q ss_pred             ccccCceeecccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhh
Q 039957           84 NATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIG  163 (481)
Q Consensus        84 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~  163 (481)
                      .+.+|+.+.+..+ +..+....|....+|+.+.+..+ ++.+...+|.         ...|+.+.+..+-. ......|.
T Consensus       135 ~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~---------~~~l~~i~ip~~~~-~i~~~af~  202 (394)
T 4gt6_A          135 HCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFT---------GTALTQIHIPAKVT-RIGTNAFS  202 (394)
T ss_dssp             TCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTT---------TCCCSEEEECTTCC-EECTTTTT
T ss_pred             hhcccccccccce-eeeecccceecccccccccccce-eeEecccccc---------ccceeEEEECCccc-ccccchhh
Confidence            7777777777543 44455666777777777777543 4544443331         23466666554322 22233333


Q ss_pred             hcccCccEEEccCCceeecCCcc--------------cccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCC
Q 039957          164 NFSTSLQRFSASECKLKGTIPKE--------------IGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQG  229 (481)
Q Consensus       164 ~~~~~L~~L~l~~n~l~~~~p~~--------------~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~  229 (481)
                      .. .++.......+.... +...              +.....+..+.+. +.++..-...|..+..|+.+.+..+. ..
T Consensus       203 ~c-~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp~~~-~~  278 (394)
T 4gt6_A          203 EC-FALSTITSDSESYPA-IDNVLYEKSANGDYALIRYPSQREDPAFKIP-NGVARIETHAFDSCAYLASVKMPDSV-VS  278 (394)
T ss_dssp             TC-TTCCEEEECCSSSCB-SSSCEEEECTTSCEEEEECCTTCCCSEEECC-TTEEEECTTTTTTCSSCCEEECCTTC-CE
T ss_pred             hc-cccceeccccccccc-ccceeecccccccccccccccccccceEEcC-CcceEcccceeeecccccEEeccccc-ce
Confidence            33 234444433332221 1111              0111223333332 23444455678888999999886653 33


Q ss_pred             CCCccccCccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCcCcccCCcchhccccCcEEEccCcccCCCCCCcccc
Q 039957          230 YVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQK  309 (481)
Q Consensus       230 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~  309 (481)
                      ....+|.++..|+.+.+. +.++.+...+|.++.+|+.+++..+ ++..-..+|.++.+|+.+.+..+ ++.+-...|.+
T Consensus       279 I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~  355 (394)
T 4gt6_A          279 IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSN  355 (394)
T ss_dssp             ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTT
T ss_pred             ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhC
Confidence            556788888999999986 4566677788999999999999764 66666788889999999999755 66666778999


Q ss_pred             CCcCcEEEccCCeeeeeccccccccCChhhhhcc
Q 039957          310 LKVLRVLDLSRNQLSGDIPSTIGALVDLETISLA  343 (481)
Q Consensus       310 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~~~  343 (481)
                      +.+|+.+++.++....   ..+..+..|+.+.+.
T Consensus       356 C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~  386 (394)
T 4gt6_A          356 CTALNNIEYSGSRSQW---NAISTDSGLQNLPVA  386 (394)
T ss_dssp             CTTCCEEEESSCHHHH---HTCBCCCCC------
T ss_pred             CCCCCEEEECCceeeh---hhhhccCCCCEEEeC
Confidence            9999999998876542   356667777777654

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.38  E-value=6.7e-11  Score=116.41  Aligned_cols=300  Identities=11%  Similarity=0.136  Sum_probs=219.3

Q ss_pred             ccccCChhccCCc-CCCEEEeeCCcCccccChhhhcCCCCccEEEccCcc---ceeecchhccccccCceeecccCccee
Q 039957           25 LSGLIPPMIFNIS-TIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNN---LIGTIPNSITNATKLIILDLGFNTFSG  100 (481)
Q Consensus        25 l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~---l~~~~p~~~~~l~~L~~L~Ls~N~l~~  100 (481)
                      ++.+-..+|.++. .|+.+.+..+ ++ .|.+..|...++|+.+.++.|.   ++.+-..+|.++.+|+.+.+..+ ++.
T Consensus        51 Vt~Ig~~aF~~~~~~L~sI~iP~s-vt-~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~  127 (394)
T 4gt6_A           51 VSKIGDRVFCNYKYVLTSVQIPDT-VT-EIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTE  127 (394)
T ss_dssp             EEEECTTTTTTCCSCCCEEEECTT-CC-EECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSE
T ss_pred             eeEcCHhhccCCCCcCEEEEECCC-ee-EEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cce
Confidence            4556677888884 6999999765 76 6777777789999999998874   66666778999999999988755 666


Q ss_pred             cCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEccCCcee
Q 039957          101 HIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLK  180 (481)
Q Consensus       101 ~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~  180 (481)
                      +...+|.+..+|+.+.+..+ ++.+...+        +..+..|+.+.+.++ ++.+-...|..  ..|+.+.+..+-..
T Consensus       128 I~~~aF~~c~~L~~i~lp~~-~~~I~~~~--------F~~c~~L~~i~~~~~-~~~I~~~aF~~--~~l~~i~ip~~~~~  195 (394)
T 4gt6_A          128 IDSEAFHHCEELDTVTIPEG-VTSVADGM--------FSYCYSLHTVTLPDS-VTAIEERAFTG--TALTQIHIPAKVTR  195 (394)
T ss_dssp             ECTTTTTTCTTCCEEECCTT-CCEECTTT--------TTTCTTCCEEECCTT-CCEECTTTTTT--CCCSEEEECTTCCE
T ss_pred             ehhhhhhhhcccccccccce-eeeecccc--------eecccccccccccce-eeEeccccccc--cceeEEEECCcccc
Confidence            77888999999999999643 45554333        467888999998765 44444455543  46888888765433


Q ss_pred             ecCCcccccCCCCCeEecccccceecCCcC--------------CcCCCCCCeeecCCCcCCCCCCccccCccCCCeeec
Q 039957          181 GTIPKEIGHLRGLIYLSLGFNDLNGTIPTS--------------IGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHL  246 (481)
Q Consensus       181 ~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--------------~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L  246 (481)
                       .-...|..+.++.......+.... +...              +.....+..+.+. +.++.....+|.++..|+.+.+
T Consensus       196 -i~~~af~~c~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~l  272 (394)
T 4gt6_A          196 -IGTNAFSECFALSTITSDSESYPA-IDNVLYEKSANGDYALIRYPSQREDPAFKIP-NGVARIETHAFDSCAYLASVKM  272 (394)
T ss_dssp             -ECTTTTTTCTTCCEEEECCSSSCB-SSSCEEEECTTSCEEEEECCTTCCCSEEECC-TTEEEECTTTTTTCSSCCEEEC
T ss_pred             -cccchhhhccccceeccccccccc-ccceeecccccccccccccccccccceEEcC-CcceEcccceeeecccccEEec
Confidence             455677788888877665544321 1111              1112233344442 2334445667889999999999


Q ss_pred             CCCeeeecCCcccccCCCCCcEEcCCCcCcccCCcchhccccCcEEEccCcccCCCCCCccccCCcCcEEEccCCeeeee
Q 039957          247 GGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGD  326 (481)
Q Consensus       247 ~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~  326 (481)
                      ..+..+ +...+|.++++|+.+.+. +.++......|.++.+|+.+.+..+ ++.+-...|.++.+|+.+.+..+ ++..
T Consensus       273 p~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I  348 (394)
T 4gt6_A          273 PDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKI  348 (394)
T ss_dssp             CTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBC
T ss_pred             ccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEE
Confidence            776543 667889999999999996 4666677788999999999999865 65566788999999999999755 6656


Q ss_pred             ccccccccCChhhhhccccc
Q 039957          327 IPSTIGALVDLETISLAGSF  346 (481)
Q Consensus       327 ~p~~~~~l~~L~~l~~~g~~  346 (481)
                      -..+|.+|.+|+.+.+.++.
T Consensus       349 ~~~aF~~C~~L~~i~~~~~~  368 (394)
T 4gt6_A          349 PESAFSNCTALNNIEYSGSR  368 (394)
T ss_dssp             CGGGGTTCTTCCEEEESSCH
T ss_pred             hHhHhhCCCCCCEEEECCce
Confidence            67899999999999887653

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.37  E-value=1.3e-12  Score=126.37  Aligned_cols=106  Identities=24%  Similarity=0.214  Sum_probs=92.4

Q ss_pred             CEEEeeCC-cCccccChhhhcCCCCccEEEccC-ccceeecchhccccccCceeecccCcceecCcccccCCCCCCEEEc
Q 039957           40 RNLNLGGN-RLSGHLPSMIGHSLPNIKYLELGD-NNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSL  117 (481)
Q Consensus        40 ~~L~L~~N-~l~~~~p~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  117 (481)
                      ..++++++ +++ .+|. +. .+++|++|+|++ |+|++..+..|.++++|++|+|++|+|+++.|..|++|++|++|+|
T Consensus        11 ~~v~~~~~n~l~-~ip~-l~-~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l   87 (347)
T 2ifg_A           11 SGLRCTRDGALD-SLHH-LP-GAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNL   87 (347)
T ss_dssp             SCEECCSSCCCT-TTTT-SC-SCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEEC
T ss_pred             CEEEcCCCCCCC-ccCC-CC-CCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeC
Confidence            45789998 898 6898 65 799999999996 9999888899999999999999999999999999999999999999


Q ss_pred             ccccCccccCCCccccccccCCCCCCCcEEEccCCcccee
Q 039957          118 LMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGI  157 (481)
Q Consensus       118 ~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~  157 (481)
                      ++|+|+++++..|        ..++ |++|+|++|.+...
T Consensus        88 ~~N~l~~~~~~~~--------~~~~-L~~l~l~~N~~~c~  118 (347)
T 2ifg_A           88 SFNALESLSWKTV--------QGLS-LQELVLSGNPLHCS  118 (347)
T ss_dssp             CSSCCSCCCSTTT--------CSCC-CCEEECCSSCCCCC
T ss_pred             CCCccceeCHHHc--------ccCC-ceEEEeeCCCccCC
Confidence            9999998865443        3333 99999999998743

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.35  E-value=5e-13  Score=128.72  Aligned_cols=126  Identities=13%  Similarity=0.085  Sum_probs=83.2

Q ss_pred             hccccccceeeeeccCCcceEEEEEeccch-----hh---------hhhhhHHHHHhhhhccCccceeecccCC------
Q 039957          341 SLAGSFGSVYKGTISDGTDVAIKIFNLQRE-----RA---------FRSFNSECEVLRNVRHQNLIKILSSCST------  400 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~g~~vavK~l~~~~~-----~~---------~~~~~~e~~~l~~l~h~niv~l~~~~~~------  400 (481)
                      .+.|++|.||+|..++|..||||.+.....     ..         ......++.+.+...|+|++++......      
T Consensus       103 IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp~p~~  182 (397)
T 4gyi_A          103 IGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVPEPIA  182 (397)
T ss_dssp             EEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCCCEEE
T ss_pred             eeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCCeeee
Confidence            378999999999988999999998754311     00         0011112222222234444444322111      


Q ss_pred             -----CCcccccCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCC---------
Q 039957          401 -----PDFKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENM---------  466 (481)
Q Consensus       401 -----~~~~~~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~---------  466 (481)
                           ..+||++++++.+....       ....+++.+++.++.|+|    ..+||||||||.|||+++++         
T Consensus       183 ~~~~~LVME~i~G~~L~~l~~~-------~~~~~l~~qll~~l~~lH----~~gIVHrDLKp~NILl~~dgd~~d~~~~~  251 (397)
T 4gyi_A          183 QSRHTIVMSLVDALPMRQVSSV-------PDPASLYADLIALILRLA----KHGLIHGDFNEFNILIREEKDAEDPSSIT  251 (397)
T ss_dssp             EETTEEEEECCSCEEGGGCCCC-------SCHHHHHHHHHHHHHHHH----HTTEECSCCSTTSEEEEEEECSSCTTSEE
T ss_pred             ccCceEEEEecCCccHhhhccc-------HHHHHHHHHHHHHHHHHH----HCCCcCCCCCHHHEEEeCCCCcccccccc
Confidence                 12678988888664321       123457899999999999    56799999999999998876         


Q ss_pred             -cEEEccccCcc
Q 039957          467 -VAHVSDFGISK  477 (481)
Q Consensus       467 -~~kl~Dfgl~~  477 (481)
                       .+.|.||+-+-
T Consensus       252 ~~~~iID~~Q~V  263 (397)
T 4gyi_A          252 LTPIIIXFPQMV  263 (397)
T ss_dssp             EEEEECCCTTCE
T ss_pred             cceEEEEeCCcc
Confidence             48999999753

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.33  E-value=7.8e-14  Score=135.86  Aligned_cols=165  Identities=18%  Similarity=0.165  Sum_probs=87.7

Q ss_pred             CCccEEEccCccceeecchhcccc-----ccCceeecccCcceecCcccc-cCCCCCCEEEcccccCccccCCCcccccc
Q 039957           62 PNIKYLELGDNNLIGTIPNSITNA-----TKLIILDLGFNTFSGHIPNTF-GNLRHLSVLSLLMNNLTTESSSAYQWSFL  135 (481)
Q Consensus        62 ~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~~~~~~~~~~  135 (481)
                      +.|++|+|++|.++......+...     ++|+.|+|++|.++......+ ..+++|++|+|++|.++......+    .
T Consensus        72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L----~  147 (372)
T 3un9_A           72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDL----R  147 (372)
T ss_dssp             TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHH----H
T ss_pred             hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHH----H
Confidence            445555555555543322222222     455555555555543222222 223455555555555543211110    0


Q ss_pred             ccC-CCCCCCcEEEccCCcccee----CChhhhhcccCccEEEccCCceee----cCCcccccCCCCCeEecccccceec
Q 039957          136 SSL-TNCRYLVYLILSGNPLGGI----LPPSIGNFSTSLQRFSASECKLKG----TIPKEIGHLRGLIYLSLGFNDLNGT  206 (481)
Q Consensus       136 ~~l-~~l~~L~~L~Ls~N~l~~~----~p~~~~~~~~~L~~L~l~~n~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~  206 (481)
                      ..+ ...+.|++|+|++|.++..    ++..+... ++|++|++++|.++.    .++..+...++|++|+|++|.++..
T Consensus       148 ~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~-~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~  226 (372)
T 3un9_A          148 DLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGN-TSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDT  226 (372)
T ss_dssp             HHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTC-SSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHH
T ss_pred             HHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcC-CCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHH
Confidence            011 1234566666666665432    11222222 456666666666653    2345566778999999999999753


Q ss_pred             ----CCcCCcCCCCCCeeecCCCcCCCCC
Q 039957          207 ----IPTSIGTLKQLQGFFLPETNLQGYV  231 (481)
Q Consensus       207 ----~p~~~~~l~~L~~l~l~~n~l~~~~  231 (481)
                          ++..+...++|+.|++++|.++...
T Consensus       227 g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g  255 (372)
T 3un9_A          227 AALALARAAREHPSLELLHLYFNELSSEG  255 (372)
T ss_dssp             HHHHHHHHHHHCSSCCEEECTTSSCCHHH
T ss_pred             HHHHHHHHHHhCCCCCEEeccCCCCCHHH
Confidence                3344556788999999999987543

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=99.18  E-value=5.1e-09  Score=102.31  Aligned_cols=303  Identities=8%  Similarity=0.017  Sum_probs=164.5

Q ss_pred             hhCCCCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccC
Q 039957            9 IGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKL   88 (481)
Q Consensus         9 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L   88 (481)
                      +....+|+.+.+.. .++.+...+|.++.+|+.+++..+ ++ .++...|.. .+|+.+.+..+ ++.+-..+|... +|
T Consensus        42 ~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~-~Ig~~aF~~-c~l~~i~~~~~-l~~I~~~aF~~~-~L  115 (379)
T 4h09_A           42 YKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VT-SIGDGAFAD-TKLQSYTGMER-VKKFGDYVFQGT-DL  115 (379)
T ss_dssp             GGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CC-EECTTTTTT-CCCCEEEECTT-CCEECTTTTTTC-CC
T ss_pred             cccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ce-EechhhhcC-CCCceEECCce-eeEeccceeccC-Cc
Confidence            45556777777754 577777778888888888888654 65 666666644 36777777654 444445556554 68


Q ss_pred             ceeecccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChh-------
Q 039957           89 IILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPS-------  161 (481)
Q Consensus        89 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~-------  161 (481)
                      +.+.+..+ ++.+...+|.+. +|+...+.. .++.+...+        +..+..++...+..+.........       
T Consensus       116 ~~i~lp~~-~~~i~~~~F~~~-~l~~~~~~~-~v~~i~~~~--------f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  184 (379)
T 4h09_A          116 DDFEFPGA-TTEIGNYIFYNS-SVKRIVIPK-SVTTIKDGI--------GYKAENLEKIEVSSNNKNYVAENYVLYNKNK  184 (379)
T ss_dssp             SEEECCTT-CCEECTTTTTTC-CCCEEEECT-TCCEECSCT--------TTTCTTCCEEEECTTCSSEEEETTEEEETTS
T ss_pred             ccccCCCc-cccccccccccc-eeeeeeccc-eeeccccch--------hcccccccccccccccceeecccceeccccc
Confidence            88877654 333444555543 455555432 233332222        345556666665544332111000       


Q ss_pred             -----hhhcccCccEEEccCCceeecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCcccc
Q 039957          162 -----IGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLC  236 (481)
Q Consensus       162 -----~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~  236 (481)
                           +... ..+..+.+.... .......+....+|+.+.+..+ +.......|..+..|+.+.+..+ ++.....+|.
T Consensus       185 ~~~~~~~~~-~~~~~~~~~~~~-~~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~  260 (379)
T 4h09_A          185 TILESYPAA-KTGTEFTIPSTV-KTVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQ  260 (379)
T ss_dssp             SEEEECCTT-CCCSEEECCTTC-CEECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTT
T ss_pred             ceecccccc-ccccccccccce-eEEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccc
Confidence                 0000 122223222221 1122334455556666655443 33344555666666666666544 4444455666


Q ss_pred             CccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCcCcccCCcchhccccCcEEEccCcccCCCCCCccccCCcCcEE
Q 039957          237 HLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVL  316 (481)
Q Consensus       237 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L  316 (481)
                      ++..|+.+.+..+ +......+|.++++|+.+.+.++.++..-+.+|.++.+|+.+.+..+ ++.+-..+|.++.+|+.+
T Consensus       261 ~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i  338 (379)
T 4h09_A          261 NCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTI  338 (379)
T ss_dssp             TCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCC
T ss_pred             eeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEE
Confidence            6666666666433 44444556666666666666666666555566666666666666543 444445556666666666


Q ss_pred             EccCCeeeeeccccccccC
Q 039957          317 DLSRNQLSGDIPSTIGALV  335 (481)
Q Consensus       317 ~l~~N~l~~~~p~~~~~l~  335 (481)
                      .+..+ ++..-..+|.++.
T Consensus       339 ~ip~~-v~~I~~~aF~~c~  356 (379)
T 4h09_A          339 SYPKS-ITLIESGAFEGSS  356 (379)
T ss_dssp             CCCTT-CCEECTTTTTTSS
T ss_pred             EECCc-cCEEchhHhhCCC
Confidence            66443 4434445555543

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=99.14  E-value=8.7e-09  Score=100.66  Aligned_cols=291  Identities=6%  Similarity=0.007  Sum_probs=203.6

Q ss_pred             cchhCCCCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccc
Q 039957            7 TEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNAT   86 (481)
Q Consensus         7 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~   86 (481)
                      .+|.++++|+.++|.. .++.+...+|.++ +|+.+.+..+ ++ .++...+ ...+|+.+.+..+- +..-..+|.++ 
T Consensus        63 ~aF~~C~~L~~I~lp~-~v~~Ig~~aF~~c-~l~~i~~~~~-l~-~I~~~aF-~~~~L~~i~lp~~~-~~i~~~~F~~~-  135 (379)
T 4h09_A           63 ANFNSCYNMTKVTVAS-TVTSIGDGAFADT-KLQSYTGMER-VK-KFGDYVF-QGTDLDDFEFPGAT-TEIGNYIFYNS-  135 (379)
T ss_dssp             TTTTTCTTCCEEEECT-TCCEECTTTTTTC-CCCEEEECTT-CC-EECTTTT-TTCCCSEEECCTTC-CEECTTTTTTC-
T ss_pred             HHhhCCCCCCEEEeCC-cceEechhhhcCC-CCceEECCce-ee-Eecccee-ccCCcccccCCCcc-ccccccccccc-
Confidence            3699999999999975 4888888899987 7888888755 55 6777777 45689999998764 43555566665 


Q ss_pred             cCceeecccCcceecCcccccCCCCCCEEEcccccCccccCCCccc----cccccCCCCCCCcEEEccCCccceeCChhh
Q 039957           87 KLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQW----SFLSSLTNCRYLVYLILSGNPLGGILPPSI  162 (481)
Q Consensus        87 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~----~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~  162 (481)
                      +|..+.+-. .++.+....|.....++...+..+............    .....+.....+....+..+.- ......+
T Consensus       136 ~l~~~~~~~-~v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~i~~~~f  213 (379)
T 4h09_A          136 SVKRIVIPK-SVTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGTEFTIPSTVK-TVTAYGF  213 (379)
T ss_dssp             CCCEEEECT-TCCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCSEEECCTTCC-EECTTTT
T ss_pred             eeeeeeccc-eeeccccchhcccccccccccccccceeecccceecccccceecccccccccccccccccee-EEeeccc
Confidence            576666654 456577788999999999988766543322111100    0112233444555555544322 2233333


Q ss_pred             hhcccCccEEEccCCceeecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCC
Q 039957          163 GNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLN  242 (481)
Q Consensus       163 ~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~  242 (481)
                      ... ..++.+.+..+ +...-...|.++..|+.+.+..+ ++..-...|.++..|+.+.+..+ +.......|.++.+|+
T Consensus       214 ~~~-~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~  289 (379)
T 4h09_A          214 SYG-KNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLT  289 (379)
T ss_dssp             TTC-SSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCC
T ss_pred             ccc-cccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccc
Confidence            333 56888877655 44355667888889999988766 66566778888999999988654 6656667888999999


Q ss_pred             eeecCCCeeeecCCcccccCCCCCcEEcCCCcCcccCCcchhccccCcEEEccCcccCCCCCCccccCCc
Q 039957          243 LLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKV  312 (481)
Q Consensus       243 ~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~  312 (481)
                      .+.+.++.++.+...+|.++.+|+.+.+..+ ++..-..+|.++.+|+.+.+..+ ++.+-..+|.+...
T Consensus       290 ~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c~~  357 (379)
T 4h09_A          290 KVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGSSI  357 (379)
T ss_dssp             EEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTSSC
T ss_pred             cccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCCCC
Confidence            9999988888778889999999999999754 66666778889999999888655 55455566766543

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.98  E-value=7.6e-10  Score=106.79  Aligned_cols=187  Identities=14%  Similarity=0.193  Sum_probs=94.5

Q ss_pred             CCCCeeeCcCCcccc-cC-------ChhccCCcCCCEEEeeCCcCc---------cccChhhhcCCCCccEEEccCccce
Q 039957           13 QNLKSLFLGANNLSG-LI-------PPMIFNISTIRNLNLGGNRLS---------GHLPSMIGHSLPNIKYLELGDNNLI   75 (481)
Q Consensus        13 ~~L~~L~L~~N~l~~-~~-------p~~~~~l~~L~~L~L~~N~l~---------~~~p~~~~~~l~~L~~L~L~~N~l~   75 (481)
                      ..++.|.+......+ ..       ..+...+++|+.|.+..+...         +.++..+. .+|+|+.|+|++|.-.
T Consensus       107 ~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~-~~P~L~~L~L~g~~~l  185 (362)
T 2ra8_A          107 PSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLD-AMPLLNNLKIKGTNNL  185 (362)
T ss_dssp             GGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHH-TCTTCCEEEEECCBTC
T ss_pred             hhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHh-cCCCCcEEEEeCCCCc
Confidence            346677777555432 11       223445678888887655321         12333333 6788888888877311


Q ss_pred             eecchhccccccCceeecccCcceecCccccc--CCCCCCEEEccc--ccCccccCCCccccccccCCCCCCCcEEEccC
Q 039957           76 GTIPNSITNATKLIILDLGFNTFSGHIPNTFG--NLRHLSVLSLLM--NNLTTESSSAYQWSFLSSLTNCRYLVYLILSG  151 (481)
Q Consensus        76 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~L~~--N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~  151 (481)
                       .++. + .+++|+.|++..+.++......+.  .+++|++|+|+.  |...+.... -.....-.-..+++|++|+|++
T Consensus       186 -~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~-~~l~~~l~~~~~p~Lr~L~L~~  261 (362)
T 2ra8_A          186 -SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDM-NVFRPLFSKDRFPNLKWLGIVD  261 (362)
T ss_dssp             -BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCG-GGTGGGSCTTTCTTCCEEEEES
T ss_pred             -eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhH-HHHHHHHhcCCCCCcCEEeCCC
Confidence             2232 3 367888888887776644333443  678888888753  221111000 0000000112456777777777


Q ss_pred             CccceeCChhhhh--cccCccEEEccCCceeec----CCcccccCCCCCeEecccccce
Q 039957          152 NPLGGILPPSIGN--FSTSLQRFSASECKLKGT----IPKEIGHLRGLIYLSLGFNDLN  204 (481)
Q Consensus       152 N~l~~~~p~~~~~--~~~~L~~L~l~~n~l~~~----~p~~~~~l~~L~~L~l~~N~l~  204 (481)
                      |.++...+..+..  ..++|++|+++.|.+...    ++..+..+++|+.|++++|.++
T Consensus       262 ~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~  320 (362)
T 2ra8_A          262 AEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS  320 (362)
T ss_dssp             CTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCC
T ss_pred             CCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCC
Confidence            7776433222221  123455555555555432    1222233445555555555443

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.91  E-value=5.6e-10  Score=107.74  Aligned_cols=186  Identities=15%  Similarity=0.157  Sum_probs=122.6

Q ss_pred             CcchhCCCCCCeeeCcCCccc---------ccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCcccee
Q 039957            6 PTEIGNLQNLKSLFLGANNLS---------GLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIG   76 (481)
Q Consensus         6 p~~~~~l~~L~~L~L~~N~l~---------~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~   76 (481)
                      ..+...+++|+.|.+..+...         +.++..+..+++|+.|+|++|.-. .++. +  .+++|++|+|..|.+..
T Consensus       132 ~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~l~~-~--~~~~L~~L~L~~~~l~~  207 (362)
T 2ra8_A          132 VENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-SIGK-K--PRPNLKSLEIISGGLPD  207 (362)
T ss_dssp             HTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-BCCS-C--BCTTCSEEEEECSBCCH
T ss_pred             HHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-eecc-c--cCCCCcEEEEecCCCCh
Confidence            344667889999999765431         124466778899999999998411 3444 2  38999999999998765


Q ss_pred             ecchhcc--ccccCceeeccc--Ccceec-----Ccccc--cCCCCCCEEEcccccCccccCCCccccccccCCCCCCCc
Q 039957           77 TIPNSIT--NATKLIILDLGF--NTFSGH-----IPNTF--GNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLV  145 (481)
Q Consensus        77 ~~p~~~~--~l~~L~~L~Ls~--N~l~~~-----~p~~~--~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~  145 (481)
                      ..-..+.  .+++|+.|+|+.  |...+.     +...+  ..+++|++|+|++|.+.......     ...-..+++|+
T Consensus       208 ~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~-----la~a~~~~~L~  282 (362)
T 2ra8_A          208 SVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEM-----FLESDILPQLE  282 (362)
T ss_dssp             HHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHH-----HHHCSSGGGCS
T ss_pred             HHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHH-----HHhCccCCCCC
Confidence            4434444  789999999974  221111     11223  35899999999999987431111     01113578999


Q ss_pred             EEEccCCccceeCC----hhhhhcccCccEEEccCCceeecCCcccccCCCCCeEeccccc
Q 039957          146 YLILSGNPLGGILP----PSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFND  202 (481)
Q Consensus       146 ~L~Ls~N~l~~~~p----~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~  202 (481)
                      +|+|+.|.+++.-+    ..+..+ ++|+.|++++|.++...-..+...- ...++++.++
T Consensus       283 ~LdLs~n~L~d~G~~~L~~~L~~l-~~L~~L~L~~n~i~d~~~~~l~~al-g~~~~~~~~~  341 (362)
T 2ra8_A          283 TMDISAGVLTDEGARLLLDHVDKI-KHLKFINMKYNYLSDEMKKELQKSL-PMKIDVSDSQ  341 (362)
T ss_dssp             EEECCSSCCBHHHHHHHHTTHHHH-TTCSEEECCSBBCCHHHHHHHHHHC-CSEEECCSBC
T ss_pred             EEECCCCCCChHHHHHHHhhcccC-CcceEEECCCCcCCHHHHHHHHHHc-CCEEEecCCc
Confidence            99999999986432    222333 6899999999988744333333311 3457777776

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.74  E-value=1.6e-09  Score=99.35  Aligned_cols=89  Identities=22%  Similarity=0.316  Sum_probs=59.1

Q ss_pred             ccCCcCCCE--EEeeCCcCccccChh---hhcCCCCccEEEccCcccee--ecchhccccccCceeecccCcceecCccc
Q 039957           33 IFNISTIRN--LNLGGNRLSGHLPSM---IGHSLPNIKYLELGDNNLIG--TIPNSITNATKLIILDLGFNTFSGHIPNT  105 (481)
Q Consensus        33 ~~~l~~L~~--L~L~~N~l~~~~p~~---~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  105 (481)
                      |...+.|+.  ++++.|+.. .++..   +...+++|++|+|++|+|++  .+|..+..+++|+.|+|++|+|++.  ..
T Consensus       137 l~~dp~L~~~~l~l~~N~~~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~  213 (267)
T 3rw6_A          137 LRSDPDLVAQNIDVVLNRRS-CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RE  213 (267)
T ss_dssp             GGGCHHHHHTTCCCCTTSHH-HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GG
T ss_pred             cCCCcchhhcCccccCCHHH-HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hh
Confidence            444555554  667777543 33322   22357788888888888876  3456677788888888888888765  33


Q ss_pred             ccCCC--CCCEEEcccccCcc
Q 039957          106 FGNLR--HLSVLSLLMNNLTT  124 (481)
Q Consensus       106 ~~~l~--~L~~L~L~~N~l~~  124 (481)
                      +..+.  +|++|+|++|.+++
T Consensus       214 l~~l~~l~L~~L~L~~Npl~~  234 (267)
T 3rw6_A          214 LDKIKGLKLEELWLDGNSLCD  234 (267)
T ss_dssp             GGGGTTSCCSEEECTTSTTGG
T ss_pred             hhhcccCCcceEEccCCcCcc
Confidence            44444  88888888888775

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.72  E-value=3.1e-09  Score=92.57  Aligned_cols=120  Identities=13%  Similarity=0.098  Sum_probs=75.8

Q ss_pred             hhccCCcCCCEEEeeCC-cCccc----cChhhhcCCCCccEEEccCccceee----cchhccccccCceeecccCcceec
Q 039957           31 PMIFNISTIRNLNLGGN-RLSGH----LPSMIGHSLPNIKYLELGDNNLIGT----IPNSITNATKLIILDLGFNTFSGH  101 (481)
Q Consensus        31 ~~~~~l~~L~~L~L~~N-~l~~~----~p~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~  101 (481)
                      ..+...++|++|+|++| .+...    +...+. ..++|++|+|++|++...    +...+...++|++|+|++|.|...
T Consensus        30 ~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~-~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~  108 (185)
T 1io0_A           30 RIQNNDPDLEEVNLNNIMNIPVPTLKACAEALK-TNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGS  108 (185)
T ss_dssp             HHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHT-TCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHH
T ss_pred             HHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHH-hCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHH
Confidence            44556677777777777 66521    222332 456777777777776532    334455557788888888877643


Q ss_pred             ----CcccccCCCCCCEEEc--ccccCccccCCCccccccccCCCCCCCcEEEccCCccc
Q 039957          102 ----IPNTFGNLRHLSVLSL--LMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLG  155 (481)
Q Consensus       102 ----~p~~~~~l~~L~~L~L--~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~  155 (481)
                          +...+...++|++|+|  ++|.+.......    +...+...+.|++|+|++|.+.
T Consensus       109 g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~----l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          109 GILALVEALQSNTSLIELRIDNQSQPLGNNVEME----IANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHH----HHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHH----HHHHHHhCCCcCEEeccCCCCC
Confidence                3556667778888888  778776532111    1133445577888888888875

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=98.71  E-value=2.5e-08  Score=92.05  Aligned_cols=130  Identities=14%  Similarity=0.078  Sum_probs=92.6

Q ss_pred             ccccccceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhhhhc-cCccceeecccCCCC-----cccccCCChhHHh
Q 039957          342 LAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVR-HQNLIKILSSCSTPD-----FKFMPNGSLEKRL  415 (481)
Q Consensus       342 ~~g~~g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-----~~~~~~g~l~~~l  415 (481)
                      ..++.+.||+.... |..+++|............+.+|.++++.+. +..+.++++++...+     ++|++|.++.+..
T Consensus        23 ~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~  101 (263)
T 3tm0_A           23 EGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEY  101 (263)
T ss_dssp             SCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHC
T ss_pred             cCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhcc
Confidence            34556778988643 6789999876532233346788999988885 556667887766543     5788988887653


Q ss_pred             hcCCCccCHHHHHHHHHHHHHHHHHHhcCC--------------------------------------------------
Q 039957          416 YSHNYFLDILERLNIMIDVGSTLEYLHHGH--------------------------------------------------  445 (481)
Q Consensus       416 ~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~--------------------------------------------------  445 (481)
                      ..      ......++.+++++++.||...                                                  
T Consensus       102 ~~------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~  175 (263)
T 3tm0_A          102 ED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLK  175 (263)
T ss_dssp             CT------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHH
T ss_pred             CC------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHH
Confidence            21      1123468889999999999710                                                  


Q ss_pred             -----CCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          446 -----SSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       446 -----~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                           ..+.++|+|++|.||+++++..+.|.||+.|..
T Consensus       176 ~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          176 TEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             HCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             hcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                 014589999999999998766678999998753

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.70  E-value=3.6e-08  Score=90.75  Aligned_cols=124  Identities=14%  Similarity=0.126  Sum_probs=87.9

Q ss_pred             cccccceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCcc--ceeecccCCCC-----cccccCCChhHHh
Q 039957          343 AGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNL--IKILSSCSTPD-----FKFMPNGSLEKRL  415 (481)
Q Consensus       343 ~g~~g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~~~-----~~~~~~g~l~~~l  415 (481)
                      .|..+.||+....+|..+++|.....   ....+..|+++++.+++..+  .+++++....+     ++|+++.++.  .
T Consensus        30 gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~  104 (264)
T 1nd4_A           30 GCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--S  104 (264)
T ss_dssp             TTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--T
T ss_pred             CCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--c
Confidence            45568899988777888999986543   23457789999988875544  45777665543     5688888873  2


Q ss_pred             hcCCCccCHHHHHHHHHHHHHHHHHHhcCC--------------------------------------------------
Q 039957          416 YSHNYFLDILERLNIMIDVGSTLEYLHHGH--------------------------------------------------  445 (481)
Q Consensus       416 ~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~--------------------------------------------------  445 (481)
                      ..    .+   ...++.++++.++.+|...                                                  
T Consensus       105 ~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  177 (264)
T 1nd4_A          105 SH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKAR  177 (264)
T ss_dssp             SC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHT
T ss_pred             Cc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHh
Confidence            11    11   2357778888888888521                                                  


Q ss_pred             ----CCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          446 ----SSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       446 ----~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                          ....++|+|++|.||+++++..++|.|||.|..
T Consensus       178 ~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          178 MPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             CCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                012299999999999998877778999999764

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.63  E-value=6.3e-09  Score=90.63  Aligned_cols=117  Identities=15%  Similarity=0.197  Sum_probs=68.8

Q ss_pred             CCCCccEEEccCc-cceee----cchhccccccCceeecccCcceec----CcccccCCCCCCEEEcccccCccccCCCc
Q 039957           60 SLPNIKYLELGDN-NLIGT----IPNSITNATKLIILDLGFNTFSGH----IPNTFGNLRHLSVLSLLMNNLTTESSSAY  130 (481)
Q Consensus        60 ~l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~~~~~  130 (481)
                      ..++|++|+|++| .+...    +...+...++|++|+|++|.|...    +...+...++|++|+|++|.|......  
T Consensus        34 ~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~--  111 (185)
T 1io0_A           34 NDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL--  111 (185)
T ss_dssp             TCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH--
T ss_pred             cCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHH--
Confidence            4677777777777 66532    334455567777777777777532    334455556777777777777643111  


Q ss_pred             cccccccCCCCCCCcEEEc--cCCccceeCChhhhhc---ccCccEEEccCCcee
Q 039957          131 QWSFLSSLTNCRYLVYLIL--SGNPLGGILPPSIGNF---STSLQRFSASECKLK  180 (481)
Q Consensus       131 ~~~~~~~l~~l~~L~~L~L--s~N~l~~~~p~~~~~~---~~~L~~L~l~~n~l~  180 (481)
                        .+...+...+.|++|+|  ++|.|+..-...+...   .++|++|++++|.+.
T Consensus       112 --~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          112 --ALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             --HHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             --HHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence              11234555667777777  6777764322222211   146777777777764

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.61  E-value=5.5e-09  Score=95.69  Aligned_cols=69  Identities=26%  Similarity=0.341  Sum_probs=39.7

Q ss_pred             cccccCceeecccCccee--cCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCC
Q 039957           83 TNATKLIILDLGFNTFSG--HIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILP  159 (481)
Q Consensus        83 ~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p  159 (481)
                      .++++|+.|+|++|+|++  .+|..+..+++|+.|+|++|+|+++..       +..+..+ +|++|+|++|.+.+.+|
T Consensus       167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~~~-------l~~l~~l-~L~~L~L~~Npl~~~~~  237 (267)
T 3rw6_A          167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERE-------LDKIKGL-KLEELWLDGNSLCDTFR  237 (267)
T ss_dssp             HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSGGG-------GGGGTTS-CCSEEECTTSTTGGGCS
T ss_pred             hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCchh-------hhhcccC-CcceEEccCCcCccccC
Confidence            456667777777776665  334555666666777776666665411       1122233 56666666666655443

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.44  E-value=4.6e-07  Score=87.68  Aligned_cols=132  Identities=14%  Similarity=0.220  Sum_probs=90.3

Q ss_pred             cccccceeeeeccCCcceEEEEEe--ccc-hhhhhhhhHHHHHhhhhcc--CccceeecccCCCC--------cccccCC
Q 039957          343 AGSFGSVYKGTISDGTDVAIKIFN--LQR-ERAFRSFNSECEVLRNVRH--QNLIKILSSCSTPD--------FKFMPNG  409 (481)
Q Consensus       343 ~g~~g~vy~~~l~~g~~vavK~l~--~~~-~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~--------~~~~~~g  409 (481)
                      .|.++.+|+....+ ..+.+|+..  ... ......+.+|.++++.++.  ..+.+++++|....        ++|+++.
T Consensus        48 ~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~  126 (359)
T 3dxp_A           48 GGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGR  126 (359)
T ss_dssp             C-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCB
T ss_pred             CcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCe
Confidence            46778899887654 466677654  221 1223467789999988874  45678888876652        4678877


Q ss_pred             ChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCC--------------------------------------------
Q 039957          410 SLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGH--------------------------------------------  445 (481)
Q Consensus       410 ~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~--------------------------------------------  445 (481)
                      .+.+...   ..++..++..++.+++++|+.||...                                            
T Consensus       127 ~l~~~~~---~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  203 (359)
T 3dxp_A          127 VLWDQSL---PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDW  203 (359)
T ss_dssp             CCCCTTC---TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHH
T ss_pred             ecCCCcc---ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHH
Confidence            7643211   12456778889999999999999621                                            


Q ss_pred             ----------CCCCeeeCCCCCCCeeeCCCCc--EEEccccCccc
Q 039957          446 ----------SSAPIIHCDLKPTSILLDENMV--AHVSDFGISKL  478 (481)
Q Consensus       446 ----------~~~~i~H~dlk~~nill~~~~~--~kl~Dfgl~~~  478 (481)
                                ....+||+|+++.||++++++.  +.|.||+.|..
T Consensus       204 l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          204 LPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             GGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                      0256999999999999998753  68999999864

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.93  E-value=5.6e-06  Score=70.25  Aligned_cols=85  Identities=8%  Similarity=0.036  Sum_probs=57.0

Q ss_pred             CcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCcc-ceeecchhcccc----ccCceeecccCc-ceecCcccccCC
Q 039957           36 ISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNN-LIGTIPNSITNA----TKLIILDLGFNT-FSGHIPNTFGNL  109 (481)
Q Consensus        36 l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l----~~L~~L~Ls~N~-l~~~~p~~~~~l  109 (481)
                      -.+|++||++++.++..--..+. .+++|++|+|++|. ++..--..+..+    ++|++|+|++|. ++..-=..+..+
T Consensus        60 ~~~L~~LDLs~~~Itd~GL~~L~-~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~  138 (176)
T 3e4g_A           60 KYKIQAIDATDSCIMSIGFDHME-GLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHF  138 (176)
T ss_dssp             CCCEEEEEEESCCCCGGGGGGGT-TCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGC
T ss_pred             CceEeEEeCcCCCccHHHHHHhc-CCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcC
Confidence            34688888888887643223343 68888888888885 543222334443    468899998874 765444457788


Q ss_pred             CCCCEEEccccc
Q 039957          110 RHLSVLSLLMNN  121 (481)
Q Consensus       110 ~~L~~L~L~~N~  121 (481)
                      ++|++|++++..
T Consensus       139 ~~L~~L~L~~c~  150 (176)
T 3e4g_A          139 RNLKYLFLSDLP  150 (176)
T ss_dssp             TTCCEEEEESCT
T ss_pred             CCCCEEECCCCC
Confidence            999999998764

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=97.74  E-value=0.0001  Score=69.12  Aligned_cols=127  Identities=20%  Similarity=0.256  Sum_probs=80.1

Q ss_pred             cccccceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhhhhc-cCc--cceeecccCCCC--------cccccCCCh
Q 039957          343 AGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVR-HQN--LIKILSSCSTPD--------FKFMPNGSL  411 (481)
Q Consensus       343 ~g~~g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~l~~~~~~~~--------~~~~~~g~l  411 (481)
                      .|....+|+..    ..+.+|.....  .....+..|.++++.+. +..  +.++++.+...+        ++++++.++
T Consensus        30 ~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l  103 (304)
T 3sg8_A           30 EGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPL  103 (304)
T ss_dssp             ECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEEC
T ss_pred             CCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeEC
Confidence            45556677753    45778875432  23456778898888774 322  234444433222        344777776


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcC-----------------------------------------------
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHG-----------------------------------------------  444 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~-----------------------------------------------  444 (481)
                      .+....   .++..++..++.++++.++.||..                                               
T Consensus       104 ~~~~~~---~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  180 (304)
T 3sg8_A          104 TPLLLN---NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDI  180 (304)
T ss_dssp             CHHHHH---TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHH
T ss_pred             Cccccc---cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHH
Confidence            543221   234456667777777777777741                                               


Q ss_pred             -------CCCCCeeeCCCCCCCeeeCC--CCcEEEccccCccc
Q 039957          445 -------HSSAPIIHCDLKPTSILLDE--NMVAHVSDFGISKL  478 (481)
Q Consensus       445 -------~~~~~i~H~dlk~~nill~~--~~~~kl~Dfgl~~~  478 (481)
                             ...+.++|+|++|.||++++  ...+.|.||+.+..
T Consensus       181 l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~  223 (304)
T 3sg8_A          181 LENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAI  223 (304)
T ss_dssp             HTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEE
T ss_pred             HhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCcc
Confidence                   11245899999999999998  56689999998764

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.71  E-value=2.5e-05  Score=66.23  Aligned_cols=84  Identities=15%  Similarity=0.221  Sum_probs=58.2

Q ss_pred             CCccEEEccCccceeecchhccccccCceeecccCc-ceecCcccccCC----CCCCEEEccccc-CccccCCCcccccc
Q 039957           62 PNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNT-FSGHIPNTFGNL----RHLSVLSLLMNN-LTTESSSAYQWSFL  135 (481)
Q Consensus        62 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l----~~L~~L~L~~N~-l~~~~~~~~~~~~~  135 (481)
                      ..|++||++++.++..--..+..+++|+.|+|+++. ++..-=..+..+    ++|++|+|+++. +|...        .
T Consensus        61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~G--------l  132 (176)
T 3e4g_A           61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKG--------I  132 (176)
T ss_dssp             CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHH--------H
T ss_pred             ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHH--------H
Confidence            468888888888765444556788888888888884 654333345554    368888888874 55321        1


Q ss_pred             ccCCCCCCCcEEEccCCc
Q 039957          136 SSLTNCRYLVYLILSGNP  153 (481)
Q Consensus       136 ~~l~~l~~L~~L~Ls~N~  153 (481)
                      ..+..+++|++|+|+++.
T Consensus       133 ~~L~~~~~L~~L~L~~c~  150 (176)
T 3e4g_A          133 IALHHFRNLKYLFLSDLP  150 (176)
T ss_dssp             HHGGGCTTCCEEEEESCT
T ss_pred             HHHhcCCCCCEEECCCCC
Confidence            345667888888888875

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=97.40  E-value=0.00088  Score=62.84  Aligned_cols=126  Identities=14%  Similarity=0.140  Sum_probs=72.7

Q ss_pred             ccccceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhhhhccC---ccceeecccCC-CC-----cccccCCChhHH
Q 039957          344 GSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQ---NLIKILSSCST-PD-----FKFMPNGSLEKR  414 (481)
Q Consensus       344 g~~g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~~-~~-----~~~~~~g~l~~~  414 (481)
                      |....+|+.    |..+.+|....  ......+..|.+++..+.+.   -+.+++.++.. .+     ++|+++.++.+.
T Consensus        30 G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~  103 (306)
T 3tdw_A           30 GFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGED  103 (306)
T ss_dssp             CSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHH
T ss_pred             CcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchh
Confidence            444567775    56778887422  22345678899999988753   23345555431 11     567777766542


Q ss_pred             hhcCCCccCHHHHHHHHHHHHHHHHHHhcCC-------------------------------------------------
Q 039957          415 LYSHNYFLDILERLNIMIDVGSTLEYLHHGH-------------------------------------------------  445 (481)
Q Consensus       415 l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~-------------------------------------------------  445 (481)
                      ...   .++..++..++.++++.++.||...                                                 
T Consensus       104 ~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l  180 (306)
T 3tdw_A          104 GMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYM  180 (306)
T ss_dssp             HHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHH
T ss_pred             hhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHH
Confidence            110   0122223333333333333333210                                                 


Q ss_pred             -------CCCCeeeCCCCCCCeeeCC---CCc-EEEccccCccc
Q 039957          446 -------SSAPIIHCDLKPTSILLDE---NMV-AHVSDFGISKL  478 (481)
Q Consensus       446 -------~~~~i~H~dlk~~nill~~---~~~-~kl~Dfgl~~~  478 (481)
                             ..+.++|+|+++.||++++   ++. +.|.||+.+..
T Consensus       181 ~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          181 THPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             hCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                   1346799999999999987   455 48999998764

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.38  E-value=8.7e-05  Score=64.17  Aligned_cols=121  Identities=10%  Similarity=0.115  Sum_probs=66.1

Q ss_pred             ccCCcCCCEEEeeCC-cCcc----ccChhhhcCCCCccEEEccCccceee----cchhccccccCceeecccCcceec--
Q 039957           33 IFNISTIRNLNLGGN-RLSG----HLPSMIGHSLPNIKYLELGDNNLIGT----IPNSITNATKLIILDLGFNTFSGH--  101 (481)
Q Consensus        33 ~~~l~~L~~L~L~~N-~l~~----~~p~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~--  101 (481)
                      +.+-+.|++|+|++| +|..    .+-..+. .-+.|++|+|++|+|...    +...+..-+.|+.|+|+.|.|...  
T Consensus        37 l~~n~~L~~L~L~~nn~igd~ga~~la~aL~-~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga  115 (197)
T 1pgv_A           37 REDDTDLKEVNINNMKRVSKERIRSLIEAAC-NSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELL  115 (197)
T ss_dssp             HTTCSSCCEEECTTCCSSCHHHHHHHHHHHT-TCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHH
T ss_pred             HhcCCCccEEECCCCCCCCHHHHHHHHHHHh-hCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHH
Confidence            445566777777764 5531    1223332 346677777777776532    233344557777777777777632  


Q ss_pred             --CcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccc
Q 039957          102 --IPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLG  155 (481)
Q Consensus       102 --~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~  155 (481)
                        +-+++..-+.|++|+|++|....+.... ...+...+..-+.|+.|+++.|.+.
T Consensus       116 ~ala~aL~~N~tL~~L~L~n~~~~~ig~~g-~~~ia~aL~~N~tL~~L~l~~~~~g  170 (197)
T 1pgv_A          116 ARLLRSTLVTQSIVEFKADNQRQSVLGNQV-EMDMMMAIEENESLLRVGISFASME  170 (197)
T ss_dssp             HHHHHHTTTTCCCSEEECCCCSSCCCCHHH-HHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred             HHHHHHHhhCCceeEEECCCCcCcCcCHHH-HHHHHHHHHhCCCcCeEeccCCCcc
Confidence              2334555567888888765321110000 0001123344567888888877654

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.13  E-value=0.00013  Score=63.15  Aligned_cols=89  Identities=16%  Similarity=0.153  Sum_probs=48.4

Q ss_pred             CCCCccEEEccCc-cceee----cchhccccccCceeecccCcceec----CcccccCCCCCCEEEcccccCccccCCCc
Q 039957           60 SLPNIKYLELGDN-NLIGT----IPNSITNATKLIILDLGFNTFSGH----IPNTFGNLRHLSVLSLLMNNLTTESSSAY  130 (481)
Q Consensus        60 ~l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~~~~~  130 (481)
                      .-+.|++|+|++| +|...    +-..+..-+.|+.|+|++|.|...    +.+.+..-+.|++|+|++|+|......  
T Consensus        39 ~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~--  116 (197)
T 1pgv_A           39 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA--  116 (197)
T ss_dssp             TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH--
T ss_pred             cCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHH--
Confidence            3467778888775 55321    334455566777777777777632    223344456677777777766543111  


Q ss_pred             cccccccCCCCCCCcEEEccCC
Q 039957          131 QWSFLSSLTNCRYLVYLILSGN  152 (481)
Q Consensus       131 ~~~~~~~l~~l~~L~~L~Ls~N  152 (481)
                        .+...+..-+.|++|+|++|
T Consensus       117 --ala~aL~~N~tL~~L~L~n~  136 (197)
T 1pgv_A          117 --RLLRSTLVTQSIVEFKADNQ  136 (197)
T ss_dssp             --HHHHHTTTTCCCSEEECCCC
T ss_pred             --HHHHHHhhCCceeEEECCCC
Confidence              11123444445666666543

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.08  E-value=0.00091  Score=64.17  Aligned_cols=32  Identities=16%  Similarity=0.236  Sum_probs=26.8

Q ss_pred             CCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          447 SAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       447 ~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      .+.++|+|+.+.||+++++..+.|.||+.|..
T Consensus       221 ~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~  252 (357)
T 3ats_A          221 EPVLLWGDARVGNVLYRDFQPVAVLDWEMVAL  252 (357)
T ss_dssp             CCEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred             CceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence            35689999999999999655579999998754

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.05  E-value=0.00058  Score=55.00  Aligned_cols=33  Identities=24%  Similarity=0.145  Sum_probs=12.7

Q ss_pred             eeecccCcceecCcccccCCCCCCEEEcccccC
Q 039957           90 ILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNL  122 (481)
Q Consensus        90 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l  122 (481)
                      .|+|++|+|+.+.+..|..+++|++|+|++|.+
T Consensus        35 ~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~   67 (130)
T 3rfe_A           35 ELVLTGNNLTALPPGLLDALPALRTAHLGANPW   67 (130)
T ss_dssp             EEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred             EEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence            333333333333333333444444444444433

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.95  E-value=0.0011  Score=53.40  Aligned_cols=55  Identities=27%  Similarity=0.405  Sum_probs=26.0

Q ss_pred             eeeCcCCccc-ccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccc
Q 039957           17 SLFLGANNLS-GLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNL   74 (481)
Q Consensus        17 ~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l   74 (481)
                      +++.+++.++ ..+|..+  -++|++|+|++|+|+ .+|...+..+++|++|+|++|.+
T Consensus        12 ~v~Cs~~~L~~~~vP~~l--p~~l~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~NP~   67 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAF--PVDTTELVLTGNNLT-ALPPGLLDALPALRTAHLGANPW   67 (130)
T ss_dssp             EEECCSSCCCTTTSCSCC--CTTCSEEECTTSCCS-SCCTTTGGGCTTCCEEECCSSCC
T ss_pred             EEEeCCCCCccccCCCCC--CcCCCEEECCCCcCC-ccChhhhhhccccCEEEecCCCe
Confidence            4555555554 1223221  123555555555555 44444444455555555555544

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=96.90  E-value=0.0044  Score=56.70  Aligned_cols=123  Identities=18%  Similarity=0.146  Sum_probs=73.9

Q ss_pred             ceeeeecc-CCcceEEEEEeccchhhhhhhhHHHHHhhhhcc-CccceeecccCCCC-----cccccCCChhHHhhcCCC
Q 039957          348 SVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECEVLRNVRH-QNLIKILSSCSTPD-----FKFMPNGSLEKRLYSHNY  420 (481)
Q Consensus       348 ~vy~~~l~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~-----~~~~~~g~l~~~l~~~~~  420 (481)
                      .+|+.... ++..+.+|.-...   ....+..|.+.++.+.. --+.++++++...+     ++++++.++.+.....  
T Consensus        40 ~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~--  114 (272)
T 4gkh_A           40 TIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY--  114 (272)
T ss_dssp             EEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC--
T ss_pred             eEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCC--
Confidence            47876544 4567788875432   23456778888877642 12446666666554     5677776665433211  


Q ss_pred             ccCHHHHHHHHHHHHHHHHHHhcC------------------------------------------------------CC
Q 039957          421 FLDILERLNIMIDVGSTLEYLHHG------------------------------------------------------HS  446 (481)
Q Consensus       421 ~~~~~~~~~i~~~ia~~l~~lH~~------------------------------------------------------~~  446 (481)
                         ...+..++.++++.++-||..                                                      ..
T Consensus       115 ---~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  191 (272)
T 4gkh_A          115 ---PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSP  191 (272)
T ss_dssp             ---GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCC
T ss_pred             ---HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccC
Confidence               011223344444444444421                                                      00


Q ss_pred             CCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          447 SAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       447 ~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      .+.++|+|+.+.||++++++.+-|.||+.+..
T Consensus       192 ~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          192 DSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             CEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             CcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence            12379999999999999888788999998764

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=96.08  E-value=0.026  Score=54.74  Aligned_cols=31  Identities=29%  Similarity=0.350  Sum_probs=26.2

Q ss_pred             CCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          447 SAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       447 ~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      .+.++|+|+.+.||+++++ .+++.||..|..
T Consensus       226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~  256 (397)
T 2olc_A          226 AETLIHGDLHTGSIFASEH-ETKVIDPEFAFY  256 (397)
T ss_dssp             CCEEECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             CCceeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence            3579999999999999876 489999987754

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=95.79  E-value=0.03  Score=51.65  Aligned_cols=46  Identities=17%  Similarity=0.099  Sum_probs=33.6

Q ss_pred             ccccccceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhhhhc
Q 039957          342 LAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVR  387 (481)
Q Consensus       342 ~~g~~g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~  387 (481)
                      +.|..+.+|+.++.||..+.+|+...........|..|.+.|+.+.
T Consensus        24 g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~   69 (288)
T 3f7w_A           24 GHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLG   69 (288)
T ss_dssp             EEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHT
T ss_pred             CCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHH
Confidence            4577788999999999999999764333333345678888888774

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=95.02  E-value=0.046  Score=50.72  Aligned_cols=31  Identities=23%  Similarity=0.328  Sum_probs=25.7

Q ss_pred             CCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          447 SAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       447 ~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      ...++|+|+.+.||+ .+++.+.+.||..|..
T Consensus       172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             CCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             CceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            345899999999999 5667789999998754

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=94.50  E-value=0.036  Score=52.32  Aligned_cols=32  Identities=28%  Similarity=0.305  Sum_probs=28.7

Q ss_pred             CCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          447 SAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       447 ~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      ...+||+|+++.||+++.++.+.|.||+.|..
T Consensus       221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             SCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             cCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            46799999999999998888999999998753

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=94.09  E-value=0.053  Score=53.18  Aligned_cols=30  Identities=27%  Similarity=0.332  Sum_probs=25.0

Q ss_pred             CCeeeCCCCCCCeeeCCC----------------------------CcEEEccccCcc
Q 039957          448 APIIHCDLKPTSILLDEN----------------------------MVAHVSDFGISK  477 (481)
Q Consensus       448 ~~i~H~dlk~~nill~~~----------------------------~~~kl~Dfgl~~  477 (481)
                      ..++|+|+.+.|||++++                            +.+.|.||..|.
T Consensus       249 ~v~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfEya~  306 (429)
T 1nw1_A          249 VTFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYAS  306 (429)
T ss_dssp             EEEECSCCCGGGEEEEC------------------------------CCEECCCTTCE
T ss_pred             eEEEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecccCC
Confidence            468999999999999875                            679999998875

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=92.70  E-value=1.1  Score=41.45  Aligned_cols=127  Identities=12%  Similarity=0.096  Sum_probs=73.2

Q ss_pred             cccccceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhhhhcc---CccceeecccCCCC-----cccccCCChh--
Q 039957          343 AGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRH---QNLIKILSSCSTPD-----FKFMPNGSLE--  412 (481)
Q Consensus       343 ~g~~g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h---~niv~l~~~~~~~~-----~~~~~~g~l~--  412 (481)
                      .|....+|+... ++..+.+|.....   ....+..|.+.++.+..   .-+.++++++...+     ++|+++..+.  
T Consensus        46 gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~~~~  121 (312)
T 3jr1_A           46 SGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKNKQS  121 (312)
T ss_dssp             CSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCCCTT
T ss_pred             CccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCCCch
Confidence            456677888765 4567778876532   23456778888877742   34556666654433     5677765441  


Q ss_pred             ------H---HhhcCCC---------------------ccCHHHHH---HHHHH----------------HH-HHHHHHh
Q 039957          413 ------K---RLYSHNY---------------------FLDILERL---NIMID----------------VG-STLEYLH  442 (481)
Q Consensus       413 ------~---~l~~~~~---------------------~~~~~~~~---~i~~~----------------ia-~~l~~lH  442 (481)
                            +   .+|....                     .-+|.+..   ++..+                +. +..+.|.
T Consensus       122 ~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~~L~  201 (312)
T 3jr1_A          122 SFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVADTLS  201 (312)
T ss_dssp             HHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHHHHT
T ss_pred             hHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHHHhc
Confidence                  1   1222100                     12464322   11111                11 1223443


Q ss_pred             cCCCCCCeeeCCCCCCCeeeCCCCcEEEcccc
Q 039957          443 HGHSSAPIIHCDLKPTSILLDENMVAHVSDFG  474 (481)
Q Consensus       443 ~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfg  474 (481)
                      .....+.+||+|+.+.|++++.++ +.|.||+
T Consensus       202 ~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          202 KHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             TCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             cCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            212257799999999999999887 8899984

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=91.69  E-value=0.18  Score=49.23  Aligned_cols=31  Identities=26%  Similarity=0.389  Sum_probs=27.5

Q ss_pred             CCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          447 SAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       447 ~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      .+.++|+|+++.||++++++ ++|.||+.+..
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~  261 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY  261 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence            56799999999999998876 99999998764

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=88.94  E-value=0.5  Score=44.26  Aligned_cols=32  Identities=25%  Similarity=0.311  Sum_probs=27.7

Q ss_pred             CCCeeeCCCCCCCeeeCCC----CcEEEccccCccc
Q 039957          447 SAPIIHCDLKPTSILLDEN----MVAHVSDFGISKL  478 (481)
Q Consensus       447 ~~~i~H~dlk~~nill~~~----~~~kl~Dfgl~~~  478 (481)
                      ...+||+|+.+.||+++++    ..+.|.||+.|..
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            4579999999999999875    7899999998764

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=87.71  E-value=0.19  Score=46.82  Aligned_cols=31  Identities=23%  Similarity=0.344  Sum_probs=26.8

Q ss_pred             CCCeeeCCCCCCCeeeCCCCcEEEccccCcc
Q 039957          447 SAPIIHCDLKPTSILLDENMVAHVSDFGISK  477 (481)
Q Consensus       447 ~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~  477 (481)
                      ...++|+|+.+.||+++++..+.|.||+.+.
T Consensus       186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          186 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             CcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            3578999999999999987667899999875

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=87.70  E-value=0.51  Score=44.00  Aligned_cols=30  Identities=17%  Similarity=0.173  Sum_probs=25.8

Q ss_pred             CCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          447 SAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       447 ~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      ...++|+|+++.||+++ + .+.|.||+.|..
T Consensus       194 ~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          194 TVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             CeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            35689999999999999 4 899999988754

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=86.67  E-value=0.34  Score=45.66  Aligned_cols=32  Identities=16%  Similarity=0.282  Sum_probs=28.2

Q ss_pred             CCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          447 SAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       447 ~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      ...++|+|+.+.||++++++.+.|.||+.+..
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            35799999999999999888899999987754

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=82.81  E-value=0.59  Score=44.50  Aligned_cols=30  Identities=23%  Similarity=0.328  Sum_probs=24.9

Q ss_pred             CCCeeeCCCCCCCeeeCCCCcEEEccccCcc
Q 039957          447 SAPIIHCDLKPTSILLDENMVAHVSDFGISK  477 (481)
Q Consensus       447 ~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~  477 (481)
                      ...++|+|+++.||+++++. +.|.||..|.
T Consensus       211 ~~~l~HgDl~~~Nil~~~~~-~~lID~e~a~  240 (369)
T 3c5i_A          211 TIVFCHNDLQENNIINTNKC-LRLIDFEYSG  240 (369)
T ss_dssp             CEEEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred             CeEEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence            34689999999999998655 8999998775

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=82.64  E-value=1.3  Score=43.62  Aligned_cols=31  Identities=29%  Similarity=0.400  Sum_probs=26.6

Q ss_pred             CCCeeeCCCCCCCeeeC-------------------------------------CCCcEEEccccCcc
Q 039957          447 SAPIIHCDLKPTSILLD-------------------------------------ENMVAHVSDFGISK  477 (481)
Q Consensus       447 ~~~i~H~dlk~~nill~-------------------------------------~~~~~kl~Dfgl~~  477 (481)
                      ...++|+|+.+.|||++                                     +++.+.|.||..|.
T Consensus       289 ~~v~cHnDl~~gNIL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~lIDfEya~  356 (458)
T 2qg7_A          289 PIVLCHCDLLSSNIINTVGGGEAGELGEAGETGEGGETGEGGETGEGGETGEGGEGDSISFIDFEYSC  356 (458)
T ss_dssp             CEEEECSCCCGGGEEECCC-----------------------------------CCCCEEECCCTTCE
T ss_pred             CeeEEecCCCCCcEEeecccccccccccccccccccccccccccccccccccCCCCCeEEEEeecCCC
Confidence            34689999999999998                                     46789999998875

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=80.19  E-value=1.6  Score=41.80  Aligned_cols=32  Identities=25%  Similarity=0.283  Sum_probs=27.7

Q ss_pred             CCCeeeCCCCCCCeeeCCC----CcEEEccccCccc
Q 039957          447 SAPIIHCDLKPTSILLDEN----MVAHVSDFGISKL  478 (481)
Q Consensus       447 ~~~i~H~dlk~~nill~~~----~~~kl~Dfgl~~~  478 (481)
                      ...++|+|+.+.||+++++    +.+.+.||..|..
T Consensus       219 ~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          219 PVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             CEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             CcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            4568999999999999876    7899999998753

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	481
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-33
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-31
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-30
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-30
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	6e-30
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-29
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	6e-29
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	7e-29
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-28
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-28
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-28
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-27
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-27
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-27
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-27
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	4e-27
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-26
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-26
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-26
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-25
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-25
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-25
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-25
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	8e-25
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	9e-25
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-24
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-24
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-24
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-24
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	8e-24
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-23
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-23
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-23
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-23
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-23
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-22
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-21
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-21
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	6e-21
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	8e-21
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-20
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-20
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-20
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-20
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-20
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-19
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-19
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-19
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	6e-19
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	6e-19
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-18
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-18
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	4e-18
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	5e-18
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	5e-18
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-17
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-17
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-17
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	6e-17
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-16
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	3e-16
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	5e-08
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-16
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	9e-16
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-15
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	7e-13
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	7e-10
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	0.004
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-15
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	4e-15
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-12
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	6e-11
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-06
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	7e-12
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	4e-11
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	8e-12
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-06
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	1e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	8e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.002
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.004
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	1e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	5e-05
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-05
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	4e-05
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	4e-04
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	8e-04
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	0.001
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	0.003
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	1e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	3e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	4e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	0.001
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	0.002
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	6e-05
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	4e-04
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	0.002
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	0.002

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 1e-33
 Identities = 41/144 (28%), Positives = 71/144 (49%), Gaps = 12/144 (8%)

Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTP 401
           GSFG+VYKG      DVA+K+ N+     +  ++F +E  VLR  RH N++  +   + P
Sbjct: 19  GSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP 76

Query: 402 D----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKP 457
                 ++    SL   L+      ++++ ++I       ++YLH       IIH DLK 
Sbjct: 77  QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA----KSIIHRDLKS 132

Query: 458 TSILLDENMVAHVSDFGISKLLGE 481
            +I L E++   + DFG++ +   
Sbjct: 133 NNIFLHEDLTVKIGDFGLATVKSR 156

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (300), Expect = 3e-31
 Identities = 34/144 (23%), Positives = 59/144 (40%), Gaps = 10/144 (6%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           G+FG VYK          A K+ + + E     +  E ++L +  H N++K+L +    +
Sbjct: 23  GAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN 82

Query: 403 -----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKP 457
                 +F   G+++  +      L   +   +       L YLH       IIH DLK 
Sbjct: 83  NLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH----DNKIIHRDLKA 138

Query: 458 TSILLDENMVAHVSDFGISKLLGE 481
            +IL   +    ++DFG+S     
Sbjct: 139 GNILFTLDGDIKLADFGVSAKNTR 162

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (292), Expect = 3e-30
 Identities = 34/143 (23%), Positives = 73/143 (51%), Gaps = 10/143 (6%)

Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD- 402
           G FG V+ G  +  T VA+K    Q   +  +F +E  +++ ++HQ L+++ +  +    
Sbjct: 24  GQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI 82

Query: 403 ---FKFMPNGSLEKRLYSHNYF-LDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPT 458
               ++M NGSL   L + +   L I + L++   +   + ++         IH DL+  
Sbjct: 83  YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE----ERNYIHRDLRAA 138

Query: 459 SILLDENMVAHVSDFGISKLLGE 481
           +IL+ + +   ++DFG+++L+ +
Sbjct: 139 NILVSDTLSCKIADFGLARLIED 161

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (292), Expect = 3e-30
 Identities = 36/146 (24%), Positives = 62/146 (42%), Gaps = 12/146 (8%)

Query: 344 GSFGSVYKGTI---SDGTDVAIKIFNLQRERAFR-SFNSECEVLRNVRHQNLIKILSSCS 399
           G+FGSV +G         DVAIK+     E+A       E +++  + +  +++++  C 
Sbjct: 20  GNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ 79

Query: 400 TPD----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDL 455
                   +    G L K L      + +     ++  V   ++YL         +H DL
Sbjct: 80  AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE----KNFVHRDL 135

Query: 456 KPTSILLDENMVAHVSDFGISKLLGE 481
              ++LL     A +SDFG+SK LG 
Sbjct: 136 AARNVLLVNRHYAKISDFGLSKALGA 161

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 6e-30
 Identities = 36/145 (24%), Positives = 64/145 (44%), Gaps = 11/145 (7%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRS-FNSECEVLRNVRHQNLIKILSSCSTP 401
           G+ G V+K +    G  +A K+ +L+ + A R+    E +VL       ++    +  + 
Sbjct: 17  GNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD 76

Query: 402 D-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLK 456
                  + M  GSL++ L      +       + I V   L YL   H    I+H D+K
Sbjct: 77  GEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLREKHK---IMHRDVK 132

Query: 457 PTSILLDENMVAHVSDFGISKLLGE 481
           P++IL++      + DFG+S  L +
Sbjct: 133 PSNILVNSRGEIKLCDFGVSGQLID 157

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  115 bits (288), Expect = 2e-29
 Identities = 36/147 (24%), Positives = 59/147 (40%), Gaps = 14/147 (9%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNL---QRERAFRSFNSECEVLRNVRHQNLIKILSSCS 399
           GSFG+VY    + +   VAIK  +    Q    ++    E   L+ +RH N I+      
Sbjct: 26  GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 85

Query: 400 TPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
                    ++    + +     H   L  +E   +       L YLH    S  +IH D
Sbjct: 86  REHTAWLVMEYCLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLH----SHNMIHRD 140

Query: 455 LKPTSILLDENMVAHVSDFGISKLLGE 481
           +K  +ILL E  +  + DFG + ++  
Sbjct: 141 VKAGNILLSEPGLVKLGDFGSASIMAP 167

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 6e-29
 Identities = 39/143 (27%), Positives = 72/143 (50%), Gaps = 10/143 (6%)

Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPDF 403
           G FG V+ GT +  T VAIK           +F  E +V++ +RH+ L+++ +  S    
Sbjct: 28  GCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSEEPI 86

Query: 404 ----KFMPNGSLEKRLYSHNYFLDIL-ERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPT 458
               ++M  GSL   L         L + +++   + S + Y+   +     +H DL+  
Sbjct: 87  YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN----YVHRDLRAA 142

Query: 459 SILLDENMVAHVSDFGISKLLGE 481
           +IL+ EN+V  V+DFG+++L+ +
Sbjct: 143 NILVGENLVCKVADFGLARLIED 165

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (282), Expect = 7e-29
 Identities = 34/152 (22%), Positives = 60/152 (39%), Gaps = 14/152 (9%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCST 400
           GS+G   K    SDG  +  K  +     E   +   SE  +LR ++H N+++       
Sbjct: 15  GSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID 74

Query: 401 PD-------FKFMPNGSLEKRLYSH---NYFLDILERLNIMIDVGSTLEYLH-HGHSSAP 449
                     ++   G L   +        +LD    L +M  +   L+  H        
Sbjct: 75  RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHT 134

Query: 450 IIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
           ++H DLKP ++ LD      + DFG++++L  
Sbjct: 135 VLHRDLKPANVFLDGKQNVKLGDFGLARILNH 166

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (278), Expect = 1e-28
 Identities = 39/143 (27%), Positives = 63/143 (44%), Gaps = 10/143 (6%)

Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD- 402
           G FG V  G      DVAIK+           F  E +V+ N+ H+ L+++   C+    
Sbjct: 15  GQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTKQRP 73

Query: 403 ----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPT 458
                ++M NG L   L    +     + L +  DV   +EYL         +H DL   
Sbjct: 74  IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES----KQFLHRDLAAR 129

Query: 459 SILLDENMVAHVSDFGISKLLGE 481
           + L+++  V  VSDFG+S+ + +
Sbjct: 130 NCLVNDQGVVKVSDFGLSRYVLD 152

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (278), Expect = 2e-28
 Identities = 43/145 (29%), Positives = 66/145 (45%), Gaps = 14/145 (9%)

Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD- 402
           G FG V  G    G  VA+K   ++ +   ++F +E  V+  +RH NL+++L        
Sbjct: 18  GEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 74

Query: 403 -----FKFMPNGSLEKRLYSHNY-FLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLK 456
                 ++M  GSL   L S     L     L   +DV   +EYL         +H DL 
Sbjct: 75  GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE----GNNFVHRDLA 130

Query: 457 PTSILLDENMVAHVSDFGISKLLGE 481
             ++L+ E+ VA VSDFG++K    
Sbjct: 131 ARNVLVSEDNVAKVSDFGLTKEASS 155

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (280), Expect = 2e-28
 Identities = 36/151 (23%), Positives = 70/151 (46%), Gaps = 17/151 (11%)

Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPDF 403
           G FG V++G    G +VA+KIF+ + ER++    +E      +RH+N++  +++ +  + 
Sbjct: 14  GRFGEVWRGKW-RGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADNKDNG 71

Query: 404 K---------FMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHG----HSSAPI 450
                     +  +GSL   L  + Y + +   + + +   S L +LH           I
Sbjct: 72  TWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAI 129

Query: 451 IHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
            H DLK  +IL+ +N    ++D G++     
Sbjct: 130 AHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  110 bits (275), Expect = 1e-27
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)

Query: 344 GSFGSVYKG----TISDGTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSC 398
           G FG V  G           VAIK       E+  R F SE  ++    H N+I +    
Sbjct: 37  GEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVV 96

Query: 399 STPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHC 453
           +         +FM NGSL+  L  ++    +++ + ++  + + ++YL   +     +H 
Sbjct: 97  TKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN----YVHR 152

Query: 454 DLKPTSILLDENMVAHVSDFGISKLLGE 481
           DL   +IL++ N+V  VSDFG+S+ L +
Sbjct: 153 DLAARNILVNSNLVCKVSDFGLSRFLED 180

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  110 bits (277), Expect = 1e-27
 Identities = 32/146 (21%), Positives = 63/146 (43%), Gaps = 12/146 (8%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           G+FG V++ T  + G + A K      E    +   E + +  +RH  L+ +  +    +
Sbjct: 37  GAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN 96

Query: 403 -----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKP 457
                ++FM  G L +++   +  +   E +  M  V   L ++H  +     +H DLKP
Sbjct: 97  EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN----YVHLDLKP 152

Query: 458 TSILL--DENMVAHVSDFGISKLLGE 481
            +I+     +    + DFG++  L  
Sbjct: 153 ENIMFTTKRSNELKLIDFGLTAHLDP 178

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  109 bits (274), Expect = 1e-27
 Identities = 40/145 (27%), Positives = 65/145 (44%), Gaps = 12/145 (8%)

Query: 344 GSFGSVYKGTISD-GTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           G +G VY+G        VA+K            F  E  V++ ++H NL+++L  C+   
Sbjct: 28  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCTREP 86

Query: 403 -----FKFMPNGSLEKRLYSHNYF-LDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLK 456
                 +FM  G+L   L   N   +  +  L +   + S +EYL         IH DL 
Sbjct: 87  PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE----KKNFIHRDLA 142

Query: 457 PTSILLDENMVAHVSDFGISKLLGE 481
             + L+ EN +  V+DFG+S+L+  
Sbjct: 143 ARNCLVGENHLVKVADFGLSRLMTG 167

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (271), Expect = 2e-27
 Identities = 33/147 (22%), Positives = 61/147 (41%), Gaps = 14/147 (9%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFN---LQRERAFRSFNSECEVLRNVRHQNLIKILSSCS 399
           G FG+VY          +A+K+     L++         E E+  ++RH N++++     
Sbjct: 17  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 76

Query: 400 TPDFKF-----MPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
                +      P G++ + L   + F D       + ++ + L Y H    S  +IH D
Sbjct: 77  DATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALSYCH----SKRVIHRD 131

Query: 455 LKPTSILLDENMVAHVSDFGISKLLGE 481
           +KP ++LL       ++DFG S     
Sbjct: 132 IKPENLLLGSAGELKIADFGWSVHAPS 158

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (268), Expect = 4e-27
 Identities = 40/143 (27%), Positives = 61/143 (42%), Gaps = 10/143 (6%)

Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD- 402
           G FG V+ G   +   VAIK            F  E EV+  + H  L+++   C     
Sbjct: 16  GQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 74

Query: 403 ----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPT 458
               F+FM +G L   L +          L + +DV   + YL        +IH DL   
Sbjct: 75  ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC----VIHRDLAAR 130

Query: 459 SILLDENMVAHVSDFGISKLLGE 481
           + L+ EN V  VSDFG+++ + +
Sbjct: 131 NCLVGENQVIKVSDFGMTRFVLD 153

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  107 bits (269), Expect = 2e-26
 Identities = 32/146 (21%), Positives = 61/146 (41%), Gaps = 12/146 (8%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           G+FG V++    + G     K  N        +  +E  ++  + H  LI +  +     
Sbjct: 40  GAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY 99

Query: 403 -----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKP 457
                 +F+  G L  R+ + +Y +   E +N M      L+++H       I+H D+KP
Sbjct: 100 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH----EHSIVHLDIKP 155

Query: 458 TSILLDENMVAHV--SDFGISKLLGE 481
            +I+ +    + V   DFG++  L  
Sbjct: 156 ENIMCETKKASSVKIIDFGLATKLNP 181

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (262), Expect = 3e-26
 Identities = 41/149 (27%), Positives = 60/149 (40%), Gaps = 15/149 (10%)

Query: 344 GSFGSVYKGTI----SDGTDVAIKIFN---LQRERAFRSFNSECEVLRNVRHQNLIKILS 396
           GSFG V +G           VA+K      L +  A   F  E   + ++ H+NLI++  
Sbjct: 19  GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG 78

Query: 397 SCSTPDFK----FMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
              TP  K      P GSL  RL  H     +       + V   + YL     S   IH
Sbjct: 79  VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE----SKRFIH 134

Query: 453 CDLKPTSILLDENMVAHVSDFGISKLLGE 481
            DL   ++LL    +  + DFG+ + L +
Sbjct: 135 RDLAARNLLLATRDLVKIGDFGLMRALPQ 163

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (262), Expect = 4e-26
 Identities = 33/147 (22%), Positives = 63/147 (42%), Gaps = 14/147 (9%)

Query: 344 GSFGSVYKGTISD---GTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSC 398
           G+FG+V KG          VA+KI   +           +E  V++ + +  +++++  C
Sbjct: 18  GNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC 77

Query: 399 STPDF----KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
               +    +    G L K L  + + +     + ++  V   ++YL   +     +H D
Sbjct: 78  EAESWMLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEESN----FVHRD 132

Query: 455 LKPTSILLDENMVAHVSDFGISKLLGE 481
           L   ++LL     A +SDFG+SK L  
Sbjct: 133 LAARNVLLVTQHYAKISDFGLSKALRA 159

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (260), Expect = 1e-25
 Identities = 36/142 (25%), Positives = 65/142 (45%), Gaps = 12/142 (8%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           G+ G+VY    ++ G +VAI+  NLQ++       +E  V+R  ++ N++  L S    D
Sbjct: 31  GASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD 90

Query: 403 -----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKP 457
                 +++  GSL   +          +   +  +    LE+LH    S  +IH D+K 
Sbjct: 91  ELWVVMEYLAGGSLTDVVTETCMDEG--QIAAVCRECLQALEFLH----SNQVIHRDIKS 144

Query: 458 TSILLDENMVAHVSDFGISKLL 479
            +ILL  +    ++DFG    +
Sbjct: 145 DNILLGMDGSVKLTDFGFCAQI 166

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  104 bits (260), Expect = 1e-25
 Identities = 41/146 (28%), Positives = 62/146 (42%), Gaps = 12/146 (8%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFN---LQRERAFRSFNSECEVLRNVRHQNLIKILSSCS 399
           GSFG V+      +G   A+K+     + R +     N E  +L  V H  +I++  +  
Sbjct: 15  GSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ 74

Query: 400 TPDFKFM----PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDL 455
                FM      G     L   +             +V   LEYLH    S  II+ DL
Sbjct: 75  DAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH----SKDIIYRDL 130

Query: 456 KPTSILLDENMVAHVSDFGISKLLGE 481
           KP +ILLD+N    ++DFG +K + +
Sbjct: 131 KPENILLDKNGHIKITDFGFAKYVPD 156

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (258), Expect = 2e-25
 Identities = 41/144 (28%), Positives = 65/144 (45%), Gaps = 14/144 (9%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFN---LQRERAFRSFNSECEVLRNVRHQNLIKILSSCS 399
           GSF +V     ++   + AIKI     + +E        E +V+  + H   +K+  +  
Sbjct: 19  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 78

Query: 400 TPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
             +       +  NG L K +     F D         ++ S LEYLH       IIH D
Sbjct: 79  DDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLH----GKGIIHRD 133

Query: 455 LKPTSILLDENMVAHVSDFGISKL 478
           LKP +ILL+E+M   ++DFG +K+
Sbjct: 134 LKPENILLNEDMHIQITDFGTAKV 157

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (256), Expect = 2e-25
 Identities = 35/149 (23%), Positives = 63/149 (42%), Gaps = 16/149 (10%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCST 400
           GSF +VYKG       +VA      ++  +   + F  E E+L+ ++H N+++   S  +
Sbjct: 20  GSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWES 79

Query: 401 PD---------FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPII 451
                       + M +G+L+  L      + I    +    +   L++LH      PII
Sbjct: 80  TVKGKKCIVLVTELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILKGLQFLHTRTP--PII 136

Query: 452 HCDLKPTSILL-DENMVAHVSDFGISKLL 479
           H DLK  +I +        + D G++ L 
Sbjct: 137 HRDLKCDNIFITGPTGSVKIGDLGLATLK 165

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (255), Expect = 8e-25
 Identities = 38/148 (25%), Positives = 66/148 (44%), Gaps = 14/148 (9%)

Query: 344 GSFGSVYKGT-ISDGTDVAIK-----IFNLQRERAFRSFNSECEVLRNVRHQNLIKILSS 397
           G+FG+VYKG  I +G  V I      +      +A +    E  V+ +V + ++ ++L  
Sbjct: 20  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 79

Query: 398 CSTPDFK----FMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHC 453
           C T   +     MP G L   +  H   +     LN  + +   + YL        ++H 
Sbjct: 80  CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED----RRLVHR 135

Query: 454 DLKPTSILLDENMVAHVSDFGISKLLGE 481
           DL   ++L+       ++DFG++KLLG 
Sbjct: 136 DLAARNVLVKTPQHVKITDFGLAKLLGA 163

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (252), Expect = 9e-25
 Identities = 33/147 (22%), Positives = 59/147 (40%), Gaps = 13/147 (8%)

Query: 344 GSFGSVYKG----TISDGTDVAIKIFNLQRERAFRS-FNSECEVLRNVRHQNLIKILSSC 398
           G FG V++G      +    VAIK        + R  F  E   +R   H +++K++   
Sbjct: 18  GQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI 77

Query: 399 STPD----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
           +        +    G L   L    Y LD+   +     + + L YL     S   +H D
Sbjct: 78  TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE----SKRFVHRD 133

Query: 455 LKPTSILLDENMVAHVSDFGISKLLGE 481
           +   ++L+  N    + DFG+S+ + +
Sbjct: 134 IAARNVLVSSNDCVKLGDFGLSRYMED 160

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  101 bits (252), Expect = 1e-24
 Identities = 45/204 (22%), Positives = 78/204 (38%), Gaps = 51/204 (25%)

Query: 313 LRVLDLSRNQLSGDIPSTIGALVDLETISLAGSFGSVYKGT------ISDGTDVAIKIFN 366
           L  L+  RN +  +    IG           G+FG V++            T VA+K+  
Sbjct: 5   LLSLEYPRNNI--EYVRDIGE----------GAFGRVFQARAPGLLPYEPFTMVAVKMLK 52

Query: 367 LQRERAFRS-FNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRLYSHNY 420
            +     ++ F  E  ++    + N++K+L  C+        F++M  G L + L S + 
Sbjct: 53  EEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSP 112

Query: 421 F-----------------------LDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKP 457
                                   L   E+L I   V + + YL         +H DL  
Sbjct: 113 HTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER----KFVHRDLAT 168

Query: 458 TSILLDENMVAHVSDFGISKLLGE 481
            + L+ ENMV  ++DFG+S+ +  
Sbjct: 169 RNCLVGENMVVKIADFGLSRNIYS 192

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (252), Expect = 2e-24
 Identities = 33/173 (19%), Positives = 64/173 (36%), Gaps = 39/173 (22%)

Query: 344 GSFGSVYKGT------ISDGTDVAIKIFNLQRERAFR-SFNSECEVLRNV-RHQNLIKIL 395
           G+FG V   T            VA+K+   + + + R +  SE +++  +  H+N++ +L
Sbjct: 48  GAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLL 107

Query: 396 SSCSTPD-----FKFMPNGSLEKRLYSHN----------------------YFLDILERL 428
            +C+        F++   G L   L S                          L   + L
Sbjct: 108 GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLL 167

Query: 429 NIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
                V   +E+L         +H DL   ++L+    V  + DFG+++ +  
Sbjct: 168 CFAYQVAKGMEFLE----FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 216

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.7 bits (248), Expect = 3e-24
 Identities = 31/145 (21%), Positives = 59/145 (40%), Gaps = 12/145 (8%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRERAFR-SFNSECEVLRNVRHQNLIKILSSCSTP 401
           G++G V           VA+KI +++R      +   E  + + + H+N++K        
Sbjct: 16  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG 75

Query: 402 DFK-----FMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLK 456
           + +     +   G L  R+          +       + + + YLH       I H D+K
Sbjct: 76  NIQYLFLEYCSGGELFDRIEPDIGM-PEPDAQRFFHQLMAGVVYLHGIG----ITHRDIK 130

Query: 457 PTSILLDENMVAHVSDFGISKLLGE 481
           P ++LLDE     +SDFG++ +   
Sbjct: 131 PENLLLDERDNLKISDFGLATVFRY 155

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =   99 bits (248), Expect = 3e-24
 Identities = 32/144 (22%), Positives = 68/144 (47%), Gaps = 10/144 (6%)

Query: 344 GSFGSVYKGTISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTP 401
           G++G VYK   + G   A+K   L++  E    +   E  +L+ ++H N++K+     T 
Sbjct: 13  GTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK 72

Query: 402 DFKFM----PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKP 457
               +     +  L+K L      L+ +   + ++ + + + Y H       ++H DLKP
Sbjct: 73  KRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH----DRRVLHRDLKP 128

Query: 458 TSILLDENMVAHVSDFGISKLLGE 481
            ++L++      ++DFG+++  G 
Sbjct: 129 QNLLINREGELKIADFGLARAFGI 152

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.5 bits (247), Expect = 8e-24
 Identities = 43/203 (21%), Positives = 82/203 (40%), Gaps = 33/203 (16%)

Query: 290 LEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAGSFGSV 349
           + I+LS+  LN  L   VQ + +        + L       IG           G FG V
Sbjct: 2   VHIDLSA--LNPELVQAVQHVVI------GPSSLIVHFNEVIGR----------GHFGCV 43

Query: 350 YKGTISD----GTDVAIKIFN-LQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPDFK 404
           Y GT+ D        A+K  N +        F +E  ++++  H N++ +L  C   +  
Sbjct: 44  YHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 103

Query: 405 ------FMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPT 458
                 +M +G L   + +  +   + + +   + V   +++L         +H DL   
Sbjct: 104 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS----KKFVHRDLAAR 159

Query: 459 SILLDENMVAHVSDFGISKLLGE 481
           + +LDE     V+DFG+++ + +
Sbjct: 160 NCMLDEKFTVKVADFGLARDMYD 182

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.4 bits (244), Expect = 1e-23
 Identities = 40/149 (26%), Positives = 71/149 (47%), Gaps = 15/149 (10%)

Query: 344 GSFGSVYKGTISDGTD-----VAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSS 397
           G FG VYKG +   +      VAIK       E+    F  E  ++    H N+I++   
Sbjct: 18  GEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGV 77

Query: 398 CSTPDFKFM-----PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
            S      +      NG+L+K L   +    +L+ + ++  + + ++YL     +   +H
Sbjct: 78  ISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA----NMNYVH 133

Query: 453 CDLKPTSILLDENMVAHVSDFGISKLLGE 481
            DL   +IL++ N+V  VSDFG+S++L +
Sbjct: 134 RDLAARNILVNSNLVCKVSDFGLSRVLED 162

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 99.4 bits (247), Expect = 2e-23
 Identities = 34/150 (22%), Positives = 59/150 (39%), Gaps = 17/150 (11%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNL------QRERAFRSFNSECEVLRNVRHQNLIKILS 396
           G FG VY       G   A+K  +       Q E    +      ++       ++ +  
Sbjct: 15  GGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSY 74

Query: 397 SCSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPII 451
           +  TPD        M  G L   L  H  F +  +      ++   LE++H+      ++
Sbjct: 75  AFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE-ADMRFYAAEIILGLEHMHNRF----VV 129

Query: 452 HCDLKPTSILLDENMVAHVSDFGISKLLGE 481
           + DLKP +ILLDE+    +SD G++    +
Sbjct: 130 YRDLKPANILLDEHGHVRISDLGLACDFSK 159

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.4 bits (244), Expect = 3e-23
 Identities = 34/147 (23%), Positives = 63/147 (42%), Gaps = 13/147 (8%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRERAFR-SFNSECEVLRNVRHQNLIKILSSCSTP 401
           G++G V       +   VAIK  +    + +      E ++L   RH+N+I I      P
Sbjct: 19  GAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAP 78

Query: 402 DFKFMPNGSLEKRLYSHNYF-------LDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
             + M +  L   L   + +       L        +  +   L+Y+H    SA ++H D
Sbjct: 79  TIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH----SANVLHRD 134

Query: 455 LKPTSILLDENMVAHVSDFGISKLLGE 481
           LKP+++LL+      + DFG++++   
Sbjct: 135 LKPSNLLLNTTCDLKICDFGLARVADP 161

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.6 bits (242), Expect = 3e-23
 Identities = 35/168 (20%), Positives = 62/168 (36%), Gaps = 34/168 (20%)

Query: 344 GSFGSVYKGTI------SDGTDVAIKIFNLQRERAFR-SFNSECEVLRNV-RHQNLIKIL 395
           G+FG V + T            VA+K+         R +  SE +VL  +  H N++ +L
Sbjct: 34  GAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLL 93

Query: 396 SSCSTPD-----FKFMPNGSLEKRLYSH-----------------NYFLDILERLNIMID 433
            +C+         ++   G L   L                       LD+ + L+    
Sbjct: 94  GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQ 153

Query: 434 VGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
           V   + +L   +     IH DL   +ILL    +  + DFG+++ +  
Sbjct: 154 VAKGMAFLASKN----CIHRDLAARNILLTHGRITKICDFGLARDIKN 197

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.8 bits (243), Expect = 3e-23
 Identities = 30/145 (20%), Positives = 63/145 (43%), Gaps = 13/145 (8%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           G FG V++    S       K   ++          E  +L   RH+N++ +  S  + +
Sbjct: 16  GEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL-VKKEISILNIARHRNILHLHESFESME 74

Query: 403 -----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKP 457
                F+F+    + +R+ +  + L+  E ++ +  V   L++LH    S  I H D++P
Sbjct: 75  ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH----SHNIGHFDIRP 130

Query: 458 TSILLDENMVAHV--SDFGISKLLG 480
            +I+      + +   +FG ++ L 
Sbjct: 131 ENIIYQTRRSSTIKIIEFGQARQLK 155

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.5 bits (234), Expect = 4e-22
 Identities = 45/160 (28%), Positives = 65/160 (40%), Gaps = 29/160 (18%)

Query: 344 GSFGSVYKGTISDG---TDVAIKIFN-LQRERAFRSFNSECEVLRNV-RHQNLIKILSSC 398
           G+FG V K  I       D AIK       +   R F  E EVL  +  H N+I +L +C
Sbjct: 21  GNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC 80

Query: 399 STPDFK-----FMPNGSLEKRLYSHNYF---------------LDILERLNIMIDVGSTL 438
               +      + P+G+L   L                     L   + L+   DV   +
Sbjct: 81  EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGM 140

Query: 439 EYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKL 478
           +YL         IH DL   +IL+ EN VA ++DFG+S+ 
Sbjct: 141 DYLS----QKQFIHRDLAARNILVGENYVAKIADFGLSRG 176

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score = 91.7 bits (227), Expect = 2e-21
 Identities = 40/154 (25%), Positives = 62/154 (40%), Gaps = 21/154 (13%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNL---------QRERAFRSFNSECEVLRNVR-HQNLI 392
           G    V +        + A+KI ++         + +    +   E ++LR V  H N+I
Sbjct: 14  GVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNII 73

Query: 393 KILSSCSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSS 447
           ++  +  T       F  M  G L   L      L   E   IM  +   +  LH     
Sbjct: 74  QLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-LSEKETRKIMRALLEVICALH----K 128

Query: 448 APIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
             I+H DLKP +ILLD++M   ++DFG S  L  
Sbjct: 129 LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 162

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 91.2 bits (226), Expect = 4e-21
 Identities = 36/148 (24%), Positives = 60/148 (40%), Gaps = 15/148 (10%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRERAFR-SFNSECEVLRNVRHQNLIKILSSCSTP 401
           G+F  V           VAIK    +       S  +E  VL  ++H N++ +     + 
Sbjct: 20  GAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESG 79

Query: 402 D-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLK 456
                  + +  G L  R+     F    +   ++  V   ++YLH       I+H DLK
Sbjct: 80  GHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLHDLG----IVHRDLK 134

Query: 457 PTSILL---DENMVAHVSDFGISKLLGE 481
           P ++L    DE+    +SDFG+SK+   
Sbjct: 135 PENLLYYSLDEDSKIMISDFGLSKMEDP 162

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 91.8 bits (227), Expect = 6e-21
 Identities = 37/143 (25%), Positives = 58/143 (40%), Gaps = 14/143 (9%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFN---LQRERAFRSFNSECEVLRNVRHQNLIKILSSCS 399
           GSFG V        G   A+KI +   + + +      +E  +L+ V    L+K+  S  
Sbjct: 52  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111

Query: 400 TPDFKFM-----PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
                +M       G +   L     F            +  T EYLH    S  +I+ D
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGRF-SEPHARFYAAQIVLTFEYLH----SLDLIYRD 166

Query: 455 LKPTSILLDENMVAHVSDFGISK 477
           LKP ++L+D+     V+DFG +K
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAK 189

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.3 bits (223), Expect = 8e-21
 Identities = 34/146 (23%), Positives = 66/146 (45%), Gaps = 12/146 (8%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNL--QRERAFRSFNSECEVLRNVRHQNLIKILSSCST 400
           G++G VYK      G  VA+K   L  + E    +   E  +L+ + H N++K+L    T
Sbjct: 13  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 72

Query: 401 PD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDL 455
            +     F+F+     +    S    + +    + +  +   L + H    S  ++H DL
Sbjct: 73  ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH----SHRVLHRDL 128

Query: 456 KPTSILLDENMVAHVSDFGISKLLGE 481
           KP ++L++      ++DFG+++  G 
Sbjct: 129 KPQNLLINTEGAIKLADFGLARAFGV 154

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.3 bits (223), Expect = 1e-20
 Identities = 43/148 (29%), Positives = 67/148 (45%), Gaps = 14/148 (9%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQ-----RERAFRSFNSECEVLRNVRHQNLIKILSS 397
           G F +VYK    +    VAIK   L      ++   R+   E ++L+ + H N+I +L +
Sbjct: 9   GQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDA 68

Query: 398 CSTPDFKFM----PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHC 453
                   +        LE  +  ++  L        M+     LEYLH       I+H 
Sbjct: 69  FGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW----ILHR 124

Query: 454 DLKPTSILLDENMVAHVSDFGISKLLGE 481
           DLKP ++LLDEN V  ++DFG++K  G 
Sbjct: 125 DLKPNNLLLDENGVLKLADFGLAKSFGS 152

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score = 89.4 bits (221), Expect = 1e-20
 Identities = 25/151 (16%), Positives = 57/151 (37%), Gaps = 18/151 (11%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFN---LQRERAFRSFNSECEVLRNVRHQNLIKILSSCS 399
           G    V+    +    DVA+K+      +    +  F  E +    + H  ++ +  +  
Sbjct: 18  GGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGE 77

Query: 400 TPD---------FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPI 450
                        +++   +L   +++    +     + ++ D    L + H       I
Sbjct: 78  AETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSH----QNGI 132

Query: 451 IHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
           IH D+KP +I++       V DFGI++ + +
Sbjct: 133 IHRDVKPANIMISATNAVKVMDFGIARAIAD 163

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.8 bits (222), Expect = 2e-20
 Identities = 34/146 (23%), Positives = 58/146 (39%), Gaps = 15/146 (10%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFN---LQRERAFRSFNSECEVL-RNVRHQNLIKILSSC 398
           GSFG V+           AIK      +  +        E  VL     H  L  +  + 
Sbjct: 13  GSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF 72

Query: 399 STPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHC 453
            T +      +++  G L   + S + F D+        ++   L++LH       I++ 
Sbjct: 73  QTKENLFFVMEYLNGGDLMYHIQSCHKF-DLSRATFYAAEIILGLQFLHSKG----IVYR 127

Query: 454 DLKPTSILLDENMVAHVSDFGISKLL 479
           DLK  +ILLD++    ++DFG+ K  
Sbjct: 128 DLKLDNILLDKDGHIKIADFGMCKEN 153

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.8 bits (222), Expect = 2e-20
 Identities = 37/153 (24%), Positives = 62/153 (40%), Gaps = 23/153 (15%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           GSFG VY+      G  VAIK     +       N E +++R + H N++++     +  
Sbjct: 31  GSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSG 86

Query: 403 -----------FKFMPNGSLE--KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAP 449
                        ++P       +        L ++     M  +  +L Y+H    S  
Sbjct: 87  EKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH----SFG 142

Query: 450 IIHCDLKPTSILLD-ENMVAHVSDFGISKLLGE 481
           I H D+KP ++LLD +  V  + DFG +K L  
Sbjct: 143 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.1 bits (220), Expect = 3e-20
 Identities = 34/159 (21%), Positives = 64/159 (40%), Gaps = 25/159 (15%)

Query: 344 GSFGSVYKGT------ISDGTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILS 396
           GSFG VY+G           T VAIK  N     R    F +E  V++     +++++L 
Sbjct: 31  GSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG 90

Query: 397 SCSTPD-----FKFMPNGSLEKRLYSHNYF---------LDILERLNIMIDVGSTLEYLH 442
             S         + M  G L+  L S               + + + +  ++   + YL+
Sbjct: 91  VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN 150

Query: 443 HGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
               +   +H DL   + ++ E+    + DFG+++ + E
Sbjct: 151 ----ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 185

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.2 bits (215), Expect = 1e-19
 Identities = 37/167 (22%), Positives = 61/167 (36%), Gaps = 33/167 (19%)

Query: 344 GSFGSVYKGT------ISDGTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILS 396
           G+FG V +         +    VA+K+          R+  SE ++L ++ H   +  L 
Sbjct: 24  GAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 83

Query: 397 SCSTPD-------FKFMPNGSLEKRLYSHNY---------------FLDILERLNIMIDV 434
              T          +F   G+L   L S                  FL +   +     V
Sbjct: 84  GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQV 143

Query: 435 GSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
              +E+L     S   IH DL   +ILL E  V  + DFG+++ + +
Sbjct: 144 AKGMEFLA----SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.3 bits (215), Expect = 1e-19
 Identities = 33/154 (21%), Positives = 67/154 (43%), Gaps = 21/154 (13%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQ--RERAFRSFNSECEVLRNVRHQNLIKILSSCST 400
           G+FG V+K      G  VA+K   ++  +E    +   E ++L+ ++H+N++ ++  C T
Sbjct: 21  GTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 80

Query: 401 PD-------------FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSS 447
                          F F  +            F  + E   +M  + + L Y+H     
Sbjct: 81  KASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKF-TLSEIKRVMQMLLNGLYYIHRNK-- 137

Query: 448 APIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
             I+H D+K  ++L+  + V  ++DFG+++    
Sbjct: 138 --ILHRDMKAANVLITRDGVLKLADFGLARAFSL 169

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.5 bits (216), Expect = 1e-19
 Identities = 32/145 (22%), Positives = 58/145 (40%), Gaps = 14/145 (9%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFN---LQRERAFRSFNSECEVLRNVRHQNLIKILSSCS 399
           G+FG V      + G   A+KI     +  +       +E  VL+N RH  L  +  +  
Sbjct: 16  GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ 75

Query: 400 TPDFKFM-----PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
           T D           G L   L     F +         ++   +  L + HS   +++ D
Sbjct: 76  THDRLCFVMEYANGGELFFHLSRERVFTEE-RARFYGAEI---VSALEYLHS-RDVVYRD 130

Query: 455 LKPTSILLDENMVAHVSDFGISKLL 479
           +K  +++LD++    ++DFG+ K  
Sbjct: 131 IKLENLMLDKDGHIKITDFGLCKEG 155

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.0 bits (209), Expect = 6e-19
 Identities = 32/145 (22%), Positives = 67/145 (46%), Gaps = 11/145 (7%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCST 400
           G++G+V+K         VA+K   L    E    S   E  +L+ ++H+N++++     +
Sbjct: 13  GTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS 72

Query: 401 PDFKFM----PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLK 456
                +     +  L+K   S N  LD     + +  +   L + H  +    ++H DLK
Sbjct: 73  DKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN----VLHRDLK 128

Query: 457 PTSILLDENMVAHVSDFGISKLLGE 481
           P ++L++ N    +++FG+++  G 
Sbjct: 129 PQNLLINRNGELKLANFGLARAFGI 153

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.6 bits (211), Expect = 6e-19
 Identities = 35/150 (23%), Positives = 63/150 (42%), Gaps = 17/150 (11%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFN--LQRERAFRSFNSECEVLRNVRHQNLIKILSSCST 400
           G++G+V        G  VAIK      Q E   +    E  +L+++RH+N+I +L   + 
Sbjct: 29  GAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTP 88

Query: 401 PDFKFMPN---------GSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPII 451
            +               G+   +L  H   L       ++  +   L Y+H       II
Sbjct: 89  DETLDDFTDFYLVMPFMGTDLGKLMKHEK-LGEDRIQFLVYQMLKGLRYIHAAG----II 143

Query: 452 HCDLKPTSILLDENMVAHVSDFGISKLLGE 481
           H DLKP ++ ++E+    + DFG+++    
Sbjct: 144 HRDLKPGNLAVNEDCELKILDFGLARQADS 173

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 84.1 bits (207), Expect = 1e-18
 Identities = 35/147 (23%), Positives = 65/147 (44%), Gaps = 15/147 (10%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           GSFG +Y GT I+ G +VAIK+  ++ +      + E ++ + ++    I  +  C    
Sbjct: 18  GSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEG 75

Query: 403 FKF-----MPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKP 457
                   +   SLE      +    +   L +   + S +EY+H    S   IH D+KP
Sbjct: 76  DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH----SKNFIHRDVKP 131

Query: 458 TSIL---LDENMVAHVSDFGISKLLGE 481
            + L     +  + ++ DFG++K   +
Sbjct: 132 DNFLMGLGKKGNLVYIIDFGLAKKYRD 158

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.2 bits (205), Expect = 3e-18
 Identities = 33/153 (21%), Positives = 58/153 (37%), Gaps = 24/153 (15%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRSFNSECEVL-RNVRHQNLIKILSSCSTP 401
           G  G V +          A+K+      +A R    E E+  R  +  ++++I+      
Sbjct: 23  GINGKVLQIFNKRTQEKFALKMLQ-DCPKARR----EVELHWRASQCPHIVRIVDVYENL 77

Query: 402 D---------FKFMPNGSLEKRLYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPII 451
                      + +  G L  R+    +      E   IM  +G  ++YLH    S  I 
Sbjct: 78  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH----SINIA 133

Query: 452 HCDLKPTSILLD---ENMVAHVSDFGISKLLGE 481
           H D+KP ++L      N +  ++DFG +K    
Sbjct: 134 HRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 166

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 82.6 bits (203), Expect = 4e-18
 Identities = 34/155 (21%), Positives = 64/155 (41%), Gaps = 21/155 (13%)

Query: 344 GSFGSVYKGT--ISDGTDVAIKIFNLQ--RERAFRSFNSECEVLR---NVRHQNLIKILS 396
           G++G V+K     + G  VA+K   +Q   E    S   E  VLR      H N++++  
Sbjct: 18  GAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFD 77

Query: 397 SCSTPD----------FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHS 446
            C+             F+ +               +      ++M  +   L++LH    
Sbjct: 78  VCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---- 133

Query: 447 SAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
           S  ++H DLKP +IL+  +    ++DFG++++   
Sbjct: 134 SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF 168

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 81.7 bits (201), Expect = 5e-18
 Identities = 36/153 (23%), Positives = 56/153 (36%), Gaps = 19/153 (12%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRS------FNSECEVLRNVR--HQNLIKI 394
           G FGSVY G  +SD   VAIK     R   +           E  +L+ V      +I++
Sbjct: 15  GGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL 74

Query: 395 LSSCSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAP 449
           L     PD      +            +    L      +    V   + + H    +  
Sbjct: 75  LDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH----NCG 130

Query: 450 IIHCDLKPTSILLDEN-MVAHVSDFGISKLLGE 481
           ++H D+K  +IL+D N     + DFG   LL +
Sbjct: 131 VLHRDIKDENILIDLNRGELKLIDFGSGALLKD 163

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 82.2 bits (202), Expect = 5e-18
 Identities = 36/168 (21%), Positives = 70/168 (41%), Gaps = 34/168 (20%)

Query: 344 GSFGSVYKGT--------ISDGTDVAIKIFNLQR-ERAFRSFNSECEVLRNV-RHQNLIK 393
           G+FG V             +  T VA+K+      E+      SE E+++ + +H+N+I 
Sbjct: 24  GAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIIN 83

Query: 394 ILSSCSTPD-----FKFMPNGSLEKRLYSHNYF---------------LDILERLNIMID 433
           +L +C+         ++   G+L + L +                   L   + ++    
Sbjct: 84  LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQ 143

Query: 434 VGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLGE 481
           V   +EYL     S   IH DL   ++L+ E+ V  ++DFG+++ +  
Sbjct: 144 VARGMEYLA----SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 187

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 81.4 bits (200), Expect = 1e-17
 Identities = 42/181 (23%), Positives = 74/181 (40%), Gaps = 23/181 (12%)

Query: 317 DLSRNQLSGDIPSTIGALVDLETISL--AGSFGSVYKG----TISDGTDVAIKIFN---- 366
           +L    L+G     +G + + E + +   G++G V+          G   A+K+      
Sbjct: 8   ELRTANLTGH-AEKVG-IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATI 65

Query: 367 LQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPDFK------FMPNGSLEKRLYSHNY 420
           +Q+ +      +E +VL ++R    +  L      + K      ++  G L   L     
Sbjct: 66  VQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER 125

Query: 421 FLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG 480
           F +      + I VG  +  L H H    II+ D+K  +ILLD N    ++DFG+SK   
Sbjct: 126 FTE----HEVQIYVGEIVLALEHLHK-LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180

Query: 481 E 481
            
Sbjct: 181 A 181

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 78.7 bits (193), Expect = 1e-17
 Identities = 23/149 (15%), Positives = 49/149 (32%), Gaps = 16/149 (10%)

Query: 344 GSFGSVYKGTISDGTDVAIKIFNL----------QRERAFRSFNSECEVLRNVRHQNLIK 393
           G   +V+        +  +K   +          +R+     F+           + L K
Sbjct: 11  GKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQK 70

Query: 394 ILSSCSTPDFKFMPNGSL-EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIH 452
           +        + +  N  L E       Y + +     ++  +   +   +H      I+H
Sbjct: 71  LQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRG----IVH 126

Query: 453 CDLKPTSILLDENMVAHVSDFGISKLLGE 481
            DL   ++L+ E  +  + DF  S  +GE
Sbjct: 127 GDLSQYNVLVSEEGI-WIIDFPQSVEVGE 154

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 81.0 bits (199), Expect = 2e-17
 Identities = 29/148 (19%), Positives = 65/148 (43%), Gaps = 21/148 (14%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVR-HQNLIKILSSCSTP 401
           G +  V++   I++   V +KI    +++  +    E ++L N+R   N+I +      P
Sbjct: 46  GKYSEVFEAINITNNEKVVVKILKPVKKKKIK---REIKILENLRGGPNIITLADIVKDP 102

Query: 402 D-------FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCD 454
                   F+ + N   ++   +    L   +    M ++   L+Y H       I+H D
Sbjct: 103 VSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMG----IMHRD 154

Query: 455 LKPTSILLD-ENMVAHVSDFGISKLLGE 481
           +KP ++++D E+    + D+G+++    
Sbjct: 155 VKPHNVMIDHEHRKLRLIDWGLAEFYHP 182

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 78.7 bits (193), Expect = 6e-17
 Identities = 26/149 (17%), Positives = 52/149 (34%), Gaps = 17/149 (11%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           GSFG +++GT + +   VAIK    + +        E    + +     I  +       
Sbjct: 16  GSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFGQEG 73

Query: 403 FKF-----MPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKP 457
                   +   SLE  L        +         + + ++ +H       +++ D+KP
Sbjct: 74  LHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS----LVYRDIKP 129

Query: 458 TSILLDENMVAH-----VSDFGISKLLGE 481
            + L+      +     V DFG+ K   +
Sbjct: 130 DNFLIGRPNSKNANMIYVVDFGMVKFYRD 158

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 78.2 bits (191), Expect = 1e-16
 Identities = 60/290 (20%), Positives = 92/290 (31%), Gaps = 24/290 (8%)

Query: 62  PNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNN 121
           P+   L+L +N +         N   L  L L  N  S   P  F  L  L  L L  N 
Sbjct: 31  PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90

Query: 122 LTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFS-TSLQRFSASECKLK 180
           L        +               L +  N +  +        +   +     +  K  
Sbjct: 91  LKELPEKMPKTLQ-----------ELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSS 139

Query: 181 GTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEM 240
           G        ++ L Y+ +   ++  TIP  +     L    L    +      +L  L  
Sbjct: 140 GIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNN 196

Query: 241 LNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLN 300
           L  L L  N +S      LA+   LREL L +NKL   +P  L    YI  + L +N ++
Sbjct: 197 LAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS 255

Query: 301 D------SLPSNVQKLKVLRVLDLSRNQLSGD--IPSTIGALVDLETISL 342
                    P    K      + L  N +      PST   +     + L
Sbjct: 256 AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 77.0 bits (188), Expect = 3e-16
 Identities = 50/279 (17%), Positives = 92/279 (32%), Gaps = 23/279 (8%)

Query: 4   QIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPN 63
           ++P ++    +   L L  N ++ +      N+  +  L L  N++S   P      L  
Sbjct: 24  KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAP-LVK 80

Query: 64  IKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLT 123
           ++ L L  N L            +L + +   N  +    + F  L  + V+ L  N L 
Sbjct: 81  LERLYLSKNQLKELPEKMPKTLQELRVHE---NEITKVRKSVFNGLNQMIVVELGTNPLK 137

Query: 124 TESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTI 183
           +       +  +  L+  R      ++   +  I          SL        K+    
Sbjct: 138 SSGIENGAFQGMKKLSYIR------IADTNITTIPQ----GLPPSLTELHLDGNKITKVD 187

Query: 184 PKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNL 243
              +  L  L  L L FN ++     S+     L+   L    L   VP  L   + + +
Sbjct: 188 AASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQV 246

Query: 244 LHLGGNKLSG------HIPPCLASLTSLRELDLGSNKLT 276
           ++L  N +S         P       S   + L SN + 
Sbjct: 247 VYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 52.3 bits (124), Expect = 5e-08
 Identities = 37/272 (13%), Positives = 74/272 (27%), Gaps = 35/272 (12%)

Query: 1   MTGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHS 60
           ++   P     L  L+ L+L  N L  L   M   +  +R       ++   + +    +
Sbjct: 67  ISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNG--LN 124

Query: 61  LPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMN 120
              +  L        G    +     KL  + +     +        +L     L L  N
Sbjct: 125 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTE---LHLDGN 181

Query: 121 NLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLK 180
            +T            +SL     L  L LS N +  +        +  L+    +  KL 
Sbjct: 182 KIT--------KVDAASLKGLNNLAKLGLSFNSISAV-DNGSLANTPHLRELHLNNNKLV 232

Query: 181 GTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEM 240
             +P  +   + +  + L  N+++                           P        
Sbjct: 233 -KVPGGLADHKYIQVVYLHNNNISAIGSNDFC------------------PPGYNTKKAS 273

Query: 241 LNLLHLGGNKLSGH--IPPCLASLTSLRELDL 270
            + + L  N +      P     +     + L
Sbjct: 274 YSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 77.1 bits (189), Expect = 2e-16
 Identities = 33/154 (21%), Positives = 56/154 (36%), Gaps = 21/154 (13%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNL------QRERAFRSFNSECEVLRNVRHQNLIKILS 396
           G F  V K    S G   A K          +R  +      E  +L+ ++H N+I +  
Sbjct: 21  GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 80

Query: 397 SCSTPD-----FKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPII 451
                       + +  G L   L       +  E    +  +   L  +++ H S  I 
Sbjct: 81  VYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQI---LNGVYYLH-SLQIA 135

Query: 452 HCDLKPTSILLDENMVA----HVSDFGISKLLGE 481
           H DLKP +I+L +  V      + DFG++  +  
Sbjct: 136 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 169

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.1 bits (186), Expect = 9e-16
 Identities = 28/148 (18%), Positives = 58/148 (39%), Gaps = 14/148 (9%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFN--LQRERAFRSFNSECEVLRNVRHQNLIKILSSCST 400
           G+ G V          +VAIK  +   Q +   +    E  +++ V H+N+I +L+  + 
Sbjct: 28  GAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP 87

Query: 401 PDFKFMPNGSLEKRLYSHNYFLDIL-------ERLNIMIDVGSTLEYLHHGHSSAPIIHC 453
                                  ++           ++  +   +++LH       IIH 
Sbjct: 88  QKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG----IIHR 143

Query: 454 DLKPTSILLDENMVAHVSDFGISKLLGE 481
           DLKP++I++  +    + DFG+++  G 
Sbjct: 144 DLKPSNIVVKSDCTLKILDFGLARTAGT 171

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 75.4 bits (184), Expect = 2e-15
 Identities = 64/337 (18%), Positives = 118/337 (35%), Gaps = 39/337 (11%)

Query: 9   IGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLE 68
           +  L NL  +    N L+ + P  + N++ + ++ +  N+++   P     +L  +    
Sbjct: 62  VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFN 119

Query: 69  LGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSS 128
               ++      +  N  +L    +   +    + +         V  L      T    
Sbjct: 120 NQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLER 179

Query: 129 AYQWS----FLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIP 184
               S     +S L     L  LI + N +  I P       T+L   S +  +LK    
Sbjct: 180 LDISSNKVSDISVLAKLTNLESLIATNNQISDITPL---GILTNLDELSLNGNQLKD--I 234

Query: 185 KEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVP------------ 232
             +  L  L  L L  N ++   P  +  L +L    L    +    P            
Sbjct: 235 GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLEL 292

Query: 233 --------HNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLW 284
                     + +L+ L  L L  N +S   P  ++SLT L+ L   +NK++    SSL 
Sbjct: 293 NENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLA 348

Query: 285 SLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRN 321
           +L  I  ++   N ++D  P  +  L  +  L L+  
Sbjct: 349 NLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 67.7 bits (164), Expect = 7e-13
 Identities = 64/358 (17%), Positives = 121/358 (33%), Gaps = 41/358 (11%)

Query: 11  NLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELG 70
            L       LG  N++  +     ++  +  L      +   +  +    L N+  +   
Sbjct: 20  ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SIDGV--EYLNNLTQINFS 74

Query: 71  DNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHL----SVLSLLMNNLTTES 126
           +N L    P  + N TKL+ + +  N  +   P             +     ++ L   +
Sbjct: 75  NNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132

Query: 127 SSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKE 186
           +        +++++   L  L        G     +   +             K +    
Sbjct: 133 NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISV 192

Query: 187 IGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHL 246
           +  L  L  L    N ++   P  I T   L    L    L+      L  L  L  L L
Sbjct: 193 LAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLDL 248

Query: 247 GGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIP--------------------SSLWSL 286
             N++S   P  L+ LT L EL LG+N++++  P                    S + +L
Sbjct: 249 ANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNL 306

Query: 287 GYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAG 344
             +  + L  N ++D  P  V  L  L+ L  + N++S    S++  L ++  +S   
Sbjct: 307 KNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGH 360

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 58.1 bits (139), Expect = 7e-10
 Identities = 39/166 (23%), Positives = 64/166 (38%), Gaps = 35/166 (21%)

Query: 6   PTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLP----------- 54
              + +L NL  L L  N +S L P  +  ++ +  L LG N++S   P           
Sbjct: 234 IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLE 291

Query: 55  --------SMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTF 106
                        +L N+ YL L  NN+    P  +++ TKL  L    N  S    ++ 
Sbjct: 292 LNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSL 347

Query: 107 GNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGN 152
            NL +++ LS   N ++           L+ L N   +  L L+  
Sbjct: 348 ANLTNINWLSAGHNQISD----------LTPLANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.3 bits (85), Expect = 0.004
 Identities = 47/273 (17%), Positives = 89/273 (32%), Gaps = 34/273 (12%)

Query: 83  TNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCR 142
           T   + +   LG    +  +  +  +L  ++ L      + +          +  +    
Sbjct: 19  TALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKS----------IDGVEYLN 66

Query: 143 YLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFND 202
            L  +  S N L  I P  + N  T L     +  ++    P         + L      
Sbjct: 67  NLTQINFSNNQLTDITP--LKNL-TKLVDILMNNNQIADITPLANLTNLTGLTLFNNQIT 123

Query: 203 LNGTIPTSIG---------TLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLH----LGGN 249
               +              T+  +       +  Q    + +  L+ L  L     L  +
Sbjct: 124 DIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDIS 183

Query: 250 KLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQK 309
                    LA LT+L  L   +N+++   P  + +   + E++L+ N L D     +  
Sbjct: 184 SNKVSDISVLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLAS 239

Query: 310 LKVLRVLDLSRNQLSGDIPSTIGALVDLETISL 342
           L  L  LDL+ NQ+S   P  +  L  L  + L
Sbjct: 240 LTNLTDLDLANNQISNLAP--LSGLTKLTELKL 270

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 74.5 bits (182), Expect = 3e-15
 Identities = 31/145 (21%), Positives = 61/145 (42%), Gaps = 17/145 (11%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFN--LQRERAFRSFNSECEVLRNVRHQNLIKILSSCST 400
           G++GSV        G  VA+K  +   Q     +    E  +L++++H+N+I +L   + 
Sbjct: 29  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 88

Query: 401 PDFK---------FMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPII 451
                            G+    +       D      ++  +   L+Y+H       II
Sbjct: 89  ARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD-HVQFLIYQILRGLKYIHSAD----II 143

Query: 452 HCDLKPTSILLDENMVAHVSDFGIS 476
           H DLKP+++ ++E+    + DFG++
Sbjct: 144 HRDLKPSNLAVNEDCELKILDFGLA 168

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 74.0 bits (180), Expect = 4e-15
 Identities = 59/262 (22%), Positives = 95/262 (36%), Gaps = 15/262 (5%)

Query: 39  IRNLNLGGNRLSG--HLPSMIGHSLPNIKYLELGDN-NLIGTIPNSITNATKLIILDLGF 95
           + NL+L G  L     +PS + + LP + +L +G   NL+G IP +I   T+L  L +  
Sbjct: 52  VNNLDLSGLNLPKPYPIPSSLAN-LPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITH 110

Query: 96  NTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLG 155
              SG IP+    ++ L  L    N            +   S+++   LV +   GN + 
Sbjct: 111 TNVSGAIPDFLSQIKTLVTLDFSYNA--------LSGTLPPSISSLPNLVGITFDGNRIS 162

Query: 156 GILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLK 215
           G +P S G+FS      + S  +L G IP    +L                         
Sbjct: 163 GAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKN 222

Query: 216 QLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKL 275
             +      +         L        L    N++ G +P  L  L  L  L++  N L
Sbjct: 223 TQKIHLAKNSLAFDLGKVGLSKNLNGLDLR--NNRIYGTLPQGLTQLKFLHSLNVSFNNL 280

Query: 276 TSSIPSSLWSLGYILEINLSSN 297
              IP    +L        ++N
Sbjct: 281 CGEIP-QGGNLQRFDVSAYANN 301

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 66.3 bits (160), Expect = 1e-12
 Identities = 51/267 (19%), Positives = 95/267 (35%), Gaps = 12/267 (4%)

Query: 80  NSITNATKLIILDLGFNTFSG--HIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSS 137
           ++ T   ++  LDL          IP++  NL +L+ L +   N               +
Sbjct: 44  DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLV-------GPIPPA 96

Query: 138 LTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLS 197
           +     L YL ++   + G   P   +   +L     S   L GT+P  I  L  L+ ++
Sbjct: 97  IAKLTQLHYLYITHTNVSGA-IPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGIT 155

Query: 198 LGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPP 257
              N ++G IP S G+  +L        N +           +          +      
Sbjct: 156 FDGNRISGAIPDSYGSFSKLFTSMTISRN-RLTGKIPPTFANLNLAFVDLSRNMLEGDAS 214

Query: 258 CLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLD 317
            L       +    +    +     +     +  ++L +N +  +LP  + +LK L  L+
Sbjct: 215 VLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLN 274

Query: 318 LSRNQLSGDIPSTIGALVDLETISLAG 344
           +S N L G+IP   G L   +  + A 
Sbjct: 275 VSFNNLCGEIPQ-GGNLQRFDVSAYAN 300

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 61.3 bits (147), Expect = 6e-11
 Identities = 54/274 (19%), Positives = 93/274 (33%), Gaps = 43/274 (15%)

Query: 2   TGQIPTEIGNLQNLKSLFLGAN-NLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHS 60
              IP+ + NL  L  L++G   NL G IPP I  ++ +  L +                
Sbjct: 65  PYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTN-VSGAIPDFLSQ 123

Query: 61  LPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMN 120
           +  +  L+   N L GT+P SI++   L+ +    N  SG IP+++G+   L     +  
Sbjct: 124 IKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISR 183

Query: 121 N--------------LTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFS 166
           N              L     S       +S+          +                S
Sbjct: 184 NRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLS 243

Query: 167 TSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETN 226
            +L        ++ GT+P+ +  L+ L  L++ FN+L G IP                  
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP------------------ 285

Query: 227 LQGYVPHNLCHLEMLNLLHLGGNKL--SGHIPPC 258
                     +L+  ++     NK      +P C
Sbjct: 286 -------QGGNLQRFDVSAYANNKCLCGSPLPAC 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 47.8 bits (112), Expect = 1e-06
 Identities = 16/57 (28%), Positives = 24/57 (42%), Gaps = 3/57 (5%)

Query: 1   MTGQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRL--SGHLPS 55
           + G +P  +  L+ L SL +  NNL G IP    N+          N+      LP+
Sbjct: 256 IYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSPLPA 311

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 63.7 bits (153), Expect = 7e-12
 Identities = 55/270 (20%), Positives = 90/270 (33%), Gaps = 13/270 (4%)

Query: 77  TIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLS 136
            +P  I  A++   + L  N  S     +F   R+L++L L  N L    ++A+    L 
Sbjct: 25  AVPVGIPAASQ--RIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82

Query: 137 SLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYL 196
              +      L          + P+  +    L       C L+   P     L  L YL
Sbjct: 83  EQLDLSDNAQL--------RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYL 134

Query: 197 SLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIP 256
            L  N L      +   L  L   FL    +          L  L+ L L  N+++   P
Sbjct: 135 YLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHP 194

Query: 257 PCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVL 316
                L  L  L L +N L++    +L  L  +  + L+ N               L+  
Sbjct: 195 HAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD-CRARPLWAWLQKF 253

Query: 317 DLSRNQLSGDIPSTIG--ALVDLETISLAG 344
             S +++   +P  +    L  L    L G
Sbjct: 254 RGSSSEVPCSLPQRLAGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 61.8 bits (148), Expect = 4e-11
 Identities = 64/323 (19%), Positives = 92/323 (28%), Gaps = 65/323 (20%)

Query: 4   QIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPN 63
            +P  I      + +FL  N +S +                                  N
Sbjct: 25  AVPVGIPA--ASQRIFLHGNRISHVPAASFRA-------------------------CRN 57

Query: 64  IKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHI-PNTFGNLRHLSVLSLLMNNL 122
           +  L L  N L      + T    L  LDL  N     + P TF  L  L  L L     
Sbjct: 58  LTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL----- 112

Query: 123 TTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGT 182
                   Q            L YL L  N L  +   +  +                  
Sbjct: 113 ---DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGN--------------- 154

Query: 183 IPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLN 242
                     L +L L  N ++     +   L  L    L +  +    PH    L  L 
Sbjct: 155 ----------LTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLM 204

Query: 243 LLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDS 302
            L+L  N LS      LA L +L+ L L  N        +     ++ +   SS+ +  S
Sbjct: 205 TLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCS 263

Query: 303 LPSNVQKLKVLRVLDLSRNQLSG 325
           LP     L    +  L+ N L G
Sbjct: 264 LPQR---LAGRDLKRLAANDLQG 283

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 64.3 bits (155), Expect = 8e-12
 Identities = 28/157 (17%), Positives = 57/157 (36%), Gaps = 26/157 (16%)

Query: 344 GSFGSVYKGT-ISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD 402
           G F +V+    + + T VA+KI    +     +   E ++L+ V   +  K  S  +   
Sbjct: 24  GHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADNTKEDSMGANHI 82

Query: 403 FKF--------------------MPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLH 442
            K                     +    L       +  + ++    I   +   L+Y+H
Sbjct: 83  LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH 142

Query: 443 HGHSSAPIIHCDLKPTSILLD-ENMVAHVSDFGISKL 478
                  IIH D+KP ++L++  +   ++    I+ L
Sbjct: 143 RRCG---IIHTDIKPENVLMEIVDSPENLIQIKIADL 176

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 51.4 bits (121), Expect = 1e-07
 Identities = 55/333 (16%), Positives = 93/333 (27%), Gaps = 31/333 (9%)

Query: 14  NLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNN 73
               L L    LS L P +  ++    +L    N L+  LP +      ++K L + +NN
Sbjct: 39  QAHELELNNLGLSSL-PELPPHL---ESLVASCNSLT-ELPELPQ----SLKSLLVDNNN 89

Query: 74  LIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWS 133
           L             L  L +  N           +   +  +         +   + ++ 
Sbjct: 90  LKALSDLP----PLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFI 145

Query: 134 FLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGL 193
              +           L           S+           +                   
Sbjct: 146 AAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPF 205

Query: 194 IYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLL--------- 244
           +      N+L  T+P    +L+ L       T+L              N+          
Sbjct: 206 LTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPN 265

Query: 245 HLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLP 304
               N  S  I        SL EL++ +NKL   +P+    L     +  S N L   +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLER---LIASFNHLA-EVP 320

Query: 305 SNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDL 337
              Q LK    L +  N L    P    ++ DL
Sbjct: 321 ELPQNLK---QLHVEYNPLRE-FPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 47.1 bits (110), Expect = 3e-06
 Identities = 39/313 (12%), Positives = 89/313 (28%), Gaps = 14/313 (4%)

Query: 4   QIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPN 63
            +P    +L+   SL    N+L+ L P +  ++ ++   N     LS   P +    + N
Sbjct: 52  SLPELPPHLE---SLVASCNSLTEL-PELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSN 107

Query: 64  IKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLT 123
            +  +L +      +     +   L  L     +                + +L      
Sbjct: 108 NQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAI 167

Query: 124 TESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSI-GNFSTSLQRFSASECKLKGT 182
              +++ +      L+    +    +          P +   ++ +    +  +      
Sbjct: 168 YADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKTLPDLPPSLE 227

Query: 183 IPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLN 242
                 +    +                   L +L             +         L 
Sbjct: 228 ALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLE 287

Query: 243 LLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDS 302
            L++  NKL   +P   A    L  L    N L   +P    +L    ++++  N L   
Sbjct: 288 ELNVSNNKLI-ELP---ALPPRLERLIASFNHLA-EVPELPQNL---KQLHVEYNPLR-E 338

Query: 303 LPSNVQKLKVLRV 315
            P   + ++ LR+
Sbjct: 339 FPDIPESVEDLRM 351

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.8 bits (112), Expect = 1e-06
 Identities = 45/258 (17%), Positives = 85/258 (32%), Gaps = 20/258 (7%)

Query: 91  LDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILS 150
           LDL         P+  G L    V++        +   A  +S          + ++ LS
Sbjct: 5   LDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFR-------VQHMDLS 54

Query: 151 GNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLG--FNDLNGTIP 208
            + +       I +  + LQ  S    +L   I   +     L+ L+L          + 
Sbjct: 55  NSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQ 114

Query: 209 TSIGTLKQLQGF------FLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASL 262
           T + +  +L            E ++Q  V H    +  LNL     N     +   +   
Sbjct: 115 TLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRC 174

Query: 263 TSLRELDLGSN-KLTSSIPSSLWSLGYILEINLSS-NLLNDSLPSNVQKLKVLRVLDLSR 320
            +L  LDL  +  L +      + L Y+  ++LS    +       + ++  L+ L +  
Sbjct: 175 PNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFG 234

Query: 321 NQLSGDIPSTIGALVDLE 338
               G +     AL  L+
Sbjct: 235 IVPDGTLQLLKEALPHLQ 252

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.5 bits (108), Expect = 5e-06
 Identities = 13/84 (15%), Positives = 31/84 (36%), Gaps = 5/84 (5%)

Query: 264 SLRELDLGSNKLTSSIPSSLWS-LGYILEINLSSNLLND----SLPSNVQKLKVLRVLDL 318
            ++ LD+   +L+ +  + L   L     + L    L +     + S ++    L  L+L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 319 SRNQLSGDIPSTIGALVDLETISL 342
             N+L       +   +   +  +
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKI 86

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.0 bits (104), Expect = 1e-05
 Identities = 22/109 (20%), Positives = 35/109 (32%), Gaps = 23/109 (21%)

Query: 230 YVPHNLCHLEMLNLLHLGGNKLSG----HIPPCLASLTSLRELDLGSNKLTSSIPSSLWS 285
                     +L +L L    +S      +   L +  SLRELDL +N L  +    L  
Sbjct: 360 LCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLV- 418

Query: 286 LGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGAL 334
                          +S+      L+    L L     S ++   + AL
Sbjct: 419 ---------------ESVRQPGCLLE---QLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.6 bits (103), Expect = 2e-05
 Identities = 14/88 (15%), Positives = 29/88 (32%), Gaps = 4/88 (4%)

Query: 39  IRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNL----IGTIPNSITNATKLIILDLG 94
           I++L++    LS    + +   L   + + L D  L       I +++     L  L+L 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 95  FNTFSGHIPNTFGNLRHLSVLSLLMNNL 122
            N       +            +   +L
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSL 91

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.0 bits (99), Expect = 6e-05
 Identities = 19/97 (19%), Positives = 35/97 (36%), Gaps = 12/97 (12%)

Query: 32  MIFNISTIRNLNLGGNRLSGHLPSMIGHSL---PNIKYLELGDNNLIGTIPNSITNA--- 85
           +    S +R L L    +S    S +  +L    +++ L+L +N L       +  +   
Sbjct: 364 LGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQ 423

Query: 86  --TKLIILDLGFNTFSGHIPNTFGNLR----HLSVLS 116
               L  L L    +S  + +    L      L V+S
Sbjct: 424 PGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.7 bits (98), Expect = 7e-05
 Identities = 20/92 (21%), Positives = 29/92 (31%), Gaps = 9/92 (9%)

Query: 91  LDLGFNTFS-GHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLIL 149
           LD+     S          L+   V+ L    LT            S+L     L  L L
Sbjct: 7   LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKD----ISSALRVNPALAELNL 62

Query: 150 SGNPLGGI----LPPSIGNFSTSLQRFSASEC 177
             N LG +    +   +   S  +Q+ S   C
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.1 bits (94), Expect = 3e-04
 Identities = 21/87 (24%), Positives = 32/87 (36%), Gaps = 13/87 (14%)

Query: 241 LNLLHLGGNKLS-GHIPPCLASLTSLRELDLGSNKLT----SSIPSSLWSLGYILEINLS 295
           +  L +   +LS       L  L   + + L    LT      I S+L     + E+NL 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 296 SNLLNDS--------LPSNVQKLKVLR 314
           SN L D         L +   K++ L 
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLS 90

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.1 bits (94), Expect = 3e-04
 Identities = 15/90 (16%), Positives = 31/90 (34%), Gaps = 11/90 (12%)

Query: 14 NLKSLFLGANNLSGL-IPPMIFNISTIRNLNLGGNRLSG----HLPSMIGHSLPNIKYLE 68
          +++SL +    LS      ++  +   + + L    L+      + S +    P +  L 
Sbjct: 3  DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSAL-RVNPALAELN 61

Query: 69 LGDNNLIGTIPNSITNA-----TKLIILDL 93
          L  N L     + +         K+  L L
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSL 91

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.6 bits (90), Expect = 8e-04
 Identities = 18/95 (18%), Positives = 30/95 (31%), Gaps = 8/95 (8%)

Query: 101 HIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGI--- 157
                      L VL L   +++  S S+      ++L     L  L LS N LG     
Sbjct: 360 LCQGLGQPGSVLRVLWLADCDVSDSSCSS----LAATLLANHSLRELDLSNNCLGDAGIL 415

Query: 158 -LPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLR 191
            L  S+      L++    +      +   +  L 
Sbjct: 416 QLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALE 450

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.4 bits (87), Expect = 0.002
 Identities = 13/57 (22%), Positives = 21/57 (36%), Gaps = 4/57 (7%)

Query: 231 VPHNLCHLEMLNLLHLGGNKLSG----HIPPCLASLTSLRELDLGSNKLTSSIPSSL 283
               L  L+   ++ L    L+      I   L    +L EL+L SN+L       +
Sbjct: 19  WAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCV 75

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.3 bits (84), Expect = 0.004
 Identities = 13/73 (17%), Positives = 23/73 (31%), Gaps = 8/73 (10%)

Query: 9  IGNLQNLKSLFLGANNLSG----LIPPMIFNISTIRNLNLGGNRLSG----HLPSMIGHS 60
          +  LQ  + + L    L+      I   +     +  LNL  N L       +   +   
Sbjct: 23 LPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82

Query: 61 LPNIKYLELGDNN 73
             I+ L L +  
Sbjct: 83 SCKIQKLSLQNCC 95

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.5 bits (103), Expect = 1e-05
 Identities = 27/235 (11%), Positives = 62/235 (26%), Gaps = 10/235 (4%)

Query: 71  DNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAY 130
             + +  IP+ +      I L              F     L         ++       
Sbjct: 16  QESKVTEIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDL-----EKIEISQNDVLEV 68

Query: 131 QWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHL 190
             + + S     + + +  + N L           +      S +  K    + K     
Sbjct: 69  IEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQ 128

Query: 191 RGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNK 250
           + L+ +    N       + +G   +    +L +  +Q          ++  L     N 
Sbjct: 129 KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNN 188

Query: 251 LSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPS 305
           L           +    LD+   ++ S     L +L  +   +  +      LP+
Sbjct: 189 LEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN---LKKLPT 240

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.6 bits (98), Expect = 5e-05
 Identities = 27/242 (11%), Positives = 60/242 (24%), Gaps = 12/242 (4%)

Query: 40  RNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFS 99
           R      ++++  +PS +     N   L      L      + +    L  +++  N   
Sbjct: 11  RVFLCQESKVT-EIPSDL---PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVL 66

Query: 100 GHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILP 159
             I     +         +         +   +  L +L         I           
Sbjct: 67  EVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGI-----KHLPDV 121

Query: 160 PSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQG 219
             I +    L     +           +G     + L L  N +      +    +  + 
Sbjct: 122 HKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDEL 181

Query: 220 FFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSI 279
                 NL+              +L +   ++       L +L  LR     + K    +
Sbjct: 182 NLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KL 238

Query: 280 PS 281
           P+
Sbjct: 239 PT 240

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.7 bits (104), Expect = 1e-05
 Identities = 43/217 (19%), Positives = 66/217 (30%), Gaps = 17/217 (7%)

Query: 35  NISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLG 94
            +++   +N     L+  LP  +     +   L L +N L      ++   T+L  L+L 
Sbjct: 8   KVASHLEVNCDKRNLT-ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNL- 62

Query: 95  FNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPL 154
                            L VL  L  +     S       L +LT        + S    
Sbjct: 63  ----DRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTS---- 114

Query: 155 GGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTL 214
              LP         LQ       +LK   P  +     L  LSL  N+L       +  L
Sbjct: 115 ---LPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGL 171

Query: 215 KQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKL 251
           + L    L + N    +P       +L    L GN  
Sbjct: 172 ENLDTLLL-QENSLYTIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.8 bits (99), Expect = 4e-05
 Identities = 40/185 (21%), Positives = 59/185 (31%), Gaps = 5/185 (2%)

Query: 142 RYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFN 201
           +    L LS N L      ++  + T L + +    +   T  +  G L  L  L L  N
Sbjct: 31  KDTTILHLSENLLYTFSLATLMPY-TRLTQLNLDRAE--LTKLQVDGTLPVLGTLDLSHN 87

Query: 202 DLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLAS 261
            L                  +    L       L  L  L  L+L GN+L    P  L  
Sbjct: 88  QLQSLPLLGQTLPAL-TVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTP 146

Query: 262 LTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRN 321
              L +L L +N LT      L  L  +  + L  N    ++P       +L    L  N
Sbjct: 147 TPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENS-LYTIPKGFFGSHLLPFAFLHGN 205

Query: 322 QLSGD 326
               +
Sbjct: 206 PWLCN 210

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.7 bits (91), Expect = 4e-04
 Identities = 45/227 (19%), Positives = 63/227 (27%), Gaps = 39/227 (17%)

Query: 71  DNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAY 130
           D   +  +P  +   T   IL L  N        T      L+ L+L    LT       
Sbjct: 18  DKRNLTALPPDLPKDTT--ILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL----Q 71

Query: 131 QWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHL 190
               L  L                                           ++P     L
Sbjct: 72  VDGTLPVLGTLDL--------------------------------SHNQLQSLPLLGQTL 99

Query: 191 RGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNK 250
             L  L + FN L      ++  L +LQ  +L    L+   P  L     L  L L  N 
Sbjct: 100 PALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN 159

Query: 251 LSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSN 297
           L+      L  L +L  L L  N L  +IP   +    +    L  N
Sbjct: 160 LTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.9 bits (89), Expect = 8e-04
 Identities = 32/195 (16%), Positives = 50/195 (25%), Gaps = 55/195 (28%)

Query: 4   QIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSL-- 61
            +P ++   ++   L L  N L       +   + +  LNL    L+          L  
Sbjct: 24  ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGT 81

Query: 62  ------------------------------------------PNIKYLELGDNNLIGTIP 79
                                                       ++ L L  N L    P
Sbjct: 82  LDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPP 141

Query: 80  NSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLT 139
             +T   KL  L L  N  +         L +L  L L  N+L         ++      
Sbjct: 142 GLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL---------YTIPKGFF 192

Query: 140 NCRYLVYLILSGNPL 154
               L +  L GNP 
Sbjct: 193 GSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.2 bits (87), Expect = 0.001
 Identities = 18/68 (26%), Positives = 29/68 (42%), Gaps = 4/68 (5%)

Query: 256 PPCLAS-LTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPSNVQKLKVLR 314
           P C  S + S  E++     LT+ +P  L        ++LS NLL     + +     L 
Sbjct: 2   PICEVSKVASHLEVNCDKRNLTA-LPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLT 58

Query: 315 VLDLSRNQ 322
            L+L R +
Sbjct: 59  QLNLDRAE 66

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.0 bits (84), Expect = 0.003
 Identities = 15/58 (25%), Positives = 25/58 (43%), Gaps = 3/58 (5%)

Query: 285 SLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISL 342
            +   LE+N     L  +LP ++ K     +L LS N L     +T+     L  ++L
Sbjct: 8   KVASHLEVNCDKRNL-TALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLNL 62

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 44.5 bits (103), Expect = 1e-05
 Identities = 31/341 (9%), Positives = 89/341 (26%), Gaps = 37/341 (10%)

Query: 13  QNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSL---PNIKYLEL 69
           ++LK   +   +   +    +    +++ + L GN +       +  ++    +++  E 
Sbjct: 8   KSLKLDAITTEDEKSVFAV-LLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66

Query: 70  GDN---NLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTES 126
            D     +   IP ++    + ++     +T            +   +  L  +      
Sbjct: 67  SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHL 126

Query: 127 SSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSI----GNFSTSLQRFSASECKLKGT 182
                     +       +  +          P        N   +      ++      
Sbjct: 127 YLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR 186

Query: 183 IPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLN 242
           +   +  ++  I      + L   +                       +   L     L 
Sbjct: 187 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLR 246

Query: 243 LLHLGGNKLSGHIPPCLA------SLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSS 296
            L L    LS      +           L+ L L  N++      +L             
Sbjct: 247 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTL------------K 294

Query: 297 NLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDL 337
            ++++ +P        L  L+L+ N+   +    +  + ++
Sbjct: 295 TVIDEKMPD-------LLFLELNGNRF-SEEDDVVDEIREV 327

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 41.2 bits (96), Expect = 3e-05
 Identities = 22/97 (22%), Positives = 34/97 (35%), Gaps = 4/97 (4%)

Query: 182 TIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEML 241
           T+   +  L  + +L L  N L    P ++  L+ L+     +  L+            L
Sbjct: 11  TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVDGVANLP--RL 67

Query: 242 NLLHLGGNKL-SGHIPPCLASLTSLRELDLGSNKLTS 277
             L L  N+L        L S   L  L+L  N L  
Sbjct: 68  QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 40.9 bits (95), Expect = 4e-05
 Identities = 23/116 (19%), Positives = 40/116 (34%), Gaps = 25/116 (21%)

Query: 244 LHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPS---------------------S 282
           LHL    L+  +   L  L  +  LDL  N+L +  P+                      
Sbjct: 3   LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDG 60

Query: 283 LWSLGYILEINLSSNLLND-SLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDL 337
           + +L  + E+ L +N L   +    +     L +L+L  N L          L ++
Sbjct: 61  VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 36.6 bits (84), Expect = 0.001
 Identities = 26/131 (19%), Positives = 49/131 (37%), Gaps = 9/131 (6%)

Query: 16  KSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLI 75
           + L L   +L+ L    +  +  + +L+L  NRL    P++   +L  ++ L+  DN L 
Sbjct: 1   RVLHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRALPPAL--AALRCLEVLQASDNALE 56

Query: 76  GTIPNSITNATKLIILDLGFNTF-SGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSF 134
                +     +   L L  N            +   L +L+L  N+L  E     Q   
Sbjct: 57  NVDGVANLPRLQ--ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG--IQERL 112

Query: 135 LSSLTNCRYLV 145
              L +   ++
Sbjct: 113 AEMLPSVSSIL 123

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 35.8 bits (82), Expect = 0.002
 Identities = 20/130 (15%), Positives = 33/130 (25%), Gaps = 14/130 (10%)

Query: 65  KYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTT 124
           + L L   +L  T+   +     +  LDL  N      P               +  L  
Sbjct: 1   RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPALAA-----------LRCLEV 47

Query: 125 ESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIP 184
             +S      +  + N   L  L+L  N L              L   +     L     
Sbjct: 48  LQASDNALENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EE 106

Query: 185 KEIGHLRGLI 194
                L  ++
Sbjct: 107 GIQERLAEML 116

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.9 bits (97), Expect = 6e-05
 Identities = 34/225 (15%), Positives = 74/225 (32%), Gaps = 29/225 (12%)

Query: 84  NATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRY 143
                I +  G +  +  +  T  +L  ++ LS     +TT          +  +     
Sbjct: 17  ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT----------IEGVQYLNN 64

Query: 144 LVYLILSGNPL------GGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLS 197
           L+ L L  N +        +   +    S +  +  ++   L+     ++   +      
Sbjct: 65  LIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTP 124

Query: 198 LGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHN-------LCHLEMLNLLHLGGNK 250
           L        +   +  +  +             + +        L +L  L  L    NK
Sbjct: 125 LAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNK 184

Query: 251 LSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLS 295
           +S   P  LASL +L E+ L +N+++   P  L +   +  + L+
Sbjct: 185 ISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.6 bits (89), Expect = 4e-04
 Identities = 26/145 (17%), Positives = 44/145 (30%), Gaps = 8/145 (5%)

Query: 4   QIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPN 63
           Q+   +    +     L    L     P +   +    LN   +        +I  ++P 
Sbjct: 11  QLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMA--ATLRIIEENIPE 66

Query: 64  IKYLELGDNNLIGT--IPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNN 121
           +  L L +N L     + + +  A  L IL+L  N               L  L L  N+
Sbjct: 67  LLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNS 126

Query: 122 LTT--ESSSAYQWSFLSSLTNCRYL 144
           L+      S Y  +          L
Sbjct: 127 LSDTFRDQSTYISAIRERFPKLLRL 151

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 37.1 bits (84), Expect = 0.002
 Identities = 34/175 (19%), Positives = 60/175 (34%), Gaps = 29/175 (16%)

Query: 182 TIPKEIGHLRGLIYLSLGFNDLNGTIPTSI-GTLKQLQGFFLPETNLQGYVPHNLCHLEM 240
            IP++I        L L  N+L       + G L  L    L    L G  P+       
Sbjct: 22  EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASH 79

Query: 241 LNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSL----------------- 283
           +  L LG NK+          L  L+ L+L  N+++  +P S                  
Sbjct: 80  IQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139

Query: 284 ------WSLGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIG 332
                 W   ++ + +L+        PS V+ +   ++ DL  ++      ++ G
Sbjct: 140 CNCHLAWFAEWLRKKSLNGGAARCGAPSKVRDV---QIKDLPHSEFKCSSENSEG 191

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.0 bits (84), Expect = 0.002
 Identities = 36/205 (17%), Positives = 66/205 (32%), Gaps = 24/205 (11%)

Query: 83  TNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCR 142
           T   + +   LG    +  +  +  +L  ++ L      + +          +  +    
Sbjct: 15  TALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKS----------IDGVEYLN 62

Query: 143 YLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFND 202
            L  +  S N L  I         T L+  +     L              +    G   
Sbjct: 63  NLTQINFSNNQLTDI---------TPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTL 113

Query: 203 LNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASL 262
            N  I              L  ++        L  L  L  L+   N+++   P  LA+L
Sbjct: 114 FNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANL 171

Query: 263 TSLRELDLGSNKLTS-SIPSSLWSL 286
           T+L  LD+ SNK++  S+ + L +L
Sbjct: 172 TTLERLDISSNKVSDISVLAKLTNL 196

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	481
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	100.0
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.96
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.96
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.96
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.96
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.95
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	99.95
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	99.94
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	99.94
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	99.94
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	99.94
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.94
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	99.94
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	99.94
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	99.93
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	99.93
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	99.93
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	99.93
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	99.93
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	99.93
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	99.92
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	99.92
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	99.92
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	99.92
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	99.92
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.92
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.92
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	99.92
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	99.92
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	99.92
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	99.92
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	99.92
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	99.91
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	99.91
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	99.91
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	99.91
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	99.91
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	99.91
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	99.91
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	99.91
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	99.91
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	99.9
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	99.9
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	99.9
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	99.9
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	99.9
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	99.9
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	99.9
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	99.89
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	99.89
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	99.89
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	99.89
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.88
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	99.88
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.88
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	99.88
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	99.88
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	99.87
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.86
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	99.86
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.86
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.85
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.85
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.84
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.84
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.84
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.84
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.84
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.84
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.84
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.83
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.82
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.82
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.82
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.81
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.79
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.79
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.77
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.77
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.77
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.77
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.76
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.75
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.72
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.7
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.65
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.65
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.65
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.63
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.62
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.62
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.55
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.53
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.5
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.49
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.42
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.4
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.39
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.58
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.53
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.89
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.72
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.3
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.06
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	96.93
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	96.22
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	95.0
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	94.19
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	91.22
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	90.73

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=6.2e-34  Score=270.85  Aligned_cols=249  Identities=29%  Similarity=0.441  Sum_probs=160.2

Q ss_pred             CCCEEEeeCCcCcc--ccChhhhcCCCCccEEEccC-ccceeecchhccccccCceeecccCcceecCcccccCCCCCCE
Q 039957           38 TIRNLNLGGNRLSG--HLPSMIGHSLPNIKYLELGD-NNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSV  114 (481)
Q Consensus        38 ~L~~L~L~~N~l~~--~~p~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  114 (481)
                      +++.|+|++|.++|  .+|+.++ .+++|++|+|++ |+++|.+|.+|+++++|++|+|++|++.+..|..+..+..|++
T Consensus        51 ~v~~L~L~~~~l~g~~~lp~~l~-~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~  129 (313)
T d1ogqa_          51 RVNNLDLSGLNLPKPYPIPSSLA-NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT  129 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGG-GCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred             EEEEEECCCCCCCCCCCCChHHh-cCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcc
Confidence            45666666666655  3556665 566666666664 5666666666666666666666666666666666666666666


Q ss_pred             EEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEccCCceeecCCcccccCCCCC
Q 039957          115 LSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLI  194 (481)
Q Consensus       115 L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~  194 (481)
                      +++++|.+.+..        +..+.+++.++++++++|.+++.+|+.++.+...++.++++.|++++..|..+..+..+ 
T Consensus       130 l~l~~N~~~~~~--------p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-  200 (313)
T d1ogqa_         130 LDFSYNALSGTL--------PPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-  200 (313)
T ss_dssp             EECCSSEEESCC--------CGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-
T ss_pred             cccccccccccC--------chhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-
Confidence            666666655431        13345566666666666666666666666654444666667777766666666655433 


Q ss_pred             eEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCc
Q 039957          195 YLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNK  274 (481)
Q Consensus       195 ~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~  274 (481)
                      +++++.+...+.+|..+..++.++.+++++|.+.+.+| .+..++.|+.|+|++|+++|.+|..|..+++|++|+|++|+
T Consensus       201 ~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~  279 (313)
T d1ogqa_         201 FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNN  279 (313)
T ss_dssp             EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSE
T ss_pred             cccccccccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCc
Confidence            56666666666666666666677777777776665443 45666677777777777777777777777777777777777


Q ss_pred             CcccCCcchhccccCcEEEccCcc
Q 039957          275 LTSSIPSSLWSLGYILEINLSSNL  298 (481)
Q Consensus       275 l~~~~p~~~~~l~~L~~L~l~~N~  298 (481)
                      ++|.+|. +..++.|+.+++++|+
T Consensus       280 l~g~iP~-~~~L~~L~~l~l~~N~  302 (313)
T d1ogqa_         280 LCGEIPQ-GGNLQRFDVSAYANNK  302 (313)
T ss_dssp             EEEECCC-STTGGGSCGGGTCSSS
T ss_pred             ccccCCC-cccCCCCCHHHhCCCc
Confidence            7766663 4566667777777775

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=1.2e-33  Score=268.72  Aligned_cols=247  Identities=28%  Similarity=0.446  Sum_probs=118.1

Q ss_pred             CCeeeCcCCcccc--cCChhccCCcCCCEEEeeC-CcCccccChhhhcCCCCccEEEccCccceeecchhccccccCcee
Q 039957           15 LKSLFLGANNLSG--LIPPMIFNISTIRNLNLGG-NRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIIL   91 (481)
Q Consensus        15 L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L   91 (481)
                      ++.|||++|++++  .+|+.+.++++|++|+|++ |+++|.+|+.++ .+++|++|+|++|++.+..+..+..+.+|+.+
T Consensus        52 v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~-~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l  130 (313)
T d1ogqa_          52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIA-KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL  130 (313)
T ss_dssp             EEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGG-GCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred             EEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccc-cccccchhhhccccccccccccccchhhhccc
Confidence            4445555555444  2444555555555555543 445444554444 35555555555555554444445555555555


Q ss_pred             ecccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCC-cEEEccCCccceeCChhhhhcccCcc
Q 039957           92 DLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYL-VYLILSGNPLGGILPPSIGNFSTSLQ  170 (481)
Q Consensus        92 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L-~~L~Ls~N~l~~~~p~~~~~~~~~L~  170 (481)
                      ++++|.+.+.+|..|++++.|+++++++|.+++..+        ..+..+..+ +.+++++|++++..|..+..+  ...
T Consensus       131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip--------~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l--~~~  200 (313)
T d1ogqa_         131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP--------DSYGSFSKLFTSMTISRNRLTGKIPPTFANL--NLA  200 (313)
T ss_dssp             ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECC--------GGGGCCCTTCCEEECCSSEEEEECCGGGGGC--CCS
T ss_pred             ccccccccccCchhhccCcccceeeccccccccccc--------ccccccccccccccccccccccccccccccc--ccc
Confidence            555555554555555555555555555554443211        112222222 445555555555444444433  233


Q ss_pred             EEEccCCceeecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCe
Q 039957          171 RFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNK  250 (481)
Q Consensus       171 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~  250 (481)
                      .++++.+...+.+|..+..+++++.+++++|.+.+.+| .++.+++|+.|++++|+++|.+|..|+.+++|++|+|++|+
T Consensus       201 ~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~  279 (313)
T d1ogqa_         201 FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNN  279 (313)
T ss_dssp             EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSE
T ss_pred             cccccccccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCc
Confidence            45555555555555444445555555555555444332 34444455555555555554455555555555555555555


Q ss_pred             eeecCCcccccCCCCCcEEcCCCc
Q 039957          251 LSGHIPPCLASLTSLRELDLGSNK  274 (481)
Q Consensus       251 l~~~~p~~~~~l~~L~~L~ls~N~  274 (481)
                      ++|.+|. ++.+++|+.+++++|+
T Consensus       280 l~g~iP~-~~~L~~L~~l~l~~N~  302 (313)
T d1ogqa_         280 LCGEIPQ-GGNLQRFDVSAYANNK  302 (313)
T ss_dssp             EEEECCC-STTGGGSCGGGTCSSS
T ss_pred             ccccCCC-cccCCCCCHHHhCCCc
Confidence            5544442 3444455555555554

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.96  E-value=9.8e-29  Score=241.30  Aligned_cols=310  Identities=23%  Similarity=0.314  Sum_probs=245.2

Q ss_pred             hCCCCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCc
Q 039957           10 GNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLI   89 (481)
Q Consensus        10 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~   89 (481)
                      ..+.+|++|++++|.|+.+  +.+..+++|++|++++|+|+ .+|+ +. .+++|++|++++|++.+..|  +.++++|+
T Consensus        41 ~~l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~-~l~~-l~-~L~~L~~L~L~~n~i~~i~~--l~~l~~L~  113 (384)
T d2omza2          41 TDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLT-DITP-LK-NLTKLVDILMNNNQIADITP--LANLTNLT  113 (384)
T ss_dssp             HHHTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCC-CCGG-GT-TCTTCCEEECCSSCCCCCGG--GTTCTTCC
T ss_pred             HHhCCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCC-CCcc-cc-CCcccccccccccccccccc--cccccccc
Confidence            4567899999999999864  45788999999999999998 5654 43 78999999999999885543  78899999


Q ss_pred             eeecccCcceecCcccccCCCCCCEEEcccccCccccCCCcc---------------------------------ccccc
Q 039957           90 ILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQ---------------------------------WSFLS  136 (481)
Q Consensus        90 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~---------------------------------~~~~~  136 (481)
                      .|++++|.+++..+  ......+.......|.+.........                                 .....
T Consensus       114 ~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (384)
T d2omza2         114 GLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDIS  191 (384)
T ss_dssp             EEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCG
T ss_pred             cccccccccccccc--ccccccccccccccccccccccccccccccccccccccchhhhhcccccccccccccccccccc
Confidence            99999998886543  44556777777777665443211100                                 00112


Q ss_pred             cCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEccCCceeecCCcccccCCCCCeEecccccceecCCcCCcCCCC
Q 039957          137 SLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQ  216 (481)
Q Consensus       137 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~  216 (481)
                      ....+++++.+++++|.+++..|.  ... ++|++|++++|.++. + ..+..+++|+.+++++|++++..+  +..+++
T Consensus       192 ~~~~l~~~~~l~l~~n~i~~~~~~--~~~-~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~  264 (384)
T d2omza2         192 VLAKLTNLESLIATNNQISDITPL--GIL-TNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAP--LSGLTK  264 (384)
T ss_dssp             GGGGCTTCSEEECCSSCCCCCGGG--GGC-TTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTT
T ss_pred             ccccccccceeeccCCccCCCCcc--ccc-CCCCEEECCCCCCCC-c-chhhcccccchhccccCccCCCCc--cccccc
Confidence            345678899999999999876543  333 589999999999984 3 468889999999999999986543  788999


Q ss_pred             CCeeecCCCcCCCCCCccccCccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCcCcccCCcchhccccCcEEEccC
Q 039957          217 LQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSS  296 (481)
Q Consensus       217 L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~  296 (481)
                      |+.++++++.+++..  .+..+..++.++++.|++++  ...+..+++++.|++++|++++..  .+..+++|++|++++
T Consensus       265 L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~  338 (384)
T d2omza2         265 LTELKLGANQISNIS--PLAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFAN  338 (384)
T ss_dssp             CSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCS
T ss_pred             CCEeeccCcccCCCC--cccccccccccccccccccc--ccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCC
Confidence            999999999998754  37788899999999999986  345888999999999999998654  378899999999999


Q ss_pred             cccCCCCCCccccCCcCcEEEccCCeeeeeccccccccCChhhhhcccc
Q 039957          297 NLLNDSLPSNVQKLKVLRVLDLSRNQLSGDIPSTIGALVDLETISLAGS  345 (481)
Q Consensus       297 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~~~g~  345 (481)
                      |++++ ++ .+.++++|++|++++|++++..|  +.++++|++|+++.+
T Consensus       339 n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N  383 (384)
T d2omza2         339 NKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ  383 (384)
T ss_dssp             SCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred             CCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence            99976 34 68999999999999999997654  888999999988653

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.96  E-value=1.6e-28  Score=232.24  Aligned_cols=280  Identities=23%  Similarity=0.246  Sum_probs=204.7

Q ss_pred             CCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeecccCcceecCcccccCCCCCCEEEc
Q 039957           38 TIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSL  117 (481)
Q Consensus        38 ~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  117 (481)
                      ..+.+|=++++++ .+|..++   +++++|+|++|+|+...+.+|.++++|++|++++|.+..+.|..|.++++|++|++
T Consensus        11 ~~~~~~C~~~~L~-~lP~~l~---~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l   86 (305)
T d1xkua_          11 HLRVVQCSDLGLE-KVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL   86 (305)
T ss_dssp             ETTEEECTTSCCC-SCCCSCC---TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred             cCCEEEecCCCCC-ccCCCCC---CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecc
Confidence            3455666666666 6666543   46777777777777555556777777777777777777766777777777777777


Q ss_pred             ccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEccCCcee--ecCCcccccCCCCCe
Q 039957          118 LMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLK--GTIPKEIGHLRGLIY  195 (481)
Q Consensus       118 ~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~--~~~p~~~~~l~~L~~  195 (481)
                      ++|+++.++...           ...+..|++++|.+.+..+..+... .....++...|...  ...+..+..+++|++
T Consensus        87 ~~n~l~~l~~~~-----------~~~l~~L~~~~n~l~~l~~~~~~~~-~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~  154 (305)
T d1xkua_          87 SKNQLKELPEKM-----------PKTLQELRVHENEITKVRKSVFNGL-NQMIVVELGTNPLKSSGIENGAFQGMKKLSY  154 (305)
T ss_dssp             CSSCCSBCCSSC-----------CTTCCEEECCSSCCCBBCHHHHTTC-TTCCEEECCSSCCCGGGBCTTGGGGCTTCCE
T ss_pred             cCCccCcCccch-----------hhhhhhhhccccchhhhhhhhhhcc-ccccccccccccccccCCCccccccccccCc
Confidence            777777664321           2457777778887775444433333 45667777776543  334556778888899


Q ss_pred             EecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCcC
Q 039957          196 LSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKL  275 (481)
Q Consensus       196 L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l  275 (481)
                      +++++|.+. .+|..+  +++|+.|++++|...+..+..|..++.++.|++++|.+++..+..|..+++|++|+|++|+|
T Consensus       155 l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L  231 (305)
T d1xkua_         155 IRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL  231 (305)
T ss_dssp             EECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCC
T ss_pred             cccccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeecccccc
Confidence            999998887 345443  57888899999988888888888888999999999999988888899999999999999998


Q ss_pred             cccCCcchhccccCcEEEccCcccCCCCCCcc------ccCCcCcEEEccCCeee--eeccccccccCCh
Q 039957          276 TSSIPSSLWSLGYILEINLSSNLLNDSLPSNV------QKLKVLRVLDLSRNQLS--GDIPSTIGALVDL  337 (481)
Q Consensus       276 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~------~~l~~L~~L~l~~N~l~--~~~p~~~~~l~~L  337 (481)
                      + .+|.++..+++|++|++++|+++......|      ..+.+|+.|++++|++.  ...|.+|..+...
T Consensus       232 ~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~~~~~f~~~~~~  300 (305)
T d1xkua_         232 V-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVR  300 (305)
T ss_dssp             S-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCG
T ss_pred             c-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccCcCCHhHhcccccC
Confidence            7 567788889999999999999886544333      45678999999999885  2445555544433

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.96  E-value=9.5e-28  Score=234.23  Aligned_cols=283  Identities=25%  Similarity=0.329  Sum_probs=229.7

Q ss_pred             cchhCCCCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccc
Q 039957            7 TEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNAT   86 (481)
Q Consensus         7 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~   86 (481)
                      +.+..+++|++|+|++|+|+++.|  +.++++|++|++++|++++ +++ +. .+++|+.|++++|.+++..+.  ....
T Consensus        60 ~gl~~L~nL~~L~Ls~N~l~~l~~--l~~L~~L~~L~L~~n~i~~-i~~-l~-~l~~L~~L~~~~~~~~~~~~~--~~~~  132 (384)
T d2omza2          60 DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-ITP-LA-NLTNLTGLTLFNNQITDIDPL--KNLT  132 (384)
T ss_dssp             TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CGG-GT-TCTTCCEEECCSSCCCCCGGG--TTCT
T ss_pred             cccccCCCCCEEeCcCCcCCCCcc--ccCCccccccccccccccc-ccc-cc-ccccccccccccccccccccc--cccc
Confidence            358899999999999999997643  9999999999999999984 554 43 799999999999998754432  2334


Q ss_pred             cCceeecccCcce-----------------------------------------ecCcccccCCCCCCEEEcccccCccc
Q 039957           87 KLIILDLGFNTFS-----------------------------------------GHIPNTFGNLRHLSVLSLLMNNLTTE  125 (481)
Q Consensus        87 ~L~~L~Ls~N~l~-----------------------------------------~~~p~~~~~l~~L~~L~L~~N~l~~~  125 (481)
                      .+..+....|.+.                                         ...+..+..+++++.+++++|.++++
T Consensus       133 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~l~~n~i~~~  212 (384)
T d2omza2         133 NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDI  212 (384)
T ss_dssp             TCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCC
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhccccccccccccccccccccccccccccceeeccCCccCCC
Confidence            4444444444332                                         12234577889999999999999876


Q ss_pred             cCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEccCCceeecCCcccccCCCCCeEeccccccee
Q 039957          126 SSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNG  205 (481)
Q Consensus       126 ~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~  205 (481)
                      .+          ...+++|++|++++|+++..  +.+..+ ++|+.+++++|.+++..  .+..+++|++|++++|++++
T Consensus       213 ~~----------~~~~~~L~~L~l~~n~l~~~--~~l~~l-~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~~~~l~~  277 (384)
T d2omza2         213 TP----------LGILTNLDELSLNGNQLKDI--GTLASL-TNLTDLDLANNQISNLA--PLSGLTKLTELKLGANQISN  277 (384)
T ss_dssp             GG----------GGGCTTCCEEECCSSCCCCC--GGGGGC-TTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCC
T ss_pred             Cc----------ccccCCCCEEECCCCCCCCc--chhhcc-cccchhccccCccCCCC--cccccccCCEeeccCcccCC
Confidence            32          24567899999999999853  456555 68999999999998644  37889999999999999986


Q ss_pred             cCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCcCcccCCcchhc
Q 039957          206 TIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWS  285 (481)
Q Consensus       206 ~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~  285 (481)
                      ..  .+..++.++.+.++.|.+++.  ..+..++.++.|++++|++++..  .+..+++|++|++++|++++ ++ .+..
T Consensus       278 ~~--~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~  349 (384)
T d2omza2         278 IS--PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLAN  349 (384)
T ss_dssp             CG--GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGG
T ss_pred             CC--ccccccccccccccccccccc--cccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcC
Confidence            44  377889999999999999863  45788899999999999999754  38899999999999999985 44 6899


Q ss_pred             cccCcEEEccCcccCCCCCCccccCCcCcEEEccCC
Q 039957          286 LGYILEINLSSNLLNDSLPSNVQKLKVLRVLDLSRN  321 (481)
Q Consensus       286 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N  321 (481)
                      +++|++|++++|++++..|  +.++++|+.|++++|
T Consensus       350 l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N  383 (384)
T d2omza2         350 LTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ  383 (384)
T ss_dssp             CTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred             CCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence            9999999999999998654  889999999999998

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.96  E-value=1.1e-27  Score=226.55  Aligned_cols=279  Identities=22%  Similarity=0.249  Sum_probs=141.0

Q ss_pred             CCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeecc
Q 039957           15 LKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLG   94 (481)
Q Consensus        15 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls   94 (481)
                      .+++|-++++++.+ |..+.  +++++|+|++|+|+ .+|+..+..+++|++|++++|.+....|..|.++++|++|+++
T Consensus        12 ~~~~~C~~~~L~~l-P~~l~--~~l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~   87 (305)
T d1xkua_          12 LRVVQCSDLGLEKV-PKDLP--PDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS   87 (305)
T ss_dssp             TTEEECTTSCCCSC-CCSCC--TTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             CCEEEecCCCCCcc-CCCCC--CCCCEEECcCCcCC-CcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence            34455555555533 33331  34555555555555 4444322345555555555555555445555555555555555


Q ss_pred             cCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccc--eeCChhhhhcccCccEE
Q 039957           95 FNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLG--GILPPSIGNFSTSLQRF  172 (481)
Q Consensus        95 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~--~~~p~~~~~~~~~L~~L  172 (481)
                      +|+++. +|..+  ...++.|+++.|.+..++...        +.....+..++...|...  ...+..+..+ ++|+.+
T Consensus        88 ~n~l~~-l~~~~--~~~l~~L~~~~n~l~~l~~~~--------~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l-~~L~~l  155 (305)
T d1xkua_          88 KNQLKE-LPEKM--PKTLQELRVHENEITKVRKSV--------FNGLNQMIVVELGTNPLKSSGIENGAFQGM-KKLSYI  155 (305)
T ss_dssp             SSCCSB-CCSSC--CTTCCEEECCSSCCCBBCHHH--------HTTCTTCCEEECCSSCCCGGGBCTTGGGGC-TTCCEE
T ss_pred             CCccCc-Cccch--hhhhhhhhccccchhhhhhhh--------hhccccccccccccccccccCCCccccccc-cccCcc
Confidence            555553 23222  234555555555555442211        122333444455444322  1122233332 345555


Q ss_pred             EccCCceeecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeee
Q 039957          173 SASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLS  252 (481)
Q Consensus       173 ~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~  252 (481)
                      ++++|.++ .+|..+  .++|+.|++++|...+..+..|..++.++.|++++|.+++..+..+..+++|++|+|++|+++
T Consensus       156 ~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~  232 (305)
T d1xkua_         156 RIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV  232 (305)
T ss_dssp             ECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS
T ss_pred             ccccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc
Confidence            55555554 233322  345556666666555555555555566666666666666555555666666666666666665


Q ss_pred             ecCCcccccCCCCCcEEcCCCcCcccCCcch------hccccCcEEEccCcccC--CCCCCccccCCcC
Q 039957          253 GHIPPCLASLTSLRELDLGSNKLTSSIPSSL------WSLGYILEINLSSNLLN--DSLPSNVQKLKVL  313 (481)
Q Consensus       253 ~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~------~~l~~L~~L~l~~N~l~--~~~p~~~~~l~~L  313 (481)
                      . +|.+|..+++|++|++++|+|+......|      ..+..|+.|++++|++.  ...|..|+.+...
T Consensus       233 ~-lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~~~~~f~~~~~~  300 (305)
T d1xkua_         233 K-VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVR  300 (305)
T ss_dssp             S-CCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCG
T ss_pred             c-cccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccCcCCHhHhcccccC
Confidence            3 35556666666666666666654322222      23455666666666654  2445555544433

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=9.4e-28  Score=224.45  Aligned_cols=223  Identities=22%  Similarity=0.190  Sum_probs=135.6

Q ss_pred             EEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeecccCcceecCcccccCCCCCCEEEcc-cc
Q 039957           42 LNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLL-MN  120 (481)
Q Consensus        42 L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~-~N  120 (481)
                      ++.++++++ .+|..++   +++++|+|++|+|++..+.+|.++++|++|++++|.+..+.+..+..+..++.+... .|
T Consensus        16 v~c~~~~L~-~iP~~ip---~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~   91 (284)
T d1ozna_          16 TSCPQQGLQ-AVPVGIP---AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA   91 (284)
T ss_dssp             EECCSSCCS-SCCTTCC---TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCT
T ss_pred             EEcCCCCCC-ccCCCCC---CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccccc
Confidence            445555565 5665443   345666666666665555566666666666666666666666666666666666543 44


Q ss_pred             cCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEccCCceeecCCcccccCCCCCeEeccc
Q 039957          121 NLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGF  200 (481)
Q Consensus       121 ~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~  200 (481)
                      .++.+++        ..+.++++|++|++++|.+....+..+... .+|+.+++++|.+++..+..|..+++|+.|++++
T Consensus        92 ~~~~l~~--------~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~-~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~  162 (284)
T d1ozna_          92 QLRSVDP--------ATFHGLGRLHTLHLDRCGLQELGPGLFRGL-AALQYLYLQDNALQALPDDTFRDLGNLTHLFLHG  162 (284)
T ss_dssp             TCCCCCT--------TTTTTCTTCCEEECTTSCCCCCCTTTTTTC-TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             ccccccc--------hhhcccccCCEEecCCcccccccccccchh-cccchhhhccccccccChhHhccccchhhccccc
Confidence            4444432        224455666666666666654433333332 4566666666666655555566666666666666


Q ss_pred             ccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCcCcc
Q 039957          201 NDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTS  277 (481)
Q Consensus       201 N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~  277 (481)
                      |++++..+..|.++++|+.+++++|++++..|..|..+++|+.|++++|++.+..|..|..+++|++|++++|.+..
T Consensus       163 N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C  239 (284)
T d1ozna_         163 NRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC  239 (284)
T ss_dssp             SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred             CcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCC
Confidence            66666666666666666666666666666666666666666666666666666666666666666666666666653

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=4.3e-28  Score=223.58  Aligned_cols=135  Identities=30%  Similarity=0.464  Sum_probs=116.5

Q ss_pred             hccccccceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHHh
Q 039957          341 SLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKRL  415 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~l  415 (481)
                      .|+|+||.||+|...++..||||.+.... ...++|.+|++++++++|||||+++|+|...+     +||+++|+|.+++
T Consensus        13 iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l   91 (263)
T d1sm2a_          13 IGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYL   91 (263)
T ss_dssp             EECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHH
T ss_pred             EeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHh
Confidence            47899999999998888899999986533 23457899999999999999999999997664     6899999999998


Q ss_pred             hcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          416 YSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       416 ~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      ......++|..+.+|+.|||+||+|+|    +.+|+||||||+|||+|+++.+||+|||+|+.+.
T Consensus        92 ~~~~~~~~~~~~~~i~~qia~gl~~lH----~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~  152 (263)
T d1sm2a_          92 RTQRGLFAAETLLGMCLDVCEGMAYLE----EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL  152 (263)
T ss_dssp             HTTTTCCCHHHHHHHHHHHHHHHHHHH----HTTCCCTTCSGGGEEECGGGCEEECSCC------
T ss_pred             hccccCCCHHHHHHHHHHHHHHHHhhh----ccceeecccchhheeecCCCCeEecccchheecc
Confidence            877777899999999999999999999    5789999999999999999999999999998653

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=5.5e-28  Score=223.90  Aligned_cols=135  Identities=25%  Similarity=0.481  Sum_probs=118.4

Q ss_pred             hccccccceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC----cccccCCChhHHhh
Q 039957          341 SLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----FKFMPNGSLEKRLY  416 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~~~~g~l~~~l~  416 (481)
                      .|+|+||.||+|...++..||||.+.... ...+.|.+|+.++++++|||||+++|+|....    +||+++|+|.+++.
T Consensus        21 iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~iv~Ey~~~g~L~~~~~   99 (272)
T d1qpca_          21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLK   99 (272)
T ss_dssp             EEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCTTCBHHHHTT
T ss_pred             EecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeeccCCeEEEEEeCCCCcHHHHHh
Confidence            47899999999998888899999986543 23457899999999999999999999987654    68999999998776


Q ss_pred             cC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          417 SH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       417 ~~-~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      .. ...++|.++++|+.+||+||+|||    +.+|+||||||+|||+|+++.+||+|||+|+.+.
T Consensus       100 ~~~~~~l~~~~~~~i~~qi~~gl~~lH----~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~  160 (272)
T d1qpca_         100 TPSGIKLTINKLLDMAAQIAEGMAFIE----ERNYIHRDLRAANILVSDTLSCKIADFGLARLIE  160 (272)
T ss_dssp             SHHHHTCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             hcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCccchhheeeecccceeeccccceEEcc
Confidence            42 235899999999999999999999    5789999999999999999999999999998764

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=6.7e-28  Score=223.44  Aligned_cols=134  Identities=31%  Similarity=0.575  Sum_probs=117.5

Q ss_pred             hhccccccceeeeeccCCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC----cccccCCChhH
Q 039957          340 ISLAGSFGSVYKGTISDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----FKFMPNGSLEK  413 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~~~~g~l~~  413 (481)
                      ..|+|+||.||+|+..  ..||||.+....  ....+.|.+|++++++++|||||+++|+|....    +||+++|+|.+
T Consensus        15 ~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~lv~Ey~~~g~L~~   92 (276)
T d1uwha_          15 RIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYH   92 (276)
T ss_dssp             EEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECCCEEEHHH
T ss_pred             EEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEeccEEEEEEecCCCCCHHH
Confidence            4589999999999864  359999986543  334567889999999999999999999987764    68999999999


Q ss_pred             HhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          414 RLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       414 ~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ++......+++..+.+|+.|||+||+|||    +.+||||||||+|||+|+++.+||+|||+|+..
T Consensus        93 ~l~~~~~~~~~~~~~~i~~qi~~gl~yLH----~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~  154 (276)
T d1uwha_          93 HLHIIETKFEMIKLIDIARQTAQGMDYLH----AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVK  154 (276)
T ss_dssp             HHHTSCCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-
T ss_pred             HHhhccCCCCHHHHHHHHHHHHHHHHHHh----cCCEeccccCHHHEEEcCCCCEEEccccceeec
Confidence            99876667899999999999999999999    578999999999999999999999999999875

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.94  E-value=1.3e-27  Score=223.01  Aligned_cols=135  Identities=29%  Similarity=0.513  Sum_probs=118.9

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHH
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKR  414 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~  414 (481)
                      .|+|+||.||+|... +|..||||.+.... ...++|.+|++++++++|||||+++|+|.+.+     +||+++|++.++
T Consensus        25 iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~  103 (287)
T d1opja_          25 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY  103 (287)
T ss_dssp             TTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHH
T ss_pred             EeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHH
Confidence            478999999999865 58899999986543 23457889999999999999999999998765     689999999999


Q ss_pred             hhc-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          415 LYS-HNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       415 l~~-~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      +.. ....+++..+.+|+.|||+||+|||    +.+||||||||+|||+|+++.+||+|||+|+...
T Consensus       104 l~~~~~~~~~~~~~~~i~~qi~~gL~yLH----~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~  166 (287)
T d1opja_         104 LRECNRQEVSAVVLLYMATQISSAMEYLE----KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT  166 (287)
T ss_dssp             HHHSCTTTSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred             hhhccccchHHHHHHHHHHHHHHHHHHHH----HCCcccCccccCeEEECCCCcEEEccccceeecC
Confidence            875 3457899999999999999999999    5789999999999999999999999999998764

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.94  E-value=9e-28  Score=225.38  Aligned_cols=139  Identities=31%  Similarity=0.526  Sum_probs=113.4

Q ss_pred             hhhhccccccceeeeecc-CC---cceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----ccccc
Q 039957          338 ETISLAGSFGSVYKGTIS-DG---TDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMP  407 (481)
Q Consensus       338 ~~l~~~g~~g~vy~~~l~-~g---~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~  407 (481)
                      ..+.|+|+||.||+|... +|   ..||||.+.... ....+.|.+|++++++++|||||+++|+|...+     +||++
T Consensus        31 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~  110 (299)
T d1jpaa_          31 EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFME  110 (299)
T ss_dssp             EEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecC
Confidence            345689999999999864 33   357888875543 334567899999999999999999999997764     68999


Q ss_pred             CCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          408 NGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       408 ~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      +|+|.+++......++|.++.+|+.|||+||+|||    +.+||||||||+|||+|+++++||+|||+|+.+.
T Consensus       111 ~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH----~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  179 (299)
T d1jpaa_         111 NGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA----DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  179 (299)
T ss_dssp             TEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             CCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHh----hCCCccCccccceEEECCCCcEEECCcccceEcc
Confidence            99999988876667899999999999999999999    5789999999999999999999999999998753

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=1.2e-26  Score=216.89  Aligned_cols=225  Identities=23%  Similarity=0.222  Sum_probs=143.8

Q ss_pred             cEEEccCccceeecchhccccccCceeecccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCC
Q 039957           65 KYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYL  144 (481)
Q Consensus        65 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L  144 (481)
                      ..++.++++++ .+|..+.  +.+++|+|++|+|+++.+.+|.++++|++|++++|++..+....        +..+..+
T Consensus        14 ~~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~--------~~~~~~~   82 (284)
T d1ozna_          14 VTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA--------FTGLALL   82 (284)
T ss_dssp             CEEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTT--------TTTCTTC
T ss_pred             eEEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccc--------ccccccc
Confidence            34567777776 5565543  56788888888888777778888888888888888888775433        3445566


Q ss_pred             cEEEcc-CCccceeCChhhhhcccCccEEEccCCceeecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecC
Q 039957          145 VYLILS-GNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLP  223 (481)
Q Consensus       145 ~~L~Ls-~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~  223 (481)
                      ..++.. .|.++...|..+..+ ++|++|++++|.+....+..+....+|+.+++++|++++..+..|..+++|+.|+++
T Consensus        83 ~~l~~~~~~~~~~l~~~~~~~l-~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~  161 (284)
T d1ozna_          83 EQLDLSDNAQLRSVDPATFHGL-GRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLH  161 (284)
T ss_dssp             CEEECCSCTTCCCCCTTTTTTC-TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             cccccccccccccccchhhccc-ccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccc
Confidence            666554 444554445555544 456666666666655555555556666666666666665555556666666666666


Q ss_pred             CCcCCCCCCccccCccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCcCcccCCcchhccccCcEEEccCcccCC
Q 039957          224 ETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLND  301 (481)
Q Consensus       224 ~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~  301 (481)
                      +|++++..+..|.++++|+.+++++|++++..|..|..+++|++||+++|++.+..|..|..+..|++|++++|.+..
T Consensus       162 ~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C  239 (284)
T d1ozna_         162 GNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC  239 (284)
T ss_dssp             SSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred             cCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCC
Confidence            666666555666666666666666666666666666666666666666666665555555566666666666665543

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=2.9e-27  Score=220.04  Aligned_cols=136  Identities=25%  Similarity=0.455  Sum_probs=119.0

Q ss_pred             hccccccceeeeecc---CCcceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC----cccccCCChh
Q 039957          341 SLAGSFGSVYKGTIS---DGTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----FKFMPNGSLE  412 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~---~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~~~~g~l~  412 (481)
                      .|+|+||.||+|...   ++..||||.+.... ....+.|.+|++++++++|||||+++|+|....    +||+++|+|.
T Consensus        17 iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~lvmE~~~~g~L~   96 (285)
T d1u59a_          17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLH   96 (285)
T ss_dssp             EECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTEEHH
T ss_pred             EecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccCeEEEEEEeCCCCcHH
Confidence            378999999999753   34579999987543 334567899999999999999999999997654    7899999999


Q ss_pred             HHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          413 KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       413 ~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      +++......+++..+.+|+.|||+||+|||    +.+||||||||+|||+++++.+||+|||+|+.+.
T Consensus        97 ~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH----~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~  160 (285)
T d1u59a_          97 KFLVGKREEIPVSNVAELLHQVSMGMKYLE----EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG  160 (285)
T ss_dssp             HHHTTCTTTSCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             HHhhccccCCCHHHHHHHHHHHHHHHHHHH----hCCeecCcCchhheeeccCCceeeccchhhhccc
Confidence            998776667899999999999999999999    5789999999999999999999999999998653

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=4.5e-27  Score=219.05  Aligned_cols=135  Identities=25%  Similarity=0.390  Sum_probs=120.7

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHH
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKR  414 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~  414 (481)
                      .|+|+||.||+|.. .+|..||+|.+........+.+.+|++++++++|||||++++++.+.+     +||+++|+|.++
T Consensus        20 iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~   99 (288)
T d2jfla1          20 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAV   99 (288)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHH
T ss_pred             EeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHH
Confidence            47899999999985 468899999998766666678999999999999999999999987765     789999999998


Q ss_pred             hhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          415 LYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       415 l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +......+++.++..++.||++||+|||    +.+||||||||+|||++.++.+||+|||+|+..
T Consensus       100 ~~~~~~~l~e~~~~~i~~qi~~gL~ylH----~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~  160 (288)
T d2jfla1         100 MLELERPLTESQIQVVCKQTLDALNYLH----DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKN  160 (288)
T ss_dssp             HHHHTSCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             HHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCEEEeecChhheeECCCCCEEEEechhhhcc
Confidence            7765556889999999999999999999    578999999999999999999999999999754

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=5.2e-27  Score=218.68  Aligned_cols=139  Identities=29%  Similarity=0.516  Sum_probs=117.0

Q ss_pred             hhhhhccccccceeeeeccCC-----cceEEEEEeccch-hhhhhhhHHHHHhhhhccCccceeecccCCCC-----ccc
Q 039957          337 LETISLAGSFGSVYKGTISDG-----TDVAIKIFNLQRE-RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKF  405 (481)
Q Consensus       337 L~~l~~~g~~g~vy~~~l~~g-----~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~  405 (481)
                      +..+.|+|+||.||+|.....     ..||||.+..... .....|.+|+.++++++|||||+++|+|...+     +||
T Consensus        11 ~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~   90 (283)
T d1mqba_          11 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEY   90 (283)
T ss_dssp             EEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             eeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEe
Confidence            445678999999999986532     3699999865432 33456889999999999999999999998765     578


Q ss_pred             ccCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          406 MPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       406 ~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +.+|++.+.+......++|.++.+++.+||+|++|||    +.+|+||||||+|||+|+++.+||+|||+|+.+
T Consensus        91 ~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH----~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  160 (283)
T d1mqba_          91 MENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA----NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL  160 (283)
T ss_dssp             CTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             cccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcc----ccccccCccccceEEECCCCeEEEcccchhhcc
Confidence            9999999988777678999999999999999999999    578999999999999999999999999999875

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=1.8e-26  Score=215.20  Aligned_cols=133  Identities=28%  Similarity=0.430  Sum_probs=118.3

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHH
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKR  414 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~  414 (481)
                      .|+|+||.||+|.. .+|..||+|.+........+.+.+|+.++++++|||||++++++...+     +||+++|+|.++
T Consensus        28 iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~  107 (293)
T d1yhwa1          28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV  107 (293)
T ss_dssp             CCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHH
T ss_pred             EecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHH
Confidence            47899999999984 568999999998765555567899999999999999999999987765     689999999998


Q ss_pred             hhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          415 LYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       415 l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +...  .++..+...++.||+.||+|||    +.+||||||||+|||++.++++||+|||+|+.+
T Consensus       108 ~~~~--~l~~~~~~~i~~qi~~aL~yLH----~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~  166 (293)
T d1yhwa1         108 VTET--CMDEGQIAAVCRECLQALEFLH----SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI  166 (293)
T ss_dssp             HHHS--CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             hhcc--CCCHHHHHHHHHHHHHHHHHHH----HCCCcccCCcHHHeEECCCCcEeeccchhheee
Confidence            7653  4788889999999999999999    578999999999999999999999999999865

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=1.5e-26  Score=212.08  Aligned_cols=136  Identities=29%  Similarity=0.443  Sum_probs=120.9

Q ss_pred             hhccccccceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHH
Q 039957          340 ISLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKR  414 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~  414 (481)
                      ..++|+||.||+|...++..||||.+..... ..++|.+|+.++++++|||||+++|+|...+     +||+++|++..+
T Consensus        11 ~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~   89 (258)
T d1k2pa_          11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY   89 (258)
T ss_dssp             CCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHH
T ss_pred             EEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHh
Confidence            3478999999999988888999999876433 3457899999999999999999999998764     689999999999


Q ss_pred             hhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          415 LYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       415 l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      +.......++..+.+++.|||+||+|||    +.+|+||||||+||++|+++.+||+|||+|+.+.
T Consensus        90 ~~~~~~~~~~~~~~~i~~qi~~gl~~LH----~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~  151 (258)
T d1k2pa_          90 LREMRHRFQTQQLLEMCKDVCEAMEYLE----SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL  151 (258)
T ss_dssp             HHSGGGCCCHHHHHHHHHHHHHHHHHHH----HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCS
T ss_pred             hhccccCCcHHHHHHHHHHHHHHHHHHh----hcCcccccccceeEEEcCCCcEEECcchhheecc
Confidence            8776667889999999999999999999    5789999999999999999999999999998653

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=1.4e-26  Score=213.58  Aligned_cols=135  Identities=23%  Similarity=0.390  Sum_probs=115.8

Q ss_pred             hhccccccceeeeec-cCCcceEEEEEeccch-hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          340 ISLAGSFGSVYKGTI-SDGTDVAIKIFNLQRE-RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       340 l~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      ..|+|+||.||+|.. .+|..||||.+..... ...+.+.+|++++++++|||||++++++.+.+     +||+++|+|.
T Consensus        12 ~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~   91 (271)
T d1nvra_          12 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELF   91 (271)
T ss_dssp             EEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGG
T ss_pred             EEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHH
Confidence            347899999999985 4689999999876542 33457889999999999999999999998765     6899999999


Q ss_pred             HHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          413 KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       413 ~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +++.. ...+++.++..++.||++||+|||    +.+||||||||+|||+++++.+||+|||+|+.+
T Consensus        92 ~~l~~-~~~l~e~~~~~i~~qi~~al~ylH----~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~  153 (271)
T d1nvra_          92 DRIEP-DIGMPEPDAQRFFHQLMAGVVYLH----GIGITHRDIKPENLLLDERDNLKISDFGLATVF  153 (271)
T ss_dssp             GGSBT-TTBCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             HHHhc-CCCCCHHHHHHHHHHHHHHHHHHH----HcCCccCcccHHHEEECCCCCEEEccchhheee
Confidence            99864 346888999999999999999999    578999999999999999999999999999864

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=1.1e-26  Score=216.03  Aligned_cols=135  Identities=29%  Similarity=0.526  Sum_probs=116.8

Q ss_pred             hccccccceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC----cccccCCChhHHhh
Q 039957          341 SLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----FKFMPNGSLEKRLY  416 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~~~~g~l~~~l~  416 (481)
                      .|+|+||.||+|...++..||||.+.... ...+.|.+|+.++++++|+|||+++|+|...+    +||+++|++...+.
T Consensus        25 iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~lv~Ey~~~g~l~~~~~  103 (285)
T d1fmka3          25 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLK  103 (285)
T ss_dssp             EEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCTTCBHHHHHS
T ss_pred             EeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEecCCeEEEEEecCCCchhhhhh
Confidence            38899999999998888889999986543 23467899999999999999999999997654    68999999998876


Q ss_pred             cC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          417 SH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       417 ~~-~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      .. ...++|.++.+|+.+||+||+|||    ..+|+||||||+|||+|+++++||+|||+|+.+.
T Consensus       104 ~~~~~~l~~~~~~~i~~~i~~gl~~LH----~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~  164 (285)
T d1fmka3         104 GETGKYLRLPQLVDMAAQIASGMAYVE----RMNYVHRDLRAANILVGENLVCKVADFGLARLIE  164 (285)
T ss_dssp             HHHHTTCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred             hcccccchHHHHHHHHHHHHHHHHHHh----hhheecccccceEEEECCCCcEEEcccchhhhcc
Confidence            53 245899999999999999999999    5789999999999999999999999999998753

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=2.2e-26  Score=213.37  Aligned_cols=134  Identities=25%  Similarity=0.415  Sum_probs=115.0

Q ss_pred             hccccccceeeeeccC---CcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTISD---GTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~---g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~~~~g~l  411 (481)
                      .|+|+||.||+|...+   +..||||.+....  ....+.+.+|+.++++++|||||+++|+|....    +||+++|+|
T Consensus        15 iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~~~lvmE~~~~g~L   94 (277)
T d1xbba_          15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPL   94 (277)
T ss_dssp             EEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTEEH
T ss_pred             cccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCCEEEEEEcCCCCcH
Confidence            4789999999997643   4679999986432  233457899999999999999999999997654    789999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+++... ..++|..+.+|+.|||+||+|||    +.+||||||||+|||++.++.+||+|||+|+.+
T Consensus        95 ~~~l~~~-~~l~~~~~~~i~~qi~~gl~ylH----~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~  157 (277)
T d1xbba_          95 NKYLQQN-RHVKDKNIIELVHQVSMGMKYLE----ESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL  157 (277)
T ss_dssp             HHHHHHC-TTCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             HHHHhhc-cCCCHHHHHHHHHHHHHHHhhHH----hCCcccCCCcchhhcccccCcccccchhhhhhc
Confidence            9988754 45889999999999999999999    578999999999999999999999999999865

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=5.5e-26  Score=214.19  Aligned_cols=137  Identities=24%  Similarity=0.466  Sum_probs=118.5

Q ss_pred             hhccccccceeeeeccCC----cceEEEEEecc-chhhhhhhhHHHHHhhhhccCccceeecccCCCC------cccccC
Q 039957          340 ISLAGSFGSVYKGTISDG----TDVAIKIFNLQ-RERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD------FKFMPN  408 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~~g----~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~~~~  408 (481)
                      +.|+|+||.||+|.+.++    ..||||+++.. .....++|.+|++++++++|||||+++|+|...+      +||+++
T Consensus        34 ~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~  113 (311)
T d1r0pa_          34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKH  113 (311)
T ss_dssp             EEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTT
T ss_pred             EEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeec
Confidence            458999999999987542    35899998643 3444577999999999999999999999986432      689999


Q ss_pred             CChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          409 GSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       409 g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      |++.+++.......++..+++++.|+|+||+|+|    +.+|+||||||+|||+|+++.+||+|||+++.+.
T Consensus       114 g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH----~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~  181 (311)
T d1r0pa_         114 GDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA----SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY  181 (311)
T ss_dssp             CBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTT
T ss_pred             CchhhhhccccccchHHHHHHHHHHHHHhhhhhc----ccCcccCCccHHhEeECCCCCEEEecccchhhcc
Confidence            9999998877777888999999999999999999    6789999999999999999999999999998753

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=8.3e-26  Score=207.55  Aligned_cols=135  Identities=23%  Similarity=0.383  Sum_probs=117.4

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      .++|+||.||+|... +|..||+|.+....   ......+.+|++++++++|||||++++++.+.+     +||+++|+|
T Consensus        14 iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L   93 (263)
T d2j4za1          14 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV   93 (263)
T ss_dssp             EEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBH
T ss_pred             EecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcH
Confidence            478999999999864 68899999986543   233456788999999999999999999998775     689999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      .+++... ..+++.+...++.||++||+|||    +.+||||||||+|||+++++.+||+|||+|+...
T Consensus        94 ~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH----~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~  157 (263)
T d2j4za1          94 YRELQKL-SKFDEQRTATYITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP  157 (263)
T ss_dssp             HHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCC
T ss_pred             HHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH----HCCeeeeeeccccceecCCCCEeecccceeeecC
Confidence            9988753 35788899999999999999999    6789999999999999999999999999998753

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=99.92  E-value=1.1e-25  Score=215.19  Aligned_cols=137  Identities=23%  Similarity=0.368  Sum_probs=120.8

Q ss_pred             hhccccccceeeeec-cCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhH
Q 039957          340 ISLAGSFGSVYKGTI-SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEK  413 (481)
Q Consensus       340 l~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~  413 (481)
                      ..|+|+||.||+|.. .+|..||||.+........+.+.+|+.++++++|||||++++++.+.+     +||+++|+|.+
T Consensus        33 ~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~  112 (350)
T d1koaa2          33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFE  112 (350)
T ss_dssp             EEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHH
T ss_pred             EEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHH
Confidence            347899999999985 568999999997766555667889999999999999999999987765     68999999999


Q ss_pred             HhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeC--CCCcEEEccccCcccCC
Q 039957          414 RLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLD--ENMVAHVSDFGISKLLG  480 (481)
Q Consensus       414 ~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~--~~~~~kl~Dfgl~~~~~  480 (481)
                      ++......+++.+...|+.||+.||+|||    +.+||||||||+|||++  +++.+||+|||+|+.+.
T Consensus       113 ~l~~~~~~l~e~~~~~i~~qi~~aL~ylH----~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~  177 (350)
T d1koaa2         113 KVADEHNKMSEDEAVEYMRQVCKGLCHMH----ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD  177 (350)
T ss_dssp             HHTCTTSCBCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred             HHHhhcCCCCHHHHHHHHHHHHHHHHHHH----hcCCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence            98766667899999999999999999999    67899999999999995  46899999999998764

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=99.92  E-value=1.5e-25  Score=214.58  Aligned_cols=137  Identities=23%  Similarity=0.389  Sum_probs=120.8

Q ss_pred             hhccccccceeeeec-cCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhH
Q 039957          340 ISLAGSFGSVYKGTI-SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEK  413 (481)
Q Consensus       340 l~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~  413 (481)
                      ..|+|+||.||+|.. .+|..||||.+..........+.+|+.++++++|||||++++++.+.+     +||+++|+|.+
T Consensus        36 ~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~  115 (352)
T d1koba_          36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFD  115 (352)
T ss_dssp             EEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHH
T ss_pred             EEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHH
Confidence            348899999999985 579999999987765555567888999999999999999999988765     68999999999


Q ss_pred             HhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeC--CCCcEEEccccCcccCC
Q 039957          414 RLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLD--ENMVAHVSDFGISKLLG  480 (481)
Q Consensus       414 ~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~--~~~~~kl~Dfgl~~~~~  480 (481)
                      ++......++..+...|+.+|++||+|||    +.+||||||||+|||++  +++.+||+|||+|+.+.
T Consensus       116 ~~~~~~~~l~e~~~~~i~~qi~~aL~ylH----~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~  180 (352)
T d1koba_         116 RIAAEDYKMSEAEVINYMRQACEGLKHMH----EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN  180 (352)
T ss_dssp             HTTCTTCCBCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred             HHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeecccccccccccccCCCeEEEeecccceecC
Confidence            88776667899999999999999999999    57899999999999998  57899999999998754

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=5.7e-26  Score=215.51  Aligned_cols=135  Identities=25%  Similarity=0.311  Sum_probs=117.0

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhH
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEK  413 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~  413 (481)
                      .|+|+||.||+|.. .+|..||+|.+.... ......+.+|+.++++++|||||+++++|.+.+     +||+++|+|.+
T Consensus        14 iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~   93 (322)
T d1s9ja_          14 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ   93 (322)
T ss_dssp             EECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHH
T ss_pred             EecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHH
Confidence            47899999999985 568999999987643 333456889999999999999999999998775     68999999999


Q ss_pred             HhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          414 RLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       414 ~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ++... ..+++.....++.|+++||+|||+   ..+|+||||||+|||+++++++||+|||+|+.+
T Consensus        94 ~l~~~-~~l~~~~~~~~~~qil~aL~yLH~---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~  155 (322)
T d1s9ja_          94 VLKKA-GRIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  155 (322)
T ss_dssp             HHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred             HHhhc-CCCCHHHHHHHHHHHHHHHHHHHH---hCCEEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence            98753 357888999999999999999994   237999999999999999999999999999753

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=1.5e-24  Score=200.33  Aligned_cols=201  Identities=24%  Similarity=0.169  Sum_probs=112.5

Q ss_pred             CCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeecccCcceecCcccccCCCCCCE
Q 039957           35 NISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSV  114 (481)
Q Consensus        35 ~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  114 (481)
                      ...++.+.+.++++++ .+|+.++   +++++|+|++|+|++..+.+|.++++|++|+|++|+|+.+ | .++.+++|++
T Consensus         8 ~~~~~~~v~C~~~~L~-~iP~~lp---~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~   81 (266)
T d1p9ag_           8 KVASHLEVNCDKRNLT-ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGT   81 (266)
T ss_dssp             CSTTCCEEECTTSCCS-SCCSCCC---TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCE
T ss_pred             ccCCCeEEEccCCCCC-eeCcCcC---cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccc-c-cccccccccc
Confidence            4445556677777776 5665443   4567777777777655556666666666666666666643 2 2455666666


Q ss_pred             EEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEccCCceeecCCcccccCCCCC
Q 039957          115 LSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLI  194 (481)
Q Consensus       115 L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~  194 (481)
                      |+|++|+++..+.         .+.++++|++|++++|.+.                         +..+..+..+.+++
T Consensus        82 L~Ls~N~l~~~~~---------~~~~l~~L~~L~l~~~~~~-------------------------~~~~~~~~~l~~l~  127 (266)
T d1p9ag_          82 LDLSHNQLQSLPL---------LGQTLPALTVLDVSFNRLT-------------------------SLPLGALRGLGELQ  127 (266)
T ss_dssp             EECCSSCCSSCCC---------CTTTCTTCCEEECCSSCCC-------------------------CCCSSTTTTCTTCC
T ss_pred             ccccccccccccc---------ccccccccccccccccccc-------------------------eeeccccccccccc
Confidence            6666666554321         1233444444444444443                         33333444455555


Q ss_pred             eEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCc
Q 039957          195 YLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNK  274 (481)
Q Consensus       195 ~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~  274 (481)
                      +|++++|.++...+..+..++.++.+++++|++++..+..|..+++|+.|+|++|+|+ .+|+.+..+++|+.|+|++|.
T Consensus       128 ~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np  206 (266)
T d1p9ag_         128 ELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNP  206 (266)
T ss_dssp             EEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCC
T ss_pred             cccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCC
Confidence            5555555555444444555555555555555555555555555566666666666665 345555555666666666665


Q ss_pred             Cc
Q 039957          275 LT  276 (481)
Q Consensus       275 l~  276 (481)
                      +.
T Consensus       207 ~~  208 (266)
T d1p9ag_         207 WL  208 (266)
T ss_dssp             BC
T ss_pred             CC
Confidence            43

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=2.3e-24  Score=199.09  Aligned_cols=203  Identities=24%  Similarity=0.217  Sum_probs=158.8

Q ss_pred             hhCCCCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccC
Q 039957            9 IGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKL   88 (481)
Q Consensus         9 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L   88 (481)
                      ....+.+.+.|.++++++. +|+.+.  +++++|+|++|+|+ .+|...+..+++|++|+|++|+|+. +| .+..+++|
T Consensus         6 ~~~~~~~~~v~C~~~~L~~-iP~~lp--~~l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L   79 (266)
T d1p9ag_           6 VSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLY-TFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVL   79 (266)
T ss_dssp             EECSTTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCS-EEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTC
T ss_pred             EcccCCCeEEEccCCCCCe-eCcCcC--cCCCEEECcCCcCC-CcCHHHhhccccccccccccccccc-cc-cccccccc
Confidence            4566778888999999996 465553  57999999999998 5665555589999999999999985 44 36789999


Q ss_pred             ceeecccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccC
Q 039957           89 IILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTS  168 (481)
Q Consensus        89 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~  168 (481)
                      ++|+|++|++++ .+..+.++++|++|++++|.+..+....        +..+.++++|++++|.++...+..+..+ +.
T Consensus        80 ~~L~Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~--------~~~l~~l~~L~l~~n~l~~l~~~~~~~l-~~  149 (266)
T d1p9ag_          80 GTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGA--------LRGLGELQELYLKGNELKTLPPGLLTPT-PK  149 (266)
T ss_dssp             CEEECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSST--------TTTCTTCCEEECTTSCCCCCCTTTTTTC-TT
T ss_pred             cccccccccccc-cccccccccccccccccccccceeeccc--------cccccccccccccccccceecccccccc-cc
Confidence            999999999985 5778999999999999999998875433        4567788889999988886555544444 56


Q ss_pred             ccEEEccCCceeecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcCC
Q 039957          169 LQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQ  228 (481)
Q Consensus       169 L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~  228 (481)
                      ++.+++++|++++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|.+.
T Consensus       150 l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~  208 (266)
T d1p9ag_         150 LEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL  208 (266)
T ss_dssp             CCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred             chhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence            778888888877766667777777777777777776 56666666777777777766553

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.92  E-value=1.1e-25  Score=211.60  Aligned_cols=134  Identities=25%  Similarity=0.350  Sum_probs=115.7

Q ss_pred             ccccccceeeeec-cCCcceEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          342 LAGSFGSVYKGTI-SDGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       342 ~~g~~g~vy~~~l-~~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      |+|+||.||+|.. .+|..||||.+....   ....+.+.+|+.++++++|||||+++++|.+.+     +||+++|++.
T Consensus        24 G~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~  103 (309)
T d1u5ra_          24 GHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASD  103 (309)
T ss_dssp             EECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHH
T ss_pred             ecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchH
Confidence            7899999999984 568899999987543   233456889999999999999999999987765     6799999987


Q ss_pred             HHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          413 KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       413 ~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      .+... ...+++.++..++.||++||+|||    +.+||||||||+|||++.++.+||+|||+|+...
T Consensus       104 ~~~~~-~~~l~e~~~~~i~~qi~~aL~yLH----~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~  166 (309)
T d1u5ra_         104 LLEVH-KKPLQEVEIAAVTHGALQGLAYLH----SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA  166 (309)
T ss_dssp             HHHHH-TSCCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred             HHHHh-CCCCCHHHHHHHHHHHHHHHHHHH----hCCEeccCCCcceEEECCCCCEEEeecccccccC
Confidence            66543 346889999999999999999999    6789999999999999999999999999998653

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=5.2e-26  Score=209.75  Aligned_cols=139  Identities=24%  Similarity=0.411  Sum_probs=109.8

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC-------cccccCCC
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-------FKFMPNGS  410 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-------~~~~~~g~  410 (481)
                      .|+|+||.||+|.. .+|..||+|.+....  ....+.+.+|++++++++|||||++++++.+..       +||+++|+
T Consensus        12 iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~   91 (269)
T d2java1          12 IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGD   91 (269)
T ss_dssp             EEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEE
T ss_pred             EecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCc
Confidence            37899999999985 568999999987653  223456889999999999999999999885431       68999999


Q ss_pred             hhHHhhc---CCCccCHHHHHHHHHHHHHHHHHHhcCC-CCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          411 LEKRLYS---HNYFLDILERLNIMIDVGSTLEYLHHGH-SSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       411 l~~~l~~---~~~~~~~~~~~~i~~~ia~~l~~lH~~~-~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      |.+++..   ....+++..+..++.||++||+|||+.+ ...+||||||||+|||+++++.+||+|||+|+.+
T Consensus        92 L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~  164 (269)
T d2java1          92 LASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL  164 (269)
T ss_dssp             HHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC
T ss_pred             HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeec
Confidence            9998864   2356889999999999999999999532 1245999999999999999999999999999865

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=2.1e-25  Score=211.79  Aligned_cols=136  Identities=24%  Similarity=0.451  Sum_probs=112.4

Q ss_pred             hhccccccceeeeeccC-C-----cceEEEEEeccc-hhhhhhhhHHHHHhhhh-ccCccceeecccCCCC-----cccc
Q 039957          340 ISLAGSFGSVYKGTISD-G-----TDVAIKIFNLQR-ERAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD-----FKFM  406 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~~-g-----~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----~~~~  406 (481)
                      ..|+|+||.||+|.... +     ..||+|.+.... ......+.+|+.++.++ +|||||+++++|...+     +||+
T Consensus        44 ~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~  123 (325)
T d1rjba_          44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYC  123 (325)
T ss_dssp             EEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             EEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcC
Confidence            34889999999998542 2     358899875433 33345688899999998 8999999999998765     6899


Q ss_pred             cCCChhHHhhcCC----------------------CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCC
Q 039957          407 PNGSLEKRLYSHN----------------------YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDE  464 (481)
Q Consensus       407 ~~g~l~~~l~~~~----------------------~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~  464 (481)
                      ++|+|.+++....                      ..++|..+..|+.+||+||+|||    +.+||||||||+|||++.
T Consensus       124 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH----~~~IiHRDlKp~Nill~~  199 (325)
T d1rjba_         124 CYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE----FKSCVHRDLAARNVLVTH  199 (325)
T ss_dssp             TTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH----HTTEEETTCSGGGEEEET
T ss_pred             CCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH----hCCeeeccCchhcccccc
Confidence            9999999987532                      24788999999999999999999    578999999999999999


Q ss_pred             CCcEEEccccCcccC
Q 039957          465 NMVAHVSDFGISKLL  479 (481)
Q Consensus       465 ~~~~kl~Dfgl~~~~  479 (481)
                      ++.+||+|||+|+..
T Consensus       200 ~~~~Kl~DFGla~~~  214 (325)
T d1rjba_         200 GKVVKICDFGLARDI  214 (325)
T ss_dssp             TTEEEECCCGGGSCG
T ss_pred             CCeEEEeeccccccc
Confidence            999999999999864

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=1.2e-25  Score=212.78  Aligned_cols=136  Identities=28%  Similarity=0.476  Sum_probs=115.5

Q ss_pred             hhccccccceeeeecc-CCc----ceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC----cccccCC
Q 039957          340 ISLAGSFGSVYKGTIS-DGT----DVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----FKFMPNG  409 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~-~g~----~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~~~~g  409 (481)
                      ..|+|+||.||+|... +|.    .||+|.+.... ....+.+.+|+.++++++|||||+++|+|.+.+    ++|+.+|
T Consensus        16 ~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~v~e~~~~~   95 (317)
T d1xkka_          16 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFG   95 (317)
T ss_dssp             EEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTC
T ss_pred             EEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeeEEEEeccCC
Confidence            3478999999999853 454    57888875432 334567899999999999999999999998775    5688999


Q ss_pred             ChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          410 SLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       410 ~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      ++.+.+......+++..+.+++.+||+||+|||    +.+||||||||+|||+|+++++||+|||+|+.+
T Consensus        96 ~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH----~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~  161 (317)
T d1xkka_          96 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE----DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  161 (317)
T ss_dssp             BHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred             cccccccccccCCCHHHHHHHHHHHHHHHHHHH----HcCcccCcchhhcceeCCCCCeEeeccccceec
Confidence            999988877778999999999999999999999    578999999999999999999999999999865

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=2.4e-25  Score=205.30  Aligned_cols=136  Identities=26%  Similarity=0.406  Sum_probs=113.7

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCC---------CcccccC
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTP---------DFKFMPN  408 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---------~~~~~~~  408 (481)
                      .|+|+||.||+|... ++..||+|.+....  ....+.+.+|++++++++|||||++++++...         .+||+++
T Consensus        17 iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~   96 (270)
T d1t4ha_          17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTS   96 (270)
T ss_dssp             EEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCS
T ss_pred             EecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCC
Confidence            488999999999864 57899999986543  23345688999999999999999999987532         1689999


Q ss_pred             CChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeC-CCCcEEEccccCcccC
Q 039957          409 GSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLD-ENMVAHVSDFGISKLL  479 (481)
Q Consensus       409 g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~-~~~~~kl~Dfgl~~~~  479 (481)
                      |+|.+++... ..+++..+..++.||++||+|||+.  .++||||||||+|||++ +++.+||+|||+|+..
T Consensus        97 g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~--~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~  165 (270)
T d1t4ha_          97 GTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTR--TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  165 (270)
T ss_dssp             CBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTS--SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             CcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHC--CCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence            9999998753 3578889999999999999999942  23499999999999996 5799999999999864

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.91  E-value=1.2e-25  Score=211.30  Aligned_cols=135  Identities=29%  Similarity=0.485  Sum_probs=115.5

Q ss_pred             hccccccceeeeecc------CCcceEEEEEeccchh-hhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccC
Q 039957          341 SLAGSFGSVYKGTIS------DGTDVAIKIFNLQRER-AFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPN  408 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~------~g~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~  408 (481)
                      .|+|+||.||+|+..      ++..||||+++..... ..+.|.+|++++++++|+|+++++++|...+     ++|+++
T Consensus        21 lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~  100 (301)
T d1lufa_          21 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAY  100 (301)
T ss_dssp             EEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred             EeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEecCC
Confidence            378999999999753      3578999998764433 3457899999999999999999999998764     679999


Q ss_pred             CChhHHhhcC-----------------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCC
Q 039957          409 GSLEKRLYSH-----------------------NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDEN  465 (481)
Q Consensus       409 g~l~~~l~~~-----------------------~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~  465 (481)
                      |+|.+++...                       ...++|..+++|+.++|+||+|||    +.+||||||||+|||+|++
T Consensus       101 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH----~~~ivHrDlKp~NILld~~  176 (301)
T d1lufa_         101 GDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS----ERKFVHRDLATRNCLVGEN  176 (301)
T ss_dssp             CBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGG
T ss_pred             CcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc----cCCeEeeEEcccceEECCC
Confidence            9999988642                       124788999999999999999999    6789999999999999999


Q ss_pred             CcEEEccccCcccC
Q 039957          466 MVAHVSDFGISKLL  479 (481)
Q Consensus       466 ~~~kl~Dfgl~~~~  479 (481)
                      +++||+|||+|+.+
T Consensus       177 ~~~Kl~DFGls~~~  190 (301)
T d1lufa_         177 MVVKIADFGLSRNI  190 (301)
T ss_dssp             GCEEECCCSCHHHH
T ss_pred             CcEEEccchhheec
Confidence            99999999999754

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=2.5e-25  Score=207.00  Aligned_cols=135  Identities=31%  Similarity=0.443  Sum_probs=117.4

Q ss_pred             hhccccccceeeeec-cCCcceEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCC
Q 039957          340 ISLAGSFGSVYKGTI-SDGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGS  410 (481)
Q Consensus       340 l~~~g~~g~vy~~~l-~~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~  410 (481)
                      ..|+|+||.||+|.. .+|..||||.+....   ....+.+.+|++++++++|||||++++++.+.+     +||+++|+
T Consensus        15 ~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~   94 (288)
T d1uu3a_          15 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE   94 (288)
T ss_dssp             EEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEE
T ss_pred             EEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCC
Confidence            447899999999985 468999999987543   233456889999999999999999999988765     68999999


Q ss_pred             hhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          411 LEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       411 l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      |.+++... ..+++.....++.+++.||+|||    +.+||||||||+|||+++++.+||+|||+|+.+
T Consensus        95 L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH----~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~  158 (288)
T d1uu3a_          95 LLKYIRKI-GSFDETCTRFYTAEIVSALEYLH----GKGIIHRDLKPENILLNEDMHIQITDFGTAKVL  158 (288)
T ss_dssp             HHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             HHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhc----cccEEcCcCCccccccCCCceEEecccccceec
Confidence            99987653 35788889999999999999999    678999999999999999999999999999875

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=2.2e-25  Score=206.13  Aligned_cols=136  Identities=29%  Similarity=0.456  Sum_probs=110.6

Q ss_pred             hccccccceeeeecc--CC--cceEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCCC----cccccCC
Q 039957          341 SLAGSFGSVYKGTIS--DG--TDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----FKFMPNG  409 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~--~g--~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~~~~g  409 (481)
                      .|+|+||.||+|...  .+  ..||||.+....   ....++|.+|+.++++++|||||+++|+|.+..    +||+++|
T Consensus        16 iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~~~lv~e~~~~~   95 (273)
T d1u46a_          16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLG   95 (273)
T ss_dssp             CC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCTTC
T ss_pred             EecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeecchheeeeeecCc
Confidence            378999999999753  23  368999886532   233467899999999999999999999997764    6799999


Q ss_pred             ChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          410 SLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       410 ~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      ++.+++......+++..+.+++.|||+||+|||    +.+|+||||||+||+++.++.+||+|||+|+.+.
T Consensus        96 ~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH----~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~  162 (273)
T d1u46a_          96 SLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE----SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  162 (273)
T ss_dssp             BHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             chhhhhhcccCCCCHHHHHHHHHHHHHHHHHhh----hCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence            999988766667899999999999999999999    5789999999999999999999999999998753

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=6.5e-25  Score=206.82  Aligned_cols=135  Identities=24%  Similarity=0.419  Sum_probs=115.4

Q ss_pred             hccccccceeeeecc------CCcceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccC
Q 039957          341 SLAGSFGSVYKGTIS------DGTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPN  408 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~------~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~  408 (481)
                      .|+|+||.||+|...      ++..||||+++... .+....|.+|+.++++++|||||+++|+|...+     ++|+++
T Consensus        28 lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~  107 (308)
T d1p4oa_          28 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTR  107 (308)
T ss_dssp             EEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred             EeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCC
Confidence            478999999999763      35789999987543 333456889999999999999999999997654     689999


Q ss_pred             CChhHHhhc---------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          409 GSLEKRLYS---------HNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       409 g~l~~~l~~---------~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      |++.+++..         ....++|..+.+|+.++|+||.|||    +.+||||||||+|||+|+++++||+|||+|+.+
T Consensus       108 g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH----~~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~  183 (308)
T d1p4oa_         108 GDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN----ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI  183 (308)
T ss_dssp             CBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH----HTTCBCSCCSGGGEEECTTCCEEECCTTCCCGG
T ss_pred             CCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh----hCCeeeceEcCCceeecCCceEEEeecccceec
Confidence            999998764         1235689999999999999999999    578999999999999999999999999999865

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.91  E-value=1.2e-24  Score=205.26  Aligned_cols=135  Identities=29%  Similarity=0.354  Sum_probs=116.4

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      .|+|+||.||+|.. .+|..||||++....   ....+.+.+|+.++++++|||||++++++...+     +||+++|++
T Consensus        12 lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l   91 (316)
T d1fota_          12 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGEL   91 (316)
T ss_dssp             EEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred             EecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCccc
Confidence            37899999999985 568999999987542   233456889999999999999999999998775     679999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      ..++... ...+......++.+|+.|++|||    +.+||||||||+|||+++++.+||+|||+|+...
T Consensus        92 ~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH----~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~  155 (316)
T d1fota_          92 FSLLRKS-QRFPNPVAKFYAAEVCLALEYLH----SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP  155 (316)
T ss_dssp             HHHHHHT-SSCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred             ccccccc-ccccccHHHHHHHHHHHhhhhhc----cCcEEccccCchheeEcCCCCEEEecCccceEec
Confidence            9887654 34567777889999999999999    6889999999999999999999999999998754

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=5.1e-25  Score=206.95  Aligned_cols=136  Identities=26%  Similarity=0.378  Sum_probs=112.4

Q ss_pred             hhccccccceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC---------cccccCCC
Q 039957          340 ISLAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD---------FKFMPNGS  410 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---------~~~~~~g~  410 (481)
                      ..|+|+||.||+|+. +|..||||.+...... ......|+..+.+++|||||+++++|...+         +||+++|+
T Consensus        10 ~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~   87 (303)
T d1vjya_          10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGS   87 (303)
T ss_dssp             EEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCB
T ss_pred             EEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCC
Confidence            358999999999986 6889999998654322 122334566667889999999999996532         67999999


Q ss_pred             hhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCC----CCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          411 LEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGH----SSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       411 l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~----~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      |.+++...  .++|..+++++.++|+|++|+|+..    ..++||||||||+|||+|+++.+||+|||+|+..
T Consensus        88 L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~  158 (303)
T d1vjya_          88 LFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             HHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence            99999764  5889999999999999999999531    1369999999999999999999999999999864

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.91  E-value=1.1e-24  Score=204.71  Aligned_cols=137  Identities=26%  Similarity=0.381  Sum_probs=108.1

Q ss_pred             hhhccccccceeeeecc-CCcceEEEEEeccch-hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          339 TISLAGSFGSVYKGTIS-DGTDVAIKIFNLQRE-RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       339 ~l~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      ...|+|+||.||+|... +|..||||.+..... .....+.+|+.++++++|||||++++++.+.+     +||+++|+|
T Consensus        15 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L   94 (307)
T d1a06a_          15 DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL   94 (307)
T ss_dssp             EESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred             EEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcH
Confidence            34589999999999854 688999999875442 23456788999999999999999999998775     689999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeC---CCCcEEEccccCcccCC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLD---ENMVAHVSDFGISKLLG  480 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~---~~~~~kl~Dfgl~~~~~  480 (481)
                      .+++... ..+++.+...++.+|+.||+|||    +.+||||||||+||+++   +++.+||+|||+|+...
T Consensus        95 ~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH----~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          95 FDRIVEK-GFYTERDASRLIFQVLDAVKYLH----DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             HHHHHTC-SCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             HHhhhcc-cCCCHHHHHHHHHHHHHHHHhhh----hceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence            9998753 46788999999999999999999    67899999999999994   57899999999998653

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=3.5e-25  Score=203.19  Aligned_cols=132  Identities=33%  Similarity=0.496  Sum_probs=111.1

Q ss_pred             ccccccceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC------cccccCCChhHHh
Q 039957          342 LAGSFGSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD------FKFMPNGSLEKRL  415 (481)
Q Consensus       342 ~~g~~g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~~~~g~l~~~l  415 (481)
                      +.|+||.||+|.. .|..||||.++..  ...+.+.+|++++++++|||||+++|+|.+.+      +||+++|+|.+++
T Consensus        16 G~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l   92 (262)
T d1byga_          16 GKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL   92 (262)
T ss_dssp             EECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHH
T ss_pred             ecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHH
Confidence            7899999999987 5788999998643  33467889999999999999999999986532      6799999999998


Q ss_pred             hcCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          416 YSHN-YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       416 ~~~~-~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      .... ..++|..+++|+.|||+||+|||    +.+||||||||+||+++.++.+|++|||+++...
T Consensus        93 ~~~~~~~l~~~~~~~i~~~i~~al~ylH----~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~  154 (262)
T d1byga_          93 RSRGRSVLGGDCLLKFSLDVCEAMEYLE----GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  154 (262)
T ss_dssp             HHHHHHHCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred             HhcCCCCCCHHHHHHHHHHHHhhccccc----cCceeccccchHhheecCCCCEeecccccceecC
Confidence            7532 35789999999999999999999    5789999999999999999999999999998753

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=6.9e-25  Score=203.20  Aligned_cols=137  Identities=23%  Similarity=0.395  Sum_probs=110.9

Q ss_pred             hhccccccceeeeeccC----CcceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC----cccccCCC
Q 039957          340 ISLAGSFGSVYKGTISD----GTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----FKFMPNGS  410 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~~----g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~~~~g~  410 (481)
                      ..|+|+||.||+|....    +..||||.+.... ....+.+.+|+.++++++|||||+++++|....    +||+++|+
T Consensus        14 ~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~iv~E~~~~g~   93 (273)
T d1mp8a_          14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGE   93 (273)
T ss_dssp             EEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEEEECCTTEE
T ss_pred             EEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCeEEEEEEeccCCc
Confidence            45899999999997542    3457888875433 333457889999999999999999999997654    67999999


Q ss_pred             hhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          411 LEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       411 l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      +.+++......+++..+..++.|||+||+|+|    +.+||||||||+||++++++.+||+|||+|+.+.
T Consensus        94 l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH----~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~  159 (273)
T d1mp8a_          94 LRSFLQVRKYSLDLASLILYAYQLSTALAYLE----SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  159 (273)
T ss_dssp             HHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             HHhhhhccCCCCCHHHHHHHHHHHHHHhhhhc----ccCeeccccchhheeecCCCcEEEccchhheecc
Confidence            99988776677899999999999999999999    6789999999999999999999999999998653

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=99.90  E-value=1.7e-24  Score=200.25  Aligned_cols=136  Identities=30%  Similarity=0.393  Sum_probs=117.6

Q ss_pred             hhccccccceeeeec-cCCcceEEEEEeccch---------hhhhhhhHHHHHhhhhc-cCccceeecccCCCC-----c
Q 039957          340 ISLAGSFGSVYKGTI-SDGTDVAIKIFNLQRE---------RAFRSFNSECEVLRNVR-HQNLIKILSSCSTPD-----F  403 (481)
Q Consensus       340 l~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~---------~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-----~  403 (481)
                      ..++|+||.||++.. .+|..+|||.+.....         ...+.+.+|+.++++++ |||||++++++.+.+     +
T Consensus        10 ~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivm   89 (277)
T d1phka_          10 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVF   89 (277)
T ss_dssp             EEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             EEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEE
Confidence            347899999999985 5789999999875431         12235778999999997 999999999998775     6


Q ss_pred             ccccCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          404 KFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       404 ~~~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      ||+++|+|.+++... ..+++.++..++.||++||+|||    +.+||||||||+|||++.++.+||+|||+|+.+.
T Consensus        90 E~~~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~~lH----~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  161 (277)
T d1phka_          90 DLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALH----KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD  161 (277)
T ss_dssp             ECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EcCCCchHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH----HcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence            899999999998753 46789999999999999999999    5789999999999999999999999999998764

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=2e-24  Score=205.23  Aligned_cols=134  Identities=26%  Similarity=0.327  Sum_probs=115.9

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      .|+|+||.||++.. .+|..||+|.+....   ....+.+.+|+.++++++|||||++++++.+.+     +||+++|+|
T Consensus        13 lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L   92 (337)
T d1o6la_          13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL   92 (337)
T ss_dssp             EEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBH
T ss_pred             EecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCCch
Confidence            37899999999985 578999999997543   223456788999999999999999999998875     679999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+++...+ .++......++.+|+.||+|+|    +.+||||||||+|||+|++|.+||+|||+|+..
T Consensus        93 ~~~~~~~~-~~~e~~~~~~~~qil~al~ylH----~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~  155 (337)
T d1o6la_          93 FFHLSRER-VFTEERARFYGAEIVSALEYLH----SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG  155 (337)
T ss_dssp             HHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             hhhhhccc-CCcHHHHHHHHHHHhhhhhhhh----hcCccccccCHHHeEecCCCCEEEeeccccccc
Confidence            99887543 4566777889999999999999    688999999999999999999999999999865

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=2e-24  Score=202.99  Aligned_cols=136  Identities=29%  Similarity=0.477  Sum_probs=104.6

Q ss_pred             hhccccccceeeeecc------CCcceEEEEEeccc-hhhhhhhhHHHHHhhhh-ccCccceeecccCCCC------ccc
Q 039957          340 ISLAGSFGSVYKGTIS------DGTDVAIKIFNLQR-ERAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD------FKF  405 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~------~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~------~~~  405 (481)
                      ..|+|+||.||+|...      +++.||||.+.... ....+.+..|+..+.++ +|+|||.+.+++...+      +||
T Consensus        20 ~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~   99 (299)
T d1ywna1          20 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEF   99 (299)
T ss_dssp             EEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEEC
T ss_pred             EEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEe
Confidence            3488999999999743      34679999986543 23345677788888776 6899999999876543      689


Q ss_pred             ccCCChhHHhhcC---------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 039957          406 MPNGSLEKRLYSH---------------NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHV  470 (481)
Q Consensus       406 ~~~g~l~~~l~~~---------------~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl  470 (481)
                      +++|+|.+++...               ...+++.++..++.|||+||+|||    +.+||||||||+|||+|+++.+||
T Consensus       100 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH----~~~ivHrDlKp~NILl~~~~~~Kl  175 (299)
T d1ywna1         100 CKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA----SRKCIHRDLAARNILLSEKNVVKI  175 (299)
T ss_dssp             CTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECGGGCEEE
T ss_pred             cCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH----hCCCcCCcCCccceeECCCCcEEE
Confidence            9999999998643               234789999999999999999999    678999999999999999999999


Q ss_pred             ccccCcccC
Q 039957          471 SDFGISKLL  479 (481)
Q Consensus       471 ~Dfgl~~~~  479 (481)
                      +|||+|+..
T Consensus       176 ~DFGla~~~  184 (299)
T d1ywna1         176 CDFGLARDI  184 (299)
T ss_dssp             CC------C
T ss_pred             ccCcchhhc
Confidence            999999864

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=5e-24  Score=199.42  Aligned_cols=135  Identities=25%  Similarity=0.364  Sum_probs=116.1

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccch------hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccC
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQRE------RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPN  408 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~  408 (481)
                      .|+|+||.||+|.. .+|..||||.+.....      ...+.+.+|++++++++|||||++++++.+.+     +||+++
T Consensus        18 lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~g   97 (293)
T d1jksa_          18 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG   97 (293)
T ss_dssp             EEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred             EecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence            37899999999986 4689999999865432      12356889999999999999999999998775     689999


Q ss_pred             CChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCC----cEEEccccCcccCC
Q 039957          409 GSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENM----VAHVSDFGISKLLG  480 (481)
Q Consensus       409 g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~----~~kl~Dfgl~~~~~  480 (481)
                      |+|.+++... ..+++.....++.++++||+|||    +.+||||||||+|||++.++    .+|++|||+|+...
T Consensus        98 g~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH----~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~  168 (293)
T d1jksa_          98 GELFDFLAEK-ESLTEEEATEFLKQILNGVYYLH----SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID  168 (293)
T ss_dssp             CBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred             ccccchhccc-cccchhHHHHHHHHHHHHHHhhh----hcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence            9999998753 35788999999999999999999    67899999999999998876    59999999998653

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=2.9e-24  Score=202.55  Aligned_cols=137  Identities=34%  Similarity=0.541  Sum_probs=114.5

Q ss_pred             hhhccccccceeeeeccC-Cc--ceEEEEEecc-chhhhhhhhHHHHHhhhh-ccCccceeecccCCCC-----cccccC
Q 039957          339 TISLAGSFGSVYKGTISD-GT--DVAIKIFNLQ-RERAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD-----FKFMPN  408 (481)
Q Consensus       339 ~l~~~g~~g~vy~~~l~~-g~--~vavK~l~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----~~~~~~  408 (481)
                      ...|+|+||.||+|...+ |.  .||||.+... .....+.+.+|++++.++ +|||||+++|+|...+     +||+++
T Consensus        16 ~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~   95 (309)
T d1fvra_          16 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   95 (309)
T ss_dssp             EEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred             EEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCC
Confidence            345899999999998753 43  4778877543 233456789999999998 7999999999998765     689999


Q ss_pred             CChhHHhhcC---------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 039957          409 GSLEKRLYSH---------------NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDF  473 (481)
Q Consensus       409 g~l~~~l~~~---------------~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Df  473 (481)
                      |+|.++++..               ...++|..+.+++.|||+|++|+|    +.+||||||||+|||++.++.+||+||
T Consensus        96 g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH----~~~iiHrDlkp~NIL~~~~~~~kl~Df  171 (309)
T d1fvra_          96 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS----QKQFIHRDLAARNILVGENYVAKIADF  171 (309)
T ss_dssp             CBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECGGGCEEECCT
T ss_pred             CcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh----cCCccccccccceEEEcCCCceEEccc
Confidence            9999998642               356899999999999999999999    678999999999999999999999999


Q ss_pred             cCcccC
Q 039957          474 GISKLL  479 (481)
Q Consensus       474 gl~~~~  479 (481)
                      |+|+..
T Consensus       172 G~a~~~  177 (309)
T d1fvra_         172 GLSRGQ  177 (309)
T ss_dssp             TCEESS
T ss_pred             cccccc
Confidence            999864

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=6.2e-24  Score=200.91  Aligned_cols=135  Identities=21%  Similarity=0.364  Sum_probs=116.9

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHH
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKR  414 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~  414 (481)
                      .|+|+||.||+|... +|..||+|.+...... ...+.+|++++++++|||||++++++.+.+     +||+++|+|.++
T Consensus        13 lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~   91 (321)
T d1tkia_          13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFER   91 (321)
T ss_dssp             EEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHH
T ss_pred             EecCCCeEEEEEEECCCCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHH
Confidence            378999999999854 6889999998765332 345778999999999999999999987765     689999999999


Q ss_pred             hhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCC--CCcEEEccccCcccCC
Q 039957          415 LYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDE--NMVAHVSDFGISKLLG  480 (481)
Q Consensus       415 l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~--~~~~kl~Dfgl~~~~~  480 (481)
                      +......++..+...|+.+|++||+|||    +.+|+||||||+|||++.  ...+||+|||+|+...
T Consensus        92 i~~~~~~l~e~~~~~i~~qi~~al~yLH----~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~  155 (321)
T d1tkia_          92 INTSAFELNEREIVSYVHQVCEALQFLH----SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             HTSSSCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred             HHhcCCCCCHHHHHHHHHHHHHHHHHHH----HcCCCcccccccceeecCCCceEEEEcccchhhccc
Confidence            9876667889999999999999999999    578999999999999985  4689999999998653

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.90  E-value=4.8e-24  Score=203.94  Aligned_cols=135  Identities=27%  Similarity=0.346  Sum_probs=116.4

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCCh
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l  411 (481)
                      .|+|+||.||+|.. .+|..||||.+....   ....+.+.+|+.++++++|||||++++++....     ++|+.+|++
T Consensus        49 lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l  128 (350)
T d1rdqe_          49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM  128 (350)
T ss_dssp             EEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBH
T ss_pred             eecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccccccch
Confidence            37899999999985 468999999987543   233456788999999999999999999987765     578999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      ..++... ..++......++.+|++||+|||    +.+||||||||+|||++.++.+||+|||+|+.+.
T Consensus       129 ~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH----~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~  192 (350)
T d1rdqe_         129 FSHLRRI-GRFSEPHARFYAAQIVLTFEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK  192 (350)
T ss_dssp             HHHHHHH-CCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             hhhHhhc-CCCCHHHHHHHHHHHHHHHHHHH----hCCEecCcCCHHHcccCCCCCEEeeeceeeeecc
Confidence            9988653 35788889999999999999999    5789999999999999999999999999998753

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.89  E-value=4.3e-24  Score=200.41  Aligned_cols=135  Identities=24%  Similarity=0.377  Sum_probs=110.3

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccch--hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChh
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQRE--RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      -|+|+||.||+|.. .+|..||||++.....  .....+.+|++++++++|||||++++++.+.+     +||+.++.+.
T Consensus        10 lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~~~~   89 (298)
T d1gz8a_          10 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKK   89 (298)
T ss_dssp             EEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHH
T ss_pred             EecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCCchhh
Confidence            37899999999985 5789999999865432  23457889999999999999999999998775     5677654443


Q ss_pred             HHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          413 KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       413 ~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .........+++.+...++.||+.||+|||    +.+||||||||+|||++.++.+||+|||+|+..
T Consensus        90 ~~~~~~~~~l~e~~~~~~~~qil~~L~yLH----~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~  152 (298)
T d1gz8a_          90 FMDASALTGIPLPLIKSYLFQLLQGLAFCH----SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF  152 (298)
T ss_dssp             HHHHTTTTCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHH
T ss_pred             hhhhhcccCCCHHHHHHHHHHHHHHHHHhh----cCCEEccccCchheeecccCcceeccCCcceec
Confidence            333334556899999999999999999999    578999999999999999999999999998754

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.89  E-value=9.1e-24  Score=203.08  Aligned_cols=136  Identities=24%  Similarity=0.298  Sum_probs=112.2

Q ss_pred             hhccccccceeeeec-cCCcceEEEEEeccch---hhhhhhhH---HHHHhhhhccCccceeecccCCCC-----ccccc
Q 039957          340 ISLAGSFGSVYKGTI-SDGTDVAIKIFNLQRE---RAFRSFNS---ECEVLRNVRHQNLIKILSSCSTPD-----FKFMP  407 (481)
Q Consensus       340 l~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~---~~~~~~~~---e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~  407 (481)
                      ..|+|+||.||+|.. .+|..||+|.+.....   .....+.+   ++++++.++|||||++++++...+     +||++
T Consensus        11 ~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~   90 (364)
T d1omwa3          11 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   90 (364)
T ss_dssp             EEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             EEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecC
Confidence            347899999999985 4689999999865431   11122333   466777788999999999988765     78999


Q ss_pred             CCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          408 NGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       408 ~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      +|+|.+++... ..+++.....++.+|+.||+|||    +.+||||||||+|||+++++.+||+|||+|+.+.
T Consensus        91 gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH----~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~  158 (364)
T d1omwa3          91 GGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMH----NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  158 (364)
T ss_dssp             SCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred             CCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHH----HCCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence            99999998754 34677888999999999999999    6789999999999999999999999999998653

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.89  E-value=9.2e-24  Score=199.24  Aligned_cols=137  Identities=26%  Similarity=0.428  Sum_probs=116.6

Q ss_pred             hhccccccceeeeec------cCCcceEEEEEeccch-hhhhhhhHHHHHhhhh-ccCccceeecccCCCC-----cccc
Q 039957          340 ISLAGSFGSVYKGTI------SDGTDVAIKIFNLQRE-RAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD-----FKFM  406 (481)
Q Consensus       340 l~~~g~~g~vy~~~l------~~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----~~~~  406 (481)
                      ..|+|+||.||+|+.      .++..||||++..... .....+.+|+.++.++ +|||||+++|+|...+     +||+
T Consensus        30 ~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~  109 (311)
T d1t46a_          30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYC  109 (311)
T ss_dssp             EEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             EEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcC
Confidence            348899999999974      2457899999976543 3345688999999998 6999999999998764     6899


Q ss_pred             cCCChhHHhhcC-----------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEE
Q 039957          407 PNGSLEKRLYSH-----------------NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAH  469 (481)
Q Consensus       407 ~~g~l~~~l~~~-----------------~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~k  469 (481)
                      ++|++.++++..                 ...+++..+.+++.|||+|++|||    +.+||||||||+||+++.++.+|
T Consensus       110 ~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH----~~~ivHrDLKp~NIl~~~~~~~k  185 (311)
T d1t46a_         110 CYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA----SKNCIHRDLAARNILLTHGRITK  185 (311)
T ss_dssp             TTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEEETTTEEE
T ss_pred             CCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH----hCCeeecccccccccccccCccc
Confidence            999999988642                 225788999999999999999999    67899999999999999999999


Q ss_pred             EccccCcccCC
Q 039957          470 VSDFGISKLLG  480 (481)
Q Consensus       470 l~Dfgl~~~~~  480 (481)
                      ++|||+++...
T Consensus       186 i~DfG~~~~~~  196 (311)
T d1t46a_         186 ICDFGLARDIK  196 (311)
T ss_dssp             ECCCGGGSCTT
T ss_pred             ccccchheecc
Confidence            99999998764

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.89  E-value=8.4e-24  Score=198.65  Aligned_cols=135  Identities=33%  Similarity=0.428  Sum_probs=110.7

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccchh-----hhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCC
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQRER-----AFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNG  409 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g  409 (481)
                      .|+|+||.||+|... +|..||||++......     ..+.+.+|+.++++++|||||++++++...+     +||+.+|
T Consensus         6 lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~   85 (299)
T d1ua2a_           6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETD   85 (299)
T ss_dssp             EEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEE
T ss_pred             eccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcch
Confidence            478999999999864 6899999998654321     2346788999999999999999999998775     6788888


Q ss_pred             ChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          410 SLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       410 ~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      ++..... ....++..+...++.||+.||+|||    +.+|+||||||+|||+++++.+||+|||+|+...
T Consensus        86 ~~~~~~~-~~~~l~~~~~~~~~~qil~aL~~lH----~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~  151 (299)
T d1ua2a_          86 LEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLH----QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG  151 (299)
T ss_dssp             HHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred             HHhhhhh-cccCCCHHHHHHHHHHHHHHHHHhh----ccceecccCCcceEEecCCCccccccCccccccC
Confidence            7766544 3445677788899999999999999    6789999999999999999999999999998653

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.88  E-value=1.5e-23  Score=195.75  Aligned_cols=133  Identities=22%  Similarity=0.409  Sum_probs=112.8

Q ss_pred             ccccccceeeeeccCCcceEEEEEeccch--hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhHH
Q 039957          342 LAGSFGSVYKGTISDGTDVAIKIFNLQRE--RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEKR  414 (481)
Q Consensus       342 ~~g~~g~vy~~~l~~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~~  414 (481)
                      |+|+||.||+|...+|..||||.+.....  .....+.+|+.++++++|||||++++++...+     ++|+.++.+...
T Consensus        11 G~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~   90 (286)
T d1ob3a_          11 GEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLL   90 (286)
T ss_dssp             EEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHH
T ss_pred             ecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHH
Confidence            78999999999988899999999866432  23457889999999999999999999998775     345555555444


Q ss_pred             hhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          415 LYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       415 l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                       ......++..+...++.||++||+|||    +.+||||||||+|||++.++.+|++|||.|+..
T Consensus        91 -~~~~~~l~~~~~~~i~~qi~~~L~~LH----~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~  150 (286)
T d1ob3a_          91 -DVCEGGLESVTAKSFLLQLLNGIAYCH----DRRVLHRDLKPQNLLINREGELKIADFGLARAF  150 (286)
T ss_dssp             -HTSTTCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHH
T ss_pred             -HhhcCCcchhhhHHHHHHHHHHHHHhc----cCcEEecCCCCceeeEcCCCCEEecccccceec
Confidence             444567888999999999999999999    578999999999999999999999999998754

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.88  E-value=2.1e-23  Score=195.65  Aligned_cols=135  Identities=26%  Similarity=0.473  Sum_probs=110.2

Q ss_pred             hccccccceeeeeccC--------CcceEEEEEeccch-hhhhhhhHHHHHhhhh-ccCccceeecccCCCC-----ccc
Q 039957          341 SLAGSFGSVYKGTISD--------GTDVAIKIFNLQRE-RAFRSFNSECEVLRNV-RHQNLIKILSSCSTPD-----FKF  405 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~--------g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----~~~  405 (481)
                      .|.|+||.||+|+...        +..||||.+..... .....+.+|+..+.++ +|||||+++++|.+.+     +||
T Consensus        21 iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~  100 (299)
T d1fgka_          21 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEY  100 (299)
T ss_dssp             CC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred             EeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEEc
Confidence            4789999999997532        24689999866443 3346788899999888 7999999999998765     689


Q ss_pred             ccCCChhHHhhcCC---------------CccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 039957          406 MPNGSLEKRLYSHN---------------YFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHV  470 (481)
Q Consensus       406 ~~~g~l~~~l~~~~---------------~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl  470 (481)
                      +++|++.+++....               ..+++.++.+++.|||.||+|||    +.+||||||||+|||++.++.+||
T Consensus       101 ~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH----~~~ivHrDiKp~NiLl~~~~~~kl  176 (299)
T d1fgka_         101 ASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA----SKKCIHRDLAARNVLVTEDNVMKI  176 (299)
T ss_dssp             CTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECTTCCEEE
T ss_pred             cCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh----hCCEEeeeecccceeecCCCCeEe
Confidence            99999999986532               35789999999999999999999    678999999999999999999999


Q ss_pred             ccccCcccC
Q 039957          471 SDFGISKLL  479 (481)
Q Consensus       471 ~Dfgl~~~~  479 (481)
                      +|||+++..
T Consensus       177 ~dfg~~~~~  185 (299)
T d1fgka_         177 ADFGLARDI  185 (299)
T ss_dssp             CSTTCCCCG
T ss_pred             ccchhhccc
Confidence            999999865

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.88  E-value=2.9e-23  Score=198.84  Aligned_cols=133  Identities=26%  Similarity=0.370  Sum_probs=112.1

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccc-hhhhhhhhHHHHHhhhhccCccceeecccCCCC---------cccccCC
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQR-ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD---------FKFMPNG  409 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---------~~~~~~g  409 (481)
                      -|+|+||.||+|.. .+|..||||++.... ....+.+.+|+.++++++|||++++++++....         ++|+.+|
T Consensus        16 LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g   95 (345)
T d1pmea_          16 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGA   95 (345)
T ss_dssp             CC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCE
T ss_pred             EeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEeecCC
Confidence            47899999999974 579999999987543 334557889999999999999999999886543         2477899


Q ss_pred             ChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          410 SLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       410 ~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +|.+++...  .+++.....++.|++.||+|||    +.+||||||||+|||+++++.+||+|||+|+..
T Consensus        96 ~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH----~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          96 DLYKLLKTQ--HLSNDHICYFLYQILRGLKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             EHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             chhhhhhcC--CCCHHHHHHHHHHHHHHHHHHH----HCCCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence            999998754  4788899999999999999999    678999999999999999999999999999764

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.88  E-value=5e-23  Score=194.42  Aligned_cols=134  Identities=25%  Similarity=0.338  Sum_probs=113.0

Q ss_pred             hccccccceeeeecc-CCcceEEEEEeccc---hhhhhhhhHHHHHhh-hhccCccceeecccCCCC-----cccccCCC
Q 039957          341 SLAGSFGSVYKGTIS-DGTDVAIKIFNLQR---ERAFRSFNSECEVLR-NVRHQNLIKILSSCSTPD-----FKFMPNGS  410 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~-----~~~~~~g~  410 (481)
                      .|+|+||.||+|... +|..||||.+....   ....+.+..|+.++. .++|||||++++++.+.+     +||+++|+
T Consensus        10 iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~   89 (320)
T d1xjda_          10 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGD   89 (320)
T ss_dssp             EEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCB
T ss_pred             EecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCCc
Confidence            378999999999864 68999999997542   222345666777665 689999999999998876     68999999


Q ss_pred             hhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          411 LEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       411 l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      |.+++.... .++..+...++.+|+.||+|||    +.+|+||||||+|||+++++.+||+|||+|+..
T Consensus        90 L~~~i~~~~-~~~e~~~~~~~~qi~~al~ylH----~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~  153 (320)
T d1xjda_          90 LMYHIQSCH-KFDLSRATFYAAEIILGLQFLH----SKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN  153 (320)
T ss_dssp             HHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             HHHHhhccC-CCCHHHHHHHHHHHHHHHHHHH----hCCeeeccCcccceeecCCCceeccccchhhhc
Confidence            999987533 4677788999999999999999    578999999999999999999999999999865

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.88  E-value=4.7e-23  Score=195.86  Aligned_cols=131  Identities=23%  Similarity=0.344  Sum_probs=110.4

Q ss_pred             hhccccccceeeeec-cCCcceEEEEEeccchhhhhhhhHHHHHhhhh-ccCccceeecccCCC---------CcccccC
Q 039957          340 ISLAGSFGSVYKGTI-SDGTDVAIKIFNLQRERAFRSFNSECEVLRNV-RHQNLIKILSSCSTP---------DFKFMPN  408 (481)
Q Consensus       340 l~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~---------~~~~~~~  408 (481)
                      +.|.|+||.||+|.. .+|..||||.+...     ..+.+|+.++.++ +|||||++++++.+.         .+|||++
T Consensus        19 ~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~g   93 (335)
T d2ozaa1          19 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG   93 (335)
T ss_dssp             EEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred             EeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCC
Confidence            457899999999985 57899999998542     3456789887655 899999999987541         1679999


Q ss_pred             CChhHHhhcC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCC---CCcEEEccccCcccC
Q 039957          409 GSLEKRLYSH-NYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDE---NMVAHVSDFGISKLL  479 (481)
Q Consensus       409 g~l~~~l~~~-~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~---~~~~kl~Dfgl~~~~  479 (481)
                      |+|.+++... ...+++.+...|+.+|++||+|||    +.+|+||||||+|||+++   .+.+||+|||+|+..
T Consensus        94 g~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH----~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~  164 (335)
T d2ozaa1          94 GELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH----SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET  164 (335)
T ss_dssp             EEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             CcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH----HcCCccccccccccccccccccccccccccceeeec
Confidence            9999999764 346889999999999999999999    678999999999999985   568999999999865

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=99.87  E-value=4.2e-23  Score=191.53  Aligned_cols=136  Identities=19%  Similarity=0.323  Sum_probs=115.9

Q ss_pred             hhhccccccceeeeec-cCCcceEEEEEeccc---hhhhhhhhHHHHHhhhhccCccceeecccCCC---------Cccc
Q 039957          339 TISLAGSFGSVYKGTI-SDGTDVAIKIFNLQR---ERAFRSFNSECEVLRNVRHQNLIKILSSCSTP---------DFKF  405 (481)
Q Consensus       339 ~l~~~g~~g~vy~~~l-~~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---------~~~~  405 (481)
                      ..-++|+||.||+|.. .+|..||+|.+....   ......+.+|++++++++|||||++++++...         .+||
T Consensus        13 ~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~   92 (277)
T d1o6ya_          13 EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEY   92 (277)
T ss_dssp             EEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred             EEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEEC
Confidence            3458899999999984 578999999987543   23345688999999999999999999887542         2679


Q ss_pred             ccCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          406 MPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       406 ~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +++|+|.+++... ..+++.+...|+.||++||+|||    +.+||||||||+|||++.++.++++|||.++..
T Consensus        93 ~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH----~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~  161 (277)
T d1o6ya_          93 VDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSH----QNGIIHRDVKPANIMISATNAVKVMDFGIARAI  161 (277)
T ss_dssp             CCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred             CCCCEehhhhccc-CCCCHHHHHHHHHHHHHHHHHHH----hCCccCccccCcccccCccccceeehhhhhhhh
Confidence            9999999887653 35788999999999999999999    578999999999999999999999999998754

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.86  E-value=1.7e-22  Score=193.89  Aligned_cols=132  Identities=29%  Similarity=0.430  Sum_probs=107.2

Q ss_pred             hhccccccceeeeecc-CCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCCC-----------Cccccc
Q 039957          340 ISLAGSFGSVYKGTIS-DGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCSTP-----------DFKFMP  407 (481)
Q Consensus       340 l~~~g~~g~vy~~~l~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----------~~~~~~  407 (481)
                      +.|+|+||.||+|... +|..||||.+....    ....+|++++++++|+|||+++++|...           .+||++
T Consensus        27 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~  102 (350)
T d1q5ka_          27 VIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP  102 (350)
T ss_dssp             EEEEETTEEEEEEEETTTCCEEEEEEEECCS----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCS
T ss_pred             EEeeCcCeEEEEEEECCCCCEEEEEEECccc----hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccC
Confidence            3578999999999864 68999999986542    2345799999999999999999887432           157887


Q ss_pred             CCChhHHhh--cCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCC-CcEEEccccCcccC
Q 039957          408 NGSLEKRLY--SHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDEN-MVAHVSDFGISKLL  479 (481)
Q Consensus       408 ~g~l~~~l~--~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~-~~~kl~Dfgl~~~~  479 (481)
                      +|.......  .....+++.++..++.||++||+|||    +.+||||||||+|||++.+ ..+||+|||+|+.+
T Consensus       103 ~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH----~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_         103 ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             CccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH----hcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            664433322  24456889999999999999999999    6889999999999999987 48999999999865

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.86  E-value=1.1e-22  Score=188.06  Aligned_cols=136  Identities=26%  Similarity=0.301  Sum_probs=111.6

Q ss_pred             hhccccccceeeeec-cCCcceEEEEEeccch------hhhhhhhHHHHHhhhhc--cCccceeecccCCCC-----ccc
Q 039957          340 ISLAGSFGSVYKGTI-SDGTDVAIKIFNLQRE------RAFRSFNSECEVLRNVR--HQNLIKILSSCSTPD-----FKF  405 (481)
Q Consensus       340 l~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~------~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~-----~~~  405 (481)
                      ..|+|+||.||+|.. .+|..||||.+.....      .....+.+|+.++++++  |||||++++++...+     ++|
T Consensus        11 ~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~   90 (273)
T d1xwsa_          11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILER   90 (273)
T ss_dssp             EEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEEC
T ss_pred             EEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEe
Confidence            457899999999985 5789999999875431      12345778999999987  899999999998776     466


Q ss_pred             ccC-CChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCC-CCcEEEccccCcccCC
Q 039957          406 MPN-GSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDE-NMVAHVSDFGISKLLG  480 (481)
Q Consensus       406 ~~~-g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~-~~~~kl~Dfgl~~~~~  480 (481)
                      +.+ +++.+++.. ...+++.+...++.||++||+|||    +.+||||||||+|||++. ++.+||+|||+|+...
T Consensus        91 ~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH----~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~  162 (273)
T d1xwsa_          91 PEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCH----NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK  162 (273)
T ss_dssp             CSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             ccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH----HCCCccccCcccceEEecCCCeEEECccccceecc
Confidence            654 677777654 345788899999999999999999    678999999999999986 4899999999998653

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.86  E-value=3.7e-22  Score=186.84  Aligned_cols=134  Identities=23%  Similarity=0.362  Sum_probs=114.2

Q ss_pred             ccccccceeeeec-cCCcceEEEEEeccch--hhhhhhhHHHHHhhhhccCccceeecccCCCC-----cccccCCChhH
Q 039957          342 LAGSFGSVYKGTI-SDGTDVAIKIFNLQRE--RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----FKFMPNGSLEK  413 (481)
Q Consensus       342 ~~g~~g~vy~~~l-~~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~~~~g~l~~  413 (481)
                      |+|+||.||+|.. .+|..||||++.....  .....+.+|+.++++++|+||+++.++|...+     ++|+.++++..
T Consensus        11 G~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~   90 (292)
T d1unla_          11 GEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKY   90 (292)
T ss_dssp             EECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHH
T ss_pred             ecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeecccccccc
Confidence            6899999999985 5688999999865432  33567889999999999999999999998775     45778888877


Q ss_pred             HhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          414 RLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       414 ~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      .... ....++..+..++.|+++||+|||    ..+||||||||+|||++.++.+|++|||.|+...
T Consensus        91 ~~~~-~~~~~~~~~~~~~~q~~~aL~~lH----~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~  152 (292)
T d1unla_          91 FDSC-NGDLDPEIVKSFLFQLLKGLGFCH----SRNVLHRDLKPQNLLINRNGELKLANFGLARAFG  152 (292)
T ss_dssp             HHHT-TTCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             cccc-ccccchhHHHHHHHHHHHHHHHhh----cCCEeeecccCcccccccCCceeeeecchhhccc
Confidence            6654 345678888999999999999999    5789999999999999999999999999998653

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.85  E-value=9.1e-22  Score=187.16  Aligned_cols=129  Identities=22%  Similarity=0.410  Sum_probs=108.6

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccchhhhhhhhHHHHHhhhhc-cCccceeecccCCCC-------cccccCCCh
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVR-HQNLIKILSSCSTPD-------FKFMPNGSL  411 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-------~~~~~~g~l  411 (481)
                      -|.|+||.||+|.. .+|..||+|++....   .+.+.+|++++.+++ ||||+++++++....       ++|+.+|+|
T Consensus        43 LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L  119 (328)
T d3bqca1          43 LGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF  119 (328)
T ss_dssp             EEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBG
T ss_pred             EecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcH
Confidence            37899999999985 568999999986543   345778999999996 999999999875432       679999999


Q ss_pred             hHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCC-CcEEEccccCcccCC
Q 039957          412 EKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDEN-MVAHVSDFGISKLLG  480 (481)
Q Consensus       412 ~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~-~~~kl~Dfgl~~~~~  480 (481)
                      .....    .++..+...++.||++||+|||    +.+||||||||+|||++.+ +.+||+|||+|+...
T Consensus       120 ~~~~~----~l~e~~i~~i~~qil~aL~~LH----~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~  181 (328)
T d3bqca1         120 KQLYQ----TLTDYDIRFYMYEILKALDYCH----SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  181 (328)
T ss_dssp             GGTTT----SCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred             HHHhc----CCCHHHHHHHHHHHHHHHHHHh----hcccccccccccceEEcCCCCeeeecccccceecc
Confidence            77542    4677888999999999999999    6789999999999999875 569999999998653

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.85  E-value=1.1e-21  Score=188.07  Aligned_cols=133  Identities=27%  Similarity=0.392  Sum_probs=105.3

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----------cccc
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----------FKFM  406 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----------~~~~  406 (481)
                      .|.|+||.||+|.. .+|..||||++....  ....+.+.+|++++++++|||+|+++++|...+           ++|+
T Consensus        26 lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~  105 (346)
T d1cm8a_          26 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM  105 (346)
T ss_dssp             C------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC
T ss_pred             EecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecc
Confidence            47899999999984 568999999986532  233456788999999999999999999886543           3466


Q ss_pred             cCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          407 PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       407 ~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                       ++++......  ..+++.....++.||+.||+|||    +.+||||||||+|||++.++.+|++|||+|+...
T Consensus       106 -~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH----~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~  172 (346)
T d1cm8a_         106 -GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIH----AAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD  172 (346)
T ss_dssp             -SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             -cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHH----hCCCcccccCcchhhcccccccccccccceeccC
Confidence             4566666543  34788899999999999999999    6789999999999999999999999999998754

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.84  E-value=9.9e-20  Score=174.40  Aligned_cols=284  Identities=23%  Similarity=0.283  Sum_probs=188.9

Q ss_pred             CCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceee
Q 039957           13 QNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILD   92 (481)
Q Consensus        13 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~   92 (481)
                      .++++|||++|.++. +|+.   .++|++|+|++|+|+ .+|+.    +.+|+.|++++|+++ .++..   .+.|++|+
T Consensus        38 ~~l~~LdLs~~~L~~-lp~~---~~~L~~L~Ls~N~l~-~lp~~----~~~L~~L~l~~n~l~-~l~~l---p~~L~~L~  104 (353)
T d1jl5a_          38 RQAHELELNNLGLSS-LPEL---PPHLESLVASCNSLT-ELPEL----PQSLKSLLVDNNNLK-ALSDL---PPLLEYLG  104 (353)
T ss_dssp             HTCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCS-SCCCC----CTTCCEEECCSSCCS-CCCSC---CTTCCEEE
T ss_pred             cCCCEEEeCCCCCCC-CCCC---CCCCCEEECCCCCCc-ccccc----hhhhhhhhhhhcccc-hhhhh---cccccccc
Confidence            468999999999985 5653   578999999999998 78864    568999999999987 44432   24699999


Q ss_pred             cccCcceecCcccccCCCCCCEEEcccccCccccCCCccc----------cccccCCCCCCCcEEEccCCccceeCChhh
Q 039957           93 LGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQW----------SFLSSLTNCRYLVYLILSGNPLGGILPPSI  162 (481)
Q Consensus        93 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~----------~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~  162 (481)
                      +++|.++. +|. ++.+++|++|++++|.++..+......          .....+..++.++.+++++|.+..... . 
T Consensus       105 L~~n~l~~-lp~-~~~l~~L~~L~l~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~~~~~-~-  180 (353)
T d1jl5a_         105 VSNNQLEK-LPE-LQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPD-L-  180 (353)
T ss_dssp             CCSSCCSS-CCC-CTTCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCC-C-
T ss_pred             cccccccc-ccc-hhhhccceeeccccccccccccccccccchhhccccccccccccccccceeccccccccccccc-c-
Confidence            99999985 554 688999999999999988765432111          112335566777888888887764321 1 


Q ss_pred             hhcccCccEEEccCCceeecCCcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCc----
Q 039957          163 GNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHL----  238 (481)
Q Consensus       163 ~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l----  238 (481)
                         ....+.+....+.+. .+| .+..++.|+.+++++|... ..|..   ..++..+.+..+.+.... .....+    
T Consensus       181 ---~~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~-~~~~~---~~~l~~~~~~~~~~~~~~-~~~~~l~~~~  250 (353)
T d1jl5a_         181 ---PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLK-TLPDL---PPSLEALNVRDNYLTDLP-ELPQSLTFLD  250 (353)
T ss_dssp             ---CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCS-SCCSC---CTTCCEEECCSSCCSCCC-CCCTTCCEEE
T ss_pred             ---ccccccccccccccc-ccc-ccccccccccccccccccc-ccccc---cccccccccccccccccc-cccccccccc
Confidence               123455566555554 333 3566788888888888765 33332   334555666666554321 111110    


Q ss_pred             -------------cCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCcCcccCCcchhccccCcEEEccCcccCCCCCC
Q 039957          239 -------------EMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSLPS  305 (481)
Q Consensus       239 -------------~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~  305 (481)
                                   ......++..+.+.+    ....+++|++|++++|+++ .+|..   +++|+.|++++|+++. +|.
T Consensus       251 ~~~~~~~~l~~l~~~~~~~~~~~~~~~~----~~~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~~-l~~  321 (353)
T d1jl5a_         251 VSENIFSGLSELPPNLYYLNASSNEIRS----LCDLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLAE-VPE  321 (353)
T ss_dssp             CCSSCCSEESCCCTTCCEEECCSSCCSE----ECCCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCSC-CCC
T ss_pred             cccccccccccccchhcccccccCcccc----ccccCCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCCc-ccc
Confidence                         111233333343332    2233578999999999998 56654   5678899999999974 565


Q ss_pred             ccccCCcCcEEEccCCeeeeeccccccccCC
Q 039957          306 NVQKLKVLRVLDLSRNQLSGDIPSTIGALVD  336 (481)
Q Consensus       306 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~  336 (481)
                      .   +.+|+.|++++|+++ .+|.....+..
T Consensus       322 ~---~~~L~~L~L~~N~L~-~lp~~~~~L~~  348 (353)
T d1jl5a_         322 L---PQNLKQLHVEYNPLR-EFPDIPESVED  348 (353)
T ss_dssp             C---CTTCCEEECCSSCCS-SCCCCCTTCCE
T ss_pred             c---cCCCCEEECcCCcCC-CCCccccccCe
Confidence            3   467899999999987 56654444433

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.84  E-value=1.1e-21  Score=184.64  Aligned_cols=134  Identities=25%  Similarity=0.402  Sum_probs=107.4

Q ss_pred             ccccccceeeeec-cC-CcceEEEEEeccc--hhhhhhhhHHHHHhhhh---ccCccceeecccCCC----------Ccc
Q 039957          342 LAGSFGSVYKGTI-SD-GTDVAIKIFNLQR--ERAFRSFNSECEVLRNV---RHQNLIKILSSCSTP----------DFK  404 (481)
Q Consensus       342 ~~g~~g~vy~~~l-~~-g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~----------~~~  404 (481)
                      |+|+||.||+|.. .+ +..||||.+....  ......+.+|+.+++.+   +||||++++++|...          .++
T Consensus        16 G~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e   95 (305)
T d1blxa_          16 GEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFE   95 (305)
T ss_dssp             EEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEE
T ss_pred             ecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEE
Confidence            7899999999985 34 5679999986543  22334566788777665   799999999987432          146


Q ss_pred             cccCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          405 FMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       405 ~~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      |+.+|.+..........+++.....++.|+++||+|||    +.+||||||||+|||+++++.+||+|||+++..
T Consensus        96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH----~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~  166 (305)
T d1blxa_          96 HVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH----SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY  166 (305)
T ss_dssp             CCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEECSCCSCCCC
T ss_pred             eccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH----hCCEEecCCCccEEEEcCCCCeeecchhhhhhh
Confidence            77877765555555566788888899999999999999    678999999999999999999999999999865

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.84  E-value=1.4e-20  Score=170.81  Aligned_cols=217  Identities=13%  Similarity=0.092  Sum_probs=124.1

Q ss_pred             CeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeec-chhccccccCceeecc
Q 039957           16 KSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTI-PNSITNATKLIILDLG   94 (481)
Q Consensus        16 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls   94 (481)
                      ++++.+++.++. +|+.+.  +++++|+|++|+|+ .+|...+..+++|++|++++|.+...+ +.+|.++++++++++.
T Consensus        11 ~~i~c~~~~l~~-iP~~l~--~~l~~L~Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~   86 (242)
T d1xwdc1          11 RVFLCQESKVTE-IPSDLP--RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE   86 (242)
T ss_dssp             SEEEEESCSCSS-CCSCSC--SCCSEEEEESCCCC-EECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEE
T ss_pred             CEEEEeCCCCCC-cCCCCC--CCCCEEECcCCcCC-ccChhHhhccchhhhhhhccccccceeecccccccccccccccc
Confidence            567777777774 444332  46788888888887 566655456888888888888776544 4467778888888765


Q ss_pred             -cCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEE
Q 039957           95 -FNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFS  173 (481)
Q Consensus        95 -~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~  173 (481)
                       .|.+....+..|.++++|+++++++|.++..+..       ..+..++.+..+..+++.+....+..+......++.++
T Consensus        87 ~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~-------~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~  159 (242)
T d1xwdc1          87 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDV-------HKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILW  159 (242)
T ss_dssp             CCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCC-------TTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEE
T ss_pred             ccccccccccccccccccccccccchhhhcccccc-------cccccccccccccccccccccccccccccccccceeee
Confidence             3677777777788888888888888877655322       12344555666666666666554444444434455556


Q ss_pred             ccCCceeecCCcccccCCCCCeE-ecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCee
Q 039957          174 ASECKLKGTIPKEIGHLRGLIYL-SLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLL  244 (481)
Q Consensus       174 l~~n~l~~~~p~~~~~l~~L~~L-~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L  244 (481)
                      +++|+++...+..+ ...++..+ ++++|+++...+..|.++++|+.|++++|+++...+..|.+++.|+.+
T Consensus       160 l~~n~l~~i~~~~~-~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l  230 (242)
T d1xwdc1         160 LNKNGIQEIHNCAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRAR  230 (242)
T ss_dssp             CCSSCCCEECTTTT-TTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESS
T ss_pred             cccccccccccccc-cchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccC
Confidence            65555553322222 22232222 334444443323334444444444444444443333333333333333

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.84  E-value=8.3e-22  Score=186.25  Aligned_cols=134  Identities=25%  Similarity=0.336  Sum_probs=111.8

Q ss_pred             hccccccceeeeec----cCCcceEEEEEeccc----hhhhhhhhHHHHHhhhhcc-CccceeecccCCCC-----cccc
Q 039957          341 SLAGSFGSVYKGTI----SDGTDVAIKIFNLQR----ERAFRSFNSECEVLRNVRH-QNLIKILSSCSTPD-----FKFM  406 (481)
Q Consensus       341 ~~~g~~g~vy~~~l----~~g~~vavK~l~~~~----~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~-----~~~~  406 (481)
                      .|+|+||.||+|..    .+|..||||.+....    ....+.+.+|++++++++| |||+++++++....     ++|+
T Consensus        32 IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~  111 (322)
T d1vzoa_          32 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYI  111 (322)
T ss_dssp             EEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             EecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeeeecc
Confidence            37899999999974    247889999986532    2334568889999999987 79999998887665     6789


Q ss_pred             cCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          407 PNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       407 ~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      .+|+|.+++..... ........++.|++.|++|+|    +.+||||||||+|||+|.++.+||+|||+|+.+
T Consensus       112 ~~~~L~~~i~~~~~-~~e~~~~~~~~Qi~~al~~lH----~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~  179 (322)
T d1vzoa_         112 NGGELFTHLSQRER-FTEHEVQIYVGEIVLALEHLH----KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  179 (322)
T ss_dssp             CSCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             cccHHHHHHHhccc-ccHHHHHHHHHHHHHHHHHhh----cCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence            99999998875433 345667788999999999999    578999999999999999999999999999865

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.84  E-value=1e-20  Score=171.79  Aligned_cols=219  Identities=15%  Similarity=0.093  Sum_probs=140.4

Q ss_pred             CCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeecccCcceec-CcccccCCCCCCEEEc
Q 039957           39 IRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGH-IPNTFGNLRHLSVLSL  117 (481)
Q Consensus        39 L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L  117 (481)
                      .+.++.+++.++ .+|+.++   +++++|+|++|+|+...+.+|.++++|++|++++|.+... .+.+|.+++.++++.+
T Consensus        10 ~~~i~c~~~~l~-~iP~~l~---~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~   85 (242)
T d1xwdc1          10 NRVFLCQESKVT-EIPSDLP---RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI   85 (242)
T ss_dssp             SSEEEEESCSCS-SCCSCSC---SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEE
T ss_pred             CCEEEEeCCCCC-CcCCCCC---CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccc
Confidence            378899999998 8997664   5799999999999877777899999999999999998764 4567999999999987


Q ss_pred             cc-ccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEccCCceeecCCcccccCC-CCCe
Q 039957          118 LM-NNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLR-GLIY  195 (481)
Q Consensus       118 ~~-N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~-~L~~  195 (481)
                      .. |++...+..        .+.++++|+++++++|.+....+..+......+..+..+++.+....+..|..++ .++.
T Consensus        86 ~~~n~l~~~~~~--------~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~  157 (242)
T d1xwdc1          86 EKANNLLYINPE--------AFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVI  157 (242)
T ss_dssp             ECCTTCCEECTT--------SEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEE
T ss_pred             cccccccccccc--------cccccccccccccchhhhccccccccccccccccccccccccccccccccccccccccee
Confidence            64 677665433        3467888999999999887543333222223455555566666655455555543 5666


Q ss_pred             EecccccceecCCcCCcCCCCCC-eeecCCCcCCCCCCccccCccCCCeeecCCCeeeecCCcccccCCCCCcEEc
Q 039957          196 LSLGFNDLNGTIPTSIGTLKQLQ-GFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDL  270 (481)
Q Consensus       196 L~l~~N~l~~~~p~~~~~l~~L~-~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l  270 (481)
                      |++++|+++...+..+. ..+++ .+++++|+++...+..|.++++|+.|++++|+++..++..|.++++|+.+++
T Consensus       158 L~l~~n~l~~i~~~~~~-~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~  232 (242)
T d1xwdc1         158 LWLNKNGIQEIHNCAFN-GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST  232 (242)
T ss_dssp             EECCSSCCCEECTTTTT-TCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSE
T ss_pred             eeccccccccccccccc-chhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcC
Confidence            66666666643333332 22322 2234445555444444555555555555555555444444444444444433

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.84  E-value=1.8e-21  Score=184.28  Aligned_cols=135  Identities=24%  Similarity=0.397  Sum_probs=106.9

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccch--hhhhhhhHHHHHhhhhccCccceeecccCCCC-------------cc
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQRE--RAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-------------FK  404 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-------------~~  404 (481)
                      -|.|+||.||+|.. .+|..||||++.....  .....+.+|+.++++++|+|++++++.+....             ++
T Consensus        18 LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e   97 (318)
T d3blha1          18 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFD   97 (318)
T ss_dssp             EEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEE
T ss_pred             EecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEe
Confidence            37899999999985 5789999998865432  23456788999999999999999998875432             45


Q ss_pred             cccCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          405 FMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       405 ~~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      |+.++.+... ..............|+.||++||+|||    +.+||||||||+|||+++++.+||+|||+|+.+.
T Consensus        98 ~~~~~~~~~~-~~~~~~~~~~~~~~i~~qil~~l~~lH----~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~  168 (318)
T d3blha1          98 FCEHDLAGLL-SNVLVKFTLSEIKRVMQMLLNGLYYIH----RNKILHRDMKAANVLITRDGVLKLADFGLARAFS  168 (318)
T ss_dssp             CCCEEHHHHH-TCTTCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             ccCCCccchh-hhcccccccHHHHHHHHHHHHHHHHhc----cCCEEecCcCchheeecCCCcEEeeecceeeecc
Confidence            6666655443 334445667788899999999999999    6789999999999999999999999999997653

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.84  E-value=2e-21  Score=186.42  Aligned_cols=133  Identities=24%  Similarity=0.359  Sum_probs=109.7

Q ss_pred             hccccccceeeeec-cCCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC----------ccccc
Q 039957          341 SLAGSFGSVYKGTI-SDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD----------FKFMP  407 (481)
Q Consensus       341 ~~~g~~g~vy~~~l-~~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----------~~~~~  407 (481)
                      -|.|+||+||+|.. .+|..||||++....  ....+.+.+|++++++++|+|+|++++++....          ++|+.
T Consensus        26 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~  105 (348)
T d2gfsa1          26 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM  105 (348)
T ss_dssp             CGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECC
T ss_pred             EecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeec
Confidence            47899999999984 579999999987543  233456788999999999999999998875331          45778


Q ss_pred             CCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          408 NGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       408 ~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +|+|.+++...  .++..+...++.+|+.||+|||    +.+||||||||+|||++.++.+|++|||+|...
T Consensus       106 gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH----~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~  171 (348)
T d2gfsa1         106 GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHT  171 (348)
T ss_dssp             SEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred             CCchhhhcccc--cccHHHHHHHHHHHHHHHHHHH----hCCCcccccCCccccccccccccccccchhccc
Confidence            99999988643  5788889999999999999999    678999999999999999999999999998764

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.83  E-value=9.8e-21  Score=176.68  Aligned_cols=133  Identities=19%  Similarity=0.242  Sum_probs=110.7

Q ss_pred             hhccccccceeeeec-cCCcceEEEEEeccchhhhhhhhHHHHHhhhhcc-CccceeecccCCCC-----cccccCCChh
Q 039957          340 ISLAGSFGSVYKGTI-SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRH-QNLIKILSSCSTPD-----FKFMPNGSLE  412 (481)
Q Consensus       340 l~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~-----~~~~~~g~l~  412 (481)
                      ..++|+||.||+|.. .+|..||||.+....  ..+.+.+|++.+..++| ++++.+.+++....     ++|+ +|+|.
T Consensus        12 ~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~   88 (293)
T d1csna_          12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLE   88 (293)
T ss_dssp             EEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHH
T ss_pred             EEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHH
Confidence            448899999999985 468899999875432  23456778888888875 89999888876654     4565 79999


Q ss_pred             HHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCC-----CCcEEEccccCcccC
Q 039957          413 KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDE-----NMVAHVSDFGISKLL  479 (481)
Q Consensus       413 ~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~-----~~~~kl~Dfgl~~~~  479 (481)
                      +.+......+++..+..++.+++.||+|+|    +.+|+||||||+|||++.     ++.+||+|||+|+.+
T Consensus        89 ~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH----~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~  156 (293)
T d1csna_          89 DLLDLCGRKFSVKTVAMAAKQMLARVQSIH----EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  156 (293)
T ss_dssp             HHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             HHHHhhccchhhHHHHHHHHHHHHHHHHHH----HCCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence            988776667889999999999999999999    688999999999999974     578999999999865

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.82  E-value=1.1e-20  Score=164.92  Aligned_cols=174  Identities=22%  Similarity=0.224  Sum_probs=129.2

Q ss_pred             CCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeecc
Q 039957           15 LKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLG   94 (481)
Q Consensus        15 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls   94 (481)
                      .++++.++++++.+ |..+.  +++++|+|++|+|++.++...+..+++|++|+|++|++.+..+..|..+++|++|+|+
T Consensus        10 ~~~v~Cs~~~L~~i-P~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls   86 (192)
T d1w8aa_          10 GTTVDCTGRGLKEI-PRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG   86 (192)
T ss_dssp             TTEEECTTSCCSSC-CSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             CCEEEEeCCCcCcc-CCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence            46789999999854 54442  6789999999999866766666679999999999999998888899999999999999


Q ss_pred             cCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEc
Q 039957           95 FNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSA  174 (481)
Q Consensus        95 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l  174 (481)
                      +|+|+.+.|.+|.++++|++|+|++|+|+++++..        +..+++|++|+|++|.+....+..+..  ..++.+.+
T Consensus        87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~--------f~~l~~L~~l~L~~N~~~~~~~~~~~~--~~l~~~~l  156 (192)
T d1w8aa_          87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGS--------FEHLNSLTSLNLASNPFNCNCHLAWFA--EWLRKKSL  156 (192)
T ss_dssp             SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTS--------STTCTTCCEEECTTCCBCCSGGGHHHH--HHHHHHCC
T ss_pred             cccccccCHHHHhCCCcccccccCCccccccCHHH--------hcCCcccccccccccccccccchHHHh--hhhhhhcc
Confidence            99999888889999999999999999999886654        457788999999999887543322211  22444455


Q ss_pred             cCCceeecCCcccccCCCCCeEecccccce
Q 039957          175 SECKLKGTIPKEIGHLRGLIYLSLGFNDLN  204 (481)
Q Consensus       175 ~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~  204 (481)
                      ..+.++...|..   +.+++.++++.|.+.
T Consensus       157 ~~~~~~c~~p~~---l~~~~l~~L~~n~l~  183 (192)
T d1w8aa_         157 NGGAARCGAPSK---VRDVQIKDLPHSEFK  183 (192)
T ss_dssp             SGGGCBBCSSTT---TTTSBGGGSCTTTCC
T ss_pred             cCCCeEeCCChh---hcCCEeeecCHhhCc
Confidence            555555444433   334445555555554

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.82  E-value=6.6e-21  Score=171.28  Aligned_cols=100  Identities=23%  Similarity=0.346  Sum_probs=50.4

Q ss_pred             CCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeecc
Q 039957           15 LKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLG   94 (481)
Q Consensus        15 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls   94 (481)
                      +..++++.+++++..  .++.+.+|+.|++.+|.|+ .++ .+. .+++|++|++++|++++..|  +..+++|++++++
T Consensus        21 ~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~-~l~-~l~-~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~   93 (227)
T d1h6ua2          21 AIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIE-GVQ-YLNNLIGLELKDNQITDLAP--LKNLTKITELELS   93 (227)
T ss_dssp             HHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCC-CCT-TGG-GCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECC
T ss_pred             HHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCC-cch-hHh-cCCCCcEeecCCceeecccc--ccccccccccccc
Confidence            344455555555432  2344555666666666655 343 232 45566666666655553322  4555555555555


Q ss_pred             cCcceecCcccccCCCCCCEEEcccccCc
Q 039957           95 FNTFSGHIPNTFGNLRHLSVLSLLMNNLT  123 (481)
Q Consensus        95 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  123 (481)
                      +|.++. ++ .|.++++|+.++++.+...
T Consensus        94 ~n~~~~-i~-~l~~l~~L~~l~l~~~~~~  120 (227)
T d1h6ua2          94 GNPLKN-VS-AIAGLQSIKTLDLTSTQIT  120 (227)
T ss_dssp             SCCCSC-CG-GGTTCTTCCEEECTTSCCC
T ss_pred             cccccc-cc-ccccccccccccccccccc
Confidence            555542 21 3445555555555544443

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.82  E-value=1e-20  Score=177.34  Aligned_cols=134  Identities=26%  Similarity=0.395  Sum_probs=107.1

Q ss_pred             hhccccccceeeeec-cCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCccceeecccCC-CC-----cccccCCChh
Q 039957          340 ISLAGSFGSVYKGTI-SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQNLIKILSSCST-PD-----FKFMPNGSLE  412 (481)
Q Consensus       340 l~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~-----~~~~~~g~l~  412 (481)
                      ..|+|+||.||+|.. .+|..||||.+....  ...++..|++++++++|++++..+..|.. .+     ++|+ +|++.
T Consensus        14 ~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~l~   90 (299)
T d1ckia_          14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLE   90 (299)
T ss_dssp             EEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CCBHH
T ss_pred             EEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CCchh
Confidence            448899999999985 568999999876543  23467889999999998887766655533 33     4555 57777


Q ss_pred             HHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCC---CCcEEEccccCcccCC
Q 039957          413 KRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDE---NMVAHVSDFGISKLLG  480 (481)
Q Consensus       413 ~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~---~~~~kl~Dfgl~~~~~  480 (481)
                      ..+......+++..+..++.++++||+|||    +.+||||||||+|||++.   +..+|++|||+|+.+.
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~  157 (299)
T d1ckia_          91 DLFNFCSRKFSLKTVLLLADQMISRIEYIH----SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  157 (299)
T ss_dssp             HHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred             hhhhhccCCCcHHHHHHHHHHHHHHHHHHH----HCCeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence            766666667899999999999999999999    678999999999998753   5689999999998753

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.81  E-value=2.2e-20  Score=167.83  Aligned_cols=209  Identities=21%  Similarity=0.283  Sum_probs=165.6

Q ss_pred             CcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeecccCcceecCcccccCCCCCCEE
Q 039957           36 ISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVL  115 (481)
Q Consensus        36 l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  115 (481)
                      +.++..++++.+++++.++.   ..+.+|++|++.+|.++. ++ .+..+++|++|++++|.+++..|  |..+++|+++
T Consensus        18 l~~~~~~~l~~~~~~d~~~~---~~l~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l   90 (227)
T d1h6ua2          18 LANAIKIAAGKSNVTDTVTQ---ADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITEL   90 (227)
T ss_dssp             HHHHHHHHTTCSSTTSEECH---HHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEE
T ss_pred             HHHHHHHHhCCCCcCCcCCH---HHcCCcCEEECCCCCCCc-ch-hHhcCCCCcEeecCCceeecccc--cccccccccc
Confidence            33444567778888765432   257889999999999984 44 58999999999999999987554  8999999999


Q ss_pred             EcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEccCCceeecCCcccccCCCCCe
Q 039957          116 SLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIY  195 (481)
Q Consensus       116 ~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~  195 (481)
                      ++++|.++.+          ..+..+++|++++++++...+..+  +... ..+..+.++.+.+...  ..+..+++|++
T Consensus        91 ~~~~n~~~~i----------~~l~~l~~L~~l~l~~~~~~~~~~--~~~~-~~~~~l~~~~~~~~~~--~~~~~~~~L~~  155 (227)
T d1h6ua2          91 ELSGNPLKNV----------SAIAGLQSIKTLDLTSTQITDVTP--LAGL-SNLQVLYLDLNQITNI--SPLAGLTNLQY  155 (227)
T ss_dssp             ECCSCCCSCC----------GGGTTCTTCCEEECTTSCCCCCGG--GTTC-TTCCEEECCSSCCCCC--GGGGGCTTCCE
T ss_pred             cccccccccc----------ccccccccccccccccccccccch--hccc-cchhhhhchhhhhchh--hhhcccccccc
Confidence            9999988765          335678899999999998875432  3332 5788999999988743  34778889999


Q ss_pred             EecccccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeeeecCCcccccCCCCCcEEcCC
Q 039957          196 LSLGFNDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGS  272 (481)
Q Consensus       196 L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~  272 (481)
                      |++++|.+...  ..+..+++|+.|++++|++++..  .++.+++|+.|++++|++++..  .+..+++|+.|++++
T Consensus       156 L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~l~~l~--~l~~l~~L~~L~Ls~N~lt~i~--~l~~l~~L~~L~lsn  226 (227)
T d1h6ua2         156 LSIGNAQVSDL--TPLANLSKLTTLKADDNKISDIS--PLASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTN  226 (227)
T ss_dssp             EECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEE
T ss_pred             ccccccccccc--hhhcccccceecccCCCccCCCh--hhcCCCCCCEEECcCCcCCCCc--ccccCCCCCEEEeeC
Confidence            99999998643  34888999999999999998743  3888999999999999998654  388999999999873

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.79  E-value=6e-20  Score=160.25  Aligned_cols=176  Identities=22%  Similarity=0.297  Sum_probs=137.3

Q ss_pred             cEEEccCCccceeCChhhhhcccCccEEEccCCceeecC-CcccccCCCCCeEecccccceecCCcCCcCCCCCCeeecC
Q 039957          145 VYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTI-PKEIGHLRGLIYLSLGFNDLNGTIPTSIGTLKQLQGFFLP  223 (481)
Q Consensus       145 ~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~  223 (481)
                      ++++.++++++ .+|..+   ++++++|+|++|+|++.+ +..|.++++|+.|++++|.+.+..+..|..+++|+.|+++
T Consensus        11 ~~v~Cs~~~L~-~iP~~l---p~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls   86 (192)
T d1w8aa_          11 TTVDCTGRGLK-EIPRDI---PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG   86 (192)
T ss_dssp             TEEECTTSCCS-SCCSCC---CTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             CEEEEeCCCcC-ccCCCC---CCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence            46677777776 345443   356888888888887544 5567889999999999999998888899999999999999


Q ss_pred             CCcCCCCCCccccCccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCcCcccCCcchhccccCcEEEccCcccCCCC
Q 039957          224 ETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINLSSNLLNDSL  303 (481)
Q Consensus       224 ~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~  303 (481)
                      +|+++...|..|.++++|+.|+|++|+|+++.|.+|..+++|++|+|++|.+....+ ..+-...+....+..|.++...
T Consensus        87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~-~~~~~~~l~~~~l~~~~~~c~~  165 (192)
T d1w8aa_          87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH-LAWFAEWLRKKSLNGGAARCGA  165 (192)
T ss_dssp             SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG-GHHHHHHHHHHCCSGGGCBBCS
T ss_pred             cccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccc-hHHHhhhhhhhcccCCCeEeCC
Confidence            999998888899999999999999999999889999999999999999999874432 2222334556677778777666


Q ss_pred             CCccccCCcCcEEEccCCeeeeecc
Q 039957          304 PSNVQKLKVLRVLDLSRNQLSGDIP  328 (481)
Q Consensus       304 p~~~~~l~~L~~L~l~~N~l~~~~p  328 (481)
                      |..+   +.++.++++.|++.+..+
T Consensus       166 p~~l---~~~~l~~L~~n~l~C~~~  187 (192)
T d1w8aa_         166 PSKV---RDVQIKDLPHSEFKCSSE  187 (192)
T ss_dssp             STTT---TTSBGGGSCTTTCCCCCC
T ss_pred             Chhh---cCCEeeecCHhhCcCCCC
Confidence            7654   456677889998876544

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.79  E-value=8.3e-20  Score=175.20  Aligned_cols=132  Identities=23%  Similarity=0.306  Sum_probs=104.0

Q ss_pred             hhccccccceeeeec-cCCcceEEEEEeccc--hhhhhhhhHHHHHhhhhccCccceeecccCCCC-----------ccc
Q 039957          340 ISLAGSFGSVYKGTI-SDGTDVAIKIFNLQR--ERAFRSFNSECEVLRNVRHQNLIKILSSCSTPD-----------FKF  405 (481)
Q Consensus       340 l~~~g~~g~vy~~~l-~~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----------~~~  405 (481)
                      .-|.|+||+||+|.. .+|..||||++....  ......+.+|+.++++++|||||++++++...+           +||
T Consensus        24 ~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey  103 (355)
T d2b1pa1          24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL  103 (355)
T ss_dssp             ECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEEC
T ss_pred             EeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEec
Confidence            348999999999985 469999999987543  223346788999999999999999999885431           568


Q ss_pred             ccCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccC
Q 039957          406 MPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLL  479 (481)
Q Consensus       406 ~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~  479 (481)
                      +.++.+ +.+.   ..+++.....++.+|+.||+|||    +.+|+||||||+|||++.++.+|++|||+++..
T Consensus       104 ~~~~l~-~~~~---~~~~~~~i~~~~~qil~gl~~LH----~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~  169 (355)
T d2b1pa1         104 MDANLC-QVIQ---MELDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_dssp             CSEEHH-HHHT---SCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             cchHHH-Hhhh---cCCCHHHHHHHHHHHHHHHHHhh----hcccccccCCccccccccccceeeechhhhhcc
Confidence            865544 4443   24678888999999999999999    678999999999999999999999999998764

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.77  E-value=1.4e-17  Score=159.24  Aligned_cols=273  Identities=22%  Similarity=0.307  Sum_probs=178.4

Q ss_pred             eccCcchhCCCCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhc
Q 039957            3 GQIPTEIGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSI   82 (481)
Q Consensus         3 g~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~   82 (481)
                      +++|+.   .++|++|+|++|+|+. +|+.   +.+|+.|++++|+++ .++..    .+.|++|++++|.+. .+|. +
T Consensus        51 ~~lp~~---~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~l~~n~l~-~l~~l----p~~L~~L~L~~n~l~-~lp~-~  116 (353)
T d1jl5a_          51 SSLPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLK-ALSDL----PPLLEYLGVSNNQLE-KLPE-L  116 (353)
T ss_dssp             SCCCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCS-CCCSC----CTTCCEEECCSSCCS-SCCC-C
T ss_pred             CCCCCC---CCCCCEEECCCCCCcc-cccc---hhhhhhhhhhhcccc-hhhhh----ccccccccccccccc-cccc-h
Confidence            357753   4689999999999985 5654   457999999999998 66631    246999999999997 5554 6


Q ss_pred             cccccCceeecccCcceecC------------------cccccCCCCCCEEEcccccCccccCCCccc----------cc
Q 039957           83 TNATKLIILDLGFNTFSGHI------------------PNTFGNLRHLSVLSLLMNNLTTESSSAYQW----------SF  134 (481)
Q Consensus        83 ~~l~~L~~L~Ls~N~l~~~~------------------p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~----------~~  134 (481)
                      ..+++|+.|++++|.++...                  +..++.++.++.+++++|.+...+......          ..
T Consensus       117 ~~l~~L~~L~l~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~~~~~~~~~~~~l~~~~~~~~~  196 (353)
T d1jl5a_         117 QNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEE  196 (353)
T ss_dssp             TTCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCCCCTTCCEEECCSSCCSS
T ss_pred             hhhccceeeccccccccccccccccccchhhccccccccccccccccceecccccccccccccccccccccccccccccc
Confidence            78999999999999876332                  233566778888888888776654322111          11


Q ss_pred             cccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEccCCceeecCCcccccCCCCCeEecccccceecCCcCCcCC
Q 039957          135 LSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNGTIPTSIGTL  214 (481)
Q Consensus       135 ~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l  214 (481)
                      ......++.|+.+++++|.... .|..    ..++..+.+.++.+.. .+.   ....+...++..+.+.+.. ..   .
T Consensus       197 ~~~~~~l~~L~~l~l~~n~~~~-~~~~----~~~l~~~~~~~~~~~~-~~~---~~~~l~~~~~~~~~~~~l~-~l---~  263 (353)
T d1jl5a_         197 LPELQNLPFLTTIYADNNLLKT-LPDL----PPSLEALNVRDNYLTD-LPE---LPQSLTFLDVSENIFSGLS-EL---P  263 (353)
T ss_dssp             CCCCTTCTTCCEEECCSSCCSS-CCSC----CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSEES-CC---C
T ss_pred             cccccccccccccccccccccc-cccc----cccccccccccccccc-ccc---ccccccccccccccccccc-cc---c
Confidence            1234456667777777766553 2221    2346666666666552 222   1234555555555544321 00   1


Q ss_pred             CCCCeeecCCCcCCCCCCccccCccCCCeeecCCCeeeecCCcccccCCCCCcEEcCCCcCcccCCcchhccccCcEEEc
Q 039957          215 KQLQGFFLPETNLQGYVPHNLCHLEMLNLLHLGGNKLSGHIPPCLASLTSLRELDLGSNKLTSSIPSSLWSLGYILEINL  294 (481)
Q Consensus       215 ~~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l  294 (481)
                      ......++..+.+.+.    ...+++|++|++++|+++. +|..   +++|+.|++++|+|+ .+|..   +++|++|++
T Consensus       264 ~~~~~~~~~~~~~~~~----~~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L  331 (353)
T d1jl5a_         264 PNLYYLNASSNEIRSL----CDLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHV  331 (353)
T ss_dssp             TTCCEEECCSSCCSEE----CCCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEEC
T ss_pred             chhcccccccCccccc----cccCCCCCEEECCCCccCc-cccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEEC
Confidence            2233445555554432    2345789999999999984 5643   578999999999998 56653   467899999


Q ss_pred             cCcccCCCCCCccccCCcCcEEEc
Q 039957          295 SSNLLNDSLPSNVQKLKVLRVLDL  318 (481)
Q Consensus       295 ~~N~l~~~~p~~~~~l~~L~~L~l  318 (481)
                      ++|+++ .+|...   ..|+.|.+
T Consensus       332 ~~N~L~-~lp~~~---~~L~~L~~  351 (353)
T d1jl5a_         332 EYNPLR-EFPDIP---ESVEDLRM  351 (353)
T ss_dssp             CSSCCS-SCCCCC---TTCCEEEC
T ss_pred             cCCcCC-CCCccc---cccCeeEC
Confidence            999997 456543   34555554

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.77  E-value=8.7e-19  Score=155.03  Aligned_cols=164  Identities=22%  Similarity=0.285  Sum_probs=83.9

Q ss_pred             eeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeecccC
Q 039957           17 SLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFN   96 (481)
Q Consensus        17 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N   96 (481)
                      ..+++.+.+++.++.  ..+.+|++|++++|.++ .++. +. .+++|++|++++|++++..  .+..+++|++|++++|
T Consensus        28 ~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~-~l~~-l~-~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n  100 (210)
T d1h6ta2          28 KDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIK-SVQG-IQ-YLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDEN  100 (210)
T ss_dssp             HHHTTCSCTTSEECH--HHHHTCCEEECTTSCCC-CCTT-GG-GCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSS
T ss_pred             HHHhCcCccCCccCH--HHhcCccEEECcCCCCC-Cchh-Hh-hCCCCCEEeCCCccccCcc--ccccCccccccccccc
Confidence            345555555554432  23556666666666665 3332 32 4666666666666665432  2456666666666666


Q ss_pred             cceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEccC
Q 039957           97 TFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASE  176 (481)
Q Consensus        97 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~  176 (481)
                      ++++ +| .+.++++|+.|++++|.+..+          ..+..++.++++++++|.+++.  ..+..+ ++|+.+++++
T Consensus       101 ~i~~-l~-~l~~l~~L~~L~l~~~~~~~~----------~~l~~l~~l~~l~~~~n~l~~~--~~~~~l-~~L~~l~l~~  165 (210)
T d1h6ta2         101 KVKD-LS-SLKDLKKLKSLSLEHNGISDI----------NGLVHLPQLESLYLGNNKITDI--TVLSRL-TKLDTLSLED  165 (210)
T ss_dssp             CCCC-GG-GGTTCTTCCEEECTTSCCCCC----------GGGGGCTTCCEEECCSSCCCCC--GGGGGC-TTCSEEECCS
T ss_pred             cccc-cc-ccccccccccccccccccccc----------cccccccccccccccccccccc--cccccc-cccccccccc
Confidence            6664 23 356666666666666655433          1234445555555555555431  122222 3444444444


Q ss_pred             CceeecCCcccccCCCCCeEecccccce
Q 039957          177 CKLKGTIPKEIGHLRGLIYLSLGFNDLN  204 (481)
Q Consensus       177 n~l~~~~p~~~~~l~~L~~L~l~~N~l~  204 (481)
                      |++++ ++ .+.++++|+.|++++|+++
T Consensus       166 n~l~~-i~-~l~~l~~L~~L~Ls~N~i~  191 (210)
T d1h6ta2         166 NQISD-IV-PLAGLTKLQNLYLSKNHIS  191 (210)
T ss_dssp             SCCCC-CG-GGTTCTTCCEEECCSSCCC
T ss_pred             ccccc-cc-cccCCCCCCEEECCCCCCC
Confidence            44442 11 1444444444444444443

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.77  E-value=2.3e-18  Score=152.29  Aligned_cols=166  Identities=24%  Similarity=0.334  Sum_probs=139.8

Q ss_pred             CCCCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCce
Q 039957           11 NLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLII   90 (481)
Q Consensus        11 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~   90 (481)
                      .+.+|+.|++++|.++...  .+..+++|++|++++|++++ ++. +. .+++|++|++++|++++ +| .+..+++|+.
T Consensus        44 ~L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~-l~~-~~-~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~  116 (210)
T d1h6ta2          44 ELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTD-IKP-LA-NLKNLGWLFLDENKVKD-LS-SLKDLKKLKS  116 (210)
T ss_dssp             HHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCC-CGG-GT-TCTTCCEEECCSSCCCC-GG-GGTTCTTCCE
T ss_pred             HhcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccC-ccc-cc-cCccccccccccccccc-cc-cccccccccc
Confidence            4678999999999998653  48899999999999999984 554 33 79999999999999984 44 5899999999


Q ss_pred             eecccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCcc
Q 039957           91 LDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQ  170 (481)
Q Consensus        91 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~  170 (481)
                      |++++|.+..  ...+..++.++.+++++|.++...          .+..+++|+++++++|++++. + .+..+ ++|+
T Consensus       117 L~l~~~~~~~--~~~l~~l~~l~~l~~~~n~l~~~~----------~~~~l~~L~~l~l~~n~l~~i-~-~l~~l-~~L~  181 (210)
T d1h6ta2         117 LSLEHNGISD--INGLVHLPQLESLYLGNNKITDIT----------VLSRLTKLDTLSLEDNQISDI-V-PLAGL-TKLQ  181 (210)
T ss_dssp             EECTTSCCCC--CGGGGGCTTCCEEECCSSCCCCCG----------GGGGCTTCSEEECCSSCCCCC-G-GGTTC-TTCC
T ss_pred             cccccccccc--cccccccccccccccccccccccc----------ccccccccccccccccccccc-c-cccCC-CCCC
Confidence            9999999874  346899999999999999988652          245678999999999999864 3 36666 6899


Q ss_pred             EEEccCCceeecCCcccccCCCCCeEeccc
Q 039957          171 RFSASECKLKGTIPKEIGHLRGLIYLSLGF  200 (481)
Q Consensus       171 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~  200 (481)
                      +|++++|+++. +| .+.++++|++|+|++
T Consensus       182 ~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         182 NLYLSKNHISD-LR-ALAGLKNLDVLELFS  209 (210)
T ss_dssp             EEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred             EEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence            99999999984 55 589999999999874

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.77  E-value=6.5e-19  Score=154.50  Aligned_cols=167  Identities=22%  Similarity=0.337  Sum_probs=90.0

Q ss_pred             CCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeec
Q 039957           14 NLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDL   93 (481)
Q Consensus        14 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L   93 (481)
                      ++..+.++.+.+++..+  ...+.++++|++++|.++ .++. +. .+++|++|++++|++++..|  +.++++|++|++
T Consensus        19 ~~i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~-~l~~-l~-~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l   91 (199)
T d2omxa2          19 EKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SIDG-VE-YLNNLTQINFSNNQLTDITP--LKNLTKLVDILM   91 (199)
T ss_dssp             HHHHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCC-CCTT-GG-GCTTCCEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred             HHHHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCC-Cccc-cc-cCCCcCcCccccccccCccc--ccCCcccccccc
Confidence            33445566666655433  234566666777666665 4432 32 46666666666666664332  666666666666


Q ss_pred             ccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEE
Q 039957           94 GFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFS  173 (481)
Q Consensus        94 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~  173 (481)
                      ++|.+... + .+++++.|+.|++++|.+....          .+..+++|+.|++++|++.. + +.+..+ ++++.|+
T Consensus        92 ~~n~~~~~-~-~l~~l~~L~~L~l~~~~~~~~~----------~~~~l~~L~~L~l~~n~l~~-~-~~l~~~-~~L~~L~  156 (199)
T d2omxa2          92 NNNQIADI-T-PLANLTNLTGLTLFNNQITDID----------PLKNLTNLNRLELSSNTISD-I-SALSGL-TSLQQLN  156 (199)
T ss_dssp             CSSCCCCC-G-GGTTCTTCSEEECCSSCCCCCG----------GGTTCTTCSEEECCSSCCCC-C-GGGTTC-TTCSEEE
T ss_pred             cccccccc-c-cccccccccccccccccccccc----------ccchhhhhHHhhhhhhhhcc-c-cccccc-ccccccc
Confidence            66666532 2 2666666666666666655431          23445556666666665542 1 223332 3455555


Q ss_pred             ccCCceeecCCcccccCCCCCeEecccccce
Q 039957          174 ASECKLKGTIPKEIGHLRGLIYLSLGFNDLN  204 (481)
Q Consensus       174 l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~  204 (481)
                      +++|++++. + .++++++|++|++++|+++
T Consensus       157 l~~n~l~~l-~-~l~~l~~L~~L~ls~N~i~  185 (199)
T d2omxa2         157 FSSNQVTDL-K-PLANLTTLERLDISSNKVS  185 (199)
T ss_dssp             CCSSCCCCC-G-GGTTCTTCCEEECCSSCCC
T ss_pred             cccccccCC-c-cccCCCCCCEEECCCCCCC
Confidence            555555432 1 2445555555555555544

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.76  E-value=4.1e-18  Score=149.35  Aligned_cols=163  Identities=22%  Similarity=0.333  Sum_probs=136.4

Q ss_pred             hCCCCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCc
Q 039957           10 GNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLI   89 (481)
Q Consensus        10 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~   89 (481)
                      ..+.++++|++++|.++.+  +.+..+++|++|++++|++++ +++ +. .+++|++|++++|.+.. ++ .+.++++|+
T Consensus        37 ~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~-~~~-l~-~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~  109 (199)
T d2omxa2          37 TDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTD-ITP-LK-NLTKLVDILMNNNQIAD-IT-PLANLTNLT  109 (199)
T ss_dssp             HHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCC-CGG-GT-TCTTCCEEECCSSCCCC-CG-GGTTCTTCS
T ss_pred             HHhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccC-ccc-cc-CCccccccccccccccc-cc-ccccccccc
Confidence            4578999999999999865  358899999999999999984 554 44 79999999999999874 44 488999999


Q ss_pred             eeecccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCc
Q 039957           90 ILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSL  169 (481)
Q Consensus        90 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L  169 (481)
                      .|++++|.+...  ..+..+++|+.|++++|+++.+          +.+..+++|++|++++|++++.  +.+..+ ++|
T Consensus       110 ~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~----------~~l~~~~~L~~L~l~~n~l~~l--~~l~~l-~~L  174 (199)
T d2omxa2         110 GLTLFNNQITDI--DPLKNLTNLNRLELSSNTISDI----------SALSGLTSLQQLNFSSNQVTDL--KPLANL-TTL  174 (199)
T ss_dssp             EEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC----------GGGTTCTTCSEEECCSSCCCCC--GGGTTC-TTC
T ss_pred             cccccccccccc--cccchhhhhHHhhhhhhhhccc----------ccccccccccccccccccccCC--ccccCC-CCC
Confidence            999999998854  3588999999999999998765          2356788999999999999864  236666 689


Q ss_pred             cEEEccCCceeecCCcccccCCCCCeE
Q 039957          170 QRFSASECKLKGTIPKEIGHLRGLIYL  196 (481)
Q Consensus       170 ~~L~l~~n~l~~~~p~~~~~l~~L~~L  196 (481)
                      ++|++++|+++. +| .++++++|+.|
T Consensus       175 ~~L~ls~N~i~~-i~-~l~~L~~L~~L  199 (199)
T d2omxa2         175 ERLDISSNKVSD-IS-VLAKLTNLESL  199 (199)
T ss_dssp             CEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred             CEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence            999999999985 44 57888888875

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.75  E-value=4.1e-21  Score=190.80  Aligned_cols=331  Identities=19%  Similarity=0.143  Sum_probs=196.8

Q ss_pred             CCCCeeeCcCCcccccC-ChhccCCcCCCEEEeeCCcCcc----ccChhhhcCCCCccEEEccCccceee----cchhcc
Q 039957           13 QNLKSLFLGANNLSGLI-PPMIFNISTIRNLNLGGNRLSG----HLPSMIGHSLPNIKYLELGDNNLIGT----IPNSIT   83 (481)
Q Consensus        13 ~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~   83 (481)
                      .+|++||+++|++++.. .+.+..++++++|+|++|.++-    .++..+. ..++|++|||++|.|+..    +...+.
T Consensus         2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~-~~~~L~~LdLs~N~i~~~~~~~l~~~l~   80 (460)
T d1z7xw1           2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALR-VNPALAELNLRSNELGDVGVHCVLQGLQ   80 (460)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHH-TCTTCCEEECTTCCCHHHHHHHHHHTTC
T ss_pred             CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHh-cCCCCCEEECcCCcCChHHHHHHHHHHh
Confidence            36889999999997532 3446677888999999998862    2344444 688999999999987532    122222


Q ss_pred             -ccccCceeecccCcceec----CcccccCCCCCCEEEcccccCccccCCCcc------------------------c-c
Q 039957           84 -NATKLIILDLGFNTFSGH----IPNTFGNLRHLSVLSLLMNNLTTESSSAYQ------------------------W-S  133 (481)
Q Consensus        84 -~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~------------------------~-~  133 (481)
                       ...+|++|+|++|.++..    ++..+..+++|++|++++|.++......+.                        + .
T Consensus        81 ~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~  160 (460)
T d1z7xw1          81 TPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEP  160 (460)
T ss_dssp             STTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHH
T ss_pred             cCCCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhcc
Confidence             235799999999988743    456778889999999999987542100000                        0 0


Q ss_pred             ccccCCCCCCCcEEEccCCcc-----------------------------ceeC----ChhhhhcccCccEEEccCCcee
Q 039957          134 FLSSLTNCRYLVYLILSGNPL-----------------------------GGIL----PPSIGNFSTSLQRFSASECKLK  180 (481)
Q Consensus       134 ~~~~l~~l~~L~~L~Ls~N~l-----------------------------~~~~----p~~~~~~~~~L~~L~l~~n~l~  180 (481)
                      ....+.....++.++++++.+                             ...-    ...+.. ...++.+++++|.+.
T Consensus       161 ~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~-~~~~~~l~~~~n~~~  239 (460)
T d1z7xw1         161 LASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVAS-KASLRELALGSNKLG  239 (460)
T ss_dssp             HHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHH-CTTCCEEECCSSBCH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccc-cccccccchhhcccc
Confidence            000111223444444444432                             1100    001111 246788888888764


Q ss_pred             e-----cCCcccccCCCCCeEecccccceec----CCcCCcCCCCCCeeecCCCcCCCCCCccc-----cCccCCCeeec
Q 039957          181 G-----TIPKEIGHLRGLIYLSLGFNDLNGT----IPTSIGTLKQLQGFFLPETNLQGYVPHNL-----CHLEMLNLLHL  246 (481)
Q Consensus       181 ~-----~~p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~l~l~~n~l~~~~p~~~-----~~l~~L~~L~L  246 (481)
                      .     ..+........++.+++++|.+...    ....+...+.++.+++++|.+.......+     .....|+.+++
T Consensus       240 ~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l  319 (460)
T d1z7xw1         240 DVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWV  319 (460)
T ss_dssp             HHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEEC
T ss_pred             ccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccccc
Confidence            2     1223334466788888888877532    22234456778888888887753221111     12346788888


Q ss_pred             CCCeeeecCCc----ccccCCCCCcEEcCCCcCccc----CCcchh-ccccCcEEEccCcccCCC----CCCccccCCcC
Q 039957          247 GGNKLSGHIPP----CLASLTSLRELDLGSNKLTSS----IPSSLW-SLGYILEINLSSNLLNDS----LPSNVQKLKVL  313 (481)
Q Consensus       247 ~~N~l~~~~p~----~~~~l~~L~~L~ls~N~l~~~----~p~~~~-~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L  313 (481)
                      ++|.++.....    .+...++|++|+|++|+++..    ++..+. ..+.|++|++++|.+++.    ++..+...++|
T Consensus       320 ~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L  399 (460)
T d1z7xw1         320 KSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSL  399 (460)
T ss_dssp             TTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCC
T ss_pred             cccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCC
Confidence            88877643222    334556788888888887642    222222 345688888888888642    33345566788


Q ss_pred             cEEEccCCeeeeecccccc-----ccCChhhhhcccc
Q 039957          314 RVLDLSRNQLSGDIPSTIG-----ALVDLETISLAGS  345 (481)
Q Consensus       314 ~~L~l~~N~l~~~~p~~~~-----~l~~L~~l~~~g~  345 (481)
                      ++||+++|+++......+.     +...|+.+++.+.
T Consensus       400 ~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~  436 (460)
T d1z7xw1         400 RELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDI  436 (460)
T ss_dssp             CEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTC
T ss_pred             CEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCC
Confidence            8888888888643322221     2235666665543

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.72  E-value=2.6e-18  Score=149.53  Aligned_cols=127  Identities=16%  Similarity=0.179  Sum_probs=93.0

Q ss_pred             hccccccceeeeeccCCcceEEEEEeccchh------------------hhhhhhHHHHHhhhhccCccceeecccCCC-
Q 039957          341 SLAGSFGSVYKGTISDGTDVAIKIFNLQRER------------------AFRSFNSECEVLRNVRHQNLIKILSSCSTP-  401 (481)
Q Consensus       341 ~~~g~~g~vy~~~l~~g~~vavK~l~~~~~~------------------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-  401 (481)
                      .++|+||.||+|...+|..||||.+......                  .......|...+.++.|.+++..+++.... 
T Consensus         8 IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~~~~l   87 (191)
T d1zara2           8 MGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEGNAV   87 (191)
T ss_dssp             EEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEETTEE
T ss_pred             eeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEecCCEE
Confidence            4789999999999888999999987532110                  012234577788888999988876553221 


Q ss_pred             CcccccCCChhHHhhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCCcEEEccccCcccCC
Q 039957          402 DFKFMPNGSLEKRLYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENMVAHVSDFGISKLLG  480 (481)
Q Consensus       402 ~~~~~~~g~l~~~l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~~~  480 (481)
                      -++|++++...+.        +.....+++.++++|++|||    ..+|+||||||+|||++++ .+++.|||+|+...
T Consensus        88 vme~~~~~~~~~l--------~~~~~~~i~~ql~~~l~~lH----~~giiHrDiKP~NILv~~~-~~~liDFG~a~~~~  153 (191)
T d1zara2          88 LMELIDAKELYRV--------RVENPDEVLDMILEEVAKFY----HRGIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVG  153 (191)
T ss_dssp             EEECCCCEEGGGC--------CCSCHHHHHHHHHHHHHHHH----HTTEECSCCSTTSEEEETT-EEEECCCTTCEETT
T ss_pred             EEEeeccccccch--------hhHHHHHHHHHHHHHHHHHh----hCCEEEccCChhheeeeCC-CEEEEECCCcccCC
Confidence            2567776554332        12234568999999999999    5789999999999999865 48999999997653

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.70  E-value=1.1e-19  Score=180.30  Aligned_cols=306  Identities=23%  Similarity=0.212  Sum_probs=206.2

Q ss_pred             cCCCEEEeeCCcCccccChhhhcCCCCccEEEccCcccee----ecchhccccccCceeecccCcceec----Cccccc-
Q 039957           37 STIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIG----TIPNSITNATKLIILDLGFNTFSGH----IPNTFG-  107 (481)
Q Consensus        37 ~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~-  107 (481)
                      .+|+.||+++|+++..--..+...++++++|+|++|.++.    .+...+..+++|++|||++|.|+..    +...+. 
T Consensus         2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~   81 (460)
T d1z7xw1           2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT   81 (460)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred             CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence            3689999999999853222333368999999999999873    3455678899999999999998632    223333 


Q ss_pred             CCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccceeCChhhh------------------------
Q 039957          108 NLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIG------------------------  163 (481)
Q Consensus       108 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~------------------------  163 (481)
                      ...+|++|+|++|+++.....    .+...+..+++|++|+|++|.++......+.                        
T Consensus        82 ~~~~L~~L~L~~n~it~~~~~----~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~  157 (460)
T d1z7xw1          82 PSCKIQKLSLQNCCLTGAGCG----VLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAAS  157 (460)
T ss_dssp             TTCCCCEEECTTSCCBGGGHH----HHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGG
T ss_pred             CCCCCCEEECCCCCccccccc----cccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhh
Confidence            235899999999999764211    1234577889999999999987532110000                        


Q ss_pred             --------hcccCccEEEccCCceeec---------------------------------CCcccccCCCCCeEeccccc
Q 039957          164 --------NFSTSLQRFSASECKLKGT---------------------------------IPKEIGHLRGLIYLSLGFND  202 (481)
Q Consensus       164 --------~~~~~L~~L~l~~n~l~~~---------------------------------~p~~~~~l~~L~~L~l~~N~  202 (481)
                              .....++.++++.+.....                                 ....+.....++.++++.|.
T Consensus       158 ~~~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~  237 (460)
T d1z7xw1         158 CEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNK  237 (460)
T ss_dssp             HHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSB
T ss_pred             hcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhcc
Confidence                    0012455555555443210                                 00112345678888888887


Q ss_pred             cee-----cCCcCCcCCCCCCeeecCCCcCCCCC----CccccCccCCCeeecCCCeeeecCCccc-----ccCCCCCcE
Q 039957          203 LNG-----TIPTSIGTLKQLQGFFLPETNLQGYV----PHNLCHLEMLNLLHLGGNKLSGHIPPCL-----ASLTSLREL  268 (481)
Q Consensus       203 l~~-----~~p~~~~~l~~L~~l~l~~n~l~~~~----p~~~~~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L  268 (481)
                      +..     ..+........++.+++++|.+....    ...+...+.++.+++++|.++......+     .....|+.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l  317 (460)
T d1z7xw1         238 LGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESL  317 (460)
T ss_dssp             CHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEE
T ss_pred             ccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccc
Confidence            542     22334455678999999999886432    2334567889999999999864222221     234689999


Q ss_pred             EcCCCcCcccCCcch----hccccCcEEEccCcccCCC----CCCccc-cCCcCcEEEccCCeeeee----ccccccccC
Q 039957          269 DLGSNKLTSSIPSSL----WSLGYILEINLSSNLLNDS----LPSNVQ-KLKVLRVLDLSRNQLSGD----IPSTIGALV  335 (481)
Q Consensus       269 ~ls~N~l~~~~p~~~----~~l~~L~~L~l~~N~l~~~----~p~~~~-~l~~L~~L~l~~N~l~~~----~p~~~~~l~  335 (481)
                      ++++|.++......+    .....|++|++++|.+.+.    ++..+. ..+.|++|++++|+|+..    ++..+..++
T Consensus       318 ~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~  397 (460)
T d1z7xw1         318 WVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANH  397 (460)
T ss_dssp             ECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCC
T ss_pred             cccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCC
Confidence            999999875533333    4456899999999998642    222232 356799999999999743    445567789


Q ss_pred             Chhhhhccccc
Q 039957          336 DLETISLAGSF  346 (481)
Q Consensus       336 ~L~~l~~~g~~  346 (481)
                      +|++|+++++.
T Consensus       398 ~L~~L~Ls~N~  408 (460)
T d1z7xw1         398 SLRELDLSNNC  408 (460)
T ss_dssp             CCCEEECCSSS
T ss_pred             CCCEEECCCCc
Confidence            99999998764

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.65  E-value=4.5e-17  Score=156.60  Aligned_cols=136  Identities=21%  Similarity=0.259  Sum_probs=98.9

Q ss_pred             hhccccccceeeeec-cCCcceEEEEEeccchhhhhhhhHHHHHhhhhc-----------cCccceeecccCCCC-----
Q 039957          340 ISLAGSFGSVYKGTI-SDGTDVAIKIFNLQRERAFRSFNSECEVLRNVR-----------HQNLIKILSSCSTPD-----  402 (481)
Q Consensus       340 l~~~g~~g~vy~~~l-~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~~~~-----  402 (481)
                      .-|.|+||.||+|+. .+|..||||+++... ...+.+.+|++++++++           |+||+++++++....     
T Consensus        20 ~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~   98 (362)
T d1q8ya_          20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVH   98 (362)
T ss_dssp             EEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEE
T ss_pred             EEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecccccee
Confidence            347899999999985 579999999987543 22345677888887775           467888887765432     


Q ss_pred             --cccccCCCh-hHH-hhcCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCCeeeCCCC------cEEEcc
Q 039957          403 --FKFMPNGSL-EKR-LYSHNYFLDILERLNIMIDVGSTLEYLHHGHSSAPIIHCDLKPTSILLDENM------VAHVSD  472 (481)
Q Consensus       403 --~~~~~~g~l-~~~-l~~~~~~~~~~~~~~i~~~ia~~l~~lH~~~~~~~i~H~dlk~~nill~~~~------~~kl~D  472 (481)
                        +.++..+.. ... ........+......++.+|++|++|||+   ..+|+||||||+|||++.++      .+|++|
T Consensus        99 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~---~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~d  175 (362)
T d1q8ya_          99 VVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSPENLIQIKIAD  175 (362)
T ss_dssp             EEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETTTTEEEEEECC
T ss_pred             eeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh---hcCcccccCChhHeeeeccCcccccceeeEee
Confidence              122222222 221 22234456777888999999999999995   36899999999999998654      499999


Q ss_pred             ccCcccC
Q 039957          473 FGISKLL  479 (481)
Q Consensus       473 fgl~~~~  479 (481)
                      ||.|+..
T Consensus       176 fg~s~~~  182 (362)
T d1q8ya_         176 LGNACWY  182 (362)
T ss_dssp             CTTCEET
T ss_pred             ccccccc
Confidence            9998754

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.65  E-value=2.4e-16  Score=126.15  Aligned_cols=104  Identities=26%  Similarity=0.332  Sum_probs=73.3

Q ss_pred             CeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeeccc
Q 039957           16 KSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGF   95 (481)
Q Consensus        16 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~   95 (481)
                      |+|||++|+++.. + .+..+++|++|++++|+|+ .+|+.+. .+++|++|++++|+|+. +| .+..+++|++|++++
T Consensus         1 R~L~Ls~n~l~~l-~-~l~~l~~L~~L~ls~N~l~-~lp~~~~-~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~   74 (124)
T d1dcea3           1 RVLHLAHKDLTVL-C-HLEQLLLVTHLDLSHNRLR-ALPPALA-ALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCN   74 (124)
T ss_dssp             SEEECTTSCCSSC-C-CGGGGTTCCEEECCSSCCC-CCCGGGG-GCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCS
T ss_pred             CEEEcCCCCCCCC-c-ccccCCCCCEEECCCCccC-cchhhhh-hhhcccccccccccccc-cC-ccccccccCeEECCC
Confidence            5678888888744 3 3777788888888888887 6776665 57788888888887764 33 367777777777777


Q ss_pred             CcceecC-cccccCCCCCCEEEcccccCccc
Q 039957           96 NTFSGHI-PNTFGNLRHLSVLSLLMNNLTTE  125 (481)
Q Consensus        96 N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~  125 (481)
                      |+++... ...++.+++|++|++++|.++..
T Consensus        75 N~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~  105 (124)
T d1dcea3          75 NRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE  105 (124)
T ss_dssp             SCCCSSSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred             CccCCCCCchhhcCCCCCCEEECCCCcCCcC
Confidence            7777543 24566777777777777776654

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.65  E-value=7.9e-17  Score=135.60  Aligned_cols=112  Identities=17%  Similarity=0.172  Sum_probs=54.7

Q ss_pred             hhCCCCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccC
Q 039957            9 IGNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKL   88 (481)
Q Consensus         9 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L   88 (481)
                      |.+..++++|||++|+|+.+ |..+..+++|++|+|++|+|+ .++. + ..+++|++|++++|+++...+..+..+++|
T Consensus        14 ~~n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~-~l~~-~-~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L   89 (162)
T d1a9na_          14 YTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIR-KLDG-F-PLLRRLKTLLVNNNRICRIGEGLDQALPDL   89 (162)
T ss_dssp             EECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCC-EECC-C-CCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred             ccCcCcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCC-ccCC-c-ccCcchhhhhcccccccCCCcccccccccc
Confidence            44445555555555555543 344445555555555555554 3332 2 245555555555555554444444445555


Q ss_pred             ceeecccCcceecCc-ccccCCCCCCEEEcccccCcc
Q 039957           89 IILDLGFNTFSGHIP-NTFGNLRHLSVLSLLMNNLTT  124 (481)
Q Consensus        89 ~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~  124 (481)
                      +.|++++|+++.... ..+..+++|++|++++|.++.
T Consensus        90 ~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~  126 (162)
T d1a9na_          90 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTN  126 (162)
T ss_dssp             CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGG
T ss_pred             ccceeccccccccccccccccccccchhhcCCCcccc
Confidence            555555555543211 234445555555555554443

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.63  E-value=6.1e-17  Score=149.94  Aligned_cols=222  Identities=18%  Similarity=0.159  Sum_probs=140.1

Q ss_pred             CeeeCcCCcccccCChhccCCc--CCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceee-cchhccccccCceee
Q 039957           16 KSLFLGANNLSGLIPPMIFNIS--TIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGT-IPNSITNATKLIILD   92 (481)
Q Consensus        16 ~~L~L~~N~l~~~~p~~~~~l~--~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~   92 (481)
                      ++|||+++.+.   |+.+..+.  .+..+.++...+...+.. .+ ...+|++||++++.++.. ++..+..+++|++|+
T Consensus         3 ~~lDLs~~~l~---~~~l~~l~~~~~~~lrl~~~~~~~~~~~-~~-~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~   77 (284)
T d2astb2           3 QTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HF-SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLS   77 (284)
T ss_dssp             SEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CC-CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEE
T ss_pred             CEEECCCCCCC---chHHHHHHhccceEeeccccccccchhh-hc-cCCCCCEEECCCCccCHHHHHHHHHhCCCccccc
Confidence            57899988874   33333222  345666666655422222 22 467899999999987644 345578899999999


Q ss_pred             cccCcceecCcccccCCCCCCEEEcccc-cCccccCCCccccccccCCCCCCCcEEEccCC-cccee-CChhhhhcccCc
Q 039957           93 LGFNTFSGHIPNTFGNLRHLSVLSLLMN-NLTTESSSAYQWSFLSSLTNCRYLVYLILSGN-PLGGI-LPPSIGNFSTSL  169 (481)
Q Consensus        93 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N-~l~~~-~p~~~~~~~~~L  169 (481)
                      |+++.++...+..++.+++|++|+++++ .++...   .    ..-..++++|++|+++++ .++.. ++..+....+.|
T Consensus        78 L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~---l----~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L  150 (284)
T d2astb2          78 LEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFA---L----QTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETI  150 (284)
T ss_dssp             CTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHH---H----HHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTC
T ss_pred             ccccCCCcHHHHHHhcCCCCcCccccccccccccc---c----chhhHHHHhccccccccccccccccchhhhccccccc
Confidence            9999988888888999999999999884 454210   0    011235678999999886 34321 222333444578


Q ss_pred             cEEEccCCc--eee-cCCcccccCCCCCeEecccc-cceecCCcCCcCCCCCCeeecCCC-cCCCCCCccccCccCCCee
Q 039957          170 QRFSASECK--LKG-TIPKEIGHLRGLIYLSLGFN-DLNGTIPTSIGTLKQLQGFFLPET-NLQGYVPHNLCHLEMLNLL  244 (481)
Q Consensus       170 ~~L~l~~n~--l~~-~~p~~~~~l~~L~~L~l~~N-~l~~~~p~~~~~l~~L~~l~l~~n-~l~~~~p~~~~~l~~L~~L  244 (481)
                      +.|+++++.  ++. .+...+.++++|++|++++| .+++.....+..+++|++|+++++ .++......+..+++|+.|
T Consensus       151 ~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L  230 (284)
T d2astb2         151 TQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTL  230 (284)
T ss_dssp             CEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEE
T ss_pred             chhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEE
Confidence            888888653  321 12233455777888888775 355555555666667777777663 4544444445555666666


Q ss_pred             ecCCC
Q 039957          245 HLGGN  249 (481)
Q Consensus       245 ~L~~N  249 (481)
                      +++++
T Consensus       231 ~l~~~  235 (284)
T d2astb2         231 QVFGI  235 (284)
T ss_dssp             ECTTS
T ss_pred             eeeCC
Confidence            66554

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.62  E-value=3.5e-16  Score=131.56  Aligned_cols=115  Identities=20%  Similarity=0.220  Sum_probs=95.7

Q ss_pred             hhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeecccCcceecCcccccCCC
Q 039957           31 PMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLR  110 (481)
Q Consensus        31 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  110 (481)
                      ..|.+..++++|+|++|+|+ .+|... ..+++|++|+|++|+|+.. + .|..+++|++|++++|+++.+.+..+..++
T Consensus        12 ~~~~n~~~lr~L~L~~n~I~-~i~~~~-~~l~~L~~L~Ls~N~i~~l-~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~   87 (162)
T d1a9na_          12 AQYTNAVRDRELDLRGYKIP-VIENLG-ATLDQFDAIDFSDNEIRKL-D-GFPLLRRLKTLLVNNNRICRIGEGLDQALP   87 (162)
T ss_dssp             CEEECTTSCEEEECTTSCCC-SCCCGG-GGTTCCSEEECCSSCCCEE-C-CCCCCSSCCEEECCSSCCCEECSCHHHHCT
T ss_pred             HhccCcCcCcEEECCCCCCC-ccCccc-cccccCCEEECCCCCCCcc-C-CcccCcchhhhhcccccccCCCcccccccc
Confidence            34778889999999999998 677644 4789999999999999854 3 488999999999999999987777788999


Q ss_pred             CCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccce
Q 039957          111 HLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGG  156 (481)
Q Consensus       111 ~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~  156 (481)
                      +|++|++++|+++.++..       ..+..+++|++|++++|.++.
T Consensus        88 ~L~~L~L~~N~i~~~~~l-------~~l~~l~~L~~L~l~~N~i~~  126 (162)
T d1a9na_          88 DLTELILTNNSLVELGDL-------DPLASLKSLTYLCILRNPVTN  126 (162)
T ss_dssp             TCCEEECCSCCCCCGGGG-------GGGGGCTTCCEEECCSSGGGG
T ss_pred             ccccceeccccccccccc-------cccccccccchhhcCCCcccc
Confidence            999999999999876321       335677888888898888863

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.62  E-value=1.2e-15  Score=122.03  Aligned_cols=104  Identities=29%  Similarity=0.361  Sum_probs=84.5

Q ss_pred             CEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeecccCcceecCcccccCCCCCCEEEccc
Q 039957           40 RNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLM  119 (481)
Q Consensus        40 ~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  119 (481)
                      |+|+|++|+++ .++. +. .+++|++|++++|+|+ .+|..|..+++|++|++++|.|+.. | .|+.+++|++|++++
T Consensus         1 R~L~Ls~n~l~-~l~~-l~-~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~   74 (124)
T d1dcea3           1 RVLHLAHKDLT-VLCH-LE-QLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCN   74 (124)
T ss_dssp             SEEECTTSCCS-SCCC-GG-GGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCS
T ss_pred             CEEEcCCCCCC-CCcc-cc-cCCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-C-ccccccccCeEECCC
Confidence            57899999998 6664 44 6899999999999997 5677788999999999999999854 4 488999999999999


Q ss_pred             ccCccccCCCccccccccCCCCCCCcEEEccCCccce
Q 039957          120 NNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGG  156 (481)
Q Consensus       120 N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~  156 (481)
                      |+++.++..       ..+..+++|++|++++|+++.
T Consensus        75 N~i~~~~~~-------~~l~~~~~L~~L~l~~N~i~~  104 (124)
T d1dcea3          75 NRLQQSAAI-------QPLVSCPRLVLLNLQGNSLCQ  104 (124)
T ss_dssp             SCCCSSSTT-------GGGGGCTTCCEEECTTSGGGG
T ss_pred             CccCCCCCc-------hhhcCCCCCCEEECCCCcCCc
Confidence            998876432       235677888899999988874

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.55  E-value=1.3e-15  Score=140.91  Aligned_cols=235  Identities=17%  Similarity=0.165  Sum_probs=156.9

Q ss_pred             CCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeec
Q 039957           14 NLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDL   93 (481)
Q Consensus        14 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L   93 (481)
                      .+..+.++...+..... ......+|++||+++|.++......++..+++|++|+|++|.++...+..+..+++|++|++
T Consensus        24 ~~~~lrl~~~~~~~~~~-~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L  102 (284)
T d2astb2          24 GVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNL  102 (284)
T ss_dssp             TCSEEECTTCEECSCCC-SCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEEC
T ss_pred             cceEeeccccccccchh-hhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccc
Confidence            35566676666654333 33456689999999998875544445557899999999999988777888889999999999


Q ss_pred             ccC-cceec-CcccccCCCCCCEEEcccc-cCccccCCCccccccccC-CCCCCCcEEEccCCc--cceeCChhhhhccc
Q 039957           94 GFN-TFSGH-IPNTFGNLRHLSVLSLLMN-NLTTESSSAYQWSFLSSL-TNCRYLVYLILSGNP--LGGILPPSIGNFST  167 (481)
Q Consensus        94 s~N-~l~~~-~p~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~~~~~~l-~~l~~L~~L~Ls~N~--l~~~~p~~~~~~~~  167 (481)
                      +++ .++.. +...+.++++|++|+++++ .++...   .    ...+ ...+.|+.|+++++.  ++...-..+....+
T Consensus       103 s~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~---~----~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~  175 (284)
T d2astb2         103 SGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKH---V----QVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCP  175 (284)
T ss_dssp             TTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHH---H----HHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCT
T ss_pred             cccccccccccchhhHHHHhcccccccccccccccc---c----hhhhcccccccchhhhcccccccccccccccccccc
Confidence            985 55522 2233567899999999885 343210   0    0111 124679999998753  33221122222236


Q ss_pred             CccEEEccCC-ceeecCCcccccCCCCCeEeccc-ccceecCCcCCcCCCCCCeeecCCCcCCCCCCccccCc-cCCCee
Q 039957          168 SLQRFSASEC-KLKGTIPKEIGHLRGLIYLSLGF-NDLNGTIPTSIGTLKQLQGFFLPETNLQGYVPHNLCHL-EMLNLL  244 (481)
Q Consensus       168 ~L~~L~l~~n-~l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l-~~L~~L  244 (481)
                      +|++|++++| .++......+..+++|++|++++ +.++......++.+++|+.|+++++ +.   ...+..+ ..+..|
T Consensus       176 ~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~---d~~l~~l~~~lp~L  251 (284)
T d2astb2         176 NLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VP---DGTLQLLKEALPHL  251 (284)
T ss_dssp             TCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SC---TTCHHHHHHHSTTS
T ss_pred             cccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC-CC---HHHHHHHHHhCccc
Confidence            8999999986 47766777888999999999999 4677666667888999999999876 22   1222211 223445


Q ss_pred             ecCCCeeeecCCcccc
Q 039957          245 HLGGNKLSGHIPPCLA  260 (481)
Q Consensus       245 ~L~~N~l~~~~p~~~~  260 (481)
                      ++..+.++...++.++
T Consensus       252 ~i~~~~ls~~~~~~~~  267 (284)
T d2astb2         252 QINCSHFTTIARPTIG  267 (284)
T ss_dssp             EESCCCSCCTTCSSCS
T ss_pred             cccCccCCCCCCCccC
Confidence            5566666655555544

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.53  E-value=5.2e-16  Score=147.93  Aligned_cols=195  Identities=16%  Similarity=0.151  Sum_probs=111.0

Q ss_pred             ccccccCceeecccCcceec----CcccccCCCCCCEEEcccccCccccCCCcc-----ccccccCCCCCCCcEEEccCC
Q 039957           82 ITNATKLIILDLGFNTFSGH----IPNTFGNLRHLSVLSLLMNNLTTESSSAYQ-----WSFLSSLTNCRYLVYLILSGN  152 (481)
Q Consensus        82 ~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~-----~~~~~~l~~l~~L~~L~Ls~N  152 (481)
                      +..+++|+.|+|++|.++..    +...+...++|++|++++|.+.......+.     ..........+.|+.+++++|
T Consensus        89 l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n  168 (344)
T d2ca6a1          89 LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRN  168 (344)
T ss_dssp             HTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSS
T ss_pred             HhhCCCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccc
Confidence            33455566666666655432    223344556666666666655321100000     000001123455677777777


Q ss_pred             ccceeCCh----hhhhcccCccEEEccCCceeec-----CCcccccCCCCCeEecccccceec----CCcCCcCCCCCCe
Q 039957          153 PLGGILPP----SIGNFSTSLQRFSASECKLKGT-----IPKEIGHLRGLIYLSLGFNDLNGT----IPTSIGTLKQLQG  219 (481)
Q Consensus       153 ~l~~~~p~----~~~~~~~~L~~L~l~~n~l~~~-----~p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~  219 (481)
                      +++.....    .+... ..++.|++++|.+...     +...+..+++|+.|++++|.++..    +...+..+++|+.
T Consensus       169 ~i~~~~~~~l~~~l~~~-~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~  247 (344)
T d2ca6a1         169 RLENGSMKEWAKTFQSH-RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRE  247 (344)
T ss_dssp             CCTGGGHHHHHHHHHHC-TTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCE
T ss_pred             cccccccccccchhhhh-hhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchh
Confidence            66432111    12222 4677777777776521     233456677888888888877532    3345667788888


Q ss_pred             eecCCCcCCCCCCccc----c--CccCCCeeecCCCeeeec----CCcccc-cCCCCCcEEcCCCcCcc
Q 039957          220 FFLPETNLQGYVPHNL----C--HLEMLNLLHLGGNKLSGH----IPPCLA-SLTSLRELDLGSNKLTS  277 (481)
Q Consensus       220 l~l~~n~l~~~~p~~~----~--~l~~L~~L~L~~N~l~~~----~p~~~~-~l~~L~~L~ls~N~l~~  277 (481)
                      |++++|.+.......+    .  ....|+.|++++|+++..    +...+. .+++|++|++++|.+..
T Consensus       248 L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~  316 (344)
T d2ca6a1         248 LGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE  316 (344)
T ss_dssp             EECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred             hhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence            8888888765322222    2  235689999999988642    223332 56789999999999964

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.50  E-value=3e-16  Score=136.70  Aligned_cols=115  Identities=25%  Similarity=0.341  Sum_probs=64.1

Q ss_pred             ChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeecchhccccccCceeecccCcceecCcccccCC
Q 039957           30 PPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNL  109 (481)
Q Consensus        30 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  109 (481)
                      |.++..+++|++|+|++|+|+ .++. +. .+++|++|+|++|+++ .+|..+..+++|++|++++|.++.+  +.+..+
T Consensus        41 ~~sl~~L~~L~~L~Ls~n~I~-~i~~-l~-~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l  114 (198)
T d1m9la_          41 DATLSTLKACKHLALSTNNIE-KISS-LS-GMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKL  114 (198)
T ss_dssp             HHHHHHTTTCCEEECSEEEES-CCCC-HH-HHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHHH
T ss_pred             hhHHhcccccceeECcccCCC-Cccc-cc-CCccccChhhcccccc-ccccccccccccccccccccccccc--cccccc
Confidence            445666666666666666665 4442 32 4566666666666654 3444444455566666666666543  235556


Q ss_pred             CCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCcccee
Q 039957          110 RHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLGGI  157 (481)
Q Consensus       110 ~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~  157 (481)
                      ++|++|++++|+++.++.       ...+..+++|++|+|++|++...
T Consensus       115 ~~L~~L~L~~N~i~~~~~-------~~~l~~l~~L~~L~L~~N~l~~~  155 (198)
T d1m9la_         115 VNLRVLYMSNNKITNWGE-------IDKLAALDKLEDLLLAGNPLYND  155 (198)
T ss_dssp             HHSSEEEESEEECCCHHH-------HHHHTTTTTCSEEEECSSHHHHH
T ss_pred             ccccccccccchhccccc-------cccccCCCccceeecCCCccccC
Confidence            666666666666654321       12244556666666666665543

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.49  E-value=1.1e-15  Score=145.68  Aligned_cols=249  Identities=19%  Similarity=0.195  Sum_probs=124.7

Q ss_pred             CCCCccEEEccCccceee----cchhccccccCceeecccCcceec----------CcccccCCCCCCEEEcccccCccc
Q 039957           60 SLPNIKYLELGDNNLIGT----IPNSITNATKLIILDLGFNTFSGH----------IPNTFGNLRHLSVLSLLMNNLTTE  125 (481)
Q Consensus        60 ~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----------~p~~~~~l~~L~~L~L~~N~l~~~  125 (481)
                      ....|++|+|++|.+...    +-..+...++|+.|+++++.....          +...+...++|++|+|++|.++..
T Consensus        29 ~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~  108 (344)
T d2ca6a1          29 EDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPT  108 (344)
T ss_dssp             HCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTT
T ss_pred             hCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccccccc
Confidence            467778888888776432    223345567777777776543211          122344556677777777666543


Q ss_pred             cCCCccccccccCCCCCCCcEEEccCCccceeCChhhhhcccCccEEEccCCceeecCCcccccCCCCCeEeccccccee
Q 039957          126 SSSAYQWSFLSSLTNCRYLVYLILSGNPLGGILPPSIGNFSTSLQRFSASECKLKGTIPKEIGHLRGLIYLSLGFNDLNG  205 (481)
Q Consensus       126 ~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~  205 (481)
                      ....    +...+...++|+.|++++|.++..-...+...   +..+         .........+.|+.+++++|.+..
T Consensus       109 ~~~~----l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~---l~~~---------~~~~~~~~~~~L~~l~l~~n~i~~  172 (344)
T d2ca6a1         109 AQEP----LIDFLSKHTPLEHLYLHNNGLGPQAGAKIARA---LQEL---------AVNKKAKNAPPLRSIICGRNRLEN  172 (344)
T ss_dssp             THHH----HHHHHHHCTTCCEEECCSSCCHHHHHHHHHHH---HHHH---------HHHHHHHTCCCCCEEECCSSCCTG
T ss_pred             cccc----hhhhhcccccchheeccccccccccccccccc---cccc---------ccccccccCcccceeecccccccc
Confidence            1111    11223345566666666666542111111100   0000         000011123345555555554431


Q ss_pred             c----CCcCCcCCCCCCeeecCCCcCCCC-----CCccccCccCCCeeecCCCeeeec----CCcccccCCCCCcEEcCC
Q 039957          206 T----IPTSIGTLKQLQGFFLPETNLQGY-----VPHNLCHLEMLNLLHLGGNKLSGH----IPPCLASLTSLRELDLGS  272 (481)
Q Consensus       206 ~----~p~~~~~l~~L~~l~l~~n~l~~~-----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~ls~  272 (481)
                      .    +...+...+.|+.+++++|.++..     +...+...+.|+.|++++|.++..    +...+..+++|++|++++
T Consensus       173 ~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~  252 (344)
T d2ca6a1         173 GSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLND  252 (344)
T ss_dssp             GGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTT
T ss_pred             cccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhc
Confidence            1    112223344555555555554421     223345556677777777766422    234456667777777777


Q ss_pred             CcCcccCCcch----h--ccccCcEEEccCcccCCC----CCCcc-ccCCcCcEEEccCCeee
Q 039957          273 NKLTSSIPSSL----W--SLGYILEINLSSNLLNDS----LPSNV-QKLKVLRVLDLSRNQLS  324 (481)
Q Consensus       273 N~l~~~~p~~~----~--~l~~L~~L~l~~N~l~~~----~p~~~-~~l~~L~~L~l~~N~l~  324 (481)
                      |.+++.-...+    .  ....|++|++++|.+...    +...+ .+.+.|+.|++++|++.
T Consensus       253 n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~  315 (344)
T d2ca6a1         253 CLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS  315 (344)
T ss_dssp             CCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred             CccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence            77754322222    1  124577777777776532    11222 24567888888888886

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.42  E-value=2.8e-15  Score=130.46  Aligned_cols=68  Identities=28%  Similarity=0.332  Sum_probs=36.0

Q ss_pred             cChhhhcCCCCccEEEccCccceeecchhccccccCceeecccCcceecCcccccCCCCCCEEEcccccCcc
Q 039957           53 LPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTT  124 (481)
Q Consensus        53 ~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  124 (481)
                      +|..+. .+++|++|+|++|+|+. ++ .+..+++|++|+|++|.|+. +|..+..+++|++|++++|+++.
T Consensus        40 l~~sl~-~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~~-i~~~~~~~~~L~~L~l~~N~i~~  107 (198)
T d1m9la_          40 MDATLS-TLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIAS  107 (198)
T ss_dssp             CHHHHH-HTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEECS-CSSHHHHHHHCCEEECSEEECCC
T ss_pred             hhhHHh-cccccceeECcccCCCC-cc-cccCCccccChhhccccccc-ccccccccccccccccccccccc
Confidence            344443 46666666666666552 32 35556666666666666552 34434444455555555555544

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.40  E-value=6.9e-13  Score=110.26  Aligned_cols=107  Identities=21%  Similarity=0.150  Sum_probs=65.9

Q ss_pred             CCCEEEeeCCcCccccChhhhcCCCCccEEEccCc-cceeecchhccccccCceeecccCcceecCcccccCCCCCCEEE
Q 039957           38 TIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDN-NLIGTIPNSITNATKLIILDLGFNTFSGHIPNTFGNLRHLSVLS  116 (481)
Q Consensus        38 ~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  116 (481)
                      ..+.++.+++.+. ..|..+. .+++|++|++++| .++.+.+.+|.++++|+.|+|++|+|+.+.|.+|..+++|++|+
T Consensus         9 ~~~~l~c~~~~~~-~~p~~l~-~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~   86 (156)
T d2ifga3           9 GSSGLRCTRDGAL-DSLHHLP-GAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLN   86 (156)
T ss_dssp             SSSCEECCSSCCC-TTTTTSC-SCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEE
T ss_pred             CCCeEEecCCCCc-cCccccc-CccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccccee
Confidence            3445566666665 4555554 4666666666544 36655556666677777777777777766666677777777777


Q ss_pred             cccccCccccCCCccccccccCCCCCCCcEEEccCCccc
Q 039957          117 LLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLG  155 (481)
Q Consensus       117 L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~  155 (481)
                      |++|+|+.++...|        . ...|++|+|++|.+.
T Consensus        87 Ls~N~l~~l~~~~~--------~-~~~l~~L~L~~Np~~  116 (156)
T d2ifga3          87 LSFNALESLSWKTV--------Q-GLSLQELVLSGNPLH  116 (156)
T ss_dssp             CCSSCCSCCCSTTT--------C-SCCCCEEECCSSCCC
T ss_pred             ccCCCCcccChhhh--------c-cccccccccCCCccc
Confidence            77777766654332        1 124666777777664

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.39  E-value=1e-12  Score=109.21  Aligned_cols=111  Identities=19%  Similarity=0.162  Sum_probs=95.1

Q ss_pred             CCCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCc-CccccChhhhcCCCCccEEEccCccceeecchhccccccCce
Q 039957           12 LQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNR-LSGHLPSMIGHSLPNIKYLELGDNNLIGTIPNSITNATKLII   90 (481)
Q Consensus        12 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~   90 (481)
                      ....+.++.+++.+.. .|..+..+++|++|++++|+ ++ .++...+..+++|+.|+|++|+|+.+.|.+|..+++|++
T Consensus         7 c~~~~~l~c~~~~~~~-~p~~l~~l~~l~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~   84 (156)
T d2ifga3           7 PHGSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQ-HLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSR   84 (156)
T ss_dssp             CSSSSCEECCSSCCCT-TTTTSCSCSCCSEEECCSCSSCC-EECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCE
T ss_pred             cCCCCeEEecCCCCcc-CcccccCccccCeeecCCCcccc-ccCchhhccccccCcceeeccccCCcccccccccccccc
Confidence            4456789999999875 57788999999999998764 87 677666668999999999999999888999999999999


Q ss_pred             eecccCcceecCcccccCCCCCCEEEcccccCccc
Q 039957           91 LDLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTE  125 (481)
Q Consensus        91 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  125 (481)
                      |+|++|+|+.+.+..|..+ +|+.|+|++|.+...
T Consensus        85 L~Ls~N~l~~l~~~~~~~~-~l~~L~L~~Np~~C~  118 (156)
T d2ifga3          85 LNLSFNALESLSWKTVQGL-SLQELVLSGNPLHCS  118 (156)
T ss_dssp             EECCSSCCSCCCSTTTCSC-CCCEEECCSSCCCCC
T ss_pred             eeccCCCCcccChhhhccc-cccccccCCCcccCC
Confidence            9999999997767677655 799999999998754

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.58  E-value=2.5e-09  Score=88.90  Aligned_cols=132  Identities=20%  Similarity=0.137  Sum_probs=88.5

Q ss_pred             CCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccChhhhcCCCCccEEEccCccceeec--chhccccccCcee
Q 039957           14 NLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPSMIGHSLPNIKYLELGDNNLIGTI--PNSITNATKLIIL   91 (481)
Q Consensus        14 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L   91 (481)
                      ..+.||++++...    +.+..+..+..++...|... .++. ++..+++|++|+|++|+|+...  +..+..+++|+.|
T Consensus        23 ~~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~-~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L   96 (162)
T d1koha1          23 SQQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRI-IEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKIL   96 (162)
T ss_dssp             SSCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHH-HHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCC
T ss_pred             hhCeeecccCCCC----chhhhccchhhcchhhhHhh-hhHH-HHHhCCCCCEeeCCCccccCCchhHHHHhhCCccccc
Confidence            4567788766532    22445555566666655543 4443 3346899999999999998643  4567889999999


Q ss_pred             ecccCcceecCcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCcc
Q 039957           92 DLGFNTFSGHIPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPL  154 (481)
Q Consensus        92 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l  154 (481)
                      +|++|.|+...+-.+....+|+.|++++|.++........+ ....+..+++|+.||  |..+
T Consensus        97 ~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y-~~~i~~~~P~L~~LD--g~~v  156 (162)
T d1koha1          97 NLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTY-ISAIRERFPKLLRLD--GHEL  156 (162)
T ss_dssp             CCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHH-HHHHHTTSTTCCEET--TEEC
T ss_pred             ccccCccccchhhhhhhccccceeecCCCCcCcCcccchhH-HHHHHHHCCCCCEEC--cCCC
Confidence            99999999765555666678999999999998653221100 001234578888876  5443

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.53  E-value=7.2e-09  Score=86.02  Aligned_cols=105  Identities=25%  Similarity=0.164  Sum_probs=74.9

Q ss_pred             hCCCCCCeeeCcCCcccccCChhccCCcCCCEEEeeCCcCccccCh--hhhcCCCCccEEEccCccceeecchhcccccc
Q 039957           10 GNLQNLKSLFLGANNLSGLIPPMIFNISTIRNLNLGGNRLSGHLPS--MIGHSLPNIKYLELGDNNLIGTIPNSITNATK   87 (481)
Q Consensus        10 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~--~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~   87 (481)
                      ..+..+..++...+.. ..++..+..+++|++|+|++|+|+ .++.  ..+..+++|++|+|++|+|+...+-.+....+
T Consensus        39 ~~~~~~~~l~~~~~~~-~~l~~~~~~~~~L~~L~Ls~N~i~-~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~  116 (162)
T d1koha1          39 VAQNIDVVLNRRSSMA-ATLRIIEENIPELLSLNLSNNRLY-RLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLK  116 (162)
T ss_dssp             TTTTCCCCTTSHHHHH-HHHHHHHHHCTTCCCCCCCSSCCC-CCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCC
T ss_pred             hhccchhhcchhhhHh-hhhHHHHHhCCCCCEeeCCCcccc-CCchhHHHHhhCCcccccccccCccccchhhhhhhccc
Confidence            3344444455554444 344566678999999999999998 4432  22336899999999999998554444555668


Q ss_pred             CceeecccCcceecCcc-------cccCCCCCCEEE
Q 039957           88 LIILDLGFNTFSGHIPN-------TFGNLRHLSVLS  116 (481)
Q Consensus        88 L~~L~Ls~N~l~~~~p~-------~~~~l~~L~~L~  116 (481)
                      |+.|++++|.++.....       .+..+|+|+.||
T Consensus       117 L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD  152 (162)
T d1koha1         117 LEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD  152 (162)
T ss_dssp             CSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred             cceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence            99999999999865443       367899999886

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.89  E-value=3.4e-06  Score=69.67  Aligned_cols=92  Identities=9%  Similarity=0.113  Sum_probs=44.1

Q ss_pred             CCccEEEccCccceee----cchhccccccCceeecccCcceec----CcccccCCCCCCEEEcccccCccccCCCcccc
Q 039957           62 PNIKYLELGDNNLIGT----IPNSITNATKLIILDLGFNTFSGH----IPNTFGNLRHLSVLSLLMNNLTTESSSAYQWS  133 (481)
Q Consensus        62 ~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~  133 (481)
                      ++|++|+|++|.+...    +...+...+.|+.|+|++|.++..    +-.++..-+.|++|++++|.+..+.... ...
T Consensus        44 ~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~-~~~  122 (167)
T d1pgva_          44 KHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQV-EMD  122 (167)
T ss_dssp             SCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHH-HHH
T ss_pred             CccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHH-HHH
Confidence            4455555555544321    112233445566666666655532    2223445566777777666554331110 001


Q ss_pred             ccccCCCCCCCcEEEccCCcc
Q 039957          134 FLSSLTNCRYLVYLILSGNPL  154 (481)
Q Consensus       134 ~~~~l~~l~~L~~L~Ls~N~l  154 (481)
                      +...+...+.|+.|+++.+..
T Consensus       123 l~~~L~~n~sL~~l~l~~~~~  143 (167)
T d1pgva_         123 MMMAIEENESLLRVGISFASM  143 (167)
T ss_dssp             HHHHHHHCSSCCEEECCCCCH
T ss_pred             HHHHHHhCCCccEeeCcCCCc
Confidence            122334456677777766644

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.72  E-value=7e-06  Score=67.76  Aligned_cols=70  Identities=19%  Similarity=0.140  Sum_probs=34.8

Q ss_pred             ccccccCceeecccCcceec----CcccccCCCCCCEEEcccccCccccCCCccccccccCCCCCCCcEEEccCCccc
Q 039957           82 ITNATKLIILDLGFNTFSGH----IPNTFGNLRHLSVLSLLMNNLTTESSSAYQWSFLSSLTNCRYLVYLILSGNPLG  155 (481)
Q Consensus        82 ~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~  155 (481)
                      +...++|+.|+|++|.+...    +...+...+.|++|+|++|.++.....    .+...+...+.|++|++++|.+.
T Consensus        40 L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~----~l~~aL~~n~sL~~L~l~~n~~~  113 (167)
T d1pgva_          40 ACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA----RLLRSTLVTQSIVEFKADNQRQS  113 (167)
T ss_dssp             HTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH----HHHHHTTTTCCCSEEECCCCSSC
T ss_pred             HhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHH----HHHHHHHhCCcCCEEECCCCcCC
Confidence            44445566666666655421    222334455666666666665532111    11233455555666666665443

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.30  E-value=5.4e-05  Score=62.11  Aligned_cols=90  Identities=12%  Similarity=0.064  Sum_probs=41.5

Q ss_pred             CCCccEEEccCccceee----cchhccccccCceeecccCcceec----CcccccCCCCCCEEEcc--cccCccccCCCc
Q 039957           61 LPNIKYLELGDNNLIGT----IPNSITNATKLIILDLGFNTFSGH----IPNTFGNLRHLSVLSLL--MNNLTTESSSAY  130 (481)
Q Consensus        61 l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~--~N~l~~~~~~~~  130 (481)
                      .++|++|++++|.++..    +-..+...++++.+++++|.+...    +...+...++|+.++|+  +|.+.....   
T Consensus        45 n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~---  121 (166)
T d1io0a_          45 NTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVE---  121 (166)
T ss_dssp             CCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHH---
T ss_pred             CCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHH---
Confidence            44555555555554322    112233445555666655555421    22344555666654443  344432100   


Q ss_pred             cccccccCCCCCCCcEEEccCCcc
Q 039957          131 QWSFLSSLTNCRYLVYLILSGNPL  154 (481)
Q Consensus       131 ~~~~~~~l~~l~~L~~L~Ls~N~l  154 (481)
                       ..+...+...+.|+.|+++.+..
T Consensus       122 -~~La~~L~~n~~L~~L~l~~~~~  144 (166)
T d1io0a_         122 -MEIANMLEKNTTLLKFGYHFTQQ  144 (166)
T ss_dssp             -HHHHHHHHHCSSCCEEECCCSSH
T ss_pred             -HHHHHHHHhCCCcCEEeCcCCCC
Confidence             01112334556677777766654

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.06  E-value=5.2e-05  Score=62.23  Aligned_cols=40  Identities=10%  Similarity=0.020  Sum_probs=17.5

Q ss_pred             ccccCceeecccCcceec----CcccccCCCCCCEEEcccccCc
Q 039957           84 NATKLIILDLGFNTFSGH----IPNTFGNLRHLSVLSLLMNNLT  123 (481)
Q Consensus        84 ~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~  123 (481)
                      ..++|+.|++++|.++..    +...+...+.++.+++++|.++
T Consensus        44 ~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~   87 (166)
T d1io0a_          44 TNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS   87 (166)
T ss_dssp             TCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred             cCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcccccc
Confidence            344455555555544321    1222334445555555544443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=96.93  E-value=0.0025  Score=55.80  Aligned_cols=125  Identities=14%  Similarity=0.122  Sum_probs=72.2

Q ss_pred             cceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhhhhc-cCccceeecccCCCC-----cccccCCChhHHhhcCCC
Q 039957          347 GSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVR-HQNLIKILSSCSTPD-----FKFMPNGSLEKRLYSHNY  420 (481)
Q Consensus       347 g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-----~~~~~~g~l~~~l~~~~~  420 (481)
                      ..+|+..- ++..+.+|+...........+.+|.+.+..+. +--+.+++.++...+     ++++++.++.+...... 
T Consensus        28 ~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~~-  105 (263)
T d1j7la_          28 AKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDEQ-  105 (263)
T ss_dssp             SEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTCS-
T ss_pred             CcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccccc-
Confidence            46787653 45567778765444444445677888777664 222345555554443     45666666543322110 


Q ss_pred             ccCHHHHHHHHHHHHHHHHHHhcC-----------------------------------------------------C--
Q 039957          421 FLDILERLNIMIDVGSTLEYLHHG-----------------------------------------------------H--  445 (481)
Q Consensus       421 ~~~~~~~~~i~~~ia~~l~~lH~~-----------------------------------------------------~--  445 (481)
                           .+.+++.++++.++.||..                                                     .  
T Consensus       106 -----~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  180 (263)
T d1j7la_         106 -----SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPE  180 (263)
T ss_dssp             -----CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCC
T ss_pred             -----cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCc
Confidence                 1122334444444444421                                                     0  


Q ss_pred             CCCCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          446 SSAPIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       446 ~~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      ....++|+|+.|.||++++++.+-|.||+.+..
T Consensus       181 ~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         181 EELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             CCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             CCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence            012379999999999999887778999998754

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=96.22  E-value=0.0041  Score=54.06  Aligned_cols=30  Identities=17%  Similarity=0.222  Sum_probs=26.3

Q ss_pred             CeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          449 PIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       449 ~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      .++|+|+.|.||+++++..+-|.||+.+..
T Consensus       176 ~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         176 VVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             EEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             eEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence            379999999999999887788999998754

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=95.00  E-value=0.074  Score=47.71  Aligned_cols=43  Identities=14%  Similarity=0.162  Sum_probs=30.0

Q ss_pred             cceeeeeccCCcceEEEEEeccchhhhhhhhHHHHHhhhhccCc
Q 039957          347 GSVYKGTISDGTDVAIKIFNLQRERAFRSFNSECEVLRNVRHQN  390 (481)
Q Consensus       347 g~vy~~~l~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~n  390 (481)
                      -.||+....+|..+++|....... ..+.+..|.+.+..+....
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~g   78 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDE   78 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTT
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcC
Confidence            469999999999999998765322 2344666777777765433

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=94.19  E-value=0.1  Score=48.18  Aligned_cols=30  Identities=30%  Similarity=0.348  Sum_probs=25.8

Q ss_pred             CCeeeCCCCCCCeeeCCCCcEEEccccCccc
Q 039957          448 APIIHCDLKPTSILLDENMVAHVSDFGISKL  478 (481)
Q Consensus       448 ~~i~H~dlk~~nill~~~~~~kl~Dfgl~~~  478 (481)
                      ..++|+|+.+.|||++++. ++|.||..|..
T Consensus       223 ~~LiHGDl~~gNIlv~~~~-~~vID~E~a~~  252 (392)
T d2pula1         223 ETLIHGDLHTGSIFASEHE-TKVIDPEFAFY  252 (392)
T ss_dssp             CEEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred             cceeccCCcCCceeEcCCc-eEEechhhccc
Confidence            4589999999999998765 89999988754

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=91.22  E-value=0.11  Score=47.93  Aligned_cols=28  Identities=29%  Similarity=0.369  Sum_probs=21.7

Q ss_pred             eeeCCCCCCCeeeC----------------------------CCCcEEEccccCcc
Q 039957          450 IIHCDLKPTSILLD----------------------------ENMVAHVSDFGISK  477 (481)
Q Consensus       450 i~H~dlk~~nill~----------------------------~~~~~kl~Dfgl~~  477 (481)
                      .+|+|+.+.||+++                            ++..+++.||..|.
T Consensus       220 ~CHnDL~~~NiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~lID~EYa~  275 (395)
T d1nw1a_         220 FCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYAS  275 (395)
T ss_dssp             EECSCCCGGGEEEEC------------------------------CCEECCCTTCE
T ss_pred             EEecCCCcccEeeccccccccccccccccccccccccccccCCCCcEEEEeecccC
Confidence            57999999999984                            35678999998764

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=90.73  E-value=0.086  Score=46.93  Aligned_cols=31  Identities=23%  Similarity=0.344  Sum_probs=28.0

Q ss_pred             CCCeeeCCCCCCCeeeCCCCcEEEccccCcc
Q 039957          447 SAPIIHCDLKPTSILLDENMVAHVSDFGISK  477 (481)
Q Consensus       447 ~~~i~H~dlk~~nill~~~~~~kl~Dfgl~~  477 (481)
                      ..++||+|+.+.||+++++...-|-||+.|.
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccccCCcchhhhhcccccceeEecccccc
Confidence            5689999999999999998888899999875